Citrus Sinensis ID: 011660
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 480 | 2.2.26 [Sep-21-2011] | |||||||
| Q9FX99 | 663 | Probable receptor-like pr | no | no | 0.489 | 0.354 | 0.438 | 6e-48 | |
| Q9FE20 | 456 | Serine/threonine-protein | no | no | 0.466 | 0.491 | 0.439 | 4e-45 | |
| Q8RWW0 | 744 | Receptor-like serine/thre | no | no | 0.464 | 0.299 | 0.420 | 3e-44 | |
| Q9ZUE0 | 720 | Proline-rich receptor-lik | no | no | 0.460 | 0.306 | 0.424 | 7e-44 | |
| Q9FFW5 | 681 | Proline-rich receptor-lik | no | no | 0.485 | 0.342 | 0.422 | 2e-43 | |
| Q0WVM4 | 634 | Probable LRR receptor-lik | no | no | 0.447 | 0.339 | 0.438 | 3e-43 | |
| Q8VYY5 | 565 | Receptor-like serine/thre | no | no | 0.489 | 0.415 | 0.406 | 3e-43 | |
| Q9SX31 | 708 | Proline-rich receptor-lik | no | no | 0.564 | 0.382 | 0.399 | 1e-42 | |
| Q9SGY7 | 718 | Putative proline-rich rec | no | no | 0.452 | 0.302 | 0.414 | 2e-42 | |
| Q8H1D6 | 467 | Receptor-like cytosolic s | no | no | 0.472 | 0.486 | 0.408 | 2e-42 |
| >sp|Q9FX99|Y1497_ARATH Probable receptor-like protein kinase At1g49730 OS=Arabidopsis thaliana GN=At1g49730 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 192 bits (487), Expect = 6e-48, Method: Compositional matrix adjust.
Identities = 111/253 (43%), Positives = 161/253 (63%), Gaps = 18/253 (7%)
Query: 213 QETVQVPESIKRKIFEKLAVLEAEGSSRRFTSQELCHLTHNFSPKMLIGQGGNSKVYRTN 272
+ T VP S+ +F K+ ++ + R+F+ +E+ + T++F+ +IGQGG VY+
Sbjct: 291 KSTKSVPSSLP--VF-KIHEDDSSSAFRKFSYKEMTNATNDFN--TVIGQGGFGTVYKAE 345
Query: 273 HVDGQVAAVKVL-KCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-N 330
DG +AAVK + K + +E++ RE+ LL+ + H N+V + G+C +K+ +VY+ + N
Sbjct: 346 FNDGLIAAVKKMNKVSEQAEQDFCREIGLLAKLHHRNLVALKGFCINKKERFLVYDYMKN 405
Query: 331 GSLKQYLKQL-----KWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHH 385
GSLK +L + W RM +AI VA ALEYLH CDPP+ HRD+KSSNILL ENF
Sbjct: 406 GSLKDHLHAIGKPPPSWGTRMKIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENF-V 464
Query: 386 PQLSDFGAAMVHHQSHQVSENVKPVN--VVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLL 443
+LSDFG A H S S +PVN + GT GY+ PEY++ ++ EK DVYSYGVVLL
Sbjct: 465 AKLSDFGLA---HSSRDGSVCFEPVNTDIRGTPGYVDPEYVVTQELTEKSDVYSYGVVLL 521
Query: 444 ELITGKEAIQTNK 456
ELITG+ A+ +
Sbjct: 522 ELITGRRAVDEGR 534
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9FE20|PBS1_ARATH Serine/threonine-protein kinase PBS1 OS=Arabidopsis thaliana GN=PBS1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 182 bits (463), Expect = 4e-45, Method: Compositional matrix adjust.
Identities = 105/239 (43%), Positives = 140/239 (58%), Gaps = 15/239 (6%)
Query: 242 FTSQELCHLTHNFSPKMLIGQGGNSKVYRTN-HVDGQVAAVKVLKCTNW-SEEEVLREVE 299
F +EL T NF P +G+GG +VY+ GQV AVK L E L EV
Sbjct: 74 FAFRELAAATMNFHPDTFLGEGGFGRVYKGRLDSTGQVVAVKQLDRNGLQGNREFLVEVL 133
Query: 300 LLSSIKHENIVRIIGYCHSKEMYAIVYNLLN-GSLKQYL-------KQLKWNERMDVAIG 351
+LS + H N+V +IGYC + +VY + GSL+ +L + L WN RM +A G
Sbjct: 134 MLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNMRMKIAAG 193
Query: 352 VAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVN 411
AK LE+LH +PP+I+RD KSSNILL E F HP+LSDFG A + + + +
Sbjct: 194 AAKGLEFLHDKANPPVIYRDFKSSNILLDEGF-HPKLSDFGLAKLGPTGDKSHVSTR--- 249
Query: 412 VVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRE-SLVLWYYVL 469
V+GT+GY APEY M G++ K DVYS+GVV LELITG++AI + + E +LV W L
Sbjct: 250 VMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSEMPHGEQNLVAWARPL 308
|
Protein kinase required for plant defense mechanism mediated by the disease resistance (R) protein RPS5. In case of infection by Pseudomonas syringae, RPS5 specifically recognizes the avrPphB type III effector avirulence protein and triggers a defense reaction. AvrPphB may trigger RPS5-mediated defense mechanism via the cleavage of PBS1. Both kinase activity and cleavage by avrPphB are independently required to trigger the RPS5-mediated resistance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RWW0|ALE2_ARATH Receptor-like serine/threonine-protein kinase ALE2 OS=Arabidopsis thaliana GN=ALE2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 179 bits (455), Expect = 3e-44, Method: Compositional matrix adjust.
Identities = 98/233 (42%), Positives = 149/233 (63%), Gaps = 10/233 (4%)
Query: 238 SSRRFTSQELCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEE-EVLR 296
S + FT EL T FS K ++G+GG +VY+ + DG AVK+L N + + E +
Sbjct: 333 SVKTFTLSELEKATDRFSAKRVLGEGGFGRVYQGSMEDGTEVAVKLLTRDNQNRDREFIA 392
Query: 297 EVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGSLKQYLKQ--LKWNERMDVAIGVA 353
EVE+LS + H N+V++IG C ++Y L+ NGS++ +L + L W+ R+ +A+G A
Sbjct: 393 EVEMLSRLHHRNLVKLIGICIEGRTRCLIYELVHNGSVESHLHEGTLDWDARLKIALGAA 452
Query: 354 KALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVV 413
+ L YLH +P +IHRD K+SN+LL ++F P++SDFG A ++ + S+++ V+
Sbjct: 453 RGLAYLHEDSNPRVIHRDFKASNVLLEDDFT-PKVSDFGLA---REATEGSQHIS-TRVM 507
Query: 414 GTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQ-TNKANRESLVLW 465
GTFGY+APEY M G + K DVYSYGVVLLEL+TG+ + + + E+LV W
Sbjct: 508 GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRRPVDMSQPSGEENLVTW 560
|
Required during the differentiation of the protoderm into shoots epidermis and cuticle. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUE0|PEK12_ARATH Proline-rich receptor-like protein kinase PERK12 OS=Arabidopsis thaliana GN=PERK12 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 178 bits (452), Expect = 7e-44, Method: Compositional matrix adjust.
Identities = 101/238 (42%), Positives = 150/238 (63%), Gaps = 17/238 (7%)
Query: 242 FTSQELCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKC-TNWSEEEVLREVEL 300
F+ +EL +T F+ K ++G+GG VY+ DG+V AVK LK + + E EVE+
Sbjct: 359 FSYEELAEITQGFARKNILGEGGFGCVYKGTLQDGKVVAVKQLKAGSGQGDREFKAEVEI 418
Query: 301 LSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGSLKQYLKQ-----LKWNERMDVAIGVAK 354
+S + H ++V ++GYC S + ++Y + N +L+ +L L+W++R+ +AIG AK
Sbjct: 419 ISRVHHRHLVSLVGYCISDQHRLLIYEYVSNQTLEHHLHGKGLPVLEWSKRVRIAIGSAK 478
Query: 355 ALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH--QSHQVSENVKPVNV 412
L YLH C P IIHRD+KS+NILL + + Q++DFG A ++ Q+H VS V
Sbjct: 479 GLAYLHEDCHPKIIHRDIKSANILLDDEYEA-QVADFGLARLNDTTQTH-VS-----TRV 531
Query: 413 VGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAI-QTNKANRESLVLWYYVL 469
+GTFGYLAPEY GK+ ++ DV+S+GVVLLEL+TG++ + QT ESLV W L
Sbjct: 532 MGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELVTGRKPVDQTQPLGEESLVEWARPL 589
|
Regulates the auxin-related MAX (More Axillary Growth) pathway during the shoot branching. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FFW5|PERK8_ARATH Proline-rich receptor-like protein kinase PERK8 OS=Arabidopsis thaliana GN=PERK8 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 177 bits (448), Expect = 2e-43, Method: Compositional matrix adjust.
Identities = 103/244 (42%), Positives = 147/244 (60%), Gaps = 11/244 (4%)
Query: 242 FTSQELCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCT-NWSEEEVLREVEL 300
F+ EL +T FS K L+G+GG VY+ DG+ AVK LK + E E EVE+
Sbjct: 327 FSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGEREFKAEVEI 386
Query: 301 LSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGSLKQYLKQ-----LKWNERMDVAIGVAK 354
+S + H ++V ++GYC S++ +VY+ + N +L +L + W R+ VA G A+
Sbjct: 387 ISRVHHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYHLHAPGRPVMTWETRVRVAAGAAR 446
Query: 355 ALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVG 414
+ YLH C P IIHRD+KSSNILL +F ++DFG A + Q ++ +V V+G
Sbjct: 447 GIAYLHEDCHPRIIHRDIKSSNILLDNSFEA-LVADFGLAKIA-QELDLNTHVS-TRVMG 503
Query: 415 TFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA-NRESLVLWYYVLAGKV 473
TFGY+APEY GK+ EK DVYSYGV+LLELITG++ + T++ ESLV W L G+
Sbjct: 504 TFGYMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDESLVEWARPLLGQA 563
Query: 474 FAQQ 477
+
Sbjct: 564 IENE 567
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0WVM4|Y2239_ARATH Probable LRR receptor-like serine/threonine-protein kinase At2g23950 OS=Arabidopsis thaliana GN=At2g23950 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 176 bits (447), Expect = 3e-43, Method: Compositional matrix adjust.
Identities = 100/228 (43%), Positives = 137/228 (60%), Gaps = 13/228 (5%)
Query: 237 GSSRRFTSQELCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWS--EEEV 294
G+ R FT +EL T FS K ++G GG VYR DG V AVK LK N + +
Sbjct: 282 GNLRSFTFRELHVATDGFSSKSILGAGGFGNVYRGKFGDGTVVAVKRLKDVNGTSGNSQF 341
Query: 295 LREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGSLKQYLKQ---LKWNERMDVAI 350
E+E++S H N++R+IGYC S +VY + NGS+ LK L WN R +AI
Sbjct: 342 RTELEMISLAVHRNLLRLIGYCASSSERLLVYPYMSNGSVASRLKAKPALDWNTRKKIAI 401
Query: 351 GVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFG-AAMVHHQSHQVSENVKP 409
G A+ L YLH CDP IIHRDVK++NILL E F + DFG A +++H+ V+ V+
Sbjct: 402 GAARGLFYLHEQCDPKIIHRDVKAANILLDEYF-EAVVGDFGLAKLLNHEDSHVTTAVR- 459
Query: 410 VNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457
GT G++APEY+ G+ EK DV+ +G++LLELITG A++ K+
Sbjct: 460 ----GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKS 503
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8VYY5|NCRK_ARATH Receptor-like serine/threonine-protein kinase NCRK OS=Arabidopsis thaliana GN=NCRK PE=1 SV=1 | Back alignment and function description |
|---|
Score = 176 bits (447), Expect = 3e-43, Method: Compositional matrix adjust.
Identities = 108/266 (40%), Positives = 149/266 (56%), Gaps = 31/266 (11%)
Query: 216 VQVPESIKRKIFEKLAVLEAEGSSRRFTSQELCHLTHNFSPKMLIGQGGNSKVYRTNHVD 275
V PE+I IF+ F+ EL T+ FS +IG GG+S VYR D
Sbjct: 185 VSKPETIHGAIFQ-------------FSYTELEQATNKFSSNSVIGHGGSSCVYRGQLKD 231
Query: 276 GQVAAVKVLKCTNWSEEEVL--REVELLSSIKHENIVRIIGYC------HSKEMYAIVYN 327
G+ AA+K L + + L EVELLS + H ++V +IGYC H++ + Y
Sbjct: 232 GKTAAIKRLNTPKGDDTDTLFSTEVELLSRLHHYHVVPLIGYCSEFHGKHAERLLVFEY- 290
Query: 328 LLNGSLKQYL-----KQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN 382
+ GSL+ L +++ WN R+ VA+G A+ LEYLH P I+HRDVKS+NILL EN
Sbjct: 291 MSYGSLRDCLDGELGEKMTWNIRISVALGAARGLEYLHEAAAPRILHRDVKSTNILLDEN 350
Query: 383 FHHPQLSDFGAAMVHHQSHQVSENVKP-VNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVV 441
+ H +++D G A S + P + GTFGY APEY + G + DV+S+GVV
Sbjct: 351 W-HAKITDLGMAKCLSSDGLQSGSSSPTTGLQGTFGYFAPEYAIAGCASQMSDVFSFGVV 409
Query: 442 LLELITGKEAIQ--TNKANRESLVLW 465
LLELITG++ IQ +N ESLV+W
Sbjct: 410 LLELITGRKPIQKPSNNKGEESLVIW 435
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SX31|PERK9_ARATH Proline-rich receptor-like protein kinase PERK9 OS=Arabidopsis thaliana GN=PERK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 174 bits (441), Expect = 1e-42, Method: Compositional matrix adjust.
Identities = 119/298 (39%), Positives = 168/298 (56%), Gaps = 27/298 (9%)
Query: 184 RQLQKSLTAPS------SSTSSTTRQESDVGVCIAQETVQVPESIKRKIFEKLAVLEAEG 237
R+ +K L+A S S SST R SD Q + V S + ++ + G
Sbjct: 304 RKREKRLSAVSGGDVTPSPMSSTAR--SDSAFFRMQSSAPVGASKRSGSYQSQS--GGLG 359
Query: 238 SSRR-FTSQELCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNW-SEEEVL 295
+S+ F+ +EL T+ FS + L+G+GG VY+ DG+V AVK LK + E
Sbjct: 360 NSKALFSYEELVKATNGFSQENLLGEGGFGCVYKGILPDGRVVAVKQLKIGGGQGDREFK 419
Query: 296 REVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGSLKQYLKQ----LKWNERMDVAI 350
EVE LS I H ++V I+G+C S + ++Y+ + N L +L L W R+ +A
Sbjct: 420 AEVETLSRIHHRHLVSIVGHCISGDRRLLIYDYVSNNDLYFHLHGEKSVLDWATRVKIAA 479
Query: 351 GVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA--MVHHQSHQVSENVK 408
G A+ L YLH C P IIHRD+KSSNILL +NF ++SDFG A + +H +
Sbjct: 480 GAARGLAYLHEDCHPRIIHRDIKSSNILLEDNFDA-RVSDFGLARLALDCNTHITTR--- 535
Query: 409 PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA-NRESLVLW 465
V+GTFGY+APEY GK+ EK DV+S+GVVLLELITG++ + T++ ESLV W
Sbjct: 536 ---VIGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDTSQPLGDESLVEW 590
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SGY7|PEK11_ARATH Putative proline-rich receptor-like protein kinase PERK11 OS=Arabidopsis thaliana GN=PERK11 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 174 bits (440), Expect = 2e-42, Method: Compositional matrix adjust.
Identities = 97/234 (41%), Positives = 142/234 (60%), Gaps = 17/234 (7%)
Query: 242 FTSQELCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSE-EEVLREVEL 300
FT +EL +T F ++G+GG VY+ +G+ A+K LK + E EVE+
Sbjct: 358 FTYEELSQITEGFCKSFVVGEGGFGCVYKGILFEGKPVAIKQLKSVSAEGYREFKAEVEI 417
Query: 301 LSSIKHENIVRIIGYCHSKEMYAIVYNLLNGSLKQY------LKQLKWNERMDVAIGVAK 354
+S + H ++V ++GYC S++ ++Y + + Y L L+W+ R+ +AIG AK
Sbjct: 418 ISRVHHRHLVSLVGYCISEQHRFLIYEFVPNNTLDYHLHGKNLPVLEWSRRVRIAIGAAK 477
Query: 355 ALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH--QSHQVSENVKPVNV 412
L YLH C P IIHRD+KSSNILL + F Q++DFG A ++ QSH + V
Sbjct: 478 GLAYLHEDCHPKIIHRDIKSSNILLDDEF-EAQVADFGLARLNDTAQSHISTR------V 530
Query: 413 VGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA-NRESLVLW 465
+GTFGYLAPEY GK+ ++ DV+S+GVVLLELITG++ + T++ ESLV W
Sbjct: 531 MGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDTSQPLGEESLVEW 584
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8H1D6|RBK1_ARATH Receptor-like cytosolic serine/threonine-protein kinase RBK1 OS=Arabidopsis thaliana GN=RBK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 174 bits (440), Expect = 2e-42, Method: Compositional matrix adjust.
Identities = 100/245 (40%), Positives = 151/245 (61%), Gaps = 18/245 (7%)
Query: 231 AVLEAEGSSRRFTSQELCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWS 290
A A+ S R FT +EL T F+P+ +IG+GG+++VY+ ++G+ A+K L
Sbjct: 130 AFFMAKPSWRNFTYEELAVATDYFNPENMIGKGGHAEVYKGVLINGETVAIKKLMSHAKE 189
Query: 291 EEE----VLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLLNGSLKQYL----KQLKW 342
EEE L E+ +++ + H N R+ G+ + ++ ++ GSL L + L+W
Sbjct: 190 EEERVSDFLSELGIIAHVNHPNAARLRGFSSDRGLHFVLEYAPYGSLASMLFGSEECLEW 249
Query: 343 NERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA--MVHHQS 400
R VA+G+A L YLH+ C IIHRD+K+SNILL+ ++ Q+SDFG A + +
Sbjct: 250 KIRYKVALGIADGLSYLHNACPRRIIHRDIKASNILLNHDYE-AQISDFGLAKWLPENWP 308
Query: 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRE 460
H V V P+ GTFGYLAPEY M+G VDEKIDV+++GV+LLE+IT + A+ T A+R+
Sbjct: 309 HHV---VFPIE--GTFGYLAPEYFMHGIVDEKIDVFAFGVLLLEIITSRRAVDT--ASRQ 361
Query: 461 SLVLW 465
S+V W
Sbjct: 362 SIVAW 366
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 480 | ||||||
| 225428253 | 566 | PREDICTED: proline-rich receptor-like pr | 0.964 | 0.818 | 0.636 | 1e-173 | |
| 297744499 | 529 | unnamed protein product [Vitis vinifera] | 0.887 | 0.805 | 0.591 | 1e-155 | |
| 255575035 | 531 | serine-threonine protein kinase, plant-t | 0.939 | 0.849 | 0.591 | 1e-153 | |
| 147785221 | 932 | hypothetical protein VITISV_042429 [Viti | 0.860 | 0.443 | 0.589 | 1e-143 | |
| 449454370 | 601 | PREDICTED: probable LRR receptor-like se | 0.927 | 0.740 | 0.508 | 1e-117 | |
| 224105105 | 284 | predicted protein [Populus trichocarpa] | 0.468 | 0.792 | 0.730 | 1e-89 | |
| 351727927 | 649 | protein kinase family protein [Glycine m | 0.927 | 0.685 | 0.344 | 3e-62 | |
| 255550554 | 674 | ATP binding protein, putative [Ricinus c | 0.883 | 0.629 | 0.343 | 1e-60 | |
| 15237563 | 705 | Protein kinase protein with adenine nucl | 0.568 | 0.387 | 0.450 | 1e-54 | |
| 356507630 | 750 | PREDICTED: probable receptor-like serine | 0.595 | 0.381 | 0.420 | 5e-54 |
| >gi|225428253|ref|XP_002279474.1| PREDICTED: proline-rich receptor-like protein kinase PERK9-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 614 bits (1584), Expect = e-173, Method: Compositional matrix adjust.
Identities = 298/468 (63%), Positives = 380/468 (81%), Gaps = 5/468 (1%)
Query: 1 MVGKLSIEKNFFSVLRTRTLKKRTVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVEE 60
M+G+ E+ F + R+RT KKRT++FGLKS + SR +LL+LL+ + GD VLAVHV+E
Sbjct: 1 MLGRTRTERRIFGLRRSRTSKKRTIVFGLKSSNGSRGVLLKLLSSVVVTGDEVLAVHVQE 60
Query: 61 Q--NDTLDLNTFHIHEDLCKSKKVDFLVKVCIGDSYITELSNQVRISYATILALGCSLSG 118
+DT DLNTFHIHEDLCKSK+VDF VKVC+G+SYI+EL++QVR+S+ATILALGCS S
Sbjct: 61 PEPDDTFDLNTFHIHEDLCKSKQVDFHVKVCVGESYISELTHQVRVSFATILALGCS-SS 119
Query: 119 LKDSEVLTRCLRALPPACTILVMDNLGRILVQRQGTSQQGSTNVLLKSSLSSSSKYPAFG 178
D ++ CL+ LPP CT+LV DN GRIL+QR GTSQQGS + +S++SSS+ +
Sbjct: 120 RPDDSIVANCLKKLPPTCTLLVTDNGGRILIQRPGTSQQGSKTEVFQSTVSSSTTHMYLN 179
Query: 179 QPATTRQLQKSLTAPSSSTSSTTRQESDVGVCIAQETVQVPESIKRKIFEKLAVLEAEGS 238
+ T +KSLT PS STS+TTR+ + G I++ T+Q+P+ ++ K+F++LA+LEA+G
Sbjct: 180 RTGTPHHFRKSLTMPSPSTSTTTREADNNGQKISKMTMQLPDFMEEKLFQRLALLEAKGL 239
Query: 239 SRRFTSQELCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREV 298
+RFTS EL T +FSP+M+IG+GG+SKVYR N DG++AAVKVLK T W E++L+EV
Sbjct: 240 GKRFTSSELKLATRDFSPEMVIGEGGHSKVYRANLGDGRLAAVKVLKPTRWYAEDLLQEV 299
Query: 299 ELLSSIKHENIVRIIGYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVAKALEY 358
E+LS + HENIV+IIGYC ++EM+A+VY+LL GSLKQ L+QL+W ERM VAIGVAKALEY
Sbjct: 300 EILSDVNHENIVQIIGYCSNREMHAVVYDLLKGSLKQKLRQLRWKERMGVAIGVAKALEY 359
Query: 359 LHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGY 418
LHH+CDPPIIHRDVKSSN+LLSEN HPQLSDFG+AMV++++ QVS VKP+ VVGTFGY
Sbjct: 360 LHHSCDPPIIHRDVKSSNVLLSENC-HPQLSDFGSAMVYNRAQQVSAKVKPLRVVGTFGY 418
Query: 419 LAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA-NRESLVLW 465
LAPEYMMYGKVDEK+DVYSYGVVLLELI+GKEAIQTN+A N ESLVLW
Sbjct: 419 LAPEYMMYGKVDEKVDVYSYGVVLLELISGKEAIQTNQASNHESLVLW 466
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297744499|emb|CBI37761.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 554 bits (1428), Expect = e-155, Method: Compositional matrix adjust.
Identities = 277/468 (59%), Positives = 352/468 (75%), Gaps = 42/468 (8%)
Query: 1 MVGKLSIEKNFFSVLRTRTLKKRTVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVEE 60
M+G+ E+ F + R+RT KKRT++FGLKS + SR +LL+LL+ + GD VLAVHV+E
Sbjct: 1 MLGRTRTERRIFGLRRSRTSKKRTIVFGLKSSNGSRGVLLKLLSSVVVTGDEVLAVHVQE 60
Query: 61 Q--NDTLDLNTFHIHEDLCKSKKVDFLVKVCIGDSYITELSNQVRISYATILALGCSLSG 118
+DT DLNTFHIHEDLCKSK+VDF VKVC+G+SYI+EL++QVR+S+ATILALGCS S
Sbjct: 61 PEPDDTFDLNTFHIHEDLCKSKQVDFHVKVCVGESYISELTHQVRVSFATILALGCS-SS 119
Query: 119 LKDSEVLTRCLRALPPACTILVMDNLGRILVQRQGTSQQGSTNVLLKSSLSSSSKYPAFG 178
D ++ CL+ LPP CT+LV DN GRIL+QR GTSQQGS + +S++SSS+ +
Sbjct: 120 RPDDSIVANCLKKLPPTCTLLVTDNGGRILIQRPGTSQQGSKTEVFQSTVSSSTTHMYLN 179
Query: 179 QPATTRQLQKSLTAPSSSTSSTTRQESDVGVCIAQETVQVPESIKRKIFEKLAVLEAEGS 238
+ T +KSLT PS STS+TTR+ + G I++ T+Q+P+ ++ K+F++LA+LEA+G
Sbjct: 180 RTGTPHHFRKSLTMPSPSTSTTTREADNNGQKISKMTMQLPDFMEEKLFQRLALLEAKGL 239
Query: 239 SRRFTSQELCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREV 298
+RFTS EL T +FSP+M+IG+GG+SKVYR
Sbjct: 240 GKRFTSSELKLATRDFSPEMVIGEGGHSKVYR---------------------------- 271
Query: 299 ELLSSIKHENIVRIIGYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVAKALEY 358
NIV+IIGYC ++EM+A+VY+LL GSLKQ L+QL+W ERM VAIGVAKALEY
Sbjct: 272 ---------NIVQIIGYCSNREMHAVVYDLLKGSLKQKLRQLRWKERMGVAIGVAKALEY 322
Query: 359 LHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGY 418
LHH+CDPPIIHRDVKSSN+LLSEN HPQLSDFG+AMV++++ QVS VKP+ VVGTFGY
Sbjct: 323 LHHSCDPPIIHRDVKSSNVLLSENC-HPQLSDFGSAMVYNRAQQVSAKVKPLRVVGTFGY 381
Query: 419 LAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA-NRESLVLW 465
LAPEYMMYGKVDEK+DVYSYGVVLLELI+GKEAIQTN+A N ESLVLW
Sbjct: 382 LAPEYMMYGKVDEKVDVYSYGVVLLELISGKEAIQTNQASNHESLVLW 429
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255575035|ref|XP_002528423.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223532159|gb|EEF33965.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 548 bits (1411), Expect = e-153, Method: Compositional matrix adjust.
Identities = 280/473 (59%), Positives = 362/473 (76%), Gaps = 22/473 (4%)
Query: 1 MVGKLSIEKNFFSVLRTRTLKKRTVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVEE 60
M G+LS+E+ +S+LRTR++KKRT+I GLKSD++SRE+LL+LL V+ KPGDNV+A+HV+E
Sbjct: 1 MAGRLSLERQIYSLLRTRSVKKRTIIVGLKSDNHSREMLLRLLNVVVKPGDNVIAIHVQE 60
Query: 61 QNDTLDLNTFHIHEDLCKSKKVDFLVKVCIGDSYITELSNQVRISYATILALGCSLSGLK 120
+ DLNTFH HEDLCKSK+VDFL+K+C G+SYI ELS QVRI+YATILA+GCS S K
Sbjct: 61 PFGSFDLNTFHTHEDLCKSKQVDFLIKICTGNSYIFELSQQVRINYATILAIGCSFSRPK 120
Query: 121 DSEVLTRCLRALPPACTILVMDNLGRILVQRQGTSQQGSTNVL---------LKSSLSSS 171
S V++ CL+ LPP C +L++DN+GRI++Q QGTSQQGS +VL SS S+
Sbjct: 121 QS-VISSCLKGLPPTCGLLIIDNVGRIILQMQGTSQQGSFHVLPGSSISSSSSSSSSSTE 179
Query: 172 SKYPAFGQPATTRQLQKSLTAPSSSTSSTTRQESDVGVCIAQETVQVPESIKRKIFEKLA 231
Y PA +LQ S+ S ST + + ++VP+ + + IF+KL
Sbjct: 180 KGYVRQNIPA---ELQNSVGETSLLAQSTKGRHG------LKRAIEVPD-LAKSIFQKLV 229
Query: 232 VLEAEGSSRRFTSQELCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSE 291
+LE +G R FT Q+L T NFSP+M+IG+GGNSKVYR N DG+ AAVKV+K +
Sbjct: 230 LLEPDGFIRLFTLQDLYSATDNFSPQMVIGEGGNSKVYRANFQDGRTAAVKVVKPAHCLA 289
Query: 292 EEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIG 351
E++ +EVE+LSSI+H+NIV+IIGYC+ K+++A+VYNL+ GSLKQ L QLKW+ERM+VAIG
Sbjct: 290 EDLFQEVEILSSIRHDNIVQIIGYCNCKDLHAVVYNLMKGSLKQNLTQLKWSERMEVAIG 349
Query: 352 VAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVN 411
VAKAL+YL H+ +PPIIH VKSSNILLSEN PQLSDFG AMV+++S ++ ++P +
Sbjct: 350 VAKALDYL-HSFNPPIIHGHVKSSNILLSENC-QPQLSDFGGAMVYNKSEEIPAKIRPFD 407
Query: 412 VVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVL 464
VVGTFGY+APEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQ N+A +ESLVL
Sbjct: 408 VVGTFGYIAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQANQAKQESLVL 460
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147785221|emb|CAN75128.1| hypothetical protein VITISV_042429 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 516 bits (1329), Expect = e-143, Method: Compositional matrix adjust.
Identities = 256/434 (58%), Positives = 329/434 (75%), Gaps = 21/434 (4%)
Query: 1 MVGKLSIEKNFFSVLRTRTLKKRTVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVEE 60
M+G+ E+ F + R+RT KKRT++FGLKS + SR +LL+LL+ + GD VLAVHV+E
Sbjct: 418 MLGRTRTERRIFGLRRSRTSKKRTIVFGLKSSNGSRGVLLKLLSSVVVTGDEVLAVHVQE 477
Query: 61 Q--NDTLDLNTFHIHEDLCKSKKVDFLVKVCIGDSYITELSNQVRISYATILALGCSLSG 118
+DT DLNTFHIHEDLCKSK+VDF VKVC+G+SYI+EL++QVR+S+ATILALGCS S
Sbjct: 478 PEPDDTFDLNTFHIHEDLCKSKQVDFQVKVCVGESYISELTHQVRVSFATILALGCS-SS 536
Query: 119 LKDSEVLTRCLRALPPACTILVMDNLGRILVQRQGTSQQGSTNVLLKSSLSSSSKYPAFG 178
D ++ CL+ LPP CT+LV DN GRIL+QR GTSQQGS + +S++SSS+ +
Sbjct: 537 RPDBSIVANCLKKLPPTCTLLVTDNGGRILIQRPGTSQQGSKTEVFQSTVSSSTTHMYLN 596
Query: 179 QPATTRQLQKSLTAPSSSTSSTTRQESDVGVCIAQETVQVPESIKRKIFEKLAVLEAEGS 238
+P T +KSLT PS S S+TTR+ + G IA+ T+Q+P+ ++ K+F++LA+LEA+G
Sbjct: 597 RPGTPHHXRKSLTMPSPSXSTTTREADNNGQKIAKMTMQLPDFMEEKLFQRLALLEAKGL 656
Query: 239 SRRFTSQELCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREV 298
+RFTS EL T +FSP+M+IG+GG+SKVYR N DG++AAVKVLK T W E++L
Sbjct: 657 GKRFTSSELKLATRDFSPEMVIGEGGHSKVYRANLGDGRLAAVKVLKPTRWYAEDLL--- 713
Query: 299 ELLSSIKHENIVRIIGYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVAKALEY 358
+ +I KEM+A+VY+LL GSLKQ L+QL+W ER VAIGVAKALEY
Sbjct: 714 -----PRSRDI---------KEMHAVVYDLLKGSLKQKLRQLRWKERXGVAIGVAKALEY 759
Query: 359 LHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGY 418
LHH+CDPPIIHRDVKSSN+LLSEN HPQLSDFG+AMV++ + QVS VKP+ VVGTFGY
Sbjct: 760 LHHSCDPPIIHRDVKSSNVLLSEN-RHPQLSDFGSAMVYNGAQQVSAKVKPLRVVGTFGY 818
Query: 419 LAPEYMMYGKVDEK 432
LAPEYMMYGKVDEK
Sbjct: 819 LAPEYMMYGKVDEK 832
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449454370|ref|XP_004144928.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At2g24230-like [Cucumis sativus] gi|449470503|ref|XP_004152956.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At2g24230-like [Cucumis sativus] gi|449526776|ref|XP_004170389.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At2g24230-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 428 bits (1101), Expect = e-117, Method: Compositional matrix adjust.
Identities = 241/474 (50%), Positives = 320/474 (67%), Gaps = 29/474 (6%)
Query: 9 KNFFSVLRTRTL------KKRTVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVEEQN 62
K FS++RT++ KKRT+I GL +++ RE LL++L VI K GDNV+AV V E N
Sbjct: 19 KEMFSLVRTKSAAAAAGRKKRTIIVGLNAENSGRETLLRMLVVIVKTGDNVVAVRVSEPN 78
Query: 63 DTLDLNTFHIHEDLCKSKKVDFLVKVCIGDSYITELSNQVRISYATILALGCSLSGLKDS 122
D D NTFHIHEDLCKSK+VDF V++C G+SYI+EL+ QVR+++AT+L LG + SG KDS
Sbjct: 79 DNFDPNTFHIHEDLCKSKQVDFQVRICEGESYISELTRQVRLNFATVLVLGTTNSGPKDS 138
Query: 123 EVLTRCLRALPPACTILVMDNLGRILVQRQGTSQQGSTNVLLK-SSLSSSSKYP------ 175
V T CL+ LPP CT+LV+DN G I +Q +GTSQ+GS + K LSS + P
Sbjct: 139 VVKT-CLKGLPPTCTLLVIDNKGNIQIQMKGTSQEGSKRPISKPPPLSSPTNDPNNIINE 197
Query: 176 ---AFGQPATTRQLQKSLTAPSSSTSSTTRQESDVGVCIAQETVQVPESIKRKIFEKLAV 232
+ P+ + S ++ SSS S+ +ES +++ VQ+P + EKL
Sbjct: 198 SSSSSIHPSLNPLTESSSSSSSSSPLSSQPEESHTPTHVSK-AVQIPTFVS----EKLRR 252
Query: 233 LEAEGSSRRFTSQELCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEE 292
++ + S R FT QE+ T NFSP MLI +G K+Y DGQ AVKV + +S E
Sbjct: 253 VDLKHSIRLFTPQEIASATKNFSPLMLIEEGVCFKMYSAKLEDGQFVAVKV-QTKQFSSE 311
Query: 293 EVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN-LLNGSLKQYLKQLKWNERMDVAIG 351
++LRE+E+L +KHENIV+I+G C+ +E+ A+VYN L G+L Q LK+LKW +R+ VAIG
Sbjct: 312 DLLREIEMLCGLKHENIVKILGCCNREEIRAVVYNHRLKGNLMQNLKKLKWTDRVKVAIG 371
Query: 352 VAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVN 411
VAKAL+YLHH+C P IIHR+VKSSNILLS++ PQLS+FG AMV + S V
Sbjct: 372 VAKALKYLHHSCSPSIIHRNVKSSNILLSDH-SQPQLSNFGEAMVRPAVQEDSTQVD--- 427
Query: 412 VVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLW 465
+G F YLAPEY+M+GKV+EK+DVYSYGV+LLELITGK A+QT NR SLV W
Sbjct: 428 -IGKFSYLAPEYLMFGKVNEKVDVYSYGVMLLELITGKLAVQTEPTNRRSLVFW 480
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224105105|ref|XP_002313688.1| predicted protein [Populus trichocarpa] gi|222850096|gb|EEE87643.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 336 bits (862), Expect = 1e-89, Method: Compositional matrix adjust.
Identities = 165/226 (73%), Positives = 191/226 (84%), Gaps = 1/226 (0%)
Query: 240 RRFTSQELCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVE 299
+ F QEL T+NFSP+M+IG GG+SKVYR N VDGQ AVK+LK T++ E++L EV
Sbjct: 1 KHFKFQELNLATNNFSPEMVIGVGGHSKVYRANLVDGQAVAVKILKETHFPAEDLLHEVR 60
Query: 300 LLSSIKHENIVRIIGYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVAKALEYL 359
+LS +KHENI++IIGYC+SKEM+AIVYNLL GSLKQ L+QLKWNERM VA+GVA+ALEYL
Sbjct: 61 ILSDVKHENIIQIIGYCYSKEMHAIVYNLLIGSLKQNLRQLKWNERMGVAVGVAQALEYL 120
Query: 360 HHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYL 419
HH+ +PPIIHRDVKSSNILLS PQLSDFGAAMV+ S Q S + KP VVGTFGYL
Sbjct: 121 HHSFNPPIIHRDVKSSNILLSGTC-QPQLSDFGAAMVNQPSKQNSASTKPFKVVGTFGYL 179
Query: 420 APEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLW 465
APEYMMYGKVDEK+DVYSYGVVLLELITG+EAIQTN+AN ESLVLW
Sbjct: 180 APEYMMYGKVDEKVDVYSYGVVLLELITGQEAIQTNEANHESLVLW 225
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351727927|ref|NP_001238713.1| protein kinase family protein [Glycine max] gi|223452363|gb|ACM89509.1| protein kinase family protein [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 245 bits (626), Expect = 3e-62, Method: Compositional matrix adjust.
Identities = 179/520 (34%), Positives = 270/520 (51%), Gaps = 75/520 (14%)
Query: 23 RTVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVEEQNDTLDL--------------N 68
R V+ G+K D +S E+L L +A+PGD VLA+HV ++ ++ +
Sbjct: 18 RIVVVGMKMDSHSTELLTWALFKVAQPGDVVLALHVLGNDEIVNREGKSSLFSLVKAFDS 77
Query: 69 TFHIHEDLCKSKKVDFLVKVCIGDSYITELSNQVRISYATILALGCSLSGLKDSE----V 124
++E C K+VD K+C G S L + AT + +G S GL + V
Sbjct: 78 ILAVYEGFCNLKQVDLKFKICRGSSVTRILVREANAYSATHIIVGSS-QGLHITRPCISV 136
Query: 125 LTRCLRALPPACTILVMDNLGRILVQRQGTSQQGST------------------------ 160
C + LP C + +DN G+I+ +R+G++ S
Sbjct: 137 ARYCAKKLPKDCWVFAVDN-GKIVFKREGSAATRSDLKEFIEKKRCSTSASEEEESCADA 195
Query: 161 ----NVLLKSSLSSSSKYPAFGQPATTRQL-------QKSLTAPSSSTSSTTRQESDVGV 209
N L + ++ G P + + Q+SL S +S V
Sbjct: 196 CDEMNPLAIVPVQTNDAASKPGWPLLRKTIVSDRKCSQRSLLC-QISVVQWAMHKSGALV 254
Query: 210 CIAQETVQVP--ESIKRKIFEKLAVLEAEGSS--RRFTSQELCHLTHNFSPKMLIGQGGN 265
+ E P E R I ++L L + SS R F QEL T NF P+ LIG+GG+
Sbjct: 255 PVDAEIGTAPSTEHNSRSIPKELEGLHEKYSSTCRLFKYQELVLATSNFLPENLIGKGGS 314
Query: 266 SKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325
S+VYR DG+ AVK+LK ++ +E + E+E+++++ H++++ ++G+C +V
Sbjct: 315 SQVYRGCLPDGKELAVKILKPSDDVLKEFVLEIEIITTLNHKSLISLLGFCFEDGNLLLV 374
Query: 326 YNLLN-GSLKQYLKQLK-------WNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNI 377
Y+ L+ GSL++ L K W ER VAIGVA+ALEYLH+ +IHRDVKSSN+
Sbjct: 375 YDFLSRGSLEENLHGNKKNPLMFGWTERYKVAIGVAEALEYLHNNDGQSVIHRDVKSSNV 434
Query: 378 LLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYS 437
LLSE+F PQLSDFG A + S ++ +V GTFGY+APEY MYGKV++KIDVY+
Sbjct: 435 LLSEDF-EPQLSDFGLA---KWASTTSSHIICTDVAGTFGYMAPEYFMYGKVNDKIDVYA 490
Query: 438 YGVVLLELITGKEAIQTN-KANRESLVLWYYVL--AGKVF 474
+GVVLLEL++G++ I + +ESLV+W + +GKV
Sbjct: 491 FGVVLLELLSGRKPISGDYPKGQESLVMWASPILNSGKVL 530
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255550554|ref|XP_002516327.1| ATP binding protein, putative [Ricinus communis] gi|223544557|gb|EEF46074.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 240 bits (612), Expect = 1e-60, Method: Compositional matrix adjust.
Identities = 180/524 (34%), Positives = 262/524 (50%), Gaps = 100/524 (19%)
Query: 30 KSDHYSREILLQLLTVIAKPGDNVLAVHVEE--------QNDTLDL-NTFH----IHEDL 76
K D SRE+L L +AKPGD V+A+HV + + L L TF ++E
Sbjct: 31 KLDGDSRELLTWTLMKLAKPGDRVIALHVLDSLTEFVGGRTSLLSLVKTFDCFLAVYEGF 90
Query: 77 CKSKKVDFLVKVCIGDSYITELSNQVRISYATILALGCSLSGLK---DSEVLTRCLRALP 133
C K+VD +KVC G S L + + S A +L G S K + V C R L
Sbjct: 91 CNLKQVDLKLKVCRGSSVRKTLVREAKSSGAAMLITGTSKKRHKIRSSTSVAKYCARNLS 150
Query: 134 PACTILVMDNLGRILVQRQGT--SQQGSTNVLLKSSLSSSSKYPAFGQP--------ATT 183
+ ++ + N G+I+ QR+ T S + L + S +SS + P + T
Sbjct: 151 KSFSVFAVSN-GKIMFQREATPASVNHFQDKLNQESQNSSQNNDSLDSPSLLSIAHNSET 209
Query: 184 RQLQKSLT----------APSSSTSSTTRQESDVGVCIAQETVQVPE-----SIKRKIF- 227
L++SL P + + T S V + PE SI R++F
Sbjct: 210 NSLEESLDDGEVDNSLALVPVQTNEAVTNFNSSV-------VERSPEYKHGWSILRRVFL 262
Query: 228 -----------------------------------EKLAVLEAEGSS--RRFTSQELCHL 250
E+L L SS R F+ +ELC
Sbjct: 263 PKRRHREESHGKRTSVVKWVFKVPSRNSSSVVGLPEELKGLHERYSSSCRLFSYEELCSA 322
Query: 251 THNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIV 310
T NF P+ L+G+GG+S VY+ DG+ AVK+LK + +E + E+++++++ H NI+
Sbjct: 323 TSNFMPENLVGKGGSSHVYKGCLPDGKELAVKILKPSEDVLKEFIAEIDIITTLHHNNII 382
Query: 311 RIIGYCHSKEMYAIVYNLLN-GSLKQYL-------KQLKWNERMDVAIGVAKALEYLHHT 362
+ G+C +VY+ L+ GSL++ L W R VA+GVA+AL+YLH
Sbjct: 383 SLFGFCFEHNNLLLVYDFLSRGSLEENLHGNKKDGNSFGWQGRFKVAVGVAEALDYLHSF 442
Query: 363 CDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPE 422
CD P+IHRDVKSSNILLS++F PQLSDFG A S S ++ +V GTFGYLAPE
Sbjct: 443 CDQPVIHRDVKSSNILLSDDF-EPQLSDFGLASWVSTS---SSHMACTDVAGTFGYLAPE 498
Query: 423 YMMYGKVDEKIDVYSYGVVLLELITGKEAIQ-TNKANRESLVLW 465
Y ++GKV +K+DV+++GVVLLEL++G+ I N +ESLV+W
Sbjct: 499 YFLHGKVSDKVDVFAFGVVLLELLSGRMPINGENPKGQESLVMW 542
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15237563|ref|NP_201199.1| Protein kinase protein with adenine nucleotide alpha hydrolases-like domain [Arabidopsis thaliana] gi|8777307|dbj|BAA96897.1| unnamed protein product [Arabidopsis thaliana] gi|20260318|gb|AAM13057.1| unknown protein [Arabidopsis thaliana] gi|31711746|gb|AAP68229.1| At5g63940 [Arabidopsis thaliana] gi|332010435|gb|AED97818.1| Protein kinase protein with adenine nucleotide alpha hydrolases-like domain [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 220 bits (560), Expect = 1e-54, Method: Compositional matrix adjust.
Identities = 133/295 (45%), Positives = 192/295 (65%), Gaps = 22/295 (7%)
Query: 199 STTRQESDVGVC-IAQETVQVPESI---KRKIFEKLAVLEAEGSS--RRFTSQELCHLTH 252
S++ DV + E +Q P S I E+L L + SS R FT +E+ +T
Sbjct: 301 SSSIDGEDVSISRFGSELMQSPLSPFIGSNNIPEELEGLHEKYSSTCRLFTYEEVLSITS 360
Query: 253 NFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLK-CTNWSEEEVLREVELLSSIKHENIVR 311
NF+ + L+G+GGNS VYR + DG+ AVK+LK C + +E +L E+E+++S+ H+NIV
Sbjct: 361 NFASENLVGEGGNSYVYRGDLPDGRELAVKILKPCLDVLKEFIL-EIEVITSVHHKNIVS 419
Query: 312 IIGYCHSKEMYAIVYNLL-NGSLKQYL-------KQLKWNERMDVAIGVAKALEYLHHTC 363
+ G+C +VY+ L GSL++ L K+ W ER VA+GVA+AL+YLH+T
Sbjct: 420 LFGFCFENNNLMLVYDYLPRGSLEENLHGNRKDAKKFGWMERYKVAVGVAEALDYLHNTH 479
Query: 364 DPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEY 423
DP +IHRDVKSSN+LL+++F PQLSDFG A + + S++V ++ GTFGYLAPEY
Sbjct: 480 DPEVIHRDVKSSNVLLADDFE-PQLSDFGFASL---ASSTSQHVAGGDIAGTFGYLAPEY 535
Query: 424 MMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA-NRESLVLWYY-VLAGKVFAQ 476
M+GKV +KIDVY++GVVLLELI+G++ I +++ +ESLVLW +L FAQ
Sbjct: 536 FMHGKVTDKIDVYAFGVVLLELISGRKPICVDQSKGQESLVLWANPILDSGKFAQ 590
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356507630|ref|XP_003522567.1| PREDICTED: probable receptor-like serine/threonine-protein kinase At5g57670-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 218 bits (555), Expect = 5e-54, Method: Compositional matrix adjust.
Identities = 130/309 (42%), Positives = 190/309 (61%), Gaps = 23/309 (7%)
Query: 179 QPATTRQLQKSLTAPSSSTSSTTRQESDVGVCIAQETVQVPESIKRKIFEKLAVLEAEGS 238
+P Q Q A S + + ++++G T +PE I ++L L + S
Sbjct: 333 KPNICDQGQDQHAALDSESGALVPVDAELG------TASLPEHNSGNIPKELEGLHEKYS 386
Query: 239 S--RRFTSQELCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLR 296
S R F QEL T NF P LIG+GG+S+VYR DG+ AVK+LK ++ E L
Sbjct: 387 STCRLFEYQELVLATSNFLPGNLIGKGGSSQVYRGCLPDGKELAVKILKPSDNVLSEFLL 446
Query: 297 EVELLSSIKHENIVRIIGYCHSKEMYAIVYNLLN-GSLKQYLKQLK-------WNERMDV 348
E+E+++++ H+NI+ ++G+C +VY+ L+ GSL++ L K W+ER V
Sbjct: 447 EIEIITTLHHKNIISLLGFCFENGKLLLVYDFLSRGSLEENLHGNKKISLVFGWSERYKV 506
Query: 349 AIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVK 408
A+G+A+AL+YLH D P+IHRDVKSSN+LLSE+F PQL DFG A + +S ++
Sbjct: 507 AVGIAEALDYLHSKDDQPVIHRDVKSSNVLLSEDF-EPQLCDFGLA---KWASTLSSHIT 562
Query: 409 PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTN-KANRESLVLWYY 467
+V GTFGYLAPEY MYGKV++KIDVY++GVVLLEL++G++ I + +ESLV+W
Sbjct: 563 CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLSGRKPISPDYPKGQESLVMWAT 622
Query: 468 VL--AGKVF 474
+ +GKV
Sbjct: 623 PILNSGKVL 631
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 480 | ||||||
| TAIR|locus:2195975 | 794 | AT1G77280 [Arabidopsis thalian | 0.508 | 0.307 | 0.455 | 1.1e-62 | |
| TAIR|locus:2160801 | 705 | AT5G63940 [Arabidopsis thalian | 0.552 | 0.375 | 0.442 | 3.7e-62 | |
| TAIR|locus:2026957 | 756 | AT1G21590 [Arabidopsis thalian | 0.489 | 0.310 | 0.441 | 2.6e-59 | |
| TAIR|locus:2059919 | 617 | AT2G16750 [Arabidopsis thalian | 0.462 | 0.359 | 0.457 | 2.6e-53 | |
| TAIR|locus:2085720 | 386 | AT3G20530 [Arabidopsis thalian | 0.502 | 0.624 | 0.414 | 4.5e-43 | |
| TAIR|locus:2012191 | 693 | AT1G49730 [Arabidopsis thalian | 0.489 | 0.339 | 0.418 | 2.3e-41 | |
| TAIR|locus:2034344 | 381 | ASG5 "ALTERED SEED GERMINATION | 0.468 | 0.590 | 0.410 | 7.5e-41 | |
| TAIR|locus:2155700 | 456 | AT5G65530 [Arabidopsis thalian | 0.470 | 0.495 | 0.401 | 1.6e-40 | |
| TAIR|locus:2183018 | 513 | AT5G18610 [Arabidopsis thalian | 0.593 | 0.555 | 0.360 | 2.6e-40 | |
| TAIR|locus:2075517 | 558 | AT3G02810 [Arabidopsis thalian | 0.497 | 0.428 | 0.392 | 2.9e-39 |
| TAIR|locus:2195975 AT1G77280 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 513 (185.6 bits), Expect = 1.1e-62, Sum P(2) = 1.1e-62
Identities = 118/259 (45%), Positives = 165/259 (63%)
Query: 218 VPESIKRKIFEKLAVLEAEGSS--RRFTSQELCHLTHNFSPKMLIGQGGNSKVYRTNHVD 275
+P++ RK+ E+L L SS R F +EL +T NFS IG+GG+S+V+R +
Sbjct: 407 IPDNSPRKLPEELEGLYERFSSTCRFFKYKELVSVTSNFSADNFIGKGGSSRVFRGCLSN 466
Query: 276 GQVAAVKVLKCTNWXXXXXXXXXXXXXXIKHENIVRIIGYCHSKEMYAIVYNLLN-GSLK 334
G+V AVK+LK T + H+NI+ ++G+C +VYN L+ GSL+
Sbjct: 467 GRVVAVKILKQTEDVLNDFVAEIEIITTLHHKNIISLLGFCFEDHNLLLVYNYLSRGSLE 526
Query: 335 QYLKQLK-------WNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQ 387
+ L K W+ER VA+GVA+AL+YLH+T P+IHRDVKSSNILLS++F PQ
Sbjct: 527 ENLHGNKKDPLAFCWSERYKVAVGVAEALDYLHNTASQPVIHRDVKSSNILLSDDFE-PQ 585
Query: 388 LSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT 447
LSDFG A S + ++ +V GTFGYLAPEY MYGKV++KIDVY++GVVLLEL++
Sbjct: 586 LSDFGLARWASIS---TTHIICSDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLS 642
Query: 448 GKEAIQTN-KANRESLVLW 465
G++ I + +ESLV+W
Sbjct: 643 GRKPISSGCPKGQESLVMW 661
|
|
| TAIR|locus:2160801 AT5G63940 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 519 (187.8 bits), Expect = 3.7e-62, Sum P(2) = 3.7e-62
Identities = 128/289 (44%), Positives = 180/289 (62%)
Query: 206 DVGVC-IAQETVQVPESI---KRKIFEKLAVLEAEGSS--RRFTSQELCHLTHNFSPKML 259
DV + E +Q P S I E+L L + SS R FT +E+ +T NF+ + L
Sbjct: 308 DVSISRFGSELMQSPLSPFIGSNNIPEELEGLHEKYSSTCRLFTYEEVLSITSNFASENL 367
Query: 260 IGQGGNSKVYRTNHVDGQVAAVKVLK-CTNWXXXXXXXXXXXXXXIKHENIVRIIGYCHS 318
+G+GGNS VYR + DG+ AVK+LK C + + H+NIV + G+C
Sbjct: 368 VGEGGNSYVYRGDLPDGRELAVKILKPCLD-VLKEFILEIEVITSVHHKNIVSLFGFCFE 426
Query: 319 KEMYAIVYNLL-NGSLKQYL-------KQLKWNERMDVAIGVAKALEYLHHTCDPPIIHR 370
+VY+ L GSL++ L K+ W ER VA+GVA+AL+YLH+T DP +IHR
Sbjct: 427 NNNLMLVYDYLPRGSLEENLHGNRKDAKKFGWMERYKVAVGVAEALDYLHNTHDPEVIHR 486
Query: 371 DVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVD 430
DVKSSN+LL+++F PQLSDFG A + + S++V ++ GTFGYLAPEY M+GKV
Sbjct: 487 DVKSSNVLLADDFE-PQLSDFGFASL---ASSTSQHVAGGDIAGTFGYLAPEYFMHGKVT 542
Query: 431 EKIDVYSYGVVLLELITGKEAIQTNKAN-RESLVLWYYVL--AGKVFAQ 476
+KIDVY++GVVLLELI+G++ I +++ +ESLVLW + +GK FAQ
Sbjct: 543 DKIDVYAFGVVLLELISGRKPICVDQSKGQESLVLWANPILDSGK-FAQ 590
|
|
| TAIR|locus:2026957 AT1G21590 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 500 (181.1 bits), Expect = 2.6e-59, Sum P(2) = 2.6e-59
Identities = 110/249 (44%), Positives = 158/249 (63%)
Query: 238 SSRRFTSQELCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWXXXXXXXX 297
S + FT +EL +T NF IG+GG+S+V+R +G+ AVK+LK T
Sbjct: 393 SCQFFTYKELVSVTSNFCADNFIGKGGSSRVFRGYLPNGREVAVKILKRTECVLKDFVAE 452
Query: 298 XXXXXXIKHENIVRIIGYCHSKEMYAIVYNLLN-GSLKQYL----KQL---KWNERMDVA 349
+ H+N++ ++GYC +VYN L+ GSL++ L K L +WNER VA
Sbjct: 453 IDIITTLHHKNVISLLGYCFENNNLLLVYNYLSRGSLEENLHGNKKDLVAFRWNERYKVA 512
Query: 350 IGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKP 409
+G+A+AL+YLH+ P+IHRDVKSSNILLS++F PQLSDFG A +S + +
Sbjct: 513 VGIAEALDYLHNDAPQPVIHRDVKSSNILLSDDFE-PQLSDFGLAKWASES---TTQIIC 568
Query: 410 VNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKAN-RESLVLWYY- 467
+V GTFGYLAPEY MYGK++ KIDVY+YGVVLLEL++G++ + + ++SLV+W
Sbjct: 569 SDVAGTFGYLAPEYFMYGKMNNKIDVYAYGVVLLELLSGRKPVNSESPKAQDSLVMWAKP 628
Query: 468 VLAGKVFAQ 476
+L K ++Q
Sbjct: 629 ILDDKEYSQ 637
|
|
| TAIR|locus:2059919 AT2G16750 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 470 (170.5 bits), Expect = 2.6e-53, Sum P(2) = 2.6e-53
Identities = 107/234 (45%), Positives = 154/234 (65%)
Query: 239 SRRFTSQELCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLK-CTNWXXXXXXXX 297
+R F+ L T +FS + LIG+GG ++VY+ DG+ AVK+LK
Sbjct: 262 NRWFSYDVLKTATSDFSLENLIGKGGCNEVYKGFLEDGKGVAVKILKPSVKEAVKEFVHE 321
Query: 298 XXXXXXIKHENIVRIIGYC-HSKEMYAIVYNLLN-GSLKQYLKQ---LKWNERMDVAIGV 352
+ H NI +IG C H ++ + VYNL + GSL++ L+ L+W ER+ +AIG+
Sbjct: 322 VSIVSSLSHSNISPLIGVCVHYNDLIS-VYNLSSKGSLEETLQGKHVLRWEERLKIAIGL 380
Query: 353 AKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNV 412
+AL+YLH+ C P+IHRDVKSSN+LLS+ F PQLSDFG +M +S + + ++ +V
Sbjct: 381 GEALDYLHNQCSNPVIHRDVKSSNVLLSDEFE-PQLSDFGLSMWGSKSCRYT--IQR-DV 436
Query: 413 VGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKAN-RESLVLW 465
VGTFGYLAPEY MYGKV +K+DVY++GVVLLELI+G+ +I ++ +ESLV+W
Sbjct: 437 VGTFGYLAPEYFMYGKVSDKVDVYAFGVVLLELISGRTSISSDSPRGQESLVMW 490
|
|
| TAIR|locus:2085720 AT3G20530 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 455 (165.2 bits), Expect = 4.5e-43, P = 4.5e-43
Identities = 107/258 (41%), Positives = 148/258 (57%)
Query: 221 SIKRKIFEKLAVL-EAEGSSRRFTSQELCHLTHNFSPKMLIGQGGNSKVYRTN-HVDGQV 278
S +R I E++A L + S+ FT +ELC T NF+P +G+GG +VY+ QV
Sbjct: 48 SRRRYISEEIAKLGKGNISAHIFTFRELCVATKNFNPDNQLGEGGFGRVYKGQIETPEQV 107
Query: 279 AAVKVLKCTNWXXXXXXXXXXXXXXI-KHENIVRIIGYCHSKEMYAIVYNLL-NGSLKQY 336
AVK L + + H+N+V ++GYC + +VY + NGSL+ +
Sbjct: 108 VAVKQLDRNGYQGNREFLVEVMMLSLLHHQNLVNLVGYCADGDQRILVYEYMQNGSLEDH 167
Query: 337 L--------KQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQL 388
L K L W+ RM VA G A+ LEYLH T DPP+I+RD K+SNILL E F+ P+L
Sbjct: 168 LLELARNKKKPLDWDTRMKVAAGAARGLEYLHETADPPVIYRDFKASNILLDEEFN-PKL 226
Query: 389 SDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITG 448
SDFG A V + + + V+GT+GY APEY + G++ K DVYS+GVV LE+ITG
Sbjct: 227 SDFGLAKVGPTGGETHVSTR---VMGTYGYCAPEYALTGQLTVKSDVYSFGVVFLEMITG 283
Query: 449 KEAIQTNKANRE-SLVLW 465
+ I T K E +LV W
Sbjct: 284 RRVIDTTKPTEEQNLVTW 301
|
|
| TAIR|locus:2012191 AT1G49730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 443 (161.0 bits), Expect = 2.3e-41, P = 2.3e-41
Identities = 106/253 (41%), Positives = 151/253 (59%)
Query: 213 QETVQVPESIKRKIFEKLAVLEAEGSSRRFTSQELCHLTHNFSPKMLIGQGGNSKVYRTN 272
+ T VP S+ +F K+ ++ + R+F+ +E+ + T++F+ +IGQGG VY+
Sbjct: 321 KSTKSVPSSLP--VF-KIHEDDSSSAFRKFSYKEMTNATNDFNT--VIGQGGFGTVYKAE 375
Query: 273 HVDGQVAAVKVL-KCTNWXXXXXXXXXXXXXXIKHENIVRIIGYCHSKEMYAIVYNLL-N 330
DG +AAVK + K + + H N+V + G+C +K+ +VY+ + N
Sbjct: 376 FNDGLIAAVKKMNKVSEQAEQDFCREIGLLAKLHHRNLVALKGFCINKKERFLVYDYMKN 435
Query: 331 GSLKQYLKQL-----KWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHH 385
GSLK +L + W RM +AI VA ALEYLH CDPP+ HRD+KSSNILL ENF
Sbjct: 436 GSLKDHLHAIGKPPPSWGTRMKIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFV- 494
Query: 386 PQLSDFGAAMVHHQSHQVSENVKPVN--VVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLL 443
+LSDFG A H S S +PVN + GT GY+ PEY++ ++ EK DVYSYGVVLL
Sbjct: 495 AKLSDFGLA---HSSRDGSVCFEPVNTDIRGTPGYVDPEYVVTQELTEKSDVYSYGVVLL 551
Query: 444 ELITGKEAIQTNK 456
ELITG+ A+ +
Sbjct: 552 ELITGRRAVDEGR 564
|
|
| TAIR|locus:2034344 ASG5 "ALTERED SEED GERMINATION 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 434 (157.8 bits), Expect = 7.5e-41, P = 7.5e-41
Identities = 98/239 (41%), Positives = 138/239 (57%)
Query: 237 GSSRRFTSQELCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWXXXXXXX 296
G +R FT +EL T NF L+G+GG +VY+ GQV A+K L
Sbjct: 61 GGARSFTFKELAAATRNFREVNLLGEGGFGRVYKGRLDSGQVVAIKQLNPDGLQGNREFI 120
Query: 297 XXXXXXXIKHE-NIVRIIGYCHSKEMYAIVYNLLN-GSLKQYL-------KQLKWNERMD 347
+ H N+V +IGYC S + +VY + GSL+ +L + L WN RM
Sbjct: 121 VEVLMLSLLHHPNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLFDLESNQEPLSWNTRMK 180
Query: 348 VAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV 407
+A+G A+ +EYLH T +PP+I+RD+KS+NILL + F P+LSDFG A + + +
Sbjct: 181 IAVGAARGIEYLHCTANPPVIYRDLKSANILLDKEFS-PKLSDFGLAKLGPVGDRTHVST 239
Query: 408 KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTN-KANRESLVLW 465
+ V+GT+GY APEY M GK+ K D+Y +GVVLLELITG++AI K ++LV W
Sbjct: 240 R---VMGTYGYCAPEYAMSGKLTVKSDIYCFGVVLLELITGRKAIDLGQKQGEQNLVTW 295
|
|
| TAIR|locus:2155700 AT5G65530 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 431 (156.8 bits), Expect = 1.6e-40, P = 1.6e-40
Identities = 98/244 (40%), Positives = 146/244 (59%)
Query: 232 VLEAEGSSRRFTSQELCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVL----KCT 287
+L A+ S R FT EL T NF+P+ +IG+GG+++VY+ DG+ A+K L K
Sbjct: 122 ILVAKPSWRNFTFDELVAATDNFNPENMIGKGGHAEVYKGVLPDGETVAIKKLTRHAKEV 181
Query: 288 NWXXXXXXXXXXXXXXIKHENIVRIIGYCHSKEMYAIVYNLLNGSLKQYL----KQLKWN 343
+ H N R+ G+ + ++ ++ +GSL L + L W
Sbjct: 182 EERVSDFLSELGIIAHVNHPNAARLRGFSCDRGLHFVLEYSSHGSLASLLFGSEECLDWK 241
Query: 344 ERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA--MVHHQSH 401
+R VA+G+A L YLH+ C IIHRD+K+SNILLS+++ Q+SDFG A + H H
Sbjct: 242 KRYKVAMGIADGLSYLHNDCPRRIIHRDIKASNILLSQDYE-AQISDFGLAKWLPEHWPH 300
Query: 402 QVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRES 461
+ V P+ GTFGYLAPEY M+G VDEK DV+++GV+LLE+ITG+ A+ T+ +R+S
Sbjct: 301 HI---VFPIE--GTFGYLAPEYFMHGIVDEKTDVFAFGVLLLEIITGRRAVDTD--SRQS 353
Query: 462 LVLW 465
+V+W
Sbjct: 354 IVMW 357
|
|
| TAIR|locus:2183018 AT5G18610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 429 (156.1 bits), Expect = 2.6e-40, P = 2.6e-40
Identities = 109/302 (36%), Positives = 160/302 (52%)
Query: 175 PAFGQPATTRQLQKSLTAPXXXXXXXXRQESDVGVCIAQETVQVPESIKRKIFEKLAVLE 234
P FG A + S+ Q + + ++ + PE K+++
Sbjct: 6 PCFGSSAKDAASKDSVKKELSAKDGSVTQSHHISLDKSKSR-RGPEQ-KKELTAPKEGPT 63
Query: 235 AEGSSRRFTSQELCHLTHNFSPKMLIGQGGNSKVYRTN-HVDGQVAAVKVLKCTNWXXXX 293
A +++ FT +EL T NF P+ L+G+GG +VY+ GQ+ AVK L
Sbjct: 64 AHIAAQTFTFRELAAATKNFRPECLLGEGGFGRVYKGRLETTGQIVAVKQLDRNGLQGNR 123
Query: 294 XXXXXXXXXXIKHE-NIVRIIGYCHSKEMYAIVYNLLN-GSLKQYL------KQ-LKWNE 344
+ H N+V +IGYC + +VY + GSL+ +L K+ L W+
Sbjct: 124 EFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKEPLDWST 183
Query: 345 RMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404
RM +A G AK LEYLH +PP+I+RD+KSSNILL + +H P+LSDFG A + +
Sbjct: 184 RMTIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLGDGYH-PKLSDFGLAKLGPVGDKTH 242
Query: 405 ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRE-SLV 463
+ + V+GT+GY APEY M G++ K DVYS+GVV LELITG++AI +A E +LV
Sbjct: 243 VSTR---VMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNARAPGEHNLV 299
Query: 464 LW 465
W
Sbjct: 300 AW 301
|
|
| TAIR|locus:2075517 AT3G02810 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 419 (152.6 bits), Expect = 2.9e-39, P = 2.9e-39
Identities = 101/257 (39%), Positives = 150/257 (58%)
Query: 223 KRKIFEKLAVLEAEGSSRR-FTSQELCHLTHNFSPKMLIGQGGNSKVYR-TNHVDGQVAA 280
+R+ E + ++EG+S + FT +EL T NF + L+G+GG +VY+ T GQV A
Sbjct: 32 RRRAEETEEIEQSEGTSLKIFTFRELATATKNFRQECLLGEGGFGRVYKGTLKSTGQVVA 91
Query: 281 VKVL-KCTNWXXXXXXXXXXXXXXIKHENIVRIIGYCHSKEMYAIVYNLLNG-SLKQYLK 338
VK L K + H N+V++IGYC + +VY+ ++G SL+ +L
Sbjct: 92 VKQLDKHGLHGNKEFQAEVLSLGQLDHPNLVKLIGYCADGDQRLLVYDYISGGSLQDHLH 151
Query: 339 QLK-------WNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDF 391
+ K W RM +A A+ L+YLH +PP+I+RD+K+SNILL ++F P+LSDF
Sbjct: 152 EPKADSDPMDWTTRMQIAYAAAQGLDYLHDKANPPVIYRDLKASNILLDDDFS-PKLSDF 210
Query: 392 GAAMVHHQSHQVSENVKPVN--VVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
G +H + + ++ V+GT+GY APEY G + K DVYS+GVVLLELITG+
Sbjct: 211 G---LHKLGPGTGDKMMALSSRVMGTYGYSAPEYTRGGNLTLKSDVYSFGVVLLELITGR 267
Query: 450 EAIQTNKANRE-SLVLW 465
A+ T + N E +LV W
Sbjct: 268 RALDTTRPNDEQNLVSW 284
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00036249001 | SubName- Full=Chromosome chr3 scaffold_8, whole genome shotgun sequence; (352 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
 | CIPK19 | SubName- Full=Chromosome chr5 scaffold_2, whole genome shotgun sequence; (392 aa) | • | 0.467 | |||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 480 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-49 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-41 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-39 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-36 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-36 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-36 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 7e-33 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 8e-33 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-32 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-30 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 9e-27 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-26 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-26 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-24 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-23 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-22 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-22 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-22 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-21 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-21 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-21 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-21 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-21 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-21 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 8e-21 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-20 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-20 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-20 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-20 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-20 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-20 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 6e-20 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-19 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-19 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-19 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-19 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 6e-19 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 7e-19 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-18 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-18 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-18 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-18 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-18 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 9e-18 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-17 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-17 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-17 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-17 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-17 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-17 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 8e-17 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 9e-17 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-16 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-16 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-16 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 7e-16 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 9e-16 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 9e-16 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 9e-16 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 9e-16 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-15 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-15 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-15 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-15 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-15 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-15 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-15 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-15 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-15 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-15 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-15 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 6e-15 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 6e-15 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 6e-15 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 6e-15 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 7e-15 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 7e-15 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 7e-15 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 7e-15 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 8e-15 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 8e-15 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-14 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-14 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-14 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-14 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-14 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-14 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-14 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-14 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-14 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-14 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-14 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-14 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-14 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-14 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 6e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 6e-14 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 6e-14 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 7e-14 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 9e-14 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 9e-14 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-13 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-13 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-13 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-13 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-13 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-13 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-13 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-13 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-13 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-13 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-13 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-13 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-13 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-13 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-13 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-13 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-13 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 7e-13 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 8e-13 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 8e-13 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 8e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 9e-13 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-12 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-12 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-12 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-12 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-12 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-12 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-12 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-12 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-12 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-12 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-12 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-12 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-12 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-12 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-12 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 8e-12 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-11 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-11 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-11 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-11 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-11 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-11 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-11 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-11 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-11 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-11 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-11 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 5e-11 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 7e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 8e-11 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 8e-11 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 9e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 9e-11 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-10 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-10 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-10 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-10 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-10 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 6e-10 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 9e-10 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-09 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-09 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-09 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-09 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-09 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-09 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-09 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-09 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-09 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-09 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-09 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 5e-09 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 5e-09 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 8e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 8e-09 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-08 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-08 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-08 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-08 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-08 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-08 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 5e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-08 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-08 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 5e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 6e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-07 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-07 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-07 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-07 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-07 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-07 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-07 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-07 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-07 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-07 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-07 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 5e-07 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 6e-07 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 7e-07 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 8e-07 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-06 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-06 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-06 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-06 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-06 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-06 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-06 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-06 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-06 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-06 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 5e-06 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 5e-06 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 6e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 6e-06 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 7e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 8e-06 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 9e-06 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-05 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-05 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-05 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-05 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-05 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-05 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-05 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-05 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 5e-05 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 5e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 7e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 8e-05 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 1e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-04 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 5e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 5e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 5e-04 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 8e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.002 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.002 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 0.002 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 0.002 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 3e-49
Identities = 69/203 (33%), Positives = 106/203 (52%), Gaps = 17/203 (8%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSE--EEVLREVELLSSIKHENIVRIIGYC 316
+G+GG VY + G+ A+K++K + S EE+LRE+E+L + H NIV++ G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 317 HSKEMYAIVYNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRD 371
+ +V GSLK LK+ L +E + + + + + LEYLH IIHRD
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIHRD 117
Query: 372 VKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPE-YMMYGKVD 430
+K NILL + +L+DFG + + +VGT Y+APE + G
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKS-----LLKTIVGTPAYMAPEVLLGKGYYS 172
Query: 431 EKIDVYSYGVVLLELITGKEAIQ 453
EK D++S GV+L EL K+ I+
Sbjct: 173 EKSDIWSLGVILYELPELKDLIR 195
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 2e-41
Identities = 70/205 (34%), Positives = 105/205 (51%), Gaps = 18/205 (8%)
Query: 254 FSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTN---WSEEEVLREVELLSSIKHENI 309
+ +G G VY+ + G++ AVK+LK + ++ RE+ +L + H NI
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 310 VRIIGYCHSKEMYAIVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDP 365
VR+I K+ +V G L YL + L +E +A+ + + LEYLH
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSN--- 117
Query: 366 PIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMM 425
IIHRD+K NILL EN +++DFG A +S + VGT Y+APE ++
Sbjct: 118 GIIHRDLKPENILLDEN-GVVKIADFGLAKKLLKS-----SSSLTTFVGTPWYMAPEVLL 171
Query: 426 YGK-VDEKIDVYSYGVVLLELITGK 449
G K+DV+S GV+L EL+TGK
Sbjct: 172 GGNGYGPKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 2e-39
Identities = 68/198 (34%), Positives = 102/198 (51%), Gaps = 17/198 (8%)
Query: 259 LIGQGGNSKVYR-TNHVDGQVAAVKVLKCTN--WSEEEVLREVELLSSIKHENIVRIIGY 315
+G+G KVY + G++ A+KV+K E +LRE+++L +KH NIVR+
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65
Query: 316 CHSKEMYAIVYNLLN-GSLKQYLKQLK-WNERM--DVAIGVAKALEYLHHTCDPPIIHRD 371
++ +V G L LK+ +E + ALEYLH I+HRD
Sbjct: 66 FEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG---IVHRD 122
Query: 372 VKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDE 431
+K NILL E+ H +L+DFG A Q+ K VGT Y+APE ++ +
Sbjct: 123 LKPENILLDED-GHVKLADFGLA------RQLDPGEKLTTFVGTPEYMAPEVLLGKGYGK 175
Query: 432 KIDVYSYGVVLLELITGK 449
+D++S GV+L EL+TGK
Sbjct: 176 AVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 2e-36
Identities = 63/203 (31%), Positives = 98/203 (48%), Gaps = 21/203 (10%)
Query: 259 LIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEV---LREVELLSSIKHENIVRIIG 314
L+G+G VY + G++ AVK ++ + SEEE+ RE+ +LSS++H NIVR G
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66
Query: 315 YCHSKEMYAIVYNLL-----NGSLKQYLKQL-KWNERM--DVAIGVAKALEYLHHTCDPP 366
+E N+ GSL LK+ K E + + + L YLH
Sbjct: 67 SERDEE--KNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLH---SNG 121
Query: 367 IIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY 426
I+HRD+K +NIL+ + +L+DFG A V GT ++APE +
Sbjct: 122 IVHRDIKGANILVDSDG-VVKLADFGCAKRLGDIETGEGTGS---VRGTPYWMAPEVIRG 177
Query: 427 GKVDEKIDVYSYGVVLLELITGK 449
+ D++S G ++E+ TGK
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 133 bits (338), Expect = 5e-36
Identities = 58/200 (29%), Positives = 98/200 (49%), Gaps = 20/200 (10%)
Query: 260 IGQGGNSKVYR-----TNHVDGQVAAVKVLK--CTNWSEEEVLREVELLSSIKHENIVRI 312
+G+G +VY+ AVK LK + EE LRE ++ + H N+V++
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 313 IGYCHSKEMYAIVYNLL-NGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPI 367
+G C +E IV + G L YL+ +L ++ + A+ +A+ +EYL
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE---SKNF 123
Query: 368 IHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYG 427
IHRD+ + N L+ EN ++SDFG + + + + + ++APE + G
Sbjct: 124 IHRDLAARNCLVGEN-LVVKISDFGLSRDLYDDDYYRKRGGKLPI----RWMAPESLKEG 178
Query: 428 KVDEKIDVYSYGVVLLELIT 447
K K DV+S+GV+L E+ T
Sbjct: 179 KFTSKSDVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 133 bits (338), Expect = 5e-36
Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 21/201 (10%)
Query: 260 IGQGGNSKVYR-----TNHVDGQVAAVKVLK--CTNWSEEEVLREVELLSSIKHENIVRI 312
+G+G +VY+ AVK LK + EE LRE ++ + H NIV++
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 313 IGYCHSKEMYAIVYNLL-NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPP 366
+G C +E IV + G L YL++ L ++ + A+ +A+ +EYL
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKN 123
Query: 367 IIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY 426
IHRD+ + N L+ EN ++SDFG + + + + ++APE +
Sbjct: 124 FIHRDLAARNCLVGEN-LVVKISDFGLSRDLYDDDYYKVKGGKLPI----RWMAPESLKE 178
Query: 427 GKVDEKIDVYSYGVVLLELIT 447
GK K DV+S+GV+L E+ T
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 7e-33
Identities = 66/207 (31%), Positives = 111/207 (53%), Gaps = 21/207 (10%)
Query: 253 NFSPKMLIGQGGNSKVYRT-NHVDGQVAAVKVLKCTNWSEE---EVLREVELLSSIKHEN 308
N+ LIG+G VY+ N G A+K + EE +++E++LL ++KH N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 309 IVRIIGYCHSKEMYAIVYNL-LNGSLKQYLKQL-KWNERMDVAIGVA---KALEYLHHTC 363
IV+ IG + + I+ NGSL+Q +K+ + E + VA+ V + L YLH
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESL-VAVYVYQVLQGLAYLH--- 116
Query: 364 DPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVN-VVGTFGYLAPE 422
+ +IHRD+K++NIL +++ +L+DFG A ++++ K VVGT ++APE
Sbjct: 117 EQGVIHRDIKAANILTTKD-GVVKLADFGVAT------KLNDVSKDDASVVGTPYWMAPE 169
Query: 423 YMMYGKVDEKIDVYSYGVVLLELITGK 449
+ D++S G ++EL+TG
Sbjct: 170 VIEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 8e-33
Identities = 72/206 (34%), Positives = 109/206 (52%), Gaps = 23/206 (11%)
Query: 254 FSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWSE-EEVLREVELLSSIKHENIVR 311
F IG+GG +VY+ H G+ A+KV+K + + E+++ E+++L KH NIV+
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 312 IIG-YCHSKEMYAIVYNLLN-GSLKQYLKQLKWNERMD------VAIGVAKALEYLHHTC 363
G Y E++ IV + GSLK LK N+ + V + K LEYLH
Sbjct: 62 YYGSYLKKDELW-IVMEFCSGGSLKDLLKS--TNQTLTESQIAYVCKELLKGLEYLH--- 115
Query: 364 DPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEY 423
IIHRD+K++NILL+ + +L DFG S Q+S+ +VGT ++APE
Sbjct: 116 SNGIIHRDIKAANILLTSDGE-VKLIDFGL------SAQLSDTKARNTMVGTPYWMAPEV 168
Query: 424 MMYGKVDEKIDVYSYGVVLLELITGK 449
+ D K D++S G+ +EL GK
Sbjct: 169 INGKPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 1e-32
Identities = 61/204 (29%), Positives = 99/204 (48%), Gaps = 25/204 (12%)
Query: 260 IGQGGNSKVYR-----TNHVDGQVAAVKVLKCTNWSE--EEVLREVELLSSIKHENIVRI 312
+G+G +VY+ AVK LK E EE L E ++ + H NIVR+
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 313 IGYCHSKEMYAIVYNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPI 367
+G C E IV + G L +L++ L + + +A+ +AK +EYL
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE---SKNF 123
Query: 368 IHRDVKSSNILLSENFHHPQLSDFGAA--MVHHQSHQVSENVK-PVNVVGTFGYLAPEYM 424
+HRD+ + N L++EN ++SDFG + + ++ K P+ ++APE +
Sbjct: 124 VHRDLAARNCLVTEN-LVVKISDFGLSRDIYEDDYYRKRGGGKLPIK------WMAPESL 176
Query: 425 MYGKVDEKIDVYSYGVVLLELITG 448
GK K DV+S+GV+L E+ T
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 2e-30
Identities = 56/210 (26%), Positives = 98/210 (46%), Gaps = 32/210 (15%)
Query: 260 IGQGGNSKVYR----TNHVDGQVAAVKVLKC--TNWSEEEVLREVELLSSIKHENIVRII 313
+G+G +VY+ AVK LK + ++ L+E ++ + H N+VR++
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62
Query: 314 GYCHSKEMYAIVYNLL-NGSLKQYLKQ------------LKWNERMDVAIGVAKALEYLH 360
G C +E +V + G L YL++ L + + AI +AK +EYL
Sbjct: 63 GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122
Query: 361 HTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA--MVHHQSHQVSENVK-PVNVVGTFG 417
+HRD+ + N L+ E+ ++SDFG + + ++ K P+
Sbjct: 123 S---KKFVHRDLAARNCLVGEDL-VVKISDFGLSRDVYDDDYYRKKTGGKLPIR------ 172
Query: 418 YLAPEYMMYGKVDEKIDVYSYGVVLLELIT 447
++APE + G K DV+S+GV+L E+ T
Sbjct: 173 WMAPESLKDGIFTSKSDVWSFGVLLWEIFT 202
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 9e-27
Identities = 65/232 (28%), Positives = 108/232 (46%), Gaps = 21/232 (9%)
Query: 253 NFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKC----TNWSEEEVLREVELLSSIKHE- 307
++ +G+G +VY D ++ A+KVL + E LRE+++L+S+ H
Sbjct: 1 SYRILRKLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 308 NIVRIIGYCHSKEMYAIVYNLLNG-SLKQYLKQLKWNERMD------VAIGVAKALEYLH 360
NIV++ + + +V ++G SL+ LK++ + + + ALEYLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 361 HTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA-MVHHQSHQVSENVKPVNVVGTFGYL 419
IIHRD+K NILL + +L DFG A ++ S P VGT GY+
Sbjct: 119 SKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 420 APEYMM---YGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWYYV 468
APE ++ D++S G+ L EL+TG + K + + +
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKII 227
|
Length = 384 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 61/197 (30%), Positives = 106/197 (53%), Gaps = 19/197 (9%)
Query: 260 IGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIG-YCH 317
IG+G + +VY+ G+ A+K ++ ++E ++ E+ ++ KH NIV Y
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLV 86
Query: 318 SKEMYAIVYNLLN-GSLKQYLKQ--LKWNERMDVAI--GVAKALEYLHHTCDPPIIHRDV 372
E++ +V ++ GSL + Q ++ NE + V + LEYLH +IHRD+
Sbjct: 87 GDELW-VVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDI 142
Query: 373 KSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV-KPVNVVGTFGYLAPEYMMYGKVDE 431
KS NILLS++ +L+DFG A Q+++ K +VVGT ++APE +
Sbjct: 143 KSDNILLSKD-GSVKLADFGFAA------QLTKEKSKRNSVVGTPYWMAPEVIKRKDYGP 195
Query: 432 KIDVYSYGVVLLELITG 448
K+D++S G++ +E+ G
Sbjct: 196 KVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 6e-26
Identities = 71/221 (32%), Positives = 105/221 (47%), Gaps = 29/221 (13%)
Query: 259 LIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEE---VLREVELLSSIKHENIVRIIG 314
IG+G KVY DG++ +K + +N SE+E L EV++L + H NI++
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIK--- 63
Query: 315 YCHS---KEMYAIVYNLLN-GSLKQYLKQLKW-------NERMDVAIGVAKALEYLHHTC 363
Y S K IV + G L Q +K+ K + +D + + AL+YLH
Sbjct: 64 YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH--- 120
Query: 364 DPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEY 423
I+HRD+K NI L+ N +L DFG + V + +++ VVGT YL+PE
Sbjct: 121 SRKILHRDIKPQNIFLTSN-GLVKLGDFGISKVLSSTVDLAK-----TVVGTPYYLSPEL 174
Query: 424 MMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVL 464
+ K D++S G VL EL T K + N L L
Sbjct: 175 CQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE--NLLELAL 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 59/229 (25%), Positives = 100/229 (43%), Gaps = 41/229 (17%)
Query: 252 HNFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVL---------KCTNWSEEEVLREVELL 301
+F +IG+G S V + A+K+L K + V E E+L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKK-----VKYVKIEKEVL 55
Query: 302 SSIK-HENIVRIIGYCHSKEMYAIVYNLL-NGSLKQYLKQLK-WNERMDVAIG--VAKAL 356
+ + H I+++ +E V NG L QY+++ +E+ + AL
Sbjct: 56 TRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLAL 115
Query: 357 EYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPV------ 410
EYLH IIHRD+K NILL ++ H +++DFG A V + E+ K
Sbjct: 116 EYLH---SKGIIHRDLKPENILLDKDM-HIKITDFGTAKVLD-PNSSPESNKGDATNIDS 170
Query: 411 ----------NVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
+ VGT Y++PE + + D+++ G ++ +++TGK
Sbjct: 171 QIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 98.4 bits (246), Expect = 3e-23
Identities = 62/202 (30%), Positives = 103/202 (50%), Gaps = 25/202 (12%)
Query: 260 IGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSE--EEVLREVELLSSIKHENIVRIIGYC 316
+GQG + VY+ H G++ A+K + E +++LRE++ L S + +V+ G
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68
Query: 317 HSKEMYAIVYNLLN-GSLKQYLKQL-KWNERM--DVAIGVAKALEYLHHTCDPPIIHRDV 372
+ + +IV ++ GSL LK++ K E + +A + K L+YLH IIHRD+
Sbjct: 69 YKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDI 126
Query: 373 KSSNILLSENFHHPQLSDFGAAMVHHQSHQVSEN--VKPVNVVGTFGYLAPEY---MMYG 427
K SN+L++ +++DFG + +V EN + VGT Y++PE Y
Sbjct: 127 KPSNLLINSK-GEVKIADFGIS-------KVLENTLDQCNTFVGTVTYMSPERIQGESYS 178
Query: 428 KVDEKIDVYSYGVVLLELITGK 449
D++S G+ LLE GK
Sbjct: 179 Y---AADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 1e-22
Identities = 59/197 (29%), Positives = 90/197 (45%), Gaps = 16/197 (8%)
Query: 259 LIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCH 317
+G+G VY+ H + GQV A+KV+ +E+++E+ +L IV+ G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVP-VEEDLQEIIKEISILKQCDSPYIVKYYGSYF 68
Query: 318 SKEMYAIVYNLLN-GSLKQYLK--QLKWNERMDVAI--GVAKALEYLHHTCDPPIIHRDV 372
IV GS+ +K E AI K LEYLH IHRD+
Sbjct: 69 KNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDI 125
Query: 373 KSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEK 432
K+ NILL+E +L+DFG + K V+GT ++APE + + K
Sbjct: 126 KAGNILLNEE-GQAKLADFGVS-----GQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNK 179
Query: 433 IDVYSYGVVLLELITGK 449
D++S G+ +E+ GK
Sbjct: 180 ADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 2e-22
Identities = 66/200 (33%), Positives = 107/200 (53%), Gaps = 19/200 (9%)
Query: 259 LIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWSEE--EVLREVELLSSIKH---ENIVRI 312
LIG+G VYR HV G+V A+K++ ++ ++ REV LLS ++ NI +
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 313 IG-YCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAI--GVAKALEYLHHTCDPPIIH 369
G Y ++ I+ GS++ +K E+ I V AL+Y+H +IH
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKV---GVIH 124
Query: 370 RDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKV 429
RD+K++NIL++ N + +L DFG A + +Q+ + K VGT ++APE + GK
Sbjct: 125 RDIKAANILVT-NTGNVKLCDFGVAALLNQN-----SSKRSTFVGTPYWMAPEVITEGKY 178
Query: 430 -DEKIDVYSYGVVLLELITG 448
D K D++S G+ + E+ TG
Sbjct: 179 YDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 6e-22
Identities = 62/211 (29%), Positives = 106/211 (50%), Gaps = 16/211 (7%)
Query: 259 LIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSE--EEVLREVELLSSIKHENIVRIIGYC 316
IG+G VY+ AVK + T + + L+E E+L H NIV++IG C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 317 HSKEMYAIVYNLL-NGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRD 371
K+ IV L+ GSL +L+ +L + + +++ A +EYL IHRD
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRD 118
Query: 372 VKSSNILLSENFHHPQLSDFGAAMVHHQS-HQVSENVKPVNVVGTFGYLAPEYMMYGKVD 430
+ + N L+ EN + ++SDFG + + VS+ +K + + T APE + YG+
Sbjct: 119 LAARNCLVGEN-NVLKISDFGMSREEEGGIYTVSDGLKQIPIKWT----APEALNYGRYT 173
Query: 431 EKIDVYSYGVVLLELITGKEAIQTNKANRES 461
+ DV+SYG++L E + + +N+++
Sbjct: 174 SESDVWSYGILLWETFSLGDTPYPGMSNQQT 204
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.5 bits (236), Expect = 1e-21
Identities = 66/218 (30%), Positives = 105/218 (48%), Gaps = 53/218 (24%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEE-----VLREVELLSSIKHENIVRII 313
IG+G +VY+ N G++ A+K ++ +E+E +RE++LL ++H NIVR+
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIR--MENEKEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 314 GYCHSKEMYAI--VY----NLLNGSL------------KQYLKQLKWNERMDVAIGVAKA 355
SK +I V+ + L G L K Y+KQL +
Sbjct: 65 EIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQL------------LEG 112
Query: 356 LEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGT 415
L+YLH I+HRD+K SNIL++ + +L+DFG A + + + N V T
Sbjct: 113 LQYLHSN---GILHRDIKGSNILINNDG-VLKLADFGLA----RPYTKRNSADYTNRVIT 164
Query: 416 FGYLAPEYMM----YGKVDEKIDVYSYGVVLLELITGK 449
Y PE ++ YG ++D++S G +L EL GK
Sbjct: 165 LWYRPPELLLGATRYG---PEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 2e-21
Identities = 63/199 (31%), Positives = 101/199 (50%), Gaps = 19/199 (9%)
Query: 259 LIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSE--EEVLREVELLSSIKHENIVRIIG- 314
IG+G +VY+ + QV A+KV+ + E++ +E++ LS + I + G
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67
Query: 315 YCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAI---GVAKALEYLHHTCDPPIIHRD 371
+ +++ I+ GS LK K +E +A V LEYLH + IHRD
Sbjct: 68 FLKGSKLWIIMEYCGGGSCLDLLKPGKLDETY-IAFILREVLLGLEYLH---EEGKIHRD 123
Query: 372 VKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNV-VGTFGYLAPEYMMYGKVD 430
+K++NILLSE +L+DFG S Q++ + N VGT ++APE + D
Sbjct: 124 IKAANILLSEE-GDVKLADFGV------SGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYD 176
Query: 431 EKIDVYSYGVVLLELITGK 449
EK D++S G+ +EL G+
Sbjct: 177 EKADIWSLGITAIELAKGE 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.7 bits (234), Expect = 2e-21
Identities = 58/216 (26%), Positives = 97/216 (44%), Gaps = 40/216 (18%)
Query: 254 FSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEV----LREVELLSSIKHEN 308
+ +G+G VY+ + G++ A+K ++ N EE + LRE+ LL +KH N
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPN 59
Query: 309 IVRIIGYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVAK--------ALEYLH 360
IV+++ H++ +V+ + LK+YL ++ + K L Y H
Sbjct: 60 IVKLLDVIHTERKLYLVFEYCDMDLKKYLD----KRPGPLSPNLIKSIMYQLLRGLAYCH 115
Query: 361 HTCDPPIIHRDVKSSNILLSENFHHPQL--SDFG-AAMVHHQSHQVSENVKPVNVVGTFG 417
I+HRD+K NIL++ + L +DFG A + V T
Sbjct: 116 SHR---ILHRDLKPQNILINRD---GVLKLADFGLARAFGIPLRTYTHEVV------TLW 163
Query: 418 YLAPEYMM----YGKVDEKIDVYSYGVVLLELITGK 449
Y APE ++ Y +D++S G + E+ITGK
Sbjct: 164 YRAPEILLGSKHYST---AVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.6 bits (231), Expect = 3e-21
Identities = 66/204 (32%), Positives = 97/204 (47%), Gaps = 28/204 (13%)
Query: 260 IGQGGNSKVYRTNHVD-GQVAAVKVLK----CTNWSEEEVLREVELLSSIKHENIVRIIG 314
+G+G KV D G++ A+KVLK E L E +LS I H IV++
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 315 YCHSKE-MYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVAK--------ALEYLHHTCDP 365
++E +Y ++ G L +L + R A+ ALEYLH +
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSK---EGRFSE--ERARFYAAEIVLALEYLH-SLG- 113
Query: 366 PIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMM 425
II+RD+K NILL + H +L+DFG A SE + GT YLAPE ++
Sbjct: 114 -IIYRDLKPENILLDAD-GHIKLTDFGLAK-----ELSSEGSRTNTFCGTPEYLAPEVLL 166
Query: 426 YGKVDEKIDVYSYGVVLLELITGK 449
+ +D +S GV+L E++TGK
Sbjct: 167 GKGYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 3e-21
Identities = 63/202 (31%), Positives = 95/202 (47%), Gaps = 18/202 (8%)
Query: 260 IGQGGNSKVYRTNHVDGQ-VAAVKVL---KCTNWSEEEVLREVELLSSIKHENIVRIIGY 315
IG G + VY + A+K + KC S +E+ +EV+ +S H N+V+
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKC-QTSVDELRKEVQAMSQCNHPNVVKYYTS 67
Query: 316 CHSKEMYAIVYNLLN-GSLKQYLKQLKWNERMDVAI------GVAKALEYLHHTCDPPII 368
+ +V L+ GSL +K +D AI V K LEYLH I
Sbjct: 68 FVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQI 124
Query: 369 HRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGK 428
HRD+K+ NILL E+ +++DFG + + V+ VGT ++APE M
Sbjct: 125 HRDIKAGNILLGED-GSVKIADFGVSASLADGGDRTRKVRK-TFVGTPCWMAPEVMEQVH 182
Query: 429 -VDEKIDVYSYGVVLLELITGK 449
D K D++S+G+ +EL TG
Sbjct: 183 GYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 4e-21
Identities = 55/176 (31%), Positives = 94/176 (53%), Gaps = 18/176 (10%)
Query: 280 AVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGSLKQYLK 338
AVK LK S E L+E +++ ++H+ +V++ C +E IV + GSL +LK
Sbjct: 34 AVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLK 93
Query: 339 -----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFG- 392
+L+ + +D+A +A+ + YL IHRD+ + NIL+ EN +++DFG
Sbjct: 94 SGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGEN-LVCKIADFGL 149
Query: 393 AAMVHHQSHQVSENVK-PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT 447
A ++ + E K P+ + APE YG+ K DV+S+G++L E++T
Sbjct: 150 ARLIEDDEYTAREGAKFPIK------WTAPEAANYGRFTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 8e-21
Identities = 66/205 (32%), Positives = 100/205 (48%), Gaps = 32/205 (15%)
Query: 260 IGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWSEE--EVLREVELLSSIKHENIVRIIGYC 316
+G G + V + H G++ AVK ++ ++LRE+++L IV G
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 317 HSKEMYAIVYNLLN-GSLKQYLKQLK--WNERM--DVAIGVAKALEYLHHTCDPPIIHRD 371
++ +I ++ GSL + LK+++ ER+ +A+ V K L YLH IIHRD
Sbjct: 69 YNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIHRD 126
Query: 372 VKSSNILLSENFHHPQ--LSDFGAAMVHHQSHQVSENVKPVN-----VVGTFGYLAPEYM 424
VK SNIL++ Q L DFG VS + VN VGT Y+APE +
Sbjct: 127 VKPSNILVN---SRGQIKLCDFG----------VSGQL--VNSLAKTFVGTSSYMAPERI 171
Query: 425 MYGKVDEKIDVYSYGVVLLELITGK 449
K D++S G+ L+EL TG+
Sbjct: 172 QGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 1e-20
Identities = 53/188 (28%), Positives = 92/188 (48%), Gaps = 17/188 (9%)
Query: 280 AVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGSLKQYLK 338
A+K+++ SE++ + E +++ + H N+V++ G C + IV + NG L YL+
Sbjct: 32 AIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLR 91
Query: 339 QLKWNERM----DVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA 394
+ K D+ V +A+EYL IHRD+ + N L+ E+ ++SDFG A
Sbjct: 92 ERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNV-VKVSDFGLA 147
Query: 395 -MVHHQSHQVSENVK-PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAI 452
V + S+ K PV + PE Y + K DV+S+GV++ E+ + +
Sbjct: 148 RYVLDDQYTSSQGTKFPVK------WAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMP 201
Query: 453 QTNKANRE 460
+N E
Sbjct: 202 YERFSNSE 209
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 2e-20
Identities = 57/195 (29%), Positives = 101/195 (51%), Gaps = 17/195 (8%)
Query: 260 IGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSK 319
+G G +V+ + A+K LK + S E L E L+ ++H +VR+ +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQE 73
Query: 320 EMYAIVYNLLNGSLKQYLK-----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKS 374
+Y I + NGSL +LK +L N+ +D+A +A+ + ++ IHRD+++
Sbjct: 74 PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRA 130
Query: 375 SNILLSENFHHPQLSDFG-AAMVHHQSHQVSENVK-PVNVVGTFGYLAPEYMMYGKVDEK 432
+NIL+SE +++DFG A ++ + E K P+ + APE + YG K
Sbjct: 131 ANILVSETL-CCKIADFGLARLIEDNEYTAREGAKFPIK------WTAPEAINYGTFTIK 183
Query: 433 IDVYSYGVVLLELIT 447
DV+S+G++L E++T
Sbjct: 184 SDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 3e-20
Identities = 63/201 (31%), Positives = 94/201 (46%), Gaps = 23/201 (11%)
Query: 260 IGQGGNSKVYRTNHVD-GQVAAVKVL---KCTNWSE-EEVLREVELLSSIKHENIVRI-I 313
IG+G KV D ++ A+K + KC VL E +L + H +V +
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWY 67
Query: 314 GYCHSKEMYAIVYNLLNGSLKQYL-KQLKWNE---RMDVAIGVAKALEYLHHTCDPPIIH 369
+ + MY +V LL G L+ +L +++K++E + + + ALEYLH IIH
Sbjct: 68 SFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWIC-EIVLALEYLH---SKGIIH 123
Query: 370 RDVKSSNILLSENFHHPQLSDFG-AAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGK 428
RD+K NILL E H ++DF A V + S GT GY+APE +
Sbjct: 124 RDIKPDNILLDEQ-GHVHITDFNIATKVTPDTLTTS-------TSGTPGYMAPEVLCRQG 175
Query: 429 VDEKIDVYSYGVVLLELITGK 449
+D +S GV E + GK
Sbjct: 176 YSVAVDWWSLGVTAYECLRGK 196
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 4e-20
Identities = 56/206 (27%), Positives = 96/206 (46%), Gaps = 22/206 (10%)
Query: 260 IGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWSEEE---VLREVELLSSIKHENIVRIIGY 315
IG+G V + DG++ K + N +E+E ++ EV +L +KH NIVR
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDR 67
Query: 316 CHSKE---MYAIVYNLLNGSLKQYLKQLKWNERM---DVAIGV----AKALEYLHHTCDP 365
+ +Y ++ G L Q +++ K + + + AL H+ DP
Sbjct: 68 IIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDP 127
Query: 366 P--IIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEY 423
++HRD+K +NI L N ++ +L DFG A + ++ VGT Y++PE
Sbjct: 128 GNTVLHRDLKPANIFLDAN-NNVKLGDFGLAKILGHDSSFAKTY-----VGTPYYMSPEQ 181
Query: 424 MMYGKVDEKIDVYSYGVVLLELITGK 449
+ + DEK D++S G ++ EL
Sbjct: 182 LNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 4e-20
Identities = 61/223 (27%), Positives = 97/223 (43%), Gaps = 52/223 (23%)
Query: 259 LIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEEVLREVELLSSI-KHENIVRIIG-- 314
+IG+G KVY+ H GQ+ A+K++ EEE+ E +L H NI G
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAF 72
Query: 315 -----YCHSKEMYAI--------VYNLLNGSLKQYLKQLKWNERMDVAI------GVAKA 355
+ +++ + V +L+ G K+ +R+ +
Sbjct: 73 IKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKK-------GKRLKEEWIAYILRETLRG 125
Query: 356 LEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV-SENVKPVNVVG 414
L YLH + +IHRD+K NILL++N +L DFG S Q+ S + +G
Sbjct: 126 LAYLH---ENKVIHRDIKGQNILLTKNA-EVKLVDFG------VSAQLDSTLGRRNTFIG 175
Query: 415 TFGYLAPEYMM--------YGKVDEKIDVYSYGVVLLELITGK 449
T ++APE + Y D + DV+S G+ +EL GK
Sbjct: 176 TPYWMAPEVIACDEQPDASY---DARSDVWSLGITAIELADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 5e-20
Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 32/208 (15%)
Query: 260 IGQGGNSKVYR---TNHVDGQ--VAAVKVLK--CTNWSEEEVLREVELLSSIKHENIVRI 312
+G+G KV D AVK L + RE+E+L ++ HENIV+
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71
Query: 313 IGYC---HSKEMYAIVYNLLNGSLKQYLKQLKWNERMDV------AIGVAKALEYLHHTC 363
G C + + I+ L +GSL+ YL++ + +++++ + + K ++YL
Sbjct: 72 KGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLG--- 126
Query: 364 DPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ--VSENVK--PVNVVGTFGYL 419
IHRD+ + NIL+ E+ ++SDFG A V + + P+ F Y
Sbjct: 127 SQRYIHRDLAARNILV-ESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPI-----FWY- 179
Query: 420 APEYMMYGKVDEKIDVYSYGVVLLELIT 447
APE + K DV+S+GV L EL T
Sbjct: 180 APECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 6e-20
Identities = 62/203 (30%), Positives = 105/203 (51%), Gaps = 20/203 (9%)
Query: 260 IGQGGNSKVYRTNHVD-GQVAAVKVLKC---TNWSEEEVLREVELLSSIKHENIVRIIGY 315
IG G KVY ++D G++ AVK ++ + +E+ E+++L +KH N+V+ G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 316 -CHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDV----AIGVAKALEYLHHTCDPPIIHR 370
H +++Y + G+L++ L+ V + + + L YLH I+HR
Sbjct: 68 EVHREKVYIFMEYCSGGTLEELLE-HGRILDEHVIRVYTLQLLEGLAYLHSH---GIVHR 123
Query: 371 DVKSSNILLSENFHHPQLSDFGAA-MVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKV 429
D+K +NI L N +L DFG A + + + + E V+ ++ GT Y+APE + GK
Sbjct: 124 DIKPANIFLDHN-GVIKLGDFGCAVKLKNNTTTMGEEVQ--SLAGTPAYMAPEVITGGKG 180
Query: 430 DEK---IDVYSYGVVLLELITGK 449
D++S G V+LE+ TGK
Sbjct: 181 KGHGRAADIWSLGCVVLEMATGK 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 3e-19
Identities = 64/205 (31%), Positives = 99/205 (48%), Gaps = 26/205 (12%)
Query: 259 LIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSE------EEVLREVELLSSIKHENIVR 311
L+G G VY N DG AVK + + + +++ +E+ LLS ++H NIV+
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 312 IIGYCHSKEMYAIVYNLLN-GSLKQYLKQLKWNERMDVAIG-----VAKALEYLHHTCDP 365
+G ++ I L+ GSL + LK K+ + I + LEYLH D
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLLK--KYGSFPEPVIRLYTRQILLGLEYLH---DR 121
Query: 366 PIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMM 425
+HRD+K +NIL+ N +L+DFG A QV E + G+ ++APE +
Sbjct: 122 NTVHRDIKGANILVDTN-GVVKLADFGMA------KQVVEFSFAKSFKGSPYWMAPEVIA 174
Query: 426 -YGKVDEKIDVYSYGVVLLELITGK 449
G D++S G +LE+ TGK
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 5e-19
Identities = 58/219 (26%), Positives = 106/219 (48%), Gaps = 45/219 (20%)
Query: 260 IGQGGNSKVYR------TNHVDGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVR 311
+G+G KVY+ + A+K LK ++E +E EL+S ++H NIV
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 312 IIGYCHSKEMYAIVYNLL-NGSLKQYL-------------------KQLKWNERMDVAIG 351
++G C ++ +++ L +G L ++L L ++ + +AI
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 352 VAKALEYL--HHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS---HQVSEN 406
+A +EYL HH +HRD+ + N L+ E ++SDFG + + + S++
Sbjct: 133 IAAGMEYLSSHH-----FVHRDLAARNCLVGEG-LTVKISDFGLSRDIYSADYYRVQSKS 186
Query: 407 VKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLEL 445
+ PV ++ PE ++YGK + D++S+GVVL E+
Sbjct: 187 LLPVR------WMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 5e-19
Identities = 58/204 (28%), Positives = 97/204 (47%), Gaps = 22/204 (10%)
Query: 260 IGQGGNSKVY-RTNHVDGQVAAVKVLKCTNWSEE----EVLREVELLSSIKHENIVRII- 313
I +G +V+ G + A+KV+K + + +VL E ++LS + +V++
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 314 GYCHSKEMYAIVYNLLNGSLKQYLKQL-KWNERMDVAI--GVAKALEYLHHTCDPPIIHR 370
+ K +Y ++ L G L L+ + +E + + ALEYLH IIHR
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSN---GIIHR 117
Query: 371 DVKSSNILLSENFHHPQLSDFG---AAMVHHQSHQVSENVKPVNVVGTFGYLAPEY---M 424
D+K NIL+ N H +L+DFG +V Q + + + +VGT Y+APE
Sbjct: 118 DLKPDNILIDSN-GHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQ 176
Query: 425 MYGKVDEKIDVYSYGVVLLELITG 448
+ K +D +S G +L E + G
Sbjct: 177 GHSK---TVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 5e-19
Identities = 58/210 (27%), Positives = 104/210 (49%), Gaps = 17/210 (8%)
Query: 260 IGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSK 319
+GQG +V+ A+K LK S E L+E +++ ++HE +V++ +
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 73
Query: 320 EMYAIVYNLLNGSLKQYLK-----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKS 374
+Y + + GSL +LK L+ + +D+A +A + Y+ +HRD+++
Sbjct: 74 PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRA 130
Query: 375 SNILLSENFHHPQLSDFG-AAMVHHQSHQVSENVK-PVNVVGTFGYLAPEYMMYGKVDEK 432
+NIL+ EN +++DFG A ++ + + K P+ + APE +YG+ K
Sbjct: 131 ANILVGENL-VCKVADFGLARLIEDNEYTARQGAKFPIK------WTAPEAALYGRFTIK 183
Query: 433 IDVYSYGVVLLELITGKEAIQTNKANRESL 462
DV+S+G++L EL T NRE L
Sbjct: 184 SDVWSFGILLTELTTKGRVPYPGMVNREVL 213
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 6e-19
Identities = 59/210 (28%), Positives = 101/210 (48%), Gaps = 17/210 (8%)
Query: 260 IGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSK 319
+G G +V+ AVK LK S E L E +++ ++H+ +V++ +
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSEE 73
Query: 320 EMYAIVYNLLNGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKS 374
+Y + + GSL +LK LK +D+A VA + Y+ IHRD++S
Sbjct: 74 PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRS 130
Query: 375 SNILLSENFHHPQLSDFG-AAMVHHQSHQVSENVK-PVNVVGTFGYLAPEYMMYGKVDEK 432
+NIL+ + +++DFG A ++ + + K P+ + APE +YG+ K
Sbjct: 131 ANILVGDGLV-CKIADFGLARLIEDNEYTARQGAKFPIK------WTAPEAALYGRFTIK 183
Query: 433 IDVYSYGVVLLELITGKEAIQTNKANRESL 462
DV+S+G++L EL+T NRE L
Sbjct: 184 SDVWSFGILLTELVTKGRVPYPGMNNREVL 213
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 7e-19
Identities = 65/200 (32%), Positives = 100/200 (50%), Gaps = 29/200 (14%)
Query: 260 IGQGGNSKVY-RTNHVDGQVAAVKVL----KCTNWSEEEVLREVELLSSIKHENIVRIIG 314
IG G VY + +V A+K + K +N +++++EV L ++H N + G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 315 YCHSKEMYA-IVYNLLNGS----LKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIH 369
C+ +E A +V GS L+ + K L+ E + G + L YLH IH
Sbjct: 83 -CYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE---RIH 138
Query: 370 RDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVN-VVGTFGYLAPEY---MM 425
RD+K+ NILL+E +L+DFG+A + V P N VGT ++APE M
Sbjct: 139 RDIKAGNILLTEP-GTVKLADFGSASL----------VSPANSFVGTPYWMAPEVILAMD 187
Query: 426 YGKVDEKIDVYSYGVVLLEL 445
G+ D K+DV+S G+ +EL
Sbjct: 188 EGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 2e-18
Identities = 57/210 (27%), Positives = 104/210 (49%), Gaps = 17/210 (8%)
Query: 260 IGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSK 319
+GQG +V+ A+K LK E L+E +++ ++H+ +V + +
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEE 73
Query: 320 EMYAIVYNLLNGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKS 374
+Y + + GSL +LK+ LK + +D+A +A + Y+ IHRD+++
Sbjct: 74 PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRA 130
Query: 375 SNILLSENFHHPQLSDFG-AAMVHHQSHQVSENVK-PVNVVGTFGYLAPEYMMYGKVDEK 432
+NIL+ +N +++DFG A ++ + + K P+ + APE +YG+ K
Sbjct: 131 ANILVGDNLV-CKIADFGLARLIEDNEYTARQGAKFPIK------WTAPEAALYGRFTIK 183
Query: 433 IDVYSYGVVLLELITGKEAIQTNKANRESL 462
DV+S+G++L EL+T NRE L
Sbjct: 184 SDVWSFGILLTELVTKGRVPYPGMVNREVL 213
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 3e-18
Identities = 54/178 (30%), Positives = 95/178 (53%), Gaps = 22/178 (12%)
Query: 280 AVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGSLKQYLK 338
AVK LK ++ L E +++ ++H ++++ C +E IV L+ GSL +YL+
Sbjct: 34 AVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQ 93
Query: 339 -----QLKWNERMDVAIGVAKALEYL--HHTCDPPIIHRDVKSSNILLSENFHHPQLSDF 391
LK + +D+A VA + YL + IHRD+ + N+L+ EN + +++DF
Sbjct: 94 GGAGRALKLPQLIDMAAQVASGMAYLEAQN-----YIHRDLAARNVLVGEN-NICKVADF 147
Query: 392 GAAMVHHQS-HQVSENVK-PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT 447
G A V + ++ E K P+ + APE +Y + K DV+S+G++L E++T
Sbjct: 148 GLARVIKEDIYEAREGAKFPIK------WTAPEAALYNRFSIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 3e-18
Identities = 53/196 (27%), Positives = 99/196 (50%), Gaps = 18/196 (9%)
Query: 260 IGQGGNSKVYRTNHVDGQVAAVKVLKCTN-WSEEEVLREVELLSSIKHENIVRIIGYCHS 318
+G G +V+ + A+K+LK + +++ +EV+ L ++H++++ + C
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73
Query: 319 KEMYAIVYNLL-NGSLKQYL-----KQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDV 372
E I+ L+ GSL +L + L +D+A VA+ + YL + IHRD+
Sbjct: 74 GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDL 130
Query: 373 KSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVK-PVNVVGTFGYLAPEYMMYGKVDE 431
+ NIL+ E+ +++DFG A + + +S + K P + APE +G
Sbjct: 131 AARNILVGEDLV-CKVADFGLARLIKEDVYLSSDKKIPYK------WTAPEAASHGTFST 183
Query: 432 KIDVYSYGVVLLELIT 447
K DV+S+G++L E+ T
Sbjct: 184 KSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 5e-18
Identities = 54/195 (27%), Positives = 98/195 (50%), Gaps = 19/195 (9%)
Query: 257 KMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYC 316
IG+G V ++ GQ AVK LK + + + L E ++++++H N+V+++G
Sbjct: 11 GATIGKGEFGDVMLGDY-RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVV 69
Query: 317 -HSKEMYAIVYNLLNGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHR 370
+Y + + GSL YL+ + +++ A+ V + +EYL + +HR
Sbjct: 70 LQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHR 126
Query: 371 DVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVD 430
D+ + N+L+SE+ ++SDFG A Q + PV + APE + K
Sbjct: 127 DLAARNVLVSEDL-VAKVSDFGLAKEASQGQDSGK--LPVK------WTAPEALREKKFS 177
Query: 431 EKIDVYSYGVVLLEL 445
K DV+S+G++L E+
Sbjct: 178 TKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 5e-18
Identities = 70/207 (33%), Positives = 104/207 (50%), Gaps = 29/207 (14%)
Query: 260 IGQGGNSKVY-RTNHVDGQVAAVKVL----KCTNWSEEEVLREVELLSSIKHENIVRIIG 314
IG G VY TN +V AVK + K TN +++++EV+ L +KH N + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 315 YCHSKEMYA-IVYNLLNGS----LKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIH 369
C+ KE A +V GS L+ + K L+ E + G + L YLH +IH
Sbjct: 89 -CYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIH 144
Query: 370 RDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVN-VVGTFGYLAPEYMMY-- 426
RD+K+ NILL+E +L+DFG+A P N VGT ++APE ++
Sbjct: 145 RDIKAGNILLTEP-GQVKLADFGSASK----------SSPANSFVGTPYWMAPEVILAMD 193
Query: 427 -GKVDEKIDVYSYGVVLLELITGKEAI 452
G+ D K+DV+S G+ +EL K +
Sbjct: 194 EGQYDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 9e-18
Identities = 56/180 (31%), Positives = 89/180 (49%), Gaps = 18/180 (10%)
Query: 276 GQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYC-HSKEMYAIVYNLLNGSLK 334
AVK LK EE L+E ++ IKH N+V+++G C Y I + G+L
Sbjct: 31 SLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 90
Query: 335 QYLKQLKWNERMDV-----AIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLS 389
YL++ E V A ++ A+EYL IHRD+ + N L+ EN H +++
Sbjct: 91 DYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGEN-HLVKVA 146
Query: 390 DFG-AAMVHHQSHQVSENVK-PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT 447
DFG + ++ ++ K P+ + APE + Y K K DV+++GV+L E+ T
Sbjct: 147 DFGLSRLMTGDTYTAHAGAKFPIK------WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 2e-17
Identities = 61/227 (26%), Positives = 107/227 (47%), Gaps = 52/227 (22%)
Query: 260 IGQGGNSKVYR------TNHVDGQVAAVKVLK--CTNWSEEEVLREVELLSSIKHENIVR 311
+G+G KV+ D ++ AVK LK +N + ++ RE ELL++ +HENIV+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 312 IIGYCHSKEMYAIVYNLL-NGSLKQYL-----------------KQLKWNERMDVAIGVA 353
G C + +V+ + +G L ++L +L ++ + +A+ +A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 354 KALEYL--HHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVN 411
+ YL H +HRD+ + N L+ + ++ DFG +S +V +
Sbjct: 133 SGMVYLASQH-----FVHRDLATRNCLVGYDL-VVKIGDFG----------MSRDVYTTD 176
Query: 412 ---VVGT----FGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKE 450
V G ++ PE +MY K + DV+S+GVVL E+ T GK+
Sbjct: 177 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQ 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 2e-17
Identities = 58/206 (28%), Positives = 98/206 (47%), Gaps = 22/206 (10%)
Query: 259 LIGQGGNSKVYRTNHV-DGQVAAVK-VLKCTNWSE------EEVLREVELLSSIKHENIV 310
+G G S Y+ V G + AVK V N S E + +E+ L++ + H +I+
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 311 RIIG-YCHSKEMYAIVYNLLNGSLKQYLKQL-KWNERMDVA--IGVAKALEYLHHTCDPP 366
R++G C V + GS+ L + + E + + + + L YLH +
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLH---ENQ 123
Query: 367 IIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMM- 425
IIHRDVK +N+L+ +++DFGAA + + ++GT ++APE +
Sbjct: 124 IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQG-QLLGTIAFMAPEVLRG 182
Query: 426 --YGKVDEKIDVYSYGVVLLELITGK 449
YG+ DV+S G V++E+ T K
Sbjct: 183 EQYGR---SCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 3e-17
Identities = 58/193 (30%), Positives = 103/193 (53%), Gaps = 19/193 (9%)
Query: 260 IGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSK 319
IG+G V + + GQ AVK +KC + + + L E +++ + H+N+VR++G
Sbjct: 14 IGEGEFGAVLQGEYT-GQKVAVKNIKC-DVTAQAFLEETAVMTKLHHKNLVRLLGVILHN 71
Query: 320 EMYAIVYNLLNGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKS 374
+Y ++ + G+L +L+ + + + ++ VA+ +EYL ++HRD+ +
Sbjct: 72 GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAA 128
Query: 375 SNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKID 434
NIL+SE+ ++SDFG A V S V + PV + APE + + K K D
Sbjct: 129 RNILVSED-GVAKVSDFGLARV--GSMGVDNSKLPVK------WTAPEALKHKKFSSKSD 179
Query: 435 VYSYGVVLLELIT 447
V+SYGV+L E+ +
Sbjct: 180 VWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 3e-17
Identities = 59/205 (28%), Positives = 90/205 (43%), Gaps = 37/205 (18%)
Query: 260 IGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSE-EEVLREVELLSSIKHENIVRIIG--- 314
IG G VY+ G++ A+KV+K + E + +E+ +L +H NIV G
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 315 ----------YCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVAKALEYLHHTCD 364
YC + I Y + G L + V K L YLH T
Sbjct: 71 RRDKLWIVMEYCGGGSLQDI-YQVTRGPLSELQIAY-------VCRETLKGLAYLHET-- 120
Query: 365 PPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVN-VVGTFGYLAPEY 423
IHRD+K +NILL+E+ +L+DFG S Q++ + +GT ++APE
Sbjct: 121 -GKIHRDIKGANILLTED-GDVKLADFGV------SAQLTATIAKRKSFIGTPYWMAPEV 172
Query: 424 M---MYGKVDEKIDVYSYGVVLLEL 445
G D K D+++ G+ +EL
Sbjct: 173 AAVERKGGYDGKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 3e-17
Identities = 53/185 (28%), Positives = 91/185 (49%), Gaps = 14/185 (7%)
Query: 283 VLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLLNG-SLKQYLKQLK 341
V+K N E+ + ++H NIV++IG C S++ +++ + G +L + L+ L
Sbjct: 719 VVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNLS 778
Query: 342 WNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLS-ENFHHPQLSDFGAAMVHHQS 400
W R +AIG+AKAL +LH C P ++ ++ I++ ++ H +LS G +
Sbjct: 779 WERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKC 838
Query: 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRE 460
S Y+APE + EK D+Y +G++L+EL+TGK
Sbjct: 839 FISS------------AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHG 886
Query: 461 SLVLW 465
S+V W
Sbjct: 887 SIVEW 891
|
Length = 968 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 4e-17
Identities = 63/205 (30%), Positives = 92/205 (44%), Gaps = 32/205 (15%)
Query: 261 GQGGN-SKVYRTNHVDGQVAAVKVLKCTNWSE--EEVLREVELLSSIKHENIVRIIGYC- 316
G GG+ +K N G + A+K + + +++LRE+E+ S K IV+ G
Sbjct: 12 GAGGSVTKCRLKN--TGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFL 69
Query: 317 --HSKEMYAIVYNLLNGSLKQYLKQLK-----WNERM--DVAIGVAKALEYLHHTCDPPI 367
S + + GSL K++K E++ +A V K L YLH I
Sbjct: 70 DESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKI 126
Query: 368 IHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS-ENVKPV--NVVGTFGYLAPEYM 424
IHRD+K SNILL+ +L DFG VS E V + GT Y+APE +
Sbjct: 127 IHRDIKPSNILLTRK-GQVKLCDFG----------VSGELVNSLAGTFTGTSFYMAPERI 175
Query: 425 MYGKVDEKIDVYSYGVVLLELITGK 449
DV+S G+ LLE+ +
Sbjct: 176 QGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 6e-17
Identities = 57/207 (27%), Positives = 95/207 (45%), Gaps = 33/207 (15%)
Query: 259 LIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEEV----LREVELLSSIKHENIVRII 313
++G+G V + + G++ A+K K + +E+V LREV++L ++HENIV +
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFK-ESEDDEDVKKTALREVKVLRQLRHENIVNLK 66
Query: 314 GYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAI------GVAKALEYLHHTCDPPI 367
K +V+ + +L + L+ + + +A+ Y H I
Sbjct: 67 EAFRRKGRLYLVFEYVERTLLELLEASPGG--LPPDAVRSYIWQLLQAIAYCHSH---NI 121
Query: 368 IHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPV--NVVGTFGYLAPE--- 422
IHRD+K NIL+SE+ +L DFG A + + V T Y APE
Sbjct: 122 IHRDIKPENILVSES-GVLKLCDFGFA------RALRARPASPLTDYVATRWYRAPELLV 174
Query: 423 -YMMYGKVDEKIDVYSYGVVLLELITG 448
YGK +DV++ G ++ EL+ G
Sbjct: 175 GDTNYGK---PVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 8e-17
Identities = 64/186 (34%), Positives = 98/186 (52%), Gaps = 26/186 (13%)
Query: 276 GQVAAVKVLKCTNWSE-EEVLREVELLSSIKHENIVRIIGYCHS---KEMYAIVYNLLNG 331
G+V AVK L+ + + RE+E+L S++H+NIV+ G C+S + + ++ L G
Sbjct: 33 GEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYG 92
Query: 332 SLKQYLKQLKWNERMD------VAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHH 385
SL+ YL+ K ER+D A + K +EYL +HRD+ + NIL+ E+ +
Sbjct: 93 SLRDYLQ--KHRERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILV-ESENR 146
Query: 386 PQLSDFGAAMVHHQS---HQVSE-NVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVV 441
++ DFG V Q ++V E P+ F Y APE + K DV+S+GVV
Sbjct: 147 VKIGDFGLTKVLPQDKEYYKVREPGESPI-----FWY-APESLTESKFSVASDVWSFGVV 200
Query: 442 LLELIT 447
L EL T
Sbjct: 201 LYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 9e-17
Identities = 68/209 (32%), Positives = 106/209 (50%), Gaps = 29/209 (13%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSI-KHENIVRIIGYCH 317
IG+G KVY+ TN DG +AAVK+L + +EE+ E +L S+ H N+V+ G +
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89
Query: 318 SKEMYA-----IVYNLLNG-SLKQYLKQL-KWNERMDVAI------GVAKALEYLHHTCD 364
+ +V L NG S+ + +K L +R+D A+ G L++LH+
Sbjct: 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN-- 147
Query: 365 PPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYM 424
IIHRDVK +NILL+ +L DFG + + S ++ VGT ++APE +
Sbjct: 148 -RIIHRDVKGNNILLTTE-GGVKLVDFGVS-----AQLTSTRLRRNTSVGTPFWMAPEVI 200
Query: 425 MYGK-----VDEKIDVYSYGVVLLELITG 448
+ D + DV+S G+ +EL G
Sbjct: 201 ACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 1e-16
Identities = 59/226 (26%), Positives = 100/226 (44%), Gaps = 29/226 (12%)
Query: 253 NFSPKMLIGQGGNSKVYRT-NHVDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHEN 308
+F IG+G V++ D +V A+K + + + EE + E +L+ +
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 309 IVRII-GYCHSKEMYAIVYNLLNGSLKQYLK---------QLKWNERMDVAIGVAKALEY 358
I+R + ++ ++ NG L + LK W + + +G L +
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG----LAH 116
Query: 359 LHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGY 418
LH I+HRD+KS N+ L + + ++ D G A + + +VGT Y
Sbjct: 117 LHSK---KILHRDIKSLNLFLDA-YDNVKIGDLGVAKLLSDN-----TNFANTIVGTPYY 167
Query: 419 LAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVL 464
L+PE +EK DV++ GVVL E TGK N N+ +L+L
Sbjct: 168 LSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDAN--NQGALIL 211
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 1e-16
Identities = 65/222 (29%), Positives = 109/222 (49%), Gaps = 35/222 (15%)
Query: 260 IGQGGNSK-VYRTNHVDGQVAAVK---VLKCTNWSEEEVLREVELLSSIKHENIVR---- 311
IG+G K + + DG+ +K + K + EE +EV +LS++KH NIV+
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67
Query: 312 ---------IIGYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVAKALEYLHHT 362
++ YC ++Y + N G L + L W + + AL+++H
Sbjct: 68 FEENGNLYIVMDYCEGGDLYKKI-NAQRGVLFPEDQILDW------FVQICLALKHVH-- 118
Query: 363 CDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPE 422
D I+HRD+KS NI L+++ +L DFG A V + + +++ +GT YL+PE
Sbjct: 119 -DRKILHRDIKSQNIFLTKD-GTIKLGDFGIARVLNSTVELAR-----TCIGTPYYLSPE 171
Query: 423 YMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVL 464
+ K D+++ G VL E+ T K A + N ++LVL
Sbjct: 172 ICENRPYNNKSDIWALGCVLYEMCTLKHAFEA--GNMKNLVL 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 3e-16
Identities = 48/183 (26%), Positives = 91/183 (49%), Gaps = 31/183 (16%)
Query: 280 AVKVLKCTN--WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLLNGSLKQYL 337
A+KVL+ + +E+L E +++S+ H ++VR++G C S ++ I + G L Y+
Sbjct: 40 AIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLSSQVQLITQLMPLGCLLDYV 99
Query: 338 KQ----------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQ 387
+ L W + +AK + YL + ++HRD+ + N+L+ + H +
Sbjct: 100 RNHKDNIGSQYLLNWCVQ------IAKGMSYLE---EKRLVHRDLAARNVLV-KTPQHVK 149
Query: 388 LSDFGAAM---VHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLE 444
++DFG A V + + P+ ++A E +++ K DV+SYGV + E
Sbjct: 150 ITDFGLAKLLDVDEKEYHAEGGKVPIK------WMALESILHRIYTHKSDVWSYGVTVWE 203
Query: 445 LIT 447
L+T
Sbjct: 204 LMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 7e-16
Identities = 60/196 (30%), Positives = 101/196 (51%), Gaps = 16/196 (8%)
Query: 260 IGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEE-VLREVELLSSIKHENIVRII-GYC 316
IGQG + VY V GQ A+K + ++E ++ E+ ++ KH NIV + Y
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 317 HSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAI--GVAKALEYLHHTCDPPIIHRDVKS 374
E++ ++ L GSL + + +E A+ +ALE+LH +IHRD+KS
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKS 143
Query: 375 SNILLSENFHHPQLSDFGAAMVHHQSHQVS-ENVKPVNVVGTFGYLAPEYMMYGKVDEKI 433
NILL + +L+DFG Q++ E K +VGT ++APE + K+
Sbjct: 144 DNILLGMD-GSVKLTDFGFCA------QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 196
Query: 434 DVYSYGVVLLELITGK 449
D++S G++ +E++ G+
Sbjct: 197 DIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 9e-16
Identities = 54/211 (25%), Positives = 99/211 (46%), Gaps = 43/211 (20%)
Query: 260 IGQGGNSKVYRTNHVD-GQVAAVKVL---KCTNWSEEEVLREVELLSSIKHENIVRIIG- 314
IG+G + V++ + G+ A+K + + + LRE++ L + +H +V+++
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 315 YCHSKEMYAIVYNLLNGSLKQYLK---------QLKWNERMDVAIGVAKALEYLHHTCDP 365
+ H +V + L + L+ Q+K RM + K + Y+H
Sbjct: 68 FPHGSGFV-LVMEYMPSDLSEVLRDEERPLPEAQVKSYMRM-----LLKGVAYMH---AN 118
Query: 366 PIIHRDVKSSNILLSENFHHPQLSDFGAAMV------HHQSHQVSENVKPVNVVGTFGYL 419
I+HRD+K +N+L+S + +++DFG A + SHQ V T Y
Sbjct: 119 GIMHRDLKPANLLISAD-GVLKIADFGLARLFSEEEPRLYSHQ----------VATRWYR 167
Query: 420 APEYMMYG--KVDEKIDVYSYGVVLLELITG 448
APE ++YG K D +D+++ G + EL+ G
Sbjct: 168 APE-LLYGARKYDPGVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 9e-16
Identities = 53/196 (27%), Positives = 102/196 (52%), Gaps = 18/196 (9%)
Query: 260 IGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSK 319
+G G +V+ + + AVK LK S + L E L+ +++H+ +VR+ +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKE 73
Query: 320 E-MYAIVYNLLNGSLKQYLK-----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVK 373
E +Y I + GSL +LK ++ + +D + +A+ + Y+ IHRD++
Sbjct: 74 EPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLR 130
Query: 374 SSNILLSENFHHPQLSDFG-AAMVHHQSHQVSENVK-PVNVVGTFGYLAPEYMMYGKVDE 431
++N+L+SE+ +++DFG A ++ + E K P+ + APE + +G
Sbjct: 131 AANVLVSESLM-CKIADFGLARVIEDNEYTAREGAKFPIK------WTAPEAINFGSFTI 183
Query: 432 KIDVYSYGVVLLELIT 447
K DV+S+G++L E++T
Sbjct: 184 KSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 9e-16
Identities = 61/215 (28%), Positives = 94/215 (43%), Gaps = 42/215 (19%)
Query: 259 LIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEE--VLREVE-LLSSIKHENIVRIIG 314
IG+G V + H G + AVK ++ T +E+ +L +++ ++ S IV+ G
Sbjct: 11 EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYG 70
Query: 315 YCHSK---------------EMYAIVYNLLNGSLKQYLKQLKWNERM--DVAIGVAKALE 357
+ + Y VY +L + E + +A+ KAL
Sbjct: 71 ALFREGDCWICMELMDISLDKFYKYVYEVLKSVI---------PEEILGKIAVATVKALN 121
Query: 358 YLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFG 417
YL IIHRDVK SNILL N + +L DFG S Q+ +++ G
Sbjct: 122 YLKEELK--IIHRDVKPSNILLDRN-GNIKLCDFGI------SGQLVDSIAKTRDAGCRP 172
Query: 418 YLAPEYM---MYGKVDEKIDVYSYGVVLLELITGK 449
Y+APE + D + DV+S G+ L E+ TGK
Sbjct: 173 YMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 9e-16
Identities = 64/216 (29%), Positives = 101/216 (46%), Gaps = 36/216 (16%)
Query: 259 LIGQGGNSKVYRTNHVD-------GQVAAVKVLKCTNWSEE--EVLREVELLSSIKHENI 309
+G G +VY D AVK L+ +E E L+E L+S+ H NI
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 310 VRIIGYCHSKE-MYAIVYNLLNGSLKQYLKQ----------LKWNERMDVAIGVAKALEY 358
V+++G C E Y I+ + G L YL+ L E +D+ + VAK Y
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121
Query: 359 LHHTCDPPIIHRDVKSSNILLSENFHHP----QLSDFGAAMVHHQS---HQVSENVKPVN 411
L IHRD+ + N L+SE + ++ DFG A ++S + E + PV
Sbjct: 122 LEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR 178
Query: 412 VVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT 447
++APE ++ GK + DV+S+GV++ E++T
Sbjct: 179 ------WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 1e-15
Identities = 65/205 (31%), Positives = 98/205 (47%), Gaps = 23/205 (11%)
Query: 259 LIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEE---EVLR---EVELLSSIKHENIVR 311
L+GQG +VY VD G+ AVK + S E EV E++LL +++HE IV+
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 312 IIGYCHSKEMYAIVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPI 367
G E +I + GS+K LK L + + +EYLH I
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLH---SNMI 125
Query: 368 IHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMM-- 425
+HRD+K +NIL + +L DFGA+ +K V GT +++PE +
Sbjct: 126 VHRDIKGANILRDSA-GNVKLGDFGASKRLQTICSSGTGMKS--VTGTPYWMSPEVISGE 182
Query: 426 -YGKVDEKIDVYSYGVVLLELITGK 449
YG+ K DV+S G ++E++T K
Sbjct: 183 GYGR---KADVWSVGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 66/206 (32%), Positives = 104/206 (50%), Gaps = 23/206 (11%)
Query: 260 IGQGGNSKVYRT-NHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIK-HENIVRIIGYCH 317
IG+G KV++ N +G AAVK+L + +EE+ E +L ++ H N+V+ G +
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYY 85
Query: 318 SKEMYA-----IVYNLLNG-SLKQYLKQ-LKWNERMD---VAIGVAKALEYLHHTCDPPI 367
K++ +V L NG S+ +K LK ERM+ +A + +AL L H
Sbjct: 86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKT 145
Query: 368 IHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYM--- 424
IHRDVK +NILL+ +L DFG + + S ++ VGT ++APE +
Sbjct: 146 IHRDVKGNNILLTTE-GGVKLVDFGVS-----AQLTSTRLRRNTSVGTPFWMAPEVIACE 199
Query: 425 --MYGKVDEKIDVYSYGVVLLELITG 448
+ D + DV+S G+ +EL G
Sbjct: 200 QQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 1e-15
Identities = 57/210 (27%), Positives = 96/210 (45%), Gaps = 25/210 (11%)
Query: 253 NFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWSE---EEVLREVELLSSIKHEN 308
+F +G+G VY+ + D Q A+K + + S+ E+ + E+ +L+S+ H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 309 IVR-----IIG--YCHSKEMYAIVYNLLN--GSLKQYLKQLKWNERMDVAIGVAKALEYL 359
I+ + G C E YA +L K+ K + E + I + + L+ L
Sbjct: 61 IISYKEAFLDGNKLCIVME-YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119
Query: 360 HHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYL 419
H + I+HRD+KS+NILL N ++ D G + +V + +GT Y+
Sbjct: 120 H---EQKILHRDLKSANILLVANDLV-KIGDLGIS-------KVLKKNMAKTQIGTPHYM 168
Query: 420 APEYMMYGKVDEKIDVYSYGVVLLELITGK 449
APE K D++S G +L E+ T
Sbjct: 169 APEVWKGRPYSYKSDIWSLGCLLYEMATFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 1e-15
Identities = 59/194 (30%), Positives = 95/194 (48%), Gaps = 17/194 (8%)
Query: 259 LIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEV--LREVELLSSIKHENIVRIIGYC 316
L+G+G +V++ D AVK K E ++ L E +L H NIV++IG C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 317 HSKEMYAIVYNLLNGS-----LKQYLKQLKWNERMDVAIGVAKALEYLH-HTCDPPIIHR 370
++ IV L+ G L++ +LK + + A+ A + YL C IHR
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNC----IHR 117
Query: 371 DVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVD 430
D+ + N L+ EN + ++SDFG + S +K + + T APE + YG+
Sbjct: 118 DLAARNCLVGEN-NVLKISDFGMSRQEDDGIYSSSGLKQIPIKWT----APEALNYGRYS 172
Query: 431 EKIDVYSYGVVLLE 444
+ DV+SYG++L E
Sbjct: 173 SESDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 1e-15
Identities = 60/196 (30%), Positives = 102/196 (52%), Gaps = 16/196 (8%)
Query: 260 IGQGGNSKV-YRTNHVDGQVAAVKVLKCTNWSEEEVL-REVELLSSIKHENIVRIIG-YC 316
IG+G V T+ G+ AVK + E+L EV ++ +H NIV + Y
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86
Query: 317 HSKEMYAIVYNLLNGSLKQYLKQLKWNERM--DVAIGVAKALEYLHHTCDPPIIHRDVKS 374
E++ ++ L G+L + + NE V + V KAL +LH +IHRD+KS
Sbjct: 87 VGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKS 143
Query: 375 SNILLSENFHHPQLSDFGAAMVHHQSHQVSENV-KPVNVVGTFGYLAPEYMMYGKVDEKI 433
+ILL+ + +LSDFG QVS+ V + ++VGT ++APE + ++
Sbjct: 144 DSILLTSD-GRVKLSDFGFCA------QVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEV 196
Query: 434 DVYSYGVVLLELITGK 449
D++S G++++E++ G+
Sbjct: 197 DIWSLGIMVIEMVDGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 2e-15
Identities = 59/178 (33%), Positives = 88/178 (49%), Gaps = 21/178 (11%)
Query: 280 AVKVLKCTN--WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLLN-GSLKQY 336
AVK LK + ++E LRE +++ + H IVR+IG C E +V L G L +Y
Sbjct: 27 AVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPLGPLLKY 85
Query: 337 LKQLKWNERMDV---AIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFG- 392
LK+ + D+ A VA + YL +HRD+ + N+LL N H ++SDFG
Sbjct: 86 LKKRREIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLL-VNRHQAKISDFGM 141
Query: 393 --AAMVHHQSHQVSENVK-PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT 447
A ++ + + P+ + APE + YGK K DV+SYGV L E +
Sbjct: 142 SRALGAGSDYYRATTAGRWPLK------WYAPECINYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 58/201 (28%), Positives = 102/201 (50%), Gaps = 27/201 (13%)
Query: 260 IGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSE-EEVLREVELLSSIKHENIVRII-GYC 316
+G G KVY+ H + G AA K+++ + E E+ + E+++LS KH NIV + Y
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 317 HSKEMYAIVYNLLNGSLKQYLKQLK--WNERMDVAIG--VAKALEYLHHTCDPPIIHRDV 372
+ +++ ++ G+L + +L+ E + + +AL +LH +IHRD+
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDL 129
Query: 373 KSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMM------- 425
K+ NILL+ + +L+DFG + + S K +GT ++APE +
Sbjct: 130 KAGNILLTLD-GDVKLADFGVS-----AKNKSTLQKRDTFIGTPYWMAPEVVACETFKDN 183
Query: 426 -YGKVDEKIDVYSYGVVLLEL 445
Y D K D++S G+ L+EL
Sbjct: 184 PY---DYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 67/200 (33%), Positives = 103/200 (51%), Gaps = 29/200 (14%)
Query: 260 IGQGGNSKVYRTNHV-DGQVAAVKVL----KCTNWSEEEVLREVELLSSIKHENIVRIIG 314
IG G VY V + +V A+K + K +N +++++EV L ++H N ++ G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 315 YCHSKEMYA-IVYNLLNGS----LKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIH 369
C+ +E A +V GS L+ + K L+ E V G + L YLH +IH
Sbjct: 83 -CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIH 138
Query: 370 RDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVN-VVGTFGYLAPEYMMY-- 426
RDVK+ NILLSE +L DFG+A + + P N VGT ++APE ++
Sbjct: 139 RDVKAGNILLSEP-GLVKLGDFGSASI----------MAPANXFVGTPYWMAPEVILAMD 187
Query: 427 -GKVDEKIDVYSYGVVLLEL 445
G+ D K+DV+S G+ +EL
Sbjct: 188 EGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 3e-15
Identities = 68/220 (30%), Positives = 108/220 (49%), Gaps = 26/220 (11%)
Query: 260 IGQGGNSKV--YR---TNHVDGQVAAVKVLK--CTNWSEEEVLREVELLSSIKHENIVRI 312
+G+G KV Y N G++ AVK LK C + +E+ +L ++ HENIV+
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 313 IGYCHS---KEMYAIVYNLLNGSLKQYLKQLKWN--ERMDVAIGVAKALEYLHHTCDPPI 367
G C K + I+ + GSL+ YL + K N + + A + + + YLH
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQ---HY 128
Query: 368 IHRDVKSSNILLSENFHHPQLSDFGAAMV---HHQSHQVSEN-VKPVNVVGTFGYLAPEY 423
IHRD+ + N+LL +N ++ DFG A H+ ++V E+ PV F Y A E
Sbjct: 129 IHRDLAARNVLL-DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV-----FWY-AVEC 181
Query: 424 MMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLV 463
+ K DV+S+GV L EL+T ++ Q+ E ++
Sbjct: 182 LKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMI 221
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 4e-15
Identities = 49/195 (25%), Positives = 102/195 (52%), Gaps = 17/195 (8%)
Query: 260 IGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSK 319
+G G +V+ + AVK +K + S E L E ++ +++H+ +V++ +
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKE 73
Query: 320 EMYAIVYNLLNGSLKQYLKQLKWNER-----MDVAIGVAKALEYLHHTCDPPIIHRDVKS 374
+Y I + GSL +LK + +++ +D + +A+ + ++ IHRD+++
Sbjct: 74 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRA 130
Query: 375 SNILLSENFHHPQLSDFG-AAMVHHQSHQVSENVK-PVNVVGTFGYLAPEYMMYGKVDEK 432
+NIL+S + +++DFG A ++ + E K P+ + APE + +G K
Sbjct: 131 ANILVSASL-VCKIADFGLARVIEDNEYTAREGAKFPIK------WTAPEAINFGSFTIK 183
Query: 433 IDVYSYGVVLLELIT 447
DV+S+G++L+E++T
Sbjct: 184 SDVWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 4e-15
Identities = 68/222 (30%), Positives = 100/222 (45%), Gaps = 34/222 (15%)
Query: 260 IGQGGNSKVY-RTNHVDGQVAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVR---- 311
IG+G K+Y D + +K + T +E +EV LL+ +KH NIV
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67
Query: 312 ---------IIGYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVAKALEYLHHT 362
++ YC ++ + N G L + L W + +++G L H
Sbjct: 68 FQENGRLFIVMEYCDGGDLMKRI-NRQRGVLFSEDQILSW--FVQISLG-------LKHI 117
Query: 363 CDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPE 422
D I+HRD+KS NI LS+N +L DFG A + S +++ VGT YL+PE
Sbjct: 118 HDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAY-----TCVGTPYYLSPE 172
Query: 423 YMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVL 464
+ K D++S G VL EL T K + N N LVL
Sbjct: 173 ICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN--NLHQLVL 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 5e-15
Identities = 62/196 (31%), Positives = 102/196 (52%), Gaps = 16/196 (8%)
Query: 260 IGQGGNSKV-YRTNHVDGQVAAVKVLKCTNWSEEEVL-REVELLSSIKHENIVRII-GYC 316
IG+G V T G+ AVK + E+L EV ++ HEN+V + Y
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 317 HSKEMYAIVYNLLNGSLKQYLKQLKWNERM--DVAIGVAKALEYLHHTCDPPIIHRDVKS 374
E++ ++ L G+L + + NE V + V +AL YLH + +IHRD+KS
Sbjct: 90 VGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKS 146
Query: 375 SNILLSENFHHPQLSDFGAAMVHHQSHQVSENV-KPVNVVGTFGYLAPEYMMYGKVDEKI 433
+ILL+ + +LSDFG QVS+ V K ++VGT ++APE + ++
Sbjct: 147 DSILLTSD-GRIKLSDFGFCA------QVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEV 199
Query: 434 DVYSYGVVLLELITGK 449
D++S G++++E+I G+
Sbjct: 200 DIWSLGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 6e-15
Identities = 65/231 (28%), Positives = 108/231 (46%), Gaps = 24/231 (10%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEV----LREVELLSSIKHENIVRIIG 314
+G+G + VY+ + ++GQ+ A+KV+ +EE V +RE LL +KH NIV +
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMK--TEEGVPFTAIREASLLKGLKHANIVLLHD 70
Query: 315 YCHSKEMYAIVYNLLNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHR 370
H+KE V+ ++ L QY+ Q L + + L Y+H I+HR
Sbjct: 71 IIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHR 127
Query: 371 DVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVD 430
D+K N+L+S +L+DFG A ++ + VV T Y P+ ++ G D
Sbjct: 128 DLKPQNLLIS-YLGELKLADFGLA----RAKSIPSQTYSSEVV-TLWYRPPDVLL-GATD 180
Query: 431 --EKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWYYVLAGKVFAQQWP 479
+D++ G + +E++ G+ A E L + VL G WP
Sbjct: 181 YSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVL-GVPTEDTWP 230
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 6e-15
Identities = 60/196 (30%), Positives = 102/196 (52%), Gaps = 16/196 (8%)
Query: 260 IGQGGNSKV-YRTNHVDGQVAAVKVLKCTNWSEEEVL-REVELLSSIKHENIVRII-GYC 316
IG+G V T G++ AVK + E+L EV ++ +HEN+V + Y
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 317 HSKEMYAIVYNLLNGSLKQYLKQLKWNERM--DVAIGVAKALEYLHHTCDPPIIHRDVKS 374
E++ ++ L G+L + + NE V + V KAL LH +IHRD+KS
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKS 144
Query: 375 SNILLSENFHHPQLSDFGAAMVHHQSHQVSENV-KPVNVVGTFGYLAPEYMMYGKVDEKI 433
+ILL+ + +LSDFG QVS+ V + ++VGT ++APE + ++
Sbjct: 145 DSILLTHD-GRVKLSDFGFCA------QVSKEVPRRKSLVGTPYWMAPELISRLPYGPEV 197
Query: 434 DVYSYGVVLLELITGK 449
D++S G++++E++ G+
Sbjct: 198 DIWSLGIMVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 6e-15
Identities = 56/213 (26%), Positives = 100/213 (46%), Gaps = 44/213 (20%)
Query: 260 IGQGGNSKVYRT-NHVDGQVAAVKVLKCTNWSEEE-----VLREVELLSSIKHENIVR-- 311
IG+G VYR + G++ A+K ++ N E + LRE+ LL +++H NIV
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDN--ERDGIPISSLREITLLLNLRHPNIVELK 72
Query: 312 -------------IIGYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVAKALEY 358
++ YC +++ +++ N+ + +K L + + + L+Y
Sbjct: 73 EVVVGKHLDSIFLVMEYC-EQDLASLLDNMPTPFSESQVKCL--------MLQLLRGLQY 123
Query: 359 LHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFG-AAMVHHQSHQVSENVKPVNVVGTFG 417
LH IIHRD+K SN+LL++ +++DFG A + ++ V T
Sbjct: 124 LHENF---IIHRDLKVSNLLLTDK-GCLKIADFGLARTYGLPAKPMTPKVV------TLW 173
Query: 418 YLAPEYMMYGKV-DEKIDVYSYGVVLLELITGK 449
Y APE ++ ID+++ G +L EL+ K
Sbjct: 174 YRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 6e-15
Identities = 49/179 (27%), Positives = 84/179 (46%), Gaps = 21/179 (11%)
Query: 280 AVKVLKCTNWSE--EEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLLNGSLKQYL 337
AVK LK S+ ++ L+E ++ S+ HEN++R+ G + + + GSL L
Sbjct: 27 AVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLMMVTELAPLGSLLDRL 86
Query: 338 KQLKWNERM-----DVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFG 392
++ + D A+ +A + YL IHRD+ + NILL+ + ++ DFG
Sbjct: 87 RKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASD-DKVKIGDFG 142
Query: 393 ---AAMVHHQSHQVSENVK-PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT 447
A + + + E++K P F + APE + DV+ +GV L E+ T
Sbjct: 143 LMRALPQNEDHYVMEEHLKVP------FAWCAPESLRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 7e-15
Identities = 55/202 (27%), Positives = 99/202 (49%), Gaps = 28/202 (13%)
Query: 260 IGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWSEEEV--LREVELLSSIK-HENIVRIIGY 315
IG+G S+V + G+ A+K +K S E+V LRE++ L + H NI+R+I
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEV 66
Query: 316 CHSKEM--YAIVYNLLNGSL-------KQYLKQLKWNERMDVAIGVAKALEYLHHTCDPP 366
++ A+V+ L++ +L K+ L + + M + K+L+++H
Sbjct: 67 LFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYM---YQLLKSLDHMHRN---G 120
Query: 367 IIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY 426
I HRD+K NIL+ +L+DFG+ + +E + T Y APE ++
Sbjct: 121 IFHRDIKPENILI--KDDILKLADFGSCRGIYSKPPYTE------YISTRWYRAPECLLT 172
Query: 427 -GKVDEKIDVYSYGVVLLELIT 447
G K+D+++ G V E+++
Sbjct: 173 DGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 7e-15
Identities = 62/197 (31%), Positives = 106/197 (53%), Gaps = 18/197 (9%)
Query: 260 IGQGGNSKV--YRTNHVDGQVAAVKVLKCTNWSEEEVL-REVELLSSIKHENIVRII-GY 315
IG+G V R H QVA VK++ E+L EV ++ +H+N+V + Y
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVA-VKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 316 CHSKEMYAIVYNLLNGSLKQYLKQLKWNERM--DVAIGVAKALEYLHHTCDPPIIHRDVK 373
+E++ ++ L G+L + Q + NE V V +AL YLH +IHRD+K
Sbjct: 88 LVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIK 144
Query: 374 SSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV-KPVNVVGTFGYLAPEYMMYGKVDEK 432
S +ILL+ + +LSDFG Q+S++V K ++VGT ++APE + +
Sbjct: 145 SDSILLTLD-GRVKLSDFGFCA------QISKDVPKRKSLVGTPYWMAPEVISRTPYGTE 197
Query: 433 IDVYSYGVVLLELITGK 449
+D++S G++++E++ G+
Sbjct: 198 VDIWSLGIMVIEMVDGE 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 7e-15
Identities = 68/207 (32%), Positives = 105/207 (50%), Gaps = 31/207 (14%)
Query: 254 FSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVL----KCTNWSEEEVLREVELLSSIKHEN 308
F+ IG G VY V +V A+K + K +N +++++EV+ L IKH N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 309 IVRIIGYCHSKEMYA-IVYNLLNGS----LKQYLKQLKWNERMDVAIGVAKALEYLH-HT 362
+ G C+ +E A +V GS L+ + K L+ E + G + L YLH H
Sbjct: 87 SIEYKG-CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN 145
Query: 363 CDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVN-VVGTFGYLAP 421
+IHRD+K+ NILL+E +L+DFG+A + P N VGT ++AP
Sbjct: 146 ----MIHRDIKAGNILLTEP-GQVKLADFGSASI----------ASPANSFVGTPYWMAP 190
Query: 422 EYMMY---GKVDEKIDVYSYGVVLLEL 445
E ++ G+ D K+DV+S G+ +EL
Sbjct: 191 EVILAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 7e-15
Identities = 61/231 (26%), Positives = 100/231 (43%), Gaps = 37/231 (16%)
Query: 260 IGQGGNSKVYR--TNHVDG----QVAAVKVLK--CTNWSEEEVLREVELLSSIKHENIVR 311
+G G +VY DG AVK L C+ E + L E ++S H+NIVR
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 312 IIGYCHSKEMYAIVYNLL-NGSLKQYLK----------QLKWNERMDVAIGVAKALEYLH 360
+IG + I+ L+ G LK +L+ L + + A VAK +YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 361 HTCDPPIIHRDVKSSNILLSENFHHPQ----LSDFGAAMVHHQSHQVSENVK---PVNVV 413
+ IHRD+ + N LL+ P ++DFG A +++ + + P+
Sbjct: 134 ---ENHFIHRDIAARNCLLTCK--GPGRVAKIADFGMARDIYRASYYRKGGRAMLPIK-- 186
Query: 414 GTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVL 464
++ PE + G K DV+S+GV+L E+ + + N+E +
Sbjct: 187 ----WMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEF 233
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 74.8 bits (183), Expect = 8e-15
Identities = 55/195 (28%), Positives = 100/195 (51%), Gaps = 14/195 (7%)
Query: 260 IGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEE-VLREVELLSSIKHENIVRII-GYC 316
IGQG + V+ V GQ A+K + ++E ++ E+ ++ +K+ NIV + +
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 317 HSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAI--GVAKALEYLHHTCDPPIIHRDVKS 374
E++ ++ L GSL + + +E A+ +ALE+LH +IHRD+KS
Sbjct: 87 VGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKS 143
Query: 375 SNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKID 434
N+LL + +L+DFG + E K +VGT ++APE + K+D
Sbjct: 144 DNVLLGMD-GSVKLTDFGFC-----AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 197
Query: 435 VYSYGVVLLELITGK 449
++S G++ +E++ G+
Sbjct: 198 IWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 8e-15
Identities = 57/222 (25%), Positives = 110/222 (49%), Gaps = 44/222 (19%)
Query: 259 LIGQGGNSKVYRT------NHVDGQVAAVKVLKCTNWSEEEV---LREVELLSSI-KHEN 308
+G+G +V + N + AVK+LK + +E+++ + E+E++ I KH+N
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLK-DDATEKDLSDLVSEMEMMKMIGKHKN 77
Query: 309 IVRIIGYCHSK-EMYAIVYNLLNGSLKQYLK-------------------QLKWNERMDV 348
I+ ++G C + +Y +V +G+L+ +L+ L + +
Sbjct: 78 IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137
Query: 349 AIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAM-VHHQSH--QVSE 405
A VA+ +E+L IHRD+ + N+L++E+ H +++DFG A +HH + + +
Sbjct: 138 AYQVARGMEFL---ASKKCIHRDLAARNVLVTED-HVMKIADFGLARDIHHIDYYRKTTN 193
Query: 406 NVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT 447
PV ++APE + + DV+S+GV+L E+ T
Sbjct: 194 GRLPVK------WMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 1e-14
Identities = 52/208 (25%), Positives = 100/208 (48%), Gaps = 17/208 (8%)
Query: 260 IGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSK 319
IG G V+ ++ + A+K ++ SEE+ + E +++ + H +V++ G C +
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTER 71
Query: 320 EMYAIVYNLL-NGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKS 374
+V+ + +G L YL+ + + + + V + + YL + +IHRD+ +
Sbjct: 72 SPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAA 128
Query: 375 SNILLSENFHHPQLSDFGAA-MVHHQSHQVSENVK-PVNVVGTFGYLAPEYMMYGKVDEK 432
N L+ EN ++SDFG V + S K PV + +PE + K K
Sbjct: 129 RNCLVGEN-QVVKVSDFGMTRFVLDDQYTSSTGTKFPVK------WSSPEVFSFSKYSSK 181
Query: 433 IDVYSYGVVLLELITGKEAIQTNKANRE 460
DV+S+GV++ E+ + + N++N E
Sbjct: 182 SDVWSFGVLMWEVFSEGKTPYENRSNSE 209
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-14
Identities = 61/219 (27%), Positives = 112/219 (51%), Gaps = 31/219 (14%)
Query: 259 LIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEE----------EVLR-EVELLSSIKH 306
LIG+G +VY +V G++ AVK ++ + LR E+E L + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 307 ENIVRIIGYCHSKEMYAIVYNLL-NGSLKQYLKQL-KWNERM--DVAIGVAKALEYLHHT 362
NIV+ +G+ ++E +I + GS+ L+ ++ E++ V + L YLH
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLH-- 125
Query: 363 CDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPE 422
I+HRD+K+ N+L+ + ++SDFG + +S + +N + +++ G+ ++APE
Sbjct: 126 -SKGILHRDLKADNLLVDAD-GICKISDFG---ISKKSDDIYDNDQNMSMQGSVFWMAPE 180
Query: 423 YM-MYGK-VDEKIDVYSYGVVLLELITGK------EAIQ 453
+ Y + K+D++S G V+LE+ G+ EAI
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 1e-14
Identities = 63/207 (30%), Positives = 98/207 (47%), Gaps = 24/207 (11%)
Query: 259 LIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEEVLREVELLSSIK-HENIVRIIGYC 316
L+G G +VY+ HV GQ+AA+KV+ T EEE+ +E+ +L H NI G
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 317 HSK-------EMYAIVYNLLNGSLKQYLKQLKWNERMD--VAIGVAKALEYLHHTCDPPI 367
K +++ ++ GS+ +K K N + +A + L L H +
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKV 132
Query: 368 IHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNV-VGTFGYLAPEYMMY 426
IHRD+K N+LL+EN +L DFG S Q+ V N +GT ++APE +
Sbjct: 133 IHRDIKGQNVLLTEN-AEVKLVDFGV------SAQLDRTVGRRNTFIGTPYWMAPEVIAC 185
Query: 427 -----GKVDEKIDVYSYGVVLLELITG 448
D K D++S G+ +E+ G
Sbjct: 186 DENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-14
Identities = 65/217 (29%), Positives = 103/217 (47%), Gaps = 24/217 (11%)
Query: 260 IGQGGNSKVYRTN-HVDGQVAAVKVLKCTNWSE--EEVLREVELLSSIKHENIVRIIGYC 316
IG+G +V+ D AVK + T + + L+E +L H NIVR+IG C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 317 HSKEMYAIVYNLLNGS-----LKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRD 371
K+ IV L+ G L+ +LK E + + A +EYL IHRD
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRD 119
Query: 372 VKSSNILLSENFHHPQLSDFGAAMVHHQSHQV---SENVKPVNVVGTFGYLAPEYMMYGK 428
+ + N L++E + ++SDFG M + V + +K + V T APE + YG+
Sbjct: 120 LAARNCLVTEK-NVLKISDFG--MSREEEDGVYASTGGMKQIPVKWT----APEALNYGR 172
Query: 429 VDEKIDVYSYGVVLLE---LITGKEAIQTNKANRESL 462
+ DV+S+G++L E L A +N+ RE++
Sbjct: 173 YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAI 209
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 65/219 (29%), Positives = 102/219 (46%), Gaps = 34/219 (15%)
Query: 260 IGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEE---EVLREVELLSSIKHENIVRIIGY 315
IGQG +V++ H Q+ A+K + N E LRE+++L +KHEN+V +I
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79
Query: 316 CHSKEMYAIVYNLLNGSL-------KQYLKQLKWNERMDVAIGVAKA--------LEYLH 360
C +K A YN GS + L L N+ + + K L Y+H
Sbjct: 80 CRTK---ATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH 136
Query: 361 HTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLA 420
I+HRD+K++NIL++++ +L+DFG A S N + N V T Y
Sbjct: 137 RN---KILHRDMKAANILITKD-GILKLADFGLARAFSLSKNSKPN-RYTNRVVTLWYRP 191
Query: 421 PEYMM----YGKVDEKIDVYSYGVVLLELITGKEAIQTN 455
PE ++ YG ID++ G ++ E+ T +Q N
Sbjct: 192 PELLLGERDYGP---PIDMWGAGCIMAEMWTRSPIMQGN 227
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 2e-14
Identities = 58/195 (29%), Positives = 99/195 (50%), Gaps = 14/195 (7%)
Query: 260 IGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWSEEE-VLREVELLSSIKHENIVRII-GYC 316
IGQG + VY V GQ A++ + ++E ++ E+ ++ K+ NIV + Y
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 317 HSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAI--GVAKALEYLHHTCDPPIIHRDVKS 374
E++ ++ L GSL + + +E A+ +ALE+LH +IHRD+KS
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKS 144
Query: 375 SNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKID 434
NILL + +L+DFG + E K +VGT ++APE + K+D
Sbjct: 145 DNILLGMD-GSVKLTDFGFC-----AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 198
Query: 435 VYSYGVVLLELITGK 449
++S G++ +E+I G+
Sbjct: 199 IWSLGIMAIEMIEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 2e-14
Identities = 62/237 (26%), Positives = 104/237 (43%), Gaps = 35/237 (14%)
Query: 260 IGQGGNSKVYRT-NHVDGQVAAVKVLKCTNWSE---EEVLREVELLSSIKHENIVRIIGY 315
IG+G V++ N ++ A+K ++ + E LRE+ LL +KH+NIVR+
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 316 CHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAI------GVAKALEYLH-HTCDPPII 368
HS + +V+ + LK+Y N +D I + K L + H H ++
Sbjct: 68 LHSDKKLTLVFEYCDQDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSHN----VL 121
Query: 369 HRDVKSSNILLSENFHHPQLSDFGAAM-----VHHQSHQVSENVKPVNVVGTFGYLAPEY 423
HRD+K N+L+++N +L+DFG A V S +V T Y P+
Sbjct: 122 HRDLKPQNLLINKN-GELKLADFGLARAFGIPVRCYSAEVV----------TLWYRPPDV 170
Query: 424 MMYGKV-DEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWYYVLAGKVFAQQWP 479
+ K+ ID++S G + EL + + L + +L G + WP
Sbjct: 171 LFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL-GTPTEESWP 226
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 3e-14
Identities = 50/205 (24%), Positives = 93/205 (45%), Gaps = 30/205 (14%)
Query: 260 IGQGGNSKVYRT-NHVDGQVAAVKVLKC---TNWSEEEVLREVELLSSIKHENIVRIIGY 315
IG+G VY+ + + G++ A+K +K + + LRE++LL + H NI++++
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 316 CHSKEMYAIVYNLLNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLH-HTCDPPIIHR 370
K +V+ ++ L + +K L + + + L + H H I+HR
Sbjct: 67 FRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG----ILHR 122
Query: 371 DVKSSNILLSENFHHPQLSDFGAAMVHHQS-----HQVSENVKPVNVVGTFGYLAPEYMM 425
D+K N+L++ +L+DFG A H V T Y APE ++
Sbjct: 123 DLKPENLLINTE-GVLKLADFGLARSFGSPVRPYTHYVV----------TRWYRAPELLL 171
Query: 426 YGKV-DEKIDVYSYGVVLLELITGK 449
K +D++S G + EL++ +
Sbjct: 172 GDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 3e-14
Identities = 57/218 (26%), Positives = 99/218 (45%), Gaps = 41/218 (18%)
Query: 253 NFSPKMLIGQGGNSKVYRT-NHVDGQVAAVKVLKCTNWSE---EEVLREVELLSSIKHEN 308
NF IG+G VY+ N + G+V A+K ++ +E +RE+ LL + H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 309 IVRIIGYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVA----IGVAKALEYLHHT-- 362
IV+++ H++ +V+ L+ LK++ MD + I + YL
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQDLKKF---------MDASPLSGIPLPLIKSYLFQLLQ 111
Query: 363 ----CDP-PIIHRDVKSSNILLSENFHHPQLSDFGAAM-----VHHQSHQVSENVKPVNV 412
C ++HRD+K N+L++ +L+DFG A V +H+V
Sbjct: 112 GLAFCHSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVV-------- 162
Query: 413 VGTFGYLAPEYMMYGKV-DEKIDVYSYGVVLLELITGK 449
T Y APE ++ K +D++S G + E++T +
Sbjct: 163 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 3e-14
Identities = 60/197 (30%), Positives = 94/197 (47%), Gaps = 17/197 (8%)
Query: 260 IGQGGNSKVYR--TNHVDGQVAAVKVLKCTNWSEE--EVLREVELLSSIKHENIVRIIG- 314
IG+G +VY+ N +V A+K++ +E ++ +E+ +LS I R G
Sbjct: 12 IGKGSFGEVYKGIDNRTK-EVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGS 70
Query: 315 YCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAI--GVAKALEYLHHTCDPPIIHRDV 372
Y +++ I+ L GS LK E I + K L+YLH IHRD+
Sbjct: 71 YLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERK---IHRDI 127
Query: 373 KSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEK 432
K++N+LLSE +L+DFG A +K VGT ++APE + D K
Sbjct: 128 KAANVLLSEQ-GDVKLADFGVA-----GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFK 181
Query: 433 IDVYSYGVVLLELITGK 449
D++S G+ +EL G+
Sbjct: 182 ADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 3e-14
Identities = 57/185 (30%), Positives = 98/185 (52%), Gaps = 23/185 (12%)
Query: 276 GQVAAVKVLKCTNWSEE--EVLREVELLSSIKHENIVRIIGYCHS---KEMYAIVYNLLN 330
G+ AVK LK + ++ +E+E+L ++ HENIV+ G C + I+ L +
Sbjct: 33 GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 92
Query: 331 GSLKQYL----KQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHP 386
GSLK+YL ++ +++ A+ + K ++YL +HRD+ + N+L+ E+ H
Sbjct: 93 GSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLV-ESEHQV 148
Query: 387 QLSDFG---AAMVHHQSHQVSENV-KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVL 442
++ DFG A + + V +++ PV F Y APE ++ K DV+S+GV L
Sbjct: 149 KIGDFGLTKAIETDKEYYTVKDDLDSPV-----FWY-APECLIQSKFYIASDVWSFGVTL 202
Query: 443 LELIT 447
EL+T
Sbjct: 203 YELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 3e-14
Identities = 50/205 (24%), Positives = 92/205 (44%), Gaps = 30/205 (14%)
Query: 260 IGQGGNSKVY----RTNHVDGQVAAVKVLK--CTNWSEEEVLREVELLSSIKHENIVRII 313
IG G +V + A+K LK ++ + L E ++ H NI+R+
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 314 GYCHSKEMYAIVYNLL-NGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPII 368
G I+ + NGSL ++L+ + + + + G+A ++YL +
Sbjct: 72 GVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN---YV 128
Query: 369 HRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFG------YLAPE 422
HRD+ + NIL++ N ++SDFG + + E+ + T G + APE
Sbjct: 129 HRDLAARNILVNSNLV-CKVSDFGLS-------RRLEDSEAT--YTTKGGKIPIRWTAPE 178
Query: 423 YMMYGKVDEKIDVYSYGVVLLELIT 447
+ Y K DV+S+G+V+ E+++
Sbjct: 179 AIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 4e-14
Identities = 54/181 (29%), Positives = 93/181 (51%), Gaps = 24/181 (13%)
Query: 280 AVKVLKCT-NWSEEEVL-REVELLSSI-KHENIVRIIGYC-HSKEMYAIVYNLLNGSLKQ 335
AVK+LK T + SE E L E++++S + HENIV ++G C + I G L
Sbjct: 69 AVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLN 128
Query: 336 YLKQ-----LKWNERMDVAIGVAKALEYL-HHTCDPPIIHRDVKSSNILLSENFHHPQLS 389
+L++ L + + + VAK + +L C IHRD+ + N+LL+ ++
Sbjct: 129 FLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNVLLTHG-KIVKIC 183
Query: 390 DFGAA--MVHHQSHQVSENVK-PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELI 446
DFG A +++ ++ V N + PV ++APE + + DV+SYG++L E+
Sbjct: 184 DFGLARDIMNDSNYVVKGNARLPVK------WMAPESIFNCVYTFESDVWSYGILLWEIF 237
Query: 447 T 447
+
Sbjct: 238 S 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 4e-14
Identities = 54/198 (27%), Positives = 107/198 (54%), Gaps = 21/198 (10%)
Query: 260 IGQGGNSKVYRT-NHVDGQVAAVKVLKCTNWSE-EEVLREVELLSSIKHENIVRIIG-YC 316
+G G KVY+ N G +AA KV++ + E E+ + E+E+L++ H IV+++G +
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 317 HSKEMYAIVYNLLNGSLKQYL----KQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDV 372
+++ ++ G++ + + L + + + +AL+YLH IIHRD+
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDL 136
Query: 373 KSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKV--- 429
K+ N+LL+ + +L+DFG + + ++ Q + + +GT ++APE +M +
Sbjct: 137 KAGNVLLTLD-GDIKLADFGVSAKNVKTLQ-----RRDSFIGTPYWMAPEVVMCETMKDT 190
Query: 430 --DEKIDVYSYGVVLLEL 445
D K D++S G+ L+E+
Sbjct: 191 PYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 5e-14
Identities = 57/239 (23%), Positives = 100/239 (41%), Gaps = 38/239 (15%)
Query: 260 IGQGGNSKVYR-------TNHVDGQVAAVKVLKCTNWSEE-EVLREVELLSSIKHENIVR 311
+GQG VY + +VA V + + E E L E ++ ++VR
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 312 IIGYCHSKEMYAIVYNLLN-GSLKQYLKQLKWNER-------------MDVAIGVAKALE 357
++G + + +V L+ G LK YL+ + + +A +A +
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 358 YLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVK---PVNVVG 414
YL +HRD+ + N +++E+ ++ DFG +++ + K PV
Sbjct: 134 YLAAK---KFVHRDLAARNCMVAEDLT-VKIGDFGMTRDIYETDYYRKGGKGLLPVR--- 186
Query: 415 TFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWYYVLAGKV 473
++APE + G K DV+S+GVVL E+ T E +N E L +V+ G
Sbjct: 187 ---WMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVL---KFVIDGGH 239
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 5e-14
Identities = 66/233 (28%), Positives = 111/233 (47%), Gaps = 28/233 (12%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEE-----VLREVELLSSIKHENIVRII 313
+G+G + VY+ + V+G++ A+KV++ EEE +RE LL +KH NIV +
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRL---QEEEGTPFTAIREASLLKGLKHANIVLLH 69
Query: 314 GYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMD----VAIGVAKALEYLHHTCDPPIIH 369
H+KE +V+ ++ L QY+ + + + + L Y+H I+H
Sbjct: 70 DIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---ILH 126
Query: 370 RDVKSSNILLSENFHHPQLSDFGAAMVHH-QSHQVSENVKPVNVVGTFGYLAPEYMMYGK 428
RD+K N+L+S+ +L+DFG A SH S N V T Y P+ ++ G
Sbjct: 127 RDLKPQNLLISDT-GELKLADFGLARAKSVPSHTYS------NEVVTLWYRPPDVLL-GS 178
Query: 429 VDEK--IDVYSYGVVLLELITGKEAIQTNKANRESLVLWYYVLAGKVFAQQWP 479
+ +D++ G + +E+I G A K ++ L + VL G WP
Sbjct: 179 TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVL-GTPNEDTWP 230
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 6e-14
Identities = 56/232 (24%), Positives = 96/232 (41%), Gaps = 65/232 (28%)
Query: 260 IGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEE-----VLREVELLSSIKHENIVRII 313
+G+G +VY+ + G+V A+K K +E++ LRE+++L +KH N+V +I
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALK--KILMHNEKDGFPITALREIKILKKLKHPNVVPLI 73
Query: 314 G--YCHSKEMY---AIVYNL-------LNGSL------------KQYLKQLKWNERMDVA 349
+ VY + L+G L K Y+ QL
Sbjct: 74 DMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQL--------- 124
Query: 350 IGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQL--SDFGAAMVHHQSHQVSENV 407
+ + YLH + I+HRD+K++NIL+ + L +DFG A + +
Sbjct: 125 ---LEGINYLH---ENHILHRDIKAANILID---NQGILKIADFGLARPYDGPPPNPKGG 175
Query: 408 KPV------NVVGTFGYLAPEYMM----YGKVDEKIDVYSYGVVLLELITGK 449
N+V T Y PE ++ Y +D++ G V E+ T +
Sbjct: 176 GGGGTRKYTNLVVTRWYRPPELLLGERRYTT---AVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 6e-14
Identities = 55/205 (26%), Positives = 101/205 (49%), Gaps = 30/205 (14%)
Query: 259 LIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEE------VLREVELLSSIKHENIVR 311
L+G+G V + H + GQ+ A+K SE++ +RE+ +L ++HEN+V
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFL---ESEDDKMVKKIAMREIRMLKQLRHENLVN 64
Query: 312 IIGYCHSKEMYAIVYNLLNGS----LKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPI 367
+I K+ +V+ ++ + L++Y L + + + +E+ H I
Sbjct: 65 LIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH---NI 121
Query: 368 IHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMM-- 425
IHRD+K NIL+S++ +L DFG A +V + V T Y APE ++
Sbjct: 122 IHRDIKPENILVSQS-GVVKLCDFGFARTLAAPGEVY-----TDYVATRWYRAPELLVGD 175
Query: 426 --YGKVDEKIDVYSYGVVLLELITG 448
YG+ +D+++ G ++ E++TG
Sbjct: 176 TKYGR---AVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 72.1 bits (176), Expect = 6e-14
Identities = 56/195 (28%), Positives = 99/195 (50%), Gaps = 14/195 (7%)
Query: 260 IGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWSEEE-VLREVELLSSIKHENIVRII-GYC 316
IGQG + VY + GQ A+K + ++E ++ E+ ++ K+ NIV + Y
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 317 HSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAI--GVAKALEYLHHTCDPPIIHRDVKS 374
E++ ++ L GSL + + +E A+ +AL++LH +IHRD+KS
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKS 143
Query: 375 SNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKID 434
NILL + +L+DFG + E K +VGT ++APE + K+D
Sbjct: 144 DNILLGMD-GSVKLTDFGFC-----AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 197
Query: 435 VYSYGVVLLELITGK 449
++S G++ +E++ G+
Sbjct: 198 IWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 7e-14
Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 24/207 (11%)
Query: 259 LIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEEVLREVELLSSIK-HENIVRIIGYC 316
++G G +VY+ HV GQ+AA+KV+ T EEE+ E+ +L H NI G
Sbjct: 23 VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAF 82
Query: 317 -------HSKEMYAIVYNLLNGSLKQYLKQLKWNERMD--VAIGVAKALEYLHHTCDPPI 367
H +++ ++ GS+ +K K N + +A + L L H +
Sbjct: 83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKV 142
Query: 368 IHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNV-VGTFGYLAPEYMMY 426
IHRD+K N+LL+EN +L DFG S Q+ V N +GT ++APE +
Sbjct: 143 IHRDIKGQNVLLTEN-AEVKLVDFGV------SAQLDRTVGRRNTFIGTPYWMAPEVIAC 195
Query: 427 -----GKVDEKIDVYSYGVVLLELITG 448
D + D++S G+ +E+ G
Sbjct: 196 DENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 9e-14
Identities = 60/232 (25%), Positives = 114/232 (49%), Gaps = 25/232 (10%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEE----EVLREVELLSSIKHENIVRIIG 314
+G+G + VY+ N G++ A+K + +EE +RE+ L+ +KHENIVR+
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLD--AEEGTPSTAIREISLMKELKHENIVRLHD 65
Query: 315 YCHSKEMYAIVYNLLNGSLKQYLK------QLKWNERMDVAIGVAKALEYLHHTCDPPII 368
H++ +V+ ++ LK+Y+ L N + K + + H + ++
Sbjct: 66 VIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVL 122
Query: 369 HRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGK 428
HRD+K N+L+++ +L+DFG A ++ + N VV T Y AP+ ++ +
Sbjct: 123 HRDLKPQNLLINKR-GELKLADFGLA----RAFGIPVNTFSNEVV-TLWYRAPDVLLGSR 176
Query: 429 V-DEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWYYVLAGKVFAQQWP 479
ID++S G ++ E+ITG+ + N + L+ + ++ G WP
Sbjct: 177 TYSTSIDIWSVGCIMAEMITGR-PLFPGTNNEDQLLKIFRIM-GTPTESTWP 226
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 9e-14
Identities = 55/203 (27%), Positives = 97/203 (47%), Gaps = 24/203 (11%)
Query: 260 IGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEE-----VLREVELLSSIKHENIVRII 313
IG+G VY+ + GQ+ A+K ++ SEEE +RE+ LL ++H NIV +
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLE--SEEEGVPSTAIREISLLKELQHPNIVCLQ 65
Query: 314 GYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAI------GVAKALEYLHHTCDPPI 367
+ +++ L+ LK+YL L + MD + + + + + H +
Sbjct: 66 DVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RV 122
Query: 368 IHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYG 427
+HRD+K N+L+ +L+DFG A ++ + V VV T Y APE ++
Sbjct: 123 LHRDLKPQNLLIDNK-GVIKLADFGLA----RAFGIPVRVYTHEVV-TLWYRAPEVLLGS 176
Query: 428 -KVDEKIDVYSYGVVLLELITGK 449
+ +D++S G + E+ T K
Sbjct: 177 PRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 28/205 (13%)
Query: 259 LIGQGGNSKVYRTNHV----DGQVAAVKVLKCTNWSEEEVLR---EVELLSSIKHENIVR 311
++GQG KV+ + GQ+ A+KVLK + +R E ++L+ + H IV+
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 312 IIGYCHSKE--MYAIVYNLLNGSLKQYL-KQLKWNERMDVAIGVAK---ALEYLHHTCDP 365
+ Y E +Y I+ L G L L K++ + E DV +A+ AL++LH
Sbjct: 63 L-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE-DVKFYLAELALALDHLHSL--- 117
Query: 366 PIIHRDVKSSNILLSENFHHPQLSDFGAA--MVHHQSHQVSENVKPVNVVGTFGYLAPEY 423
II+RD+K NILL E H +L+DFG + + H+ K + GT Y+APE
Sbjct: 118 GIIYRDLKPENILLDEE-GHIKLTDFGLSKESIDHEK-------KAYSFCGTVEYMAPEV 169
Query: 424 MMYGKVDEKIDVYSYGVVLLELITG 448
+ + D +S+GV++ E++TG
Sbjct: 170 VNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 60/204 (29%), Positives = 104/204 (50%), Gaps = 29/204 (14%)
Query: 260 IGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWSEEEVL----REVELLSSIKHENIVRIIG 314
IG G VY+ H G++ A+KV+ + E+ V RE+E+L + H N+V+
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHD 139
Query: 315 -YCHSKEMYAIVYNLLNGSLKQYLKQLKWNERM--DVAIGVAKALEYLHHTCDPPIIHRD 371
+ H+ E+ ++ + GSL+ +E+ DVA + + YLH I+HRD
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLE---GTHIADEQFLADVARQILSGIAYLHRR---HIVHRD 193
Query: 372 VKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVN-VVGTFGYLAPEY----MMY 426
+K SN+L++ + +++DFG + + Q+ + P N VGT Y++PE + +
Sbjct: 194 IKPSNLLINSA-KNVKIADFGVSRILAQT------MDPCNSSVGTIAYMSPERINTDLNH 246
Query: 427 GKVDEKI-DVYSYGVVLLELITGK 449
G D D++S GV +LE G+
Sbjct: 247 GAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (175), Expect = 1e-13
Identities = 58/204 (28%), Positives = 96/204 (47%), Gaps = 33/204 (16%)
Query: 260 IGQGGNSKVYRTNHVD-GQVAAVKVLK----CTNWSEEEVLREVELLSSIKHENIVRIIG 314
+G G +V H G+ A+K+L E VL E +L SI+H +V + G
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68
Query: 315 -YCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDV------AIGVAKALEYLHHTCDPPI 367
+ +Y ++ + G L +L++ + R A V ALEYLH D I
Sbjct: 69 SFQDDSNLYLVMEYVPGGELFSHLRK---SGRFPEPVARFYAAQVVLALEYLHS-LD--I 122
Query: 368 IHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMM-- 425
++RD+K N+LL + + +++DFG A V + GT YLAPE ++
Sbjct: 123 VYRDLKPENLLLDSD-GYIKITDFGFAKR------VKGRTY--TLCGTPEYLAPEIILSK 173
Query: 426 -YGKVDEKIDVYSYGVVLLELITG 448
YGK +D ++ G+++ E++ G
Sbjct: 174 GYGK---AVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 71.1 bits (175), Expect = 1e-13
Identities = 56/219 (25%), Positives = 95/219 (43%), Gaps = 53/219 (24%)
Query: 259 LIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEV------LREVELLSSIKHENIVR 311
+G+G + VY+ + G++ A+K +K E + LRE++LL +KH NI+
Sbjct: 7 KLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIG 66
Query: 312 IIG-YCHSKEMYAIVYNLLNGSL----------------KQYLKQLKWNERMDVAIGVAK 354
++ + H + +V+ + L K Y+ +
Sbjct: 67 LLDVFGHKSNIN-LVFEFMETDLEKVIKDKSIVLTPADIKSYMLMT------------LR 113
Query: 355 ALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVG 414
LEYLH I+HRD+K +N+L++ + +L+DFG A S N K + V
Sbjct: 114 GLEYLHSNW---ILHRDLKPNNLLIASD-GVLKLADFGLARSF-----GSPNRKMTHQVV 164
Query: 415 TFGYLAPEYMM----YGKVDEKIDVYSYGVVLLELITGK 449
T Y APE + YG +D++S G + EL+
Sbjct: 165 TRWYRAPELLFGARHYGV---GVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 1e-13
Identities = 67/230 (29%), Positives = 108/230 (46%), Gaps = 28/230 (12%)
Query: 259 LIGQGGNSKVYRTNHVDGQVAAVK--VLKCTNWSEEE-----VLREVELLSSIKHENIVR 311
++G+G VY GQ+ AVK L +N E + EV+LL S+KH NIV+
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 312 IIGYCHSKEMYAIVYNLL-NGSLKQYLKQLKWNERMDVAIGVAKALE---YLHHTCDPPI 367
+G C +I + GS+ L + + L+ YLH+ C +
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC---V 123
Query: 368 IHRDVKSSNILLSENFHHPQLSDFGAA----MVH-HQSHQVSENVKPVNVVGTFGYLAPE 422
+HRD+K +N++L N +L DFG A V H +H S +K ++ GT ++APE
Sbjct: 124 VHRDIKGNNVMLMPN-GIIKLIDFGCARRLAWVGLHGTH--SNMLKSMH--GTPYWMAPE 178
Query: 423 YMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWYYVLAGK 472
+ K D++S G + E+ TGK + A+ + L +Y+ A +
Sbjct: 179 VINESGYGRKSDIWSIGCTVFEMATGKPPL----ASMDRLAAMFYIGAHR 224
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 64/205 (31%), Positives = 100/205 (48%), Gaps = 25/205 (12%)
Query: 259 LIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEE--EVLREVE-LLSSIKHENIVRIIG 314
IG G +VY+ G V AVK ++ T EE +L +++ +L S IV+ G
Sbjct: 22 EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYG 81
Query: 315 YCHSKEMYAIVYNLLNGSLKQYLKQLK--WNERM--DVAIGVAKALEYLHHTCDPPIIHR 370
Y + I L++ L + LK+++ E + + + + KAL YL +IHR
Sbjct: 82 YFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG--VIHR 139
Query: 371 DVKSSNILLSENFHHPQLSDFGAA--MVHHQSHQVSENVKPVNVVGTFGYLAPEYM---- 424
DVK SNILL + + +L DFG + +V ++ S G Y+APE +
Sbjct: 140 DVKPSNILLDAS-GNVKLCDFGISGRLVDSKAKTRS--------AGCAAYMAPERIDPPD 190
Query: 425 MYGKVDEKIDVYSYGVVLLELITGK 449
K D + DV+S G+ L+EL TG+
Sbjct: 191 PNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 2e-13
Identities = 62/219 (28%), Positives = 103/219 (47%), Gaps = 44/219 (20%)
Query: 259 LIGQGGNSKVY-RTNHVDGQVAAVKVLKCTNWSE----------EEVLREVELLSSIKHE 307
LIG G VY N G++ AVK ++ + S + + RE+ LL ++HE
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 308 NIVRIIGYCHSKEMYAI---------VYNLLN--GSL-----KQYLKQLKWNERMDVAIG 351
NIV+ +G + I V LLN G+ + +++Q
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQ------------ 114
Query: 352 VAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFG-AAMVHHQSHQVSENVKPV 410
+ K L YLH+ IIHRD+K +NIL+ +N ++SDFG + + S N
Sbjct: 115 ILKGLNYLHNR---GIIHRDIKGANILV-DNKGGIKISDFGISKKLEANSLSTKTNGARP 170
Query: 411 NVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
++ G+ ++APE + K D++S G +++E++TGK
Sbjct: 171 SLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 2e-13
Identities = 53/188 (28%), Positives = 88/188 (46%), Gaps = 17/188 (9%)
Query: 280 AVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYC-HSKEMYAIVYNLLNGSLKQYLK 338
A+K + SEE+ + E +++ + H +V++ G C K +Y + + NG L YL+
Sbjct: 32 AIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLR 91
Query: 339 QLKWNERMDVAIG----VAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA 394
Q + D+ + V + +EYL IHRD+ + N L+S ++SDFG
Sbjct: 92 QRQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSST-GVVKVSDFGMT 147
Query: 395 -MVHHQSHQVSENVK-PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAI 452
V + S K PV + PE + K K DV+S+GV++ E+ T +
Sbjct: 148 RYVLDDEYTSSSGAKFPVK------WSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMP 201
Query: 453 QTNKANRE 460
K+N E
Sbjct: 202 FEKKSNYE 209
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 2e-13
Identities = 60/242 (24%), Positives = 106/242 (43%), Gaps = 41/242 (16%)
Query: 228 EKLAVLEAEGSSRRFTSQELCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVA--AVKVLK 285
+ L +E G +F LC Q + K + N AVKVL+
Sbjct: 5 QPLNFVEKLGE-GQFGEVHLCE---ADGL-----QDFSEKAFAENDNADAPVLVAVKVLR 55
Query: 286 CTNWSE--EEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV-YNLLNGSLKQYL----- 337
E+ L+EV++LS + NI R++G C ++ + NG L Q+L
Sbjct: 56 PDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVA 115
Query: 338 ---------KQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQL 388
K L ++ + +A +A + YL +HRD+ + N L+ +N+ ++
Sbjct: 116 ETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLVGKNY-TIKI 171
Query: 389 SDFGAAMVHHQS--HQVSEN-VKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLEL 445
+DFG + + S ++V P+ ++A E ++ GK K DV+++GV L E+
Sbjct: 172 ADFGMSRNLYSSDYYRVQGRAPLPIR------WMAWESVLLGKFTTKSDVWAFGVTLWEI 225
Query: 446 IT 447
+T
Sbjct: 226 LT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 3e-13
Identities = 54/187 (28%), Positives = 94/187 (50%), Gaps = 21/187 (11%)
Query: 271 TNHVDGQVAAVKVLK---CTNWSEEEVLREVELLSSIKHENIVRI--IGYCHSKEMYAIV 325
+ + GQ A+K + T + RE++LL ++HENI+ + I +++Y V
Sbjct: 30 RDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY-FV 88
Query: 326 YNLLNGSLKQYLKQLKWNERMD--VAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENF 383
LL L + L ++ + + L+Y+H ++HRD+K SNIL++EN
Sbjct: 89 TELLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENC 145
Query: 384 HHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMM-YGKVDEKIDVYSYGVVL 442
++ DFG A + Q Q++ V T Y APE M+ + K D ++D++S G +
Sbjct: 146 DL-KICDFGLARI--QDPQMT------GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIF 196
Query: 443 LELITGK 449
E++ GK
Sbjct: 197 AEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 3e-13
Identities = 55/198 (27%), Positives = 95/198 (47%), Gaps = 19/198 (9%)
Query: 260 IGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSE-----EEVLREVELLSSIKHENIVRIIG 314
IG+G +V++ +D + V +K + E E++ +E+ +LS + + G
Sbjct: 12 IGKGSFGEVFKG--IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 315 -YCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAI--GVAKALEYLHHTCDPPIIHRD 371
Y +++ I+ L GS L+ ++E + + K L+YLH IHRD
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLH---SEKKIHRD 126
Query: 372 VKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDE 431
+K++N+LLSE +L+DFG A +K VGT ++APE + D
Sbjct: 127 IKAANVLLSEQ-GDVKLADFGVA-----GQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDS 180
Query: 432 KIDVYSYGVVLLELITGK 449
K D++S G+ +EL G+
Sbjct: 181 KADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 4e-13
Identities = 64/220 (29%), Positives = 109/220 (49%), Gaps = 35/220 (15%)
Query: 260 IGQGGNSKVYRT-NHVDGQVAAVKVLKCTNWSEEE-----VLREVELLSSIKHENIVRI- 312
IG+G +VY+ + G++ A+K ++ N E+E +RE+++L + H NIV +
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVRLDN--EKEGFPITAIREIKILRQLNHRNIVNLK 72
Query: 313 ---------IGYCHSKEMYAIVYNLLNGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHH 361
+ + K + +V+ ++ L L+ + ++E + + + LE L++
Sbjct: 73 EIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSED-HIKSFMKQLLEGLNY 131
Query: 362 TCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKP-VNVVGTFGYLA 420
+HRD+K SNILL+ N +L+DFG A +++ SE +P N V T Y
Sbjct: 132 CHKKNFLHRDIKCSNILLN-NKGQIKLADFGLARLYN-----SEESRPYTNKVITLWYRP 185
Query: 421 PEYM----MYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456
PE + YG IDV+S G +L EL T K Q N+
Sbjct: 186 PELLLGEERYGPA---IDVWSCGCILGELFTKKPIFQANQ 222
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 4e-13
Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 25/207 (12%)
Query: 257 KMLIGQGGNSKVYRTNHVDGQVA-AVKVLKCTNWSEEEVL-REVELLSSIKHENIVRIIG 314
++++G+G VY + QV A+K + + + L E+ L S +KH NIV+ +G
Sbjct: 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLG 72
Query: 315 YCHSKEMYAI-VYNLLNGSLKQYLKQ----LKWNERMDVAIG--VAKALEYLHHTCDPPI 367
+ I + + GSL L+ LK NE+ + + + L+YLH D I
Sbjct: 73 SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQI 129
Query: 368 IHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYM--- 424
+HRD+K N+L++ ++SDFG + + +E GT Y+APE +
Sbjct: 130 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT-----GTLQYMAPEVIDKG 184
Query: 425 --MYGKVDEKIDVYSYGVVLLELITGK 449
YG D++S G ++E+ TGK
Sbjct: 185 PRGYGA---PADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.9 bits (172), Expect = 4e-13
Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 41/215 (19%)
Query: 259 LIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEE-----VLREVELLSSIKHENIVRI 312
IG G V + G+ A+K K +N ++ +LRE++LL ++HENI+ +
Sbjct: 7 PIGSGAYGVVCSAVDKRTGRKVAIK--KISNVFDDLIDAKRILREIKLLRHLRHENIIGL 64
Query: 313 I------GYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIG------VAKALEYLH 360
+ ++Y IV L+ L + +K + + + + L+YLH
Sbjct: 65 LDILRPPSPEDFNDVY-IVTELMETDLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLH 120
Query: 361 HTCDPPIIHRDVKSSNILLSENFHHPQLS--DFGAAMVHHQSHQVSENVKPVNV---VGT 415
+ + +IHRD+K SNIL++ N L DFG A + + + V T
Sbjct: 121 -SAN--VIHRDLKPSNILVNSNC---DLKICDFGLARG-----VDPDEDEKGFLTEYVVT 169
Query: 416 FGYLAPEYMM-YGKVDEKIDVYSYGVVLLELITGK 449
Y APE ++ + + ID++S G + EL+T K
Sbjct: 170 RWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 4e-13
Identities = 57/225 (25%), Positives = 105/225 (46%), Gaps = 22/225 (9%)
Query: 251 THNFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSE----EEVLREVELLSSIK 305
NF + IG+G S VY+ +DG+V A+K ++ + ++ L+E++LL +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 306 HENIVRIIGYCHSKEMYAIVYNLLN-GSLKQYLKQLKWNERM-------DVAIGVAKALE 357
H N+++ + IV L + G L + +K K +R+ + + ALE
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 358 YLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFG 417
++H I+HRD+K +N+ ++ +L D G S+ ++VGT
Sbjct: 121 HMHSK---RIMHRDIKPANVFITAT-GVVKLGDLGLGRFFS-----SKTTAAHSLVGTPY 171
Query: 418 YLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESL 462
Y++PE + + K D++S G +L E+ + +K N SL
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL 216
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 5e-13
Identities = 63/233 (27%), Positives = 106/233 (45%), Gaps = 28/233 (12%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEE-----VLREVELLSSIKHENIVRII 313
+G+G + VY+ + + GQ+ A+K ++ EE +RE LL +KH NIV +
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRL---EHEEGAPFTAIREASLLKDLKHANIVTLH 69
Query: 314 GYCHSKEMYAIVYNLLNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIH 369
H+K+ +V+ L+ LKQY+ L + + + L Y H ++H
Sbjct: 70 DIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLH 126
Query: 370 RDVKSSNILLSENFHHPQLSDFGAAMVHH-QSHQVSENVKPVNVVGTFGYLAPEYMMYGK 428
RD+K N+L+SE +L+DFG A S S N V T Y P+ ++ G
Sbjct: 127 RDLKPQNLLISER-GELKLADFGLARAKSVPSKTYS------NEVVTLWYRPPDVLL-GS 178
Query: 429 VD--EKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWYYVLAGKVFAQQWP 479
+ +D++ G + E+ TG+ + + L + VL G + WP
Sbjct: 179 TEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVL-GTPTEETWP 230
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 5e-13
Identities = 59/231 (25%), Positives = 96/231 (41%), Gaps = 32/231 (13%)
Query: 260 IGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIKH-----ENIVRII 313
I +G VY G A+KVLK ++ + + V+ +I + ++
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 314 GYCHSKEMYAIVYNLLNG----SLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIH 369
SK+ +V LNG SL + L L + V +E LH IIH
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLH---QRGIIH 120
Query: 370 RDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV-KPVNVVGTFGYLAPEYMMYGK 428
RD+K N+L+ + H +L+DFG +S N + VGT YLAPE ++
Sbjct: 121 RDIKPENLLIDQT-GHLKLTDFG----------LSRNGLENKKFVGTPDYLAPETILGVG 169
Query: 429 VDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWYYVLAGKVFAQQWP 479
D+ D +S G V+ E + G + ++ +L+ ++ WP
Sbjct: 170 DDKMSDWWSLGCVIFEFLFGYPPFHAETPDA----VFDNILSRRI---NWP 213
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 5e-13
Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 36/207 (17%)
Query: 260 IGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEE------VLREVELLSSIKHENIVRI 312
IG+G V++ + + GQ+ A+K K SE++ LRE+ +L +KH N+V +
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIK--KFVE-SEDDPVIKKIALREIRMLKQLKHPNLVNL 65
Query: 313 IGYCHSKEMYAIV-----YNLLNGSLKQYLKQLKWNERMDVAIGVAKALEYLH-HTCDPP 366
I K +V + +LN L++ + + + + +A+ + H H C
Sbjct: 66 IEVFRRKRKLHLVFEYCDHTVLN-ELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNC--- 121
Query: 367 IIHRDVKSSNILLSENFHHPQLSDFG-AAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMM 425
IHRDVK NIL+++ +L DFG A ++ ++ V T Y APE ++
Sbjct: 122 -IHRDVKPENILITKQ-GQIKLCDFGFARILTGPGDDYTD------YVATRWYRAPELLV 173
Query: 426 ----YGKVDEKIDVYSYGVVLLELITG 448
YG +DV++ G V EL+TG
Sbjct: 174 GDTQYGP---PVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 5e-13
Identities = 66/214 (30%), Positives = 96/214 (44%), Gaps = 29/214 (13%)
Query: 257 KMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWSEEEVLR---EVELLSSIKHENIVRI 312
++G G V V DG+ AVKV+ SE + R EV L + +IV+
Sbjct: 37 SRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVK- 95
Query: 313 IGYCH------------SKEMYAIVYNLLN-GSLKQYLKQLKWNERM----DVAIGVAKA 355
CH + M A+V + N G L+Q +K R + + +
Sbjct: 96 ---CHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQV 152
Query: 356 LEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGT 415
L +HH +IHRD+KS+NILL N +L DFG + VS++V GT
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSN-GLVKLGDFG--FSKMYAATVSDDVGR-TFCGT 208
Query: 416 FGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
Y+APE +K D++S GV+L EL+T K
Sbjct: 209 PYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLK 242
|
Length = 496 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 5e-13
Identities = 58/213 (27%), Positives = 98/213 (46%), Gaps = 27/213 (12%)
Query: 254 FSPKMLIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEE---EVLREVELLSSIK---H 306
+ P IG G VY+ G A+K ++ + +REV LL ++ H
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61
Query: 307 ENIVRIIGYCHSKEM-----YAIVYNLLNGSLKQYLKQ-----LKWNERMDVAIGVAKAL 356
NIVR++ C + +V+ ++ L+ YL + L D+ + L
Sbjct: 62 PNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGL 121
Query: 357 EYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTF 416
++LH C I+HRD+K NIL++ +L+DFG A ++ S Q++ + PV V T
Sbjct: 122 DFLHANC---IVHRDLKPENILVTSG-GQVKLADFGLARIY--SCQMA--LTPVVV--TL 171
Query: 417 GYLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
Y APE ++ +D++S G + E+ K
Sbjct: 172 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 7e-13
Identities = 43/179 (24%), Positives = 92/179 (51%), Gaps = 23/179 (12%)
Query: 280 AVKVLKCTNWSEEEVLREVE----LLSSIKHENIVRIIGYCHSKEMYAIVYNLLNGSLKQ 335
A+K ++ + S + +E+ + S+ H IVR++G C + + GSL
Sbjct: 40 AIKTIQ--DRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGASLQLVTQLSPLGSLLD 97
Query: 336 YLKQLKWN----ERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDF 391
+++Q + + ++ + +AK + YL ++HR++ + NILL + Q++DF
Sbjct: 98 HVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDS-IVQIADF 153
Query: 392 GAAMVHH---QSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT 447
G A + + + + SE+ P+ ++A E +++G+ + DV+SYGV + E+++
Sbjct: 154 GVADLLYPDDKKYFYSEHKTPIK------WMALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 8e-13
Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 33/209 (15%)
Query: 259 LIGQGGNSKVYRTNHVDG----QVAAVKVL-KCTNWSE-EEVLREVELLSSIKHENIVRI 312
+IG+G VY +D AVK L + T+ E E+ L+E ++ H N++ +
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61
Query: 313 IGYCHSKEMYAIVY--NLLNGSLKQYLKQLKWNERMDVAIG----VAKALEYLHHTCDPP 366
+G C E +V + +G L+ +++ N + IG VAK +EYL
Sbjct: 62 LGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYL---ASKK 118
Query: 367 IIHRDVKSSNILLSENFHHPQLSDFGAA--------MVHHQSHQVSENVKPVNVVGTFGY 418
+HRD+ + N +L E+F +++DFG A H VK +
Sbjct: 119 FVHRDLAARNCMLDESFT-VKVADFGLARDIYDKEYYSVHNHTGAKLPVK---------W 168
Query: 419 LAPEYMMYGKVDEKIDVYSYGVVLLELIT 447
+A E + K K DV+S+GV+L EL+T
Sbjct: 169 MALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 8e-13
Identities = 59/215 (27%), Positives = 104/215 (48%), Gaps = 23/215 (10%)
Query: 249 HLTHNFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEE----EVLREVELLSS 303
+ + IG+G V T+ G A+K K + + + LRE+++L
Sbjct: 2 DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIK--KISPFEHQTFCQRTLREIKILRR 59
Query: 304 IKHENIVRI------IGYCHSKEMYAIVYNLLNGSLKQYLK-QLKWNERMDVAI-GVAKA 355
KHENI+ I + ++Y IV L+ L + +K Q N+ + + + +
Sbjct: 60 FKHENIIGILDIIRPPSFESFNDVY-IVQELMETDLYKLIKTQHLSNDHIQYFLYQILRG 118
Query: 356 LEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGT 415
L+Y+ H+ + ++HRD+K SN+LL+ N ++ DFG A + H + + V T
Sbjct: 119 LKYI-HSAN--VLHRDLKPSNLLLNTNC-DLKICDFGLARIADPEHDHTGFL--TEYVAT 172
Query: 416 FGYLAPEYMMYGKVDEK-IDVYSYGVVLLELITGK 449
Y APE M+ K K ID++S G +L E+++ +
Sbjct: 173 RWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 8e-13
Identities = 67/228 (29%), Positives = 109/228 (47%), Gaps = 30/228 (13%)
Query: 260 IGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEE---VLREVELLSSIKHENIVRIIGY 315
+G+G +V H DG+ +K L N S E +E +LLS +KH NIV Y
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIV---AY 64
Query: 316 CHSKE-----MYAIVYNLLNGSLKQYLKQLKW-----NERMDVAIGVAKALEYLHHTCDP 365
S E +Y ++ G L LK+ K N+ ++ + +A AL+YLH +
Sbjct: 65 RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EK 121
Query: 366 PIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMM 425
I+HRD+K+ N+ L+ + ++ D G A V ++ + +GT Y++PE
Sbjct: 122 HILHRDLKTQNVFLTRT-NIIKVGDLGIARVLENQCDMASTL-----IGTPYYMSPELFS 175
Query: 426 YGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWYYVLAGKV 473
+ K DV++ G + E+ T K A N + SLV Y ++ GK+
Sbjct: 176 NKPYNYKSDVWALGCCVYEMATLKHAF--NAKDMNSLV--YRIIEGKL 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 9e-13
Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 39/210 (18%)
Query: 259 LIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEV----LREVELLSSIK---HENIV 310
IG+G VY+ + G+ A+K ++ SEE + LRE+ LL ++ H NIV
Sbjct: 6 EIGEGAYGTVYKARDLNTGRFVALKKVRVPL-SEEGIPLSTLREIALLKQLESFEHPNIV 64
Query: 311 RIIGYCHSKEMY-----AIVYNLLNGSLKQYL----------KQLKWNERMDVAIGVAKA 355
R++ CH +V+ ++ L YL + +K D+ + +
Sbjct: 65 RLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIK-----DLMRQLLRG 119
Query: 356 LEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGT 415
+++LH I+HRD+K NIL++ + +++DFG A ++ S + +VV T
Sbjct: 120 VDFLHSHR---IVHRDLKPQNILVTSD-GQVKIADFGLARIY------SFEMALTSVVVT 169
Query: 416 FGYLAPEYMMYGKVDEKIDVYSYGVVLLEL 445
Y APE ++ +D++S G + EL
Sbjct: 170 LWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 1e-12
Identities = 48/176 (27%), Positives = 93/176 (52%), Gaps = 19/176 (10%)
Query: 280 AVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKE--MYAIVYNLLNGSLKQYL 337
A+K++K + SE+E + E +++ + HE +V++ G C +K+ +Y + + NG L YL
Sbjct: 32 AIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVC-TKQRPIYIVTEYMSNGCLLNYL 90
Query: 338 ----KQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGA 393
K+ + ++ +++ V + + YL IHRD+ + N L+ + ++SDFG
Sbjct: 91 REHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQG-CVKVSDFGL 146
Query: 394 A-MVHHQSHQVSENVK-PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT 447
+ V + S K PV + PE ++Y K K DV+++GV++ E+ +
Sbjct: 147 SRYVLDDEYTSSVGSKFPVR------WSPPEVLLYSKFSSKSDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 1e-12
Identities = 60/227 (26%), Positives = 108/227 (47%), Gaps = 38/227 (16%)
Query: 252 HNFSPKMLIGQGGNSKVYRTN------HVDGQVAAVKVLK-CTNWSEEEVLREVELLSSI 304
HN K +G+G KV+ D + AVK LK ++ + ++ RE ELL+++
Sbjct: 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL 64
Query: 305 KHENIVRIIGYCHSKEMYAIVYNLL-NGSLKQYLK----------------QLKWNERMD 347
+HE+IV+ G C + +V+ + +G L ++L+ +L ++ +
Sbjct: 65 QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124
Query: 348 VAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV---S 404
+A +A + YL +HRD+ + N L+ EN ++ DFG + + +
Sbjct: 125 IAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLL-VKIGDFGMSRDVYSTDYYRVGG 180
Query: 405 ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKE 450
+ P+ ++ PE +MY K + DV+S GVVL E+ T GK+
Sbjct: 181 HTMLPIR------WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQ 221
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 54/191 (28%), Positives = 96/191 (50%), Gaps = 30/191 (15%)
Query: 280 AVKVLK--CTNWSEEEVLREVELLSSI-KHENIVRIIGYC-HSKEMYAIVYNLLNGSLKQ 335
AVK+LK T+ +++ E+E++ I KH+NI+ ++G C +Y +V G+L++
Sbjct: 48 AVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLRE 107
Query: 336 YLK-------------------QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSN 376
YL+ QL + + + A VA+ +EYL IHRD+ + N
Sbjct: 108 YLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARN 164
Query: 377 ILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVY 436
+L++E+ + +++DFG A H + K N ++APE + + DV+
Sbjct: 165 VLVTED-NVMKIADFGLA---RDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVW 220
Query: 437 SYGVVLLELIT 447
S+GV+L E+ T
Sbjct: 221 SFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 1e-12
Identities = 53/214 (24%), Positives = 100/214 (46%), Gaps = 27/214 (12%)
Query: 255 SPKMLIGQGGNSKVYR---TNHVDGQVA-AVKVLK--CTNWSEEEVLREVELLSSIKHEN 308
+ IG+G VY+ + + ++A AVK K + E+ L+E ++ H +
Sbjct: 9 TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPH 68
Query: 309 IVRIIGYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIGV------AKALEYLHHT 362
IV++IG ++ ++ G L+ YL+ K +D+A + + AL YL
Sbjct: 69 IVKLIGVITENPVWIVMELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYLESK 126
Query: 363 CDPPIIHRDVKSSNILLSENFHHPQLSDFG-AAMVHHQSHQVSENVK-PVNVVGTFGYLA 420
+HRD+ + N+L+S +L DFG + + +S+ + K P+ ++A
Sbjct: 127 ---RFVHRDIAARNVLVSSP-DCVKLGDFGLSRYLEDESYYKASKGKLPIK------WMA 176
Query: 421 PEYMMYGKVDEKIDVYSYGVVLLE-LITGKEAIQ 453
PE + + + DV+ +GV + E L+ G + Q
Sbjct: 177 PESINFRRFTSASDVWMFGVCMWEILMLGVKPFQ 210
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 1e-12
Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 23/211 (10%)
Query: 253 NFSPKMLIGQG--GNSKVYRTNHVDGQVAAVKVLKCTNWSEEE---VLREVELLSSIKHE 307
++ P ++G+G G + +YR D + K + T SE+E L E+ +LS ++H
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTE-DDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHP 59
Query: 308 NIVRIIGYCHSKEMYAIVYNLLNG-SLKQYL---KQLKWNERM--DVAIGVAKALEYLHH 361
NI+ + I NG +L + K + E M + A+ Y+H
Sbjct: 60 NIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK 119
Query: 362 TCDPPIIHRDVKSSNILLSE-NFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLA 420
I+HRD+K+ NI L++ +L DFG + + + ++E V VGT Y++
Sbjct: 120 A---GILHRDIKTLNIFLTKAGL--IKLGDFGISKILGSEYSMAETV-----VGTPYYMS 169
Query: 421 PEYMMYGKVDEKIDVYSYGVVLLELITGKEA 451
PE K + K D+++ G VL EL+T K
Sbjct: 170 PELCQGVKYNFKSDIWALGCVLYELLTLKRT 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 55/214 (25%), Positives = 95/214 (44%), Gaps = 25/214 (11%)
Query: 260 IGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWS----EEEVLREVELLSSIKHENIVRIIG 314
+G+GG +V G++ A K L E+ L E ++L + IV +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 315 YCHSKEMYAIVYNLLNG-SLKQYLKQLKWNER-------MDVAIGVAKALEYLHHTCDPP 366
+K+ +V L+NG LK ++ + E + A + LE+LH
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNV--GEPGFPEARAIFYAAQIICGLEHLHQR---R 115
Query: 367 IIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY 426
I++RD+K N+LL ++ + ++SD G A+ ++ K GT GY+APE +
Sbjct: 116 IVYRDLKPENVLLDDH-GNVRISDLGLAV------ELKGGKKIKGRAGTPGYMAPEVLQG 168
Query: 427 GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRE 460
D +D ++ G L E+I G+ + K E
Sbjct: 169 EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 56/198 (28%), Positives = 95/198 (47%), Gaps = 19/198 (9%)
Query: 260 IGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSE-----EEVLREVELLSSIKHENIVRIIG 314
IG+G +V++ +D + V +K + E E++ +E+ +LS + + G
Sbjct: 12 IGKGSFGEVFKG--IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 315 -YCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAI--GVAKALEYLHHTCDPPIIHRD 371
Y +++ I+ L GS L+ +E I + K L+YLH IHRD
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLH---SEKKIHRD 126
Query: 372 VKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDE 431
+K++N+LLSE+ +L+DFG A +K VGT ++APE + D
Sbjct: 127 IKAANVLLSEH-GEVKLADFGVA-----GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS 180
Query: 432 KIDVYSYGVVLLELITGK 449
K D++S G+ +EL G+
Sbjct: 181 KADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 62/212 (29%), Positives = 102/212 (48%), Gaps = 24/212 (11%)
Query: 253 NFSPKMLIGQGGNSKVYR----TNHVDGQVAAVKVLKCTNW-----SEEEVLREVELLSS 303
NF ++G G KV+ + H G++ A+KVLK + E E ++L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 304 IKHENIVRIIGYCHSKE--MYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVAK---ALEY 358
I+ + + Y + ++ I+ + G L +L Q + + +V I + ALE+
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEH 120
Query: 359 LHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGY 418
LH II+RD+K NILL N H L+DFG + H+ E + + GT Y
Sbjct: 121 LHKL---GIIYRDIKLENILLDSN-GHVVLTDFGLSKEFHE----DEVERAYSFCGTIEY 172
Query: 419 LAPEYMMYGKV--DEKIDVYSYGVVLLELITG 448
+AP+ + G D+ +D +S GV++ EL+TG
Sbjct: 173 MAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 55/198 (27%), Positives = 105/198 (53%), Gaps = 21/198 (10%)
Query: 260 IGQGGNSKVYRT-NHVDGQVAAVKVLKCTNWSE-EEVLREVELLSSIKHENIVRII-GYC 316
+G G KVY+ N G +AA KV+ + E E+ + E+++L+S H NIV+++ +
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 317 HSKEMYAIVYNLLNGSLKQYLKQLKWNERM----DVAIGVAKALEYLHHTCDPPIIHRDV 372
+ ++ ++ G++ + +L ER + + + LE L++ + IIHRD+
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLEL---ERPLTEPQIRVVCKQTLEALNYLHENKIIHRDL 129
Query: 373 KSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGK---- 428
K+ NIL + + +L+DFG + + ++ Q + + +GT ++APE +M
Sbjct: 130 KAGNILFTLD-GDIKLADFGVSAKNTRTIQRRD-----SFIGTPYWMAPEVVMCETSKDR 183
Query: 429 -VDEKIDVYSYGVVLLEL 445
D K DV+S G+ L+E+
Sbjct: 184 PYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 2e-12
Identities = 57/224 (25%), Positives = 104/224 (46%), Gaps = 40/224 (17%)
Query: 257 KMLIGQGGNSKVYRTN------HVDGQVAAVKVLKCTNWS-EEEVLREVELLSSIKHENI 309
K +G+G KV+ D + AVK LK + S ++ RE ELL+ ++H++I
Sbjct: 10 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHI 69
Query: 310 VRIIGYCHSKEMYAIVYNLL-NGSLKQYLK------------------QLKWNERMDVAI 350
VR G C +V+ + +G L ++L+ QL + + +A
Sbjct: 70 VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129
Query: 351 GVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA--MVHHQSHQV-SENV 407
+A + YL +HRD+ + N L+ + ++ DFG + + ++V +
Sbjct: 130 QIASGMVYL---ASLHFVHRDLATRNCLVGQGL-VVKIGDFGMSRDIYSTDYYRVGGRTM 185
Query: 408 KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKE 450
P+ ++ PE ++Y K + D++S+GVVL E+ T GK+
Sbjct: 186 LPIR------WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQ 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 3e-12
Identities = 59/205 (28%), Positives = 101/205 (49%), Gaps = 24/205 (11%)
Query: 260 IGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWSEEE--VLREVEL-LSSIKHENIVRIIGY 315
+G+G V + HV G + AVK ++ T S+E+ +L ++++ + S+ V G
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGA 68
Query: 316 CHSKEMYAIVYNLLNGSLKQYLKQ-LKWNERM------DVAIGVAKALEYLHHTCDPPII 368
+ I +++ SL ++ K+ + +A+ + KALEYLH +I
Sbjct: 69 LFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VI 126
Query: 369 HRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEY----M 424
HRDVK SN+L++ N +L DFG + + V K ++ G Y+APE +
Sbjct: 127 HRDVKPSNVLINRN-GQVKLCDFGIS-----GYLVDSVAKTID-AGCKPYMAPERINPEL 179
Query: 425 MYGKVDEKIDVYSYGVVLLELITGK 449
D K DV+S G+ ++EL TG+
Sbjct: 180 NQKGYDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 3e-12
Identities = 50/237 (21%), Positives = 98/237 (41%), Gaps = 41/237 (17%)
Query: 253 NFSPKMLIGQGGNSKVYRTN------HVDGQVAAVKVLKCT--NWSEEEVLREVELLSSI 304
N +G+G +V+ + VK L+ T + E RE+++ +
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65
Query: 305 KHENIVRIIGYCHSKEMYAIVYNLLN-GSLKQYL------------KQLKWNERMDVAIG 351
H+N+VR++G C E + ++ + G LKQ+L L +++ +
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 352 VAKALEYLHHTCDPPIIHRDVKSSNILLSENFH----HPQLSD--FGAAMVHHQSHQVSE 405
+A +++L + +HRD+ + N L+S LS + + ++ +
Sbjct: 126 IALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-- 180
Query: 406 NVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESL 462
P+ +LAPE + K DV+S+GV++ E+ T E ++ E L
Sbjct: 181 ---PLR------WLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVL 228
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 56/194 (28%), Positives = 99/194 (51%), Gaps = 36/194 (18%)
Query: 280 AVKVLK--CTNWSEEEVLREVELLSSI-KHENIVRIIGYC-HSKEMYAIVYNLLNGSLKQ 335
AVK+LK T +++ E+E++ I KH+NI+ ++G C +Y IV G+L++
Sbjct: 54 AVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 113
Query: 336 YLK-------------------QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSN 376
YL+ QL + + + A VA+ +EYL IHRD+ + N
Sbjct: 114 YLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARN 170
Query: 377 ILLSENFHHPQLSDFGAAM-VHHQSH--QVSENVKPVNVVGTFGYLAPEYMMYGKVDEKI 433
+L++E+ + +++DFG A +HH + + + PV ++APE + +
Sbjct: 171 VLVTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVK------WMAPEALFDRIYTHQS 223
Query: 434 DVYSYGVVLLELIT 447
DV+S+GV+L E+ T
Sbjct: 224 DVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 3e-12
Identities = 60/205 (29%), Positives = 94/205 (45%), Gaps = 44/205 (21%)
Query: 268 VYRTNHVD-GQVAAVKVLKCTNWSEEE-----VLREVELLSSIKHENIVRIIGYCHSKEM 321
VYR G++ A+K LK E+E LRE+ +L ++H NIV + KE+
Sbjct: 21 VYRARDKKTGEIVALKKLK--MEKEKEGFPITSLREINILLKLQHPNIVTV------KEV 72
Query: 322 YA--------IVYNLLNGSLKQYLKQLKWN----ERMDVAIGVAKALEYLHHTCDPPIIH 369
+V + LK ++ +K E + + + + +LH D I+H
Sbjct: 73 VVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH---DNWILH 129
Query: 370 RDVKSSNILLSENFHHPQL--SDFGAAMVHHQSHQVSENVKPV--NVVGTFGYLAPEYMM 425
RD+K+SN+LL+ + L DFG A + +KP VV T Y APE ++
Sbjct: 130 RDLKTSNLLLN---NRGILKICDFGLA------REYGSPLKPYTQLVV-TLWYRAPELLL 179
Query: 426 YGKV-DEKIDVYSYGVVLLELITGK 449
K ID++S G + EL+T K
Sbjct: 180 GAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 4e-12
Identities = 58/195 (29%), Positives = 97/195 (49%), Gaps = 21/195 (10%)
Query: 261 GQGGNSK--VYRTNHVDGQVAAVKVLKCTNWSE---EEVLREVELLSSIKHENIVRIIGY 315
G G K +Y+ + + AVK+LK N +E+LRE ++ + + IVR+IG
Sbjct: 6 GNFGTVKKGMYKMKKSE-KTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGI 64
Query: 316 CHSKEMYAIVYNLLN-GSLKQYL---KQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRD 371
C + E + +V L G L ++L K + ++ V+ ++YL T +HRD
Sbjct: 65 CEA-ESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEET---NFVHRD 120
Query: 372 VKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTF--GYLAPEYMMYGKV 429
+ + N+LL H+ ++SDFG + ++ EN G + + APE M Y K
Sbjct: 121 LAARNVLLVTQ-HYAKISDFGLS----KALGADENYYKAKTHGKWPVKWYAPECMNYYKF 175
Query: 430 DEKIDVYSYGVVLLE 444
K DV+S+GV++ E
Sbjct: 176 SSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 4e-12
Identities = 54/193 (27%), Positives = 98/193 (50%), Gaps = 14/193 (7%)
Query: 260 IGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEEVLR-EVELLSSIKHENIVRIIG-YC 316
IG G VY+ +V+ G++AA+KV+K + V++ E+ ++ KH NIV G Y
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 317 HSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSN 376
+++ + GSL+ +A + L+ L++ +HRD+K +N
Sbjct: 77 RRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGAN 136
Query: 377 ILLSENFHHPQLSDFGAAMVHHQSHQVSENV-KPVNVVGTFGYLAPEYMMY---GKVDEK 432
ILL++N H +L+DFG S Q++ + K + +GT ++APE G ++
Sbjct: 137 ILLTDN-GHVKLADFGV------SAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQL 189
Query: 433 IDVYSYGVVLLEL 445
D+++ G+ +EL
Sbjct: 190 CDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 4e-12
Identities = 56/195 (28%), Positives = 100/195 (51%), Gaps = 38/195 (19%)
Query: 280 AVKVLK--CTNWSEEEVLREVELLSSI-KHENIVRIIGYC-HSKEMYAIVYNLLNGSLKQ 335
AVK+LK T+ +++ E+EL+ I KH+NI+ ++G C +Y IV G+L++
Sbjct: 48 AVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLRE 107
Query: 336 YLK-------------------QLKWNERMDVAIGVAKALEYLH-HTCDPPIIHRDVKSS 375
+L+ QL + + + A VA+ +EYL C IHRD+ +
Sbjct: 108 FLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRC----IHRDLAAR 163
Query: 376 NILLSENFHHPQLSDFGAAM-VHHQSH--QVSENVKPVNVVGTFGYLAPEYMMYGKVDEK 432
N+L++E+ + +++DFG A VH + + S PV ++APE + +
Sbjct: 164 NVLVTED-NVMKIADFGLARGVHDIDYYKKTSNGRLPVK------WMAPEALFDRVYTHQ 216
Query: 433 IDVYSYGVVLLELIT 447
DV+S+G+++ E+ T
Sbjct: 217 SDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 4e-12
Identities = 56/214 (26%), Positives = 100/214 (46%), Gaps = 17/214 (7%)
Query: 259 LIGQGGNSKVY----RTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRII- 313
++G+G V+ + + + + V + T E ++L + H NI+
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 314 GYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMD---VAIGVAKALEYLHHTCDPPIIHR 370
+ K + ++ G+L +Y+++ + N +D + + L LHH I+HR
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAEYIQK-RCNSLLDEDTILHFFVQILLALHHVHTKLILHR 125
Query: 371 DVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVD 430
D+K+ NILL ++ ++ DFG S +S K VVGT Y++PE +
Sbjct: 126 DLKTQNILLDKHKMVVKIGDFGI------SKILSSKSKAYTVVGTPCYISPELCEGKPYN 179
Query: 431 EKIDVYSYGVVLLELITGKEAIQTNKANRESLVL 464
+K D+++ G VL EL + K A + AN +LVL
Sbjct: 180 QKSDIWALGCVLYELASLKRAFEA--ANLPALVL 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 4e-12
Identities = 46/162 (28%), Positives = 71/162 (43%), Gaps = 26/162 (16%)
Query: 295 LREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVAK 354
L E LL ++ H +++R+ S + +V + L YL + +D A+ + K
Sbjct: 105 LIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEK 164
Query: 355 A----LEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPV 410
L YLH IIHRDVK+ NI + + + D GAA PV
Sbjct: 165 QILEGLRYLHAQ---RIIHRDVKTENIFI-NDVDQVCIGDLGAAQF------------PV 208
Query: 411 N------VVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELI 446
+ GT APE + K + K D++S G+VL E++
Sbjct: 209 VAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 5e-12
Identities = 53/192 (27%), Positives = 95/192 (49%), Gaps = 32/192 (16%)
Query: 280 AVKVLK--CTNWSEEEVLREVELLSSI-KHENIVRIIGYC-HSKEMYAIVYNLLNGSLKQ 335
AVK+LK T +++ E+E++ I KH+NI+ ++G C +Y IV G+L++
Sbjct: 51 AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 110
Query: 336 YLK-------------------QLKWNERMDVAIGVAKALEYL-HHTCDPPIIHRDVKSS 375
YL+ Q+ + + + VA+ +EYL C IHRD+ +
Sbjct: 111 YLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKC----IHRDLAAR 166
Query: 376 NILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDV 435
N+L++EN + +++DFG A + + K N ++APE + + DV
Sbjct: 167 NVLVTEN-NVMKIADFGLA---RDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV 222
Query: 436 YSYGVVLLELIT 447
+S+GV++ E+ T
Sbjct: 223 WSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 6e-12
Identities = 58/217 (26%), Positives = 103/217 (47%), Gaps = 25/217 (11%)
Query: 259 LIGQGGNSKVYRTN-HVDGQ---VAAVKVLKC--TNWSEEEVLREVELLSSIKHENIVRI 312
+IG G +V+R + G+ A+K LK T ++ L E ++ H NI+R+
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 313 IGYCHS-KEMYAIVYNLLNGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPI 367
G K I + NG+L +YL+ + + + + G+A ++YL D
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL---SDMNY 128
Query: 368 IHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ----SHQVSENVKPVNVVGTFGYLAPEY 423
+HRD+ + NIL++ N ++SDFG + V ++ S P+ + APE
Sbjct: 129 VHRDLAARNILVNSNLE-CKVSDFGLSRVLEDDPEGTYTTSGGKIPIR------WTAPEA 181
Query: 424 MMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRE 460
+ Y K DV+S+G+V+ E+++ E + +N E
Sbjct: 182 IAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE 218
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 8e-12
Identities = 61/207 (29%), Positives = 101/207 (48%), Gaps = 30/207 (14%)
Query: 259 LIGQGGNSKVYRTNHVDG----QVAAVKVLK----CTNWSEEEVLR-EVELLSSIKHENI 309
++G+GG KV++ V G ++ A+KVLK N + + E +L ++KH I
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 310 VRII-GYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERM---DVAI----GVAKALEYLHH 361
V +I + ++Y I+ L G L +L++ E + D A ++ ALE+LH
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQ 118
Query: 362 TCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAP 421
II+RD+K NILL H +L+DFG + E GT Y+AP
Sbjct: 119 Q---GIIYRDLKPENILLDAQ-GHVKLTDFGLC-----KESIHEGTVTHTFCGTIEYMAP 169
Query: 422 EYMMYGKVDEKIDVYSYGVVLLELITG 448
E +M + +D +S G ++ +++TG
Sbjct: 170 EILMRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 55/216 (25%), Positives = 104/216 (48%), Gaps = 35/216 (16%)
Query: 260 IGQGGNSKVYRTN-HVDG----QVAAVKVLKCTNWSEE--EVLREVELLSSIKHENIVRI 312
+G+ K+Y+ + ++ G Q+ A+K LK N ++ E +E L++ + H NIV +
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 313 IGYCHSKEMYAIVYNLLN-GSLKQYL--------------------KQLKWNERMDVAIG 351
+G ++ +++ LN G L ++L L + + +AI
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 352 VAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVN 411
+A +EYL +H+D+ + NIL+ E H ++SD G + + + V+P
Sbjct: 133 IAAGMEYLSSHF---FVHKDLAARNILIGEQLH-VKISDLGLSREIYSADYY--RVQP-K 185
Query: 412 VVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT 447
+ ++ PE +MYGK D++S+GVVL E+ +
Sbjct: 186 SLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 18/208 (8%)
Query: 259 LIGQGGNSKVYRTNHVD-GQVAAVKVLKC----TNWSEEEVLREVELLSSIKHEN---IV 310
+IG+GG +VY D G++ A+K L E L E +LS + + IV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 311 RIIGYCHSKEMYAIVYNLLNG-SLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIH 369
+ H+ + + +L+NG L +L Q ++ + + L H + +++
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVY 120
Query: 370 RDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKV 429
RD+K +NILL E+ H ++SD G A + KP VGT GY+APE + G
Sbjct: 121 RDLKPANILLDEH-GHVRISDLGLACDFSKK-------KPHASVGTHGYMAPEVLQKGTA 172
Query: 430 -DEKIDVYSYGVVLLELITGKEAIQTNK 456
D D +S G +L +L+ G + +K
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSPFRQHK 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 1e-11
Identities = 51/192 (26%), Positives = 91/192 (47%), Gaps = 21/192 (10%)
Query: 280 AVKVLKC--TNWSEEEVLREVELLSSIKHENIVRIIGYC-HSKEMYAIVYNLLNGSLKQY 336
A+K LK T + L E ++ H NI+ + G SK + + + NGSL +
Sbjct: 36 AIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAF 95
Query: 337 LK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFG 392
L+ Q + + + G+A ++YL D +HRD+ + NIL++ N ++SDFG
Sbjct: 96 LRKHDGQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILVNSNLV-CKVSDFG 151
Query: 393 AAMVHHQSHQVSENVK----PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITG 448
+ V + + + P+ + APE + Y K DV+SYG+V+ E+++
Sbjct: 152 LSRVLEDDPEAAYTTRGGKIPIR------WTAPEAIAYRKFTSASDVWSYGIVMWEVMSY 205
Query: 449 KEAIQTNKANRE 460
E +N++
Sbjct: 206 GERPYWEMSNQD 217
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 62/230 (26%), Positives = 107/230 (46%), Gaps = 23/230 (10%)
Query: 260 IGQGGNSKVY--RTNHVDGQVAAVKVLKCTNWSEEE-----VLREVELLSSIKHENIVRI 312
+G+G + VY R+ D VA LK EE +REV LL +KH NIV +
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVA----LKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTL 69
Query: 313 IGYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERM-DVAIGVAKALEYLHHTCDPPIIHRD 371
H+++ +V+ L+ LKQYL + M +V + + + L L++ ++HRD
Sbjct: 70 HDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRD 129
Query: 372 VKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVD- 430
+K N+L++E +L+DFG A + N V T Y P+ ++ G D
Sbjct: 130 LKPQNLLINER-GELKLADFGLARAKSIPTKTYS-----NEVVTLWYRPPDILL-GSTDY 182
Query: 431 -EKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWYYVLAGKVFAQQWP 479
+ID++ G + E+ TG+ + + + + + + G + WP
Sbjct: 183 STQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ--LHFIFRILGTPTEETWP 230
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 1e-11
Identities = 55/223 (24%), Positives = 103/223 (46%), Gaps = 22/223 (9%)
Query: 253 NFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNW----SEEEVLREVELLSSIKHE 307
NF + IG+G S+VYR + DG A+K ++ + + + ++E++LL + H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 308 NIVRIIGYCHSKEMYAIVYNLLN-GSLKQYLKQLKWNERM-------DVAIGVAKALEYL 359
N+++ IV L + G L + +K K +R+ + + ALE++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 360 HHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYL 419
H ++HRD+K +N+ ++ +L D G S+ ++VGT Y+
Sbjct: 123 HSR---RVMHRDIKPANVFITAT-GVVKLGDLGLGRFFS-----SKTTAAHSLVGTPYYM 173
Query: 420 APEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESL 462
+PE + + K D++S G +L E+ + +K N SL
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL 216
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 57/225 (25%), Positives = 107/225 (47%), Gaps = 41/225 (18%)
Query: 257 KMLIGQGGNSKVYRTNHV------DGQVAAVKVLKCTNWS-EEEVLREVELLSSIKHENI 309
K +G+G KV+ D + AVK LK + ++ RE ELL++++HE+I
Sbjct: 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69
Query: 310 VRIIGYCHSKEMYAIVYNLL-NGSLKQYLK-------------------QLKWNERMDVA 349
V+ G C + +V+ + +G L ++L+ +L ++ + +A
Sbjct: 70 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129
Query: 350 IGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS--HQVS-EN 406
+A + YL +HRD+ + N L+ N ++ DFG + + + ++V
Sbjct: 130 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLL-VKIGDFGMSRDVYSTDYYRVGGHT 185
Query: 407 VKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKE 450
+ P+ ++ PE +MY K + DV+S+GV+L E+ T GK+
Sbjct: 186 MLPIR------WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQ 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-11
Identities = 60/209 (28%), Positives = 98/209 (46%), Gaps = 18/209 (8%)
Query: 259 LIGQGGNSKVYRTNHVD-GQVAAVKVLKC----TNWSEEEVLREVELLSSIKHEN---IV 310
+IG+GG +VY D G++ A+K L E L E +LS + + IV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 311 RIIGYCHSKEMYAIVYNLLNG-SLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIH 369
+ H+ + + + +L+NG L +L Q ++ A+ + L H + +++
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVY 120
Query: 370 RDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYG-K 428
RD+K +NILL E H ++SD G A + KP VGT GY+APE + G
Sbjct: 121 RDLKPANILLDE-HGHVRISDLGLACDFSKK-------KPHASVGTHGYMAPEVLQKGVA 172
Query: 429 VDEKIDVYSYGVVLLELITGKEAIQTNKA 457
D D +S G +L +L+ G + +K
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSPFRQHKT 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 52/203 (25%), Positives = 104/203 (51%), Gaps = 24/203 (11%)
Query: 259 LIGQGGNSKVYRTNHV-DGQVA----AVKVLKCTNWSEE--EVLREVELLSSIKHENIVR 311
++G G VY+ V +G+ A+K+L T + E + E +++S+ H ++VR
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 312 IIGYCHSKEMYAIVYNLLNGSLKQYLKQLKWN----ERMDVAIGVAKALEYLHHTCDPPI 367
++G C S + + + +G L Y+ + K N ++ + +AK + YL + +
Sbjct: 74 LLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERRL 130
Query: 368 IHRDVKSSNILLSENFHHPQLSDFGAAMV---HHQSHQVSENVKPVNVVGTFGYLAPEYM 424
+HRD+ + N+L+ ++ +H +++DFG A + + + P+ ++A E +
Sbjct: 131 VHRDLAARNVLV-KSPNHVKITDFGLARLLEGDEKEYNADGGKMPIK------WMALECI 183
Query: 425 MYGKVDEKIDVYSYGVVLLELIT 447
Y K + DV+SYGV + EL+T
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 2e-11
Identities = 58/204 (28%), Positives = 96/204 (47%), Gaps = 31/204 (15%)
Query: 260 IGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWSE--EEVLREVELLSSIKHENIVRIIGYC 316
+G G V + H+ G V A KV+ S +++LRE++++ + IV G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 317 HSKEMYAIVYNLLN-GSLKQYLKQLKWNERMDV----AIGVAKALEYL---HHTCDPPII 368
++ + ++ GSL + K+ +++ A+ V + L YL H I+
Sbjct: 73 LNENNICMCMEFMDCGSLDRIYKKGG-PIPVEILGKIAVAVVEGLTYLYNVHR-----IM 126
Query: 369 HRDVKSSNILLSENFH-HPQLSDFGAAMVHHQSHQVSENVKPV--NVVGTFGYLAPEYMM 425
HRD+K SNIL+ N +L DFG + E + + VGT Y++PE +
Sbjct: 127 HRDIKPSNILV--NSRGQIKLCDFGVS---------GELINSIADTFVGTSTYMSPERIQ 175
Query: 426 YGKVDEKIDVYSYGVVLLELITGK 449
GK K DV+S G+ ++EL GK
Sbjct: 176 GGKYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 3e-11
Identities = 64/255 (25%), Positives = 114/255 (44%), Gaps = 54/255 (21%)
Query: 260 IGQGGNSKVYRTNH---VDGQ---VAAVKVLK--CTNWSEEEVLREVELLSSIKHENIVR 311
IGQG +V++ + + + AVK+LK + + + RE L++ H NIV+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 312 IIGYCH-SKEMYAIVYNLLNGSLKQYLK-------------------------QLKWNER 345
++G C K M + + G L ++L+ L E+
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 346 MDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA--MVHHQSHQV 403
+ +A VA + YL + +HRD+ + N L+ EN +++DFG + + ++
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMV-VKIADFGLSRNIYSADYYKA 188
Query: 404 SEN-VKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQT--NKANRE 460
SEN P+ ++ PE + Y + + DV++YGVVL E+ + +Q A+ E
Sbjct: 189 SENDAIPIR------WMPPESIFYNRYTTESDVWAYGVVLWEIFS--YGMQPYYGMAHEE 240
Query: 461 SLVLWYYVLAGKVFA 475
+ YYV G V +
Sbjct: 241 VI---YYVRDGNVLS 252
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 3e-11
Identities = 47/176 (26%), Positives = 86/176 (48%), Gaps = 22/176 (12%)
Query: 280 AVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLLNGSLKQYL 337
A+KVLK N +E++RE E++ + + IVR+IG C ++ + ++ G L ++L
Sbjct: 26 AIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVMEMASGGPLNKFL 85
Query: 338 KQLKWNERMDVAIGVAKALEYLHHTC-------DPPIIHRDVKSSNILLSENFHHPQLSD 390
K I V+ +E +H +HRD+ + N+LL N H+ ++SD
Sbjct: 86 SGKK------DEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLV-NQHYAKISD 138
Query: 391 FGAAMVHHQSHQVSENVKPVNVVGTF--GYLAPEYMMYGKVDEKIDVYSYGVVLLE 444
FG + ++ ++ G + + APE + + K + DV+SYG+ + E
Sbjct: 139 FGLS----KALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 3e-11
Identities = 55/223 (24%), Positives = 105/223 (47%), Gaps = 22/223 (9%)
Query: 253 NFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNW----SEEEVLREVELLSSIKHE 307
NF + IG+G S+VYR T +D + A+K ++ + ++ ++E++LL + H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 308 NIVRIIGYCHSKEMYAIVYNLLN-GSLKQYLKQLKWNERM-------DVAIGVAKALEYL 359
N+++ + IV L + G L Q +K K +R+ + + A+E++
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 360 HHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYL 419
H ++HRD+K +N+ ++ +L D G S+ ++VGT Y+
Sbjct: 123 HSR---RVMHRDIKPANVFITAT-GVVKLGDLGLGRFFS-----SKTTAAHSLVGTPYYM 173
Query: 420 APEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESL 462
+PE + + K D++S G +L E+ + +K N SL
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSL 216
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 3e-11
Identities = 51/209 (24%), Positives = 93/209 (44%), Gaps = 37/209 (17%)
Query: 260 IGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEE-----VLREVELLSSIKHENIVRII 313
IG+G VY+ + G++ A+K ++ +E+E +RE+ LL + H NIVR++
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLE--TEDEGVPSTAIREISLLKELNHPNIVRLL 64
Query: 314 GYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDP-------P 366
HS+ +V+ L+ LK+Y+ + YL+
Sbjct: 65 DVVHSENKLYLVFEFLDLDLKKYMDSSP-----LTGLDPPLIKSYLYQLLQGIAYCHSHR 119
Query: 367 IIHRDVKSSNILLSENFHHPQLSDFGAAM-----VHHQSHQVSENVKPVNVVGTFGYLAP 421
++HRD+K N+L+ +L+DFG A V +H+V T Y AP
Sbjct: 120 VLHRDLKPQNLLIDRE-GALKLADFGLARAFGVPVRTYTHEVV----------TLWYRAP 168
Query: 422 EYMMYGK-VDEKIDVYSYGVVLLELITGK 449
E ++ + +D++S G + E++ +
Sbjct: 169 EILLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 3e-11
Identities = 59/208 (28%), Positives = 100/208 (48%), Gaps = 16/208 (7%)
Query: 260 IGQGGNSKVYRTNHV-DGQVAAVKV--LKCTNWSEEEVLREVELLSSIKHENIVRIIGYC 316
+G G VY+ H+ ++ AVKV L T +++++ E+E+L I+ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 317 HSKEMYAIVYNLLNG-SLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSS 375
+ +I ++G SL Y +++ + +A+ V K L YL I+HRDVK S
Sbjct: 69 FVENRISICTEFMDGGSLDVY-RKIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPS 124
Query: 376 NILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDV 435
N+L++ +L DFG S Q+ ++ VGT Y+APE + + DV
Sbjct: 125 NMLVNTR-GQVKLCDFGV------STQLVNSIAK-TYVGTNAYMAPERISGEQYGIHSDV 176
Query: 436 YSYGVVLLELITGKEAIQTNKANRESLV 463
+S G+ +EL G+ + N+ SL+
Sbjct: 177 WSLGISFMELALGRFPYPQIQKNQGSLM 204
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 4e-11
Identities = 54/187 (28%), Positives = 90/187 (48%), Gaps = 10/187 (5%)
Query: 295 LREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERM-DVAIGVA 353
+REV LL ++KH NIV + H++ +V+ L+ LKQYL M +V I +
Sbjct: 51 IREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMF 110
Query: 354 KALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVV 413
+ L L + I+HRD+K N+L++E +L+DFG A ++ V VV
Sbjct: 111 QLLRGLSYCHKRKILHRDLKPQNLLINEK-GELKLADFGLA----RAKSVPTKTYSNEVV 165
Query: 414 GTFGYLAPEYMM-YGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWYYVLAGK 472
T Y P+ ++ + ID++ G +L E+ TG+ + E ++ + L G
Sbjct: 166 -TLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLI--FRLLGT 222
Query: 473 VFAQQWP 479
+ WP
Sbjct: 223 PTEETWP 229
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 62.6 bits (153), Expect = 5e-11
Identities = 58/200 (29%), Positives = 94/200 (47%), Gaps = 21/200 (10%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLK---CTNWSEEE-VLREVELLSSIKHENIVRII- 313
+G GG +V + A+K +K ++E + E E+L H IV++
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 314 GYCHSKEMYAIVYNLLNGSLKQYLKQL----KWNERMDVAIGVAKALEYLHHTCDPPIIH 369
+ K +Y ++ L G L L+ ++ R +A V A EYLH+ II+
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIA-CVVLAFEYLHNR---GIIY 116
Query: 370 RDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKV 429
RD+K N+LL N + +L DFG A ++ K GT Y+APE ++
Sbjct: 117 RDLKPENLLLDSN-GYVKLVDFGFA------KKLKSGQKTWTFCGTPEYVAPEIILNKGY 169
Query: 430 DEKIDVYSYGVVLLELITGK 449
D +D +S G++L EL+TG+
Sbjct: 170 DFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 5e-11
Identities = 50/202 (24%), Positives = 92/202 (45%), Gaps = 25/202 (12%)
Query: 259 LIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLREVELLSSIKHENIVRII 313
+G G +V+ + A+KV+ E+ V E +L + H I+R+
Sbjct: 8 TVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL- 66
Query: 314 GYCHSKE---MYAIVYNLLNGSLKQYLKQL-KWNERMDV--AIGVAKALEYLHHTCDPPI 367
+ + +Y ++ + G L YL+ +++ + A + ALEYLH I
Sbjct: 67 -FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK---EI 122
Query: 368 IHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYG 427
++RD+K NILL + H +L+DFG A + + GT YLAPE +
Sbjct: 123 VYRDLKPENILLDKE-GHIKLTDFGFAKKLRD--------RTWTLCGTPEYLAPEVIQSK 173
Query: 428 KVDEKIDVYSYGVVLLELITGK 449
++ +D ++ G+++ E++ G
Sbjct: 174 GHNKAVDWWALGILIYEMLVGY 195
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 5e-11
Identities = 51/190 (26%), Positives = 90/190 (47%), Gaps = 14/190 (7%)
Query: 276 GQVAAVKVLKCTNWSEEEVL-----REVELLSSIKHENIVRII--GYCHSKEMYAIVYNL 328
G A+K+L+ T+ EEE RE L + + H NIV ++ G ++A V+
Sbjct: 3 GHEVAIKLLR-TDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFA-VFEY 60
Query: 329 LNG-SLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN--FHH 385
+ G +L++ L + + + L+ L + I+HRD+K NI++S+ H
Sbjct: 61 VPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPH 120
Query: 386 PQLSDFGAAMVHHQSHQVSEN--VKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLL 443
++ DFG + + V+GT Y APE + V D+Y++G++ L
Sbjct: 121 AKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFL 180
Query: 444 ELITGKEAIQ 453
E +TG+ +Q
Sbjct: 181 ECLTGQRVVQ 190
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 7e-11
Identities = 44/170 (25%), Positives = 76/170 (44%), Gaps = 33/170 (19%)
Query: 297 EVELLSSIKHENIVRIIGYCHSKEMYAIVYNLLNGSLKQYL---KQLKWNERMDVAIGVA 353
E +L +I H +I+++ G + ++ L YL + + + + + V
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAAKRNIAICDILAIERSVL 192
Query: 354 KALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQ---LSDFGAAMVHHQSHQVSENVKPV 410
+A++YLH IIHRD+K+ NI ++ HP L DFGAA PV
Sbjct: 193 RAIQYLHEN---RIIHRDIKAENIFIN----HPGDVCLGDFGAACF------------PV 233
Query: 411 NV--------VGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAI 452
++ GT APE + +D++S G+VL E+ T +++
Sbjct: 234 DINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 8e-11
Identities = 61/209 (29%), Positives = 90/209 (43%), Gaps = 39/209 (18%)
Query: 260 IGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVE----------LLSSIKHEN 308
IG+G KV H DG+ AVKVL ++ +L++ E LL ++KH
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVL-----QKKAILKKKEQKHIMAERNVLLKNVKHPF 57
Query: 309 IVRIIGYCHSKEMYAIVYNLLNGS-----LKQYLKQLKWNERMDVAIGVAKALEYLHHTC 363
+V + + + V + +NG L++ + R A +A AL YLH
Sbjct: 58 LVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIASALGYLHSL- 115
Query: 364 DPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTF----GYL 419
II+RD+K NILL H L+DFG E ++ TF YL
Sbjct: 116 --NIIYRDLKPENILLDSQ-GHVVLTDFGLC---------KEGIEHSKTTSTFCGTPEYL 163
Query: 420 APEYMMYGKVDEKIDVYSYGVVLLELITG 448
APE + D +D + G VL E++ G
Sbjct: 164 APEVLRKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 8e-11
Identities = 59/213 (27%), Positives = 101/213 (47%), Gaps = 35/213 (16%)
Query: 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLR---------EVELL 301
+F +G G +V H G+ A+K LK + E+L+ E +L
Sbjct: 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLK-----KREILKMKQVQHVAQEKSIL 72
Query: 302 SSIKHENIVRII-GYCHSKEMYAIVYNLLNGSLKQYLKQL-KWNERMDVA----IGVAKA 355
+ H IV ++ + +Y ++ ++ G L +L++ ++ DVA + A
Sbjct: 73 MELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPN--DVAKFYHAELVLA 130
Query: 356 LEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGT 415
EYLH + D II+RD+K N+LL +N H +++DFG A +V + + + GT
Sbjct: 131 FEYLH-SKD--IIYRDLKPENLLL-DNKGHVKVTDFGFA------KKVPD--RTFTLCGT 178
Query: 416 FGYLAPEYMMYGKVDEKIDVYSYGVVLLELITG 448
YLAPE + + +D ++ GV+L E I G
Sbjct: 179 PEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 9e-11
Identities = 63/223 (28%), Positives = 105/223 (47%), Gaps = 40/223 (17%)
Query: 260 IGQGGNSKVY---RTNHVDGQVAAVKVLKCTNWSEEEV----LREVELLSSIKHENIVRI 312
IG+G +VY R N DG+ A+K K + RE+ LL +KHEN+V +
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 313 IGYC---HSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVAKAL--------EYLHH 361
+ K +Y ++++ L Q +K + +R+ + + K+L YLH
Sbjct: 68 VEVFLEHADKSVY-LLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS 126
Query: 362 TCDPPIIHRDVKSSNILL-SENFHHP--QLSDFGAAMVHHQSHQVSENVKPVNVVGTFGY 418
++HRD+K +NIL+ E ++ D G A + + + ++ PV VV T Y
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPV-VV-TIWY 181
Query: 419 LAPEYMM----YGKVDEKIDVYSYGVVLLELIT------GKEA 451
APE ++ Y K ID+++ G + EL+T G+EA
Sbjct: 182 RAPELLLGARHYTKA---IDIWAIGCIFAELLTLEPIFKGREA 221
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 9e-11
Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 17/207 (8%)
Query: 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKV--LKCTNWSEEEVLREVELLSSIKHENI 309
+F +G G V + H G + A K+ L+ +++RE+++L I
Sbjct: 6 DFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 65
Query: 310 VRIIGYCHSK-EMYAIVYNLLNGSLKQYLKQLK-WNERM--DVAIGVAKALEYLHHTCDP 365
V G +S E+ + ++ GSL Q LK+ K E + V+I V + L YL
Sbjct: 66 VGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQ- 124
Query: 366 PIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMM 425
I+HRDVK SNIL++ +L DFG S Q+ +++ + VGT Y++PE +
Sbjct: 125 -IMHRDVKPSNILVNSR-GEIKLCDFGV------SGQLIDSMAN-SFVGTRSYMSPERLQ 175
Query: 426 YGKVDEKIDVYSYGVVLLELITGKEAI 452
+ D++S G+ L+EL G+ I
Sbjct: 176 GTHYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 1e-10
Identities = 52/194 (26%), Positives = 100/194 (51%), Gaps = 23/194 (11%)
Query: 260 IGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSK 319
IG+G V ++ G AVK +K + + + L E +++ ++H N+V+++G +
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIK-NDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE 71
Query: 320 E--MYAIVYNLLNGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDV 372
+ +Y + + GSL YL+ L + + ++ V +A+EYL +HRD+
Sbjct: 72 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDL 128
Query: 373 KSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVK-PVNVVGTFGYLAPEYMMYGKVDE 431
+ N+L+SE+ + ++SDFG + ++ + K PV + APE + K
Sbjct: 129 AARNVLVSED-NVAKVSDFG---LTKEASSTQDTGKLPVK------WTAPEALREKKFST 178
Query: 432 KIDVYSYGVVLLEL 445
K DV+S+G++L E+
Sbjct: 179 KSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 44/171 (25%), Positives = 80/171 (46%), Gaps = 27/171 (15%)
Query: 295 LREVELLSSIKHENIVRIIGYC-----HSKEMYAIVYNLLNGSLKQ--YLKQLKWNERMD 347
LRE+++L KH+NI+ I K++Y +V +L+ L + Q E +
Sbjct: 52 LRELKILRHFKHDNIIAIRDILRPPGADFKDVY-VVMDLMESDLHHIIHSDQPLTEEHIR 110
Query: 348 VAIG-VAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAM------VHHQS 400
+ + + L+Y+H +IHRD+K SN+L++E+ ++ DFG A H+
Sbjct: 111 YFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCEL-RIGDFGMARGLSSSPTEHKY 166
Query: 401 HQVSENVKPVNVVGTFGYLAPEYMM-YGKVDEKIDVYSYGVVLLELITGKE 450
V T Y APE ++ + ID++S G + E++ ++
Sbjct: 167 FMTEY-------VATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQ 210
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 53/224 (23%), Positives = 102/224 (45%), Gaps = 32/224 (14%)
Query: 252 HNFSPKMLIGQGGNSKVYRTNHVD--GQVAAVKVLKCTNWSEEE-----VLREVELL--- 301
+ IG+G KV++ + G+ A+K ++ + EE +REV +L
Sbjct: 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQ--TGEEGMPLSTIREVAVLRHL 58
Query: 302 SSIKHENIVRIIGYC-----HSKEMYAIVYNLLNGSLKQYLKQ-----LKWNERMDVAIG 351
+ +H N+VR+ C + +V+ ++ L YL + + D+
Sbjct: 59 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 118
Query: 352 VAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVN 411
+ + L++LH ++HRD+K NIL++ + +L+DFG A ++ S Q++
Sbjct: 119 LLRGLDFLH---SHRVVHRDLKPQNILVTSS-GQIKLADFGLARIY--SFQMALTS---- 168
Query: 412 VVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTN 455
VV T Y APE ++ +D++S G + E+ K + +
Sbjct: 169 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS 212
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 61/212 (28%), Positives = 104/212 (49%), Gaps = 17/212 (8%)
Query: 260 IGQGGNSKVYRTNHV-DGQVAAVKV--LKCTNWSEEEVLREVELLSSIKHENIVRIIGYC 316
+G G V++ +H G + A K+ L+ +++RE+++L IV G
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 317 HSK-EMYAIVYNLLNGSLKQYLKQL-KWNERM--DVAIGVAKALEYLHHTCDPPIIHRDV 372
+S E+ + ++ GSL Q LK+ + E++ V+I V K L YL I+HRDV
Sbjct: 73 YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDV 130
Query: 373 KSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEK 432
K SNIL++ +L DFG S Q+ +++ + VGT Y++PE + +
Sbjct: 131 KPSNILVNSR-GEIKLCDFGV------SGQLIDSMAN-SFVGTRSYMSPERLQGTHYSVQ 182
Query: 433 IDVYSYGVVLLELITGKEAIQTNKANRESLVL 464
D++S G+ L+E+ G+ I A L+
Sbjct: 183 SDIWSMGLSLVEMAIGRYPIPPPDAKELELMF 214
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 49/163 (30%), Positives = 84/163 (51%), Gaps = 21/163 (12%)
Query: 296 REVELLSSIKHENIVRIIGYCH---SKEMYAIVY---NLLNGSLKQYLKQLKWNERMDVA 349
RE+ LL + HEN++ ++ S E + VY +L+ L +K K ++
Sbjct: 63 RELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQF 122
Query: 350 I--GVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV 407
+ + + L+Y+H + IIHRD+K SNI ++E+ L DFG A H +++
Sbjct: 123 LVYQILRGLKYIH-SAG--IIHRDLKPSNIAVNEDCELKIL-DFGLA--RHTDDEMT--- 173
Query: 408 KPVNVVGTFGYLAPEYMM-YGKVDEKIDVYSYGVVLLELITGK 449
V T Y APE M+ + ++ +D++S G ++ EL+TGK
Sbjct: 174 ---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 36/215 (16%)
Query: 259 LIGQGGNSKVYRTNHVDG-QVAAVKVLKCTNWSE--EEVLREVELLSSIKHENIVRIIGY 315
++G+G + HV+ Q A+K ++ S E+ +E LL+ +KH NIV +
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIV---AF 63
Query: 316 CHSKE----MYAIVYNLLNGSLKQYLKQ-----------LKWNERMDVAIGVAKALEYLH 360
S E +Y ++ G L Q +K L+W +M + +
Sbjct: 64 KESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGV---------Q 114
Query: 361 HTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLA 420
H + ++HRD+KS NI L++N +L DFG+A + + + VGT Y+
Sbjct: 115 HIHEKRVLHRDIKSKNIFLTQN-GKVKLGDFGSARL--LTSPGA---YACTYVGTPYYVP 168
Query: 421 PEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTN 455
PE + K D++S G +L EL T K Q N
Sbjct: 169 PEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 2e-10
Identities = 51/172 (29%), Positives = 84/172 (48%), Gaps = 28/172 (16%)
Query: 290 SEEEVLREVELL-SSIKHENIVRII-GYCHSKEMYAIVYNLLNG-SLKQYLKQLK----- 341
S +++ EV ++ ++H NIVR + + +Y IV +L+ G L ++ LK
Sbjct: 51 SIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLY-IVMDLIEGAPLGEHFNSLKEKKQR 109
Query: 342 ------WNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAM 395
WN + + + AL YLH + I+HRD+ +NI+L E+ ++DFG A
Sbjct: 110 FTEERIWN----IFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGED-DKVTITDFGLA- 161
Query: 396 VHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT 447
Q K +VVGT Y PE + EK DV+++G +L ++ T
Sbjct: 162 -----KQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 49/169 (28%), Positives = 82/169 (48%), Gaps = 28/169 (16%)
Query: 295 LREVELLSSIKHENIVRI------IGYCHSKEMYAIVYNLLNGSLKQYLK--QLKWNERM 346
LRE++LL + HEN++ I ++Y IVY L++ L Q ++ Q ++
Sbjct: 52 LREIKLLRHLDHENVIAIKDIMPPPHREAFNDVY-IVYELMDTDLHQIIRSSQTLSDDHC 110
Query: 347 DVAI-GVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ-VS 404
+ + + L+Y+H ++HRD+K SN+LL+ N ++ DFG A + ++
Sbjct: 111 QYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDL-KICDFGLARTTSEKGDFMT 166
Query: 405 ENVKPVNVVGTFGYLAPEYMM----YGKVDEKIDVYSYGVVLLELITGK 449
E V T Y APE ++ Y IDV+S G + EL+ K
Sbjct: 167 E------YVVTRWYRAPELLLNCSEYTTA---IDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 42/177 (23%), Positives = 92/177 (51%), Gaps = 19/177 (10%)
Query: 280 AVKVLK--CTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLLNGSLKQYL 337
A+K L+ + + +E+L E +++S+ + ++ R++G C + + I + G L Y+
Sbjct: 40 AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYV 99
Query: 338 KQLKWN----ERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGA 393
++ K N ++ + +AK + YL + ++HRD+ + N+L+ + H +++DFG
Sbjct: 100 REHKDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLV-KTPQHVKITDFGL 155
Query: 394 AMV---HHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT 447
A + + + P+ ++A E +++ + DV+SYGV + EL+T
Sbjct: 156 AKLLGADEKEYHAEGGKVPIK------WMALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 3e-10
Identities = 64/210 (30%), Positives = 92/210 (43%), Gaps = 39/210 (18%)
Query: 259 LIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVE----------LLSSIKHE 307
+IG+G KV DG AVKVL+ ++ +L++ E LL ++KH
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQ-----KKTILKKKEQNHIMAERNVLLKNLKHP 56
Query: 308 NIVRIIGYCHSKEMYAIVYNLLNGS-----LKQYLKQLKWNERMDVAIGVAKALEYLHHT 362
+V + + E V + +NG L++ L+ R A VA A+ YLH
Sbjct: 57 FLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVASAIGYLHSL 115
Query: 363 CDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTF----GY 418
II+RD+K NILL H L+DFG E V+P TF Y
Sbjct: 116 ---NIIYRDLKPENILLDSQ-GHVVLTDFGLC---------KEGVEPEETTSTFCGTPEY 162
Query: 419 LAPEYMMYGKVDEKIDVYSYGVVLLELITG 448
LAPE + D +D + G VL E++ G
Sbjct: 163 LAPEVLRKEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 59/229 (25%), Positives = 103/229 (44%), Gaps = 21/229 (9%)
Query: 260 IGQGGNSKVY--RTNHVDGQVAAVKVLKCTNWSEEE-----VLREVELLSSIKHENIVRI 312
+G+G + V+ R+ + VA LK EE +REV LL +KH NIV +
Sbjct: 14 LGEGTYATVFKGRSKLTENLVA----LKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTL 69
Query: 313 IGYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERM-DVAIGVAKALEYLHHTCDPPIIHRD 371
H+ + +V+ L+ LKQY+ M +V I + + L L + ++HRD
Sbjct: 70 HDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRD 129
Query: 372 VKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMM-YGKVD 430
+K N+L++E +L+DFG A + N V T Y P+ ++ +
Sbjct: 130 LKPQNLLINER-GELKLADFGLARAKSVPTKTYS-----NEVVTLWYRPPDVLLGSSEYS 183
Query: 431 EKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWYYVLAGKVFAQQWP 479
+ID++ G + E+ +G+ + E ++ + L G + WP
Sbjct: 184 TQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLI--FRLLGTPTEETWP 230
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 60/205 (29%), Positives = 95/205 (46%), Gaps = 29/205 (14%)
Query: 259 LIGQGGNSKVYRTNH-VDGQVAAVKVLK----CTNWSEEEVLREVE-LLSSIKHENIVRI 312
+IG+G KV H + + AVKVL+ E+ ++ E LL ++KH +V +
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 313 -IGYCHSKEMYAIVYNLLNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPI 367
+ + ++Y ++ + G L +L++ L+ R A +A AL YLH I
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLHSL---NI 117
Query: 368 IHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTF----GYLAPEY 423
++RD+K NILL H L+DFG EN++ TF YLAPE
Sbjct: 118 VYRDLKPENILLDSQ-GHIVLTDFGLC---------KENIEHNGTTSTFCGTPEYLAPEV 167
Query: 424 MMYGKVDEKIDVYSYGVVLLELITG 448
+ D +D + G VL E++ G
Sbjct: 168 LHKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 4e-10
Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 28/205 (13%)
Query: 260 IGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSE---EEVLREVELLSSIKHENIVRIIGY 315
IG+G VY+ V + A+K ++ E +RE+ LL ++H NIVR+
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 316 CHSKEMYAIVYNLLNGSLKQYLKQ---LKWNERM--DVAIGVAKALEYLHHTCDPPIIHR 370
HS++ +V+ L+ LK+++ N R+ + + + Y H ++HR
Sbjct: 70 VHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHR 126
Query: 371 DVKSSNILLSENFHHPQLSDFGAAM-----VHHQSHQVSENVKPVNVVGTFGYLAPEYMM 425
D+K N+L+ + +L+DFG A V +H+V T Y APE ++
Sbjct: 127 DLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV----------TLWYRAPEILL 176
Query: 426 YGK-VDEKIDVYSYGVVLLELITGK 449
+ +D++S G + E++ K
Sbjct: 177 GSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 4e-10
Identities = 60/225 (26%), Positives = 102/225 (45%), Gaps = 43/225 (19%)
Query: 259 LIGQGGNSKVYRT-NHVDGQVAAVKVLKCTNWSEEEVL-----REVELLSSIKHENIVRI 312
LIG+GG +VY + V + A+K ++ + SE +L RE ++ + + H IV +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIR-EDLSENPLLKKRFLREAKIAADLIHPGIVPV 67
Query: 313 IGYCHSKEM--YAIVYNLLNG-SLKQYLKQLKWNERM--DVAIG------------VAKA 355
C + Y + Y + G +LK LK + E + ++A +
Sbjct: 68 YSICSDGDPVYYTMPY--IEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICAT 125
Query: 356 LEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV------------ 403
+EY+H ++HRD+K NILL F + D+GAA+ +
Sbjct: 126 IEYVH---SKGVLHRDLKPDNILLGL-FGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181
Query: 404 -SENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT 447
S P +VGT Y+APE ++ E D+Y+ GV+L +++T
Sbjct: 182 YSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 5e-10
Identities = 59/212 (27%), Positives = 100/212 (47%), Gaps = 24/212 (11%)
Query: 253 NFSPKMLIGQGGNSKVY----RTNHVDGQVAAVKVLKCTNW-----SEEEVLREVELLSS 303
NF ++G G KV+ H G++ A+KVLK + E E ++L +
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 304 IKHENIVRIIGYCHSKE--MYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVAK---ALEY 358
++ + + Y + ++ I+ + G L +L Q + +V + +A+ AL++
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDH 120
Query: 359 LHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGY 418
LH II+RD+K NILL H L+DFG + + E + + GT Y
Sbjct: 121 LHQL---GIIYRDIKLENILLDSE-GHVVLTDFGLS----KEFLAEEEERAYSFCGTIEY 172
Query: 419 LAPEYMMYGKV--DEKIDVYSYGVVLLELITG 448
+APE + G D+ +D +S GV+ EL+TG
Sbjct: 173 MAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.9 bits (146), Expect = 6e-10
Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 40/210 (19%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLK--CTNWSEEEVLREVELLSSIK-HENIVRIIGY 315
+G G VY N G++ A+K +K +W E LREV+ L + H NIV++
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKL--- 63
Query: 316 CHSKEMYA------IVYNLLNGSLKQYLKQLKWNERMDVAIGVAK--------ALEYLHH 361
KE++ V+ + G+L Q +K + + V + L ++H
Sbjct: 64 ---KEVFRENDELYFVFEYMEGNLYQLMKD---RKGKPFSESVIRSIIYQILQGLAHIHK 117
Query: 362 TCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKP-VNVVGTFGYLA 420
HRD+K N+L+S +++DFG A + + P + V T Y A
Sbjct: 118 H---GFFHRDLKPENLLVSGPE-VVKIADFGLA-------REIRSRPPYTDYVSTRWYRA 166
Query: 421 PEYMMY-GKVDEKIDVYSYGVVLLELITGK 449
PE ++ +D+++ G ++ EL T +
Sbjct: 167 PEILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 9e-10
Identities = 47/197 (23%), Positives = 95/197 (48%), Gaps = 38/197 (19%)
Query: 278 VAAVKVLK--CTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGSLK 334
+ AVK+L+ + + L+EV++LS +K NI+R++G C ++ ++ + NG L
Sbjct: 48 LVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLN 107
Query: 335 QYLKQLKWNER----------------------MDVAIGVAKALEYLHHTCDPPIIHRDV 372
Q+L +++ + VA+ +A ++YL +HRD+
Sbjct: 108 QFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVHRDL 164
Query: 373 KSSNILLSENFHHPQLSDFGAA--MVHHQSHQVS-ENVKPVNVVGTFGYLAPEYMMYGKV 429
+ N L+ EN +++DFG + + +++ V P+ ++A E ++ GK
Sbjct: 165 ATRNCLVGENL-TIKIADFGMSRNLYAGDYYRIQGRAVLPIR------WMAWECILMGKF 217
Query: 430 DEKIDVYSYGVVLLELI 446
DV+++GV L E++
Sbjct: 218 TTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 61/207 (29%), Positives = 98/207 (47%), Gaps = 39/207 (18%)
Query: 260 IGQGGNSKVYRTNHVD-GQVAAVKVL-KCTNWSEEE---VLREVELLSSIKHENIVRII- 313
+GQGG +V+ D G++ A+K + K + E VL E ++L++ K E +V+++
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 314 GYCHSKEMY-AIVY-------NLLN--GSLKQYLKQLKWNERMDVAIGVAKALEYLHHTC 363
+ + +Y A+ Y LLN G L + + E M A+ L Y
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAE-MFEAVDALHELGY----- 122
Query: 364 DPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVN-VVGTFGYLAPE 422
IHRD+K N L+ + H +L+DFG + V N VVG+ Y+APE
Sbjct: 123 ----IHRDLKPENFLIDAS-GHIKLTDFGLS---------KGIVTYANSVVGSPDYMAPE 168
Query: 423 YMMYGK-VDEKIDVYSYGVVLLELITG 448
++ GK D +D +S G +L E + G
Sbjct: 169 -VLRGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 38/210 (18%)
Query: 260 IGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVR------- 311
IG+G +VY+ D ++ A+KVL S++E++ + E+ +I NI+
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVL-----SKKEIVAKKEVAHTIGERNILVRTLLDES 55
Query: 312 --IIGYCHS----KEMYAIVYNLLNGSLKQYL-KQLKWNE-RMDVAIG-VAKALEYLHHT 362
I+G S ++Y + + G L +L K+ +++E R I + ALE+LH
Sbjct: 56 PFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKY 115
Query: 363 CDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPE 422
I++RD+K NILL H L DFG + + +++N GT YLAPE
Sbjct: 116 ---DIVYRDLKPENILLDAT-GHIALCDFGLSKAN-----LTDNKTTNTFCGTTEYLAPE 166
Query: 423 YMM----YGKVDEKIDVYSYGVVLLELITG 448
++ Y K +D +S GV++ E+ G
Sbjct: 167 VLLDEKGYTK---HVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 51/198 (25%), Positives = 98/198 (49%), Gaps = 14/198 (7%)
Query: 259 LIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEE---EVLREVELLSSIKHENIVRIIG 314
++G+G V + H + ++ A+K K + +EE LRE+++L ++K ENIV +
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 315 YCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMD-VAIGVAKALEYLHHTCDPPIIHRDVK 373
+ +V+ + ++ + L+++ + V + + ++ +H I+HRD+K
Sbjct: 68 AFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIK 127
Query: 374 SSNILLSENFHHPQLSDFGAAMVHHQSHQVSE--NVKPVNVVGTFGYLAPEYMMYGKVDE 431
N+L+S N +L DFG A +SE N V T Y +PE ++ +
Sbjct: 128 PENLLISHN-DVLKLCDFGFA------RNLSEGSNANYTEYVATRWYRSPELLLGAPYGK 180
Query: 432 KIDVYSYGVVLLELITGK 449
+D++S G +L EL G+
Sbjct: 181 AVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 47/198 (23%), Positives = 88/198 (44%), Gaps = 37/198 (18%)
Query: 280 AVKVLKCTNWSEE--EVLREVELLSSIKHENIVRIIGYCHSKE-MYAIVYNLLNGSLKQY 336
AVK+LK S E ++L E LL + H +++++ G C + IV GSL+ +
Sbjct: 34 AVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSF 93
Query: 337 LKQLKWNERMDVAIGVAKALEYLHHTCDPPI------------------------IHRDV 372
L++ + + + YL + + + +HRD+
Sbjct: 94 LRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDL 153
Query: 373 KSSNILLSENFHHPQLSDFGAAM-VHHQSHQV--SENVKPVNVVGTFGYLAPEYMMYGKV 429
+ N+L++E ++SDFG + V+ + V S+ PV ++A E +
Sbjct: 154 AARNVLVAEG-RKMKISDFGLSRDVYEEDSYVKRSKGRIPVK------WMAIESLFDHIY 206
Query: 430 DEKIDVYSYGVVLLELIT 447
+ DV+S+GV+L E++T
Sbjct: 207 TTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 49/167 (29%), Positives = 80/167 (47%), Gaps = 20/167 (11%)
Query: 293 EVLREVELLSSIKHENIVRIIG-YCHSKEMYAIVYNLLNGSLKQYLKQLKWNERM----- 346
+++RE+++L IV G + E+ + ++ GSL Q LK+ R+
Sbjct: 45 QIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPENIL 101
Query: 347 -DVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE 405
++I V + L YL I+HRDVK SNIL++ +L DFG V Q
Sbjct: 102 GKISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSR-GEIKLCDFG---VSGQLIDSMA 155
Query: 406 NVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAI 452
N + VGT Y++PE + + D++S G+ L+E+ G+ I
Sbjct: 156 N----SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 2e-09
Identities = 49/187 (26%), Positives = 84/187 (44%), Gaps = 29/187 (15%)
Query: 280 AVKVLKC--TNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGSLKQY 336
A+K LK T + L E ++ H NI+ + G I+ + NG+L +
Sbjct: 36 AIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSF 95
Query: 337 LKQLKWNERMDVAI-------GVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLS 389
L+Q N+ I G+A ++YL + +HRD+ + NIL++ N ++S
Sbjct: 96 LRQ---NDGQFTVIQLVGMLRGIAAGMKYL---SEMNYVHRDLAARNILVNSNLV-CKVS 148
Query: 390 DFGAAMVHHQSHQVSENVKPVNVVGTFG------YLAPEYMMYGKVDEKIDVYSYGVVLL 443
DFG S + ++ + G + APE + Y K DV+SYG+V+
Sbjct: 149 DFGL------SRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMW 202
Query: 444 ELITGKE 450
E+++ E
Sbjct: 203 EVMSYGE 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 49/200 (24%), Positives = 96/200 (48%), Gaps = 33/200 (16%)
Query: 271 TNHVDGQ--VAAVKVLK--CTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326
DGQ + AVK+L+ T + + L+E++++S +K+ NI+R++G C S + ++
Sbjct: 37 APEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMIT 96
Query: 327 NLL-NGSLKQYLKQ---------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHR 370
+ NG L Q+L Q + + +A+ +A ++YL +HR
Sbjct: 97 EYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHR 153
Query: 371 DVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV---SENVKPVNVVGTFGYLAPEYMMYG 427
D+ + N L+ ++ +++DFG + + V P+ ++A E ++ G
Sbjct: 154 DLATRNCLVGNHY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIR------WMAWESILLG 206
Query: 428 KVDEKIDVYSYGVVLLELIT 447
K DV+++GV L E+ T
Sbjct: 207 KFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 57/204 (27%), Positives = 96/204 (47%), Gaps = 19/204 (9%)
Query: 259 LIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEEVLR------EVELLSSIKHENIVR 311
L+GQG +VY D G+ AVK ++ S E E++LL ++ HE IV+
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 312 IIGYCH---SKEMYAIVYNLLNGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDP 365
G + + + ++ GS+K LK L N + + + YLH
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM-- 126
Query: 366 PIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMM 425
I+HRD+K +NI L ++ + +L DFGA+ +K +V GT +++PE +
Sbjct: 127 -IVHRDIKGANI-LRDSVGNVKLGDFGASKRLQTICLSGTGMK--SVTGTPYWMSPEVIS 182
Query: 426 YGKVDEKIDVYSYGVVLLELITGK 449
K D++S G ++E++T K
Sbjct: 183 GEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 3e-09
Identities = 59/211 (27%), Positives = 100/211 (47%), Gaps = 21/211 (9%)
Query: 253 NFSPKMLIGQGGNSKVYRTNHVD-GQVAAVKVL----KCTNWSEE--EVLREVELLSSIK 305
N+ L+G+G +VY D G+ AVK + S+E + E++LL +++
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 306 HENIVRIIGYC----HSKEMYAIVYNLLNGSLKQYLKQ---LKWNERMDVAIGVAKALEY 358
H+ IV+ G C K++ V + GS+K LK L N + + + Y
Sbjct: 63 HDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSY 121
Query: 359 LHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGY 418
LH I+HRD+K +NI L ++ + +L DFGA+ +K +V GT +
Sbjct: 122 LHSNM---IVHRDIKGANI-LRDSAGNVKLGDFGASKRIQTICMSGTGIK--SVTGTPYW 175
Query: 419 LAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
++PE + K DV+S ++E++T K
Sbjct: 176 MSPEVISGEGYGRKADVWSVACTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 3e-09
Identities = 45/204 (22%), Positives = 103/204 (50%), Gaps = 24/204 (11%)
Query: 258 MLIGQGGNSKVYRTNHV-DGQ----VAAVKVLK--CTNWSEEEVLREVELLSSIKHENIV 310
++G G VY+ + DG+ A+KVL+ + + +E+L E +++ + +
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72
Query: 311 RIIGYCHSKEMYAIVYNLLNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPP 366
R++G C + + + + G L Y+++ + + ++ + +AK + YL +
Sbjct: 73 RLLGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVR 129
Query: 367 IIHRDVKSSNILLSENFHHPQLSDFGAAM---VHHQSHQVSENVKPVNVVGTFGYLAPEY 423
++HRD+ + N+L+ ++ +H +++DFG A + + P+ ++A E
Sbjct: 130 LVHRDLAARNVLV-KSPNHVKITDFGLARLLDIDETEYHADGGKVPIK------WMALES 182
Query: 424 MMYGKVDEKIDVYSYGVVLLELIT 447
+++ + + DV+SYGV + EL+T
Sbjct: 183 ILHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 4e-09
Identities = 52/200 (26%), Positives = 96/200 (48%), Gaps = 12/200 (6%)
Query: 252 HNFSPKMLIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEEVLR-EVELLSSIKHENI 309
H++ +G G VY+ ++ G++AAVK++K + +++ E+ ++ KH NI
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNI 68
Query: 310 VRIIGYCHSKEMYAIVYNLLNG-SLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPII 368
V G S+E I G SL+ + +A + L+ L + +
Sbjct: 69 VAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKM 128
Query: 369 HRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY-- 426
HRD+K +NILL++N +L+DFG A + + K + +GT ++APE
Sbjct: 129 HRDIKGANILLTDN-GDVKLADFGVA-----AKITATIAKRKSFIGTPYWMAPEVAAVEK 182
Query: 427 -GKVDEKIDVYSYGVVLLEL 445
G ++ D+++ G+ +EL
Sbjct: 183 NGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 4e-09
Identities = 48/172 (27%), Positives = 82/172 (47%), Gaps = 16/172 (9%)
Query: 291 EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLLNG-SLKQYLKQLK---WNERM 346
E L E ++L + +V + +K+ +V L+NG LK ++ + ++E
Sbjct: 44 EAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEER 103
Query: 347 DV--AIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404
V A + LE LH I++RD+K NILL +++ H ++SD G A+ ++
Sbjct: 104 AVFYAAEITCGLEDLHRE---RIVYRDLKPENILL-DDYGHIRISDLGLAV------EIP 153
Query: 405 ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456
E VGT GY+APE + + D + G ++ E+I GK + K
Sbjct: 154 EGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 5e-09
Identities = 52/172 (30%), Positives = 81/172 (47%), Gaps = 16/172 (9%)
Query: 291 EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLLNG-SLK---QYLKQLKWNERM 346
E L E ++L + +V + +K+ +V L+NG LK ++ + + E
Sbjct: 44 ESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGR 103
Query: 347 DV--AIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404
V A + LE LH I++RD+K NILL ++ H ++SD G A VH V
Sbjct: 104 AVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDH-GHIRISDLGLA-VH-----VP 153
Query: 405 ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456
E VGT GY+APE + + D ++ G +L E+I G+ Q K
Sbjct: 154 EGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 5e-09
Identities = 56/243 (23%), Positives = 101/243 (41%), Gaps = 37/243 (15%)
Query: 260 IGQGGNSKVYRT-NHVDGQVAAVKVLKCTNWSEEE-----VLREVELLSSIKHEN-IVRI 312
IG+G KVY+ + G++ A+K K +EE LRE+ LL + IVR+
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALK--KTRLEMDEEGIPPTALREISLLQMLSESIYIVRL 66
Query: 313 IGYCHSKE-----MYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVAKALEY-----LHHT 362
+ H +E +V+ L+ LK+++ + K+ Y + H
Sbjct: 67 LDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHC 126
Query: 363 CDPPIIHRDVKSSNILLSENFHHPQLSDFGAAM-----VHHQSHQVSENVKPVNVVGTFG 417
++HRD+K N+L+ + +++D G V +H++ T
Sbjct: 127 HKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV----------TLW 176
Query: 418 YLAPEYMMYGK-VDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWYYVLAGKVFAQ 476
Y APE ++ +D++S G + E+ K+ + + + L L + L G Q
Sbjct: 177 YRAPEVLLGSTHYSTPVDIWSVGCIFAEMSR-KQPLFPGDSELQQL-LHIFKLLGTPTEQ 234
Query: 477 QWP 479
WP
Sbjct: 235 VWP 237
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 5e-09
Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 21/205 (10%)
Query: 259 LIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEE---EVLR---EVELLSSIKHENIVR 311
L+GQG +VY VD G+ A K ++ S E EV E++LL +++HE IV+
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 312 IIGYC---HSKEMYAIVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCD 364
G C +++ I + GS+K LK L + + + + YLH
Sbjct: 69 YYG-CLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM- 126
Query: 365 PPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYM 424
I+HRD+K +NIL ++ + +L DFGA+ ++ +V GT +++PE +
Sbjct: 127 --IVHRDIKGANIL-RDSAGNVKLGDFGASKRLQTICMSGTGIR--SVTGTPYWMSPEVI 181
Query: 425 MYGKVDEKIDVYSYGVVLLELITGK 449
K DV+S G ++E++T K
Sbjct: 182 SGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 8e-09
Identities = 50/163 (30%), Positives = 84/163 (51%), Gaps = 21/163 (12%)
Query: 296 REVELLSSIKHENIVRIIGY---CHSKEMYAIVY---NLLNGSLKQYLK-QLKWNERMDV 348
RE+ LL +KHEN++ ++ S E + VY NL+ L +K Q +E +
Sbjct: 63 RELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQF 122
Query: 349 AI-GVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV 407
I + + L+Y+H IIHRD+K SN+ ++E+ ++ DFG A Q + +
Sbjct: 123 LIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCEL-RILDFGLA------RQADDEM 172
Query: 408 KPVNVVGTFGYLAPEYMM-YGKVDEKIDVYSYGVVLLELITGK 449
V T Y APE M+ + ++ +D++S G ++ EL+ GK
Sbjct: 173 --TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 8e-09
Identities = 48/163 (29%), Positives = 84/163 (51%), Gaps = 21/163 (12%)
Query: 296 REVELLSSIKHENIVRIIGY---CHSKEMYAIVY---NLLNGSLKQYLK--QLKWNERMD 347
RE+ LL +KHEN++ ++ S E + VY +L+ L +K +L +
Sbjct: 65 RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 124
Query: 348 VAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV 407
+ + + L+Y+H IIHRD+K SN+ ++E+ L DFG A H +++
Sbjct: 125 LIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKIL-DFGLA--RHTDDEMT--- 175
Query: 408 KPVNVVGTFGYLAPEYMM-YGKVDEKIDVYSYGVVLLELITGK 449
V T Y APE M+ + ++ +D++S G ++ EL+TG+
Sbjct: 176 ---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 52/172 (30%), Positives = 81/172 (47%), Gaps = 28/172 (16%)
Query: 294 VLREVELLSSIKHENIVRI--IGYCHS----KEMYAIVYNLLNGSLKQYLK---QLKWNE 344
+LRE++LL ++H +IV I I S K++Y +V+ L+ L Q +K L
Sbjct: 46 ILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY-VVFELMESDLHQVIKANDDLTPEH 104
Query: 345 RMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404
+ +AL+Y+H + HRD+K NIL + + ++ DFG A V
Sbjct: 105 HQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKL-KICDFGLARVAF------ 154
Query: 405 ENVKPVNV-----VGTFGYLAPEYM--MYGKVDEKIDVYSYGVVLLELITGK 449
N P + V T Y APE + K ID++S G + E++TGK
Sbjct: 155 -NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 51/212 (24%), Positives = 105/212 (49%), Gaps = 29/212 (13%)
Query: 253 NFSPKMLIGQGGNSKVYRTN-HVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVR 311
+F+ M++G+G KV ++ A+K+LK ++ V+++ ++ ++ + ++
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILK-----KDVVIQDDDVECTMVEKRVLA 55
Query: 312 I------IGYCHS-----KEMYAIVYNLLNGSLKQYLKQL-KWNERMDV--AIGVAKALE 357
+ + HS +Y ++ + G L +++Q+ K+ E V A ++ L
Sbjct: 56 LQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLF 115
Query: 358 YLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFG 417
+LH II+RD+K N++L H +++DFG H + + V GT
Sbjct: 116 FLHRR---GIIYRDLKLDNVMLDSE-GHIKIADFGMCKEH-----MVDGVTTRTFCGTPD 166
Query: 418 YLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
Y+APE + Y + +D ++YGV+L E++ G+
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 33/209 (15%)
Query: 259 LIGQGGNSKVYRTNHVDG--QVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGY- 315
+IG G VY +D +VA KVL+ + RE+ ++ ++ H NI+ + Y
Sbjct: 73 IIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKN----RELLIMKNLNHINIIFLKDYY 128
Query: 316 ---CHSKEMYAIVYNLLNGSLKQYL-KQLKWNERMDVAI----------GVAKALEYLHH 361
C K I N++ + Q + K +K R + A+ + +AL Y+H
Sbjct: 129 YTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS 188
Query: 362 TCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAP 421
I HRD+K N+L+ N H +L DFG+A + + V+ + + Y AP
Sbjct: 189 KF---ICHRDLKPQNLLIDPNTHTLKLCDFGSA------KNLLAGQRSVSYICSRFYRAP 239
Query: 422 EYMMYGKVD--EKIDVYSYGVVLLELITG 448
E +M G + ID++S G ++ E+I G
Sbjct: 240 E-LMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 52/222 (23%), Positives = 97/222 (43%), Gaps = 39/222 (17%)
Query: 260 IGQGGNSKVYRT-NHVDGQVAAVKVLKCTNWSEEE---------------VLREVELLSS 303
+G+G KV + + + G++ A+K +K S + LRE+++++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 304 IKHENIVRIIGYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVA------IGVAKALE 357
IKHENI+ ++ + +V +++ LK K + R+ + + + L
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIMASDLK---KVVDRKIRLTESQVKCILLQILNGLN 133
Query: 358 YLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNV----- 412
LH +HRD+ +NI ++ + +++DFG A + K +
Sbjct: 134 VLHKWY---FMHRDLSPANIFIN-SKGICKIADFGLARRYGYPPYSDTLSKDETMQRREE 189
Query: 413 ----VGTFGYLAPEYMM-YGKVDEKIDVYSYGVVLLELITGK 449
V T Y APE +M K +D++S G + EL+TGK
Sbjct: 190 MTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 60/201 (29%), Positives = 94/201 (46%), Gaps = 21/201 (10%)
Query: 259 LIGQGGNSKVYRTNH-VDGQVAAVKVLK---CTNWSEEEVL---REVELLSSIKHENIVR 311
+IG+G KV +DG+ AVKVL+ N E++ + R V LL ++KH +V
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNV-LLKNVKHPFLVG 60
Query: 312 IIGYCHSKEMYAIVYNLLNGS--LKQYLKQLKWNE-RMDVAIG-VAKALEYLHHTCDPPI 367
+ + E V + +NG ++ + E R +A AL YLH I
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSI---NI 117
Query: 368 IHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYG 427
++RD+K NILL ++ H L+DFG ++++ GT YLAPE +
Sbjct: 118 VYRDLKPENILL-DSQGHVVLTDFGLC-----KEGIAQSDTTTTFCGTPEYLAPEVIRKQ 171
Query: 428 KVDEKIDVYSYGVVLLELITG 448
D +D + G VL E++ G
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 54/215 (25%), Positives = 99/215 (46%), Gaps = 36/215 (16%)
Query: 259 LIGQGGNSKVYRTN-HVDG--QVAAVKVLK--CTNWSEEEVLREVELLSSI-KHENIVRI 312
+IG+G +V R DG AA+K+LK + + E+E+L + H NI+ +
Sbjct: 9 VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINL 68
Query: 313 IGYCHSK-EMYAIVYNLLNGSLKQYLKQ-------------------LKWNERMDVAIGV 352
+G C ++ +Y + G+L +L++ L + + A V
Sbjct: 69 LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDV 128
Query: 353 AKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNV 412
A ++YL + IHRD+ + N+L+ EN +++DFG + + + PV
Sbjct: 129 ATGMQYL---SEKQFIHRDLAARNVLVGENL-ASKIADFGLSRGEEVYVKKTMGRLPVR- 183
Query: 413 VGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT 447
++A E + Y K DV+S+GV+L E+++
Sbjct: 184 -----WMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 35/104 (33%), Positives = 52/104 (50%), Gaps = 18/104 (17%)
Query: 352 VAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVN 411
V AL+ +H IHRDVK N+LL ++ H +L+DFG M + V +
Sbjct: 151 VVLALDAIHSM---GFIHRDVKPDNMLLDKS-GHLKLADFGTCMKMDANGMVRCD----T 202
Query: 412 VVGTFGYLAPEYMM-------YGKVDEKIDVYSYGVVLLELITG 448
VGT Y++PE + YG+ + D +S GV L E++ G
Sbjct: 203 AVGTPDYISPEVLKSQGGDGYYGR---ECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 52/216 (24%), Positives = 96/216 (44%), Gaps = 38/216 (17%)
Query: 260 IGQGGNSKVYRT--NHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRI----- 312
+G G N V+ + D +VA K++ S + LRE++++ + H+NIV++
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 313 ---------IGYCHSKEMYAIVYNLLNGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHH 361
+G IV + L L+Q L + + L+Y+H
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIHS 132
Query: 362 TCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA--MVHHQSHQ--VSENVKPVNVVGTFG 417
++HRD+K +N+ ++ ++ DFG A + H SH+ +SE + T
Sbjct: 133 A---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV------TKW 183
Query: 418 YLAPEYMM----YGKVDEKIDVYSYGVVLLELITGK 449
Y +P ++ Y K ID+++ G + E++TGK
Sbjct: 184 YRSPRLLLSPNNYTKA---IDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 46/158 (29%), Positives = 71/158 (44%), Gaps = 20/158 (12%)
Query: 296 REVELLSSIKHENIVRIIGYCHSKEMYAIV--------YNLLNGSLKQYLKQLKWNERMD 347
RE+++L +I H I+ +I K +V + ++ S L+Q +R
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQR-- 192
Query: 348 VAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV 407
+ +AL YLH IIHRDVK+ NI L E + L DFGAA + +
Sbjct: 193 ---RLLEALAYLH---GRGIIHRDVKTENIFLDEP-ENAVLGDFGAAC---KLDAHPDTP 242
Query: 408 KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLEL 445
+ GT +PE + K D++S G+VL E+
Sbjct: 243 QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 4e-08
Identities = 31/118 (26%), Positives = 49/118 (41%), Gaps = 28/118 (23%)
Query: 355 ALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV----------- 403
AL+ +H IHRD+K NIL+ + H +L+DFG +++
Sbjct: 113 ALDSVH---KLGFIHRDIKPDNILIDAD-GHIKLADFGLCKKMNKAKDREYYLNDSHNLL 168
Query: 404 ----------SENVKPVN---VVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITG 448
+ V VGT Y+APE + + D +S GV+L E++ G
Sbjct: 169 FRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 4e-08
Identities = 54/212 (25%), Positives = 93/212 (43%), Gaps = 39/212 (18%)
Query: 258 MLIGQGGNSKV----YRTNHVDGQVAAVKVLK-----------CTNWSEEEVLREVELLS 302
++G+G KV + ++ AVKVLK CT +E+ VL
Sbjct: 1 KVLGKGSFGKVLLAELKGT---DELYAVKVLKKDVILQDDDVECT-MTEKRVLALAG--- 53
Query: 303 SIKHENIVRIIGYCHSKEMYAIVYNLLNGS--LKQYLKQLKWNERMDV--AIGVAKALEY 358
KH + ++ +K+ V +NG + + +++E A + L++
Sbjct: 54 --KHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQF 111
Query: 359 LHHTCDPPIIHRDVKSSNILL-SENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFG 417
LH + II+RD+K N+LL SE H +++DFG + V GT
Sbjct: 112 LH---ERGIIYRDLKLDNVLLDSEG--HIKIADFGMC-----KEGILGGVTTSTFCGTPD 161
Query: 418 YLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
Y+APE + Y +D ++ GV+L E++ G+
Sbjct: 162 YIAPEILSYQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 5e-08
Identities = 53/208 (25%), Positives = 101/208 (48%), Gaps = 21/208 (10%)
Query: 260 IGQGGNSKVYRTNHVDGQVA---AVKVLKCTNWSEEEVLREVELLSSIKHENIVRI--IG 314
+G+G VY+ DG+ A+K ++ T S RE+ LL +KH N++ + +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMS-ACREIALLRELKHPNVIALQKVF 67
Query: 315 YCHSKEMYAIVYNLLNGSLKQYLK---QLKWNER-MDVAIGVAKALEY-----LHHTCDP 365
HS ++++ L +K K N++ M + + K+L Y +H+
Sbjct: 68 LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127
Query: 366 PIIHRDVKSSNILL---SENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPE 422
++HRD+K +NIL+ +++D G A + + + ++ PV V TF Y APE
Sbjct: 128 WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV--TFWYRAPE 185
Query: 423 YMMYGK-VDEKIDVYSYGVVLLELITGK 449
++ + + ID+++ G + EL+T +
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 5e-08
Identities = 47/164 (28%), Positives = 76/164 (46%), Gaps = 15/164 (9%)
Query: 296 REVELLSSIKHENIVRIIGYC---HSKEMYAIVY---NLLNGSLKQYLKQLKWNERMDVA 349
RE+ LL + H+NI+ ++ S E + VY L++ +L Q + +ERM
Sbjct: 69 RELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYL 128
Query: 350 IGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKP 409
+ + L + H IIHRD+K SNI++ + ++ DFG A N
Sbjct: 129 L--YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL-KILDFGLA------RTACTNFMM 179
Query: 410 VNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQ 453
V T Y APE ++ E +D++S G ++ EL+ G Q
Sbjct: 180 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQ 223
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 5e-08
Identities = 55/205 (26%), Positives = 94/205 (45%), Gaps = 24/205 (11%)
Query: 257 KMLIGQGGNSKVYRTN-HVDGQVAAVKVLK----CTNWSEEEVLREVELLS-SIKHENIV 310
KML G+G KV+ Q A+K LK + E + E +LS + +H +
Sbjct: 1 KML-GKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 59
Query: 311 RIIGYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDV------AIGVAKALEYLHHTCD 364
+ +KE V LNG + ++ + D+ A + L++LH
Sbjct: 60 HLYCTFQTKENLFFVMEYLNGGDLMF--HIQSCHKFDLPRATFYAAEIICGLQFLH---S 114
Query: 365 PPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYM 424
I++RD+K NILL + H +++DFG + + K GT Y+APE +
Sbjct: 115 KGIVYRDLKLDNILLDTD-GHIKIADFGMC-----KENMLGDAKTCTFCGTPDYIAPEIL 168
Query: 425 MYGKVDEKIDVYSYGVVLLELITGK 449
+ K + +D +S+GV+L E++ G+
Sbjct: 169 LGQKYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 5e-08
Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 29/214 (13%)
Query: 253 NFSPKMLIGQGGNSKVYR----TNHVDGQVAAVKVL-KCT----NWSEEEVLREVELLSS 303
NF ++G G KV+ T H G++ A+KVL K + E E +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 304 IKHENIVRIIGYCHSKE--MYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVAK---ALEY 358
++ + + Y E ++ I+ + G + +L Q +V + ALE+
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEH 120
Query: 359 LHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGY 418
LH I++RD+K NILL H L+DFG + + E + + GT Y
Sbjct: 121 LHKL---GIVYRDIKLENILLDSE-GHVVLTDFGLS----KEFLSEEKERTYSFCGTIEY 172
Query: 419 LAPEYMM----YGKVDEKIDVYSYGVVLLELITG 448
+APE + +GK +D +S G+++ EL+TG
Sbjct: 173 MAPEIIRGKGGHGKA---VDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 5e-08
Identities = 40/189 (21%), Positives = 85/189 (44%), Gaps = 25/189 (13%)
Query: 275 DGQVAAVKVLKCTNWSEEEVLR----EVELLSSIKHENIVRIIGY----CHSKEMYAIVY 326
+ + ++ K + + ++ E++ L I NI++I G+ +++
Sbjct: 42 NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLIL 101
Query: 327 N-LLNGSLKQYL---KQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN 382
G L++ L K L + ++D+AI K L L+ + P ++++ S + L++EN
Sbjct: 102 EYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTEN 159
Query: 383 FHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYM--MYGKVDEKIDVYSYGV 440
+ ++ H ++ + P V Y + + + ++ + K D+YS GV
Sbjct: 160 YK--------LKIICHGLEKIL-SSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGV 210
Query: 441 VLLELITGK 449
VL E+ TGK
Sbjct: 211 VLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 6e-08
Identities = 52/208 (25%), Positives = 102/208 (49%), Gaps = 21/208 (10%)
Query: 260 IGQGGNSKVYRTNHVDGQVA---AVKVLKCTNWSEEEVLREVELLSSIKHENIVRI--IG 314
+G+G VY+ DG+ A+K ++ T S RE+ LL +KH N++ + +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMS-ACREIALLRELKHPNVISLQKVF 67
Query: 315 YCHSKEMYAIVYNLLNGSLKQYLK---QLKWNER-MDVAIGVAKALEY-----LHHTCDP 365
H+ ++++ L +K K N++ + + G+ K+L Y +H+
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 127
Query: 366 PIIHRDVKSSNILL---SENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPE 422
++HRD+K +NIL+ +++D G A + + + ++ PV V TF Y APE
Sbjct: 128 WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV--TFWYRAPE 185
Query: 423 YMMYGK-VDEKIDVYSYGVVLLELITGK 449
++ + + ID+++ G + EL+T +
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 24/209 (11%)
Query: 258 MLIGQG--GNSKVYRTNHVD-GQVAAVKVLKCTNWSEEEVLR---EVELLSSIKHENIVR 311
LIG+ V+ H + AVK + + S+E++ E+ ++H NI+
Sbjct: 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP 63
Query: 312 IIGYCHSKEMYAIVYNLLN-GSLKQYLKQLKWNERM-DVAI-----GVAKALEYLHHTCD 364
+ +V L+ GS + LK + E + ++AI V AL+Y+H
Sbjct: 64 YVTSFIVDSELYVVSPLMAYGSCEDLLKT-HFPEGLPELAIAFILKDVLNALDYIHSK-- 120
Query: 365 PPIIHRDVKSSNILLSENFHHPQLSDFGAA--MVHHQSHQVSENVKPVNVVGTFGYLAPE 422
IHR VK+S+ILLS + LS + M+ H Q + P + V +L+PE
Sbjct: 121 -GFIHRSVKASHILLSGD-GKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPE 178
Query: 423 YM---MYGKVDEKIDVYSYGVVLLELITG 448
+ + G +EK D+YS G+ EL G
Sbjct: 179 VLQQNLQG-YNEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 54/215 (25%), Positives = 98/215 (45%), Gaps = 36/215 (16%)
Query: 259 LIGQGGNSKVYRTN-HVDG--QVAAVKVLK--CTNWSEEEVLREVELLSSI-KHENIVRI 312
+IG+G +V + DG AA+K +K + + E+E+L + H NI+ +
Sbjct: 14 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73
Query: 313 IGYC-HSKEMYAIVYNLLNGSLKQYLKQ-------------------LKWNERMDVAIGV 352
+G C H +Y + +G+L +L++ L + + A V
Sbjct: 74 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133
Query: 353 AKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNV 412
A+ ++YL IHRD+ + NIL+ EN+ +++DFG + + + PV
Sbjct: 134 ARGMDYLSQK---QFIHRDLAARNILVGENY-VAKIADFGLSRGQEVYVKKTMGRLPVR- 188
Query: 413 VGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT 447
++A E + Y DV+SYGV+L E+++
Sbjct: 189 -----WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 1e-07
Identities = 55/205 (26%), Positives = 90/205 (43%), Gaps = 29/205 (14%)
Query: 259 LIGQGGNSKVYRTN-HVDGQVAAVKVLK----CTNWSEEEVLREVELLSSIKHENIVRII 313
++G+G KV G++ AVKVLK + E + E +LS ++ + +
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 314 GYC-HSKEMYAIVYNLLNGSLKQYLKQLKWNERMD------VAIGVAKALEYLHHTCDPP 366
C + + V +NG + ++ + R D A + AL +LH D
Sbjct: 62 YCCFQTPDRLFFVMEFVNGG--DLMFHIQKSRRFDEARARFYAAEITSALMFLH---DKG 116
Query: 367 IIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEY--- 423
II+RD+K N+LL H +L+DFG + GT Y+APE
Sbjct: 117 IIYRDLKLDNVLLDHE-GHCKLADFGMC-----KEGIFNGKTTSTFCGTPDYIAPEILQE 170
Query: 424 MMYGKVDEKIDVYSYGVVLLELITG 448
M+YG +D ++ GV+L E++ G
Sbjct: 171 MLYGPS---VDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 61/233 (26%), Positives = 104/233 (44%), Gaps = 36/233 (15%)
Query: 253 NFSPKMLIGQG--GNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIV 310
+F +IG+G G V + H + ++ A+K+L W E+L+ E + + E V
Sbjct: 2 DFEIIKVIGRGAFGEVAVVKMKHTE-RIYAMKIL--NKW---EMLKRAET-ACFREERNV 54
Query: 311 RIIGYCH-----------SKEMYAIVYNLLNGSLKQYLKQLKWNERMDVA-IGVAKALEY 358
+ G C +Y ++ + G L L + + D+A +A+ +
Sbjct: 55 LVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLA 114
Query: 359 LHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGY 418
+H +HRD+K N+LL N H +L+DFG+ + +Q V +V VGT Y
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMN-GHIRLADFGSCLKMNQDGTVQSSV----AVGTPDY 169
Query: 419 LAPEYMM-----YGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWY 466
++PE + GK + D +S GV + E++ G+ ESLV Y
Sbjct: 170 ISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA-----ESLVETY 217
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 2e-07
Identities = 53/215 (24%), Positives = 98/215 (45%), Gaps = 36/215 (16%)
Query: 259 LIGQGGNSKVYRTN-HVDG--QVAAVKVLK--CTNWSEEEVLREVELLSSIKHE-NIVRI 312
+IG+G +V + DG AA+K +K + + E+E+L + H NI+ +
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 313 IGYCHSK-EMYAIVYNLLNGSLKQYLKQ-------------------LKWNERMDVAIGV 352
+G C + +Y + +G+L +L++ L + + A V
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 353 AKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNV 412
A+ ++YL IHRD+ + NIL+ EN+ +++DFG + + + PV
Sbjct: 122 ARGMDYLS---QKQFIHRDLAARNILVGENYV-AKIADFGLSRGQEVYVKKTMGRLPVR- 176
Query: 413 VGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT 447
++A E + Y DV+SYGV+L E+++
Sbjct: 177 -----WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 59/239 (24%), Positives = 94/239 (39%), Gaps = 53/239 (22%)
Query: 252 HNFSPKMLIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEE----VLREVELLSSIKH 306
+F L+G+G +V+ G++ A+KVL + VL E E+L+++ H
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60
Query: 307 -------------ENIVRIIGYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVA 353
+ ++ YC E++ LL +Q K L A V
Sbjct: 61 PFLPTLYASFQTETYLCLVMDYCPGGELFR----LLQ---RQPGKCLSEEVARFYAAEVL 113
Query: 354 KALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDF---------GAAMVHH-----Q 399
ALEYLH I++RD+K NILL E+ H LSDF + +
Sbjct: 114 LALEYLHLL---GIVYRDLKPENILLHES-GHIMLSDFDLSKQSDVEPPPVSKALRKGSR 169
Query: 400 SHQVSENVKPVNV----------VGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITG 448
V+ VGT Y+APE + +D ++ G++L E++ G
Sbjct: 170 RSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 44/172 (25%), Positives = 81/172 (47%), Gaps = 16/172 (9%)
Query: 291 EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLLNG-SLKQYLKQLK---WNERM 346
E L E ++L + + +V + +K+ +V ++NG LK ++ + + E
Sbjct: 44 ESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEER 103
Query: 347 DV--AIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404
+ A + LE LH ++RD+K NILL +++ H ++SD G A+ ++
Sbjct: 104 ALFYAAEILCGLEDLHRE---NTVYRDLKPENILL-DDYGHIRISDLGLAV------KIP 153
Query: 405 ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456
E VGT GY+APE + + D + G ++ E+I G+ + K
Sbjct: 154 EGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 2e-07
Identities = 58/238 (24%), Positives = 104/238 (43%), Gaps = 44/238 (18%)
Query: 260 IGQGGNSKVYRTNHVDGQV----AAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGY 315
IG G +V+ H Q A+ + +++ EV ++ +KH+NIVR I
Sbjct: 21 IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDR 80
Query: 316 CHSK---EMYAIVYNLLNGSLKQYLKQ-------LKWNERMDVAIGVAKALEYLHHTCDP 365
+K ++Y ++ G L + +++ ++ + +D+ + AL Y H+ D
Sbjct: 81 FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDG 140
Query: 366 P----IIHRDVKSSNILLSENFHH----------------PQLSDFGAAMVHHQSHQVSE 405
P ++HRD+K NI LS H ++ DFG S +
Sbjct: 141 PNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGL------SKNIGI 194
Query: 406 NVKPVNVVGTFGYLAPEYMMY--GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRES 461
+ VGT Y +PE +++ D+K D+++ G ++ EL +GK +KAN S
Sbjct: 195 ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF--HKANNFS 250
|
Length = 1021 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 55/228 (24%), Positives = 98/228 (42%), Gaps = 35/228 (15%)
Query: 260 IGQGGNSKVYRTNHVD---GQVAAVKVLKCTNWSEE-----EVLREVELLSSIKHENIVR 311
+GQG VY N D G+ +K N S E L E ++ ++VR
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 312 IIGYCHSKEMYAIVYNLL-NGSLKQYLKQLK-------------WNERMDVAIGVAKALE 357
++G + +V L+ +G LK YL+ L+ E + +A +A +
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 358 YLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVK---PVNVVG 414
YL+ +HRD+ + N +++ +F ++ DFG +++ + K PV
Sbjct: 134 YLNAK---KFVHRDLAARNCMVAHDFT-VKIGDFGMTRDIYETDYYRKGGKGLLPVR--- 186
Query: 415 TFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESL 462
++APE + G D++S+GVVL E+ + E +N + L
Sbjct: 187 ---WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVL 231
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 52.2 bits (126), Expect = 3e-07
Identities = 54/175 (30%), Positives = 83/175 (47%), Gaps = 40/175 (22%)
Query: 296 REVELLSSIK-HENIVR---IIGYCHSKEMY------------AIVYNLLNGSLKQY-LK 338
RE+ L + H NIV+ +I + K++Y I N+L K+Y +
Sbjct: 55 REIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKRYIMY 114
Query: 339 QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398
QL KAL+Y+H +IHRD+K SNILL+ + +L+DFG A
Sbjct: 115 QL------------LKALKYIHSG---NVIHRDLKPSNILLNSDC-RVKLADFGLARSLS 158
Query: 399 QSHQVSENVKPVNVVGTFGYLAPEYMM----YGKVDEKIDVYSYGVVLLELITGK 449
+ + EN + V T Y APE ++ Y K +D++S G +L E++ GK
Sbjct: 159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTK---GVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 3e-07
Identities = 31/95 (32%), Positives = 53/95 (55%), Gaps = 9/95 (9%)
Query: 355 ALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVG 414
L++LH II+RD+K N+LL ++ H +++DFG ++ K G
Sbjct: 108 GLQFLHKK---GIIYRDLKLDNVLLDKD-GHIKIADFGMC-----KENMNGEGKASTFCG 158
Query: 415 TFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
T Y+APE + K +E +D +S+GV+L E++ G+
Sbjct: 159 TPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 3e-07
Identities = 53/228 (23%), Positives = 98/228 (42%), Gaps = 35/228 (15%)
Query: 260 IGQGGNSKVYR-------TNHVDGQVAAVKVLKCTNWSEE-EVLREVELLSSIKHENIVR 311
+GQG VY + + +VA V + + E E L E ++ ++VR
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 312 IIGYCHSKEMYAIVYNLLN-GSLKQYLKQLKWNER-------------MDVAIGVAKALE 357
++G + ++ L+ G LK YL+ L+ + +A +A +
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 358 YLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVK---PVNVVG 414
YL+ +HRD+ + N +++E+F ++ DFG +++ + K PV
Sbjct: 134 YLNAN---KFVHRDLAARNCMVAEDFT-VKIGDFGMTRDIYETDYYRKGGKGLLPVR--- 186
Query: 415 TFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESL 462
+++PE + G DV+S+GVVL E+ T E +N + L
Sbjct: 187 ---WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVL 231
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 3e-07
Identities = 39/118 (33%), Positives = 60/118 (50%), Gaps = 23/118 (19%)
Query: 345 RMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMV-------- 396
RM A V ALEYLH+ I+HRD+K N+L++ + H +L+DFG + +
Sbjct: 104 RMYFAETVL-ALEYLHNY---GIVHRDLKPDNLLIT-SMGHIKLTDFGLSKIGLMSLTTN 158
Query: 397 ---HHQSHQVSENVKPVNVVGTFGYLAPEYMM---YGKVDEKIDVYSYGVVLLELITG 448
H E + V GT Y+APE ++ YGK +D ++ G++L E + G
Sbjct: 159 LYEGHIEKDTREFLDK-QVCGTPEYIAPEVILRQGYGK---PVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 4e-07
Identities = 42/157 (26%), Positives = 71/157 (45%), Gaps = 18/157 (11%)
Query: 297 EVELLSSIKHENIVRIIGYCHSKEMYAIVYNLLNG--------SLKQYLKQLKWNERMDV 348
E +LLS + H IV+ ++ + I+ G LK K L N+ +
Sbjct: 52 EAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW 111
Query: 349 AIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVK 408
I + + Y+H I+HRD+K+ NI L N ++ DFG + + S ++
Sbjct: 112 FIQLLLGVHYMHQR---RILHRDLKAKNIFLKNNL--LKIGDFGVSRLLMGSCDLA---- 162
Query: 409 PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLEL 445
GT Y++PE + + D K D++S G +L E+
Sbjct: 163 -TTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 4e-07
Identities = 35/122 (28%), Positives = 62/122 (50%), Gaps = 12/122 (9%)
Query: 331 GSLKQYLKQL-KWNERMDV--AIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQ 387
G L +++Q+ K+ E V A +A L +LH II+RD+K N++L H +
Sbjct: 86 GDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAE-GHIK 141
Query: 388 LSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT 447
++DFG + + GT Y+APE + Y + +D +++GV+L E++
Sbjct: 142 IADFGMCKEN-----IFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 196
Query: 448 GK 449
G+
Sbjct: 197 GQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 4e-07
Identities = 47/179 (26%), Positives = 83/179 (46%), Gaps = 25/179 (13%)
Query: 290 SEEEVLREVELLSSIKHENIVRIIGYCHS------KEMYAIVYNLLNGSLKQYL--KQLK 341
S + V RE+++L KH+N++ + +E+Y +V L+ L + + Q
Sbjct: 42 SCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY-VVTELMQSDLHKIIVSPQPL 100
Query: 342 WNERMDVAI-GVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400
++ + V + + + L+YLH I+HRD+K N+L++ N ++ DFG A V
Sbjct: 101 SSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNC-VLKICDFGLARVEEP- 155
Query: 401 HQVSENVKPVNVVGTFGYLAPEYMM----YGKVDEKIDVYSYGVVLLELITGKEAIQTN 455
E+ V T Y APE +M Y +D++S G + EL+ + Q
Sbjct: 156 ---DESKHMTQEVVTQYYRAPEILMGSRHYT---SAVDIWSVGCIFAELLGRRILFQAQ 208
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 48/159 (30%), Positives = 78/159 (49%), Gaps = 15/159 (9%)
Query: 297 EVELLSSIKHENIVRIIGYCHSKEMYAIVYNL-----LNGSLKQYLKQLKWNERMDVAI- 350
E+ L++ H IV+ S + ++ LN +KQ LK+ + +V +
Sbjct: 115 ELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLL 174
Query: 351 --GVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVK 408
+ AL+ +H ++HRD+KS+NI L +L DFG + + S VS +V
Sbjct: 175 FYQIVLALDEVHSRK---MMHRDLKSANIFLMPT-GIIKLGDFGFSKQYSDS--VSLDVA 228
Query: 409 PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT 447
+ GT YLAPE + +K D++S GV+L EL+T
Sbjct: 229 S-SFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 5e-07
Identities = 57/214 (26%), Positives = 95/214 (44%), Gaps = 26/214 (12%)
Query: 253 NFSPKMLIGQG--GNSKVYRTNHVDGQVAAVKVLKCTNWSEEE----VLREVELLSSIKH 306
+F K L+G+G G +V R G + A+KV+K + +E E ++LS
Sbjct: 2 DFDVKSLVGRGHFGEVQVVR-EKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 307 ENIVRIIGYCHSKEMYAIVYNLLNGS-----LKQYLKQLKWNERMDVAIGVAKALEYLHH 361
I ++ K+ +V G L +Y Q +E M +A+ + +H
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQF--DEDM-AQFYLAELVLAIHS 117
Query: 362 TCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAP 421
+HRD+K N+L+ + H +L+DFG+A ++ V VGT Y+AP
Sbjct: 118 VHQMGYVHRDIKPENVLI-DRTGHIKLADFGSA----ARLTANKMVNSKLPVGTPDYIAP 172
Query: 422 EYMM----YGK--VDEKIDVYSYGVVLLELITGK 449
E + GK + D +S GV+ E+I G+
Sbjct: 173 EVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 6e-07
Identities = 42/172 (24%), Positives = 80/172 (46%), Gaps = 16/172 (9%)
Query: 291 EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLLNG-SLKQYL-----KQLKWNE 344
E+ L E E+L + IV + SK +V +L+NG LK ++ + L+
Sbjct: 37 EKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMER 96
Query: 345 RMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404
+ + + + +LH I++RD+K N+LL + + +LSD G A+ ++
Sbjct: 97 VIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQ-GNCRLSDLGLAV------ELK 146
Query: 405 ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456
+ GT GY+APE + +D ++ G + E++ G+ + +K
Sbjct: 147 DGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 7e-07
Identities = 33/94 (35%), Positives = 51/94 (54%), Gaps = 9/94 (9%)
Query: 356 LEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGT 415
LE+LH II+RD+K N+LL +N + ++SD G A V + Q K GT
Sbjct: 110 LEHLHQR---RIIYRDLKPENVLL-DNDGNVRISDLGLA-VELKDGQS----KTKGYAGT 160
Query: 416 FGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
G++APE + + D +D ++ GV L E+I +
Sbjct: 161 PGFMAPELLQGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 8e-07
Identities = 46/172 (26%), Positives = 79/172 (45%), Gaps = 16/172 (9%)
Query: 291 EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLLNG-SLKQYLKQLK---WNERM 346
E L E +L + +V + +K+ +V ++NG LK ++ + ++E+
Sbjct: 44 EAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQR 103
Query: 347 DV--AIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404
+ A + LE L I++RD+K NILL + H ++SD G A+ Q+
Sbjct: 104 AIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDR-GHIRISDLGLAV------QIP 153
Query: 405 ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456
E VGT GY+APE + K D + G ++ E+I G+ + K
Sbjct: 154 EGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 50/219 (22%), Positives = 98/219 (44%), Gaps = 41/219 (18%)
Query: 260 IGQGGNSKVYRTNHVDG-------QVAAVKVLK--CTNWSEEEVLREVELLSSIKHENIV 310
+G+ KVY+ H+ G Q A+K LK EE E + S ++H NIV
Sbjct: 13 LGEDRFGKVYK-GHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71
Query: 311 RIIGYCHSKEMYAIVYNLLN-GSLKQYL-------------------KQLKWNERMDVAI 350
++G ++ +++++ + L ++L L+ + + +
Sbjct: 72 CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131
Query: 351 GVAKALEYL--HHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVK 408
+A +E+L HH H+D+ + N+L+ + + ++SD G + + +
Sbjct: 132 QIAAGMEFLSSHHVV-----HKDLATRNVLVFDKLN-VKISDLG---LFREVYAADYYKL 182
Query: 409 PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT 447
N + +++PE +MYGK D++SYGVVL E+ +
Sbjct: 183 MGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 55/213 (25%), Positives = 89/213 (41%), Gaps = 42/213 (19%)
Query: 253 NFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLK-----------CTNWSEEEVLREVELL 301
+F ML G +VY A+KVLK CT + E +L
Sbjct: 7 SFGKVMLAELKGTDEVY----------AIKVLKKDVILQDDDVDCT-------MTEKRIL 49
Query: 302 S-SIKHENIVRIIGYCHSKEMYAIVYNLLNGS--LKQYLKQLKWNERMD--VAIGVAKAL 356
+ + KH + + +K+ V +NG + Q + K++E A V AL
Sbjct: 50 ALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLAL 109
Query: 357 EYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTF 416
+LH +I+RD+K NILL H +L+DFG + V GT
Sbjct: 110 MFLHRH---GVIYRDLKLDNILLDAE-GHCKLADFGMC-----KEGILNGVTTTTFCGTP 160
Query: 417 GYLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
Y+APE + + +D ++ GV++ E++ G+
Sbjct: 161 DYIAPEILQELEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 56/197 (28%), Positives = 92/197 (46%), Gaps = 16/197 (8%)
Query: 260 IGQGGNSKVYRTNHVDGQ-VAAVKVLKCTNW-SEEEV---LREVELLSSIKHENIVRIIG 314
IG+G KV + D Q + A+K ++ + S EV L E +L+ + IV +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 315 YCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIG---VAKALEYLHHTCDPPIIHRD 371
S E +V +NG + L+ R D++ A+ L L + +I+RD
Sbjct: 61 SFQSPEKLYLVLAFINGG--ELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRD 118
Query: 372 VKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDE 431
+K NILL H L DFG ++ + ++ K GT YLAPE ++ +
Sbjct: 119 LKPENILLDYQ-GHIALCDFGLCKLN-----MKDDDKTNTFCGTPEYLAPELLLGHGYTK 172
Query: 432 KIDVYSYGVVLLELITG 448
+D ++ GV+L E++TG
Sbjct: 173 AVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 44/160 (27%), Positives = 78/160 (48%), Gaps = 15/160 (9%)
Query: 296 REVELLSSIKHENIVRIIG-YCHSKEMYA-----IVYNLLNGSLKQYLKQLKWNERMDVA 349
RE+ L+ + H+NI+ ++ + K + IV L++ +L Q ++ +ERM
Sbjct: 72 RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL 131
Query: 350 IGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKP 409
+ + L + H IIHRD+K SNI++ + ++ DFG A S ++ V
Sbjct: 132 L--YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL-KILDFGLARTAGTSFMMTPYVV- 187
Query: 410 VNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
T Y APE ++ E +D++S G ++ E+I G
Sbjct: 188 -----TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 46/163 (28%), Positives = 79/163 (48%), Gaps = 21/163 (12%)
Query: 296 REVELLSSIKHENIVRIIGYCHSKEM------YAIVYNLLNGSLKQYLKQLKWNE-RMDV 348
RE+ LL +KHEN++ ++ + +V + L + +K K +E R+
Sbjct: 63 RELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQF 122
Query: 349 AI-GVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV 407
+ + K L+Y+H IIHRD+K N+ ++E+ L DFG A SE
Sbjct: 123 LVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKIL-DFGLA-----RQTDSEMT 173
Query: 408 KPVNVVGTFGYLAPEYMM-YGKVDEKIDVYSYGVVLLELITGK 449
V T Y APE ++ + + +D++S G ++ E++TGK
Sbjct: 174 ---GYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 41/178 (23%), Positives = 81/178 (45%), Gaps = 15/178 (8%)
Query: 280 AVKVLK--CTNWSEEEVLREVELLSSIKHENIVRIIGY-CHSKEMYAIVYNLLNGSLKQY 336
A+ L+ C++ L E L H NIVR+ G M + + NG+L +
Sbjct: 37 AIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSF 96
Query: 337 LK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFG 392
L+ QL + M + G+A ++YL + +H+ + + +L++ + ++S F
Sbjct: 97 LRKHEGQLVAGQLMGMLPGLASGMKYL---SEMGYVHKGLAAHKVLVNSDLV-CKISGFR 152
Query: 393 AAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKE 450
+ +S + + + V + APE + Y DV+S+G+V+ E+++ E
Sbjct: 153 R-LQEDKSEAIYTTMSGKSPVL---WAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGE 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 33/119 (27%), Positives = 59/119 (49%), Gaps = 13/119 (10%)
Query: 355 ALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVG 414
AL YLH +CD +++RD+K N++L + H +++DFG +S+ G
Sbjct: 107 ALGYLH-SCD--VVYRDLKLENLML-DKDGHIKITDFGLC-----KEGISDGATMKTFCG 157
Query: 415 TFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWYYVLAGKV 473
T YLAPE + +D + GVV+ E++ G+ N++ L+ +L ++
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY----NQDHEKLFELILMEEI 212
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 44/162 (27%), Positives = 80/162 (49%), Gaps = 19/162 (11%)
Query: 296 REVELLSSIKHENIVRIIG-------YCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDV 348
RE+ L+ + H+NI+ ++ +++Y +V L++ +L Q ++ +ERM
Sbjct: 64 RELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVY-LVMELMDANLCQVIQMDLDHERMSY 122
Query: 349 AI-GVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV 407
+ + +++LH IIHRD+K SNI++ + L DFG A S ++ V
Sbjct: 123 LLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL-DFGLARTAGTSFMMTPYV 178
Query: 408 KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
T Y APE ++ E +D++S G ++ E+I G
Sbjct: 179 V------TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 50/200 (25%), Positives = 92/200 (46%), Gaps = 18/200 (9%)
Query: 259 LIGQGGNSKVYRTNH-VDGQVAAVKVLKC-TNWSEEEV---LREVELLSSIKHENIVRII 313
L+G+G KV G+ A+K+LK +++EV L E +L + +H + +
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 314 GYCHSKEMYAIVYNLLNGS--LKQYLKQLKWNERMDVAIG--VAKALEYLHHTCDPPIIH 369
+K+ V +NG ++ ++E G + AL+YLH I++
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLH---SGKIVY 118
Query: 370 RDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKV 429
RD+K N++L ++ H +++DFG +++ GT YLAPE +
Sbjct: 119 RDLKLENLMLDKD-GHIKITDFGLC-----KEGITDAATMKTFCGTPEYLAPEVLEDNDY 172
Query: 430 DEKIDVYSYGVVLLELITGK 449
+D + GVV+ E++ G+
Sbjct: 173 GRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 56/220 (25%), Positives = 95/220 (43%), Gaps = 38/220 (17%)
Query: 260 IGQGGNSKVYRTNH-------VDGQVAAV----KVLKCTNWSEEEVLREVELLSSIKHEN 308
+GQG + +Y+ + G V KVL + L+S + H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 309 IVRIIGYCHSKEMYAIVYNLLN-GSLKQYLKQLKWNE----RMDVAIGVAKALEYLHHTC 363
+V++ G C E +V + G L +L + K N ++DVA +A AL YL
Sbjct: 63 LVKLYGVCVRDE-NIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE--- 118
Query: 364 DPPIIHRDVKSSNILL---SENFHHP---QLSDFGAAMVHHQSHQVSENVKPVNVVGTFG 417
D ++H +V NIL+ N + +LSD G + E V+ +
Sbjct: 119 DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPIT---VLSREERVERIP------ 169
Query: 418 YLAPEYMMYG--KVDEKIDVYSYGVVLLELIT-GKEAIQT 454
++APE + G + D +S+G LLE+ + G+E + T
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLST 209
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 55/212 (25%), Positives = 96/212 (45%), Gaps = 40/212 (18%)
Query: 259 LIGQGGNSKVYRTNHVDGQ-VAAVKVLKCTNWSEEEVLR---------EVELLSSIKHEN 308
+IG+G +V H Q V A+K+L S+ E+++ E ++++
Sbjct: 50 VIGRGAFGEVQLVRHKSSQKVYAMKLL-----SKFEMIKRSDSAFFWEERDIMAFANSPW 104
Query: 309 IVRII-GYCHSKEMYAIVYNLLNGSLKQYLKQL----KWNERMDVAIGVAKALEYLHHTC 363
+V++ + K +Y ++ + G L + KW + V AL+ +H
Sbjct: 105 VVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAE--VVLALDAIHSM- 161
Query: 364 DPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEY 423
+IHRDVK N+LL + H +L+DFG M ++ V + VGT Y++PE
Sbjct: 162 --GLIHRDVKPDNMLL-DKHGHLKLADFGTCMKMDETGMVRCD----TAVGTPDYISPEV 214
Query: 424 M-------MYGKVDEKIDVYSYGVVLLELITG 448
+ YG+ + D +S GV L E++ G
Sbjct: 215 LKSQGGDGYYGR---ECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 3e-06
Identities = 45/193 (23%), Positives = 79/193 (40%), Gaps = 38/193 (19%)
Query: 280 AVKVLKCTNWSE---EEVLREVELLSSIKHENIVRIIGYC---HSKEMYAIVYNLL---- 329
AVK +K + EE L E + H N++++IG C S + +L
Sbjct: 31 AVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMK 90
Query: 330 NGSLKQYL---------KQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLS 380
+G L +L ++L + + +A +EYL + IHRD+ + N +L
Sbjct: 91 HGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLR 147
Query: 381 ENFHHPQLSDFGAAM------VHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKID 434
E+ ++DFG + + Q VK ++A E + K D
Sbjct: 148 EDM-TVCVADFGLSKKIYSGDYYRQGRIAKMPVK---------WIAIESLADRVYTSKSD 197
Query: 435 VYSYGVVLLELIT 447
V+++GV + E+ T
Sbjct: 198 VWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 3e-06
Identities = 50/212 (23%), Positives = 103/212 (48%), Gaps = 29/212 (13%)
Query: 253 NFSPKMLIGQGGNSKVYRTNHVDG-QVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVR 311
+F+ M++G+G KV ++ A+K+LK ++ V+++ ++ ++ + ++
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILK-----KDVVIQDDDVECTMVEKRVLA 55
Query: 312 IIG------YCHS-----KEMYAIVYNLLNGSLKQYLKQL-KWNERMDV--AIGVAKALE 357
+ G HS +Y ++ + G L ++Q+ ++ E V A +A L
Sbjct: 56 LSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLF 115
Query: 358 YLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFG 417
+LH II+RD+K N++L H +++DFG + + V GT
Sbjct: 116 FLH---SKGIIYRDLKLDNVMLDSE-GHIKIADFGMC-----KENMWDGVTTKTFCGTPD 166
Query: 418 YLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
Y+APE + Y + +D +++GV+L E++ G+
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 33/117 (28%), Positives = 47/117 (40%), Gaps = 40/117 (34%)
Query: 368 IHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH-----QVSENVKPVN----------- 411
IHRD+K N+LL H +LSDFG +SH ++ + P N
Sbjct: 123 IHRDIKPDNLLLDAK-GHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSS 181
Query: 412 -----------------VVGTFGYLAPEYMM---YGKVDEKIDVYSYGVVLLELITG 448
VGT Y+APE + Y K D +S GV++ E++ G
Sbjct: 182 KRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKE---CDWWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 3e-06
Identities = 47/188 (25%), Positives = 86/188 (45%), Gaps = 29/188 (15%)
Query: 276 GQVAAVKVLKCTNWSE---EEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN--LLN 330
G+ A+K L SE + RE+ LL ++HEN++ ++ S + L+
Sbjct: 40 GEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVM 99
Query: 331 GSLKQYLKQLKWNERMDVAI-----GVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHH 385
++ L+++ + + + + L+Y+H IIHRD+K N+ ++E+
Sbjct: 100 PYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCEL 156
Query: 386 PQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPE----YMMYGKVDEKIDVYSYGVV 441
L DFG A + + V T Y APE +M Y + +D++S G +
Sbjct: 157 KIL-DFGLAR--------HADAEMTGYVVTRWYRAPEVILNWMHYNQT---VDIWSVGCI 204
Query: 442 LLELITGK 449
+ E++TGK
Sbjct: 205 MAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 4e-06
Identities = 42/143 (29%), Positives = 69/143 (48%), Gaps = 19/143 (13%)
Query: 315 YC--HSKEMYAIVYNLLNGSLKQYLKQLKWNERMDV------AIGVAKALEYLHHTCDPP 366
YC +KE V LNG + Q K R D+ A + L++LH
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSK---G 116
Query: 367 IIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY 426
II+RD+K N++L + H +++DFG + + +N + GT Y+APE +
Sbjct: 117 IIYRDLKLDNVMLDRD-GHIKIADFGMC----KENVFGDN-RASTFCGTPDYIAPEILQG 170
Query: 427 GKVDEKIDVYSYGVVLLELITGK 449
K +D +S+GV+L E++ G+
Sbjct: 171 LKYTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 5e-06
Identities = 78/384 (20%), Positives = 138/384 (35%), Gaps = 76/384 (19%)
Query: 87 KVCIGDSYITELSNQVRISYATIL--ALGCSLSGLKDSEVLT---------RCLRALPPA 135
+ I D + + A IL A C+ + K S + R L PA
Sbjct: 33 RCAILDDFDEDGRLA---HIAEILPNAEECAEAAEKVSIMAPERADPTGAHRALEDAAPA 89
Query: 136 CTILVMDNLGRILVQRQGTSQQGSTNVLLKSSLSSSSKYPAFGQPATTRQLQKSLTAPSS 195
G +LV R S A P+ S
Sbjct: 90 ---------GELLVPRSNADLFAS----------------AGDGPSGAEDSDASHLDFDE 124
Query: 196 STSSTTRQESDVGVCIAQETVQVPESIKRKIFEKLAVLEAEGSSRRFTSQELCHLTHNFS 255
+ + V +AQ ++ + F + L G+ F +C L +
Sbjct: 125 APPD-----AAGPVPLAQAKLKHDDEFLAH-FRVIDDL-PAGA---FGKIFICAL-RAST 173
Query: 256 PKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRI--- 312
+ +G NS + +A K +K + + ++ E+ L + HENI++I
Sbjct: 174 EEAEARRGVNSTNQGKPKCERLIA--KRVKAGSRAAIQLENEILALGRLNHENILKIEEI 231
Query: 313 ---------IGYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVAKALEYLHHTC 363
I + ++Y+ +Y+ + + L R + + A+EY+H
Sbjct: 232 LRSEANTYMITQKYDFDLYSFMYD---EAFDWKDRPLLKQTRA-IMKQLLCAVEYIH--- 284
Query: 364 DPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEY 423
D +IHRD+K NI L+ + L DFG AM + + + VGT +PE
Sbjct: 285 DKKLIHRDIKLENIFLNCD-GKIVLGDFGTAMPFEKEREAFD----YGWVGTVATNSPEI 339
Query: 424 MMYGKVDEKIDVYSYGVVLLELIT 447
+ E D++S G++LL++++
Sbjct: 340 LAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 5e-06
Identities = 52/213 (24%), Positives = 92/213 (43%), Gaps = 36/213 (16%)
Query: 260 IGQGGNSKVYRTNHV---DGQVAAVKVLKCTNWSEEEVL-----REVELLSSIK-HENIV 310
+GQG V + + + A+K K TN +++L RE++LL + H+NI
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIK--KITNVFSKKILAKRALRELKLLRHFRGHKNIT 65
Query: 311 RIIGYCHSKEMYAIVYNLLNGS-LKQYLKQLKWNE--RMDVAIGVAK----------ALE 357
+ +M + N L + L + ++ R + A L+
Sbjct: 66 CLY------DMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLK 119
Query: 358 YLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFG 417
Y+H ++HRD+K N+L++ + ++ DFG A ++ + V T
Sbjct: 120 YIHSA---NVLHRDLKPGNLLVNADCEL-KICDFGLARGFSENPGENAG-FMTEYVATRW 174
Query: 418 YLAPEYMM-YGKVDEKIDVYSYGVVLLELITGK 449
Y APE M+ + + IDV+S G +L EL+ K
Sbjct: 175 YRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 6e-06
Identities = 29/99 (29%), Positives = 50/99 (50%), Gaps = 17/99 (17%)
Query: 355 ALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVG 414
AL +LH + II+RD+K N+LL H +L+D+G E ++P +
Sbjct: 108 ALNFLH---ERGIIYRDLKLDNVLLDAE-GHIKLTDYG---------MCKEGIRPGDTTS 154
Query: 415 TF----GYLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
TF Y+APE + +D ++ GV++ E++ G+
Sbjct: 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 6e-06
Identities = 36/115 (31%), Positives = 56/115 (48%), Gaps = 19/115 (16%)
Query: 368 IHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMM-- 425
+HRD+K N+LL +N H +L+DFG+ + V NV VGT Y++PE +
Sbjct: 124 VHRDIKPDNVLLDKN-GHIRLADFGSCLRLLADGTVQSNV----AVGTPDYISPEILQAM 178
Query: 426 ---YGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWYYVLAGKVFAQQ 477
G+ + D +S GV + E++ G+ ESLV Y GK+ +
Sbjct: 179 EDGKGRYGPECDWWSLGVCMYEMLYGETPFYA-----ESLVETY----GKIMNHK 224
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 7e-06
Identities = 45/188 (23%), Positives = 93/188 (49%), Gaps = 30/188 (15%)
Query: 280 AVKVLK--CTNWSEEEVLREVELLSSIKHENIVRIIGYC-HSKEMYAIVYNLLNGSLKQY 336
AVK+L+ + + L+E++++S +K NI+R++ C S + I + NG L Q+
Sbjct: 50 AVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQF 109
Query: 337 LKQLKWNERMD--------------VAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN 382
L + + E + +A +A ++YL +HRD+ + N L+ +N
Sbjct: 110 LSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLVGKN 166
Query: 383 FHHPQLSDFGAA--MVHHQSHQVS-ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYG 439
+ +++DFG + + +++ V P+ +++ E ++ GK DV+++G
Sbjct: 167 Y-TIKIADFGMSRNLYSGDYYRIQGRAVLPIR------WMSWESILLGKFTTASDVWAFG 219
Query: 440 VVLLELIT 447
V L E++T
Sbjct: 220 VTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 8e-06
Identities = 41/160 (25%), Positives = 77/160 (48%), Gaps = 15/160 (9%)
Query: 296 REVELLSSIKHENIVRIIGYCHSKEMYA------IVYNLLNGSLKQYLKQLKWNERMDVA 349
RE+ L+ + H+NI+ ++ ++ +V L++ +L Q ++ +ERM
Sbjct: 65 RELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL 124
Query: 350 IGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKP 409
+ + L + H IIHRD+K SNI++ + ++ DFG A S ++ V
Sbjct: 125 L--YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL-KILDFGLARTAGTSFMMTPYVV- 180
Query: 410 VNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
T Y APE ++ E +D++S G ++ E++ K
Sbjct: 181 -----TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 9e-06
Identities = 47/188 (25%), Positives = 83/188 (44%), Gaps = 28/188 (14%)
Query: 280 AVKVLK---CTNWSEEEVLREVELLSSIKHENIVRIIGYC---HSKEMY----AIVYNLL 329
AVK +K CT E+ L E + H N++R+IG C E Y I+ +
Sbjct: 30 AVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMK 89
Query: 330 NGSLKQYLKQLKWNER---------MDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLS 380
+G L +L + + + +A +EYL IHRD+ + N +L+
Sbjct: 90 HGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYL---SSKSFIHRDLAARNCMLN 146
Query: 381 ENFHHPQLSDFG-AAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYG 439
EN + ++DFG + +++ + + + V ++A E + K DV+S+G
Sbjct: 147 ENM-NVCVADFGLSKKIYNGDYYRQGRIAKMPV----KWIAIESLADRVYTTKSDVWSFG 201
Query: 440 VVLLELIT 447
V + E+ T
Sbjct: 202 VTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 57/223 (25%), Positives = 95/223 (42%), Gaps = 35/223 (15%)
Query: 276 GQVAAVKVLKCTNWSE---EEVLREVELLSSIKHENIVRIIGYC-HSKEM------YAIV 325
Q AVK+LK +S EE LRE + H N++++IG S+ I+
Sbjct: 27 FQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVIL 86
Query: 326 YNLLNGSLKQYLKQLKWNER---------MDVAIGVAKALEYLHHTCDPPIIHRDVKSSN 376
+ +G L +L + E + I +A +EYL IHRD+ + N
Sbjct: 87 PFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARN 143
Query: 377 ILLSENFHHPQLSDFGAAMVHHQS---HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKI 433
+L+EN ++DFG + + Q + PV +LA E +
Sbjct: 144 CMLNENM-TVCVADFGLSKKIYSGDYYRQGCASKLPVK------WLALESLADNVYTTHS 196
Query: 434 DVYSYGVVLLELITGKEAIQTNKANRESLVLWYYVLAGKVFAQ 476
DV+++GV + E++T QT A E+ ++ Y++ G Q
Sbjct: 197 DVWAFGVTMWEIMTRG---QTPYAGVENSEIYNYLIKGNRLKQ 236
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 1e-05
Identities = 51/210 (24%), Positives = 91/210 (43%), Gaps = 30/210 (14%)
Query: 260 IGQGGNSKVYRTNHVDGQVAA---VKVLKCTNWSEEEV--LREVELLSSIKHENIVRIIG 314
IG G KV G A VK L+ + +E++ L+EV+ + H N+++ +G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 315 YCHSKEMYAIVYNLLN-GSLKQYLKQLKWNERMD--------VAIGVAKALEYLHHTCDP 365
C Y +V G LK YL+ + +A VA L +LH
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA--- 119
Query: 366 PIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH-QSHQVSENVKPVNVVGTFGYLAPEYM 424
IH D+ N L+ + ++ D+G A+ + + + ++++ V + +LAPE +
Sbjct: 120 DFIHSDLALRNCQLTADL-SVKIGDYGLALEQYPEDYYITKDCHAVPL----RWLAPELV 174
Query: 425 -------MYGKVDEKIDVYSYGVVLLELIT 447
+ +K +++S GV + EL T
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 1e-05
Identities = 57/218 (26%), Positives = 98/218 (44%), Gaps = 39/218 (17%)
Query: 281 VKVLKCTNWSEEEV---LREVELLSSIKHENIVRIIGYC---HSKEMYAIVYNLLNGSLK 334
VK +K + SE +V L+E LL + H+NI+ I+ C Y G+LK
Sbjct: 40 VKTVK-DHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNW-GNLK 97
Query: 335 QYLKQLKWNER-----------MDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENF 383
+L+Q + E + +AI +A + YLH +IH+D+ + N ++ E
Sbjct: 98 LFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEEL 154
Query: 384 HHPQLSDFGAA-----MVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSY 438
+++D + M +H +EN +PV ++A E ++ + DV+S+
Sbjct: 155 -QVKITDNALSRDLFPMDYH-CLGDNEN-RPVK------WMALESLVNKEYSSASDVWSF 205
Query: 439 GVVLLELITGKEAIQTNKANRESLVLWYYVLAGKVFAQ 476
GV+L EL+T QT + + Y+ G AQ
Sbjct: 206 GVLLWELMT---LGQTPYVEIDPFEMAAYLKDGYRLAQ 240
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 29/98 (29%), Positives = 50/98 (51%), Gaps = 9/98 (9%)
Query: 352 VAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVN 411
+ ALEYLH +++RD+K N++L ++ H +++DFG +S+
Sbjct: 104 IVSALEYLHSR---DVVYRDIKLENLMLDKD-GHIKITDFGLC-----KEGISDGATMKT 154
Query: 412 VVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
GT YLAPE + +D + GVV+ E++ G+
Sbjct: 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 58/212 (27%), Positives = 93/212 (43%), Gaps = 24/212 (11%)
Query: 260 IGQGGN--SKVYRTNHV-DGQVAAVKVLKCTNWSEEEV---LREVELLSSIKHENIVRII 313
IG+G + VY H G + V++ N +EE + EV L +H NI+
Sbjct: 6 IGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSW 65
Query: 314 G-YCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAI------GVAKALEYLHHTCDPP 366
+ ++ I + GS LK + E M A+ G + L YLH
Sbjct: 66 TVFTTGSWLWVISPFMAYGSANSLLKTY-FPEGMSEALIGNILFGALRGLNYLHQN---G 121
Query: 367 IIHRDVKSSNILLSEN--FHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYM 424
IHR++K+S+IL+S + LS + + + Q +V + P +L+PE +
Sbjct: 122 YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDF-PQFSTSVLPWLSPELL 180
Query: 425 ---MYGKVDEKIDVYSYGVVLLELITGKEAIQ 453
+YG + K D+YS G+ EL TG+ Q
Sbjct: 181 RQDLYG-YNVKSDIYSVGITACELATGRVPFQ 211
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 44/190 (23%), Positives = 88/190 (46%), Gaps = 26/190 (13%)
Query: 292 EEVLREVELLSSIKHENIVRIIG-YCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAI 350
+ V E ++L+ I H V + G + +Y ++ ++ G +L++ N+R +
Sbjct: 76 DHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRR---NKRFPNDV 132
Query: 351 GVAKA------LEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404
G A EYL I++RD+K N+LL ++ +++DFG A V
Sbjct: 133 GCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKD-GFIKMTDFGFAKV-------- 180
Query: 405 ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVL 464
+ + + GT Y+APE ++ + D ++ G+ + E++ G N E L++
Sbjct: 181 VDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYAN----EPLLI 236
Query: 465 WYYVLAGKVF 474
+ +L G ++
Sbjct: 237 YQKILEGIIY 246
|
Length = 340 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 34/109 (31%), Positives = 53/109 (48%), Gaps = 19/109 (17%)
Query: 346 MDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE 405
M +AI L Y +HRD+K NIL+ N H +L+DFG+ + + V
Sbjct: 111 MVIAIDSVHQLHY---------VHRDIKPDNILMDMN-GHIRLADFGSCLKLMEDGTVQS 160
Query: 406 NVKPVNVVGTFGYLAPEYMMY-----GKVDEKIDVYSYGVVLLELITGK 449
+V VGT Y++PE + GK + D +S GV + E++ G+
Sbjct: 161 SV----AVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 18/104 (17%)
Query: 352 VAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVN 411
V AL+ +H IHRDVK N+LL ++ H +L+DFG M ++ V +
Sbjct: 151 VVLALDAIHSM---GFIHRDVKPDNMLLDKS-GHLKLADFGTCMKMNKEGMVRCD----T 202
Query: 412 VVGTFGYLAPEYM-------MYGKVDEKIDVYSYGVVLLELITG 448
VGT Y++PE + YG+ + D +S GV L E++ G
Sbjct: 203 AVGTPDYISPEVLKSQGGDGYYGR---ECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 29/99 (29%), Positives = 51/99 (51%), Gaps = 17/99 (17%)
Query: 355 ALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVG 414
AL +LH + II+RD+K N+LL + H +L+D+G E + P +
Sbjct: 108 ALNFLH---ERGIIYRDLKLDNVLLDAD-GHIKLTDYG---------MCKEGLGPGDTTS 154
Query: 415 TF----GYLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
TF Y+APE + + +D ++ GV++ E++ G+
Sbjct: 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 27/98 (27%), Positives = 50/98 (51%), Gaps = 8/98 (8%)
Query: 352 VAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVN 411
+ AL+YLH + +++RD+K N++L ++ H +++DFG + +
Sbjct: 104 IVSALDYLH--SEKNVVYRDLKLENLMLDKD-GHIKITDFGLC-----KEGIKDGATMKT 155
Query: 412 VVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
GT YLAPE + +D + GVV+ E++ G+
Sbjct: 156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 4e-05
Identities = 50/148 (33%), Positives = 75/148 (50%), Gaps = 17/148 (11%)
Query: 260 IGQGGNSKVY--RTNHVDGQVAAVKVLKCTNWSE----EEVLREVELLSSIKHENIVRII 313
I +G KVY R + + ++ AVKV+K + +V E + L+ K IV +
Sbjct: 12 ISRGAFGKVYLGRKKN-NSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLY 70
Query: 314 GYCHS-KEMYAIVYNLLNGSLKQYLKQLKW-NERMDVAI--GVAKALEYLH-HTCDPPII 368
S +Y ++ L+ G +K L + +E M V VA AL+YLH H II
Sbjct: 71 YSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHG----II 126
Query: 369 HRDVKSSNILLSENFHHPQLSDFGAAMV 396
HRD+K N+L+S N H +L+DFG + V
Sbjct: 127 HRDLKPDNMLIS-NEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 5e-05
Identities = 34/105 (32%), Positives = 52/105 (49%), Gaps = 8/105 (7%)
Query: 348 VAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN--FHHPQLSDFGAAMVHHQSHQVSE 405
+ GV KAL+Y+HH +HR VK+S+IL+S + + L + + H Q +V
Sbjct: 106 ILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVH 162
Query: 406 NVKPVNVVGTFGYLAPEYMMYG--KVDEKIDVYSYGVVLLELITG 448
+ P V +L+PE + D K D+YS G+ EL G
Sbjct: 163 DF-PKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 5e-05
Identities = 30/102 (29%), Positives = 52/102 (50%), Gaps = 17/102 (16%)
Query: 352 VAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVN 411
++ AL YLH + II+RD+K N+LL H +L+D+G E ++P +
Sbjct: 105 ISLALNYLH---ERGIIYRDLKLDNVLLDSE-GHIKLTDYG---------MCKEGLRPGD 151
Query: 412 VV----GTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
GT Y+APE + +D ++ GV++ E++ G+
Sbjct: 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 5e-05
Identities = 54/233 (23%), Positives = 95/233 (40%), Gaps = 39/233 (16%)
Query: 253 NFSPKMLIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEE----VLREVELLSSIKHE 307
+F +IG+G +V D G V A+K+L+ + E+E + E ++L
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61
Query: 308 NIVRIIGYCHSK-EMYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPP 366
+V++ K +Y I+ L G + L + + +A+ + +
Sbjct: 62 WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG 121
Query: 367 IIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVN--------------- 411
IHRD+K N+LL H +LSDFG ++H+ +E + +N
Sbjct: 122 FIHRDIKPDNLLLDSK-GHVKLSDFGLCTGLKKAHR-TEFYRNLNHSLPSDFTFQNMNSK 179
Query: 412 ----------------VVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITG 448
VGT Y+APE M ++ D +S GV++ E++ G
Sbjct: 180 RKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 7e-05
Identities = 54/235 (22%), Positives = 97/235 (41%), Gaps = 43/235 (18%)
Query: 253 NFSPKMLIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEE----VLREVELLSSIKHE 307
+F +IG+G +V D G + A+K+L+ + E+E + E ++L
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGA 61
Query: 308 NIVRII-GYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVAK---ALEYLHHTC 363
+V++ + + +Y I+ L G + L + +A+ A++ +H
Sbjct: 62 WVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL- 120
Query: 364 DPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV-------------------- 403
IHRD+K N+LL H +LSDFG ++H+
Sbjct: 121 --GFIHRDIKPDNLLLDAK-GHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177
Query: 404 ----SENVK------PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITG 448
+E K + VGT Y+APE M ++ D +S GV++ E++ G
Sbjct: 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 8e-05
Identities = 29/93 (31%), Positives = 45/93 (48%), Gaps = 13/93 (13%)
Query: 355 ALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQ---LSDFGAAMVHHQSHQVSENVKPVN 411
A++Y+H IIHRD+K+ N+L++ P+ L DFGAA S
Sbjct: 272 AIDYIHGE---GIIHRDIKTENVLVNG----PEDICLGDFGAACFARGSWSTP---FHYG 321
Query: 412 VVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLE 444
+ GT APE + +D++S G+V+ E
Sbjct: 322 IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 27/101 (26%), Positives = 46/101 (45%), Gaps = 17/101 (16%)
Query: 352 VAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVN 411
V L+YLH + I++RD+K N+LL +++DFG E + +
Sbjct: 110 VVLGLQYLH---ENKIVYRDLKLDNLLLDTE-GFVKIADFGLC---------KEGMGFGD 156
Query: 412 VVGTF----GYLAPEYMMYGKVDEKIDVYSYGVVLLELITG 448
TF +LAPE + +D + GV++ E++ G
Sbjct: 157 RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 42/142 (29%), Positives = 57/142 (40%), Gaps = 37/142 (26%)
Query: 354 KALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVV 413
AL+ LH T I+HRDVK NI+ SE ++ D GAA +V N P +
Sbjct: 266 FALDGLHST---GIVHRDVKPQNIIFSEGSGSFKIIDLGAA----ADLRVGINYIPKEFL 318
Query: 414 GTFGYLAPE-YMMYGKVDE---------------------KIDVYSYGVVLLE-----LI 446
Y APE Y+M + + D+YS G++ L+ L
Sbjct: 319 LDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLR 378
Query: 447 TGKEAIQTN---KANRESLVLW 465
+ IQ N K N LV W
Sbjct: 379 SDSNLIQFNRQLKRNDYDLVAW 400
|
Length = 566 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 31/97 (31%), Positives = 53/97 (54%), Gaps = 9/97 (9%)
Query: 352 VAKALEYL-HHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPV 410
VA+ +E+L C IHRD+ + NILLSEN + ++ DFG A ++ + V+
Sbjct: 183 VARGMEFLASRKC----IHRDLAARNILLSEN-NVVKICDFGLA---RDIYKDPDYVRKG 234
Query: 411 NVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT 447
+ ++APE + + DV+S+GV+L E+ +
Sbjct: 235 SARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 52/207 (25%), Positives = 90/207 (43%), Gaps = 28/207 (13%)
Query: 260 IGQGGNSKVYRTNH-VDGQVAAVKV--LKCTNWSEEEVLREVELLSSIKHENIVRIIG-- 314
+G+G VY+ H G A+K L+ +++ E+++L IV G
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 315 YCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMD------VAIGVAKALEYLHHTCDPPII 368
+ + Y + GSL + E + + V K L++L + II
Sbjct: 69 FIEGAVYMCMEY-MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNII 125
Query: 369 HRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGK 428
HRDVK +N+L++ N +L DFG S + ++ N +G Y+APE + G
Sbjct: 126 HRDVKPTNVLVNGN-GQVKLCDFGV------SGNLVASLAKTN-IGCQSYMAPERIKSGG 177
Query: 429 VDEKI------DVYSYGVVLLELITGK 449
++ DV+S G+ +LE+ G+
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 31/97 (31%), Positives = 53/97 (54%), Gaps = 9/97 (9%)
Query: 352 VAKALEYL-HHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPV 410
VA+ +E+L C IHRD+ + NILLSEN + ++ DFG A ++ + V+
Sbjct: 182 VARGMEFLASRKC----IHRDLAARNILLSEN-NVVKICDFGLA---RDIYKDPDYVRKG 233
Query: 411 NVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT 447
+ ++APE + + DV+S+GV+L E+ +
Sbjct: 234 DARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 3e-04
Identities = 30/100 (30%), Positives = 55/100 (55%), Gaps = 15/100 (15%)
Query: 352 VAKALEYL-HHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA--MVHHQSHQVSENVK 408
VA+ +++L C IHRDV + N+LL+ + ++ DFG A +++ ++ V N +
Sbjct: 221 VAQGMDFLASKNC----IHRDVAARNVLLT-DGRVAKICDFGLARDIMNDSNYVVKGNAR 275
Query: 409 -PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT 447
PV ++APE + + DV+SYG++L E+ +
Sbjct: 276 LPVK------WMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 5e-04
Identities = 37/136 (27%), Positives = 58/136 (42%), Gaps = 42/136 (30%)
Query: 352 VAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAM--------------VH 397
+ A+E +H IHRD+K NIL+ + H +L+DFG H
Sbjct: 110 LTCAIESVHKM---GFIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHDSKYYQKGDH 165
Query: 398 HQ------SHQVSEN----VKPVNV--------------VGTFGYLAPEYMMYGKVDEKI 433
H+ S + SE +KP+ VGT Y+APE ++ +
Sbjct: 166 HRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLC 225
Query: 434 DVYSYGVVLLELITGK 449
D +S GV+L E++ G+
Sbjct: 226 DWWSVGVILYEMLVGQ 241
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 5e-04
Identities = 32/97 (32%), Positives = 53/97 (54%), Gaps = 9/97 (9%)
Query: 352 VAKALEYL-HHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPV 410
VAK +E+L C IHRD+ + NILLSEN + ++ DFG A ++ + V+
Sbjct: 188 VAKGMEFLASRKC----IHRDLAARNILLSEN-NVVKICDFGLA---RDIYKDPDYVRKG 239
Query: 411 NVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT 447
+ ++APE + + DV+S+GV+L E+ +
Sbjct: 240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 5e-04
Identities = 30/123 (24%), Positives = 45/123 (36%), Gaps = 43/123 (34%)
Query: 368 IHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH---------QVSENVKPVN------- 411
IHRD+K NIL+ H +LSDFG + H+ H Q N ++
Sbjct: 123 IHRDIKPDNILIDRG-GHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAV 181
Query: 412 --------------------------VVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLEL 445
VGT Y+APE + ++ D +S G ++ E
Sbjct: 182 DSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFEC 241
Query: 446 ITG 448
+ G
Sbjct: 242 LIG 244
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 5e-04
Identities = 24/126 (19%), Positives = 53/126 (42%), Gaps = 7/126 (5%)
Query: 259 LIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIV--RIIGYC 316
L+ G ++VY + +K+ + + REV +L + + + +++
Sbjct: 5 LLKGGLTNRVYLL-GTKDEDYVLKINP-SREKGADREREVAILQLLARKGLPVPKVLASG 62
Query: 317 HSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSN 376
S ++ + G + L ++ E+ D+A +A+ L LH + H D+ N
Sbjct: 63 ESDGWSYLLMEWIEG---ETLDEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGN 119
Query: 377 ILLSEN 382
IL+ +
Sbjct: 120 ILVDDG 125
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 8e-04
Identities = 30/100 (30%), Positives = 43/100 (43%), Gaps = 16/100 (16%)
Query: 352 VAKALEYLH-HTCDPPIIHRDVKSSNILLSENFHHPQLSDFG-AAMVHHQSHQVSENVKP 409
+ +AL LH H IIH D+K N+L L D+G ++ S
Sbjct: 118 LVEALNDLHKHN----IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY------- 166
Query: 410 VNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
GT Y +PE + D D ++ GV+ EL+TGK
Sbjct: 167 ---DGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 30/124 (24%), Positives = 51/124 (41%), Gaps = 43/124 (34%)
Query: 368 IHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH-------------------------- 401
IHRD+K NIL+ + H +L+DFG +H
Sbjct: 123 IHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPA 181
Query: 402 --QVSENVKPV--------------NVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLEL 445
+ + +KP+ ++VGT Y+APE ++ + D +S GV+L E+
Sbjct: 182 NCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 241
Query: 446 ITGK 449
+ G+
Sbjct: 242 LVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 32/112 (28%), Positives = 56/112 (50%), Gaps = 15/112 (13%)
Query: 340 LKWNERMDVAIGVAKALEYL-HHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAM-VH 397
L + + VA+ +E+L C +HRD+ + N+LL++ ++ DFG A +
Sbjct: 234 LTTLDLLSFTYQVARGMEFLASKNC----VHRDLAARNVLLAQG-KIVKICDFGLARDIM 288
Query: 398 HQSHQVSENVK--PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT 447
H S+ VS+ PV ++APE + DV+SYG++L E+ +
Sbjct: 289 HDSNYVSKGSTFLPVK------WMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.002
Identities = 35/132 (26%), Positives = 62/132 (46%), Gaps = 13/132 (9%)
Query: 260 IGQGGNSKVYRTNHVD----GQVAAVKVL------KCTNWSEEEVLREVELLSSIKHENI 309
+GQG +K+++ + G++ +VL N+SE ++S + H+++
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSES-FFEAASMMSQLSHKHL 61
Query: 310 VRIIGYCHSKEMYAIVYNLL-NGSLKQYLKQLKWNERMDVAIGVAKALEY-LHHTCDPPI 367
V G C + +V + GSL YLK+ K + + VAK L + LH D +
Sbjct: 62 VLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGL 121
Query: 368 IHRDVKSSNILL 379
H +V + N+LL
Sbjct: 122 THGNVCAKNVLL 133
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.002
Identities = 54/228 (23%), Positives = 91/228 (39%), Gaps = 37/228 (16%)
Query: 260 IGQGGNSKVYRTN-HVDGQVA--AVKVLKCTNWSEE--EVLREVELLSSIKHENIVRIIG 314
IG G KV + + D VA VK LK S+E E L++ + ++H NI++ +G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 315 YCHSKEMYAIVYNLLN-GSLKQYLKQLKWN---------ERMDVAIGVAKALEYLHHTCD 364
C Y +V+ G LK YL Q +W+ +RM I + H+
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--- 119
Query: 365 PPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPV--------NVVGTF 416
+H D+ N L+ + ++ D+G ++ + +VG F
Sbjct: 120 --FLHSDLALRNCFLTSDL-TVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEF 176
Query: 417 --GYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESL 462
G + E +V++ GV L EL ++ ++RE L
Sbjct: 177 HGGLITAEQTKPS------NVWALGVTLWELFENAAQPYSHLSDREVL 218
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.004
Identities = 29/101 (28%), Positives = 50/101 (49%), Gaps = 17/101 (16%)
Query: 352 VAKALEYL-HHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAM-VHHQSHQVSENVKP 409
VA +E+L C +HRD+ + N+L+ E ++ DFG A + S+ +S+
Sbjct: 248 VANGMEFLASKNC----VHRDLAARNVLICEG-KLVKICDFGLARDIMRDSNYISKG--- 299
Query: 410 VNVVGTF---GYLAPEYMMYGKVDEKIDVYSYGVVLLELIT 447
TF ++APE + DV+S+G++L E+ T
Sbjct: 300 ----STFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 480 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.98 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.98 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.98 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.98 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.98 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.98 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.98 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.98 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.98 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.98 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.98 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.98 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.98 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.98 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.98 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.98 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.98 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.98 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.98 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.97 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.97 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.94 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.91 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.89 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.87 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.85 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.85 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.83 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.83 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.82 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.82 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.81 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.76 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.75 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.75 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.74 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.72 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.72 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.72 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.71 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.71 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.69 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.66 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.65 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.65 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.59 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.58 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.53 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.5 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.42 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.31 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.27 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.26 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.25 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.22 | |
| cd01989 | 146 | STK_N The N-terminal domain of Eukaryotic Serine T | 99.2 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.17 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.14 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.13 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.09 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.96 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.94 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.86 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.78 | |
| PF00582 | 140 | Usp: Universal stress protein family; InterPro: IP | 98.75 | |
| cd01987 | 124 | USP_OKCHK USP domain is located between the N-term | 98.62 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.6 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.55 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.46 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.46 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.46 | |
| PRK15005 | 144 | universal stress protein F; Provisional | 98.39 | |
| PRK15456 | 142 | universal stress protein UspG; Provisional | 98.35 | |
| PRK15118 | 144 | universal stress global response regulator UspA; P | 98.32 | |
| cd00293 | 130 | USP_Like Usp: Universal stress protein family. The | 98.32 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.29 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.29 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.28 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.25 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.24 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.2 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.17 | |
| cd01988 | 132 | Na_H_Antiporter_C The C-terminal domain of a subfa | 98.17 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.1 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.07 | |
| PRK09982 | 142 | universal stress protein UspD; Provisional | 98.05 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.03 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.01 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.01 | |
| PRK10116 | 142 | universal stress protein UspC; Provisional | 97.95 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.84 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.83 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.74 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.72 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.71 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.63 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.56 | |
| PRK11175 | 305 | universal stress protein UspE; Provisional | 97.52 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.49 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.47 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.35 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.06 | |
| PRK11175 | 305 | universal stress protein UspE; Provisional | 97.05 | |
| PRK12652 | 357 | putative monovalent cation/H+ antiporter subunit E | 96.9 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.81 | |
| PLN02236 | 344 | choline kinase | 96.65 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.61 | |
| PRK10490 | 895 | sensor protein KdpD; Provisional | 96.48 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.45 | |
| COG0589 | 154 | UspA Universal stress protein UspA and related nuc | 96.39 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.35 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.34 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.24 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.2 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.12 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-47 Score=384.60 Aligned_cols=230 Identities=48% Similarity=0.803 Sum_probs=204.5
Q ss_pred CccccCHHHHhhhhcCCCCceeecccCceEEEEEEecCCcEEEEEEeccCCcc-HHHHHHHHHHHhcCCCCCeeeEEEEE
Q 011660 238 SSRRFTSQELCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWS-EEEVLREVELLSSIKHENIVRIIGYC 316 (480)
Q Consensus 238 ~~~~~~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~-~~~~~~Ei~il~~l~HpnIv~l~~~~ 316 (480)
..+.|++.++..+|++|...+.||+|+||.||+|...+|..+|||++...... ..+|..|++++.+++|||+++|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 45679999999999999999999999999999999999999999988776554 67799999999999999999999999
Q ss_pred ecCC-eeEEEEecc-CCCHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEe
Q 011660 317 HSKE-MYAIVYNLL-NGSLKQYLK-----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLS 389 (480)
Q Consensus 317 ~~~~-~~~lV~e~~-~GsL~~~l~-----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~ 389 (480)
.+.+ ..++||||+ +|+|.++|. .++|.++++||.++|+||+|||+.+.+.||||||||+|||||+++ ++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~-~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDF-NAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCC-CEEcc
Confidence 9988 599999999 899999993 568999999999999999999999888999999999999999995 89999
Q ss_pred eeccccccccccccccCcccccc-ccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc-cchhHHHHHH
Q 011660 390 DFGAAMVHHQSHQVSENVKPVNV-VGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA-NRESLVLWYY 467 (480)
Q Consensus 390 DFGla~~~~~~~~~~~~~~~~~~-~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~-~~e~l~~~~~ 467 (480)
|||+|+..... ....... .||++|+|||++..+..+.|+|||||||+|+||+||++|.+...+ +++.++.|+.
T Consensus 220 DFGLa~~~~~~-----~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~ 294 (361)
T KOG1187|consen 220 DFGLAKLGPEG-----DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAK 294 (361)
T ss_pred CccCcccCCcc-----ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHH
Confidence 99999654321 1111122 799999999999999999999999999999999999999997664 6667999998
Q ss_pred HHhCCC
Q 011660 468 VLAGKV 473 (480)
Q Consensus 468 ~~~~~~ 473 (480)
++..+.
T Consensus 295 ~~~~~~ 300 (361)
T KOG1187|consen 295 PLLEEG 300 (361)
T ss_pred HHHHCc
Confidence 887765
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-46 Score=363.29 Aligned_cols=209 Identities=31% Similarity=0.455 Sum_probs=183.6
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc----cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEE
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~----~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 325 (480)
.++|++.++||+|+||+||.++. .+++.||+|++++... ..+....|..||..++||+||+++-.|++.+.+|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 35799999999999999999976 4599999999987643 235688999999999999999999999999999999
Q ss_pred Eecc-CCCHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccc
Q 011660 326 YNLL-NGSLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (480)
Q Consensus 326 ~e~~-~GsL~~~l~---~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (480)
+||+ +|.|..+|+ .+.+..+.-++.+|+.||.|||+. +||||||||+|||||.+ |+++|+||||++...
T Consensus 104 ld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~-GHi~LtDFgL~k~~~--- 176 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQ-GHIKLTDFGLCKEDL--- 176 (357)
T ss_pred EeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCC-CcEEEeccccchhcc---
Confidence 9999 679999997 488888999999999999999999 99999999999999999 899999999996432
Q ss_pred ccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHhCC
Q 011660 402 QVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWYYVLAGK 472 (480)
Q Consensus 402 ~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~~~e~l~~~~~~~~~~ 472 (480)
.......++|||+.|||||++.+.+|+..+|+||+|+++|||++|.+||...+.. .+..+.+.++
T Consensus 177 --~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~----~~~~~I~~~k 241 (357)
T KOG0598|consen 177 --KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK----KMYDKILKGK 241 (357)
T ss_pred --cCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH----HHHHHHhcCc
Confidence 2333445689999999999999999999999999999999999999999976542 4455566665
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-46 Score=363.72 Aligned_cols=198 Identities=30% Similarity=0.491 Sum_probs=176.1
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCcc---HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEE
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 326 (480)
..+|...+.||+|+||.||+|.+ .++..||||.+.+.... .+.+..|++||+.++|||||.|++++..++.+++||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 35688888899999999999987 45889999999776432 345789999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecC--C---CceEEeeecccccc
Q 011660 327 NLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN--F---HHPQLSDFGAAMVH 397 (480)
Q Consensus 327 e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~--~---~~~kL~DFGla~~~ 397 (480)
||| +|||.+|++. +++.....++.|++.||++||++ +||||||||.||||+.. . -.+||+|||+|+..
T Consensus 89 EyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 999 5899999964 78899999999999999999999 99999999999999764 1 25899999999876
Q ss_pred ccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 398 HQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 398 ~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
.+ ..-..+.||+|-|||||+++...|+.|+|+||+|+|||||++|++||+..+.
T Consensus 166 ~~------~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~ 219 (429)
T KOG0595|consen 166 QP------GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP 219 (429)
T ss_pred Cc------hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence 53 3345588999999999999999999999999999999999999999997653
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-44 Score=366.71 Aligned_cols=196 Identities=32% Similarity=0.509 Sum_probs=179.2
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEecc----CCccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKC----TNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~----~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 326 (480)
.+|...++||+|||++||.+.. .+|..||+|++.+ .....+.+.+||+|.+.|+|||||+++++|++.+..|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 3599999999999999999977 7799999999976 3344567899999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccc
Q 011660 327 NLL-NGSLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 327 e~~-~GsL~~~l~---~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (480)
|+| .|+|.++++ .+++.++..+..||+.||.|||++ +|||||||..|+||++++ ++||+|||||.....
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~-~VKIgDFGLAt~le~--- 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENM-NVKIGDFGLATQLEY--- 170 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcC-cEEecccceeeeecC---
Confidence 999 899999996 489999999999999999999999 999999999999999995 899999999976543
Q ss_pred cccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 403 ~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
...+..+.||||.|+|||++....+++.+||||+|||||-||.|++||+..+
T Consensus 171 --~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~ 222 (592)
T KOG0575|consen 171 --DGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT 222 (592)
T ss_pred --cccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch
Confidence 3345668999999999999999999999999999999999999999999874
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=331.17 Aligned_cols=206 Identities=28% Similarity=0.434 Sum_probs=184.5
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCcc----HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS----EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~----~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 326 (480)
++|+..+.||.|+||+|.+++. .+|..||+|++++.... .+....|..+|+.+.||+++++++.|.+.+.+++||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 4699999999999999999976 45889999999866532 245788999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccc
Q 011660 327 NLL-NGSLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 327 e~~-~GsL~~~l~---~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (480)
||. +|.|..+++ ++++..+..+|.||+.||+|||++ +|++|||||+|||||.+ |++||+|||.|+....
T Consensus 124 eyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~-G~iKitDFGFAK~v~~--- 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQN-GHIKITDFGFAKRVSG--- 196 (355)
T ss_pred eccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccC-CcEEEEeccceEEecC---
Confidence 999 678999995 499999999999999999999999 99999999999999999 8999999999965332
Q ss_pred cccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHhCCC
Q 011660 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWYYVLAGKV 473 (480)
Q Consensus 403 ~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~~~e~l~~~~~~~~~~~ 473 (480)
...+.||||.|+|||++...+|+.++|+|||||++|||+.|.+||...++ +..+.+++.++.
T Consensus 197 -----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~----~~iY~KI~~~~v 258 (355)
T KOG0616|consen 197 -----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP----IQIYEKILEGKV 258 (355)
T ss_pred -----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh----HHHHHHHHhCcc
Confidence 35588999999999999999999999999999999999999999998776 456777777764
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-43 Score=360.81 Aligned_cols=210 Identities=23% Similarity=0.364 Sum_probs=180.7
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc----cHHHHHHHHHHHhcCC-CCCeeeEEEEEecCCeeEEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLREVELLSSIK-HENIVRIIGYCHSKEMYAIV 325 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~----~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV 325 (480)
++|.+.++||+|.||+|+++.. .+++.||||++++... +.+..+.|.+|+...+ ||++++|+++|++.+++|+|
T Consensus 368 ~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fv 447 (694)
T KOG0694|consen 368 DDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFV 447 (694)
T ss_pred cceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEE
Confidence 5799999999999999999977 4588999999998753 3456889999998875 99999999999999999999
Q ss_pred Eecc-CCCHHHHH--HhCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccc
Q 011660 326 YNLL-NGSLKQYL--KQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 326 ~e~~-~GsL~~~l--~~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (480)
|||+ +|++..+. ..+++..+.-++..|+.||+|||++ +|||||||.+|||||.+ |++||+||||++. .
T Consensus 448 mey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~e-Gh~kiADFGlcKe-----~ 518 (694)
T KOG0694|consen 448 MEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTE-GHVKIADFGLCKE-----G 518 (694)
T ss_pred EEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEccc-CcEEecccccccc-----c
Confidence 9999 56754444 3588888999999999999999999 99999999999999999 8999999999963 2
Q ss_pred cccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHhCCCC
Q 011660 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWYYVLAGKVF 474 (480)
Q Consensus 403 ~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~~~e~l~~~~~~~~~~~~ 474 (480)
......+.++||||.|||||++.+..|+..+|+|||||+|||||.|..||.+++.+ ..+..++...+.
T Consensus 519 m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe----e~FdsI~~d~~~ 586 (694)
T KOG0694|consen 519 MGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE----EVFDSIVNDEVR 586 (694)
T ss_pred CCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH----HHHHHHhcCCCC
Confidence 33445677999999999999999999999999999999999999999999987542 234444444433
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=347.45 Aligned_cols=199 Identities=28% Similarity=0.409 Sum_probs=170.8
Q ss_pred hcCCCCceeecccCceEEEEE-EecCCcEEEEEEeccCCc--------cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCe
Q 011660 251 THNFSPKMLIGQGGNSKVYRT-NHVDGQVAAVKVLKCTNW--------SEEEVLREVELLSSIKHENIVRIIGYCHSKEM 321 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~-~~~~g~~vAvK~~~~~~~--------~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 321 (480)
.+.|.+.+.||+|+||.|-+| +..+|+.||||++++... ...++.+|++||++|+|||||+++++|+..+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 456888899999999999999 457899999999976432 22346799999999999999999999999999
Q ss_pred eEEEEecc-CCCHHHHH---HhCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecC--CCceEEeeecccc
Q 011660 322 YAIVYNLL-NGSLKQYL---KQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN--FHHPQLSDFGAAM 395 (480)
Q Consensus 322 ~~lV~e~~-~GsL~~~l---~~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~--~~~~kL~DFGla~ 395 (480)
.|+||||+ +|+|.+++ +.+.+..-..+++|++.|+.|||++ ||+||||||+|||+..+ .-.+||+|||+|+
T Consensus 251 ~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred eEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccchhh
Confidence 99999999 78999998 3467777788999999999999999 99999999999999755 2368999999998
Q ss_pred ccccccccccCccccccccCCCccccccccCCCC---CchHHHHHHHHHHHHHHcCCCCCCCCccc
Q 011660 396 VHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKV---DEKIDVYSYGVVLLELITGKEAIQTNKAN 458 (480)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~---~~k~DvwSlGvil~eLltG~~pf~~~~~~ 458 (480)
.... .....+.||||.|.|||++.+..+ ..++|+||+||+||-+++|.+||.+....
T Consensus 328 ~~g~------~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~ 387 (475)
T KOG0615|consen 328 VSGE------GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD 387 (475)
T ss_pred cccc------ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC
Confidence 7543 334458899999999999987654 34889999999999999999999987643
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=344.50 Aligned_cols=203 Identities=28% Similarity=0.439 Sum_probs=178.8
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCcc----HHHHHHHHHHHhcC-CCCCeeeEEEEEecCCeeEE
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS----EEEVLREVELLSSI-KHENIVRIIGYCHSKEMYAI 324 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~----~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~l 324 (480)
.++|.+++.||+|+|++||+|.. .+++.||||++.+.... .+-+.+|.++|..| +||.|++|+..|++...+|+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF 151 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF 151 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence 46799999999999999999955 56999999999765432 23467899999999 89999999999999999999
Q ss_pred EEecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccc
Q 011660 325 VYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (480)
Q Consensus 325 V~e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (480)
|+||+ +|+|.++|.+ |++.....++.+|+.||+|||++ |||||||||+|||||.| ++++|+|||-|+.+...
T Consensus 152 vLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~d-mhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKD-GHIKITDFGSAKILSPS 227 (604)
T ss_pred EEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCC-CcEEEeeccccccCChh
Confidence 99999 8999999965 77788889999999999999999 99999999999999999 69999999999887665
Q ss_pred ccc-----c---cCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 401 HQV-----S---ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 401 ~~~-----~---~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
... . .......++||..|.+||++..+..++.+|+||||||||+|+.|.+||.+.+.
T Consensus 228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne 292 (604)
T KOG0592|consen 228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE 292 (604)
T ss_pred hccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH
Confidence 433 1 11122569999999999999999999999999999999999999999998764
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=332.18 Aligned_cols=197 Identities=26% Similarity=0.416 Sum_probs=171.6
Q ss_pred CCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCccH---HHHHHHHHHHhcCCCCCeeeEEE-EEe-cCCeeEEEE
Q 011660 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSE---EEVLREVELLSSIKHENIVRIIG-YCH-SKEMYAIVY 326 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~~---~~~~~Ei~il~~l~HpnIv~l~~-~~~-~~~~~~lV~ 326 (480)
+|.+.+.||+|.||+||++.+ .+|+.+|.|.++-...+. .++..|+.+|+.|+|||||++++ .+. ++..++|||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 588889999999999999955 789999999997555443 45789999999999999999998 344 444599999
Q ss_pred ecc-CCCHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhCCCC-CeEeccCCCCCEEEecCCCceEEeeecccccc
Q 011660 327 NLL-NGSLKQYLKQ-------LKWNERMDVAIGVAKALEYLHHTCDP-PIIHRDVKSSNILLSENFHHPQLSDFGAAMVH 397 (480)
Q Consensus 327 e~~-~GsL~~~l~~-------~~~~~~~~i~~~ia~aL~yLH~~~~~-~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~ 397 (480)
|++ .|||...++. +++.++++++.|++.||..+|+...+ -|+||||||.||+|+.+ |.+||+||||++.+
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~-gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTAN-GVVKLGDFGLGRFL 178 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCC-CceeeccchhHhHh
Confidence 999 7999999853 78899999999999999999994332 38999999999999999 89999999999876
Q ss_pred ccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 011660 398 HQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTN 455 (480)
Q Consensus 398 ~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~ 455 (480)
.... ....+.+|||.||+||.+...+|++|+||||+||++|||+.-++||.+.
T Consensus 179 ~s~~-----tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~ 231 (375)
T KOG0591|consen 179 SSKT-----TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD 231 (375)
T ss_pred cchh-----HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc
Confidence 5532 2345789999999999999999999999999999999999999999987
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=346.26 Aligned_cols=218 Identities=27% Similarity=0.435 Sum_probs=188.4
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCcc---HHHHHHHHHHHhcCCCCCeeeEEEEEecC--CeeEEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSK--EMYAIV 325 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~lV 325 (480)
+.|+.+..||+|+||.||+|+. .+|+.||+|.++.+... .....+||.||++|+||||++|.+...+. ..+|+|
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 4588888999999999999965 67999999999876533 34578999999999999999999988765 689999
Q ss_pred EeccCCCHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccc
Q 011660 326 YNLLNGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (480)
Q Consensus 326 ~e~~~GsL~~~l~----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (480)
+|||+.||.-++. .|...++..++.|++.||+|||++ +|+|||||.+|||||.+ |.+||+|||||+++....
T Consensus 197 FeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~-G~LKiaDFGLAr~y~~~~ 272 (560)
T KOG0600|consen 197 FEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNN-GVLKIADFGLARFYTPSG 272 (560)
T ss_pred EecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCC-CCEEeccccceeeccCCC
Confidence 9999999999985 489999999999999999999999 99999999999999999 899999999998765432
Q ss_pred ccccCccccccccCCCccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHhCCCCCCCCC
Q 011660 402 QVSENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWYYVLAGKVFAQQWP 479 (480)
Q Consensus 402 ~~~~~~~~~~~~GT~~y~APE~~~~~-~~~~k~DvwSlGvil~eLltG~~pf~~~~~~~e~l~~~~~~~~~~~~~~~~~ 479 (480)
.. ..+..+-|.+|.|||.+.|. .|+.++|+||.||||.||++|++.|++.+.- +.|. -.+.+.|.+..+.||
T Consensus 273 ~~----~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEv-eQl~-kIfklcGSP~e~~W~ 345 (560)
T KOG0600|consen 273 SA----PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEV-EQLH-KIFKLCGSPTEDYWP 345 (560)
T ss_pred Cc----ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHH-HHHH-HHHHHhCCCChhccc
Confidence 21 24456779999999998864 6999999999999999999999999998753 2333 356788999999998
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=344.82 Aligned_cols=218 Identities=24% Similarity=0.362 Sum_probs=185.8
Q ss_pred hhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCcc----HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEE
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS----EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAI 324 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~----~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 324 (480)
..++|++++.||+|+||.||+|+. .+|..||+|+++++... .+.+..|..||...++|+||+|+-.|++.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 457899999999999999999965 56999999999887643 3568899999999999999999999999999999
Q ss_pred EEecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccc
Q 011660 325 VYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (480)
Q Consensus 325 V~e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (480)
||||+ +||+..+|.. +++..+..++.+++.|++-||.. |+|||||||+|+|||.. |++||+||||+.-+...
T Consensus 219 iMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~-GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAK-GHIKLSDFGLSTGLDKK 294 (550)
T ss_pred EEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCC-CCEeeccccccchhhhh
Confidence 99999 7899888854 88899999999999999999999 99999999999999999 89999999998433211
Q ss_pred cccc-----------------c-Cc------------------------cccccccCCCccccccccCCCCCchHHHHHH
Q 011660 401 HQVS-----------------E-NV------------------------KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSY 438 (480)
Q Consensus 401 ~~~~-----------------~-~~------------------------~~~~~~GT~~y~APE~~~~~~~~~k~DvwSl 438 (480)
.... . .. .....+|||.|||||++.+.+|+..+|+|||
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL 374 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL 374 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence 1000 0 00 0113789999999999999999999999999
Q ss_pred HHHHHHHHcCCCCCCCCcc--cchhHHHHHHHHhC
Q 011660 439 GVVLLELITGKEAIQTNKA--NRESLVLWYYVLAG 471 (480)
Q Consensus 439 Gvil~eLltG~~pf~~~~~--~~e~l~~~~~~~~~ 471 (480)
|||+||||.|-+||.++++ .-..++-|...+..
T Consensus 375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~f 409 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKF 409 (550)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccC
Confidence 9999999999999999886 34567777766544
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=332.76 Aligned_cols=209 Identities=29% Similarity=0.432 Sum_probs=179.1
Q ss_pred CCCCceeecccCceEEEEEEe-cCCcEEEEEEeccC--CccHHHHHHHHHHHhcCCCCCeeeEEEEEecCC-eeEEEEec
Q 011660 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCT--NWSEEEVLREVELLSSIKHENIVRIIGYCHSKE-MYAIVYNL 328 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-~~~lV~e~ 328 (480)
+.+..+.||+|..|+||++.| .+++.+|+|++... ....+++.+|++|++.++|||||.+||.|..+. ...|+|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 355667899999999999988 46899999999433 334567899999999999999999999999888 49999999
Q ss_pred c-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccc
Q 011660 329 L-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (480)
Q Consensus 329 ~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (480)
| +|+|+.+++. .++...-+++.+|++||.|||+.+ +||||||||+|||++.. |++||||||.+..+..+
T Consensus 160 MDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNsk-GeVKicDFGVS~~lvnS---- 232 (364)
T KOG0581|consen 160 MDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSK-GEVKICDFGVSGILVNS---- 232 (364)
T ss_pred cCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccC-CCEEeccccccHHhhhh----
Confidence 9 6899999975 899999999999999999999632 99999999999999998 89999999998654332
Q ss_pred cCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc-cchhHHHHHHHHhC
Q 011660 405 ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA-NRESLVLWYYVLAG 471 (480)
Q Consensus 405 ~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~-~~e~l~~~~~~~~~ 471 (480)
...+++||..|||||.+.+..|+.++||||||+.++||.+|+.||..... ...-+.+...++.+
T Consensus 233 ---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ 297 (364)
T KOG0581|consen 233 ---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDE 297 (364)
T ss_pred ---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcC
Confidence 45688999999999999999999999999999999999999999988633 33334445555553
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=316.43 Aligned_cols=217 Identities=25% Similarity=0.427 Sum_probs=188.2
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCcc---HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEe
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e 327 (480)
.+|...+.||+|.||.||+|++ .+|+.||||.++..+.. .....+|++.|+.++|+||+.|+++|-..+.+.+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 3577888999999999999965 77999999999876533 4568999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccc
Q 011660 328 LLNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (480)
Q Consensus 328 ~~~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (480)
|+..+|+..++. +...++..++.++++||+|||.+ .|+||||||.|+|++++ |.+||+|||+|+........
T Consensus 82 fm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~-g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 82 FMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSD-GQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred eccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCC-CcEEeecccchhccCCCCcc
Confidence 999999999965 77888999999999999999999 99999999999999999 89999999999876553332
Q ss_pred ccCccccccccCCCccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHhCCCCCCCCC
Q 011660 404 SENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWYYVLAGKVFAQQWP 479 (480)
Q Consensus 404 ~~~~~~~~~~GT~~y~APE~~~~-~~~~~k~DvwSlGvil~eLltG~~pf~~~~~~~e~l~~~~~~~~~~~~~~~~~ 479 (480)
.. ..+-|.+|.|||.+.| ..|+..+||||.|||+.||+-|.+.|.+.++ -+.|.. ..-..|.++.++||
T Consensus 158 ~~-----~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sD-idQL~~-If~~LGTP~~~~WP 227 (318)
T KOG0659|consen 158 QT-----HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSD-IDQLSK-IFRALGTPTPDQWP 227 (318)
T ss_pred cc-----cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCch-HHHHHH-HHHHcCCCCcccCc
Confidence 22 2267899999998876 4689999999999999999999999998875 333333 45678999999999
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=341.31 Aligned_cols=196 Identities=34% Similarity=0.563 Sum_probs=170.5
Q ss_pred CCCceeecccCceEEEEEEecCCcEEEEEEeccCCcc---HHHHHHHHHHHhcCCCCCeeeEEEEEecCC-eeEEEEecc
Q 011660 254 FSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSKE-MYAIVYNLL 329 (480)
Q Consensus 254 f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-~~~lV~e~~ 329 (480)
+...+.||+|+||+||+|.+.....+|+|++...... .+.|.+|+.+|++++|||||+++|+|.+.. .+++||||+
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 3444559999999999999865555999999765433 347999999999999999999999999887 799999999
Q ss_pred -CCCHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhCCCCC-eEeccCCCCCEEEecCCCceEEeeeccccccccccc
Q 011660 330 -NGSLKQYLK-----QLKWNERMDVAIGVAKALEYLHHTCDPP-IIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 330 -~GsL~~~l~-----~~~~~~~~~i~~~ia~aL~yLH~~~~~~-IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (480)
+|+|.+++. .+++..+..++.|||+||.|||++ + ||||||||+|||++.++.++||+|||+++......
T Consensus 123 ~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~- 198 (362)
T KOG0192|consen 123 PGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK- 198 (362)
T ss_pred CCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence 899999993 488999999999999999999999 7 99999999999999993389999999997654432
Q ss_pred cccCccccccccCCCcccccccc--CCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 403 VSENVKPVNVVGTFGYLAPEYMM--YGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 403 ~~~~~~~~~~~GT~~y~APE~~~--~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
.......||+.|||||++. ...|+.|+||||||++||||+||+.||.....
T Consensus 199 ----~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~ 251 (362)
T KOG0192|consen 199 ----TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP 251 (362)
T ss_pred ----ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH
Confidence 2223368999999999999 66999999999999999999999999998875
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=344.08 Aligned_cols=196 Identities=30% Similarity=0.445 Sum_probs=176.8
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCccHH---HHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEe
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEE---EVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~~~---~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e 327 (480)
++|.+...||+|.||+||+|+. .+.+.||+|.+.+....++ .+.+|++|++.++||||+.++++|++..++++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 4688888999999999999965 5689999999987765554 47899999999999999999999999999999999
Q ss_pred ccCCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccc
Q 011660 328 LLNGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (480)
Q Consensus 328 ~~~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (480)
|+.|+|..+|.+ ++++.+..++.+++.||.|||++ +|+|||+||.|||++.+ +.+|+||||+|+.....
T Consensus 82 ~a~g~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~-~~~KlcdFg~Ar~m~~~---- 153 (808)
T KOG0597|consen 82 YAVGDLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKG-GTLKLCDFGLARAMSTN---- 153 (808)
T ss_pred hhhhhHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCC-CceeechhhhhhhcccC----
Confidence 999999999964 89999999999999999999999 99999999999999999 78999999999865542
Q ss_pred cCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 405 ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 405 ~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
....+.+.|||.|||||.+.+.+|+..+|+||+|||||||++|++||....
T Consensus 154 -t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s 204 (808)
T KOG0597|consen 154 -TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS 204 (808)
T ss_pred -ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH
Confidence 223346779999999999999999999999999999999999999998653
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=320.00 Aligned_cols=196 Identities=26% Similarity=0.391 Sum_probs=172.9
Q ss_pred CCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCccH---HHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEec
Q 011660 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSE---EEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~~---~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~ 328 (480)
.|+.+..+|+|+||.||++++ .+|+.||||.+..++.+. +-.++|+++|++|+|+|+|.|+++|.....+++|+||
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 577788899999999999977 459999999997665432 4478999999999999999999999999999999999
Q ss_pred cCCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccc
Q 011660 329 LNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (480)
Q Consensus 329 ~~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (480)
++.++.+-|+. .+.....++++|++.|+.|+|++ ++|||||||+||||+.+ +.+||||||+|+.+..
T Consensus 83 ~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~-gvvKLCDFGFAR~L~~----- 153 (396)
T KOG0593|consen 83 CDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQN-GVVKLCDFGFARTLSA----- 153 (396)
T ss_pred cchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecC-CcEEeccchhhHhhcC-----
Confidence 99887776654 67788899999999999999999 99999999999999999 7999999999987653
Q ss_pred cCccccccccCCCccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 405 ENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 405 ~~~~~~~~~GT~~y~APE~~~~-~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
.+..-++.+.|.+|.|||.+.+ ..|+..+||||+||++.||++|.+.|.+..+
T Consensus 154 pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SD 207 (396)
T KOG0593|consen 154 PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSD 207 (396)
T ss_pred CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcch
Confidence 2223346678999999999988 6899999999999999999999999998875
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=315.09 Aligned_cols=218 Identities=27% Similarity=0.366 Sum_probs=185.8
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCccH---HHHHHHHHHHhcCCCCCeeeEEEEEe--cCCeeEE
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSE---EEVLREVELLSSIKHENIVRIIGYCH--SKEMYAI 324 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~~---~~~~~Ei~il~~l~HpnIv~l~~~~~--~~~~~~l 324 (480)
.++|+..+.|++|+||.||+|+. .++..||+|.++.+...+ -...+||.+|.+++|||||.+-.+.. +-+.+|+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 35688999999999999999965 678999999998765322 23689999999999999999988775 4457999
Q ss_pred EEeccCCCHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccc
Q 011660 325 VYNLLNGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (480)
Q Consensus 325 V~e~~~GsL~~~l~----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (480)
||||+..||...|. +|...+...++.|+++|+.|||.+ .|+||||||+|+|++.. |.+||+|||+|+.+..
T Consensus 155 VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~-G~lKiaDFGLAR~ygs- 229 (419)
T KOG0663|consen 155 VMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHK-GILKIADFGLAREYGS- 229 (419)
T ss_pred eHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccC-CcEEecccchhhhhcC-
Confidence 99999999988884 577888999999999999999999 99999999999999998 8999999999976543
Q ss_pred cccccCccccccccCCCccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHhCCCCCCCCC
Q 011660 401 HQVSENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWYYVLAGKVFAQQWP 479 (480)
Q Consensus 401 ~~~~~~~~~~~~~GT~~y~APE~~~~~-~~~~k~DvwSlGvil~eLltG~~pf~~~~~~~e~l~~~~~~~~~~~~~~~~~ 479 (480)
.....+..+-|.+|.|||.+.+. .|+..+||||+|||+.||+++++.|.+...-++ +.-.+.++|.++...||
T Consensus 230 ----p~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQ--l~~If~llGtPte~iwp 303 (419)
T KOG0663|consen 230 ----PLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQ--LDKIFKLLGTPSEAIWP 303 (419)
T ss_pred ----CcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHH--HHHHHHHhCCCccccCC
Confidence 23344566789999999998875 589999999999999999999999998875222 23356789999999998
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=328.21 Aligned_cols=199 Identities=28% Similarity=0.429 Sum_probs=174.2
Q ss_pred hhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccC----C--ccHHHHHHHHHHHhcCC-CCCeeeEEEEEecCCe
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCT----N--WSEEEVLREVELLSSIK-HENIVRIIGYCHSKEM 321 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~----~--~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~ 321 (480)
...+|.+.+.||+|+||+|++|.+ .++..+|+|++++. . ...+.+.+|+.+++.++ ||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 346799999999999999999966 56899999987654 1 12445678999999998 9999999999999999
Q ss_pred eEEEEecc-CCCHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccc
Q 011660 322 YAIVYNLL-NGSLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVH 397 (480)
Q Consensus 322 ~~lV~e~~-~GsL~~~l~---~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~ 397 (480)
+++||||+ +|+|.+++. ++.+.++..++.|++.|++|||++ +|+||||||+|||++.+.+++||+|||++...
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLSAIS 171 (370)
T ss_pred EEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence 99999999 679999995 478889999999999999999999 99999999999999987458999999999654
Q ss_pred ccccccccCccccccccCCCccccccccCCC-CC-chHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 398 HQSHQVSENVKPVNVVGTFGYLAPEYMMYGK-VD-EKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 398 ~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~-~~-~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
. .......+.|||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||++.+
T Consensus 172 ~-----~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~ 227 (370)
T KOG0583|consen 172 P-----GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN 227 (370)
T ss_pred C-----CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc
Confidence 2 2334456789999999999999988 85 88999999999999999999999843
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=321.49 Aligned_cols=211 Identities=25% Similarity=0.398 Sum_probs=183.0
Q ss_pred hcCCCCceeecccCceEEEEE-EecCCcEEEEEEeccCCccH----HHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEE
Q 011660 251 THNFSPKMLIGQGGNSKVYRT-NHVDGQVAAVKVLKCTNWSE----EEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~-~~~~g~~vAvK~~~~~~~~~----~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 325 (480)
.++|++.+.||+|+||+|-++ ++..|+.||||.++++.... -.+.+||+||+.|+||||++++++|++.+...||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 456888889999999999999 45889999999998775433 2467999999999999999999999999999999
Q ss_pred Eecc-CCCHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccc
Q 011660 326 YNLL-NGSLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (480)
Q Consensus 326 ~e~~-~GsL~~~l~---~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (480)
|||. +|.|.+|+. ++++.+...++.||..|+.|+|.+ +++|||||.+|||+|.+ +++||+||||+.++.
T Consensus 132 MEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N-~NiKIADFGLSNly~--- 204 (668)
T KOG0611|consen 132 MEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQN-NNIKIADFGLSNLYA--- 204 (668)
T ss_pred EEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCC-CCeeeeccchhhhhc---
Confidence 9999 789999995 488999999999999999999999 99999999999999999 799999999986543
Q ss_pred ccccCccccccccCCCccccccccCCCC-CchHHHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHhCCCCC
Q 011660 402 QVSENVKPVNVVGTFGYLAPEYMMYGKV-DEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWYYVLAGKVFA 475 (480)
Q Consensus 402 ~~~~~~~~~~~~GT~~y~APE~~~~~~~-~~k~DvwSlGvil~eLltG~~pf~~~~~~~e~l~~~~~~~~~~~~~ 475 (480)
......++||+|-|.+||++.+.+| ++.+|-|||||+||-|+.|..||++.+. -.+-.++.-|..+-
T Consensus 205 ---~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh----k~lvrQIs~GaYrE 272 (668)
T KOG0611|consen 205 ---DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH----KRLVRQISRGAYRE 272 (668)
T ss_pred ---cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH----HHHHHHhhcccccC
Confidence 3344568999999999999999999 7899999999999999999999997653 23444444444443
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=313.73 Aligned_cols=216 Identities=25% Similarity=0.428 Sum_probs=185.3
Q ss_pred CCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc---cHHHHHHHHHHHhcCCCCC-eeeEEEEEecCC------e
Q 011660 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW---SEEEVLREVELLSSIKHEN-IVRIIGYCHSKE------M 321 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~---~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~~~------~ 321 (480)
.|...+.||+|+||+||+|.. .+|+.||+|.++.+.. ......+|+.+|+.|+|+| |+.|++++.+.+ .
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 355566799999999999965 6799999999976644 3456799999999999999 999999998877 8
Q ss_pred eEEEEeccCCCHHHHHHhCC-------HHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccc
Q 011660 322 YAIVYNLLNGSLKQYLKQLK-------WNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA 394 (480)
Q Consensus 322 ~~lV~e~~~GsL~~~l~~~~-------~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla 394 (480)
+++|+||++-+|..|+.... ...+..++.||+.||+|||++ +|+||||||.||||+++ |.+||+|||+|
T Consensus 92 l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~-G~lKlaDFGlA 167 (323)
T KOG0594|consen 92 LYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSS-GVLKLADFGLA 167 (323)
T ss_pred EEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCC-CcEeeeccchH
Confidence 99999999999999996543 457889999999999999999 99999999999999998 89999999999
Q ss_pred cccccccccccCccccccccCCCccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHhCCC
Q 011660 395 MVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWYYVLAGKV 473 (480)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~-~~~~k~DvwSlGvil~eLltG~~pf~~~~~~~e~l~~~~~~~~~~~ 473 (480)
+...- .....+..++|.+|.|||++.+. .|+...||||+|||++||+++++.|.+..+ .....-...+.|.+
T Consensus 168 ra~~i-----p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se--~~ql~~If~~lGtP 240 (323)
T KOG0594|consen 168 RAFSI-----PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE--IDQLFRIFRLLGTP 240 (323)
T ss_pred HHhcC-----CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH--HHHHHHHHHHcCCC
Confidence 74332 11223456789999999999987 789999999999999999999999999876 22345567889999
Q ss_pred CCCCCC
Q 011660 474 FAQQWP 479 (480)
Q Consensus 474 ~~~~~~ 479 (480)
.-+.||
T Consensus 241 ~e~~Wp 246 (323)
T KOG0594|consen 241 NEKDWP 246 (323)
T ss_pred CccCCC
Confidence 999998
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=328.34 Aligned_cols=218 Identities=24% Similarity=0.395 Sum_probs=186.8
Q ss_pred hhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCccHHH--HHHHHHHHhcCC-CCCeeeEEEEEecCC-eeEE
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEE--VLREVELLSSIK-HENIVRIIGYCHSKE-MYAI 324 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~~~~--~~~Ei~il~~l~-HpnIv~l~~~~~~~~-~~~l 324 (480)
+.++|...+.||.|+||.||+|.. .+|..||||.+++.-...++ -.+|++-|++|+ ||||++|.+++.+.+ .+++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 356788999999999999999965 66999999999876555554 469999999999 999999999998877 9999
Q ss_pred EEeccCCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccc
Q 011660 325 VYNLLNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (480)
Q Consensus 325 V~e~~~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (480)
|||||+-+|.+.++. |.+..+..|+.||++||+|+|.+ |+.|||+||+|||+... ..+||+|||+|+.....
T Consensus 88 VfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~-~~iKiaDFGLARev~Sk 163 (538)
T KOG0661|consen 88 VFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGN-DVIKIADFGLAREVRSK 163 (538)
T ss_pred eHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEeccc-ceeEecccccccccccC
Confidence 999999999999964 88999999999999999999999 99999999999999965 37999999999865432
Q ss_pred cccccCccccccccCCCcccccccc-CCCCCchHHHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHhCCCCCCCCC
Q 011660 401 HQVSENVKPVNVVGTFGYLAPEYMM-YGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWYYVLAGKVFAQQWP 479 (480)
Q Consensus 401 ~~~~~~~~~~~~~GT~~y~APE~~~-~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~~~e~l~~~~~~~~~~~~~~~~~ 479 (480)
..-+..+.|.+|+|||++. .+-|+.++||||+|||++|+++-++.|-+.++-++ +-. .=.++|.+.++.||
T Consensus 164 ------pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dq-i~K-Ic~VLGtP~~~~~~ 235 (538)
T KOG0661|consen 164 ------PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQ-IYK-ICEVLGTPDKDSWP 235 (538)
T ss_pred ------CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHH-HHH-HHHHhCCCccccch
Confidence 3334567899999999876 56789999999999999999999999998875332 211 12578999999997
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=334.38 Aligned_cols=194 Identities=27% Similarity=0.410 Sum_probs=173.1
Q ss_pred CCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCC----ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEe
Q 011660 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e 327 (480)
-|+.++-||.|+.|.|-+|++ .+|+.+|||++.+.. .....+.+||-||+.+.|||+++||++++++..+|+|.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 478888999999999999977 779999999997652 223568899999999999999999999999999999999
Q ss_pred cc-CCCHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccc
Q 011660 328 LL-NGSLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (480)
Q Consensus 328 ~~-~GsL~~~l~---~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (480)
|+ +|.|++||- .+.+.++.+++.||+.|+.|||.. +|+||||||+|+|||.+ .++||+|||+|....
T Consensus 93 yv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~-~nIKIADFGMAsLe~----- 163 (786)
T KOG0588|consen 93 YVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVK-NNIKIADFGMASLEV----- 163 (786)
T ss_pred ecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcc-cCEeeeccceeeccc-----
Confidence 99 789999993 488999999999999999999999 99999999999999998 579999999996532
Q ss_pred ccCccccccccCCCccccccccCCCC-CchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 404 SENVKPVNVVGTFGYLAPEYMMYGKV-DEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 404 ~~~~~~~~~~GT~~y~APE~~~~~~~-~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.+.-..+-||+|.|.|||+++|.+| +.++||||.|||||.||||+.||++++
T Consensus 164 -~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN 216 (786)
T KOG0588|consen 164 -PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN 216 (786)
T ss_pred -CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc
Confidence 2333457799999999999999999 689999999999999999999999654
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=329.62 Aligned_cols=196 Identities=31% Similarity=0.491 Sum_probs=172.6
Q ss_pred CCCceeecccCceEEEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc-CCC
Q 011660 254 FSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGS 332 (480)
Q Consensus 254 f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~-~Gs 332 (480)
+...+.||+|-||.||.|.+.....+|+|.++......++|.+|+++|++|+|+|||+|+++|..++.++|||||+ .|+
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~Gs 287 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGS 287 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCc
Confidence 3445569999999999999987779999999988888899999999999999999999999999988999999999 899
Q ss_pred HHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccCc
Q 011660 333 LKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV 407 (480)
Q Consensus 333 L~~~l~~-----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~ 407 (480)
|.+||+. +...+.+.++.|||+|++||+++ ++|||||.++||||+++ ..+||+|||||+...+..+.....
T Consensus 288 Ll~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~-~~vKIsDFGLAr~~~d~~Y~~~~~ 363 (468)
T KOG0197|consen 288 LLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDED-LVVKISDFGLARLIGDDEYTASEG 363 (468)
T ss_pred HHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccC-ceEEEcccccccccCCCceeecCC
Confidence 9999975 67788899999999999999999 99999999999999999 699999999998544433322221
Q ss_pred cccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCcc
Q 011660 408 KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKA 457 (480)
Q Consensus 408 ~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~~ 457 (480)
. .-...|.|||.+..+.++.|+|||||||+||||+| |+.||.....
T Consensus 364 ~----kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn 410 (468)
T KOG0197|consen 364 G----KFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN 410 (468)
T ss_pred C----CCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH
Confidence 1 22557999999999999999999999999999999 8888887653
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=300.41 Aligned_cols=194 Identities=28% Similarity=0.454 Sum_probs=175.3
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc----cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~----~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 326 (480)
++|++.+.||+|.||.||.|.. .++..+|+|++-++.. .+.++.+|++|.+.|+||||+++|++|.+....|+++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 5799999999999999999965 5688999999976642 3467889999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccc
Q 011660 327 NLL-NGSLKQYLK-----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (480)
Q Consensus 327 e~~-~GsL~~~l~-----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (480)
||. .|.|...|+ ++++.....++.|+|.||.|+|.. +||||||||+|+|++.+ +.+||+|||.+...
T Consensus 102 Eya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~-~~lkiAdfGwsV~~--- 174 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSA-GELKIADFGWSVHA--- 174 (281)
T ss_pred EecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCC-CCeeccCCCceeec---
Confidence 999 899999886 377888899999999999999999 99999999999999998 79999999998542
Q ss_pred cccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 401 ~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
...+..+.|||..|++||...+..++..+|+|++|++.||++.|.+||.+..
T Consensus 175 ----p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~ 226 (281)
T KOG0580|consen 175 ----PSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS 226 (281)
T ss_pred ----CCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh
Confidence 2344557899999999999999999999999999999999999999999876
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=321.86 Aligned_cols=202 Identities=25% Similarity=0.386 Sum_probs=171.4
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc----cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~----~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 326 (480)
++|++.+.||+|+||+||++.. .+++.+|+|++++... ....+.+|+.++..++||||+++++.+.+.+.+++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 3689999999999999999976 4589999999975422 2245778999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccc
Q 011660 327 NLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 327 e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (480)
||+ +|+|.+++.+ +++.++..++.|++.||.|||++ +|+||||||+|||++.+ +++||+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~-~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSK-GHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCC-CCEEEeeccCccccccccc
Confidence 999 6799999853 78889999999999999999999 99999999999999998 7899999999865432110
Q ss_pred cc------------------------------cCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCC
Q 011660 403 VS------------------------------ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAI 452 (480)
Q Consensus 403 ~~------------------------------~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf 452 (480)
.. ........+||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 00 000113468999999999999999999999999999999999999999
Q ss_pred CCCcc
Q 011660 453 QTNKA 457 (480)
Q Consensus 453 ~~~~~ 457 (480)
.....
T Consensus 237 ~~~~~ 241 (363)
T cd05628 237 CSETP 241 (363)
T ss_pred CCCCH
Confidence 87553
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=307.22 Aligned_cols=217 Identities=26% Similarity=0.471 Sum_probs=177.2
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc--cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEec
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~ 328 (480)
++|.+.+.||+|+||.||+|.. .+++.||+|+++.... ....+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 4699999999999999999976 4688999999975432 235678999999999999999999999999999999999
Q ss_pred cCCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccc
Q 011660 329 LNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (480)
Q Consensus 329 ~~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (480)
+.|+|.+++.. +++.....++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||+++.....
T Consensus 85 ~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~-~~~kl~DfG~~~~~~~~---- 156 (288)
T cd07871 85 LDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEK-GELKLADFGLARAKSVP---- 156 (288)
T ss_pred CCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCC-CCEEECcCcceeeccCC----
Confidence 99999998853 57788889999999999999999 99999999999999998 68999999998653221
Q ss_pred cCccccccccCCCccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHhCCCCCCCCC
Q 011660 405 ENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWYYVLAGKVFAQQWP 479 (480)
Q Consensus 405 ~~~~~~~~~GT~~y~APE~~~~-~~~~~k~DvwSlGvil~eLltG~~pf~~~~~~~e~l~~~~~~~~~~~~~~~~~ 479 (480)
........||+.|+|||++.+ ..++.++|||||||++|||++|++||...+..+. + .......+.+..+.||
T Consensus 157 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~-~-~~~~~~~~~~~~~~~~ 229 (288)
T cd07871 157 -TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE-L-HLIFRLLGTPTEETWP 229 (288)
T ss_pred -CccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-H-HHHHHHhCCCChHHhh
Confidence 112234568999999998875 5689999999999999999999999987654322 2 2222334444445554
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=307.82 Aligned_cols=214 Identities=24% Similarity=0.338 Sum_probs=180.2
Q ss_pred cCCCCceeecccCceEEEEEEecC-CcEEEEEEeccCCcc----HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWS----EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~~-g~~vAvK~~~~~~~~----~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 326 (480)
++|+..+.||.|.-|+||+++..+ +..+|+|++.+.... ..++..|-+||+.++||.++.||..|+.++..+++|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 458888899999999999998754 689999999765433 235678999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccc
Q 011660 327 NLL-NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (480)
Q Consensus 327 e~~-~GsL~~~l~~-----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (480)
||| +|+|...+++ +++..+..++.+|+.||+|||.+ |||+|||||+||||.++ |++-|+||.|+......
T Consensus 157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvred-GHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVRED-GHIMLSDFDLSLRCPVS 232 (459)
T ss_pred ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecC-CcEEeeeccccccCCCC
Confidence 999 8899998854 78888999999999999999999 99999999999999999 89999999986432110
Q ss_pred c---------------------------------c------------------cccCccccccccCCCccccccccCCCC
Q 011660 401 H---------------------------------Q------------------VSENVKPVNVVGTFGYLAPEYMMYGKV 429 (480)
Q Consensus 401 ~---------------------------------~------------------~~~~~~~~~~~GT~~y~APE~~~~~~~ 429 (480)
. . .....+...++||-.|+|||++.+...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 0 0 001123345899999999999999999
Q ss_pred CchHHHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHhCCC
Q 011660 430 DEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWYYVLAGKV 473 (480)
Q Consensus 430 ~~k~DvwSlGvil~eLltG~~pf~~~~~~~e~l~~~~~~~~~~~ 473 (480)
+.++|+|+|||+||||+.|+.||.+.++.+. ..+++....
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~T----l~NIv~~~l 352 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKET----LRNIVGQPL 352 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhh----HHHHhcCCC
Confidence 9999999999999999999999999876533 455655543
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=307.61 Aligned_cols=219 Identities=26% Similarity=0.468 Sum_probs=178.6
Q ss_pred hcCCCCceeecccCceEEEEEEec-CCcEEEEEEeccCCc--cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEe
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e 327 (480)
.++|.+.+.||+|+||.||+|... +++.+|+|+++.... ....+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 467999999999999999999764 689999999975432 23457889999999999999999999999999999999
Q ss_pred ccCCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccc
Q 011660 328 LLNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (480)
Q Consensus 328 ~~~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (480)
|+.++|.+++.. +....+..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||++......
T Consensus 84 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~--- 156 (303)
T cd07869 84 YVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDT-GELKLADFGLARAKSVP--- 156 (303)
T ss_pred CCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCC-CCEEECCCCcceeccCC---
Confidence 999999988853 67888899999999999999999 99999999999999988 78999999998643221
Q ss_pred ccCccccccccCCCccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHhCCCCCCCCC
Q 011660 404 SENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWYYVLAGKVFAQQWP 479 (480)
Q Consensus 404 ~~~~~~~~~~GT~~y~APE~~~~-~~~~~k~DvwSlGvil~eLltG~~pf~~~~~~~e~l~~~~~~~~~~~~~~~~~ 479 (480)
........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....++.+. ......+.+..+.||
T Consensus 157 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~ 230 (303)
T cd07869 157 --SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLE-RIFLVLGTPNEDTWP 230 (303)
T ss_pred --CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHH-HHHHHhCCCChhhcc
Confidence 112234578999999998875 4589999999999999999999999987654333332 233334444444443
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=315.62 Aligned_cols=205 Identities=29% Similarity=0.412 Sum_probs=169.3
Q ss_pred hhhhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc---------------cHHHHHHHHHHHhcCCCCCeee
Q 011660 248 CHLTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW---------------SEEEVLREVELLSSIKHENIVR 311 (480)
Q Consensus 248 ~~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~---------------~~~~~~~Ei~il~~l~HpnIv~ 311 (480)
....+.|++.+.||+|.||.|-+|.. .+++.||||++.+... ..+.+.+||.||++|+|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 34457799999999999999999966 6799999999965322 1257889999999999999999
Q ss_pred EEEEEecC--CeeEEEEecc-CCCHHHHH--Hh-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCc
Q 011660 312 IIGYCHSK--EMYAIVYNLL-NGSLKQYL--KQ-LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHH 385 (480)
Q Consensus 312 l~~~~~~~--~~~~lV~e~~-~GsL~~~l--~~-~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~ 385 (480)
|+++..+. +.+|||+||+ .|.+...- +. +.+.++++++.++..||+|||.+ +||||||||+|+||+++ |+
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~-g~ 248 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSD-GT 248 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCC-Cc
Confidence 99998754 6899999999 45543322 22 78899999999999999999999 99999999999999999 89
Q ss_pred eEEeeeccccccccccccccCccccccccCCCccccccccCCC---C-CchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 386 PQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGK---V-DEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 386 ~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~---~-~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
+||+|||.+.....+............+|||.|+|||...++. + +.+.||||+||+||.|+.|+.||-++.
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~ 323 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF 323 (576)
T ss_pred EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch
Confidence 9999999987664432222223334578999999999987632 3 688999999999999999999998754
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=309.75 Aligned_cols=198 Identities=32% Similarity=0.495 Sum_probs=166.6
Q ss_pred cCCCCceeecccCceEEEEEEec-CCcEEEEEEeccCCcc-HHHHHHHHHHHhcCCCCCeeeEEEEEecCC--eeEEEEe
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWS-EEEVLREVELLSSIKHENIVRIIGYCHSKE--MYAIVYN 327 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~-~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--~~~lV~e 327 (480)
.+|...+.||+|+||.||++... +|..+|||.+...... .+.+.+|+.+|+.++|||||+++|...... .+++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 35778889999999999999764 4899999998755322 355889999999999999999999854444 6999999
Q ss_pred cc-CCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEec-CCCceEEeeecccccccccc
Q 011660 328 LL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSE-NFHHPQLSDFGAAMVHHQSH 401 (480)
Q Consensus 328 ~~-~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~-~~~~~kL~DFGla~~~~~~~ 401 (480)
|+ +|+|.+++.. +++..+..++.||++||.|||++ +||||||||+|||++. + +.+||+|||++.....
T Consensus 97 y~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~-~~~KlaDFG~a~~~~~-- 170 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSN-GDVKLADFGLAKKLES-- 170 (313)
T ss_pred ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCC-CeEEeccCcccccccc--
Confidence 99 7899999964 68899999999999999999999 9999999999999999 5 6899999999865442
Q ss_pred ccccCccccccccCCCccccccccCCC-CCchHHHHHHHHHHHHHHcCCCCCCCC
Q 011660 402 QVSENVKPVNVVGTFGYLAPEYMMYGK-VDEKIDVYSYGVVLLELITGKEAIQTN 455 (480)
Q Consensus 402 ~~~~~~~~~~~~GT~~y~APE~~~~~~-~~~k~DvwSlGvil~eLltG~~pf~~~ 455 (480)
............||+.|||||++..+. .++++|||||||++.||+||++||...
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~ 225 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF 225 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh
Confidence 111222334578999999999999643 346999999999999999999999974
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=306.58 Aligned_cols=201 Identities=29% Similarity=0.423 Sum_probs=174.8
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCcc--HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEec
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~ 328 (480)
++|+....||.|..+.||+|.. ..+..||||+++.+... .+.+.+|+..|+.++||||++++..|..++.+|+||.|
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf 105 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF 105 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence 5699999999999999999965 56899999999765433 46789999999999999999999999999999999999
Q ss_pred c-CCCHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccc
Q 011660 329 L-NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 329 ~-~GsL~~~l~~-----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (480)
+ .|++.+.++. +.+..+..|..++++||.|||.+ |.||||||+.||||+.+ |.+||+|||..-.+..+.
T Consensus 106 Ma~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~d-G~VkLadFgvsa~l~~~G- 180 (516)
T KOG0582|consen 106 MAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSD-GTVKLADFGVSASLFDSG- 180 (516)
T ss_pred hcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCC-CcEEEcCceeeeeecccC-
Confidence 9 7999999854 78888889999999999999999 99999999999999999 899999999765444433
Q ss_pred cccCccccccccCCCcccccccc--CCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 403 VSENVKPVNVVGTFGYLAPEYMM--YGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 403 ~~~~~~~~~~~GT~~y~APE~~~--~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
........+++|||.|||||+++ ..+|+.|+||||||+...||.+|..||....+
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP 237 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP 237 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh
Confidence 11222226789999999999965 45799999999999999999999999987664
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=318.76 Aligned_cols=202 Identities=24% Similarity=0.381 Sum_probs=171.1
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCC----ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 326 (480)
++|++.+.||+|+||.||++.. .+++.||+|+++... .....+.+|+.+++.++||||+++++++.+++.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 4699999999999999999976 468999999997542 12245678999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccc
Q 011660 327 NLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 327 e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (480)
||+ +|+|.+++.. +.+.++..++.|++.||.|||+. +|+||||||+|||++.+ +.++|+|||++........
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAK-GHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCC-CCEEEeecccceecccccc
Confidence 999 6789999853 78888999999999999999999 99999999999999998 7899999999865432110
Q ss_pred cc---------------------------------cCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCC
Q 011660 403 VS---------------------------------ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449 (480)
Q Consensus 403 ~~---------------------------------~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~ 449 (480)
.. ........+||+.|+|||++....++.++|||||||++|||++|.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 00 000112357999999999999999999999999999999999999
Q ss_pred CCCCCCcc
Q 011660 450 EAIQTNKA 457 (480)
Q Consensus 450 ~pf~~~~~ 457 (480)
.||...+.
T Consensus 237 ~Pf~~~~~ 244 (364)
T cd05599 237 PPFCSDNP 244 (364)
T ss_pred CCCCCCCH
Confidence 99987653
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=319.55 Aligned_cols=201 Identities=23% Similarity=0.332 Sum_probs=169.6
Q ss_pred CCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc----cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEe
Q 011660 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~----~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e 327 (480)
.|...+.||+|+||+||+|.. .+++.+|+|++++... ....+.+|+++++.++||||+++++++.+.+.+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 588899999999999999966 5688999999975432 22457889999999999999999999999999999999
Q ss_pred cc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccc
Q 011660 328 LL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (480)
Q Consensus 328 ~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (480)
|+ +|+|.+++.+ +++..+..++.|++.||.|||+. +|+||||||+|||++.+ +++||+|||++.........
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~-~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLD-GHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCC-CCEEEeeCcCCccccccccc
Confidence 99 7799999854 67788888999999999999999 99999999999999988 78999999997532110000
Q ss_pred ------------------------------------------ccCccccccccCCCccccccccCCCCCchHHHHHHHHH
Q 011660 404 ------------------------------------------SENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVV 441 (480)
Q Consensus 404 ------------------------------------------~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvi 441 (480)
.........+||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 00001134679999999999999999999999999999
Q ss_pred HHHHHcCCCCCCCCcc
Q 011660 442 LLELITGKEAIQTNKA 457 (480)
Q Consensus 442 l~eLltG~~pf~~~~~ 457 (480)
+|||++|+.||...+.
T Consensus 238 l~elltG~~Pf~~~~~ 253 (381)
T cd05626 238 LFEMLVGQPPFLAPTP 253 (381)
T ss_pred HHHHHhCCCCCcCCCH
Confidence 9999999999987654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=325.06 Aligned_cols=201 Identities=21% Similarity=0.323 Sum_probs=166.4
Q ss_pred HHhhhhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCccHHHHHHHHHHHhcCCC------CCeeeEEEEEec
Q 011660 246 ELCHLTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIKH------ENIVRIIGYCHS 318 (480)
Q Consensus 246 el~~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~H------pnIv~l~~~~~~ 318 (480)
++...+.+|++.+.||+|+||+||+|.+ .+++.||||+++.......+...|+.+++.++| ++++++++++..
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 3444567899999999999999999976 458899999997544344556677777776654 568899998875
Q ss_pred C-CeeEEEEeccCCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeccCCCCCEEEecCCC---------
Q 011660 319 K-EMYAIVYNLLNGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHH-TCDPPIIHRDVKSSNILLSENFH--------- 384 (480)
Q Consensus 319 ~-~~~~lV~e~~~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~-~~~~~IiHrDlKp~NILl~~~~~--------- 384 (480)
+ ..+++||++++++|.+++.+ +.+.++..++.||+.||.|||+ . +||||||||+|||++.+..
T Consensus 203 ~~~~~~iv~~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~~~~~~~~ 279 (467)
T PTZ00284 203 ETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVVDPVTNRA 279 (467)
T ss_pred CCceEEEEEeccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCcccccccccc
Confidence 4 57899999999999998854 7888999999999999999997 6 9999999999999986521
Q ss_pred ------ceEEeeeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 385 ------HPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 385 ------~~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
.+||+|||.+.... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||...+.
T Consensus 280 ~~~~~~~vkl~DfG~~~~~~--------~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~ 350 (467)
T PTZ00284 280 LPPDPCRVRICDLGGCCDER--------HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDN 350 (467)
T ss_pred cCCCCceEEECCCCccccCc--------cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 48999999874321 122356899999999999999999999999999999999999999987653
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=307.57 Aligned_cols=193 Identities=26% Similarity=0.426 Sum_probs=169.4
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc----cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~----~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 326 (480)
++|++.+.||+|+||.||++.. .+++.+|+|++..... ..+.+.+|+++++.++||||+++++++.+++.+++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 3688999999999999999976 4689999999965431 2345788999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccc
Q 011660 327 NLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 327 e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (480)
||+ +|+|.+++.. +.+.....++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~-~~~kl~Dfg~~~~~~~--- 153 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKE-GHIKLTDFGFAKKLRD--- 153 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCC-CCEEEEecCcchhccC---
Confidence 998 6899999853 67888889999999999999999 99999999999999988 7899999999865322
Q ss_pred cccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 403 ~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 154 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~ 202 (291)
T cd05612 154 -----RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN 202 (291)
T ss_pred -----CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1224579999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=312.32 Aligned_cols=193 Identities=26% Similarity=0.391 Sum_probs=169.8
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCC----ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 326 (480)
++|.+.+.||+|+||.||+|.. .+++.+|+|+++... ...+.+.+|+.+++.++||||+++++++.+++.++++|
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 5699999999999999999976 458999999997542 12346789999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccc
Q 011660 327 NLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 327 e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (480)
||+ +|+|.+++.. +++.....++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||++.....
T Consensus 98 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~-~~~kl~Dfg~~~~~~~--- 170 (329)
T PTZ00263 98 EFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNK-GHVKVTDFGFAKKVPD--- 170 (329)
T ss_pred cCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCC-CCEEEeeccCceEcCC---
Confidence 998 6789998854 67788888999999999999999 99999999999999998 7899999999865322
Q ss_pred cccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 403 ~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 171 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 219 (329)
T PTZ00263 171 -----RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT 219 (329)
T ss_pred -----CcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC
Confidence 1224579999999999999999999999999999999999999997654
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=318.96 Aligned_cols=202 Identities=24% Similarity=0.369 Sum_probs=169.1
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc----cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~----~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 326 (480)
++|.+.+.||+|+||.||++.. .+++.||+|++.+... ..+.+.+|+++++.++||||+++++++.+++.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 3688999999999999999965 5689999999865321 2245778999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccc
Q 011660 327 NLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 327 e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (480)
||+ +|+|.+++.. +.+..+..++.|++.||.|||+. +|+||||||+|||++.+ +.++|+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~-~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRG-GHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCC-CCEEEeecccccccccccc
Confidence 999 7899999854 67788888999999999999999 99999999999999988 7899999999853211000
Q ss_pred c----------cc--------------------------------CccccccccCCCccccccccCCCCCchHHHHHHHH
Q 011660 403 V----------SE--------------------------------NVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGV 440 (480)
Q Consensus 403 ~----------~~--------------------------------~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGv 440 (480)
. .. .......+||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 0 00 00011357999999999999999999999999999
Q ss_pred HHHHHHcCCCCCCCCcc
Q 011660 441 VLLELITGKEAIQTNKA 457 (480)
Q Consensus 441 il~eLltG~~pf~~~~~ 457 (480)
++|||++|+.||.....
T Consensus 237 il~elltG~~Pf~~~~~ 253 (377)
T cd05629 237 IMFECLIGWPPFCSENS 253 (377)
T ss_pred hhhhhhcCCCCCCCCCH
Confidence 99999999999976543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=318.74 Aligned_cols=200 Identities=32% Similarity=0.473 Sum_probs=169.5
Q ss_pred HHHhhhhcCCCCceeecccCceEEEEEEecCCcEEEEEEeccCCccH---HHHHHHHHHHhcCCCCCeeeEEEEEecCCe
Q 011660 245 QELCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSE---EEVLREVELLSSIKHENIVRIIGYCHSKEM 321 (480)
Q Consensus 245 ~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~---~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 321 (480)
++.....+++.+...||+|.||+||+|.+. ..||||+++.+.... +.|..|+..+++-+|.||+-+.|||.....
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 444444566778889999999999999873 368999998776554 458899999999999999999999998777
Q ss_pred eEEEEeccCC-CHHHHH----HhCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccc
Q 011660 322 YAIVYNLLNG-SLKQYL----KQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMV 396 (480)
Q Consensus 322 ~~lV~e~~~G-sL~~~l----~~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~ 396 (480)
.||..+|+| +|..++ .+|+..+..+|+.||++|+.|||.+ +|||||||..||++.++ +.+||+|||||..
T Consensus 463 -AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~-~kVkIgDFGLatv 537 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHED-LKVKIGDFGLATV 537 (678)
T ss_pred -eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccC-CcEEEecccceee
Confidence 999999976 699998 3578888899999999999999999 99999999999999998 7899999999965
Q ss_pred cccccccccCccccccccCCCcccccccc---CCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 011660 397 HHQSHQVSENVKPVNVVGTFGYLAPEYMM---YGKVDEKIDVYSYGVVLLELITGKEAIQT 454 (480)
Q Consensus 397 ~~~~~~~~~~~~~~~~~GT~~y~APE~~~---~~~~~~k~DvwSlGvil~eLltG~~pf~~ 454 (480)
.... ..........|...|||||+++ ..+|++.+|||||||++|||+||..||..
T Consensus 538 k~~w---~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi 595 (678)
T KOG0193|consen 538 KTRW---SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI 595 (678)
T ss_pred eeee---ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC
Confidence 4332 2223334556888999999986 45789999999999999999999999993
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=319.76 Aligned_cols=201 Identities=24% Similarity=0.348 Sum_probs=169.2
Q ss_pred CCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc----cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEe
Q 011660 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~----~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e 327 (480)
+|+..+.||+|+||.||+|.. .+++.+|+|++.+... ....+.+|+++++.++||||+++++.+.+++.+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 588999999999999999976 5688999999975432 22457889999999999999999999999999999999
Q ss_pred cc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccc-
Q 011660 328 LL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ- 402 (480)
Q Consensus 328 ~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~- 402 (480)
|+ +|+|.+++.. +.+.....++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||+|........
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~-g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCC-CCEEEeECCCCccccccccc
Confidence 99 6799999854 67788888999999999999999 99999999999999998 7899999999753211000
Q ss_pred -----------------------------------------cccCccccccccCCCccccccccCCCCCchHHHHHHHHH
Q 011660 403 -----------------------------------------VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVV 441 (480)
Q Consensus 403 -----------------------------------------~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvi 441 (480)
..........+||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 237 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence 000011124579999999999999999999999999999
Q ss_pred HHHHHcCCCCCCCCcc
Q 011660 442 LLELITGKEAIQTNKA 457 (480)
Q Consensus 442 l~eLltG~~pf~~~~~ 457 (480)
||||++|++||...+.
T Consensus 238 l~elltG~~Pf~~~~~ 253 (382)
T cd05625 238 LYEMLVGQPPFLAQTP 253 (382)
T ss_pred HHHHHhCCCCCCCCCH
Confidence 9999999999987653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=317.48 Aligned_cols=198 Identities=26% Similarity=0.438 Sum_probs=175.2
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCccHHH-HHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEE-VLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~~~~-~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~ 329 (480)
..|.....||+|+.|.||.+.. .+++.||||.+.......++ +..|+.+|+..+|+|||.+++.|..++.+|+||||+
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 3467777899999999999955 66899999999877665554 679999999999999999999988889999999999
Q ss_pred -CCCHHHHHHh--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccC
Q 011660 330 -NGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSEN 406 (480)
Q Consensus 330 -~GsL~~~l~~--~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~ 406 (480)
+|+|.+.+.. +++.++..|+.++++||+|||.+ +|||||||.+|||++.+ +.+||+|||++..+.. ..
T Consensus 353 ~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~-g~vKltDFGFcaqi~~-----~~ 423 (550)
T KOG0578|consen 353 EGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMD-GSVKLTDFGFCAQISE-----EQ 423 (550)
T ss_pred CCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccC-CcEEEeeeeeeecccc-----cc
Confidence 6789998854 78899999999999999999999 99999999999999999 7999999998854332 23
Q ss_pred ccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCccc
Q 011660 407 VKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKAN 458 (480)
Q Consensus 407 ~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~~ 458 (480)
....+.+|||.|||||++....|++|+||||||++++||+-|.+||-..++-
T Consensus 424 ~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl 475 (550)
T KOG0578|consen 424 SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPL 475 (550)
T ss_pred CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChH
Confidence 3556789999999999999999999999999999999999999999875543
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=301.01 Aligned_cols=194 Identities=26% Similarity=0.390 Sum_probs=167.8
Q ss_pred CCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc----cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEec
Q 011660 254 FSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (480)
Q Consensus 254 f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~----~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~ 328 (480)
|+..+.||+|+||.||++.. .+++.+|+|.+.+... ....+.+|+++++.++|+||+++++++.+++.++++|||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 77888999999999999966 5799999999865432 223577899999999999999999999999999999999
Q ss_pred c-CCCHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccc
Q 011660 329 L-NGSLKQYLK-----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 329 ~-~GsL~~~l~-----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (480)
+ +|+|.+++. .+++..+..++.|++.||.|||+. +|+||||||+|||++++ +.++|+|||++......
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~-~~~kl~Dfg~~~~~~~~-- 155 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDR-GHIRISDLGLAVQIPEG-- 155 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCC-CCEEEeeCCCcEEcCCC--
Confidence 9 678988773 367888899999999999999999 99999999999999988 68999999998653221
Q ss_pred cccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 403 ~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.
T Consensus 156 ----~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~ 206 (285)
T cd05631 156 ----ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKE 206 (285)
T ss_pred ----CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCc
Confidence 112345799999999999999999999999999999999999999987653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=300.80 Aligned_cols=195 Identities=25% Similarity=0.476 Sum_probs=165.0
Q ss_pred CCCCceeecccCceEEEEEEe-c-CCcEEEEEEeccCCc---cHHHHHHHHHHHhcC---CCCCeeeEEEEEe-----cC
Q 011660 253 NFSPKMLIGQGGNSKVYRTNH-V-DGQVAAVKVLKCTNW---SEEEVLREVELLSSI---KHENIVRIIGYCH-----SK 319 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~-~-~g~~vAvK~~~~~~~---~~~~~~~Ei~il~~l---~HpnIv~l~~~~~-----~~ 319 (480)
+|++.+.||+|+||.||+|.. . +++.+|+|+++.... ....+.+|+.+++.+ +||||++++++|. ..
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 688999999999999999976 3 468899999875432 224566788777665 6999999999885 34
Q ss_pred CeeEEEEeccCCCHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccc
Q 011660 320 EMYAIVYNLLNGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA 394 (480)
Q Consensus 320 ~~~~lV~e~~~GsL~~~l~~-----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla 394 (480)
..+++||||+.++|.+++.. +++.++..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||++
T Consensus 82 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~-~~~kl~Dfg~~ 157 (290)
T cd07862 82 TKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSS-GQIKLADFGLA 157 (290)
T ss_pred CcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCC-CCEEEccccce
Confidence 56899999999999999854 67888999999999999999999 99999999999999998 68999999998
Q ss_pred cccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 395 MVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
...... .......||+.|+|||.+.+..++.++|||||||++|||++|++||.....
T Consensus 158 ~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~ 214 (290)
T cd07862 158 RIYSFQ------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 214 (290)
T ss_pred EeccCC------cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCH
Confidence 654321 222345799999999999989999999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=318.57 Aligned_cols=202 Identities=24% Similarity=0.356 Sum_probs=169.8
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCC----ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 326 (480)
++|++.+.||+|+||.||++.. .+++.+|+|++.+.. .....+.+|+++|+.++||||+++++.+.+++.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 3689999999999999999976 458999999996532 22345788999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccc
Q 011660 327 NLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 327 e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (480)
||+ +|+|.+++.. +.......++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||+|........
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~-~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCC-CCEEEEeCCCCcccccccc
Confidence 999 6899999854 56777888999999999999999 99999999999999988 7899999999743210000
Q ss_pred --------------------------------------cccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHH
Q 011660 403 --------------------------------------VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLE 444 (480)
Q Consensus 403 --------------------------------------~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~e 444 (480)
..........+||+.|||||++.+..++.++|||||||++||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 000011124579999999999999999999999999999999
Q ss_pred HHcCCCCCCCCcc
Q 011660 445 LITGKEAIQTNKA 457 (480)
Q Consensus 445 LltG~~pf~~~~~ 457 (480)
|++|+.||.....
T Consensus 237 ll~G~~Pf~~~~~ 249 (376)
T cd05598 237 MLVGQPPFLADTP 249 (376)
T ss_pred hhhCCCCCCCCCH
Confidence 9999999987654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=315.68 Aligned_cols=200 Identities=24% Similarity=0.353 Sum_probs=170.4
Q ss_pred hhhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCC----ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeE
Q 011660 249 HLTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYA 323 (480)
Q Consensus 249 ~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 323 (480)
...++|++.+.||+|+||.||++.+ .+++.+|+|++.+.. .....+.+|+.+++.++||||+++++++.+++.++
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 3456799999999999999999977 458899999986422 12345778999999999999999999999999999
Q ss_pred EEEecc-CCCHHHHHHh--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccc
Q 011660 324 IVYNLL-NGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (480)
Q Consensus 324 lV~e~~-~GsL~~~l~~--~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (480)
+||||+ +|+|.+++.. +++..+..++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||+|......
T Consensus 120 lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~-~~~kL~DFG~a~~~~~~ 195 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKH-GHLKLADFGTCMKMDET 195 (370)
T ss_pred EEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCC-CCEEEEecccceecccC
Confidence 999999 6899999864 67778888999999999999999 99999999999999988 78999999999654321
Q ss_pred cccccCccccccccCCCccccccccCCC----CCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 401 HQVSENVKPVNVVGTFGYLAPEYMMYGK----VDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 401 ~~~~~~~~~~~~~GT~~y~APE~~~~~~----~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
. .......+||+.|+|||++.+.. ++.++|||||||+||||++|+.||...+
T Consensus 196 ~----~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~ 251 (370)
T cd05621 196 G----MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS 251 (370)
T ss_pred C----ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC
Confidence 1 11223567999999999987543 7899999999999999999999998654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=309.59 Aligned_cols=190 Identities=24% Similarity=0.354 Sum_probs=164.4
Q ss_pred eeecccCceEEEEEEe-cCCcEEEEEEeccCC----ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc-CC
Q 011660 258 MLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NG 331 (480)
Q Consensus 258 ~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~-~G 331 (480)
+.||+|+||.||++.. .+|+.+|+|++++.. .....+.+|+++++.++||||+++++++.+++.+++||||+ +|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999976 568999999997542 12245778999999999999999999999999999999999 67
Q ss_pred CHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccCcc
Q 011660 332 SLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVK 408 (480)
Q Consensus 332 sL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~ 408 (480)
+|.+++.. +.+.++..++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||+++.... ....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~-~~~kl~DfG~a~~~~~-----~~~~ 151 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIS-----DGAT 151 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCC-CCEEEeeCCCCccccc-----CCCc
Confidence 89888854 78888899999999999999999 99999999999999998 7899999999864221 1122
Q ss_pred ccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 409 PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 409 ~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~ 199 (323)
T cd05571 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (323)
T ss_pred ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC
Confidence 335679999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=320.22 Aligned_cols=196 Identities=29% Similarity=0.441 Sum_probs=172.4
Q ss_pred hcCCCCceeecccCceEEEEE-EecCCcEEEEEEeccCCccHHHHHHHHHHHhcCC-C-----CCeeeEEEEEecCCeeE
Q 011660 251 THNFSPKMLIGQGGNSKVYRT-NHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIK-H-----ENIVRIIGYCHSKEMYA 323 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~-~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~-H-----pnIv~l~~~~~~~~~~~ 323 (480)
..+|.+.++||+|+||.|.+| ++.+++.||||+++....-..+...|+.||..|+ | -|+|+++++|.-.+++|
T Consensus 185 ~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc 264 (586)
T KOG0667|consen 185 AYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC 264 (586)
T ss_pred EEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence 347889999999999999999 4577999999999977766677789999999997 4 38999999999999999
Q ss_pred EEEeccCCCHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEec-CCCceEEeeecccccc
Q 011660 324 IVYNLLNGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSE-NFHHPQLSDFGAAMVH 397 (480)
Q Consensus 324 lV~e~~~GsL~~~l~~-----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~-~~~~~kL~DFGla~~~ 397 (480)
||+|.+.-+|.++|+. ++...+..|+.||+.||.+||+. +|||+||||+||||.+ +...+||+|||.|...
T Consensus 265 iVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 265 IVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 9999999999999965 67788999999999999999999 9999999999999954 3347999999999654
Q ss_pred ccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 398 HQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 398 ~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
.... .+.+.+..|+|||++.+.+|+.++||||||||++||++|.+.|.+.+.
T Consensus 342 ~q~v--------ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne 393 (586)
T KOG0667|consen 342 SQRV--------YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE 393 (586)
T ss_pred CCcc--------eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCH
Confidence 3322 255678889999999999999999999999999999999999988775
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=312.03 Aligned_cols=193 Identities=22% Similarity=0.368 Sum_probs=168.8
Q ss_pred cCCCCceeecccCceEEEEEEecC--CcEEEEEEeccCC----ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHVD--GQVAAVKVLKCTN----WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 325 (480)
++|.+.+.||+|+||.||+|.+.+ +..+|+|++.+.. ...+.+.+|+.+++.++||||+++++++.+++.+++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 469999999999999999996533 4689999986432 2234678899999999999999999999999999999
Q ss_pred Eecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccc
Q 011660 326 YNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (480)
Q Consensus 326 ~e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (480)
|||+ +|+|.+++.. +++..+..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||++.....
T Consensus 110 ~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~-~~ikL~DFG~a~~~~~-- 183 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKD-GFIKMTDFGFAKVVDT-- 183 (340)
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCC-CCEEEecCCCCeecCC--
Confidence 9999 7899999853 77888899999999999999999 99999999999999988 7899999999865322
Q ss_pred ccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 402 QVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 402 ~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 184 ------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~ 232 (340)
T PTZ00426 184 ------RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE 232 (340)
T ss_pred ------CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC
Confidence 1235679999999999999999999999999999999999999998654
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=309.88 Aligned_cols=216 Identities=26% Similarity=0.411 Sum_probs=184.7
Q ss_pred hcCCCCceeecccCceEEEEEEec-CCcEEEEEEeccCCc----cHHHHHHHHHHHhcCC-CCCeeeEEEEEecCCeeEE
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNW----SEEEVLREVELLSSIK-HENIVRIIGYCHSKEMYAI 324 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~----~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~l 324 (480)
...|++.+.||+|.||.||++... +|+.+|+|++.+... ..+.+.+|+.||+++. ||||+.+++.|++.+.+++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 456888899999999999999764 599999999976543 3367899999999998 9999999999999999999
Q ss_pred EEecc-CCCHHHHHHh--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCC---CceEEeeeccccccc
Q 011660 325 VYNLL-NGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENF---HHPQLSDFGAAMVHH 398 (480)
Q Consensus 325 V~e~~-~GsL~~~l~~--~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~---~~~kL~DFGla~~~~ 398 (480)
|||++ +|.|.+.+.. +++.++..++.|++.++.|||+. ||+||||||+|+|+.... +.+|++|||+|....
T Consensus 114 vmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred EEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 99999 6889999865 89999999999999999999999 999999999999996542 369999999997644
Q ss_pred cccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHhCCC--CCC
Q 011660 399 QSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWYYVLAGKV--FAQ 476 (480)
Q Consensus 399 ~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~~~e~l~~~~~~~~~~~--~~~ 476 (480)
. .......+|||.|+|||++....|+..+||||+||++|.|++|.+||.+...... ..+.+.++. ..+
T Consensus 191 ~------~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~----~~~i~~~~~~f~~~ 260 (382)
T KOG0032|consen 191 P------GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEI----FLAILRGDFDFTSE 260 (382)
T ss_pred C------CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHH----HHHHHcCCCCCCCC
Confidence 3 3345578999999999999999999999999999999999999999998765333 225555544 346
Q ss_pred CCC
Q 011660 477 QWP 479 (480)
Q Consensus 477 ~~~ 479 (480)
.||
T Consensus 261 ~w~ 263 (382)
T KOG0032|consen 261 PWD 263 (382)
T ss_pred Ccc
Confidence 665
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=309.85 Aligned_cols=194 Identities=26% Similarity=0.399 Sum_probs=171.1
Q ss_pred cCCCCceeecccCceEEEEEEec-CCcEEEEEEeccCC----ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTN----WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 326 (480)
++|++.+.||+|+||.||+|... +++.||+|++++.. .....+..|++++..++||||+++++++.+.+.+++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36899999999999999999774 58899999997542 12345788999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccc
Q 011660 327 NLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 327 e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (480)
||+ +|+|.+++.. +.+.++..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~-~~~kL~Dfg~a~~~~~--- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDAS-GHIKLTDFGLSKGIVT--- 153 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCC-CCEEEEeCcCCccccc---
Confidence 999 6799999853 67888899999999999999999 99999999999999998 7899999999864322
Q ss_pred cccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 403 ~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.
T Consensus 154 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~ 203 (333)
T cd05600 154 -----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP 203 (333)
T ss_pred -----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH
Confidence 23356799999999999999999999999999999999999999987653
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=308.87 Aligned_cols=200 Identities=26% Similarity=0.428 Sum_probs=164.8
Q ss_pred hcCCCCceeecccCceEEEEEEe------cCCcEEEEEEeccCCc--cHHHHHHHHHHHhcC-CCCCeeeEEEEEecC-C
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH------VDGQVAAVKVLKCTNW--SEEEVLREVELLSSI-KHENIVRIIGYCHSK-E 320 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~------~~g~~vAvK~~~~~~~--~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~-~ 320 (480)
.++|.+.+.||+|+||.||+|.+ .+++.||+|+++.... ....+.+|++++..+ +||||++++++|... +
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 35799999999999999999963 2356899999975432 234688999999999 899999999988754 4
Q ss_pred eeEEEEecc-CCCHHHHHHh------------------------------------------------------------
Q 011660 321 MYAIVYNLL-NGSLKQYLKQ------------------------------------------------------------ 339 (480)
Q Consensus 321 ~~~lV~e~~-~GsL~~~l~~------------------------------------------------------------ 339 (480)
.++++|||+ +|+|.+++..
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 688999999 7899998853
Q ss_pred -----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccCcccccccc
Q 011660 340 -----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVG 414 (480)
Q Consensus 340 -----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~G 414 (480)
+.+.+...++.||++||.|||+. +|+||||||+|||++.+ +.+||+|||+++....... ........+
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~-~~~kl~DfG~a~~~~~~~~---~~~~~~~~~ 238 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPD---YVRKGSARL 238 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCC-CcEEEeecccccccccCcc---hhcccCCCC
Confidence 45567788999999999999999 99999999999999988 6899999999965432111 111223456
Q ss_pred CCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCcc
Q 011660 415 TFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKA 457 (480)
Q Consensus 415 T~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~~ 457 (480)
|+.|+|||++.+..++.++|||||||+||||++ |..||.....
T Consensus 239 ~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~ 282 (338)
T cd05102 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI 282 (338)
T ss_pred CccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCc
Confidence 789999999999999999999999999999997 9999987543
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=305.46 Aligned_cols=190 Identities=23% Similarity=0.357 Sum_probs=163.9
Q ss_pred eeecccCceEEEEEEe-cCCcEEEEEEeccCC----ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc-CC
Q 011660 258 MLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NG 331 (480)
Q Consensus 258 ~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~-~G 331 (480)
+.||+|+||.||++.. .+|+.||+|+++... .....+.+|+++++.++||||+++++++..++.+++||||+ +|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 3699999999999976 568999999997542 12345678999999999999999999999999999999999 67
Q ss_pred CHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccCcc
Q 011660 332 SLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVK 408 (480)
Q Consensus 332 sL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~ 408 (480)
+|..++.. +++..+..++.|++.||.|||++ +|+||||||+|||++.+ +.+||+|||++..... ....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~-~~~kL~Dfg~~~~~~~-----~~~~ 151 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKD-GHIKITDFGLCKEGIS-----DGAT 151 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCC-CCEEecccHHhccccC-----CCCc
Confidence 89888853 78889999999999999999999 99999999999999998 7899999999864211 1112
Q ss_pred ccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 409 PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 409 ~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~ 199 (323)
T cd05595 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (323)
T ss_pred cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCC
Confidence 234679999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=299.89 Aligned_cols=197 Identities=24% Similarity=0.362 Sum_probs=173.9
Q ss_pred cCCCCceeecccCceEEEEEE-ecCCcEEEEEEeccCCccH----HHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTN-HVDGQVAAVKVLKCTNWSE----EEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vAvK~~~~~~~~~----~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 326 (480)
++|..+++||+|+||+|.+++ ..+++.||+|++++..... .....|-++|+..+||++..|--.|+..+.+|+||
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 579999999999999999995 4679999999998865332 34578999999999999999988899999999999
Q ss_pred ecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccc
Q 011660 327 NLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 327 e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (480)
||. +|.|.-+|.+ +++.....+-..|+.||.|||+. +||+||||.+|+|+|.| |++||+|||+++. .
T Consensus 248 eyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkD-GHIKitDFGLCKE-----~ 318 (516)
T KOG0690|consen 248 EYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKD-GHIKITDFGLCKE-----E 318 (516)
T ss_pred EEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccC-CceEeeecccchh-----c
Confidence 999 5778877754 77777788899999999999999 99999999999999999 8999999999953 3
Q ss_pred cccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 403 ~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
........++||||.|+|||++....|+.++|+|.+||++|||++|+.||...++
T Consensus 319 I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh 373 (516)
T KOG0690|consen 319 IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH 373 (516)
T ss_pred ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch
Confidence 4445566789999999999999999999999999999999999999999986544
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=290.98 Aligned_cols=217 Identities=26% Similarity=0.418 Sum_probs=179.9
Q ss_pred hhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccC---CccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEE
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCT---NWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 325 (480)
+.+.|++...||+|.|+.||++.+ .+|+.+|+|+++.. ..+.+++.+|++|.+.|+||||++|.+...+....|+|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 345688888999999999999855 67999999998543 33567889999999999999999999999999999999
Q ss_pred Eecc-CCCHHHHH-Hh--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecC--CCceEEeeecccccccc
Q 011660 326 YNLL-NGSLKQYL-KQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN--FHHPQLSDFGAAMVHHQ 399 (480)
Q Consensus 326 ~e~~-~GsL~~~l-~~--~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~--~~~~kL~DFGla~~~~~ 399 (480)
+|++ +|+|..-+ ++ +++..+-.++.||++||.|+|.+ +|||||+||+|+|+-.. ..-+||+|||+|....
T Consensus 89 Fe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~- 164 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN- 164 (355)
T ss_pred EecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEeC-
Confidence 9999 55665444 44 45566677999999999999999 99999999999999532 2458999999997644
Q ss_pred ccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHhCCCCC--CC
Q 011660 400 SHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWYYVLAGKVFA--QQ 477 (480)
Q Consensus 400 ~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~~~e~l~~~~~~~~~~~~~--~~ 477 (480)
.......++|||+|||||++...+|+..+||||.|||||-|+.|.+||.+.+.. .++.+++.|..-- ++
T Consensus 165 -----~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~----rlye~I~~g~yd~~~~~ 235 (355)
T KOG0033|consen 165 -----DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH----RLYEQIKAGAYDYPSPE 235 (355)
T ss_pred -----CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH----HHHHHHhccccCCCCcc
Confidence 333445678999999999999999999999999999999999999999975432 4577777776543 47
Q ss_pred CC
Q 011660 478 WP 479 (480)
Q Consensus 478 ~~ 479 (480)
||
T Consensus 236 w~ 237 (355)
T KOG0033|consen 236 WD 237 (355)
T ss_pred cC
Confidence 76
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=312.42 Aligned_cols=202 Identities=24% Similarity=0.381 Sum_probs=170.9
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCC----ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 326 (480)
++|+..+.||+|+||.||++.. .+++.+|+|+++... .....+..|+.++..++||||+++++.+.+++.+++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 3688999999999999999976 468999999997432 22345778999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccc
Q 011660 327 NLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 327 e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (480)
||+ +|+|.+++.. +++..+..++.|++.||.|||+. +|+||||||+|||++.+ +.++|+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~-~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAK-GHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCC-CCEEEeeccCCcccccccc
Confidence 999 6789999853 77888899999999999999999 99999999999999988 7999999999864422110
Q ss_pred c------------------------------ccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCC
Q 011660 403 V------------------------------SENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAI 452 (480)
Q Consensus 403 ~------------------------------~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf 452 (480)
. .........+||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 0 0001122457999999999999999999999999999999999999999
Q ss_pred CCCcc
Q 011660 453 QTNKA 457 (480)
Q Consensus 453 ~~~~~ 457 (480)
.....
T Consensus 237 ~~~~~ 241 (360)
T cd05627 237 CSETP 241 (360)
T ss_pred CCCCH
Confidence 87653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=304.98 Aligned_cols=198 Identities=27% Similarity=0.403 Sum_probs=166.4
Q ss_pred CCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCC---ccHHHHHHHHHHHhcCCCCCeeeEEEEEecC-----CeeE
Q 011660 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN---WSEEEVLREVELLSSIKHENIVRIIGYCHSK-----EMYA 323 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~~~ 323 (480)
+|++.+.||+|+||.||+|.. .+++.||+|.++... .....+.+|+++++.++||||+++++++... ..++
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 478889999999999999976 568999999986432 2234678999999999999999999988533 3589
Q ss_pred EEEeccCCCHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccc
Q 011660 324 IVYNLLNGSLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (480)
Q Consensus 324 lV~e~~~GsL~~~l~---~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (480)
+||||++++|.+++. .+++..+..++.|+++||.|||+. +|+||||||+|||++.+ +.+||+|||+++.....
T Consensus 81 lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~-~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 81 VVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANAD-CKLKICDFGLARVAFND 156 (338)
T ss_pred EEEecCCCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCC-CcEEEccCccccccccc
Confidence 999999999999885 378899999999999999999999 99999999999999998 78999999998653221
Q ss_pred cccccCccccccccCCCccccccccC--CCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 401 HQVSENVKPVNVVGTFGYLAPEYMMY--GKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 401 ~~~~~~~~~~~~~GT~~y~APE~~~~--~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.. .........||+.|+|||++.+ ..++.++|||||||++|||++|++||...+
T Consensus 157 ~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~ 212 (338)
T cd07859 157 TP--TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 212 (338)
T ss_pred cC--ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 11 1112234679999999999875 678999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=311.11 Aligned_cols=202 Identities=24% Similarity=0.336 Sum_probs=170.8
Q ss_pred HhhhhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCC----ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCe
Q 011660 247 LCHLTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVELLSSIKHENIVRIIGYCHSKEM 321 (480)
Q Consensus 247 l~~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 321 (480)
+....++|++.+.||+|+||.||++.+ .+++.+|+|++.+.. .....+.+|+.+++.++||||+++++.+.+++.
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 117 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 344457899999999999999999977 468899999986432 122446789999999999999999999999999
Q ss_pred eEEEEecc-CCCHHHHHHh--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccc
Q 011660 322 YAIVYNLL-NGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (480)
Q Consensus 322 ~~lV~e~~-~GsL~~~l~~--~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~ 398 (480)
+++||||+ +|+|.+++.. ++...+..++.||+.||.|||+. +|+||||||+|||++.+ +++||+|||++....
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~-~~ikL~DfG~a~~~~ 193 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKS-GHLKLADFGTCMKMN 193 (371)
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCC-CCEEEEeCCceeEcC
Confidence 99999999 6889999864 66777888999999999999999 99999999999999998 789999999997543
Q ss_pred cccccccCccccccccCCCccccccccCC----CCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 399 QSHQVSENVKPVNVVGTFGYLAPEYMMYG----KVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 399 ~~~~~~~~~~~~~~~GT~~y~APE~~~~~----~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
... .......+||+.|+|||++.+. .++.++|||||||++|||++|+.||...+
T Consensus 194 ~~~----~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 251 (371)
T cd05622 194 KEG----MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 251 (371)
T ss_pred cCC----cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC
Confidence 211 1122356799999999998754 37899999999999999999999998754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=303.69 Aligned_cols=188 Identities=27% Similarity=0.375 Sum_probs=163.1
Q ss_pred ecccCceEEEEEEec-CCcEEEEEEeccCC----ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc-CCCH
Q 011660 260 IGQGGNSKVYRTNHV-DGQVAAVKVLKCTN----WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGSL 333 (480)
Q Consensus 260 LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~-~GsL 333 (480)
||+|+||.||++.+. +++.+|+|+++... .....+.+|+.+++.++||||+++++++.+.+.+++||||+ +|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999764 58899999996532 22345778999999999999999999999999999999999 6899
Q ss_pred HHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccCcccc
Q 011660 334 KQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPV 410 (480)
Q Consensus 334 ~~~l~---~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~ 410 (480)
.+++. .+++..+..++.|++.||.|||+. +|+||||||+|||++.+ +.++|+|||+++..... .....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~-~~~kl~Dfg~~~~~~~~-----~~~~~ 151 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQ-GHIALCDFGLCKLNMKD-----DDKTN 151 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCC-CcEEEEECcccccCccC-----CCccc
Confidence 99985 378888999999999999999999 99999999999999998 68999999998643211 11233
Q ss_pred ccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 411 NVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 411 ~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
..+||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~ 197 (312)
T cd05585 152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN 197 (312)
T ss_pred cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC
Confidence 5679999999999999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=301.16 Aligned_cols=204 Identities=25% Similarity=0.394 Sum_probs=169.2
Q ss_pred CCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEEEecC---C--eeEEEE
Q 011660 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSK---E--MYAIVY 326 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~---~--~~~lV~ 326 (480)
.|...+++|.|+||.||+|.. .+++.+|||.+-.+. +.-.+|+.||+.++|||||+|.-+|... + ...+||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~---r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl 101 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK---RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL 101 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC---CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence 477788999999999999976 457899999886543 2334899999999999999998877422 2 456899
Q ss_pred eccCCCHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccc
Q 011660 327 NLLNGSLKQYLKQ-------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (480)
Q Consensus 327 e~~~GsL~~~l~~-------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~ 399 (480)
||+..+|.++++. ++..++.-+.+||.+||.|||+. +|+||||||.|+|+|.+.|.+||||||.|+.+..
T Consensus 102 eymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~ 178 (364)
T KOG0658|consen 102 EYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVK 178 (364)
T ss_pred HhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceeecc
Confidence 9999999999863 55566777999999999999998 9999999999999999989999999999987544
Q ss_pred ccccccCccccccccCCCccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHH
Q 011660 400 SHQVSENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWYYVL 469 (480)
Q Consensus 400 ~~~~~~~~~~~~~~GT~~y~APE~~~~-~~~~~k~DvwSlGvil~eLltG~~pf~~~~~~~e~l~~~~~~~ 469 (480)
. ........|..|+|||.+.+ ..|+.++||||.||++.||+-|++.|.+.+ +.+.|++-.+.+
T Consensus 179 ~------epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s-~~dQL~eIik~l 242 (364)
T KOG0658|consen 179 G------EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDS-SVDQLVEIIKVL 242 (364)
T ss_pred C------CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCC-HHHHHHHHHHHh
Confidence 2 22345567889999998875 579999999999999999999999999955 455667766554
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=305.08 Aligned_cols=190 Identities=25% Similarity=0.366 Sum_probs=164.3
Q ss_pred eeecccCceEEEEEEe-cCCcEEEEEEeccCC----ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc-CC
Q 011660 258 MLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NG 331 (480)
Q Consensus 258 ~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~-~G 331 (480)
+.||+|+||.||++.. .+++.+|+|++++.. .....+.+|+++++.++||||+++++++.+++.+++||||+ +|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999976 568999999997542 12345788999999999999999999999999999999999 67
Q ss_pred CHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccCcc
Q 011660 332 SLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVK 408 (480)
Q Consensus 332 sL~~~l~---~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~ 408 (480)
+|..++. .+.+.++..++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||+++.... ....
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~-~~~kL~DfG~~~~~~~-----~~~~ 151 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKD-GHIKITDFGLCKEGIT-----DAAT 151 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCC-CcEEEecCcCCccCCC-----cccc
Confidence 8988884 378889999999999999999999 99999999999999988 7899999999864221 1112
Q ss_pred ccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 409 PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 409 ~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~ 199 (328)
T cd05593 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (328)
T ss_pred cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCC
Confidence 234679999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=302.44 Aligned_cols=195 Identities=24% Similarity=0.371 Sum_probs=166.5
Q ss_pred CCCCceeecccCceEEEEEEec-CCcEEEEEEeccCC----ccHHHHHHHHHHHhcCCCC-CeeeEEEEEecCCeeEEEE
Q 011660 253 NFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTN----WSEEEVLREVELLSSIKHE-NIVRIIGYCHSKEMYAIVY 326 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~----~~~~~~~~Ei~il~~l~Hp-nIv~l~~~~~~~~~~~lV~ 326 (480)
+|++.+.||+|+||.||+|... +++.||+|++++.. ...+.+..|++++..++|+ +|+++++++.+.+.+++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4888999999999999999764 57899999997532 2334577899999999764 6888999999999999999
Q ss_pred ecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccc
Q 011660 327 NLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 327 e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (480)
||+ +|+|.+++.. +.+..+..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||++.....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~-~~~kL~Dfg~~~~~~~--- 153 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAE-GHIKIADFGMCKENIF--- 153 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCC-CCEEEeecCcceecCC---
Confidence 999 6899988853 68888999999999999999999 99999999999999998 7899999999853211
Q ss_pred cccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 403 ~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 154 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~ 205 (324)
T cd05587 154 --GGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED 205 (324)
T ss_pred --CCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence 1112335679999999999999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=302.74 Aligned_cols=195 Identities=25% Similarity=0.399 Sum_probs=166.8
Q ss_pred CCCCceeecccCceEEEEEEec-CCcEEEEEEeccCCc----cHHHHHHHHHHHhcC-CCCCeeeEEEEEecCCeeEEEE
Q 011660 253 NFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNW----SEEEVLREVELLSSI-KHENIVRIIGYCHSKEMYAIVY 326 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~----~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~ 326 (480)
+|.+.+.||+|+||.||+|... +++.+|+|++++... ....+..|..++..+ +||+|+++++++.+.+.+++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5888999999999999999764 578999999975421 223466788888777 5899999999999999999999
Q ss_pred ecc-CCCHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccc
Q 011660 327 NLL-NGSLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 327 e~~-~GsL~~~l~---~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (480)
||+ +|+|.+++. .+++.++..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~-~~~kL~DfG~~~~~~~--- 153 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSE-GHIKIADFGMCKENMW--- 153 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCC-CcEEEccCCCceecCC---
Confidence 999 689998885 378889999999999999999999 99999999999999998 7899999999864221
Q ss_pred cccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 403 ~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 154 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~ 205 (323)
T cd05616 154 --DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 205 (323)
T ss_pred --CCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC
Confidence 1122335679999999999999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=309.75 Aligned_cols=198 Identities=26% Similarity=0.359 Sum_probs=168.7
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCC----ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEE
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 325 (480)
.++|++.+.||+|+||.||++.. .+++.+|+|++++.. .....+..|+.+++.++||||+++++++.+++.+++|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 45799999999999999999976 468899999996432 1224467899999999999999999999999999999
Q ss_pred Eecc-CCCHHHHHHh--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccc
Q 011660 326 YNLL-NGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 326 ~e~~-~GsL~~~l~~--~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (480)
|||+ +|+|.+++.. ++......++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||++.......
T Consensus 122 ~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~-~~~kL~DfG~~~~~~~~~- 196 (370)
T cd05596 122 MEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKS-GHLKLADFGTCMKMDANG- 196 (370)
T ss_pred EcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCC-CCEEEEeccceeeccCCC-
Confidence 9999 7899999865 66777888999999999999999 99999999999999998 789999999986543211
Q ss_pred cccCccccccccCCCccccccccCC----CCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 403 VSENVKPVNVVGTFGYLAPEYMMYG----KVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 403 ~~~~~~~~~~~GT~~y~APE~~~~~----~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.......+||+.|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus 197 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 251 (370)
T cd05596 197 ---MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 251 (370)
T ss_pred ---cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC
Confidence 1122356799999999998653 47899999999999999999999998754
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=295.99 Aligned_cols=198 Identities=25% Similarity=0.404 Sum_probs=169.3
Q ss_pred cCCCCceeecccCceEEEEEEec-CCcEEEEEEeccCCc---cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEe
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e 327 (480)
++|++.+.||+|+||.||++... +++.+|+|+++.... ..+.+.+|+++++.++||||+++++++.+++.+++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36899999999999999999774 588999999975432 23567899999999999999999999999999999999
Q ss_pred ccCCCHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccc
Q 011660 328 LLNGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (480)
Q Consensus 328 ~~~GsL~~~l~----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (480)
|+.+++.+.+. .+.+..+..++.|++.||.|||+. +|+||||||+||+++.+ +.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~-- 154 (287)
T cd07848 81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHN-DVLKLCDFGFARNLSEGS-- 154 (287)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCC-CcEEEeeccCcccccccc--
Confidence 99766555553 377888899999999999999999 99999999999999988 789999999997543211
Q ss_pred ccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 404 SENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 404 ~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
........||+.|+|||++.+..++.++|||||||++|||++|++||.....
T Consensus 155 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~ 206 (287)
T cd07848 155 --NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESE 206 (287)
T ss_pred --cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCH
Confidence 1122345799999999999999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=302.29 Aligned_cols=194 Identities=23% Similarity=0.357 Sum_probs=165.3
Q ss_pred CCCceeecccCceEEEEEEe-cCCcEEEEEEeccCC----ccHHHHHHHHHHH---hcCCCCCeeeEEEEEecCCeeEEE
Q 011660 254 FSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVELL---SSIKHENIVRIIGYCHSKEMYAIV 325 (480)
Q Consensus 254 f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ei~il---~~l~HpnIv~l~~~~~~~~~~~lV 325 (480)
|.+.+.||+|+||.||++.. .+++.||+|++++.. ...+.+.+|++++ +.++||||+++++++.+.+.+++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 66788999999999999976 468999999997542 1234566676655 567899999999999999999999
Q ss_pred Eecc-CCCHHHHHH--hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccc
Q 011660 326 YNLL-NGSLKQYLK--QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 326 ~e~~-~GsL~~~l~--~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (480)
|||+ +|+|..++. .+.+.++..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||++.....
T Consensus 81 ~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~-~~~kL~Dfg~~~~~~~--- 153 (324)
T cd05589 81 MEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTE-GFVKIADFGLCKEGMG--- 153 (324)
T ss_pred EcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCC-CcEEeCcccCCccCCC---
Confidence 9999 678888875 478889999999999999999999 99999999999999998 7899999999854221
Q ss_pred cccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 403 ~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 154 --~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~ 205 (324)
T cd05589 154 --FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD 205 (324)
T ss_pred --CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC
Confidence 1122345689999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=295.98 Aligned_cols=201 Identities=27% Similarity=0.426 Sum_probs=172.1
Q ss_pred hhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEecc---CCccHHHHHHHHHHHhcCCCCCeeeEEEEEec-----CC
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKC---TNWSEEEVLREVELLSSIKHENIVRIIGYCHS-----KE 320 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-----~~ 320 (480)
+...|...+.||+|+||.|..+.. .+|+.||||.+.. .....++..+|+++|++++|+||+.+++++.. -+
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 345577788999999999999965 6789999999863 22345678999999999999999999998854 46
Q ss_pred eeEEEEeccCCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccc
Q 011660 321 MYAIVYNLLNGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVH 397 (480)
Q Consensus 321 ~~~lV~e~~~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~ 397 (480)
..|+|+|+++-+|.+.++. +.......+++|+++||.|+|+. +|+||||||+|+|++.+ ..+||||||+|+..
T Consensus 100 DvYiV~elMetDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~-c~lKI~DFGLAR~~ 175 (359)
T KOG0660|consen 100 DVYLVFELMETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNAD-CDLKICDFGLARYL 175 (359)
T ss_pred eeEEehhHHhhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccC-CCEEeccccceeec
Confidence 7999999999999999954 77888888999999999999999 99999999999999999 57999999999876
Q ss_pred ccccccccCccccccccCCCcccccccc-CCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 398 HQSHQVSENVKPVNVVGTFGYLAPEYMM-YGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 398 ~~~~~~~~~~~~~~~~GT~~y~APE~~~-~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
... ......+..+-|.+|.|||++. ...|+.++||||.||||.||++|++.|.+.+.
T Consensus 176 ~~~---~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~ 233 (359)
T KOG0660|consen 176 DKF---FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDY 233 (359)
T ss_pred ccc---CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCch
Confidence 543 2233335667899999999875 56899999999999999999999999998775
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=308.74 Aligned_cols=191 Identities=24% Similarity=0.363 Sum_probs=166.9
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEeccC
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLLN 330 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~ 330 (480)
.+|++.+.||+|+||.||++.. .+++.+|+|... ...+.+|+++++.++||||+++++++..+...++|+|++.
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~ 166 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK 166 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-----hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC
Confidence 5699999999999999999965 568899999754 2457899999999999999999999999999999999999
Q ss_pred CCHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccCc
Q 011660 331 GSLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV 407 (480)
Q Consensus 331 GsL~~~l~---~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~ 407 (480)
++|.+++. .+++.++..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||+|...... ...
T Consensus 167 ~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~-~~vkL~DFG~a~~~~~~----~~~ 238 (391)
T PHA03212 167 TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHP-GDVCLGDFGAACFPVDI----NAN 238 (391)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCC-CCEEEEeCCcccccccc----ccc
Confidence 99998884 377888999999999999999999 99999999999999988 68999999998643221 111
Q ss_pred cccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 011660 408 KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTN 455 (480)
Q Consensus 408 ~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~ 455 (480)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~ 286 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEK 286 (391)
T ss_pred ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCc
Confidence 223568999999999999999999999999999999999999887543
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=300.70 Aligned_cols=190 Identities=26% Similarity=0.363 Sum_probs=162.6
Q ss_pred eeecccCceEEEEEEe-cCCcEEEEEEeccCC----ccHHHHHHHHHHHhcC-CCCCeeeEEEEEecCCeeEEEEecc-C
Q 011660 258 MLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVELLSSI-KHENIVRIIGYCHSKEMYAIVYNLL-N 330 (480)
Q Consensus 258 ~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~e~~-~ 330 (480)
+.||+|+||.||+|.. .+++.+|+|++++.. .....+..|.+++..+ +||||+++++++.+++.+++||||+ +
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 3699999999999976 458899999997532 2234567899998866 8999999999999999999999999 6
Q ss_pred CCHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccCc
Q 011660 331 GSLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV 407 (480)
Q Consensus 331 GsL~~~l~---~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~ 407 (480)
|+|..++. .+.+..+..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||++..... ...
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~-~~~kL~Dfg~~~~~~~-----~~~ 151 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAE-GHCKLADFGMCKEGIL-----NGV 151 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCC-CCEEEeecccceeccc-----CCc
Confidence 78988884 377888899999999999999999 99999999999999998 7899999999864321 112
Q ss_pred cccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 408 KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 408 ~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~ 200 (321)
T cd05591 152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN 200 (321)
T ss_pred cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC
Confidence 2335679999999999999999999999999999999999999998765
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=285.74 Aligned_cols=214 Identities=29% Similarity=0.486 Sum_probs=178.5
Q ss_pred hhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCC-----ccH----HHHHHHHHHHhcC-CCCCeeeEEEEEec
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN-----WSE----EEVLREVELLSSI-KHENIVRIIGYCHS 318 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~-----~~~----~~~~~Ei~il~~l-~HpnIv~l~~~~~~ 318 (480)
+.+.|...+.||.|..+.|-++.+ .+|+.+|+|++.... ... +....|+.||+++ .||||+++.+++++
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 455788899999999999999865 678999999985321 112 3356899999998 69999999999999
Q ss_pred CCeeEEEEecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccc
Q 011660 319 KEMYAIVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA 394 (480)
Q Consensus 319 ~~~~~lV~e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla 394 (480)
+..+++|+|.+ .|.|++||.. +++.+...|+.|+.+|++|||.. +||||||||+|||++++ .+++|+|||.|
T Consensus 95 ~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn-~~i~isDFGFa 170 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDN-MNIKISDFGFA 170 (411)
T ss_pred cchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccc-cceEEecccee
Confidence 99999999999 7999999965 78888999999999999999999 99999999999999999 58999999998
Q ss_pred cccccccccccCccccccccCCCcccccccc------CCCCCchHHHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHH
Q 011660 395 MVHHQSHQVSENVKPVNVVGTFGYLAPEYMM------YGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWYYV 468 (480)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~------~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~~~e~l~~~~~~ 468 (480)
..+. ...+....||||+|+|||.+. ..+|+..+|+||+|||||-|+.|.+||-.. ..+.| ...
T Consensus 171 ~~l~------~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR----kQmlM-LR~ 239 (411)
T KOG0599|consen 171 CQLE------PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR----KQMLM-LRM 239 (411)
T ss_pred eccC------CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH----HHHHH-HHH
Confidence 7544 344556789999999999885 457899999999999999999999999863 33344 444
Q ss_pred HhCCC---CCCCC
Q 011660 469 LAGKV---FAQQW 478 (480)
Q Consensus 469 ~~~~~---~~~~~ 478 (480)
+++.. ..++|
T Consensus 240 ImeGkyqF~speW 252 (411)
T KOG0599|consen 240 IMEGKYQFRSPEW 252 (411)
T ss_pred HHhcccccCCcch
Confidence 44433 33666
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=302.01 Aligned_cols=190 Identities=28% Similarity=0.430 Sum_probs=162.7
Q ss_pred eeecccCceEEEEEEe----cCCcEEEEEEeccCC-----ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEec
Q 011660 258 MLIGQGGNSKVYRTNH----VDGQVAAVKVLKCTN-----WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (480)
Q Consensus 258 ~~LG~G~fg~Vy~~~~----~~g~~vAvK~~~~~~-----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~ 328 (480)
+.||+|+||.||++.. .+++.+|+|++++.. .....+..|+++|+.++||||+++++++.+++.+++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999965 357899999997532 1224567899999999999999999999999999999999
Q ss_pred c-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccc
Q 011660 329 L-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (480)
Q Consensus 329 ~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (480)
+ +|+|.+++.. +.+..+..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||+++.....
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~---- 153 (323)
T cd05584 82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQ-GHVKLTDFGLCKESIHE---- 153 (323)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCC-CCEEEeeCcCCeecccC----
Confidence 9 6789998854 56778888999999999999999 99999999999999988 78999999998643221
Q ss_pred cCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 405 ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 405 ~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 154 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~ 204 (323)
T cd05584 154 -GTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN 204 (323)
T ss_pred -CCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC
Confidence 112234579999999999999899999999999999999999999998754
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=308.31 Aligned_cols=202 Identities=26% Similarity=0.381 Sum_probs=173.0
Q ss_pred cCCCCceeecccCceEEEEEEec-CCcEEEEEEeccCC----ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTN----WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 326 (480)
++|.+.+.||+|+||.||+|... +++.||+|+++... .....+..|++++..++||||+++++++.+++.+++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36899999999999999999764 68999999997542 23356788999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccc
Q 011660 327 NLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 327 e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (480)
||+ +|+|.+++.. ++...+..++.|++.||.|||+. +|+||||||+|||++.+ +.++|+|||++........
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~-~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDAD-GHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCC-CCEEeecCCCCccCcccCc
Confidence 999 6799999853 78888999999999999999998 99999999999999998 7899999999865433210
Q ss_pred ------------------------cccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 403 ------------------------VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 403 ------------------------~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
...........||+.|+|||++.+..++.++|||||||+||||++|+.||...+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 235 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence 0001123346799999999999999999999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=301.21 Aligned_cols=196 Identities=26% Similarity=0.370 Sum_probs=166.0
Q ss_pred CCCCceeecccCceEEEEEEe----cCCcEEEEEEeccCC-----ccHHHHHHHHHHHhcC-CCCCeeeEEEEEecCCee
Q 011660 253 NFSPKMLIGQGGNSKVYRTNH----VDGQVAAVKVLKCTN-----WSEEEVLREVELLSSI-KHENIVRIIGYCHSKEMY 322 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~----~~g~~vAvK~~~~~~-----~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 322 (480)
+|++.+.||+|+||.||++.. .+++.+|+|++++.. ...+.+..|+.+++.+ +||||+++++++.+++.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 488899999999999999865 357899999996532 1234577899999999 599999999999999999
Q ss_pred EEEEecc-CCCHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccc
Q 011660 323 AIVYNLL-NGSLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (480)
Q Consensus 323 ~lV~e~~-~GsL~~~l~---~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~ 398 (480)
++||||+ +|+|.+++. .+++.++..++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||+++...
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~-~~~kl~DfG~~~~~~ 156 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSE-GHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCC-CCEEEeeCcCCcccc
Confidence 9999999 679999884 378888999999999999999999 99999999999999998 789999999986532
Q ss_pred cccccccCccccccccCCCccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 399 QSHQVSENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 399 ~~~~~~~~~~~~~~~GT~~y~APE~~~~~-~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.. ........+||+.|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus 157 ~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 211 (332)
T cd05614 157 SE----EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEG 211 (332)
T ss_pred cc----CCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCC
Confidence 21 11122346799999999998865 47899999999999999999999997544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=313.58 Aligned_cols=195 Identities=25% Similarity=0.386 Sum_probs=163.1
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEEEecC--------Ce
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSK--------EM 321 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--------~~ 321 (480)
..+|.+.+.||+|+||.||+|.. .+++.||+|.+.... ....+|+.+|+.++||||+++++++... ..
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 141 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIF 141 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceE
Confidence 35699999999999999999976 468899999886543 3345799999999999999999876421 24
Q ss_pred eEEEEeccCCCHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccc
Q 011660 322 YAIVYNLLNGSLKQYLK-------QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA 394 (480)
Q Consensus 322 ~~lV~e~~~GsL~~~l~-------~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla 394 (480)
+++||||+.++|.+++. .+++..+..++.||+.||.|||+. +|+||||||+|||++.+.+.+||+|||+|
T Consensus 142 l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFGla 218 (440)
T PTZ00036 142 LNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSA 218 (440)
T ss_pred EEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccccc
Confidence 67999999999888774 367888899999999999999999 99999999999999976457999999999
Q ss_pred cccccccccccCccccccccCCCccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 395 MVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~-~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
+.... ........||+.|+|||++.+. .|+.++|||||||+||||++|.+||.+...
T Consensus 219 ~~~~~------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~ 276 (440)
T PTZ00036 219 KNLLA------GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSS 276 (440)
T ss_pred hhccC------CCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 75432 1122345789999999988764 689999999999999999999999987653
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=296.25 Aligned_cols=197 Identities=24% Similarity=0.450 Sum_probs=168.5
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc--cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEec
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~ 328 (480)
++|.+.+.||+|+||.||+|.. .+++.+|+|.++.... ....+.+|+++++.++||||+++++++..++.+++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 4689999999999999999976 4688999999875432 234577899999999999999999999999999999999
Q ss_pred cCCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccc
Q 011660 329 LNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (480)
Q Consensus 329 ~~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (480)
+.++|.+++.. +.+..+..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||++.......
T Consensus 86 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~--- 158 (309)
T cd07872 86 LDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINER-GELKLADFGLARAKSVPT--- 158 (309)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCC-CCEEECccccceecCCCc---
Confidence 99999998853 67788888999999999999999 99999999999999988 789999999986432211
Q ss_pred cCccccccccCCCccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 405 ENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 405 ~~~~~~~~~GT~~y~APE~~~~-~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
.......+|+.|+|||++.+ ..++.++|||||||++|||+||+.||...+.
T Consensus 159 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~ 210 (309)
T cd07872 159 --KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTV 210 (309)
T ss_pred --cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 11223468999999998865 4689999999999999999999999987654
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=303.73 Aligned_cols=190 Identities=24% Similarity=0.360 Sum_probs=163.3
Q ss_pred eeecccCceEEEEEEe-cCCcEEEEEEeccCC----ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc-CC
Q 011660 258 MLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NG 331 (480)
Q Consensus 258 ~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~-~G 331 (480)
+.||+|+||.||++.. .+++.+|+|++++.. .....+..|+++++.++||||+++++++.+++.+++||||+ +|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999976 568999999997542 12345678999999999999999999999999999999999 67
Q ss_pred CHHHHHHh---CCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccCc
Q 011660 332 SLKQYLKQ---LKWNERMDVAIGVAKALEYLHH-TCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV 407 (480)
Q Consensus 332 sL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~-~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~ 407 (480)
+|..++.. +++.++..++.||+.||.|||+ . +|+||||||+|||++.+ +.+||+|||+++.... ...
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~-~~~kL~Dfg~~~~~~~-----~~~ 151 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIK-----DGA 151 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCC-CCEEEecCCCCeecCC-----CCc
Confidence 89888843 7888899999999999999997 6 99999999999999998 7899999999864221 111
Q ss_pred cccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 408 KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 408 ~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~ 200 (325)
T cd05594 152 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 200 (325)
T ss_pred ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCC
Confidence 2234579999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=297.46 Aligned_cols=190 Identities=27% Similarity=0.401 Sum_probs=162.5
Q ss_pred eeecccCceEEEEEEec-CCcEEEEEEeccCC----ccHHHHHHHHHHHhc-CCCCCeeeEEEEEecCCeeEEEEecc-C
Q 011660 258 MLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTN----WSEEEVLREVELLSS-IKHENIVRIIGYCHSKEMYAIVYNLL-N 330 (480)
Q Consensus 258 ~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~----~~~~~~~~Ei~il~~-l~HpnIv~l~~~~~~~~~~~lV~e~~-~ 330 (480)
+.||+|+||.||+|... +++.+|+|+++... ........|..++.. ++||||+++++++.+++.+++||||+ +
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999764 58899999997542 223456678888875 59999999999999999999999999 6
Q ss_pred CCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccCc
Q 011660 331 GSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV 407 (480)
Q Consensus 331 GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~ 407 (480)
|+|.+++.. +++.+...++.|++.||.|||+. +|+||||||+|||++.+ +.++|+|||++..... ...
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~-~~~kl~Dfg~~~~~~~-----~~~ 151 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTD-GHIKIADFGMCKENML-----GDA 151 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCC-CCEEEccCCcceECCC-----CCC
Confidence 899999854 78888999999999999999999 99999999999999998 6899999999864221 111
Q ss_pred cccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 408 KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 408 ~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~ 200 (316)
T cd05619 152 KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD 200 (316)
T ss_pred ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC
Confidence 2235679999999999999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=298.59 Aligned_cols=190 Identities=26% Similarity=0.360 Sum_probs=162.8
Q ss_pred eeecccCceEEEEEEe-cCCcEEEEEEeccCC----ccHHHHHHHHHHHhcC-CCCCeeeEEEEEecCCeeEEEEecc-C
Q 011660 258 MLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVELLSSI-KHENIVRIIGYCHSKEMYAIVYNLL-N 330 (480)
Q Consensus 258 ~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~e~~-~ 330 (480)
+.||+|+||.||++.. .+++.||+|++++.. .....+..|..++..+ +||||+++++++.+.+.+++||||+ +
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999976 458899999997532 2234567888888876 7999999999999999999999999 6
Q ss_pred CCHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccCc
Q 011660 331 GSLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV 407 (480)
Q Consensus 331 GsL~~~l~---~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~ 407 (480)
|+|.+++. .+++..+..++.|++.||.|||+. +|+||||||+|||++.+ +.++|+|||++..... ...
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~-~~~kL~DfG~~~~~~~-----~~~ 151 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHE-GHCKLADFGMCKEGIF-----NGK 151 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCC-CcEEEeeCCCCeecCc-----CCC
Confidence 78988885 378888899999999999999999 99999999999999998 7899999999864221 112
Q ss_pred cccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 408 KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 408 ~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~ 200 (320)
T cd05590 152 TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN 200 (320)
T ss_pred cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC
Confidence 2335679999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=301.54 Aligned_cols=197 Identities=24% Similarity=0.345 Sum_probs=167.1
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCC----ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 326 (480)
++|++.+.||+|+||.||++.. .+++.||+|++++.. ...+.+.+|+.++..++||||+++++++.+++.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 3689999999999999999976 458999999997522 22345788999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccc
Q 011660 327 NLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (480)
Q Consensus 327 e~~-~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (480)
||+ +|+|.+++.+ +++..+..++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++.......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKN-GHIRLADFGSCLRLLADG 156 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCC-CCEEEEECCceeecCCCC
Confidence 998 7899999854 67788889999999999999999 99999999999999988 789999999986433211
Q ss_pred ccccCccccccccCCCccccccccC-----CCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 402 QVSENVKPVNVVGTFGYLAPEYMMY-----GKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 402 ~~~~~~~~~~~~GT~~y~APE~~~~-----~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.......+||+.|+|||++.. ..++.++|||||||++|||++|+.||...+
T Consensus 157 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~ 212 (331)
T cd05597 157 ----TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES 212 (331)
T ss_pred ----CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC
Confidence 111123469999999999863 457889999999999999999999997654
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=299.57 Aligned_cols=195 Identities=25% Similarity=0.402 Sum_probs=166.7
Q ss_pred CCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCC----ccHHHHHHHHHHHhcCC-CCCeeeEEEEEecCCeeEEEE
Q 011660 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVELLSSIK-HENIVRIIGYCHSKEMYAIVY 326 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~ 326 (480)
+|+..+.||+|+||.||++.. .+++.||+|++++.. ...+.+..|..++..+. |++|+++++++.+.+.+++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 477889999999999999976 468999999997532 22345678899998885 577888999999999999999
Q ss_pred ecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccc
Q 011660 327 NLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 327 e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (480)
||+ +|+|.+++.. +++.++..++.|++.||.|||+. +|+||||||+|||++.+ +.++|+|||+++....
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~-~~ikL~Dfg~~~~~~~--- 153 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSE-GHIKIADFGMCKEHMV--- 153 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCC-CCEEEeccccccccCC---
Confidence 999 6899999854 78899999999999999999999 99999999999999998 7899999999864321
Q ss_pred cccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 403 ~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 154 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~ 205 (323)
T cd05615 154 --DGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED 205 (323)
T ss_pred --CCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC
Confidence 1112234579999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=295.80 Aligned_cols=194 Identities=24% Similarity=0.382 Sum_probs=159.8
Q ss_pred ceeecccCceEEEEEEec---CCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEEEec--CCeeEEEEeccCC
Q 011660 257 KMLIGQGGNSKVYRTNHV---DGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHS--KEMYAIVYNLLNG 331 (480)
Q Consensus 257 ~~~LG~G~fg~Vy~~~~~---~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lV~e~~~G 331 (480)
.+.||+|+||.||+|... +++.+|+|.+..... ...+.+|++++++++||||+++++++.. +..++++|||+++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH 84 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence 357999999999999754 467899999875442 3457899999999999999999998853 4578999999999
Q ss_pred CHHHHHH------------hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEec---CCCceEEeeeccccc
Q 011660 332 SLKQYLK------------QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSE---NFHHPQLSDFGAAMV 396 (480)
Q Consensus 332 sL~~~l~------------~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~---~~~~~kL~DFGla~~ 396 (480)
+|.+++. .+++..+..++.||+.||.|||+. +|+||||||+|||++. ..+.+||+|||+|+.
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07868 85 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence 9988874 367788889999999999999999 9999999999999942 225899999999976
Q ss_pred cccccccccCccccccccCCCccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 397 HHQSHQVSENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 397 ~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~-~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
...... .........||+.|+|||++.+. .++.++|||||||++|||++|++||....
T Consensus 162 ~~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 162 FNSPLK--PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred cCCCCc--cccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 433211 11122356789999999998774 58999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=309.75 Aligned_cols=184 Identities=31% Similarity=0.526 Sum_probs=162.3
Q ss_pred CceeecccCceEEEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc-CCCHH
Q 011660 256 PKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGSLK 334 (480)
Q Consensus 256 ~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~-~GsL~ 334 (480)
.++-||.|+-|.||+|+. .++.||||.++ +.-..+|+-|++|+||||+.+.|+|.....|+|+|||| .|-|.
T Consensus 128 ELeWlGSGaQGAVF~Grl-~netVAVKKV~------elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~ 200 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRL-HNETVAVKKVR------ELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY 200 (904)
T ss_pred hhhhhccCcccceeeeec-cCceehhHHHh------hhhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence 445699999999999987 47889999875 33346789999999999999999999999999999999 89999
Q ss_pred HHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccCccccc
Q 011660 335 QYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVN 411 (480)
Q Consensus 335 ~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~ 411 (480)
+.|+. ........+..+||.|+.|||.+ .|||||||.-||||+.+ ..+||+|||-++.... ......
T Consensus 201 ~VLka~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~-d~VKIsDFGTS~e~~~------~STkMS 270 (904)
T KOG4721|consen 201 EVLKAGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYD-DVVKISDFGTSKELSD------KSTKMS 270 (904)
T ss_pred HHHhccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeecc-ceEEeccccchHhhhh------hhhhhh
Confidence 99965 56666778999999999999999 99999999999999998 5899999998765332 234457
Q ss_pred cccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 412 VVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 412 ~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
++||..|||||++.+.++++|+|||||||+|||||||..||.+-.
T Consensus 271 FaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVd 315 (904)
T KOG4721|consen 271 FAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVD 315 (904)
T ss_pred hhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccc
Confidence 899999999999999999999999999999999999999998653
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=300.27 Aligned_cols=198 Identities=25% Similarity=0.397 Sum_probs=175.0
Q ss_pred hcCCCCceeecccCceEEEEEEec-CCcEEEEEEeccCCcc----HHHHHHHHHHHhcC-CCCCeeeEEEEEecCCeeEE
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWS----EEEVLREVELLSSI-KHENIVRIIGYCHSKEMYAI 324 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~----~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~l 324 (480)
..+|..+.+||+|+||+|.+++.. +...||||+++++... .+-.+.|.++|... +-|.+++|..+|++.+.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 457999999999999999999764 4778999999886432 23357888999877 46889999999999999999
Q ss_pred EEecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccc
Q 011660 325 VYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (480)
Q Consensus 325 V~e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (480)
||||+ +|+|.-.+++ +++..+..+|.+|+-||-+||+. |||+||||.+|||||.+ |++||+|||+++.
T Consensus 428 VMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~e-GHiKi~DFGmcKE---- 499 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSE-GHIKIADFGMCKE---- 499 (683)
T ss_pred EEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccC-CceEeeecccccc----
Confidence 99999 6789888876 78888999999999999999999 99999999999999999 8999999999953
Q ss_pred cccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 401 ~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
.........++||||.|+|||++.+.+|+..+|+|||||+||||+.|++||++.+.
T Consensus 500 -ni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE 555 (683)
T KOG0696|consen 500 -NIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE 555 (683)
T ss_pred -cccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 34455666789999999999999999999999999999999999999999998653
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=297.17 Aligned_cols=190 Identities=25% Similarity=0.361 Sum_probs=162.1
Q ss_pred eeecccCceEEEEEEe-cCCcEEEEEEeccCC----ccHHHHHHHHHHHhc-CCCCCeeeEEEEEecCCeeEEEEecc-C
Q 011660 258 MLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVELLSS-IKHENIVRIIGYCHSKEMYAIVYNLL-N 330 (480)
Q Consensus 258 ~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ei~il~~-l~HpnIv~l~~~~~~~~~~~lV~e~~-~ 330 (480)
+.||+|+||.||++.. .+|+.+|+|++++.. ........|..++.. ++||||+++++++.+++.+++||||+ +
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 3699999999999976 468899999997542 223456778888875 48999999999999999999999999 6
Q ss_pred CCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccCc
Q 011660 331 GSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV 407 (480)
Q Consensus 331 GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~ 407 (480)
|+|.+++.. +++.++..++.|++.||.|||+. +|+||||||+|||++.+ +.++|+|||+++.... ...
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~-~~~kl~Dfg~~~~~~~-----~~~ 151 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRD-GHIKIADFGMCKENVF-----GDN 151 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCC-CCEEeCccCCCeeccc-----CCC
Confidence 789888853 67888889999999999999999 99999999999999998 6899999999863211 112
Q ss_pred cccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 408 KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 408 ~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~ 200 (316)
T cd05620 152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD 200 (316)
T ss_pred ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence 2345679999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=298.05 Aligned_cols=190 Identities=26% Similarity=0.382 Sum_probs=161.3
Q ss_pred eeecccCceEEEEEEe-cCCcEEEEEEeccCC----ccHHHHHHHHHHHhc-CCCCCeeeEEEEEecCCeeEEEEecc-C
Q 011660 258 MLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVELLSS-IKHENIVRIIGYCHSKEMYAIVYNLL-N 330 (480)
Q Consensus 258 ~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ei~il~~-l~HpnIv~l~~~~~~~~~~~lV~e~~-~ 330 (480)
+.||+|+||.||+|.. .+++.||+|+++... ...+.+..|..++.. .+||||+++++++..++.+++||||+ +
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999976 458899999997542 223345667777765 48999999999999999999999999 6
Q ss_pred CCHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccCc
Q 011660 331 GSLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV 407 (480)
Q Consensus 331 GsL~~~l~---~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~ 407 (480)
|+|.+++. .++..+...++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||++...... ..
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~-~~~kL~Dfg~a~~~~~~-----~~ 151 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKD-GHIKIADFGMCKENMNG-----EG 151 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCC-CCEEEccCcCCeECCCC-----CC
Confidence 78998885 377888889999999999999998 99999999999999998 78999999998643221 12
Q ss_pred cccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 408 KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 408 ~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~ 200 (316)
T cd05592 152 KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED 200 (316)
T ss_pred ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC
Confidence 2335679999999999999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=300.78 Aligned_cols=188 Identities=23% Similarity=0.352 Sum_probs=162.7
Q ss_pred eeecccCceEEEEEEe-cCCcEEEEEEeccCCc----cHHHHHHHHHHHhcC-CCCCeeeEEEEEecCCeeEEEEecc-C
Q 011660 258 MLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLREVELLSSI-KHENIVRIIGYCHSKEMYAIVYNLL-N 330 (480)
Q Consensus 258 ~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~----~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~e~~-~ 330 (480)
+.||+|+||.||++.+ .+++.||+|++++... ..+.+..|..++..+ +||||+++++++.+.+.+++||||+ +
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 3699999999999976 4688999999976432 224577899999888 7999999999999999999999999 6
Q ss_pred CCHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccCc
Q 011660 331 GSLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV 407 (480)
Q Consensus 331 GsL~~~l~---~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~ 407 (480)
|+|.+++. .+++..+..++.|++.||.|||++ +|+||||||+|||++.+ +.+||+|||+++.... ...
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~-~~~kL~Dfg~~~~~~~-----~~~ 151 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAE-GHIKLTDYGMCKEGIR-----PGD 151 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCC-CCEEECcCcccccccc-----CCC
Confidence 78988884 478899999999999999999999 99999999999999998 6899999999853211 122
Q ss_pred cccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 011660 408 KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQT 454 (480)
Q Consensus 408 ~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~ 454 (480)
.....+||+.|+|||++.+..++.++|+|||||++|||++|+.||..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence 23456899999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=302.34 Aligned_cols=197 Identities=24% Similarity=0.336 Sum_probs=167.5
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCC----ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 326 (480)
++|.+.+.||+|+||.||++.. .+++.+|+|++++.. .....+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4689999999999999999976 458899999986532 12234778999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccc
Q 011660 327 NLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (480)
Q Consensus 327 e~~-~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (480)
||+ +|+|.+++.. +.+..+..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||++.......
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~-~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMN-GHIRLADFGSCLKMNQDG 156 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCC-CCEEEEeccceeeccCCC
Confidence 999 7899999854 57788888999999999999999 99999999999999988 689999999986543211
Q ss_pred ccccCccccccccCCCccccccccC-----CCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 402 QVSENVKPVNVVGTFGYLAPEYMMY-----GKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 402 ~~~~~~~~~~~~GT~~y~APE~~~~-----~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
. ......+||+.|+|||++.+ +.++.++|||||||+||||++|+.||...+
T Consensus 157 ~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~ 212 (331)
T cd05624 157 T----VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES 212 (331)
T ss_pred c----eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC
Confidence 1 11223579999999999875 568899999999999999999999997654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=322.74 Aligned_cols=204 Identities=31% Similarity=0.543 Sum_probs=174.0
Q ss_pred hcCCCCceeecccCceEEEEEEec------CCcEEEEEEeccCCcc--HHHHHHHHHHHhcCCCCCeeeEEEEEecCCee
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHV------DGQVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSKEMY 322 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 322 (480)
+.+....+.||+|+||+||+|+.. +...||||.++..... ..+|.+|+++|..|+|||||+|+|+|.+++.+
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 345566677999999999999642 2458999999866543 46899999999999999999999999999999
Q ss_pred EEEEecc-CCCHHHHHH-------------h----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCC
Q 011660 323 AIVYNLL-NGSLKQYLK-------------Q----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFH 384 (480)
Q Consensus 323 ~lV~e~~-~GsL~~~l~-------------~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~ 384 (480)
++|+||+ .|||.+||. . +...+.+.||.|||.|++||-++ .+|||||..+|+||.+++
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l- 640 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENL- 640 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccce-
Confidence 9999999 799999993 2 67788999999999999999999 999999999999999995
Q ss_pred ceEEeeeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCcccchhH
Q 011660 385 HPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESL 462 (480)
Q Consensus 385 ~~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~~~~e~l 462 (480)
.+||+||||++.....++..... +..-..+|||||.+++++|+.++|||||||+|||++| |+-||.+-. ++|.+
T Consensus 641 ~VKIsDfGLsRdiYssDYYk~~~---~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glS-n~EVI 715 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDYYKVRG---NTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS-NQEVI 715 (774)
T ss_pred EEEecccccchhhhhhhhhcccC---CceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccc-hHHHH
Confidence 89999999998766555443221 2234678999999999999999999999999999998 999998876 44544
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=302.16 Aligned_cols=197 Identities=26% Similarity=0.355 Sum_probs=168.9
Q ss_pred hhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc---cHHHHHHHHHHHhcCCCCCeeeEEEEEecCC-----
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVRIIGYCHSKE----- 320 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----- 320 (480)
..++|.+.+.||+|+||.||++.. .+|+.+|+|++..... ....+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 346799999999999999999976 5689999999975432 2356789999999999999999999986443
Q ss_pred -eeEEEEeccCCCHHHHHH-hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccc
Q 011660 321 -MYAIVYNLLNGSLKQYLK-QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (480)
Q Consensus 321 -~~~lV~e~~~GsL~~~l~-~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~ 398 (480)
.+++||||+.++|.+.+. .++...+..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||+++...
T Consensus 99 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~-~~~kl~Dfg~a~~~~ 174 (359)
T cd07876 99 QDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSD-CTLKILDFGLARTAC 174 (359)
T ss_pred ceeEEEEeCCCcCHHHHHhccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCC-CCEEEecCCCccccc
Confidence 579999999988887764 478888889999999999999999 99999999999999998 789999999986432
Q ss_pred cccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 399 QSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 399 ~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
. ........||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 175 ~------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~ 226 (359)
T cd07876 175 T------NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTD 226 (359)
T ss_pred c------CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 2 112234578999999999999999999999999999999999999998664
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=296.42 Aligned_cols=196 Identities=29% Similarity=0.418 Sum_probs=170.2
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc--cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEe
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e 327 (480)
.++|++.+.||+|+||.||++.. .++..+|+|+++.... ....+.+|+++++.++||||+++++++.+++.+++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 36799999999999999999976 4688999999875432 23568899999999999999999999999999999999
Q ss_pred cc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccc
Q 011660 328 LL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (480)
Q Consensus 328 ~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (480)
|+ +|+|.+++.. +++..+..++.|++.||.|||+.+ +|+||||||+|||++.+ +.++|+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~--- 157 (331)
T cd06649 84 HMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS--- 157 (331)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCC-CcEEEccCccccccccc---
Confidence 99 6799999854 778888999999999999999852 69999999999999998 68999999998643221
Q ss_pred ccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 404 SENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 404 ~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 158 ----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~ 206 (331)
T cd06649 158 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPD 206 (331)
T ss_pred ----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1234579999999999999999999999999999999999999997543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=304.32 Aligned_cols=197 Identities=25% Similarity=0.360 Sum_probs=169.0
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc----cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~----~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 326 (480)
++|.+.+.||+|+||.||++.. .+++.+|+|+++.... ....+.+|+.+++.++||||+++++++.+++.+++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 3689999999999999999976 5689999999975432 2345788999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccc
Q 011660 327 NLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (480)
Q Consensus 327 e~~-~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (480)
||+ +|+|.+++.. +++..+..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~-~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRT-GHIKLADFGSAARLTANK 156 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCC-CCEEeccCCCCeECCCCC
Confidence 999 7899999853 67888889999999999999999 99999999999999998 789999999996543221
Q ss_pred ccccCccccccccCCCcccccccc------CCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 402 QVSENVKPVNVVGTFGYLAPEYMM------YGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 402 ~~~~~~~~~~~~GT~~y~APE~~~------~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
. .......||+.|+|||++. ...++.++|||||||++|||++|+.||....
T Consensus 157 ~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~ 213 (330)
T cd05601 157 M----VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT 213 (330)
T ss_pred c----eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCC
Confidence 1 1223457999999999986 4567899999999999999999999997654
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=292.10 Aligned_cols=198 Identities=26% Similarity=0.448 Sum_probs=164.5
Q ss_pred cCCCCceeecccCceEEEEEEecC-----------------CcEEEEEEeccCCc--cHHHHHHHHHHHhcCCCCCeeeE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHVD-----------------GQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRI 312 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~~-----------------g~~vAvK~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l 312 (480)
++|.+.+.||+|+||.||++...+ +..+|+|+++.... ...++.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 468899999999999999996432 34799999876432 23468899999999999999999
Q ss_pred EEEEecCCeeEEEEecc-CCCHHHHHHh----------------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 011660 313 IGYCHSKEMYAIVYNLL-NGSLKQYLKQ----------------------LKWNERMDVAIGVAKALEYLHHTCDPPIIH 369 (480)
Q Consensus 313 ~~~~~~~~~~~lV~e~~-~GsL~~~l~~----------------------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiH 369 (480)
++++.+.+..+++|||+ +|+|.+++.. +.+.+...++.|++.||.|||+. +|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cccc
Confidence 99999999999999999 6899998843 35567889999999999999999 9999
Q ss_pred ccCCCCCEEEecCCCceEEeeeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc--
Q 011660 370 RDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-- 447 (480)
Q Consensus 370 rDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-- 447 (480)
|||||+|||++.+ +.+||+|||+++....... ........+++.|+|||++.++.++.++|||||||++|||++
T Consensus 162 ~dlkp~Nill~~~-~~~kl~DfG~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~ 237 (304)
T cd05096 162 RDLATRNCLVGEN-LTIKIADFGMSRNLYAGDY---YRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC 237 (304)
T ss_pred cCcchhheEEcCC-ccEEECCCccceecccCce---eEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHcc
Confidence 9999999999998 6899999999865433211 111223456889999999998999999999999999999986
Q ss_pred CCCCCCCCc
Q 011660 448 GKEAIQTNK 456 (480)
Q Consensus 448 G~~pf~~~~ 456 (480)
|..||....
T Consensus 238 ~~~p~~~~~ 246 (304)
T cd05096 238 KEQPYGELT 246 (304)
T ss_pred CCCCCCcCC
Confidence 567777643
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=290.09 Aligned_cols=195 Identities=28% Similarity=0.488 Sum_probs=164.1
Q ss_pred CCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc---cHHHHHHHHHHHhcC---CCCCeeeEEEEEec-----CC
Q 011660 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW---SEEEVLREVELLSSI---KHENIVRIIGYCHS-----KE 320 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~---~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~-----~~ 320 (480)
+|++.+.||+|+||.||+|.. .+++.+|+|.++.... ....+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 488889999999999999976 4689999999875422 224566787777665 79999999998854 34
Q ss_pred eeEEEEeccCCCHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccc
Q 011660 321 MYAIVYNLLNGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAM 395 (480)
Q Consensus 321 ~~~lV~e~~~GsL~~~l~~-----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~ 395 (480)
..++++|++.++|.+++.. +++.++..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||++.
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~-~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSG-GQVKLADFGLAR 156 (288)
T ss_pred eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCC-CCEEECccCccc
Confidence 5889999999999998854 67888999999999999999999 99999999999999988 689999999986
Q ss_pred ccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 396 VHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
..... .......||+.|+|||++.+..++.++|||||||++|||++|++||.....
T Consensus 157 ~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~ 212 (288)
T cd07863 157 IYSCQ------MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE 212 (288)
T ss_pred cccCc------ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCH
Confidence 54321 122345689999999999999999999999999999999999999976653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=299.28 Aligned_cols=197 Identities=24% Similarity=0.336 Sum_probs=166.6
Q ss_pred cCCCCceeecccCceEEEEEEec-CCcEEEEEEeccCC----ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTN----WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 326 (480)
++|.+.+.||+|+||.||++... +++.+|+|++.+.. .....+..|+.++..++|+||+++++++.+.+.+++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 36889999999999999999764 57899999986422 12234778999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccc
Q 011660 327 NLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (480)
Q Consensus 327 e~~-~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (480)
||+ +|+|.+++.+ +++..+..++.|++.||.|||+. +|+||||||+|||++.+ +.++|+|||++.......
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~-~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMN-GHIRLADFGSCLKLMEDG 156 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCC-CCEEEeecchheecccCC
Confidence 998 7899999954 67788888999999999999999 99999999999999988 689999999986432211
Q ss_pred ccccCccccccccCCCcccccccc-----CCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 402 QVSENVKPVNVVGTFGYLAPEYMM-----YGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 402 ~~~~~~~~~~~~GT~~y~APE~~~-----~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.......+||+.|+|||++. ...++.++|||||||++|||++|+.||...+
T Consensus 157 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~ 212 (332)
T cd05623 157 ----TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES 212 (332)
T ss_pred ----cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC
Confidence 11122357999999999886 3468899999999999999999999998654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=304.71 Aligned_cols=196 Identities=25% Similarity=0.367 Sum_probs=169.9
Q ss_pred hcCCCCceeecccCceEEEEEEec---CCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEe
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHV---DGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~---~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e 327 (480)
..+|.+.+.||+|+||.||++... .++.+|+|.+... ....+|+++|+.++||||+++++++...+.++++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP 166 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence 456999999999999999999643 3578999988643 345689999999999999999999999999999999
Q ss_pred ccCCCHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccc
Q 011660 328 LLNGSLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (480)
Q Consensus 328 ~~~GsL~~~l~---~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (480)
++.++|.+++. .+++.++..++.|++.||.|||+. +|+||||||+|||++.+ +.++|+|||++.......
T Consensus 167 ~~~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~-~~~~l~DfG~a~~~~~~~--- 239 (392)
T PHA03207 167 KYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEP-ENAVLGDFGAACKLDAHP--- 239 (392)
T ss_pred hcCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCC-CCEEEccCccccccCccc---
Confidence 99999999884 378899999999999999999999 99999999999999998 689999999986543321
Q ss_pred cCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 405 ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 405 ~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||.+...
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~ 292 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQV 292 (392)
T ss_pred ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCC
Confidence 11223356799999999999999999999999999999999999999977653
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=295.74 Aligned_cols=193 Identities=26% Similarity=0.427 Sum_probs=160.4
Q ss_pred CCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc--cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc
Q 011660 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~ 329 (480)
+|+..+.||+|+||.||++.+ .+++.||+|++..... ....+.+|+++++.++|+||+++++++.+++.+++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 466778899999999999976 4689999999965432 2356889999999999999999999999999999999999
Q ss_pred -CCCHHHHHHhCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccCcc
Q 011660 330 -NGSLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVK 408 (480)
Q Consensus 330 -~GsL~~~l~~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~ 408 (480)
+|+|.+.. ...+.....++.||+.||.|||+. +|+||||||+|||++++ +.+||+|||+++...... ..
T Consensus 155 ~~~~L~~~~-~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~-~~~kL~DfG~~~~~~~~~-----~~ 224 (353)
T PLN00034 155 DGGSLEGTH-IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSA-KNVKIADFGVSRILAQTM-----DP 224 (353)
T ss_pred CCCcccccc-cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCC-CCEEEcccccceeccccc-----cc
Confidence 56776532 345667788999999999999999 99999999999999998 789999999987543211 11
Q ss_pred ccccccCCCccccccccC-----CCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 011660 409 PVNVVGTFGYLAPEYMMY-----GKVDEKIDVYSYGVVLLELITGKEAIQTN 455 (480)
Q Consensus 409 ~~~~~GT~~y~APE~~~~-----~~~~~k~DvwSlGvil~eLltG~~pf~~~ 455 (480)
.....||+.|+|||++.. ...+.++|||||||++|||++|+.||...
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 276 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVG 276 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 234579999999998743 23457899999999999999999999843
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=300.31 Aligned_cols=197 Identities=26% Similarity=0.434 Sum_probs=176.3
Q ss_pred CCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc---cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEec
Q 011660 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~ 328 (480)
-|...+-||+|-|+.|-++++ .+|..||||++.+... ....++.|++-|+.++|||||+||++..+...+|+|.|+
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 477778899999999999977 7899999999976543 346789999999999999999999999999999999999
Q ss_pred c-CCCHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccc
Q 011660 329 L-NGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (480)
Q Consensus 329 ~-~GsL~~~l~----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (480)
. +|+|++|+- .+.++...+++.||+.|+.|+|+. .+|||||||+|+++-+..|-+||+|||++.- .
T Consensus 99 GD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNk------f 169 (864)
T KOG4717|consen 99 GDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNK------F 169 (864)
T ss_pred cCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeecccccc------C
Confidence 9 679999993 378888999999999999999999 8999999999999988889999999999743 3
Q ss_pred ccCccccccccCCCccccccccCCCCC-chHHHHHHHHHHHHHHcCCCCCCCCccc
Q 011660 404 SENVKPVNVVGTFGYLAPEYMMYGKVD-EKIDVYSYGVVLLELITGKEAIQTNKAN 458 (480)
Q Consensus 404 ~~~~~~~~~~GT~~y~APE~~~~~~~~-~k~DvwSlGvil~eLltG~~pf~~~~~~ 458 (480)
.......+.||+..|-|||++.+..|+ +++||||||||||-|++|++||+..++.
T Consensus 170 ~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS 225 (864)
T KOG4717|consen 170 QPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS 225 (864)
T ss_pred CCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch
Confidence 344556788999999999999999996 7899999999999999999999987653
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=298.02 Aligned_cols=190 Identities=31% Similarity=0.405 Sum_probs=160.2
Q ss_pred eeecccCceEEEEEEe-cCCcEEEEEEeccCCc----cHHHHHHHHH-HHhcCCCCCeeeEEEEEecCCeeEEEEecc-C
Q 011660 258 MLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLREVE-LLSSIKHENIVRIIGYCHSKEMYAIVYNLL-N 330 (480)
Q Consensus 258 ~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~----~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~lV~e~~-~ 330 (480)
+.||+|+||.||++.. .+++.+|+|++.+... ....+..|.. +++.++||||+++++++.+.+..++||||+ +
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999977 4688999999965321 2234555554 678899999999999999999999999999 6
Q ss_pred CCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccCc
Q 011660 331 GSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV 407 (480)
Q Consensus 331 GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~ 407 (480)
|+|..++.. +...+...++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++..... ...
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~-~~~kl~Dfg~~~~~~~-----~~~ 151 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQ-GHVVLTDFGLCKEGVE-----PEE 151 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCC-CCEEEccCCCCccCCC-----CCC
Confidence 789888743 67788888999999999999998 99999999999999998 7899999999864221 112
Q ss_pred cccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 408 KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 408 ~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 200 (321)
T cd05603 152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD 200 (321)
T ss_pred ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC
Confidence 2335679999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=299.22 Aligned_cols=188 Identities=24% Similarity=0.350 Sum_probs=161.4
Q ss_pred eeecccCceEEEEEEe-cCCcEEEEEEeccCCc----cHHHHHHHHHHHhcC-CCCCeeeEEEEEecCCeeEEEEecc-C
Q 011660 258 MLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLREVELLSSI-KHENIVRIIGYCHSKEMYAIVYNLL-N 330 (480)
Q Consensus 258 ~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~----~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~e~~-~ 330 (480)
+.||+|+||.||++.. .+++.+|+|++++... ....+..|+.++..+ +||||+++++++.+++.+++||||+ +
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 3699999999999976 4688999999975421 224567888888776 8999999999999999999999999 6
Q ss_pred CCHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccCc
Q 011660 331 GSLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV 407 (480)
Q Consensus 331 GsL~~~l~---~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~ 407 (480)
|+|..++. .+++..+..++.|++.||.|||++ +|+||||||+|||++.+ +.+||+|||+++.... ...
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~-~~~kL~DfG~~~~~~~-----~~~ 151 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLR-----PGD 151 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCC-CCEEEeeCCccccccC-----CCC
Confidence 78988874 378888999999999999999999 99999999999999998 7899999999864221 111
Q ss_pred cccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 011660 408 KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQT 454 (480)
Q Consensus 408 ~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~ 454 (480)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 198 (329)
T cd05618 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCcc
Confidence 22356799999999999999999999999999999999999999963
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=302.76 Aligned_cols=196 Identities=30% Similarity=0.413 Sum_probs=172.9
Q ss_pred CCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc--cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc
Q 011660 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~ 329 (480)
.|....+||+|.||.||+|.. .+++.||+|++..+.. ..+++..|+.+|..++++||.++|+.+..+..++++|||+
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 477778999999999999955 6799999999976643 3468899999999999999999999999999999999999
Q ss_pred -CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccccc
Q 011660 330 -NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE 405 (480)
Q Consensus 330 -~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~ 405 (480)
+|++.+.|+. +.+.++.-++.+++.||.|||.. +.+|||||+.|||+..+ +.+||+|||.+-.+.. .
T Consensus 94 ~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~-g~vkl~DfgVa~ql~~-----~ 164 (467)
T KOG0201|consen 94 GGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSES-GDVKLADFGVAGQLTN-----T 164 (467)
T ss_pred cCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEecc-CcEEEEecceeeeeec-----h
Confidence 6889998864 46667777889999999999999 99999999999999999 7999999999854332 2
Q ss_pred CccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 406 NVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 406 ~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
..+..+++|||.|||||++....|+.|+||||||++.|||.+|.+|+....+
T Consensus 165 ~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP 216 (467)
T KOG0201|consen 165 VKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP 216 (467)
T ss_pred hhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc
Confidence 2333689999999999999988999999999999999999999999987654
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=310.96 Aligned_cols=197 Identities=24% Similarity=0.305 Sum_probs=168.1
Q ss_pred CCCCceeecccCceEEEEEEe-cC-CcEEEEEEeccCCcc-HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc
Q 011660 253 NFSPKMLIGQGGNSKVYRTNH-VD-GQVAAVKVLKCTNWS-EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~-~~-g~~vAvK~~~~~~~~-~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~ 329 (480)
.|.+.+.||+|+||.||++.. .+ ++.+|+|.+...... ...+.+|+.+|+.++||||++++++|..++.+++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 388899999999999999965 34 678888877544322 235678999999999999999999999999999999999
Q ss_pred -CCCHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccc
Q 011660 330 -NGSLKQYLKQ-------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (480)
Q Consensus 330 -~GsL~~~l~~-------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (480)
+|+|.+++.+ +.+.++..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||+++......
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~-~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPT-GIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCC-CcEEEEeCcCceecCCcc
Confidence 7899988742 67788888999999999999999 99999999999999988 789999999997643321
Q ss_pred ccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 402 QVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 402 ~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 224 ---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~ 275 (478)
T PTZ00267 224 ---SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS 275 (478)
T ss_pred ---ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1112345679999999999999999999999999999999999999997654
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=303.88 Aligned_cols=196 Identities=27% Similarity=0.432 Sum_probs=174.4
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCcc---HHHHHHHHHHHhcCCCCCeeeEEEEEecCCe-eEEEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSKEM-YAIVY 326 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~-~~lV~ 326 (480)
++|...+.+|+|+||.++.+.+ .+++.+++|.++..... ......|+.++++++|||||.+.+.|.+++. ++|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 5688899999999999999976 45789999999765533 3457899999999999999999999998888 99999
Q ss_pred ecc-CCCHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccc
Q 011660 327 NLL-NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (480)
Q Consensus 327 e~~-~GsL~~~l~~-----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (480)
+|+ +|+|.+.+.+ ++++.+..++.|++.|+.|||++ .|+|||||+.||+++.+ +.++|+|||+|+.....
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~-~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKD-KKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhcccc-CceeecchhhhhhcCCc
Confidence 999 7899999853 78888999999999999999998 99999999999999999 67899999999876543
Q ss_pred cccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 401 ~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
. ....+.+|||.||.||++.+.+|+.|+|||||||++|||++-+++|...+
T Consensus 160 ~-----~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~ 210 (426)
T KOG0589|consen 160 D-----SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN 210 (426)
T ss_pred h-----hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc
Confidence 2 23457899999999999999999999999999999999999999999875
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=297.09 Aligned_cols=189 Identities=24% Similarity=0.337 Sum_probs=162.9
Q ss_pred eeecccCceEEEEEEe-cCCcEEEEEEeccCCc----cHHHHHHHHHHHhcC-CCCCeeeEEEEEecCCeeEEEEecc-C
Q 011660 258 MLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLREVELLSSI-KHENIVRIIGYCHSKEMYAIVYNLL-N 330 (480)
Q Consensus 258 ~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~----~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~e~~-~ 330 (480)
+.||+|+||.||++.. .+++.+|+|++++... ..+.+..|+.++.++ +||||+++++++.+.+.+++||||+ +
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 3699999999999976 5588999999976432 224577899999888 6999999999999999999999999 6
Q ss_pred CCHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccCc
Q 011660 331 GSLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV 407 (480)
Q Consensus 331 GsL~~~l~---~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~ 407 (480)
|+|..++. .+++..+..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||+++.... ...
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~-~~~kl~Dfg~~~~~~~-----~~~ 151 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDAD-GHIKLTDYGMCKEGLG-----PGD 151 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCC-CCEEEeccccceeccC-----CCC
Confidence 78988874 488899999999999999999999 99999999999999998 6899999999864211 112
Q ss_pred cccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 011660 408 KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTN 455 (480)
Q Consensus 408 ~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~ 455 (480)
.....+||+.|+|||++.+..++.++|||||||+||||++|+.||...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~ 199 (327)
T cd05617 152 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDII 199 (327)
T ss_pred ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCcc
Confidence 233567999999999999999999999999999999999999999653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=297.63 Aligned_cols=190 Identities=31% Similarity=0.422 Sum_probs=160.7
Q ss_pred eeecccCceEEEEEEe-cCCcEEEEEEeccCCc----cHHHHHHHHH-HHhcCCCCCeeeEEEEEecCCeeEEEEecc-C
Q 011660 258 MLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLREVE-LLSSIKHENIVRIIGYCHSKEMYAIVYNLL-N 330 (480)
Q Consensus 258 ~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~----~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~lV~e~~-~ 330 (480)
+.||+|+||.||++.. .+|+.+|+|++.+... ....+..|.. +++.++||||+++++++.+++.+++||||+ +
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 3699999999999976 4689999999965321 2234555555 568899999999999999999999999999 6
Q ss_pred CCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccCc
Q 011660 331 GSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV 407 (480)
Q Consensus 331 GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~ 407 (480)
|+|.+++.. +.+..+..++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||++..... ...
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~-~~~kl~Dfg~~~~~~~-----~~~ 151 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQ-GHVVLTDFGLCKEGIE-----HSK 151 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCC-CcEEEeccCCCccccc-----CCC
Confidence 789988853 67888889999999999999999 99999999999999998 7899999999854221 112
Q ss_pred cccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 408 KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 408 ~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~ 200 (323)
T cd05575 152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD 200 (323)
T ss_pred ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC
Confidence 2335679999999999999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=288.88 Aligned_cols=188 Identities=25% Similarity=0.384 Sum_probs=161.8
Q ss_pred ecccCceEEEEEEe-cCCcEEEEEEeccCCcc----HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc-CCCH
Q 011660 260 IGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS----EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGSL 333 (480)
Q Consensus 260 LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~----~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~-~GsL 333 (480)
||+|+||+||++.. .+++.+|+|.+...... .+.+..|+++++.++||||+++.+++..++.+++||||+ +|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999976 56899999998654322 245678999999999999999999999999999999999 6789
Q ss_pred HHHHH-------hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccC
Q 011660 334 KQYLK-------QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSEN 406 (480)
Q Consensus 334 ~~~l~-------~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~ 406 (480)
.+++. .+++..+..++.|++.||.|||+. +|+||||||+||+++.+ +.++|+|||++.......
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~-~~~~l~dfg~~~~~~~~~----- 151 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDND-GNVRISDLGLAVELKDGQ----- 151 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCC-CCEEEeeCccceecCCCC-----
Confidence 88773 267888899999999999999999 99999999999999988 689999999986543321
Q ss_pred ccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 407 VKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 407 ~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 152 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~ 201 (280)
T cd05608 152 SKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARG 201 (280)
T ss_pred ccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 11234579999999999999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=297.62 Aligned_cols=190 Identities=30% Similarity=0.405 Sum_probs=159.6
Q ss_pred eeecccCceEEEEEEec-CCcEEEEEEeccCCc----cHHHHHHHH-HHHhcCCCCCeeeEEEEEecCCeeEEEEecc-C
Q 011660 258 MLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNW----SEEEVLREV-ELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-N 330 (480)
Q Consensus 258 ~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~----~~~~~~~Ei-~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~-~ 330 (480)
+.||+|+||.||++.+. +++.+|+|++.+... ....+..|. .+++.++||||+++++++.+.+.+++||||+ +
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999764 578999999975321 223344444 4578899999999999999999999999999 6
Q ss_pred CCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccCc
Q 011660 331 GSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV 407 (480)
Q Consensus 331 GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~ 407 (480)
|+|.+++.. +.......++.||++||.|||+. +|+||||||+|||++.+ +.+||+|||+++.... ...
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~-~~~kl~DfG~a~~~~~-----~~~ 151 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQ-GHIVLTDFGLCKENIE-----HNG 151 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCC-CCEEEccCCCCccccc-----CCC
Confidence 789998854 66778888999999999999999 99999999999999988 7899999999864221 112
Q ss_pred cccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 408 KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 408 ~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 200 (325)
T cd05602 152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 200 (325)
T ss_pred CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC
Confidence 2335679999999999999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=298.63 Aligned_cols=190 Identities=30% Similarity=0.407 Sum_probs=160.8
Q ss_pred eeecccCceEEEEEEe-cCCcEEEEEEeccCC----ccHHHHHHHHH-HHhcCCCCCeeeEEEEEecCCeeEEEEecc-C
Q 011660 258 MLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVE-LLSSIKHENIVRIIGYCHSKEMYAIVYNLL-N 330 (480)
Q Consensus 258 ~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~lV~e~~-~ 330 (480)
+.||+|+||.||++.. .+|+.+|+|++.+.. .....+..|.. +++.++||||+++++++..++.+++||||+ +
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 3699999999999976 568999999996532 12234555655 577899999999999999999999999999 6
Q ss_pred CCHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccCc
Q 011660 331 GSLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV 407 (480)
Q Consensus 331 GsL~~~l~---~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~ 407 (480)
|+|..++. .+++.++..++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++..... ...
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~-~~~kL~DfG~~~~~~~-----~~~ 151 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQ-GHVVLTDFGLCKEGIA-----QSD 151 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCC-CCEEEeecCCcccCCC-----CCC
Confidence 78988884 377888999999999999999999 99999999999999998 7899999999864221 112
Q ss_pred cccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 408 KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 408 ~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~ 200 (325)
T cd05604 152 TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD 200 (325)
T ss_pred CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC
Confidence 2335679999999999999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=300.14 Aligned_cols=198 Identities=24% Similarity=0.335 Sum_probs=169.2
Q ss_pred hhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCC---ccHHHHHHHHHHHhcCCCCCeeeEEEEEecC------
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN---WSEEEVLREVELLSSIKHENIVRIIGYCHSK------ 319 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------ 319 (480)
..++|.+.+.||+|+||.||++.. ..++.+|+|++.... .....+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 346799999999999999999965 568899999997543 2235678999999999999999999987543
Q ss_pred CeeEEEEeccCCCHHHHHH-hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccc
Q 011660 320 EMYAIVYNLLNGSLKQYLK-QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (480)
Q Consensus 320 ~~~~lV~e~~~GsL~~~l~-~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~ 398 (480)
..+++||||+.++|.+++. .+++..+..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||+++...
T Consensus 102 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~-~~~kL~DfG~a~~~~ 177 (364)
T cd07875 102 QDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSD-CTLKILDFGLARTAG 177 (364)
T ss_pred CeEEEEEeCCCCCHHHHHHhcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCC-CcEEEEeCCCccccC
Confidence 3579999999999888774 478888889999999999999999 99999999999999998 689999999996533
Q ss_pred cccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 399 QSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 399 ~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.
T Consensus 178 ~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 230 (364)
T cd07875 178 TS------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH 230 (364)
T ss_pred CC------CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCH
Confidence 21 122345789999999999999999999999999999999999999986553
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=299.97 Aligned_cols=197 Identities=24% Similarity=0.330 Sum_probs=168.9
Q ss_pred hhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc---cHHHHHHHHHHHhcCCCCCeeeEEEEEecC------
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVRIIGYCHSK------ 319 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------ 319 (480)
..++|...+.||+|+||.||++.. ..++.+|+|.+..... ....+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 456899999999999999999965 4688999999975432 234677899999999999999999988543
Q ss_pred CeeEEEEeccCCCHHHHHH-hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccc
Q 011660 320 EMYAIVYNLLNGSLKQYLK-QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (480)
Q Consensus 320 ~~~~lV~e~~~GsL~~~l~-~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~ 398 (480)
...++||||++++|.+++. .+++..+..++.|+++||.|||+. +|+||||||+|||++.+ +.+||+|||+++...
T Consensus 95 ~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~-~~~kl~Dfg~~~~~~ 170 (355)
T cd07874 95 QDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSD-CTLKILDFGLARTAG 170 (355)
T ss_pred ceeEEEhhhhcccHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCC-CCEEEeeCcccccCC
Confidence 3579999999999888774 478888889999999999999999 99999999999999998 689999999996533
Q ss_pred cccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 399 QSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 399 ~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+
T Consensus 171 ~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 222 (355)
T cd07874 171 TS------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222 (355)
T ss_pred Cc------cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 21 12234578999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=301.38 Aligned_cols=197 Identities=26% Similarity=0.402 Sum_probs=168.2
Q ss_pred CCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc---cHHHHHHHHHHHhcCCCCCeeeEEEEEecCC-----eeE
Q 011660 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVRIIGYCHSKE-----MYA 323 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-----~~~ 323 (480)
+|++.+.||+|+||.||++.. .+++.||+|.+..... ..+.+.+|+++++.++||||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 488899999999999999976 5789999999865322 2356889999999999999999999998766 789
Q ss_pred EEEeccCCCHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccc
Q 011660 324 IVYNLLNGSLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (480)
Q Consensus 324 lV~e~~~GsL~~~l~---~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (480)
+|+||+.++|.+++. .+.+..+..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||+++.....
T Consensus 81 lv~e~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~-~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 81 VVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSN-CVLKICDFGLARVEEPD 156 (372)
T ss_pred EEeeccccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCC-CCEEeccccceeecccC
Confidence 999999999988884 378889999999999999999999 99999999999999998 68999999999754321
Q ss_pred cccccCccccccccCCCccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 401 HQVSENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 401 ~~~~~~~~~~~~~GT~~y~APE~~~~~-~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
. ........+|+.|+|||++.+. .++.++|||||||++|||++|+.||...+.
T Consensus 157 ~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 210 (372)
T cd07853 157 E----SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSP 210 (372)
T ss_pred c----cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCH
Confidence 1 1122344689999999998874 479999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=294.32 Aligned_cols=190 Identities=26% Similarity=0.385 Sum_probs=163.0
Q ss_pred eeecccCceEEEEEEec-CCcEEEEEEeccCC----ccHHHHHHHHHHHhcC-CCCCeeeEEEEEecCCeeEEEEecc-C
Q 011660 258 MLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTN----WSEEEVLREVELLSSI-KHENIVRIIGYCHSKEMYAIVYNLL-N 330 (480)
Q Consensus 258 ~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~----~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~e~~-~ 330 (480)
+.||+|+||.||++... +++.+|+|++++.. .....+..|++++..+ +||||+++++++.+.+.+++||||+ +
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999764 58899999997542 2234567899999887 7999999999999999999999999 6
Q ss_pred CCHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccCc
Q 011660 331 GSLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV 407 (480)
Q Consensus 331 GsL~~~l~---~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~ 407 (480)
|+|..++. .+++.++..++.|++.||.|||+. +|+||||||+|||++++ +.++|+|||++..... ...
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~-----~~~ 151 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSE-GHIKIADFGMCKEGIL-----GGV 151 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCC-CcEEecccCCCeecCc-----CCC
Confidence 78988885 478899999999999999999999 99999999999999998 6899999999854211 112
Q ss_pred cccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 408 KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 408 ~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 152 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~ 200 (318)
T cd05570 152 TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD 200 (318)
T ss_pred cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC
Confidence 2234579999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=287.95 Aligned_cols=194 Identities=27% Similarity=0.404 Sum_probs=167.4
Q ss_pred CCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCcc----HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEe
Q 011660 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS----EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~----~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e 327 (480)
+|+..+.||+|+||.||++.. .+++.+|+|++...... ...+.+|+.+++.++||||+++++.+.+++.+++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 478889999999999999976 46899999999654321 2346789999999999999999999999999999999
Q ss_pred cc-CCCHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccc
Q 011660 328 LL-NGSLKQYLK-----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (480)
Q Consensus 328 ~~-~GsL~~~l~-----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (480)
|+ +|+|.+++. .+++.++..++.|++.||.|||+. +|+||||||+||+++++ +.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~-~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDY-GHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCC-CCEEEeeCCCceecCCCC
Confidence 99 678988873 367888899999999999999999 99999999999999988 789999999986543211
Q ss_pred ccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 402 QVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 402 ~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+
T Consensus 157 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~ 205 (285)
T cd05605 157 ------TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRK 205 (285)
T ss_pred ------ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCc
Confidence 1124578999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=293.19 Aligned_cols=196 Identities=29% Similarity=0.429 Sum_probs=169.5
Q ss_pred hcCCCCceeecccCceEEEEEEec-CCcEEEEEEeccCCc--cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEe
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e 327 (480)
.++|++.+.||+|+||.||++.+. ++..+|+|+++.... ....+.+|+++++.++||||++++++|.+++.+++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 367999999999999999999764 688999999875432 23568899999999999999999999999999999999
Q ss_pred cc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccc
Q 011660 328 LL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (480)
Q Consensus 328 ~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (480)
|+ +|+|.+++.. +.+.....++.|++.||.|||+.+ +|+||||||+|||++.+ +.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~-~~~kL~Dfg~~~~~~~~--- 157 (333)
T cd06650 84 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS--- 157 (333)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCC-CCEEEeeCCcchhhhhh---
Confidence 99 6799999854 677888899999999999999742 79999999999999988 68999999998643221
Q ss_pred ccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 404 SENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 404 ~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 158 ----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~ 206 (333)
T cd06650 158 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD 206 (333)
T ss_pred ----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcc
Confidence 1224579999999999999899999999999999999999999997654
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=297.54 Aligned_cols=190 Identities=29% Similarity=0.422 Sum_probs=164.2
Q ss_pred eeecccCceEEEEEEe----cCCcEEEEEEeccCCc---cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc-
Q 011660 258 MLIGQGGNSKVYRTNH----VDGQVAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL- 329 (480)
Q Consensus 258 ~~LG~G~fg~Vy~~~~----~~g~~vAvK~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~- 329 (480)
+.||+|+||.||++.. .+|+.+|+|+++.... ....+..|++++++++||||+++++++.+++.+++||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999864 3578999999975432 2245678999999999999999999999999999999999
Q ss_pred CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccC
Q 011660 330 NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSEN 406 (480)
Q Consensus 330 ~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~ 406 (480)
+|+|.+++.. +++.++..++.|++.||.|||+. +|+||||||+|||++.+ +.++|+|||++...... .
T Consensus 82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~-~~~kL~Dfg~~~~~~~~-----~ 152 (318)
T cd05582 82 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEE-GHIKLTDFGLSKESIDH-----E 152 (318)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCC-CcEEEeeccCCcccCCC-----C
Confidence 6899999853 78889999999999999999999 99999999999999988 68999999998643221 1
Q ss_pred ccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 407 VKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 407 ~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 153 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~ 202 (318)
T cd05582 153 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD 202 (318)
T ss_pred CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC
Confidence 22335679999999999998899999999999999999999999998654
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=299.81 Aligned_cols=200 Identities=27% Similarity=0.439 Sum_probs=165.9
Q ss_pred cCCCCceeecccCceEEEEEEe------cCCcEEEEEEeccCCcc--HHHHHHHHHHHhcC-CCCCeeeEEEEEecCCee
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH------VDGQVAAVKVLKCTNWS--EEEVLREVELLSSI-KHENIVRIIGYCHSKEMY 322 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~------~~g~~vAvK~~~~~~~~--~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 322 (480)
++|++.+.||+|+||.||++.. .+++.||+|+++..... ...+.+|+.+++.+ +||||++++++|.+.+..
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 4689999999999999999863 22458999999754322 34578999999999 899999999999999999
Q ss_pred EEEEecc-CCCHHHHHHh--------------------------------------------------------------
Q 011660 323 AIVYNLL-NGSLKQYLKQ-------------------------------------------------------------- 339 (480)
Q Consensus 323 ~lV~e~~-~GsL~~~l~~-------------------------------------------------------------- 339 (480)
++||||+ +|+|.+++..
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 9999999 7899998842
Q ss_pred -----------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccCcc
Q 011660 340 -----------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVK 408 (480)
Q Consensus 340 -----------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~ 408 (480)
+++.+...++.||+.||.|||+. +|+||||||+|||++++ +.++|+|||+++....... ...
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~-~~~kL~DfGla~~~~~~~~---~~~ 270 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDG-RVAKICDFGLARDIMNDSN---YVV 270 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCC-CeEEEeeceeeeeccCCcc---eee
Confidence 45667789999999999999999 99999999999999988 6899999999865432111 111
Q ss_pred ccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCccc
Q 011660 409 PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKAN 458 (480)
Q Consensus 409 ~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~~~ 458 (480)
.....+++.|||||++.+..++.++|||||||++|||++ |+.||......
T Consensus 271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~ 321 (374)
T cd05106 271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN 321 (374)
T ss_pred ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc
Confidence 122345678999999999999999999999999999997 99999876543
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=287.80 Aligned_cols=192 Identities=25% Similarity=0.398 Sum_probs=158.7
Q ss_pred eeecccCceEEEEEEec---CCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEEEe--cCCeeEEEEeccCCC
Q 011660 258 MLIGQGGNSKVYRTNHV---DGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCH--SKEMYAIVYNLLNGS 332 (480)
Q Consensus 258 ~~LG~G~fg~Vy~~~~~---~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~--~~~~~~lV~e~~~Gs 332 (480)
..||+|+||.||+|... +++.+|+|.++... ....+.+|+++++.++||||+++++++. .+..+++++||+.++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~ 85 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHD 85 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC-CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCCc
Confidence 57999999999999764 35789999987544 2346789999999999999999999884 456789999999999
Q ss_pred HHHHHH------------hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEe----cCCCceEEeeeccccc
Q 011660 333 LKQYLK------------QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLS----ENFHHPQLSDFGAAMV 396 (480)
Q Consensus 333 L~~~l~------------~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~----~~~~~~kL~DFGla~~ 396 (480)
|.+++. .+++..+..++.|++.||.|||+. +|+||||||+|||+. .+ +.+||+|||+++.
T Consensus 86 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~-~~~kl~DfG~a~~ 161 (317)
T cd07867 86 LWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPER-GRVKIADMGFARL 161 (317)
T ss_pred HHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCC-CcEEEeeccceec
Confidence 988873 266777889999999999999999 999999999999993 34 6899999999976
Q ss_pred cccccccccCccccccccCCCccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 397 HHQSHQVSENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 397 ~~~~~~~~~~~~~~~~~GT~~y~APE~~~~-~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
...... .........||+.|+|||++.+ ..++.++|||||||++|||+||++||....
T Consensus 162 ~~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 162 FNSPLK--PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred cCCCcc--cccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 443211 1112234578999999999876 457999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=280.52 Aligned_cols=197 Identities=25% Similarity=0.415 Sum_probs=171.1
Q ss_pred cCCCCceeecccCceEEEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc-C
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-N 330 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~-~ 330 (480)
++|++.+.||+|+||.||++...++..+|+|.++.......++..|+.+++.++||||+++++++.+++..+++|||+ +
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN 83 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence 458888999999999999998878889999998876666778999999999999999999999999999999999999 6
Q ss_pred CCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccC
Q 011660 331 GSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSEN 406 (480)
Q Consensus 331 GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~ 406 (480)
|+|.+++.. +++..+..++.|++.||.|||+. +|+||||||+||+++.+ +.++|+|||+++........
T Consensus 84 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~-~~~kl~d~g~~~~~~~~~~~--- 156 (256)
T cd05114 84 GCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSST-GVVKVSDFGMTRYVLDDEYT--- 156 (256)
T ss_pred CcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCC-CeEEECCCCCccccCCCcee---
Confidence 899998853 67888999999999999999999 99999999999999988 68999999998654321111
Q ss_pred ccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 407 VKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 407 ~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
......++..|+|||.+.+..++.++|+||||+++|||++ |+.||...+
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~ 206 (256)
T cd05114 157 -SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS 206 (256)
T ss_pred -ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence 1122345678999999998899999999999999999999 999997654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=286.53 Aligned_cols=197 Identities=25% Similarity=0.454 Sum_probs=168.0
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCC--ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEec
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN--WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~ 328 (480)
++|.+.+.||+|+||.||+|.. .+++.+|+|.++... .....+.+|+.+++.++||||+++++++.+++.+++|+||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 4689999999999999999976 468899999986543 2334678899999999999999999999999999999999
Q ss_pred cCCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccc
Q 011660 329 LNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (480)
Q Consensus 329 ~~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (480)
+.++|.+++.. +.+..+..++.|+++||.|||+. +|+|+||||+||+++.+ +.++|+|||++.......
T Consensus 86 ~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~-~~~kl~dfg~~~~~~~~~--- 158 (301)
T cd07873 86 LDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINER-GELKLADFGLARAKSIPT--- 158 (301)
T ss_pred cccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCC-CcEEECcCcchhccCCCC---
Confidence 99999998853 67788889999999999999999 99999999999999998 689999999986432211
Q ss_pred cCccccccccCCCccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 405 ENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 405 ~~~~~~~~~GT~~y~APE~~~~~-~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
.......+++.|+|||.+.+. .++.++|||||||++|||++|++||...+.
T Consensus 159 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~ 210 (301)
T cd07873 159 --KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV 210 (301)
T ss_pred --CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 112234678999999988754 578999999999999999999999987653
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=308.76 Aligned_cols=201 Identities=30% Similarity=0.372 Sum_probs=169.3
Q ss_pred hhhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCccH---HHHHHHHHHHhcCCCCCeeeEEEEEecCC----
Q 011660 249 HLTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSE---EEVLREVELLSSIKHENIVRIIGYCHSKE---- 320 (480)
Q Consensus 249 ~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~~---~~~~~Ei~il~~l~HpnIv~l~~~~~~~~---- 320 (480)
...++|.+.+.||+|+||.||++.. .+++.||+|++....... ..+.+|+.++..++|+||+++++.+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 3457899999999999999999965 569999999997654332 35678999999999999999988764322
Q ss_pred ----eeEEEEecc-CCCHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEE
Q 011660 321 ----MYAIVYNLL-NGSLKQYLKQ-------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQL 388 (480)
Q Consensus 321 ----~~~lV~e~~-~GsL~~~l~~-------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL 388 (480)
.+++||||+ +|+|.+++.. +.+.++..++.|++.||.|||+. +|+||||||+|||++.+ +.+||
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~-~~vkL 184 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSN-GLVKL 184 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCC-CCEEE
Confidence 468999999 6899998843 67788889999999999999999 99999999999999998 68999
Q ss_pred eeeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 389 SDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 389 ~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
+|||+++...... ........+||+.|+|||++.+..++.++|||||||+||||++|+.||...+
T Consensus 185 ~DFGls~~~~~~~---~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~ 249 (496)
T PTZ00283 185 GDFGFSKMYAATV---SDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN 249 (496)
T ss_pred EecccCeeccccc---cccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 9999987543321 1122335689999999999999999999999999999999999999997654
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=286.88 Aligned_cols=188 Identities=22% Similarity=0.346 Sum_probs=161.3
Q ss_pred ceeecccCceEEEEEEecCCcEEEEEEeccCCccH----HHHHHHHHHHhcCCCCCeeeEEEEEec----CCeeEEEEec
Q 011660 257 KMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSE----EEVLREVELLSSIKHENIVRIIGYCHS----KEMYAIVYNL 328 (480)
Q Consensus 257 ~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~----~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~~lV~e~ 328 (480)
...||+|++|.||+|.. +|+.||+|.++...... +.+.+|+.+|++++||||+++++++.+ ...++++|||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 36799999999999987 78999999997654433 456799999999999999999999866 3578899999
Q ss_pred c-CCCHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccc
Q 011660 329 L-NGSLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (480)
Q Consensus 329 ~-~GsL~~~l~---~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (480)
+ +|+|.+++. .+++.....++.+++.||.|||+.. +++||||||+|||++.+ +.+||+|||+++.....
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~-~~~kl~dfg~~~~~~~~---- 176 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTEN-YKLKIICHGLEKILSSP---- 176 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCC-CcEEEcccchHhhhccc----
Confidence 9 678999995 3788888999999999999999732 78899999999999998 68999999998643221
Q ss_pred cCccccccccCCCccccccccC--CCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 405 ENVKPVNVVGTFGYLAPEYMMY--GKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 405 ~~~~~~~~~GT~~y~APE~~~~--~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+
T Consensus 177 ----~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~ 226 (283)
T PHA02988 177 ----PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT 226 (283)
T ss_pred ----cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC
Confidence 123468999999999876 689999999999999999999999998664
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=298.60 Aligned_cols=198 Identities=27% Similarity=0.409 Sum_probs=165.3
Q ss_pred cCCCCceeecccCceEEEEEEe------cCCcEEEEEEeccCCc--cHHHHHHHHHHHhcC-CCCCeeeEEEEEecCCee
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH------VDGQVAAVKVLKCTNW--SEEEVLREVELLSSI-KHENIVRIIGYCHSKEMY 322 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~------~~g~~vAvK~~~~~~~--~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 322 (480)
++|++.+.||+|+||.||+|.. .++..+|+|+++.... ..+.+.+|+.+++.+ +||||++++++|.+.+..
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~ 114 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT 114 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence 4688899999999999999853 2356899999975432 234678999999999 899999999999999999
Q ss_pred EEEEecc-CCCHHHHHHh--------------------------------------------------------------
Q 011660 323 AIVYNLL-NGSLKQYLKQ-------------------------------------------------------------- 339 (480)
Q Consensus 323 ~lV~e~~-~GsL~~~l~~-------------------------------------------------------------- 339 (480)
++||||+ +|+|.+++..
T Consensus 115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (375)
T cd05104 115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY 194 (375)
T ss_pred eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence 9999999 7899888842
Q ss_pred ----------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccc
Q 011660 340 ----------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (480)
Q Consensus 340 ----------------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (480)
+++..+..++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||+++........
T Consensus 195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~-~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHG-RITKICDFGLARDIRNDSNY 270 (375)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECC-CcEEEecCccceeccCcccc
Confidence 45667788999999999999998 99999999999999988 68999999999754332111
Q ss_pred ccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 404 SENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 404 ~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
.......++..|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus 271 ---~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~ 321 (375)
T cd05104 271 ---VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMP 321 (375)
T ss_pred ---cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCC
Confidence 11122345678999999999999999999999999999998 899997654
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=294.87 Aligned_cols=196 Identities=27% Similarity=0.406 Sum_probs=167.6
Q ss_pred hhhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc---cHHHHHHHHHHHhcCCCCCeeeEEEEEecC-----
Q 011660 249 HLTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVRIIGYCHSK----- 319 (480)
Q Consensus 249 ~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~----- 319 (480)
.+.++|.+.+.||+|+||.||++.. .+++.||+|.+..... ....+.+|+++++.++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 3457899999999999999999976 5688999999875432 234577899999999999999999987533
Q ss_pred -CeeEEEEeccCCCHHHHHH--hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccc
Q 011660 320 -EMYAIVYNLLNGSLKQYLK--QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMV 396 (480)
Q Consensus 320 -~~~~lV~e~~~GsL~~~l~--~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~ 396 (480)
..+++++++++++|.++++ .+++..+..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||++..
T Consensus 92 ~~~~~~~~~~~~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~-~~~kl~Dfg~~~~ 167 (343)
T cd07878 92 FNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNED-CELRILDFGLARQ 167 (343)
T ss_pred cCcEEEEeecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCC-CCEEEcCCcccee
Confidence 4578999999999998885 488899999999999999999999 99999999999999998 6899999999864
Q ss_pred cccccccccCccccccccCCCccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 397 HHQSHQVSENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 397 ~~~~~~~~~~~~~~~~~GT~~y~APE~~~~-~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+
T Consensus 168 ~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 220 (343)
T cd07878 168 ADD--------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGND 220 (343)
T ss_pred cCC--------CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCC
Confidence 322 1234578999999999876 568999999999999999999999997654
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=280.63 Aligned_cols=187 Identities=26% Similarity=0.399 Sum_probs=160.4
Q ss_pred ecccCceEEEEEEe-cCCcEEEEEEeccCCc----cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc-CCCH
Q 011660 260 IGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGSL 333 (480)
Q Consensus 260 LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~----~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~-~GsL 333 (480)
||+|+||.||++.. .+|+.+|+|.+..... ....+..|+++++.++||||+++++++.++..+++||||+ +|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999976 5689999999864321 2234567999999999999999999999999999999999 6789
Q ss_pred HHHHH-----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccCcc
Q 011660 334 KQYLK-----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVK 408 (480)
Q Consensus 334 ~~~l~-----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~ 408 (480)
.+++. .+.+..+..++.|++.||.|||+. +|+||||||+||+++.+ +.++|+|||++...... ..
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~-~~~~l~Dfg~~~~~~~~------~~ 150 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQ-GNCRLSDLGLAVELKDG------KT 150 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCC-CCEEEeeceeeeecCCC------ce
Confidence 88773 367788888999999999999999 99999999999999998 68999999998654321 11
Q ss_pred ccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 409 PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 409 ~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 151 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~ 198 (277)
T cd05607 151 ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHK 198 (277)
T ss_pred eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCc
Confidence 224568999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=320.94 Aligned_cols=205 Identities=29% Similarity=0.468 Sum_probs=172.8
Q ss_pred cCCCCceeecccCceEEEEEEecC--Cc----EEEEEEeccCC--ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHVD--GQ----VAAVKVLKCTN--WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYA 323 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~~--g~----~vAvK~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 323 (480)
.+.+..+.||+|+||.||.|...+ |. .||+|.+++.. ....+|.+|..+|+.++||||++++|+|.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 345566789999999999997643 43 48999997653 44567999999999999999999999999999999
Q ss_pred EEEecc-CCCHHHHHHh----------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeec
Q 011660 324 IVYNLL-NGSLKQYLKQ----------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFG 392 (480)
Q Consensus 324 lV~e~~-~GsL~~~l~~----------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFG 392 (480)
|++||| +|||..||+. +...+.+.++.|||+|+.||+++ ++|||||..+|+||+.. ..+||+|||
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~-r~VKIaDFG 847 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDER-RVVKIADFG 847 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeeccc-CcEEEcccc
Confidence 999999 7999999964 56788899999999999999999 99999999999999999 689999999
Q ss_pred cccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCcccchhHHH
Q 011660 393 AAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVL 464 (480)
Q Consensus 393 la~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~~~~e~l~~ 464 (480)
||+.+...++...... -.-...|||||.++.+.++.|+|||||||+|||++| |..||.+.+ +.+.+.+
T Consensus 848 lArDiy~~~yyr~~~~---a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~-n~~v~~~ 916 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGE---AMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRS-NFEVLLD 916 (1025)
T ss_pred hhHhhhhchheeccCc---cccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcc-hHHHHHH
Confidence 9997666554443332 223468999999999999999999999999999999 788887665 4454433
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=279.45 Aligned_cols=197 Identities=26% Similarity=0.428 Sum_probs=171.3
Q ss_pred cCCCCceeecccCceEEEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc-C
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-N 330 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~-~ 330 (480)
++|++.+.||+|+||.||+|...++..+|+|.+.......+.+.+|+.+++.++||||+++++++.+.+..+++|||+ +
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAK 85 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCC
Confidence 468999999999999999998878889999998766656678899999999999999999999999999999999998 6
Q ss_pred CCHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccccc
Q 011660 331 GSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE 405 (480)
Q Consensus 331 GsL~~~l~~-----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~ 405 (480)
|+|.+++.. +++..+..++.|++.||.|||+. +++||||||+||+++.+ +.++|+|||++........
T Consensus 86 ~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~-~~~~l~dfg~~~~~~~~~~--- 158 (261)
T cd05072 86 GSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSES-LMCKIADFGLARVIEDNEY--- 158 (261)
T ss_pred CcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCC-CcEEECCCccceecCCCce---
Confidence 899999853 57788889999999999999998 99999999999999998 6899999999976433211
Q ss_pred CccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 406 NVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 406 ~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
.......++..|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus 159 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~ 209 (261)
T cd05072 159 -TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS 209 (261)
T ss_pred -eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCC
Confidence 11123346778999999998999999999999999999998 999997654
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=315.37 Aligned_cols=201 Identities=26% Similarity=0.411 Sum_probs=168.4
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc----cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~----~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 326 (480)
.+|++.+.||+|+||.||+|.. .+++.||+|+++.... ..+.+.+|+++++.++||||+++++++.+++..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 4689999999999999999976 4589999999975432 2346889999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHh--------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeee
Q 011660 327 NLL-NGSLKQYLKQ--------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDF 391 (480)
Q Consensus 327 e~~-~GsL~~~l~~--------------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DF 391 (480)
||+ +|+|.+++.. ..+.....++.||++||.|||+. +|+||||||+|||++.+ +.++|+||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~d-g~vKLiDF 157 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLF-GEVVILDW 157 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCC-CCEEEEec
Confidence 999 6789988853 23456678999999999999999 99999999999999988 78999999
Q ss_pred cccccccccccc-------------ccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 392 GAAMVHHQSHQV-------------SENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 392 Gla~~~~~~~~~-------------~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
|+++........ .........+||+.|||||++.+..++.++|||||||++|||+||+.||....
T Consensus 158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~ 235 (932)
T PRK13184 158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKK 235 (932)
T ss_pred CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcc
Confidence 999765211100 00111224579999999999999999999999999999999999999997643
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=279.69 Aligned_cols=197 Identities=21% Similarity=0.345 Sum_probs=165.3
Q ss_pred cCCCCceeecccCceEEEEEEec----CCcEEEEEEeccCCcc--HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHV----DGQVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~----~g~~vAvK~~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 325 (480)
++|++.+.||+|+||.||+|.+. .+..+|+|.++..... ...+.+|+.+++.++||||+++++++..++..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 46899999999999999999642 3568999999765322 34688999999999999999999999999999999
Q ss_pred Eecc-CCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccc
Q 011660 326 YNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (480)
Q Consensus 326 ~e~~-~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (480)
|||+ +|+|.+++.. +++..+..++.|++.||.|||+. +++||||||+|||++.+ +.++++|||.+......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~-~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 85 TEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSD-LVCKISGFRRLQEDKSE 160 (266)
T ss_pred EEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCC-CcEEECCCccccccccc
Confidence 9999 6789998853 68889999999999999999999 99999999999999998 68999999987542211
Q ss_pred cccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 401 ~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
. ........++..|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus 161 ~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~ 213 (266)
T cd05064 161 A----IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMS 213 (266)
T ss_pred c----hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCC
Confidence 1 011112345678999999999999999999999999999775 999997654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=279.44 Aligned_cols=195 Identities=24% Similarity=0.396 Sum_probs=166.6
Q ss_pred CCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc---cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEec
Q 011660 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~ 328 (480)
+|++.+.||+|+||.||+|.. .+++.+|+|.++.... ..+.+.+|+.+++.++||||+++++++.+++.+++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 478889999999999999976 4689999999865432 235678999999999999999999999999999999999
Q ss_pred cCCCHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccc
Q 011660 329 LNGSLKQYLK------QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 329 ~~GsL~~~l~------~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (480)
+.++|.+++. .+++..+..++.|++.||.|||+. +|+|+||||+||+++.+ +.++|+|||++......
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~-- 154 (285)
T cd07861 81 LSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNK-GVIKLADFGLARAFGIP-- 154 (285)
T ss_pred CCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCC-CcEEECcccceeecCCC--
Confidence 9999998884 367888889999999999999998 99999999999999998 78999999998643221
Q ss_pred cccCccccccccCCCccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 403 VSENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 403 ~~~~~~~~~~~GT~~y~APE~~~~~-~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
........+++.|+|||++.+. .++.++|||||||++|||+||++||....
T Consensus 155 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~ 206 (285)
T cd07861 155 ---VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDS 206 (285)
T ss_pred ---cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 1112234678999999988754 57899999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=282.21 Aligned_cols=193 Identities=28% Similarity=0.419 Sum_probs=166.4
Q ss_pred CCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCcc----HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEec
Q 011660 254 FSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS----EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (480)
Q Consensus 254 f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~----~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~ 328 (480)
|+..+.||+|+||.||++.. .+++.+|+|.+...... ...+..|+.+++.++|+||+++++.+.+++..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 77788999999999999966 56899999998654322 23467899999999999999999999999999999999
Q ss_pred c-CCCHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccc
Q 011660 329 L-NGSLKQYLK-----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 329 ~-~GsL~~~l~-----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (480)
+ +|+|.+++. .+.+.++..++.|++.||.|||+. +|+||||||+||+++++ +.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~-~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDH-GHIRISDLGLAVHVPEGQ- 156 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCC-CCEEEeeccceeecCCCc-
Confidence 8 678988883 377788899999999999999998 99999999999999998 689999999986533211
Q ss_pred cccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 403 ~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 157 -----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~ 205 (285)
T cd05630 157 -----TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 205 (285)
T ss_pred -----cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence 1123479999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=294.05 Aligned_cols=197 Identities=28% Similarity=0.404 Sum_probs=172.5
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc----cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEE
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~----~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 325 (480)
.+.|..-++||+|+||.||-++. .+|+.||+|.+.+... .+.-.+.|..||.+++.++||.+--.|++.+.+++|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 35688889999999999999965 5699999998854332 234467899999999999999999899999999999
Q ss_pred Eecc-CCCHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccc
Q 011660 326 YNLL-NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (480)
Q Consensus 326 ~e~~-~GsL~~~l~~-----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~ 399 (480)
+..| +|||.-+|.. +++..+..++.+|+.||++||+. +||+|||||+|||||++ |+++|+|.|||..+..
T Consensus 264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~-GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDH-GHVRISDLGLAVEIPE 339 (591)
T ss_pred EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccC-CCeEeeccceEEecCC
Confidence 9999 6789888743 77888899999999999999999 99999999999999999 8999999999976554
Q ss_pred ccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 400 SHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 400 ~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
.. .....+||.+|||||++.+..|+...|+|||||++|||+.|+.||.....
T Consensus 340 g~------~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke 391 (591)
T KOG0986|consen 340 GK------PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE 391 (591)
T ss_pred CC------ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh
Confidence 32 23345899999999999999999999999999999999999999988754
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=322.24 Aligned_cols=204 Identities=25% Similarity=0.359 Sum_probs=176.7
Q ss_pred HHHhhhhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccC----CccHHHHHHHHHHHhcCCCCCeeeEEEEEecC
Q 011660 245 QELCHLTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCT----NWSEEEVLREVELLSSIKHENIVRIIGYCHSK 319 (480)
Q Consensus 245 ~el~~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 319 (480)
.++..-.++|.+.++||+|+||.|..+++ .+++.||+|++++- ......|..|.+||..-+.+-|++|+-.|+++
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 34555668899999999999999999987 56899999999862 23345688999999999999999999999999
Q ss_pred CeeEEEEecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccc
Q 011660 320 EMYAIVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAM 395 (480)
Q Consensus 320 ~~~~lV~e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~ 395 (480)
+++|+||||+ +|||..+|.. +++..+..++..|+-||+-||+. |+|||||||+|||||.. |++||+|||-+.
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~-GHikLADFGsCl 223 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKS-GHIKLADFGSCL 223 (1317)
T ss_pred cceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEeccc-CcEeeccchhHH
Confidence 9999999999 8999999965 55777788999999999999999 99999999999999999 899999999875
Q ss_pred ccccccccccCccccccccCCCcccccccc----C-CCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 396 VHHQSHQVSENVKPVNVVGTFGYLAPEYMM----Y-GKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~-~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
... ..........+|||.|++||++. + +.|++.+|+||+||++|||+.|..||....
T Consensus 224 km~----~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads 285 (1317)
T KOG0612|consen 224 KMD----ADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS 285 (1317)
T ss_pred hcC----CCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH
Confidence 433 23344556778999999999985 3 679999999999999999999999998754
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=298.80 Aligned_cols=216 Identities=25% Similarity=0.369 Sum_probs=182.1
Q ss_pred cCCCCceeecccCceEEEEEEecC-CcEEEEEEeccCCccH----HHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSE----EEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~~-g~~vAvK~~~~~~~~~----~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 326 (480)
+-|..++-||-|+||+|.++...| ...||+|.+++.+... ..+..|.+||...+.+-||+||-.|++++.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 446777889999999999997654 6789999998765433 34678999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccc---ccccc
Q 011660 327 NLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA---MVHHQ 399 (480)
Q Consensus 327 e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla---~~~~~ 399 (480)
+|+ +|++..+|-+ |.+..+..++.++.+|+++.|.. |+|||||||+|||||.| |++||+||||+ +|.++
T Consensus 709 dYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrd-GHIKLTDFGLCTGfRWTHd 784 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHD 784 (1034)
T ss_pred eccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccC-Cceeeeeccccccceeccc
Confidence 999 8898888754 67777788999999999999999 99999999999999999 89999999998 44443
Q ss_pred ccccccC----------------------------------ccccccccCCCccccccccCCCCCchHHHHHHHHHHHHH
Q 011660 400 SHQVSEN----------------------------------VKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLEL 445 (480)
Q Consensus 400 ~~~~~~~----------------------------------~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eL 445 (480)
+.+...+ ...-..+||+.|+|||++....|+.-+|+||.|||||||
T Consensus 785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em 864 (1034)
T KOG0608|consen 785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEM 864 (1034)
T ss_pred cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHH
Confidence 3322110 011136899999999999999999999999999999999
Q ss_pred HcCCCCCCCCcc--cchhHHHHHHHHhC
Q 011660 446 ITGKEAIQTNKA--NRESLVLWYYVLAG 471 (480)
Q Consensus 446 ltG~~pf~~~~~--~~e~l~~~~~~~~~ 471 (480)
+.|++||-...+ .|-.++-|.+.|.-
T Consensus 865 ~~g~~pf~~~tp~~tq~kv~nw~~~l~~ 892 (1034)
T KOG0608|consen 865 LVGQPPFLADTPGETQYKVINWRNFLHI 892 (1034)
T ss_pred hhCCCCccCCCCCcceeeeeehhhcccc
Confidence 999999988876 46678889887653
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=271.56 Aligned_cols=201 Identities=29% Similarity=0.413 Sum_probs=168.2
Q ss_pred CCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCccH--HHHHHHHHHHhcCC-CCCeeeEEEEEecCCeeEEEEecc
Q 011660 254 FSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSE--EEVLREVELLSSIK-HENIVRIIGYCHSKEMYAIVYNLL 329 (480)
Q Consensus 254 f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~~--~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~e~~ 329 (480)
.+.+..||.|+.|.|+++.+ .+|...|||.+.+....+ +.+++.++++...+ .|+||+.+|||..+...++.||.+
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM 173 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM 173 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence 44455699999999999977 458999999998765443 46778888877665 899999999999999999999998
Q ss_pred CCCHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccccc
Q 011660 330 NGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE 405 (480)
Q Consensus 330 ~GsL~~~l~----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~ 405 (480)
..-++.+++ .+++.-.-++...+..||.||.++| +|||||+||+|||+|+. |++||||||++-.+ ..
T Consensus 174 s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~-GniKlCDFGIsGrl------vd 244 (391)
T KOG0983|consen 174 STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDER-GNIKLCDFGISGRL------VD 244 (391)
T ss_pred HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccC-CCEEeeccccccee------ec
Confidence 766666653 3667777789999999999999886 99999999999999998 89999999998443 23
Q ss_pred CccccccccCCCcccccccc---CCCCCchHHHHHHHHHHHHHHcCCCCCCCCcccchhHH
Q 011660 406 NVKPVNVVGTFGYLAPEYMM---YGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLV 463 (480)
Q Consensus 406 ~~~~~~~~GT~~y~APE~~~---~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~~~e~l~ 463 (480)
....+..+|.+.|||||.+. ...|+.++||||||+.|+||.||+.||..++.+.+.+-
T Consensus 245 SkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~lt 305 (391)
T KOG0983|consen 245 SKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLT 305 (391)
T ss_pred ccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHH
Confidence 33445668999999999986 45799999999999999999999999999888777553
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=276.68 Aligned_cols=198 Identities=28% Similarity=0.440 Sum_probs=171.8
Q ss_pred hcCCCCceeecccCceEEEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc-
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL- 329 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~- 329 (480)
.++|++.+.||+|+||.||+|...+++.+|+|.++......+++.+|+.++++++||||+++++++...+..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMK 84 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeeccc
Confidence 4568999999999999999998777889999999876666778999999999999999999999999999999999999
Q ss_pred CCCHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccc
Q 011660 330 NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (480)
Q Consensus 330 ~GsL~~~l~~-----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (480)
+++|.+++.. +++.+...++.|++.||.|||+. +|+||||||+||+++++ +.++|+|||++.........
T Consensus 85 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~-~~~~l~dfg~~~~~~~~~~~- 159 (261)
T cd05068 85 YGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGEN-NICKVADFGLARVIKEDIYE- 159 (261)
T ss_pred CCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCC-CCEEECCcceEEEccCCccc-
Confidence 7899999853 67889999999999999999999 99999999999999998 68999999998765421111
Q ss_pred cCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 405 ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 405 ~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
......++..|+|||++.+..++.++|+||||+++|||++ |+.||.+..
T Consensus 160 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 209 (261)
T cd05068 160 ---AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT 209 (261)
T ss_pred ---ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 1111223467999999999999999999999999999999 999997654
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=302.61 Aligned_cols=197 Identities=31% Similarity=0.455 Sum_probs=164.8
Q ss_pred cCCCCceeecccCceEEEEEEec--CC--cE-EEEEEeccCC----ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCee
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHV--DG--QV-AAVKVLKCTN----WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMY 322 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~--~g--~~-vAvK~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 322 (480)
++-...+.||+|+||.||+|... ++ .. ||+|..+.+. ....++++|.++|+.++||||+++||++.....+
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 34455689999999999999653 23 23 8999988532 2235789999999999999999999999999999
Q ss_pred EEEEecc-CCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccc
Q 011660 323 AIVYNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVH 397 (480)
Q Consensus 323 ~lV~e~~-~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~ 397 (480)
++|||++ +|+|.+||+. ++..++..++.+.|+||+|||++ ++|||||..+|+|++.+ +.+||+||||++..
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~-~~vKISDFGLs~~~ 312 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKK-GVVKISDFGLSRAG 312 (474)
T ss_pred EEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCC-CeEEeCccccccCC
Confidence 9999999 7899999976 66899999999999999999999 99999999999999998 56899999998653
Q ss_pred ccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCcc
Q 011660 398 HQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKA 457 (480)
Q Consensus 398 ~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~~ 457 (480)
.. ..... ..-.-...|+|||.+..+.|++++|||||||++||+++ |..||.+.+.
T Consensus 313 ~~---~~~~~--~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~ 368 (474)
T KOG0194|consen 313 SQ---YVMKK--FLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN 368 (474)
T ss_pred cc---eeecc--ccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH
Confidence 21 11100 01123568999999999999999999999999999999 8999998764
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=280.55 Aligned_cols=193 Identities=26% Similarity=0.397 Sum_probs=166.3
Q ss_pred CCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCcc----HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEec
Q 011660 254 FSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS----EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (480)
Q Consensus 254 f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~----~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~ 328 (480)
|+..+.||+|+||+||++.. .+++.+|+|.+...... ...+.+|+++++.++|+||+++++++..++..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 66778999999999999966 56899999998654322 23467899999999999999999999999999999999
Q ss_pred c-CCCHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccc
Q 011660 329 L-NGSLKQYLK-----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 329 ~-~GsL~~~l~-----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (480)
+ +|+|.+++. .+++.....++.|++.||.|||+. +|+||||||+||+++++ +.++|+|||++......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~-~~~kl~Dfg~~~~~~~~-- 155 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDY-GHIRISDLGLAVKIPEG-- 155 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCC-CCEEEecCCcceecCCC--
Confidence 9 578988873 377889999999999999999999 99999999999999988 68999999998653221
Q ss_pred cccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 403 ~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.......||+.|+|||++.+..++.++|+|||||++|||++|..||....
T Consensus 156 ----~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~ 205 (285)
T cd05632 156 ----ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRK 205 (285)
T ss_pred ----CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 11224579999999999999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=280.42 Aligned_cols=192 Identities=27% Similarity=0.439 Sum_probs=166.2
Q ss_pred CCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc--cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc
Q 011660 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~ 329 (480)
+|++.+.||+|+||.||+|.. .+++.+|+|++..... ....+.+|++++++++||||+++++++...+..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 578889999999999999965 5688999999865432 2356889999999999999999999999999999999999
Q ss_pred -CCCHHHHHHhCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccCcc
Q 011660 330 -NGSLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVK 408 (480)
Q Consensus 330 -~GsL~~~l~~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~ 408 (480)
+|+|..+ ..+++.....++.|++.||.|||+. +|+|+||||+|||++.+ +.++|+|||++..... ..
T Consensus 82 ~~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~-~~~~l~dfg~~~~~~~-------~~ 149 (279)
T cd06619 82 DGGSLDVY-RKIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTR-GQVKLCDFGVSTQLVN-------SI 149 (279)
T ss_pred CCCChHHh-hcCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCC-CCEEEeeCCcceeccc-------cc
Confidence 4566544 5678888899999999999999999 99999999999999998 7899999999864322 12
Q ss_pred ccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 409 PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 409 ~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.....||+.|+|||++.+..++.++|+|||||++|||++|+.||....
T Consensus 150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~ 197 (279)
T cd06619 150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQ 197 (279)
T ss_pred ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhc
Confidence 234579999999999999999999999999999999999999997643
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=304.75 Aligned_cols=195 Identities=31% Similarity=0.448 Sum_probs=166.7
Q ss_pred CCCceeecccCceEEEEEEe-cCCcEEEEEEeccCC--ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCC------eeEE
Q 011660 254 FSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN--WSEEEVLREVELLSSIKHENIVRIIGYCHSKE------MYAI 324 (480)
Q Consensus 254 f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------~~~l 324 (480)
|.....||+|+||.||+|++ .+|+.+|||.++... ...+.-.+|+++|++|+|||||+++++-++.. .-.+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 44456799999999999974 679999999998643 33456789999999999999999999876543 5678
Q ss_pred EEecc-CCCHHHHHHh------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecC---CCceEEeeeccc
Q 011660 325 VYNLL-NGSLKQYLKQ------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN---FHHPQLSDFGAA 394 (480)
Q Consensus 325 V~e~~-~GsL~~~l~~------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~---~~~~kL~DFGla 394 (480)
+|||| +|||...|.+ +++.+.+.+..+++.||.|||++ +||||||||.||++-.. ...-||+|||+|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 99999 7899999964 88999999999999999999999 99999999999998432 124589999999
Q ss_pred cccccccccccCccccccccCCCcccccccc-CCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 395 MVHHQSHQVSENVKPVNVVGTFGYLAPEYMM-YGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
+...+ +.....++||+.|+|||.+. .+.|+..+|.|||||++||..||..||.....
T Consensus 172 rel~d------~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~ 229 (732)
T KOG4250|consen 172 RELDD------NSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGG 229 (732)
T ss_pred ccCCC------CCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCC
Confidence 86443 34567889999999999988 48899999999999999999999999987764
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=258.14 Aligned_cols=216 Identities=26% Similarity=0.457 Sum_probs=180.0
Q ss_pred CCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCcc---HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEec
Q 011660 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~ 328 (480)
+|...+.||+|+||+||+++. .++..||+|.++.++.+ .....+|+.+|+.++|+||++++++...+..+-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 456667899999999999965 56889999999866543 35689999999999999999999999999999999999
Q ss_pred cCCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccc
Q 011660 329 LNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (480)
Q Consensus 329 ~~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (480)
|..+|..|... ++.+....++.|+++||.|+|++ ++.|||+||.|+|++.+ |++||+|||+|+-..-.-.
T Consensus 83 cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~n-gelkladfglarafgipvr-- 156 (292)
T KOG0662|consen 83 CDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRN-GELKLADFGLARAFGIPVR-- 156 (292)
T ss_pred hhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccC-CcEEecccchhhhcCCceE--
Confidence 99999999865 66777888999999999999999 99999999999999999 8999999999975432110
Q ss_pred cCccccccccCCCccccccccCCC-CCchHHHHHHHHHHHHHHc-CCCCCCCCcccchhHHHHHHHHhCCCCCCCCC
Q 011660 405 ENVKPVNVVGTFGYLAPEYMMYGK-VDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWYYVLAGKVFAQQWP 479 (480)
Q Consensus 405 ~~~~~~~~~GT~~y~APE~~~~~~-~~~k~DvwSlGvil~eLlt-G~~pf~~~~~~~e~l~~~~~~~~~~~~~~~~~ 479 (480)
.....+-|.+|.+|.++.+.+ |+...|+||-|||+.|+.. |++.|.+++-. +.+ +-.+-+.|.++.++||
T Consensus 157 ---cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvd-dql-krif~~lg~p~ed~wp 228 (292)
T KOG0662|consen 157 ---CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD-DQL-KRIFRLLGTPTEDQWP 228 (292)
T ss_pred ---eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHH-HHH-HHHHHHhCCCccccCC
Confidence 112235689999999988754 7999999999999999976 66777666543 333 3355678999999999
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=295.08 Aligned_cols=199 Identities=25% Similarity=0.392 Sum_probs=165.7
Q ss_pred hcCCCCceeecccCceEEEEEEec------CCcEEEEEEeccCCc--cHHHHHHHHHHHhcCC-CCCeeeEEEEEecCCe
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHV------DGQVAAVKVLKCTNW--SEEEVLREVELLSSIK-HENIVRIIGYCHSKEM 321 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~~~~~~~--~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~ 321 (480)
.++|.+.+.||+|+||.||+|... .+..||+|+++.... ..+.+.+|+++++++. ||||++++++|.+.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 457889999999999999999642 134799999975432 2356889999999996 9999999999999999
Q ss_pred eEEEEecc-CCCHHHHHHh-------------------------------------------------------------
Q 011660 322 YAIVYNLL-NGSLKQYLKQ------------------------------------------------------------- 339 (480)
Q Consensus 322 ~~lV~e~~-~GsL~~~l~~------------------------------------------------------------- 339 (480)
.++||||+ +|+|.+++.+
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 99999999 7899888742
Q ss_pred --------------------------------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEec
Q 011660 340 --------------------------------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSE 381 (480)
Q Consensus 340 --------------------------------------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~ 381 (480)
+.+.++..++.|++.||.|||+. +|+||||||+|||++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeC
Confidence 45566778999999999999998 9999999999999999
Q ss_pred CCCceEEeeeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 382 NFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 382 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
+ +.+||+|||+++...... .........+++.|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus 273 ~-~~~kL~DfGla~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~ 344 (400)
T cd05105 273 G-KIVKICDFGLARDIMHDS---NYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMI 344 (400)
T ss_pred C-CEEEEEeCCcceeccccc---cccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccc
Confidence 8 689999999987543211 1112234457889999999999999999999999999999997 999997654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=276.53 Aligned_cols=197 Identities=24% Similarity=0.430 Sum_probs=170.4
Q ss_pred cCCCCceeecccCceEEEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc-C
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-N 330 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~-~ 330 (480)
++|.+.+.||+|+||.||++...++..+|+|.++......+.+.+|+.+++.++||||+++++++.+.+.++++|||+ +
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 358888999999999999998777778999999876666778999999999999999999999999888999999999 6
Q ss_pred CCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccC
Q 011660 331 GSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSEN 406 (480)
Q Consensus 331 GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~ 406 (480)
|+|.+++.. +.+..+..++.|++.||.|||+. +++|+||||+||+++.+ +.+||+|||+++.......
T Consensus 84 ~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~-~~~kl~d~g~~~~~~~~~~---- 155 (256)
T cd05113 84 GCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQ-GCVKVSDFGLSRYVLDDEY---- 155 (256)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCC-CCEEECCCccceecCCCce----
Confidence 789999853 68888999999999999999999 99999999999999988 6899999999865432211
Q ss_pred ccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 407 VKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 407 ~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
.......++..|+|||.+.+..++.++|||||||++|||++ |+.||...+
T Consensus 156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~ 206 (256)
T cd05113 156 TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFN 206 (256)
T ss_pred eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCC
Confidence 11112345678999999998899999999999999999999 999997654
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=300.56 Aligned_cols=192 Identities=24% Similarity=0.336 Sum_probs=165.6
Q ss_pred hcCCCCceeecccCceEEEEEEec-CCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~ 329 (480)
...|.+.+.||+|+||.||++.+. .++.||+|... ...+.+|+++|++++||||+++++++..++..+++|+++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-----~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~ 242 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-----YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY 242 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-----ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence 457999999999999999999774 58899999643 234678999999999999999999999999999999999
Q ss_pred CCCHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccccc
Q 011660 330 NGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE 405 (480)
Q Consensus 330 ~GsL~~~l~----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~ 405 (480)
.++|.+++. .+.+.++..++.|++.||.|||+. +||||||||+|||++.+ +.++|+|||+++...... .
T Consensus 243 ~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~-~~vkL~DFGla~~~~~~~---~ 315 (461)
T PHA03211 243 RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGP-EDICLGDFGAACFARGSW---S 315 (461)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCC-CCEEEcccCCceeccccc---c
Confidence 999999884 378999999999999999999999 99999999999999988 689999999997543321 1
Q ss_pred CccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 011660 406 NVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQT 454 (480)
Q Consensus 406 ~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~ 454 (480)
.......+||+.|+|||++.+..++.++|||||||+||||++|..|+..
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~ 364 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFS 364 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCccc
Confidence 1112346799999999999999999999999999999999998876543
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=278.99 Aligned_cols=205 Identities=25% Similarity=0.406 Sum_probs=169.6
Q ss_pred HHHHhhhhcCCCCceeecccCceEEEEE-EecCCcEEEEEEeccCCc-cHHHHHHHHHHHhcC-CCCCeeeEEEEEecCC
Q 011660 244 SQELCHLTHNFSPKMLIGQGGNSKVYRT-NHVDGQVAAVKVLKCTNW-SEEEVLREVELLSSI-KHENIVRIIGYCHSKE 320 (480)
Q Consensus 244 ~~el~~~~~~f~~~~~LG~G~fg~Vy~~-~~~~g~~vAvK~~~~~~~-~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 320 (480)
++++..++++ +||+|+|+.|--+ ...+|+.||||++.+... ....+.+|++++.++ .|+||++|++||+++.
T Consensus 75 F~d~YkLt~e-----~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~ 149 (463)
T KOG0607|consen 75 FEDMYKLTSE-----LLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT 149 (463)
T ss_pred HHHHHHhHHH-----HhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence 4555555554 6999999999988 457899999999977653 346789999999999 5999999999999999
Q ss_pred eeEEEEecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCC--CceEEeeeccc
Q 011660 321 MYAIVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENF--HHPQLSDFGAA 394 (480)
Q Consensus 321 ~~~lV~e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~--~~~kL~DFGla 394 (480)
.+|+|||-+ +|.|..++++ |.+.++.++..+|+.||+|||.+ ||.||||||+|||-.+.. .-+|||||.|+
T Consensus 150 ~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLg 226 (463)
T KOG0607|consen 150 RFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLG 226 (463)
T ss_pred eEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccc
Confidence 999999999 7788888854 88999999999999999999999 999999999999986431 24799999987
Q ss_pred ccccccc--ccccCccccccccCCCcccccccc-----CCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 395 MVHHQSH--QVSENVKPVNVVGTFGYLAPEYMM-----YGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 395 ~~~~~~~--~~~~~~~~~~~~GT~~y~APE~~~-----~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.-..... .........+.+|+..|||||+.. ...|+.++|.||||||||.|++|-+||.+.-
T Consensus 227 Sg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~C 295 (463)
T KOG0607|consen 227 SGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHC 295 (463)
T ss_pred cccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCcc
Confidence 4332211 122233445789999999999763 3568999999999999999999999998874
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=276.04 Aligned_cols=197 Identities=26% Similarity=0.418 Sum_probs=169.4
Q ss_pred CCCCceeecccCceEEEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc-CC
Q 011660 253 NFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NG 331 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~-~G 331 (480)
+|++.+.||+|+||.||++...++..+|+|++........++.+|+++++.++||||+++++++.+.+..+++|||+ ++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANG 84 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCC
Confidence 58888999999999999998877788999999876666678899999999999999999999999999999999999 67
Q ss_pred CHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccCc
Q 011660 332 SLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV 407 (480)
Q Consensus 332 sL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~ 407 (480)
+|.+++.. +++.....++.|++.||.|||+. +|+||||||+||+++.+ +.+||+|||+++....... .
T Consensus 85 ~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~-~~~kl~dfg~~~~~~~~~~----~ 156 (256)
T cd05059 85 CLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGED-NVVKVSDFGLARYVLDDQY----T 156 (256)
T ss_pred CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCC-CcEEECCcccceecccccc----c
Confidence 89999853 67888899999999999999999 99999999999999998 7899999999865432111 1
Q ss_pred cccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCcc
Q 011660 408 KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKA 457 (480)
Q Consensus 408 ~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~~ 457 (480)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 207 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN 207 (256)
T ss_pred ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH
Confidence 1112234567999999999999999999999999999999 8999976543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=285.76 Aligned_cols=197 Identities=23% Similarity=0.467 Sum_probs=162.5
Q ss_pred cCCCCceeecccCceEEEEEEec-CCc----EEEEEEeccCCc--cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHV-DGQ----VAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAI 324 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~----~vAvK~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 324 (480)
.+|+..+.||+|+||.||+|.+. ++. .+|+|+++.... ..+++..|+.+++.++||||++++++|.... .++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~-~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCC-cee
Confidence 46999999999999999999753 343 489999875432 2456889999999999999999999998754 567
Q ss_pred EEecc-CCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccc
Q 011660 325 VYNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (480)
Q Consensus 325 V~e~~-~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~ 399 (480)
+++|+ +|+|.+++.. +++.....++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||+++....
T Consensus 86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~-~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTP-QHVKITDFGLAKLLGA 161 (316)
T ss_pred eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCC-CcEEEccccccccccC
Confidence 77777 7899999854 56788889999999999999999 99999999999999998 6899999999976443
Q ss_pred ccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 400 SHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 400 ~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
... ........+++.|+|||.+.+..++.++|||||||++|||++ |+.||.+..
T Consensus 162 ~~~---~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~ 216 (316)
T cd05108 162 DEK---EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 216 (316)
T ss_pred CCc---ceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence 211 111122335678999999999999999999999999999998 999998654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=289.17 Aligned_cols=194 Identities=28% Similarity=0.417 Sum_probs=173.0
Q ss_pred CCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc-CC
Q 011660 254 FSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NG 331 (480)
Q Consensus 254 f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~-~G 331 (480)
|.+...||+|+||.||++.+ .+|+.+|+|.+..+. +..++..|+.||++++.|++|++||.+.....+++||||| .|
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAG 113 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAG 113 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCC
Confidence 55666799999999999966 569999999986543 5578899999999999999999999999999999999999 69
Q ss_pred CHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccCc
Q 011660 332 SLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV 407 (480)
Q Consensus 332 sL~~~l~----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~ 407 (480)
++.+.++ .+.+.++..++...+.||+|||.. .=||||||..|||++.+ |++||+|||.|-. ....-.
T Consensus 114 SiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~-G~AKLADFGVAGQ-----LTDTMA 184 (502)
T KOG0574|consen 114 SISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTD-GIAKLADFGVAGQ-----LTDTMA 184 (502)
T ss_pred cHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEccc-chhhhhhccccch-----hhhhHH
Confidence 9999984 488899999999999999999998 88999999999999999 8999999999833 233334
Q ss_pred cccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 408 KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 408 ~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
...++.|||-|||||++..-.|+.++||||||+...||.-|++||.+..+
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHP 234 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHP 234 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccc
Confidence 55688999999999999999999999999999999999999999988765
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=279.01 Aligned_cols=197 Identities=26% Similarity=0.468 Sum_probs=167.5
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc--cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEec
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~ 328 (480)
++|+..+.||+|+||.||+|.. .+++.||+|.+..... ....+.+|+++++.++||||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 5689999999999999999976 4689999999865432 234567899999999999999999999999999999999
Q ss_pred cCCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccc
Q 011660 329 LNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (480)
Q Consensus 329 ~~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (480)
+.++|.+++.. +.+.....++.|+++||.|||+. +|+||||||+||+++.+ +.++|+|||+++.....
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~~---- 156 (291)
T cd07844 85 LDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISER-GELKLADFGLARAKSVP---- 156 (291)
T ss_pred CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCC-CCEEECccccccccCCC----
Confidence 99999998853 67788899999999999999999 99999999999999998 68999999998643211
Q ss_pred cCccccccccCCCccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 405 ENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 405 ~~~~~~~~~GT~~y~APE~~~~-~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
........+++.|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 157 -~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~ 209 (291)
T cd07844 157 -SKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTD 209 (291)
T ss_pred -CccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCcc
Confidence 111123357889999998875 4579999999999999999999999976653
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=293.20 Aligned_cols=188 Identities=26% Similarity=0.358 Sum_probs=157.2
Q ss_pred ecccCceEEEEEEe-cCCcEEEEEEeccCCc----cHHHHHHHHHHHhcC---CCCCeeeEEEEEecCCeeEEEEecc-C
Q 011660 260 IGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLREVELLSSI---KHENIVRIIGYCHSKEMYAIVYNLL-N 330 (480)
Q Consensus 260 LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~----~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~~~~~~lV~e~~-~ 330 (480)
||+|+||+||+|.. .+++.+|+|++.+... .......|..++..+ +||||+++++++.+.+.+++||||+ +
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 69999999999976 4689999999964321 122345677777655 7999999999999999999999999 6
Q ss_pred CCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccCc
Q 011660 331 GSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV 407 (480)
Q Consensus 331 GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~ 407 (480)
|+|.+++.. +++..+..++.||+.||.|||++ +|+||||||+|||++.+ +.++|+|||++..... ...
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~-~~~kl~Dfg~a~~~~~-----~~~ 151 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDAT-GHIALCDFGLSKANLT-----DNK 151 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCC-CCEEEecCCcCcCCCC-----CCC
Confidence 789888853 78888999999999999999999 99999999999999998 6899999999854222 112
Q ss_pred cccccccCCCccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 408 KPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 408 ~~~~~~GT~~y~APE~~~~~-~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.....+||+.|+|||++.+. .++.++|||||||++|||++|+.||...+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~ 201 (330)
T cd05586 152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED 201 (330)
T ss_pred CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC
Confidence 23356799999999998764 48999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=279.72 Aligned_cols=198 Identities=28% Similarity=0.476 Sum_probs=168.0
Q ss_pred cCCCCceeecccCceEEEEEEecC------CcEEEEEEeccCCcc--HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHVD------GQVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSKEMYA 323 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~~------g~~vAvK~~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 323 (480)
.+|.+.+.||+|+||.||+|...+ ++.+|+|.++..... .+.+.+|+++++.++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 458888999999999999996532 478999999765433 357889999999999999999999999999999
Q ss_pred EEEecc-CCCHHHHHHh-----------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCc
Q 011660 324 IVYNLL-NGSLKQYLKQ-----------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHH 385 (480)
Q Consensus 324 lV~e~~-~GsL~~~l~~-----------------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~ 385 (480)
++|||+ +|+|.+++.. +++.+...++.|++.||.|||+. +++||||||+||+++.+ +.
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~-~~ 160 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYD-LV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCC-Ce
Confidence 999999 7899999853 46777888999999999999999 99999999999999998 78
Q ss_pred eEEeeeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 386 PQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 386 ~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
++|+|||++........ ........+++.|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 161 ~kl~d~g~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~ 229 (280)
T cd05049 161 VKIGDFGMSRDVYTTDY---YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS 229 (280)
T ss_pred EEECCcccceecccCcc---eecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 99999999865332111 111223456789999999999999999999999999999998 999997654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=291.55 Aligned_cols=186 Identities=25% Similarity=0.391 Sum_probs=161.7
Q ss_pred cCCCCceeecccCceEEEEEEec-CCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEeccC
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLLN 330 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~ 330 (480)
.+|.+.+.||+|+||.||+|... +++.+|+|+.... ....|+.+++.++||||+++++++...+..++|++++.
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 140 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS 140 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC
Confidence 46999999999999999999764 5788999975432 24579999999999999999999999999999999999
Q ss_pred CCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccC
Q 011660 331 GSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSEN 406 (480)
Q Consensus 331 GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~ 406 (480)
|+|.+++.. +++.++..++.||+.||.|||+. +|+||||||+|||++.+ +.++|+|||+++.... .
T Consensus 141 ~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~-~~~kl~DfG~a~~~~~------~ 210 (357)
T PHA03209 141 SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDV-DQVCIGDLGAAQFPVV------A 210 (357)
T ss_pred CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCC-CCEEEecCcccccccc------C
Confidence 999998843 78899999999999999999999 99999999999999998 6899999999864221 1
Q ss_pred ccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCC
Q 011660 407 VKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAI 452 (480)
Q Consensus 407 ~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf 452 (480)
.......||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1223457999999999999999999999999999999999865554
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=279.49 Aligned_cols=199 Identities=27% Similarity=0.478 Sum_probs=166.8
Q ss_pred cCCCCceeecccCceEEEEEEecC-C-----cEEEEEEeccCCc--cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHVD-G-----QVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYA 323 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~~-g-----~~vAvK~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 323 (480)
++|++.+.||+|+||.||+|.... + +.+|+|.++.... ....+.+|+.+++.++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 368889999999999999996533 2 5799999875432 2346889999999999999999999999888999
Q ss_pred EEEecc-CCCHHHHHHh-------------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCC
Q 011660 324 IVYNLL-NGSLKQYLKQ-------------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENF 383 (480)
Q Consensus 324 lV~e~~-~GsL~~~l~~-------------------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~ 383 (480)
++|||+ +|+|.+++.. +++.+...++.|++.||.|||+. +++|+||||+||+++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~- 160 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEG- 160 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCC-
Confidence 999999 6899999843 45677889999999999999999 99999999999999998
Q ss_pred CceEEeeeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCcc
Q 011660 384 HHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKA 457 (480)
Q Consensus 384 ~~~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~~ 457 (480)
+.++|+|||++........ ........+|+.|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 161 ~~~~L~dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~ 232 (283)
T cd05048 161 LTVKISDFGLSRDIYSADY---YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN 232 (283)
T ss_pred CcEEECCCcceeecccccc---ccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 6899999999865432211 111223457889999999998999999999999999999998 9999986543
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=278.32 Aligned_cols=200 Identities=23% Similarity=0.368 Sum_probs=166.0
Q ss_pred hhcCCCCceeecccCceEEEEEEec------CCcEEEEEEeccCCc--cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCe
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNHV------DGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEM 321 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 321 (480)
.+++|++.+.||+|+||.||+|... ++..+|+|.++.... ...++.+|+.+++.++||||+++++++.++..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3567999999999999999998642 256799999865432 23457899999999999999999999999999
Q ss_pred eEEEEecc-CCCHHHHHHh-------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceE
Q 011660 322 YAIVYNLL-NGSLKQYLKQ-------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQ 387 (480)
Q Consensus 322 ~~lV~e~~-~GsL~~~l~~-------------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~k 387 (480)
.++||||+ +|+|.+++.. +.+..+..++.|++.||.|||+. +++|+||||+||+++++ +.++
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~-~~~~ 159 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED-FTVK 159 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCC-CCEE
Confidence 99999998 6899999864 24567788999999999999998 99999999999999998 6899
Q ss_pred EeeeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 388 LSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 388 L~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
|+|||+++......... ......+++.|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 160 l~dfg~~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~ 226 (277)
T cd05062 160 IGDFGMTRDIYETDYYR---KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS 226 (277)
T ss_pred ECCCCCccccCCcceee---cCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 99999986543221111 1122356788999999999999999999999999999999 788987654
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=305.25 Aligned_cols=195 Identities=22% Similarity=0.294 Sum_probs=157.0
Q ss_pred hcCCCCceeecccCceEEEEEEec--CCcEEEEE------------------EeccCCccHHHHHHHHHHHhcCCCCCee
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHV--DGQVAAVK------------------VLKCTNWSEEEVLREVELLSSIKHENIV 310 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~--~g~~vAvK------------------~~~~~~~~~~~~~~Ei~il~~l~HpnIv 310 (480)
.++|++.+.||+|+||+||++... ++...+.| .++........+.+|+.+|++++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 467999999999999999998542 22222222 1111122234578999999999999999
Q ss_pred eEEEEEecCCeeEEEEeccCCCHHHHHHh--------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecC
Q 011660 311 RIIGYCHSKEMYAIVYNLLNGSLKQYLKQ--------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN 382 (480)
Q Consensus 311 ~l~~~~~~~~~~~lV~e~~~GsL~~~l~~--------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~ 382 (480)
++++++.+.+..+++++++.++|.+++.. ....+...++.|++.||.|||++ +||||||||+|||++.+
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~~~ 303 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCD 303 (501)
T ss_pred cEeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCC
Confidence 99999999999999999999999888743 12345677999999999999999 99999999999999998
Q ss_pred CCceEEeeeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCC
Q 011660 383 FHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQ 453 (480)
Q Consensus 383 ~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~ 453 (480)
+.+||+|||+++...... .......+||+.|+|||++.+..++.++|||||||+||||++|..++.
T Consensus 304 -~~vkL~DFGla~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~ 369 (501)
T PHA03210 304 -GKIVLGDFGTAMPFEKER----EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPI 369 (501)
T ss_pred -CCEEEEeCCCceecCccc----ccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCc
Confidence 789999999997643321 112234679999999999999999999999999999999999986543
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=279.05 Aligned_cols=198 Identities=26% Similarity=0.446 Sum_probs=166.2
Q ss_pred cCCCCceeecccCceEEEEEEe-----cCCcEEEEEEeccCCcc--HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-----VDGQVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAI 324 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-----~~g~~vAvK~~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 324 (480)
++|++.+.||+|+||.||+|.. .+++.+|+|.++..... ...+.+|+++++.++||||+++++++..++..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4688889999999999999963 24678999999754332 2468899999999999999999999999999999
Q ss_pred EEecc-CCCHHHHHH--------------------hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCC
Q 011660 325 VYNLL-NGSLKQYLK--------------------QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENF 383 (480)
Q Consensus 325 V~e~~-~GsL~~~l~--------------------~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~ 383 (480)
+|||+ +|+|.+++. .+++.+...++.|++.||.|||++ +|+||||||+|||++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~- 160 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQ- 160 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCC-
Confidence 99999 679999983 256777888999999999999999 99999999999999988
Q ss_pred CceEEeeeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 384 HHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 384 ~~~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
+.+||+|||+++....... ........++..|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 161 ~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~ 231 (283)
T cd05090 161 LHVKISDLGLSREIYSADY---YRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS 231 (283)
T ss_pred CcEEeccccccccccCCcc---eecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence 6899999999975433211 111233446788999999998899999999999999999998 999997643
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=272.51 Aligned_cols=199 Identities=29% Similarity=0.401 Sum_probs=169.0
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCcc------HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS------EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAI 324 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~------~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 324 (480)
++|...+.||+|++|.||++.. .+++.+|+|.+...... ...+.+|++++++++||||+++++++.+++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4689999999999999999965 56899999998654321 2357889999999999999999999999999999
Q ss_pred EEecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccc
Q 011660 325 VYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (480)
Q Consensus 325 V~e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (480)
++||+ +++|.+++.. +++.....++.|++.||.|||+. +|+||||+|+||+++++ +.++|+|||++......
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~-~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSA-GNVKLGDFGASKRLQTI 157 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCC-CCEEEeecccceecccc
Confidence 99999 6789988854 67788889999999999999999 99999999999999988 68999999998654321
Q ss_pred cccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 401 ~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
... ........|++.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 158 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 211 (263)
T cd06625 158 CSS--GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFE 211 (263)
T ss_pred ccc--cccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccc
Confidence 111 111124568899999999999999999999999999999999999997653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=278.76 Aligned_cols=196 Identities=24% Similarity=0.400 Sum_probs=166.3
Q ss_pred CCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc---cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEec
Q 011660 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~ 328 (480)
+|++.+.||+|+||.||++.. .+|+.+|+|.++.... ....+.+|+++++.++||||+++++++.+.+.+++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 478889999999999999976 4689999999865432 234577899999999999999999999999999999999
Q ss_pred cCCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccc
Q 011660 329 LNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (480)
Q Consensus 329 ~~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (480)
+.++|.+++.. +++..+..++.||++||.|||+. +|+||||||+||+++.+ +.++|+|||++.......
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~-~~~~l~dfg~~~~~~~~~--- 153 (284)
T cd07839 81 CDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKN-GELKLADFGLARAFGIPV--- 153 (284)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCC-CcEEECccchhhccCCCC---
Confidence 99999888753 68889999999999999999999 99999999999999988 789999999986433211
Q ss_pred cCccccccccCCCccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 405 ENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 405 ~~~~~~~~~GT~~y~APE~~~~~-~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
.......+++.|+|||.+.+. .++.++|||||||++|||+||..||.....
T Consensus 154 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~ 205 (284)
T cd07839 154 --RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND 205 (284)
T ss_pred --CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCC
Confidence 112234678999999988765 479999999999999999999999765443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=273.94 Aligned_cols=193 Identities=36% Similarity=0.587 Sum_probs=168.2
Q ss_pred CCCceeecccCceEEEEEEec-CCcEEEEEEeccCCccHHH---HHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc
Q 011660 254 FSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWSEEE---VLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (480)
Q Consensus 254 f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~---~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~ 329 (480)
|+..+.||+|+||+||++... +++.+|+|++......... ..+|+.++++++||||+++++++.+.+..+++||++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 566789999999999999774 5779999999877654433 356999999999999999999999999999999999
Q ss_pred CC-CHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccccc
Q 011660 330 NG-SLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE 405 (480)
Q Consensus 330 ~G-sL~~~l~---~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~ 405 (480)
.+ +|.+++. .+++.++..++.|+++||.|||+. +|+|+||||+||+++.+ +.++|+|||.+.... ..
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~-~~~~l~Dfg~~~~~~-----~~ 151 (260)
T PF00069_consen 81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDEN-GEVKLIDFGSSVKLS-----EN 151 (260)
T ss_dssp TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTT-SEEEESSGTTTEEST-----ST
T ss_pred ccccccccccccccccccccccccccccccccccccc---ccccccccccccccccc-ccccccccccccccc-----cc
Confidence 66 9999986 378899999999999999999999 99999999999999987 789999999985431 12
Q ss_pred CccccccccCCCcccccccc-CCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 011660 406 NVKPVNVVGTFGYLAPEYMM-YGKVDEKIDVYSYGVVLLELITGKEAIQTN 455 (480)
Q Consensus 406 ~~~~~~~~GT~~y~APE~~~-~~~~~~k~DvwSlGvil~eLltG~~pf~~~ 455 (480)
........||+.|+|||++. +..++.++||||+|+++|+|++|..||...
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 22334567899999999998 888999999999999999999999999987
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=274.89 Aligned_cols=196 Identities=28% Similarity=0.452 Sum_probs=168.3
Q ss_pred cCCCCceeecccCceEEEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc-C
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-N 330 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~-~ 330 (480)
.+|.+.+.||+|+||.||+|...+...+|+|.++......+.+.+|+++++.++||||+++++++.+ +..+++|||+ +
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~ 84 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK 84 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCCC
Confidence 4699999999999999999987666789999998766667789999999999999999999998755 5578999999 6
Q ss_pred CCHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccccc
Q 011660 331 GSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE 405 (480)
Q Consensus 331 GsL~~~l~~-----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~ 405 (480)
|+|.+++.. +++..+..++.|++.||.|||+. +|+||||||+||+++++ +.++|+|||++.........
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~-~~~~L~dfg~~~~~~~~~~~-- 158 (262)
T cd05071 85 GSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGEN-LVCKVADFGLARLIEDNEYT-- 158 (262)
T ss_pred CcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCC-CcEEeccCCceeeccccccc--
Confidence 799999964 67788899999999999999999 99999999999999998 68999999998654332211
Q ss_pred CccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 406 NVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 406 ~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
......++..|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 159 --~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~ 208 (262)
T cd05071 159 --ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV 208 (262)
T ss_pred --cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 1123346778999999988999999999999999999999 888997654
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=276.06 Aligned_cols=198 Identities=30% Similarity=0.452 Sum_probs=168.0
Q ss_pred hhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCccHHHHHHHHHHHhcC-CCCCeeeEEEEEecC------Ce
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSI-KHENIVRIIGYCHSK------EM 321 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~------~~ 321 (480)
++..|++.+.||+|+||.||+|.. .+++.+|+|++.........+..|+.+++.+ +||||+++++++... +.
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 83 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence 456688888999999999999976 4588999999987666667889999999998 799999999998642 46
Q ss_pred eEEEEecc-CCCHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccc
Q 011660 322 YAIVYNLL-NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAM 395 (480)
Q Consensus 322 ~~lV~e~~-~GsL~~~l~~-----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~ 395 (480)
++++|||+ +|+|.+++.. +++..+..++.|++.||.|||+. +|+|+||||+||+++++ +.++|+|||++.
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~-~~~~l~Dfg~~~ 159 (272)
T cd06637 84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTEN-AEVKLVDFGVSA 159 (272)
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCC-CCEEEccCCCce
Confidence 89999999 6789998853 67888889999999999999999 99999999999999998 689999999986
Q ss_pred ccccccccccCccccccccCCCcccccccc-----CCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 396 VHHQSHQVSENVKPVNVVGTFGYLAPEYMM-----YGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
..... ........|++.|+|||++. ...++.++|||||||++|||++|+.||....
T Consensus 160 ~~~~~-----~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~ 220 (272)
T cd06637 160 QLDRT-----VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 220 (272)
T ss_pred ecccc-----cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccC
Confidence 53321 11223567999999999886 3468899999999999999999999997554
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=300.51 Aligned_cols=191 Identities=32% Similarity=0.475 Sum_probs=168.0
Q ss_pred CCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc----cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEec
Q 011660 254 FSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (480)
Q Consensus 254 f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~----~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~ 328 (480)
|..++-||.|+||-||-+.. .+...||||.+..+.. ...++..|++.|++++|||++.+-|+|-.+...|+||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 55556799999999999965 6688999999975542 235799999999999999999999999999999999999
Q ss_pred cCCCHHHHH----HhCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccc
Q 011660 329 LNGSLKQYL----KQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (480)
Q Consensus 329 ~~GsL~~~l----~~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (480)
|-|+-.+.+ +.+.+.++..|..+.+.||.|||+. +.||||||..|||+++. |.+||+|||.|...
T Consensus 108 ClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~-g~VKLaDFGSAsi~------- 176 (948)
T KOG0577|consen 108 CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEP-GLVKLADFGSASIM------- 176 (948)
T ss_pred HhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCC-Ceeeeccccchhhc-------
Confidence 988876666 4588899999999999999999999 99999999999999998 89999999998543
Q ss_pred cCccccccccCCCcccccccc---CCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 405 ENVKPVNVVGTFGYLAPEYMM---YGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 405 ~~~~~~~~~GT~~y~APE~~~---~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
.....++|||.|||||++. .+.|+-|+||||||+...||.-.++|+...+.
T Consensus 177 --~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA 230 (948)
T KOG0577|consen 177 --APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 230 (948)
T ss_pred --CchhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH
Confidence 2345789999999999875 67899999999999999999999999887653
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=276.87 Aligned_cols=199 Identities=26% Similarity=0.426 Sum_probs=168.3
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc--cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEe
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e 327 (480)
+++|.+.+.||+|+||.||+|.. .+++.+|+|++..... ....+.+|+++++.++|+||+++++++.+++..++|+|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 46799999999999999999965 5688999999865432 23467789999999999999999999999999999999
Q ss_pred ccCCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccc
Q 011660 328 LLNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (480)
Q Consensus 328 ~~~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (480)
|+.++|.+++.. +.+.++..++.|++.||.|||+. +|+|+||||+||+++.+ +.++|+|||+++......
T Consensus 84 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~-~~~~l~Dfg~~~~~~~~~-- 157 (291)
T cd07870 84 YMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYL-GELKLADFGLARAKSIPS-- 157 (291)
T ss_pred cccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCC-CcEEEeccccccccCCCC--
Confidence 999998887743 56778888999999999999999 99999999999999988 789999999986432211
Q ss_pred ccCccccccccCCCccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCccc
Q 011660 404 SENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKAN 458 (480)
Q Consensus 404 ~~~~~~~~~~GT~~y~APE~~~~~-~~~~k~DvwSlGvil~eLltG~~pf~~~~~~ 458 (480)
.......+++.|+|||.+.+. .++.++|||||||++|||++|+.||......
T Consensus 158 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~ 210 (291)
T cd07870 158 ---QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV 210 (291)
T ss_pred ---CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH
Confidence 112234579999999998764 5789999999999999999999999876543
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=274.05 Aligned_cols=197 Identities=29% Similarity=0.471 Sum_probs=169.1
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc-
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL- 329 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~- 329 (480)
.+|.+.+.||+|+||.||+|.. .+++.+|+|+++.+.....++.+|+++++.++||||+++++++..++.++++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 3588889999999999999965 45889999999876655677899999999999999999999999999999999998
Q ss_pred CCCHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccc
Q 011660 330 NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (480)
Q Consensus 330 ~GsL~~~l~~-----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (480)
+|+|.+++.. +++..+..++.|+++||.|||+. +++||||||+||+++++ +.+||+|||++.........
T Consensus 86 ~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~-~~~kl~df~~~~~~~~~~~~- 160 (263)
T cd05052 86 YGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTYT- 160 (263)
T ss_pred CCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCC-CcEEeCCCccccccccceee-
Confidence 6899999853 67888899999999999999998 99999999999999988 68999999998654332111
Q ss_pred cCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 405 ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 405 ~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
......+++.|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus 161 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~ 210 (263)
T cd05052 161 ---AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 210 (263)
T ss_pred ---ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 1112234678999999999999999999999999999998 999997643
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=276.13 Aligned_cols=222 Identities=23% Similarity=0.364 Sum_probs=181.9
Q ss_pred CCCCceeecccCceEEEEEEec---C--CcEEEEEEeccCCc---cHHHHHHHHHHHhcCCCCCeeeEEEEEec-CCeeE
Q 011660 253 NFSPKMLIGQGGNSKVYRTNHV---D--GQVAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVRIIGYCHS-KEMYA 323 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~~---~--g~~vAvK~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~ 323 (480)
.|+....||+|+||.||+|... + .+.+|+|.++.+.. ......+|+.+++.++|||++.|..++.+ +...+
T Consensus 25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~ 104 (438)
T KOG0666|consen 25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVW 104 (438)
T ss_pred HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEE
Confidence 5888999999999999999432 2 23799999975522 22457899999999999999999998876 77899
Q ss_pred EEEeccCCCHHHHHH--------hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecC---CCceEEeeec
Q 011660 324 IVYNLLNGSLKQYLK--------QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN---FHHPQLSDFG 392 (480)
Q Consensus 324 lV~e~~~GsL~~~l~--------~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~---~~~~kL~DFG 392 (480)
+++||.+.+|.+.++ .++......|++||+.|+.|||++ -|+||||||.|||+..+ .|.+||+|||
T Consensus 105 l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaDlG 181 (438)
T KOG0666|consen 105 LLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIADLG 181 (438)
T ss_pred EEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeeccc
Confidence 999999999999983 377788899999999999999999 99999999999999755 3689999999
Q ss_pred cccccccccccccCccccccccCCCccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCccc-------chhHHH
Q 011660 393 AAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKAN-------RESLVL 464 (480)
Q Consensus 393 la~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~-~~~~k~DvwSlGvil~eLltG~~pf~~~~~~-------~e~l~~ 464 (480)
+|+.+...... -.....++-|++|.|||.+.+. .|++++||||+|||+.||+|-.+.|.+.+.. +-.-..
T Consensus 182 laR~~~~plkp--l~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 182 LARLFNNPLKP--LASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred HHHHhhccccc--cccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 99876653221 1123356779999999998875 5899999999999999999999999887531 111233
Q ss_pred HHHHHhCCCCCCCCC
Q 011660 465 WYYVLAGKVFAQQWP 479 (480)
Q Consensus 465 ~~~~~~~~~~~~~~~ 479 (480)
-...++|.++...||
T Consensus 260 rIf~vLG~Pt~~~Wp 274 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWP 274 (438)
T ss_pred HHHHHcCCCccccch
Confidence 355789999999998
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=278.16 Aligned_cols=198 Identities=30% Similarity=0.490 Sum_probs=167.4
Q ss_pred cCCCCceeecccCceEEEEEEe------cCCcEEEEEEeccCCc-cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH------VDGQVAAVKVLKCTNW-SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAI 324 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~------~~g~~vAvK~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 324 (480)
++|.+.+.||+|+||.||++.. .++..+|+|.+..... ..+.+.+|+.++++++||||+++++++...+.+++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 4688999999999999999964 2345789999875432 34568899999999999999999999999999999
Q ss_pred EEecc-CCCHHHHHH----------------hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceE
Q 011660 325 VYNLL-NGSLKQYLK----------------QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQ 387 (480)
Q Consensus 325 V~e~~-~GsL~~~l~----------------~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~k 387 (480)
+|||+ +|+|.+++. .+++.....++.|++.||.|||+. +++||||||+||+++++ +.++
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~-~~~k 160 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGEN-LLVK 160 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccC-CcEE
Confidence 99999 689999985 268888999999999999999998 99999999999999998 6899
Q ss_pred EeeeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 388 LSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 388 L~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
|+|||++........ ........+++.|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 161 l~dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~ 227 (288)
T cd05093 161 IGDFGMSRDVYSTDY---YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS 227 (288)
T ss_pred eccCCccccccCCce---eecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999865432111 111223446788999999999999999999999999999998 999997654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=305.73 Aligned_cols=203 Identities=27% Similarity=0.428 Sum_probs=163.3
Q ss_pred hcCCCCceeecccCceEEEEEEecCC-cEEEEEEeccCC-ccHHHHHHHHHHHhcCC-CCCeeeEEEEE-e---cC---C
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHVDG-QVAAVKVLKCTN-WSEEEVLREVELLSSIK-HENIVRIIGYC-H---SK---E 320 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~~g-~~vAvK~~~~~~-~~~~~~~~Ei~il~~l~-HpnIv~l~~~~-~---~~---~ 320 (480)
..++++.+.|.+|||+.||+|....+ ..||+|++-..+ .....+.+|+++|+.|+ |||||.+++.. . .+ -
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 45688899999999999999987665 999999885443 33456889999999996 99999999932 1 12 2
Q ss_pred eeEEEEeccC-CCHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccc
Q 011660 321 MYAIVYNLLN-GSLKQYLK-----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA 394 (480)
Q Consensus 321 ~~~lV~e~~~-GsL~~~l~-----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla 394 (480)
.++|.||||. |+|-++|. .|.+.++++|+.++++|+.+||.+ +++|||||||-+||||+.+ ++.||||||.|
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~-g~~KLCDFGSa 193 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSAD-GNYKLCDFGSA 193 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCC-CCEEeCccccc
Confidence 5789999995 89999994 388999999999999999999988 5579999999999999999 79999999998
Q ss_pred cccccccccccCc----cccccccCCCcccccccc---CCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 011660 395 MVHHQSHQVSENV----KPVNVVGTFGYLAPEYMM---YGKVDEKIDVYSYGVVLLELITGKEAIQTN 455 (480)
Q Consensus 395 ~~~~~~~~~~~~~----~~~~~~GT~~y~APE~~~---~~~~~~k~DvwSlGvil~eLltG~~pf~~~ 455 (480)
.-.-......... ......-|+.|+|||++. +.+.++|+|||||||+||-|+....||...
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s 261 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES 261 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence 4321111000000 001123589999999874 677899999999999999999999999877
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=312.18 Aligned_cols=202 Identities=24% Similarity=0.398 Sum_probs=166.0
Q ss_pred hhhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCcc---HHHHHHHHHHHhcCCCCCeeeEEEEEec--CCee
Q 011660 249 HLTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHS--KEMY 322 (480)
Q Consensus 249 ~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~ 322 (480)
...++|.+.+.||+|+||.||++.+ .+++.+|+|++...... ...+..|+.+++.|+||||++++++|.+ ...+
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 3456899999999999999999976 45789999998754332 3468899999999999999999998853 4578
Q ss_pred EEEEecc-CCCHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhCC----CCCeEeccCCCCCEEEecC--------
Q 011660 323 AIVYNLL-NGSLKQYLKQ-------LKWNERMDVAIGVAKALEYLHHTC----DPPIIHRDVKSSNILLSEN-------- 382 (480)
Q Consensus 323 ~lV~e~~-~GsL~~~l~~-------~~~~~~~~i~~~ia~aL~yLH~~~----~~~IiHrDlKp~NILl~~~-------- 382 (480)
++||||+ +|+|.++|.. +++..++.|+.||+.||.|||+.. .++||||||||+||||+.+
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 9999999 6799998843 788899999999999999999852 1369999999999999653
Q ss_pred --------CCceEEeeeccccccccccccccCccccccccCCCccccccccC--CCCCchHHHHHHHHHHHHHHcCCCCC
Q 011660 383 --------FHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY--GKVDEKIDVYSYGVVLLELITGKEAI 452 (480)
Q Consensus 383 --------~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~--~~~~~k~DvwSlGvil~eLltG~~pf 452 (480)
...+||+|||++...... .......||+.|+|||++.+ ..++.++||||||||||||+||+.||
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~------s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF 243 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIE------SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243 (1021)
T ss_pred ccccccCCCCceEEccCCcccccccc------ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence 134899999998653221 11234579999999999864 45899999999999999999999999
Q ss_pred CCCc
Q 011660 453 QTNK 456 (480)
Q Consensus 453 ~~~~ 456 (480)
....
T Consensus 244 ~~~~ 247 (1021)
T PTZ00266 244 HKAN 247 (1021)
T ss_pred CcCC
Confidence 7654
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=272.17 Aligned_cols=196 Identities=29% Similarity=0.455 Sum_probs=168.4
Q ss_pred cCCCCceeecccCceEEEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc-C
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-N 330 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~-~ 330 (480)
++|++.+.||+|+||.||++...++..+|+|.++......+.+.+|+.++++++||||+++++++.+ +..+++|||+ +
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~ 84 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMSK 84 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEecCC
Confidence 4688999999999999999988788889999998766667789999999999999999999998865 4578999999 6
Q ss_pred CCHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccccc
Q 011660 331 GSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE 405 (480)
Q Consensus 331 GsL~~~l~~-----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~ 405 (480)
++|.+++.. +++.++..++.+++.||.|||+. +|+||||||+||+++++ +.++|+|||++........
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~-~~~~l~dfg~~~~~~~~~~--- 157 (260)
T cd05070 85 GSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDG-LVCKIADFGLARLIEDNEY--- 157 (260)
T ss_pred CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCC-ceEEeCCceeeeeccCccc---
Confidence 799999853 67888999999999999999999 99999999999999998 6899999999865432111
Q ss_pred CccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 406 NVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 406 ~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
.......++..|+|||.+.+..++.++|+||||+++|||++ |+.||...+
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~ 208 (260)
T cd05070 158 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN 208 (260)
T ss_pred -ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 11122345678999999988899999999999999999999 899997654
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=279.11 Aligned_cols=195 Identities=29% Similarity=0.411 Sum_probs=167.6
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc--cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEec
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~ 328 (480)
++|++.+.||+|+||.||++.+ .++..+|+|.++.... ....+.+|++++++++||||++++++|.+++.+++++||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 3689999999999999999976 4688999999875432 224578999999999999999999999999999999999
Q ss_pred c-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccc
Q 011660 329 L-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (480)
Q Consensus 329 ~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (480)
+ +|+|.+++.. +++.....++.|+++||.|||+.+ +++|+||||+|||++.+ +.++|+|||++......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~---- 153 (308)
T cd06615 81 MDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS---- 153 (308)
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecC-CcEEEccCCCccccccc----
Confidence 9 5799999854 678888999999999999999731 89999999999999998 68999999998543221
Q ss_pred cCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 405 ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 405 ~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
......|++.|+|||.+.+..++.++|+|||||++|||++|+.||...+
T Consensus 154 ---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~ 202 (308)
T cd06615 154 ---MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD 202 (308)
T ss_pred ---ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc
Confidence 1234578999999999988889999999999999999999999997543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=287.11 Aligned_cols=198 Identities=27% Similarity=0.437 Sum_probs=163.7
Q ss_pred cCCCCceeecccCceEEEEEEec------CCcEEEEEEeccCCcc--HHHHHHHHHHHhcC-CCCCeeeEEEEEec-CCe
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHV------DGQVAAVKVLKCTNWS--EEEVLREVELLSSI-KHENIVRIIGYCHS-KEM 321 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~~~~~~~~--~~~~~~Ei~il~~l-~HpnIv~l~~~~~~-~~~ 321 (480)
++|++.+.||+|+||.||+|... +++.||+|+++..... .+.+..|+.++.++ +||||++++++|.. +..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 46999999999999999999532 2578999999754322 24577899999999 89999999998864 457
Q ss_pred eEEEEecc-CCCHHHHHH--------------------------------------------------------------
Q 011660 322 YAIVYNLL-NGSLKQYLK-------------------------------------------------------------- 338 (480)
Q Consensus 322 ~~lV~e~~-~GsL~~~l~-------------------------------------------------------------- 338 (480)
+++++||+ +|+|.+++.
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 88999999 678988873
Q ss_pred --hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccCccccccccCC
Q 011660 339 --QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTF 416 (480)
Q Consensus 339 --~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~ 416 (480)
.+++..+..++.||+.||.|||+. +|+||||||+|||++.+ +.++|+|||++........ ........++.
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~-~~vkL~DfG~a~~~~~~~~---~~~~~~~~~~~ 239 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPD---YVRKGDARLPL 239 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCC-CcEEEeccccchhcccCcc---hhhccCCCCCc
Confidence 357788899999999999999999 99999999999999988 6899999999975432111 11122345678
Q ss_pred CccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 417 GYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 417 ~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
.|+|||++.+..++.++|||||||+||||++ |+.||....
T Consensus 240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~ 280 (337)
T cd05054 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ 280 (337)
T ss_pred cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCC
Confidence 8999999999999999999999999999998 999997654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=271.88 Aligned_cols=197 Identities=24% Similarity=0.415 Sum_probs=168.1
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc----cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~----~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 326 (480)
++|++.+.||+|+||.||+|.. .+++.+|+|.++.... ....+..|+++++.++||||+++++++.+.+.+++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 4689999999999999999976 5689999998864321 2245788999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccc
Q 011660 327 NLL-NGSLKQYLKQ-------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (480)
Q Consensus 327 e~~-~GsL~~~l~~-------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~ 398 (480)
||+ +|+|.+++.. ++......++.|++.||.|||+. +++|+||||+||+++.+ +.++|+|||++....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~-~~~~l~d~g~~~~~~ 157 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITAT-GVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCC-CCEEECccccceecc
Confidence 999 5789888742 56778889999999999999998 99999999999999988 689999999987643
Q ss_pred cccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 399 QSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 399 ~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
... .......|++.|+|||.+.+..++.++|+||||+++|||++|+.||.....
T Consensus 158 ~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~ 211 (267)
T cd08228 158 SKT-----TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM 211 (267)
T ss_pred chh-----HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc
Confidence 321 111234688999999999988999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=270.00 Aligned_cols=195 Identities=30% Similarity=0.423 Sum_probs=169.1
Q ss_pred CCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCC---ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEec
Q 011660 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN---WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~ 328 (480)
+|.+.+.||+|+||.||++.. .+++.+++|.+.... ...+.+..|+++++.++||||+++++++.+++.+++++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 478889999999999999976 468999999986543 2345688999999999999999999999999999999999
Q ss_pred c-CCCHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccc
Q 011660 329 L-NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 329 ~-~GsL~~~l~~-----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (480)
+ +++|.+++.. +++.....++.|++.||.|||+. +++|+||||+||+++++ +.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~-~~~~l~df~~~~~~~~~~- 155 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAY-DNVKIGDLGVAKLLSDNT- 155 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCC-CCEEEcccccceeccCcc-
Confidence 9 6799999844 56788889999999999999998 99999999999999998 689999999986544321
Q ss_pred cccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 403 ~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.......|++.|+|||++.+..++.++|+|||||++|||++|+.||...+
T Consensus 156 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 205 (256)
T cd08529 156 ----NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN 205 (256)
T ss_pred ----chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 11234568999999999999999999999999999999999999997665
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=271.16 Aligned_cols=198 Identities=28% Similarity=0.462 Sum_probs=172.3
Q ss_pred hcCCCCceeecccCceEEEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc-
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL- 329 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~- 329 (480)
.++|.+.+.||+|+||.||++...+++.+|+|.+.......+++.+|+.+++.++||||+++++++.+....+++|||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 84 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMS 84 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccC
Confidence 4679999999999999999998877889999999877777788999999999999999999999999888999999998
Q ss_pred CCCHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccc
Q 011660 330 NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (480)
Q Consensus 330 ~GsL~~~l~~-----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (480)
+++|.+++.. +++.++..++.+++.||.|||++ +++|+||||+||+++++ +.++|+|||++.......
T Consensus 85 ~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~-~~~~l~d~g~~~~~~~~~--- 157 (261)
T cd05034 85 KGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGEN-LVCKIADFGLARLIEDDE--- 157 (261)
T ss_pred CCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCC-CCEEECccccceeccchh---
Confidence 6799999853 67888899999999999999999 99999999999999998 789999999986543211
Q ss_pred cCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 405 ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 405 ~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
........++..|+|||.+.+..++.++|+|||||++|||++ |+.||....
T Consensus 158 -~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 209 (261)
T cd05034 158 -YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT 209 (261)
T ss_pred -hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 111112234678999999998899999999999999999998 999997654
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=296.45 Aligned_cols=206 Identities=29% Similarity=0.492 Sum_probs=169.2
Q ss_pred ceeecccCceEEEEEEe-cCCcEEEEEEec-----cCCccHHHHHHHHHHHhcCCCCCeeeEEEEEecCC--eeEEEEec
Q 011660 257 KMLIGQGGNSKVYRTNH-VDGQVAAVKVLK-----CTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKE--MYAIVYNL 328 (480)
Q Consensus 257 ~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~-----~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--~~~lV~e~ 328 (480)
...||+|+|-+||+|-. .+|..||--.++ ++....+.|..|+.+|+.|+||||+++|++|.+.. .+.+|.|+
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 34699999999999955 568888743332 22223367899999999999999999999997655 47788999
Q ss_pred c-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccc
Q 011660 329 L-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (480)
Q Consensus 329 ~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (480)
+ .|+|..|+++ .+..-...++.||++||.|||++ +++|||||||-+||+|+.+.|.+||+|.|||.....+.
T Consensus 125 ~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~--- 200 (632)
T KOG0584|consen 125 FTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH--- 200 (632)
T ss_pred ccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhccc---
Confidence 9 8999999965 56677788999999999999997 66999999999999999999999999999997644322
Q ss_pred cCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHhCCCCC
Q 011660 405 ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWYYVLAGKVFA 475 (480)
Q Consensus 405 ~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~~~e~l~~~~~~~~~~~~~ 475 (480)
...++|||.|||||++. ..|++.+||||||++++||.|+..||....+. .+-++.++....+
T Consensus 201 ----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~----AQIYKKV~SGiKP 262 (632)
T KOG0584|consen 201 ----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNP----AQIYKKVTSGIKP 262 (632)
T ss_pred ----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCH----HHHHHHHHcCCCH
Confidence 23478999999999877 88999999999999999999999999988753 2335555554444
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=291.29 Aligned_cols=192 Identities=28% Similarity=0.427 Sum_probs=168.5
Q ss_pred ceeecccCceEEEEEEe-cCCcEEEEEEeccCC---ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEeccCCC
Q 011660 257 KMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN---WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLLNGS 332 (480)
Q Consensus 257 ~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~Gs 332 (480)
.+.||.|-||+||-|.+ .+|+.||||++.+-. ..+..+..|+.||..++||.||.|...|++.+..++|||-+.|+
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 36899999999999976 679999999996532 33467889999999999999999999999999999999999999
Q ss_pred HHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEec--CCCceEEeeecccccccccccccc
Q 011660 333 LKQYLK-----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSE--NFHHPQLSDFGAAMVHHQSHQVSE 405 (480)
Q Consensus 333 L~~~l~-----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~--~~~~~kL~DFGla~~~~~~~~~~~ 405 (480)
+.+.+- ++++..-..++.||+.||.|||.+ +|+|+||||+|||+.+ +|.++||||||.|+.+.+.
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk----- 720 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK----- 720 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchh-----
Confidence 877772 366666667888999999999999 9999999999999963 5678999999999886542
Q ss_pred CccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 406 NVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 406 ~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
.....++|||.|+|||++..+.|+..-||||.|||+|--++|..||..+++
T Consensus 721 -sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd 771 (888)
T KOG4236|consen 721 -SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED 771 (888)
T ss_pred -hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc
Confidence 223467999999999999999999999999999999999999999988765
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=271.58 Aligned_cols=197 Identities=28% Similarity=0.434 Sum_probs=170.1
Q ss_pred hcCCCCceeecccCceEEEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc-
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL- 329 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~- 329 (480)
.++|++.+.||+|+||.||+|...+++.+|+|.+........++.+|+.+++.++||||+++++++.. +..++++||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQ-EPIYIITEYME 83 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEcc-CCcEEEEEcCC
Confidence 45689999999999999999988888999999998777777889999999999999999999998754 5688999998
Q ss_pred CCCHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccc
Q 011660 330 NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (480)
Q Consensus 330 ~GsL~~~l~~-----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (480)
+|+|.+++.. +++.+...++.|++.||.|||+. +++||||||+||+++++ +.++|+|||++........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~~~~-- 157 (260)
T cd05067 84 NGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSET-LCCKIADFGLARLIEDNEY-- 157 (260)
T ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCC-CCEEEccCcceeecCCCCc--
Confidence 6899998843 67888899999999999999998 99999999999999998 6899999999865432111
Q ss_pred cCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 405 ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 405 ~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
.......++..|+|||++.+..++.++||||||+++|||++ |+.||...+
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 208 (260)
T cd05067 158 --TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT 208 (260)
T ss_pred --ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC
Confidence 11123346788999999998999999999999999999999 999997654
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=274.05 Aligned_cols=196 Identities=29% Similarity=0.431 Sum_probs=163.8
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc--cHHHHHHHHHH-HhcCCCCCeeeEEEEEecCCeeEEEEe
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW--SEEEVLREVEL-LSSIKHENIVRIIGYCHSKEMYAIVYN 327 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~--~~~~~~~Ei~i-l~~l~HpnIv~l~~~~~~~~~~~lV~e 327 (480)
++|++.+.||+|+||.||++.. .+|+.||+|+++.... ....+..|+.+ ++.++||||+++++++..++..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 3688999999999999999976 4699999999976543 23456667665 667799999999999999999999999
Q ss_pred ccCCCHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccc
Q 011660 328 LLNGSLKQYLKQ-------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (480)
Q Consensus 328 ~~~GsL~~~l~~-------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (480)
|++|+|.+++.. +++..+..++.|++.||.|||++. +++||||||+||+++.+ +.+||+|||++......
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~-~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRN-GQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCC-CCEEEeecccccccccc
Confidence 999999888743 678888999999999999999742 89999999999999998 68999999998654221
Q ss_pred cccccCccccccccCCCccccccccC----CCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 401 HQVSENVKPVNVVGTFGYLAPEYMMY----GKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 401 ~~~~~~~~~~~~~GT~~y~APE~~~~----~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.......|+..|+|||.+.+ ..++.++|+|||||++|||++|+.||....
T Consensus 158 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 211 (283)
T cd06617 158 ------VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWK 211 (283)
T ss_pred ------cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccc
Confidence 11223568999999998864 456899999999999999999999997543
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=271.68 Aligned_cols=197 Identities=28% Similarity=0.400 Sum_probs=167.2
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc-cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEec
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW-SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~ 328 (480)
.++|++.+.||+|+||.||+|.. .+++.+|+|++..... ....+.+|+.+++.++||||+++++++..++.+++|+||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 35699999999999999999976 5688999999975432 335677899999999999999999999999999999999
Q ss_pred c-CCCHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccc
Q 011660 329 L-NGSLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (480)
Q Consensus 329 ~-~GsL~~~l~---~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (480)
+ +|+|.+++. .+++.++..++.|++.||.|||+. +|+||||||+||+++.+ +.++|+|||++......
T Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~-~~~~l~dfg~~~~~~~~---- 159 (267)
T cd06646 88 CGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDN-GDVKLADFGVAAKITAT---- 159 (267)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCC-CCEEECcCccceeeccc----
Confidence 9 578998885 367888899999999999999998 99999999999999988 68999999998654221
Q ss_pred cCccccccccCCCcccccccc---CCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 405 ENVKPVNVVGTFGYLAPEYMM---YGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 405 ~~~~~~~~~GT~~y~APE~~~---~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
........|++.|+|||.+. ...++.++|+|||||++|||++|+.||....
T Consensus 160 -~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~ 213 (267)
T cd06646 160 -IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLH 213 (267)
T ss_pred -ccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccc
Confidence 11122456899999999874 4557889999999999999999999996543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=285.90 Aligned_cols=199 Identities=24% Similarity=0.405 Sum_probs=170.5
Q ss_pred cCCCCceeecccCceEEEEEEecCCcEEEEEEeccCCcc--HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~ 329 (480)
+...+.+.||+|-||.|.+++...+..||||.++..... ..+|.+|+++|.+|+||||+.|+|+|..++.+++++||+
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 345667789999999999999888899999999876533 367999999999999999999999999999999999999
Q ss_pred -CCCHHHHHHhC-----CHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccc
Q 011660 330 -NGSLKQYLKQL-----KWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (480)
Q Consensus 330 -~GsL~~~l~~~-----~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (480)
+|+|.+|+... ....-..|+.||+.||.||.+. ++|||||.++|+|++.++ ++||+|||+++.+...++.
T Consensus 618 EnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~-~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 618 ENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEF-TIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred hcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcc-cEEecCcccccccccCCce
Confidence 89999999764 2334466999999999999999 999999999999999995 8999999999865443332
Q ss_pred ccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHH--HcCCCCCCCCcc
Q 011660 404 SENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLEL--ITGKEAIQTNKA 457 (480)
Q Consensus 404 ~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eL--ltG~~pf~~~~~ 457 (480)
.. ....+-..+|||||.+..++++.++|+|+||+.|||+ ++...||....+
T Consensus 694 ~v---qgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~ 746 (807)
T KOG1094|consen 694 RV---QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD 746 (807)
T ss_pred ee---ecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH
Confidence 22 2244567899999999999999999999999999996 568999987754
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=275.95 Aligned_cols=193 Identities=27% Similarity=0.408 Sum_probs=169.7
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCC----ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 326 (480)
++|.+.+.||+|+||.||++.. .+++.+|+|+++... ...+.+.+|++++++++||||+++++++.+++.++++|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 3688999999999999999976 468999999986543 22356789999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccc
Q 011660 327 NLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 327 e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (480)
||+ +|+|.+++.. ++...+..++.|++.||.|||+. +|+|+||+|+||+++.+ +.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~-~~~kl~dfg~~~~~~~~-- 154 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSD-GYIKITDFGFAKRVKGR-- 154 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCC-CCEEEeeCCCccccCCC--
Confidence 999 7899999853 78888899999999999999998 99999999999999998 78999999998654321
Q ss_pred cccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 403 ~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.....|++.|+|||.+.+..++.++|+||||+++|+|++|+.||....
T Consensus 155 ------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 202 (290)
T cd05580 155 ------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN 202 (290)
T ss_pred ------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 234578999999999988889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=276.22 Aligned_cols=198 Identities=27% Similarity=0.436 Sum_probs=171.3
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc-cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEec
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW-SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~ 328 (480)
..+|+..+.||+|+||.||++.. .+++.+|+|.+..... ..+.+.+|+.+++.++||||+++++++......++||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 35789999999999999999965 5688999999876543 345678999999999999999999999999999999999
Q ss_pred c-CCCHHHHHHh--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccccc
Q 011660 329 L-NGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE 405 (480)
Q Consensus 329 ~-~GsL~~~l~~--~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~ 405 (480)
+ +|+|.+++.. +.+.+...++.|++.||.|||+. +|+||||||+||+++.+ +.++|+|||++.......
T Consensus 99 ~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~-~~~kl~dfg~~~~~~~~~---- 170 (296)
T cd06654 99 LAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQ---- 170 (296)
T ss_pred cCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCC-CCEEECccccchhccccc----
Confidence 9 6789999864 78888999999999999999999 99999999999999988 689999999986432211
Q ss_pred CccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 406 NVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 406 ~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
.......|++.|+|||.+.+..++.++|||||||++|||++|+.||.....
T Consensus 171 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~ 221 (296)
T cd06654 171 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP 221 (296)
T ss_pred -cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH
Confidence 112234689999999999988899999999999999999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=292.16 Aligned_cols=196 Identities=29% Similarity=0.464 Sum_probs=174.2
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCccH---HHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEE
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSE---EEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~~---~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 326 (480)
...|.+.+.||+|.|++|.++.+ .++..||+|++.++..+. ..+.+|+++|+.|+||||++++++.+....+|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 34689999999999999999977 569999999998776443 34789999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccc
Q 011660 327 NLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 327 e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (480)
||. +|.+++|+.. ..+.++..++.|+.+|++|||.+ .|||||||++||||+.++ ++||+|||++..+..
T Consensus 135 eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~m-nikIaDfgfS~~~~~--- 207 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENM-NIKIADFGFSTFFDY--- 207 (596)
T ss_pred EeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhccccccc-ceeeeccccceeecc---
Confidence 999 8899999954 55577788999999999999999 999999999999999994 799999999876443
Q ss_pred cccCccccccccCCCccccccccCCCC-CchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 403 VSENVKPVNVVGTFGYLAPEYMMYGKV-DEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 403 ~~~~~~~~~~~GT~~y~APE~~~~~~~-~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.....++||++.|.|||++.+..| ++.+|+||+|++||-|+.|..||++.+
T Consensus 208 ---~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~ 259 (596)
T KOG0586|consen 208 ---GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN 259 (596)
T ss_pred ---cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc
Confidence 334457899999999999999988 689999999999999999999999765
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=272.86 Aligned_cols=196 Identities=23% Similarity=0.396 Sum_probs=168.1
Q ss_pred CCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc---cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEec
Q 011660 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~ 328 (480)
+|++.+.||+|+||.||+|.. .+|+.+|+|++..... ..+.+.+|+.+++.++||||+++++++..++.+++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 478889999999999999976 4689999999975542 245788999999999999999999999999999999999
Q ss_pred cCCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccc
Q 011660 329 LNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (480)
Q Consensus 329 ~~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (480)
++++|.+++.. +.+.++..++.|+++||.|||+. +++|+||||+||+++.+ +.++|+|||++........
T Consensus 81 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~-~~~~l~dfg~~~~~~~~~~-- 154 (286)
T cd07832 81 MPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISAD-GVLKIADFGLARLFSEEEP-- 154 (286)
T ss_pred cCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCC-CcEEEeeeeecccccCCCC--
Confidence 98899999853 78889999999999999999998 99999999999999998 6899999999865433211
Q ss_pred cCccccccccCCCccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 405 ENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 405 ~~~~~~~~~GT~~y~APE~~~~~-~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.......|+..|+|||.+.+. .++.++|||||||++|||++|.+||....
T Consensus 155 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~ 205 (286)
T cd07832 155 --RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEN 205 (286)
T ss_pred --CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCC
Confidence 112245689999999988654 46899999999999999999988887654
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=274.87 Aligned_cols=197 Identities=27% Similarity=0.399 Sum_probs=163.3
Q ss_pred CCCceeecccCceEEEEEEe-----cCCcEEEEEEeccCCc--cHHHHHHHHHHHhcCCCCCeeeEEEEEec--CCeeEE
Q 011660 254 FSPKMLIGQGGNSKVYRTNH-----VDGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHS--KEMYAI 324 (480)
Q Consensus 254 f~~~~~LG~G~fg~Vy~~~~-----~~g~~vAvK~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~l 324 (480)
|...+.||+|+||+||++.. .+++.+|+|+++.... ....+.+|+++++.++||||+++++++.. ...+++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 38889999999999988642 4578999999976533 34568899999999999999999998865 346889
Q ss_pred EEecc-CCCHHHHHH--hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccc
Q 011660 325 VYNLL-NGSLKQYLK--QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (480)
Q Consensus 325 V~e~~-~GsL~~~l~--~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (480)
+|||+ .|+|.+++. .+++.++..++.|++.||.|||+. +|+||||||+|||++++ +.++|+|||++.......
T Consensus 86 v~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~-~~~~l~dfg~~~~~~~~~ 161 (283)
T cd05080 86 IMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDND-RLVKIGDFGLAKAVPEGH 161 (283)
T ss_pred EecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCC-CcEEEeecccccccCCcc
Confidence 99999 678999985 488899999999999999999999 99999999999999998 689999999987544321
Q ss_pred ccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 402 QVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 402 ~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
... .......++..|+|||.+.+..++.++||||||+++|||++|..||....
T Consensus 162 ~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~ 214 (283)
T cd05080 162 EYY--RVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPP 214 (283)
T ss_pred hhh--ccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCc
Confidence 110 11112345677999999998899999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=276.29 Aligned_cols=206 Identities=27% Similarity=0.381 Sum_probs=171.0
Q ss_pred CHHHHhhhhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCccHHHHHHHHHHHhcC-CCCCeeeEEEEEe---
Q 011660 243 TSQELCHLTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSI-KHENIVRIIGYCH--- 317 (480)
Q Consensus 243 ~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~--- 317 (480)
.++.+..+.++|++.+.||+|+||.||++.. .+++.+|+|+++........+..|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 3445566788999999999999999999966 4588999999876554556788999999999 7999999999873
Q ss_pred --cCCeeEEEEecc-CCCHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceE
Q 011660 318 --SKEMYAIVYNLL-NGSLKQYLK-------QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQ 387 (480)
Q Consensus 318 --~~~~~~lV~e~~-~GsL~~~l~-------~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~k 387 (480)
.++.++++|||+ +|+|.+++. .+++..+..++.|++.||.|||+. +|+||||||+||+++++ +.++
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~-~~~k 164 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTE-GGVK 164 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCC-CCEE
Confidence 446789999999 678988763 366777888999999999999999 99999999999999998 6899
Q ss_pred EeeeccccccccccccccCccccccccCCCcccccccc-----CCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 388 LSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMM-----YGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 388 L~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
|+|||++...... ........|++.|+|||++. ...++.++|||||||++|||++|+.||.....
T Consensus 165 l~dfg~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~ 234 (286)
T cd06638 165 LVDFGVSAQLTST-----RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP 234 (286)
T ss_pred EccCCceeecccC-----CCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch
Confidence 9999998654321 11223446899999999875 34578999999999999999999999976543
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=275.13 Aligned_cols=221 Identities=27% Similarity=0.481 Sum_probs=185.1
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCC---ccHHHHHHHHHHHhcCCCCCeeeEEEEEec--------C
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN---WSEEEVLREVELLSSIKHENIVRIIGYCHS--------K 319 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--------~ 319 (480)
+.|+....||+|.||.||+|+. .+|+.||+|.+-.++ .-.....+|+++|..|+|+|++.+++.|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 4466677899999999999966 558888888664322 223567899999999999999999988843 2
Q ss_pred CeeEEEEeccCCCHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccc
Q 011660 320 EMYAIVYNLLNGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAM 395 (480)
Q Consensus 320 ~~~~lV~e~~~GsL~~~l~----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~ 395 (480)
..+|+||.+|..+|.-.|. ++...++.+++.++..||.|+|.. .|+|||+||.|+||+.+ +.+||+|||+|+
T Consensus 97 ~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~d-gilklADFGlar 172 (376)
T KOG0669|consen 97 ATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKD-GILKLADFGLAR 172 (376)
T ss_pred ceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCC-ceEEeecccccc
Confidence 3699999999999888883 588899999999999999999999 99999999999999999 799999999998
Q ss_pred ccccccccccCccccccccCCCccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHhCCCC
Q 011660 396 VHHQSHQVSENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWYYVLAGKVF 474 (480)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~-~~~~~k~DvwSlGvil~eLltG~~pf~~~~~~~e~l~~~~~~~~~~~~ 474 (480)
.+..+...... .-++.+-|.+|++||.+.+ ..|+++.|||+-|||+.||+||.+.++++.+.+. ......|.|+.+
T Consensus 173 ~fs~~~n~~kp-rytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqq--l~~Is~LcGs~t 249 (376)
T KOG0669|consen 173 AFSTSKNVVKP-RYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQ--LHLISQLCGSIT 249 (376)
T ss_pred ceecccccCCC-CcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHH--HHHHHHHhccCC
Confidence 77665543332 2445667999999998875 5689999999999999999999999999875433 455789999999
Q ss_pred CCCCC
Q 011660 475 AQQWP 479 (480)
Q Consensus 475 ~~~~~ 479 (480)
+|.||
T Consensus 250 kevWP 254 (376)
T KOG0669|consen 250 KEVWP 254 (376)
T ss_pred cccCC
Confidence 99999
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=269.91 Aligned_cols=198 Identities=28% Similarity=0.381 Sum_probs=165.5
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc------cHHHHHHHHHHHhcCCCCCeeeEEEEEecC--Cee
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW------SEEEVLREVELLSSIKHENIVRIIGYCHSK--EMY 322 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~------~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~ 322 (480)
++|++.+.||+|+||.||++.. .+++.+|+|.+..... ..+.+.+|+.+++.++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4789999999999999999976 5589999998864321 124577899999999999999999988653 567
Q ss_pred EEEEecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccc
Q 011660 323 AIVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (480)
Q Consensus 323 ~lV~e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~ 398 (480)
+++|||+ +|+|.+++.. +.+.....++.|++.||.|||+. +|+|+||||+||+++.+ +.++|+|||++....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~-~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSV-GNVKLGDFGASKRLQ 157 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCC-CCEEECcCccccccc
Confidence 8999999 6789999854 57778889999999999999999 99999999999999988 689999999986543
Q ss_pred cccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 011660 399 QSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTN 455 (480)
Q Consensus 399 ~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~ 455 (480)
.... .........||..|+|||.+.+..++.++|+|||||++|||++|+.||...
T Consensus 158 ~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 212 (265)
T cd06652 158 TICL--SGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEF 212 (265)
T ss_pred cccc--cccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCcc
Confidence 2111 111122356899999999999888999999999999999999999999764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=289.01 Aligned_cols=198 Identities=26% Similarity=0.345 Sum_probs=169.7
Q ss_pred hcCCCCceeecccCceEEEEEEecCCcEEEEEEeccCCcc---HHHHHHHHHHHhcCC-CCCeeeEEEEEecCCeeEEEE
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWS---EEEVLREVELLSSIK-HENIVRIIGYCHSKEMYAIVY 326 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~---~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~ 326 (480)
...|++.+.||+||.++||++...+.+.||+|.+.....+ ..-+..|+..|.+|+ |.+|++|++|-..++.+|+||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 4569999999999999999999888888888877644333 356899999999995 899999999999999999999
Q ss_pred eccCCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccc
Q 011660 327 NLLNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 327 e~~~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (480)
|+.+-||..+|++ .....++.+..||+.|+.++|.. ||||.||||.|+|+-.. .+||+|||+|.....
T Consensus 440 E~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVkG--~LKLIDFGIA~aI~~--- 511 (677)
T KOG0596|consen 440 ECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVKG--RLKLIDFGIANAIQP--- 511 (677)
T ss_pred ecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEee--eEEeeeechhcccCc---
Confidence 9999999999975 22226677899999999999999 99999999999999885 799999999976544
Q ss_pred cccCccccccccCCCccccccccCC-----------CCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 403 VSENVKPVNVVGTFGYLAPEYMMYG-----------KVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 403 ~~~~~~~~~~~GT~~y~APE~~~~~-----------~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
..........+||+.||+||.+... +++.++||||+|||||+|+.|++||....
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~ 576 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII 576 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH
Confidence 3445555677999999999998632 25688999999999999999999998765
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=276.55 Aligned_cols=197 Identities=24% Similarity=0.392 Sum_probs=164.2
Q ss_pred CCCCceeecccCceEEEEEEec------CCcEEEEEEeccCCcc--HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEE
Q 011660 253 NFSPKMLIGQGGNSKVYRTNHV------DGQVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAI 324 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 324 (480)
+|.+.+.||+|+||.||+|... +++.+|+|+++..... .+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 4777788999999999999653 2578999999755432 2457889999999999999999999999999999
Q ss_pred EEecc-CCCHHHHHH-------------------hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCC
Q 011660 325 VYNLL-NGSLKQYLK-------------------QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFH 384 (480)
Q Consensus 325 V~e~~-~GsL~~~l~-------------------~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~ 384 (480)
++||+ .++|.+++. .+.+..+..++.|++.||.|||+. +|+||||||+||+++++ +
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~-~ 161 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDK-L 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCC-C
Confidence 99998 678998873 256777888999999999999999 99999999999999988 6
Q ss_pred ceEEeeeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 385 HPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 385 ~~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
.+||+|||+++....... ........+++.|+|||.+.++.++.++|||||||++|||++ |..||....
T Consensus 162 ~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 231 (283)
T cd05091 162 NVKISDLGLFREVYAADY---YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS 231 (283)
T ss_pred ceEecccccccccccchh---eeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 899999999865432211 111223456789999999998999999999999999999998 888987654
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=275.17 Aligned_cols=202 Identities=28% Similarity=0.445 Sum_probs=166.9
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc---cHHHHHHHHHHHhcCCCCCeeeEEEEEecCC------
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVRIIGYCHSKE------ 320 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------ 320 (480)
.++|++.+.||+|+||.||++.. .+++.+|+|.+..... ....+.+|++++++++||||+++++++...+
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 35699999999999999999976 4689999999864332 2235678999999999999999999986543
Q ss_pred --eeEEEEeccCCCHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccc
Q 011660 321 --MYAIVYNLLNGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA 394 (480)
Q Consensus 321 --~~~lV~e~~~GsL~~~l~----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla 394 (480)
..++||||+.++|.+++. .+++.++..++.|++.||.|||+. +++|+||||+||+++.+ +.++|+|||++
T Consensus 91 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~-~~~kl~dfg~~ 166 (310)
T cd07865 91 KGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKD-GILKLADFGLA 166 (310)
T ss_pred CceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCC-CcEEECcCCCc
Confidence 459999999999988885 368899999999999999999999 99999999999999988 68999999998
Q ss_pred cccccccccccCccccccccCCCccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 395 MVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~-~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
.......... ........++..|+|||.+.+. .++.++||||||+++|||++|++||...+.
T Consensus 167 ~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~ 229 (310)
T cd07865 167 RAFSLSKNSK-PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTE 229 (310)
T ss_pred ccccCCcccC-CCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 7544322111 1122345678999999988765 478999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=275.88 Aligned_cols=199 Identities=28% Similarity=0.485 Sum_probs=167.7
Q ss_pred cCCCCceeecccCceEEEEEEec------CCcEEEEEEeccCCcc-HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHV------DGQVAAVKVLKCTNWS-EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAI 324 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~~~~~~~~-~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 324 (480)
.+|.+.+.||+|+||.||++... ++..+++|.++..... .+.+.+|++++++++||||+++++++.+.+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 35888899999999999999642 3567899988755432 3568899999999999999999999999999999
Q ss_pred EEecc-CCCHHHHHHh-------------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCC
Q 011660 325 VYNLL-NGSLKQYLKQ-------------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFH 384 (480)
Q Consensus 325 V~e~~-~GsL~~~l~~-------------------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~ 384 (480)
||||+ +++|.+++.. +++..+..++.|++.||.|||+. +|+||||||+|||++.+ +
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~-~ 160 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGAN-L 160 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccC-C
Confidence 99999 7899999853 57788899999999999999999 99999999999999998 6
Q ss_pred ceEEeeeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCcc
Q 011660 385 HPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKA 457 (480)
Q Consensus 385 ~~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~~ 457 (480)
.++|+|||++........ ........|++.|+|||++.+..++.++|||||||++|||+| |+.||.....
T Consensus 161 ~~~l~dfg~a~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 231 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDY---YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN 231 (291)
T ss_pred cEEECCCCcccccCCCce---eecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 899999999865432211 111224457889999999999999999999999999999999 9999976543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=278.55 Aligned_cols=198 Identities=27% Similarity=0.457 Sum_probs=164.6
Q ss_pred cCCCCceeecccCceEEEEEEec--------CCcEEEEEEeccCCc--cHHHHHHHHHHHhcC-CCCCeeeEEEEEecCC
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHV--------DGQVAAVKVLKCTNW--SEEEVLREVELLSSI-KHENIVRIIGYCHSKE 320 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~--------~g~~vAvK~~~~~~~--~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 320 (480)
++|.+.+.||+|+||.||++... +...+|+|.++.... ...++..|+++++.+ +||||+++++++...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 56899999999999999999642 235799999976432 234678899999999 7999999999999999
Q ss_pred eeEEEEecc-CCCHHHHHHh-------------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEe
Q 011660 321 MYAIVYNLL-NGSLKQYLKQ-------------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLS 380 (480)
Q Consensus 321 ~~~lV~e~~-~GsL~~~l~~-------------------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~ 380 (480)
..++||||+ +|+|.+++.. +++.++..++.|++.||.|||+. +++||||||+||+++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEEc
Confidence 999999999 6799999953 56788899999999999999998 999999999999999
Q ss_pred cCCCceEEeeeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 381 ENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 381 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
.+ +.++|+|||++......... .......+++.|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 175 ~~-~~~kL~dfg~a~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~ 247 (307)
T cd05098 175 ED-NVMKIADFGLARDIHHIDYY---KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 247 (307)
T ss_pred CC-CcEEECCCcccccccccchh---hccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence 88 68999999998654321111 11112234578999999998999999999999999999998 889986544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=276.02 Aligned_cols=199 Identities=25% Similarity=0.388 Sum_probs=167.2
Q ss_pred CCCCceeecccCceEEEEEEec---CCcEEEEEEeccCC----ccHHHHHHHHHHHhcCCCCCeeeEEEEEecC--CeeE
Q 011660 253 NFSPKMLIGQGGNSKVYRTNHV---DGQVAAVKVLKCTN----WSEEEVLREVELLSSIKHENIVRIIGYCHSK--EMYA 323 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~~---~g~~vAvK~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~ 323 (480)
.|.+.+.||+|+||.||+|... +++.+|+|.+.... .....+.+|+.+++.++||||+++++++.+. +.++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 3788889999999999999763 57899999997632 2235678899999999999999999999887 8899
Q ss_pred EEEeccCCCHHHHHH--------hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEec----CCCceEEeee
Q 011660 324 IVYNLLNGSLKQYLK--------QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSE----NFHHPQLSDF 391 (480)
Q Consensus 324 lV~e~~~GsL~~~l~--------~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~----~~~~~kL~DF 391 (480)
+||||++++|.+++. .++......++.|++.||.|||+. +|+||||||+||+++. + +.+||+||
T Consensus 81 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~-~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPER-GVVKIGDL 156 (316)
T ss_pred EEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCcc-ceEEECCC
Confidence 999999988888773 356778889999999999999999 9999999999999998 7 68999999
Q ss_pred ccccccccccccccCccccccccCCCccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 392 GAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 392 Gla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~-~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
|++........ .........+|+.|+|||++.+. .++.++|||||||++|||++|++||.....
T Consensus 157 g~~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~ 221 (316)
T cd07842 157 GLARLFNAPLK--PLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA 221 (316)
T ss_pred ccccccCCCcc--cccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence 99875433221 11222345789999999988764 579999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=268.65 Aligned_cols=198 Identities=25% Similarity=0.404 Sum_probs=166.9
Q ss_pred cCCCCceeecccCceEEEEEEecC----CcEEEEEEeccCCcc--HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHVD----GQVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~~----g~~vAvK~~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 325 (480)
++|++.+.||+|+||.||+|.... ...+|+|.++..... ..++.+|+.+++.++||||+++++++.+.+..+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 568999999999999999997632 457999998754322 34688999999999999999999999999999999
Q ss_pred Eecc-CCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccc
Q 011660 326 YNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (480)
Q Consensus 326 ~e~~-~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (480)
|||+ +|+|.+++.. +++.++..++.|++.||.|||+. +|+|+||||+||+++++ +.++|+|||+++.....
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~-~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSN-LVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCC-CCEEECccchhhccccc
Confidence 9999 6799999853 78889999999999999999998 99999999999999998 68999999999765421
Q ss_pred cccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 401 ~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
.. ........+++.|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus 160 ~~---~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~ 213 (266)
T cd05033 160 EA---TYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS 213 (266)
T ss_pred cc---ceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC
Confidence 11 111112345678999999999999999999999999999998 999996543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=271.49 Aligned_cols=201 Identities=25% Similarity=0.412 Sum_probs=164.9
Q ss_pred cCCCCceeecccCceEEEEEEec-CC---cEEEEEEeccCCc--cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHV-DG---QVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~-~g---~~vAvK~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 325 (480)
.+|++.+.||+|+||.||+|... ++ ..+|+|.++.... ...++..|+.+++.++||||+++++++.+++.+++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 35788899999999999999763 33 3699999875432 235688999999999999999999999999999999
Q ss_pred Eecc-CCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccc
Q 011660 326 YNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (480)
Q Consensus 326 ~e~~-~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (480)
|||+ +|+|.+++.. +++.++..++.|++.||.|||+. +++|+||||+||+++.+ +.++|+|||++......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~-~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSN-LVCKVSDFGLSRFLEDD 159 (269)
T ss_pred EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCC-CcEEECCCccccccccC
Confidence 9999 5789999853 67888999999999999999998 99999999999999988 68999999998755432
Q ss_pred cccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 401 ~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
.............++..|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~ 216 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS 216 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCC
Confidence 21111111111112457999999999999999999999999999886 999997654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=272.46 Aligned_cols=196 Identities=28% Similarity=0.416 Sum_probs=167.3
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc-cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW-SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~ 329 (480)
++|.+.+.||+|+||.||++.. .+++.+|+|+++.... ....+.+|+.+++.++||||+++++++.+.+.+++++||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 4688888999999999999976 5688999999876542 2345778999999999999999999999999999999999
Q ss_pred -CCCHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccccc
Q 011660 330 -NGSLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE 405 (480)
Q Consensus 330 -~GsL~~~l~---~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~ 405 (480)
+|+|.+++. .+++.+...++.|++.||.|||+. +++|+||||+||+++.+ +.++|+|||++......
T Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~-~~~~l~dfg~~~~~~~~----- 159 (267)
T cd06645 89 GGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDN-GHVKLADFGVSAQITAT----- 159 (267)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCC-CCEEECcceeeeEccCc-----
Confidence 578999885 378889999999999999999999 99999999999999988 68999999998643321
Q ss_pred CccccccccCCCcccccccc---CCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 406 NVKPVNVVGTFGYLAPEYMM---YGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 406 ~~~~~~~~GT~~y~APE~~~---~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
........||+.|+|||++. ...++.++|+|||||++|||++|+.||....
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~ 213 (267)
T cd06645 160 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLH 213 (267)
T ss_pred ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCccccc
Confidence 11123457999999999874 5568899999999999999999999997654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-33 Score=269.09 Aligned_cols=200 Identities=28% Similarity=0.415 Sum_probs=169.3
Q ss_pred CCCCceeecccCceEEEEEEecCCcEEEEEEeccCCcc-------HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEE
Q 011660 253 NFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWS-------EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~-------~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 325 (480)
+|...+.||+|+||.||+|...+++.+|+|.++..... ...+.+|+++++.++|+||+++++++.+.+.++++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 47888999999999999998778999999998654321 13477899999999999999999999999999999
Q ss_pred Eecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccc
Q 011660 326 YNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (480)
Q Consensus 326 ~e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (480)
+||+ +|+|.+++.+ +.+..+..++.|++.||.|||+. +|+|+||+|+||+++++ +.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 81 MEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPN-GIIKLIDFGCARRLAWVG 156 (265)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCC-CeEEeccchhhHhhhhcc
Confidence 9999 6799999854 67888889999999999999998 99999999999999988 789999999986542211
Q ss_pred cc-ccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 402 QV-SENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 402 ~~-~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.. ..........||+.|+|||++.+..++.++|+|||||++|||++|+.||...+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 212 (265)
T cd06631 157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMD 212 (265)
T ss_pred ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCC
Confidence 11 11111234568999999999998899999999999999999999999997654
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=268.69 Aligned_cols=196 Identities=28% Similarity=0.461 Sum_probs=166.9
Q ss_pred cCCCCceeecccCceEEEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc-C
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-N 330 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~-~ 330 (480)
.+|.+...||+|+||.||++...++..+|+|.+.......+.+.+|+++++.++|||++++++++.. +..+++|||+ +
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~ 84 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMGK 84 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCCC
Confidence 4588889999999999999987777789999987666566778999999999999999999998864 5678999999 5
Q ss_pred CCHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccccc
Q 011660 331 GSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE 405 (480)
Q Consensus 331 GsL~~~l~~-----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~ 405 (480)
|+|.+++.. +++..+..++.|++.||.|||+. +++|+||||+||+++++ +.++|+|||++........
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~-~~~~l~dfg~~~~~~~~~~--- 157 (260)
T cd05069 85 GSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDN-LVCKIADFGLARLIEDNEY--- 157 (260)
T ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCC-CeEEECCCccceEccCCcc---
Confidence 799999954 57788899999999999999998 99999999999999998 6899999999865432211
Q ss_pred CccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 406 NVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 406 ~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
.......++..|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus 158 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 208 (260)
T cd05069 158 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMV 208 (260)
T ss_pred -cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 11122346778999999998999999999999999999999 999998754
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=268.61 Aligned_cols=195 Identities=30% Similarity=0.450 Sum_probs=170.6
Q ss_pred cCCCCceeecccCceEEEEEEecC-CcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc-
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL- 329 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~~-g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~- 329 (480)
++|++.+.||+|+||.||++...+ ++.+++|.++.... .+.+.+|+++++.++||||+++++++.++..+++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 81 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG 81 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence 578999999999999999997754 88999999975543 678899999999999999999999999999999999999
Q ss_pred CCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccccc
Q 011660 330 NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE 405 (480)
Q Consensus 330 ~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~ 405 (480)
+++|.+++.. +++.....++.|++.||.|||+. +++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 82 ~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~-~~~~l~dfg~~~~~~~~~---- 153 (256)
T cd06612 82 AGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEE-GQAKLADFGVSGQLTDTM---- 153 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCC-CcEEEcccccchhcccCc----
Confidence 5689998843 68889999999999999999999 99999999999999998 689999999986543321
Q ss_pred CccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 406 NVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 406 ~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.......|+..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 154 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~ 203 (256)
T cd06612 154 -AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIH 203 (256)
T ss_pred -cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 12223458899999999999999999999999999999999999997654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=272.13 Aligned_cols=197 Identities=26% Similarity=0.450 Sum_probs=171.3
Q ss_pred hcCCCCceeecccCceEEEEEEecCCcEEEEEEeccCCc-cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNW-SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~ 329 (480)
..+|++.+.||+|+||.||+|...+++.+|+|++..... ....+..|+.+++.++||||+++++++.+.+.++++|||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 356888999999999999999887799999999976654 4567889999999999999999999999999999999999
Q ss_pred -CCCHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccc
Q 011660 330 -NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (480)
Q Consensus 330 -~GsL~~~l~~-----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (480)
+|+|.+++.. +.+.....++.|++.||.|||+. +|+|+||||+||+++++ +.+||+|||++........
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~-~~~kl~d~g~~~~~~~~~~- 159 (261)
T cd05148 85 EKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGED-LVCKVADFGLARLIKEDVY- 159 (261)
T ss_pred ccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCC-ceEEEccccchhhcCCccc-
Confidence 6799999953 67888999999999999999998 99999999999999998 6899999999865432111
Q ss_pred ccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 404 SENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 404 ~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
......++..|+|||.+.+..++.++||||||+++|+|++ |+.||....
T Consensus 160 ----~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~ 209 (261)
T cd05148 160 ----LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN 209 (261)
T ss_pred ----cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC
Confidence 1113346778999999998899999999999999999998 899997654
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=272.22 Aligned_cols=198 Identities=22% Similarity=0.348 Sum_probs=164.6
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc---cHHHHHHHHHHHhcCC-CCCeeeEEEEEecCCe-----
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW---SEEEVLREVELLSSIK-HENIVRIIGYCHSKEM----- 321 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~---~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~----- 321 (480)
++|++.+.||+|+||.||+|.. .+++.||+|.++.... ....+.+|+.+++.+. ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 3688999999999999999976 4689999999865432 2356788999999995 6999999999876655
Q ss_pred eEEEEeccCCCHHHHHHh--------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecc
Q 011660 322 YAIVYNLLNGSLKQYLKQ--------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGA 393 (480)
Q Consensus 322 ~~lV~e~~~GsL~~~l~~--------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGl 393 (480)
.+++|||+.++|.+++.. +.+..+..++.||++||.|||+. +|+||||||+||+++.+.+.++|+|||+
T Consensus 81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg~ 157 (295)
T cd07837 81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGL 157 (295)
T ss_pred EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeeccc
Confidence 899999999899988742 57888899999999999999999 9999999999999998337899999999
Q ss_pred ccccccccccccCccccccccCCCccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 394 AMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 394 a~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~-~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
+....... .......+++.|+|||++.+ ..++.++||||||+++|||++|..||.+.+.
T Consensus 158 ~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~ 217 (295)
T cd07837 158 GRAFSIPV-----KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSE 217 (295)
T ss_pred ceecCCCc-----cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH
Confidence 86432211 11123357889999998865 4579999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=273.03 Aligned_cols=199 Identities=24% Similarity=0.372 Sum_probs=167.2
Q ss_pred hcCCCCceeecccCceEEEEEEec------CCcEEEEEEeccCCcc--HHHHHHHHHHHhcCCCCCeeeEEEEEecCCee
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHV------DGQVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSKEMY 322 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 322 (480)
.++|.+.+.||+|+||.||++... .+..+|+|.+...... ...+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 357899999999999999999653 2468999998654322 34678999999999999999999999999999
Q ss_pred EEEEecc-CCCHHHHHHh-------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEE
Q 011660 323 AIVYNLL-NGSLKQYLKQ-------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQL 388 (480)
Q Consensus 323 ~lV~e~~-~GsL~~~l~~-------------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL 388 (480)
+++|||+ +|+|.+++.. +.+..+..++.|++.||.|||+. +|+||||||+||+++.+ +.++|
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~-~~~kl 160 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAED-LTVKI 160 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCC-CCEEE
Confidence 9999999 6899999853 45677888999999999999998 99999999999999998 78999
Q ss_pred eeeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 389 SDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 389 ~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
+|||+++....... ........+|..|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus 161 ~dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 226 (277)
T cd05032 161 GDFGMTRDIYETDY---YRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS 226 (277)
T ss_pred CCcccchhhccCcc---cccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC
Confidence 99999865433211 111223457889999999998899999999999999999998 999997654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=274.81 Aligned_cols=206 Identities=31% Similarity=0.432 Sum_probs=172.5
Q ss_pred cCHHHHhhhhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCccHHHHHHHHHHHhcC-CCCCeeeEEEEEecC
Q 011660 242 FTSQELCHLTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSI-KHENIVRIIGYCHSK 319 (480)
Q Consensus 242 ~~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~ 319 (480)
++..++....++|.+...||+|+||.||++.. .+++.+|+|++.........+.+|+.+++++ +|||++++++++...
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 44556667788999999999999999999976 5688999999976655566788999999998 899999999998643
Q ss_pred -----CeeEEEEecc-CCCHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCce
Q 011660 320 -----EMYAIVYNLL-NGSLKQYLK-------QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHP 386 (480)
Q Consensus 320 -----~~~~lV~e~~-~GsL~~~l~-------~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~ 386 (480)
+.+++|+||+ +|+|.+++. .+.+..+..++.|++.||.|||+. +++|+||||+||+++.+ +.+
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~-~~~ 167 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTE-GGV 167 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCC-CCE
Confidence 3689999999 678988874 367888899999999999999998 99999999999999988 689
Q ss_pred EEeeeccccccccccccccCccccccccCCCccccccccCC-----CCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 387 QLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYG-----KVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 387 kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~-----~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
+|+|||++........ ......|++.|+|||++... .++.++|||||||++|||++|+.||....
T Consensus 168 kl~dfg~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~ 237 (291)
T cd06639 168 KLVDFGVSAQLTSTRL-----RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH 237 (291)
T ss_pred EEeecccchhcccccc-----cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCc
Confidence 9999999865432211 12234689999999988643 36899999999999999999999998654
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=273.02 Aligned_cols=200 Identities=28% Similarity=0.397 Sum_probs=165.6
Q ss_pred hcCCCCceeecccCceEEEEEEec------CCcEEEEEEeccCCc--cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCee
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHV------DGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMY 322 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 322 (480)
+++|.+.+.||+|+||.||+|... .+..+|+|.++.... ....+..|+.+++.++||||+++++++.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 456899999999999999999764 356899998864432 235688999999999999999999999988899
Q ss_pred EEEEecc-CCCHHHHHHh----------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCC--CceEEe
Q 011660 323 AIVYNLL-NGSLKQYLKQ----------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENF--HHPQLS 389 (480)
Q Consensus 323 ~lV~e~~-~GsL~~~l~~----------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~--~~~kL~ 389 (480)
+++|||+ +|+|.+++.. +++..+..++.||+.||.|||+. +++||||||+||+++.+. ..+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEec
Confidence 9999999 6899999843 67788899999999999999999 999999999999998651 258999
Q ss_pred eeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 390 DFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 390 DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
|||+++....... ........+++.|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 162 dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~ 226 (277)
T cd05036 162 DFGMARDIYRASY---YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT 226 (277)
T ss_pred cCccccccCCccc---eecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 9999975432111 111112334578999999999999999999999999999997 999998654
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=271.79 Aligned_cols=198 Identities=24% Similarity=0.389 Sum_probs=166.3
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc---cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEe
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e 327 (480)
++|++.+.||+|++|.||+|.. .+++.+|+|.+..... ..+.+.+|+++++.++||||+++++++.+.+.+++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 4688999999999999999976 4688999999865432 23567899999999999999999999999999999999
Q ss_pred ccCCCHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccc
Q 011660 328 LLNGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 328 ~~~GsL~~~l~~-----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (480)
|++++|.+++.. +++.....++.||+.||.|||+. +++|+||+|+||+++.+.+.+||+|||++......
T Consensus 82 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~-- 156 (294)
T PLN00009 82 YLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP-- 156 (294)
T ss_pred cccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCC--
Confidence 999999888843 45667778999999999999998 99999999999999865457999999998643221
Q ss_pred cccCccccccccCCCccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 403 VSENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 403 ~~~~~~~~~~~GT~~y~APE~~~~~-~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
........|++.|+|||++.+. .++.++|||||||++|+|+||++||.....
T Consensus 157 ---~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~ 209 (294)
T PLN00009 157 ---VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSE 209 (294)
T ss_pred ---ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 1111234678999999988764 578999999999999999999999987543
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=267.83 Aligned_cols=191 Identities=29% Similarity=0.448 Sum_probs=159.9
Q ss_pred eecccCceEEEEEEe-cCCcEEEEEEeccCCc--cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc-CCCHH
Q 011660 259 LIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGSLK 334 (480)
Q Consensus 259 ~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~-~GsL~ 334 (480)
.||+|+||.||+|.. .+++.+|+|.+..... ....+.+|+++++.++||||++++++|...+.+++||||+ +++|.
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 81 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL 81 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHH
Confidence 589999999999976 4689999998865432 2356889999999999999999999999999999999998 67999
Q ss_pred HHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccCcccc
Q 011660 335 QYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPV 410 (480)
Q Consensus 335 ~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~ 410 (480)
+++.. +++.++..++.|++.||.|||+. +|+||||||+||+++.+ +.++|+|||++......... ....
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~~~~~---~~~~ 154 (252)
T cd05084 82 TFLRTEGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEK-NVLKISDFGMSREEEDGVYA---STGG 154 (252)
T ss_pred HHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCC-CcEEECccccCccccccccc---ccCC
Confidence 99853 67888899999999999999999 99999999999999988 68999999998653321100 0011
Q ss_pred ccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 411 NVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 411 ~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
...++..|+|||.+.++.++.++|||||||++|||++ |..||....
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~ 201 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLS 201 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccC
Confidence 1223567999999999999999999999999999998 999997554
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=269.12 Aligned_cols=200 Identities=28% Similarity=0.449 Sum_probs=168.1
Q ss_pred CCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCcc----------HHHHHHHHHHHhcCCCCCeeeEEEEEecCCe
Q 011660 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS----------EEEVLREVELLSSIKHENIVRIIGYCHSKEM 321 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~----------~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 321 (480)
+|.+...||+|+||.||+|.. .+++.+|+|.+...... .+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 377788999999999999966 46889999988654321 1357789999999999999999999999999
Q ss_pred eEEEEecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccc
Q 011660 322 YAIVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVH 397 (480)
Q Consensus 322 ~~lV~e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~ 397 (480)
.++++||+ +++|.+++.. +++..+..++.|++.||.|||+. +++||||+|+||+++++ +.++|+|||+++..
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~-~~~~l~dfg~~~~~ 156 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNK-GGIKISDFGISKKL 156 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCC-CCEEecccCCCccc
Confidence 99999999 6789999854 67788889999999999999998 99999999999999988 68999999998765
Q ss_pred ccccc-cccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 398 HQSHQ-VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 398 ~~~~~-~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
..... ...........|++.|+|||.+.+..++.++|+|||||++|+|++|+.||...+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 216 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCT 216 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCcc
Confidence 42111 111112234568999999999999899999999999999999999999998654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=277.31 Aligned_cols=199 Identities=28% Similarity=0.419 Sum_probs=167.6
Q ss_pred cCCCCceeecccCceEEEEEEe------cCCcEEEEEEeccCCcc--HHHHHHHHHHHhcC-CCCCeeeEEEEEecCCee
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH------VDGQVAAVKVLKCTNWS--EEEVLREVELLSSI-KHENIVRIIGYCHSKEMY 322 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~------~~g~~vAvK~~~~~~~~--~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 322 (480)
++|.+.+.||+|+||.||++.. .++..+|+|.++..... .+.+.+|+++++++ +||||+++++++...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 4689999999999999999853 23558999998755322 34688999999999 799999999999999999
Q ss_pred EEEEecc-CCCHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccc
Q 011660 323 AIVYNLL-NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMV 396 (480)
Q Consensus 323 ~lV~e~~-~GsL~~~l~~-----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~ 396 (480)
+++|||+ +|+|.+++.. +++.+...++.|++.||.|||+. +|+|+||||+|||++.+ +.++|+|||++..
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~-~~~~l~dfg~~~~ 190 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHG-KIVKICDFGLARD 190 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCC-CeEEECCCccccc
Confidence 9999998 6899999854 68889999999999999999999 99999999999999988 6899999999865
Q ss_pred cccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCcc
Q 011660 397 HHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKA 457 (480)
Q Consensus 397 ~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~~ 457 (480)
...... ........+++.|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 191 ~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~ 249 (302)
T cd05055 191 IMNDSN---YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV 249 (302)
T ss_pred ccCCCc---eeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc
Confidence 432211 111123346788999999999999999999999999999998 9999987653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=272.57 Aligned_cols=195 Identities=25% Similarity=0.456 Sum_probs=166.6
Q ss_pred CCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc---cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEec
Q 011660 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~ 328 (480)
+|+..+.||+|+||.||+|.. .+++.+|+|.++.... ....+..|++++++++||||+++++++.+++.++++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 488899999999999999976 4689999999865432 234688999999999999999999999999999999999
Q ss_pred cCCCHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccc
Q 011660 329 LNGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (480)
Q Consensus 329 ~~GsL~~~l~~-----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (480)
+.++|.+++.. +++..+..++.|++.||.|||+. +++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 81 ~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~-~~~~l~dfg~~~~~~~~~-- 154 (284)
T cd07860 81 LHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPV-- 154 (284)
T ss_pred cccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCC-CCEEEeeccchhhcccCc--
Confidence 98899998843 67888999999999999999999 99999999999999998 689999999986433211
Q ss_pred ccCccccccccCCCccccccccCCC-CCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 404 SENVKPVNVVGTFGYLAPEYMMYGK-VDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 404 ~~~~~~~~~~GT~~y~APE~~~~~~-~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.......+++.|+|||.+.+.. ++.++|||||||++|||+||+.||...+
T Consensus 155 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 205 (284)
T cd07860 155 ---RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 205 (284)
T ss_pred ---cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 1122345788999999887654 5899999999999999999999998765
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=268.77 Aligned_cols=195 Identities=27% Similarity=0.387 Sum_probs=168.4
Q ss_pred CCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCC--ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc
Q 011660 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN--WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~ 329 (480)
+|++.+.||+|+||.||++.. .+++.+|+|.++... ...+.+..|+.+++.++||||+++++++.+++.+++++||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 478889999999999999976 468899999986432 23456788999999999999999999999999999999999
Q ss_pred -CCCHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccc
Q 011660 330 -NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (480)
Q Consensus 330 -~GsL~~~l~~-----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (480)
+|+|.+++.. ++......++.|++.||.|||+. +|+|+||||+||+++++ +.++|+|||++.......
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~-~~~~l~dfg~~~~~~~~~-- 154 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQN-GKVKLGDFGSARLLTSPG-- 154 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCC-CcEEEcccCcceeecccc--
Confidence 6789888843 67788889999999999999998 99999999999999988 689999999986543211
Q ss_pred ccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 404 SENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 404 ~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.......|++.|+|||++.+..++.++|+||||+++|+|++|+.||...+
T Consensus 155 ---~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~ 204 (255)
T cd08219 155 ---AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS 204 (255)
T ss_pred ---cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC
Confidence 11234568999999999998899999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=275.95 Aligned_cols=195 Identities=28% Similarity=0.449 Sum_probs=161.7
Q ss_pred cCCCCceeecccCceEEEEEEec-CCc--EEEEEEeccCC--ccHHHHHHHHHHHhcC-CCCCeeeEEEEEecCCeeEEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHV-DGQ--VAAVKVLKCTN--WSEEEVLREVELLSSI-KHENIVRIIGYCHSKEMYAIV 325 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~--~vAvK~~~~~~--~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV 325 (480)
++|++.+.||+|+||.||+|... ++. .+++|.++... ...+.+.+|+.+++++ +||||+++++++.+.+.++++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 46899999999999999999764 343 47888886422 2235688999999999 799999999999999999999
Q ss_pred Eecc-CCCHHHHHHh-------------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCc
Q 011660 326 YNLL-NGSLKQYLKQ-------------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHH 385 (480)
Q Consensus 326 ~e~~-~GsL~~~l~~-------------------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~ 385 (480)
+||+ +|+|.+++.. +++..+..++.|++.||.|||+. +|+||||||+|||++++ +.
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~-~~ 157 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGEN-LA 157 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCC-Ce
Confidence 9998 6899999853 56778899999999999999998 99999999999999988 68
Q ss_pred eEEeeeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 386 PQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 386 ~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
+||+|||++...... ........+..|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 158 ~kl~dfg~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~ 223 (297)
T cd05089 158 SKIADFGLSRGEEVY------VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT 223 (297)
T ss_pred EEECCcCCCccccce------eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 999999998532111 01111223567999999998899999999999999999997 999997654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=271.91 Aligned_cols=197 Identities=25% Similarity=0.415 Sum_probs=160.9
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCc----EEEEEEeccCCc--cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQ----VAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAI 324 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~----~vAvK~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 324 (480)
.+|++.+.||+|+||.||+|.. .+++ .+++|.+..... ...++..|+.++++++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~-~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGA-SLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECCC-ccEE
Confidence 3588889999999999999976 3444 477787753321 224577888899999999999999998654 4566
Q ss_pred EEecc-CCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccc
Q 011660 325 VYNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (480)
Q Consensus 325 V~e~~-~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~ 399 (480)
++||+ +|+|.+++.. +++.....++.|++.||.|||+. +++||||||+|||++++ +.+||+|||+++....
T Consensus 86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~-~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSD-SIVQIADFGVADLLYP 161 (279)
T ss_pred EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCC-CcEEEcCCccceeccC
Confidence 77777 7999999953 67888999999999999999998 99999999999999998 6899999999975433
Q ss_pred ccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 400 SHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 400 ~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
.. .........|+..|+|||.+.++.++.++|||||||++|||++ |+.||.+..
T Consensus 162 ~~---~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~ 216 (279)
T cd05111 162 DD---KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR 216 (279)
T ss_pred CC---cccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 21 1112234557789999999999999999999999999999998 999998754
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=273.08 Aligned_cols=196 Identities=27% Similarity=0.400 Sum_probs=165.7
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc-cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW-SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~ 329 (480)
+.|++.+.||+|+||.||+|.. .+++.+++|.+..... ..+.+..|+.+++.++||||+++++++..++.+++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 5688999999999999999977 4589999999875542 2456788999999999999999999999999999999999
Q ss_pred -CCCHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccc
Q 011660 330 -NGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (480)
Q Consensus 330 -~GsL~~~l~----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (480)
+++|..++. .+.+..+..++.|++.||.|||+. +|+||||||+||+++.+ +.++|+|||++.....
T Consensus 92 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~-~~~kl~dfg~~~~~~~----- 162 (292)
T cd06644 92 PGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLD-GDIKLADFGVSAKNVK----- 162 (292)
T ss_pred CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCC-CCEEEccCccceeccc-----
Confidence 567877763 368899999999999999999998 99999999999999988 6899999998854222
Q ss_pred cCccccccccCCCcccccccc-----CCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 405 ENVKPVNVVGTFGYLAPEYMM-----YGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 405 ~~~~~~~~~GT~~y~APE~~~-----~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.........|++.|+|||++. ...++.++|+|||||++|||++|++||...+
T Consensus 163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 219 (292)
T cd06644 163 TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN 219 (292)
T ss_pred cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc
Confidence 111223456889999999884 3457889999999999999999999997654
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=273.39 Aligned_cols=197 Identities=24% Similarity=0.421 Sum_probs=163.8
Q ss_pred CCCCceeecccCceEEEEEEec------CCcEEEEEEeccCCc--cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEE
Q 011660 253 NFSPKMLIGQGGNSKVYRTNHV------DGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAI 324 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 324 (480)
+|.+.+.||+|+||.||+|... ....+++|.+..... ....+.+|+.+++.++||||+++++.|..++..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4778889999999999999642 235789998865432 23468899999999999999999999999999999
Q ss_pred EEecc-CCCHHHHHHh---------------------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCC
Q 011660 325 VYNLL-NGSLKQYLKQ---------------------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSN 376 (480)
Q Consensus 325 V~e~~-~GsL~~~l~~---------------------------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~N 376 (480)
++||+ +|+|.+++.. +++.....++.|++.||.|||+. +|+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence 99999 6899998743 56777889999999999999998 99999999999
Q ss_pred EEEecCCCceEEeeeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 011660 377 ILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTN 455 (480)
Q Consensus 377 ILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~ 455 (480)
||++++ +.++|+|||+++....... ........++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 158 ill~~~-~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 233 (290)
T cd05045 158 VLVAEG-RKMKISDFGLSRDVYEEDS---YVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 233 (290)
T ss_pred EEEcCC-CcEEeccccccccccCccc---hhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCC
Confidence 999988 6899999999865432111 111223456788999999988899999999999999999998 99999765
Q ss_pred c
Q 011660 456 K 456 (480)
Q Consensus 456 ~ 456 (480)
.
T Consensus 234 ~ 234 (290)
T cd05045 234 A 234 (290)
T ss_pred C
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=271.50 Aligned_cols=194 Identities=38% Similarity=0.597 Sum_probs=159.5
Q ss_pred CceeecccCceEEEEEEec-----CCcEEEEEEeccCCcc--HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEec
Q 011660 256 PKMLIGQGGNSKVYRTNHV-----DGQVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (480)
Q Consensus 256 ~~~~LG~G~fg~Vy~~~~~-----~g~~vAvK~~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~ 328 (480)
..+.||.|.||.||+|.+. .+..|+||.++..... .+.+.+|++++++++||||++++|++...+.+++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3567999999999999775 2568999999654332 46789999999999999999999999988889999999
Q ss_pred c-CCCHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccc
Q 011660 329 L-NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 329 ~-~GsL~~~l~~-----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (480)
+ .|+|.++|.. +++.++..++.|+++||.|||+. +++|+||+++||+++.+ +.+||+|||++........
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~-~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSN-GQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETT-TEEEEESTTTGEETTTSSS
T ss_pred cccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccc-ccccccccccccccccccc
Confidence 9 5899999954 77889999999999999999999 99999999999999998 6999999999865422111
Q ss_pred cccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 403 ~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
. .......+...|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 159 ~---~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~ 210 (259)
T PF07714_consen 159 Y---KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD 210 (259)
T ss_dssp E---EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC
T ss_pred c---ccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 1 11223346778999999998999999999999999999999 789987763
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-33 Score=269.59 Aligned_cols=196 Identities=23% Similarity=0.373 Sum_probs=161.2
Q ss_pred CCCceeecccCceEEEEEEec-C---CcEEEEEEeccCCcc---HHHHHHHHHHHhcCCCCCeeeEEEEEecCCe-----
Q 011660 254 FSPKMLIGQGGNSKVYRTNHV-D---GQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSKEM----- 321 (480)
Q Consensus 254 f~~~~~LG~G~fg~Vy~~~~~-~---g~~vAvK~~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~----- 321 (480)
|.+.+.||+|+||.||+|... + +..+|+|.++..... ...+.+|+++++.++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 567788999999999999753 2 368999999765433 3467899999999999999999998865443
Q ss_pred -eEEEEecc-CCCHHHHHH---------hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEee
Q 011660 322 -YAIVYNLL-NGSLKQYLK---------QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSD 390 (480)
Q Consensus 322 -~~lV~e~~-~GsL~~~l~---------~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~D 390 (480)
.++++||+ +|+|..++. .+++.....++.|++.||.|||+. +|+||||||+||+++++ +.+||+|
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~-~~~kl~d 156 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLRED-MTVCVAD 156 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCC-CeEEECC
Confidence 78999998 689988872 367788889999999999999998 99999999999999998 6899999
Q ss_pred eccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 391 FGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 391 FGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
||+++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||.+..
T Consensus 157 fg~~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~ 220 (273)
T cd05035 157 FGLSKKIYSGDYY---RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE 220 (273)
T ss_pred ccceeeccccccc---cccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Confidence 9998754332111 11112335678999999988899999999999999999999 899997654
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=266.91 Aligned_cols=196 Identities=26% Similarity=0.434 Sum_probs=169.4
Q ss_pred cCCCCceeecccCceEEEEEEec-CCcEEEEEEeccCC----ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTN----WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 326 (480)
++|++.+.||+|+||.||+|... +|+.+|+|.++... ...+.+.+|++++++++|+||+++++++.+++..+++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57999999999999999999775 79999999886432 12456889999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccc
Q 011660 327 NLL-NGSLKQYLKQ-------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (480)
Q Consensus 327 e~~-~GsL~~~l~~-------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~ 398 (480)
||+ +|+|.+++.. +++.++..++.+++.||.|||+. +|+|+||+|+||+++.+ +.++|+|||++....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~-~~~~l~d~~~~~~~~ 157 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITAT-GVVKLGDLGLGRFFS 157 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCC-CcEEEeccceeeecc
Confidence 999 5799998843 57788899999999999999999 99999999999999988 689999999986543
Q ss_pred cccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 399 QSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 399 ~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
... .......|++.|+|||.+.+..++.++|+|||||++|+|++|+.||....
T Consensus 158 ~~~-----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 210 (267)
T cd08224 158 SKT-----TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred CCC-----cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC
Confidence 211 11224568999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=276.07 Aligned_cols=199 Identities=26% Similarity=0.448 Sum_probs=165.2
Q ss_pred hcCCCCceeecccCceEEEEEEec--------CCcEEEEEEeccCC--ccHHHHHHHHHHHhcC-CCCCeeeEEEEEecC
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHV--------DGQVAAVKVLKCTN--WSEEEVLREVELLSSI-KHENIVRIIGYCHSK 319 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~--------~g~~vAvK~~~~~~--~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~ 319 (480)
..+|.+.+.||+|+||.||++... ++..+|+|.++... ....++.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 356888999999999999999641 24579999987542 2335688999999999 899999999999999
Q ss_pred CeeEEEEecc-CCCHHHHHHh-------------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEE
Q 011660 320 EMYAIVYNLL-NGSLKQYLKQ-------------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILL 379 (480)
Q Consensus 320 ~~~~lV~e~~-~GsL~~~l~~-------------------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl 379 (480)
+..+++|||+ +|+|.+++.. +++.++..++.|++.||.|||+. +|+||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEEE
Confidence 9999999999 6799999853 45677888999999999999999 99999999999999
Q ss_pred ecCCCceEEeeeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 380 SENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 380 ~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
+.+ +.++|+|||+++....... ........+++.|+|||++.+..++.++||||||+++|||++ |..||....
T Consensus 171 ~~~-~~~kl~D~g~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 244 (304)
T cd05101 171 TEN-NVMKIADFGLARDVNNIDY---YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 244 (304)
T ss_pred cCC-CcEEECCCccceecccccc---cccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 988 6899999999865432111 111223346788999999998899999999999999999998 888887653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=273.95 Aligned_cols=197 Identities=27% Similarity=0.435 Sum_probs=170.9
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc-cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEec
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW-SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~ 328 (480)
..+|.+.+.||+|+||.||++.. .+++.+|+|.+..... ..+.+.+|+.+++.++||||+++++++..++.+++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 36799999999999999999975 5799999999975443 335678899999999999999999999999999999999
Q ss_pred c-CCCHHHHHHh--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccccc
Q 011660 329 L-NGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE 405 (480)
Q Consensus 329 ~-~GsL~~~l~~--~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~ 405 (480)
+ +++|.+++.. +++.++..++.|++.||.|||+. +|+||||||+||+++.+ +.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~-~~~~l~Dfg~~~~~~~~~---- 169 (297)
T cd06656 98 LAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQ---- 169 (297)
T ss_pred cCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCC-CCEEECcCccceEccCCc----
Confidence 9 6789999854 67888899999999999999999 99999999999999988 789999999986433211
Q ss_pred CccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 406 NVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 406 ~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.......|++.|+|||.+.+..++.++|+|||||++|+|++|+.||...+
T Consensus 170 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~ 219 (297)
T cd06656 170 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219 (297)
T ss_pred -cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 11224568999999999999999999999999999999999999997654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=266.01 Aligned_cols=197 Identities=23% Similarity=0.476 Sum_probs=169.6
Q ss_pred cCCCCceeecccCceEEEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc-C
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-N 330 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~-~ 330 (480)
.+|++.+.||+|+||.||++...+++.+|+|.++........+.+|+++++.++||||+++++++.....+++++||+ +
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH 83 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence 468888999999999999998777889999999877666778999999999999999999999999989999999999 6
Q ss_pred CCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccC
Q 011660 331 GSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSEN 406 (480)
Q Consensus 331 GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~ 406 (480)
|+|.+++.. +.+..+..++.+++.||.|||+. +++|+||||+||+++.+ +.++|+|||++........
T Consensus 84 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~-~~~~l~d~g~~~~~~~~~~---- 155 (256)
T cd05112 84 GCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGEN-QVVKVSDFGMTRFVLDDQY---- 155 (256)
T ss_pred CcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCC-CeEEECCCcceeecccCcc----
Confidence 789998853 67888899999999999999999 99999999999999988 6899999999864322111
Q ss_pred ccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 407 VKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 407 ~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
.......++..|+|||.+.++.++.++||||||+++|||++ |+.||....
T Consensus 156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 206 (256)
T cd05112 156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS 206 (256)
T ss_pred cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence 11112335678999999998999999999999999999998 999997654
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=272.57 Aligned_cols=198 Identities=27% Similarity=0.472 Sum_probs=165.7
Q ss_pred cCCCCceeecccCceEEEEEEe------cCCcEEEEEEeccCCc-cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH------VDGQVAAVKVLKCTNW-SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAI 324 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~------~~g~~vAvK~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 324 (480)
.+|...+.||+|+||.||++.. .++..+|+|.++.... ....+.+|+++++.++||||+++++++.+.+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 4678888999999999999953 2356899998865432 34568899999999999999999999999999999
Q ss_pred EEecc-CCCHHHHHHh------------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCc
Q 011660 325 VYNLL-NGSLKQYLKQ------------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHH 385 (480)
Q Consensus 325 V~e~~-~GsL~~~l~~------------------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~ 385 (480)
++||+ +|+|.+++.. +++..+..++.|++.||.|||+. +++||||||+|||++++ +.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~-~~ 160 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQG-LV 160 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCC-CC
Confidence 99999 6899999843 56788899999999999999998 99999999999999988 68
Q ss_pred eEEeeeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 386 PQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 386 ~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
++|+|||++........ ........+++.|+|||.+.+..++.++|||||||++|||++ |++||....
T Consensus 161 ~kL~dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 229 (280)
T cd05092 161 VKIGDFGMSRDIYSTDY---YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLS 229 (280)
T ss_pred EEECCCCceeEcCCCce---eecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCC
Confidence 99999999865432111 111223346788999999999999999999999999999998 999996644
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=269.46 Aligned_cols=192 Identities=24% Similarity=0.348 Sum_probs=156.6
Q ss_pred eecccCceEEEEEEecC---CcEEEEEEeccCCc--cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc-CCC
Q 011660 259 LIGQGGNSKVYRTNHVD---GQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGS 332 (480)
Q Consensus 259 ~LG~G~fg~Vy~~~~~~---g~~vAvK~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~-~Gs 332 (480)
.||+|+||.||+|...+ +..+|+|.++.... ....+.+|+.+++.++||||+++++++.+...+++||||+ +|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 58999999999996533 46789998875543 2346888999999999999999999999989999999999 689
Q ss_pred HHHHHHh--------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccc
Q 011660 333 LKQYLKQ--------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (480)
Q Consensus 333 L~~~l~~--------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (480)
|.+++.. ..+..+..++.|++.||.|||+. +++||||||+||+++.+ +.++|+|||++.......
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~-~~~kL~dfg~~~~~~~~~--- 154 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTAD-LTVKIGDYGLSHNKYKED--- 154 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCC-CcEEECCccccccccCcc---
Confidence 9999853 34456678899999999999999 99999999999999998 689999999986432211
Q ss_pred cCccccccccCCCccccccccCC-------CCCchHHHHHHHHHHHHHHc-CCCCCCCCcc
Q 011660 405 ENVKPVNVVGTFGYLAPEYMMYG-------KVDEKIDVYSYGVVLLELIT-GKEAIQTNKA 457 (480)
Q Consensus 405 ~~~~~~~~~GT~~y~APE~~~~~-------~~~~k~DvwSlGvil~eLlt-G~~pf~~~~~ 457 (480)
.........|++.|+|||++.+. .++.++|||||||++|||++ |+.||.....
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~ 215 (269)
T cd05087 155 YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD 215 (269)
T ss_pred eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCCh
Confidence 11122345678899999988642 35789999999999999996 9999976543
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=265.34 Aligned_cols=204 Identities=26% Similarity=0.403 Sum_probs=166.8
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCC-ccHHHHHHHHHHHhcCCCCCeeeEEEEEec-----CCeeE
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN-WSEEEVLREVELLSSIKHENIVRIIGYCHS-----KEMYA 323 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-----~~~~~ 323 (480)
.++|.+.+.||+|||+.||+++. .+++.||+|.+.+.. .+.+..++|++..++++|||++++++++.. ....|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 46799999999999999999975 668999999998776 455678999999999999999999987733 33588
Q ss_pred EEEecc-CCCHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccc
Q 011660 324 IVYNLL-NGSLKQYLKQ-------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAM 395 (480)
Q Consensus 324 lV~e~~-~GsL~~~l~~-------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~ 395 (480)
++++|. .|+|.++++. +++.+.+.++.++++||++||+. ..+.+||||||.|||++++ +.++|.|||.+.
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~-~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDS-GLPVLMDLGSAT 177 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCC-CceEEEeccCcc
Confidence 888887 8999999853 77889999999999999999998 2259999999999999997 689999999885
Q ss_pred ccccc----cccccCccccccccCCCcccccccc---CCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 396 VHHQS----HQVSENVKPVNVVGTFGYLAPEYMM---YGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 396 ~~~~~----~~~~~~~~~~~~~GT~~y~APE~~~---~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
...-. .+...-.....-..|..|.|||.+. +...++++|||||||+||+|+.|..||....
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~ 245 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIY 245 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHh
Confidence 43211 1111111112234688999999886 4567899999999999999999999998654
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=272.69 Aligned_cols=199 Identities=24% Similarity=0.390 Sum_probs=164.6
Q ss_pred hcCCCCceeecccCceEEEEEEec------CCcEEEEEEeccCCcc--HHHHHHHHHHHhcCCCCCeeeEEEEEecCCee
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHV------DGQVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSKEMY 322 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 322 (480)
.++|++.+.||+|+||.||+|... .+..+|+|.++..... ...+.+|+.+++.++||||+++++++.+.+..
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPT 84 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 467999999999999999998543 2458999998754422 23577899999999999999999999999999
Q ss_pred EEEEecc-CCCHHHHHHhC-------------CHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEE
Q 011660 323 AIVYNLL-NGSLKQYLKQL-------------KWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQL 388 (480)
Q Consensus 323 ~lV~e~~-~GsL~~~l~~~-------------~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL 388 (480)
+++|||+ +|+|.+++... .+..+..++.|++.||.|||+. +|+||||||+||+++++ +.++|
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~-~~~~L 160 (288)
T cd05061 85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHD-FTVKI 160 (288)
T ss_pred EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCC-CcEEE
Confidence 9999999 78999999642 3456778999999999999999 99999999999999998 68999
Q ss_pred eeeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 389 SDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 389 ~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
+|||+++....... ........++..|+|||.+.++.++.++|+|||||++|||++ |..||....
T Consensus 161 ~Dfg~~~~~~~~~~---~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~ 226 (288)
T cd05061 161 GDFGMTRDIYETDY---YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS 226 (288)
T ss_pred CcCCcccccccccc---ccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999865432211 111122346778999999998999999999999999999998 788997643
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=274.56 Aligned_cols=201 Identities=27% Similarity=0.398 Sum_probs=170.0
Q ss_pred CCCCceeecccCceEEEEEEec-CCcEEEEEEeccCCcc----HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEe
Q 011660 253 NFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWS----EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~----~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e 327 (480)
+|+..+.||+|+||.||++... +++.+|+|.+...... .+.+..|+++++.++||||+++++++.+.+..+++||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 6888999999999999999774 4899999999765432 2457889999999999999999999999999999999
Q ss_pred cc-CCCHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccc
Q 011660 328 LL-NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (480)
Q Consensus 328 ~~-~GsL~~~l~~-----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (480)
|+ +++|.+++.. +++.....++.|++.||.|||+. +++|+||||+||+++.+ +.++|+|||++.......
T Consensus 82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~-~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHES-GHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCC-CCEEEeecchhhcccccc
Confidence 98 6799999853 67888888999999999999999 99999999999999988 789999999986432211
Q ss_pred ccc------------------------cCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 402 QVS------------------------ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 402 ~~~------------------------~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
... .........||..|+|||++.+..++.++||||||+++|+|++|+.||...+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 100 01112245789999999999988999999999999999999999999976553
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=268.39 Aligned_cols=197 Identities=24% Similarity=0.418 Sum_probs=168.6
Q ss_pred hcCCCCceeecccCceEEEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc-
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL- 329 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~- 329 (480)
..+|.+.+.||+|+||.||++...++..+|+|.++......+.+.+|+++++.++|+||+++++++.+ ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMA 83 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCC
Confidence 35789999999999999999987777889999987665555678899999999999999999999887 7789999999
Q ss_pred CCCHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccc
Q 011660 330 NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (480)
Q Consensus 330 ~GsL~~~l~~-----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (480)
+|+|.+++.. +++.++..++.|++.||.|||+. +++|+||||+||+++.+ +.++|+|||++........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~-- 157 (260)
T cd05073 84 KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSAS-LVCKIADFGLARVIEDNEY-- 157 (260)
T ss_pred CCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCC-CcEEECCCcceeeccCCCc--
Confidence 6799999954 56778888999999999999998 99999999999999998 6899999999865433211
Q ss_pred cCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 405 ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 405 ~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
.......++..|+|||++....++.++|+|||||++|+|++ |+.||....
T Consensus 158 --~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~ 208 (260)
T cd05073 158 --TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS 208 (260)
T ss_pred --ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCC
Confidence 11122346678999999998889999999999999999999 999997654
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=279.99 Aligned_cols=201 Identities=27% Similarity=0.416 Sum_probs=167.8
Q ss_pred hhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCC--ccHHHHHHHHHHHhcCCCCCeeeEEEEEecC-----Ce
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN--WSEEEVLREVELLSSIKHENIVRIIGYCHSK-----EM 321 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~ 321 (480)
+.++|++.+.||+|+||.||+|.. .+|+.||+|+++... .....+.+|+.+++.++||||+++++++... ..
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 457899999999999999999965 568999999986432 2235678899999999999999999887543 35
Q ss_pred eEEEEeccCCCHHHHHHh--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccc
Q 011660 322 YAIVYNLLNGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (480)
Q Consensus 322 ~~lV~e~~~GsL~~~l~~--~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~ 399 (480)
.++++||+.++|.+++.. +.+..+..++.|+++||.|||+. +|+||||||+||+++.+ +.++|+|||++.....
T Consensus 83 ~~lv~e~~~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~-~~~kl~dfg~~~~~~~ 158 (336)
T cd07849 83 VYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTN-CDLKICDFGLARIADP 158 (336)
T ss_pred EEEEehhcccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCC-CCEEECcccceeeccc
Confidence 799999999999988854 78888999999999999999999 99999999999999998 7899999999865433
Q ss_pred ccccccCccccccccCCCccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 400 SHQVSENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 400 ~~~~~~~~~~~~~~GT~~y~APE~~~~-~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
... .........||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...+
T Consensus 159 ~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~ 214 (336)
T cd07849 159 EHD--HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKD 214 (336)
T ss_pred ccc--ccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 211 1112234578999999998754 568999999999999999999999997653
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=264.04 Aligned_cols=190 Identities=29% Similarity=0.456 Sum_probs=161.9
Q ss_pred eecccCceEEEEEEecCCcEEEEEEeccCCcc--HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc-CCCHHH
Q 011660 259 LIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGSLKQ 335 (480)
Q Consensus 259 ~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~-~GsL~~ 335 (480)
+||+|+||.||+|...+++.+|+|.++..... ...+..|+++++.++||||+++++++...+..++||||+ +|+|.+
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 81 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS 81 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHH
Confidence 68999999999998878899999998755422 345789999999999999999999999999999999998 688999
Q ss_pred HHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccCccccc
Q 011660 336 YLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVN 411 (480)
Q Consensus 336 ~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~ 411 (480)
++.. +.+.....++.+++.||.|||+. +++||||||+||+++.+ +.++|+|||++........ .....
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~-~~~~l~d~g~~~~~~~~~~----~~~~~ 153 (250)
T cd05085 82 FLRKKKDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGEN-NVLKISDFGMSRQEDDGIY----SSSGL 153 (250)
T ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCC-CeEEECCCccceecccccc----ccCCC
Confidence 8853 67888899999999999999998 99999999999999988 6899999999864322111 11112
Q ss_pred cccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 412 VVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 412 ~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
..+++.|+|||++.++.++.++||||||+++|||++ |..||....
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~ 199 (250)
T cd05085 154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMT 199 (250)
T ss_pred CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCC
Confidence 244678999999998999999999999999999998 999997654
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=265.22 Aligned_cols=197 Identities=29% Similarity=0.420 Sum_probs=169.8
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc-cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW-SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~ 329 (480)
++|++.+.||+|+||.||++.. .+++.+++|++..... ..+.+.+|+++++.++||||+++++++.+.+.++++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 5789999999999999999976 4578999999976543 3467889999999999999999999999999999999999
Q ss_pred -CCCHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccc
Q 011660 330 -NGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (480)
Q Consensus 330 -~GsL~~~l~----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (480)
+++|.+++. .++..++..++.|++.||.|||+. +|+|+||||+||+++++ +.++|+|||++.......
T Consensus 83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~-~~~~l~d~g~~~~~~~~~--- 155 (262)
T cd06613 83 GGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTED-GDVKLADFGVSAQLTATI--- 155 (262)
T ss_pred CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCC-CCEEECccccchhhhhhh---
Confidence 568888874 367888899999999999999998 99999999999999988 789999999986533211
Q ss_pred cCccccccccCCCccccccccCC---CCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 405 ENVKPVNVVGTFGYLAPEYMMYG---KVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 405 ~~~~~~~~~GT~~y~APE~~~~~---~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
.......|+..|+|||.+.+. .++.++|+|||||++|||++|+.||.....
T Consensus 156 --~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~ 209 (262)
T cd06613 156 --AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHP 209 (262)
T ss_pred --hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 122345789999999998776 889999999999999999999999987653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=270.26 Aligned_cols=194 Identities=28% Similarity=0.411 Sum_probs=163.8
Q ss_pred CCCceeecccCceEEEEEEec-CCcEEEEEEeccCC-ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc-C
Q 011660 254 FSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTN-WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-N 330 (480)
Q Consensus 254 f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~-~ 330 (480)
|++.+.||+|+||.||++... ++..+++|.+.... ...+.+.+|+++++.++||||+++++++..++..++|+||+ +
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 567778999999999999764 57889999986543 23456788999999999999999999999999999999999 5
Q ss_pred CCHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccC
Q 011660 331 GSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSEN 406 (480)
Q Consensus 331 GsL~~~l~----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~ 406 (480)
|+|..++. .+++..+..++.|+++||.|||+. +|+||||||+||+++.+ +.++|+|||++...... .
T Consensus 87 ~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~-~~~kl~dfg~~~~~~~~-----~ 157 (282)
T cd06643 87 GAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRT-----I 157 (282)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccC-CCEEEcccccccccccc-----c
Confidence 67887763 378889999999999999999999 99999999999999988 68999999998643221 1
Q ss_pred ccccccccCCCcccccccc-----CCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 407 VKPVNVVGTFGYLAPEYMM-----YGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 407 ~~~~~~~GT~~y~APE~~~-----~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.......||+.|+|||++. +..++.++|||||||++|||++|++||...+
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~ 212 (282)
T cd06643 158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN 212 (282)
T ss_pred cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC
Confidence 1223456899999999884 4557889999999999999999999997654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=272.10 Aligned_cols=195 Identities=26% Similarity=0.422 Sum_probs=166.5
Q ss_pred CCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCcc------HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEE
Q 011660 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS------EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~------~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 325 (480)
+|...+.||+|+||.||+|.. .+++.+|+|.++..... ...+..|+++++.++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 477888999999999999976 46899999999765432 34567899999999999999999999999999999
Q ss_pred EeccCCCHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccc
Q 011660 326 YNLLNGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (480)
Q Consensus 326 ~e~~~GsL~~~l~----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (480)
|||+.|+|.+++. .+++..+..++.||++||.|||+. +|+|+||||+||+++.+ +.++|+|||++.......
T Consensus 81 ~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~-~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 81 FEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASD-GVLKLADFGLARSFGSPN 156 (298)
T ss_pred EcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCC-CCEEEccceeeeeccCCC
Confidence 9999999999984 377888999999999999999999 99999999999999998 789999999986543321
Q ss_pred ccccCccccccccCCCccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 402 QVSENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 402 ~~~~~~~~~~~~GT~~y~APE~~~~-~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.......+++.|+|||.+.+ ..++.++|+|||||++|||++|.+||....
T Consensus 157 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~ 207 (298)
T cd07841 157 -----RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDS 207 (298)
T ss_pred -----ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCc
Confidence 11223457889999998865 457899999999999999999988887654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=281.39 Aligned_cols=198 Identities=27% Similarity=0.435 Sum_probs=162.5
Q ss_pred cCCCCceeecccCceEEEEEEe------cCCcEEEEEEeccCCcc--HHHHHHHHHHHhcC-CCCCeeeEEEEEec-CCe
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH------VDGQVAAVKVLKCTNWS--EEEVLREVELLSSI-KHENIVRIIGYCHS-KEM 321 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~------~~g~~vAvK~~~~~~~~--~~~~~~Ei~il~~l-~HpnIv~l~~~~~~-~~~ 321 (480)
++|++.+.||+|+||.||+|.. .+++.||||+++..... ...+.+|+.++.++ +||||++++++|.. +..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 4699999999999999999953 34789999999764322 34578999999999 78999999998864 456
Q ss_pred eEEEEecc-CCCHHHHHHh-------------------------------------------------------------
Q 011660 322 YAIVYNLL-NGSLKQYLKQ------------------------------------------------------------- 339 (480)
Q Consensus 322 ~~lV~e~~-~GsL~~~l~~------------------------------------------------------------- 339 (480)
++++|||+ +|+|.+++..
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 78999999 7899988742
Q ss_pred ---------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccCcccc
Q 011660 340 ---------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPV 410 (480)
Q Consensus 340 ---------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~ 410 (480)
+++.....++.|++.||.|||+. +|+||||||+|||++.+ +.++|+|||++....... ......
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~-~~~kl~dfg~~~~~~~~~---~~~~~~ 239 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEN-NVVKICDFGLARDIYKDP---DYVRKG 239 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCC-CcEEEEecccccccccCc---chhhcC
Confidence 45666778999999999999999 99999999999999988 689999999986542211 111122
Q ss_pred ccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 411 NVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 411 ~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
...+++.|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus 240 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 286 (343)
T cd05103 240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 286 (343)
T ss_pred CCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcc
Confidence 3346778999999999999999999999999999997 999997654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=269.36 Aligned_cols=197 Identities=26% Similarity=0.401 Sum_probs=166.2
Q ss_pred cCCCCceeecccCceEEEEEEec-CCcEEEEEEeccCCc---cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEe
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e 327 (480)
++|+..+.||+|+||.||++... +++.+|+|++..... ..+.+.+|+++++.++||||+++++++.+.+.++++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 36888999999999999999764 689999999865432 23567899999999999999999999999999999999
Q ss_pred ccCCC-HHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccc
Q 011660 328 LLNGS-LKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (480)
Q Consensus 328 ~~~Gs-L~~~l~---~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (480)
|+.+. |..++. .+++..+..++.|++.||.|||+. +++|+||||+||+++.+ +.++|+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~~~- 155 (286)
T cd07847 81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQ-GQIKLCDFGFARILTGPGD- 155 (286)
T ss_pred ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCC-CcEEECccccceecCCCcc-
Confidence 99655 555543 478889999999999999999998 99999999999999988 6899999999865433211
Q ss_pred ccCccccccccCCCccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 404 SENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 404 ~~~~~~~~~~GT~~y~APE~~~~-~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||.+...
T Consensus 156 ----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~ 206 (286)
T cd07847 156 ----DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSD 206 (286)
T ss_pred ----cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCCh
Confidence 1223467889999999876 4578999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=268.88 Aligned_cols=191 Identities=25% Similarity=0.355 Sum_probs=154.0
Q ss_pred eecccCceEEEEEEecC---CcEEEEEEeccCCcc--HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc-CCC
Q 011660 259 LIGQGGNSKVYRTNHVD---GQVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGS 332 (480)
Q Consensus 259 ~LG~G~fg~Vy~~~~~~---g~~vAvK~~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~-~Gs 332 (480)
.||+|+||.||+|...+ ...+|+|.+...... ...+.+|+.+++.++||||+++++++.+.+.+++||||+ +|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999996533 357888877644322 345789999999999999999999999999999999999 679
Q ss_pred HHHHHHh--------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccc
Q 011660 333 LKQYLKQ--------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (480)
Q Consensus 333 L~~~l~~--------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (480)
|.+++.. ..+.....++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++.........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~-~~~kl~dfg~~~~~~~~~~~- 156 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTAD-LSVKIGDYGLALEQYPEDYY- 156 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCC-CcEEEeccccccccccchhe-
Confidence 9999854 24566788999999999999999 99999999999999998 68999999998543221111
Q ss_pred cCccccccccCCCccccccccC-------CCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 405 ENVKPVNVVGTFGYLAPEYMMY-------GKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 405 ~~~~~~~~~GT~~y~APE~~~~-------~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
.......+++.|+|||++.. ..++.++|||||||++|||++ |..||....
T Consensus 157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~ 214 (269)
T cd05042 157 --ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLS 214 (269)
T ss_pred --eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCC
Confidence 11123346788999998743 456889999999999999999 788887654
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=268.55 Aligned_cols=194 Identities=23% Similarity=0.345 Sum_probs=171.4
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc----cHHHHHHHHHHHhcC-CCCCeeeEEEEEecCCeeEE
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLREVELLSSI-KHENIVRIIGYCHSKEMYAI 324 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~----~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~l 324 (480)
.++|..+.+||+|+|++|..+++ .+.+.||+|++++.-. +.+-+..|..+.... +||++|-|..+|+++..+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 35799999999999999999977 5688999999987532 234577888888765 79999999999999999999
Q ss_pred EEecc-CCCHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccc
Q 011660 325 VYNLL-NGSLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (480)
Q Consensus 325 V~e~~-~GsL~~~l~---~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (480)
|.||. +|+|.-+++ +++++.+..+...|+.||.|||+. |||+||||.+|+|+|.. |++||+|+|+++.
T Consensus 329 vieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldae-ghikltdygmcke---- 400 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAE-GHIKLTDYGMCKE---- 400 (593)
T ss_pred EEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccC-Cceeecccchhhc----
Confidence 99999 678876664 488899999999999999999999 99999999999999999 8999999999953
Q ss_pred cccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCC
Q 011660 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQ 453 (480)
Q Consensus 401 ~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~ 453 (480)
.........++||||.|+|||++.+..|++.+|+|||||+++||+.|+.||+
T Consensus 401 -~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfd 452 (593)
T KOG0695|consen 401 -GLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 452 (593)
T ss_pred -CCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcc
Confidence 2344555678999999999999999999999999999999999999999996
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=277.02 Aligned_cols=195 Identities=27% Similarity=0.452 Sum_probs=161.8
Q ss_pred cCCCCceeecccCceEEEEEEec-CCc--EEEEEEeccCC--ccHHHHHHHHHHHhcC-CCCCeeeEEEEEecCCeeEEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHV-DGQ--VAAVKVLKCTN--WSEEEVLREVELLSSI-KHENIVRIIGYCHSKEMYAIV 325 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~--~vAvK~~~~~~--~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV 325 (480)
++|++.+.||+|+||.||+|.+. ++. .+|+|.++... .....+.+|++++.++ +||||+++++++.+++.++++
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 46899999999999999999763 454 45777765432 2234678899999999 899999999999999999999
Q ss_pred Eecc-CCCHHHHHHh-------------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCc
Q 011660 326 YNLL-NGSLKQYLKQ-------------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHH 385 (480)
Q Consensus 326 ~e~~-~GsL~~~l~~-------------------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~ 385 (480)
+||+ +|+|.+++.. +++.++..++.|++.||+|||+. +|+||||||+|||++.+ +.
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~-~~ 162 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGEN-YV 162 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCC-Cc
Confidence 9999 6899999852 56788899999999999999998 99999999999999988 68
Q ss_pred eEEeeeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 386 PQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 386 ~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
++|+|||++..... ........+++.|+|||++.+..++.++|||||||++|||+| |..||....
T Consensus 163 ~kl~dfg~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 228 (303)
T cd05088 163 AKIADFGLSRGQEV------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 228 (303)
T ss_pred EEeCccccCcccch------hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCC
Confidence 99999999853211 011112234678999999988889999999999999999998 999997554
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=268.84 Aligned_cols=196 Identities=23% Similarity=0.352 Sum_probs=158.6
Q ss_pred CCCceeecccCceEEEEEEecC-Cc--EEEEEEeccCCc---cHHHHHHHHHHHhcCCCCCeeeEEEEEecC------Ce
Q 011660 254 FSPKMLIGQGGNSKVYRTNHVD-GQ--VAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVRIIGYCHSK------EM 321 (480)
Q Consensus 254 f~~~~~LG~G~fg~Vy~~~~~~-g~--~vAvK~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------~~ 321 (480)
|.+.+.||+|+||.||+|...+ +. .+|+|.++.... ..+.+.+|+++++.++||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3466789999999999997644 33 689999875432 235678899999999999999999987432 24
Q ss_pred eEEEEecc-CCCHHHHHH---------hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeee
Q 011660 322 YAIVYNLL-NGSLKQYLK---------QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDF 391 (480)
Q Consensus 322 ~~lV~e~~-~GsL~~~l~---------~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DF 391 (480)
.++++||+ +|+|.+++. .+++.....++.|++.||.|||+. +|+||||||+|||++++ +.++|+||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~-~~~kl~Df 156 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNEN-MNVCVADF 156 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCC-CCEEECCC
Confidence 68889998 689988872 257888899999999999999998 99999999999999988 68999999
Q ss_pred ccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 392 GAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 392 Gla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
|+++........ .......+++.|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus 157 g~~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 219 (272)
T cd05075 157 GLSKKIYNGDYY---RQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE 219 (272)
T ss_pred CcccccCcccce---ecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 998764332111 11122346778999999999999999999999999999999 899997643
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=269.04 Aligned_cols=197 Identities=25% Similarity=0.426 Sum_probs=168.4
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc----cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~----~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 326 (480)
++|++.+.||+|+||.||++.. .+++.+|+|.+..... ...++.+|+.+++.++||||+++++++.+++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 3688889999999999999975 5789999998865322 2246788999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccc
Q 011660 327 NLL-NGSLKQYLKQ-------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (480)
Q Consensus 327 e~~-~GsL~~~l~~-------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~ 398 (480)
||+ +++|.+++.. +++.....++.|++.||.|||+. +++|+||||+||+++.+ +.++|+|||++....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~-~~~~l~dfg~~~~~~ 157 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITAT-GVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCC-CCEEECcchhhhccc
Confidence 999 5689988752 67788899999999999999999 99999999999999988 689999999986543
Q ss_pred cccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 399 QSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 399 ~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
... .......|++.|+|||.+.+..++.++|+||||+++|||++|..||.....
T Consensus 158 ~~~-----~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 211 (267)
T cd08229 158 SKT-----TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM 211 (267)
T ss_pred cCC-----cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 221 111245689999999999988999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=272.01 Aligned_cols=197 Identities=28% Similarity=0.406 Sum_probs=167.8
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc-cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEec
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW-SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~ 328 (480)
.++|++.+.||+|+||.||++.. .+++.+|+|+++.... ..+.+..|+++++.++||||+++++++.+++.+++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 35688899999999999999976 4688999999875442 235688999999999999999999999999999999999
Q ss_pred c-CCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccc
Q 011660 329 L-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (480)
Q Consensus 329 ~-~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (480)
+ +|+|.+++.. +++.++..++.|++.||.|||+. +|+|+||||+||+++.+ +.++|+|||++......
T Consensus 84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~-~~~~l~d~g~~~~~~~~--- 156 (280)
T cd06611 84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLD-GDVKLADFGVSAKNKST--- 156 (280)
T ss_pred cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCC-CCEEEccCccchhhccc---
Confidence 9 5689888853 78889999999999999999999 99999999999999988 68999999987543221
Q ss_pred ccCccccccccCCCcccccccc-----CCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 404 SENVKPVNVVGTFGYLAPEYMM-----YGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 404 ~~~~~~~~~~GT~~y~APE~~~-----~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
........||+.|+|||.+. ...++.++|+|||||++|||++|+.||....
T Consensus 157 --~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~ 212 (280)
T cd06611 157 --LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELN 212 (280)
T ss_pred --ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCC
Confidence 11223457899999999875 3457889999999999999999999997654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=272.21 Aligned_cols=197 Identities=26% Similarity=0.445 Sum_probs=170.9
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc-cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW-SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~ 329 (480)
.+|+..+.||.|+||.||++.. .+++.+|+|.+..... ..+.+.+|+.+++.++||||+++++++...+.+++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4688899999999999999965 5789999999865433 3456789999999999999999999999999999999999
Q ss_pred -CCCHHHHHHh--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccC
Q 011660 330 -NGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSEN 406 (480)
Q Consensus 330 -~GsL~~~l~~--~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~ 406 (480)
+|+|.+++.. +++.++..++.|++.||.|||+. +++|+||||+||+++.+ +.++|+|||++.......
T Consensus 99 ~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~-~~~kl~dfg~~~~~~~~~----- 169 (296)
T cd06655 99 AGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMD-GSVKLTDFGFCAQITPEQ----- 169 (296)
T ss_pred CCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCC-CCEEEccCccchhccccc-----
Confidence 6789988864 78899999999999999999999 99999999999999988 689999999986433211
Q ss_pred ccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 407 VKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 407 ~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
.......|++.|+|||.+.+..++.++|+|||||++|+|++|+.||...+.
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~ 220 (296)
T cd06655 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP 220 (296)
T ss_pred ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 112245689999999999988899999999999999999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=268.15 Aligned_cols=196 Identities=27% Similarity=0.485 Sum_probs=167.9
Q ss_pred CCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc--cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc
Q 011660 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~ 329 (480)
+|+..+.||+|++|.||+|.. .+|+.+|+|+++.... ....+.+|+.+++.++||||+++++++.+.+.+++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 488899999999999999977 4688999999976532 2456778999999999999999999999999999999999
Q ss_pred CCCHHHHHHh------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccc
Q 011660 330 NGSLKQYLKQ------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (480)
Q Consensus 330 ~GsL~~~l~~------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (480)
.|+|.+++.. +++..+..++.|++.||.|||+. +++||||||+||+++++ +.++|+|||++.......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~-~~~~l~d~g~~~~~~~~~-- 154 (284)
T cd07836 81 DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKR-GELKLADFGLARAFGIPV-- 154 (284)
T ss_pred CccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCC-CcEEEeecchhhhhcCCc--
Confidence 9999998853 68888999999999999999998 99999999999999988 689999999986432211
Q ss_pred ccCccccccccCCCccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 404 SENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 404 ~~~~~~~~~~GT~~y~APE~~~~~-~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
.......+|+.|+|||.+.+. .++.++|+|||||++|||++|+.||...+.
T Consensus 155 ---~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~ 206 (284)
T cd07836 155 ---NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNN 206 (284)
T ss_pred ---cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence 111234678999999988764 568999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=275.87 Aligned_cols=198 Identities=27% Similarity=0.456 Sum_probs=163.9
Q ss_pred cCCCCceeecccCceEEEEEEec--------CCcEEEEEEeccCCc--cHHHHHHHHHHHhcC-CCCCeeeEEEEEecCC
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHV--------DGQVAAVKVLKCTNW--SEEEVLREVELLSSI-KHENIVRIIGYCHSKE 320 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~--------~g~~vAvK~~~~~~~--~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 320 (480)
.+|.+.+.||+|+||.||++... +...+|+|.++.... ...++..|+++++.+ +||||++++++|.+++
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 46889999999999999999642 245789999875432 234678999999999 6999999999999989
Q ss_pred eeEEEEecc-CCCHHHHHHh-------------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEe
Q 011660 321 MYAIVYNLL-NGSLKQYLKQ-------------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLS 380 (480)
Q Consensus 321 ~~~lV~e~~-~GsL~~~l~~-------------------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~ 380 (480)
.+++++||+ +|+|.+++.. +.+.+...++.|++.||.|||+. +|+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEEc
Confidence 999999999 6899999853 56778889999999999999998 999999999999999
Q ss_pred cCCCceEEeeeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 381 ENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 381 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
.+ +.+||+|||+++........ .......+++.|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus 169 ~~-~~~kL~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~ 241 (314)
T cd05099 169 ED-NVMKIADFGLARGVHDIDYY---KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP 241 (314)
T ss_pred CC-CcEEEccccccccccccccc---cccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC
Confidence 88 68999999999654322111 11112234568999999998999999999999999999999 899997653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=280.95 Aligned_cols=197 Identities=25% Similarity=0.355 Sum_probs=168.8
Q ss_pred hhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc---cHHHHHHHHHHHhcCCCCCeeeEEEEEecC------
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVRIIGYCHSK------ 319 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------ 319 (480)
+.++|+..+.||+|+||.||++.. .+++.+|+|++.+... ....+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 456799999999999999999976 5689999999865322 234577899999999999999999988543
Q ss_pred CeeEEEEeccCCCHHHHHH-hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccc
Q 011660 320 EMYAIVYNLLNGSLKQYLK-QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (480)
Q Consensus 320 ~~~~lV~e~~~GsL~~~l~-~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~ 398 (480)
...++||||+.++|.+++. .++...+..++.|++.||.|||+. +|+||||||+||+++.+ +.++|+|||++....
T Consensus 94 ~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~-~~~kL~Dfg~~~~~~ 169 (353)
T cd07850 94 QDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSD-CTLKILDFGLARTAG 169 (353)
T ss_pred CcEEEEEeccCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCC-CCEEEccCccceeCC
Confidence 3579999999999998875 478888899999999999999999 99999999999999998 689999999996543
Q ss_pred cccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 399 QSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 399 ~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.. .......||+.|+|||.+.+..++.++|||||||++|+|++|+.||...+
T Consensus 170 ~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~ 221 (353)
T cd07850 170 TS------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTD 221 (353)
T ss_pred CC------CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCC
Confidence 21 11234568999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=273.29 Aligned_cols=194 Identities=25% Similarity=0.372 Sum_probs=164.4
Q ss_pred CCCCceeecccCceEEEEEEec-CCcEEEEEEeccCCc--cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc
Q 011660 253 NFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~ 329 (480)
+|++.+.||+|+||.||++... +++.+|+|.++.... ....+.+|++++++++||||+++++++..++.+++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 5888899999999999999764 689999998875422 2356889999999999999999999999999999999999
Q ss_pred -CCCHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccc
Q 011660 330 -NGSLKQYLK------QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 330 -~GsL~~~l~------~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (480)
+++|.+++. .+++..+..++.|++.||.|||+.+ +|+|+||||+||+++.+ +.++|+|||++......
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~-- 156 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGN-GQVKLCDFGVSGNLVAS-- 156 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCC-CCEEEeecCCcccccCC--
Confidence 568988885 3778889999999999999999632 89999999999999997 78999999998643221
Q ss_pred cccCccccccccCCCccccccccCC------CCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 403 VSENVKPVNVVGTFGYLAPEYMMYG------KVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 403 ~~~~~~~~~~~GT~~y~APE~~~~~------~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
......|++.|+|||.+.+. .++.++|+|||||++|||++|+.||....
T Consensus 157 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 211 (286)
T cd06622 157 -----LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET 211 (286)
T ss_pred -----ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcc
Confidence 12234688999999988544 35889999999999999999999997654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=269.25 Aligned_cols=195 Identities=31% Similarity=0.407 Sum_probs=170.4
Q ss_pred CCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc--cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc
Q 011660 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~ 329 (480)
+|++.+.||.|+||.||+|.. .+++.+|+|++..... ....+.+|+++++.++||||+++++++.++..+++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 588888999999999999976 4688999999875532 2356789999999999999999999999999999999999
Q ss_pred -CCCHHHHHHh--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccC
Q 011660 330 -NGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSEN 406 (480)
Q Consensus 330 -~GsL~~~l~~--~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~ 406 (480)
+++|.+++.. +++.....++.|++.||.|||+. +++|+||+|+||+++++ +.++|+|||++.......
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~-~~~~l~d~g~~~~~~~~~----- 152 (274)
T cd06609 82 GGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEE-GDVKLADFGVSGQLTSTM----- 152 (274)
T ss_pred CCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCC-CCEEEcccccceeecccc-----
Confidence 6789999864 78899999999999999999998 99999999999999998 689999999986654321
Q ss_pred ccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 407 VKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 407 ~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.......|++.|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus 153 ~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~ 202 (274)
T cd06609 153 SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLH 202 (274)
T ss_pred cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCc
Confidence 12234578999999999998889999999999999999999999997654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=276.22 Aligned_cols=197 Identities=24% Similarity=0.295 Sum_probs=160.5
Q ss_pred Cceeeccc--CceEEEEEEe-cCCcEEEEEEeccCCcc---HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc
Q 011660 256 PKMLIGQG--GNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (480)
Q Consensus 256 ~~~~LG~G--~fg~Vy~~~~-~~g~~vAvK~~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~ 329 (480)
+..+||+| +|++||++.. .+|+.||+|+++..... .+.+.+|+++++.++||||++++++|..++.+++|+||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35679999 7889999965 67899999999765322 245678999999999999999999999999999999999
Q ss_pred -CCCHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccc
Q 011660 330 -NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (480)
Q Consensus 330 -~GsL~~~l~~-----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (480)
+|+|.+++.. +++..+..++.|++.||.|||+. +|+||||||+|||++.+ +.++++||+.+.........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~-~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVD-GKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecC-CcEEEcccchhhcccccccc
Confidence 6789998843 67888999999999999999999 99999999999999998 68999999865332111100
Q ss_pred c--cCccccccccCCCccccccccC--CCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 404 S--ENVKPVNVVGTFGYLAPEYMMY--GKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 404 ~--~~~~~~~~~GT~~y~APE~~~~--~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
. .........++..|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 214 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP 214 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 0 0111122357788999999876 468999999999999999999999998654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=269.06 Aligned_cols=197 Identities=24% Similarity=0.463 Sum_probs=162.2
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCc----EEEEEEeccCCc--cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQ----VAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAI 324 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~----~vAvK~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 324 (480)
++|++.+.||+|+||.||+|.+ .+++ .||+|+++.... ....+..|+.+++.++||||+++++++.... .++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTST-VQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCCC-cEE
Confidence 4688999999999999999975 3454 489999875432 2456789999999999999999999997654 567
Q ss_pred EEecc-CCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccc
Q 011660 325 VYNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (480)
Q Consensus 325 V~e~~-~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~ 399 (480)
+++|+ +|+|.+++.. +++.+...++.|++.||.|||+. +|+||||||+|||++++ +.+||+|||+++....
T Consensus 86 ~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~-~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 86 VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSP-NHVKITDFGLARLLDI 161 (279)
T ss_pred EEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCC-CcEEECCCCceeeccc
Confidence 78887 7899999853 68889999999999999999999 99999999999999887 6899999999875432
Q ss_pred ccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 400 SHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 400 ~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
.... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus 162 ~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 216 (279)
T cd05109 162 DETE---YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP 216 (279)
T ss_pred ccce---eecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 1111 11112235678999999999999999999999999999998 999997643
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=270.99 Aligned_cols=203 Identities=22% Similarity=0.204 Sum_probs=155.6
Q ss_pred hcCCCCceeecccCceEEEEEEecC----CcEEEEEEeccCCccH--H----------HHHHHHHHHhcCCCCCeeeEEE
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHVD----GQVAAVKVLKCTNWSE--E----------EVLREVELLSSIKHENIVRIIG 314 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~~----g~~vAvK~~~~~~~~~--~----------~~~~Ei~il~~l~HpnIv~l~~ 314 (480)
.++|.+.+.||+|+||.||+|...+ +..+|+|+........ + ....+...+..+.|+||+++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 3579999999999999999997644 4567777654322111 1 1223344566779999999998
Q ss_pred EEecCC----eeEEEEeccCCCHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceE
Q 011660 315 YCHSKE----MYAIVYNLLNGSLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQ 387 (480)
Q Consensus 315 ~~~~~~----~~~lV~e~~~GsL~~~l~---~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~k 387 (480)
++.... ..+++++++.+++.+.++ ..++..+..++.|++.||.|||+. +|+||||||+|||++.+ +.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~-~~~~ 166 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGN-NRGY 166 (294)
T ss_pred eeeEecCCceEEEEEEehhccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCC-CcEE
Confidence 765443 346778887777766664 356777889999999999999999 99999999999999988 6899
Q ss_pred Eeeeccccccccccccc--cCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 388 LSDFGAAMVHHQSHQVS--ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 388 L~DFGla~~~~~~~~~~--~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
|+|||+|+......... .........||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~ 238 (294)
T PHA02882 167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGH 238 (294)
T ss_pred EEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcccc
Confidence 99999997653221111 11122335799999999999999999999999999999999999999987743
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=265.41 Aligned_cols=191 Identities=27% Similarity=0.444 Sum_probs=163.1
Q ss_pred cCCCCceeecccCceEEEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEEE-ecCCeeEEEEecc-
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYC-HSKEMYAIVYNLL- 329 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-~~~~~~~lV~e~~- 329 (480)
++|.+.+.||+|+||.||++.. .+..+|+|.++... ..+.+.+|+.+++.++|+|++++++++ .+++..++++||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~ 83 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 83 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc-hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCC
Confidence 4688999999999999999976 47789999986543 356788999999999999999999975 4556789999999
Q ss_pred CCCHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccc
Q 011660 330 NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (480)
Q Consensus 330 ~GsL~~~l~~-----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (480)
+|+|.+++.. +++.....++.|++.||.|||+. +|+||||||+||+++++ +.+||+|||++......
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~-~~~kl~dfg~~~~~~~~---- 155 (256)
T cd05082 84 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSED-NVAKVSDFGLTKEASST---- 155 (256)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCC-CcEEecCCccceecccc----
Confidence 5799999854 56788899999999999999998 99999999999999988 78999999998643221
Q ss_pred cCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 405 ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 405 ~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 156 ----~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~ 204 (256)
T cd05082 156 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 204 (256)
T ss_pred ----CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC
Confidence 112345678999999998899999999999999999997 999997653
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=273.78 Aligned_cols=199 Identities=28% Similarity=0.465 Sum_probs=166.3
Q ss_pred hcCCCCceeecccCceEEEEEEec------CCcEEEEEEeccCCcc--HHHHHHHHHHHhcC-CCCCeeeEEEEEecCCe
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHV------DGQVAAVKVLKCTNWS--EEEVLREVELLSSI-KHENIVRIIGYCHSKEM 321 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~~~~~~~~--~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~ 321 (480)
.++|+..+.||+|+||.||++... +...+|+|.++..... ..++.+|+++++.+ +||||+++++++..++.
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP 90 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence 456889999999999999999753 2368999998754322 24578999999999 89999999999999999
Q ss_pred eEEEEecc-CCCHHHHHH-------------------hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEec
Q 011660 322 YAIVYNLL-NGSLKQYLK-------------------QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSE 381 (480)
Q Consensus 322 ~~lV~e~~-~GsL~~~l~-------------------~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~ 381 (480)
++++|||+ +|+|.+++. .+++..++.++.|++.||.|||+. +|+||||||+||+++.
T Consensus 91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~ 167 (293)
T cd05053 91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTE 167 (293)
T ss_pred eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcC
Confidence 99999998 789999984 267788899999999999999998 9999999999999998
Q ss_pred CCCceEEeeeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 382 NFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 382 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
+ +.++|+|||+++....... ........++..|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus 168 ~-~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 239 (293)
T cd05053 168 D-HVMKIADFGLARDIHHIDY---YRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 239 (293)
T ss_pred C-CeEEeCccccccccccccc---eeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC
Confidence 8 7899999999975443211 111122345678999999998999999999999999999998 999997654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=266.01 Aligned_cols=200 Identities=25% Similarity=0.380 Sum_probs=166.8
Q ss_pred hhhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc-cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEE
Q 011660 249 HLTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW-SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (480)
Q Consensus 249 ~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 326 (480)
..++++.....||+|+||.||+|.. .++..+|+|.+..... ..+.+.+|+.+++.++|+||+++++++..++..++++
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 3456677778999999999999975 4578899998875543 3456889999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHh----C--CHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccc
Q 011660 327 NLL-NGSLKQYLKQ----L--KWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (480)
Q Consensus 327 e~~-~GsL~~~l~~----~--~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~ 399 (480)
||+ +++|.+++.. + +...+..++.|++.||.|||+. +|+||||||+||+++.+.+.++|+|||++.....
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 161 (268)
T cd06624 85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161 (268)
T ss_pred ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence 999 6799999853 3 6677788899999999999999 9999999999999987546899999999865432
Q ss_pred ccccccCccccccccCCCccccccccCCC--CCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 400 SHQVSENVKPVNVVGTFGYLAPEYMMYGK--VDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 400 ~~~~~~~~~~~~~~GT~~y~APE~~~~~~--~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.. .......|++.|+|||++.... ++.++|+||||+++|+|++|+.||....
T Consensus 162 ~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~ 215 (268)
T cd06624 162 IN-----PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELG 215 (268)
T ss_pred CC-----CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcccc
Confidence 11 1122345899999999987644 7899999999999999999999997643
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=272.60 Aligned_cols=198 Identities=28% Similarity=0.409 Sum_probs=166.6
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCcc---HHHHHHHHHHHhcCCCCCeeeEEEEEecC--CeeEE
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSK--EMYAI 324 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~l 324 (480)
.++|++.+.||+|+||.||+|.. .+|+.||+|+++..... ...+.+|+.+++.++|+||+++++++.+. +.+++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 46799999999999999999976 56899999998754322 23467899999999999999999998654 56899
Q ss_pred EEeccCCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccc
Q 011660 325 VYNLLNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (480)
Q Consensus 325 V~e~~~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (480)
||||+.++|.+++.. +.+.++..++.|++.||.|||+. +++||||||+||+++.+ +.++|+|||++......
T Consensus 86 v~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~-~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 86 VMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDK-GCLKIADFGLARTYGLP 161 (309)
T ss_pred EEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCC-CCEEECccceeeecCCc
Confidence 999999999888854 68889999999999999999999 99999999999999988 78999999998654332
Q ss_pred cccccCccccccccCCCccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 401 HQVSENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 401 ~~~~~~~~~~~~~GT~~y~APE~~~~-~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
. .......+++.|+|||.+.+ ..++.++|||||||++|||++|++||...+.
T Consensus 162 ~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~ 214 (309)
T cd07845 162 A-----KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE 214 (309)
T ss_pred c-----CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 1 11123346888999998865 4579999999999999999999999986553
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=270.35 Aligned_cols=199 Identities=24% Similarity=0.349 Sum_probs=165.9
Q ss_pred hcCCCCceeecccCceEEEEEEecC-----CcEEEEEEeccCCc--cHHHHHHHHHHHhcCCCCCeeeEEEEEec-CCee
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHVD-----GQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHS-KEMY 322 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~~-----g~~vAvK~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~ 322 (480)
.++|.+.+.||+|+||.||+|.+.+ +..+++|.++.... ....+.+|+.+++.++||||+++++++.. +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4578899999999999999997755 68899998874432 23557899999999999999999998765 5678
Q ss_pred EEEEecc-CCCHHHHHHh-----------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEee
Q 011660 323 AIVYNLL-NGSLKQYLKQ-----------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSD 390 (480)
Q Consensus 323 ~lV~e~~-~GsL~~~l~~-----------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~D 390 (480)
+++++|+ .|+|.+++.. +.+.++..++.|++.||.|||+. +++||||||+||+++++ +.+||+|
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~-~~~kl~d 160 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEE-LQVKITD 160 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCC-CcEEECC
Confidence 8999998 6899999843 56888899999999999999998 99999999999999988 6899999
Q ss_pred eccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 391 FGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 391 FGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
||+++......... ......++..|+|||++.+..++.++|||||||++|||++ |+.||...+
T Consensus 161 ~g~~~~~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 224 (280)
T cd05043 161 NALSRDLFPMDYHC---LGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID 224 (280)
T ss_pred CCCcccccCCceEE---eCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC
Confidence 99996543221111 1112346778999999998899999999999999999999 999997653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=265.58 Aligned_cols=199 Identities=28% Similarity=0.391 Sum_probs=165.8
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCcc------HHHHHHHHHHHhcCCCCCeeeEEEEEec--CCee
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS------EEEVLREVELLSSIKHENIVRIIGYCHS--KEMY 322 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~------~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~ 322 (480)
.+|...+.||+|+||.||++.. .+++.+|+|.++..... ...+.+|+.+++.++||||+++++++.+ .+.+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4689999999999999999976 45899999998654211 2357789999999999999999998865 3678
Q ss_pred EEEEecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccc
Q 011660 323 AIVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (480)
Q Consensus 323 ~lV~e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~ 398 (480)
++++||+ +++|.+++.. +++.....++.|++.||.|||+. +|+||||||+||+++.+ +.++|+|||++....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~-~~~~l~dfg~~~~~~ 157 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSA-GNVKLGDFGASKRLQ 157 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCC-CCEEEccCCCccccc
Confidence 8999999 5789998853 67888889999999999999998 99999999999999988 689999999986543
Q ss_pred cccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 399 QSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 399 ~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
..... ........|+..|+|||.+.+..++.++|+|||||++|||++|+.||....
T Consensus 158 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~ 213 (266)
T cd06651 158 TICMS--GTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYE 213 (266)
T ss_pred ccccc--CCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccc
Confidence 21111 111123468999999999998889999999999999999999999998653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=271.42 Aligned_cols=197 Identities=26% Similarity=0.372 Sum_probs=167.4
Q ss_pred cCCCCceeecccCceEEEEEEec-CCcEEEEEEeccCCcc---HHHHHHHHHHHhcCCCCCeeeEEEEEecC--CeeEEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSK--EMYAIV 325 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~lV 325 (480)
++|++.+.||+|+||.||+|... +++.+|+|.++..... ...+.+|+.+++.++||||+++++++... +..+++
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888999999999999999774 5889999999754322 23467899999999999999999998877 899999
Q ss_pred EeccCCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccc
Q 011660 326 YNLLNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (480)
Q Consensus 326 ~e~~~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (480)
+||+.++|.+++.. +++.+...++.|++.||.|||+. +++|+||||+||+++.+ +.++|+|||++.......
T Consensus 85 ~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~-~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 85 MEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNR-GILKICDFGLAREYGSPL 160 (293)
T ss_pred ehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCC-CcEEEeecCceeeccCCc
Confidence 99999999888843 78889999999999999999999 99999999999999998 789999999986543321
Q ss_pred ccccCccccccccCCCccccccccCCC-CCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 402 QVSENVKPVNVVGTFGYLAPEYMMYGK-VDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 402 ~~~~~~~~~~~~GT~~y~APE~~~~~~-~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
.......+++.|+|||.+.+.. ++.++|+||||+++|||++|++||.....
T Consensus 161 -----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~ 212 (293)
T cd07843 161 -----KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSE 212 (293)
T ss_pred -----cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 1122345789999999887654 68999999999999999999999986553
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=266.37 Aligned_cols=200 Identities=26% Similarity=0.435 Sum_probs=168.4
Q ss_pred CCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc-------cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEE
Q 011660 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW-------SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAI 324 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~-------~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 324 (480)
+|+..+.||+|+||.||++.. .+++.+|+|+++.... ..+.+.+|++++++++||||+++++++.+.+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 478889999999999999965 6689999999864331 13467899999999999999999999999999999
Q ss_pred EEecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccc
Q 011660 325 VYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (480)
Q Consensus 325 V~e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (480)
|+||+ +++|.+++.+ +++.....++.|++.||.|||+. +++|+||+|+||+++.+...++|+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 99999 5789998854 67788899999999999999999 99999999999999877346999999998655432
Q ss_pred cccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 401 ~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
... .........||..|+|||.+.+..++.++|+||+||++|+|++|+.||....
T Consensus 158 ~~~-~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 212 (268)
T cd06630 158 GTG-AGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEK 212 (268)
T ss_pred ccc-CCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 111 1111224568999999999988889999999999999999999999997554
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=264.01 Aligned_cols=192 Identities=28% Similarity=0.455 Sum_probs=168.2
Q ss_pred cCCCCceeecccCceEEEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc-C
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-N 330 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~-~ 330 (480)
++|++.+.||+|+||.||++.. .|+.+|+|.++......+.+..|+.+++.++|+||+++++++.+.+..++||||+ +
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 84 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAK 84 (256)
T ss_pred hhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCC
Confidence 4688999999999999999976 4789999999876555667899999999999999999999999889999999999 5
Q ss_pred CCHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccccc
Q 011660 331 GSLKQYLK-----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE 405 (480)
Q Consensus 331 GsL~~~l~-----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~ 405 (480)
++|.+++. .+.+.....++.|++.||.|||+. +++|+||||+||+++.+ +.++|+|||.+.......
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~-~~~~l~d~g~~~~~~~~~---- 156 (256)
T cd05039 85 GSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSED-LVAKVSDFGLAKEASQGQ---- 156 (256)
T ss_pred CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCC-CCEEEccccccccccccc----
Confidence 79999985 368889999999999999999999 99999999999999988 689999999986542211
Q ss_pred CccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 406 NVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 406 ~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
....++..|+|||.+..+.++.++||||||+++|||++ |+.||....
T Consensus 157 ----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 204 (256)
T cd05039 157 ----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 204 (256)
T ss_pred ----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC
Confidence 12234668999999998899999999999999999997 999997664
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=263.59 Aligned_cols=195 Identities=25% Similarity=0.365 Sum_probs=169.1
Q ss_pred CCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCC---ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEec
Q 011660 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN---WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~ 328 (480)
+|+..+.||+|+||.||.+.. .+++.+++|.+.... ....++.+|++++++++|+||+++++++.+.+.++++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 488899999999999999865 568899999886543 2335688999999999999999999999999999999999
Q ss_pred c-CCCHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccc
Q 011660 329 L-NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 329 ~-~GsL~~~l~~-----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (480)
+ +|+|.+++.. +++.++..++.|++.||.|||+. +++|+||+|+||+++.+ +.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~-~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKA-GLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCC-CCEEECcCcceEEcccccc
Confidence 9 6799999854 67888899999999999999998 99999999999999998 6899999999865433221
Q ss_pred cccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 403 ~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
......|++.|+|||.+.+..++.++|+||||+++|||++|+.||....
T Consensus 157 -----~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~ 205 (256)
T cd08221 157 -----MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN 205 (256)
T ss_pred -----cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC
Confidence 2234568999999999988889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=273.87 Aligned_cols=198 Identities=24% Similarity=0.422 Sum_probs=163.5
Q ss_pred cCCCCceeecccCceEEEEEEecC---------------CcEEEEEEeccCCc--cHHHHHHHHHHHhcCCCCCeeeEEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHVD---------------GQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIG 314 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~~---------------g~~vAvK~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~ 314 (480)
++|++.+.||+|+||.||++.... ...+|+|.++.... ....+.+|++++++++||||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 468999999999999999986532 23589999875432 2346889999999999999999999
Q ss_pred EEecCCeeEEEEecc-CCCHHHHHHh---------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEE
Q 011660 315 YCHSKEMYAIVYNLL-NGSLKQYLKQ---------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNIL 378 (480)
Q Consensus 315 ~~~~~~~~~lV~e~~-~GsL~~~l~~---------------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NIL 378 (480)
++...+..++||||+ +++|.+++.. +.+..+..++.|++.||.|||+. +++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEE
Confidence 999999999999999 6799998843 46677888999999999999999 9999999999999
Q ss_pred EecCCCceEEeeeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc--CCCCCCCCc
Q 011660 379 LSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT--GKEAIQTNK 456 (480)
Q Consensus 379 l~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt--G~~pf~~~~ 456 (480)
++++ +.+||+|||++........ ........+++.|+|||++.++.++.++|||||||++|||++ |..||....
T Consensus 162 l~~~-~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~ 237 (295)
T cd05097 162 VGNH-YTIKIADFGMSRNLYSGDY---YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS 237 (295)
T ss_pred EcCC-CcEEecccccccccccCcc---eeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence 9988 6899999999865432111 111123345788999999999999999999999999999988 667887654
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=262.93 Aligned_cols=195 Identities=29% Similarity=0.425 Sum_probs=166.2
Q ss_pred CCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc---cHHHHHHHHHHHhcCCCCCeeeEEEEEec-CCeeEEEEe
Q 011660 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVRIIGYCHS-KEMYAIVYN 327 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~lV~e 327 (480)
+|++.+.||+|++|.||++.. .+++.+|+|.+..... ..+.+.+|++++++++|||++++++.+.. +..++++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 488899999999999999965 4578999999875432 23457889999999999999999998764 446889999
Q ss_pred cc-CCCHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccc
Q 011660 328 LL-NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (480)
Q Consensus 328 ~~-~GsL~~~l~~-----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (480)
|+ +++|.+++.. +++.++..++.+++.||.|||+. +++|+||||+||+++.+ +.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~-~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRT-NIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecC-CcEEEecccceEEecccC
Confidence 99 5789988843 68888999999999999999999 99999999999999988 689999999986543211
Q ss_pred ccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 402 QVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 402 ~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.......|++.|+|||++.+..++.++|+|||||++|||++|+.||...+
T Consensus 157 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 206 (257)
T cd08223 157 -----DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD 206 (257)
T ss_pred -----CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 12234568999999999999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=270.19 Aligned_cols=203 Identities=28% Similarity=0.432 Sum_probs=169.0
Q ss_pred HHHhhhhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCccHHHHHHHHHHHhcC-CCCCeeeEEEEEe-----
Q 011660 245 QELCHLTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSI-KHENIVRIIGYCH----- 317 (480)
Q Consensus 245 ~el~~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~----- 317 (480)
.++......|++.+.||+|+||.||+|.. .+++.+|+|++.........+..|+.+++++ +||||+++++++.
T Consensus 9 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 88 (282)
T cd06636 9 SALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPP 88 (282)
T ss_pred hhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhccccc
Confidence 34444567799999999999999999976 5688999999876655556788999999998 7999999999985
Q ss_pred -cCCeeEEEEecc-CCCHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEee
Q 011660 318 -SKEMYAIVYNLL-NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSD 390 (480)
Q Consensus 318 -~~~~~~lV~e~~-~GsL~~~l~~-----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~D 390 (480)
..+.++++|||+ .|+|.+++.. +++..+..++.|++.||.|||+. +|+|+||||+||+++++ +.++|+|
T Consensus 89 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~-~~~~l~d 164 (282)
T cd06636 89 GHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTEN-AEVKLVD 164 (282)
T ss_pred CCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCC-CCEEEee
Confidence 246789999999 5689998854 56777888999999999999999 99999999999999988 6899999
Q ss_pred eccccccccccccccCccccccccCCCcccccccc-----CCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 391 FGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMM-----YGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 391 FGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
||++....... .......|++.|+|||.+. ...++.++|+|||||++|||++|+.||....
T Consensus 165 fg~~~~~~~~~-----~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~ 230 (282)
T cd06636 165 FGVSAQLDRTV-----GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMH 230 (282)
T ss_pred Ccchhhhhccc-----cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccC
Confidence 99986432211 1223457899999999876 3568889999999999999999999997654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=275.34 Aligned_cols=223 Identities=24% Similarity=0.396 Sum_probs=175.5
Q ss_pred hcCCCC-ceeecccCceEEEEEEe-cCCcEEEEEEeccCCccH---------------HHHHHHHHHHhcCCCCCeeeEE
Q 011660 251 THNFSP-KMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSE---------------EEVLREVELLSSIKHENIVRII 313 (480)
Q Consensus 251 ~~~f~~-~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~~---------------~~~~~Ei~il~~l~HpnIv~l~ 313 (480)
.++|.. .+.||+|+||.||++.. .+++.+|+|.++...... ..+.+|+++++.++||||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 455654 57799999999999975 468999999986543221 2467899999999999999999
Q ss_pred EEEecCCeeEEEEeccCCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEee
Q 011660 314 GYCHSKEMYAIVYNLLNGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSD 390 (480)
Q Consensus 314 ~~~~~~~~~~lV~e~~~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~D 390 (480)
+++..++..+++|||+.|+|.+++.. ++......++.|++.||.|||+. +|+|+||+|+||+++.+ +.++|+|
T Consensus 87 ~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~-~~~kl~d 162 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSK-GICKIAD 162 (335)
T ss_pred EEEecCCcEEEEEeccccCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCC-CCEEECC
Confidence 99999999999999999999999854 68888899999999999999998 99999999999999988 7899999
Q ss_pred ecccccccccccc---------ccCccccccccCCCccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCcccch
Q 011660 391 FGAAMVHHQSHQV---------SENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKANRE 460 (480)
Q Consensus 391 FGla~~~~~~~~~---------~~~~~~~~~~GT~~y~APE~~~~~-~~~~k~DvwSlGvil~eLltG~~pf~~~~~~~e 460 (480)
||++......... ..........+++.|+|||.+.+. .++.++|+|||||++|||++|++||...+..
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~-- 240 (335)
T PTZ00024 163 FGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI-- 240 (335)
T ss_pred ccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--
Confidence 9998654411100 001112234578899999998764 4689999999999999999999999876532
Q ss_pred hHHHHHHHHhCCCCCCCCC
Q 011660 461 SLVLWYYVLAGKVFAQQWP 479 (480)
Q Consensus 461 ~l~~~~~~~~~~~~~~~~~ 479 (480)
..........+.+....||
T Consensus 241 ~~~~~i~~~~~~~~~~~~~ 259 (335)
T PTZ00024 241 DQLGRIFELLGTPNEDNWP 259 (335)
T ss_pred HHHHHHHHHhCCCchhhCc
Confidence 2222333344555555554
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=264.53 Aligned_cols=192 Identities=29% Similarity=0.482 Sum_probs=166.4
Q ss_pred eeecccCceEEEEEEecC----CcEEEEEEeccCCcc--HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc-C
Q 011660 258 MLIGQGGNSKVYRTNHVD----GQVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-N 330 (480)
Q Consensus 258 ~~LG~G~fg~Vy~~~~~~----g~~vAvK~~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~-~ 330 (480)
+.||+|+||.||++.... +..+++|+++..... .+.+.+|+++++.++|+||+++++++.+...++++|||+ +
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 369999999999997643 789999999876544 467889999999999999999999999999999999999 7
Q ss_pred CCHHHHHHh------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccc
Q 011660 331 GSLKQYLKQ------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (480)
Q Consensus 331 GsL~~~l~~------------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~ 398 (480)
|+|.+++.. +++.+...++.|++.||.|||+. +++|+||||+||+++.+ +.++|+|||.+....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~-~~~~l~dfg~~~~~~ 156 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGED-LVVKISDFGLSRDVY 156 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCC-CcEEEcccccccccc
Confidence 899999854 47888999999999999999998 99999999999999998 789999999997654
Q ss_pred cccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 399 QSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 399 ~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
.... ........+++.|+|||.+....++.++|||||||++|||++ |..||....
T Consensus 157 ~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 212 (262)
T cd00192 157 DDDY---YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS 212 (262)
T ss_pred cccc---cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC
Confidence 3221 122334567899999999998899999999999999999999 699998764
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=284.27 Aligned_cols=198 Identities=25% Similarity=0.422 Sum_probs=164.4
Q ss_pred cCCCCceeecccCceEEEEEEec------CCcEEEEEEeccCCcc--HHHHHHHHHHHhcCC-CCCeeeEEEEEecCCee
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHV------DGQVAAVKVLKCTNWS--EEEVLREVELLSSIK-HENIVRIIGYCHSKEMY 322 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~~~~~~~~--~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~ 322 (480)
++|.+.+.||+|+||.||+|.+. .++.||+|+++..... .+.+..|+++|.++. ||||++++++|.+.+..
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~ 116 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI 116 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence 45778889999999999999742 3468999999765322 246889999999997 99999999999999999
Q ss_pred EEEEecc-CCCHHHHHHh--------------------------------------------------------------
Q 011660 323 AIVYNLL-NGSLKQYLKQ-------------------------------------------------------------- 339 (480)
Q Consensus 323 ~lV~e~~-~GsL~~~l~~-------------------------------------------------------------- 339 (480)
++|+||+ +|+|.+++..
T Consensus 117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (401)
T cd05107 117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK 196 (401)
T ss_pred EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence 9999999 7899998843
Q ss_pred ---------------------------------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEe
Q 011660 340 ---------------------------------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLS 380 (480)
Q Consensus 340 ---------------------------------------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~ 380 (480)
+++.....++.|++.||.|||+. +|+||||||+|||++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiLl~ 273 (401)
T cd05107 197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLIC 273 (401)
T ss_pred hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEEEe
Confidence 23455677899999999999998 999999999999999
Q ss_pred cCCCceEEeeeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 381 ENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 381 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
++ +.++|+|||+++........ .......|++.|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus 274 ~~-~~~kL~DfGla~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~ 346 (401)
T cd05107 274 EG-KLVKICDFGLARDIMRDSNY---ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP 346 (401)
T ss_pred CC-CEEEEEecCcceeccccccc---ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 88 68999999998654321111 11223467889999999998899999999999999999998 899997654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=271.67 Aligned_cols=201 Identities=26% Similarity=0.389 Sum_probs=167.9
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc----cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~----~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 326 (480)
++|++.+.||+|+||.||++.+ .+++.||+|.+..... ....+..|+++++.++||||+++++.+.+++.++++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 3688999999999999999976 4578999999875432 2245778999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccc
Q 011660 327 NLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 327 e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (480)
||+ +|+|.+++.. +.+.....++.|++.||.|||+. +++||||||+||+++.+ +.++|+|||+++.......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~-~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSM-GHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCC-CCEEEeeCCCccccCcCcc
Confidence 999 5789999854 67888888999999999999998 99999999999999988 7899999999863211100
Q ss_pred c----------ccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 403 V----------SENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 403 ~----------~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
. ..........|+..|+|||.+.+..++.++|+|||||++|||++|..||.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~ 220 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT 220 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 0 00111123568899999999998899999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=294.54 Aligned_cols=197 Identities=28% Similarity=0.404 Sum_probs=164.8
Q ss_pred cCCCCceeecccCceEEEEEEecC-CcEEEEEEecc-CCccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHVD-GQVAAVKVLKC-TNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~~-g~~vAvK~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~ 329 (480)
+.|.++.-||.|+||+||++...+ +-..|.|++.- +....++++-||+||..++||+|++|++.|.-++.++|+.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 347777789999999999996544 55677888853 3344578999999999999999999999887778899999999
Q ss_pred C-CCHHHHH----HhCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccc
Q 011660 330 N-GSLKQYL----KQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (480)
Q Consensus 330 ~-GsL~~~l----~~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (480)
+ |-++..+ ..+.+.++..+++|++.||.|||++ +|||||||..|||++-| |.++|+|||.+-- ...
T Consensus 112 ~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~Tld-GdirLADFGVSAK-----n~~ 182 (1187)
T KOG0579|consen 112 GGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLD-GDIRLADFGVSAK-----NKS 182 (1187)
T ss_pred CCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEec-CcEeeeccccccc-----chh
Confidence 5 5566555 4588999999999999999999999 99999999999999999 7999999998622 122
Q ss_pred cCccccccccCCCcccccccc-----CCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 405 ENVKPVNVVGTFGYLAPEYMM-----YGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 405 ~~~~~~~~~GT~~y~APE~~~-----~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
.......++|||+|||||+++ ..+|++++||||||+.|.||.-+.+|-..-++
T Consensus 183 t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp 240 (1187)
T KOG0579|consen 183 TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP 240 (1187)
T ss_pred HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch
Confidence 333445789999999999875 56899999999999999999999999776553
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=264.09 Aligned_cols=191 Identities=29% Similarity=0.484 Sum_probs=158.3
Q ss_pred eecccCceEEEEEEe---cCCcEEEEEEeccCCcc---HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc-CC
Q 011660 259 LIGQGGNSKVYRTNH---VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NG 331 (480)
Q Consensus 259 ~LG~G~fg~Vy~~~~---~~g~~vAvK~~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~-~G 331 (480)
.||+|+||.||+|.. .+++.+|+|+++..... .+++..|+.+++.++||||+++++++.. +.++++|||+ .|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 489999999999954 35789999998755432 3568899999999999999999999865 4678899998 57
Q ss_pred CHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccCcc
Q 011660 332 SLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVK 408 (480)
Q Consensus 332 sL~~~l~---~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~ 408 (480)
+|.+++. .+++.....++.|++.||.|||+. +|+||||||+||+++.+ +.++|+|||++.......... ..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~-~~~kl~Dfg~~~~~~~~~~~~--~~ 154 (257)
T cd05116 81 PLNKFLQKNKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQ-HYAKISDFGLSKALGADENYY--KA 154 (257)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCC-CeEEECCCccccccCCCCCee--ee
Confidence 8999985 378888999999999999999998 99999999999999998 689999999986543322111 11
Q ss_pred ccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 409 PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 409 ~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
.....+++.|+|||.+....++.++|+|||||++|||++ |+.||....
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 203 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMK 203 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 122345679999999988889999999999999999998 999998654
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=288.89 Aligned_cols=196 Identities=26% Similarity=0.357 Sum_probs=173.5
Q ss_pred cCCCCceeecccCceEEEEEEecCCc-EEEEEEeccCCcc----HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHVDGQ-VAAVKVLKCTNWS----EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~~g~-~vAvK~~~~~~~~----~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 326 (480)
.+++...-||-|+||+|=++...+.+ .+|+|++++.... .+.+..|.+||..++.|+|++||-.|.+....|+.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 34556667999999999998765443 4899999876532 356889999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccc
Q 011660 327 NLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 327 e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (480)
|.| +|.|...|+. |+..+...++..+++|++|||.+ +||+|||||+|++++.+ |-+||.|||+|+...
T Consensus 500 EaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~-Gy~KLVDFGFAKki~---- 571 (732)
T KOG0614|consen 500 EACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNR-GYLKLVDFGFAKKIG---- 571 (732)
T ss_pred HhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccC-CceEEeehhhHHHhc----
Confidence 999 8999999964 78888888999999999999999 99999999999999999 899999999997644
Q ss_pred cccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 403 ~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
.+.+..++||||.|.|||++.+...+.++|.||||+++|||++|.+||++.++
T Consensus 572 --~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dp 624 (732)
T KOG0614|consen 572 --SGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDP 624 (732)
T ss_pred --cCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCch
Confidence 34455689999999999999999999999999999999999999999998875
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=267.70 Aligned_cols=198 Identities=31% Similarity=0.468 Sum_probs=167.5
Q ss_pred hhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCccHHHHHHHHHHHhcC-CCCCeeeEEEEEecCC------e
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSI-KHENIVRIIGYCHSKE------M 321 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~------~ 321 (480)
.+++|++.+.||+|+||.||+|.. .+++.+++|++.......+.+.+|+.+++++ +||||+++++++.+.. .
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ 83 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence 467899999999999999999977 4578999999987766667889999999999 7999999999996544 4
Q ss_pred eEEEEecc-CCCHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecc
Q 011660 322 YAIVYNLL-NGSLKQYLK-------QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGA 393 (480)
Q Consensus 322 ~~lV~e~~-~GsL~~~l~-------~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGl 393 (480)
++++|||+ +++|.+++. .+.+..+..++.|++.||.|||+. +++|+||+|+||+++.+ +.++|+|||+
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~-~~~~l~d~~~ 159 (275)
T cd06608 84 LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKN-AEVKLVDFGV 159 (275)
T ss_pred EEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccC-CeEEECCCcc
Confidence 89999999 568888874 367788889999999999999998 99999999999999998 6899999999
Q ss_pred ccccccccccccCccccccccCCCccccccccC-----CCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 394 AMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY-----GKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 394 a~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~-----~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
+....... .......|++.|+|||++.. ..++.++|||||||+||||++|+.||....
T Consensus 160 ~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 222 (275)
T cd06608 160 SAQLDSTL-----GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMH 222 (275)
T ss_pred ceecccch-----hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccc
Confidence 86543211 12234568999999998753 346789999999999999999999997543
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=266.69 Aligned_cols=199 Identities=25% Similarity=0.397 Sum_probs=165.5
Q ss_pred cCCCCceeecccCceEEEEEEec-C---CcEEEEEEeccCCc--cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHV-D---GQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~-~---g~~vAvK~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 325 (480)
.+|++.+.||+|+||.||+|... + +..+|+|.++.... ..+.+..|+.+++.++||||+++++++.+++..+++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46888999999999999999653 2 34799999875432 235688999999999999999999999999999999
Q ss_pred Eecc-CCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccc
Q 011660 326 YNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (480)
Q Consensus 326 ~e~~-~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (480)
|||+ +|+|.+++.. +++.+...++.|++.||.|||+. +++||||||+|||++.+ +.++|+|||++......
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~-~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSN-LVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCC-CeEEeCCCCcccccccc
Confidence 9999 6789999853 67888899999999999999999 99999999999999988 68999999998654332
Q ss_pred cccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 401 ~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
... ........++..|+|||.+.+..++.++|+|||||++|||++ |+.||....
T Consensus 160 ~~~--~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~ 214 (267)
T cd05066 160 PEA--AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMS 214 (267)
T ss_pred cce--eeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCC
Confidence 111 111112234568999999999999999999999999999886 999997654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-32 Score=266.90 Aligned_cols=188 Identities=31% Similarity=0.455 Sum_probs=154.8
Q ss_pred eecccCceEEEEEEe-cCCcEEEEEEeccCCcc----HHHHHHHHHHH---hcCCCCCeeeEEEEEecCCeeEEEEecc-
Q 011660 259 LIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS----EEEVLREVELL---SSIKHENIVRIIGYCHSKEMYAIVYNLL- 329 (480)
Q Consensus 259 ~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~----~~~~~~Ei~il---~~l~HpnIv~l~~~~~~~~~~~lV~e~~- 329 (480)
+||+|+||.||++.. .+++.+|+|.+.+.... ...+..|..++ ...+||||+.+++++..++.+++||||+
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999976 45899999998654321 22334454443 4457999999999999989999999999
Q ss_pred CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccC
Q 011660 330 NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSEN 406 (480)
Q Consensus 330 ~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~ 406 (480)
+|+|.+++.. +.+.....++.|++.||.|||+. +|+||||||+|||++++ +.++|+|||++......
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~-~~~~l~dfg~~~~~~~~------ 150 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEH-GHVRISDLGLACDFSKK------ 150 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCC-CCEEEccCCcceecccc------
Confidence 6789988843 78899999999999999999999 99999999999999988 68999999998543221
Q ss_pred ccccccccCCCcccccccc-CCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 407 VKPVNVVGTFGYLAPEYMM-YGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 407 ~~~~~~~GT~~y~APE~~~-~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
......||+.|+|||.+. +..++.++|+|||||++|||++|+.||.....
T Consensus 151 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 201 (279)
T cd05633 151 -KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 201 (279)
T ss_pred -CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCC
Confidence 112346999999999886 45689999999999999999999999976543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=271.11 Aligned_cols=196 Identities=28% Similarity=0.426 Sum_probs=168.4
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCC--ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEec
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN--WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~ 328 (480)
++|++.+.||+|+||.||++.. .+++.+|+|++.... ...+.+.+|+++++.++||||+++++++...+.+++|+||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 4688889999999999999976 468899999886543 2345788999999999999999999999999999999999
Q ss_pred c-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccc
Q 011660 329 L-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (480)
Q Consensus 329 ~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (480)
+ +|+|.+++.. +.+.....++.+++.||.|||+.+ +++||||||+||+++++ +.++|+|||++......
T Consensus 85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~-~~~~l~d~gl~~~~~~~---- 157 (284)
T cd06620 85 MDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSR-GQIKLCDFGVSGELINS---- 157 (284)
T ss_pred CCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCC-CcEEEccCCcccchhhh----
Confidence 9 6789888854 678888999999999999999732 89999999999999988 68999999998543211
Q ss_pred cCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 405 ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 405 ~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
......||..|+|||++.+..++.++|+|||||++|||++|+.||.....
T Consensus 158 ---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~ 207 (284)
T cd06620 158 ---IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNI 207 (284)
T ss_pred ---ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccch
Confidence 11245789999999999888999999999999999999999999986543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=265.95 Aligned_cols=200 Identities=26% Similarity=0.438 Sum_probs=165.3
Q ss_pred hcCCCCceeecccCceEEEEEEec-CCc---EEEEEEeccCCc--cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEE
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHV-DGQ---VAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAI 324 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~---~vAvK~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 324 (480)
.++|+..+.||+|+||.||+|... +++ .+|+|.++.... ....+..|+++++.++||||+++++++.+.+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 356888999999999999999763 333 799999865432 23568899999999999999999999999999999
Q ss_pred EEecc-CCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccc
Q 011660 325 VYNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (480)
Q Consensus 325 V~e~~-~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~ 399 (480)
||||+ +++|.+++.. +++.++..++.|++.||.|||+. +++|+||||+||+++.+ +.++|+|||++.....
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~-~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSN-LECKVSDFGLSRVLED 159 (268)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCC-CcEEECCCccceeccc
Confidence 99999 6789999853 67888999999999999999999 99999999999999988 6899999999865433
Q ss_pred ccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 400 SHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 400 ~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
.... .........++.|+|||++.+..++.++|||||||++|||++ |+.||...+
T Consensus 160 ~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~ 215 (268)
T cd05063 160 DPEG--TYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS 215 (268)
T ss_pred cccc--ceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCC
Confidence 2111 111111223567999999998999999999999999999997 999997654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=272.13 Aligned_cols=198 Identities=23% Similarity=0.415 Sum_probs=163.8
Q ss_pred cCCCCceeecccCceEEEEEEec-----------------CCcEEEEEEeccCCc--cHHHHHHHHHHHhcCCCCCeeeE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHV-----------------DGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRI 312 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~-----------------~g~~vAvK~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l 312 (480)
++|++.+.||+|+||.||++... ++..+|+|+++.... ...++.+|+.+++.++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 46999999999999999998532 244789999975432 23568899999999999999999
Q ss_pred EEEEecCCeeEEEEecc-CCCHHHHHHh--------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCE
Q 011660 313 IGYCHSKEMYAIVYNLL-NGSLKQYLKQ--------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNI 377 (480)
Q Consensus 313 ~~~~~~~~~~~lV~e~~-~GsL~~~l~~--------------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NI 377 (480)
++++..++..+++|||+ +|+|.+++.. +.+.+...++.|++.||.|||+. +++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheE
Confidence 99999999999999999 6799999854 34567889999999999999999 999999999999
Q ss_pred EEecCCCceEEeeeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc--CCCCCCCC
Q 011660 378 LLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT--GKEAIQTN 455 (480)
Q Consensus 378 Ll~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt--G~~pf~~~ 455 (480)
|++.+ +.++|+|||++........ ........+++.|+|||...++.++.++|||||||++|||++ |..||...
T Consensus 162 li~~~-~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05095 162 LVGKN-YTIKIADFGMSRNLYSGDY---YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL 237 (296)
T ss_pred EEcCC-CCEEeccCcccccccCCcc---eeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence 99988 6899999999865432111 111122345678999999888899999999999999999998 77888754
Q ss_pred c
Q 011660 456 K 456 (480)
Q Consensus 456 ~ 456 (480)
.
T Consensus 238 ~ 238 (296)
T cd05095 238 S 238 (296)
T ss_pred C
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=263.85 Aligned_cols=190 Identities=26% Similarity=0.475 Sum_probs=156.6
Q ss_pred ecccCceEEEEEEec---CCcEEEEEEeccCCcc--HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc-CCCH
Q 011660 260 IGQGGNSKVYRTNHV---DGQVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGSL 333 (480)
Q Consensus 260 LG~G~fg~Vy~~~~~---~g~~vAvK~~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~-~GsL 333 (480)
||+|+||.||+|... ++..+|+|++...... .+.+.+|+.++++++||||+++++++.. +.+++||||+ +|+|
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~L 81 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGPL 81 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCCH
Confidence 899999999999653 3557999998755322 3568899999999999999999999864 5678999999 6899
Q ss_pred HHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccCccc
Q 011660 334 KQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKP 409 (480)
Q Consensus 334 ~~~l~----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 409 (480)
.+++. .+++.++..++.|++.||.|||+. +++||||||+|||++.+ +.+||+|||++........... ..
T Consensus 82 ~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~--~~ 155 (257)
T cd05115 82 NKFLSGKKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQ-HYAKISDFGLSKALGADDSYYK--AR 155 (257)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCC-CcEEeccCCccccccCCcccee--cc
Confidence 99985 378899999999999999999998 99999999999999988 6899999999865432211111 11
Q ss_pred cccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 410 VNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 410 ~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
....+++.|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 203 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMK 203 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCC
Confidence 12234678999999988889999999999999999996 999998654
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=270.02 Aligned_cols=199 Identities=26% Similarity=0.415 Sum_probs=166.1
Q ss_pred hcCCCCceeecccCceEEEEEEecC-----------------CcEEEEEEeccCCc--cHHHHHHHHHHHhcCCCCCeee
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHVD-----------------GQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVR 311 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~~-----------------g~~vAvK~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~ 311 (480)
..+|++.+.||+|+||.||++...+ +..+|+|.+..... ..+.+.+|+++++.++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3568999999999999999986532 24689999876542 2456889999999999999999
Q ss_pred EEEEEecCCeeEEEEecc-CCCHHHHHH--------------hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCC
Q 011660 312 IIGYCHSKEMYAIVYNLL-NGSLKQYLK--------------QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSN 376 (480)
Q Consensus 312 l~~~~~~~~~~~lV~e~~-~GsL~~~l~--------------~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~N 376 (480)
+++++..++.+++++|++ +++|.+++. .+++..+..++.|++.||.|||+. +|+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence 999999999999999999 678999984 356788899999999999999998 99999999999
Q ss_pred EEEecCCCceEEeeeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc--CCCCCCC
Q 011660 377 ILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT--GKEAIQT 454 (480)
Q Consensus 377 ILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt--G~~pf~~ 454 (480)
|+++.+ +.++|+|||++........ ........+|+.|+|||.+.+..++.++|||||||++|||++ |..||..
T Consensus 161 ili~~~-~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~ 236 (296)
T cd05051 161 CLVGKN-YTIKIADFGMSRNLYSSDY---YRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236 (296)
T ss_pred eeecCC-CceEEccccceeecccCcc---eeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence 999998 6899999999865432211 111224457889999999998899999999999999999998 7778865
Q ss_pred Cc
Q 011660 455 NK 456 (480)
Q Consensus 455 ~~ 456 (480)
..
T Consensus 237 ~~ 238 (296)
T cd05051 237 LT 238 (296)
T ss_pred cC
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-32 Score=264.80 Aligned_cols=196 Identities=29% Similarity=0.455 Sum_probs=167.0
Q ss_pred CCCceeecccCceEEEEEEec-CCcEEEEEEeccCC---ccHHHHHHHHHHHhcCCCCCeeeEEEEEecC--CeeEEEEe
Q 011660 254 FSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTN---WSEEEVLREVELLSSIKHENIVRIIGYCHSK--EMYAIVYN 327 (480)
Q Consensus 254 f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~lV~e 327 (480)
|++.+.||+|+||.||+|... +++.+|+|.++... .....+.+|+++++.++|||++++++++.+. +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567889999999999999764 58899999998653 2235688999999999999999999999887 89999999
Q ss_pred ccCCCHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccc
Q 011660 328 LLNGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (480)
Q Consensus 328 ~~~GsL~~~l~----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (480)
|+.++|.+++. .+++..+..++.|+++||.|||+. +++|+||||+||+++++ +.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~-~~~~l~d~g~~~~~~~~~~- 155 (287)
T cd07840 81 YMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINND-GVLKLADFGLARPYTKRNS- 155 (287)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCC-CCEEEccccceeeccCCCc-
Confidence 99989998884 378888899999999999999998 99999999999999998 7899999999875443221
Q ss_pred ccCccccccccCCCccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 404 SENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 404 ~~~~~~~~~~GT~~y~APE~~~~-~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
.......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+.
T Consensus 156 ---~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~ 207 (287)
T cd07840 156 ---ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE 207 (287)
T ss_pred ---ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 11223457889999998765 4578999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=276.79 Aligned_cols=202 Identities=26% Similarity=0.401 Sum_probs=170.5
Q ss_pred CHHHHhhhhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCcc---HHHHHHHHHHHhcCCCCCeeeEEEEEec
Q 011660 243 TSQELCHLTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHS 318 (480)
Q Consensus 243 ~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 318 (480)
..+++-.++++|.+.+.||+|+||.||++.. .+++.||+|++++.... .+.+.+|++++++++||||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 3455666788999999999999999999965 56899999999754322 3457789999999999999999998853
Q ss_pred C------CeeEEEEeccCCCHHHHHHh--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEee
Q 011660 319 K------EMYAIVYNLLNGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSD 390 (480)
Q Consensus 319 ~------~~~~lV~e~~~GsL~~~l~~--~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~D 390 (480)
. +..++++++++++|.+++.. +++..+..++.|+++||.|||+. +|+||||||+||+++++ +.++|+|
T Consensus 88 ~~~~~~~~~~~lv~~~~~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~-~~~kl~d 163 (345)
T cd07877 88 ARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNED-CELKILD 163 (345)
T ss_pred cccccccccEEEEehhcccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCC-CCEEEec
Confidence 2 35788999999999888853 88899999999999999999999 99999999999999998 6899999
Q ss_pred eccccccccccccccCccccccccCCCccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 391 FGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 391 FGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~-~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
||++..... ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...+
T Consensus 164 fg~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~ 222 (345)
T cd07877 164 FGLARHTDD--------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 222 (345)
T ss_pred ccccccccc--------cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999864321 1234568999999998876 568899999999999999999999997544
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=262.15 Aligned_cols=194 Identities=29% Similarity=0.406 Sum_probs=167.4
Q ss_pred CCCCceeecccCceEEEEEEec-CCcEEEEEEeccCCc------cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEE
Q 011660 253 NFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNW------SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~------~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 325 (480)
+|+..+.||+|+||.||+|... +++.+++|.+..... ..+.+.+|+.+++.++||||+++++++.+++.++++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4777889999999999999764 789999999865431 235688999999999999999999999999999999
Q ss_pred Eecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccc
Q 011660 326 YNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (480)
Q Consensus 326 ~e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (480)
+||+ +++|.+++.. +++.....++.|++.||.|||+. +|+|+||+|+||+++.+ +.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~-~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTN-GVVKLADFGMAKQVVEFS 156 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCC-CCEEEccCccceeccccc
Confidence 9999 5789999854 67888888999999999999999 99999999999999988 689999999986543211
Q ss_pred ccccCccccccccCCCccccccccCCC-CCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 402 QVSENVKPVNVVGTFGYLAPEYMMYGK-VDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 402 ~~~~~~~~~~~~GT~~y~APE~~~~~~-~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
......|++.|+|||.+.... ++.++|+|||||++|+|++|+.||....
T Consensus 157 ------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~ 206 (258)
T cd06632 157 ------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE 206 (258)
T ss_pred ------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc
Confidence 123456899999999988776 8999999999999999999999997655
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=277.61 Aligned_cols=210 Identities=28% Similarity=0.402 Sum_probs=182.7
Q ss_pred hhcCCCCceeecccCceEEEEEE-ecCCcEEEEEEeccCCccHHHHHHHHHHHhcCCC--C----CeeeEEEEEecCCee
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTN-HVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKH--E----NIVRIIGYCHSKEMY 322 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~H--p----nIv~l~~~~~~~~~~ 322 (480)
++++|.+...+|+|+||+|-.+- +..+..+|+|+++.-..-.+..+.|+++|.++++ | -++++.++|+-.++.
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 47889999999999999999984 4558899999998665555677899999999943 3 378888999999999
Q ss_pred EEEEeccCCCHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecC---------------
Q 011660 323 AIVYNLLNGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN--------------- 382 (480)
Q Consensus 323 ~lV~e~~~GsL~~~l~~-----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~--------------- 382 (480)
+||+|.++-++.++|+. ++...+..|++|+++++.|||+. +++|.||||+|||+.+.
T Consensus 167 CivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~~~~~ 243 (415)
T KOG0671|consen 167 CIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKKVCFI 243 (415)
T ss_pred EEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCcccee
Confidence 99999999999999976 88899999999999999999999 99999999999998421
Q ss_pred ----CCceEEeeeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCccc
Q 011660 383 ----FHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKAN 458 (480)
Q Consensus 383 ----~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~~ 458 (480)
...++++|||.|+..... ...++.|..|.|||++.+-+++.++||||+||||+||+||...|++.+ +
T Consensus 244 r~~ks~~I~vIDFGsAtf~~e~--------hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe-n 314 (415)
T KOG0671|consen 244 RPLKSTAIKVIDFGSATFDHEH--------HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHE-N 314 (415)
T ss_pred ccCCCcceEEEecCCcceeccC--------cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCC-c
Confidence 125789999999764432 246778999999999999999999999999999999999999999988 7
Q ss_pred chhHHHHHHHHhC
Q 011660 459 RESLVLWYYVLAG 471 (480)
Q Consensus 459 ~e~l~~~~~~~~~ 471 (480)
.|+|.|+..++..
T Consensus 315 ~EHLaMMerIlGp 327 (415)
T KOG0671|consen 315 LEHLAMMERILGP 327 (415)
T ss_pred HHHHHHHHHhhCC
Confidence 8999998887763
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-32 Score=261.25 Aligned_cols=192 Identities=31% Similarity=0.493 Sum_probs=159.2
Q ss_pred eeecccCceEEEEEEe-cC---CcEEEEEEeccCCc--cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc-C
Q 011660 258 MLIGQGGNSKVYRTNH-VD---GQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-N 330 (480)
Q Consensus 258 ~~LG~G~fg~Vy~~~~-~~---g~~vAvK~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~-~ 330 (480)
+.||+|+||.||+|.. .. +..+|+|.+..... ..+.+..|+.+++.++||||+++++++.. +.++++|||+ +
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCC
Confidence 3699999999999954 22 36899999976654 34578899999999999999999998864 4678999998 6
Q ss_pred CCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccCc
Q 011660 331 GSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV 407 (480)
Q Consensus 331 GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~ 407 (480)
|+|.+++.. +++..+..++.|++.||.|||.. +++|+||||+|||++.+ +.++|+|||+++........ ..
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~-~~~kl~df~~~~~~~~~~~~--~~ 153 (257)
T cd05060 80 GPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNR-HQAKISDFGMSRALGAGSDY--YR 153 (257)
T ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCC-CcEEeccccccceeecCCcc--cc
Confidence 799999964 77889999999999999999998 99999999999999998 68999999998754332111 11
Q ss_pred cccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 408 KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 408 ~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
......++..|+|||.+.+..++.++|||||||++|||++ |..||...+
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~ 203 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK 203 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCC
Confidence 1112234568999999999999999999999999999998 999997654
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=265.95 Aligned_cols=195 Identities=29% Similarity=0.398 Sum_probs=169.9
Q ss_pred CCCCceeecccCceEEEEEEec-CCcEEEEEEeccCC----ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEe
Q 011660 253 NFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTN----WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e 327 (480)
+|++.+.||.|+||.||++... +++.+|+|++.+.. ...+.+.+|++++++++||||+++++++.+++..++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4888999999999999999764 58999999997543 234578899999999999999999999999999999999
Q ss_pred cc-CCCHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccc
Q 011660 328 LL-NGSLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (480)
Q Consensus 328 ~~-~GsL~~~l~---~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (480)
|+ +++|.+++. .+++.++..++.|+++||.|||++ +++|+||+|+||+++++ +.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~-~~~~l~d~~~~~~~~~~~-- 154 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQ-GHVHITDFNIATKVTPDT-- 154 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCC-CCEEEeecccccccCCCc--
Confidence 99 678999884 477888999999999999999998 99999999999999998 689999999986543221
Q ss_pred ccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 404 SENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 404 ~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
......|+..|+|||.+....++.++|+||||+++|+|++|+.||.....
T Consensus 155 ----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 204 (258)
T cd05578 155 ----LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSR 204 (258)
T ss_pred ----cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCc
Confidence 22345688999999999988899999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-32 Score=262.66 Aligned_cols=199 Identities=27% Similarity=0.374 Sum_probs=165.8
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCC------ccHHHHHHHHHHHhcCCCCCeeeEEEEEecC--Cee
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN------WSEEEVLREVELLSSIKHENIVRIIGYCHSK--EMY 322 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~------~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~ 322 (480)
.+|.+.+.||+|+||.||++.. .+++.+|+|.+.... .....+.+|+++++.++||||+++++++.+. +.+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4689999999999999999976 568999999875321 1124678899999999999999999998654 468
Q ss_pred EEEEecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccc
Q 011660 323 AIVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (480)
Q Consensus 323 ~lV~e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~ 398 (480)
++++||+ +++|.+++.. +.+.....++.|++.||.|||+. +++|+||||+||+++.+ +.++|+|||+++...
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~-~~~~l~dfg~~~~~~ 157 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSA-GNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCC-CCEEECccccccccc
Confidence 8999998 6789998854 67788889999999999999999 99999999999999988 689999999986543
Q ss_pred cccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 399 QSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 399 ~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
... ..........|++.|+|||.+.+..++.++|+|||||++|||++|+.||....
T Consensus 158 ~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 213 (264)
T cd06653 158 TIC--MSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYE 213 (264)
T ss_pred ccc--ccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccC
Confidence 211 11111224568999999999998889999999999999999999999997653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=265.61 Aligned_cols=193 Identities=31% Similarity=0.448 Sum_probs=167.8
Q ss_pred CCCCceeecccCceEEEEEEec-CCcEEEEEEeccCCc--cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc
Q 011660 253 NFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~ 329 (480)
+|+..+.||+|+||.||++... +++.+|+|.+..... ....+.+|+++++.++||||+++++++..++.+++++||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5778889999999999999764 689999999876532 3356889999999999999999999999999999999999
Q ss_pred C-CCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccc
Q 011660 330 N-GSLKQYLKQ----LKWNERMDVAIGVAKALEYLHH-TCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (480)
Q Consensus 330 ~-GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~-~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (480)
. ++|.+++.. ++......++.|++.||.|||+ . +++|+||||+||+++.+ +.++|+|||.+.......
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~-~~~~l~d~g~~~~~~~~~-- 155 (265)
T cd06605 82 DGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSR-GQIKLCDFGVSGQLVNSL-- 155 (265)
T ss_pred CCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCC-CCEEEeecccchhhHHHH--
Confidence 5 789999853 5778888999999999999999 7 99999999999999998 689999999985432211
Q ss_pred ccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 404 SENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 404 ~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.....|+..|+|||.+.+..++.++||||||+++|+|++|+.||....
T Consensus 156 -----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 203 (265)
T cd06605 156 -----AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPEN 203 (265)
T ss_pred -----hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccc
Confidence 112678999999999999999999999999999999999999997664
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=275.60 Aligned_cols=198 Identities=27% Similarity=0.453 Sum_probs=164.2
Q ss_pred cCCCCceeecccCceEEEEEEecC--------CcEEEEEEeccCCc--cHHHHHHHHHHHhcC-CCCCeeeEEEEEecCC
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHVD--------GQVAAVKVLKCTNW--SEEEVLREVELLSSI-KHENIVRIIGYCHSKE 320 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~~--------g~~vAvK~~~~~~~--~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 320 (480)
.+|.+.+.||+|+||.||++.... +..+|+|.++.... ..+.+.+|+++++++ +||||++++++|..++
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 468899999999999999996421 23689998875432 235688999999999 7999999999999989
Q ss_pred eeEEEEecc-CCCHHHHHHh-------------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEe
Q 011660 321 MYAIVYNLL-NGSLKQYLKQ-------------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLS 380 (480)
Q Consensus 321 ~~~lV~e~~-~GsL~~~l~~-------------------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~ 380 (480)
..++++||+ +|+|.+++.+ +.+.++..++.|++.||.|||+. +|+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEc
Confidence 999999999 6799999853 56677888999999999999998 999999999999999
Q ss_pred cCCCceEEeeeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 381 ENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 381 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
.+ +.+||+|||+++....... ........++..|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 169 ~~-~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 241 (334)
T cd05100 169 ED-NVMKIADFGLARDVHNIDY---YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 241 (334)
T ss_pred CC-CcEEECCcccceecccccc---cccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 88 6899999999875433211 111122334678999999999999999999999999999998 899997654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=268.90 Aligned_cols=199 Identities=27% Similarity=0.463 Sum_probs=165.8
Q ss_pred hcCCCCceeecccCceEEEEEEec------CCcEEEEEEeccCCc--cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCee
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHV------DGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMY 322 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 322 (480)
.++|++.+.||+|+||.||++... ++..+|+|++..... ...++.+|+.+++.++||||+++++++.+++.+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 457999999999999999999753 467899999875432 235688999999999999999999999999999
Q ss_pred EEEEecc-CCCHHHHHHh-------------------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCC
Q 011660 323 AIVYNLL-NGSLKQYLKQ-------------------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSN 376 (480)
Q Consensus 323 ~lV~e~~-~GsL~~~l~~-------------------------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~N 376 (480)
++++||+ +|+|.+++.. +++.+++.++.|++.||.|||+. +++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhh
Confidence 9999999 6799999852 45677889999999999999998 99999999999
Q ss_pred EEEecCCCceEEeeeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 011660 377 ILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTN 455 (480)
Q Consensus 377 ILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~ 455 (480)
|+++.+ +.++|+|||++........ ........+++.|+|||.+.+..++.++|||||||++|||++ |..||...
T Consensus 161 il~~~~-~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~ 236 (288)
T cd05050 161 CLVGEN-MVVKIADFGLSRNIYSADY---YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM 236 (288)
T ss_pred eEecCC-CceEECccccceecccCcc---ccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999988 6899999999864322111 111122345678999999998999999999999999999997 88898654
Q ss_pred c
Q 011660 456 K 456 (480)
Q Consensus 456 ~ 456 (480)
.
T Consensus 237 ~ 237 (288)
T cd05050 237 A 237 (288)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-32 Score=268.14 Aligned_cols=199 Identities=28% Similarity=0.440 Sum_probs=166.9
Q ss_pred hhcCCCCceeecccCceEEEEEEec-CCcEEEEEEeccCC---ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCC-----
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTN---WSEEEVLREVELLSSIKHENIVRIIGYCHSKE----- 320 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----- 320 (480)
..++|++.+.||+|+||.||+|... +++.+|+|+++... .....+.+|+++++.++||||+++++++.+.+
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 3567999999999999999999774 58899999997543 22346778999999999999999999987654
Q ss_pred -----eeEEEEeccCCCHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeee
Q 011660 321 -----MYAIVYNLLNGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDF 391 (480)
Q Consensus 321 -----~~~lV~e~~~GsL~~~l~----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DF 391 (480)
.+++++||+.+++..++. .+++..+..++.|++.||.|||+. +|+|+||||+||+++++ +.+||+||
T Consensus 85 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~-~~~kl~df 160 (302)
T cd07864 85 KKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNK-GQIKLADF 160 (302)
T ss_pred cccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCC-CcEEeCcc
Confidence 789999999988888775 378899999999999999999999 99999999999999998 68999999
Q ss_pred ccccccccccccccCccccccccCCCccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 392 GAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 392 Gla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~-~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
|++........ .......+++.|+|||.+.+. .++.++|||||||++|||++|++||...+
T Consensus 161 g~~~~~~~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~ 222 (302)
T cd07864 161 GLARLYNSEES----RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQ 222 (302)
T ss_pred cccccccCCcc----cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99865433211 111223568889999988654 57899999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-32 Score=266.21 Aligned_cols=195 Identities=28% Similarity=0.411 Sum_probs=168.0
Q ss_pred CCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc--cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc
Q 011660 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~ 329 (480)
.|+..+.||+|+||.||+|.. .++..+|+|++..... ....+.+|+.++++++||||+++++++.+++.+++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 477788899999999999976 4588999999875432 2356889999999999999999999999999999999999
Q ss_pred -CCCHHHHHHh--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccC
Q 011660 330 -NGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSEN 406 (480)
Q Consensus 330 -~GsL~~~l~~--~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~ 406 (480)
+|+|.+++.. +.+.+...++.|++.||.|||+. +++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 85 ~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~-~~~~l~dfg~~~~~~~~~----- 155 (277)
T cd06640 85 GGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQ-GDVKLADFGVAGQLTDTQ----- 155 (277)
T ss_pred CCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCC-CCEEEcccccceeccCCc-----
Confidence 6789998854 67788888999999999999998 99999999999999988 689999999986543211
Q ss_pred ccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 407 VKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 407 ~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.......++..|+|||++.+..++.++|+|||||++|||++|+.||....
T Consensus 156 ~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~ 205 (277)
T cd06640 156 IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMH 205 (277)
T ss_pred cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 11223468899999999998899999999999999999999999997654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-32 Score=261.62 Aligned_cols=195 Identities=25% Similarity=0.394 Sum_probs=168.1
Q ss_pred CCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc---cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEec
Q 011660 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~ 328 (480)
+|+..+.||+|+||.||++.. .+++.+|+|.+..... ....+..|+++++.++||||+++++++..++.+++|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 488889999999999999966 4688999999875432 235688999999999999999999999999999999999
Q ss_pred c-CCCHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccc
Q 011660 329 L-NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 329 ~-~GsL~~~l~~-----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (480)
+ +++|.+++.. +++..+..++.+++.||.|||++ +++|+||||+||+++++.+.++|+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~-- 155 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK-- 155 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC--
Confidence 9 6789999854 67788899999999999999998 99999999999999876456899999998654321
Q ss_pred cccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 403 ~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.......|++.|+|||.+.+..++.++||||||+++|+|++|+.||...+
T Consensus 156 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 205 (256)
T cd08220 156 ----SKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN 205 (256)
T ss_pred ----ccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc
Confidence 11224568999999999998889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-32 Score=266.11 Aligned_cols=195 Identities=25% Similarity=0.444 Sum_probs=166.1
Q ss_pred CCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc---cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc
Q 011660 254 FSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (480)
Q Consensus 254 f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~ 329 (480)
|++.+.||.|++|.||+|.. .+|+.+|+|++..... ....+..|+++++.++||||+++++++.+++..++++||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 66788999999999999976 5799999999875432 2356788999999999999999999999999999999999
Q ss_pred CCCHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccc
Q 011660 330 NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (480)
Q Consensus 330 ~GsL~~~l~~-----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (480)
+++|.+++.. +++..+..++.|+++||.|||+. +++||||+|+||+++.+ +.++|+|||++.......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~-~~~~l~df~~~~~~~~~~--- 153 (283)
T cd07835 81 DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDRE-GALKLADFGLARAFGVPV--- 153 (283)
T ss_pred CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCC-CcEEEeecccccccCCCc---
Confidence 9999999843 67888999999999999999998 99999999999999998 789999999986432211
Q ss_pred cCccccccccCCCccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 405 ENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 405 ~~~~~~~~~GT~~y~APE~~~~~-~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
.......+++.|+|||++.+. .++.++|||||||++|||++|++||...+.
T Consensus 154 --~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 205 (283)
T cd07835 154 --RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSE 205 (283)
T ss_pred --cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 111233578899999988764 578999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=269.49 Aligned_cols=194 Identities=30% Similarity=0.422 Sum_probs=166.2
Q ss_pred CCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc--cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc-
Q 011660 254 FSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL- 329 (480)
Q Consensus 254 f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~- 329 (480)
|+..+.||+|+||.||+|.. .+++.+|+|.++.... ..+.+.+|++++++++||||+++++++..++.+++|+||+
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 56667899999999999965 5588999999875432 2346889999999999999999999999999999999999
Q ss_pred CCCHHHHHHh--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccCc
Q 011660 330 NGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV 407 (480)
Q Consensus 330 ~GsL~~~l~~--~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~ 407 (480)
+++|.+++.. +.+..+..++.|+++||.|||+. +++|+||+|+||+++++ +.++|+|||++....... .
T Consensus 86 ~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~~~-----~ 156 (277)
T cd06642 86 GGSALDLLKPGPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQ-GDVKLADFGVAGQLTDTQ-----I 156 (277)
T ss_pred CCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCC-CCEEEccccccccccCcc-----h
Confidence 5789988854 67888889999999999999998 99999999999999988 689999999986543211 1
Q ss_pred cccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 408 KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 408 ~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
......|+..|+|||++.+..++.++|+|||||++|||++|+.||....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~ 205 (277)
T cd06642 157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLH 205 (277)
T ss_pred hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccc
Confidence 2223568999999999999999999999999999999999999997543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=264.34 Aligned_cols=187 Identities=32% Similarity=0.473 Sum_probs=155.1
Q ss_pred eecccCceEEEEEEe-cCCcEEEEEEeccCCcc----HHHHHHHH---HHHhcCCCCCeeeEEEEEecCCeeEEEEecc-
Q 011660 259 LIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS----EEEVLREV---ELLSSIKHENIVRIIGYCHSKEMYAIVYNLL- 329 (480)
Q Consensus 259 ~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~----~~~~~~Ei---~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~- 329 (480)
+||+|+||.||++.. .+++.||+|.+.+.... ...+..|. .+++..+||||+.+++++.+.+.+++||||+
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999976 45889999998654321 12233443 4455568999999999999999999999999
Q ss_pred CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccC
Q 011660 330 NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSEN 406 (480)
Q Consensus 330 ~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~ 406 (480)
+|+|.+++.. +++.++..++.|++.||.|||+. +|+||||||+||+++.+ +.++|+|||++......
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~-~~~kl~dfg~~~~~~~~------ 150 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEH-GHVRISDLGLACDFSKK------ 150 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCC-CCEEEccCcCccccCcc------
Confidence 6789888843 78899999999999999999998 99999999999999998 68999999998643221
Q ss_pred ccccccccCCCccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 407 VKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 407 ~~~~~~~GT~~y~APE~~~~~-~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
......||..|+|||.+.++ .++.++|||||||++|||++|+.||....
T Consensus 151 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~ 200 (278)
T cd05606 151 -KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200 (278)
T ss_pred -CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCC
Confidence 12245799999999998754 68999999999999999999999998763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-32 Score=266.10 Aligned_cols=197 Identities=25% Similarity=0.479 Sum_probs=164.1
Q ss_pred cCCCCceeecccCceEEEEEEec-CCc----EEEEEEeccCCc--cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHV-DGQ----VAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAI 324 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~----~vAvK~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 324 (480)
.+|.+.+.||+|+||.||+|... +|. .+|+|.++.... ....+.+|+.+++.++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 46888899999999999999753 333 689998876543 23567899999999999999999999987 67889
Q ss_pred EEecc-CCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccc
Q 011660 325 VYNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (480)
Q Consensus 325 V~e~~-~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~ 399 (480)
++||+ +|+|.+++.. +++.....++.|++.||.|||+. +|+||||||+||+++++ +.++|+|||+++....
T Consensus 86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~-~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTP-QHVKITDFGLAKLLDV 161 (279)
T ss_pred EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCC-CeEEECCCcccccccC
Confidence 99998 7899999854 67889999999999999999998 99999999999999988 6899999999976442
Q ss_pred ccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 400 SHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 400 ~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
.... .......+++.|+|||.+....++.++|+|||||++|||++ |+.||....
T Consensus 162 ~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 216 (279)
T cd05057 162 DEKE---YHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP 216 (279)
T ss_pred cccc---eecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC
Confidence 2111 11112234678999999988899999999999999999998 999998764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=275.63 Aligned_cols=203 Identities=25% Similarity=0.402 Sum_probs=168.3
Q ss_pred hhcCCCCceeecccCceEEEEEEec-CCcEEEEEEeccCC---ccHHHHHHHHHHHhcC-CCCCeeeEEEEEecC--Cee
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTN---WSEEEVLREVELLSSI-KHENIVRIIGYCHSK--EMY 322 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~--~~~ 322 (480)
+.++|++.+.||+|+||.||+|... +++.+|+|.+.... .....+.+|+.+++++ +||||++++++|... ..+
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4567899999999999999999764 68899999885432 2234577899999999 999999999998643 468
Q ss_pred EEEEeccCCCHHHHHHh--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccc
Q 011660 323 AIVYNLLNGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (480)
Q Consensus 323 ~lV~e~~~GsL~~~l~~--~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (480)
++||||+.++|.+++.. +.+.....++.||+.||.|||+. +|+||||||+||+++.+ +.++|+|||++......
T Consensus 85 ~lv~e~~~~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~-~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 85 YLVFEYMETDLHAVIRANILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSD-CRVKLADFGLARSLSEL 160 (337)
T ss_pred EEEecccccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCC-CcEEEeeccchhccccc
Confidence 99999999999999864 67888888999999999999998 99999999999999998 78999999998765432
Q ss_pred cccccCccccccccCCCccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 401 HQVSENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 401 ~~~~~~~~~~~~~GT~~y~APE~~~~-~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.............||+.|+|||++.+ ..++.++|+|||||++|||++|+.||....
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~ 217 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTS 217 (337)
T ss_pred cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCC
Confidence 22111123334678999999998765 457899999999999999999999997654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-32 Score=262.08 Aligned_cols=184 Identities=26% Similarity=0.435 Sum_probs=156.1
Q ss_pred eecccCceEEEEEEecC-C----------cEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEe
Q 011660 259 LIGQGGNSKVYRTNHVD-G----------QVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (480)
Q Consensus 259 ~LG~G~fg~Vy~~~~~~-g----------~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e 327 (480)
.||+|+||.||+|...+ + ..+++|++.........+.+|+.+++.++||||+++++++.. ...++|||
T Consensus 2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e 80 (259)
T cd05037 2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVEE 80 (259)
T ss_pred cccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEEE
Confidence 58999999999997644 3 257888876655446778899999999999999999999988 77899999
Q ss_pred cc-CCCHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCC-------ceEEeeecccc
Q 011660 328 LL-NGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFH-------HPQLSDFGAAM 395 (480)
Q Consensus 328 ~~-~GsL~~~l~----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~-------~~kL~DFGla~ 395 (480)
|+ +|+|.+++. .+++..+..++.|++.||.|||+. +|+||||||+|||++.+ + .++|+|||++.
T Consensus 81 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~-~~~~~~~~~~kl~Dfg~a~ 156 (259)
T cd05037 81 YVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARY-GLNEGYVPFIKLSDPGIPI 156 (259)
T ss_pred cCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecC-ccccCCceeEEeCCCCccc
Confidence 99 688999985 367888899999999999999998 99999999999999987 4 69999999986
Q ss_pred ccccccccccCccccccccCCCccccccccCC--CCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 396 VHHQSHQVSENVKPVNVVGTFGYLAPEYMMYG--KVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~--~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
.... .....++..|+|||++.+. .++.++|||||||++|||++ |..||....
T Consensus 157 ~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~ 211 (259)
T cd05037 157 TVLS---------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS 211 (259)
T ss_pred cccc---------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC
Confidence 4322 1234567889999998876 78999999999999999999 588887664
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-32 Score=264.63 Aligned_cols=197 Identities=26% Similarity=0.445 Sum_probs=165.3
Q ss_pred CCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc-----------cHHHHHHHHHHHhcCCCCCeeeEEEEEecCC
Q 011660 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW-----------SEEEVLREVELLSSIKHENIVRIIGYCHSKE 320 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~-----------~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 320 (480)
+|...+.||+|+||.||+|.. .+++.+|+|.++.... ..+.+..|+.+++.++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 477788999999999999965 5689999998853211 0134678999999999999999999999999
Q ss_pred eeEEEEecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccc
Q 011660 321 MYAIVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMV 396 (480)
Q Consensus 321 ~~~lV~e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~ 396 (480)
.+++|+||+ +|+|.+++.. +++..+..++.|++.||.|||+. +++|+||+|+||+++.+ +.++|+|||++..
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~-~~~~l~d~~~~~~ 157 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDAD-GICKISDFGISKK 157 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCC-CeEEEeecccccc
Confidence 999999999 7789999854 77888889999999999999998 99999999999999988 7899999999865
Q ss_pred cccccccccCccccccccCCCccccccccCCC--CCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 397 HHQSHQVSENVKPVNVVGTFGYLAPEYMMYGK--VDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 397 ~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~--~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.... ..........|+..|+|||.+.... ++.++|+||||+++|||++|..||....
T Consensus 158 ~~~~---~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 216 (272)
T cd06629 158 SDDI---YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE 216 (272)
T ss_pred cccc---ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcc
Confidence 3321 1112223456899999999987654 8899999999999999999999997543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-32 Score=261.81 Aligned_cols=200 Identities=30% Similarity=0.403 Sum_probs=170.3
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc--cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEec
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~ 328 (480)
++|++.+.||.|+||.||+|.. .++..+|+|++..... ..+.+.+|+++++.++|+||+++++.+..++.+++++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 3689999999999999999975 4688999999875432 346788999999999999999999999999999999999
Q ss_pred c-CCCHHHHHHh------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccc
Q 011660 329 L-NGSLKQYLKQ------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (480)
Q Consensus 329 ~-~GsL~~~l~~------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (480)
+ +++|.+++.. +++.....++.|++.||.|||+. +|+|+||+|+||+++++ +.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~-~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGED-GSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCC-CCEEEcccchHHHhccCc
Confidence 9 6789988843 67888889999999999999998 99999999999999998 689999999986544322
Q ss_pred ccccCccccccccCCCccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 402 QVSENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 402 ~~~~~~~~~~~~GT~~y~APE~~~~~-~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.... .......|++.|+|||++... .++.++|+|||||++|||++|+.||...+
T Consensus 157 ~~~~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~ 211 (267)
T cd06610 157 DRTR-KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYP 211 (267)
T ss_pred cccc-cccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccC
Confidence 2111 122345789999999998877 78999999999999999999999997654
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-32 Score=265.39 Aligned_cols=188 Identities=28% Similarity=0.470 Sum_probs=156.4
Q ss_pred eecccCceEEEEEEec-CCc--EEEEEEeccCC--ccHHHHHHHHHHHhcC-CCCCeeeEEEEEecCCeeEEEEecc-CC
Q 011660 259 LIGQGGNSKVYRTNHV-DGQ--VAAVKVLKCTN--WSEEEVLREVELLSSI-KHENIVRIIGYCHSKEMYAIVYNLL-NG 331 (480)
Q Consensus 259 ~LG~G~fg~Vy~~~~~-~g~--~vAvK~~~~~~--~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~e~~-~G 331 (480)
+||+|+||.||+|... ++. .+++|.++... ...+.+..|++++.++ +||||+++++++...+..+++|||+ +|
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 81 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence 5899999999999764 344 46888887432 2335688999999999 8999999999999999999999999 68
Q ss_pred CHHHHHHh-------------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeec
Q 011660 332 SLKQYLKQ-------------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFG 392 (480)
Q Consensus 332 sL~~~l~~-------------------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFG 392 (480)
+|.+++.. +++.++..++.|++.||.|||+. +++||||||+||+++++ +.++|+|||
T Consensus 82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~-~~~kl~dfg 157 (270)
T cd05047 82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGEN-YVAKIADFG 157 (270)
T ss_pred cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCC-CeEEECCCC
Confidence 99999853 56788899999999999999998 99999999999999998 689999999
Q ss_pred cccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 393 AAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 393 la~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
++..... .........++.|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 158 l~~~~~~------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~ 216 (270)
T cd05047 158 LSRGQEV------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 216 (270)
T ss_pred Cccccch------hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccC
Confidence 9853211 111112234678999999998899999999999999999997 999997643
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-32 Score=266.03 Aligned_cols=198 Identities=30% Similarity=0.430 Sum_probs=162.6
Q ss_pred cCCCCceeecccCceEEEEEEe-----cCCcEEEEEEeccCCc-cHHHHHHHHHHHhcCCCCCeeeEEEEEec--CCeeE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-----VDGQVAAVKVLKCTNW-SEEEVLREVELLSSIKHENIVRIIGYCHS--KEMYA 323 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-----~~g~~vAvK~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~ 323 (480)
.+|++.+.||+|+||.||++.. .+++.+|+|.++.... ..+.+.+|+++++.++||||+++++++.. ...++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4688999999999999999864 3578999999875542 23568899999999999999999998743 45689
Q ss_pred EEEecc-CCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccc
Q 011660 324 IVYNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (480)
Q Consensus 324 lV~e~~-~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~ 398 (480)
+|+||+ +|+|.+++.. +++..+..++.|++.||.|||+. +|+||||||+||+++++ +.++|+|||++....
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~-~~~~l~dfg~~~~~~ 159 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESE-NRVKIGDFGLTKVLP 159 (284)
T ss_pred EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCC-CeEEECCCccccccc
Confidence 999999 7899999853 67888999999999999999999 99999999999999998 689999999997643
Q ss_pred cccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 011660 399 QSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTN 455 (480)
Q Consensus 399 ~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~ 455 (480)
...... .......++..|+|||++.+..++.++|||||||++|||++|..|+...
T Consensus 160 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~ 214 (284)
T cd05081 160 QDKEYY--KVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSP 214 (284)
T ss_pred CCCcce--eecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCc
Confidence 321110 0111123455699999999889999999999999999999998776543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=269.37 Aligned_cols=196 Identities=26% Similarity=0.428 Sum_probs=165.2
Q ss_pred cCCCCceeecccCceEEEEEEec-CCcEEEEEEeccCCc---cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEe
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e 327 (480)
++|+..+.||+|+||.||+|... +++.+|+|++..... ..+.+.+|+++++.++||||+++++++.+++.+++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 36888999999999999999774 589999999865432 23567899999999999999999999999999999999
Q ss_pred ccCC-CHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccc
Q 011660 328 LLNG-SLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (480)
Q Consensus 328 ~~~G-sL~~~l~---~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (480)
|+.+ .|.++.. .+++.++..++.|++.||.|||+. +|+|+||+|+||+++++ +.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~-~~~~l~dfg~~~~~~~~~-- 154 (286)
T cd07846 81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQS-GVVKLCDFGFARTLAAPG-- 154 (286)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCC-CcEEEEeeeeeeeccCCc--
Confidence 9965 5665553 378999999999999999999999 99999999999999998 689999999986543321
Q ss_pred ccCccccccccCCCccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 404 SENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 404 ~~~~~~~~~~GT~~y~APE~~~~-~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.......|+..|+|||++.+ ..++.++|||||||++|||++|++||....
T Consensus 155 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~ 205 (286)
T cd07846 155 ---EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDS 205 (286)
T ss_pred ---cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCc
Confidence 11223468899999999875 447889999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=311.61 Aligned_cols=208 Identities=25% Similarity=0.488 Sum_probs=174.6
Q ss_pred hhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEec
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~ 328 (480)
....|...+.||+|+||.||+|.. .+++.||+|.++.... ....|++++++++||||++++|+|.+.+..++||||
T Consensus 688 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 688 ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS---IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred HHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc---ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 345678888999999999999976 5789999999875432 223568899999999999999999999999999999
Q ss_pred c-CCCHHHHHHhCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccCc
Q 011660 329 L-NGSLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV 407 (480)
Q Consensus 329 ~-~GsL~~~l~~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~ 407 (480)
+ +|+|.++++.++|.++..++.|+++||.|||..+.++|+||||||+||+++.+ ..+++. ||.+.....
T Consensus 765 ~~~g~L~~~l~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~-~~~~~~-~~~~~~~~~-------- 834 (968)
T PLN00113 765 IEGKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGK-DEPHLR-LSLPGLLCT-------- 834 (968)
T ss_pred CCCCcHHHHHhcCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCC-CceEEE-ecccccccc--------
Confidence 9 78999999999999999999999999999997666699999999999999988 467765 666532211
Q ss_pred cccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHhC
Q 011660 408 KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWYYVLAG 471 (480)
Q Consensus 408 ~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~~~e~l~~~~~~~~~ 471 (480)
.....||+.|||||++.+..++.++|||||||++|||+||+.||+........+..|......
T Consensus 835 -~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 897 (968)
T PLN00113 835 -DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYS 897 (968)
T ss_pred -CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcC
Confidence 112368999999999999999999999999999999999999997665555667777765443
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-32 Score=265.91 Aligned_cols=196 Identities=27% Similarity=0.418 Sum_probs=167.3
Q ss_pred CCCCceeecccCceEEEEEEec-CCcEEEEEEeccCCc---cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEec
Q 011660 253 NFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~ 328 (480)
+|++.+.||+|+||.||+|... +++.+|+|.++.... ..+.+.+|+++++.++|+||+++++++.+++.+++++||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 6889999999999999999764 588999999875432 235688999999999999999999999999999999999
Q ss_pred cCCCHHHHH-H---hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccc
Q 011660 329 LNGSLKQYL-K---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (480)
Q Consensus 329 ~~GsL~~~l-~---~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (480)
+.+++.+.+ . .+.+.++..++.|++.||.|||+. +++|+||+|+||+++++ +.++|+|||++........
T Consensus 82 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~-~~~kl~d~g~~~~~~~~~~-- 155 (288)
T cd07833 82 VERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSES-GVLKLCDFGFARALRARPA-- 155 (288)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCC-CCEEEEeeecccccCCCcc--
Confidence 976655443 3 277889999999999999999999 99999999999999998 6899999999865443221
Q ss_pred cCccccccccCCCccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 405 ENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 405 ~~~~~~~~~GT~~y~APE~~~~~-~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.......|+..|+|||++.+. .++.++|+||||+++|+|++|++||....
T Consensus 156 --~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~ 206 (288)
T cd07833 156 --SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDS 206 (288)
T ss_pred --ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 122345788999999999888 88999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=262.77 Aligned_cols=191 Identities=29% Similarity=0.444 Sum_probs=161.4
Q ss_pred eecccCceEEEEEEecC--C--cEEEEEEeccCCc--cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc-CC
Q 011660 259 LIGQGGNSKVYRTNHVD--G--QVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NG 331 (480)
Q Consensus 259 ~LG~G~fg~Vy~~~~~~--g--~~vAvK~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~-~G 331 (480)
.||+|++|.||+|.+.+ + ..+|+|.+..... ..+.+..|+.++++++||||+++++++.+ ..+++++||+ .|
T Consensus 2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~ 80 (257)
T cd05040 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLG 80 (257)
T ss_pred cCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCC
Confidence 58999999999997633 3 3689999976654 34568899999999999999999999988 8899999999 68
Q ss_pred CHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccC
Q 011660 332 SLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSEN 406 (480)
Q Consensus 332 sL~~~l~~-----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~ 406 (480)
+|.+++.+ +++.....++.|++.||.|||+. +++|+||||+||+++.+ +.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~-~~~kl~dfg~~~~~~~~~~~~-- 154 (257)
T cd05040 81 SLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASD-DKVKIGDFGLMRALPQNEDHY-- 154 (257)
T ss_pred cHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecC-CEEEeccccccccccccccce--
Confidence 99999843 57788899999999999999999 99999999999999998 789999999987654322111
Q ss_pred ccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 407 VKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 407 ~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
.......++..|+|||++.+..++.++|||||||++|||++ |+.||...+
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 205 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLS 205 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCC
Confidence 11123457889999999998999999999999999999998 999997554
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=262.54 Aligned_cols=195 Identities=30% Similarity=0.392 Sum_probs=164.9
Q ss_pred hhcCCCCc-eeecccCceEEEEEEe-cCCcEEEEEEeccCCccHHHHHHHHHHHhcC-CCCCeeeEEEEEe----cCCee
Q 011660 250 LTHNFSPK-MLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSI-KHENIVRIIGYCH----SKEMY 322 (480)
Q Consensus 250 ~~~~f~~~-~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~----~~~~~ 322 (480)
++++|.+- ++||-|-.|+|..+.+ .+++.+|+|++..+ ....+|+++--.. .|||||.++++|+ ....+
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 45667654 5799999999999965 67999999999743 4567888876555 6999999999874 45688
Q ss_pred EEEEecc-CCCHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecC--CCceEEeeeccc
Q 011660 323 AIVYNLL-NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN--FHHPQLSDFGAA 394 (480)
Q Consensus 323 ~lV~e~~-~GsL~~~l~~-----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~--~~~~kL~DFGla 394 (480)
.+|||++ +|.|++.+++ |++.++..|+.||+.|+.|||+. +|.||||||+|+|.... ...+||+|||+|
T Consensus 135 LiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred EeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccccc
Confidence 9999999 7789999854 88899999999999999999999 99999999999999643 146899999999
Q ss_pred cccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 395 MVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
+.-. ......+.|-||.|.|||++-..+|+..+|+||+||++|-|++|-+||.++..
T Consensus 212 K~t~------~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg 268 (400)
T KOG0604|consen 212 KETQ------EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 268 (400)
T ss_pred cccC------CCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC
Confidence 7522 23444577899999999999999999999999999999999999999988753
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=267.89 Aligned_cols=195 Identities=27% Similarity=0.445 Sum_probs=163.3
Q ss_pred CCCCceeecccCceEEEEEEe-----cCCcEEEEEEeccCCc--cHHHHHHHHHHHhcCCCCCeeeEEEEEecC--CeeE
Q 011660 253 NFSPKMLIGQGGNSKVYRTNH-----VDGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSK--EMYA 323 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~-----~~g~~vAvK~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~ 323 (480)
.|++.+.||+|+||.||++.. .+++.+|+|.++.... ....+.+|+.+++.++||||+++++++.+. ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 478889999999999999963 3578999999875432 235688999999999999999999998765 5788
Q ss_pred EEEecc-CCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccc
Q 011660 324 IVYNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (480)
Q Consensus 324 lV~e~~-~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~ 398 (480)
+||||+ +++|.+++.+ +++.++..++.|++.||.|||+. +|+||||||+||+++.+ +.++|+|||+++...
T Consensus 85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~-~~~~l~dfg~~~~~~ 160 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESE-HQVKIGDFGLTKAIE 160 (284)
T ss_pred EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCC-CCEEECCCccccccc
Confidence 999999 7899999843 68889999999999999999999 99999999999999998 689999999987654
Q ss_pred cccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCC
Q 011660 399 QSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQ 453 (480)
Q Consensus 399 ~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~ 453 (480)
...... .......|+..|+|||++.+..++.++|||||||++|||++++.|+.
T Consensus 161 ~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~ 213 (284)
T cd05079 161 TDKEYY--TVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSES 213 (284)
T ss_pred cCccce--eecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCc
Confidence 322111 11123457788999999998899999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-31 Score=259.49 Aligned_cols=198 Identities=27% Similarity=0.400 Sum_probs=165.6
Q ss_pred CCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCcc---HHHHHHHHHHHhcCCCCCeeeEEEEEe--cCCeeEEEE
Q 011660 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCH--SKEMYAIVY 326 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~~~~~--~~~~~~lV~ 326 (480)
+|++.+.||.|+||.||++.. .+++.+|+|+++..... .+.+..|+++++.++||||+++++++. .+...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 478889999999999999965 56889999998754432 345778999999999999999999875 345688999
Q ss_pred ecc-CCCHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhCC--CCCeEeccCCCCCEEEecCCCceEEeeeccccc
Q 011660 327 NLL-NGSLKQYLKQ-------LKWNERMDVAIGVAKALEYLHHTC--DPPIIHRDVKSSNILLSENFHHPQLSDFGAAMV 396 (480)
Q Consensus 327 e~~-~GsL~~~l~~-------~~~~~~~~i~~~ia~aL~yLH~~~--~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~ 396 (480)
||+ +++|.+++.. +++.....++.|++.||.|||..+ +.+++|+||||+||+++.+ +.++|+|||++..
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~-~~~kl~d~g~~~~ 159 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDAN-NNVKLGDFGLAKI 159 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecC-CCEEEeccccccc
Confidence 999 6789998843 677888999999999999999322 2299999999999999988 7899999999876
Q ss_pred cccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 397 HHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 397 ~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
...... ......|++.|+|||.+.+..++.++|+||||+++|+|++|+.||....
T Consensus 160 ~~~~~~-----~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 214 (265)
T cd08217 160 LGHDSS-----FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN 214 (265)
T ss_pred ccCCcc-----cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC
Confidence 433211 1224568999999999999889999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=288.80 Aligned_cols=192 Identities=27% Similarity=0.452 Sum_probs=164.6
Q ss_pred eeecccCceEEEEEEecC-CcEEEEEEeccCCc-cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc-CCCHH
Q 011660 258 MLIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNW-SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGSLK 334 (480)
Q Consensus 258 ~~LG~G~fg~Vy~~~~~~-g~~vAvK~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~-~GsL~ 334 (480)
-+||+|+||+||-|+..+ ....|||.+...+. ...-+..||.+-++|+|.|||+++|.|.+++.+-|.||-. +|+|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 469999999999997654 56789999864442 3345889999999999999999999999999998999887 89999
Q ss_pred HHHHh----C--CHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccCcc
Q 011660 335 QYLKQ----L--KWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVK 408 (480)
Q Consensus 335 ~~l~~----~--~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~ 408 (480)
+.|+. + .+.+...+..||++||.|||++ .|||||||-+|+|++--.|.+||+|||-++.+.. .+..
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-----inP~ 732 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-----INPC 732 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhcc-----CCcc
Confidence 99964 3 5667778899999999999999 9999999999999998778999999998865433 2334
Q ss_pred ccccccCCCccccccccCC--CCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 409 PVNVVGTFGYLAPEYMMYG--KVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 409 ~~~~~GT~~y~APE~~~~~--~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
..++.||..|||||++..+ +|+.++|||||||.+.||.||++||..-..
T Consensus 733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgs 783 (1226)
T KOG4279|consen 733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGS 783 (1226)
T ss_pred ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCC
Confidence 5578899999999999865 589999999999999999999999976543
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-32 Score=264.00 Aligned_cols=192 Identities=26% Similarity=0.393 Sum_probs=161.9
Q ss_pred CCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc--cHHHHHHHHHHHhcCC-CCCeeeEEEEEecC--CeeEEEEe
Q 011660 254 FSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW--SEEEVLREVELLSSIK-HENIVRIIGYCHSK--EMYAIVYN 327 (480)
Q Consensus 254 f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~--~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~--~~~~lV~e 327 (480)
|++.+.||+|+||.||++.. .+++.+|+|.++.... ......+|+.++.++. ||||+++++++.++ +.+++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 56778899999999999975 5689999999876432 2234567999999885 99999999999877 88999999
Q ss_pred ccCCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccc
Q 011660 328 LLNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (480)
Q Consensus 328 ~~~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (480)
|+.|+|.+++.. +++.++..++.|++.||.|||+. +++||||||+||+++. +.++|+|||++.......
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~--~~~kl~dfg~~~~~~~~~-- 153 (282)
T cd07831 81 LMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD--DILKLADFGSCRGIYSKP-- 153 (282)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC--CCeEEEecccccccccCC--
Confidence 999999888853 68899999999999999999999 9999999999999998 589999999986543211
Q ss_pred ccCccccccccCCCccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 404 SENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 404 ~~~~~~~~~~GT~~y~APE~~~~-~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
......+++.|+|||.+.. +.++.++|||||||++|||++|.+||...+
T Consensus 154 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~ 203 (282)
T cd07831 154 ----PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTN 203 (282)
T ss_pred ----CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCC
Confidence 1123468899999997654 557899999999999999999999997754
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=265.69 Aligned_cols=191 Identities=32% Similarity=0.527 Sum_probs=159.6
Q ss_pred eecccCceEEEEEEecC-------CcEEEEEEeccCC--ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc
Q 011660 259 LIGQGGNSKVYRTNHVD-------GQVAAVKVLKCTN--WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (480)
Q Consensus 259 ~LG~G~fg~Vy~~~~~~-------g~~vAvK~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~ 329 (480)
.||+|+||.||+|...+ ++.+|+|.+.... .....+.+|+.+++.++||||+++++++...+..+++|||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 58999999999996532 3579999886543 23456889999999999999999999999989999999998
Q ss_pred -CCCHHHHHHh----------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCC-----ceEEeeecc
Q 011660 330 -NGSLKQYLKQ----------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFH-----HPQLSDFGA 393 (480)
Q Consensus 330 -~GsL~~~l~~----------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~-----~~kL~DFGl 393 (480)
+|+|.+++.. +.+.++..++.|++.||.|||+. +++|+||||+||+++.+ + .++|+|||+
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~-~~~~~~~~~l~dfg~ 157 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEK-GYDADRVVKIGDFGL 157 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecC-CCCCCcceEECCccc
Confidence 6899999853 56788889999999999999998 99999999999999987 4 799999999
Q ss_pred ccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 394 AMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 394 a~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
+........ ........++..|+|||++.++.++.++|||||||++|||++ |+.||...+
T Consensus 158 ~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~ 218 (269)
T cd05044 158 ARDIYKSDY---YRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN 218 (269)
T ss_pred ccccccccc---cccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccC
Confidence 865432211 111123356789999999999999999999999999999998 999997554
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=271.33 Aligned_cols=194 Identities=27% Similarity=0.434 Sum_probs=165.5
Q ss_pred CCCceeecccCceEEEEEEe-cCCcEEEEEEeccCC-ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc-C
Q 011660 254 FSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN-WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-N 330 (480)
Q Consensus 254 f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~-~ 330 (480)
|.....||+|+||.||++.. .+++.+|+|++.... ...+.+.+|+.+++.++||||+++++++..++.+++++||+ +
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 33444699999999999966 468999999986543 23456889999999999999999999999999999999999 5
Q ss_pred CCHHHHHHh--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccCcc
Q 011660 331 GSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVK 408 (480)
Q Consensus 331 GsL~~~l~~--~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~ 408 (480)
++|.+++.. +++..+..++.|++.||.|||+. +++||||||+||+++.+ +.++|+|||++...... ...
T Consensus 103 ~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~-~~~kL~dfg~~~~~~~~-----~~~ 173 (297)
T cd06659 103 GALTDIVSQTRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLD-GRVKLSDFGFCAQISKD-----VPK 173 (297)
T ss_pred CCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccC-CcEEEeechhHhhcccc-----ccc
Confidence 788888753 78889999999999999999999 99999999999999998 68999999998543221 111
Q ss_pred ccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 409 PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 409 ~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 221 (297)
T cd06659 174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS 221 (297)
T ss_pred ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 234578999999999998899999999999999999999999997554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-31 Score=263.81 Aligned_cols=194 Identities=29% Similarity=0.372 Sum_probs=165.3
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc--cHHHHHHHHHHHhcCCCCCeeeEEEEEec--CCeeEEEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHS--KEMYAIVY 326 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lV~ 326 (480)
++|...+.||.|++|.||++.. .+++.+|+|.+..... ....+.+|+++++.++||||++++++|.+ .+.+++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 3688889999999999999976 4688999999875443 34568899999999999999999998854 34789999
Q ss_pred ecc-CCCHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccc
Q 011660 327 NLL-NGSLKQYLKQ-------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (480)
Q Consensus 327 e~~-~GsL~~~l~~-------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~ 398 (480)
||+ +++|.+++.. +.......++.|++.||.|||+. +++|+||+|+||+++.+ +.++|+|||++....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~-~~~~l~dfg~~~~~~ 156 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRK-GQVKLCDFGVSGELV 156 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecC-CeEEEeecccccccc
Confidence 999 6789887642 66778889999999999999999 99999999999999988 689999999985432
Q ss_pred cccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 399 QSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 399 ~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.. ......++..|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 157 ~~-------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 207 (287)
T cd06621 157 NS-------LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEG 207 (287)
T ss_pred cc-------ccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCccc
Confidence 21 1123467889999999999999999999999999999999999998763
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-32 Score=261.07 Aligned_cols=196 Identities=29% Similarity=0.444 Sum_probs=172.0
Q ss_pred cCCCCceeecccCceEEEEEEec-CCcEEEEEEeccCCc--cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEec
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~ 328 (480)
++|++.+.||+|++|.||++... +++.+++|++..... ....+.+|+++++.++||||+++++++...+..++++||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36888999999999999999775 599999999876543 346789999999999999999999999999999999999
Q ss_pred c-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccc
Q 011660 329 L-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHH-TCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (480)
Q Consensus 329 ~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~-~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (480)
+ +++|.+++.. ++......++.|+++||.|||+ . +++|+||+|+||+++.+ +.++|+|||++........
T Consensus 81 ~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~-~~~~l~df~~~~~~~~~~~- 155 (264)
T cd06623 81 MDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSK-GEVKIADFGISKVLENTLD- 155 (264)
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCC-CCEEEccCccceecccCCC-
Confidence 9 4899999964 7888899999999999999999 8 99999999999999998 7899999999865433211
Q ss_pred ccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 404 SENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 404 ~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
......|+..|+|||.+....++.++|+||||+++|||++|+.||....
T Consensus 156 ----~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 204 (264)
T cd06623 156 ----QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPG 204 (264)
T ss_pred ----cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 1124568899999999998899999999999999999999999998775
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-32 Score=268.43 Aligned_cols=192 Identities=30% Similarity=0.452 Sum_probs=165.5
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCcc----HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS----EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~----~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 326 (480)
..|...+.||+|+||.||+|.. .+++.+|+|++...... ..++.+|+++++.++||||++++++|.+++..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 4588889999999999999976 46899999998644321 245789999999999999999999999999999999
Q ss_pred eccCCCHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccc
Q 011660 327 NLLNGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 327 e~~~GsL~~~l~----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (480)
||+.|++.+++. .+.+..+..++.|++.||.|||+. +|+|+||+|+||+++++ +.++|+|||++.....
T Consensus 95 e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~-~~~kL~dfg~~~~~~~--- 167 (307)
T cd06607 95 EYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEP-GTVKLADFGSASLVSP--- 167 (307)
T ss_pred HhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCC-CCEEEeecCcceecCC---
Confidence 999999888774 378888999999999999999998 99999999999999998 6899999999854321
Q ss_pred cccCccccccccCCCcccccccc---CCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 403 VSENVKPVNVVGTFGYLAPEYMM---YGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 403 ~~~~~~~~~~~GT~~y~APE~~~---~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.....|++.|+|||++. ...++.++||||||+++|||++|++||...+
T Consensus 168 ------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~ 218 (307)
T cd06607 168 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218 (307)
T ss_pred ------CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCcc
Confidence 12346889999999874 4568899999999999999999999997643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=259.49 Aligned_cols=191 Identities=31% Similarity=0.480 Sum_probs=161.5
Q ss_pred eecccCceEEEEEEecCCcEEEEEEeccCCcc--HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc-CCCHHH
Q 011660 259 LIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGSLKQ 335 (480)
Q Consensus 259 ~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~-~GsL~~ 335 (480)
.||+|+||.||++...+++.+|+|.++..... ...+..|+++++.++||||+++++++.+.+..++||||+ +++|.+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~ 81 (251)
T cd05041 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLT 81 (251)
T ss_pred ccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHH
Confidence 68999999999998766999999998765433 356889999999999999999999999999999999999 678999
Q ss_pred HHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccCccccc
Q 011660 336 YLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVN 411 (480)
Q Consensus 336 ~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~ 411 (480)
++.. +++.....++.+++.||.|||++ +++||||||+||+++.+ +.++|+|||++........ ......
T Consensus 82 ~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~-~~~~l~d~g~~~~~~~~~~---~~~~~~ 154 (251)
T cd05041 82 FLRKKKNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGEN-NVLKISDFGMSREEEGGIY---TVSDGL 154 (251)
T ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCC-CcEEEeeccccccccCCcc---eecccc
Confidence 9843 57778889999999999999999 99999999999999988 6899999999865332110 111112
Q ss_pred cccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 412 VVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 412 ~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
..++..|+|||.+.++.++.++|+|||||++|||+| |..||....
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~ 200 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMS 200 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCC
Confidence 234677999999998999999999999999999999 899997654
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=265.79 Aligned_cols=205 Identities=30% Similarity=0.393 Sum_probs=167.5
Q ss_pred ceeecccCceEEEEEEe-cCCcEEEEEEeccCCc--cHHHHHHHHHHH-hcCCCCCeeeEEEEEecCCeeEEEEeccCCC
Q 011660 257 KMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW--SEEEVLREVELL-SSIKHENIVRIIGYCHSKEMYAIVYNLLNGS 332 (480)
Q Consensus 257 ~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~--~~~~~~~Ei~il-~~l~HpnIv~l~~~~~~~~~~~lV~e~~~Gs 332 (480)
+..||.|+||.|++..+ ..|+..|||.++..+. +.++++.|.+.. +.-+.||||++||.+..++..|+.||+++-+
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~S 148 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDIS 148 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhhh
Confidence 44699999999999976 5699999999987654 345688888865 5557999999999999999999999999998
Q ss_pred HHHHHH--------hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccc
Q 011660 333 LKQYLK--------QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (480)
Q Consensus 333 L~~~l~--------~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (480)
|+.+.+ .+++.-.-+|....+.||+||.+.+ .|||||+||+|||++.. |.+||||||++-. ..
T Consensus 149 lDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~-G~vKLCDFGIcGq------Lv 219 (361)
T KOG1006|consen 149 LDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRH-GDVKLCDFGICGQ------LV 219 (361)
T ss_pred HHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecC-CCEeeecccchHh------HH
Confidence 877653 3677777788889999999998765 89999999999999998 8999999999743 22
Q ss_pred cCccccccccCCCcccccccc--CCCCCchHHHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHhCCC
Q 011660 405 ENVKPVNVVGTFGYLAPEYMM--YGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWYYVLAGKV 473 (480)
Q Consensus 405 ~~~~~~~~~GT~~y~APE~~~--~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~~~e~l~~~~~~~~~~~ 473 (480)
.....+..+|...|||||.+. ...|+.++|+||||+.|||+.||+.||+.-+.-.|++ .++..|-+
T Consensus 220 ~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql---~~Vv~gdp 287 (361)
T KOG1006|consen 220 DSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQL---CQVVIGDP 287 (361)
T ss_pred HHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHH---HHHHcCCC
Confidence 333445567899999999986 3469999999999999999999999999766544433 44555543
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=275.80 Aligned_cols=202 Identities=24% Similarity=0.363 Sum_probs=168.7
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCC---ccHHHHHHHHHHHhcCCCCCeeeEEEEEe----cCCee
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN---WSEEEVLREVELLSSIKHENIVRIIGYCH----SKEMY 322 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~----~~~~~ 322 (480)
.++|++.+.||+|+||.||++.. .+++.||+|++.... .....+.+|+.+++.++||||+++++++. ....+
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 46799999999999999999965 569999999987543 23356778999999999999999998875 33578
Q ss_pred EEEEeccCCCHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccc
Q 011660 323 AIVYNLLNGSLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (480)
Q Consensus 323 ~lV~e~~~GsL~~~l~---~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~ 399 (480)
++||||+.|+|.+++. .+++.....++.|++.||.|||+. +|+||||||+||+++++ +.+||+|||++.....
T Consensus 84 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~-~~~kl~dfg~~~~~~~ 159 (334)
T cd07855 84 YVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNED-CELRIGDFGMARGLSS 159 (334)
T ss_pred EEEEehhhhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCC-CcEEecccccceeecc
Confidence 9999999999999884 378889999999999999999998 99999999999999998 7899999999865433
Q ss_pred ccccccCccccccccCCCccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 400 SHQVSENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 400 ~~~~~~~~~~~~~~GT~~y~APE~~~~-~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
.... .........|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...+.
T Consensus 160 ~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~ 217 (334)
T cd07855 160 SPTE-HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNY 217 (334)
T ss_pred cCcC-CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCCh
Confidence 2211 1112234578999999998865 4689999999999999999999999977543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-31 Score=261.41 Aligned_cols=191 Identities=23% Similarity=0.320 Sum_probs=152.1
Q ss_pred eecccCceEEEEEEecCC---cEEEEEEeccCCc--cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc-CCC
Q 011660 259 LIGQGGNSKVYRTNHVDG---QVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGS 332 (480)
Q Consensus 259 ~LG~G~fg~Vy~~~~~~g---~~vAvK~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~-~Gs 332 (480)
.||+|+||.||++...++ ..+++|.++.... ..+.+.+|+.+++.++||||+++++.|.+....++||||+ +|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 589999999999965443 3566777654432 3457889999999999999999999999999999999999 579
Q ss_pred HHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccccc
Q 011660 333 LKQYLKQ-------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE 405 (480)
Q Consensus 333 L~~~l~~-------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~ 405 (480)
|.+++.+ ........++.|++.||.|||+. +++||||||+|||++.+ +.++|+|||++........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~-~~~~l~Dfg~~~~~~~~~~--- 154 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSD-LTVKVGDYGIGPSRYKEDY--- 154 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCC-ccEEecccccccccCcchh---
Confidence 9999854 34455678899999999999998 99999999999999988 6899999999854222111
Q ss_pred CccccccccCCCccccccccC-------CCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 406 NVKPVNVVGTFGYLAPEYMMY-------GKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 406 ~~~~~~~~GT~~y~APE~~~~-------~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
........|++.|+|||++.. ..++.++|||||||++|||++ |..||...+
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~ 213 (268)
T cd05086 155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS 213 (268)
T ss_pred hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Confidence 111124568899999998753 245789999999999999997 577886544
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=270.94 Aligned_cols=194 Identities=27% Similarity=0.442 Sum_probs=165.0
Q ss_pred CCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc-cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc-C
Q 011660 254 FSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW-SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-N 330 (480)
Q Consensus 254 f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~-~ 330 (480)
|.....||+|+||.||++.. .++..+|+|.+..... ..+.+.+|+.+++.++||||+++++.+...+..+++|||+ +
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 34445699999999999976 4688999999865432 2346789999999999999999999999999999999999 5
Q ss_pred CCHHHHHH--hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccCcc
Q 011660 331 GSLKQYLK--QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVK 408 (480)
Q Consensus 331 GsL~~~l~--~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~ 408 (480)
++|.+++. .+.+.+...++.|++.||.|||+. +|+||||||+||+++++ +.++|+|||++...... ...
T Consensus 104 ~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~-~~~kL~dfg~~~~~~~~-----~~~ 174 (292)
T cd06658 104 GALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSD-GRIKLSDFGFCAQVSKE-----VPK 174 (292)
T ss_pred CcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCC-CCEEEccCcchhhcccc-----ccc
Confidence 68888874 478889999999999999999999 99999999999999998 68999999998543221 111
Q ss_pred ccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 409 PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 409 ~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.....||+.|+|||.+.+..++.++|+||||+++|||++|+.||....
T Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~ 222 (292)
T cd06658 175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEP 222 (292)
T ss_pred CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 234568999999999998899999999999999999999999997654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-32 Score=269.39 Aligned_cols=203 Identities=25% Similarity=0.391 Sum_probs=166.8
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc---cHHHHHHHHHHHhcCCCCCeeeEEEEEecC-------
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVRIIGYCHSK------- 319 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------- 319 (480)
.++|++.+.||+|+||.||+|.. .+++.+|+|++..... ....+.+|+++++.++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 46899999999999999999976 4688999999864332 234578899999999999999999887433
Q ss_pred -CeeEEEEeccCCCHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccc
Q 011660 320 -EMYAIVYNLLNGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA 394 (480)
Q Consensus 320 -~~~~lV~e~~~GsL~~~l~----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla 394 (480)
..++++++|+.++|...+. .+++.++..++.|+++||.|||+. +|+|+||||+||+++++ +.++|+|||++
T Consensus 87 ~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~-~~~~l~dfg~~ 162 (311)
T cd07866 87 RGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQ-GILKIADFGLA 162 (311)
T ss_pred CceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCC-CCEEECcCccc
Confidence 3579999999988888774 478899999999999999999999 99999999999999998 78999999998
Q ss_pred ccccccccccc------CccccccccCCCccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 395 MVHHQSHQVSE------NVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 395 ~~~~~~~~~~~------~~~~~~~~GT~~y~APE~~~~~-~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
........... ........|++.|+|||.+.+. .++.++|||||||++|||++|++||...+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~ 232 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSD 232 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCH
Confidence 65433221111 1122345678999999987654 579999999999999999999999986654
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.2e-32 Score=267.93 Aligned_cols=195 Identities=29% Similarity=0.382 Sum_probs=162.3
Q ss_pred CCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc--cHHHHHHHHHHHhcCC-CCCeeeEEEEEecCCeeEEEEec
Q 011660 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW--SEEEVLREVELLSSIK-HENIVRIIGYCHSKEMYAIVYNL 328 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~--~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~e~ 328 (480)
+|.....||+|+||.||++.. .+++.+|+|.+..... ....+.+|+.++.++. ||||+++++++..++..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 466677899999999999976 4589999999875432 2346789999999996 99999999999988899999999
Q ss_pred cCCCHHHHH--------HhCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccc
Q 011660 329 LNGSLKQYL--------KQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (480)
Q Consensus 329 ~~GsL~~~l--------~~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (480)
+.+++.++. ..+++.....++.+++.||.|||+.+ +|+||||||+||+++.+ +.++|+|||++......
T Consensus 85 ~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~-~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRN-GNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccC-CcEEEeecchhHHhccC
Confidence 988765543 23778888999999999999999632 89999999999999988 68999999998654321
Q ss_pred cccccCccccccccCCCccccccccCC---CCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 401 HQVSENVKPVNVVGTFGYLAPEYMMYG---KVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 401 ~~~~~~~~~~~~~GT~~y~APE~~~~~---~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.......||+.|+|||++... .++.++|||||||++|||++|+.||....
T Consensus 162 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 214 (288)
T cd06616 162 ------IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN 214 (288)
T ss_pred ------CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc
Confidence 112234689999999998876 68999999999999999999999997643
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=260.27 Aligned_cols=199 Identities=30% Similarity=0.447 Sum_probs=169.9
Q ss_pred CCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc---cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEec
Q 011660 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~ 328 (480)
+|...+.||+|+||.||++.. .+++.+|+|.++.... ....+..|+.+++.++|+||+++++++.+.+.+++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 478889999999999999976 4689999999976654 345688999999999999999999999999999999999
Q ss_pred c-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccc
Q 011660 329 L-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (480)
Q Consensus 329 ~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (480)
+ +++|.+++.. +.+..+..++.+++.||.|||+. +|+|+||+|+||+++++ +.++|+|||++..........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~-~~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHN-GVIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCC-CCEEEcccccccccCCCCCcc
Confidence 9 6789999854 67888889999999999999999 99999999999999998 789999999986654322111
Q ss_pred cCccccccccCCCccccccccCCC---CCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 405 ENVKPVNVVGTFGYLAPEYMMYGK---VDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 405 ~~~~~~~~~GT~~y~APE~~~~~~---~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
. .......|++.|+|||++.+.. ++.++||||||+++|||++|+.||....
T Consensus 157 ~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~ 210 (264)
T cd06626 157 G-EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELD 210 (264)
T ss_pred c-ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCc
Confidence 1 1022356889999999998766 8899999999999999999999997654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.2e-32 Score=267.48 Aligned_cols=197 Identities=28% Similarity=0.441 Sum_probs=170.3
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCC-ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN-WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~ 329 (480)
++|.+.+.||+|+||.||++.. .+++.+|+|.+.... ...+.+.+|+.+++.++||||+++++++...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 5799999999999999999965 568899999986543 23456789999999999999999999999999999999999
Q ss_pred -CCCHHHHHHh--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccC
Q 011660 330 -NGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSEN 406 (480)
Q Consensus 330 -~GsL~~~l~~--~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~ 406 (480)
+|+|.+++.+ +++.++..++.|++.||.|||+. +++|+||||+||+++.+ +.++|+|||++.......
T Consensus 99 ~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~-~~~kL~dfg~~~~~~~~~----- 169 (293)
T cd06647 99 AGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQ----- 169 (293)
T ss_pred CCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCC-CCEEEccCcceecccccc-----
Confidence 6799999864 67888899999999999999999 99999999999999988 689999999886443221
Q ss_pred ccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 407 VKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 407 ~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
.......|++.|+|||.+.++.++.++|+|||||++|||++|+.||...+.
T Consensus 170 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~ 220 (293)
T cd06647 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP 220 (293)
T ss_pred cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 122334689999999999888899999999999999999999999976543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.5e-32 Score=263.72 Aligned_cols=195 Identities=31% Similarity=0.480 Sum_probs=166.6
Q ss_pred CCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCC--ccHHHHHHHHHHHhcCC---CCCeeeEEEEEecCCeeEEEE
Q 011660 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN--WSEEEVLREVELLSSIK---HENIVRIIGYCHSKEMYAIVY 326 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~--~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~lV~ 326 (480)
.|+..+.||+|+||.||+|.. .+++.+|+|.++... ....++.+|+.+++.++ |||++++++++.+++.++++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477788999999999999976 568999999987543 23456889999999986 999999999999999999999
Q ss_pred ecc-CCCHHHHHHh--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccc
Q 011660 327 NLL-NGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (480)
Q Consensus 327 e~~-~GsL~~~l~~--~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (480)
||+ +++|.++++. +++.....++.|++.||.|||+. +|+|+||+|+||+++++ +.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~~~-- 155 (277)
T cd06917 82 EYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNT-GNVKLCDFGVAALLNQNS-- 155 (277)
T ss_pred ecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCC-CCEEEccCCceeecCCCc--
Confidence 999 6789998854 67888899999999999999999 99999999999999998 789999999986644322
Q ss_pred ccCccccccccCCCccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 404 SENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 404 ~~~~~~~~~~GT~~y~APE~~~~~-~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.......|++.|+|||.+.++ .++.++|+|||||++|+|++|+.||....
T Consensus 156 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~ 206 (277)
T cd06917 156 ---SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVD 206 (277)
T ss_pred ---cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 122345789999999988754 46899999999999999999999997654
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=258.20 Aligned_cols=195 Identities=31% Similarity=0.495 Sum_probs=166.1
Q ss_pred CCCceeecccCceEEEEEEecC-----CcEEEEEEeccCCc--cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEE
Q 011660 254 FSPKMLIGQGGNSKVYRTNHVD-----GQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (480)
Q Consensus 254 f~~~~~LG~G~fg~Vy~~~~~~-----g~~vAvK~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 326 (480)
|.+.+.||+|+||.||++...+ +..+|+|.++.... ..+.+..|+.+++.++||||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 4567789999999999997643 38899999976654 3567889999999999999999999999989999999
Q ss_pred ecc-CCCHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccc
Q 011660 327 NLL-NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (480)
Q Consensus 327 e~~-~GsL~~~l~~-----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (480)
|++ +++|.+++.. +++.++..++.|++.||.|||+. +++|+||||+||+++++ +.++|+|||++......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~-~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGEN-LVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccC-CeEEEcccCCceecccc
Confidence 999 6799999843 78889999999999999999999 99999999999999998 68999999998765433
Q ss_pred cccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 401 ~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
..... ....+++.|+|||.+.+..++.++|+||||+++|||++ |++||....
T Consensus 157 ~~~~~----~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~ 209 (258)
T smart00219 157 DYYKK----KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS 209 (258)
T ss_pred ccccc----ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 11111 12237889999999988889999999999999999998 889987643
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.6e-32 Score=260.88 Aligned_cols=190 Identities=31% Similarity=0.510 Sum_probs=161.9
Q ss_pred cCCCCceeecccCceEEEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc-C
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-N 330 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~-~ 330 (480)
++|.+.+.||+|+||.||++.. +++.+|+|.++... ....+.+|+.+++.++||||+++++++..+ ..+++|||+ +
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~ 82 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV-TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSK 82 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc-hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCC
Confidence 3588999999999999999874 67889999987543 346788999999999999999999998765 468999998 6
Q ss_pred CCHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccccc
Q 011660 331 GSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE 405 (480)
Q Consensus 331 GsL~~~l~~-----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~ 405 (480)
|+|.+++.. +++..+..++.|++.||.|||+. +++||||||+||+++.+ +.++|+|||++......
T Consensus 83 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~-~~~kl~Dfg~~~~~~~~----- 153 (254)
T cd05083 83 GNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSED-GVAKVSDFGLARVGSMG----- 153 (254)
T ss_pred CCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCC-CcEEECCCccceecccc-----
Confidence 799999853 57788889999999999999998 99999999999999988 68999999998643221
Q ss_pred CccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 406 NVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 406 ~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
......+..|+|||.+.++.++.++|+|||||++|||++ |+.||....
T Consensus 154 ---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 202 (254)
T cd05083 154 ---VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS 202 (254)
T ss_pred ---CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC
Confidence 112234678999999998999999999999999999997 999997654
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=260.35 Aligned_cols=193 Identities=25% Similarity=0.393 Sum_probs=153.8
Q ss_pred eeecccCceEEEEEEec----CCcEEEEEEeccCCc--cHHHHHHHHHHHhcCCCCCeeeEEEEEe-cCCeeEEEEecc-
Q 011660 258 MLIGQGGNSKVYRTNHV----DGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCH-SKEMYAIVYNLL- 329 (480)
Q Consensus 258 ~~LG~G~fg~Vy~~~~~----~g~~vAvK~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~-~~~~~~lV~e~~- 329 (480)
+.||+|+||.||+|... +...+|+|.+..... ..+.+.+|+.+++.++||||+++++++. .++..++++||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 36899999999999653 245799998854322 2356788999999999999999999875 455678999998
Q ss_pred CCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccccc
Q 011660 330 NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE 405 (480)
Q Consensus 330 ~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~ 405 (480)
+|+|.+++.. ..+.....++.|++.||.|||+. +++||||||+|||++++ +.+||+|||+++....... ..
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~-~~~kl~dfg~~~~~~~~~~-~~ 155 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDES-FTVKVADFGLARDIYDKEY-YS 155 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCC-CcEEECCccccccccCCcc-ee
Confidence 6899999854 45667788999999999999998 99999999999999998 6899999999864332110 01
Q ss_pred CccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcC-CCCCCCC
Q 011660 406 NVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITG-KEAIQTN 455 (480)
Q Consensus 406 ~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG-~~pf~~~ 455 (480)
........+++.|+|||.+.+..++.++|||||||++|||++| .+||...
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~ 206 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 206 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 1111234567889999999989999999999999999999995 5666543
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=260.13 Aligned_cols=195 Identities=29% Similarity=0.407 Sum_probs=167.6
Q ss_pred CCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCC---ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEec
Q 011660 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN---WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~ 328 (480)
+|++.+.||+|+||.+|++.. .+++.+|+|.++... ...+++.+|+.+++.++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 488899999999999999965 568999999987543 2235688999999999999999999999999999999999
Q ss_pred c-CCCHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccc
Q 011660 329 L-NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 329 ~-~GsL~~~l~~-----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (480)
+ +++|.+++.. +++.+...++.|++.||.|||+. +++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~-~~~~l~d~~~~~~~~~~~- 155 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKD-GTIKLGDFGIARVLNSTV- 155 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCC-CCEEEeeccceeecCcch-
Confidence 9 6789988843 57788899999999999999998 99999999999999988 689999999986543211
Q ss_pred cccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 403 ~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.......|++.|+|||++.+..++.++|+|||||++|+|++|+.||...+
T Consensus 156 ----~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~ 205 (256)
T cd08218 156 ----ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN 205 (256)
T ss_pred ----hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC
Confidence 11123468899999999998899999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.7e-32 Score=273.74 Aligned_cols=194 Identities=24% Similarity=0.395 Sum_probs=165.7
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc---cHHHHHHHHHHHhcCCCCCeeeEEEEEecC------C
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVRIIGYCHSK------E 320 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------~ 320 (480)
.++|...+.||+|+||.||+|.. .+++.+|+|.++.... ....+.+|+.+++.++||||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 46899999999999999999976 4689999999865322 234578999999999999999999988654 3
Q ss_pred eeEEEEeccCCCHHHHHH-hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccc
Q 011660 321 MYAIVYNLLNGSLKQYLK-QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (480)
Q Consensus 321 ~~~lV~e~~~GsL~~~l~-~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~ 399 (480)
.+++|++|+.++|..++. .+.+..+..++.|++.||.|||+. +|+||||||+||+++.+ +.++|+|||+++....
T Consensus 94 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~-~~~kL~dfg~~~~~~~ 169 (342)
T cd07879 94 DFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNED-CELKILDFGLARHADA 169 (342)
T ss_pred eEEEEecccccCHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCC-CCEEEeeCCCCcCCCC
Confidence 568999999888888775 588999999999999999999999 99999999999999998 7899999999864321
Q ss_pred ccccccCccccccccCCCccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 400 SHQVSENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 400 ~~~~~~~~~~~~~~GT~~y~APE~~~~-~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...+
T Consensus 170 --------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~ 219 (342)
T cd07879 170 --------EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 219 (342)
T ss_pred --------CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 1224567899999999876 468999999999999999999999998654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=262.99 Aligned_cols=197 Identities=25% Similarity=0.406 Sum_probs=166.4
Q ss_pred cCCCCceeecccCceEEEEEEec------CCcEEEEEEeccCCcc--HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHV------DGQVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSKEMYA 323 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 323 (480)
++|++...||+|+||.||+|... +.+.+++|.+...... .+.+.+|++++++++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 46889999999999999999753 3467999988654432 356889999999999999999999999989999
Q ss_pred EEEecc-CCCHHHHHH------------hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEee
Q 011660 324 IVYNLL-NGSLKQYLK------------QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSD 390 (480)
Q Consensus 324 lV~e~~-~GsL~~~l~------------~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~D 390 (480)
+||||+ .|+|.+++. .+++..+..++.|++.||.|||+. +|+||||||+||+++.+ +.++|+|
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~-~~~~l~~ 160 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQ-REVKVSL 160 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCC-CcEEEcc
Confidence 999999 589999985 367888999999999999999999 99999999999999998 6899999
Q ss_pred eccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 391 FGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 391 FGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
||++....... ........+++.|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus 161 ~~~~~~~~~~~----~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~ 223 (275)
T cd05046 161 LSLSKDVYNSE----YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS 223 (275)
T ss_pred cccccccCccc----ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccc
Confidence 99986432211 112223456788999999988889999999999999999999 888996543
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=262.17 Aligned_cols=194 Identities=28% Similarity=0.427 Sum_probs=167.3
Q ss_pred CCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc--cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc-
Q 011660 254 FSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL- 329 (480)
Q Consensus 254 f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~- 329 (480)
|+..+.||+|+||.||+|.. .+++.+|+|++..... ....+.+|+++++.++||||+++++++.+++.+++||||+
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 77888999999999999965 5688999999865432 2356789999999999999999999999999999999999
Q ss_pred CCCHHHHHHh--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccCc
Q 011660 330 NGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV 407 (480)
Q Consensus 330 ~GsL~~~l~~--~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~ 407 (480)
+|+|.+++.. +++.....++.|++.||.|||+. +++|+||+|+||+++.+ +.++|+|||++...... ..
T Consensus 86 ~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~-~~~~l~dfg~~~~~~~~-----~~ 156 (277)
T cd06641 86 GGSALDLLEPGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEH-GEVKLADFGVAGQLTDT-----QI 156 (277)
T ss_pred CCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCC-CCEEEeecccceecccc-----hh
Confidence 5789998854 67888899999999999999998 99999999999999988 78999999998654321 11
Q ss_pred cccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 408 KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 408 ~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
......|+..|+|||.+.+..++.++|+|||||++|||++|..||....
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 205 (277)
T cd06641 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELH 205 (277)
T ss_pred hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccc
Confidence 1223568999999999998889999999999999999999999997543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.5e-33 Score=274.35 Aligned_cols=215 Identities=27% Similarity=0.496 Sum_probs=174.2
Q ss_pred HHHhhhhcCCCCceeecccCceEEEEEE-ecCCcEEEEEEeccCCcc--------HHHHHHHHHHHhcCCCCCeeeEEEE
Q 011660 245 QELCHLTHNFSPKMLIGQGGNSKVYRTN-HVDGQVAAVKVLKCTNWS--------EEEVLREVELLSSIKHENIVRIIGY 315 (480)
Q Consensus 245 ~el~~~~~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vAvK~~~~~~~~--------~~~~~~Ei~il~~l~HpnIv~l~~~ 315 (480)
.+-..+.++|-.+.+||+|||+.||++- ....+.||+|+-...... .+...+|.+|-+.|+||.||++|+|
T Consensus 456 kDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDy 535 (775)
T KOG1151|consen 456 KDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDY 535 (775)
T ss_pred ccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeee
Confidence 3444556778888999999999999994 456889999986433221 1346799999999999999999999
Q ss_pred Ee-cCCeeEEEEeccCC-CHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecC--CCceEE
Q 011660 316 CH-SKEMYAIVYNLLNG-SLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN--FHHPQL 388 (480)
Q Consensus 316 ~~-~~~~~~lV~e~~~G-sL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~--~~~~kL 388 (480)
|. +.+.+|.|+|||.| +|+-||++ +.+.++..|+.||+.||.||.+. ..+|||-||||.||||... .|.+||
T Consensus 536 fslDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKI 614 (775)
T KOG1151|consen 536 FSLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKI 614 (775)
T ss_pred eeeccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEe
Confidence 85 66789999999965 68889965 77889999999999999999987 5699999999999999653 367999
Q ss_pred eeecccccccccccc--ccCccccccccCCCccccccccCC----CCCchHHHHHHHHHHHHHHcCCCCCCCCcccch
Q 011660 389 SDFGAAMVHHQSHQV--SENVKPVNVVGTFGYLAPEYMMYG----KVDEKIDVYSYGVVLLELITGKEAIQTNKANRE 460 (480)
Q Consensus 389 ~DFGla~~~~~~~~~--~~~~~~~~~~GT~~y~APE~~~~~----~~~~k~DvwSlGvil~eLltG~~pf~~~~~~~e 460 (480)
+||||++........ ..-.......||.+|++||.|.-+ +.+.|+||||+|||+|+.+.|++||..+...++
T Consensus 615 TDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd 692 (775)
T KOG1151|consen 615 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD 692 (775)
T ss_pred eecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH
Confidence 999999876553322 122233467899999999988643 468899999999999999999999988765444
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.5e-32 Score=273.17 Aligned_cols=197 Identities=27% Similarity=0.411 Sum_probs=166.4
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCC---ccHHHHHHHHHHHhcCCCCCeeeEEEEEecC-----Ce
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN---WSEEEVLREVELLSSIKHENIVRIIGYCHSK-----EM 321 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~ 321 (480)
.++|.+.+.||+|+||.||++.. .+++.+|+|.++... .....+.+|+.+++.++||||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 45799999999999999999976 568999999986532 2335677899999999999999999988643 35
Q ss_pred eEEEEeccCCCHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccc
Q 011660 322 YAIVYNLLNGSLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (480)
Q Consensus 322 ~~lV~e~~~GsL~~~l~---~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~ 398 (480)
.++++||++++|.+++. .+.+.....++.|++.||.|||+. +++||||||+||+++.+ +.++|+|||++....
T Consensus 84 ~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~-~~~kL~Dfg~~~~~~ 159 (337)
T cd07858 84 VYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNAN-CDLKICDFGLARTTS 159 (337)
T ss_pred EEEEEeCCCCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCC-CCEEECcCccccccC
Confidence 79999999999999884 378889999999999999999999 99999999999999988 689999999986543
Q ss_pred cccccccCccccccccCCCccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 399 QSHQVSENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 399 ~~~~~~~~~~~~~~~GT~~y~APE~~~~-~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
... .......||..|+|||.+.. ..++.++|||||||++|+|++|+.||...+
T Consensus 160 ~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 213 (337)
T cd07858 160 EKG-----DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKD 213 (337)
T ss_pred CCc-----ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCC
Confidence 221 11234568899999998865 468999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=260.93 Aligned_cols=186 Identities=23% Similarity=0.363 Sum_probs=152.6
Q ss_pred eecccCceEEEEEEecC-------------CcEEEEEEeccCCcc-HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEE
Q 011660 259 LIGQGGNSKVYRTNHVD-------------GQVAAVKVLKCTNWS-EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAI 324 (480)
Q Consensus 259 ~LG~G~fg~Vy~~~~~~-------------g~~vAvK~~~~~~~~-~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 324 (480)
.||+|+||.||+|...+ ...+++|++...... ...+.+|+.+++.++||||+++++++.++...++
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l 81 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM 81 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence 58999999999996422 235888887654322 2457889999999999999999999999899999
Q ss_pred EEecc-CCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCC------ceEEeeecc
Q 011660 325 VYNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFH------HPQLSDFGA 393 (480)
Q Consensus 325 V~e~~-~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~------~~kL~DFGl 393 (480)
+|||+ +|+|..++.. +++..+..++.||++||.|||+. +|+||||||+|||++.+.. .++++|||+
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~ 158 (262)
T cd05077 82 VEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI 158 (262)
T ss_pred EEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCCCCC
Confidence 99999 5778888743 78888999999999999999999 9999999999999986521 289999999
Q ss_pred ccccccccccccCccccccccCCCcccccccc-CCCCCchHHHHHHHHHHHHHH-cCCCCCCCCc
Q 011660 394 AMVHHQSHQVSENVKPVNVVGTFGYLAPEYMM-YGKVDEKIDVYSYGVVLLELI-TGKEAIQTNK 456 (480)
Q Consensus 394 a~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-~~~~~~k~DvwSlGvil~eLl-tG~~pf~~~~ 456 (480)
+..... .....|+..|+|||.+. +..++.++|||||||++|||+ +|+.||....
T Consensus 159 ~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~ 214 (262)
T cd05077 159 PITVLS---------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT 214 (262)
T ss_pred CccccC---------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcc
Confidence 854321 12345788999999887 567899999999999999997 6888887654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=264.05 Aligned_cols=199 Identities=28% Similarity=0.445 Sum_probs=172.5
Q ss_pred hhcCCCCceeecccCceEEEEEEec-CCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEec
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~ 328 (480)
.++.|+..+.||+|+||.||++.+. +++.+++|++.......+.+..|+++++.++|+||+++++++...+..++++||
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 96 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEY 96 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEec
Confidence 4567888899999999999999774 688999999976554456788999999999999999999999999999999999
Q ss_pred cC-CCHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccc
Q 011660 329 LN-GSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (480)
Q Consensus 329 ~~-GsL~~~l~----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (480)
+. ++|.+++. .+++..+..++.|++.||.|||+. +++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 97 ~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~-- 170 (286)
T cd06614 97 MDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKD-GSVKLADFGFAAQLTKEK-- 170 (286)
T ss_pred cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCC-CCEEECccchhhhhccch--
Confidence 95 89999985 468888899999999999999998 99999999999999988 789999999885433211
Q ss_pred ccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 404 SENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 404 ~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
.......|++.|+|||++.+..++.++|+|||||++|+|++|+.||...+.
T Consensus 171 ---~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~ 221 (286)
T cd06614 171 ---SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP 221 (286)
T ss_pred ---hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH
Confidence 112234588999999999988899999999999999999999999976543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.9e-31 Score=257.84 Aligned_cols=193 Identities=23% Similarity=0.328 Sum_probs=159.8
Q ss_pred hhhhcCCCCceee--cccCceEEEEEEe-cCCcEEEEEEeccCCccHHHHHHHHHHHhcC-CCCCeeeEEEEEecCCeeE
Q 011660 248 CHLTHNFSPKMLI--GQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSI-KHENIVRIIGYCHSKEMYA 323 (480)
Q Consensus 248 ~~~~~~f~~~~~L--G~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~ 323 (480)
....++|.+.+.+ |+|+||.||++.. .+++.+|+|.+........ |+.....+ +||||+++++++..++.++
T Consensus 10 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~----e~~~~~~~~~h~~iv~~~~~~~~~~~~~ 85 (267)
T PHA03390 10 VQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI----EPMVHQLMKDNPNFIKLYYSVTTLKGHV 85 (267)
T ss_pred HHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh----hHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence 3344567777666 9999999999965 5688999999875443221 22222222 7999999999999999999
Q ss_pred EEEecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccc
Q 011660 324 IVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (480)
Q Consensus 324 lV~e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~ 399 (480)
+||||+ +|+|.+++.. +++.++..++.|+++||.|||+. +++||||||+||+++.+.+.++|+|||++.....
T Consensus 86 iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 162 (267)
T PHA03390 86 LIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT 162 (267)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceecCC
Confidence 999999 6899999854 78999999999999999999999 9999999999999999833899999999864322
Q ss_pred ccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 400 SHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 400 ~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
. ....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 163 ~---------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~ 210 (267)
T PHA03390 163 P---------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDE 210 (267)
T ss_pred C---------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 1 13468999999999999999999999999999999999999998554
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-31 Score=262.58 Aligned_cols=196 Identities=30% Similarity=0.429 Sum_probs=164.4
Q ss_pred CCCCceeecccCceEEEEEEe----cCCcEEEEEEeccCC-----ccHHHHHHHHHHHhcC-CCCCeeeEEEEEecCCee
Q 011660 253 NFSPKMLIGQGGNSKVYRTNH----VDGQVAAVKVLKCTN-----WSEEEVLREVELLSSI-KHENIVRIIGYCHSKEMY 322 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~----~~g~~vAvK~~~~~~-----~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 322 (480)
+|++.+.||+|+||.||++.. .+|+.+|+|+++... ...+.+..|+.+++.+ +||||+++++++..+..+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478889999999999999965 368899999997532 1235678899999999 699999999999999999
Q ss_pred EEEEecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccc
Q 011660 323 AIVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (480)
Q Consensus 323 ~lV~e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~ 398 (480)
++|+||+ +++|.+++.. +.+.....++.|++.||.|||+. +++||||+|+|||++.+ +.++|+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~ 156 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSN-GHVVLTDFGLSKEFH 156 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCC-CCEEEeeCccceecc
Confidence 9999999 6789999854 67788888899999999999998 99999999999999998 789999999986543
Q ss_pred cccccccCccccccccCCCccccccccCC--CCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 399 QSHQVSENVKPVNVVGTFGYLAPEYMMYG--KVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 399 ~~~~~~~~~~~~~~~GT~~y~APE~~~~~--~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
... ........|+..|+|||.+... .++.++||||||+++|+|++|+.||....
T Consensus 157 ~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~ 212 (290)
T cd05613 157 EDE----VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDG 212 (290)
T ss_pred ccc----ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCC
Confidence 211 1112245689999999988753 46889999999999999999999997543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-31 Score=265.75 Aligned_cols=190 Identities=31% Similarity=0.479 Sum_probs=163.6
Q ss_pred CCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCcc----HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEec
Q 011660 254 FSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS----EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (480)
Q Consensus 254 f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~----~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~ 328 (480)
|...+.||+|+||.||++.. .++..+|+|.+...... ...+..|+++++.++|||++++++++.+++..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 67778899999999999976 46889999998654321 24578899999999999999999999999999999999
Q ss_pred cCCCHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccc
Q 011660 329 LNGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (480)
Q Consensus 329 ~~GsL~~~l~----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (480)
+.|+|.+++. .+++.++..++.|++.||.|||+. +|+||||+|+||+++.+ +.++|+|||++.....
T Consensus 107 ~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~-~~~kl~dfg~~~~~~~----- 177 (317)
T cd06635 107 CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEP-GQVKLADFGSASIASP----- 177 (317)
T ss_pred CCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCC-CCEEEecCCCccccCC-----
Confidence 9999888773 378889999999999999999999 99999999999999988 6899999998754221
Q ss_pred cCccccccccCCCcccccccc---CCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 405 ENVKPVNVVGTFGYLAPEYMM---YGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 405 ~~~~~~~~~GT~~y~APE~~~---~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.....|++.|+|||.+. .+.++.++|||||||++|||++|+.||....
T Consensus 178 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~ 228 (317)
T cd06635 178 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 228 (317)
T ss_pred ----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc
Confidence 12346899999999874 4568999999999999999999999997653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=263.14 Aligned_cols=188 Identities=28% Similarity=0.402 Sum_probs=160.7
Q ss_pred ecccCceEEEEEEe-cCCcEEEEEEeccCCc----cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc-CCCH
Q 011660 260 IGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGSL 333 (480)
Q Consensus 260 LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~----~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~-~GsL 333 (480)
||+|+||+||++.. .+|+.+|+|.+..... ....+..|+++++.++||||+++++++...+.+++|+||+ +++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999965 5689999999865321 2345678999999999999999999999999999999999 5789
Q ss_pred HHHHH-----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccCcc
Q 011660 334 KQYLK-----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVK 408 (480)
Q Consensus 334 ~~~l~-----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~ 408 (480)
.+++. .+.+.++..++.|++.||.|||+. +++||||+|+||+++++ +.++|+|||++..... ...
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~-~~~~l~dfg~~~~~~~------~~~ 150 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDH-GNVRISDLGLAVELKG------GKK 150 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCC-CCEEEccCcchhhhcc------CCc
Confidence 98884 367888889999999999999999 99999999999999998 6899999999865432 111
Q ss_pred ccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 409 PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 409 ~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
.....|+..|+|||++.+..++.++|+|||||++|+|++|+.||.....
T Consensus 151 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 199 (277)
T cd05577 151 IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKE 199 (277)
T ss_pred cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcc
Confidence 1234678899999999988899999999999999999999999976653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=267.40 Aligned_cols=197 Identities=26% Similarity=0.481 Sum_probs=161.7
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCc----EEEEEEeccCCcc--HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQ----VAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAI 324 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~----~vAvK~~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 324 (480)
.+|+..+.||+|+||.||+|.. .++. .+|+|.+...... ...+.+|+.+++.++||||++++++|.... .++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~-~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPT-IQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCC-cee
Confidence 4688889999999999999965 3444 5788988754322 236789999999999999999999997654 567
Q ss_pred EEecc-CCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccc
Q 011660 325 VYNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (480)
Q Consensus 325 V~e~~-~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~ 399 (480)
+++|+ +|+|.+++.. +.+..+..++.|++.||.|||+. +|+||||||+||+++.+ +.+||+|||+++....
T Consensus 86 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~-~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSP-NHVKITDFGLARLLEG 161 (303)
T ss_pred eehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCC-CceEEccccccccccC
Confidence 78888 6899999853 67788899999999999999998 99999999999999888 6899999999976433
Q ss_pred ccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 400 SHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 400 ~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
... ........++..|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus 162 ~~~---~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~ 216 (303)
T cd05110 162 DEK---EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP 216 (303)
T ss_pred ccc---ccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 211 111223346788999999999999999999999999999997 999997653
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=265.27 Aligned_cols=196 Identities=30% Similarity=0.437 Sum_probs=163.8
Q ss_pred cCCCCceeecccCceEEEEEEecC-CcEEEEEEeccCCc--cHHHHHHHHHHHhcC-CCCCeeeEEEEEecCCeeEEEEe
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNW--SEEEVLREVELLSSI-KHENIVRIIGYCHSKEMYAIVYN 327 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~~-g~~vAvK~~~~~~~--~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~e 327 (480)
++|++.+.||+|+||.||+|.+.+ ++.+|+|.++.... ....+..|+.++... .||||+++++++.+...++++||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 568899999999999999998754 89999999976543 234566788777666 49999999999999999999999
Q ss_pred ccCCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccc
Q 011660 328 LLNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHH-TCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 328 ~~~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~-~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (480)
|+.++|.+++.. +++..+..++.|++.||.|||+ . +|+||||+|+||+++++ +.++|+|||++.......
T Consensus 95 ~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~-~~~kL~dfg~~~~~~~~~- 169 (296)
T cd06618 95 LMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDAS-GNVKLCDFGISGRLVDSK- 169 (296)
T ss_pred ccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCC-CCEEECccccchhccCCC-
Confidence 998888877754 7788888999999999999997 5 89999999999999988 789999999986533211
Q ss_pred cccCccccccccCCCccccccccCCC----CCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 403 VSENVKPVNVVGTFGYLAPEYMMYGK----VDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 403 ~~~~~~~~~~~GT~~y~APE~~~~~~----~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
......|++.|+|||.+.+.. ++.++||||||+++|||++|+.||.....
T Consensus 170 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 223 (296)
T cd06618 170 -----AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT 223 (296)
T ss_pred -----cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh
Confidence 112345788999999987554 78999999999999999999999976443
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=261.84 Aligned_cols=197 Identities=26% Similarity=0.398 Sum_probs=163.2
Q ss_pred cCCCCceeecccCceEEEEEEecC----CcEEEEEEeccCCc--cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHVD----GQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~~----g~~vAvK~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 325 (480)
++|.+.+.||+|+||.||+|...+ ...+|+|....... ..+.+..|+.+++.++||||+++++++.+. ..+++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN-PVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC-CcEEE
Confidence 458888999999999999997533 24689998865432 235688999999999999999999998764 56789
Q ss_pred Eecc-CCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccc
Q 011660 326 YNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (480)
Q Consensus 326 ~e~~-~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (480)
|||+ .|+|.+++.. +++..+..++.+++.||.|||+. +++|+||||+||+++.+ +.++|+|||+++.....
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~-~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSP-DCVKLGDFGLSRYLEDE 160 (270)
T ss_pred EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecC-CCeEEccCceeeecccc
Confidence 9998 6899999953 68888999999999999999998 99999999999999998 68999999998754332
Q ss_pred cccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCcc
Q 011660 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKA 457 (480)
Q Consensus 401 ~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~~ 457 (480)
.. .......+++.|+|||.+....++.++|||||||++|||++ |..||.....
T Consensus 161 ~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~ 214 (270)
T cd05056 161 SY----YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN 214 (270)
T ss_pred cc----eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 11 11112335678999999988899999999999999999986 9999976653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-31 Score=254.22 Aligned_cols=194 Identities=35% Similarity=0.510 Sum_probs=170.1
Q ss_pred CCCCceeecccCceEEEEEEec-CCcEEEEEEeccCCc-cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEeccC
Q 011660 253 NFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNW-SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLLN 330 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~ 330 (480)
+|...+.||+|++|.||++... +++.+++|++..... ....+.+|+++++.++|||++++++++..++..++++||+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4778889999999999999774 688999999976554 45678899999999999999999999999999999999995
Q ss_pred -CCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccccc
Q 011660 331 -GSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE 405 (480)
Q Consensus 331 -GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~ 405 (480)
++|.+++.. +++..+..++.|++.||.|||.. +++|+||+|+||+++++ +.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~--- 153 (253)
T cd05122 81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSD-GEVKLIDFGLSAQLSDTKA--- 153 (253)
T ss_pred CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccC-CeEEEeecccccccccccc---
Confidence 789998844 58889999999999999999998 99999999999999998 6899999999865433211
Q ss_pred CccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 406 NVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 406 ~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.....|+..|+|||.+.+..++.++|+||||+++|+|++|+.||....
T Consensus 154 ---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 201 (253)
T cd05122 154 ---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELP 201 (253)
T ss_pred ---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCc
Confidence 234578999999999998889999999999999999999999998763
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=259.07 Aligned_cols=196 Identities=30% Similarity=0.421 Sum_probs=167.8
Q ss_pred CCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCC---ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEec
Q 011660 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN---WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~ 328 (480)
+|++.+.||+|+||.||++.. .+|..+|+|.+.... ...+.+.+|+.+++.++||||+++++++.+++..++++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 478889999999999999976 458899999986542 2345678999999999999999999999999999999999
Q ss_pred c-CCCHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccc
Q 011660 329 L-NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 329 ~-~GsL~~~l~~-----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (480)
+ +++|.+++.. +++..+..++.|+++||.|||+. +++|+||||+||+++++...++|+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 9 6799998853 57888999999999999999998 9999999999999998744579999999865432211
Q ss_pred cccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 403 ~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
......|++.|+|||++.+..++.++|+||||+++|||++|..||...+
T Consensus 158 -----~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 206 (257)
T cd08225 158 -----LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN 206 (257)
T ss_pred -----cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 1123468999999999988889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=271.09 Aligned_cols=196 Identities=25% Similarity=0.398 Sum_probs=167.0
Q ss_pred hhhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCcc---HHHHHHHHHHHhcCCCCCeeeEEEEEecCC----
Q 011660 249 HLTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSKE---- 320 (480)
Q Consensus 249 ~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~---- 320 (480)
.+.++|++.+.||+|+||.||++.. .+++.||+|++...... ...+.+|+.+++.++||||+++++++..+.
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 4567899999999999999999965 57899999998653322 345789999999999999999999986543
Q ss_pred --eeEEEEeccCCCHHHHHH--hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccc
Q 011660 321 --MYAIVYNLLNGSLKQYLK--QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMV 396 (480)
Q Consensus 321 --~~~lV~e~~~GsL~~~l~--~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~ 396 (480)
.+++||+|++++|.+++. .+++..+..++.|++.||.|||+. +|+||||||+||+++.+ +.++|+|||++..
T Consensus 92 ~~~~~lv~e~~~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~-~~~kl~dfg~~~~ 167 (343)
T cd07880 92 FHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNED-CELKILDFGLARQ 167 (343)
T ss_pred cceEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCC-CCEEEeecccccc
Confidence 468999999889998884 588899999999999999999998 99999999999999988 6899999999864
Q ss_pred cccccccccCccccccccCCCccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 397 HHQSHQVSENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 397 ~~~~~~~~~~~~~~~~~GT~~y~APE~~~~-~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
... ......+++.|+|||.+.+ ..++.++|+|||||++|+|++|+.||...+
T Consensus 168 ~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 220 (343)
T cd07880 168 TDS--------EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHD 220 (343)
T ss_pred ccc--------CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 322 1223467899999998876 458899999999999999999999998654
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=262.66 Aligned_cols=199 Identities=28% Similarity=0.425 Sum_probs=167.6
Q ss_pred cCCCCceeecccCceEEEEEEec-----CCcEEEEEEeccCCcc--HHHHHHHHHHHhcCCCCCeeeEEEEEec--CCee
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHV-----DGQVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHS--KEMY 322 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~-----~g~~vAvK~~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~ 322 (480)
.+|.+.+.||+|+||.||++... +++.+|+|+++..... .+.+..|+++++.++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 35778889999999999999753 3689999999876653 5678999999999999999999999877 5678
Q ss_pred EEEEecc-CCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccc
Q 011660 323 AIVYNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVH 397 (480)
Q Consensus 323 ~lV~e~~-~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~ 397 (480)
+++|||+ +|+|.+++.. +++..+..++.|++.||.|||+. +++|+||||+||+++.+ +.++|+|||++...
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~ 159 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESE-DLVKISDFGLAKVL 159 (284)
T ss_pred EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCC-CCEEEccccccccc
Confidence 9999999 6799999953 78888999999999999999998 99999999999999998 78999999999765
Q ss_pred ccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 398 HQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 398 ~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
...... ........++..|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 160 ~~~~~~--~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~ 216 (284)
T cd05038 160 PEDKDY--YYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPP 216 (284)
T ss_pred ccCCcc--eeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCccccc
Confidence 422111 111112345667999999998899999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=269.12 Aligned_cols=197 Identities=28% Similarity=0.423 Sum_probs=167.5
Q ss_pred hhhhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCC---ccHHHHHHHHHHHhcCCCCCeeeEEEEEec-CCee
Q 011660 248 CHLTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN---WSEEEVLREVELLSSIKHENIVRIIGYCHS-KEMY 322 (480)
Q Consensus 248 ~~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~ 322 (480)
..++++|++.+.||+|+||.||++.. .+++.+|+|++.+.. ...+.+..|+++++.++||||++++++|.. .+..
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 44678899999999999999999965 578999999886432 234567899999999999999999998865 5678
Q ss_pred EEEEeccCCCHHHHHHh--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccc
Q 011660 323 AIVYNLLNGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (480)
Q Consensus 323 ~lV~e~~~GsL~~~l~~--~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (480)
++++||++++|.+++.. +.......++.|+++||.|||+. +|+||||+|+||+++++ +.++|+|||++.....
T Consensus 86 ~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~-~~~~l~dfg~~~~~~~- 160 (328)
T cd07856 86 YFVTELLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINEN-CDLKICDFGLARIQDP- 160 (328)
T ss_pred EEEeehhccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCC-CCEEeCccccccccCC-
Confidence 89999999999998854 66777788999999999999999 99999999999999988 7899999999853221
Q ss_pred cccccCccccccccCCCccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 401 HQVSENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 401 ~~~~~~~~~~~~~GT~~y~APE~~~~-~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||....
T Consensus 161 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~ 210 (328)
T cd07856 161 -------QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKD 210 (328)
T ss_pred -------CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 1223467889999998765 568999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-31 Score=258.13 Aligned_cols=188 Identities=29% Similarity=0.408 Sum_probs=163.5
Q ss_pred ecccCceEEEEEEec-CCcEEEEEEeccCCc----cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc-CCCH
Q 011660 260 IGQGGNSKVYRTNHV-DGQVAAVKVLKCTNW----SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGSL 333 (480)
Q Consensus 260 LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~----~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~-~GsL 333 (480)
||.|+||.||++... +++.+|+|++..... ..+.+..|+.+++.++||||+++++++.+++.+++++||+ +++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999764 488999999975432 2356889999999999999999999999999999999998 6899
Q ss_pred HHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccCcccc
Q 011660 334 KQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPV 410 (480)
Q Consensus 334 ~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~ 410 (480)
.+++.. ++...+..++.|++.||.|||+. +++|+||+|+||+++.+ +.++|+|||++....... ...
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~-~~~~l~df~~~~~~~~~~------~~~ 150 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSN-GYVKLVDFGFAKKLKSGQ------KTW 150 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCC-CCEEEeeCCcccccCccc------ccc
Confidence 999853 67888889999999999999998 99999999999999998 689999999986543321 223
Q ss_pred ccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 411 NVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 411 ~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
...|++.|+|||.+.+..++.++|+||||+++|||++|..||.....
T Consensus 151 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 197 (262)
T cd05572 151 TFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE 197 (262)
T ss_pred cccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC
Confidence 45789999999999888899999999999999999999999987653
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=241.89 Aligned_cols=197 Identities=24% Similarity=0.374 Sum_probs=165.1
Q ss_pred ceeecccCceEEEEEEe-cCCcEEEEEEeccCCc--cHHHHHHHHHHHh-cCCCCCeeeEEEEEecCCeeEEEEeccCCC
Q 011660 257 KMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW--SEEEVLREVELLS-SIKHENIVRIIGYCHSKEMYAIVYNLLNGS 332 (480)
Q Consensus 257 ~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~--~~~~~~~Ei~il~-~l~HpnIv~l~~~~~~~~~~~lV~e~~~Gs 332 (480)
...||+|++|.|=+.++ .+|...|+|.++..-. ..++..+|+++.. ....|++|.+||........++.||.+..+
T Consensus 51 i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~tS 130 (282)
T KOG0984|consen 51 IEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDTS 130 (282)
T ss_pred hhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhhh
Confidence 34599999999988876 6799999999976543 3456788998765 457999999999988888999999999999
Q ss_pred HHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccccc
Q 011660 333 LKQYLKQ-------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE 405 (480)
Q Consensus 333 L~~~l~~-------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~ 405 (480)
|+.+.++ .++.-.-+|+..+..||.|||++. .|||||+||+|||++.+ |++|+||||.+-++.+
T Consensus 131 ldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~-GqVKiCDFGIsG~L~d------ 201 (282)
T KOG0984|consen 131 LDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYD-GQVKICDFGISGYLVD------ 201 (282)
T ss_pred HHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccC-CcEEEcccccceeehh------
Confidence 9888743 677888899999999999999875 89999999999999999 8999999999855433
Q ss_pred CccccccccCCCcccccccc----CCCCCchHHHHHHHHHHHHHHcCCCCCCCCcccchhH
Q 011660 406 NVKPVNVVGTFGYLAPEYMM----YGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESL 462 (480)
Q Consensus 406 ~~~~~~~~GT~~y~APE~~~----~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~~~e~l 462 (480)
....+-..|.-.|||||.+. ...|+.|+||||||+.+.||.+++.||..-....+.|
T Consensus 202 SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qL 262 (282)
T KOG0984|consen 202 SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQL 262 (282)
T ss_pred hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHH
Confidence 22223356888999999875 3479999999999999999999999999877665544
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=260.63 Aligned_cols=193 Identities=27% Similarity=0.503 Sum_probs=163.5
Q ss_pred CCCceeecccCceEEEEEEec-CCcEEEEEEeccCCcc---HHHHHHHHHHHhcC---CCCCeeeEEEEEecCCe-----
Q 011660 254 FSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWS---EEEVLREVELLSSI---KHENIVRIIGYCHSKEM----- 321 (480)
Q Consensus 254 f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~---~~~~~~Ei~il~~l---~HpnIv~l~~~~~~~~~----- 321 (480)
|++.+.||+|+||.||++... +++.+|+|+++..... ...+..|+.+++++ +||||+++++++.+.+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567789999999999999875 4899999999754322 23466788777665 69999999999987776
Q ss_pred eEEEEeccCCCHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccc
Q 011660 322 YAIVYNLLNGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMV 396 (480)
Q Consensus 322 ~~lV~e~~~GsL~~~l~~-----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~ 396 (480)
++++||++.++|.+++.. +++..+..++.|++.||.|||+. +++|+||+|+||+++.+ +.++|+|||++..
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~-~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSD-GQVKIADFGLARI 156 (287)
T ss_pred eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccC-CCEEEeccCccee
Confidence 999999999899988843 68889999999999999999999 99999999999999999 7999999999865
Q ss_pred cccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 397 HHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 397 ~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.... .......+++.|+|||++.+..++.++|+|||||++|||++|++||....
T Consensus 157 ~~~~------~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~ 210 (287)
T cd07838 157 YSFE------MALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTS 210 (287)
T ss_pred ccCC------cccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCC
Confidence 4321 11123457899999999999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=262.13 Aligned_cols=187 Identities=24% Similarity=0.367 Sum_probs=152.7
Q ss_pred eecccCceEEEEEEecC-------------------------CcEEEEEEeccCCcc-HHHHHHHHHHHhcCCCCCeeeE
Q 011660 259 LIGQGGNSKVYRTNHVD-------------------------GQVAAVKVLKCTNWS-EEEVLREVELLSSIKHENIVRI 312 (480)
Q Consensus 259 ~LG~G~fg~Vy~~~~~~-------------------------g~~vAvK~~~~~~~~-~~~~~~Ei~il~~l~HpnIv~l 312 (480)
.||+|+||.||+|.... ...+++|++...... ...+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999986411 135888988654322 2467889999999999999999
Q ss_pred EEEEecCCeeEEEEecc-CCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCC----
Q 011660 313 IGYCHSKEMYAIVYNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENF---- 383 (480)
Q Consensus 313 ~~~~~~~~~~~lV~e~~-~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~---- 383 (480)
+++|.+++..++||||+ +|+|..++.. +++..+..++.|++.||.|||+. +|+||||||+|||++.+.
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCcccC
Confidence 99999999999999999 6789888843 67888999999999999999998 999999999999997541
Q ss_pred --CceEEeeeccccccccccccccCccccccccCCCccccccccC-CCCCchHHHHHHHHHHHHH-HcCCCCCCCCcc
Q 011660 384 --HHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLEL-ITGKEAIQTNKA 457 (480)
Q Consensus 384 --~~~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~-~~~~~k~DvwSlGvil~eL-ltG~~pf~~~~~ 457 (480)
..++++|||++..... .....+++.|+|||.+.+ ..++.++|||||||++||| ++|+.||.....
T Consensus 159 ~~~~~kl~d~g~~~~~~~---------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~ 227 (274)
T cd05076 159 TSPFIKLSDPGVSFTALS---------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP 227 (274)
T ss_pred ccceeeecCCcccccccc---------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh
Confidence 2379999998743211 112357888999998875 5689999999999999998 579999986543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=268.12 Aligned_cols=199 Identities=24% Similarity=0.326 Sum_probs=163.8
Q ss_pred CCCCceeecccCceEEEEEEec-C--CcEEEEEEeccCC---ccHHHHHHHHHHHhcC-CCCCeeeEEEEEec----CCe
Q 011660 253 NFSPKMLIGQGGNSKVYRTNHV-D--GQVAAVKVLKCTN---WSEEEVLREVELLSSI-KHENIVRIIGYCHS----KEM 321 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~~-~--g~~vAvK~~~~~~---~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~----~~~ 321 (480)
+|.+.+.||+|+||.||++... + +..+|+|.+.... ...+.+.+|+.+++++ +||||+++++++.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4788899999999999999763 4 7799999986432 1235678899999999 59999999987532 246
Q ss_pred eEEEEeccCCCHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccc
Q 011660 322 YAIVYNLLNGSLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (480)
Q Consensus 322 ~~lV~e~~~GsL~~~l~---~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~ 398 (480)
.++++++++++|.+++. .+++..+..++.||+.||.|||+. +|+||||||+||+++.+ +.++|+|||+++...
T Consensus 81 ~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~-~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 81 LYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNAD-CELKICDFGLARGFS 156 (332)
T ss_pred EEEEEecccCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCC-CCEEeCcCCCceecc
Confidence 78999999999999984 378889999999999999999999 99999999999999998 689999999997654
Q ss_pred cccccccCccccccccCCCccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 399 QSHQVSENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 399 ~~~~~~~~~~~~~~~GT~~y~APE~~~~-~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
..... .........||+.|+|||.+.+ ..++.++|||||||++|+|++|++||...+
T Consensus 157 ~~~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~ 214 (332)
T cd07857 157 ENPGE-NAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKD 214 (332)
T ss_pred ccccc-ccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCC
Confidence 32211 1112234579999999998765 468999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=258.22 Aligned_cols=194 Identities=26% Similarity=0.450 Sum_probs=163.0
Q ss_pred CCCCceeecccCceEEEEEEecC--CcEEEEEEeccCC-----------ccHHHHHHHHHHHhc-CCCCCeeeEEEEEec
Q 011660 253 NFSPKMLIGQGGNSKVYRTNHVD--GQVAAVKVLKCTN-----------WSEEEVLREVELLSS-IKHENIVRIIGYCHS 318 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~~~--g~~vAvK~~~~~~-----------~~~~~~~~Ei~il~~-l~HpnIv~l~~~~~~ 318 (480)
+|++.+.||+|+||.||++.... ++.+|+|.+.... ....++..|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788899999999999997644 7889999885321 112346788888865 799999999999999
Q ss_pred CCeeEEEEecc-CCCHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeccCCCCCEEEecCCCceEEe
Q 011660 319 KEMYAIVYNLL-NGSLKQYLK-------QLKWNERMDVAIGVAKALEYLHH-TCDPPIIHRDVKSSNILLSENFHHPQLS 389 (480)
Q Consensus 319 ~~~~~lV~e~~-~GsL~~~l~-------~~~~~~~~~i~~~ia~aL~yLH~-~~~~~IiHrDlKp~NILl~~~~~~~kL~ 389 (480)
++..+++|||+ +++|.+++. .+++..++.++.|++.||.|||+ . +++|+||+|+||+++.+ +.++|+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~-~~~~l~ 156 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGED-DKVTIT 156 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCC-CcEEEe
Confidence 99999999999 568888773 26778889999999999999996 5 89999999999999998 689999
Q ss_pred eeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 390 DFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 390 DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
|||++....... ......|+..|+|||.+.+..++.++|+||||+++|||++|+.||....
T Consensus 157 dfg~~~~~~~~~------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~ 217 (269)
T cd08528 157 DFGLAKQKQPES------KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN 217 (269)
T ss_pred cccceeeccccc------ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC
Confidence 999986533211 2234568999999999998889999999999999999999999997653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=259.17 Aligned_cols=196 Identities=26% Similarity=0.397 Sum_probs=158.8
Q ss_pred CCCceeecccCceEEEEEEec----CCcEEEEEEeccCCcc---HHHHHHHHHHHhcCCCCCeeeEEEEEecCC------
Q 011660 254 FSPKMLIGQGGNSKVYRTNHV----DGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSKE------ 320 (480)
Q Consensus 254 f~~~~~LG~G~fg~Vy~~~~~----~g~~vAvK~~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------ 320 (480)
|.+.+.||+|+||.||+|... +++.+|+|+++..... .+++.+|+++++.++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567788999999999999642 3689999999765322 346789999999999999999999885432
Q ss_pred eeEEEEecc-CCCHHHHHH---------hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEee
Q 011660 321 MYAIVYNLL-NGSLKQYLK---------QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSD 390 (480)
Q Consensus 321 ~~~lV~e~~-~GsL~~~l~---------~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~D 390 (480)
..+++++|. .|+|.+++. .+++.....++.|++.||.|||+. +|+||||||+||+++.+ +.++|+|
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~-~~~kl~d 156 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNEN-MTVCVAD 156 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCC-CCEEECc
Confidence 246778888 688988763 256778899999999999999999 99999999999999988 6899999
Q ss_pred eccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 391 FGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 391 FGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
||+++....... ........+++.|++||.+....++.++|||||||++|||++ |++||...+
T Consensus 157 fg~~~~~~~~~~---~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~ 220 (273)
T cd05074 157 FGLSKKIYSGDY---YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE 220 (273)
T ss_pred ccccccccCCcc---eecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCC
Confidence 999875432211 111123345678999999998899999999999999999999 899997654
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=259.22 Aligned_cols=195 Identities=25% Similarity=0.399 Sum_probs=167.7
Q ss_pred CCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCcc---HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc
Q 011660 254 FSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (480)
Q Consensus 254 f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~ 329 (480)
|.+.+.||+|++|.||++.. .+++.+++|.++..... ...+.+|+++++.++||||+++++++.+++..++++||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 56778899999999999976 46889999998755433 456788999999999999999999999999999999999
Q ss_pred CCCHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccccc
Q 011660 330 NGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE 405 (480)
Q Consensus 330 ~GsL~~~l~----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~ 405 (480)
.++|.+++. .+++.++..++.|++.||.|||+. +|+|+||||+||+++.+ +.++|+|||.+.......
T Consensus 81 ~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~-~~~~l~df~~~~~~~~~~---- 152 (283)
T cd05118 81 DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTE-GVLKLADFGLARSFGSPV---- 152 (283)
T ss_pred CCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCC-CcEEEeeeeeeEecCCCc----
Confidence 989988884 367888999999999999999999 99999999999999988 689999999986544322
Q ss_pred CccccccccCCCccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 406 NVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 406 ~~~~~~~~GT~~y~APE~~~~~-~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
.......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+.
T Consensus 153 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~ 204 (283)
T cd05118 153 -RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE 204 (283)
T ss_pred -ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 112234588899999998876 789999999999999999999999976654
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=260.21 Aligned_cols=195 Identities=26% Similarity=0.425 Sum_probs=166.6
Q ss_pred CCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc-cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc-
Q 011660 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW-SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL- 329 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~- 329 (480)
.|...+.||+|++|.||++.. .+++.+++|.++.... ..+.+.+|+.+++.++||||+++++++...+..++++||+
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 456667999999999999975 5688999999865432 2345789999999999999999999999999999999999
Q ss_pred CCCHHHHHHh--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccCc
Q 011660 330 NGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV 407 (480)
Q Consensus 330 ~GsL~~~l~~--~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~ 407 (480)
+++|.+++.. +++.++..++.|++.||.|||+. +|+||||+|+||+++.+ +.++|+|||++...... ..
T Consensus 100 ~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~-~~~~l~d~g~~~~~~~~-----~~ 170 (285)
T cd06648 100 GGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSD-GRVKLSDFGFCAQVSKE-----VP 170 (285)
T ss_pred CCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCC-CcEEEcccccchhhccC-----Cc
Confidence 6789998854 67788899999999999999999 99999999999999998 68999999987543221 11
Q ss_pred cccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 408 KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 408 ~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
......|++.|+|||.+.+..++.++|+|||||++|||++|+.||...+
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~ 219 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP 219 (285)
T ss_pred ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC
Confidence 1223568999999999998889999999999999999999999997644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-32 Score=269.49 Aligned_cols=193 Identities=32% Similarity=0.504 Sum_probs=158.9
Q ss_pred CCCCceeecccCceEEEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhc--CCCCCeeeEEEEEecCC----eeEEEE
Q 011660 253 NFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSS--IKHENIVRIIGYCHSKE----MYAIVY 326 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~~~~~~~~----~~~lV~ 326 (480)
......+||+|.||.||+|.+ +++.||||++... ....+..|.+|.+. ++|+||+++++.-...+ .+++|+
T Consensus 211 pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~~--~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt 287 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPEQ--EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT 287 (534)
T ss_pred chhhHHHhhcCccceeehhhc-cCceeEEEecCHH--HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence 345567899999999999987 4699999999643 24568888888875 58999999999876544 899999
Q ss_pred ecc-CCCHHHHHHh--CCHHHHHHHHHHHHHHHHHHHhC------CCCCeEeccCCCCCEEEecCCCceEEeeecccccc
Q 011660 327 NLL-NGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHT------CDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVH 397 (480)
Q Consensus 327 e~~-~GsL~~~l~~--~~~~~~~~i~~~ia~aL~yLH~~------~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~ 397 (480)
+|. .|+|.+||+. .+|.+..+++.-+++||.|||+. ++++|+|||||++||||..| ....|+|||+|..+
T Consensus 288 ~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~D-lTccIaDFGLAl~~ 366 (534)
T KOG3653|consen 288 EFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKND-LTCCIADFGLALRL 366 (534)
T ss_pred eeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccC-CcEEeeccceeEEe
Confidence 998 8999999976 79999999999999999999974 46689999999999999999 68999999999876
Q ss_pred ccccccccCccccccccCCCccccccccCCC-CC-----chHHHHHHHHHHHHHHcCCCCC
Q 011660 398 HQSHQVSENVKPVNVVGTFGYLAPEYMMYGK-VD-----EKIDVYSYGVVLLELITGKEAI 452 (480)
Q Consensus 398 ~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~-~~-----~k~DvwSlGvil~eLltG~~pf 452 (480)
..... ......-+||.+|||||++.+.. +. .+.||||+|.+||||++.-.-+
T Consensus 367 ~p~~~---~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~ 424 (534)
T KOG3653|consen 367 EPGKP---QGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDA 424 (534)
T ss_pred cCCCC---CcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccc
Confidence 64322 22223478999999999987531 11 3699999999999999975444
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=260.57 Aligned_cols=194 Identities=24% Similarity=0.378 Sum_probs=164.6
Q ss_pred CCCceeecccCceEEEEEEec-CCcEEEEEEeccCCc--cHHHHHHHHHHHhcCC-CCCeeeEEEEEecCCeeEEEEecc
Q 011660 254 FSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNW--SEEEVLREVELLSSIK-HENIVRIIGYCHSKEMYAIVYNLL 329 (480)
Q Consensus 254 f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~e~~ 329 (480)
|.+.+.||+|+||.||+|... +++.+++|.+..... ......+|+..+++++ ||||+++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567789999999999999774 588999999875533 2234567999999999 999999999999999999999999
Q ss_pred CCCHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccc
Q 011660 330 NGSLKQYLK-----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (480)
Q Consensus 330 ~GsL~~~l~-----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (480)
+|+|.+++. .+++.++..++.|++.+|.|||++ +++|+||+|+||+++++ +.++|+|||++......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~-~~~~l~d~~~~~~~~~~---- 152 (283)
T cd07830 81 EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGP-EVVKIADFGLAREIRSR---- 152 (283)
T ss_pred CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCC-CCEEEeecccceeccCC----
Confidence 999998884 358889999999999999999998 99999999999999998 68999999998653321
Q ss_pred cCccccccccCCCcccccccc-CCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 405 ENVKPVNVVGTFGYLAPEYMM-YGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 405 ~~~~~~~~~GT~~y~APE~~~-~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
.......|+..|+|||++. ...++.++|+||||+++|||++|++||.....
T Consensus 153 --~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~ 204 (283)
T cd07830 153 --PPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSE 204 (283)
T ss_pred --CCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCCh
Confidence 1122356889999999875 44579999999999999999999999976653
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-31 Score=252.02 Aligned_cols=197 Identities=29% Similarity=0.414 Sum_probs=170.9
Q ss_pred CCCCceeecccCceEEEEEEec-CCcEEEEEEeccCCc---cHHHHHHHHHHHhcCCCCCeeeEEEEEecC--CeeEEEE
Q 011660 253 NFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVRIIGYCHSK--EMYAIVY 326 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~lV~ 326 (480)
+|...+.||+|++|.||+|... +++.+++|+++.... ..+.+.+|++++++++||||+++++.+.+. +.+++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4778889999999999999775 689999999976552 346788999999999999999999999888 8999999
Q ss_pred ecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccc
Q 011660 327 NLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 327 e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (480)
|++ +++|.+++.. +++.++..++.|++.||.|||+. +++|+||+|+||+++.+ +.++|+|||.+........
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSD-GVVKLADFGCAKRLGDIET 156 (260)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCC-CCEEEcccccEEecccccc
Confidence 999 7889999854 68889999999999999999998 99999999999999998 6899999999865443221
Q ss_pred cccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 403 ~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
. .......++..|+|||.+....++.++|+||||+++|+|++|..||....
T Consensus 157 ~---~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 207 (260)
T cd06606 157 G---EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG 207 (260)
T ss_pred c---ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1 11234568999999999988889999999999999999999999998765
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=267.33 Aligned_cols=199 Identities=27% Similarity=0.392 Sum_probs=169.9
Q ss_pred CCCCceeecccCceEEEEEEec-CCcEEEEEEeccCC---ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCC-----eeE
Q 011660 253 NFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTN---WSEEEVLREVELLSSIKHENIVRIIGYCHSKE-----MYA 323 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-----~~~ 323 (480)
+|.+.+.||+|+||.||+|... +++.+|+|.+.... ...+.+.+|+.+++.++||||+++++++...+ .++
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4788899999999999999764 58999999987543 23457889999999999999999999987765 789
Q ss_pred EEEeccCCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccc
Q 011660 324 IVYNLLNGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (480)
Q Consensus 324 lV~e~~~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (480)
++|+|+.++|.+++.. +++..+..++.|++.||.|||+. +|+|+||||+|||++.+ +.++|+|||++......
T Consensus 81 lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~-~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 81 IVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSN-CDLKICDFGLARGVDPD 156 (330)
T ss_pred EEecchhhhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCC-CCEEEcccCceEeeccc
Confidence 9999999899998854 68888999999999999999999 99999999999999998 79999999998764432
Q ss_pred cccccCccccccccCCCccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 401 HQVSENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 401 ~~~~~~~~~~~~~GT~~y~APE~~~~~-~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
... ........+|+.|+|||.+.+. .++.++|+||||+++|+|++|++||...+.
T Consensus 157 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~ 212 (330)
T cd07834 157 EDE--KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDY 212 (330)
T ss_pred ccc--cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCH
Confidence 210 1122345689999999999887 789999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-31 Score=254.87 Aligned_cols=187 Identities=27% Similarity=0.373 Sum_probs=157.5
Q ss_pred eeecccCceEEEEEEe-cCCcEEEEEEeccCCcc----HHHHHHHHHHH-hcCCCCCeeeEEEEEecCCeeEEEEecc-C
Q 011660 258 MLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS----EEEVLREVELL-SSIKHENIVRIIGYCHSKEMYAIVYNLL-N 330 (480)
Q Consensus 258 ~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~----~~~~~~Ei~il-~~l~HpnIv~l~~~~~~~~~~~lV~e~~-~ 330 (480)
+.||+|+||.||+|.. .+++.+|+|++++.... ...+..|..++ ...+||||+++++++.+++.+++++||+ +
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 4689999999999976 46899999999754321 12344555544 4568999999999999999999999999 6
Q ss_pred CCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccCc
Q 011660 331 GSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV 407 (480)
Q Consensus 331 GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~ 407 (480)
|+|.++++. +++..+..++.|++.||.|||+. +++|+||+|+||+++.+ +.++|+|||++.....
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~-------- 149 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQT-GHLKLTDFGLSRNGLE-------- 149 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCC-CcEEEeecccceeccc--------
Confidence 789999854 78888999999999999999998 99999999999999988 6899999999854221
Q ss_pred cccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 408 KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 408 ~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
.....|++.|+|||.+.+..++.++||||||+++|||++|..||...+.
T Consensus 150 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 198 (260)
T cd05611 150 -NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP 198 (260)
T ss_pred -cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH
Confidence 2245689999999999988899999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=259.94 Aligned_cols=194 Identities=29% Similarity=0.478 Sum_probs=166.5
Q ss_pred CCCceeecccCceEEEEEEec-CCcEEEEEEeccCC---ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc
Q 011660 254 FSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTN---WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (480)
Q Consensus 254 f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~ 329 (480)
|+..+.||+|+||.||+|... +++.+|+|+++... ...+.+..|+.+++.++||||+++++++.+.+.+++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 556678999999999999774 58999999997653 23456788999999999999999999999999999999999
Q ss_pred CCCHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccccc
Q 011660 330 NGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE 405 (480)
Q Consensus 330 ~GsL~~~l~----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~ 405 (480)
.++|.+++. .+++..+..++.+++.||.|||+. +|+||||+|+||+++++ +.++|+|||++........
T Consensus 81 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~-~~~~l~d~g~~~~~~~~~~--- 153 (282)
T cd07829 81 DMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRD-GVLKLADFGLARAFGIPLR--- 153 (282)
T ss_pred CcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCC-CCEEEecCCcccccCCCcc---
Confidence 999999995 368889999999999999999999 99999999999999998 7899999999865432111
Q ss_pred CccccccccCCCccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 406 NVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 406 ~~~~~~~~GT~~y~APE~~~~~-~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
......++..|+|||.+... .++.++|||||||++|||++|++||....
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 203 (282)
T cd07829 154 --TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDS 203 (282)
T ss_pred --ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCcc
Confidence 12233567889999998776 78999999999999999999999997755
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-33 Score=303.62 Aligned_cols=208 Identities=29% Similarity=0.382 Sum_probs=173.2
Q ss_pred HhhhhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCcc---HHHHHHHHHHHhcCCCCCeeeEEEEEecCCee
Q 011660 247 LCHLTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSKEMY 322 (480)
Q Consensus 247 l~~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 322 (480)
+...+-+|.-...||.|.||.||-|.. .+|...|+|.++-.+.. .+...+|.++|..++|||+|+++|+-...+..
T Consensus 1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence 344556778888999999999999954 66899999988654433 24578999999999999999999999988999
Q ss_pred EEEEecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccc
Q 011660 323 AIVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (480)
Q Consensus 323 ~lV~e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~ 398 (480)
+|.|||| +|+|.+.++. .++.....+..|++.|+.|||+. |||||||||.||+|+.+ |.+|++|||.|....
T Consensus 1310 ~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~-g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFN-GLIKYGDFGSAVKIK 1385 (1509)
T ss_pred HHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecC-CcEEeecccceeEec
Confidence 9999999 7899999865 34444456788999999999999 99999999999999999 799999999998766
Q ss_pred cccccccCccccccccCCCccccccccCC---CCCchHHHHHHHHHHHHHHcCCCCCCCCcccc
Q 011660 399 QSHQVSENVKPVNVVGTFGYLAPEYMMYG---KVDEKIDVYSYGVVLLELITGKEAIQTNKANR 459 (480)
Q Consensus 399 ~~~~~~~~~~~~~~~GT~~y~APE~~~~~---~~~~k~DvwSlGvil~eLltG~~pf~~~~~~~ 459 (480)
..-+ .........+||+.|||||++.+. +..-+.||||+||+..||+||+.||...+++-
T Consensus 1386 ~~~~-~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~ 1448 (1509)
T KOG4645|consen 1386 NNAQ-TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW 1448 (1509)
T ss_pred Cchh-cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh
Confidence 5422 222334567899999999999864 35678999999999999999999999876553
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=274.17 Aligned_cols=197 Identities=28% Similarity=0.460 Sum_probs=166.2
Q ss_pred CCCCceeecccCceEEEEEEecC---Cc--EEEEEEeccCC--ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEE
Q 011660 253 NFSPKMLIGQGGNSKVYRTNHVD---GQ--VAAVKVLKCTN--WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~~~---g~--~vAvK~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 325 (480)
.....++||+|-||.||+|.+.+ |. -||||..+.+. .+.+.|+.|.-+|+.++||||++|+|+|.+. ..+||
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wiv 468 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIV 468 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEE
Confidence 34556789999999999996533 22 58999998643 3456799999999999999999999999885 46889
Q ss_pred Eecc-CCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccc
Q 011660 326 YNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (480)
Q Consensus 326 ~e~~-~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (480)
||.+ -|.|.+||++ ++......+++||+.||.|||+. .+|||||..+|||+... ..+||+|||++++....
T Consensus 469 mEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp-~CVKLaDFGLSR~~ed~ 544 (974)
T KOG4257|consen 469 MELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSP-QCVKLADFGLSRYLEDD 544 (974)
T ss_pred EecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCc-ceeeecccchhhhcccc
Confidence 9998 7999999975 56667778999999999999999 99999999999999988 68999999999998765
Q ss_pred cccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCccc
Q 011660 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKAN 458 (480)
Q Consensus 401 ~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~~~ 458 (480)
.+... ....-...|||||.+....++.++|||-|||++||+++ |..||.+-++.
T Consensus 545 ~yYka----S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs 599 (974)
T KOG4257|consen 545 AYYKA----SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS 599 (974)
T ss_pred chhhc----cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc
Confidence 43322 23344678999999999999999999999999999655 99999987643
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=269.11 Aligned_cols=201 Identities=22% Similarity=0.330 Sum_probs=165.7
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc-cHHHHHHHHHHHhcCCCCCeeeEEEEEecC---------
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW-SEEEVLREVELLSSIKHENIVRIIGYCHSK--------- 319 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--------- 319 (480)
..+|.+.+.||+|+||.||+|.. .+++.+|+|.+..... ..+.+.+|+++++.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 46799999999999999999966 5689999999865543 345688999999999999999999776543
Q ss_pred -----CeeEEEEeccCCCHHHHHHh--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeec
Q 011660 320 -----EMYAIVYNLLNGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFG 392 (480)
Q Consensus 320 -----~~~~lV~e~~~GsL~~~l~~--~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFG 392 (480)
...++++||+.++|.+++.. +.+.....++.|+++||.|||+. +|+||||||+||+++.+.+.++|+|||
T Consensus 84 ~~~~~~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl~dfg 160 (342)
T cd07854 84 SLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFG 160 (342)
T ss_pred cccccceEEEEeecccccHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEECCcc
Confidence 35789999999999988853 78889999999999999999998 999999999999998654678999999
Q ss_pred cccccccccccccCccccccccCCCccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 393 AAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 393 la~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~-~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
++......... ........|+..|+|||.+.. ..++.++|||||||++|||++|+.||...+
T Consensus 161 ~~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~ 223 (342)
T cd07854 161 LARIVDPHYSH--KGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAH 223 (342)
T ss_pred cceecCCcccc--ccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 98654321111 111123467899999998754 567899999999999999999999997654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-32 Score=276.04 Aligned_cols=199 Identities=28% Similarity=0.456 Sum_probs=171.2
Q ss_pred hcCCCCceeecccCceEEEEEEecC-CcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~~-g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~ 329 (480)
..+....+.||-|-||.||.|.+.. .-.+|||.++.+....++|+.|..+|+.++|||+|+|+|+|..+..+|||.|||
T Consensus 266 RtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM 345 (1157)
T KOG4278|consen 266 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFM 345 (1157)
T ss_pred chheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecc
Confidence 4455566789999999999998744 668999999988888899999999999999999999999999999999999998
Q ss_pred -CCCHHHHHHhCC-----HHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccc
Q 011660 330 -NGSLKQYLKQLK-----WNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (480)
Q Consensus 330 -~GsL~~~l~~~~-----~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (480)
+|+|.+||++.. .-..+.++.||..|++||... ++|||||..+|+|+.++ ..+|++||||++......+.
T Consensus 346 ~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEn-hiVKvADFGLsRlMtgDTYT 421 (1157)
T KOG4278|consen 346 CYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGEN-HIVKVADFGLSRLMTGDTYT 421 (1157)
T ss_pred cCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhcccccc-ceEEeeccchhhhhcCCcee
Confidence 899999997644 344577899999999999999 99999999999999999 78999999999876543332
Q ss_pred ccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCcc
Q 011660 404 SENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKA 457 (480)
Q Consensus 404 ~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~~ 457 (480)
.... .--...|.|||.+.++.++.|+|||+|||+|||+.| |..||.+.+-
T Consensus 422 AHAG----AKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl 472 (1157)
T KOG4278|consen 422 AHAG----AKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 472 (1157)
T ss_pred cccC----ccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH
Confidence 2211 112567999999999999999999999999999876 8999987654
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=259.18 Aligned_cols=201 Identities=28% Similarity=0.432 Sum_probs=172.1
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCC----ccHHHHHHHHHHHhcCC-CCCeeeEEEEEecCCeeEEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVELLSSIK-HENIVRIIGYCHSKEMYAIV 325 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV 325 (480)
++|.+.+.||+|+||.||++.. .+++.+|+|++..+. ...+.+.+|++++++++ ||||+++++++.+++..+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 4688999999999999999976 469999999997632 22356788999999998 99999999999999999999
Q ss_pred Eecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccc
Q 011660 326 YNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (480)
Q Consensus 326 ~e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (480)
||++ +++|.+++.. +++..+..++.|++.||.|||+. +++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~-~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKD-MHIKITDFGTAKVLDPNS 156 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCC-CCEEecCCccccccCCcc
Confidence 9999 8899999954 68899999999999999999998 99999999999999988 689999999987654322
Q ss_pred ccc---------------cCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 402 QVS---------------ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 402 ~~~---------------~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
... .........|+..|+|||.+....++.++|+||||+++|+|++|+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 226 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN 226 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 110 0122334568999999999988889999999999999999999999998765
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=260.35 Aligned_cols=190 Identities=31% Similarity=0.469 Sum_probs=163.2
Q ss_pred CCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc----cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEec
Q 011660 254 FSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (480)
Q Consensus 254 f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~----~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~ 328 (480)
|...+.||+|+||.||+|.. .+++.+++|.+..... ....+..|+++++.++|||++++++++.+.+..+++|||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 66677899999999999976 4688999999865432 124578899999999999999999999999999999999
Q ss_pred cCCCHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccc
Q 011660 329 LNGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (480)
Q Consensus 329 ~~GsL~~~l~----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (480)
+.|++.+++. .+++.++..++.|++.||.|||+. +++|+||+|+||+++.+ +.++|+|||++....
T Consensus 103 ~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~-~~~kL~dfg~~~~~~------ 172 (313)
T cd06633 103 CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEP-GQVKLADFGSASKSS------ 172 (313)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCC-CCEEEeecCCCcccC------
Confidence 9999888874 367888899999999999999999 99999999999999988 689999999874321
Q ss_pred cCccccccccCCCcccccccc---CCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 405 ENVKPVNVVGTFGYLAPEYMM---YGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 405 ~~~~~~~~~GT~~y~APE~~~---~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
......|++.|+|||++. ...++.++|||||||++|||++|..||...+
T Consensus 173 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~ 224 (313)
T cd06633 173 ---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 224 (313)
T ss_pred ---CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 122457899999999874 4668899999999999999999999997654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=253.79 Aligned_cols=193 Identities=27% Similarity=0.408 Sum_probs=168.1
Q ss_pred CCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc---cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEec
Q 011660 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~ 328 (480)
+|++.+.||+|+||.||++.. .+++.+|+|.+..... ....+.+|+++++.++||||+++++++.+...+++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 478889999999999999965 5688999999875432 234577899999999999999999999999999999999
Q ss_pred c-CCCHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccc
Q 011660 329 L-NGSLKQYLKQ-------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (480)
Q Consensus 329 ~-~GsL~~~l~~-------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (480)
+ +++|.+++.+ +++..+..++.|++.||.|||+. +++|+||+|+||+++++ +.++|+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~-~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVAN-DLVKIGDLGISKVLKKN 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecC-CcEEEeeccchhhhccC
Confidence 9 6789998854 77888899999999999999999 99999999999999998 68999999998654332
Q ss_pred cccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 401 ~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
......|++.|+|||.+.+..++.++|+||||+++|||++|+.||...+
T Consensus 157 -------~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~ 205 (256)
T cd08530 157 -------MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS 205 (256)
T ss_pred -------CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1123468899999999999999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=258.73 Aligned_cols=186 Identities=23% Similarity=0.383 Sum_probs=152.7
Q ss_pred eecccCceEEEEEEecC--------CcEEEEEEeccCCc-cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc
Q 011660 259 LIGQGGNSKVYRTNHVD--------GQVAAVKVLKCTNW-SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (480)
Q Consensus 259 ~LG~G~fg~Vy~~~~~~--------g~~vAvK~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~ 329 (480)
.||+|+||.||+|.... ...+|+|.+..... ..+.+..|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYV 81 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecC
Confidence 58999999999996532 23478888754432 2356788999999999999999999999988999999999
Q ss_pred -CCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCC-------ceEEeeecccccc
Q 011660 330 -NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFH-------HPQLSDFGAAMVH 397 (480)
Q Consensus 330 -~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~-------~~kL~DFGla~~~ 397 (480)
.|+|.+++.. +++.....++.||+.||.|||+. +|+||||||+||+++.+.. .++++|||++...
T Consensus 82 ~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~ 158 (258)
T cd05078 82 KFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV 158 (258)
T ss_pred CCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccccccc
Confidence 6789999953 68888889999999999999999 9999999999999987632 2699999987532
Q ss_pred ccccccccCccccccccCCCccccccccCC-CCCchHHHHHHHHHHHHHHcCC-CCCCCCc
Q 011660 398 HQSHQVSENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGK-EAIQTNK 456 (480)
Q Consensus 398 ~~~~~~~~~~~~~~~~GT~~y~APE~~~~~-~~~~k~DvwSlGvil~eLltG~-~pf~~~~ 456 (480)
.. .....|++.|+|||.+.+. .++.++|||||||++|||++|. +||....
T Consensus 159 ~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~ 210 (258)
T cd05078 159 LP---------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALD 210 (258)
T ss_pred CC---------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhcc
Confidence 21 1234688999999998864 5799999999999999999995 6665443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=250.03 Aligned_cols=195 Identities=30% Similarity=0.489 Sum_probs=169.6
Q ss_pred CCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc---cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEec
Q 011660 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~ 328 (480)
+|++.+.||+|++|.||++.. .+++.+++|.+..... ..+.+.+|++++++++|||++++++++.+.+..++++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 478889999999999999966 4688999999976653 345688999999999999999999999999999999999
Q ss_pred c-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccc
Q 011660 329 L-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (480)
Q Consensus 329 ~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (480)
+ +++|.+++.. +++..+..++.|++.||.|||+. +|+||||+|+||+++.+ +.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~-- 154 (254)
T cd06627 81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKD-GVVKLADFGVATKLNDVSK-- 154 (254)
T ss_pred CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCC-CCEEEeccccceecCCCcc--
Confidence 9 5689998854 78899999999999999999999 99999999999999997 6899999999865443221
Q ss_pred cCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 405 ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 405 ~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||....
T Consensus 155 ---~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~ 203 (254)
T cd06627 155 ---DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN 203 (254)
T ss_pred ---cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc
Confidence 1234568999999999988889999999999999999999999997654
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-31 Score=262.19 Aligned_cols=196 Identities=23% Similarity=0.258 Sum_probs=157.4
Q ss_pred ceeecccCceEEEEEEecCCcEEEEEEeccCC---ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc-CCC
Q 011660 257 KMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTN---WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGS 332 (480)
Q Consensus 257 ~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~-~Gs 332 (480)
.+.+|.|+++.||++.. +++.+|+|+++... ...+.+..|+++++.++||||+++++++.+++..+++|||+ .|+
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 33445555555555544 69999999997652 23356889999999999999999999999999999999999 578
Q ss_pred HHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccc--cc
Q 011660 333 LKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV--SE 405 (480)
Q Consensus 333 L~~~l~~-----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~--~~ 405 (480)
|.+++.. +++.....++.|+++||.|||+. +|+||||||+||+++.+ +.++|+|||.+......... ..
T Consensus 86 l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~-~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 86 CEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGD-GKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred HHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecC-CceEEecCccceeecccccccccc
Confidence 9998853 67788889999999999999999 99999999999999988 78999999988644321111 11
Q ss_pred CccccccccCCCccccccccC--CCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 406 NVKPVNVVGTFGYLAPEYMMY--GKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 406 ~~~~~~~~GT~~y~APE~~~~--~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
........++..|+|||++.. ..++.++|+|||||++|||++|+.||.....
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~ 215 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPA 215 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 112234467889999999876 3588999999999999999999999987553
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=254.71 Aligned_cols=193 Identities=30% Similarity=0.478 Sum_probs=163.4
Q ss_pred ecccCceEEEEEEec-CCcEEEEEEeccCCc----cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc-CCCH
Q 011660 260 IGQGGNSKVYRTNHV-DGQVAAVKVLKCTNW----SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGSL 333 (480)
Q Consensus 260 LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~----~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~-~GsL 333 (480)
||+|+||.||++... +++.+++|++..... ..+.+.+|++++++++||||+++++.+..++.+++++||+ +++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999875 499999999975543 2356788999999999999999999999999999999999 5799
Q ss_pred HHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccc---ccCc
Q 011660 334 KQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV---SENV 407 (480)
Q Consensus 334 ~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~---~~~~ 407 (480)
.+++.. +++..+..++.|+++||.|||+. +++|+||+|+||+++++ +.++|+|||++......... ....
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSN-GHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCC-CCEEEEecccchhcccCcccccccccc
Confidence 999854 68888999999999999999998 99999999999999998 78999999998643322110 0011
Q ss_pred cccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 408 KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 408 ~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
......+++.|+|||.+....++.++|+||||+++|||++|+.||....
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 205 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET 205 (265)
T ss_pred cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 2234568899999999988889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=259.41 Aligned_cols=193 Identities=26% Similarity=0.428 Sum_probs=163.9
Q ss_pred CCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc-cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc-CC
Q 011660 255 SPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW-SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NG 331 (480)
Q Consensus 255 ~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~-~G 331 (480)
.....||+|+||.||++.. .+++.+|+|.+..... ....+.+|+.+++.++||||+++++++...+..+++|||+ ++
T Consensus 23 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 102 (292)
T cd06657 23 DNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG 102 (292)
T ss_pred hhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCC
Confidence 3345799999999999976 5689999998854332 3456889999999999999999999999999999999999 66
Q ss_pred CHHHHHH--hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccCccc
Q 011660 332 SLKQYLK--QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKP 409 (480)
Q Consensus 332 sL~~~l~--~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 409 (480)
+|.+++. .+++.....++.|++.||.|||+. +++|+||+|+||+++.+ +.++|+|||++...... ....
T Consensus 103 ~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~-~~~~l~dfg~~~~~~~~-----~~~~ 173 (292)
T cd06657 103 ALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHD-GRVKLSDFGFCAQVSKE-----VPRR 173 (292)
T ss_pred cHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCC-CCEEEcccccceecccc-----cccc
Confidence 8888874 368888899999999999999999 99999999999999998 68999999987543221 1112
Q ss_pred cccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 410 VNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 410 ~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
....||+.|+|||.+....++.++|+||||+++|||++|..||....
T Consensus 174 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~ 220 (292)
T cd06657 174 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP 220 (292)
T ss_pred cccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 34568999999999988889999999999999999999999997653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=255.47 Aligned_cols=195 Identities=28% Similarity=0.412 Sum_probs=163.5
Q ss_pred CCCCceeecccCceEEEEEEe----cCCcEEEEEEeccCCc-----cHHHHHHHHHHHhcC-CCCCeeeEEEEEecCCee
Q 011660 253 NFSPKMLIGQGGNSKVYRTNH----VDGQVAAVKVLKCTNW-----SEEEVLREVELLSSI-KHENIVRIIGYCHSKEMY 322 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~----~~g~~vAvK~~~~~~~-----~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 322 (480)
+|++.+.||+|+||.||++.. .+++.+|+|++++... ..+.+..|+.++.++ +||||+++++.+..+..+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 477889999999999999864 3578899999875421 234578899999999 699999999999999999
Q ss_pred EEEEecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccc
Q 011660 323 AIVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (480)
Q Consensus 323 ~lV~e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~ 398 (480)
++||||+ +|+|.+++.. +.+.....++.|+++||.|||+. +++||||||+||+++.+ +.++|+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~ 156 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSE-GHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCC-CCEEEEECccccccc
Confidence 9999999 6799988843 67888888999999999999998 99999999999999988 789999999986543
Q ss_pred cccccccCccccccccCCCccccccccCCC--CCchHHHHHHHHHHHHHHcCCCCCCCC
Q 011660 399 QSHQVSENVKPVNVVGTFGYLAPEYMMYGK--VDEKIDVYSYGVVLLELITGKEAIQTN 455 (480)
Q Consensus 399 ~~~~~~~~~~~~~~~GT~~y~APE~~~~~~--~~~k~DvwSlGvil~eLltG~~pf~~~ 455 (480)
... ........|++.|+|||.+.+.. ++.++|+||||+++|||++|..||...
T Consensus 157 ~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 211 (288)
T cd05583 157 AEE----EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVD 211 (288)
T ss_pred ccc----ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccC
Confidence 221 11122356899999999987665 788999999999999999999999654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=267.79 Aligned_cols=196 Identities=26% Similarity=0.411 Sum_probs=166.6
Q ss_pred hhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc---cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCe----
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVRIIGYCHSKEM---- 321 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~---- 321 (480)
+.++|.+.+.||+|+||.||+|.. .+++.+|+|++..... ....+.+|+.+++.++||||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 467899999999999999999977 4588999999865322 23457789999999999999999987765544
Q ss_pred --eEEEEeccCCCHHHHHHh--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccc
Q 011660 322 --YAIVYNLLNGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVH 397 (480)
Q Consensus 322 --~~lV~e~~~GsL~~~l~~--~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~ 397 (480)
+++|+||++++|.+++.. +++.++..++.|+++||.|||+. +|+||||||+||+++.+ +.++|+|||++...
T Consensus 93 ~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~-~~~kL~dfg~~~~~ 168 (343)
T cd07851 93 QDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNED-CELKILDFGLARHT 168 (343)
T ss_pred ccEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCC-CCEEEccccccccc
Confidence 899999999999999854 78899999999999999999999 99999999999999998 78999999998643
Q ss_pred ccccccccCccccccccCCCccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 398 HQSHQVSENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 398 ~~~~~~~~~~~~~~~~GT~~y~APE~~~~-~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
.. ......+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||...+.
T Consensus 169 ~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~ 221 (343)
T cd07851 169 DD--------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH 221 (343)
T ss_pred cc--------cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 22 1224468899999998865 3678999999999999999999999976543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=261.40 Aligned_cols=195 Identities=25% Similarity=0.346 Sum_probs=156.8
Q ss_pred eeccc--CceEEEEEEe-cCCcEEEEEEeccCCcc---HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc-CC
Q 011660 259 LIGQG--GNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NG 331 (480)
Q Consensus 259 ~LG~G--~fg~Vy~~~~-~~g~~vAvK~~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~-~G 331 (480)
.||+| +||+||++.+ .+|+.||+|++...... .+.+.+|+.+++.++||||++++++|..++.+++++||+ .|
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 46666 9999999976 57999999998755433 245788999999999999999999999999999999999 57
Q ss_pred CHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccc--
Q 011660 332 SLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS-- 404 (480)
Q Consensus 332 sL~~~l~~-----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~-- 404 (480)
+|.+++.+ +++..+..++.|++.||+|||+. +|+||||||+|||++.+ +.++++||+.+..........
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~-~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 85 SANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGD-GLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCC-CcEEEechHHHhhhhccCccccc
Confidence 99998864 67788889999999999999998 99999999999999988 689999998653221111000
Q ss_pred cCccccccccCCCccccccccCC--CCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 405 ENVKPVNVVGTFGYLAPEYMMYG--KVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 405 ~~~~~~~~~GT~~y~APE~~~~~--~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
.........++..|+|||++.+. .++.++|||||||++|||++|+.||.....
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~ 215 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLR 215 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcCh
Confidence 00001112356779999998764 478999999999999999999999987643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=248.39 Aligned_cols=195 Identities=32% Similarity=0.474 Sum_probs=169.0
Q ss_pred CCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc---cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEec
Q 011660 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~ 328 (480)
+|.+.+.||.|+||.||++.. .+++.+|+|++..... ....+.+|+++++.++|||++++++.+...+..++++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 478889999999999999976 4688999999976543 345688999999999999999999999988999999999
Q ss_pred c-CCCHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccc
Q 011660 329 L-NGSLKQYLKQ-------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (480)
Q Consensus 329 ~-~GsL~~~l~~-------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (480)
+ +++|.+++.. +++.+...++.+++.||.|||+. +++|+||+|+||+++++ +.++|+|||++......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~-~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSN-GLVKLGDFGISKVLSST 156 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCC-CcEEECCccceeecccC
Confidence 9 4689988854 67888999999999999999999 99999999999999988 68999999998654332
Q ss_pred cccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 401 ~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
. .......|++.|+|||.+....++.++|+||||+++|+|++|+.||...+
T Consensus 157 ~-----~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 207 (258)
T cd08215 157 V-----DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN 207 (258)
T ss_pred c-----ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc
Confidence 1 12234578999999999998889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-32 Score=281.99 Aligned_cols=198 Identities=27% Similarity=0.462 Sum_probs=167.5
Q ss_pred CCceeecccCceEEEEEEec-CC---cEEEEEEeccCCc--cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEec
Q 011660 255 SPKMLIGQGGNSKVYRTNHV-DG---QVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (480)
Q Consensus 255 ~~~~~LG~G~fg~Vy~~~~~-~g---~~vAvK~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~ 328 (480)
.+.++||.|.||.|++|.++ .| ..||||.+|.... ...+|+.|..||-+++||||++|.|+.......+|+.||
T Consensus 632 ~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEy 711 (996)
T KOG0196|consen 632 KIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEY 711 (996)
T ss_pred EEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhh
Confidence 46789999999999999763 23 4799999986543 235799999999999999999999999999999999999
Q ss_pred c-CCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccc
Q 011660 329 L-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (480)
Q Consensus 329 ~-~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (480)
| +|+|+.||++ |.+.+...+..+|+.|+.||..+ +.|||||..+|||++.+ -..|++||||++++.+....
T Consensus 712 MENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsn-LvCKVsDFGLSRvledd~~~ 787 (996)
T KOG0196|consen 712 MENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSN-LVCKVSDFGLSRVLEDDPEA 787 (996)
T ss_pred hhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhc---Cchhhhhhhhheeeccc-eEEEeccccceeecccCCCc
Confidence 9 8999999964 77888899999999999999999 99999999999999999 58999999999987553311
Q ss_pred ccCcccccccc--CCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCcccchh
Q 011660 404 SENVKPVNVVG--TFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRES 461 (480)
Q Consensus 404 ~~~~~~~~~~G--T~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~~~~e~ 461 (480)
..++.-| ..+|.|||.+.+.+++.++|||||||+|||.++ |..||=+.. +|+.
T Consensus 788 ----~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS-NQdV 843 (996)
T KOG0196|consen 788 ----AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS-NQDV 843 (996)
T ss_pred ----cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc-hHHH
Confidence 1111122 468999999999999999999999999999655 999986655 3443
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=260.41 Aligned_cols=191 Identities=32% Similarity=0.467 Sum_probs=162.7
Q ss_pred CCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc----cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEe
Q 011660 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~----~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e 327 (480)
.|...+.||+|+||.||+|.. .++..+|+|.+..... ...++.+|+++++.++|||++++++++...+..++|+|
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 366677899999999999976 4588999999864321 23457789999999999999999999999999999999
Q ss_pred ccCCCHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccc
Q 011660 328 LLNGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (480)
Q Consensus 328 ~~~GsL~~~l~----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (480)
|+.|+|.+++. .+++.++..++.|++.||.|||+. +++||||||+||+++.+ +.++|+|||++.....
T Consensus 96 ~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~---- 167 (308)
T cd06634 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEP-GLVKLGDFGSASIMAP---- 167 (308)
T ss_pred ccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCC-CcEEECCcccceeecC----
Confidence 99989888773 377888899999999999999998 99999999999999988 7899999999854322
Q ss_pred ccCccccccccCCCcccccccc---CCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 404 SENVKPVNVVGTFGYLAPEYMM---YGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 404 ~~~~~~~~~~GT~~y~APE~~~---~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.....|++.|+|||.+. ...++.++|||||||++|||++|+.||...+
T Consensus 168 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 218 (308)
T cd06634 168 -----ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218 (308)
T ss_pred -----cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcccc
Confidence 12346899999999874 3568899999999999999999999987643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=257.12 Aligned_cols=233 Identities=27% Similarity=0.414 Sum_probs=181.9
Q ss_pred HHhhcCCccccCHHHHhhhhcCCCCceeecccCceEEEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhc--CCCCCe
Q 011660 232 VLEAEGSSRRFTSQELCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSS--IKHENI 309 (480)
Q Consensus 232 ~~~~~~~~~~~~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~--l~HpnI 309 (480)
.++..++..-.+.--...+.......+.||+|.||.||+|.+ .|..||||++... +++...+|.+|.+. |+|+||
T Consensus 191 ~~~tSGSGSGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~sr--dE~SWfrEtEIYqTvmLRHENI 267 (513)
T KOG2052|consen 191 DLETSGSGSGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSR--DERSWFRETEIYQTVMLRHENI 267 (513)
T ss_pred hhccCCCCCCchhHhHHhhhheeEEEEEecCccccceeeccc-cCCceEEEEeccc--chhhhhhHHHHHHHHHhccchh
Confidence 344444443333334445566778889999999999999988 5889999999744 35668899999875 599999
Q ss_pred eeEEEEEecC----CeeEEEEecc-CCCHHHHHHh--CCHHHHHHHHHHHHHHHHHHHh-----CCCCCeEeccCCCCCE
Q 011660 310 VRIIGYCHSK----EMYAIVYNLL-NGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHH-----TCDPPIIHRDVKSSNI 377 (480)
Q Consensus 310 v~l~~~~~~~----~~~~lV~e~~-~GsL~~~l~~--~~~~~~~~i~~~ia~aL~yLH~-----~~~~~IiHrDlKp~NI 377 (480)
+.+++.-..+ ..+++|.+|. .|+|++||.. ++.+..++++.-+|.||.+||. +.++.|.|||||+.||
T Consensus 268 LgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNI 347 (513)
T KOG2052|consen 268 LGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNI 347 (513)
T ss_pred hhhhhccccCCCceEEEEEeeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccE
Confidence 9999876433 3689999998 8999999975 7778889999999999999995 4567899999999999
Q ss_pred EEecCCCceEEeeeccccccccccccccCccccccccCCCccccccccCCC----C-C-chHHHHHHHHHHHHHHcC---
Q 011660 378 LLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGK----V-D-EKIDVYSYGVVLLELITG--- 448 (480)
Q Consensus 378 Ll~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~----~-~-~k~DvwSlGvil~eLltG--- 448 (480)
|+..+ +...|+|+|||..+.... .......+..+||-+|||||++...- + + ..+||||||.++||+...
T Consensus 348 LVKkn-~~C~IADLGLAv~h~~~t-~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ 425 (513)
T KOG2052|consen 348 LVKKN-GTCCIADLGLAVRHDSDT-DTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCES 425 (513)
T ss_pred EEccC-CcEEEeeceeeEEecccC-CcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhc
Confidence 99999 789999999997655432 33445556789999999999986431 1 2 359999999999999752
Q ss_pred -------CCCCCCCcccchhHHHHHHHH
Q 011660 449 -------KEAIQTNKANRESLVLWYYVL 469 (480)
Q Consensus 449 -------~~pf~~~~~~~e~l~~~~~~~ 469 (480)
++||.+--+++.+...+.+++
T Consensus 426 ggi~eey~~Pyyd~Vp~DPs~eeMrkVV 453 (513)
T KOG2052|consen 426 GGIVEEYQLPYYDVVPSDPSFEEMRKVV 453 (513)
T ss_pred CCEehhhcCCcccCCCCCCCHHHHhcce
Confidence 678887777666666665544
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-30 Score=282.15 Aligned_cols=140 Identities=31% Similarity=0.397 Sum_probs=125.3
Q ss_pred cCCCCceeecccCceEEEEEEec-CCcEEEEEEeccCCcc----HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWS----EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~----~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 326 (480)
++|.+.+.||+|+||.||+|.+. +++.||+|+++..... ...+..|+.+++.++||||+++++++...+.+++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57899999999999999999774 6899999999754322 246788999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccc
Q 011660 327 NLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAM 395 (480)
Q Consensus 327 e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~ 395 (480)
||+ +|+|.+++.. +.+..++.++.||+.||.|||.. +||||||||+|||++.+ +.++|+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~-g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNE-GHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCC-CCEEEEeCCCCc
Confidence 999 7899999854 67788899999999999999998 99999999999999988 689999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=243.30 Aligned_cols=209 Identities=24% Similarity=0.413 Sum_probs=180.2
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCccHHHHHHHHHHHhcCC-CCCeeeEEEEEecC--CeeEEEE
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIK-HENIVRIIGYCHSK--EMYAIVY 326 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~--~~~~lV~ 326 (480)
.++|++.+.+|+|.++.||.|.. .+...++||+++. ...+.+.+|++||..|. ||||++|+++..+. ....+++
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP--VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiF 114 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP--VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIF 114 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech--HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHh
Confidence 46799999999999999999965 6688999999973 34577999999999997 99999999998654 4567899
Q ss_pred ecc-CCCHHHHHHhCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccccc
Q 011660 327 NLL-NGSLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE 405 (480)
Q Consensus 327 e~~-~GsL~~~l~~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~ 405 (480)
|+. +.+.......++..++..++.+++.||+|||++ ||+|||+||.|+++|.....++|+|+|+|.+.+......-
T Consensus 115 E~v~n~Dfk~ly~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYnV 191 (338)
T KOG0668|consen 115 EYVNNTDFKQLYPTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV 191 (338)
T ss_pred hhhccccHHHHhhhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCCCceeee
Confidence 999 567777778888899999999999999999999 9999999999999998767899999999988766543322
Q ss_pred CccccccccCCCcccccccc-CCCCCchHHHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHh
Q 011660 406 NVKPVNVVGTFGYLAPEYMM-YGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWYYVLA 470 (480)
Q Consensus 406 ~~~~~~~~GT~~y~APE~~~-~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~~~e~l~~~~~~~~ 470 (480)
.+.+..|--||.+. ...|+..-|+|||||+|..|+..+.||.....+.+.|+.-+++|.
T Consensus 192 ------RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLG 251 (338)
T KOG0668|consen 192 ------RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLG 251 (338)
T ss_pred ------eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhC
Confidence 24566788999875 567899999999999999999999999998889999999888775
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=288.29 Aligned_cols=194 Identities=29% Similarity=0.454 Sum_probs=154.7
Q ss_pred hhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCC--ccHHHHHHHHHHHhcCCCCCeeeEEEEEec--------
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN--WSEEEVLREVELLSSIKHENIVRIIGYCHS-------- 318 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-------- 318 (480)
..++|+...+||+||||.||+++. .||+.||||.+.... .....+.+|+++|++|+|||||+++..|.+
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 456789999999999999999965 799999999997653 334568899999999999999998742200
Q ss_pred --------------------------------------------------------------------------------
Q 011660 319 -------------------------------------------------------------------------------- 318 (480)
Q Consensus 319 -------------------------------------------------------------------------------- 318 (480)
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence
Q ss_pred -----------------------C--------CeeEEEEeccCCCHHHHH-Hh--C--CHHHHHHHHHHHHHHHHHHHhC
Q 011660 319 -----------------------K--------EMYAIVYNLLNGSLKQYL-KQ--L--KWNERMDVAIGVAKALEYLHHT 362 (480)
Q Consensus 319 -----------------------~--------~~~~lV~e~~~GsL~~~l-~~--~--~~~~~~~i~~~ia~aL~yLH~~ 362 (480)
+ ..+||.||||..++..++ .+ + .....++++.+|++||.|+|++
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~ 716 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQ 716 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhC
Confidence 0 136888999976655444 33 2 3567789999999999999999
Q ss_pred CCCCeEeccCCCCCEEEecCCCceEEeeeccccccc----ccc---------ccccCccccccccCCCccccccccCCC-
Q 011660 363 CDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH----QSH---------QVSENVKPVNVVGTFGYLAPEYMMYGK- 428 (480)
Q Consensus 363 ~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~----~~~---------~~~~~~~~~~~~GT~~y~APE~~~~~~- 428 (480)
|||||||||.||+++++ ..+||+|||+|.... ... ........+..+||.-|+|||++.+..
T Consensus 717 ---giIHRDLKP~NIFLd~~-~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~ 792 (1351)
T KOG1035|consen 717 ---GIIHRDLKPRNIFLDSR-NSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS 792 (1351)
T ss_pred ---ceeeccCCcceeEEcCC-CCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence 99999999999999998 689999999997722 111 111222445688999999999997654
Q ss_pred --CCchHHHHHHHHHHHHHHc
Q 011660 429 --VDEKIDVYSYGVVLLELIT 447 (480)
Q Consensus 429 --~~~k~DvwSlGvil~eLlt 447 (480)
|+.|+|||||||||+||+.
T Consensus 793 ~~Yn~KiDmYSLGIVlFEM~y 813 (1351)
T KOG1035|consen 793 NKYNSKIDMYSLGIVLFEMLY 813 (1351)
T ss_pred ccccchhhhHHHHHHHHHHhc
Confidence 9999999999999999984
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-30 Score=245.88 Aligned_cols=188 Identities=33% Similarity=0.440 Sum_probs=163.5
Q ss_pred ecccCceEEEEEEec-CCcEEEEEEeccCCc----cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc-CCCH
Q 011660 260 IGQGGNSKVYRTNHV-DGQVAAVKVLKCTNW----SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGSL 333 (480)
Q Consensus 260 LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~----~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~-~GsL 333 (480)
||+|+||.||++... +++.+|+|+++.... ..+.+..|+++++.++||||+++++.+..++..+++||++ +++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999764 588999999876543 2346889999999999999999999999999999999999 7899
Q ss_pred HHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccCcccc
Q 011660 334 KQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPV 410 (480)
Q Consensus 334 ~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~ 410 (480)
.+++.. +++.....++.|++.||.|||+. +++|+||+|+||+++.+ +.++|+|||++....... ....
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~-~~~~l~d~~~~~~~~~~~-----~~~~ 151 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDAD-GHIKLTDFGLAKELSSEG-----SRTN 151 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCC-CcEEEeecCcceecccCC-----Cccc
Confidence 999854 68888999999999999999998 99999999999999998 689999999986543221 1233
Q ss_pred ccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 411 NVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 411 ~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
...|+..|+|||.+.+..++.++|+||||+++|||++|+.||....
T Consensus 152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~ 197 (250)
T cd05123 152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAED 197 (250)
T ss_pred CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 4568999999999998889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=250.22 Aligned_cols=194 Identities=25% Similarity=0.365 Sum_probs=160.4
Q ss_pred CCCCceeecccCceEEEEEEecC-CcEEEEEEeccCC------ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEE
Q 011660 253 NFSPKMLIGQGGNSKVYRTNHVD-GQVAAVKVLKCTN------WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~~~-g~~vAvK~~~~~~------~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 325 (480)
+|.+.+.||+|+||.||++.... +..+++|+++... .....+.+|+.+++.++||||+++++++.+.+..+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47888999999999999996643 4556666654321 1233567899999999999999999999988899999
Q ss_pred Eecc-CCCHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccc
Q 011660 326 YNLL-NGSLKQYLK-------QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVH 397 (480)
Q Consensus 326 ~e~~-~GsL~~~l~-------~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~ 397 (480)
+||+ +++|.+++. .+++.++..++.|++.||.|||+. +++|+||||+||+++.+ .++|+|||++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~~--~~~l~d~g~~~~~ 155 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKNN--LLKIGDFGVSRLL 155 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeecC--CEeecccCceeec
Confidence 9999 678988774 267888999999999999999998 99999999999999865 5999999998654
Q ss_pred ccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 398 HQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 398 ~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.... .......|++.|+|||.+.+..++.++|+||||+++|+|++|..||....
T Consensus 156 ~~~~-----~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~ 209 (260)
T cd08222 156 MGSC-----DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN 209 (260)
T ss_pred CCCc-----ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 3221 12234568999999999988889999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=268.42 Aligned_cols=193 Identities=27% Similarity=0.390 Sum_probs=161.8
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCccHHHHHHHHHHHhcC-CCCCeeeEEEEEecCCeeEEEEec
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSI-KHENIVRIIGYCHSKEMYAIVYNL 328 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~e~ 328 (480)
+..|.+...+|.|+|+.|-.+.+ .+++.+++|++.+.. .+..+|+.++... +||||+++.+.+.++...++|||.
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~---~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~ 397 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA---DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMEL 397 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc---cccccccchhhhhcCCCcceeecceecCCceeeeeehh
Confidence 45688888899999999999866 568999999997662 3455677666555 899999999999999999999999
Q ss_pred cCC-CHHHHHHhCC--HHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEe-cCCCceEEeeeccccccccccccc
Q 011660 329 LNG-SLKQYLKQLK--WNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLS-ENFHHPQLSDFGAAMVHHQSHQVS 404 (480)
Q Consensus 329 ~~G-sL~~~l~~~~--~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~-~~~~~~kL~DFGla~~~~~~~~~~ 404 (480)
++| -+.+.+.... ..++..|+.+|+.|+.|||.+ |||||||||+|||++ +. ++++|+|||.++.....
T Consensus 398 l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~-g~lrltyFG~a~~~~~~---- 469 (612)
T KOG0603|consen 398 LDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSA-GHLRLTYFGFWSELERS---- 469 (612)
T ss_pred ccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCC-CcEEEEEechhhhCchh----
Confidence 954 4555553322 256667999999999999998 999999999999995 55 78999999998654332
Q ss_pred cCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCccc
Q 011660 405 ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKAN 458 (480)
Q Consensus 405 ~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~~ 458 (480)
..+.+-|..|.|||++....|++++||||||++||+|++|+.||.....+
T Consensus 470 ----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~ 519 (612)
T KOG0603|consen 470 ----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG 519 (612)
T ss_pred ----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch
Confidence 34567899999999999999999999999999999999999999987755
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=267.69 Aligned_cols=193 Identities=22% Similarity=0.396 Sum_probs=168.1
Q ss_pred hcCCCCceeecccCceEEEEEEec-CCcEEEEEEeccCCccHH---------HHHHHHHHHhcCC---CCCeeeEEEEEe
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWSEE---------EVLREVELLSSIK---HENIVRIIGYCH 317 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~---------~~~~Ei~il~~l~---HpnIv~l~~~~~ 317 (480)
..+|...+.+|+|+||.|++|.++ +...|++|.+.++..-.+ .+-.||.||..|+ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 356899999999999999999774 467899999987653221 2557999999998 999999999999
Q ss_pred cCCeeEEEEeccC-C-CHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeec
Q 011660 318 SKEMYAIVYNLLN-G-SLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFG 392 (480)
Q Consensus 318 ~~~~~~lV~e~~~-G-sL~~~l~---~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFG 392 (480)
+++.||+++|.-+ | +|++++. .+.+.++..|+.||+.|+++||.+ +|||||||-+|+.++.+ |.+||+|||
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~-g~~klidfg 715 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSN-GFVKLIDFG 715 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecC-CeEEEeecc
Confidence 9999999999983 3 7999994 488999999999999999999999 99999999999999999 899999999
Q ss_pred cccccccccccccCccccccccCCCccccccccCCCC-CchHHHHHHHHHHHHHHcCCCCCCC
Q 011660 393 AAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKV-DEKIDVYSYGVVLLELITGKEAIQT 454 (480)
Q Consensus 393 la~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~-~~k~DvwSlGvil~eLltG~~pf~~ 454 (480)
.|.+.. +.....++||.+|.|||++.+.+| +..-||||+|++||-++....||..
T Consensus 716 saa~~k-------sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 716 SAAYTK-------SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred chhhhc-------CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 986533 334457899999999999999998 6779999999999999999999863
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=244.04 Aligned_cols=177 Identities=26% Similarity=0.245 Sum_probs=150.1
Q ss_pred cCceEEEEEEe-cCCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc-CCCHHHHHHh-
Q 011660 263 GGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGSLKQYLKQ- 339 (480)
Q Consensus 263 G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~-~GsL~~~l~~- 339 (480)
|.||.||++.. .+++.+|+|.++... ....|...+....||||+++++++.+.+.++++|||+ +|+|.+++.+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 79 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF 79 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh
Confidence 89999999966 568999999997543 2344555556667999999999999999999999999 5789998843
Q ss_pred --CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccCccccccccCCC
Q 011660 340 --LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFG 417 (480)
Q Consensus 340 --~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~ 417 (480)
+++.....++.|+++||.|||+. +|+||||||+||+++.+ +.++|+|||.+..... ......++..
T Consensus 80 ~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~-~~~~l~df~~~~~~~~--------~~~~~~~~~~ 147 (237)
T cd05576 80 LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDR-GHIQLTYFSRWSEVED--------SCDGEAVENM 147 (237)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCC-CCEEEecccchhcccc--------ccccCCcCcc
Confidence 78888999999999999999998 99999999999999998 6899999998754322 1123456778
Q ss_pred ccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 011660 418 YLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTN 455 (480)
Q Consensus 418 y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~ 455 (480)
|+|||.+.+..++.++|+||+||++|||++|+.||...
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~ 185 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECH 185 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcC
Confidence 99999998888999999999999999999999887654
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-30 Score=270.37 Aligned_cols=205 Identities=28% Similarity=0.412 Sum_probs=176.2
Q ss_pred HHHHhhhhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCccHHHHHHHHHHHhcC-CCCCeeeEEEEEe----
Q 011660 244 SQELCHLTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSI-KHENIVRIIGYCH---- 317 (480)
Q Consensus 244 ~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~---- 317 (480)
++.+..-++.|++...||.|.+|.||++.. .+++.+|+|+........+++..|.+||+.+ +|||++.++|++.
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~ 90 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDP 90 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence 334445567799999999999999999965 5689999999988887788899999999987 6999999999884
Q ss_pred -cCCeeEEEEecc-CCCHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEee
Q 011660 318 -SKEMYAIVYNLL-NGSLKQYLK-----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSD 390 (480)
Q Consensus 318 -~~~~~~lV~e~~-~GsL~~~l~-----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~D 390 (480)
.++.+|+||||| +|+.-++++ ++.|..+..|+..++.||.+||.+ .+||||||-.|||++.+ +.+||+|
T Consensus 91 ~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e-~~VKLvD 166 (953)
T KOG0587|consen 91 GNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTEN-AEVKLVD 166 (953)
T ss_pred CCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEecc-CcEEEee
Confidence 356899999999 688888885 377888888999999999999999 99999999999999999 7899999
Q ss_pred eccccccccccccccCccccccccCCCccccccccC-----CCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 391 FGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY-----GKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 391 FGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~-----~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
||.+... .....+..+.+|||.|||||++.. ..|+..+|+||||++..||--|.+|+.+..+
T Consensus 167 FGvSaQl-----dsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP 233 (953)
T KOG0587|consen 167 FGVSAQL-----DSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP 233 (953)
T ss_pred eeeeeee-----ecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch
Confidence 9987432 334455668899999999999863 3578899999999999999999999987654
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-30 Score=267.05 Aligned_cols=193 Identities=27% Similarity=0.441 Sum_probs=163.5
Q ss_pred eeecccCceEEEEEEec--CCc--EEEEEEeccCCc--cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc-C
Q 011660 258 MLIGQGGNSKVYRTNHV--DGQ--VAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-N 330 (480)
Q Consensus 258 ~~LG~G~fg~Vy~~~~~--~g~--~vAvK~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~-~ 330 (480)
++||+|.||.|++|.+. +|+ .||||+++.... ..++|++|+.+|.+|+|||+++|||+..+ .-..+|+|++ .
T Consensus 116 e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELapl 194 (1039)
T KOG0199|consen 116 ELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPL 194 (1039)
T ss_pred HHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhccc
Confidence 46999999999999763 355 589999987654 35789999999999999999999999988 6778999999 7
Q ss_pred CCHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccccc
Q 011660 331 GSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE 405 (480)
Q Consensus 331 GsL~~~l~~-----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~ 405 (480)
|+|.+.|.. |-......++.|||.||.||..+ ++|||||..+|+||-.. ..+||+||||.+-+........
T Consensus 195 GSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasp-rtVKI~DFGLmRaLg~ned~Yv 270 (1039)
T KOG0199|consen 195 GSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASP-RTVKICDFGLMRALGENEDMYV 270 (1039)
T ss_pred chHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheeccc-ceeeeecccceeccCCCCcceE
Confidence 999999965 55566778999999999999999 99999999999999876 5899999999987665443331
Q ss_pred CccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCcc
Q 011660 406 NVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKA 457 (480)
Q Consensus 406 ~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~~ 457 (480)
.....--.+.|+|||.+....++.++|||+|||.+|||+| |..||.+...
T Consensus 271 --m~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g 321 (1039)
T KOG0199|consen 271 --MAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG 321 (1039)
T ss_pred --ecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH
Confidence 1112223678999999999999999999999999999998 7999998764
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-32 Score=253.06 Aligned_cols=214 Identities=25% Similarity=0.395 Sum_probs=173.3
Q ss_pred CCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCC---ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCC-----eeE
Q 011660 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN---WSEEEVLREVELLSSIKHENIVRIIGYCHSKE-----MYA 323 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-----~~~ 323 (480)
+.+..+.||-|+||.||.+.. .+|+.+|+|.+..-- ...+.+.+|+++|..++|.|++..+++.+-.+ .+|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 467778999999999999865 779999999875321 23467899999999999999999887664332 467
Q ss_pred EEEeccCCCHHHHH---HhCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccc
Q 011660 324 IVYNLLNGSLKQYL---KQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (480)
Q Consensus 324 lV~e~~~GsL~~~l---~~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (480)
++.|.+..+|...+ +.++.+.++-+.+||++||.|||+. +|.||||||.|+|++.| -.+||||||+|+.....
T Consensus 134 V~TELmQSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSN-CvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 134 VLTELMQSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSN-CILKICDFGLARTWDQR 209 (449)
T ss_pred HHHHHHHhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccC-ceEEecccccccccchh
Confidence 88888988999888 4588888999999999999999999 99999999999999999 58999999999865432
Q ss_pred cccccCccccccccCCCccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHhCCCCCC
Q 011660 401 HQVSENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWYYVLAGKVFAQ 476 (480)
Q Consensus 401 ~~~~~~~~~~~~~GT~~y~APE~~~~~-~~~~k~DvwSlGvil~eLltG~~pf~~~~~~~e~l~~~~~~~~~~~~~~ 476 (480)
.....+..+-|-.|.|||++++. .|+.++||||.|||+.||+-.+..|+..++-++ ....-.++|.+..|
T Consensus 210 ----~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQ--L~lItdLLGTPs~E 280 (449)
T KOG0664|consen 210 ----DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQ--LQMIIDLLGTPSQE 280 (449)
T ss_pred ----hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHH--HHHHHHHhCCCcHH
Confidence 22223344568899999999975 589999999999999999999999998876433 23344566655443
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-28 Score=229.76 Aligned_cols=193 Identities=37% Similarity=0.514 Sum_probs=166.7
Q ss_pred CCCceeecccCceEEEEEEecC-CcEEEEEEeccCCc--cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEeccC
Q 011660 254 FSPKMLIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLLN 330 (480)
Q Consensus 254 f~~~~~LG~G~fg~Vy~~~~~~-g~~vAvK~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~ 330 (480)
|.+.+.||+|++|.||++...+ ++.+|+|.+..... ..+.+.+|++.++.++|+|++++++++...+..++++|++.
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5667889999999999998754 88999999986654 35678899999999999999999999999899999999995
Q ss_pred C-CHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccccc
Q 011660 331 G-SLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE 405 (480)
Q Consensus 331 G-sL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~ 405 (480)
+ +|.+++.. +++.....++.+++.+|.|||.. +++|+||+|+||+++.+ +.++|+|||.+.......
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~-~~~~l~d~g~~~~~~~~~---- 152 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMD-GLVKLADFGLARFIHRDL---- 152 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCC-CCEEEeeCceeeEecCcc----
Confidence 5 99999854 77888899999999999999999 99999999999999998 689999999986644321
Q ss_pred CccccccccCCCccccccc-cCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 011660 406 NVKPVNVVGTFGYLAPEYM-MYGKVDEKIDVYSYGVVLLELITGKEAIQT 454 (480)
Q Consensus 406 ~~~~~~~~GT~~y~APE~~-~~~~~~~k~DvwSlGvil~eLltG~~pf~~ 454 (480)
........++..|++||.+ ....++.++|+|+||+++|||++|+.||..
T Consensus 153 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 153 AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 0022345688899999998 677788899999999999999999999966
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=267.99 Aligned_cols=215 Identities=26% Similarity=0.452 Sum_probs=169.7
Q ss_pred hcCCCCceeecccCceEEEEEEec----C----CcEEEEEEeccCCcc--HHHHHHHHHHHhcC-CCCCeeeEEEEEecC
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHV----D----GQVAAVKVLKCTNWS--EEEVLREVELLSSI-KHENIVRIIGYCHSK 319 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~----~----g~~vAvK~~~~~~~~--~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~ 319 (480)
.++..+.+.||+|.||.|++|... . ...||||.++..... .+.+..|+++|+.+ +||||+.++|+|..+
T Consensus 295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~ 374 (609)
T KOG0200|consen 295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQD 374 (609)
T ss_pred hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence 344556669999999999999532 1 347999999865443 45789999999988 699999999999998
Q ss_pred CeeEEEEecc-CCCHHHHHHh-------------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEE
Q 011660 320 EMYAIVYNLL-NGSLKQYLKQ-------------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILL 379 (480)
Q Consensus 320 ~~~~lV~e~~-~GsL~~~l~~-------------------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl 379 (480)
+.+++|.||+ .|+|.+|++. +...+.+.++.|||.|++||++. ++|||||..+|||+
T Consensus 375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi 451 (609)
T KOG0200|consen 375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLI 451 (609)
T ss_pred CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEe
Confidence 9999999999 8999999943 55677889999999999999999 99999999999999
Q ss_pred ecCCCceEEeeeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCccc
Q 011660 380 SENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKAN 458 (480)
Q Consensus 380 ~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~~~ 458 (480)
..+ ..+||+|||+|+.............. .. -...|||||.+....|+.++|||||||+|||++| |..||.+....
T Consensus 452 ~~~-~~~kIaDFGlar~~~~~~~y~~~~~~-~~-LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~ 528 (609)
T KOG0200|consen 452 TKN-KVIKIADFGLARDHYNKDYYRTKSSA-GT-LPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT 528 (609)
T ss_pred cCC-CEEEEccccceeccCCCCceEecCCC-Cc-cceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence 999 68999999999865443322211110 01 2345999999999999999999999999999998 88898764322
Q ss_pred chhHHHHHHHHhCCCC
Q 011660 459 RESLVLWYYVLAGKVF 474 (480)
Q Consensus 459 ~e~l~~~~~~~~~~~~ 474 (480)
.+ + |...--|.++
T Consensus 529 ~~-l--~~~l~~G~r~ 541 (609)
T KOG0200|consen 529 EE-L--LEFLKEGNRM 541 (609)
T ss_pred HH-H--HHHHhcCCCC
Confidence 22 2 4444444443
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-28 Score=263.05 Aligned_cols=194 Identities=22% Similarity=0.276 Sum_probs=138.7
Q ss_pred hcCCCCceeecccCceEEEEEEec-C----CcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEE------EecC
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHV-D----GQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGY------CHSK 319 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~-~----g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~------~~~~ 319 (480)
.++|.+.+.||+|+||.||+|.+. + +..+|+|.++.....+ ....| .++...+.++..++.. +.++
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e-~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~ 207 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVE-IWMNE--RVRRACPNSCADFVYGFLEPVSSKKE 207 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhH-HHHHH--HHHhhchhhHHHHHHhhhcccccccC
Confidence 467999999999999999999764 4 6899999886433211 11111 1222222222222211 3456
Q ss_pred CeeEEEEecc-CCCHHHHHHhCC-----------------------HHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCC
Q 011660 320 EMYAIVYNLL-NGSLKQYLKQLK-----------------------WNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSS 375 (480)
Q Consensus 320 ~~~~lV~e~~-~GsL~~~l~~~~-----------------------~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~ 375 (480)
..+++|+||+ +++|.+++.... ...+..++.|++.||.|||+. +|+||||||+
T Consensus 208 ~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP~ 284 (566)
T PLN03225 208 DEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQ 284 (566)
T ss_pred CceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCHH
Confidence 7899999999 678988885321 123456899999999999998 9999999999
Q ss_pred CEEEecCCCceEEeeeccccccccccccccCccccccccCCCccccccccCC----------------------CCCchH
Q 011660 376 NILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYG----------------------KVDEKI 433 (480)
Q Consensus 376 NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~----------------------~~~~k~ 433 (480)
|||++.+.+.+||+|||+|+...... .......+||+.|||||.+... .++.++
T Consensus 285 NILl~~~~~~~KL~DFGlA~~l~~~~----~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 285 NIIFSEGSGSFKIIDLGAAADLRVGI----NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred HEEEeCCCCcEEEEeCCCcccccccc----ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 99999754689999999996543211 1223456899999999966432 234567
Q ss_pred HHHHHHHHHHHHHcCCCCCCC
Q 011660 434 DVYSYGVVLLELITGKEAIQT 454 (480)
Q Consensus 434 DvwSlGvil~eLltG~~pf~~ 454 (480)
|||||||+||||+++..|+..
T Consensus 361 DVwSlGviL~el~~~~~~~~~ 381 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRSDS 381 (566)
T ss_pred ccHHHHHHHHHHHhCcCCCch
Confidence 999999999999998776554
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=262.34 Aligned_cols=196 Identities=26% Similarity=0.453 Sum_probs=163.5
Q ss_pred CCCceeecccCceEEEEEEec-CC----cEEEEEEeccCCc--cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEE
Q 011660 254 FSPKMLIGQGGNSKVYRTNHV-DG----QVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (480)
Q Consensus 254 f~~~~~LG~G~fg~Vy~~~~~-~g----~~vAvK~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 326 (480)
....++||+|+||+||+|.+. .| -+||+|++..... ...+++.|+-+|.+++|||+++|+++|.... ..||.
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 556778999999999999653 23 3789999976543 3578999999999999999999999998765 77888
Q ss_pred ecc-CCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccc
Q 011660 327 NLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (480)
Q Consensus 327 e~~-~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (480)
+|+ .|.|.+|++. +.....+.+..|||+||.|||.+ +++||||..+|||+..- .++|++|||+|+......
T Consensus 777 q~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP-~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSP-NHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred HhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCC-CeEEEEecchhhccCccc
Confidence 888 7999999964 56677888999999999999988 99999999999999887 689999999998755422
Q ss_pred ccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCcc
Q 011660 402 QVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKA 457 (480)
Q Consensus 402 ~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~~ 457 (480)
.. .......-.+.|||-|.+....|+.++|||||||..||++| |..|+++...
T Consensus 853 ~e---y~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~ 906 (1177)
T KOG1025|consen 853 KE---YSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA 906 (1177)
T ss_pred cc---ccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH
Confidence 11 11111223568999999999999999999999999999887 9999998764
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.3e-30 Score=256.66 Aligned_cols=208 Identities=26% Similarity=0.343 Sum_probs=174.3
Q ss_pred cCHHHHhhhhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCccHHHHHHHHHHHhcCCC------CCeeeEEE
Q 011660 242 FTSQELCHLTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIKH------ENIVRIIG 314 (480)
Q Consensus 242 ~~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~H------pnIv~l~~ 314 (480)
|.+.-.+.+..+|.+....|+|-|++|.+|.. ..|+.||||+++....-.+.=+.|++||++|+. -++++|+-
T Consensus 422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r 501 (752)
T KOG0670|consen 422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFR 501 (752)
T ss_pred EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHH
Confidence 44444455678899999999999999999965 458899999998665444556789999999963 37899999
Q ss_pred EEecCCeeEEEEeccCCCHHHHHHh------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEE
Q 011660 315 YCHSKEMYAIVYNLLNGSLKQYLKQ------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQL 388 (480)
Q Consensus 315 ~~~~~~~~~lV~e~~~GsL~~~l~~------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL 388 (480)
.|...+++|+|+|.+.-+|-+.|+. +....+..++.|+.-||..|..+ +|+|.||||+|||+.+....+||
T Consensus 502 ~F~hknHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKL 578 (752)
T KOG0670|consen 502 HFKHKNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKL 578 (752)
T ss_pred HhhhcceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeee
Confidence 9999999999999999999999976 44556778999999999999999 99999999999999998778999
Q ss_pred eeeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcccc
Q 011660 389 SDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANR 459 (480)
Q Consensus 389 ~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~~~ 459 (480)
||||.|....... .+...-+.-|.|||++.|-+|+...|+||.||.||||+||+..|.+..+++
T Consensus 579 CDfGSA~~~~ene-------itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~ 642 (752)
T KOG0670|consen 579 CDFGSASFASENE-------ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQ 642 (752)
T ss_pred ccCcccccccccc-------ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHH
Confidence 9999996543321 112233456999999999999999999999999999999999999987653
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.9e-28 Score=255.47 Aligned_cols=196 Identities=22% Similarity=0.325 Sum_probs=147.1
Q ss_pred hcCCCCceeecccCceEEEEEEe-----------------cCCcEEEEEEeccCCcc-HH--------------HHHHHH
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-----------------VDGQVAAVKVLKCTNWS-EE--------------EVLREV 298 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-----------------~~g~~vAvK~~~~~~~~-~~--------------~~~~Ei 298 (480)
.++|++.++||+|+||.||+|.. .+++.||||.++..... .+ ....|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 56899999999999999999853 23568999998654321 11 233467
Q ss_pred HHHhcCCCCCe-----eeEEEEEec--------CCeeEEEEecc-CCCHHHHHHh-------------------------
Q 011660 299 ELLSSIKHENI-----VRIIGYCHS--------KEMYAIVYNLL-NGSLKQYLKQ------------------------- 339 (480)
Q Consensus 299 ~il~~l~HpnI-----v~l~~~~~~--------~~~~~lV~e~~-~GsL~~~l~~------------------------- 339 (480)
.++.+++|.++ ++++++|.. .+..++||||+ +|+|.+++..
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77777776654 667777743 35689999999 7788887742
Q ss_pred --CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccCccccccccCCC
Q 011660 340 --LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFG 417 (480)
Q Consensus 340 --~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~ 417 (480)
+++..+..++.|++.+|.|||+. +|+||||||+|||++.+ +.+||+|||++....... ........+|+.
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~-~~~kL~DFGla~~~~~~~----~~~~~~g~~tp~ 375 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVD-GQVKIIDFGAAVDMCTGI----NFNPLYGMLDPR 375 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCC-CcEEEEeCcCccccccCC----ccCccccCCCcc
Confidence 24556778999999999999999 99999999999999998 689999999986543211 111112345899
Q ss_pred ccccccccCCC--------------------C--CchHHHHHHHHHHHHHHcCCC-CCCC
Q 011660 418 YLAPEYMMYGK--------------------V--DEKIDVYSYGVVLLELITGKE-AIQT 454 (480)
Q Consensus 418 y~APE~~~~~~--------------------~--~~k~DvwSlGvil~eLltG~~-pf~~ 454 (480)
|+|||.+.... | ..+.||||+||++|||++|.. ||..
T Consensus 376 Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~ 435 (507)
T PLN03224 376 YSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN 435 (507)
T ss_pred eeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence 99999876432 1 134799999999999999986 7754
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.4e-29 Score=236.72 Aligned_cols=210 Identities=24% Similarity=0.352 Sum_probs=174.6
Q ss_pred hcCCCCceeecccCceEEEEE-EecCCcEEEEEEeccCC---ccHHHHHHHHHHHhcCCCCCeeeEEEEEe------cCC
Q 011660 251 THNFSPKMLIGQGGNSKVYRT-NHVDGQVAAVKVLKCTN---WSEEEVLREVELLSSIKHENIVRIIGYCH------SKE 320 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~-~~~~g~~vAvK~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~------~~~ 320 (480)
..+|...+.+|.|+- .|..+ +...++.+|+|.+...- ...+...+|...+..++|+||++++.+|. +..
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 346777888999988 55555 34568899999875432 23466889999999999999999999883 334
Q ss_pred eeEEEEeccCCCHHHHHH-hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccc
Q 011660 321 MYAIVYNLLNGSLKQYLK-QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (480)
Q Consensus 321 ~~~lV~e~~~GsL~~~l~-~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~ 399 (480)
..|+|||++..+|.+.+. +++-.+...+.+|+++|+.|||+. +|+||||||+||++..+ ..+||.|||+|+-...
T Consensus 95 e~y~v~e~m~~nl~~vi~~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~-~~lKi~dfg~ar~e~~ 170 (369)
T KOG0665|consen 95 EVYLVMELMDANLCQVILMELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSD-CTLKILDFGLARTEDT 170 (369)
T ss_pred hHHHHHHhhhhHHHHHHHHhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecch-hheeeccchhhcccCc
Confidence 789999999999988874 577788889999999999999999 99999999999999999 6899999999964222
Q ss_pred ccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHhCCCCC
Q 011660 400 SHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWYYVLAGKVFA 475 (480)
Q Consensus 400 ~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~~~e~l~~~~~~~~~~~~~ 475 (480)
....+..+.|..|.|||++.+..|.+.+||||+||++.||++|+..|. +++.+.+|.+..-.-.++
T Consensus 171 ------~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~----g~d~idQ~~ki~~~lgtp 236 (369)
T KOG0665|consen 171 ------DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFP----GKDHIDQWNKIIEQLGTP 236 (369)
T ss_pred ------ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEec----CchHHHHHHHHHHHhcCC
Confidence 234456788999999999999999999999999999999999999998 577788898876554443
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-27 Score=236.53 Aligned_cols=126 Identities=26% Similarity=0.455 Sum_probs=111.3
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCccHHHHHHHHHHHhcCC-----C---CCeeeEEEEEe----c
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIK-----H---ENIVRIIGYCH----S 318 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~-----H---pnIv~l~~~~~----~ 318 (480)
.+|.+.+.||.|-|++||++-. .+.+.||+|+.+....-.+..+.||++|+++. | ..||+|++.|. .
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpN 157 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPN 157 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCC
Confidence 5788999999999999999954 66889999999877666677889999999883 3 36999999995 4
Q ss_pred CCeeEEEEeccCCCHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEE
Q 011660 319 KEMYAIVYNLLNGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILL 379 (480)
Q Consensus 319 ~~~~~lV~e~~~GsL~~~l~~-----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl 379 (480)
+.+.++|+|+++.+|..+|+. ++...+.+|+.||+.||.|||..| +|||.||||+|||+
T Consensus 158 G~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 158 GQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 568999999999999999954 788899999999999999999987 99999999999998
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-27 Score=223.90 Aligned_cols=182 Identities=37% Similarity=0.555 Sum_probs=159.5
Q ss_pred CceEEEEEEec-CCcEEEEEEeccCCcc--HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEeccCC-CHHHHHHh
Q 011660 264 GNSKVYRTNHV-DGQVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLLNG-SLKQYLKQ 339 (480)
Q Consensus 264 ~fg~Vy~~~~~-~g~~vAvK~~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~G-sL~~~l~~ 339 (480)
+||.||++... +++.+|+|++...... .+.+.+|++.++.++|+||+++++++......++++|+..+ +|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999775 4899999999765433 47889999999999999999999999998999999999955 99999865
Q ss_pred ---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccCccccccccCC
Q 011660 340 ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTF 416 (480)
Q Consensus 340 ---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~ 416 (480)
+++.....++.+++.+|.|||+. +++|+||+|+||+++++ +.++|+|||.+....... ......|+.
T Consensus 81 ~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~-~~~~l~d~~~~~~~~~~~------~~~~~~~~~ 150 (244)
T smart00220 81 RGRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDED-GHVKLADFGLARQLDPGG------LLTTFVGTP 150 (244)
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCC-CcEEEccccceeeecccc------ccccccCCc
Confidence 67888899999999999999999 99999999999999998 789999999986543321 223456889
Q ss_pred CccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 011660 417 GYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTN 455 (480)
Q Consensus 417 ~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~ 455 (480)
.|+|||.+.+..++.++|+||||+++|+|++|..||...
T Consensus 151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~ 189 (244)
T smart00220 151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGD 189 (244)
T ss_pred CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999888999999999999999999999999773
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=230.25 Aligned_cols=211 Identities=20% Similarity=0.337 Sum_probs=170.6
Q ss_pred hhcCCCCceeecccCceEEEEEEec-CCcEEEEEEeccCCccHHHHHHHHHHHhcC-CCCCeeeEEE-EEecCCeeEEEE
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWSEEEVLREVELLSSI-KHENIVRIIG-YCHSKEMYAIVY 326 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~-~~~~~~~~~lV~ 326 (480)
+.+.|.+.+.||+|-||.+-+++|. +...+++|-+.+......+|.+|...--.| .|.||+.-|+ .|++.+.+++++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 4467999999999999999999885 467899999988888889999998876666 5899998776 467888999999
Q ss_pred ecc-CCCHHHHHHh--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEE-ecCCCceEEeeeccccccccccc
Q 011660 327 NLL-NGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILL-SENFHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 327 e~~-~GsL~~~l~~--~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl-~~~~~~~kL~DFGla~~~~~~~~ 402 (480)
||+ .|+|.+.+.. ..+..-..++.|+++||.|+|+. ++||||||.+|||| +.|+..+||||||+.+....
T Consensus 102 E~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~--- 175 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT--- 175 (378)
T ss_pred ccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccCc---
Confidence 999 7999998854 66667788999999999999999 99999999999998 67778999999998743221
Q ss_pred cccCccccccccCCCccccccccC---C--CCCchHHHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHhC
Q 011660 403 VSENVKPVNVVGTFGYLAPEYMMY---G--KVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWYYVLAG 471 (480)
Q Consensus 403 ~~~~~~~~~~~GT~~y~APE~~~~---~--~~~~k~DvwSlGvil~eLltG~~pf~~~~~~~e~l~~~~~~~~~ 471 (480)
.-...--+..|.|||.... + ..++.+|+|.||++++..+||.+||+-..-.+.....|.+-+.+
T Consensus 176 -----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~r 244 (378)
T KOG1345|consen 176 -----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKR 244 (378)
T ss_pred -----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcc
Confidence 1112223567999997642 2 24788999999999999999999999655556666666665544
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=226.72 Aligned_cols=218 Identities=22% Similarity=0.280 Sum_probs=168.5
Q ss_pred HhhhhcCCCCceeecccCceEEEEEEec------CCcEEEEEEeccCCcc--HHHHHHHHHHHhcCCCCCeeeEEEEEec
Q 011660 247 LCHLTHNFSPKMLIGQGGNSKVYRTNHV------DGQVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHS 318 (480)
Q Consensus 247 l~~~~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 318 (480)
+..-..+++...++-+|+||+||+|.+. +.+.+-+|.++..... ...+..|.-++..+.|||+.++.+++.+
T Consensus 279 l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie 358 (563)
T KOG1024|consen 279 LTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE 358 (563)
T ss_pred hhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEee
Confidence 3334456777788999999999999443 3455677877644322 2457889999999999999999999865
Q ss_pred C-CeeEEEEecc-CCCHHHHHHh-----------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCc
Q 011660 319 K-EMYAIVYNLL-NGSLKQYLKQ-----------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHH 385 (480)
Q Consensus 319 ~-~~~~lV~e~~-~GsL~~~l~~-----------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~ 385 (480)
+ ..-++++.+. -|+|..||+. ....+...++.|++.|++|||+. +|||.||..+|++||+. -+
T Consensus 359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~-Lq 434 (563)
T KOG1024|consen 359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQ-LQ 434 (563)
T ss_pred ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhh-ee
Confidence 4 4556667777 5899999962 45566778999999999999999 99999999999999998 58
Q ss_pred eEEeeeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCcccchhHHH
Q 011660 386 PQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVL 464 (480)
Q Consensus 386 ~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~~~~e~l~~ 464 (480)
+||+|=.+++.+-+.++.--+.... -...||+||.+.+..|+.++|+|||||+||||+| |+.|+...++. .|
T Consensus 435 VkltDsaLSRDLFP~DYhcLGDnEn---RPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPf----Em 507 (563)
T KOG1024|consen 435 VKLTDSALSRDLFPGDYHCLGDNEN---RPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPF----EM 507 (563)
T ss_pred EEeccchhccccCcccccccCCCCC---CcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHH----HH
Confidence 9999999998766554432222221 2457999999999999999999999999999988 99999887762 23
Q ss_pred HHHHHhCCCCC
Q 011660 465 WYYVLAGKVFA 475 (480)
Q Consensus 465 ~~~~~~~~~~~ 475 (480)
.....-|.+++
T Consensus 508 ~~ylkdGyRla 518 (563)
T KOG1024|consen 508 EHYLKDGYRLA 518 (563)
T ss_pred HHHHhccceec
Confidence 33444444444
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-27 Score=251.80 Aligned_cols=196 Identities=28% Similarity=0.414 Sum_probs=161.0
Q ss_pred CCCceeecccCceE-EEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhcC-CCCCeeeEEEEEecCCeeEEEEeccCC
Q 011660 254 FSPKMLIGQGGNSK-VYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSI-KHENIVRIIGYCHSKEMYAIVYNLLNG 331 (480)
Q Consensus 254 f~~~~~LG~G~fg~-Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~e~~~G 331 (480)
|...+++|.|..|+ ||+|.. .|+.||||++-.+. .+...+|+..|+.- +|||||++++.-.+....||..|.|.-
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~--~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~ 587 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF--FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC 587 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh--HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh
Confidence 45556789999985 699987 68899999885332 24567999999877 699999999999999999999999999
Q ss_pred CHHHHHHhC--CH-----HHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEec---C-CCceEEeeeccccccccc
Q 011660 332 SLKQYLKQL--KW-----NERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSE---N-FHHPQLSDFGAAMVHHQS 400 (480)
Q Consensus 332 sL~~~l~~~--~~-----~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~---~-~~~~kL~DFGla~~~~~~ 400 (480)
+|.++++.- +. .....+..|+++||.+||+. +||||||||.||||+. + ...++|+|||+++.....
T Consensus 588 sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~ 664 (903)
T KOG1027|consen 588 SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG 664 (903)
T ss_pred hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence 999999761 11 22356788999999999999 9999999999999986 2 246899999999776554
Q ss_pred cccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcC-CCCCCCCcc
Q 011660 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITG-KEAIQTNKA 457 (480)
Q Consensus 401 ~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG-~~pf~~~~~ 457 (480)
.... .+.....||-+|+|||++....-..++||||+||++|..++| ..||.+.-.
T Consensus 665 ~sS~--~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~ 720 (903)
T KOG1027|consen 665 KSSF--SRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE 720 (903)
T ss_pred cchh--hcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHH
Confidence 3322 225567899999999999988888899999999999988776 999987654
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-27 Score=233.53 Aligned_cols=217 Identities=26% Similarity=0.401 Sum_probs=177.7
Q ss_pred HhhhhcCCCCceeecccCceEEEEEEec----CCcEEEEEEeccCCccHHHHHHHHHHHhcC-CCCCeeeEEEEEecCCe
Q 011660 247 LCHLTHNFSPKMLIGQGGNSKVYRTNHV----DGQVAAVKVLKCTNWSEEEVLREVELLSSI-KHENIVRIIGYCHSKEM 321 (480)
Q Consensus 247 l~~~~~~f~~~~~LG~G~fg~Vy~~~~~----~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~ 321 (480)
+..+.+.|...+.||+|.|+.||++... ..+.+|+|.+.... ....+..|+++|..+ .+.||+++.+++..++.
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-CchHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 4445677999999999999999999542 46789999886543 446789999999998 58999999999999999
Q ss_pred eEEEEeccC-CCHHHHHHhCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccc
Q 011660 322 YAIVYNLLN-GSLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (480)
Q Consensus 322 ~~lV~e~~~-GsL~~~l~~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (480)
..+|+||+. -+..+++..++..++..++..+..||.++|.+ |||||||||+|+|.+...+.-.|.|||+|.+....
T Consensus 110 v~ivlp~~~H~~f~~l~~~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~ 186 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRSLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGY 186 (418)
T ss_pred eEEEecccCccCHHHHHhcCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHHHHHhh
Confidence 999999994 57889999999999999999999999999999 99999999999999988777889999999732111
Q ss_pred c------c------c---------------------------ccCccccccccCCCccccccccC-CCCCchHHHHHHHH
Q 011660 401 H------Q------V---------------------------SENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGV 440 (480)
Q Consensus 401 ~------~------~---------------------------~~~~~~~~~~GT~~y~APE~~~~-~~~~~k~DvwSlGv 440 (480)
. . . .......+.+||++|.|||++.. ...++++||||.||
T Consensus 187 ~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GV 266 (418)
T KOG1167|consen 187 QQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGV 266 (418)
T ss_pred hhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccc
Confidence 0 0 0 00011124679999999999875 45689999999999
Q ss_pred HHHHHHcCCCCCCCCcccchhHHHHHH
Q 011660 441 VLLELITGKEAIQTNKANRESLVLWYY 467 (480)
Q Consensus 441 il~eLltG~~pf~~~~~~~e~l~~~~~ 467 (480)
|++-+++++.||.....+-+.+..-+.
T Consensus 267 I~Lslls~~~PFf~a~dd~~al~ei~t 293 (418)
T KOG1167|consen 267 ILLSLLSRRYPFFKAKDDADALAEIAT 293 (418)
T ss_pred eeehhhccccccccCccccchHHHHHH
Confidence 999999999999877766665554443
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-24 Score=199.28 Aligned_cols=177 Identities=38% Similarity=0.615 Sum_probs=153.9
Q ss_pred ecccCceEEEEEEecC-CcEEEEEEeccCCcc--HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEeccC-CCHHH
Q 011660 260 IGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLLN-GSLKQ 335 (480)
Q Consensus 260 LG~G~fg~Vy~~~~~~-g~~vAvK~~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~-GsL~~ 335 (480)
||+|.+|.||++...+ ++.+++|++...... .+.+.+|+++++.+.|++|+++++++......++++|++. ++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999998754 899999999866542 4678999999999999999999999999899999999996 89999
Q ss_pred HHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEec-CCCceEEeeeccccccccccccccCcccc
Q 011660 336 YLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSE-NFHHPQLSDFGAAMVHHQSHQVSENVKPV 410 (480)
Q Consensus 336 ~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~-~~~~~kL~DFGla~~~~~~~~~~~~~~~~ 410 (480)
++.. ++...+..++.+++++|.|||+. +++|+||+|.||+++. + +.++|+|||.+........ ...
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~-~~~~l~d~~~~~~~~~~~~-----~~~ 151 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDN-GKVKLADFGLSKLLTSDKS-----LLK 151 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCC-CcEEEecCCceEEccCCcc-----hhh
Confidence 9854 68888999999999999999999 9999999999999998 6 6899999999865433211 123
Q ss_pred ccccCCCccccccccCC-CCCchHHHHHHHHHHHHH
Q 011660 411 NVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLEL 445 (480)
Q Consensus 411 ~~~GT~~y~APE~~~~~-~~~~k~DvwSlGvil~eL 445 (480)
...+...|++||.+... .++.+.|+|++|+++++|
T Consensus 152 ~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 152 TIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred cccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 45578899999998877 888999999999999999
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.8e-26 Score=235.95 Aligned_cols=197 Identities=26% Similarity=0.391 Sum_probs=167.9
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCcc-HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEec
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS-EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~-~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~ 328 (480)
.++|+....+|.|+||.||+++. ..++..|+|+++..... ..-+..|+-+++.++||||+.++|.+...+.++++|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 46799999999999999999965 56899999999877643 34567899999999999999999999999999999999
Q ss_pred c-CCCHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccc
Q 011660 329 L-NGSLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (480)
Q Consensus 329 ~-~GsL~~~l~---~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (480)
| +|+|.+... .+++.++..+....++||.|||+. +=+|||||-.|||+++. +.+|++|||.+-. ...
T Consensus 94 cgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~-gDvklaDfgvsaq-----ita 164 (829)
T KOG0576|consen 94 CGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDE-GDVKLADFGVSAQ-----ITA 164 (829)
T ss_pred cCCCcccceeeecccchhHHHHHHHhhhhccchhhhcC---Ccccccccccceeeccc-CceeecccCchhh-----hhh
Confidence 9 577877663 477888888899999999999999 88999999999999998 7999999998732 233
Q ss_pred cCccccccccCCCccccccc---cCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 405 ENVKPVNVVGTFGYLAPEYM---MYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 405 ~~~~~~~~~GT~~y~APE~~---~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.-.+...+.|||.|||||+- ..+.|+..+||||+|+...||---++|...-.
T Consensus 165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlh 219 (829)
T KOG0576|consen 165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLH 219 (829)
T ss_pred hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccc
Confidence 33445578999999999975 36789999999999999999988777765443
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.4e-24 Score=216.73 Aligned_cols=165 Identities=18% Similarity=0.192 Sum_probs=125.9
Q ss_pred hhcCCCCceeecccCceEEEEEEec--CCcEEEEEEeccCC------ccHHHHHHHHHHHhcCCCCCeee-EEEEEecCC
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNHV--DGQVAAVKVLKCTN------WSEEEVLREVELLSSIKHENIVR-IIGYCHSKE 320 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~~--~g~~vAvK~~~~~~------~~~~~~~~Ei~il~~l~HpnIv~-l~~~~~~~~ 320 (480)
+.++|.+.+.||+|+||+||+|.+. +++.+|||++.... .....+.+|+++|+.++|+|+++ ++++ +
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~ 91 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----G 91 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----C
Confidence 4567999999999999999999763 57888999875321 12345889999999999999985 5442 4
Q ss_pred eeEEEEeccC-CCHHHHHHhCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccC-CCCCEEEecCCCceEEeeeccccccc
Q 011660 321 MYAIVYNLLN-GSLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDV-KSSNILLSENFHHPQLSDFGAAMVHH 398 (480)
Q Consensus 321 ~~~lV~e~~~-GsL~~~l~~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDl-Kp~NILl~~~~~~~kL~DFGla~~~~ 398 (480)
..++||||+. ++|. .+.... ...++.++++||.|||+. ||+|||| ||+|||++.+ +.++|+|||+|+...
T Consensus 92 ~~~LVmE~~~G~~L~-~~~~~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~-~~ikLiDFGlA~~~~ 163 (365)
T PRK09188 92 KDGLVRGWTEGVPLH-LARPHG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPD-GEAAVIDFQLASVFR 163 (365)
T ss_pred CcEEEEEccCCCCHH-HhCccc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCC-CCEEEEECccceecc
Confidence 5799999995 5675 332221 246788999999999999 9999999 9999999887 689999999998665
Q ss_pred ccccccc---CccccccccCCCccccccccC
Q 011660 399 QSHQVSE---NVKPVNVVGTFGYLAPEYMMY 426 (480)
Q Consensus 399 ~~~~~~~---~~~~~~~~GT~~y~APE~~~~ 426 (480)
....... .....+..+++.|+|||.+.-
T Consensus 164 ~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 164 RRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred cCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 4321111 111246789999999998863
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=212.07 Aligned_cols=202 Identities=23% Similarity=0.261 Sum_probs=166.3
Q ss_pred CCCCceeecccCceEEEEEEecCC--cEEEEEEeccCCcc-HHHHHHHHHHHhcCCC----CCeeeEEEEE-ecCCeeEE
Q 011660 253 NFSPKMLIGQGGNSKVYRTNHVDG--QVAAVKVLKCTNWS-EEEVLREVELLSSIKH----ENIVRIIGYC-HSKEMYAI 324 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~~~g--~~vAvK~~~~~~~~-~~~~~~Ei~il~~l~H----pnIv~l~~~~-~~~~~~~l 324 (480)
+|.+.+.||+|+||.||++..... ..+|+|+....... ...+..|..++..+.. +++..+++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999976543 58999988754322 2267889999988863 6899999998 57788999
Q ss_pred EEeccCCCHHHHH-----HhCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCC----CceEEeeecccc
Q 011660 325 VYNLLNGSLKQYL-----KQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENF----HHPQLSDFGAAM 395 (480)
Q Consensus 325 V~e~~~GsL~~~l-----~~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~----~~~kL~DFGla~ 395 (480)
||+.++.+|.++. +.++..+...++.|++.+|++||+. |+|||||||+|+++.... ..+.|.|||+|+
T Consensus 99 VM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar 175 (322)
T KOG1164|consen 99 VMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR 175 (322)
T ss_pred EEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence 9999999999988 3578899999999999999999999 999999999999997642 368999999997
Q ss_pred ccc--ccccc---ccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 396 VHH--QSHQV---SENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 396 ~~~--~~~~~---~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
... ..... ........+.||..|.++....+...+.+.|+||++.++.||+.|..||...+.
T Consensus 176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~ 242 (322)
T KOG1164|consen 176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEM 242 (322)
T ss_pred cccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccc
Confidence 322 11111 111112346699999999999999999999999999999999999999977664
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-24 Score=244.16 Aligned_cols=150 Identities=18% Similarity=0.212 Sum_probs=115.5
Q ss_pred hcCCC-CCeeeEEEEE-------ecCCeeEEEEeccCCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 011660 302 SSIKH-ENIVRIIGYC-------HSKEMYAIVYNLLNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIH 369 (480)
Q Consensus 302 ~~l~H-pnIv~l~~~~-------~~~~~~~lV~e~~~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiH 369 (480)
+.++| +||.+++++| .....++.++|+++++|.++|.. +++.++..++.||++||.|||++ +|||
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---gIvH 103 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQ---GIVV 103 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhC---Ceee
Confidence 34556 6888888877 23346788899999999999953 78889999999999999999999 9999
Q ss_pred ccCCCCCEEEecC------------------CCceEEeeecccccccccccc-----------ccCccccccccCCCccc
Q 011660 370 RDVKSSNILLSEN------------------FHHPQLSDFGAAMVHHQSHQV-----------SENVKPVNVVGTFGYLA 420 (480)
Q Consensus 370 rDlKp~NILl~~~------------------~~~~kL~DFGla~~~~~~~~~-----------~~~~~~~~~~GT~~y~A 420 (480)
|||||+||||+.. .+.+|++|||+++........ .........+||+.|||
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 9999999999642 134666677766432110000 00011122468999999
Q ss_pred cccccCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 011660 421 PEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQT 454 (480)
Q Consensus 421 PE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~ 454 (480)
||++.+..|+.++|||||||+||||++|.+|+..
T Consensus 184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~ 217 (793)
T PLN00181 184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREE 217 (793)
T ss_pred hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhh
Confidence 9999999999999999999999999999998764
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.8e-22 Score=195.32 Aligned_cols=199 Identities=34% Similarity=0.508 Sum_probs=165.3
Q ss_pred CCCceeecccCceEEEEEEecCCcEEEEEEeccCCcc----HHHHHHHHHHHhcCCCC-CeeeEEEEEecCCeeEEEEec
Q 011660 254 FSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWS----EEEVLREVELLSSIKHE-NIVRIIGYCHSKEMYAIVYNL 328 (480)
Q Consensus 254 f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~----~~~~~~Ei~il~~l~Hp-nIv~l~~~~~~~~~~~lV~e~ 328 (480)
|...+.||.|+||.||++... ..+++|.+...... ...+.+|+.+++.+.|+ +|+++.+++......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 667788999999999999776 88899998765432 45688999999999988 799999999877778999999
Q ss_pred c-CCCHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccc
Q 011660 329 L-NGSLKQYLK------QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (480)
Q Consensus 329 ~-~GsL~~~l~------~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (480)
+ ++++.+++. .+.......++.|++.++.|+|+. +++|||+||+||+++.....++++|||.+.......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 9 577887775 477788889999999999999999 999999999999999883269999999987543322
Q ss_pred ccccC-ccccccccCCCccccccccC---CCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 402 QVSEN-VKPVNVVGTFGYLAPEYMMY---GKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 402 ~~~~~-~~~~~~~GT~~y~APE~~~~---~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
..... .......||..|+|||.+.+ ..++...|+||+|++++++++|..||.....
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~ 216 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKN 216 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 11111 13456789999999999987 5789999999999999999999999776653
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.2e-23 Score=190.40 Aligned_cols=203 Identities=24% Similarity=0.287 Sum_probs=169.8
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCccHHHHHHHHHHHhcCCC-CCeeeEEEEEecCCeeEEEEec
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIKH-ENIVRIIGYCHSKEMYAIVYNL 328 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~~~~~lV~e~ 328 (480)
...|...+.||.|+||.+|.|.. .+|..||||+-+.. .....+..|.++.+.|.| ..|..+..|..+.+.-.+||+.
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~-a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdL 92 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK-AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDL 92 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc-CCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeec
Confidence 45699999999999999999965 67999999986533 334567889999999975 6788888888899999999999
Q ss_pred cCCCHHHHH----HhCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecC--CCceEEeeecccccccccc-
Q 011660 329 LNGSLKQYL----KQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN--FHHPQLSDFGAAMVHHQSH- 401 (480)
Q Consensus 329 ~~GsL~~~l----~~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~--~~~~kL~DFGla~~~~~~~- 401 (480)
++.+|++.. +.++..+.+.++-|++.-++|+|.. ++|||||||+|+|+.-+ ...+.|+|||+|+...+..
T Consensus 93 LGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t 169 (341)
T KOG1163|consen 93 LGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRT 169 (341)
T ss_pred cCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhccccc
Confidence 999998887 4588888999999999999999999 99999999999998643 2357899999997554322
Q ss_pred -ccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 402 -QVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 402 -~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
.........+..||..|.+-....+-.-+.+.|+-|+|.+|..+.-|..||++-..
T Consensus 170 ~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka 226 (341)
T KOG1163|consen 170 RQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA 226 (341)
T ss_pred cccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence 12223334567899999998888888889999999999999999999999999875
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-22 Score=194.67 Aligned_cols=201 Identities=19% Similarity=0.263 Sum_probs=169.7
Q ss_pred CCCCceeecccCceEEEEEE-ecCCcEEEEEEeccCCccHHHHHHHHHHHhcCC-CCCeeeEEEEEecCCeeEEEEeccC
Q 011660 253 NFSPKMLIGQGGNSKVYRTN-HVDGQVAAVKVLKCTNWSEEEVLREVELLSSIK-HENIVRIIGYCHSKEMYAIVYNLLN 330 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~-~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~e~~~ 330 (480)
+|.+.+.||+|.||..|.|. ..+++.||||.-.. .....++..|.+..+.|. .++|.+.+-|..++-+-.+|+|+++
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr-kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLLG 107 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR-KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLLG 107 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccc-cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhhC
Confidence 69999999999999999994 57899999997532 223456888999888885 6899999988888888899999999
Q ss_pred CCHHHHH----HhCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEec----CCCceEEeeecccccccccc-
Q 011660 331 GSLKQYL----KQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSE----NFHHPQLSDFGAAMVHHQSH- 401 (480)
Q Consensus 331 GsL~~~l----~~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~----~~~~~kL~DFGla~~~~~~~- 401 (480)
.+|+++. +.|+..+...+|.|++.-++|+|++ .+|+|||||+|+||.. +-..+.|+|||+|+...+..
T Consensus 108 PSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~T 184 (449)
T KOG1165|consen 108 PSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKT 184 (449)
T ss_pred cCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccc
Confidence 9988877 4689999999999999999999999 9999999999999953 22357899999998764432
Q ss_pred -ccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 402 -QVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 402 -~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
............||.+||+-.-..+..-+.+.|+-|||=++...|-|..||++-+.
T Consensus 185 kqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA 241 (449)
T KOG1165|consen 185 KQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 241 (449)
T ss_pred cccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence 22222333457799999999999999999999999999999999999999998764
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.2e-21 Score=180.93 Aligned_cols=193 Identities=13% Similarity=0.139 Sum_probs=144.8
Q ss_pred CCCceeecccCceEEEEEEecCCcEEEEEEeccCCccHH-----HHHHHHHHHhcCC-CCCeeeEEEEEecCCeeEEEEe
Q 011660 254 FSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEE-----EVLREVELLSSIK-HENIVRIIGYCHSKEMYAIVYN 327 (480)
Q Consensus 254 f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~-----~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~e 327 (480)
+.+...|++|+||+||.+.. ++..++.+.+........ .+.+|+++|++|+ |+++++++++ +..+++|+
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred cccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 34566899999999998876 788888888876665433 4789999999995 5889999886 34689999
Q ss_pred ccCC-CHHHHHHhCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccC-CCCCEEEecCCCceEEeeecccccccccccc--
Q 011660 328 LLNG-SLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDV-KSSNILLSENFHHPQLSDFGAAMVHHQSHQV-- 403 (480)
Q Consensus 328 ~~~G-sL~~~l~~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDl-Kp~NILl~~~~~~~kL~DFGla~~~~~~~~~-- 403 (480)
|+.| +|.+.+.. ....++.|++.+|.++|.. ||+|||| ||+|||++.+ +.++|+|||+|.........
T Consensus 79 yI~G~~L~~~~~~----~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~-g~i~LIDFG~A~~~~~~~~~~r 150 (218)
T PRK12274 79 YLAGAAMYQRPPR----GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQED-GSPAVIDFQLAVRGNPRARWMR 150 (218)
T ss_pred eecCccHHhhhhh----hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCC-CCEEEEECCCceecCCcchHHH
Confidence 9965 56544322 1245778999999999999 9999999 7999999987 78999999999754432210
Q ss_pred --c----cCccccccccCCCccccccccCC-CCC-chHHHHHHHHHHHHHHcCCCCCCCCcccc
Q 011660 404 --S----ENVKPVNVVGTFGYLAPEYMMYG-KVD-EKIDVYSYGVVLLELITGKEAIQTNKANR 459 (480)
Q Consensus 404 --~----~~~~~~~~~GT~~y~APE~~~~~-~~~-~k~DvwSlGvil~eLltG~~pf~~~~~~~ 459 (480)
. .+.......+++.|++|+.-... ..+ ...++++-|+-+|.++||+.|.-+++.++
T Consensus 151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~~~ 214 (218)
T PRK12274 151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNEGQ 214 (218)
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCCCC
Confidence 0 00001123378899999854322 334 67899999999999999999987776643
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.5e-21 Score=185.46 Aligned_cols=169 Identities=16% Similarity=0.197 Sum_probs=131.0
Q ss_pred hhcCCCCceeecccCceEEEEEEecCCcEEEEEEeccCCccHHH----------HHHHHHHHhcCCCCCeeeEEEEEecC
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEE----------VLREVELLSSIKHENIVRIIGYCHSK 319 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~----------~~~Ei~il~~l~HpnIv~l~~~~~~~ 319 (480)
+..+|...++||.|+||.||+.+. +++.+|+|+++......+. +.+|+..+.++.||+|..+.+++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 467899999999999999999766 5778999999755433322 57899999999999999998886533
Q ss_pred --------CeeEEEEeccCC-CHHHHHHhCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEee
Q 011660 320 --------EMYAIVYNLLNG-SLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSD 390 (480)
Q Consensus 320 --------~~~~lV~e~~~G-sL~~~l~~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~D 390 (480)
+..+++|||++| +|.++. .... ....+++.+|..||.. |++|||+||+||+++++ + ++|+|
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~-~~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~-g-i~liD 177 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMP-EISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKN-G-LRIID 177 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhh-hccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCC-C-EEEEE
Confidence 357899999976 687763 2222 3456999999999999 99999999999999988 6 99999
Q ss_pred eccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHH
Q 011660 391 FGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELI 446 (480)
Q Consensus 391 FGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLl 446 (480)
||......... . ...+++...|+.++|+||||+.+..+.
T Consensus 178 fg~~~~~~e~~-------a----------~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 178 LSGKRCTAQRK-------A----------KDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCCcccccchh-------h----------HHHHHHHhHhcccccccceeEeehHHH
Confidence 99874321110 0 011455667888999999999986653
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.1e-21 Score=175.13 Aligned_cols=105 Identities=28% Similarity=0.310 Sum_probs=91.7
Q ss_pred CCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccC
Q 011660 331 GSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSEN 406 (480)
Q Consensus 331 GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~ 406 (480)
|+|.+++.. +++.++..++.|++.||.|||+. + ||+|||++.+ +.+++ ||++......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~-~~~~~--fG~~~~~~~~------ 62 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWD-GLLKL--DGSVAFKTPE------ 62 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCc-cceee--ccceEeeccc------
Confidence 788899853 78999999999999999999998 5 9999999998 68888 9998654321
Q ss_pred ccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 407 VKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 407 ~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
...||+.|||||++.+..++.++|||||||++|||++|+.||.....
T Consensus 63 ----~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~ 109 (176)
T smart00750 63 ----QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE 109 (176)
T ss_pred ----cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch
Confidence 12689999999999999999999999999999999999999976544
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.6e-20 Score=175.01 Aligned_cols=133 Identities=16% Similarity=0.219 Sum_probs=102.3
Q ss_pred ceeecccCceEEEEEEecCCcEEEEEEeccCCcc---H------------------------HHHHHHHHHHhcCCCCCe
Q 011660 257 KMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWS---E------------------------EEVLREVELLSSIKHENI 309 (480)
Q Consensus 257 ~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~---~------------------------~~~~~Ei~il~~l~HpnI 309 (480)
...||+|+||.||+|...+|+.||+|+++..... . .....|++++.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3579999999999998778999999999754211 0 112359999999988776
Q ss_pred eeEEEEEecCCeeEEEEeccCCC-HHHH-H--HhCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEeccCCCCCEEEecCCC
Q 011660 310 VRIIGYCHSKEMYAIVYNLLNGS-LKQY-L--KQLKWNERMDVAIGVAKALEYL-HHTCDPPIIHRDVKSSNILLSENFH 384 (480)
Q Consensus 310 v~l~~~~~~~~~~~lV~e~~~Gs-L~~~-l--~~~~~~~~~~i~~~ia~aL~yL-H~~~~~~IiHrDlKp~NILl~~~~~ 384 (480)
.....+... ..++||||++|+ +... + ..++..+...++.|++.+|.|+ |+. +|+||||||+|||+++ +
T Consensus 82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~~--~ 154 (190)
T cd05147 82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYHD--G 154 (190)
T ss_pred CCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEEC--C
Confidence 443333222 237999999654 4333 2 2477788899999999999999 677 9999999999999985 4
Q ss_pred ceEEeeeccccc
Q 011660 385 HPQLSDFGAAMV 396 (480)
Q Consensus 385 ~~kL~DFGla~~ 396 (480)
.++|+|||+|..
T Consensus 155 ~v~LiDFG~a~~ 166 (190)
T cd05147 155 KLYIIDVSQSVE 166 (190)
T ss_pred cEEEEEcccccc
Confidence 799999999854
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=1e-19 Score=169.71 Aligned_cols=134 Identities=22% Similarity=0.250 Sum_probs=104.9
Q ss_pred ceeecccCceEEEEEEecCCcEEEEEEeccCCcc---------------------------HHHHHHHHHHHhcCCCCCe
Q 011660 257 KMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWS---------------------------EEEVLREVELLSSIKHENI 309 (480)
Q Consensus 257 ~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~---------------------------~~~~~~Ei~il~~l~HpnI 309 (480)
...||+|+||.||+|...+|+.||||+++..... ...+.+|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4579999999999998778999999999764211 1123578999999999987
Q ss_pred eeEEEEEecCCeeEEEEeccCCC-H-HHHHH--hCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeccCCCCCEEEecCCC
Q 011660 310 VRIIGYCHSKEMYAIVYNLLNGS-L-KQYLK--QLKWNERMDVAIGVAKALEYLHH-TCDPPIIHRDVKSSNILLSENFH 384 (480)
Q Consensus 310 v~l~~~~~~~~~~~lV~e~~~Gs-L-~~~l~--~~~~~~~~~i~~~ia~aL~yLH~-~~~~~IiHrDlKp~NILl~~~~~ 384 (480)
.....+.... .++||||++|. + ...+. .++..+...++.|++.+|.++|+ . ||+||||||+|||++ + +
T Consensus 82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~-~-~ 154 (190)
T cd05145 82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH-D-G 154 (190)
T ss_pred CCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-C-C
Confidence 5444433332 47999999664 3 23343 35667888999999999999999 8 999999999999999 5 5
Q ss_pred ceEEeeecccccc
Q 011660 385 HPQLSDFGAAMVH 397 (480)
Q Consensus 385 ~~kL~DFGla~~~ 397 (480)
.++|+|||+|...
T Consensus 155 ~~~liDFG~a~~~ 167 (190)
T cd05145 155 KPYIIDVSQAVEL 167 (190)
T ss_pred CEEEEEcccceec
Confidence 8999999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.8e-21 Score=206.55 Aligned_cols=201 Identities=24% Similarity=0.316 Sum_probs=159.6
Q ss_pred CCceeecccCceEEEEEEe-cCCcEEEEEEecc---CCccH----HHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEE
Q 011660 255 SPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKC---TNWSE----EEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (480)
Q Consensus 255 ~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~---~~~~~----~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 326 (480)
....++|.|++|.|+.... .....++.|..+. ..... ..+..|..+-..++|||++..+..+.+.......|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 4567899999998887744 3444455554431 11111 12567888889999999988887777666666669
Q ss_pred eccCCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccc
Q 011660 327 NLLNGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (480)
Q Consensus 327 e~~~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (480)
||+.++|..++.. +...++..++.|++.|+.|+|.. ||.|||+|++|++++.+ +.+||+|||.+.........
T Consensus 401 E~~~~Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~-g~lki~Dfg~~~vf~~~~e~ 476 (601)
T KOG0590|consen 401 EYCPYDLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTEN-GILKIIDFGAASVFRYPWEK 476 (601)
T ss_pred hcccHHHHHHHhcccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecC-CceEEeecCcceeeccCcch
Confidence 9997799999854 78888889999999999999999 99999999999999999 79999999998765543221
Q ss_pred ccCccccccccCCCccccccccCCCCCc-hHHHHHHHHHHHHHHcCCCCCCCCcccch
Q 011660 404 SENVKPVNVVGTFGYLAPEYMMYGKVDE-KIDVYSYGVVLLELITGKEAIQTNKANRE 460 (480)
Q Consensus 404 ~~~~~~~~~~GT~~y~APE~~~~~~~~~-k~DvwSlGvil~eLltG~~pf~~~~~~~e 460 (480)
.......++|+..|+|||++.+..|++ ..||||.|+++..|.+|+.||......+.
T Consensus 477 -~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~ 533 (601)
T KOG0590|consen 477 -NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDN 533 (601)
T ss_pred -hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccccccc
Confidence 123455789999999999999999976 58999999999999999999988776544
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.2e-19 Score=169.58 Aligned_cols=136 Identities=21% Similarity=0.330 Sum_probs=103.6
Q ss_pred CCCceeecccCceEEEEEEecCCcEEEEEEeccCC-ccHHHHHHHHHHHhcC-----CCCCeeeEEEEEecCC---e-eE
Q 011660 254 FSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTN-WSEEEVLREVELLSSI-----KHENIVRIIGYCHSKE---M-YA 323 (480)
Q Consensus 254 f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~-~~~~~~~~Ei~il~~l-----~HpnIv~l~~~~~~~~---~-~~ 323 (480)
.....+||+|+||.||. ...++.. +||++.... ...+.+.+|+++++.+ +||||++++|+++++. . +.
T Consensus 4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 34456899999999996 2233444 689886543 2346789999999999 5799999999998863 3 44
Q ss_pred EEEeccC---CCHHHHHHhCCHHHHHHHHHHHHHHH-HHHHhCCCCCeEeccCCCCCEEEecC---CCceEEeeeccc
Q 011660 324 IVYNLLN---GSLKQYLKQLKWNERMDVAIGVAKAL-EYLHHTCDPPIIHRDVKSSNILLSEN---FHHPQLSDFGAA 394 (480)
Q Consensus 324 lV~e~~~---GsL~~~l~~~~~~~~~~i~~~ia~aL-~yLH~~~~~~IiHrDlKp~NILl~~~---~~~~kL~DFGla 394 (480)
+|+||.+ |+|.+++++....+...++.+++.++ +|||++ +||||||||+|||++.. ...++|+||+.+
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~~~~e~~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQCRYEEDVAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEecCCCCcchhHHHHHHcccccHhHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 7899954 79999997543333345677888777 999999 99999999999999742 237999994433
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.4e-21 Score=200.98 Aligned_cols=180 Identities=27% Similarity=0.345 Sum_probs=150.7
Q ss_pred ecccCceEEEEEE----ecCCcEEEEEEeccCCccH---HHHHHHHHHHhcCC-CCCeeeEEEEEecCCeeEEEEecc-C
Q 011660 260 IGQGGNSKVYRTN----HVDGQVAAVKVLKCTNWSE---EEVLREVELLSSIK-HENIVRIIGYCHSKEMYAIVYNLL-N 330 (480)
Q Consensus 260 LG~G~fg~Vy~~~----~~~g~~vAvK~~~~~~~~~---~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~e~~-~ 330 (480)
+|+|.||.|+++. ...|..||+|++++..... .....|..++..++ ||+++++.-.++.+...+++.++. +
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 7999999999873 2347889999987643221 24567889999887 999999999999999999999999 6
Q ss_pred CCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccCc
Q 011660 331 GSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV 407 (480)
Q Consensus 331 GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~ 407 (480)
|+|...+.. +.+.....+...++-+++++|+. +|+|||+|++||+++.+ |++++.|||+.+..-.. .
T Consensus 82 g~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~-Ghi~~tdfglske~v~~------~ 151 (612)
T KOG0603|consen 82 GDLFTRLSKEVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLE-GHIKLTDFGLSKEAVKE------K 151 (612)
T ss_pred chhhhccccCCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeeccc-CccccCCchhhhHhHhh------h
Confidence 688888754 55566667788999999999999 99999999999999999 89999999998653221 1
Q ss_pred cccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 011660 408 KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQT 454 (480)
Q Consensus 408 ~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~ 454 (480)
..|||..|||||++. ......|+||||++++||+||..||..
T Consensus 152 ---~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 152 ---IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred ---hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 118999999999988 667889999999999999999999998
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1e-18 Score=192.82 Aligned_cols=194 Identities=23% Similarity=0.228 Sum_probs=152.2
Q ss_pred hhcCCCCceeecccCceEEEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhcCC---CCCeeeEEEEEecCCeeEEEE
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIK---HENIVRIIGYCHSKEMYAIVY 326 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~lV~ 326 (480)
-...|.+.+.||+|+||.||+|...+|+.+|+|+-+..... +|..-.+++.+|+ -+-|+.+.....-.+.-++|+
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W--EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ 773 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW--EFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVS 773 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce--eeeehHHHHHhhchhhhcchHHHHHHHccCCcceeee
Confidence 34568888999999999999998888999999998765532 2333344555555 123334433334456677889
Q ss_pred ecc-CCCHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEec------CCCceEEeeeccccc
Q 011660 327 NLL-NGSLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSE------NFHHPQLSDFGAAMV 396 (480)
Q Consensus 327 e~~-~GsL~~~l~---~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~------~~~~~kL~DFGla~~ 396 (480)
+|. .|+|.+++. -+++.-...++.|++..++.||.. +|||+||||+|+||.. +..-++|+|||.+..
T Consensus 774 ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siD 850 (974)
T KOG1166|consen 774 EYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSID 850 (974)
T ss_pred eccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEeccccee
Confidence 998 799999995 377888889999999999999999 9999999999999952 223589999999865
Q ss_pred cccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCC
Q 011660 397 HHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEA 451 (480)
Q Consensus 397 ~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~p 451 (480)
... .....+....++|-.+--+|+..|..|++.+|-|.|+-+++-||.|+..
T Consensus 851 m~l---fp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 851 MKL---FPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred eeE---cCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 443 2233455667889999999999999999999999999999999999764
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.6e-17 Score=162.52 Aligned_cols=192 Identities=18% Similarity=0.267 Sum_probs=124.6
Q ss_pred CCCceeecccCceEEEEEEe-cCCcEEEEEEeccCC----ccHHHHHHHHHHHhcCCC----------CCeeeEEEE---
Q 011660 254 FSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVELLSSIKH----------ENIVRIIGY--- 315 (480)
Q Consensus 254 f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ei~il~~l~H----------pnIv~l~~~--- 315 (480)
+.....||.|+++.||.+.+ .+++.+|+|++.... ...+++.+|.-....+.+ -.++-.++.
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 44567899999999999987 459999999985332 123455665544433322 122222221
Q ss_pred ------EecC---C-----eeEEEEeccCCCHHHHHHh----------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 011660 316 ------CHSK---E-----MYAIVYNLLNGSLKQYLKQ----------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRD 371 (480)
Q Consensus 316 ------~~~~---~-----~~~lV~e~~~GsL~~~l~~----------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrD 371 (480)
+... + .++++|+-+.++|.+++.- +...-+..+..|+++.+.+||+. |++|+|
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgd 170 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGD 170 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST
T ss_pred cCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEecc
Confidence 1111 1 3467778888999888742 22233455668999999999999 999999
Q ss_pred CCCCCEEEecCCCceEEeeeccccccccccccccCccccccccCCCccccccccC--------CCCCchHHHHHHHHHHH
Q 011660 372 VKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY--------GKVDEKIDVYSYGVVLL 443 (480)
Q Consensus 372 lKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~--------~~~~~k~DvwSlGvil~ 443 (480)
|+|+|++++.+ |.++|+||+.......... ....+..|.+||.... -.++.+.|.|++|+++|
T Consensus 171 i~~~nfll~~~-G~v~Lg~F~~~~r~g~~~~--------~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly 241 (288)
T PF14531_consen 171 IKPENFLLDQD-GGVFLGDFSSLVRAGTRYR--------CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLY 241 (288)
T ss_dssp -SGGGEEE-TT-S-EEE--GGGEEETTEEEE--------GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHH
T ss_pred cceeeEEEcCC-CCEEEcChHHHeecCceee--------ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHH
Confidence 99999999999 8999999997754322111 1234577999997643 24789999999999999
Q ss_pred HHHcCCCCCCCCcc
Q 011660 444 ELITGKEAIQTNKA 457 (480)
Q Consensus 444 eLltG~~pf~~~~~ 457 (480)
.|.||+.||.....
T Consensus 242 ~lWC~~lPf~~~~~ 255 (288)
T PF14531_consen 242 SLWCGRLPFGLSSP 255 (288)
T ss_dssp HHHHSS-STCCCGG
T ss_pred HHHHccCCCCCCCc
Confidence 99999999986643
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.5e-19 Score=191.13 Aligned_cols=169 Identities=27% Similarity=0.414 Sum_probs=125.2
Q ss_pred hhcCCCCceeecccCceEEEEEEecC-CcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEec
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~~~-g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~ 328 (480)
..++|..+++|..|+||.||...+.. .+.+|+| +++.+...+. |+.....|+++
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~lilRn------ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLILRN------ILTFAGNPFVV------------------ 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhc-ccccchhhhc------cccccCCccee------------------
Confidence 34689999999999999999998754 6788885 4433311111 45555556555
Q ss_pred cCCCHHHHH---HhCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccc---
Q 011660 329 LNGSLKQYL---KQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ--- 402 (480)
Q Consensus 329 ~~GsL~~~l---~~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~--- 402 (480)
||=...+ ..++- +++.+++|||+. +|+|||+||+|++|+.- |++|++|||+.+..-....
T Consensus 136 --gDc~tllk~~g~lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~m-GhiKlTDfgLsk~GLms~atnl 201 (1205)
T KOG0606|consen 136 --GDCATLLKNIGPLPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSM-GHIKLTDFGLSKKGLMSLATNL 201 (1205)
T ss_pred --chhhhhcccCCCCcc--------hhhHHhHhhccC---CeecCCCCCCcceeeec-ccccccchhhhhhhhhhccchh
Confidence 3322222 22222 237899999999 99999999999999987 8999999999754321110
Q ss_pred -------cccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 403 -------VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 403 -------~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
.........+||||.|+|||++.-..|+..+|+|++|+|+||.+-|..||.++.+
T Consensus 202 ~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtp 263 (1205)
T KOG0606|consen 202 KEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP 263 (1205)
T ss_pred hhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCH
Confidence 1111222357999999999999999999999999999999999999999999864
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.8e-17 Score=156.37 Aligned_cols=132 Identities=25% Similarity=0.372 Sum_probs=111.1
Q ss_pred eeecccCceEEEEEEecCCcEEEEEEeccCCcc---------HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEec
Q 011660 258 MLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWS---------EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (480)
Q Consensus 258 ~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~---------~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~ 328 (480)
+.||+|++|.||+|.. +|..+++|+....... ...+.+|++++..+.|++|.....++.+.+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 4699999999999987 6778899986543211 13467899999999999988777777777788999999
Q ss_pred c-CCCHHHHHHhCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccc
Q 011660 329 L-NGSLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMV 396 (480)
Q Consensus 329 ~-~GsL~~~l~~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~ 396 (480)
+ +++|.+++..... +...++.+++.+|.++|+. +++|+|++|.|||++ + +.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~-~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNGM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-G-GKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhccH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-C-CCEEEEECCcccC
Confidence 9 5689999877665 7888999999999999999 999999999999999 4 5799999999864
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.8e-18 Score=187.88 Aligned_cols=196 Identities=22% Similarity=0.238 Sum_probs=146.1
Q ss_pred CCCCceeecccCceEEEEEEecCCcEEEEEEeccCC--ccHH---HHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEe
Q 011660 253 NFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTN--WSEE---EVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~--~~~~---~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e 327 (480)
+|...+.||.+.|=+|.+|++..|. ++||++-+.. .+-+ +..+|++ ....+|||.+++.-+-..+...|+|-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 5677788999999999999987776 8899985443 2223 3445555 667799999998888777788899999
Q ss_pred ccCCCHHHHHHhC---CHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccc--cccccc
Q 011660 328 LLNGSLKQYLKQL---KWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMV--HHQSHQ 402 (480)
Q Consensus 328 ~~~GsL~~~l~~~---~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~--~~~~~~ 402 (480)
|...+|.+.+... ...+.+.|+.|++.||.-+|.. ||+|+|||.+||||+.- .=+.|+||-..+. ++....
T Consensus 102 yvkhnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSW-NW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 102 YVKHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSW-NWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred HHhhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeee-chhhhhcccccCCccCCCCCc
Confidence 9999999999653 3456677999999999999999 99999999999999875 3488999986532 111110
Q ss_pred cccCccccccccCCCccccccccCC----------C-CCchHHHHHHHHHHHHHHc-CCCCCCC
Q 011660 403 VSENVKPVNVVGTFGYLAPEYMMYG----------K-VDEKIDVYSYGVVLLELIT-GKEAIQT 454 (480)
Q Consensus 403 ~~~~~~~~~~~GT~~y~APE~~~~~----------~-~~~k~DvwSlGvil~eLlt-G~~pf~~ 454 (480)
.+-.....+..--..|+|||.|... . .+++-||||+||++.||++ |++||.-
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L 241 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL 241 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH
Confidence 0000000111123469999988542 1 5688999999999999988 6888864
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.7e-17 Score=157.64 Aligned_cols=135 Identities=17% Similarity=0.226 Sum_probs=104.2
Q ss_pred CCCCceeecccCceEEEEEE--ecCCcEEEEEEeccCCcc-------------------------HHHHHHHHHHHhcCC
Q 011660 253 NFSPKMLIGQGGNSKVYRTN--HVDGQVAAVKVLKCTNWS-------------------------EEEVLREVELLSSIK 305 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~--~~~g~~vAvK~~~~~~~~-------------------------~~~~~~Ei~il~~l~ 305 (480)
.|.+.+.||+|+||.||+|. ..+|+.||+|+++..... ...+.+|++++..+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47888999999999999997 467999999999754210 012468999999997
Q ss_pred CC--CeeeEEEEEecCCeeEEEEeccCC-CHHHHH-Hh--CCHHHHHHHHHHHHHHHHHHHhCCCCC-eEeccCCCCCEE
Q 011660 306 HE--NIVRIIGYCHSKEMYAIVYNLLNG-SLKQYL-KQ--LKWNERMDVAIGVAKALEYLHHTCDPP-IIHRDVKSSNIL 378 (480)
Q Consensus 306 Hp--nIv~l~~~~~~~~~~~lV~e~~~G-sL~~~l-~~--~~~~~~~~i~~~ia~aL~yLH~~~~~~-IiHrDlKp~NIL 378 (480)
+. .+.+++++ ...++||||++| +|..++ .. ....+...++.|++.+|.+||.. + |+||||||+||+
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~NIl 181 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYNIL 181 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhhEE
Confidence 53 34455543 234799999976 455443 22 34445678999999999999999 9 999999999999
Q ss_pred EecCCCceEEeeeccccc
Q 011660 379 LSENFHHPQLSDFGAAMV 396 (480)
Q Consensus 379 l~~~~~~~kL~DFGla~~ 396 (480)
++ + +.++|+|||.|..
T Consensus 182 i~-~-~~i~LiDFg~a~~ 197 (237)
T smart00090 182 VH-D-GKVVIIDVSQSVE 197 (237)
T ss_pred EE-C-CCEEEEEChhhhc
Confidence 99 5 5899999999854
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.72 E-value=8.2e-17 Score=150.62 Aligned_cols=128 Identities=23% Similarity=0.339 Sum_probs=102.3
Q ss_pred eecccCceEEEEEEecCCcEEEEEEeccCCc--c-------HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc
Q 011660 259 LIGQGGNSKVYRTNHVDGQVAAVKVLKCTNW--S-------EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (480)
Q Consensus 259 ~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~--~-------~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~ 329 (480)
+||+|+||.||+|.. +++.+++|+...... . ...+.+|+++++.+.|+++.....++...+..+++|||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999985 678899998653221 1 144678999999999887655555555566678999999
Q ss_pred -CCCHHHHHHhCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccc
Q 011660 330 -NGSLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMV 396 (480)
Q Consensus 330 -~GsL~~~l~~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~ 396 (480)
+++|.+++..... .++.+++.+|.+||+. +++|+|++|+||+++ + +.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~~----~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~-~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGND----ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-D-DKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHH----HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-C-CcEEEEECCCCcC
Confidence 5688887754322 7899999999999999 999999999999999 4 5899999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=5e-17 Score=152.40 Aligned_cols=138 Identities=22% Similarity=0.246 Sum_probs=106.3
Q ss_pred HhhhhcCCCCceeecccCceEEEEEEecCCcEEEEEEeccCCcc-----------------------HHHHHHHHHHHhc
Q 011660 247 LCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWS-----------------------EEEVLREVELLSS 303 (480)
Q Consensus 247 l~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~-----------------------~~~~~~Ei~il~~ 303 (480)
+......|.+.+.||+|+||.||++...+|+.+|||+++..... ...+..|..++..
T Consensus 10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 89 (198)
T cd05144 10 LVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA 89 (198)
T ss_pred HHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence 33333447788899999999999998878999999987643211 1125678999999
Q ss_pred CCCC--CeeeEEEEEecCCeeEEEEeccCC-CHHHHHHhCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEe
Q 011660 304 IKHE--NIVRIIGYCHSKEMYAIVYNLLNG-SLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLS 380 (480)
Q Consensus 304 l~Hp--nIv~l~~~~~~~~~~~lV~e~~~G-sL~~~l~~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~ 380 (480)
+.|+ .+...++. ...+++|||+.| +|.+.... .....++.+++.++.++|+. +|+||||||+||+++
T Consensus 90 l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~---~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill~ 159 (198)
T cd05144 90 LYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL---EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILVD 159 (198)
T ss_pred HHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc---ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEEc
Confidence 9887 44555542 345899999954 66654331 34567889999999999998 999999999999999
Q ss_pred cCCCceEEeeecccc
Q 011660 381 ENFHHPQLSDFGAAM 395 (480)
Q Consensus 381 ~~~~~~kL~DFGla~ 395 (480)
++ +.++|+|||++.
T Consensus 160 ~~-~~~~liDfg~~~ 173 (198)
T cd05144 160 DD-EKIYIIDWPQMV 173 (198)
T ss_pred CC-CcEEEEECCccc
Confidence 87 689999999984
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.71 E-value=8.5e-17 Score=173.21 Aligned_cols=134 Identities=23% Similarity=0.334 Sum_probs=107.1
Q ss_pred cCCCCceeecccCceEEEEEEecCCcEEEEEE-eccCCc--------cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCee
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKV-LKCTNW--------SEEEVLREVELLSSIKHENIVRIIGYCHSKEMY 322 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~-~~~~~~--------~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 322 (480)
..|...+.||+|+||.||++...+.. +++|+ +.+... ..+.+.+|+++++.++|++++....++.+.+..
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 44567789999999999999775443 33333 222111 124578999999999999999888787777778
Q ss_pred EEEEecc-CCCHHHHHHhCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccc
Q 011660 323 AIVYNLL-NGSLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMV 396 (480)
Q Consensus 323 ~lV~e~~-~GsL~~~l~~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~ 396 (480)
++||||+ +++|.+++. ....++.+++++|.|||+. +++||||||+|||+++ +.++|+|||+++.
T Consensus 412 ~lv~E~~~g~~L~~~l~-----~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl~~--~~~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE-----GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIVRD--DRLYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH-----HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEEEC--CcEEEEeCccccc
Confidence 8999999 668988875 4567899999999999999 9999999999999954 4799999999965
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.1e-17 Score=157.43 Aligned_cols=183 Identities=20% Similarity=0.366 Sum_probs=145.6
Q ss_pred eecccCceEEEEEEecCCcEEEEEEeccCCcc---HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc-CCCHH
Q 011660 259 LIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGSLK 334 (480)
Q Consensus 259 ~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~-~GsL~ 334 (480)
.|.+...|..|+|++.. ..+++|+++..... ..+|..|.-.|+.+.||||+++++.|.....+.++..|+ .|+|.
T Consensus 197 kl~e~hsgelwrgrwqg-ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsly 275 (448)
T KOG0195|consen 197 KLAESHSGELWRGRWQG-NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLY 275 (448)
T ss_pred hhccCCCcccccccccC-cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHH
Confidence 47788899999999854 45566877655443 357899999999999999999999999999999999998 79999
Q ss_pred HHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeE-eccCCCCCEEEecCCCceEEe--eeccccccccccccccC
Q 011660 335 QYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPII-HRDVKSSNILLSENFHHPQLS--DFGAAMVHHQSHQVSEN 406 (480)
Q Consensus 335 ~~l~~-----~~~~~~~~i~~~ia~aL~yLH~~~~~~Ii-HrDlKp~NILl~~~~~~~kL~--DFGla~~~~~~~~~~~~ 406 (480)
..|.. .+..++.+++.+|++|+.|||+.. ++| ---|.+..+++|++. +.+|+ |--++
T Consensus 276 nvlhe~t~vvvd~sqav~faldiargmaflhsle--p~ipr~~lns~hvmidedl-tarismad~kfs------------ 340 (448)
T KOG0195|consen 276 NVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE--PMIPRFYLNSKHVMIDEDL-TARISMADTKFS------------ 340 (448)
T ss_pred HHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc--hhhhhhhcccceEEecchh-hhheecccceee------------
Confidence 99954 566788999999999999999983 444 446889999999994 66653 32221
Q ss_pred ccccccccCCCccccccccCCCCC---chHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 407 VKPVNVVGTFGYLAPEYMMYGKVD---EKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 407 ~~~~~~~GT~~y~APE~~~~~~~~---~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
.......-.|.||+||.+...+-+ .++|+|||+++||||.|...||.+-.+
T Consensus 341 fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlsp 394 (448)
T KOG0195|consen 341 FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSP 394 (448)
T ss_pred eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCc
Confidence 011123457899999999866543 469999999999999999999987664
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.2e-16 Score=154.61 Aligned_cols=148 Identities=26% Similarity=0.385 Sum_probs=110.7
Q ss_pred CCCCeeeEEEEEec---------------------------CCeeEEEEeccCCCHHHHHH--hCCHHHHHHHHHHHHHH
Q 011660 305 KHENIVRIIGYCHS---------------------------KEMYAIVYNLLNGSLKQYLK--QLKWNERMDVAIGVAKA 355 (480)
Q Consensus 305 ~HpnIv~l~~~~~~---------------------------~~~~~lV~e~~~GsL~~~l~--~~~~~~~~~i~~~ia~a 355 (480)
+|||||.++++|.+ +..+|+||.-...+|.+|+. ..+.....-++.|+++|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~~~s~r~~~~~laQlLEa 353 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTRHRSYRTGRVILAQLLEA 353 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcCCCchHHHHHHHHHHHHH
Confidence 69999999886632 23688999888899999994 35566667788999999
Q ss_pred HHHHHhCCCCCeEeccCCCCCEEEe--cC-CCceEEeeeccccccccc-cccccCccccccccCCCccccccccCCC---
Q 011660 356 LEYLHHTCDPPIIHRDVKSSNILLS--EN-FHHPQLSDFGAAMVHHQS-HQVSENVKPVNVVGTFGYLAPEYMMYGK--- 428 (480)
Q Consensus 356 L~yLH~~~~~~IiHrDlKp~NILl~--~~-~~~~kL~DFGla~~~~~~-~~~~~~~~~~~~~GT~~y~APE~~~~~~--- 428 (480)
+.|||.+ ||.|||+|++|||+. +| ...+.|+|||++---... -+..-.....+.-|.-.-||||+....+
T Consensus 354 v~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~ 430 (598)
T KOG4158|consen 354 VTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPN 430 (598)
T ss_pred HHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCc
Confidence 9999999 999999999999984 33 124578999987321110 1111122223456788899999876322
Q ss_pred --CC-chHHHHHHHHHHHHHHcCCCCCCCC
Q 011660 429 --VD-EKIDVYSYGVVLLELITGKEAIQTN 455 (480)
Q Consensus 429 --~~-~k~DvwSlGvil~eLltG~~pf~~~ 455 (480)
.+ .|.|.|+.|.+.||+++...||...
T Consensus 431 avvny~kAD~WA~GalaYEIfg~~NPFY~r 460 (598)
T KOG4158|consen 431 AVVNYEKADTWAAGALAYEIFGRSNPFYKR 460 (598)
T ss_pred eeeccchhhhhhhhhhHHHHhccCCccccc
Confidence 12 4899999999999999999999873
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.4e-15 Score=133.80 Aligned_cols=134 Identities=20% Similarity=0.244 Sum_probs=111.7
Q ss_pred CceeecccCceEEEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhcCCC--CCeeeEEEEEecCCeeEEEEeccCCC-
Q 011660 256 PKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKH--ENIVRIIGYCHSKEMYAIVYNLLNGS- 332 (480)
Q Consensus 256 ~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~~~~~lV~e~~~Gs- 332 (480)
+.+.||+|.++.||++...+ +.+++|..+.... ...+..|+.+++.+.| .+++++++++...+..++++||+.|.
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 35679999999999998744 7899999876543 5678899999999976 58999999988888899999999654
Q ss_pred HHHHHHhCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccc
Q 011660 333 LKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMV 396 (480)
Q Consensus 333 L~~~l~~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~ 396 (480)
+..+ +......++.+++++|.+||..+..+++|+|++|+||+++++ +.+++.|||.+..
T Consensus 80 ~~~~----~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~-~~~~l~Df~~~~~ 138 (155)
T cd05120 80 LDEV----SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDG-KILGIIDWEYAGY 138 (155)
T ss_pred cccC----CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECC-cEEEEEecccccC
Confidence 4433 556667789999999999998755579999999999999986 6899999999854
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.65 E-value=4.5e-16 Score=144.06 Aligned_cols=131 Identities=20% Similarity=0.289 Sum_probs=94.8
Q ss_pred ceeecccCceEEEEEEecCCcEEEEEEeccCCccHHH-------------------------HHHHHHHHhcCCCC--Ce
Q 011660 257 KMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEE-------------------------VLREVELLSSIKHE--NI 309 (480)
Q Consensus 257 ~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~-------------------------~~~Ei~il~~l~Hp--nI 309 (480)
.+.||+|+||.||+|...+++.||||+++........ ...|.+.+..+.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4579999999999998878999999998754322111 13456666666443 24
Q ss_pred eeEEEEEecCCeeEEEEeccCC-CH-HHHHHhCCH-HHHHHHHHHHHHHHHHHHh-CCCCCeEeccCCCCCEEEecCCCc
Q 011660 310 VRIIGYCHSKEMYAIVYNLLNG-SL-KQYLKQLKW-NERMDVAIGVAKALEYLHH-TCDPPIIHRDVKSSNILLSENFHH 385 (480)
Q Consensus 310 v~l~~~~~~~~~~~lV~e~~~G-sL-~~~l~~~~~-~~~~~i~~~ia~aL~yLH~-~~~~~IiHrDlKp~NILl~~~~~~ 385 (480)
.+.+++ ...+++|||+.| .+ ...+..... .+...++.+++.++.++|. . +|+|+||||+||+++ + +.
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~-~-~~ 152 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLLEDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD-D-GK 152 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhhhcccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-C-Cc
Confidence 445543 235899999965 21 112222222 6677899999999999998 7 999999999999999 5 58
Q ss_pred eEEeeeccccc
Q 011660 386 PQLSDFGAAMV 396 (480)
Q Consensus 386 ~kL~DFGla~~ 396 (480)
++|+|||.+..
T Consensus 153 ~~liDfg~a~~ 163 (187)
T cd05119 153 VYIIDVPQAVE 163 (187)
T ss_pred EEEEECccccc
Confidence 99999999853
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.59 E-value=3.2e-16 Score=160.27 Aligned_cols=120 Identities=30% Similarity=0.534 Sum_probs=100.5
Q ss_pred eeEEEEecc-CCCHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecc
Q 011660 321 MYAIVYNLL-NGSLKQYLK------QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGA 393 (480)
Q Consensus 321 ~~~lV~e~~-~GsL~~~l~------~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGl 393 (480)
+++|.|++| .++|.+||. ..++.....++.|++.|++| + +.+|+|+||.||+...+ ..+||.|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d-~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDD-DQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccc-hhhhhhhhhh
Confidence 578999999 688999995 25677788899999999999 5 89999999999999888 5899999999
Q ss_pred cccccccc-ccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc
Q 011660 394 AMVHHQSH-QVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT 447 (480)
Q Consensus 394 a~~~~~~~-~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt 447 (480)
........ ........+...||..||+||.+.+..|+.|+||||||+||+||+.
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 85433211 1111224456789999999999999999999999999999999988
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.4e-14 Score=139.91 Aligned_cols=132 Identities=17% Similarity=0.285 Sum_probs=100.5
Q ss_pred eeec-ccCceEEEEEEecCCcEEEEEEeccCC--------------ccHHHHHHHHHHHhcCCCCCe--eeEEEEEecCC
Q 011660 258 MLIG-QGGNSKVYRTNHVDGQVAAVKVLKCTN--------------WSEEEVLREVELLSSIKHENI--VRIIGYCHSKE 320 (480)
Q Consensus 258 ~~LG-~G~fg~Vy~~~~~~g~~vAvK~~~~~~--------------~~~~~~~~Ei~il~~l~HpnI--v~l~~~~~~~~ 320 (480)
..|| .|+.|.||.+... +..+++|.+.... .....+.+|++++..|.|++| +..+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4687 8999999998774 6778888875321 112457889999999998775 67777654322
Q ss_pred -e---eEEEEeccCC--CHHHHHHhCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccc
Q 011660 321 -M---YAIVYNLLNG--SLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA 394 (480)
Q Consensus 321 -~---~~lV~e~~~G--sL~~~l~~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla 394 (480)
. .++|+|++.| +|.+++....... ..+.+++.+|.+||.. ||+||||||+|||++.+ +.++|+|||.+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~--~~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~-~~v~LIDfg~~ 189 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEAPLSE--EQWQAIGQLIARFHDA---GVYHADLNAHNILLDPD-GKFWLIDFDRG 189 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcCCCCH--HHHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCC-CCEEEEECCCc
Confidence 2 2489999964 7988886543222 2467899999999999 99999999999999987 58999999988
Q ss_pred cc
Q 011660 395 MV 396 (480)
Q Consensus 395 ~~ 396 (480)
..
T Consensus 190 ~~ 191 (239)
T PRK01723 190 EL 191 (239)
T ss_pred cc
Confidence 54
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.9e-14 Score=149.60 Aligned_cols=160 Identities=24% Similarity=0.433 Sum_probs=125.6
Q ss_pred HhcCCCCCeeeEEEEEecCCeeEEEEecc-CCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCe-EeccCCC
Q 011660 301 LSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPI-IHRDVKS 374 (480)
Q Consensus 301 l~~l~HpnIv~l~~~~~~~~~~~lV~e~~-~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~I-iHrDlKp 374 (480)
|+.+.|.|+.+++|.+.++...++|.+|| .|+|.+.+.. +++.-...+..+++.||.|||+- +| .|+.+++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeeecc
Confidence 46789999999999999999999999999 7999999953 66777778899999999999988 55 8999999
Q ss_pred CCEEEecCCCceEEeeeccccccccccccccCccccccccCCCccccccccCCC-------CCchHHHHHHHHHHHHHHc
Q 011660 375 SNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGK-------VDEKIDVYSYGVVLLELIT 447 (480)
Q Consensus 375 ~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~-------~~~k~DvwSlGvil~eLlt 447 (480)
.|+++|..+ .+||+|||+....... ..........-..-|.|||.+.+.. .+.+.||||||++++|+++
T Consensus 78 ~nClvd~~w-~lklt~~Gl~~~~~~~---~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~ 153 (484)
T KOG1023|consen 78 SNCLVDSRW-VLKLTDFGLNSLLEET---AEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILF 153 (484)
T ss_pred ccceeeeeE-EEEechhhhccccccc---ccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHh
Confidence 999999995 8999999998654320 0001111111234699999887532 4667999999999999999
Q ss_pred CCCCCCCCcc--cchhHHHHHH
Q 011660 448 GKEAIQTNKA--NRESLVLWYY 467 (480)
Q Consensus 448 G~~pf~~~~~--~~e~l~~~~~ 467 (480)
.+.||..... ..+.++++.+
T Consensus 154 r~~~~~~~~~~~~~~eii~~~~ 175 (484)
T KOG1023|consen 154 RSGPFDLRNLVEDPDEIILRVK 175 (484)
T ss_pred ccCccccccccCChHHHHHHHH
Confidence 9999988554 2334555533
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.7e-15 Score=163.74 Aligned_cols=209 Identities=23% Similarity=0.306 Sum_probs=163.5
Q ss_pred CCCCceeecccCceEEEEEEec--CCcEEEEEEeccCCcc---HHHHHHHHHHHhcCC-CCCeeeEEEEEecCCeeEEEE
Q 011660 253 NFSPKMLIGQGGNSKVYRTNHV--DGQVAAVKVLKCTNWS---EEEVLREVELLSSIK-HENIVRIIGYCHSKEMYAIVY 326 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~~--~g~~vAvK~~~~~~~~---~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~ 326 (480)
.|.+.+.||+|+|+.|-..... ....+|+|.+...... .+....|..+-+.+. |+|++.+++.....+.+++..
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 3667777999999999887553 3456777776544322 234556888888887 999999999999999999999
Q ss_pred ecc-CCCHHHHH-H----hCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEeccCCCCCEEEecCCC-ceEEeeeccccccc
Q 011660 327 NLL-NGSLKQYL-K----QLKWNERMDVAIGVAKALEYLH-HTCDPPIIHRDVKSSNILLSENFH-HPQLSDFGAAMVHH 398 (480)
Q Consensus 327 e~~-~GsL~~~l-~----~~~~~~~~~i~~~ia~aL~yLH-~~~~~~IiHrDlKp~NILl~~~~~-~~kL~DFGla~~~~ 398 (480)
++. +|++.+-+ . .........++.|+..++.|+| +. ++.|||+||+|.+++.. + .++++|||+|..+.
T Consensus 101 ~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s-~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDES-GSALKIADFGLATAYR 176 (601)
T ss_pred CcccccccccccccCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccC-CCcccCCCchhhcccc
Confidence 998 56777766 2 2455667778999999999999 77 99999999999999988 6 89999999997655
Q ss_pred cccccccCcccccccc-CCCccccccccCCCC-CchHHHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHH
Q 011660 399 QSHQVSENVKPVNVVG-TFGYLAPEYMMYGKV-DEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWYY 467 (480)
Q Consensus 399 ~~~~~~~~~~~~~~~G-T~~y~APE~~~~~~~-~~k~DvwSlGvil~eLltG~~pf~~~~~~~e~l~~~~~ 467 (480)
.. ..........+| ++.|+|||...+..| .+..|+||.|+++.-+++|..|+............|..
T Consensus 177 ~~--~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~ 245 (601)
T KOG0590|consen 177 NK--NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKS 245 (601)
T ss_pred cc--CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecc
Confidence 42 112233345678 999999999888544 78899999999999999999999887765554444443
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.2e-12 Score=137.26 Aligned_cols=140 Identities=19% Similarity=0.216 Sum_probs=94.6
Q ss_pred cCCCCceeecccCceEEEEEEecCCcEEEEEEeccCCccH----------------------------------------
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSE---------------------------------------- 291 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~---------------------------------------- 291 (480)
..|. .+.||.|++|.||+|...+|+.||||+.+......
T Consensus 118 ~~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~ 196 (437)
T TIGR01982 118 AEFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRR 196 (437)
T ss_pred hhCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHH
Confidence 3344 36899999999999999999999999986432100
Q ss_pred -HHHHHHHHHHhcC----C-CCCeeeEEEEE-ecCCeeEEEEeccC-CCHHHHHHh--CCHHHHHHHHHHHHH-HHHHHH
Q 011660 292 -EEVLREVELLSSI----K-HENIVRIIGYC-HSKEMYAIVYNLLN-GSLKQYLKQ--LKWNERMDVAIGVAK-ALEYLH 360 (480)
Q Consensus 292 -~~~~~Ei~il~~l----~-HpnIv~l~~~~-~~~~~~~lV~e~~~-GsL~~~l~~--~~~~~~~~i~~~ia~-aL~yLH 360 (480)
-++.+|...+.++ . ++++ .+-.++ ...+..++||||+. ++|.++... ... ....++..++. .+..+|
T Consensus 197 Eldf~~Ea~n~~~~~~~~~~~~~v-~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~-~~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 197 ELDLRREAANASELGENFKNDPGV-YVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL-DRKALAENLARSFLNQVL 274 (437)
T ss_pred HHCHHHHHHHHHHHHHhcCCCCCE-EeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC-CHHHHHHHHHHHHHHHHH
Confidence 0134455544444 2 3332 222222 22345689999995 567766532 111 34456666665 467788
Q ss_pred hCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccc
Q 011660 361 HTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (480)
Q Consensus 361 ~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~ 398 (480)
.. |++|+|+||.||+++++ +.++|+|||++....
T Consensus 275 ~~---g~~H~D~hPgNilv~~~-g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 275 RD---GFFHADLHPGNIFVLKD-GKIIALDFGIVGRLS 308 (437)
T ss_pred hC---CceeCCCCcccEEECCC-CcEEEEeCCCeeECC
Confidence 87 99999999999999888 789999999986544
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.31 E-value=7.9e-12 Score=113.44 Aligned_cols=128 Identities=20% Similarity=0.142 Sum_probs=93.1
Q ss_pred eeecccCceEEEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCe-eeEEEEEecCCeeEEEEeccCC-CHHH
Q 011660 258 MLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENI-VRIIGYCHSKEMYAIVYNLLNG-SLKQ 335 (480)
Q Consensus 258 ~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lV~e~~~G-sL~~ 335 (480)
+.|+.|.++.||++... ++.+++|+..........+..|+.+++.+.+.++ .+++.+.. ...++|||++.| ++..
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~~ 80 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELLT 80 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcccc
Confidence 46889999999999864 7789999886544333456789999998865554 45555543 234789999966 4443
Q ss_pred HHHhCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEeccCCCCCEEEecCCCceEEeeecccc
Q 011660 336 YLKQLKWNERMDVAIGVAKALEYLHHTC--DPPIIHRDVKSSNILLSENFHHPQLSDFGAAM 395 (480)
Q Consensus 336 ~l~~~~~~~~~~i~~~ia~aL~yLH~~~--~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~ 395 (480)
. . ......+.+++++|..||... ..+++|+|++|.||+++. +.++++|||.+.
T Consensus 81 ~--~---~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~~--~~~~liDf~~a~ 135 (170)
T cd05151 81 E--D---FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLDD--GRLWLIDWEYAG 135 (170)
T ss_pred c--c---ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEEC--CeEEEEeccccc
Confidence 2 1 112345678999999999882 123699999999999994 479999999884
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.27 E-value=9e-12 Score=129.90 Aligned_cols=201 Identities=26% Similarity=0.273 Sum_probs=157.6
Q ss_pred hcCCCCceeecc--cCceEEEEEEe---cCCcEEEEEEeccCC---ccHHHHHHHHHHHhcCC-CCCeeeEEEEEecCCe
Q 011660 251 THNFSPKMLIGQ--GGNSKVYRTNH---VDGQVAAVKVLKCTN---WSEEEVLREVELLSSIK-HENIVRIIGYCHSKEM 321 (480)
Q Consensus 251 ~~~f~~~~~LG~--G~fg~Vy~~~~---~~g~~vAvK~~~~~~---~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~ 321 (480)
...|.+.+.+|. |.+|.||.+.. .++..+|+|.-+... .....-.+|....++++ |+|.++.+..+++.+.
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCc
Confidence 345778888999 99999999854 568889998743222 22233456777777774 9999999999999999
Q ss_pred eEEEEeccCCCHHHHHHh----CCHHHHHHHHHHHHH----HHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecc
Q 011660 322 YAIVYNLLNGSLKQYLKQ----LKWNERMDVAIGVAK----ALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGA 393 (480)
Q Consensus 322 ~~lV~e~~~GsL~~~l~~----~~~~~~~~i~~~ia~----aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGl 393 (480)
.++.+|+++.+|.++... ++....+....+..+ ||.++|+. +++|-|+||.||++..+....+++|||+
T Consensus 193 lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 193 LFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred ceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCcce
Confidence 999999999999888743 556667777778888 99999999 9999999999999999855789999999
Q ss_pred ccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 011660 394 AMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTN 455 (480)
Q Consensus 394 a~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~ 455 (480)
...+....-........+..|...|++||.. .+-++...|+||+|-+..+-.+|-.+....
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g 330 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVG 330 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCC
Confidence 8766554322222222344678889999954 477889999999999999999987777655
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.26 E-value=8.5e-12 Score=132.75 Aligned_cols=144 Identities=15% Similarity=0.158 Sum_probs=88.4
Q ss_pred hhcCCCCceeecccCceEEEEEEecC-CcEEEEEEeccCCc---------------------------cH--------H-
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNW---------------------------SE--------E- 292 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~~~-g~~vAvK~~~~~~~---------------------------~~--------~- 292 (480)
...+|+. +.||.|++|+||+|.+.+ |+.||||+.+..-. .. +
T Consensus 118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~ 196 (537)
T PRK04750 118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT 196 (537)
T ss_pred HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence 3456777 789999999999998877 99999999974310 00 1
Q ss_pred -----HHHHHHHHHhcC----CCCCeeeEEEEEe-cCCeeEEEEeccC-CCHHHH--HHhCCHHHHHHHHHHHHHH-HHH
Q 011660 293 -----EVLREVELLSSI----KHENIVRIIGYCH-SKEMYAIVYNLLN-GSLKQY--LKQLKWNERMDVAIGVAKA-LEY 358 (480)
Q Consensus 293 -----~~~~Ei~il~~l----~HpnIv~l~~~~~-~~~~~~lV~e~~~-GsL~~~--l~~~~~~~~~~i~~~ia~a-L~y 358 (480)
++.+|...+.++ .+.+.+.+-.++. -....++||||+. +.+.++ +..... ....++...++. +.-
T Consensus 197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~-d~~~la~~~v~~~~~Q 275 (537)
T PRK04750 197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGT-DMKLLAERGVEVFFTQ 275 (537)
T ss_pred HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCC-CHHHHHHHHHHHHHHH
Confidence 133444444443 2333333322222 2345689999995 467653 222111 111222222211 222
Q ss_pred HHhCCCCCeEeccCCCCCEEEecCCC----ceEEeeecccccccc
Q 011660 359 LHHTCDPPIIHRDVKSSNILLSENFH----HPQLSDFGAAMVHHQ 399 (480)
Q Consensus 359 LH~~~~~~IiHrDlKp~NILl~~~~~----~~kL~DFGla~~~~~ 399 (480)
+... |++|+|+||.||+++.+ + .++++|||++.....
T Consensus 276 if~~---GffHaDpHPGNIlv~~~-g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 276 VFRD---GFFHADMHPGNIFVSYD-PPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHhC---CeeeCCCChHHeEEecC-CCCCCeEEEEecceEEECCH
Confidence 3334 99999999999999987 5 899999999865443
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.25 E-value=6.3e-11 Score=124.92 Aligned_cols=166 Identities=21% Similarity=0.279 Sum_probs=126.6
Q ss_pred EecCCcEEEEEEeccCCcc-HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEeccCCCHHHHHHhCCHHHHHHHHH
Q 011660 272 NHVDGQVAAVKVLKCTNWS-EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAI 350 (480)
Q Consensus 272 ~~~~g~~vAvK~~~~~~~~-~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~GsL~~~l~~~~~~~~~~i~~ 350 (480)
...++.++.|...+.++.. .....+-++-|+.++||||+++++.+++++.+|+|+|-+. .|..+++++........+.
T Consensus 33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~-Pl~~~lk~l~~~~v~~Gl~ 111 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR-PLETVLKELGKEEVCLGLF 111 (690)
T ss_pred eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc-cHHHHHHHhHHHHHHHHHH
Confidence 4467888888888766542 2346677889999999999999999999999999999885 3667777777777777889
Q ss_pred HHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccCccccccccCCCccccccccCCCCC
Q 011660 351 GVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVD 430 (480)
Q Consensus 351 ~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~ 430 (480)
||+.||.|||+.+ +++|++|.-+.|++++. |+-||++|-++........ ......---.|..|+.+....
T Consensus 112 qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~-GeWkLggle~v~~~~~~~~-----~~~~~~~~~s~~~P~~~~~s~-- 181 (690)
T KOG1243|consen 112 QILAALSFLNDDC--NLVHGNVCKDSVFVNES-GEWKLGGLELVSKASGFNA-----PAKSLYLIESFDDPEEIDPSE-- 181 (690)
T ss_pred HHHHHHHHHhccC--CeeeccEeeeeEEEcCC-CcEEEeeeEEEeccccCCc-----ccccchhhhcccChhhcCccc--
Confidence 9999999998654 89999999999999999 8999999998743222110 000111122356666544332
Q ss_pred chHHHHHHHHHHHHHHcC
Q 011660 431 EKIDVYSYGVVLLELITG 448 (480)
Q Consensus 431 ~k~DvwSlGvil~eLltG 448 (480)
-..|.|-|||+++|++.|
T Consensus 182 ~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cchhhhhHHHHHHHHhCc
Confidence 246999999999999999
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.22 E-value=1e-10 Score=109.03 Aligned_cols=130 Identities=18% Similarity=0.217 Sum_probs=94.7
Q ss_pred eeecccCceEEEEEEecC-------CcEEEEEEeccCC----------------------cc-HHH----HHHHHHHHhc
Q 011660 258 MLIGQGGNSKVYRTNHVD-------GQVAAVKVLKCTN----------------------WS-EEE----VLREVELLSS 303 (480)
Q Consensus 258 ~~LG~G~fg~Vy~~~~~~-------g~~vAvK~~~~~~----------------------~~-~~~----~~~Ei~il~~ 303 (480)
..||.|.-+.||.|...+ +..+|+|+.+.+. .+ ... ..+|.+.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999996543 4799999975211 01 111 2479999998
Q ss_pred CC--CCCeeeEEEEEecCCeeEEEEeccCCC-H-HHHHHh--CCHHHHHHHHHHHHHHHHHH-HhCCCCCeEeccCCCCC
Q 011660 304 IK--HENIVRIIGYCHSKEMYAIVYNLLNGS-L-KQYLKQ--LKWNERMDVAIGVAKALEYL-HHTCDPPIIHRDVKSSN 376 (480)
Q Consensus 304 l~--HpnIv~l~~~~~~~~~~~lV~e~~~Gs-L-~~~l~~--~~~~~~~~i~~~ia~aL~yL-H~~~~~~IiHrDlKp~N 376 (480)
+. .-++..++++ ...++||||++|+ + ...++. +...+...+..+++.+|..| |.. +|||+||++.|
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDLs~~N 155 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADLSEYN 155 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHH
Confidence 85 3566777765 4567899999763 2 122332 33345567788999999998 777 99999999999
Q ss_pred EEEecCCCceEEeeeccccc
Q 011660 377 ILLSENFHHPQLSDFGAAMV 396 (480)
Q Consensus 377 ILl~~~~~~~kL~DFGla~~ 396 (480)
||++++ .+.|+|||.|..
T Consensus 156 IL~~~~--~v~iIDF~qav~ 173 (197)
T cd05146 156 MLWHDG--KVWFIDVSQSVE 173 (197)
T ss_pred EEEECC--cEEEEECCCcee
Confidence 999864 699999998853
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd01989 STK_N The N-terminal domain of Eukaryotic Serine Threonine kinases | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.8e-10 Score=102.27 Aligned_cols=120 Identities=23% Similarity=0.261 Sum_probs=97.6
Q ss_pred EEEEEEecChhhHHHHHHHHHhhcCCCCeEEEEEeeccCCccc--------c------------chhHHHHhhhcccCcc
Q 011660 24 TVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVEEQNDTLD--------L------------NTFHIHEDLCKSKKVD 83 (480)
Q Consensus 24 ~v~v~~~~~~~~~~~l~wal~~~~~~~d~v~~~hv~~~~~~~~--------~------------~~~~~~~~~c~~~~~~ 83 (480)
+|||++|.+.+|+.+|.||+......|+.|++|||.++..... . +.+..+...|....++
T Consensus 1 ~ILVavD~S~~s~~al~~a~~~a~~~~~~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 80 (146)
T cd01989 1 SVAVAVDKDKKSKNALKWALDNLATKGQTIVLVHVHPPITSIPSSSGKLEVASAYKQEEDKEAKELLLPYRCFCSRKGVQ 80 (146)
T ss_pred CEEEEecCccccHHHHHHHHHhccCCCCcEEEEEeccCcccCCCCccchHHHHHHHHHHHHHHHHHHHHHHHHHhhcCCe
Confidence 4899999999999999999998888899999999986532100 0 1124556678778888
Q ss_pred eEEEEEecCchhhHHHHHHhhhcceEEEeecccc----CCCc-hhHHHHhhhcCCCCceEEEEec
Q 011660 84 FLVKVCIGDSYITELSNQVRISYATILALGCSLS----GLKD-SEVLTRCLRALPPACTILVMDN 143 (480)
Q Consensus 84 ~~~~v~~~~~~~~~~v~eak~~~~~~l~lg~~~~----~~~~-~~v~~~c~~~~~~~c~v~~~~~ 143 (480)
.+..+..|.+...+|+++|+...|+.||+|++.+ +.-. +.|+.+++++.|+.|.|+.+.+
T Consensus 81 ~~~~~~~g~~~~~~I~~~a~~~~~dlIV~Gs~g~~~l~~~~~gssva~~Vi~~a~~~c~Vlvv~~ 145 (146)
T cd01989 81 CEDVVLEDDDVAKAIVEYVADHGITKLVMGASSDNHFSMKFKKSDVASSVLKEAPDFCTVYVVSK 145 (146)
T ss_pred EEEEEEeCCcHHHHHHHHHHHcCCCEEEEeccCCCceeecccCCchhHHHHhcCCCCceEEEEeC
Confidence 8888888878899999999999999999999865 1222 2399999999999999999875
|
The Serine Threonine kinases are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. The N-terminal domain is homologous to the USP family which has a ATP binding fold. The N-terminal domain is predicted to be involved in ATP binding. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.17 E-value=4e-10 Score=102.24 Aligned_cols=128 Identities=29% Similarity=0.370 Sum_probs=93.6
Q ss_pred eecccCceEEEEEEecCCcEEEEEEec-cCCcc--------HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc
Q 011660 259 LIGQGGNSKVYRTNHVDGQVAAVKVLK-CTNWS--------EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (480)
Q Consensus 259 ~LG~G~fg~Vy~~~~~~g~~vAvK~~~-~~~~~--------~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~ 329 (480)
++++|+-+.+|.+.+.+ ..+++|.-. +.-.. .+...+|.++++++.--.|...+=+..+.+...|+|||.
T Consensus 3 ~i~~GAEa~i~~~~~~g-~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFLG-LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeeccC-cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 57899999999997744 346666542 22111 134678999999886544443344445556778999999
Q ss_pred CCC-HHHHHHhCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccc
Q 011660 330 NGS-LKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMV 396 (480)
Q Consensus 330 ~Gs-L~~~l~~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~ 396 (480)
+|. |.+++... ...++..+-.-+.-||.. +|||+||.++||++..+ .+.++||||+.+
T Consensus 82 ~G~~lkd~l~~~----~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~--~i~~IDfGLg~~ 140 (204)
T COG3642 82 EGELLKDALEEA----RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGG--RIYFIDFGLGEF 140 (204)
T ss_pred CChhHHHHHHhc----chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCC--cEEEEECCcccc
Confidence 876 56577655 345667777778889999 99999999999999987 599999999853
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.14 E-value=3.2e-10 Score=107.09 Aligned_cols=139 Identities=20% Similarity=0.296 Sum_probs=104.2
Q ss_pred eeecccCceEEEEEEecCCcEEEEEEeccCCc--cHHHHHHHHHHHhcCCC--CCeeeEEEEEecCC---eeEEEEeccC
Q 011660 258 MLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNW--SEEEVLREVELLSSIKH--ENIVRIIGYCHSKE---MYAIVYNLLN 330 (480)
Q Consensus 258 ~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~--~~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~~---~~~lV~e~~~ 330 (480)
+.|+.|.++.||++...+|+.+++|+...... ....+..|.++++.+.+ .++.+++.+..... ..+++||++.
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 46899999999999876678999999865443 34578899999999975 44677888876543 6689999996
Q ss_pred C-CHHHHH--HhCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------------
Q 011660 331 G-SLKQYL--KQLKWNERMDVAIGVAKALEYLHHTC-------------------------------------------- 363 (480)
Q Consensus 331 G-sL~~~l--~~~~~~~~~~i~~~ia~aL~yLH~~~-------------------------------------------- 363 (480)
| ++.+.+ ..++..+...++.+++++|..||+..
T Consensus 84 G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (223)
T cd05154 84 GRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRW 163 (223)
T ss_pred CEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHH
Confidence 5 454433 23555666677778888887777421
Q ss_pred ---------CCCeEeccCCCCCEEEecC-CCceEEeeeccccc
Q 011660 364 ---------DPPIIHRDVKSSNILLSEN-FHHPQLSDFGAAMV 396 (480)
Q Consensus 364 ---------~~~IiHrDlKp~NILl~~~-~~~~kL~DFGla~~ 396 (480)
...++|+|++|.||+++++ .+.+.|+||+.+.+
T Consensus 164 ~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 164 LEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 2468999999999999983 25678999998743
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.13 E-value=1.4e-11 Score=134.74 Aligned_cols=205 Identities=24% Similarity=0.309 Sum_probs=146.0
Q ss_pred hhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCcc----HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEE
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS----EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAI 324 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~----~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 324 (480)
..+.|.+.+.+-.|.++.++.+.- ..|...+.|+....+.. .+....+-.++-...+|.++...--+.-....++
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 345677777888999999998854 34666666666544321 1223334444444455666655444445567889
Q ss_pred EEecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccc
Q 011660 325 VYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (480)
Q Consensus 325 V~e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (480)
+++|. +|+|...|.. ...+........+..+++|||.. .++|||++|.|+|...+ ++.+++|||........
T Consensus 882 ~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~-gh~~l~~~~t~~~vg~~ 957 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYD-GHRPLTDFGTLSKVGLI 957 (1205)
T ss_pred hhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccc---hhhcccccccchhhccc-CCcccCccccccccccc
Confidence 99998 5788887754 33334455677889999999998 79999999999999998 78999999843211100
Q ss_pred -----c-------------------ccc--cCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 011660 401 -----H-------------------QVS--ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQT 454 (480)
Q Consensus 401 -----~-------------------~~~--~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~ 454 (480)
. ... .........||+.|.|||...+.......|+|++|++++|.++|.+||..
T Consensus 958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen 958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence 0 000 01223456799999999999999999999999999999999999999998
Q ss_pred Cccc
Q 011660 455 NKAN 458 (480)
Q Consensus 455 ~~~~ 458 (480)
..+.
T Consensus 1038 ~tpq 1041 (1205)
T KOG0606|consen 1038 ETPQ 1041 (1205)
T ss_pred cchh
Confidence 8764
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.6e-09 Score=98.02 Aligned_cols=137 Identities=25% Similarity=0.305 Sum_probs=100.3
Q ss_pred CceeecccCceEEEEEEecCCcEEEEEEe-ccCC--------ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEE
Q 011660 256 PKMLIGQGGNSKVYRTNHVDGQVAAVKVL-KCTN--------WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (480)
Q Consensus 256 ~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~-~~~~--------~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 326 (480)
...+|-+|+-++|+++.. .|+.+.||.- .+.- ........|+++|.++.--.|.-..=++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 567899999999999987 5777777753 2211 11245678999999886444433333445555667889
Q ss_pred eccCC--CHHHHHHh----CCHHHH-HHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCce--EEeeeccccc
Q 011660 327 NLLNG--SLKQYLKQ----LKWNER-MDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHP--QLSDFGAAMV 396 (480)
Q Consensus 327 e~~~G--sL~~~l~~----~~~~~~-~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~--kL~DFGla~~ 396 (480)
||+.| ++.+++.. -..++. ..++..|-+.+.-||.+ +|||+||..+||++.++.... .|+|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99988 78888854 222233 56888999999999999 999999999999998764443 8999999743
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.96 E-value=2.8e-10 Score=118.90 Aligned_cols=196 Identities=22% Similarity=0.170 Sum_probs=143.2
Q ss_pred HhhhhcCCCCceeecccCceEEEEEEe--cCCcEEEEEEeccCCccH-HH--HHHHHHHHhcC-CCCCeeeEEEEEecCC
Q 011660 247 LCHLTHNFSPKMLIGQGGNSKVYRTNH--VDGQVAAVKVLKCTNWSE-EE--VLREVELLSSI-KHENIVRIIGYCHSKE 320 (480)
Q Consensus 247 l~~~~~~f~~~~~LG~G~fg~Vy~~~~--~~g~~vAvK~~~~~~~~~-~~--~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 320 (480)
......+|.....||.|.|+.|+.... .++..|++|.+.+.-... .+ -..|+-+...+ .|.+++.++..|...+
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence 344556789999999999999999743 467899999876543221 22 24566666665 4788888887777667
Q ss_pred eeEEEEecc-CCCHHHHH---HhCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccc
Q 011660 321 MYAIVYNLL-NGSLKQYL---KQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMV 396 (480)
Q Consensus 321 ~~~lV~e~~-~GsL~~~l---~~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~ 396 (480)
..++-.||+ ++++...+ +-++....+.+..|++.++.++|+. .++|+|+||+||++..+.+.-++.|||++..
T Consensus 340 ~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred cccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccccc
Confidence 777999999 45543333 3477888899999999999999999 9999999999999988645678999998842
Q ss_pred cccccccccCccccccccCCCcc--ccccccCCCCCchHHHHHHHHHHHHHHcCCCCCC
Q 011660 397 HHQSHQVSENVKPVNVVGTFGYL--APEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQ 453 (480)
Q Consensus 397 ~~~~~~~~~~~~~~~~~GT~~y~--APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~ 453 (480)
..- ......++-+++ +|+......+..+.|++|||.-+.|..+|...-.
T Consensus 417 ~~~--------~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~ 467 (524)
T KOG0601|consen 417 LAF--------SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSE 467 (524)
T ss_pred cce--------ecccccccccccccchhhccccccccccccccccccccccccCcccCc
Confidence 111 111222333444 4555556678899999999999999999876543
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.94 E-value=7.5e-09 Score=96.02 Aligned_cols=121 Identities=25% Similarity=0.336 Sum_probs=81.6
Q ss_pred EEEEEEecCCcEEEEEEeccCCc----------------------c-----HHHHHHHHHHHhcCCCC--CeeeEEEEEe
Q 011660 267 KVYRTNHVDGQVAAVKVLKCTNW----------------------S-----EEEVLREVELLSSIKHE--NIVRIIGYCH 317 (480)
Q Consensus 267 ~Vy~~~~~~g~~vAvK~~~~~~~----------------------~-----~~~~~~Ei~il~~l~Hp--nIv~l~~~~~ 317 (480)
.||.|...+|..+|+|+.+.... . .....+|.+.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999888899999999753110 0 12357899999999755 566777553
Q ss_pred cCCeeEEEEeccC--CCHHHHHHhCC--HHHHHHHHHHHHHHHHH-HHhCCCCCeEeccCCCCCEEEecCCCceEEeeec
Q 011660 318 SKEMYAIVYNLLN--GSLKQYLKQLK--WNERMDVAIGVAKALEY-LHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFG 392 (480)
Q Consensus 318 ~~~~~~lV~e~~~--GsL~~~l~~~~--~~~~~~i~~~ia~aL~y-LH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFG 392 (480)
..++||||++ |.....+.... ..+...++.+++..+.. +|.. ||||+||.+.|||++++ .+.|+|||
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~--~~~iIDf~ 151 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVDLSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG--KVYIIDFG 151 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCGGGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT--CEEE--GT
T ss_pred ---CCEEEEEecCCCccchhhHHhccccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc--eEEEEecC
Confidence 3479999997 75444444433 45556677788885555 5677 99999999999999987 69999999
Q ss_pred cccc
Q 011660 393 AAMV 396 (480)
Q Consensus 393 la~~ 396 (480)
.|..
T Consensus 152 qav~ 155 (188)
T PF01163_consen 152 QAVD 155 (188)
T ss_dssp TEEE
T ss_pred ccee
Confidence 8854
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.86 E-value=3.7e-09 Score=103.01 Aligned_cols=149 Identities=26% Similarity=0.370 Sum_probs=107.2
Q ss_pred HHhcCCCCCeeeEEEEEec-----CCeeEEEEecc-CCCHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 011660 300 LLSSIKHENIVRIIGYCHS-----KEMYAIVYNLL-NGSLKQYLKQ-------LKWNERMDVAIGVAKALEYLHHTCDPP 366 (480)
Q Consensus 300 il~~l~HpnIv~l~~~~~~-----~~~~~lV~e~~-~GsL~~~l~~-------~~~~~~~~i~~~ia~aL~yLH~~~~~~ 366 (480)
-|-.+.|.||++++.|+.+ .....++.||+ .|+|..+|++ +......+++-||..||.|||+. +++
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~Pp 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCc
Confidence 3445679999999988854 34567788888 7999999965 34445567899999999999987 679
Q ss_pred eEeccCCCCCEEEecCCCceEEeeeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHH
Q 011660 367 IIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELI 446 (480)
Q Consensus 367 IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLl 446 (480)
|+|+++..+.|++..+ +-+|+. -+.-...+.+-............|-++|.|||+=.....+.++|||+||...+||-
T Consensus 199 iihgnlTc~tifiq~n-gLIkig-~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHN-GLIKIG-SVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred cccCCcchhheeecCC-ceEEec-ccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 9999999999999987 666653 22111111111111111112234678999999877777788999999999999998
Q ss_pred cCCCC
Q 011660 447 TGKEA 451 (480)
Q Consensus 447 tG~~p 451 (480)
-|..-
T Consensus 277 ilEiq 281 (458)
T KOG1266|consen 277 ILEIQ 281 (458)
T ss_pred Hheec
Confidence 77653
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.78 E-value=1.8e-07 Score=91.79 Aligned_cols=134 Identities=17% Similarity=0.145 Sum_probs=95.7
Q ss_pred eeecccCceEEEEEEecCCcEEEEEEeccCCcc------------HHHHHHHHHHHhcCCCCC--eeeEEEEEec-----
Q 011660 258 MLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWS------------EEEVLREVELLSSIKHEN--IVRIIGYCHS----- 318 (480)
Q Consensus 258 ~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~------------~~~~~~Ei~il~~l~Hpn--Iv~l~~~~~~----- 318 (480)
..+-+.....|++... +|+.+.||........ ...+.+|...+..|..-+ .++++.+.+.
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3455555556777765 6788999977433311 114778999888874333 3445555532
Q ss_pred CCeeEEEEeccCC--CHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEec------CCCc
Q 011660 319 KEMYAIVYNLLNG--SLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSE------NFHH 385 (480)
Q Consensus 319 ~~~~~lV~e~~~G--sL~~~l~~-----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~------~~~~ 385 (480)
....++|+|+++| +|.+++.. ........++.+++..+.-||.. ||+|+|+++.|||++. +...
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCce
Confidence 2346799999976 68888753 33456678899999999999999 9999999999999985 1247
Q ss_pred eEEeeecccc
Q 011660 386 PQLSDFGAAM 395 (480)
Q Consensus 386 ~kL~DFGla~ 395 (480)
+.|+||+.+.
T Consensus 184 ~~LIDl~r~~ 193 (268)
T PRK15123 184 LSVIDLHRAQ 193 (268)
T ss_pred EEEEECCccc
Confidence 8999999874
|
|
| >PF00582 Usp: Universal stress protein family; InterPro: IPR006016 The universal stress protein UspA P28242 from SWISSPROT [] is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents | Back alignment and domain information |
|---|
Probab=98.75 E-value=9.8e-08 Score=82.33 Aligned_cols=116 Identities=16% Similarity=0.225 Sum_probs=87.5
Q ss_pred eEEEEEEecChhhHHHHHHHHHhhcCCCCeEEEEEeeccCCcccc-------ch--h-------HHHHhhhcccCcceEE
Q 011660 23 RTVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVEEQNDTLDL-------NT--F-------HIHEDLCKSKKVDFLV 86 (480)
Q Consensus 23 ~~v~v~~~~~~~~~~~l~wal~~~~~~~d~v~~~hv~~~~~~~~~-------~~--~-------~~~~~~c~~~~~~~~~ 86 (480)
++|||++|.+..+++++.||+....+.|+.|++|||.+....... .. . ......+...+.....
T Consensus 3 ~~Ilv~~d~~~~~~~al~~a~~la~~~~~~i~~l~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (140)
T PF00582_consen 3 KRILVAIDGSEESRRALRFALELAKRSGAEITLLHVIPPPPQYSFSAAEDEESEEEAEEEEQARQAEAEEAEAEGGIVIE 82 (140)
T ss_dssp SEEEEEESSSHHHHHHHHHHHHHHHHHTCEEEEEEEEESCHCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTTSEEE
T ss_pred CEEEEEECCCHHHHHHHHHHHHHHHhhCCeEEEEEeeccccccccccccccccccccchhhhhhhHHHHHHhhhccceeE
Confidence 699999999999999999999999999999999999965542111 00 0 0001334555566666
Q ss_pred EEEecCchhhHHHHHHhhhcceEEEeecccc----CCCchhHHHHhhhcCCCCceEEE
Q 011660 87 KVCIGDSYITELSNQVRISYATILALGCSLS----GLKDSEVLTRCLRALPPACTILV 140 (480)
Q Consensus 87 ~v~~~~~~~~~~v~eak~~~~~~l~lg~~~~----~~~~~~v~~~c~~~~~~~c~v~~ 140 (480)
.+..+.+..+.++++++...++.||+|.+.. +.-.+.++++++++.| |-|+.
T Consensus 83 ~~~~~~~~~~~i~~~~~~~~~dliv~G~~~~~~~~~~~~gs~~~~l~~~~~--~pVlv 138 (140)
T PF00582_consen 83 VVIESGDVADAIIEFAEEHNADLIVMGSRGRSGLERLLFGSVAEKLLRHAP--CPVLV 138 (140)
T ss_dssp EEEEESSHHHHHHHHHHHTTCSEEEEESSSTTSTTTSSSHHHHHHHHHHTS--SEEEE
T ss_pred EEEEeeccchhhhhccccccceeEEEeccCCCCccCCCcCCHHHHHHHcCC--CCEEE
Confidence 6666778999999999999999999999984 2223459999999998 55544
|
UspA enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. The crystal structure of Haemophilus influenzae UspA [] reveals an alpha/beta fold similar to that of the Methanocaldococcus jannaschii (Methanococcus jannaschii) MJ0577 protein, which binds ATP [], though UspA lacks ATP-binding activity.; GO: 0006950 response to stress; PDB: 3DLO_C 3QTB_A 2PFS_A 3TNJ_A 1JMV_D 3FH0_B 3FDX_B 3AB7_A 3AB8_A 2GM3_F .... |
| >cd01987 USP_OKCHK USP domain is located between the N-terminal sensor domain and C-terminal catalytic domain of this Osmosensitive K+ channel histidine kinase family | Back alignment and domain information |
|---|
Probab=98.62 E-value=3.5e-07 Score=78.62 Aligned_cols=115 Identities=13% Similarity=0.100 Sum_probs=88.1
Q ss_pred EEEEEEecChhhHHHHHHHHHhhcCCCCeEEEEEeeccCCcc---c-cchhHHHHhhhcccCcceEEEEEecCchhhHHH
Q 011660 24 TVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVEEQNDTL---D-LNTFHIHEDLCKSKKVDFLVKVCIGDSYITELS 99 (480)
Q Consensus 24 ~v~v~~~~~~~~~~~l~wal~~~~~~~d~v~~~hv~~~~~~~---~-~~~~~~~~~~c~~~~~~~~~~v~~~~~~~~~~v 99 (480)
+|||++|.+..++++|.||....-+.+..+.+|||.++.... . .+.+..+..+++..++ ...+..+.+...+|+
T Consensus 1 ~Ilv~vd~s~~s~~al~~a~~la~~~~~~l~ll~v~~~~~~~~~~~~~~~l~~~~~~~~~~~~--~~~~~~~~~~~~~I~ 78 (124)
T cd01987 1 RILVCISGGPNAERLIRRAARLADRLKAPWYVVYVETPRLNRLSEAERRRLAEALRLAEELGA--EVVTLPGDDVAEAIV 78 (124)
T ss_pred CEEEEECCCcchHHHHHHHHHHHHHhCCCEEEEEEecCccccCCHHHHHHHHHHHHHHHHcCC--EEEEEeCCcHHHHHH
Confidence 599999999999999999999988999999999999765421 1 1223444556655444 444566778899999
Q ss_pred HHHhhhcceEEEeecccc----CCCchhHHHHhhhcCCCCceEEEE
Q 011660 100 NQVRISYATILALGCSLS----GLKDSEVLTRCLRALPPACTILVM 141 (480)
Q Consensus 100 ~eak~~~~~~l~lg~~~~----~~~~~~v~~~c~~~~~~~c~v~~~ 141 (480)
++|+...++.||+|.... +.-.+.++.+.+.+. +.|.|+.+
T Consensus 79 ~~~~~~~~dllviG~~~~~~~~~~~~Gs~~~~v~~~a-~~~~v~v~ 123 (124)
T cd01987 79 EFAREHNVTQIVVGKSRRSRWRELFRGSLVDRLLRRA-GNIDVHIV 123 (124)
T ss_pred HHHHHcCCCEEEeCCCCCchHHHHhcccHHHHHHHhC-CCCeEEEe
Confidence 999999999999999966 212234899999988 77877653
|
The family of KdpD sensor kinase proteins regulates the kdpFABC operon responsible for potassium transport. The USP domain is homologous to the universal stress protein Usp Usp is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. Usp enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.60 E-value=9.1e-07 Score=91.41 Aligned_cols=160 Identities=20% Similarity=0.256 Sum_probs=116.1
Q ss_pred ceEEEEEE-ecCCcEEEEEEeccCC-ccHHHHHHHHHHHhcCCCCCeeeEEEEEe----cCCeeEEEEeccC--CCHHHH
Q 011660 265 NSKVYRTN-HVDGQVAAVKVLKCTN-WSEEEVLREVELLSSIKHENIVRIIGYCH----SKEMYAIVYNLLN--GSLKQY 336 (480)
Q Consensus 265 fg~Vy~~~-~~~g~~vAvK~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~----~~~~~~lV~e~~~--GsL~~~ 336 (480)
-.+.|++. ..||..|++|+++-.. ........-+++++++.|+|+|++.+++. .+..+++||+|.. ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 35779984 4789999999994221 12223345688999999999999998875 4567899999984 567766
Q ss_pred HH------------------hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccc
Q 011660 337 LK------------------QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (480)
Q Consensus 337 l~------------------~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~ 398 (480)
-. ..++...+.++.|+..||.++|+. |...+-|.|.+||++.+. +++|+.-|......
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~-RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKM-RIRISGCGIMDVLQ 444 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcc-eEEEecccceeeec
Confidence 51 145677889999999999999999 999999999999999873 66766555432211
Q ss_pred cccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCC
Q 011660 399 QSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKE 450 (480)
Q Consensus 399 ~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~ 450 (480)
... .+| +... .+-|.=.||.+++-|.||..
T Consensus 445 ~d~-----------------~~~--le~~---Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 445 EDP-----------------TEP--LESQ---QQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CCC-----------------Ccc--hhHH---hhhhHHHHHHHHHHHhhccc
Confidence 100 011 2111 46788899999999999954
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.55 E-value=3.3e-07 Score=88.17 Aligned_cols=132 Identities=23% Similarity=0.266 Sum_probs=92.2
Q ss_pred CCCceeecccCceEEEEEEecCCcEEEEEEeccCCc-----------------------cHHHHHHHHHHHhcCCCC--C
Q 011660 254 FSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNW-----------------------SEEEVLREVELLSSIKHE--N 308 (480)
Q Consensus 254 f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~-----------------------~~~~~~~Ei~il~~l~Hp--n 308 (480)
..+...||-|.-+.||.|....|..+|+|.=+.... +.....+|.++|.+|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 345678999999999999988899999997431100 012357899999999654 6
Q ss_pred eeeEEEEEecCCeeEEEEeccCCCHHHHHHhCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEE
Q 011660 309 IVRIIGYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQL 388 (480)
Q Consensus 309 Iv~l~~~~~~~~~~~lV~e~~~GsL~~~l~~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL 388 (480)
+...+++ +...+|||+.+|-...-+. ++......++..|++-+.-+-.. ||||+|+.+-||++++| |.+.+
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r-~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~d-g~~~v 243 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR-LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTED-GDIVV 243 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc-CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEecC-CCEEE
Confidence 6666644 5678999999884222222 12233333444444444444466 99999999999999999 78999
Q ss_pred eeeccc
Q 011660 389 SDFGAA 394 (480)
Q Consensus 389 ~DFGla 394 (480)
+||--+
T Consensus 244 IDwPQ~ 249 (304)
T COG0478 244 IDWPQA 249 (304)
T ss_pred EeCccc
Confidence 999866
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.46 E-value=2.6e-06 Score=81.66 Aligned_cols=131 Identities=16% Similarity=0.238 Sum_probs=85.2
Q ss_pred eeecccCceEEEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCC--eeeEEEEEecCCeeEEEEeccCCC--H
Q 011660 258 MLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHEN--IVRIIGYCHSKEMYAIVYNLLNGS--L 333 (480)
Q Consensus 258 ~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~~~~~~~~~lV~e~~~Gs--L 333 (480)
..||+|..+.||+. .+..+++|+... ......+.+|.++++.+..-. +.+.+++....+.+.++|+++.|. +
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~-~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~ 82 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNP-GFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF 82 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCC-CCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence 46899999999984 245677888764 334566889999999886433 467788888777888999999773 2
Q ss_pred HHHHHhCCHHHHHHHHHHHHH---------------------------------------HHHHHHhCC-CCCeEeccCC
Q 011660 334 KQYLKQLKWNERMDVAIGVAK---------------------------------------ALEYLHHTC-DPPIIHRDVK 373 (480)
Q Consensus 334 ~~~l~~~~~~~~~~i~~~ia~---------------------------------------aL~yLH~~~-~~~IiHrDlK 373 (480)
.+.+. ........++..+++ ...+|.... ...++|+|+.
T Consensus 83 ~~~~~-~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 83 SRIIS-DNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhc-CCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 11110 000000111111111 122332221 2367899999
Q ss_pred CCCEEEecCCCceEEeeecccc
Q 011660 374 SSNILLSENFHHPQLSDFGAAM 395 (480)
Q Consensus 374 p~NILl~~~~~~~kL~DFGla~ 395 (480)
|.||+++++ + +.++||+.+.
T Consensus 162 ~~Nii~~~~-~-~~iIDwe~a~ 181 (226)
T TIGR02172 162 IGNLITSGK-G-TYWIDLGDFG 181 (226)
T ss_pred CCcEEEcCC-C-cEEEechhcC
Confidence 999999987 5 8999999874
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.46 E-value=1.7e-06 Score=81.68 Aligned_cols=103 Identities=22% Similarity=0.295 Sum_probs=79.9
Q ss_pred HHHHHHHHHHHhcCCCC--CeeeEEEEEecC----CeeEEEEeccCC--CHHHHHHh---CCHHHHHHHHHHHHHHHHHH
Q 011660 291 EEEVLREVELLSSIKHE--NIVRIIGYCHSK----EMYAIVYNLLNG--SLKQYLKQ---LKWNERMDVAIGVAKALEYL 359 (480)
Q Consensus 291 ~~~~~~Ei~il~~l~Hp--nIv~l~~~~~~~----~~~~lV~e~~~G--sL~~~l~~---~~~~~~~~i~~~ia~aL~yL 359 (480)
.....+|...+..|..- ..++.+++.+.. ...++|+|++.| +|.+++.. .+......++.+++..+.-|
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence 34578888888777433 345566666542 245788999966 68998876 55667788999999999999
Q ss_pred HhCCCCCeEeccCCCCCEEEecCC--CceEEeeeccccc
Q 011660 360 HHTCDPPIIHRDVKSSNILLSENF--HHPQLSDFGAAMV 396 (480)
Q Consensus 360 H~~~~~~IiHrDlKp~NILl~~~~--~~~kL~DFGla~~ 396 (480)
|.. ||+|+|+++.|||++.+. ..+.|+||+-++.
T Consensus 135 H~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 135 HDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999 999999999999999872 1688999998754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.46 E-value=2.2e-06 Score=86.61 Aligned_cols=187 Identities=18% Similarity=0.274 Sum_probs=123.1
Q ss_pred CCceeecccCceEEEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhc-CCCCCeee--------EEEEEecCCeeEEE
Q 011660 255 SPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSS-IKHENIVR--------IIGYCHSKEMYAIV 325 (480)
Q Consensus 255 ~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~-l~HpnIv~--------l~~~~~~~~~~~lV 325 (480)
.....||+|+-+.+|-..-. +-.+.|+......... ..-+..|.. -.||-+-. |+|-- .....-++
T Consensus 14 ~~gr~LgqGgea~ly~l~e~--~d~VAKIYh~Pppa~~--aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~-~~~~iGfl 88 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV--RDQVAKIYHAPPPAAQ--AQKVAELAATPDAPLLNYRVAWPQATLHGGR-RGKVIGFL 88 (637)
T ss_pred CCCccccCCccceeeecchh--hchhheeecCCCchHH--HHHHHHhccCCCCcchhhhhcccHHHhhCCC-ccceeEEe
Confidence 34567999999999964221 2234577765432211 112233333 25553322 11111 11225566
Q ss_pred EeccCC--CHHHHHH---------hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccc
Q 011660 326 YNLLNG--SLKQYLK---------QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA 394 (480)
Q Consensus 326 ~e~~~G--sL~~~l~---------~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla 394 (480)
|..+.| .+..++. .+.|.-.++.+..++.+..-||+. |.+-+|+.++|+|++++ +.+.|.|-...
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~-~~V~LVdsDsf 164 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDD-SKVVLVDSDSF 164 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecC-ceEEEEcccce
Confidence 776644 2444442 278899999999999999999999 99999999999999998 68888865432
Q ss_pred cccccccccccCccccccccCCCcccccccc-----CCCCCchHHHHHHHHHHHHHHcC-CCCCCCCc
Q 011660 395 MVHHQSHQVSENVKPVNVVGTFGYLAPEYMM-----YGKVDEKIDVYSYGVVLLELITG-KEAIQTNK 456 (480)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~~~k~DvwSlGvil~eLltG-~~pf~~~~ 456 (480)
... .........+|.+.|.+||... +-.-+...|-|.|||++++|+.| +.||.+..
T Consensus 165 qi~------~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~ 226 (637)
T COG4248 165 QIN------ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIP 226 (637)
T ss_pred eec------cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCccc
Confidence 211 1122223457999999999654 34456789999999999998876 99998764
|
|
| >PRK15005 universal stress protein F; Provisional | Back alignment and domain information |
|---|
Probab=98.39 E-value=4.5e-06 Score=73.58 Aligned_cols=116 Identities=14% Similarity=0.122 Sum_probs=84.3
Q ss_pred eEEEEEEecChh--hHHHHHHHHHhhcCCCCeEEEEEeeccCCcc--------c-------c--chhHHHHhhhcccC--
Q 011660 23 RTVIFGLKSDHY--SREILLQLLTVIAKPGDNVLAVHVEEQNDTL--------D-------L--NTFHIHEDLCKSKK-- 81 (480)
Q Consensus 23 ~~v~v~~~~~~~--~~~~l~wal~~~~~~~d~v~~~hv~~~~~~~--------~-------~--~~~~~~~~~c~~~~-- 81 (480)
++|||++|.+.+ ++.++.||+....+.|..|++|||.++.... . + .+...++.+++...
T Consensus 3 ~~ILv~~D~s~~~~~~~a~~~a~~la~~~~~~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 82 (144)
T PRK15005 3 RTILVPIDISDSELTQRVISHVEAEAKIDDAEVHFLTVIPSLPYYASLGLAYSAELPAMDDLKAEAKSQLEEIIKKFKLP 82 (144)
T ss_pred ccEEEecCCCchhHHHHHHHHHHHHHhccCCeEEEEEEEccCcccccccccccccchHHHHHHHHHHHHHHHHHHHhCCC
Confidence 689999999987 6899999999888899999999998542110 0 0 11134455555433
Q ss_pred -cceEEEEEecCchhhHHHHHHhhhcceEEEeecccc---CCCchhHHHHhhhcCCCCceEEEE
Q 011660 82 -VDFLVKVCIGDSYITELSNQVRISYATILALGCSLS---GLKDSEVLTRCLRALPPACTILVM 141 (480)
Q Consensus 82 -~~~~~~v~~~~~~~~~~v~eak~~~~~~l~lg~~~~---~~~~~~v~~~c~~~~~~~c~v~~~ 141 (480)
++++..+..|. ....|++.|+...++.||+|.++. +.-.+.++.+++++.+ |-|+.+
T Consensus 83 ~~~~~~~v~~G~-p~~~I~~~a~~~~~DLIV~Gs~~~~~~~~llGS~a~~vl~~a~--cpVlvV 143 (144)
T PRK15005 83 TDRVHVHVEEGS-PKDRILELAKKIPADMIIIASHRPDITTYLLGSNAAAVVRHAE--CSVLVV 143 (144)
T ss_pred CCceEEEEeCCC-HHHHHHHHHHHcCCCEEEEeCCCCCchheeecchHHHHHHhCC--CCEEEe
Confidence 45677778875 467999999999999999998754 1122348999999887 666543
|
|
| >PRK15456 universal stress protein UspG; Provisional | Back alignment and domain information |
|---|
Probab=98.35 E-value=4.8e-06 Score=73.47 Aligned_cols=115 Identities=15% Similarity=0.163 Sum_probs=81.5
Q ss_pred eEEEEEEecC--hhhHHHHHHHHHhhcCCCCeEEEEEeeccCCccc-----c--chh---------HHHHhhhcc---cC
Q 011660 23 RTVIFGLKSD--HYSREILLQLLTVIAKPGDNVLAVHVEEQNDTLD-----L--NTF---------HIHEDLCKS---KK 81 (480)
Q Consensus 23 ~~v~v~~~~~--~~~~~~l~wal~~~~~~~d~v~~~hv~~~~~~~~-----~--~~~---------~~~~~~c~~---~~ 81 (480)
++|||++|.+ ..|..+|.||+.. |+.+..|.+|||.++..... . ..+ ..++.+++. ..
T Consensus 3 ~~ILv~vD~S~~~~s~~al~~A~~l-a~~~~~l~llhv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 81 (142)
T PRK15456 3 KTIIMPVDVFEMELSDKAVRHAEFL-AQDDGVIHLLHVLPGSASLSLHRFAADVRRFEEHLQHEAEERLQTMVSHFTIDP 81 (142)
T ss_pred ccEEEeccCCchhHHHHHHHHHHHH-HhcCCeEEEEEEecCcccccccccccchhhHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 6899999998 4899999999975 66678999999996532100 0 001 234445543 23
Q ss_pred cceEEEEEecCchhhHHHHHHhhhcceEEEeeccccCC---CchhHHHHhhhcCCCCceEEEE
Q 011660 82 VDFLVKVCIGDSYITELSNQVRISYATILALGCSLSGL---KDSEVLTRCLRALPPACTILVM 141 (480)
Q Consensus 82 ~~~~~~v~~~~~~~~~~v~eak~~~~~~l~lg~~~~~~---~~~~v~~~c~~~~~~~c~v~~~ 141 (480)
++++..+..| +....|++.|+...|+.||+|++.+.. -.+.++++.+++.+ |.|+.+
T Consensus 82 ~~v~~~v~~G-~~~~~I~~~a~~~~~DLIVmG~~g~~~~~~llGS~a~~v~~~a~--~pVLvV 141 (142)
T PRK15456 82 SRIKQHVRFG-SVRDEVNELAEELGADVVVIGSRNPSISTHLLGSNASSVIRHAN--LPVLVV 141 (142)
T ss_pred cceEEEEcCC-ChHHHHHHHHhhcCCCEEEEcCCCCCccceecCccHHHHHHcCC--CCEEEe
Confidence 5667677777 557789999999999999999986521 12348999999876 666554
|
|
| >PRK15118 universal stress global response regulator UspA; Provisional | Back alignment and domain information |
|---|
Probab=98.32 E-value=5.3e-06 Score=73.31 Aligned_cols=116 Identities=12% Similarity=0.184 Sum_probs=82.4
Q ss_pred ceEEEEEEecChhhHHHHHHHHHhhcCCCCeEEEEEeeccC-Cc------ccc---------chhHHHHhhhcccCcceE
Q 011660 22 KRTVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVEEQN-DT------LDL---------NTFHIHEDLCKSKKVDFL 85 (480)
Q Consensus 22 ~~~v~v~~~~~~~~~~~l~wal~~~~~~~d~v~~~hv~~~~-~~------~~~---------~~~~~~~~~c~~~~~~~~ 85 (480)
-++|||++|.+..|+.+|.||+.-....|..|++|||..+. .. ... +....++.++....++..
T Consensus 3 ~~~ILvavD~S~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 82 (144)
T PRK15118 3 YKHILIAVDLSPESKVLVEKAVSMARPYNAKVSLIHVDVNYSDLYTGLIDVNLGDMQKRISEETHHALTELSTNAGYPIT 82 (144)
T ss_pred ceEEEEEccCChhHHHHHHHHHHHHHhhCCEEEEEEEccChhhhhhhhhhcchHHHHHHHHHHHHHHHHHHHHhCCCCce
Confidence 37899999999999999999999776778899999994221 10 000 001334555655556654
Q ss_pred EEEE-ecCchhhHHHHHHhhhcceEEEeecccc--CCCchhHHHHhhhcCCCCceEEEE
Q 011660 86 VKVC-IGDSYITELSNQVRISYATILALGCSLS--GLKDSEVLTRCLRALPPACTILVM 141 (480)
Q Consensus 86 ~~v~-~~~~~~~~~v~eak~~~~~~l~lg~~~~--~~~~~~v~~~c~~~~~~~c~v~~~ 141 (480)
..+. .| +...+|+++|+...++.||+|.... +.-.+ ++++.+++.+ |.|+.+
T Consensus 83 ~~~~~~G-~p~~~I~~~a~~~~~DLIV~Gs~~~~~~~lgS-va~~v~~~a~--~pVLvv 137 (144)
T PRK15118 83 ETLSGSG-DLGQVLVDAIKKYDMDLVVCGHHQDFWSKLMS-SARQLINTVH--VDMLIV 137 (144)
T ss_pred EEEEEec-CHHHHHHHHHHHhCCCEEEEeCcccHHHHHHH-HHHHHHhhCC--CCEEEe
Confidence 3344 55 4577999999999999999999854 11124 9999999888 666554
|
|
| >cd00293 USP_Like Usp: Universal stress protein family | Back alignment and domain information |
|---|
Probab=98.32 E-value=6.6e-06 Score=70.00 Aligned_cols=107 Identities=15% Similarity=0.148 Sum_probs=84.0
Q ss_pred EEEEEEecChhhHHHHHHHHHhhcCCCCeEEEEEeeccCCccc------c-----chhHHHHhhhcccCcceEEEEEecC
Q 011660 24 TVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVEEQNDTLD------L-----NTFHIHEDLCKSKKVDFLVKVCIGD 92 (480)
Q Consensus 24 ~v~v~~~~~~~~~~~l~wal~~~~~~~d~v~~~hv~~~~~~~~------~-----~~~~~~~~~c~~~~~~~~~~v~~~~ 92 (480)
+|+|+++.+..++.++.||+...-+.+..|++|||..+..... . ..+..+...|...++++...+..|.
T Consensus 1 ~ilv~i~~~~~~~~~l~~a~~~a~~~~~~i~~l~v~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 80 (130)
T cd00293 1 RILVAVDGSEESERALRWAARLARRLGAELVLLHVVDPPPSSAAELAELLEEEARALLEALREALAEAGVKVETVVLEGD 80 (130)
T ss_pred CEEEEeCCCHHHHHHHHHHHHHHHhcCCEEEEEEEecCCCCcchhHHHHHHHHHHHHHHHHHHHHhcCCCceEEEEecCC
Confidence 5899999999999999999999999999999999986543210 1 2235556667777888888888887
Q ss_pred chhhHHHHHHhhhcceEEEeeccccCC----CchhHHHHhhhc
Q 011660 93 SYITELSNQVRISYATILALGCSLSGL----KDSEVLTRCLRA 131 (480)
Q Consensus 93 ~~~~~~v~eak~~~~~~l~lg~~~~~~----~~~~v~~~c~~~ 131 (480)
. .++|+++++...++.||+|.++... ..+.++++-+++
T Consensus 81 ~-~~~i~~~~~~~~~dlvvig~~~~~~~~~~~~~~~~~~ll~~ 122 (130)
T cd00293 81 P-AEAILEAAEELGADLIVMGSRGRSGLRRLLLGSVAERVLRH 122 (130)
T ss_pred C-HHHHHHHHHHcCCCEEEEcCCCCCccceeeeccHHHHHHhC
Confidence 6 8899999999999999999886521 123366777666
|
The universal stress protein Usp is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. Usp enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. The crystal structure of Haemophilus influenzae Usp reveals an alpha/beta fold similar to that of the Methanococcus jannaschii MJ0577 protein, which binds ATP, athough Usp lacks ATP-binding activity. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.29 E-value=5.8e-08 Score=102.21 Aligned_cols=182 Identities=21% Similarity=0.192 Sum_probs=131.3
Q ss_pred CCCceeecccCceEEEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCC-eeeEEEEEecCCeeEEEEeccCCC
Q 011660 254 FSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHEN-IVRIIGYCHSKEMYAIVYNLLNGS 332 (480)
Q Consensus 254 f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~~~~~~lV~e~~~Gs 332 (480)
+...+-+++|+++++++.+..-.+....+.+... ....-++++|.+++||| .+..++-++.++..+++++++.+.
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~~----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~ 319 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTG 319 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhheeceeeccc----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCC
Confidence 3344457899999999876544444445655433 45667899999999999 777777788888999999999543
Q ss_pred --HHHHH--H--hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccC
Q 011660 333 --LKQYL--K--QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSEN 406 (480)
Q Consensus 333 --L~~~l--~--~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~ 406 (480)
...-+ . .+...+...+...-.++|+|+|+. .=+|+| ||+..++ ..++.||+.+..+.. .
T Consensus 320 rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~~--~~~~~~~~v~~~L~~------~ 384 (829)
T KOG0576|consen 320 RSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSEE--EVKLLDFAVPPQLTR------T 384 (829)
T ss_pred ccccccCChhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----ccccccc--ccccccccCCcccCc------c
Confidence 11111 0 122233334455667789999977 458888 9988875 689999998754333 2
Q ss_pred ccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 011660 407 VKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQT 454 (480)
Q Consensus 407 ~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~ 454 (480)
....+..+|+.|+|||+...+.++.+.|.|++|+-..+|--|-+|-..
T Consensus 385 ~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 385 MKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred cccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 245577899999999999999999999999999877777777666443
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.29 E-value=1.7e-05 Score=74.59 Aligned_cols=130 Identities=16% Similarity=0.192 Sum_probs=96.0
Q ss_pred ecccCceEEEEEEecCCcEEEEEEecc----C---CccHHHHHHHHHHHhcCCCC--CeeeEEEEEe-c----CCeeEEE
Q 011660 260 IGQGGNSKVYRTNHVDGQVAAVKVLKC----T---NWSEEEVLREVELLSSIKHE--NIVRIIGYCH-S----KEMYAIV 325 (480)
Q Consensus 260 LG~G~fg~Vy~~~~~~g~~vAvK~~~~----~---~~~~~~~~~Ei~il~~l~Hp--nIv~l~~~~~-~----~~~~~lV 325 (480)
-|+||.+-|++..+. |+.+-+|.-.. + +.....|.+|...|..|..- .+.++. ++. . .-..+||
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 467999999998764 44677776531 1 33456799999999988532 244444 332 1 1246788
Q ss_pred EeccC--CCHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCc--eEEeeecccc
Q 011660 326 YNLLN--GSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHH--PQLSDFGAAM 395 (480)
Q Consensus 326 ~e~~~--GsL~~~l~~-----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~--~kL~DFGla~ 395 (480)
+|-++ -+|.+++.+ .+......+..+++.++.-||.. |+.|+|+-+.||+++.+ +. +.++||--++
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~-g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTE-GKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCC-CCeeEEEEEhhccc
Confidence 89886 579998854 34556678999999999999999 99999999999999855 45 8999998664
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.28 E-value=6.7e-06 Score=87.49 Aligned_cols=141 Identities=21% Similarity=0.245 Sum_probs=87.6
Q ss_pred cCCCCceeecccCceEEEEEEecCCcEEEEEEeccCCc---------------------------cH----H--------
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNW---------------------------SE----E-------- 292 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~---------------------------~~----~-------- 292 (480)
.+|+. ..|+.++-|+||+|...+|+.||||+.+..-. .. +
T Consensus 126 ~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ 204 (517)
T COG0661 126 SEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLRE 204 (517)
T ss_pred HHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHH
Confidence 34443 57999999999999999999999999753210 00 0
Q ss_pred --HHHHHHHHHhcC-----CCCCeeeEEEEEecCCeeEEEEeccCC-CHHHH--HHhCCHHHHHHHHHHHHHH-HHHHHh
Q 011660 293 --EVLREVELLSSI-----KHENIVRIIGYCHSKEMYAIVYNLLNG-SLKQY--LKQLKWNERMDVAIGVAKA-LEYLHH 361 (480)
Q Consensus 293 --~~~~Ei~il~~l-----~HpnIv~l~~~~~~~~~~~lV~e~~~G-sL~~~--l~~~~~~~~~~i~~~ia~a-L~yLH~ 361 (480)
++.+|..-+.++ +.|++.---=|++-.+.-.++|||++| .+.+. ++.-..+ ...++..++++ +..+-.
T Consensus 205 ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d-~k~ia~~~~~~f~~q~~~ 283 (517)
T COG0661 205 ELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGID-RKELAELLVRAFLRQLLR 283 (517)
T ss_pred HhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCC-HHHHHHHHHHHHHHHHHh
Confidence 134455555444 234432222223333566899999987 35544 3331111 23333333332 222222
Q ss_pred CCCCCeEeccCCCCCEEEecCCCceEEeeeccccccc
Q 011660 362 TCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (480)
Q Consensus 362 ~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~ 398 (480)
. |++|.|..|.||+++.+ +.+.+.|||+.....
T Consensus 284 d---gffHaDpHpGNi~v~~~-g~i~~lDfGi~g~l~ 316 (517)
T COG0661 284 D---GFFHADPHPGNILVRSD-GRIVLLDFGIVGRLD 316 (517)
T ss_pred c---CccccCCCccceEEecC-CcEEEEcCcceecCC
Confidence 3 99999999999999999 789999999975433
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.25 E-value=1e-05 Score=77.31 Aligned_cols=147 Identities=20% Similarity=0.245 Sum_probs=99.4
Q ss_pred cCHHHHhhhhcCCCCcee---ecccCceEEEEEEecCCcEEEEEEeccCCccH--------------------H-----H
Q 011660 242 FTSQELCHLTHNFSPKML---IGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSE--------------------E-----E 293 (480)
Q Consensus 242 ~~~~el~~~~~~f~~~~~---LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~--------------------~-----~ 293 (480)
.+.+.+..+.++..+..+ |+.|.-+.||+|...++..+|+|+.+.+.... . -
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 345556666666666554 55788889999988889999999986432111 1 1
Q ss_pred HHHHHHHHhcCC--CCCeeeEEEEEecCCeeEEEEeccCCC--HHHHHHhC--CHHHHHHHHHHHHHHHHHHHh-CCCCC
Q 011660 294 VLREVELLSSIK--HENIVRIIGYCHSKEMYAIVYNLLNGS--LKQYLKQL--KWNERMDVAIGVAKALEYLHH-TCDPP 366 (480)
Q Consensus 294 ~~~Ei~il~~l~--HpnIv~l~~~~~~~~~~~lV~e~~~Gs--L~~~l~~~--~~~~~~~i~~~ia~aL~yLH~-~~~~~ 366 (480)
...|..-|+++. +-.+.+.+++.. -.+||||++.. -.-.|+.. ...+...+..++++.+.-|-. . +
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a---~ 187 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEA---G 187 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhc---C
Confidence 356777787773 455666666653 36899999533 22222222 222455566677777766655 4 9
Q ss_pred eEeccCCCCCEEEecCCCceEEeeecccccc
Q 011660 367 IIHRDVKSSNILLSENFHHPQLSDFGAAMVH 397 (480)
Q Consensus 367 IiHrDlKp~NILl~~~~~~~kL~DFGla~~~ 397 (480)
+||+||..=|||+.+ +.+.++|||-|...
T Consensus 188 LVHgDLSEyNiL~~~--~~p~iID~~QaV~~ 216 (268)
T COG1718 188 LVHGDLSEYNILVHD--GEPYIIDVSQAVTI 216 (268)
T ss_pred cccccchhhheEEEC--CeEEEEECcccccc
Confidence 999999999999995 47999999988543
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.24 E-value=1.5e-05 Score=75.36 Aligned_cols=137 Identities=20% Similarity=0.221 Sum_probs=80.3
Q ss_pred eeecccCceEEEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhcCCCC--CeeeEEEEEe---cCCeeEEEEeccCCC
Q 011660 258 MLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHE--NIVRIIGYCH---SKEMYAIVYNLLNGS 332 (480)
Q Consensus 258 ~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~~~~~---~~~~~~lV~e~~~Gs 332 (480)
+.|+.|..+.||+....+ ..+++|..... .....+..|..+++.+... .+.+++.++. .....+++|+++.|.
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~ 80 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR 80 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence 568999999999998866 68999987654 3456788999998887432 3566776543 233568899998764
Q ss_pred -HHH----------------HHH---hC-------CHHH---------HH-----H-------HHHHHHH-HHHHHHh--
Q 011660 333 -LKQ----------------YLK---QL-------KWNE---------RM-----D-------VAIGVAK-ALEYLHH-- 361 (480)
Q Consensus 333 -L~~----------------~l~---~~-------~~~~---------~~-----~-------i~~~ia~-aL~yLH~-- 361 (480)
+.. .+. +. .... .. . ....+.+ .+..++.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (239)
T PF01636_consen 81 PLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALL 160 (239)
T ss_dssp EHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhh
Confidence 433 110 01 0000 00 0 0112222 3333432
Q ss_pred --CCCCCeEeccCCCCCEEEecCCCceEEeeeccccc
Q 011660 362 --TCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMV 396 (480)
Q Consensus 362 --~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~ 396 (480)
.....++|+|+.|.|||++++.+.+-|+||+.+.+
T Consensus 161 ~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 161 PKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred ccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 13347999999999999993324567999998743
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.20 E-value=3.8e-05 Score=71.93 Aligned_cols=127 Identities=25% Similarity=0.407 Sum_probs=92.0
Q ss_pred ceeecccCceEEEEEEecCCcEEEEEEeccCC-----------------ccHHHHHHHHHHHhcCC------CCCeeeEE
Q 011660 257 KMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTN-----------------WSEEEVLREVELLSSIK------HENIVRII 313 (480)
Q Consensus 257 ~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~-----------------~~~~~~~~Ei~il~~l~------HpnIv~l~ 313 (480)
..+||+|+.=.||. |.+.....||+.+... ...++..+|+.-...+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 45799999999996 4556667789887655 22356677777665555 78899999
Q ss_pred EEEecCCeeEEEEecc---CC----CHHHHHHhCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCC--C
Q 011660 314 GYCHSKEMYAIVYNLL---NG----SLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENF--H 384 (480)
Q Consensus 314 ~~~~~~~~~~lV~e~~---~G----sL~~~l~~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~--~ 384 (480)
|+.+++-..-+|+|.+ +| +|.++++.-.... .+...+-+-..||-.. +|+.+|++|.||++.... .
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~--~~~~~L~~f~~~l~~~---~Iv~~dl~~~NIv~~~~~~~~ 158 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEGGLTE--ELRQALDEFKRYLLDH---HIVIRDLNPHNIVVQRRDSGE 158 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcCCccH--HHHHHHHHHHHHHHHc---CCeecCCCcccEEEEecCCCc
Confidence 9999999889999887 34 5888886533333 3444555566778777 899999999999996542 1
Q ss_pred -ceEEee
Q 011660 385 -HPQLSD 390 (480)
Q Consensus 385 -~~kL~D 390 (480)
.+.|+|
T Consensus 159 ~~lvlID 165 (199)
T PF10707_consen 159 FRLVLID 165 (199)
T ss_pred eEEEEEe
Confidence 456665
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.17 E-value=3.3e-07 Score=97.60 Aligned_cols=103 Identities=24% Similarity=0.452 Sum_probs=76.7
Q ss_pred HHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccc----ccCccccccccCCCcccccccc
Q 011660 350 IGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV----SENVKPVNVVGTFGYLAPEYMM 425 (480)
Q Consensus 350 ~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~----~~~~~~~~~~GT~~y~APE~~~ 425 (480)
.+++.||.|+|... ++||++|.|++|.++.+ +..||+.|+.+......... .......-..-...|.|||++.
T Consensus 106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~-~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNAN-GDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hcccchhhhhccCc--ceeecccchhheeeccC-cceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 35569999999875 89999999999999998 78999999987544331110 0111111122356899999999
Q ss_pred CCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 011660 426 YGKVDEKIDVYSYGVVLLELIT-GKEAIQTN 455 (480)
Q Consensus 426 ~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~ 455 (480)
+...+.++|+||+||++|-++. |+..+...
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~ 213 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAAN 213 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhcc
Confidence 9888999999999999999994 55555544
|
|
| >cd01988 Na_H_Antiporter_C The C-terminal domain of a subfamily of Na+ /H+ antiporter existed in bacteria and archea | Back alignment and domain information |
|---|
Probab=98.17 E-value=3.2e-05 Score=66.65 Aligned_cols=116 Identities=14% Similarity=0.210 Sum_probs=88.4
Q ss_pred EEEEEEecChhhHHHHHHHHHhhcCCCCeEEEEEeeccCCccc------c-----chhHHHHhhhcccCcceEEEEEecC
Q 011660 24 TVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVEEQNDTLD------L-----NTFHIHEDLCKSKKVDFLVKVCIGD 92 (480)
Q Consensus 24 ~v~v~~~~~~~~~~~l~wal~~~~~~~d~v~~~hv~~~~~~~~------~-----~~~~~~~~~c~~~~~~~~~~v~~~~ 92 (480)
+|||.++.+..+..+|.||..-.-+.+=.|++|||.+...... . ..+.....++....++++..+..+.
T Consensus 1 ~ILv~vd~s~~~~~~l~~a~~la~~~~~~v~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~ 80 (132)
T cd01988 1 RILVPVANPNTARDLLELAAALARAQNGEIIPLNVIEVPNHSSPSQLEVNVQRARKLLRQAERIAASLGVPVHTIIRIDH 80 (132)
T ss_pred CEEEecCCchhHHHHHHHHHHHhhcCCCeEEEEEEEecCCCCCcchhHHHHHHHHHHHHHHHHHhhhcCCceEEEEEecC
Confidence 5999999999999999999998888888999999996543211 0 1224445666666677777776666
Q ss_pred chhhHHHHHHhhhcceEEEeeccccCCC----chhHHHHhhhcCCCCceEEEE
Q 011660 93 SYITELSNQVRISYATILALGCSLSGLK----DSEVLTRCLRALPPACTILVM 141 (480)
Q Consensus 93 ~~~~~~v~eak~~~~~~l~lg~~~~~~~----~~~v~~~c~~~~~~~c~v~~~ 141 (480)
+....|.+.|+...++.||+|....... .+.++.+.+++.+ |.|+.+
T Consensus 81 ~~~~~I~~~a~~~~~dlIV~G~~~~~~~~~~~lGs~~~~v~~~~~--~pvlvv 131 (132)
T cd01988 81 DIASGILRTAKERQADLIIMGWHGSTSLRDRLFGGVIDQVLESAP--CDVAVV 131 (132)
T ss_pred CHHHHHHHHHHhcCCCEEEEecCCCCCccceecCchHHHHHhcCC--CCEEEe
Confidence 7888999999999999999999976221 2348899998877 666543
|
Na+/H+ exchange proteins eject protons from cells, effectively eliminating excess acid from actively metabolising cells. Na+ /H+ exchange activity is also crucial for the regulation of cell volume, and for the reabsorption of NaCl across renal, intestinal, and other epithelia. These antiports exchange Na+ for H+ in an electroneutral manner, and this activity is carried out by a family of Na+ /H+ exchangers, or NHEs, which are known to be present in both prokaryotic and eukaryotic cells. These exchangers are highly-regulated (glyco)phosphoproteins, which, based on their primary structure, appear to contain 10-12 membrane-spanning regions (M) at the N-terminus and a large cytoplasmic region at the C-terminus. The transmembrane regions M3-M12 share identity wit h other members of the family. The M6 and M7 regions are highly conserved. Thus, this is thought to be the regio |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.10 E-value=4.7e-05 Score=71.91 Aligned_cols=135 Identities=19% Similarity=0.211 Sum_probs=87.8
Q ss_pred hhcCCCCceeecccCceEEEEEEecCCcEEEEEEeccCCccHHH----------HHHHHHHHhcCCC---CCeeeEEEE-
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEE----------VLREVELLSSIKH---ENIVRIIGY- 315 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~----------~~~Ei~il~~l~H---pnIv~l~~~- 315 (480)
+..+|...+++-......|.+-+. +|+.+++|..+......+. ..+++..+.++.. ..+..++-.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 356788888888877777777665 6789999988754432222 2234443333321 122222211
Q ss_pred ----EecCCeeEEEEeccCC-CHHHHHHhCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEee
Q 011660 316 ----CHSKEMYAIVYNLLNG-SLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSD 390 (480)
Q Consensus 316 ----~~~~~~~~lV~e~~~G-sL~~~l~~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~D 390 (480)
+.-...++++|||++| .|.++. .++. .++..+.+++.-||.. |+.|+|..|.|++++++ .++++|
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~-~i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~--~i~iID 177 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIE-DIDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN--GIRIID 177 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccch-hcCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC--cEEEEE
Confidence 2222456789999977 354442 1222 2445677888999999 99999999999999977 499999
Q ss_pred ecccc
Q 011660 391 FGAAM 395 (480)
Q Consensus 391 FGla~ 395 (480)
|+..+
T Consensus 178 ~~~k~ 182 (229)
T PF06176_consen 178 TQGKR 182 (229)
T ss_pred Ccccc
Confidence 99763
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.07 E-value=5.1e-05 Score=73.20 Aligned_cols=70 Identities=19% Similarity=0.233 Sum_probs=50.5
Q ss_pred ecccCc-eEEEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhcCC-CCCeeeEEEEEecCCeeEEEEeccCCC
Q 011660 260 IGQGGN-SKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIK-HENIVRIIGYCHSKEMYAIVYNLLNGS 332 (480)
Q Consensus 260 LG~G~f-g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~e~~~Gs 332 (480)
|..|.. ..||+.... +..+.+|+..... ..++.+|+++++.+. +--+.+++++...++..++||+++.|.
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~ 77 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGV 77 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCc
Confidence 445555 789998764 4678888875443 345778999988874 344667888887766788999999763
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PRK09982 universal stress protein UspD; Provisional | Back alignment and domain information |
|---|
Probab=98.05 E-value=4.2e-05 Score=67.64 Aligned_cols=115 Identities=9% Similarity=0.125 Sum_probs=80.4
Q ss_pred eEEEEEEecChhhHHHHHHHHHhhcCCCCeEEEEEeeccCCc-----c--c---c-chh-----HHHHhhhcc-cCcceE
Q 011660 23 RTVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVEEQNDT-----L--D---L-NTF-----HIHEDLCKS-KKVDFL 85 (480)
Q Consensus 23 ~~v~v~~~~~~~~~~~l~wal~~~~~~~d~v~~~hv~~~~~~-----~--~---~-~~~-----~~~~~~c~~-~~~~~~ 85 (480)
++|||++|.+..|+.+|.||+...-+.|-.|++|||.++... . . . ... ..++.+... ....++
T Consensus 4 k~ILvavD~S~~s~~al~~A~~lA~~~~a~l~llhV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 83 (142)
T PRK09982 4 KHIGVAISGNEEDALLVNKALELARHNDAHLTLIHIDDGLSELYPGIYFPATEDILQLLKNKSDNKLYKLTKNIQWPKTK 83 (142)
T ss_pred eEEEEEecCCcchHHHHHHHHHHHHHhCCeEEEEEEccCcchhchhhhccchHHHHHHHHHHHHHHHHHHHHhcCCCcce
Confidence 689999999999999999999988899999999999853210 0 0 0 000 122333321 234577
Q ss_pred EEEEecCchhhHHHHHHhhhcceEEEeeccccC--CCchhHHHHhhhcCCCCceEEEE
Q 011660 86 VKVCIGDSYITELSNQVRISYATILALGCSLSG--LKDSEVLTRCLRALPPACTILVM 141 (480)
Q Consensus 86 ~~v~~~~~~~~~~v~eak~~~~~~l~lg~~~~~--~~~~~v~~~c~~~~~~~c~v~~~ 141 (480)
..+..| +...+|++.|+..+|+.||+|..++. ...+ ++.+.+++.+ |-|+.+
T Consensus 84 ~~v~~G-~p~~~I~~~A~~~~aDLIVmG~~~~~~~~~~~-va~~V~~~s~--~pVLvv 137 (142)
T PRK09982 84 LRIERG-EMPETLLEIMQKEQCDLLVCGHHHSFINRLMP-AYRGMINKMS--ADLLIV 137 (142)
T ss_pred EEEEec-CHHHHHHHHHHHcCCCEEEEeCChhHHHHHHH-HHHHHHhcCC--CCEEEe
Confidence 777777 55789999999999999999976331 1114 8888888765 444443
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.03 E-value=2.8e-05 Score=82.66 Aligned_cols=133 Identities=18% Similarity=0.187 Sum_probs=82.9
Q ss_pred eeecccCceEEEEEEecCCcEEEEEEeccCCccH----------------------------H----------HHHHHHH
Q 011660 258 MLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSE----------------------------E----------EVLREVE 299 (480)
Q Consensus 258 ~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~----------------------------~----------~~~~Ei~ 299 (480)
+.||..+.|.||+|+..+|+.||||+-+..-... + +|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 4799999999999999999999999965321100 0 1344444
Q ss_pred HHh----cCCCCC------eeeEEEEEecCCeeEEEEeccCC----CHHHHHHh--CCHHHHHHHHHHHHHHHHHHHhCC
Q 011660 300 LLS----SIKHEN------IVRIIGYCHSKEMYAIVYNLLNG----SLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTC 363 (480)
Q Consensus 300 il~----~l~Hpn------Iv~l~~~~~~~~~~~lV~e~~~G----sL~~~l~~--~~~~~~~~i~~~ia~aL~yLH~~~ 363 (480)
-.. .+.|-+ |.+++-.+ .....++|||++| |+ ++|++ .+...+ +..+.++ |++...
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl-~~i~~~gi~~~~i---~~~l~~~--~~~qIf 318 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDL-DAIDKRGISPHDI---LNKLVEA--YLEQIF 318 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCH-HHHHHcCCCHHHH---HHHHHHH--HHHHHH
Confidence 322 234444 33333222 3456899999976 34 44433 333333 3333332 222222
Q ss_pred CCCeEeccCCCCCEEEec---CCCceEEeeeccccccc
Q 011660 364 DPPIIHRDVKSSNILLSE---NFHHPQLSDFGAAMVHH 398 (480)
Q Consensus 364 ~~~IiHrDlKp~NILl~~---~~~~~kL~DFGla~~~~ 398 (480)
.+|++|.|-.|.||++++ ....+.+-|||+.....
T Consensus 319 ~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 319 KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred hcCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 239999999999999994 23689999999975543
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.01 E-value=6.6e-05 Score=85.27 Aligned_cols=76 Identities=16% Similarity=0.270 Sum_probs=55.8
Q ss_pred ceeecccCceEEEEEEecCC---cEEEEEEeccCC--ccHHHHHHHHHHHhcCC-CCCe--eeEEEEEecC---CeeEEE
Q 011660 257 KMLIGQGGNSKVYRTNHVDG---QVAAVKVLKCTN--WSEEEVLREVELLSSIK-HENI--VRIIGYCHSK---EMYAIV 325 (480)
Q Consensus 257 ~~~LG~G~fg~Vy~~~~~~g---~~vAvK~~~~~~--~~~~~~~~Ei~il~~l~-HpnI--v~l~~~~~~~---~~~~lV 325 (480)
...++.|.+..+|+....++ ..+++|+..... .....+.+|.++|+.+. |+++ .+++.+|.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 45689999999999876553 467777764332 23356889999999995 6664 7888888764 357899
Q ss_pred EeccCCC
Q 011660 326 YNLLNGS 332 (480)
Q Consensus 326 ~e~~~Gs 332 (480)
||++.|.
T Consensus 123 ME~v~G~ 129 (822)
T PLN02876 123 MEYLEGR 129 (822)
T ss_pred EEecCCc
Confidence 9999774
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.01 E-value=2.9e-05 Score=72.24 Aligned_cols=96 Identities=26% Similarity=0.409 Sum_probs=78.3
Q ss_pred HHHHHHhcCCC-CCeeeEEEEEecCCeeEEEEeccC-CCH-------HHHHHhCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 011660 296 REVELLSSIKH-ENIVRIIGYCHSKEMYAIVYNLLN-GSL-------KQYLKQLKWNERMDVAIGVAKALEYLHHTCDPP 366 (480)
Q Consensus 296 ~Ei~il~~l~H-pnIv~l~~~~~~~~~~~lV~e~~~-GsL-------~~~l~~~~~~~~~~i~~~ia~aL~yLH~~~~~~ 366 (480)
.|.-+|+.+.+ +++++++|+| +.+ ++.||.+ +++ .++ ...+|..+.+||.++++.+++|++.....
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~C---G~~-~v~E~~~~~~~~~~~~~l~~~-~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSC---GRF-YVVEYVGAGSLYGIYRPLSQF-LQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeEC---CCE-EEEEeecCccccccccccccc-cccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 57888898976 6999999999 444 4556664 544 333 35799999999999999999999876667
Q ss_pred eEeccCCCCCEEEecCCCceEEeeecccccc
Q 011660 367 IIHRDVKSSNILLSENFHHPQLSDFGAAMVH 397 (480)
Q Consensus 367 IiHrDlKp~NILl~~~~~~~kL~DFGla~~~ 397 (480)
+.-.|++++|+-++++ +++|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~-~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDD-GRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCC-CcEEEEechhcchh
Confidence 9999999999999988 68999999987443
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK10116 universal stress protein UspC; Provisional | Back alignment and domain information |
|---|
Probab=97.95 E-value=0.00011 Score=64.63 Aligned_cols=114 Identities=6% Similarity=0.120 Sum_probs=80.8
Q ss_pred ceEEEEEEecChhhHHHHHHHHHhhcCCCCeEEEEEeeccCCcc-cc-----chh---------HHHHhhhcccCcceE-
Q 011660 22 KRTVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVEEQNDTL-DL-----NTF---------HIHEDLCKSKKVDFL- 85 (480)
Q Consensus 22 ~~~v~v~~~~~~~~~~~l~wal~~~~~~~d~v~~~hv~~~~~~~-~~-----~~~---------~~~~~~c~~~~~~~~- 85 (480)
-++|||++|.+..+..+|.+|+.-..+-|..|++||+....... .. ..+ ..++.++..-.++..
T Consensus 3 ~~~ILv~~D~s~~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 82 (142)
T PRK10116 3 YSNILVAVAVTPESQQLLAKAVSIARPVNGKISLITLASDPEMYNQFAAPMLEDLRSVMQEETQSFLDKLIQDADYPIEK 82 (142)
T ss_pred CceEEEEccCCcchHHHHHHHHHHHHHhCCEEEEEEEccCcccchhhhHHHHHHHHHHHHHHHHHHHHHHHHhcCCCeEE
Confidence 37999999999999999999999877778899999997543211 00 000 223455555445544
Q ss_pred EEEEecCchhhHHHHHHhhhcceEEEeecccc----CCCchhHHHHhhhcCCCCceE
Q 011660 86 VKVCIGDSYITELSNQVRISYATILALGCSLS----GLKDSEVLTRCLRALPPACTI 138 (480)
Q Consensus 86 ~~v~~~~~~~~~~v~eak~~~~~~l~lg~~~~----~~~~~~v~~~c~~~~~~~c~v 138 (480)
+.+..| +...++++.|+...++.||+|++.. +. .+ ++++++++.+-...|
T Consensus 83 ~~~~~G-~~~~~I~~~a~~~~~DLiV~g~~~~~~~~~~-~s-~a~~v~~~~~~pVLv 136 (142)
T PRK10116 83 TFIAYG-ELSEHILEVCRKHHFDLVICGNHNHSFFSRA-SC-SAKRVIASSEVDVLL 136 (142)
T ss_pred EEEecC-CHHHHHHHHHHHhCCCEEEEcCCcchHHHHH-HH-HHHHHHhcCCCCEEE
Confidence 333455 5567999999999999999999965 22 24 889999987743333
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00016 Score=65.62 Aligned_cols=127 Identities=18% Similarity=0.228 Sum_probs=86.3
Q ss_pred CceeecccCceEEEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCee-eEEEEEecCCeeEEEEeccCC-CH
Q 011660 256 PKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIV-RIIGYCHSKEMYAIVYNLLNG-SL 333 (480)
Q Consensus 256 ~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv-~l~~~~~~~~~~~lV~e~~~G-sL 333 (480)
..+.|++|++|.||++.+. |..+|+|+-+ .+.....+..|.++|..++.-++. +++.|..+ ++.|||..| .|
T Consensus 26 v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr-~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~~L 99 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWR-GGEVALKVRR-RDSPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGRPL 99 (201)
T ss_pred hhhhhhcccccEEEEeecc-CceEEEEEec-CCcchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCcch
Confidence 3456999999999999885 5588888765 344567789999999999876664 45655544 344999977 67
Q ss_pred HHHHHhCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCC-CCCEEEecCCCceEEeeeccccc
Q 011660 334 KQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVK-SSNILLSENFHHPQLSDFGAAMV 396 (480)
Q Consensus 334 ~~~l~~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlK-p~NILl~~~~~~~kL~DFGla~~ 396 (480)
.+.-...+... ...+++.-.-|-.. ||-|..|. |...+|..+ +.+.|+||.-|+.
T Consensus 100 ~~~~~~~~rk~----l~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~-~~~~iIDFd~At~ 155 (201)
T COG2112 100 GKLEIGGDRKH----LLRVLEKAYKLDRL---GIEHGELSRPWKNVLVND-RDVYIIDFDSATF 155 (201)
T ss_pred hhhhhcccHHH----HHHHHHHHHHHHHh---ccchhhhcCCceeEEecC-CcEEEEEccchhh
Confidence 66544333233 33444443344455 88888886 444444444 3799999999863
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00014 Score=69.88 Aligned_cols=69 Identities=20% Similarity=0.284 Sum_probs=44.0
Q ss_pred eeecccCce-EEEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhcCCCC---CeeeEEEEEecCC---eeEEEEeccC
Q 011660 258 MLIGQGGNS-KVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHE---NIVRIIGYCHSKE---MYAIVYNLLN 330 (480)
Q Consensus 258 ~~LG~G~fg-~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~Hp---nIv~l~~~~~~~~---~~~lV~e~~~ 330 (480)
..|+.|+.. .||+. +..+++|+.+. ......+.+|.++|..+... .+..+++.....+ ..+++|+++.
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~-~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~ 77 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA-AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE 77 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc-cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence 457777776 58975 23567787654 33455789999999887532 3445555543322 3478899986
Q ss_pred C
Q 011660 331 G 331 (480)
Q Consensus 331 G 331 (480)
|
T Consensus 78 G 78 (235)
T cd05155 78 G 78 (235)
T ss_pred C
Confidence 6
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00041 Score=64.80 Aligned_cols=124 Identities=23% Similarity=0.396 Sum_probs=87.9
Q ss_pred cCCCCceeecccCc-eEEEEEEecCCcEEEEEEecc---CC-------c------------cHHHHHHHHHHHhcC---C
Q 011660 252 HNFSPKMLIGQGGN-SKVYRTNHVDGQVAAVKVLKC---TN-------W------------SEEEVLREVELLSSI---K 305 (480)
Q Consensus 252 ~~f~~~~~LG~G~f-g~Vy~~~~~~g~~vAvK~~~~---~~-------~------------~~~~~~~Ei~il~~l---~ 305 (480)
.+++..+.||.|.- |.||+++. +|+.||+|+++. .. . ....|..|.+...+| +
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 67889999999999 99999987 688999999421 00 0 012367788877666 4
Q ss_pred CCCe--eeEEEEEecC------------------CeeEEEEeccCCCHHHHHHhCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 011660 306 HENI--VRIIGYCHSK------------------EMYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDP 365 (480)
Q Consensus 306 HpnI--v~l~~~~~~~------------------~~~~lV~e~~~GsL~~~l~~~~~~~~~~i~~~ia~aL~yLH~~~~~ 365 (480)
+.++ ++.+||..-. ..+.||.||....- .+. ..-+.+|.+-|.-+|..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----~~~----~~~~~~~~~dl~~~~k~--- 183 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----PLQ----IRDIPQMLRDLKILHKL--- 183 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----ccc----hhHHHHHHHHHHHHHHC---
Confidence 5566 8999987211 13567888774432 111 12245677777888988
Q ss_pred CeEeccCCCCCEEEecCCCceEEeeeccc
Q 011660 366 PIIHRDVKSSNILLSENFHHPQLSDFGAA 394 (480)
Q Consensus 366 ~IiHrDlKp~NILl~~~~~~~kL~DFGla 394 (480)
||+-+|+++.|.. + -+|+|||.+
T Consensus 184 gI~~~Dv~~~ny~---~---G~lvDfs~~ 206 (207)
T PF13095_consen 184 GIVPRDVKPRNYR---G---GKLVDFSSS 206 (207)
T ss_pred CeeeccCcccccc---C---CEEEecccC
Confidence 9999999999987 2 489999964
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00097 Score=67.04 Aligned_cols=135 Identities=16% Similarity=0.246 Sum_probs=76.2
Q ss_pred eeecccCceEEEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCC--eeeEEE------EEecCCeeEEEEecc
Q 011660 258 MLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHEN--IVRIIG------YCHSKEMYAIVYNLL 329 (480)
Q Consensus 258 ~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~------~~~~~~~~~lV~e~~ 329 (480)
+.|+.|....+|+.+..+| .+++|+.. ....+.+..|..++..|...+ +.+.+. +....+..+++++++
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~--~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~l 104 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFE--RLTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTFL 104 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEec--cCChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEec
Confidence 3466777789999876555 68889876 223455556677776663221 333332 122345678899998
Q ss_pred CCC-H-----------HHHH-------HhCC----------H-HHHHH------------HH-HHHHHHHHHHHhC----
Q 011660 330 NGS-L-----------KQYL-------KQLK----------W-NERMD------------VA-IGVAKALEYLHHT---- 362 (480)
Q Consensus 330 ~Gs-L-----------~~~l-------~~~~----------~-~~~~~------------i~-~~ia~aL~yLH~~---- 362 (480)
.|. + -+.| +.+. | .+... .. ..+...+..+...
T Consensus 105 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 184 (319)
T PRK05231 105 EGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWPA 184 (319)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccccc
Confidence 663 1 1111 1110 1 11110 01 1111222333211
Q ss_pred CCCCeEeccCCCCCEEEecCCCceEEeeeccccc
Q 011660 363 CDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMV 396 (480)
Q Consensus 363 ~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~ 396 (480)
...++||+|+.|.||+++.+ ...-|+||+.+..
T Consensus 185 lp~~liHgD~~~~Nil~~~~-~~~~iIDf~~~~~ 217 (319)
T PRK05231 185 LPRGVIHADLFRDNVLFEGD-RLSGFIDFYFACN 217 (319)
T ss_pred CCcccCCCCCCCCcEEEECC-ceEEEEecccccC
Confidence 24489999999999999876 4457999998854
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00059 Score=68.17 Aligned_cols=74 Identities=11% Similarity=0.080 Sum_probs=54.8
Q ss_pred CceeecccCceEEEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhcCCC---CCeeeEEEEEec---CCeeEEEEecc
Q 011660 256 PKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKH---ENIVRIIGYCHS---KEMYAIVYNLL 329 (480)
Q Consensus 256 ~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~H---pnIv~l~~~~~~---~~~~~lV~e~~ 329 (480)
..+.||.|..+.||+....+++ +++|..+ .......+..|.+.|+.+.. ..+.+++++|.. .+..++|||++
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~-~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i 95 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQGN-PMPLMAR-SFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERL 95 (297)
T ss_pred eeeecCCccceeEEEEEcCCCC-EEEEEec-ccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEecc
Confidence 3456999999999998765564 6677754 32244678999999998853 467888888754 35689999998
Q ss_pred CC
Q 011660 330 NG 331 (480)
Q Consensus 330 ~G 331 (480)
.|
T Consensus 96 ~G 97 (297)
T PRK10593 96 RG 97 (297)
T ss_pred CC
Confidence 65
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00082 Score=64.28 Aligned_cols=70 Identities=11% Similarity=0.186 Sum_probs=46.4
Q ss_pred eeecccCceEEEEEEecC--CcEEEEEEeccCCccHHHHHHHHHHHhcCCCC-CeeeEEEEEecCCeeEEEEeccCC
Q 011660 258 MLIGQGGNSKVYRTNHVD--GQVAAVKVLKCTNWSEEEVLREVELLSSIKHE-NIVRIIGYCHSKEMYAIVYNLLNG 331 (480)
Q Consensus 258 ~~LG~G~fg~Vy~~~~~~--g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~Hp-nIv~l~~~~~~~~~~~lV~e~~~G 331 (480)
+.|..|-...+|+....+ ++.+++|+........-+..+|..+++.+... -.+++++.+.. .++|||+.|
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l~e~i~G 76 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQN----GLIYEFIPG 76 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEEEEeeCC
Confidence 457788888999987654 67888997764332222345789899888533 34455554432 379999866
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00042 Score=68.83 Aligned_cols=136 Identities=19% Similarity=0.194 Sum_probs=83.1
Q ss_pred ceeecccCceEEEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhcCCCC--CeeeEEEE------EecCCeeEEEEec
Q 011660 257 KMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHE--NIVRIIGY------CHSKEMYAIVYNL 328 (480)
Q Consensus 257 ~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~~~------~~~~~~~~lV~e~ 328 (480)
.+.|..|....+|+.... +..+++|+... .....+..|++++..+.+. .+.+++.. ...++..++++++
T Consensus 19 i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~ 95 (296)
T cd05153 19 FEGISAGIENTNYFVTTD-SGRYVLTLFEK--VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEF 95 (296)
T ss_pred eecccCccccceEEEEeC-CCcEEEEEcCC--CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEe
Confidence 445777888899998654 44788898764 3456677888888887432 24454432 2334566889999
Q ss_pred cCCC-HH-----------HHH-------HhC----------CHHHHH----------HHHHHHHHHHHHHHh----CCCC
Q 011660 329 LNGS-LK-----------QYL-------KQL----------KWNERM----------DVAIGVAKALEYLHH----TCDP 365 (480)
Q Consensus 329 ~~Gs-L~-----------~~l-------~~~----------~~~~~~----------~i~~~ia~aL~yLH~----~~~~ 365 (480)
+.|. +. +.+ ..+ .|.... .....+..++.++.. ....
T Consensus 96 i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~ 175 (296)
T cd05153 96 LAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPR 175 (296)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCC
Confidence 8663 11 111 001 111110 011123344555553 1234
Q ss_pred CeEeccCCCCCEEEecCCCceEEeeeccccc
Q 011660 366 PIIHRDVKSSNILLSENFHHPQLSDFGAAMV 396 (480)
Q Consensus 366 ~IiHrDlKp~NILl~~~~~~~kL~DFGla~~ 396 (480)
+++|+|+.|.||+++++ +.+.|+||+.+..
T Consensus 176 ~l~HgD~~~~Nil~~~~-~~~~iIDfe~a~~ 205 (296)
T cd05153 176 GVIHADLFRDNVLFDGD-ELSGVIDFYFACT 205 (296)
T ss_pred cCCccCcCcccEEEeCC-ceEEEeehhhhcC
Confidence 79999999999999987 4568999998754
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK11175 universal stress protein UspE; Provisional | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.00067 Score=67.66 Aligned_cols=119 Identities=9% Similarity=0.075 Sum_probs=82.9
Q ss_pred ceEEEEEEecChhhHHHHHHHHHhhcCCCCeEEEEEeeccCCc--cc---c------------chhHHHHh---hhcccC
Q 011660 22 KRTVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVEEQNDT--LD---L------------NTFHIHED---LCKSKK 81 (480)
Q Consensus 22 ~~~v~v~~~~~~~~~~~l~wal~~~~~~~d~v~~~hv~~~~~~--~~---~------------~~~~~~~~---~c~~~~ 81 (480)
-++|||++|.+..+..+|.||+.-..+-|..+++|||..+... .. . ......+. .+...+
T Consensus 3 ~~~ILv~~D~s~~~~~al~~a~~lA~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 82 (305)
T PRK11175 3 YQNILVVIDPNQDDQPALRRAVYLAQRNGGKITAFLPIYDFSYEMTTLLSPDEREAMRQGVISQRTAWIREQAKPYLDAG 82 (305)
T ss_pred cceEEEEcCCCccccHHHHHHHHHHHhcCCCEEEEEeccCchhhhhcccchhHHHHHHHHHHHHHHHHHHHHHHHHhhcC
Confidence 3689999999999999999999976667789999998743210 00 0 00011233 334456
Q ss_pred cceEEEEEecCchhhHHHHHHhhhcceEEEeecccc----CCCchhHHHHhhhcCCCCceEEEEe
Q 011660 82 VDFLVKVCIGDSYITELSNQVRISYATILALGCSLS----GLKDSEVLTRCLRALPPACTILVMD 142 (480)
Q Consensus 82 ~~~~~~v~~~~~~~~~~v~eak~~~~~~l~lg~~~~----~~~~~~v~~~c~~~~~~~c~v~~~~ 142 (480)
+.++..+..+......|++.|+...++.||+|.... +...+.+..+.+++.+ |-|+.+.
T Consensus 83 ~~~~~~v~~~g~~~~~i~~~a~~~~~DLiV~G~~~~~~~~~~~~gs~~~~l~~~~~--~pvlvv~ 145 (305)
T PRK11175 83 IPIEIKVVWHNRPFEAIIQEVIAGGHDLVVKMTHQHDKLESVIFTPTDWHLLRKCP--CPVLMVK 145 (305)
T ss_pred CceEEEEecCCCcHHHHHHHHHhcCCCEEEEeCCCCcHHHhhccChhHHHHHhcCC--CCEEEec
Confidence 777777765446678999999999999999998754 2222237788888776 6666653
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.0032 Score=65.21 Aligned_cols=72 Identities=21% Similarity=0.239 Sum_probs=52.4
Q ss_pred eeecccCceEEEEEEecCC-cEEEEEEecc------C--CccHHHHHHHHHHHhcCC---CCCeeeEEEEEecCCeeEEE
Q 011660 258 MLIGQGGNSKVYRTNHVDG-QVAAVKVLKC------T--NWSEEEVLREVELLSSIK---HENIVRIIGYCHSKEMYAIV 325 (480)
Q Consensus 258 ~~LG~G~fg~Vy~~~~~~g-~~vAvK~~~~------~--~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~lV 325 (480)
+.||.|.+..||++...+| +.++||.-.. . +...+....|.+.|+.+. -.++++++.+.. +..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCCEEE
Confidence 4689999999999988776 5899998431 1 224466778888888763 346777887744 557899
Q ss_pred EeccCC
Q 011660 326 YNLLNG 331 (480)
Q Consensus 326 ~e~~~G 331 (480)
||++.+
T Consensus 110 ME~L~~ 115 (401)
T PRK09550 110 MEDLSD 115 (401)
T ss_pred EecCCC
Confidence 999853
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.0029 Score=63.33 Aligned_cols=137 Identities=18% Similarity=0.201 Sum_probs=81.8
Q ss_pred ceeecccCceEEEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhcCCCC--CeeeEEEEE------ecCCeeEEEEec
Q 011660 257 KMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHE--NIVRIIGYC------HSKEMYAIVYNL 328 (480)
Q Consensus 257 ~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~~~~------~~~~~~~lV~e~ 328 (480)
.+.++.|....+|+.+..++ .+++|+.+.. ...+.+..|.+++..|... .+.+++... ...+..++++++
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~-~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~ 104 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKR-VKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEF 104 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCC-CCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEe
Confidence 45577787789999875444 5778887543 2345667788888777422 244444321 224567889999
Q ss_pred cCCC------HH------HHH-------HhCC-----------HHHHH------------HHHHHHHHHHHHHHh----C
Q 011660 329 LNGS------LK------QYL-------KQLK-----------WNERM------------DVAIGVAKALEYLHH----T 362 (480)
Q Consensus 329 ~~Gs------L~------~~l-------~~~~-----------~~~~~------------~i~~~ia~aL~yLH~----~ 362 (480)
+.|. .. ..+ ..+. |.... .....+...++++.. .
T Consensus 105 i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~ 184 (307)
T TIGR00938 105 LQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRD 184 (307)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhc
Confidence 8662 11 111 0010 11000 011123345555543 2
Q ss_pred CCCCeEeccCCCCCEEEecCCCceEEeeeccccc
Q 011660 363 CDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMV 396 (480)
Q Consensus 363 ~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~ 396 (480)
...+++|+|+.+.||+++++ +...|+||+.+..
T Consensus 185 ~~~~l~HgD~~~~Nvl~~~~-~~~~vIDfd~~~~ 217 (307)
T TIGR00938 185 LPRGVIHADLFPDNVLFDGD-SVKGVIDFYFACT 217 (307)
T ss_pred CCCccCCCCCCcCcEEEECC-ceEEEeecccccC
Confidence 24589999999999999988 5568999998743
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.0011 Score=64.55 Aligned_cols=130 Identities=15% Similarity=0.165 Sum_probs=75.1
Q ss_pred ecccCceEEEEEEecCCcEEEEEEeccCCccH-HHHHHHHHHHhcCCCCCe-eeEEEEEecCCeeEEEEeccCCC-HH--
Q 011660 260 IGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSE-EEVLREVELLSSIKHENI-VRIIGYCHSKEMYAIVYNLLNGS-LK-- 334 (480)
Q Consensus 260 LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~-~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lV~e~~~Gs-L~-- 334 (480)
+..|-.+.+|+.. .+++.+++|+........ -+..+|.++++.+....+ .+++..+. -++|++|+.|. +.
T Consensus 4 ~~~G~tn~~y~~~-~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIE-HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEE-eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence 4567778999987 457788888765432221 245789999998864333 34454442 25889998663 21
Q ss_pred ------------HHHHh----------CCHHHH-HHHHH---------HHHHHHHHHHhC-----CCCCeEeccCCCCCE
Q 011660 335 ------------QYLKQ----------LKWNER-MDVAI---------GVAKALEYLHHT-----CDPPIIHRDVKSSNI 377 (480)
Q Consensus 335 ------------~~l~~----------~~~~~~-~~i~~---------~ia~aL~yLH~~-----~~~~IiHrDlKp~NI 377 (480)
+.+.+ +..... ..+.. .+...+..+-.. ....++|+|+.|.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 11111 111111 11111 111112222211 123589999999999
Q ss_pred EEecCCCceEEeeeccccc
Q 011660 378 LLSENFHHPQLSDFGAAMV 396 (480)
Q Consensus 378 Ll~~~~~~~kL~DFGla~~ 396 (480)
+++++ + +.|+||..|..
T Consensus 159 l~~~~-~-~~lIDwE~a~~ 175 (256)
T TIGR02721 159 VVTPQ-G-LKLIDWEYASD 175 (256)
T ss_pred EEeCC-C-CEEEeccccCc
Confidence 99987 4 79999998854
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.0043 Score=61.81 Aligned_cols=70 Identities=14% Similarity=0.160 Sum_probs=46.3
Q ss_pred eeecccCceEEEEEEecC-------CcEEEEEEeccCCccHHHHHHHHHHHhcCCCCC-eeeEEEEEecCCeeEEEEecc
Q 011660 258 MLIGQGGNSKVYRTNHVD-------GQVAAVKVLKCTNWSEEEVLREVELLSSIKHEN-IVRIIGYCHSKEMYAIVYNLL 329 (480)
Q Consensus 258 ~~LG~G~fg~Vy~~~~~~-------g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~~~~~~lV~e~~ 329 (480)
+.|..|-...+|+....+ ++.+++|+.........+..+|.+++..+.... ..++++++.. .+|++|+
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i 79 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFI 79 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhee
Confidence 346667777899987654 578999997655433356778988888885332 3455665542 2467887
Q ss_pred CC
Q 011660 330 NG 331 (480)
Q Consensus 330 ~G 331 (480)
.|
T Consensus 80 ~G 81 (302)
T cd05156 80 PS 81 (302)
T ss_pred CC
Confidence 55
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK11175 universal stress protein UspE; Provisional | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.0049 Score=61.38 Aligned_cols=119 Identities=11% Similarity=0.092 Sum_probs=80.8
Q ss_pred CceEEEEEEecChh-------hHHHHHHHHHhhcCC-CCeEEEEEeeccCCcc--------cc---------chhHHHHh
Q 011660 21 KKRTVIFGLKSDHY-------SREILLQLLTVIAKP-GDNVLAVHVEEQNDTL--------DL---------NTFHIHED 75 (480)
Q Consensus 21 ~~~~v~v~~~~~~~-------~~~~l~wal~~~~~~-~d~v~~~hv~~~~~~~--------~~---------~~~~~~~~ 75 (480)
..++|||++|.+.+ +..+|.+|+.-...- +-.|.+|||....... .. .....++.
T Consensus 151 ~~~~Ilva~D~s~~~~~~~~~~~~al~~a~~la~~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 230 (305)
T PRK11175 151 EGGKILVAVNVASEEPYHDALNEKLVEEAIDLAEQLNHAEVHLVNAYPVTPINIAIELPEFDPSVYNDAIRGQHLLAMKA 230 (305)
T ss_pred CCCeEEEEeCCCCCccchhHHHHHHHHHHHHHHhhCcCCceEEEEEecCcchhccccccccchhhHHHHHHHHHHHHHHH
Confidence 45799999998764 367999999766654 7789999997432100 00 01123445
Q ss_pred hhcccCcce-EEEEEecCchhhHHHHHHhhhcceEEEeecccc----CCCchhHHHHhhhcCCCCceEEEEe
Q 011660 76 LCKSKKVDF-LVKVCIGDSYITELSNQVRISYATILALGCSLS----GLKDSEVLTRCLRALPPACTILVMD 142 (480)
Q Consensus 76 ~c~~~~~~~-~~~v~~~~~~~~~~v~eak~~~~~~l~lg~~~~----~~~~~~v~~~c~~~~~~~c~v~~~~ 142 (480)
+.+...++. ...+..| +....|.+.|+...|+.||+|...+ +.-.+.++++.+++++ |.|+.+.
T Consensus 231 ~~~~~~~~~~~~~v~~G-~~~~~I~~~a~~~~~DLIVmG~~~~~~~~~~llGS~a~~v~~~~~--~pVLvv~ 299 (305)
T PRK11175 231 LRQKFGIDEEQTHVEEG-LPEEVIPDLAEHLDAELVILGTVGRTGLSAAFLGNTAEHVIDHLN--CDLLAIK 299 (305)
T ss_pred HHHHhCCChhheeeccC-CHHHHHHHHHHHhCCCEEEECCCccCCCcceeecchHHHHHhcCC--CCEEEEc
Confidence 555445443 2444555 5677899999999999999999754 2222348999999888 7777763
|
|
| >PRK12652 putative monovalent cation/H+ antiporter subunit E; Reviewed | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.0065 Score=61.98 Aligned_cols=96 Identities=8% Similarity=-0.021 Sum_probs=70.1
Q ss_pred ceEEEEEEecChhhHHHHHHHHHhhcCC--CCeEEEEEeeccCCccc----c-----chhHHHHhhhcc------cCcce
Q 011660 22 KRTVIFGLKSDHYSREILLQLLTVIAKP--GDNVLAVHVEEQNDTLD----L-----NTFHIHEDLCKS------KKVDF 84 (480)
Q Consensus 22 ~~~v~v~~~~~~~~~~~l~wal~~~~~~--~d~v~~~hv~~~~~~~~----~-----~~~~~~~~~c~~------~~~~~ 84 (480)
-++|||.+|-|..|+.++..|+...-.. +..|.+|||.+...... . ..+...+..... ..+++
T Consensus 5 ykkILVavDGSe~S~~Al~~AielA~~~g~~AeL~lL~Vv~~~~~~~~~~~~~~~~eelle~~~~~~~~~l~~~~~gV~v 84 (357)
T PRK12652 5 ANRLLVPVADSVTVRQTVAYAVESAEEAAETPTVHLVAAASGRAVDPEGQDELAAAEELLERVEVWATEDLGDDASSVTI 84 (357)
T ss_pred cCeEEEEeCCCHHHHHHHHHHHHHHHhcCCCCEEEEEEEecCcccccchhHHHHHHHHHHHHHHHHHHHhhhcccCCCce
Confidence 4689999999999999999999977554 58999999986432110 0 111222222222 35777
Q ss_pred EEEEEec-------CchhhHHHHHHhhhcceEEEeecccc
Q 011660 85 LVKVCIG-------DSYITELSNQVRISYATILALGCSLS 117 (480)
Q Consensus 85 ~~~v~~~-------~~~~~~~v~eak~~~~~~l~lg~~~~ 117 (480)
+..+..+ .+...+|++.|+..+|+.||+|-..+
T Consensus 85 e~~vv~~~~~~~~~G~pae~Iv~~Aee~~aDLIVm~~~~~ 124 (357)
T PRK12652 85 ETALLGTDEYLFGPGDYAEVLIAYAEEHGIDRVVLDPEYN 124 (357)
T ss_pred EEEEEeccccccCCCCHHHHHHHHHHHcCCCEEEECCCCC
Confidence 7777663 46688999999999999999999876
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.0044 Score=62.60 Aligned_cols=135 Identities=18% Similarity=0.243 Sum_probs=91.6
Q ss_pred CceeecccCceEEEEEEecCCcEEEEEEeccCCc-----------------------cHH----HHHHHHHHHhcCCCCC
Q 011660 256 PKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNW-----------------------SEE----EVLREVELLSSIKHEN 308 (480)
Q Consensus 256 ~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~-----------------------~~~----~~~~Ei~il~~l~Hpn 308 (480)
+..+|..|.-+.||.+...+|..+|||+++.+-. ..+ -...|++-|.+++.-.
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 4457889999999999999999999999763211 011 1356888888886544
Q ss_pred eeeEEEEEecCCeeEEEEeccCCC--HHHHHH--hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCC
Q 011660 309 IVRIIGYCHSKEMYAIVYNLLNGS--LKQYLK--QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFH 384 (480)
Q Consensus 309 Iv~l~~~~~~~~~~~lV~e~~~Gs--L~~~l~--~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~ 384 (480)
|.-.--+.. ....|||+|++++ -.-.|+ .++...+..+-.+++.-+.-|-+.| ++||.||.--|+|+.++
T Consensus 228 IP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~LyhdG-- 301 (520)
T KOG2270|consen 228 IPCPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYHDG-- 301 (520)
T ss_pred CCCCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEECC--
Confidence 321111111 2357899999643 222232 2455566666667777777666554 89999999999999875
Q ss_pred ceEEeeeccccc
Q 011660 385 HPQLSDFGAAMV 396 (480)
Q Consensus 385 ~~kL~DFGla~~ 396 (480)
.+.|+|.+-+..
T Consensus 302 ~lyiIDVSQSVE 313 (520)
T KOG2270|consen 302 KLYIIDVSQSVE 313 (520)
T ss_pred EEEEEEcccccc
Confidence 799999997754
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.65 E-value=0.02 Score=58.47 Aligned_cols=135 Identities=14% Similarity=0.218 Sum_probs=77.3
Q ss_pred eeecccCceEEEEEEecC-----CcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCe-eeEEEEEecCCeeEEEEeccCC
Q 011660 258 MLIGQGGNSKVYRTNHVD-----GQVAAVKVLKCTNWSEEEVLREVELLSSIKHENI-VRIIGYCHSKEMYAIVYNLLNG 331 (480)
Q Consensus 258 ~~LG~G~fg~Vy~~~~~~-----g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lV~e~~~G 331 (480)
..|-.|-...+|+....+ ++.+++|+........-+...|..+++.+..-++ .++++++... .+++|++|
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g 117 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA 117 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence 345567888999986532 3688899886543222234678999888854333 3556666432 46777754
Q ss_pred -CHHH-------H-------HHh---C---------CHHHHHHHHH-----------------HHHHHHHHH----Hh-C
Q 011660 332 -SLKQ-------Y-------LKQ---L---------KWNERMDVAI-----------------GVAKALEYL----HH-T 362 (480)
Q Consensus 332 -sL~~-------~-------l~~---~---------~~~~~~~i~~-----------------~ia~aL~yL----H~-~ 362 (480)
++.. . |.+ . .+.+...+.. .+...+..| .. .
T Consensus 118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~ 197 (344)
T PLN02236 118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD 197 (344)
T ss_pred CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence 2211 1 110 0 0111111111 111112222 21 2
Q ss_pred CCCCeEeccCCCCCEEEecCCCceEEeeeccccc
Q 011660 363 CDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMV 396 (480)
Q Consensus 363 ~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~ 396 (480)
....++|+|+++.|||++++.+.+.|+||..|.+
T Consensus 198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 2337899999999999987435799999998854
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.61 E-value=0.017 Score=56.99 Aligned_cols=45 Identities=16% Similarity=0.144 Sum_probs=31.4
Q ss_pred ecccCceEEEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhcCC
Q 011660 260 IGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIK 305 (480)
Q Consensus 260 LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~ 305 (480)
.++|-...||.....+|+.+++|.-+. ......+.+|.++|+.+.
T Consensus 19 ~~~g~~~~v~~i~~~~g~~~VlR~p~~-~~~~~~l~rE~~vL~~L~ 63 (276)
T cd05152 19 NESGLDFQVVFAKDTDGVPWVLRIPRR-PDVSERAAAEKRVLALVR 63 (276)
T ss_pred cCCcceeEEEEEEcCCCCeEEEEecCC-HHHHHHHHHHHHHHHHHH
Confidence 455555667776556788999887753 223456789999998885
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PRK10490 sensor protein KdpD; Provisional | Back alignment and domain information |
|---|
Probab=96.48 E-value=0.012 Score=67.70 Aligned_cols=114 Identities=13% Similarity=0.049 Sum_probs=87.8
Q ss_pred CceEEEEEEecChhhHHHHHHHHHhhcCCCCeEEEEEeeccCCcc--ccchhHHHHhhhcccCcceEEEEEecCchhhHH
Q 011660 21 KKRTVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVEEQNDTL--DLNTFHIHEDLCKSKKVDFLVKVCIGDSYITEL 98 (480)
Q Consensus 21 ~~~~v~v~~~~~~~~~~~l~wal~~~~~~~d~v~~~hv~~~~~~~--~~~~~~~~~~~c~~~~~~~~~~v~~~~~~~~~~ 98 (480)
.+.+|||+|+.+.++..++.+|-.-..+-|-...+|||.++.... ..+.-..-+++.-+++..-++.+..|.++..+|
T Consensus 249 ~~eriLV~v~~~~~~~~lIr~~~rlA~~~~a~~~~l~V~~~~~~~~~~~~~~~l~~~~~lA~~lGa~~~~~~~~dva~~i 328 (895)
T PRK10490 249 TRDAILLCIGHNTGSEKLVRTAARLAARLGSVWHAVYVETPRLHRLPEKKRRAILSALRLAQELGAETATLSDPAEEKAV 328 (895)
T ss_pred cCCeEEEEECCCcchHHHHHHHHHHHHhcCCCEEEEEEecCCcCcCCHHHHHHHHHHHHHHHHcCCEEEEEeCCCHHHHH
Confidence 445899999999999999999998888878899999999764321 111112224555666777788889999999999
Q ss_pred HHHHhhhcceEEEeeccccCCC--chhHHHHhhhcCCC
Q 011660 99 SNQVRISYATILALGCSLSGLK--DSEVLTRCLRALPP 134 (480)
Q Consensus 99 v~eak~~~~~~l~lg~~~~~~~--~~~v~~~c~~~~~~ 134 (480)
++-|+..+|+.||+|++.++.+ ...+++.-++..+.
T Consensus 329 ~~~A~~~~vt~IViG~s~~~~~~~~~s~~~~l~r~~~~ 366 (895)
T PRK10490 329 LRYAREHNLGKIIIGRRASRRWWRRESFADRLARLGPD 366 (895)
T ss_pred HHHHHHhCCCEEEECCCCCCCCccCCCHHHHHHHhCCC
Confidence 9999999999999999977322 22388888876653
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.45 E-value=0.0027 Score=63.08 Aligned_cols=142 Identities=18% Similarity=0.215 Sum_probs=92.2
Q ss_pred cCHHHHhhhhcC---CCCceeecccCceEEEEEEecCCcEEEEEEeccCCcc-----------------------HHHHH
Q 011660 242 FTSQELCHLTHN---FSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWS-----------------------EEEVL 295 (480)
Q Consensus 242 ~~~~el~~~~~~---f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~-----------------------~~~~~ 295 (480)
+++-.|..+.++ +...+.||=|.-+.+|.+-..+|+..++|+-+....+ .-...
T Consensus 79 yDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~ 158 (465)
T KOG2268|consen 79 YDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAAT 158 (465)
T ss_pred chHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHH
Confidence 444455544443 6778899999999999998888999999864211100 01245
Q ss_pred HHHHHHhcCC-CCC-eeeEEEEEecCCeeEEEEeccCCC-HHHHHHhCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccC
Q 011660 296 REVELLSSIK-HEN-IVRIIGYCHSKEMYAIVYNLLNGS-LKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDV 372 (480)
Q Consensus 296 ~Ei~il~~l~-Hpn-Iv~l~~~~~~~~~~~lV~e~~~Gs-L~~~l~~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDl 372 (480)
+|...|+.|. |.+ +.+.+++ +..++|||++.|- |...-.-.+.... ...+...+--|... |+||+|.
T Consensus 159 kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v~d~~~l---y~~lm~~Iv~la~~---GlIHgDF 228 (465)
T KOG2268|consen 159 KEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRHVEDPPTL---YDDLMGLIVRLANH---GLIHGDF 228 (465)
T ss_pred HHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeeecCChHHH---HHHHHHHHHHHHHc---Cceeccc
Confidence 7888888884 322 3444443 4678999999763 3322222222322 22333333445555 9999999
Q ss_pred CCCCEEEecCCCceEEeeeccc
Q 011660 373 KSSNILLSENFHHPQLSDFGAA 394 (480)
Q Consensus 373 Kp~NILl~~~~~~~kL~DFGla 394 (480)
.-=||+++++ +.++++||--.
T Consensus 229 NEFNimv~dd-~~i~vIDFPQm 249 (465)
T KOG2268|consen 229 NEFNIMVKDD-DKIVVIDFPQM 249 (465)
T ss_pred chheeEEecC-CCEEEeechHh
Confidence 9999999987 68999999754
|
|
| >COG0589 UspA Universal stress protein UspA and related nucleotide-binding proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.39 E-value=0.063 Score=46.84 Aligned_cols=115 Identities=14% Similarity=0.184 Sum_probs=84.1
Q ss_pred CceEEEEEEe-cChhhHHHHHHHHHhhcCCCCeEEEEEeeccCCcccc----------------------chhHHHHhhh
Q 011660 21 KKRTVIFGLK-SDHYSREILLQLLTVIAKPGDNVLAVHVEEQNDTLDL----------------------NTFHIHEDLC 77 (480)
Q Consensus 21 ~~~~v~v~~~-~~~~~~~~l~wal~~~~~~~d~v~~~hv~~~~~~~~~----------------------~~~~~~~~~c 77 (480)
..++|++++| .+..++.++.+|+......+..+.++||......... ......+..=
T Consensus 4 ~~~~il~~~d~~s~~~~~a~~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 83 (154)
T COG0589 4 MYKKILVAVDVGSEAAEKALEEAVALAKRLGAPLILLVVIDPLEPTALVSVALADAPIPLSEEELEEEAEELLAEAKALA 83 (154)
T ss_pred ccceEEEEeCCCCHHHHHHHHHHHHHHHhcCCeEEEEEEecccccccccccccccchhhhhHHHHHHHHHHHHHHHHHHH
Confidence 3579999999 8889999999999999999999999999955542111 0012222222
Q ss_pred cccCcc-eEEEEEecCchhhHHHHHHhhhcceEEEeecccc----CCCchhHHHHhhhcCCCC
Q 011660 78 KSKKVD-FLVKVCIGDSYITELSNQVRISYATILALGCSLS----GLKDSEVLTRCLRALPPA 135 (480)
Q Consensus 78 ~~~~~~-~~~~v~~~~~~~~~~v~eak~~~~~~l~lg~~~~----~~~~~~v~~~c~~~~~~~ 135 (480)
....++ .+..+..|.+....+.+.|....|+.||+|.... +.-.++++++.+++.+..
T Consensus 84 ~~~~~~~~~~~~~~g~~~~~~i~~~a~~~~adliV~G~~g~~~l~~~llGsvs~~v~~~~~~p 146 (154)
T COG0589 84 EAAGVPVVETEVVEGSPSAEEILELAEEEDADLIVVGSRGRSGLSRLLLGSVAEKVLRHAPCP 146 (154)
T ss_pred HHcCCCeeEEEEecCCCcHHHHHHHHHHhCCCEEEECCCCCccccceeeehhHHHHHhcCCCC
Confidence 233344 4777788988888999999999999999999754 212345899999877633
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.35 E-value=0.015 Score=58.78 Aligned_cols=74 Identities=18% Similarity=0.264 Sum_probs=59.1
Q ss_pred cCCeeEEEEeccCCCHHHHHHhCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccc
Q 011660 318 SKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMV 396 (480)
Q Consensus 318 ~~~~~~lV~e~~~GsL~~~l~~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~ 396 (480)
+....|++|++.++++. .++.-.+.++..++.+-+..+.-+.... +.=|||+.-+||||+ + |++-|+||-+++.
T Consensus 297 e~~y~yl~~kdhgt~is-~ik~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~-GnvtLIDfklsRl 370 (488)
T COG5072 297 ETLYLYLHFKDHGTPIS-IIKADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-E-GNVTLIDFKLSRL 370 (488)
T ss_pred CceEEEEEEecCCceee-eeecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-c-CceEEEEeeeeec
Confidence 33456777777777654 3455678889999999888888887664 788999999999999 5 6899999999973
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.34 E-value=0.00079 Score=77.92 Aligned_cols=154 Identities=12% Similarity=-0.036 Sum_probs=106.1
Q ss_pred HHHHHHHHhcCCCCCeeeEEEEEe--cCCeeEEEEecc-CCCHHHHHHh----CCHHHH--HHHHHHH-HHHHHHHHhCC
Q 011660 294 VLREVELLSSIKHENIVRIIGYCH--SKEMYAIVYNLL-NGSLKQYLKQ----LKWNER--MDVAIGV-AKALEYLHHTC 363 (480)
Q Consensus 294 ~~~Ei~il~~l~HpnIv~l~~~~~--~~~~~~lV~e~~-~GsL~~~l~~----~~~~~~--~~i~~~i-a~aL~yLH~~~ 363 (480)
...|.+-++...|+++.....-.. +....+..++++ .|++.+.+-+ ++...+ .....++ .....-+|...
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 345556667778998877655432 334567778887 7888888732 211111 1122233 44555555433
Q ss_pred --CCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHH
Q 011660 364 --DPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVV 441 (480)
Q Consensus 364 --~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvi 441 (480)
++-.+|+++|+-|.+|..+ .++++.++|+.+.... .........+++.|++|++...-.++.++|+|..|+.
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtn-y~v~~gk~gLdKIknp-----~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ 1429 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTN-YNVKLGKGGLDKIKNP-----VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLS 1429 (2724)
T ss_pred cCCccchhhhhhhhccceecC-CcccccccccccccCc-----hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHH
Confidence 3457899999999999998 4799999999973222 1112234567889999999888889999999999999
Q ss_pred HHHHHcCCCCCC
Q 011660 442 LLELITGKEAIQ 453 (480)
Q Consensus 442 l~eLltG~~pf~ 453 (480)
+|++.-|.++|.
T Consensus 1430 ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1430 LYLRSDGNAYFI 1441 (2724)
T ss_pred HHHHhcccHHHH
Confidence 999998887753
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.24 E-value=0.035 Score=56.19 Aligned_cols=134 Identities=22% Similarity=0.372 Sum_probs=80.6
Q ss_pred ecccCceEEEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhcCCC---CCeee---EEE----EEecCCeeEEEEecc
Q 011660 260 IGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKH---ENIVR---IIG----YCHSKEMYAIVYNLL 329 (480)
Q Consensus 260 LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~H---pnIv~---l~~----~~~~~~~~~lV~e~~ 329 (480)
|.+ .-..+|+....+|+. ++|+.+.. ....++..|+..|..|.- +=.++ +=| ........+-+++|+
T Consensus 34 l~s-~eN~~f~~~~~~g~~-iLki~~~~-~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l 110 (331)
T COG2334 34 LNS-EENSNFRVQTEDGRY-ILKIYRPG-WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYL 110 (331)
T ss_pred ccc-ccCceEEEEecCCCe-EEEEecCC-CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEec
Confidence 444 456789988877776 89999877 777888899999888732 21122 111 222223667788888
Q ss_pred CCCHHH-------------HH-------Hh-----------CCHHH---H----------HHHHHHHHHHHHHHHhC---
Q 011660 330 NGSLKQ-------------YL-------KQ-----------LKWNE---R----------MDVAIGVAKALEYLHHT--- 362 (480)
Q Consensus 330 ~GsL~~-------------~l-------~~-----------~~~~~---~----------~~i~~~ia~aL~yLH~~--- 362 (480)
.|.... ++ +. ..|.. . .....++...+..+...
T Consensus 111 ~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~ 190 (331)
T COG2334 111 PGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPA 190 (331)
T ss_pred CCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchh
Confidence 663222 11 11 12220 0 11223444445444432
Q ss_pred -CCCC---eEeccCCCCCEEEecCCCceEEeeeccccc
Q 011660 363 -CDPP---IIHRDVKSSNILLSENFHHPQLSDFGAAMV 396 (480)
Q Consensus 363 -~~~~---IiHrDlKp~NILl~~~~~~~kL~DFGla~~ 396 (480)
.... +||+|+.|.||+++.+....-+.||+.|..
T Consensus 191 ~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 191 HLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred hCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 1223 999999999999998821378999998743
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.20 E-value=0.052 Score=54.54 Aligned_cols=137 Identities=18% Similarity=0.340 Sum_probs=77.8
Q ss_pred ecccCceEEEEEEecCCcEEEEEEeccCC---ccHHHHHHHHHHHhcCCC--CCeeeEEEEEecCC--eeEEEEeccCC-
Q 011660 260 IGQGGNSKVYRTNHVDGQVAAVKVLKCTN---WSEEEVLREVELLSSIKH--ENIVRIIGYCHSKE--MYAIVYNLLNG- 331 (480)
Q Consensus 260 LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~---~~~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~~--~~~lV~e~~~G- 331 (480)
+..|..-.+|.... +++.+++. ..... ....+..+|.++++.+.- .-+...+++|.++. ..+.||+++.|
T Consensus 33 ~~~G~sn~t~~~~~-~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe 110 (321)
T COG3173 33 ISGGWSNDTFRLGD-TGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGE 110 (321)
T ss_pred ccCCcccceEEEec-CCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecce
Confidence 33343344555433 27788888 32111 123456788888888754 23445567776555 66889999876
Q ss_pred C------------------HHHHHHh-----------------------CCHHHHHHHH--------HHHHHHHHHHHhC
Q 011660 332 S------------------LKQYLKQ-----------------------LKWNERMDVA--------IGVAKALEYLHHT 362 (480)
Q Consensus 332 s------------------L~~~l~~-----------------------~~~~~~~~i~--------~~ia~aL~yLH~~ 362 (480)
. |-+.|.. ..|...+..+ -....-..||+.+
T Consensus 111 ~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~ 190 (321)
T COG3173 111 VVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEAN 190 (321)
T ss_pred eccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhc
Confidence 1 1112210 0011111100 1222234455443
Q ss_pred -----CCCCeEeccCCCCCEEEecCCCceEEeeecccccccc
Q 011660 363 -----CDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (480)
Q Consensus 363 -----~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~ 399 (480)
....++|+|+.+.|++++++ +.+-+.||+++....+
T Consensus 191 ~p~~~~~~~lvHGD~~~gNlii~~~-~~~gVlDwe~~~lGDP 231 (321)
T COG3173 191 RPPWAGPPVLVHGDYRPGNLIIDPG-RPTGVLDWELATLGDP 231 (321)
T ss_pred CCCcCCCceeeeCCcccCCEEEeCC-CeeEEEeccccccCCc
Confidence 23479999999999999998 4588999999865443
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.12 E-value=0.14 Score=51.70 Aligned_cols=69 Identities=17% Similarity=0.353 Sum_probs=44.8
Q ss_pred cCceEEEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhcCCCC--CeeeEE---E--EEecCCeeEEEEeccCC
Q 011660 263 GGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHE--NIVRII---G--YCHSKEMYAIVYNLLNG 331 (480)
Q Consensus 263 G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~---~--~~~~~~~~~lV~e~~~G 331 (480)
+.-..||+....++..+++|+.+........+..|++.+..|... .++... | +..-++..+.++++..|
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G 111 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGG 111 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCC
Confidence 344679998877788999999875555667788888888766321 122211 1 12224567778888765
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 480 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-37 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-36 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 7e-29 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 8e-29 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-23 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-23 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-23 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-22 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 6e-17 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-15 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 7e-15 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 6e-14 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-14 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-13 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-13 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-13 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-13 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-13 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-13 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-13 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-13 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-13 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-13 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-13 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-13 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-13 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-13 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-13 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-13 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-13 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 7e-13 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 8e-13 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 8e-13 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 9e-13 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 9e-13 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 9e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-12 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-12 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-12 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-12 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-12 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-12 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-12 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-12 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-12 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-12 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-12 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-12 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-12 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-12 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-12 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-12 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-12 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-12 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-12 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-12 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-12 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-12 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-12 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-12 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-12 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-12 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-12 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-12 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-12 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-12 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-12 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-12 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-12 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-12 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-12 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-12 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-12 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 6e-12 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 6e-12 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 7e-12 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 7e-12 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 8e-12 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-12 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 9e-12 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-11 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-11 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-11 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-11 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-11 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-11 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-11 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-11 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-11 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-11 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-11 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-11 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-11 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-11 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-11 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 5e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 5e-11 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 6e-11 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 6e-11 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 7e-11 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 8e-11 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 8e-11 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 8e-11 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-11 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 8e-11 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-11 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 8e-11 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 8e-11 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 9e-11 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 9e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 9e-11 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-10 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-10 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-10 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-10 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-10 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-10 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-10 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-10 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-10 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-10 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-10 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-10 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-10 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-10 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-10 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-10 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-10 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-10 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-10 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-10 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-10 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-10 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-10 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-10 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-10 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-10 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-10 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-10 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-10 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-10 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-10 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-10 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-10 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 5e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-10 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-10 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-10 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 6e-10 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-10 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 7e-10 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 7e-10 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 7e-10 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-10 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 8e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 8e-10 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 8e-10 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 8e-10 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 9e-10 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 9e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-09 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-09 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-09 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-09 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-09 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-09 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-09 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-09 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-09 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-09 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-09 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-09 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-09 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-09 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-09 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-09 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-09 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-09 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-09 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-09 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-09 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-09 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-09 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-09 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-09 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-09 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-09 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-09 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-09 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-09 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-09 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-09 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-09 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-09 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-09 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-09 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-09 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 5e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 5e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 5e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 5e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 6e-09 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 6e-09 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 6e-09 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-09 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 7e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 7e-09 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 8e-09 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 8e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 8e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-08 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-08 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-08 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-08 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-08 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-08 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-08 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-08 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-08 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-08 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-08 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-08 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-08 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-08 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-08 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-08 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-08 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-08 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-08 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-08 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-08 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-08 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-08 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-08 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-08 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-08 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-08 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-08 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-08 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-08 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-08 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-08 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-08 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-08 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-08 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-08 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-08 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-08 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-08 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-08 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-08 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 5e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 5e-08 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-08 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 6e-08 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 6e-08 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-08 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 7e-08 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 7e-08 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 7e-08 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 7e-08 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 8e-08 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 8e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-08 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 8e-08 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 8e-08 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 8e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 8e-08 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 8e-08 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-08 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 9e-08 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 9e-08 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 9e-08 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-07 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-07 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-07 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-07 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-07 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-07 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-07 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-07 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-07 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-07 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-07 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-07 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-07 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-07 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-07 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-07 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-07 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-07 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-07 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-07 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-07 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-07 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-07 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-07 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-07 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-07 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-07 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-07 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-07 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-07 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-07 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-07 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-07 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-07 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 5e-07 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-07 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-07 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-07 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 5e-07 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-07 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-07 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 6e-07 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 6e-07 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 7e-07 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 7e-07 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 7e-07 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 7e-07 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 7e-07 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 7e-07 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-07 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 8e-07 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-07 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 8e-07 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 8e-07 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 8e-07 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-07 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 8e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-07 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 8e-07 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-07 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 9e-07 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 9e-07 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 9e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 9e-07 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-07 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-06 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-06 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-06 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-06 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-06 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-06 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-06 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-06 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-06 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-06 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-06 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-06 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-06 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-06 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-06 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-06 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-06 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-06 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-06 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-06 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-06 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-06 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-06 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-06 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-06 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-06 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-06 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-06 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-06 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-06 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-06 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-06 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-06 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-06 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-06 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-06 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-06 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-06 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-06 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-06 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-06 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-06 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-06 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-06 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-06 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-06 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-06 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-06 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-06 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-06 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-06 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-06 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-06 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 3e-06 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-06 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-06 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-06 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-06 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-06 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-06 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-06 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-06 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-06 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-06 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-06 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-06 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-06 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-06 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-06 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-06 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-06 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-06 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-06 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-06 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-06 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-06 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 5e-06 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-06 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-06 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-06 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-06 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-06 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-06 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-06 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-06 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-06 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-06 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 5e-06 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-06 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-06 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-06 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 6e-06 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 6e-06 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 6e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-06 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 6e-06 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 6e-06 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 6e-06 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 6e-06 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-06 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 6e-06 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 6e-06 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 6e-06 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 6e-06 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 6e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 6e-06 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-06 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 6e-06 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 6e-06 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-06 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-06 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-06 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 6e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-06 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-06 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 6e-06 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 6e-06 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 6e-06 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-06 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 7e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-06 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 7e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 7e-06 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 7e-06 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 7e-06 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 7e-06 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 7e-06 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-06 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 7e-06 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-06 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-06 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 7e-06 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 7e-06 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 7e-06 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 7e-06 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-06 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 7e-06 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 7e-06 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 8e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 8e-06 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 8e-06 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 8e-06 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 8e-06 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 8e-06 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 8e-06 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 8e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-06 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 8e-06 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-06 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 8e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-06 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-06 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 8e-06 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-06 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 8e-06 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 8e-06 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 8e-06 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 8e-06 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-06 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-06 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-06 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 9e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-06 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 9e-06 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-06 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 9e-06 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 9e-06 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 9e-06 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 9e-06 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 9e-06 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 9e-06 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-05 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-05 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-05 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-05 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-05 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-05 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-05 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-05 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-05 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-05 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-05 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-05 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-05 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-05 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-05 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-05 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-05 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-05 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-05 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-05 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-05 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-05 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-05 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-05 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-05 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-05 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-05 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-05 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-05 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-05 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-05 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-05 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-05 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-05 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-05 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-05 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-05 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-05 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-05 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-05 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-05 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-05 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-05 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-05 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-05 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-05 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-05 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-05 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-05 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-05 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-05 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-05 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-05 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-05 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-05 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-05 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-05 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-05 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-05 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-05 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-05 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-05 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-05 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-05 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-05 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-05 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-05 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-05 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-05 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-05 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-05 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-05 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-05 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-05 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-05 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-05 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-05 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-05 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-05 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-05 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 4e-05 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-05 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-05 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 4e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 4e-05 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 5e-05 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-05 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-05 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 5e-05 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 6e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-05 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 6e-05 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 6e-05 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 6e-05 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 6e-05 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 6e-05 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 6e-05 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 6e-05 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 6e-05 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 6e-05 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 6e-05 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 6e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 6e-05 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-05 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 6e-05 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-05 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 7e-05 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 7e-05 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 7e-05 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 7e-05 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 7e-05 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 7e-05 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 7e-05 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 7e-05 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 7e-05 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 8e-05 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 8e-05 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 8e-05 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 8e-05 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 8e-05 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 8e-05 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 9e-05 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 9e-05 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 9e-05 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 9e-05 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-04 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 1e-04 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-04 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-04 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-04 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-04 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-04 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-04 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-04 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 1e-04 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-04 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-04 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-04 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-04 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-04 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 1e-04 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-04 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-04 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-04 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-04 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-04 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-04 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-04 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-04 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 2e-04 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-04 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-04 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-04 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-04 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-04 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-04 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-04 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-04 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-04 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-04 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-04 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-04 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-04 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-04 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-04 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-04 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-04 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-04 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-04 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-04 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-04 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-04 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-04 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-04 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-04 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-04 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-04 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-04 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-04 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-04 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-04 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-04 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-04 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-04 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-04 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-04 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-04 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-04 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-04 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 3e-04 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 3e-04 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-04 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-04 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 4e-04 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-04 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-04 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-04 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-04 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-04 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-04 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-04 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-04 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-04 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 4e-04 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-04 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 4e-04 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 5e-04 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 5e-04 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 5e-04 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-04 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 5e-04 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 5e-04 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 5e-04 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 5e-04 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-04 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 5e-04 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 5e-04 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 5e-04 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 5e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-04 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-04 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 5e-04 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-04 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 5e-04 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-04 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 5e-04 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 5e-04 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 6e-04 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 6e-04 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 6e-04 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 6e-04 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 6e-04 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-04 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 6e-04 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 6e-04 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-04 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 6e-04 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 6e-04 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 6e-04 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 6e-04 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 6e-04 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 6e-04 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 7e-04 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 7e-04 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 7e-04 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 7e-04 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 7e-04 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 7e-04 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 8e-04 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 8e-04 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 8e-04 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-04 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 8e-04 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 8e-04 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 8e-04 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 8e-04 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 8e-04 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-04 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 9e-04 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 9e-04 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 9e-04 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 263 bits (674), Expect = 9e-85
Identities = 99/248 (39%), Positives = 138/248 (55%), Gaps = 22/248 (8%)
Query: 237 GSSRRFTSQELCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNW--SEEEV 294
G +RF+ +EL + NFS K ++G+GG KVY+ DG + AVK LK E +
Sbjct: 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQF 74
Query: 295 LREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGSLKQYL-------KQLKWNERM 346
EVE++S H N++R+ G+C + +VY + NGS+ L L W +R
Sbjct: 75 QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQ 134
Query: 347 DVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA--MVHHQSHQVS 404
+A+G A+ L YLH CDP IIHRDVK++NILL E F + DFG A M + +H V+
Sbjct: 135 RIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAKLMDYKDTH-VT 192
Query: 405 ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRES--- 461
V GT G++APEY+ GK EK DV+ YGV+LLELITG+ A + +
Sbjct: 193 -----TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 247
Query: 462 LVLWYYVL 469
L+ W L
Sbjct: 248 LLDWVKGL 255
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 249 bits (639), Expect = 1e-79
Identities = 91/243 (37%), Positives = 130/243 (53%), Gaps = 23/243 (9%)
Query: 236 EGSSRRFTSQELCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNW-SEEEV 294
S R +L T+NF K LIG G KVY+ DG A+K + EE
Sbjct: 23 PFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEF 82
Query: 295 LREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGSLKQYL-------KQLKWNERM 346
E+E LS +H ++V +IG+C + ++Y + NG+LK++L + W +R+
Sbjct: 83 ETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRL 142
Query: 347 DVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFG---AAMVHHQSHQV 403
++ IG A+ L YLH IIHRDVKS NILL ENF P+++DFG Q+H +
Sbjct: 143 EICIGAARGLHYLH---TRAIIHRDVKSINILLDENFV-PKITDFGISKKGTELDQTH-L 197
Query: 404 SENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRE-SL 462
S VK GT GY+ PEY + G++ EK DVYS+GVVL E++ + AI + +L
Sbjct: 198 STVVK-----GTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNL 252
Query: 463 VLW 465
W
Sbjct: 253 AEW 255
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 233 bits (598), Expect = 8e-74
Identities = 79/259 (30%), Positives = 135/259 (52%), Gaps = 34/259 (13%)
Query: 228 EKLAVLEAEGSSRRFTSQELCHLTHNFSPKM------LIGQGGNSKVYRTNHVDGQVAAV 281
E ++ ++ F+ EL ++T+NF + +G+GG VY+ +V+ AV
Sbjct: 1 ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYK-GYVNNTTVAV 59
Query: 282 KVLKCTNWS-----EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGSLKQ 335
K L +++ +E+++++ +HEN+V ++G+ + +VY + NGSL
Sbjct: 60 KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119
Query: 336 YL------KQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLS 389
L L W+ R +A G A + +LH + IHRD+KS+NILL E F ++S
Sbjct: 120 RLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFT-AKIS 175
Query: 390 DFGAA---MVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELI 446
DFG A Q+ ++ + VGT Y+APE + G++ K D+YS+GVVLLE+I
Sbjct: 176 DFGLARASEKFAQTV-MTSRI-----VGTTAYMAPEALR-GEITPKSDIYSFGVVLLEII 228
Query: 447 TGKEAIQTNKANRESLVLW 465
TG A+ ++ + L+
Sbjct: 229 TGLPAVDEHREP-QLLLDI 246
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 8e-64
Identities = 62/234 (26%), Positives = 96/234 (41%), Gaps = 24/234 (10%)
Query: 238 SSRRFTSQELCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLRE 297
S ++ L + + +G V++ + AVK+ + + E
Sbjct: 10 SGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSWQNEYE 68
Query: 298 VELLSSIKHENIVRIIGYC----HSKEMYAIVYNLL-NGSLKQYLKQ--LKWNERMDVAI 350
V L +KHENI++ IG ++ GSL +LK + WNE +A
Sbjct: 69 VYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAE 128
Query: 351 GVAKALEYLHH-------TCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403
+A+ L YLH P I HRD+KS N+LL N ++DFG A+
Sbjct: 129 TMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL-TACIADFGLALKFEAGKSA 187
Query: 404 SENVKPVNVVGTFGYLAPEYMMYG-----KVDEKIDVYSYGVVLLELITGKEAI 452
+ VGT Y+APE + +ID+Y+ G+VL EL + A
Sbjct: 188 GDT---HGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAA 238
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 4e-55
Identities = 50/198 (25%), Positives = 85/198 (42%), Gaps = 19/198 (9%)
Query: 260 IGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSK 319
+G+G V + + A+K ++ + + + E+ LS + H NIV++ G C +
Sbjct: 16 VGRGAFGVVCKAKW-RAKDVAIKQIESES-ERKAFIVELRQLSRVNHPNIVKLYGACLNP 73
Query: 320 EMYAIVYNLL-NGSLKQYL------KQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDV 372
+V GSL L M + ++ + YLH +IHRD+
Sbjct: 74 --VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDL 131
Query: 373 KSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEK 432
K N+LL ++ DFG A N G+ ++APE EK
Sbjct: 132 KPPNLLLVAGGTVLKICDFGTACDIQTHM--------TNNKGSAAWMAPEVFEGSNYSEK 183
Query: 433 IDVYSYGVVLLELITGKE 450
DV+S+G++L E+IT ++
Sbjct: 184 CDVFSWGIILWEVITRRK 201
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 9e-54
Identities = 65/207 (31%), Positives = 105/207 (50%), Gaps = 25/207 (12%)
Query: 260 IGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSE-----EEVLREVELLSSIKHENIVRIIG 314
IG GG KVYR G AVK + + E V +E +L + +KH NI+ + G
Sbjct: 15 IGIGGFGKVYR-AFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 315 YCHSKEMYAIV--YNLLNGSLKQYL--KQLKWNERMDVAIGVAKALEYLHHTCDPPIIHR 370
C + +V + G L + L K++ + ++ A+ +A+ + YLH PIIHR
Sbjct: 74 VCLKEPNLCLVMEF-ARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHR 132
Query: 371 DVKSSNILLSENFHHPQ-------LSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEY 423
D+KSSNIL+ + + ++DFG A H++ ++S G + ++APE
Sbjct: 133 DLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA-------AGAYAWMAPEV 185
Query: 424 MMYGKVDEKIDVYSYGVVLLELITGKE 450
+ + DV+SYGV+L EL+TG+
Sbjct: 186 IRASMFSKGSDVWSYGVLLWELLTGEV 212
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 1e-53
Identities = 68/202 (33%), Positives = 106/202 (52%), Gaps = 20/202 (9%)
Query: 260 IGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSE---EEVLREVELLSSIKHENIVRIIGYC 316
IG G V+R G AVK+L ++ E LREV ++ ++H NIV +G
Sbjct: 45 IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 317 HSKEMYAIV--YNLLNGSLKQYL------KQLKWNERMDVAIGVAKALEYLHHTCDPPII 368
+IV Y L GSL + L +QL R+ +A VAK + YLH +PPI+
Sbjct: 104 TQPPNLSIVTEY-LSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIV 161
Query: 369 HRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGK 428
HR++KS N+L+ + + ++ DFG + + + S++ GT ++APE +
Sbjct: 162 HRNLKSPNLLVDKKYT-VKVCDFGLSRLKASTFLSSKSA-----AGTPEWMAPEVLRDEP 215
Query: 429 VDEKIDVYSYGVVLLELITGKE 450
+EK DVYS+GV+L EL T ++
Sbjct: 216 SNEKSDVYSFGVILWELATLQQ 237
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 9e-52
Identities = 56/211 (26%), Positives = 99/211 (46%), Gaps = 31/211 (14%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSE--------EEVLREVELLSSIKHENIV 310
IG+GG V++ D V A+K L + +E REV ++S++ H NIV
Sbjct: 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 311 RIIGYCHSKEMYAIVYNLL-NGSLKQYL----KQLKWNERMDVAIGVAKALEYLHHTCDP 365
++ G +V + G L L +KW+ ++ + + +A +EY+ + +P
Sbjct: 87 KLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQN-QNP 143
Query: 366 PIIHRDVKSSNILLSENFHHPQ----LSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAP 421
PI+HRD++S NI L + ++DFG + S ++G F ++AP
Sbjct: 144 PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS--------VSGLLGNFQWMAP 195
Query: 422 EYMMY--GKVDEKIDVYSYGVVLLELITGKE 450
E + EK D YS+ ++L ++TG+
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTGEG 226
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 6e-50
Identities = 62/254 (24%), Positives = 104/254 (40%), Gaps = 30/254 (11%)
Query: 242 FTSQELCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVE-- 299
+ E N LIG+G VY+ + D + AVKV N + + E
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN--RQNFINEKNIY 59
Query: 300 LLSSIKHENIVRIIGYC-----HSKEMYAIVYNLL-NGSLKQYLKQ--LKWNERMDVAIG 351
+ ++H+NI R I + Y +V NGSL +YL W +A
Sbjct: 60 RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHS 119
Query: 352 VAKALEYLH------HTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV-- 403
V + L YLH P I HRD+ S N+L+ + +SDFG +M + V
Sbjct: 120 VTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG-TCVISDFGLSMRLTGNRLVRP 178
Query: 404 -SENVKPVNVVGTFGYLAPEYMM-------YGKVDEKIDVYSYGVVLLELITGKEAIQTN 455
E+ ++ VGT Y+APE + +++D+Y+ G++ E+ +
Sbjct: 179 GEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238
Query: 456 KANRESLVLWYYVL 469
++ E + + +
Sbjct: 239 ESVPEYQMAFQTEV 252
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 168 bits (429), Expect = 3e-49
Identities = 39/206 (18%), Positives = 84/206 (40%), Gaps = 29/206 (14%)
Query: 260 IGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSE---EEVLREVELLSSIKHENIVRIIGYC 316
+ + + ++++ G VKVLK +WS + E L H N++ ++G C
Sbjct: 18 LNENHSGELWK-GRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 317 HS--KEMYAIV--YNLLNGSLKQYL-----KQLKWNERMDVAIGVAKALEYLHHTCDPPI 367
S ++ + + GSL L + ++ + A+ +A+ + +LH T +P I
Sbjct: 77 QSPPAPHPTLITHW-MPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLEPLI 134
Query: 368 IHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMM-- 425
+ S ++++ E+ ++S + ++APE +
Sbjct: 135 PRHALNSRSVMIDEDM-TARISMADVKFSFQSP----------GRMYAPAWVAPEALQKK 183
Query: 426 -YGKVDEKIDVYSYGVVLLELITGKE 450
D++S+ V+L EL+T +
Sbjct: 184 PEDTNRRSADMWSFAVLLWELVTREV 209
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 5e-49
Identities = 50/208 (24%), Positives = 84/208 (40%), Gaps = 24/208 (11%)
Query: 260 IGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSE---EEVLREVELLSSIKHENIVRIIGYC 316
IG+G +VY G+VA ++++ +E + REV +HEN+V +G C
Sbjct: 41 IGKGRFGQVYHGRW-HGEVA-IRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC 98
Query: 317 HSKEMYAIVYNLL-NGSLKQYL----KQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRD 371
S AI+ +L +L + L N+ +A + K + YLH I+H+D
Sbjct: 99 MSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKD 155
Query: 372 VKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKV-- 429
+KS N+ ++DFG + K G +LAPE +
Sbjct: 156 LKSKNVFYDNG--KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDT 213
Query: 430 -------DEKIDVYSYGVVLLELITGKE 450
+ DV++ G + EL +
Sbjct: 214 EEDKLPFSKHSDVFALGTIWYELHAREW 241
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 7e-48
Identities = 59/209 (28%), Positives = 107/209 (51%), Gaps = 22/209 (10%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVL-KCTNWSEEEVLREVELLSSIKHENIVRIIGYCH 317
+G+G + + T+ G+V +K L + ++ L+EV+++ ++H N+++ IG +
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 318 SKEMYAIV--YNLLNGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRD 371
+ + Y + G+L+ +K Q W++R+ A +A + YLH IIHRD
Sbjct: 78 KDKRLNFITEY-IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRD 133
Query: 372 VKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVN---------VVGTFGYLAPE 422
+ S N L+ EN + ++DFG A + E ++ + VVG ++APE
Sbjct: 134 LNSHNCLVREN-KNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192
Query: 423 YMMYGKVDEKIDVYSYGVVLLELITGKEA 451
+ DEK+DV+S+G+VL E+I A
Sbjct: 193 MINGRSYDEKVDVFSFGIVLCEIIGRVNA 221
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 2e-47
Identities = 61/202 (30%), Positives = 97/202 (48%), Gaps = 21/202 (10%)
Query: 260 IGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEE---EVLREVELLSSIKHENIVRIIGYC 316
IG G VY+ G VA VK+L T + + EV +L +H NI+ +GY
Sbjct: 32 IGSGSFGTVYK-GKWHGDVA-VKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 317 HSKEMYAIVYNLL-NGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRD 371
+ AIV SL +L + + + +D+A A+ ++YLH IIHRD
Sbjct: 90 -TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA---KSIIHRD 145
Query: 372 VKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY---GK 428
+KS+NI L E+ ++ DFG A + + + G+ ++APE +
Sbjct: 146 LKSNNIFLHEDNT-VKIGDFGLATEKSRWSGSHQFEQLS---GSILWMAPEVIRMQDSNP 201
Query: 429 VDEKIDVYSYGVVLLELITGKE 450
+ DVY++G+VL EL+TG+
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQL 223
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 7e-47
Identities = 56/211 (26%), Positives = 97/211 (45%), Gaps = 21/211 (9%)
Query: 259 LIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYC-- 316
+G+G +V+R + G+ AVK+ + E+ ++HENI+ I
Sbjct: 15 CVGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMT 73
Query: 317 --HSKEMYAIVYNLL-NGSLKQYLKQ--LKWNERMDVAIGVAKALEYLH-----HTCDPP 366
HS ++ + GSL YL+ L + + + +A L +LH P
Sbjct: 74 SRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA 133
Query: 367 IIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPE---- 422
I HRD+KS NIL+ +N ++D G A++H QS +V VGT Y+APE
Sbjct: 134 IAHRDLKSKNILVKKNG-QCCIADLGLAVMHSQSTN-QLDVGNNPRVGTKRYMAPEVLDE 191
Query: 423 --YMMYGKVDEKIDVYSYGVVLLELITGKEA 451
+ +++D++++G+VL E+ +
Sbjct: 192 TIQVDCFDSYKRVDIWAFGLVLWEVARRMVS 222
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 3e-46
Identities = 55/211 (26%), Positives = 92/211 (43%), Gaps = 21/211 (9%)
Query: 259 LIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHS 318
IG+G +V+R G+ AVK+ E+ ++HENI+ I +
Sbjct: 49 SIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNK 107
Query: 319 KEMYAIVYNLL-----NGSLKQYLKQ--LKWNERMDVAIGVAKALEYLH-----HTCDPP 366
L+ +GSL YL + + + +A+ A L +LH P
Sbjct: 108 DNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA 167
Query: 367 IIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPE---- 422
I HRD+KS NIL+ +N ++D G A+ H + + + P + VGT Y+APE
Sbjct: 168 IAHRDLKSKNILVKKNG-TCCIADLGLAVRHDSATDTID-IAPNHRVGTKRYMAPEVLDD 225
Query: 423 --YMMYGKVDEKIDVYSYGVVLLELITGKEA 451
M + + ++ D+Y+ G+V E+
Sbjct: 226 SINMKHFESFKRADIYAMGLVFWEIARRCSI 256
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 6e-46
Identities = 56/212 (26%), Positives = 89/212 (41%), Gaps = 23/212 (10%)
Query: 259 LIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYC-- 316
IG+G +V+ G+ AVKV T + E+ ++HENI+ I
Sbjct: 44 QIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIK 102
Query: 317 --HSKEMYAIVYNLL-NGSLKQYLKQ--LKWNERMDVAIGVAKALEYLH-----HTCDPP 366
S ++ + NGSL YLK L + +A L +LH P
Sbjct: 103 GTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA 162
Query: 367 IIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY 426
I HRD+KS NIL+ +N ++D G A+ ++ P VGT Y+ PE ++
Sbjct: 163 IAHRDLKSKNILVKKNG-TCCIADLGLAVKFISDTN-EVDIPPNTRVGTKRYMPPE-VLD 219
Query: 427 GKV-------DEKIDVYSYGVVLLELITGKEA 451
+ D+YS+G++L E+ +
Sbjct: 220 ESLNRNHFQSYIMADMYSFGLILWEVARRCVS 251
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 8e-40
Identities = 62/203 (30%), Positives = 96/203 (47%), Gaps = 21/203 (10%)
Query: 259 LIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEVLR---EVELLSSIKHENIVRIIG 314
IG+G VY+ + A L+ ++ E R E E+L ++H NIVR
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 315 YCHSKEMYAIVYNLL-----NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPP 366
S L+ +G+LK YLK+ +K + K L++LH T PP
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH-TRTPP 151
Query: 367 IIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY 426
IIHRD+K NI ++ ++ D G A + S + V+GT ++APE M
Sbjct: 152 IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA-------VIGTPEFMAPE-MYE 203
Query: 427 GKVDEKIDVYSYGVVLLELITGK 449
K DE +DVY++G+ +LE+ T +
Sbjct: 204 EKYDESVDVYAFGMCMLEMATSE 226
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-37
Identities = 61/235 (25%), Positives = 99/235 (42%), Gaps = 27/235 (11%)
Query: 252 HNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTN-WSEEEVLREVELLSSIKHENI 309
++ +G+GG S V + DG A+K + C EE RE ++ H NI
Sbjct: 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNI 88
Query: 310 VRIIGYCH-SKEMYAIVYNLL----NGSLKQYLKQLKWNER-------MDVAIGVAKALE 357
+R++ YC + + LL G+L +++LK + + +G+ + LE
Sbjct: 89 LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLE 148
Query: 358 YLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFG----AAMVHHQSHQVSENVKPVNVV 413
+H HRD+K +NILL + P L D G A + S Q
Sbjct: 149 AIH---AKGYAHRDLKPTNILLGDE-GQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR 204
Query: 414 GTFGYLAPEYMM----YGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVL 464
T Y APE + + +DE+ DV+S G VL ++ G+ +S+ L
Sbjct: 205 CTISYRAPE-LFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL 258
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 6e-33
Identities = 54/224 (24%), Positives = 98/224 (43%), Gaps = 33/224 (14%)
Query: 253 NFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTN--WSEEEVLREVELLSSIKHENI 309
+F P +G+GG V+ N VD A+K ++ N + E+V+REV+ L+ ++H I
Sbjct: 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65
Query: 310 VRIIGY---------CHSKEMYAIVYNLL----NGSLKQYLKQLKWNERMDVAIG----- 351
VR +Y + +LK ++ E + ++
Sbjct: 66 VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFL 125
Query: 352 -VAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA-------MVHHQSHQV 403
+A+A+E+LH ++HRD+K SNI + + ++ DFG +
Sbjct: 126 QIAEAVEFLH---SKGLMHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 404 SENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT 447
+ VGT Y++PE + K+D++S G++L EL+
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 7e-33
Identities = 58/228 (25%), Positives = 101/228 (44%), Gaps = 35/228 (15%)
Query: 251 THNFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENI 309
+F ++GQG +V + N +D + A+K ++ T +L EV LL+S+ H+ +
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYV 64
Query: 310 VRIIGYCHSKEMYAIVYNLL--------------NGSLKQYLKQLKWNERMDVAIG---- 351
VR + + + NG+L + N++ D
Sbjct: 65 VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQ 124
Query: 352 VAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVN 411
+ +AL Y+H IIHRD+K NI + E+ + ++ DFG A H+S + +
Sbjct: 125 ILEALSYIH---SQGIIHRDLKPMNIFIDES-RNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 412 ---------VVGTFGYLAPEYMMYGKV--DEKIDVYSYGVVLLELITG 448
+GT Y+A E ++ G +EKID+YS G++ E+I
Sbjct: 181 PGSSDNLTSAIGTAMYVATE-VLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-32
Identities = 57/200 (28%), Positives = 94/200 (47%), Gaps = 17/200 (8%)
Query: 259 LIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEVL----REVELLSSIKHENIVRII 313
+G GG S VY + + A+K + +EE L REV S + H+NIV +I
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 314 GYCHSKEMYAIVYNLLNG-SLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIH 369
+ Y +V + G +L +Y++ L + ++ + +++ H I+H
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM---RIVH 134
Query: 370 RDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKV 429
RD+K NIL+ N ++ DFG A ++ N V+GT Y +PE
Sbjct: 135 RDIKPQNILIDSN-KTLKIFDFGIAKALSETSLTQTNH----VLGTVQYFSPEQAKGEAT 189
Query: 430 DEKIDVYSYGVVLLELITGK 449
DE D+YS G+VL E++ G+
Sbjct: 190 DECTDIYSIGIVLYEMLVGE 209
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-31
Identities = 51/201 (25%), Positives = 79/201 (39%), Gaps = 19/201 (9%)
Query: 259 LIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEEVL-----REVELLSSIKHENIVRI 312
L+G+GG VY ++ A+K++ S + V RE ++ ++V I
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMS-ETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99
Query: 313 IGYCHSKEMYAIVYNLLNG-SLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPII 368
+ + L+NG L L++ L + + + AL+ H
Sbjct: 100 HDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAA---GAT 156
Query: 369 HRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGK 428
HRDVK NIL+S + L DFG A VGT Y+APE
Sbjct: 157 HRDVKPENILVSAD-DFAYLVDFGIASATTDEKLTQLGN----TVGTLYYMAPERFSESH 211
Query: 429 VDEKIDVYSYGVVLLELITGK 449
+ D+Y+ VL E +TG
Sbjct: 212 ATYRADIYALTCVLYECLTGS 232
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-31
Identities = 52/212 (24%), Positives = 91/212 (42%), Gaps = 31/212 (14%)
Query: 259 LIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEE---VLREVELLSSIKH--ENIVRII 313
IG GG+SKV++ + Q+ A+K + + E+ L+ ++ + I+R+
Sbjct: 16 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 314 GYCHSKEMYAIVYNLLNGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHR 370
Y + + +V N L +LK+ + ER + +A+ +H I+H
Sbjct: 76 DYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH---QHGIVHS 132
Query: 371 DVKSSNILLSENFHHPQLSDFGAA--MVHHQSHQVSENVKPVNVVGTFGYLAPE------ 422
D+K +N L+ + +L DFG A M + V + + VGT Y+ PE
Sbjct: 133 DLKPANFLIVDG--MLKLIDFGIANQMQPDTTSVVKD-----SQVGTVNYMPPEAIKDMS 185
Query: 423 -----YMMYGKVDEKIDVYSYGVVLLELITGK 449
K+ K DV+S G +L + GK
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 5e-31
Identities = 52/212 (24%), Positives = 91/212 (42%), Gaps = 31/212 (14%)
Query: 259 LIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEE---VLREVELLSSIKH--ENIVRII 313
IG GG+SKV++ + Q+ A+K + + E+ L+ ++ + I+R+
Sbjct: 35 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 314 GYCHSKEMYAIVYNLLNGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHR 370
Y + + +V N L +LK+ + ER + +A+ +H I+H
Sbjct: 95 DYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH---QHGIVHS 151
Query: 371 DVKSSNILLSENFHHPQLSDFGAA--MVHHQSHQVSENVKPVNVVGTFGYLAPE------ 422
D+K +N L+ + +L DFG A M + V + + VGT Y+ PE
Sbjct: 152 DLKPANFLIVDG--MLKLIDFGIANQMQPDTTSVVKD-----SQVGTVNYMPPEAIKDMS 204
Query: 423 -----YMMYGKVDEKIDVYSYGVVLLELITGK 449
K+ K DV+S G +L + GK
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-31
Identities = 54/221 (24%), Positives = 90/221 (40%), Gaps = 24/221 (10%)
Query: 259 LIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEE---VLREVELLSSIKHENIVRIIG 314
IG G + + DG++ K L + +E E ++ EV LL +KH NIVR
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 315 YCHSKE--MYAIVYNLL-NGSLKQYLKQLKWNER-------MDVAIGVAKALEYLH--HT 362
+ IV G L + + + + V + AL+ H
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 363 CDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPE 422
++HRD+K +N+ L + +L DFG A + + ++ VGT Y++PE
Sbjct: 133 GGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAK-----TFVGTPYYMSPE 186
Query: 423 YMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLV 463
M +EK D++S G +L EL +++ L
Sbjct: 187 QMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF--SQKELA 225
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 6e-31
Identities = 54/207 (26%), Positives = 88/207 (42%), Gaps = 22/207 (10%)
Query: 260 IGQGGNS--KVYRTNHVD-GQVAAVKVL---KCTNWSEEEVLREVELLSSIKHENIVRII 313
IG+G V + G+ V+ + C+N + E+ + H NIV
Sbjct: 33 IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYR 92
Query: 314 G-YCHSKEMYAIVYNLLN-GSLKQYLKQLKWNERMDVAIG-----VAKALEYLHHTCDPP 366
+ E++ +V + + GS K + + ++AI V KAL+Y+HH
Sbjct: 93 ATFIADNELW-VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---G 148
Query: 367 IIHRDVKSSNILLSENFHHPQLSDFG--AAMVHHQSHQVSENVKPVNVVGTFGYLAPEYM 424
+HR VK+S+IL+S + LS +M+ H Q + P V +L+PE +
Sbjct: 149 YVHRSVKASHILISVDG-KVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVL 207
Query: 425 MYGKV--DEKIDVYSYGVVLLELITGK 449
D K D+YS G+ EL G
Sbjct: 208 QQNLQGYDAKSDIYSVGITACELANGH 234
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 7e-31
Identities = 53/219 (24%), Positives = 98/219 (44%), Gaps = 22/219 (10%)
Query: 259 LIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSE----EEVLREVELLSSIKHENIVRII 313
IG+G S+VYR +DG A+K ++ + + + ++E++LL + H N+++
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 314 GYCHSKEMYAIVYNLL-NGSLKQYLKQLKWNER-------MDVAIGVAKALEYLHHTCDP 365
IV L G L + +K K +R + + ALE++H
Sbjct: 99 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SR 155
Query: 366 PIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMM 425
++HRD+K +N+ ++ +L D G S+ ++VGT Y++PE +
Sbjct: 156 RVMHRDIKPANVFITAT-GVVKLGDLGLG-----RFFSSKTTAAHSLVGTPYYMSPERIH 209
Query: 426 YGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVL 464
+ K D++S G +L E+ + +K N SL
Sbjct: 210 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK 248
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 7e-31
Identities = 54/228 (23%), Positives = 89/228 (39%), Gaps = 42/228 (18%)
Query: 248 CHLTHNFSPKM--------------LIGQGGNSKVYRTNH--VDGQVAAVKVLKCTNWSE 291
C ++F P++ I GG +Y V+G+ +K L +
Sbjct: 62 CGSPYSFLPQLNPGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-DA 120
Query: 292 EEV---LREVELLSSIKHENIVRIIGY-----CHSKEMYAIVYNLLNG-SLKQYLKQ-LK 341
E + E + L+ + H +IV+I + H + IV + G SLK+ Q L
Sbjct: 121 EAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLP 180
Query: 342 WNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401
E + + + AL YLH +++ D+K NI+L+E +L D GA +
Sbjct: 181 VAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE--QLKLIDLGAVSRINSFG 235
Query: 402 QVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
+ GT G+ APE + D+Y+ G L L
Sbjct: 236 Y---------LYGTPGFQAPEIVR-TGPTVATDIYTVGRTLAALTLDL 273
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-30
Identities = 52/219 (23%), Positives = 95/219 (43%), Gaps = 31/219 (14%)
Query: 259 LIGQGGNSKVYRTNHV-DGQVAAVKVLKCTN-WSEEEVLREVELLSSIK-HENIVRIIGY 315
++ +GG + VY V G+ A+K L +++EV + + H NIV+
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 316 C--------HSKEMYAIVYNLLNGSLKQYLKQLKWNERM------DVAIGVAKALEYLHH 361
+ + ++ L G L ++LK+++ + + +A++++H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154
Query: 362 TCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVV-------G 414
PPIIHRD+K N+LLS +L DFG+A S + + +V
Sbjct: 155 -QKPPIIHRDLKVENLLLSNQ-GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT 212
Query: 415 TFGYLAPEYM--MYGK--VDEKIDVYSYGVVLLELITGK 449
T Y PE + +Y + EK D+++ G +L L +
Sbjct: 213 TPMYRTPE-IIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-30
Identities = 53/240 (22%), Positives = 91/240 (37%), Gaps = 26/240 (10%)
Query: 223 KRKIFEKLAVLEAEGSSRRFTSQELCHLTHNFSPKMLIGQGGNSKVYR-TNHVDGQVAAV 281
R++ + E S S+ +F +G G +V++ + DG++ AV
Sbjct: 28 PRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAV 87
Query: 282 KVLKCTNWSEEEV---LREVELLSSI-KHENIVRIIG-YCHSKEMYAIVYNLLNGSLKQY 336
K ++ L EV + +H VR+ + +Y + L SL+Q+
Sbjct: 88 KRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILY-LQTELCGPSLQQH 146
Query: 337 LKQLKWNERM------DVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSD 390
+ W + AL +LH ++H DVK +NI L +L D
Sbjct: 147 CE--AWGASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPR-GRCKLGD 200
Query: 391 FGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKE 450
FG + ++ G Y+APE + G DV+S G+ +LE+ E
Sbjct: 201 FGLLV------ELGTAGAGEVQEGDPRYMAPELLQ-GSYGTAADVFSLGLTILEVACNME 253
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-30
Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 19/207 (9%)
Query: 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEE---VLREVELLSSIKHEN 308
+ IG+G K DG+ +K + + S +E REV +L+++KH N
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPN 84
Query: 309 IVRIIGYCHSKEMYAIVYNLL-NGSLKQYLKQLKW-----NERMDVAIGVAKALEYLHHT 362
IV+ IV + G L + + K ++ +D + + AL+++H
Sbjct: 85 IVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH-- 142
Query: 363 CDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPE 422
D I+HRD+KS NI L+++ QL DFG A V + + +++ +GT YL+PE
Sbjct: 143 -DRKILHRDIKSQNIFLTKD-GTVQLGDFGIARVLNSTVELAR-----ACIGTPYYLSPE 195
Query: 423 YMMYGKVDEKIDVYSYGVVLLELITGK 449
+ K D+++ G VL EL T K
Sbjct: 196 ICENKPYNNKSDIWALGCVLYELCTLK 222
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-30
Identities = 52/219 (23%), Positives = 99/219 (45%), Gaps = 36/219 (16%)
Query: 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVR 311
+F LIG GG +V++ H +DG+ +K +K N E+ REV+ L+ + H NIV
Sbjct: 12 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVH 68
Query: 312 IIGYCHSKEMYAIVYNLL-----------------NGSLKQYLKQLKWN-----ERMDVA 349
G + + G+L+Q++++ + +++
Sbjct: 69 YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128
Query: 350 IGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKP 409
+ K ++Y+H +I+RD+K SNI L + ++ DFG + + K
Sbjct: 129 EQITKGVDYIH---SKKLINRDLKPSNIFLVDT-KQVKIGDFGLVTS------LKNDGKR 178
Query: 410 VNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITG 448
GT Y++PE + +++D+Y+ G++L EL+
Sbjct: 179 TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHV 217
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-30
Identities = 51/210 (24%), Positives = 91/210 (43%), Gaps = 27/210 (12%)
Query: 259 LIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEE---VLREVELLSSIKH--ENIVRII 313
IG GG+SKV++ + Q+ A+K + + E+ L+ ++ + I+R+
Sbjct: 63 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 314 GYCHSKEMYAIVYNLLNGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHR 370
Y + + +V N L +LK+ + ER + +A+ +H I+H
Sbjct: 123 DYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH---QHGIVHS 179
Query: 371 DVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPE-------- 422
D+K +N L+ + +L DFG A +Q + +V + VG Y+ PE
Sbjct: 180 DLKPANFLIVDG--MLKLIDFGIA---NQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSS 234
Query: 423 ---YMMYGKVDEKIDVYSYGVVLLELITGK 449
K+ K DV+S G +L + GK
Sbjct: 235 RENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 5e-30
Identities = 63/284 (22%), Positives = 107/284 (37%), Gaps = 38/284 (13%)
Query: 172 SKYPAFGQPATTRQLQKSLTAPSSSTSSTTRQESDVGVCIAQETVQVPESIKRKIFEKLA 231
S + GQ + L K+ ++ S+ + D + E ++ +
Sbjct: 2 SGSVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDY---------- 51
Query: 232 VLEAEGSSRRFTSQELCHLTHNFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWS 290
E T Q +G+G +V+R + G AVK ++ +
Sbjct: 52 --EYREEVHWMTHQPR------------VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR 97
Query: 291 EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV--YNLLNGSLKQYLKQLKWNERMDV 348
EE+ + + IV + G I L GSL Q +KQ+
Sbjct: 98 VEEL----VACAGLSSPRIVPLYGAVREGPWVNIFMEL-LEGGSLGQLIKQMGCLPEDRA 152
Query: 349 AIGVA---KALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE 405
+ + LEYLH I+H DVK+ N+LLS + L DFG A+
Sbjct: 153 LYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKS 209
Query: 406 NVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
+ + GT ++APE +M D K+D++S ++L ++ G
Sbjct: 210 LLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC 253
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 9e-30
Identities = 53/208 (25%), Positives = 87/208 (41%), Gaps = 19/208 (9%)
Query: 253 NFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLS-SIKHENIVR 311
+F PK ++G G + D + AVK + REV+LL S +H N++R
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC--FSFADREVQLLRESDEHPNVIR 82
Query: 312 IIGYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVAK----ALEYLHHTCDPPI 367
++ I L +L++Y++Q + I + + L +LH I
Sbjct: 83 YFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN---I 139
Query: 368 IHRDVKSSNILLSENFHHPQ----LSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEY 423
+HRD+K NIL+S H + +SDFG V GT G++APE
Sbjct: 140 VHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSG--VPGTEGWIAPEM 197
Query: 424 M---MYGKVDEKIDVYSYGVVLLELITG 448
+ +D++S G V +I+
Sbjct: 198 LSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-29
Identities = 59/208 (28%), Positives = 100/208 (48%), Gaps = 27/208 (12%)
Query: 259 LIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEVL----REVELLSSIKHENIVRI- 312
++G GG S+V+ + D + AVKVL+ + RE + +++ H IV +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 313 -IG--YCHSKEMYAIVYNLLNG-SLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDP 365
G + + IV ++G +L+ + + ++V +AL + H
Sbjct: 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN--- 135
Query: 366 PIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPV----NVVGTFGYLAP 421
IIHRDVK +NI++S + ++ DFG A ++++ V V+GT YL+P
Sbjct: 136 GIIHRDVKPANIMISAT-NAVKVMDFGIARA------IADSGNSVTQTAAVIGTAQYLSP 188
Query: 422 EYMMYGKVDEKIDVYSYGVVLLELITGK 449
E VD + DVYS G VL E++TG+
Sbjct: 189 EQARGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-28
Identities = 55/197 (27%), Positives = 98/197 (49%), Gaps = 17/197 (8%)
Query: 260 IGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSE--EEVLREVELLSSIKHENIVRIIG-Y 315
IG+G +V++ +V A+K++ + E++ +E+ +LS + + G Y
Sbjct: 30 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 316 CHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAI--GVAKALEYLHHTCDPPIIHRDVK 373
+++ I+ L GS L+ +E I + K L+YLH IHRD+K
Sbjct: 90 LKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSE---KKIHRDIK 146
Query: 374 SSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVN-VVGTFGYLAPEYMMYGKVDEK 432
++N+LLSE+ +L+DFG + Q+++ N VGT ++APE + D K
Sbjct: 147 AANVLLSEH-GEVKLADFGV------AGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK 199
Query: 433 IDVYSYGVVLLELITGK 449
D++S G+ +EL G+
Sbjct: 200 ADIWSLGITAIELARGE 216
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-27
Identities = 64/207 (30%), Positives = 103/207 (49%), Gaps = 34/207 (16%)
Query: 259 LIGQGGNSKVYRTNHVD-GQVAAVKVLK----CTNWSEEEVLREVELLSSIKHENIVRII 313
+G+G VY + A+KVL E ++ REVE+ S ++H NI+R+
Sbjct: 16 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75
Query: 314 GYCHSKEMYAIVYNLL----NGSLKQYLKQLKWNERMDVAIG------VAKALEYLHHTC 363
GY H VY +L G++ + L++L + D +A AL Y H
Sbjct: 76 GYFHDATR---VYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSKR 129
Query: 364 DPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEY 423
+IHRD+K N+LL +++DFG + VH + + + ++ GT YL PE
Sbjct: 130 ---VIHRDIKPENLLLGSA-GELKIADFGWS-VH------APSSRRTDLCGTLDYLPPE- 177
Query: 424 MMYGKV-DEKIDVYSYGVVLLELITGK 449
M+ G++ DEK+D++S GV+ E + GK
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVGK 204
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 42/226 (18%), Positives = 75/226 (33%), Gaps = 34/226 (15%)
Query: 251 THNFSPKMLIGQGGNSKVYRTNHVD------GQVAAVKVLKCTN-WSEEEVLREVELLSS 303
+ L+G+G ++VY D Q +KV K N W + +E L
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123
Query: 304 IKHENIVRIIGYCHSKEMYAIVYNLLN-GSLKQYLKQLKW--------NERMDVAIGVAK 354
++ + +V L + G+L + K + A+ +
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183
Query: 355 ALEYLHHTCDPPIIHRDVKSSNILLSENFHHP----------QLSDFGAAMVHHQSHQVS 404
+E +H D IIH D+K N +L F L D G ++
Sbjct: 184 MIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI---DMKLFP 237
Query: 405 ENVKPVNVVGTFGYLAPEYMMYGKV-DEKIDVYSYGVVLLELITGK 449
+ T G+ E M+ K + +ID + + ++ G
Sbjct: 238 KGTIFTAKCETSGFQCVE-MLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 6e-27
Identities = 61/207 (29%), Positives = 96/207 (46%), Gaps = 22/207 (10%)
Query: 260 IGQGGNSKVYRTNHVD-GQVAAVKV--LKCTNWSEEEVLREVELLSSIKHENIVRIIG-Y 315
IG G + V + A+K L+ S +E+L+E++ +S H NIV +
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82
Query: 316 CHSKEMYAIVYNLLN-GSLKQYLKQLKWNERMDVAI-----------GVAKALEYLHHTC 363
E++ +V LL+ GS+ +K + + V + LEYLH
Sbjct: 83 VVKDELW-LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN- 140
Query: 364 DPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEY 423
IHRDVK+ NILL E+ Q++DFG + ++ N VGT ++APE
Sbjct: 141 --GQIHRDVKAGNILLGED-GSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEV 197
Query: 424 MMYGKV-DEKIDVYSYGVVLLELITGK 449
M + D K D++S+G+ +EL TG
Sbjct: 198 MEQVRGYDFKADIWSFGITAIELATGA 224
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-27
Identities = 54/188 (28%), Positives = 90/188 (47%), Gaps = 19/188 (10%)
Query: 268 VYRTNHVDGQVAAVKVLKCTNWSEE--EVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325
R ++ VA VK + T + + L+E +L H NIVR+IG C K+ IV
Sbjct: 134 RLRADNT--LVA-VKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 190
Query: 326 YNLL-NGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLS 380
L+ G +L+ +L+ + + A +EYL IHRD+ + N L++
Sbjct: 191 MELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVT 247
Query: 381 ENFHHPQLSDFG-AAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYG 439
E + ++SDFG + + S ++ V V T APE + YG+ + DV+S+G
Sbjct: 248 EK-NVLKISDFGMSREEADGVYAASGGLRQVPVKWT----APEALNYGRYSSESDVWSFG 302
Query: 440 VVLLELIT 447
++L E +
Sbjct: 303 ILLWETFS 310
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 7e-27
Identities = 59/222 (26%), Positives = 97/222 (43%), Gaps = 20/222 (9%)
Query: 238 SSRRFTSQELCHLTHNFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVL---KCTNWSEEE 293
+ F + + HL+ + +G G +V + V A+K++ + S +
Sbjct: 23 TPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSK 82
Query: 294 VLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLLNG-SLKQYLKQLKW-NERM--DVA 349
+L EV +L + H NI+++ + K Y +V G L + NE +
Sbjct: 83 LLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVII 142
Query: 350 IGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQL--SDFGAAMVHHQSHQVSENV 407
V + YLH I+HRD+K N+LL + DFG + V ++ E
Sbjct: 143 KQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKE-- 197
Query: 408 KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
+GT Y+APE ++ K DEK DV+S GV+L L+ G
Sbjct: 198 ----RLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGY 234
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 58/226 (25%), Positives = 99/226 (43%), Gaps = 29/226 (12%)
Query: 260 IGQGGNSKVYR-----TNHVDGQVAAVKVLK--CTNWSEEEVLREVELLSSIKHENIVRI 312
+G+G KV G+ AVK LK ++ +E+E+L ++ HENIV+
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 313 IGYCHSKE---MYAIVYNLLNGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDP 365
G C + I+ L +GSLK+YL ++ +++ A+ + K ++YL
Sbjct: 89 KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SR 145
Query: 366 PIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH---QVSENVK-PVNVVGTFGYLAP 421
+HRD+ + N+L+ H ++ DFG V ++ PV + AP
Sbjct: 146 QYVHRDLAARNVLVESE-HQVKIGDFGLTKAIETDKEYYTVKDDRDSPVF------WYAP 198
Query: 422 EYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWY 466
E +M K DV+S+GV L EL+T + + +
Sbjct: 199 ECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTH 244
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 42/178 (23%), Positives = 92/178 (51%), Gaps = 21/178 (11%)
Query: 280 AVKVLK--CTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGSLKQY 336
A+K L+ + + +E+L E +++S+ + ++ R++G C + + ++ L+ G L Y
Sbjct: 48 AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDY 106
Query: 337 LK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFG 392
++ + ++ + +AK + YL ++HRD+ + N+L+ H +++DFG
Sbjct: 107 VREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTP-QHVKITDFG 162
Query: 393 AA--MVHHQSHQVSENVK-PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT 447
A + + +E K P+ ++A E +++ + DV+SYGV + EL+T
Sbjct: 163 LAKLLGAEEKEYHAEGGKVPIK------WMALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 24/282 (8%), Positives = 62/282 (21%), Gaps = 56/282 (19%)
Query: 211 IAQETVQVPESIKRKIFEKLAVLEAEGSSRRFTSQELCHLTHNFSPKMLIGQGGNSKVYR 270
I + + + A + + + S L + G S V+
Sbjct: 22 IGYCREEALKEPAAMVEAVTATVWPQNAETTVDS-LLSQGERKLKLVEPLRVGDRSVVFL 80
Query: 271 -TNHVDGQVAAVKVLKCTNWS----EEEVLREVELLSSIKHENIVRIIGYCH-------- 317
+ + A+KV + E + + + E+
Sbjct: 81 VRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140
Query: 318 ------------------SKEMYAIVYNLLNGSLKQYLKQLK----------WNERMDVA 349
+ Y ++ + L+ L +
Sbjct: 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILT 200
Query: 350 IGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKP 409
+ + L ++H N+ + + L D A +
Sbjct: 201 AQLIRLAANLQSKG---LVHGHFTPDNLFIMPD-GRLMLGDVSAL--------WKVGTRG 248
Query: 410 VNVVGTFGYLAPEYMM--YGKVDEKIDVYSYGVVLLELITGK 449
Y E++ ++ + G+ + +
Sbjct: 249 PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 1e-26
Identities = 54/195 (27%), Positives = 100/195 (51%), Gaps = 17/195 (8%)
Query: 260 IGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSK 319
+GQG +V+ A+K LK S E L+E +++ ++HE +V++ +
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 251
Query: 320 EMYAIVYNLLNGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKS 374
+Y + + GSL +LK L+ + +D+A +A + Y+ +HRD+++
Sbjct: 252 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRA 308
Query: 375 SNILLSENFHHPQLSDFGAA-MVHHQSHQVSENVK-PVNVVGTFGYLAPEYMMYGKVDEK 432
+NIL+ EN +++DFG A ++ + + K P+ + APE +YG+ K
Sbjct: 309 ANILVGEN-LVCKVADFGLARLIEDNEYTARQGAKFPIK------WTAPEAALYGRFTIK 361
Query: 433 IDVYSYGVVLLELIT 447
DV+S+G++L EL T
Sbjct: 362 SDVWSFGILLTELTT 376
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-26
Identities = 51/208 (24%), Positives = 95/208 (45%), Gaps = 34/208 (16%)
Query: 259 LIGQGGNSKVYRTNHVD-GQVAAVKVLK----CTNWSEEEVLREVELLSSIKHENIVRII 313
+G+GG +K + + D +V A K++ E++ E+ + S+ H+++V
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 314 GYCHSKEMYAIVYNLL----NGSLKQYLKQLKWNERM--DVA----IGVAKALEYLHHTC 363
G+ + V+ +L SL + K+ K + A + +YLH
Sbjct: 108 GFFEDNDF---VFVVLELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRNR 161
Query: 364 DPPIIHRDVKSSNILLSENFHHPQLSDFG-AAMVHHQSHQVSENVKPVNVVGTFGYLAPE 422
+IHRD+K N+ L+E+ ++ DFG A V + + + GT Y+APE
Sbjct: 162 ---VIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYDGE------RKKVLCGTPNYIAPE 211
Query: 423 YMMYGKV-DEKIDVYSYGVVLLELITGK 449
++ K ++DV+S G ++ L+ GK
Sbjct: 212 -VLSKKGHSFEVDVWSIGCIMYTLLVGK 238
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 54/195 (27%), Positives = 100/195 (51%), Gaps = 17/195 (8%)
Query: 260 IGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSK 319
+GQG +V+ A+K LK S E L+E +++ ++HE +V++ +
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 334
Query: 320 EMYAIVYNLLNGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKS 374
+Y + + GSL +LK L+ + +D+A +A + Y+ +HRD+++
Sbjct: 335 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRA 391
Query: 375 SNILLSENFHHPQLSDFGAA-MVHHQSHQVSENVK-PVNVVGTFGYLAPEYMMYGKVDEK 432
+NIL+ EN +++DFG A ++ + + K P+ + APE +YG+ K
Sbjct: 392 ANILVGEN-LVCKVADFGLARLIEDNEYTARQGAKFPIK------WTAPEAALYGRFTIK 444
Query: 433 IDVYSYGVVLLELIT 447
DV+S+G++L EL T
Sbjct: 445 SDVWSFGILLTELTT 459
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 51/208 (24%), Positives = 95/208 (45%), Gaps = 34/208 (16%)
Query: 259 LIGQGGNSKVYRTNHVD-GQVAAVKVLK----CTNWSEEEVLREVELLSSIKHENIVRII 313
+G+GG +K + + D +V A K++ E++ E+ + S+ H+++V
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 314 GYCHSKEMYAIVYNLL----NGSLKQYLKQLKWNERM--DVA----IGVAKALEYLHHTC 363
G+ + V+ +L SL + K+ K + A + +YLH
Sbjct: 82 GFFEDNDF---VFVVLELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRNR 135
Query: 364 DPPIIHRDVKSSNILLSENFHHPQLSDFG-AAMVHHQSHQVSENVKPVNVVGTFGYLAPE 422
+IHRD+K N+ L+E+ ++ DFG A V + + + GT Y+APE
Sbjct: 136 ---VIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYDGE------RKKVLCGTPNYIAPE 185
Query: 423 YMMYGKV-DEKIDVYSYGVVLLELITGK 449
++ K ++DV+S G ++ L+ GK
Sbjct: 186 -VLSKKGHSFEVDVWSIGCIMYTLLVGK 212
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 49/195 (25%), Positives = 100/195 (51%), Gaps = 17/195 (8%)
Query: 260 IGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSK 319
+G G +V+ + AVK +K + S E L E ++ +++H+ +V++ +
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKE 255
Query: 320 EMYAIVYNLLNGSLKQYLK-----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKS 374
+Y I + GSL +LK + + +D + +A+ + ++ IHRD+++
Sbjct: 256 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRA 312
Query: 375 SNILLSENFHHPQLSDFGAA-MVHHQSHQVSENVK-PVNVVGTFGYLAPEYMMYGKVDEK 432
+NIL+S + +++DFG A ++ + E K P+ + APE + +G K
Sbjct: 313 ANILVSAS-LVCKIADFGLARVIEDNEYTAREGAKFPIK------WTAPEAINFGSFTIK 365
Query: 433 IDVYSYGVVLLELIT 447
DV+S+G++L+E++T
Sbjct: 366 SDVWSFGILLMEIVT 380
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 5e-26
Identities = 58/200 (29%), Positives = 97/200 (48%), Gaps = 21/200 (10%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLK----CTNWSEEEVLREVELLSSIKHENIVRIIG 314
+G+G +V + + GQ AVKV+ +E +LREV+LL + H NI+++
Sbjct: 34 LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 315 YCHSKEMYAIVYNLLNG-SLKQYLKQLKW-NERM--DVAIGVAKALEYLHHTCDPPIIHR 370
+ K + +V + G L + K +E + V + Y+H I+HR
Sbjct: 94 FFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK---IVHR 150
Query: 371 DVKSSNILLSENFHHPQL--SDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGK 428
D+K N+LL + DFG + S ++ + +GT Y+APE +++G
Sbjct: 151 DLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD------KIGTAYYIAPE-VLHGT 203
Query: 429 VDEKIDVYSYGVVLLELITG 448
DEK DV+S GV+L L++G
Sbjct: 204 YDEKCDVWSTGVILYILLSG 223
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 6e-26
Identities = 58/198 (29%), Positives = 97/198 (48%), Gaps = 21/198 (10%)
Query: 260 IGQGGNSKVYR--TNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYC- 316
+G G +VY VA VK LK EE L+E ++ IKH N+V+++G C
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVA-VKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 317 HSKEMYAIVYNLLNGSLKQYLK-----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRD 371
Y I + G+L YL+ ++ + +A ++ A+EYL IHR+
Sbjct: 287 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRN 343
Query: 372 VKSSNILLSENFHHPQLSDFGAA-MVHHQSHQVSENVK-PVNVVGTFGYLAPEYMMYGKV 429
+ + N L+ EN H +++DFG + ++ ++ K P+ + APE + Y K
Sbjct: 344 LAARNCLVGEN-HLVKVADFGLSRLMTGDTYTAHAGAKFPIK------WTAPESLAYNKF 396
Query: 430 DEKIDVYSYGVVLLELIT 447
K DV+++GV+L E+ T
Sbjct: 397 SIKSDVWAFGVLLWEIAT 414
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 7e-26
Identities = 60/199 (30%), Positives = 95/199 (47%), Gaps = 20/199 (10%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVL---KCTNWSEEEVLREVELLSSIKHENIVRIIGY 315
+G+G +V + + + Q AVKV+ N +LREVELL + H NI+++
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 316 CHSKEMYAIVYNLLNG-SLKQYLKQLKW-NERM--DVAIGVAKALEYLHHTCDPPIIHRD 371
+ IV L G L + + K +E + V + Y+H I+HRD
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRD 146
Query: 372 VKSSNILLSENFHHPQL--SDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKV 429
+K NILL + DFG + Q+ ++ + +GT Y+APE ++ G
Sbjct: 147 LKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD------RIGTAYYIAPE-VLRGTY 199
Query: 430 DEKIDVYSYGVVLLELITG 448
DEK DV+S GV+L L++G
Sbjct: 200 DEKCDVWSAGVILYILLSG 218
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 9e-26
Identities = 56/205 (27%), Positives = 95/205 (46%), Gaps = 28/205 (13%)
Query: 260 IGQGGNSKVYR-----TNHVDGQVAAVKVLK--CTNWSEEEVLREVELLSSIKHENIVRI 312
+G+G KV TN G++ AVK LK +E+++L ++ HE+I++
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 313 IGYCHSKE---MYAIVYNLLNGSLKQYLK--QLKWNERMDVAIGVAKALEYLH-HTCDPP 366
G C + ++ + GSL+ YL + + + A + + + YLH
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHY--- 155
Query: 367 IIHRDVKSSNILLSENFHHPQLSDFGAA--MVHHQSH-QVSENVK-PVNVVGTFGYLAPE 422
IHRD+ + N+LL + ++ DFG A + + +V E+ PV + APE
Sbjct: 156 -IHRDLAARNVLLDND-RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF------WYAPE 207
Query: 423 YMMYGKVDEKIDVYSYGVVLLELIT 447
+ K DV+S+GV L EL+T
Sbjct: 208 CLKEYKFYYASDVWSFGVTLYELLT 232
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 21/203 (10%)
Query: 259 LIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSE-EEVLREVELLSSIKHENIVRIIGYC 316
++G+G VY + + A+K + + + + E+ L +KH+NIV+ +G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 317 HSKEMYAIVYNLL-NGSLKQYLKQ----LKWNERMDVAIGVA---KALEYLHHTCDPPII 368
I + GSL L+ LK NE+ + + L+YLH I+
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQT-IGFYTKQILEGLKYLHDNQ---IV 144
Query: 369 HRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGK 428
HRD+K N+L++ ++SDFG + N GT Y+APE + G
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTS-----KRLAGINPCTETFTGTLQYMAPEIIDKGP 199
Query: 429 V--DEKIDVYSYGVVLLELITGK 449
+ D++S G ++E+ TGK
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGK 222
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 52/229 (22%), Positives = 87/229 (37%), Gaps = 36/229 (15%)
Query: 250 LTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLS-SIKHEN 308
L + + ++G G + V G+ AVK + + L E++LL+ S H N
Sbjct: 13 LKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF--CDIALMEIKLLTESDDHPN 70
Query: 309 IVRIIGYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIG----------VAKALEY 358
++R + I L N +L+ ++ ++ +A + +
Sbjct: 71 VIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 359 LHHTCDPPIIHRDVKSSNILLSENFHHPQ------------LSDFGAAMVHHQSHQVSEN 406
LH IIHRD+K NIL+S + +SDFG S Q S
Sbjct: 131 LHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC-KKLDSGQSSFR 186
Query: 407 VKPVNVVGTFGYLAPE-------YMMYGKVDEKIDVYSYGVVLLELITG 448
N GT G+ APE ++ ID++S G V +++
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 44/217 (20%), Positives = 78/217 (35%), Gaps = 28/217 (12%)
Query: 259 LIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEE---VLREVELLSSI-KHENIVRII 313
IG G V++ +DG + A+K K + LREV + + +H ++VR
Sbjct: 18 KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYF 77
Query: 314 G-YCHSKEMYAIVYNLLN-GSLKQYLKQLKWNER-------MDVAIGVAKALEYLHHTCD 364
+ M I N GSL + + D+ + V + L Y+H
Sbjct: 78 SAWAEDDHML-IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---S 133
Query: 365 PPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ---------VSENVKPVNVVGT 415
++H D+K SNI +S S+ G + V+ P G
Sbjct: 134 MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGD 193
Query: 416 FGYLAPEYMMYGKV-DEKIDVYSYGVVLLELITGKEA 451
+LA E + K D+++ + ++ +
Sbjct: 194 SRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 56/195 (28%), Positives = 102/195 (52%), Gaps = 17/195 (8%)
Query: 260 IGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSK 319
+G G +V+ + AVK LK + S + L E L+ ++H+ +VR+ +
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 80
Query: 320 EMYAIVYNLLNGSLKQYLK-----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKS 374
+Y I + NGSL +LK +L N+ +D+A +A+ + ++ IHRD+++
Sbjct: 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRA 137
Query: 375 SNILLSENFHHPQLSDFGAA-MVHHQSHQVSENVK-PVNVVGTFGYLAPEYMMYGKVDEK 432
+NIL+S+ +++DFG A ++ + E K P+ + APE + YG K
Sbjct: 138 ANILVSDT-LSCKIADFGLARLIEDNEYTAREGAKFPIK------WTAPEAINYGTFTIK 190
Query: 433 IDVYSYGVVLLELIT 447
DV+S+G++L E++T
Sbjct: 191 SDVWSFGILLTEIVT 205
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 52/206 (25%), Positives = 102/206 (49%), Gaps = 22/206 (10%)
Query: 253 NFSPKMLIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVR 311
F +G+G VY+ H + GQ+ A+K + + +E+++E+ ++ ++V+
Sbjct: 30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVK 88
Query: 312 IIG-YCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMD------VAIGVAKALEYLHHTCD 364
G Y + +++ ++ GS+ ++ N+ + + K LEYLH
Sbjct: 89 YYGSYFKNTDLWIVMEYCGAGSVSDIIRLR--NKTLTEDEIATILQSTLKGLEYLHFM-- 144
Query: 365 PPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVN-VVGTFGYLAPEY 423
IHRD+K+ NILL+ H +L+DFG + Q+++ + N V+GT ++APE
Sbjct: 145 -RKIHRDIKAGNILLNTE-GHAKLADFGV------AGQLTDTMAKRNTVIGTPFWMAPEV 196
Query: 424 MMYGKVDEKIDVYSYGVVLLELITGK 449
+ + D++S G+ +E+ GK
Sbjct: 197 IQEIGYNCVADIWSLGITAIEMAEGK 222
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 36/208 (17%)
Query: 259 LIGQGGNSKVYRTNHVD-GQVAAVKVLK----CTNWSEEEVLREVELLSSIKHENIVRII 313
+G+G VY + A+KVL E ++ RE+E+ S ++H NI+R+
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 314 GYCHSKEMYAIVYNLL----NGSLKQYLKQLKWNERMDVAIG------VAKALEYLHHTC 363
Y H ++ +Y +L G L + L++ R D +A AL Y H
Sbjct: 81 NYFHDRKR---IYLMLEFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYCHERK 134
Query: 364 DPPIIHRDVKSSNILLSENFHHPQLSDFG-AAMVHHQSHQVSENVKPVNVVGTFGYLAPE 422
+IHRD+K N+L+ +++DFG + + GT YL PE
Sbjct: 135 ---VIHRDIKPENLLMGYK-GELKIADFGWSVHAPSLRRRTM--------CGTLDYLPPE 182
Query: 423 YMMYGKV-DEKIDVYSYGVVLLELITGK 449
M+ GK DEK+D++ GV+ E + G
Sbjct: 183 -MIEGKTHDEKVDLWCAGVLCYEFLVGM 209
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 56/210 (26%), Positives = 95/210 (45%), Gaps = 31/210 (14%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWS--------------EEEVLREVELLSSI 304
+G G +V A+KV+K + + EE+ E+ LL S+
Sbjct: 44 LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 305 KHENIVRIIGYCHSKEMYAIVYNLLNGS--LKQYLKQLKWNERM--DVAIGVAKALEYLH 360
H NI+++ K+ + +V G +Q + + K++E ++ + + YLH
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLH 163
Query: 361 HTCDPPIIHRDVKSSNILLSENFHHPQL--SDFGAAMVHHQSHQVSENVKPVNVVGTFGY 418
I+HRD+K NILL + DFG S S++ K + +GT Y
Sbjct: 164 KHN---IVHRDIKPENILLENKNSLLNIKIVDFGL------SSFFSKDYKLRDRLGTAYY 214
Query: 419 LAPEYMMYGKVDEKIDVYSYGVVLLELITG 448
+APE ++ K +EK DV+S GV++ L+ G
Sbjct: 215 IAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-25
Identities = 49/197 (24%), Positives = 90/197 (45%), Gaps = 21/197 (10%)
Query: 260 IGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSK 319
IG G V+ ++ A+K ++ SEE+ + E E++ + H +V++ G C +
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 75
Query: 320 EMYAIVYNLL-NGSLKQYLK----QLKWNERMDVAIGVAKALEYL--HHTCDPPIIHRDV 372
+V + +G L YL+ + + + V + + YL +IHRD+
Sbjct: 76 APICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC-----VIHRDL 130
Query: 373 KSSNILLSENFHHPQLSDFGAA-MVHHQSHQVSENVK-PVNVVGTFGYLAPEYMMYGKVD 430
+ N L+ EN ++SDFG V + S K PV + +PE + +
Sbjct: 131 AARNCLVGEN-QVIKVSDFGMTRFVLDDQYTSSTGTKFPVK------WASPEVFSFSRYS 183
Query: 431 EKIDVYSYGVVLLELIT 447
K DV+S+GV++ E+ +
Sbjct: 184 SKSDVWSFGVLMWEVFS 200
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 49/214 (22%), Positives = 88/214 (41%), Gaps = 32/214 (14%)
Query: 259 LIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEE--VLREVELLSSIKHENIVRIIGY 315
++GQG + V+R H G + A+KV ++ +RE E+L + H+NIV++
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 316 --CHSKEMYAIVYNLLN-GSLKQYLKQLKWNERM--DVAIG----VAKALEYLHHTCDPP 366
+ ++ GSL L++ + + V + +L
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--- 132
Query: 367 IIHRDVKSSNILLSENFHHPQ---LSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPE- 422
I+HR++K NI+ L+DFGAA ++ ++ + V++ GT YL P+
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA------RELEDDEQFVSLYGTEEYLHPDM 186
Query: 423 -------YMMYGKVDEKIDVYSYGVVLLELITGK 449
K +D++S GV TG
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-25
Identities = 58/196 (29%), Positives = 104/196 (53%), Gaps = 16/196 (8%)
Query: 260 IGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEEVL-REVELLSSIKHENIVRIIG-YC 316
IG+G V G+ AVK++ E+L EV ++ +H N+V + Y
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 317 HSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAI--GVAKALEYLHHTCDPPIIHRDVKS 374
+E++ ++ L G+L + Q++ NE + V +AL YLH +IHRD+KS
Sbjct: 113 VGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKS 169
Query: 375 SNILLSENFHHPQLSDFGAAMVHHQSHQVSENV-KPVNVVGTFGYLAPEYMMYGKVDEKI 433
+ILL+ + +LSDFG Q+S++V K ++VGT ++APE + ++
Sbjct: 170 DSILLTLD-GRVKLSDFGF------CAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEV 222
Query: 434 DVYSYGVVLLELITGK 449
D++S G++++E++ G+
Sbjct: 223 DIWSLGIMVIEMVDGE 238
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-25
Identities = 42/177 (23%), Positives = 90/177 (50%), Gaps = 19/177 (10%)
Query: 280 AVKVLK--CTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLLNGSLKQYL 337
A+K L+ + + +E+L E +++S+ + ++ R++G C + + I + G L Y+
Sbjct: 48 AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYV 107
Query: 338 K----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGA 393
+ + ++ + +AK + YL ++HRD+ + N+L+ H +++DFG
Sbjct: 108 REHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTP-QHVKITDFGL 163
Query: 394 A--MVHHQSHQVSENVK-PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT 447
A + + +E K P+ ++A E +++ + DV+SYGV + EL+T
Sbjct: 164 AKLLGAEEKEYHAEGGKVPIK------WMALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 45/177 (25%), Positives = 84/177 (47%), Gaps = 19/177 (10%)
Query: 280 AVKVLK--CTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLLNGSLKQYL 337
+KV++ S + V + + S+ H +IVR++G C + + L GSL ++
Sbjct: 46 CIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQLVTQYLPLGSLLDHV 105
Query: 338 K----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGA 393
+ L ++ + +AK + YL ++HR++ + N+LL Q++DFG
Sbjct: 106 RQHRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSP-SQVQVADFGV 161
Query: 394 A--MVHHQSHQVSENVK-PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT 447
A + + K P+ ++A E + +GK + DV+SYGV + EL+T
Sbjct: 162 ADLLPPDDKQLLYSEAKTPIK------WMALESIHFGKYTHQSDVWSYGVTVWELMT 212
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-25
Identities = 58/196 (29%), Positives = 100/196 (51%), Gaps = 16/196 (8%)
Query: 260 IGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEE-VLREVELLSSIKHENIVRIIG-YC 316
IGQG + VY V GQ A++ + ++E ++ E+ ++ K+ NIV + Y
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 317 HSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAI--GVAKALEYLHHTCDPPIIHRDVKS 374
E++ ++ L GSL + + +E A+ +ALE+LH +IHRD+KS
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKS 144
Query: 375 SNILLSENFHHPQLSDFGAAMVHHQSHQVSENV-KPVNVVGTFGYLAPEYMMYGKVDEKI 433
NILL + +L+DFG Q++ K +VGT ++APE + K+
Sbjct: 145 DNILLGMD-GSVKLTDFGFCA------QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 197
Query: 434 DVYSYGVVLLELITGK 449
D++S G++ +E+I G+
Sbjct: 198 DIWSLGIMAIEMIEGE 213
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 6e-25
Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 27/205 (13%)
Query: 259 LIGQGGNSKVYRTNHVD-GQVAAVKVLK----CTNWSEEEVLREVELLSSIKHENIVRII 313
L+G+G + VYR + G A+K++ + V EV++ +KH +I+ +
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 314 GYCHSKEMYAIVYNLL----NGSLKQYLKQLKWNERMDVAIG----VAKALEYLHHTCDP 365
Y VY +L NG + +YLK + A + + YLH
Sbjct: 78 NYFEDSNY---VYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG-- 132
Query: 366 PIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMM 425
I+HRD+ SN+LL+ N + +++DFG A + + K + GT Y++PE +
Sbjct: 133 -ILHRDLTLSNLLLTRN-MNIKIADFGLA-----TQLKMPHEKHYTLCGTPNYISPE-IA 184
Query: 426 YGKV-DEKIDVYSYGVVLLELITGK 449
+ DV+S G + L+ G+
Sbjct: 185 TRSAHGLESDVWSLGCMFYTLLIGR 209
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 58/198 (29%), Positives = 96/198 (48%), Gaps = 19/198 (9%)
Query: 260 IGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWSEE--EVLREVELLSSIKHENIVRIIG-Y 315
+G G V++ +H G V A K++ +++RE+++L IV G +
Sbjct: 41 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 100
Query: 316 CHSKEMYAIVYNLLN-GSLKQYLKQLK-WNERM--DVAIGVAKALEYLHHTCDPPIIHRD 371
E+ I ++ GSL Q LK+ E++ V+I V K L YL I+HRD
Sbjct: 101 YSDGEIS-ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRD 157
Query: 372 VKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDE 431
VK SNIL++ +L DFG S Q+ +++ V GT Y++PE +
Sbjct: 158 VKPSNILVNSR-GEIKLCDFGV------SGQLIDSMANSFV-GTRSYMSPERLQGTHYSV 209
Query: 432 KIDVYSYGVVLLELITGK 449
+ D++S G+ L+E+ G+
Sbjct: 210 QSDIWSMGLSLVEMAVGR 227
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 7e-25
Identities = 50/197 (25%), Positives = 97/197 (49%), Gaps = 21/197 (10%)
Query: 260 IGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSK 319
+G G V A+K++K + SE+E + E +++ ++ HE +V++ G C +
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 91
Query: 320 EMYAIVYNLL-NGSLKQYLK----QLKWNERMDVAIGVAKALEYL--HHTCDPPIIHRDV 372
I+ + NG L YL+ + + + +++ V +A+EYL +HRD+
Sbjct: 92 RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ-----FLHRDL 146
Query: 373 KSSNILLSENFHHPQLSDFGAA-MVHHQSHQVSENVK-PVNVVGTFGYLAPEYMMYGKVD 430
+ N L+++ ++SDFG + V + S K PV + PE +MY K
Sbjct: 147 AARNCLVNDQ-GVVKVSDFGLSRYVLDDEYTSSVGSKFPVR------WSPPEVLMYSKFS 199
Query: 431 EKIDVYSYGVVLLELIT 447
K D++++GV++ E+ +
Sbjct: 200 SKSDIWAFGVLMWEIYS 216
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 7e-25
Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 25/206 (12%)
Query: 260 IGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWSEE--EVLREVE-LLSSIKHENIVRIIGY 315
IG+G V + H GQ+ AVK ++ T +E ++L +++ ++ S IV+ G
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 316 CHSKEMYAIVYNLLNGSLKQYLKQLKWNERMD--------VAIGVAKALEYLHHTCDPPI 367
+ I L++ S ++ K + + + KAL +L + I
Sbjct: 90 LFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE--NLKI 147
Query: 368 IHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYG 427
IHRD+K SNILL + + +L DFG + S Q+ +++ G Y+APE +
Sbjct: 148 IHRDIKPSNILLDRS-GNIKLCDFG---I---SGQLVDSIAKTRDAGCRPYMAPERIDPS 200
Query: 428 KV----DEKIDVYSYGVVLLELITGK 449
D + DV+S G+ L EL TG+
Sbjct: 201 ASRQGYDVRSDVWSLGITLYELATGR 226
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 8e-25
Identities = 51/197 (25%), Positives = 90/197 (45%), Gaps = 21/197 (10%)
Query: 260 IGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSK 319
+G G V AVK++K + SE+E +E + + + H +V+ G C +
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKE 75
Query: 320 EMYAIVYNLL-NGSLKQYLK----QLKWNERMDVAIGVAKALEYL--HHTCDPPIIHRDV 372
IV + NG L YL+ L+ ++ +++ V + + +L H IHRD+
Sbjct: 76 YPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ-----FIHRDL 130
Query: 373 KSSNILLSENFHHPQLSDFGAA-MVHHQSHQVSENVK-PVNVVGTFGYLAPEYMMYGKVD 430
+ N L+ + ++SDFG V + S K PV + APE Y K
Sbjct: 131 AARNCLVDRD-LCVKVSDFGMTRYVLDDQYVSSVGTKFPVK------WSAPEVFHYFKYS 183
Query: 431 EKIDVYSYGVVLLELIT 447
K DV+++G+++ E+ +
Sbjct: 184 SKSDVWAFGILMWEVFS 200
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 62/236 (26%), Positives = 108/236 (45%), Gaps = 31/236 (13%)
Query: 228 EKLAVLEAEGSSRRFTSQELCHLTHNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKC 286
++ L G + +L +L +G G +V++ G V AVK ++
Sbjct: 8 KQTGYLTIGGQRYQAEINDLENLG-------EMGSGTCGQVWKMRFRKTGHVIAVKQMRR 60
Query: 287 TNWSEE--EVLREVE-LLSSIKHENIVRIIG-YCHSKEMYAIVYNLLNGSLKQYLKQLK- 341
+ EE +L +++ +L S IV+ G + + +++ I L+ ++ K+++
Sbjct: 61 SGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVF-IAMELMGTCAEKLKKRMQG 119
Query: 342 -WNERM--DVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398
ER+ + + + KAL YL +IHRDVK SNILL E +L DFG
Sbjct: 120 PIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDER-GQIKLCDFGI----- 171
Query: 399 QSHQVSENVKPVNVVGTFGYLAPEYMMYGKV-----DEKIDVYSYGVVLLELITGK 449
S ++ ++ G Y+APE + D + DV+S G+ L+EL TG+
Sbjct: 172 -SGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 51/206 (24%), Positives = 93/206 (45%), Gaps = 29/206 (14%)
Query: 260 IGQGGNSKVYR-----TNHVDGQVAAVKVLK-CTNWSEEEVLREVELLSSIKHENIVRII 313
+G+G V G + AVK L+ + + RE+++L ++ + IV+
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 314 GYCHSKE---MYAIVYNLLNGSLKQYLK----QLKWNERMDVAIGVAKALEYLH-HTCDP 365
G + + ++ L +G L+ +L+ +L + + + + K +EYL C
Sbjct: 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRC-- 148
Query: 366 PIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH---QVSENVK-PVNVVGTFGYLAP 421
+HRD+ + NIL+ H +++DFG A + V E + P+ + AP
Sbjct: 149 --VHRDLAARNILVESE-AHVKIADFGLAKLLPLDKDYYVVREPGQSPIF------WYAP 199
Query: 422 EYMMYGKVDEKIDVYSYGVVLLELIT 447
E + + DV+S+GVVL EL T
Sbjct: 200 ESLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-24
Identities = 62/206 (30%), Positives = 97/206 (47%), Gaps = 29/206 (14%)
Query: 260 IGQGGNSKVYR-----TNHVDGQVAAVKVLK-CTNWSEEEVLREVELLSSIKHENIVRII 313
+G+G V G+V AVK L+ T + RE+E+L S++H+NIV+
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 314 GYCHSKE---MYAIVYNLLNGSLKQYLK----QLKWNERMDVAIGVAKALEYLH-HTCDP 365
G C+S + I+ L GSL+ YL+ ++ + + + K +EYL
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY-- 135
Query: 366 PIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ---VSENVK-PVNVVGTFGYLAP 421
IHRD+ + NIL+ + ++ DFG V Q + V E + P+ + AP
Sbjct: 136 --IHRDLATRNILVENE-NRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF------WYAP 186
Query: 422 EYMMYGKVDEKIDVYSYGVVLLELIT 447
E + K DV+S+GVVL EL T
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFT 212
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-24
Identities = 50/207 (24%), Positives = 96/207 (46%), Gaps = 29/207 (14%)
Query: 257 KMLIGQGGNSKVYR--TNHVDGQVA-AVKVLK--CTNWSEEEVLREVELLSSIKHENIVR 311
+ +G G V + Q+ A+KVLK EE++RE +++ + + IVR
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 312 IIGYCHSKEMYAIVYNLL-NGSLKQYLK----QLKWNERMDVAIGVAKALEYL--HHTCD 364
+IG C ++ + +V + G L ++L ++ + ++ V+ ++YL +
Sbjct: 75 LIGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--- 130
Query: 365 PPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH---QVSENVK-PVNVVGTFGYLA 420
+HRD+ + N+LL H+ ++SDFG + K P+ + A
Sbjct: 131 --FVHRDLAARNVLLVNR-HYAKISDFGLSKALGADDSYYTARSAGKWPLK------WYA 181
Query: 421 PEYMMYGKVDEKIDVYSYGVVLLELIT 447
PE + + K + DV+SYGV + E ++
Sbjct: 182 PECINFRKFSSRSDVWSYGVTMWEALS 208
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-24
Identities = 58/198 (29%), Positives = 99/198 (50%), Gaps = 21/198 (10%)
Query: 260 IGQGGNSKVYR--TNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCH 317
+G G +VY VA VK LK EE L+E ++ IKH N+V+++G C
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVA-VKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 318 SKEMYAIVYNLL-NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRD 371
+ + I+ + G+L YL++ + + +A ++ A+EYL IHRD
Sbjct: 80 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRD 136
Query: 372 VKSSNILLSENFHHPQLSDFGAA-MVHHQSHQVSENVK-PVNVVGTFGYLAPEYMMYGKV 429
+ + N L+ EN H +++DFG + ++ ++ K P+ + APE + Y K
Sbjct: 137 LAARNCLVGEN-HLVKVADFGLSRLMTGDTYTAHAGAKFPIK------WTAPESLAYNKF 189
Query: 430 DEKIDVYSYGVVLLELIT 447
K DV+++GV+L E+ T
Sbjct: 190 SIKSDVWAFGVLLWEIAT 207
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 54/205 (26%), Positives = 97/205 (47%), Gaps = 24/205 (11%)
Query: 260 IGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWSEE--EVLREVE-LLSSIKHENIVRIIGY 315
+G+G V + HV GQ+ AVK ++ T S+E +L +++ + ++ V G
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 316 CHSKEMYAIVYNLLNGSLKQYLKQL-KWNERMD------VAIGVAKALEYLHHTCDPPII 368
+ I L++ SL ++ KQ+ + + +A+ + KALE+LH +I
Sbjct: 75 LFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VI 132
Query: 369 HRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPE----YM 424
HRDVK SN+L++ ++ DFG S + ++V G Y+APE +
Sbjct: 133 HRDVKPSNVLINAL-GQVKMCDFGI------SGYLVDDVAKDIDAGCKPYMAPERINPEL 185
Query: 425 MYGKVDEKIDVYSYGVVLLELITGK 449
K D++S G+ ++EL +
Sbjct: 186 NQKGYSVKSDIWSLGITMIELAILR 210
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-24
Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 27/205 (13%)
Query: 260 IGQGGNSKVYR-----TNHVDGQVAAVKVLK-CTNWSEEEVLREVELLSSIKHENIVRII 313
+G+G V G+V AVK L+ T + RE+E+L S++H+NIV+
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 314 GYCHSKE---MYAIVYNLLNGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPP 366
G C+S + I+ L GSL+ YL+ ++ + + + K +EYL
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--- 165
Query: 367 IIHRDVKSSNILLSENFHHPQLSDFGAA--MVHHQSH-QVSENVK-PVNVVGTFGYLAPE 422
IHRD+ + NIL+ + ++ DFG + + + +V E + P+ + APE
Sbjct: 166 YIHRDLATRNILVENE-NRVKIGDFGLTKVLPQDKEYYKVKEPGESPIF------WYAPE 218
Query: 423 YMMYGKVDEKIDVYSYGVVLLELIT 447
+ K DV+S+GVVL EL T
Sbjct: 219 SLTESKFSVASDVWSFGVVLYELFT 243
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 30/238 (12%), Positives = 73/238 (30%), Gaps = 55/238 (23%)
Query: 259 LIGQGGNSKVYR-TNHVDGQVAAVKVL---KCTNWSEEEVLRE----VELLSSIKHE--- 307
++GQ T+ G+ V V + + + ++E + LL IK++
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 308 ----------NIVRIIGYCHSKE-----------MYAIVYNLLNGSLKQYLKQLK----- 341
++V+ +Y + +L+ + + L
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 342 -----WNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMV 396
+ R+ + + V + L LHH ++H ++ +I+L + L+ F +
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQR-GGVFLTGFEHLVR 260
Query: 397 HHQSHQVSENVKPVNVVGTFGYLAPEYMMY-----GKVDEKIDVYSYGVVLLELITGK 449
S A + + + D ++ G+ + +
Sbjct: 261 DGASAVSPIGR----GFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 49/214 (22%), Positives = 83/214 (38%), Gaps = 32/214 (14%)
Query: 259 LIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEE--VLREVELLSSIKHENIVRIIGY 315
++GQG + V+R H G + A+KV ++ +RE E+L + H+NIV++
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 316 --CHSKEMYAIVYNLLN-GSLKQYLKQLKWNERM--DVAIG----VAKALEYLHHTCDPP 366
+ ++ GSL L++ + + V + +L +
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENG 132
Query: 367 IIHRDVKSSNILLSENFHHPQ---LSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPE- 422
I+HR++K NI+ L+DFGAA Q + GT YL P+
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS------LYGTEEYLHPDM 186
Query: 423 -------YMMYGKVDEKIDVYSYGVVLLELITGK 449
K +D++S GV TG
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 6e-24
Identities = 53/208 (25%), Positives = 84/208 (40%), Gaps = 27/208 (12%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVL--KCTNWSEEEVLREVELLSSIKHENIVRII--- 313
+G GG V R + G+ A+K + + + E E++++ + H N+V
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 314 ---GYCHSKEMYAIVYNLLN-GSLKQYLKQLKWNERM--DVAIGV----AKALEYLHHTC 363
++ + G L++YL Q + + + + AL YLH
Sbjct: 82 DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR 141
Query: 364 DPPIIHRDVKSSNILLSENFHHPQ--LSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAP 421
IIHRD+K NI+L + D G A Q +E VGT YLAP
Sbjct: 142 ---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTE------FVGTLQYLAP 192
Query: 422 EYMMYGKVDEKIDVYSYGVVLLELITGK 449
E + K +D +S+G + E ITG
Sbjct: 193 ELLEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 6e-24
Identities = 49/203 (24%), Positives = 99/203 (48%), Gaps = 28/203 (13%)
Query: 260 IGQGGNSKVYR---TNHVDGQVA-AVKVLK--CTNWSEEEVLREVELLSSIKHENIVRII 313
+G+G +VY TNH ++ AVK K CT ++E+ + E ++ ++ H +IV++I
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 314 GYCHSKEMYAIVYNLL-NGSLKQYLK----QLKWNERMDVAIGVAKALEYL--HHTCDPP 366
G + + I+ L G L YL+ LK + ++ + KA+ YL +
Sbjct: 80 GIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN----- 133
Query: 367 IIHRDVKSSNILLSENFHHPQLSDFGAA-MVHHQSHQVSENVK-PVNVVGTFGYLAPEYM 424
+HRD+ NIL++ +L DFG + + + + + + P+ +++PE +
Sbjct: 134 CVHRDIAVRNILVASP-ECVKLGDFGLSRYIEDEDYYKASVTRLPIK------WMSPESI 186
Query: 425 MYGKVDEKIDVYSYGVVLLELIT 447
+ + DV+ + V + E+++
Sbjct: 187 NFRRFTTASDVWMFAVCMWEILS 209
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 7e-24
Identities = 57/193 (29%), Positives = 93/193 (48%), Gaps = 20/193 (10%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVL---KCTNWSEEEVLREVELLSSIKHENIVRIIGY 315
+G+G +V + + + Q AVKV+ N +LREVELL + H NI+++
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 316 CHSKEMYAIVYNLLNGS--LKQYLKQLKWNERM--DVAIGVAKALEYLHHTCDPPIIHRD 371
+ IV L G + +K+ +++E + V + Y+H I+HRD
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMH---KHNIVHRD 146
Query: 372 VKSSNILLSENFHHPQL--SDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKV 429
+K NILL + DFG + Q+ ++ + +GT Y+APE ++ G
Sbjct: 147 LKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD------RIGTAYYIAPE-VLRGTY 199
Query: 430 DEKIDVYSYGVVL 442
DEK DV+S GV+L
Sbjct: 200 DEKCDVWSAGVIL 212
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 49/223 (21%), Positives = 90/223 (40%), Gaps = 45/223 (20%)
Query: 260 IGQGGNSKVYRTNHVDGQVAAVKVLK------------------CTNWSEEEVLREVELL 301
+ QG +K+ D + A+K + ++ E++++
Sbjct: 39 LNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 302 SSIKHENIVRIIGYCHS-KEMYAIVYNLLNGSLKQYL---KQLKWNERMDVAIGVAK--- 354
+ IK+E + G + E+Y I + N S+ ++ L N + I V K
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 355 -----ALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKP 409
+ Y+H+ + I HRDVK SNIL+ +N +LSDFG + + + K
Sbjct: 158 KSVLNSFSYIHNEKN--ICHRDVKPSNILMDKN-GRVKLSDFGES-------EYMVDKKI 207
Query: 410 VNVVGTFGYLAPEYMMYGK---VDEKIDVYSYGVVLLELITGK 449
GT+ ++ PE + K+D++S G+ L +
Sbjct: 208 KGSRGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 7e-24
Identities = 63/211 (29%), Positives = 98/211 (46%), Gaps = 32/211 (15%)
Query: 260 IGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEEVLREVELLSSI-KHENIVRIIGYCH 317
+G G +VY+ HV GQ+AA+KV+ T EEE+ +E+ +L H NI G
Sbjct: 32 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYG-AF 90
Query: 318 SKEMYAIVYNLL--------NGSLKQYLKQLKWNERMDVAIG-----VAKALEYLHHTCD 364
K+ + + L GS+ +K K N + I + + L +LH
Sbjct: 91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK- 149
Query: 365 PPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVN-VVGTFGYLAPEY 423
+IHRD+K N+LL+EN +L DFG S Q+ V N +GT ++APE
Sbjct: 150 --VIHRDIKGQNVLLTENA-EVKLVDFGV------SAQLDRTVGRRNTFIGTPYWMAPEV 200
Query: 424 MMYGKV-----DEKIDVYSYGVVLLELITGK 449
+ + D K D++S G+ +E+ G
Sbjct: 201 IACDENPDATYDFKSDLWSLGITAIEMAEGA 231
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 8e-24
Identities = 52/196 (26%), Positives = 100/196 (51%), Gaps = 23/196 (11%)
Query: 260 IGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSK 319
IG+G V ++ +VA VK +K + + L E +++ ++H N+V+++G +
Sbjct: 201 IGKGEFGDVMLGDYRGNKVA-VKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEE 258
Query: 320 E--MYAIVYNLLNGSLKQYLK-----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDV 372
+ +Y + + GSL YL+ L + + ++ V +A+EYL +HRD+
Sbjct: 259 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDL 315
Query: 373 KSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVK-PVNVVGTFGYLAPEYMMYGKVDE 431
+ N+L+SE+ + ++SDFG ++ + K PV + APE + K
Sbjct: 316 AARNVLVSED-NVAKVSDFGLT---KEASSTQDTGKLPVK------WTAPEALREKKFST 365
Query: 432 KIDVYSYGVVLLELIT 447
K DV+S+G++L E+ +
Sbjct: 366 KSDVWSFGILLWEIYS 381
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 9e-24
Identities = 53/207 (25%), Positives = 95/207 (45%), Gaps = 31/207 (14%)
Query: 260 IGQGGNSKVYR---TNHVDGQVA-AVKVLK--CTNWSEEEVLREVELLSSIKHENIVRII 313
IG+G VY + ++ A+K L E LRE L+ + H N++ +I
Sbjct: 29 IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 314 GYCHSKE--MYAIVYNLLNGSLKQYLK----QLKWNERMDVAIGVAKALEYL--HHTCDP 365
G E + ++ + +G L Q+++ + + + VA+ +EYL
Sbjct: 89 GIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK---- 144
Query: 366 PIIHRDVKSSNILLSENFHHPQLSDFGAA-MVHHQ---SHQVSENVK-PVNVVGTFGYLA 420
+HRD+ + N +L E+F +++DFG A + + S Q + + PV + A
Sbjct: 145 -FVHRDLAARNCMLDESFT-VKVADFGLARDILDREYYSVQQHRHARLPVK------WTA 196
Query: 421 PEYMMYGKVDEKIDVYSYGVVLLELIT 447
E + + K DV+S+GV+L EL+T
Sbjct: 197 LESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 1e-23
Identities = 47/201 (23%), Positives = 93/201 (46%), Gaps = 24/201 (11%)
Query: 260 IGQGGNSKVYR---TNHVDGQVA-AVKVLK--CTNWSEEEVLREVELLSSIKHENIVRII 313
IG+G V++ + + +A A+K K ++ E+ L+E + H +IV++I
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 314 GYCHSKEMYAIVYNLLNGSLKQYLK----QLKWNERMDVAIGVAKALEYL-HHTCDPPII 368
G ++ I+ G L+ +L+ L + A ++ AL YL +
Sbjct: 83 GVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF----V 138
Query: 369 HRDVKSSNILLSENFHHPQLSDFGAA-MVHHQSHQVSENVK-PVNVVGTFGYLAPEYMMY 426
HRD+ + N+L+S N +L DFG + + ++ + K P+ ++APE + +
Sbjct: 139 HRDIAARNVLVSSN-DCVKLGDFGLSRYMEDSTYYKASKGKLPIK------WMAPESINF 191
Query: 427 GKVDEKIDVYSYGVVLLELIT 447
+ DV+ +GV + E++
Sbjct: 192 RRFTSASDVWMFGVCMWEILM 212
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 45/216 (20%), Positives = 87/216 (40%), Gaps = 40/216 (18%)
Query: 260 IGQGGNSKVYR---TNHVDGQVA-AVKVLKCTNWSEEEV---LREVELLSSIKHENIVRI 312
+G+G V V AVK+LK + ++ LRE + H ++ ++
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 313 IGYC-------HSKEMYAIVYNLLNGSLKQYLKQLKWNER---------MDVAIGVAKAL 356
+G I+ + +G L +L + E + + +A +
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 357 EYL--HHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA-MVHHQS-HQVSENVK-PVN 411
EYL + IHRD+ + N +L+E+ ++DFG + ++ ++ K PV
Sbjct: 151 EYLSSRN-----FIHRDLAARNCMLAEDMT-VCVADFGLSRKIYSGDYYRQGCASKLPVK 204
Query: 412 VVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT 447
+LA E + DV+++GV + E++T
Sbjct: 205 ------WLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 1e-23
Identities = 48/181 (26%), Positives = 78/181 (43%), Gaps = 24/181 (13%)
Query: 280 AVKVLKCTNWSE----EEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGSLK 334
AVK LK S+ ++ +REV + S+ H N++R+ G + M +V L GSL
Sbjct: 50 AVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLL 108
Query: 335 QYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSD 390
L+ A+ VA+ + YL IHRD+ + N+LL+ ++ D
Sbjct: 109 DRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATR-DLVKIGD 164
Query: 391 FGAA---MVHHQSHQVSENVK-PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELI 446
FG + + + E+ K P + APE + D + +GV L E+
Sbjct: 165 FGLMRALPQNDDHYVMQEHRKVPFA------WCAPESLKTRTFSHASDTWMFGVTLWEMF 218
Query: 447 T 447
T
Sbjct: 219 T 219
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 68/258 (26%), Positives = 105/258 (40%), Gaps = 35/258 (13%)
Query: 212 AQETVQVPESIKRKIFEKLAVLEAEGSSRRFTSQELCHLTHNFSPKML------IGQGGN 265
+P + + + A G + ++ L P+ L IG G
Sbjct: 8 HHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSF 67
Query: 266 SKVYRTNHVD-GQVAAVKVLKCTNWSEEE----VLREVELLSSIKHENIVRIIG-YCHSK 319
VY V +V A+K + + E +++EV L ++H N ++ G Y
Sbjct: 68 GAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH 127
Query: 320 EMYAIVYNLLNGSLKQYLKQLK--WNERMDVAI--GVAKALEYLHHTCDPPIIHRDVKSS 375
+ +V GS L+ K E A+ G + L YLH +IHRDVK+
Sbjct: 128 TAW-LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAG 183
Query: 376 NILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVN-VVGTFGYLAPEYMMYGKV---DE 431
NILLSE +L DFG + + P N VGT ++APE ++ D
Sbjct: 184 NILLSEP-GLVKLGDFG----------SASIMAPANSFVGTPYWMAPEVILAMDEGQYDG 232
Query: 432 KIDVYSYGVVLLELITGK 449
K+DV+S G+ +EL K
Sbjct: 233 KVDVWSLGITCIELAERK 250
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 1e-23
Identities = 49/202 (24%), Positives = 81/202 (40%), Gaps = 23/202 (11%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVL--KCTNWSEEEVLREVELLSSIKHENIVRIIGYC 316
+G G V+ G +K + + E++ E+E+L S+ H NI++I
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 317 HSKEMYAIVYNLLNGS------LKQYLKQLKWNERM--DVAIGVAKALEYLHHTCDPPII 368
IV G + + +E ++ + AL Y H ++
Sbjct: 90 EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVV 146
Query: 369 HRDVKSSNILLSENFHHPQL--SDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY 426
H+D+K NIL + H + DFG + + N GT Y+APE +
Sbjct: 147 HKDLKPENILFQDTSPHSPIKIIDFGL------AELFKSDEHSTNAAGTALYMAPE-VFK 199
Query: 427 GKVDEKIDVYSYGVVLLELITG 448
V K D++S GVV+ L+TG
Sbjct: 200 RDVTFKCDIWSAGVVMYFLLTG 221
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 2e-23
Identities = 52/193 (26%), Positives = 97/193 (50%), Gaps = 27/193 (13%)
Query: 268 VYRTNHVDGQVAAVKVLK---CTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAI 324
Y+ V VA VK+LK ++E+L E ++ + + IVR+IG C ++ +
Sbjct: 37 YYQMKKVVKTVA-VKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWM-L 94
Query: 325 VYNLL-NGSLKQYL---KQLKWNERMDVAIGVAKALEYL--HHTCDPPIIHRDVKSSNIL 378
V + G L +YL + +K +++ V+ ++YL + +HRD+ + N+L
Sbjct: 95 VMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN-----FVHRDLAARNVL 149
Query: 379 LSENFHHPQLSDFGAA--MVHHQSH-QVSENVK-PVNVVGTFGYLAPEYMMYGKVDEKID 434
L H+ ++SDFG + + +++ + + K PV + APE + Y K K D
Sbjct: 150 LVTQ-HYAKISDFGLSKALRADENYYKAQTHGKWPVK------WYAPECINYYKFSSKSD 202
Query: 435 VYSYGVVLLELIT 447
V+S+GV++ E +
Sbjct: 203 VWSFGVLMWEAFS 215
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-23
Identities = 63/316 (19%), Positives = 124/316 (39%), Gaps = 32/316 (10%)
Query: 148 LVQRQGTSQQGSTNVLLKSSLSSSSKYPAFGQPATTRQLQKSLTAPSSSTSSTTRQESDV 207
LV+ G L ++ +SS+ + T +LT P +
Sbjct: 235 LVEYLKLKADGLIYCLKEACPNSSASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTP 294
Query: 208 GVCIAQETVQ-VPESIKRKIFEKLAVLEAEGSSRRFTSQELCHLTHNFSPKMLIGQGGNS 266
+ P + +FE E ++ + L + +G G
Sbjct: 295 EPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLI----ADIELGCGNFG 350
Query: 267 KVYR--TNHVDGQVA-AVKVLK--CTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEM 321
V + Q+ A+KVLK EE++RE +++ + + IVR+IG C ++ +
Sbjct: 351 SVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEAL 410
Query: 322 YAIVYNLLNGSLKQYLK----QLKWNERMDVAIGVAKALEYL--HHTCDPPIIHRDVKSS 375
++ G L ++L ++ + ++ V+ ++YL + +HR++ +
Sbjct: 411 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN-----FVHRNLAAR 465
Query: 376 NILLSENFHHPQLSDFGAAMVHHQSHQV---SENVK-PVNVVGTFGYLAPEYMMYGKVDE 431
N+LL H+ ++SDFG + K P+ + APE + + K
Sbjct: 466 NVLLVNR-HYAKISDFGLSKALGADDSYYTARSAGKWPLK------WYAPECINFRKFSS 518
Query: 432 KIDVYSYGVVLLELIT 447
+ DV+SYGV + E ++
Sbjct: 519 RSDVWSYGVTMWEALS 534
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 3e-23
Identities = 53/192 (27%), Positives = 95/192 (49%), Gaps = 18/192 (9%)
Query: 259 LIGQGGNSKVYR-TNHVDGQVAAVKVL-KCTNWSEEEVLREVELLSSIKHENIVRIIGYC 316
++G G S+V+ + G++ A+K + K + + + E+ +L IKHENIV +
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 317 HSKEMYAIVYNLLNGS--LKQYLKQLKWNERM--DVAIGVAKALEYLHHTCDPPIIHRDV 372
S Y +V L++G + L++ + E+ V V A++YLH + I+HRD+
Sbjct: 76 ESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLH---ENGIVHRDL 132
Query: 373 KSSNILLSENFHHPQL--SDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVD 430
K N+L + ++ +DFG + Q+ +S GT GY+APE +
Sbjct: 133 KPENLLYLTPEENSKIMITDFGLS-KMEQNGIMST------ACGTPGYVAPEVLAQKPYS 185
Query: 431 EKIDVYSYGVVL 442
+ +D +S GV+
Sbjct: 186 KAVDCWSIGVIT 197
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 3e-23
Identities = 52/197 (26%), Positives = 101/197 (51%), Gaps = 25/197 (12%)
Query: 260 IGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSK 319
IG+G V ++ +VA VK +K + + L E +++ ++H N+V+++G +
Sbjct: 29 IGKGEFGDVMLGDYRGNKVA-VKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEE 86
Query: 320 E--MYAIVYNLLNGSLKQYLKQ-----LKWNERMDVAIGVAKALEYL-HHTCDPPIIHRD 371
+ +Y + + GSL YL+ L + + ++ V +A+EYL + +HRD
Sbjct: 87 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF----VHRD 142
Query: 372 VKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVK-PVNVVGTFGYLAPEYMMYGKVD 430
+ + N+L+SE+ + ++SDFG ++ + K PV + APE + K
Sbjct: 143 LAARNVLVSED-NVAKVSDFGLT---KEASSTQDTGKLPVK------WTAPEALREKKFS 192
Query: 431 EKIDVYSYGVVLLELIT 447
K DV+S+G++L E+ +
Sbjct: 193 TKSDVWSFGILLWEIYS 209
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 100 bits (249), Expect = 3e-23
Identities = 30/244 (12%), Positives = 76/244 (31%), Gaps = 66/244 (27%)
Query: 259 LIGQGGNSKVYR-TNHVDGQVAAVKVL---KCTNWSEEEVLRE----------------- 297
++GQ T+ G+ V V + + + ++E
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 298 ---------VELLSSIKHENIVRIIGYCHSKEM--YAIVYNLLNGSLKQYLKQLK----- 341
+L+ + + ++R+ + +Y + +L+ + + L
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 342 -----WNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMV 396
+ R+ + + V + L LHH ++H ++ +I+L + L+ F +
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQR-GGVFLTGFEHLV- 254
Query: 397 HHQSHQVSENVKPVNVVGTFGYLAPEYMMY-----------GKVDEKIDVYSYGVVLLEL 445
+ V + G+ PE + D ++ G+V+ +
Sbjct: 255 --------RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI 306
Query: 446 ITGK 449
Sbjct: 307 WCAD 310
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 4e-23
Identities = 54/203 (26%), Positives = 107/203 (52%), Gaps = 23/203 (11%)
Query: 260 IGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSE-EEVLREVELLSSIKHENIVRIIG-YC 316
+G G KVY+ + + G +AA KV++ + E E+ + E+E+L++ H IV+++G Y
Sbjct: 27 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 317 HSKEMYAIVYNLLNGSLKQYLKQLK--WNERMDVAI--GVAKALEYLHHTCDPPIIHRDV 372
H +++ ++ G++ + +L E + + +AL +LH IIHRD+
Sbjct: 87 HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDL 143
Query: 373 KSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVN-VVGTFGYLAPEYMMYGKV-- 429
K+ N+L++ +L+DFG S + + ++ + +GT ++APE +M +
Sbjct: 144 KAGNVLMTLE-GDIRLADFGV------SAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 196
Query: 430 ---DEKIDVYSYGVVLLELITGK 449
D K D++S G+ L+E+ +
Sbjct: 197 TPYDYKADIWSLGITLIEMAQIE 219
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 5e-23
Identities = 47/216 (21%), Positives = 87/216 (40%), Gaps = 41/216 (18%)
Query: 260 IGQGGNSKVYR-----TNHVDGQVAAVKVLKCTNWSEEEV---LREVELLSSIKHENIVR 311
+G+G V + +VA VK +K N S+ E+ L E + H N++R
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVA-VKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100
Query: 312 IIGYCHSKEMYAIVYNLL------NGSLKQYLK---------QLKWNERMDVAIGVAKAL 356
++G C I ++ G L YL + + + +A +
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM 160
Query: 357 EYL--HHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA--MVHHQSHQVSENVK-PVN 411
EYL + +HRD+ + N +L ++ ++DFG + + ++ K PV
Sbjct: 161 EYLSNRN-----FLHRDLAARNCMLRDDMT-VCVADFGLSKKIYSGDYYRQGRIAKMPVK 214
Query: 412 VVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT 447
++A E + K DV+++GV + E+ T
Sbjct: 215 ------WIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 5e-23
Identities = 48/216 (22%), Positives = 98/216 (45%), Gaps = 19/216 (8%)
Query: 237 GSSRRFTSQELCHLTHNFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVL---KCTNWSEE 292
G F + N+ K +G+G S V R + G A K++ K + +
Sbjct: 14 GRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ 73
Query: 293 EVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLLNGS--LKQYLKQLKWNERM--DV 348
++ RE + ++H NIVR+ + + +V++L+ G + + + ++E
Sbjct: 74 KLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC 133
Query: 349 AIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQL--SDFGAAMVHHQSHQVSEN 406
+ +++ Y H I+HR++K N+LL+ + +DFG + +V+++
Sbjct: 134 IQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGL------AIEVNDS 184
Query: 407 VKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVL 442
GT GYL+PE + + +D+++ GV+L
Sbjct: 185 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 5e-23
Identities = 50/206 (24%), Positives = 90/206 (43%), Gaps = 29/206 (14%)
Query: 260 IGQGGNSKVYR-----TNHVDGQVAAVKVLK--CTNWSEEEVLREVELLSSIKHENIVRI 312
IG+G VY + A VK L + L E ++ H N++ +
Sbjct: 33 IGRGHFGCVYHGTLLDNDGKKIHCA-VKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91
Query: 313 IGYCHSKE--MYAIVYNLLNGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPP 366
+G C E ++ + +G L+ +++ + + + VAK ++YL
Sbjct: 92 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SKK 148
Query: 367 IIHRDVKSSNILLSENFHHPQLSDFGAA-MVHHQSHQVSENVK----PVNVVGTFGYLAP 421
+HRD+ + N +L E F +++DFG A ++ + + N PV ++A
Sbjct: 149 FVHRDLAARNCMLDEKFT-VKVADFGLARDMYDKEYYSVHNKTGAKLPVK------WMAL 201
Query: 422 EYMMYGKVDEKIDVYSYGVVLLELIT 447
E + K K DV+S+GV+L EL+T
Sbjct: 202 ESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-23
Identities = 47/201 (23%), Positives = 93/201 (46%), Gaps = 24/201 (11%)
Query: 260 IGQGGNSKVYR---TNHVDGQVA-AVKVLK--CTNWSEEEVLREVELLSSIKHENIVRII 313
IG+G V++ + + +A A+K K ++ E+ L+E + H +IV++I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 314 GYCHSKEMYAIVYNLLNGSLKQYLK----QLKWNERMDVAIGVAKALEYLH-HTCDPPII 368
G ++ I+ G L+ +L+ L + A ++ AL YL +
Sbjct: 458 GVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRF----V 513
Query: 369 HRDVKSSNILLSENFHHPQLSDFGAA-MVHHQSHQVSENVK-PVNVVGTFGYLAPEYMMY 426
HRD+ + N+L+S N +L DFG + + ++ + K P+ ++APE + +
Sbjct: 514 HRDIAARNVLVSSN-DCVKLGDFGLSRYMEDSTYYKASKGKLPIK------WMAPESINF 566
Query: 427 GKVDEKIDVYSYGVVLLELIT 447
+ DV+ +GV + E++
Sbjct: 567 RRFTSASDVWMFGVCMWEILM 587
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 6e-23
Identities = 46/203 (22%), Positives = 96/203 (47%), Gaps = 19/203 (9%)
Query: 250 LTHNFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVL---KCTNWSEEEVLREVELLSSIK 305
+ N+ K +G+G S V R + G A K++ K + +++ RE + ++
Sbjct: 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ 63
Query: 306 HENIVRIIGYCHSKEMYAIVYNLLNGS--LKQYLKQLKWNERM--DVAIGVAKALEYLHH 361
H NIVR+ + + +V++L+ G + + + ++E + +++ Y H
Sbjct: 64 HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH- 122
Query: 362 TCDPPIIHRDVKSSNILLSENFHHPQL--SDFGAAMVHHQSHQVSENVKPVNVVGTFGYL 419
I+HR++K N+LL+ + +DFG + +V+++ GT GYL
Sbjct: 123 --SNGIVHRNLKPENLLLASKAKGAAVKLADFGL------AIEVNDSEAWHGFAGTPGYL 174
Query: 420 APEYMMYGKVDEKIDVYSYGVVL 442
+PE + + +D+++ GV+L
Sbjct: 175 SPEVLKKDPYSKPVDIWACGVIL 197
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 9e-23
Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 25/210 (11%)
Query: 250 LTHNFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLK------CTNWSEEEVLREVELLS 302
+ +IG+G S V R N GQ AVK++ S E++ RE +
Sbjct: 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICH 81
Query: 303 SIKHENIVRIIGYCHSKEMYAIVYNLLNGS------LKQYLKQLKWNERM--DVAIGVAK 354
+KH +IV ++ S M +V+ ++G+ +K+ ++E + + +
Sbjct: 82 MLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE 141
Query: 355 ALEYLHHTCDPPIIHRDVKSSNILL-SENFHHP-QLSDFGAAMVHHQSHQVSENVKPVNV 412
AL Y H D IIHRDVK +LL S+ P +L FG A+ +S V+
Sbjct: 142 ALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAG-----GR 193
Query: 413 VGTFGYLAPEYMMYGKVDEKIDVYSYGVVL 442
VGT ++APE + + +DV+ GV+L
Sbjct: 194 VGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-22
Identities = 44/193 (22%), Positives = 89/193 (46%), Gaps = 18/193 (9%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVL---KCTNWSEEEVLREVELLSSIKHENIVRIIGY 315
+G+G S V R + GQ A ++ K + +++ RE + +KH NIVR+
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 316 CHSKEMYAIVYNLLNGS--LKQYLKQLKWNERM--DVAIGVAKALEYLHHTCDPPIIHRD 371
+ + ++++L+ G + + + ++E + +A+ + H ++HR+
Sbjct: 79 ISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG---VVHRN 135
Query: 372 VKSSNILLSENFHHPQL--SDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKV 429
+K N+LL+ + +DFG A+ Q GT GYL+PE +
Sbjct: 136 LKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF-----GFAGTPGYLSPEVLRKDPY 190
Query: 430 DEKIDVYSYGVVL 442
+ +D+++ GV+L
Sbjct: 191 GKPVDLWACGVIL 203
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 1e-22
Identities = 52/191 (27%), Positives = 89/191 (46%), Gaps = 17/191 (8%)
Query: 259 LIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCH 317
+G+G S VYR + A+KVLK ++ V E+ +L + H NI+++
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLK-KTVDKKIVRTEIGVLLRLSHPNIIKLKEIFE 118
Query: 318 SKEMYAIVYNLLNGS--LKQYLKQLKWNERM--DVAIGVAKALEYLHHTCDPPIIHRDVK 373
+ ++V L+ G + +++ ++ER D + +A+ YLH I+HRD+K
Sbjct: 119 TPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLK 175
Query: 374 SSNILLSENFHHPQL--SDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDE 431
N+L + L +DFG S V V V GT GY APE +
Sbjct: 176 PENLLYATPAPDAPLKIADFGL------SKIVEHQVLMKTVCGTPGYCAPEILRGCAYGP 229
Query: 432 KIDVYSYGVVL 442
++D++S G++
Sbjct: 230 EVDMWSVGIIT 240
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 2e-22
Identities = 49/209 (23%), Positives = 87/209 (41%), Gaps = 35/209 (16%)
Query: 260 IGQGGNSKVYR-----TNHVDGQVAAVKVLK--CTNWSEEEVLREVELLSSIKHENIVRI 312
IG+G VY + A VK L + L E ++ H N++ +
Sbjct: 97 IGRGHFGCVYHGTLLDNDGKKIHCA-VKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155
Query: 313 IGYCHSKE--MYAIVYNLLNGSLKQYLK----QLKWNERMDVAIGVAKALEYL--HHTCD 364
+G C E ++ + +G L+ +++ + + + VAK +++L
Sbjct: 156 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--- 212
Query: 365 PPIIHRDVKSSNILLSENFHHPQLSDFGAA-MVHHQSHQVSENVKPVNVVGTFGYL---- 419
+HRD+ + N +L E F +++DFG A ++ + N T L
Sbjct: 213 --FVHRDLAARNCMLDEKFT-VKVADFGLARDMYDKEFDSVHN-------KTGAKLPVKW 262
Query: 420 -APEYMMYGKVDEKIDVYSYGVVLLELIT 447
A E + K K DV+S+GV+L EL+T
Sbjct: 263 MALESLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 2e-22
Identities = 42/191 (21%), Positives = 75/191 (39%), Gaps = 18/191 (9%)
Query: 260 IGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEE-VLREVELLSSIKHENIVRIIGYCH 317
IG+G +V A K + + + +E+E++ S+ H NI+R+
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 318 SKEMYAIVYNLLNGS--LKQYLKQLKWNERM--DVAIGVAKALEYLHHTCDPPIIHRDVK 373
+V L G ++ + + + E + V A+ Y H + HRD+K
Sbjct: 77 DNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCH---KLNVAHRDLK 133
Query: 374 SSNILLSENFHHPQL--SDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDE 431
N L + L DFG A + VGT Y++P+ ++ G
Sbjct: 134 PENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT------KVGTPYYVSPQ-VLEGLYGP 186
Query: 432 KIDVYSYGVVL 442
+ D +S GV++
Sbjct: 187 ECDEWSAGVMM 197
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 3e-22
Identities = 45/212 (21%), Positives = 84/212 (39%), Gaps = 38/212 (17%)
Query: 260 IGQGGNSKVYR--------TNHVDGQVAAVKVLK-CTNWSEEEVLREVELLSSIKHENIV 310
+GQG +K+++ + +KVL E ++S + H+++V
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 311 RIIGYCHSKEMYAIVYNLL-NGSLKQYLK----QLKWNERMDVAIGVAKALEYL--HHTC 363
G C + +V + GSL YLK + +++VA +A A+ +L +
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT-- 133
Query: 364 DPPIIHRDVKSSNILLSENFHHPQ-------LSDFGAAMVHHQSHQVSENVKPVNVVGTF 416
+IH +V + NILL LSD G ++ + E +
Sbjct: 134 ---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP-------- 182
Query: 417 GYLAPEYMMYGKV-DEKIDVYSYGVVLLELIT 447
++ PE + K + D +S+G L E+ +
Sbjct: 183 -WVPPECIENPKNLNLATDKWSFGTTLWEICS 213
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 3e-22
Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 29/205 (14%)
Query: 260 IGQGGNSKVYR---TNHVDGQVA-AVKVLK--CTNWSEEEVLREVELLSSIKHENIVRII 313
+G G +V +++ A+K LK T + L E ++ H NI+R+
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 314 GYCHSKEMYAIVYNLL-NGSLKQYLK----QLKWNERMDVAIGVAKALEYL--HHTCDPP 366
G + IV + NGSL +L+ Q + + + G+A ++YL
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG----- 167
Query: 367 IIHRDVKSSNILLSENFHHPQLSDFGAAMV---HHQSHQVSENVK-PVNVVGTFGYLAPE 422
+HRD+ + NIL++ N ++SDFG V ++ + K P+ + +PE
Sbjct: 168 YVHRDLAARNILINSN-LVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIR------WTSPE 220
Query: 423 YMMYGKVDEKIDVYSYGVVLLELIT 447
+ Y K DV+SYG+VL E+++
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMS 245
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 3e-22
Identities = 55/220 (25%), Positives = 103/220 (46%), Gaps = 44/220 (20%)
Query: 260 IGQGGNSKVYR---TNHVDGQVA---AVKVLK-CTNWSEEEVLREVELLSSIKHENIVRI 312
+G+G KV+ N + AVK LK T + ++ RE ELL++++HE+IV+
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 313 IGYCHSKE-MYAIVYNLLNGSLKQYLK-------------------QLKWNERMDVAIGV 352
G C + + + + +G L ++L+ +L ++ + +A +
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 353 AKALEYL--HHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA--MVHHQSHQVSENVK 408
A + YL H +HRD+ + N L+ N ++ DFG + + ++V +
Sbjct: 143 ASGMVYLASQH-----FVHRDLATRNCLVGAN-LLVKIGDFGMSRDVYSTDYYRVGGHTM 196
Query: 409 -PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT 447
P+ ++ PE +MY K + DV+S+GV+L E+ T
Sbjct: 197 LPIR------WMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 3e-22
Identities = 52/205 (25%), Positives = 97/205 (47%), Gaps = 28/205 (13%)
Query: 260 IGQGGNSKVYR------TNHVDGQVAAVKVLK--CTNWSEEEVLREVELLSSIKHENIVR 311
IG G +VY+ + + VA +K LK T + L E ++ H NI+R
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVA-IKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 312 IIGYCHSKEMYAIVYNLL-NGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPP 366
+ G + I+ + NG+L ++L+ + + + + G+A ++YL +
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--- 167
Query: 367 IIHRDVKSSNILLSENFHHPQLSDFGAA---MVHHQSHQVSENVK-PVNVVGTFGYLAPE 422
+HRD+ + NIL++ N ++SDFG + ++ + K P+ + APE
Sbjct: 168 YVHRDLAARNILVNSN-LVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR------WTAPE 220
Query: 423 YMMYGKVDEKIDVYSYGVVLLELIT 447
+ Y K DV+S+G+V+ E++T
Sbjct: 221 AISYRKFTSASDVWSFGIVMWEVMT 245
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 4e-22
Identities = 54/202 (26%), Positives = 91/202 (45%), Gaps = 19/202 (9%)
Query: 257 KMLIGQGGNSKVYR-TNHVDGQVAAVKVL-KCTNWSEEEVLREVELLSSIK-HENIVRII 313
+ ++G+G +++V N + Q AVK++ K V REVE+L + H N++ +I
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 314 GYCHSKEMYAIVYNLLNGS--LKQYLKQLKWNERM--DVAIGVAKALEYLHHTCDPPIIH 369
+ ++ + +V+ + G L K+ +NE V VA AL++LH + I H
Sbjct: 78 EFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLH---NKGIAH 134
Query: 370 RDVKSSNILLSENFHHPQL--SDFGAAMVHHQSHQVSENVKPV--NVVGTFGYLAPE--- 422
RD+K NIL + DF + S P G+ Y+APE
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVE 194
Query: 423 --YMMYGKVDEKIDVYSYGVVL 442
D++ D++S GV+L
Sbjct: 195 AFSEEASIYDKRCDLWSLGVIL 216
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 6e-22
Identities = 57/203 (28%), Positives = 92/203 (45%), Gaps = 20/203 (9%)
Query: 249 HLTHNFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEVLREVE-LLSSIKH 306
T + K IG G S R + AVK++ + S+ + E+E LL +H
Sbjct: 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKII---DKSKRDPTEEIEILLRYGQH 75
Query: 307 ENIVRIIGYCHSKEMYAIVYNLLNGS--LKQYLKQLKWNERM--DVAIGVAKALEYLHHT 362
NI+ + + +V L+ G L + L+Q ++ER V + K +EYLH
Sbjct: 76 PNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLH-- 133
Query: 363 CDPPIIHRDVKSSNILLSENFHHPQ---LSDFGAAMVHHQSHQVSENVKPVNVVGTFGYL 419
++HRD+K SNIL + +P+ + DFG A +EN + T ++
Sbjct: 134 -AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR-----AENGLLMTPCYTANFV 187
Query: 420 APEYMMYGKVDEKIDVYSYGVVL 442
APE + D D++S GV+L
Sbjct: 188 APEVLERQGYDAACDIWSLGVLL 210
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 8e-22
Identities = 57/222 (25%), Positives = 96/222 (43%), Gaps = 49/222 (22%)
Query: 260 IGQGGNSKVYR---TNHVDGQVA---AVKVLK-CTNWSEEEVLREVELLSSIKHENIVRI 312
+G+G KV+ N + Q AVK LK + + ++ RE ELL+ ++H++IVR
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 313 IGYCHSKE-MYAIVYNLLNGSLKQYL------------------KQLKWNERMDVAIGVA 353
G C + + + +G L ++L L + + VA VA
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 354 KALEYL--HHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA-MVHHQSHQVSENVKPV 410
+ YL H +HRD+ + N L+ + ++ DFG + ++ +
Sbjct: 169 AGMVYLAGLH-----FVHRDLATRNCLVGQGL-VVKIGDFGMSRDIYSTDYY-------- 214
Query: 411 NVVGTFGYL-----APEYMMYGKVDEKIDVYSYGVVLLELIT 447
VG L PE ++Y K + DV+S+GVVL E+ T
Sbjct: 215 -RVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 8e-22
Identities = 51/212 (24%), Positives = 97/212 (45%), Gaps = 29/212 (13%)
Query: 253 NFSPKMLIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEEVLREVELLSSIK-HENIV 310
++ +G+G S+V+ ++ + VK+LK ++++ RE+++L +++ NI+
Sbjct: 37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK--PVKKKKIKREIKILENLRGGPNII 94
Query: 311 R---IIGYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAI---GVAKALEYLHHTCD 364
I+ S+ + ++ N KQ + L D+ + KAL+Y H
Sbjct: 95 TLADIVKDPVSRTPALVFEHVNNTDFKQLYQTL---TDYDIRFYMYEILKALDYCHSMG- 150
Query: 365 PPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPE-- 422
I+HRDVK N+++ +L D+G A +H + + V + + PE
Sbjct: 151 --IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR------VASRYFKGPELL 202
Query: 423 --YMMYGKVDEKIDVYSYGVVLLELITGKEAI 452
Y MY D +D++S G +L +I KE
Sbjct: 203 VDYQMY---DYSLDMWSLGCMLASMIFRKEPF 231
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 9e-22
Identities = 51/205 (24%), Positives = 86/205 (41%), Gaps = 29/205 (14%)
Query: 260 IGQGGNSKVYR---TNHVDGQVA-AVKVLK--CTNWSEEEVLREVELLSSIKHENIVRII 313
IG G + +V V A+K LK T + L E ++ H NI+R+
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 314 GYCHSKEMYAIVYNLL-NGSLKQYLK----QLKWNERMDVAIGVAKALEYL--HHTCDPP 366
G + IV + NGSL +L+ Q + + + GV + YL
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG----- 171
Query: 367 IIHRDVKSSNILLSENFHHPQLSDFGAA---MVHHQSHQVSENVK-PVNVVGTFGYLAPE 422
+HRD+ + N+L+ N ++SDFG + + + K P+ + APE
Sbjct: 172 YVHRDLAARNVLVDSN-LVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIR------WTAPE 224
Query: 423 YMMYGKVDEKIDVYSYGVVLLELIT 447
+ + DV+S+GVV+ E++
Sbjct: 225 AIAFRTFSSASDVWSFGVVMWEVLA 249
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 1e-21
Identities = 47/192 (24%), Positives = 86/192 (44%), Gaps = 20/192 (10%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIK-HENIVRIIGYCH 317
+G+G S + + Q AVK++ E +E+ L + H NIV++ H
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFH 76
Query: 318 SKEMYAIVYNLLNGS--LKQYLKQLKWNERM--DVAIGVAKALEYLHHTCDPPIIHRDVK 373
+ +V LLNG ++ K+ ++E + + A+ ++H D ++HRD+K
Sbjct: 77 DQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLK 133
Query: 374 SSNILLSENFHHPQL--SDFG-AAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVD 430
N+L ++ + ++ DFG A + + + T Y APE + D
Sbjct: 134 PENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT------PCFTLHYAAPELLNQNGYD 187
Query: 431 EKIDVYSYGVVL 442
E D++S GV+L
Sbjct: 188 ESCDLWSLGVIL 199
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 2e-21
Identities = 41/200 (20%), Positives = 80/200 (40%), Gaps = 24/200 (12%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHS 318
+G+G V+R + K +K + V +E+ +L+ +H NI+ + S
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES 72
Query: 319 KEMYAIVYNLLNG-----SLKQYLKQLKWNERMDVAIGVAK----ALEYLHHTCDPPIIH 369
E +++ ++G + + NER + AL++LH I H
Sbjct: 73 MEELVMIFEFISGLDIFERINT--SAFELNERE--IVSYVHQVCEALQFLH---SHNIGH 125
Query: 370 RDVKSSNILLSENFHHP-QLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGK 428
D++ NI+ ++ +FG Q+ Q+ + Y APE +
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFG------QARQLKPGDNFRLLFTAPEYYAPEVHQHDV 179
Query: 429 VDEKIDVYSYGVVLLELITG 448
V D++S G ++ L++G
Sbjct: 180 VSTATDMWSLGTLVYVLLSG 199
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 2e-21
Identities = 46/213 (21%), Positives = 88/213 (41%), Gaps = 35/213 (16%)
Query: 260 IGQGGNSKVYR------TNHVDGQVAAVKVLK--CTNWSEEEVLREVELLSSIKHENIVR 311
+GQG VY A+K + + E L E ++ ++VR
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 312 IIGYCHSKE-MYAIVYNLLNGSLKQYL-------------KQLKWNERMDVAIGVAKALE 357
++G + I+ + G LK YL ++ + +A +A +
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 358 YLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA-MVHHQSH--QVSENVKPVNVVG 414
YL+ +HRD+ + N +++E+F ++ DFG ++ + + + + PV
Sbjct: 153 YLN---ANKFVHRDLAARNCMVAEDF-TVKIGDFGMTRDIYETDYYRKGGKGLLPVR--- 205
Query: 415 TFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT 447
+++PE + G DV+S+GVVL E+ T
Sbjct: 206 ---WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 3e-21
Identities = 56/217 (25%), Positives = 86/217 (39%), Gaps = 43/217 (19%)
Query: 260 IGQGGNSKVYR---TNHVDGQVA---AVKVLK--CTNWSEEEVLREVELLSSIKHENIVR 311
+G G +VY + + AVK L C+ E + L E ++S H+NIVR
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 312 IIGYCHSKE-MYAIVYNLLNGSLKQYL----------KQLKWNERMDVAIGVAKALEYL- 359
IG + ++ + G LK +L L + + VA +A +YL
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 360 -HHTCDPPIIHRDVKSSNILLSENFHHPQL--SDFGAA-MVHHQSHQVSENVKPVNVVGT 415
+H IHRD+ + N LL+ DFG A ++ S+ G
Sbjct: 158 ENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY---------RKGG 203
Query: 416 FGYL-----APEYMMYGKVDEKIDVYSYGVVLLELIT 447
L PE M G K D +S+GV+L E+ +
Sbjct: 204 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 4e-21
Identities = 54/228 (23%), Positives = 101/228 (44%), Gaps = 31/228 (13%)
Query: 240 RRFTSQELC----HLTHNFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEV 294
F S E+ + + IG G V + + + A+K K + + +
Sbjct: 9 NNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIK--KLSRPFQNQT 66
Query: 295 -----LREVELLSSIKHENIVRII-------GYCHSKEMYAIVYNLLNGSLKQYLKQLKW 342
RE+ L+ + H+NI+ ++ +++Y IV L++ +L Q ++
Sbjct: 67 HAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY-IVMELMDANLCQVIQMELD 125
Query: 343 NERMDVAI-GVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401
+ERM + + +++LH IIHRD+K SNI++ + ++ DFG A S
Sbjct: 126 HERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCT-LKILDFGLARTAGTSF 181
Query: 402 QVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
++ V T Y APE ++ E +D++S G ++ E+I G
Sbjct: 182 MMTPYV------VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 4e-21
Identities = 53/221 (23%), Positives = 98/221 (44%), Gaps = 45/221 (20%)
Query: 260 IGQGGNSKVYR---TNHVDGQVA---AVKVLK--CTNWSEEEVLREVELLSSIKHENIVR 311
+G+ KVY+ G+ A+K LK EE E L + ++H N+V
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 312 IIGYCHSKE-MYAIVYNLLNGSLKQYLK-------------------QLKWNERMDVAIG 351
++G + + I +G L ++L L+ + + +
Sbjct: 77 LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 352 VAKALEYL--HHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA-MVHHQSH-QVSENV 407
+A +EYL HH ++H+D+ + N+L+ + + ++SD G V+ + ++ N
Sbjct: 137 IAAGMEYLSSHH-----VVHKDLATRNVLVYDK-LNVKISDLGLFREVYAADYYKLLGNS 190
Query: 408 K-PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT 447
P+ ++APE +MYGK D++SYGVVL E+ +
Sbjct: 191 LLPIR------WMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 6e-21
Identities = 52/208 (25%), Positives = 90/208 (43%), Gaps = 29/208 (13%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVL---KCTNWSEEE------VLREVELLSSIKHENI 309
+G G +V + A++++ K S E V E+E+L + H I
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 310 VRIIGYCHSKEMYAIVYNLLN-GSLKQYLKQL-KWNERM--DVAIGVAKALEYLHHTCDP 365
++I + +++ Y IV L+ G L + + E + A++YLH +
Sbjct: 203 IKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH---EN 258
Query: 366 PIIHRDVKSSNILLSENFHHPQL--SDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPE- 422
IIHRD+K N+LLS + +DFG + + + E + GT YLAPE
Sbjct: 259 GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI------LGETSLMRTLCGTPTYLAPEV 312
Query: 423 --YMMYGKVDEKIDVYSYGVVLLELITG 448
+ + +D +S GV+L ++G
Sbjct: 313 LVSVGTAGYNRAVDCWSLGVILFICLSG 340
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 7e-21
Identities = 24/198 (12%), Positives = 55/198 (27%), Gaps = 43/198 (21%)
Query: 259 LIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSE----EEVLREVELLSSIKHENIVRII 313
G + ++ + + A+ + +E L LS I + R++
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 314 GYCHSKEMYAIVYNLLNG-SLKQYLKQ-LKWNERMDVAIGVAKALEYLHHTCDPPIIHRD 371
H++ +V + G SL++ + +A A + H +
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRA---GVALSI 154
Query: 372 VKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDE 431
S + +S + G V+ + +
Sbjct: 155 DHPSRVRVSID---------GDV-----------------VLAYPATMPD-------ANP 181
Query: 432 KIDVYSYGVVLLELITGK 449
+ D+ G L L+ +
Sbjct: 182 QDDIRGIGASLYALLVNR 199
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 9e-21
Identities = 51/194 (26%), Positives = 91/194 (46%), Gaps = 38/194 (19%)
Query: 280 AVKVLK--CTNWSEEEVLREVELLSSI-KHENIVRIIGYC-HSKEMYAIVYNLLNGSLKQ 335
AVK+LK +E ++ E++++S + +HENIV ++G C H + I G L
Sbjct: 80 AVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLN 139
Query: 336 YLK-----------------QLKWNERMDVAIGVAKALEYL--HHTCDPPIIHRDVKSSN 376
+L+ + + + VA+ + +L + IHRDV + N
Sbjct: 140 FLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN-----CIHRDVAARN 194
Query: 377 ILLSENFHHPQLSDFGAA-MVHHQSH-QVSENVK-PVNVVGTFGYLAPEYMMYGKVDEKI 433
+LL+ H ++ DFG A + + S+ V N + PV ++APE + +
Sbjct: 195 VLLTNG-HVAKIGDFGLARDIMNDSNYIVKGNARLPVK------WMAPESIFDCVYTVQS 247
Query: 434 DVYSYGVVLLELIT 447
DV+SYG++L E+ +
Sbjct: 248 DVWSYGILLWEIFS 261
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 1e-20
Identities = 55/217 (25%), Positives = 85/217 (39%), Gaps = 43/217 (19%)
Query: 260 IGQGGNSKVYR---TNHVDGQVA---AVKVLK--CTNWSEEEVLREVELLSSIKHENIVR 311
+G G +VY + + AVK L C+ E + L E ++S H+NIVR
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 312 IIGYCHSKE-MYAIVYNLLNGSLKQYL----------KQLKWNERMDVAIGVAKALEYL- 359
IG + ++ + G LK +L L + + VA +A +YL
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 360 -HHTCDPPIIHRDVKSSNILLSENFHHPQL--SDFGAA-MVHHQSHQVSENVKPVNVVGT 415
+H IHRD+ + N LL+ DFG A ++ + G
Sbjct: 199 ENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRK---------GG 244
Query: 416 FGYL-----APEYMMYGKVDEKIDVYSYGVVLLELIT 447
L PE M G K D +S+GV+L E+ +
Sbjct: 245 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 2e-20
Identities = 55/255 (21%), Positives = 82/255 (32%), Gaps = 58/255 (22%)
Query: 249 HLTHNFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLK------CTNWSEEEVLREVELL 301
L + K IGQG V + + A+K++ E + EV L+
Sbjct: 23 ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLM 82
Query: 302 SSIKHENIVRIIGYCHSKEMYAIVYNLLN-GSLKQYLKQLKWNERMDVAIG--------- 351
+ H NI R+ ++ +V L + G L L + A+
Sbjct: 83 KKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPC 142
Query: 352 ----------------------------------VAKALEYLHHTCDPPIIHRDVKSSNI 377
+ AL YLH + I HRD+K N
Sbjct: 143 PECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENF 199
Query: 378 LLSENFHHP-QLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYG--KVDEKID 434
L S N +L DFG + E GT ++APE + K D
Sbjct: 200 LFSTNKSFEIKLVDFGLS-KEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258
Query: 435 VYSYGVVLLELITGK 449
+S GV+L L+ G
Sbjct: 259 AWSAGVLLHLLLMGA 273
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 2e-20
Identities = 53/230 (23%), Positives = 102/230 (44%), Gaps = 31/230 (13%)
Query: 238 SSRRFTSQELC----HLTHNFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEE 292
+F S E+ + + IG G V + V + A+K K + +
Sbjct: 44 VDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK--KLSRPFQN 101
Query: 293 EV-----LREVELLSSIKHENIVRII-------GYCHSKEMYAIVYNLLNGSLKQYLKQL 340
+ RE+ L+ + H+NI+ ++ +++Y +V L++ +L Q ++
Sbjct: 102 QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY-LVMELMDANLCQVIQME 160
Query: 341 KWNERMDVAI-GVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399
+ERM + + +++LH IIHRD+K SNI++ + ++ DFG A
Sbjct: 161 LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCT-LKILDFGLARTAGT 216
Query: 400 SHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
S ++ V T Y APE ++ E +D++S G ++ E++ K
Sbjct: 217 SFMMTPYV------VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 4e-20
Identities = 53/211 (25%), Positives = 93/211 (44%), Gaps = 38/211 (18%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLK-------CTNWSEEEVLREVELLSSIKHENIVR 311
+G G + V + G A K +K S EE+ REV +L + H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 312 IIGYCHSKEMYAIVYNLLNG-------SLKQYLKQLKWNERMDVAIGVAK----ALEYLH 360
+ ++ ++ L++G + K+ L +E A K + YLH
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESL-----SEEE--ATSFIKQILDGVNYLH 132
Query: 361 HTCDPPIIHRDVKSSNILL-SENFHHPQL--SDFGAAMVHHQSHQVSENVKPVNVVGTFG 417
I H D+K NI+L +N P + DFG +H++ + V+ N+ GT
Sbjct: 133 ---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL------AHEIEDGVEFKNIFGTPE 183
Query: 418 YLAPEYMMYGKVDEKIDVYSYGVVLLELITG 448
++APE + Y + + D++S GV+ L++G
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 6e-20
Identities = 38/199 (19%), Positives = 80/199 (40%), Gaps = 21/199 (10%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSE-EEVLREVELLSSIKHENIVRIIGYCH 317
+G G V+R G+V K + + V E+ +++ + H ++ +
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 318 SKEMYAIVYNLLNGS-LKQYL--KQLKWNERMDVAIGVAK----ALEYLHHTCDPPIIHR 370
K ++ L+G L + + K +E I + L+++H + I+H
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAAEDYKMSEA--EVINYMRQACEGLKHMH---EHSIVHL 173
Query: 371 DVKSSNILLSENFHHP-QLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKV 429
D+K NI+ ++ DFG + +++ + T + APE + V
Sbjct: 174 DIKPENIMCETKKASSVKIIDFG------LATKLNPDEIVKVTTATAEFAAPEIVDREPV 227
Query: 430 DEKIDVYSYGVVLLELITG 448
D+++ GV+ L++G
Sbjct: 228 GFYTDMWAIGVLGYVLLSG 246
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 6e-20
Identities = 40/222 (18%), Positives = 79/222 (35%), Gaps = 21/222 (9%)
Query: 247 LCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKH 306
L L H + +D + S + + +
Sbjct: 58 LAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDP 117
Query: 307 ENIVRIIGYCHSKEMYAIVYNLL----NGSLKQYLKQLKWNERMDVAIG------VAKAL 356
+ +G +Y + +LK ++ + E + + +A+A+
Sbjct: 118 FSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAV 177
Query: 357 EYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNV---- 412
E+LH ++HRD+K SNI + + ++ DFG Q + + P+
Sbjct: 178 EFLHSKG---LMHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATH 233
Query: 413 ---VGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEA 451
VGT Y++PE + K+D++S G++L EL+
Sbjct: 234 TGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST 275
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 3e-07
Identities = 22/73 (30%), Positives = 34/73 (46%), Gaps = 3/73 (4%)
Query: 253 NFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKV--LKCTNWSEEEVLREVELLSSIKHENI 309
+F P +G+GG V+ N VD A+K L + E+V+REV+ L+ ++H I
Sbjct: 7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 66
Query: 310 VRIIGYCHSKEMY 322
VR
Sbjct: 67 VRYFNAWLETPPE 79
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 8e-20
Identities = 50/216 (23%), Positives = 89/216 (41%), Gaps = 48/216 (22%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSE-------EEVLREVELLSSIKHENIVR 311
+G G + V + G A K +K EE+ REV +L + H NI+
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 312 IIGYCHSKEMYAIVYNLLNG----------------SLKQYLKQLKWNERMDVAIGVAKA 355
+ ++ ++ L++G ++KQ +
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ------------ILDG 127
Query: 356 LEYLHHTCDPPIIHRDVKSSNILL-SENFHHPQL--SDFGAAMVHHQSHQVSENVKPVNV 412
+ YLH I H D+K NI+L +N P + DFG +H++ + V+ N+
Sbjct: 128 VNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL------AHEIEDGVEFKNI 178
Query: 413 VGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITG 448
GT ++APE + Y + + D++S GV+ L++G
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 9e-20
Identities = 65/298 (21%), Positives = 123/298 (41%), Gaps = 39/298 (13%)
Query: 166 SSLSSSSKYPAFGQPATTRQLQKSLTAPSSSTSSTTRQESDVGVCIAQETVQVPESIKRK 225
+ ++ P R+ +++ S + + + E++ +
Sbjct: 16 NKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQ 75
Query: 226 IFEKLAVLEAEGSSRRFTSQELCHLTHNFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVL 284
L +++ F + + PK +IG+G +S V R + G AVK++
Sbjct: 76 SMGPEDELPDWAAAKEFYQK--------YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIM 127
Query: 285 K---------CTNWSEEEVLREVELLSSIK-HENIVRIIGYCHSKEMYAIVYNLL-NGSL 333
+ E RE +L + H +I+ +I S +V++L+ G L
Sbjct: 128 EVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL 187
Query: 334 KQYL-KQLKWNERM--DVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSD 390
YL +++ +E+ + + +A+ +LH I+HRD+K NILL +N +LSD
Sbjct: 188 FDYLTEKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNM-QIRLSD 243
Query: 391 FGAAMVHHQSHQVSENVKPVNVVGTFGYLAPE------YMMYGKVDEKIDVYSYGVVL 442
FG S + K + GT GYLAPE + +++D+++ GV+L
Sbjct: 244 FG------FSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-19
Identities = 52/196 (26%), Positives = 100/196 (51%), Gaps = 40/196 (20%)
Query: 280 AVKVLK--CTNWSEEEVLREVELLSSI-KHENIVRIIGYC-HSKEMYAIVYNLLNGSLKQ 335
AVK+LK T +++ E+E++ I KH+NI+ ++G C +Y IV G+L++
Sbjct: 71 AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 130
Query: 336 YLK-------------------QLKWNERMDVAIGVAKALEYL--HHTCDPPIIHRDVKS 374
YL+ Q+ + + + +A+ +EYL IHRD+ +
Sbjct: 131 YLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK-----CIHRDLAA 185
Query: 375 SNILLSENFHHPQLSDFGAA-MVHHQSH-QVSENVK-PVNVVGTFGYLAPEYMMYGKVDE 431
N+L++EN + +++DFG A +++ + + + N + PV ++APE +
Sbjct: 186 RNVLVTEN-NVMKIADFGLARDINNIDYYKKTTNGRLPVK------WMAPEALFDRVYTH 238
Query: 432 KIDVYSYGVVLLELIT 447
+ DV+S+GV++ E+ T
Sbjct: 239 QSDVWSFGVLMWEIFT 254
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 50/232 (21%), Positives = 93/232 (40%), Gaps = 59/232 (25%)
Query: 260 IGQGGNSKVYR------TNHVDGQVAAVKVLK--CTNWSEEEVLREVELLSSIKHENIVR 311
IG+G +V++ + + AVK+LK + + + RE L++ + NIV+
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 312 IIGYC-HSKEMYAIVYNLLNGSLKQYL---------------------------KQLKWN 343
++G C K M + + G L ++L L
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 344 ERMDVAIGVAKALEYL--HHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA-MVHHQS 400
E++ +A VA + YL +HRD+ + N L+ EN +++DFG + ++
Sbjct: 175 EQLCIARQVAAGMAYLSERK-----FVHRDLATRNCLVGEN-MVVKIADFGLSRNIYSAD 228
Query: 401 HQVSENVKPVNVVGTFGYL-----APEYMMYGKVDEKIDVYSYGVVLLELIT 447
+ + PE + Y + + DV++YGVVL E+ +
Sbjct: 229 YY---------KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 91.1 bits (226), Expect = 1e-19
Identities = 44/199 (22%), Positives = 85/199 (42%), Gaps = 21/199 (10%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSE-EEVLREVELLSSIKHENIVRIIGYCH 317
+G G V+R T G A K + + S+ E V +E++ +S ++H +V +
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224
Query: 318 SKEMYAIVYNLLNGS-LKQYL--KQLKWNERMDVAIGVAK----ALEYLHHTCDPPIIHR 370
++Y ++G L + + + K +E A+ + L ++H + +H
Sbjct: 225 DDNEMVMIYEFMSGGELFEKVADEHNKMSED--EAVEYMRQVCKGLCHMH---ENNYVHL 279
Query: 371 DVKSSNILL-SENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKV 429
D+K NI+ ++ + +L DFG + + GT + APE V
Sbjct: 280 DLKPENIMFTTKRSNELKLIDFG------LTAHLDPKQSVKVTTGTAEFAAPEVAEGKPV 333
Query: 430 DEKIDVYSYGVVLLELITG 448
D++S GV+ L++G
Sbjct: 334 GYYTDMWSVGVLSYILLSG 352
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 51/202 (25%), Positives = 87/202 (43%), Gaps = 29/202 (14%)
Query: 260 IGQGGNSKVYRTNHVD-GQVAAVKVL---KCTNWSEEE------VLREVELLSSIKHENI 309
+G G +V + A+K++ K S E V E+E+L + H I
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 310 VRIIGYCHSKEMYAIVYNLLN-GSLKQYLKQL-KWNERM--DVAIGVAKALEYLHHTCDP 365
++I + +++ Y IV L+ G L + + E + A++YLH
Sbjct: 78 IKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG-- 134
Query: 366 PIIHRDVKSSNILLSENFHHPQL--SDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPE- 422
IIHRD+K N+LLS + +DFG + + ++ + + GT YLAPE
Sbjct: 135 -IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT------LCGTPTYLAPEV 187
Query: 423 --YMMYGKVDEKIDVYSYGVVL 442
+ + +D +S GV+L
Sbjct: 188 LVSVGTAGYNRAVDCWSLGVIL 209
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 2e-19
Identities = 46/211 (21%), Positives = 89/211 (42%), Gaps = 34/211 (16%)
Query: 259 LIGQGGNSKVYRTNHV-DGQVAAVKVL---KCTNWSE----EEVLREVELLSSIKHE--N 308
L+G GG VY V D A+K + + ++W E V EV LL +
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 309 IVRIIGYCHSKEMYAIV--YNLLNGSLKQYLKQLKWNERM--DVAIG----VAKALEYLH 360
++R++ + + + ++ L ++ + + ++A V +A+ + H
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCH 166
Query: 361 HTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH-QVSENVKPVNVVGTFGYL 419
+ ++HRD+K NIL+ N +L DFG+ + + GT Y
Sbjct: 167 NCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF--------DGTRVYS 215
Query: 420 APEYMMYGKVD-EKIDVYSYGVVLLELITGK 449
PE++ Y + V+S G++L +++ G
Sbjct: 216 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 246
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 57/224 (25%), Positives = 92/224 (41%), Gaps = 48/224 (21%)
Query: 260 IGQGGNSKVYR---TNHVDGQVA---AVKVLK--CTNWSEEEVLREVELLSSI-KHENIV 310
+G G KV + A AVK+LK E ++ E+++LS + H NIV
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 311 RIIGYC-HSKEMYAIVYNLLNGSLKQYLK---------------------QLKWNERMDV 348
++G C I G L +L+ L + +
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 349 AIGVAKALEYL--HHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA-MVHHQSH-QVS 404
+ VAK + +L + IHRD+ + NILL+ ++ DFG A + + S+ V
Sbjct: 151 SYQVAKGMAFLASKN-----CIHRDLAARNILLTHG-RITKICDFGLARDIKNDSNYVVK 204
Query: 405 ENVK-PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT 447
N + PV ++APE + + DV+SYG+ L EL +
Sbjct: 205 GNARLPVK------WMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 53/211 (25%), Positives = 90/211 (42%), Gaps = 38/211 (18%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLKC-------TNWSEEEVLREVELLSSIKHENIVR 311
+G G + V + G A K +K S E++ REV +L I+H N++
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 312 IIGYCHSKEMYAIVYNLLNG-------SLKQYLKQLKWNERMDVAIGVAK----ALEYLH 360
+ +K ++ L+ G + K+ L E A K + YLH
Sbjct: 79 LHEVYENKTDVILILELVAGGELFDFLAEKESL-----TEEE--ATEFLKQILNGVYYLH 131
Query: 361 HTCDPPIIHRDVKSSNILL-SENFHHPQL--SDFGAAMVHHQSHQVSENVKPVNVVGTFG 417
I H D+K NI+L N P++ DFG +H++ + N+ GT
Sbjct: 132 ---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL------AHKIDFGNEFKNIFGTPE 182
Query: 418 YLAPEYMMYGKVDEKIDVYSYGVVLLELITG 448
++APE + Y + + D++S GV+ L++G
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 59/293 (20%), Positives = 113/293 (38%), Gaps = 28/293 (9%)
Query: 169 SSSSKYPAFGQPATTRQLQKSLTAPSSSTSSTTRQESDVGVCIAQETVQVPESIKRKIFE 228
SS + + ++ S S S + ++ A T ++P KR
Sbjct: 7 HHSSGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVW----SNADLTERMPVKSKRTSAL 62
Query: 229 KLAVLEAEG-SSRRFTSQELCHLTH--NFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVL 284
+ + R + + + S ++G G +V++ G A K++
Sbjct: 63 AVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKII 122
Query: 285 KCTNWSE-EEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLLNGS-LKQYL--KQL 340
K + EEV E+ +++ + H N++++ SK +V ++G L + +
Sbjct: 123 KTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESY 182
Query: 341 KWNERMDVAIGVAK----ALEYLHHTCDPPIIHRDVKSSNILL-SENFHHPQLSDFGAAM 395
E I K + ++H I+H D+K NIL + + ++ DFG
Sbjct: 183 NLTELD--TILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFG--- 234
Query: 396 VHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITG 448
+ + K GT +LAPE + Y V D++S GV+ L++G
Sbjct: 235 ---LARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 3e-19
Identities = 50/200 (25%), Positives = 83/200 (41%), Gaps = 28/200 (14%)
Query: 257 KMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEVLREVELL-SSIKHENIVRIIG 314
K ++G G N KV + GQ A+K+L + +EV+ + +IV I+
Sbjct: 34 KQVLGLGVNGKVLECFHRRTGQKCALKLLY----DSPKARQEVDHHWQASGGPHIVCILD 89
Query: 315 YC----HSKEMYAIVYNLLN-GSLKQYL---KQLKWNERM--DVAIGVAKALEYLHHTCD 364
H K I+ + G L + + ER ++ + A+++LH
Sbjct: 90 VYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN- 148
Query: 365 PPIIHRDVKSSNILLSENFHHPQL--SDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPE 422
I HRDVK N+L + L +DFG A + + T Y+APE
Sbjct: 149 --IAHRDVKPENLLYTSKEKDAVLKLTDFGFA-KETTQNALQT------PCYTPYYVAPE 199
Query: 423 YMMYGKVDEKIDVYSYGVVL 442
+ K D+ D++S GV++
Sbjct: 200 VLGPEKYDKSCDMWSLGVIM 219
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 3e-19
Identities = 55/211 (26%), Positives = 94/211 (44%), Gaps = 38/211 (18%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLK-------CTNWSEEEVLREVELLSSIKHENIVR 311
+G G + V + G+ A K +K S EE+ REV +L I+H NI+
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 312 IIGYCHSKEMYAIVYNLLNG-------SLKQYLKQLKWNERMDVAIGVAK----ALEYLH 360
+ +K ++ L++G + K+ L E A K + YLH
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLAEKESL-----TED--EATQFLKQILDGVHYLH 125
Query: 361 HTCDPPIIHRDVKSSNILL-SENFHHPQL--SDFGAAMVHHQSHQVSENVKPVNVVGTFG 417
I H D+K NI+L +N +P++ DFG +H++ + N+ GT
Sbjct: 126 ---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGI------AHKIEAGNEFKNIFGTPE 176
Query: 418 YLAPEYMMYGKVDEKIDVYSYGVVLLELITG 448
++APE + Y + + D++S GV+ L++G
Sbjct: 177 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 3e-19
Identities = 50/229 (21%), Positives = 105/229 (45%), Gaps = 34/229 (14%)
Query: 240 RRFTSQELC----HLTHNFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEV 294
+ F Q++ L + +G G V + G+ A+K K + + E+
Sbjct: 8 KGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIK--KLSRPFQSEI 65
Query: 295 -----LREVELLSSIKHENIVRII-------GYCHSKEMYAIVYNLLNGSLKQYLKQLKW 342
RE+ LL ++HEN++ ++ + + Y +V + L++ +
Sbjct: 66 FAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFY-LVMPFMQTDLQKIMGLKFS 124
Query: 343 NERMDVAI-GVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401
E++ + + K L+Y+H ++HRD+K N+ ++E+ ++ DFG A H
Sbjct: 125 EEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDC-ELKILDFGLA--RHADA 178
Query: 402 QVSENVKPVNVVGTFGYLAPEYMM-YGKVDEKIDVYSYGVVLLELITGK 449
+++ V T Y APE ++ + ++ +D++S G ++ E++TGK
Sbjct: 179 EMTGY------VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 4e-19
Identities = 52/196 (26%), Positives = 100/196 (51%), Gaps = 40/196 (20%)
Query: 280 AVKVLK--CTNWSEEEVLREVELLSSI-KHENIVRIIGYC-HSKEMYAIVYNLLNGSLKQ 335
AVK+LK T +++ E+E++ I KH+NI+ ++G C +Y IV G+L++
Sbjct: 117 AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 176
Query: 336 YL-------------------KQLKWNERMDVAIGVAKALEYL--HHTCDPPIIHRDVKS 374
YL +Q+ + + + +A+ +EYL IHRD+ +
Sbjct: 177 YLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK-----CIHRDLAA 231
Query: 375 SNILLSENFHHPQLSDFGAA-MVHHQSH-QVSENVK-PVNVVGTFGYLAPEYMMYGKVDE 431
N+L++EN + +++DFG A +++ + + + N + PV ++APE +
Sbjct: 232 RNVLVTEN-NVMKIADFGLARDINNIDYYKKTTNGRLPVK------WMAPEALFDRVYTH 284
Query: 432 KIDVYSYGVVLLELIT 447
+ DV+S+GV++ E+ T
Sbjct: 285 QSDVWSFGVLMWEIFT 300
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 4e-19
Identities = 49/232 (21%), Positives = 94/232 (40%), Gaps = 59/232 (25%)
Query: 260 IGQGGNSKVYR------TNHVDGQVAAVKVLK--CTNWSEEEVLREVELLSSIKHENIVR 311
+G+G KV + AVK+LK + ++L E +L + H ++++
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 312 IIGYC-HSKEMYAIVYNLLNGSLKQYL---------------------------KQLKWN 343
+ G C + IV GSL+ +L + L
Sbjct: 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 344 ERMDVAIGVAKALEYL--HHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA-MVHHQS 400
+ + A +++ ++YL ++HRD+ + NIL++E ++SDFG + V+ +
Sbjct: 151 DLISFAWQISQGMQYLAEMK-----LVHRDLAARNILVAEG-RKMKISDFGLSRDVYEED 204
Query: 401 HQVSENVKPVNVVGTFGYL-----APEYMMYGKVDEKIDVYSYGVVLLELIT 447
V + G + A E + + DV+S+GV+L E++T
Sbjct: 205 ---------SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 4e-19
Identities = 48/212 (22%), Positives = 91/212 (42%), Gaps = 36/212 (16%)
Query: 259 LIGQGGNSKVYRTNHV-DGQVAAVKVL---KCTNWSEEE----VLREVELL----SSIKH 306
L+G+GG V+ + + D A+KV+ + WS EV LL + H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 307 ENIVRIIGYCHSKEMYAIV--YNLLNGSLKQYLKQLKWNERM--DVAIG----VAKALEY 358
++R++ + ++E + +V L L Y+ + + + V A+++
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQH 154
Query: 359 LHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFG-AAMVHHQSHQVSENVKPVNVVGTFG 417
H ++HRD+K NIL+ +L DFG A++H + + GT
Sbjct: 155 CHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDF--------DGTRV 203
Query: 418 YLAPEYMMYGKVD-EKIDVYSYGVVLLELITG 448
Y PE++ + V+S G++L +++ G
Sbjct: 204 YSPPEWISRHQYHALPATVWSLGILLYDMVCG 235
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 5e-19
Identities = 57/216 (26%), Positives = 104/216 (48%), Gaps = 32/216 (14%)
Query: 249 HLTHNFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWS----------EEEVLRE 297
N+ PK ++G+G +S V R + + AVK++ T E L+E
Sbjct: 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKE 73
Query: 298 VELLSSIK-HENIVRIIGYCHSKEMYAIVYNLL-NGSLKQYL-KQLKWNERM--DVAIGV 352
V++L + H NI+++ + + +V++L+ G L YL +++ +E+ + +
Sbjct: 74 VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 133
Query: 353 AKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNV 412
+ + LH I+HRD+K NILL ++ + +L+DFG S Q+ K V
Sbjct: 134 LEVICALH---KLNIVHRDLKPENILLDDDM-NIKLTDFG------FSCQLDPGEKLREV 183
Query: 413 VGTFGYLAPE------YMMYGKVDEKIDVYSYGVVL 442
GT YLAPE + +++D++S GV++
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 5e-19
Identities = 54/223 (24%), Positives = 93/223 (41%), Gaps = 47/223 (21%)
Query: 260 IGQGGNSKVYR------TNHVDGQVAAVKVLK--CTNWSEEEVLREVELLSSI-KHENIV 310
+G+G +V + AVK+LK T+ ++ E+++L I H N+V
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 311 RIIGYC--HSKEMYAIVYNLLNGSLKQYLK-------------------QLKWNERMDVA 349
++G C + IV G+L YL+ L + +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 350 IGVAKALEYL--HHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA-MVHHQSH-QVSE 405
VAK +E+L IHRD+ + NILLSE ++ DFG A ++
Sbjct: 155 FQVAKGMEFLASRK-----CIHRDLAARNILLSEKNV-VKICDFGLARDIYKDPDYVRKG 208
Query: 406 NVK-PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT 447
+ + P+ ++APE + + DV+S+GV+L E+ +
Sbjct: 209 DARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 5e-19
Identities = 51/209 (24%), Positives = 95/209 (45%), Gaps = 36/209 (17%)
Query: 260 IGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHS 318
IG G V++ V+ +VA KVL+ + RE++++ +KH N+V + + +S
Sbjct: 48 IGNGSFGVVFQAKLVESDEVAIKKVLQ----DKRFKNRELQIMRIVKHPNVVDLKAFFYS 103
Query: 319 KEMYA------IVYNLLNGSLKQYLKQL-KWNERMDVAIG------VAKALEYLHHTCDP 365
+V + ++ + + K + M + + + ++L Y+H
Sbjct: 104 NGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG-- 161
Query: 366 PIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKP-VNVVGTFGYLAPEYM 424
I HRD+K N+LL +L DFG+A ++ +P V+ + + Y APE +
Sbjct: 162 -ICHRDIKPQNLLLDPPSGVLKLIDFGSA-------KILIAGEPNVSYICSRYYRAPELI 213
Query: 425 M----YGKVDEKIDVYSYGVVLLELITGK 449
Y ID++S G V+ EL+ G+
Sbjct: 214 FGATNYTT---NIDIWSTGCVMAELMQGQ 239
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 6e-19
Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 39/203 (19%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSI-KHENIVRIIGYCH 317
+G G N KV + N + A+K+L+ + REVEL + +IVRI+
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALKMLQ----DCPKARREVELHWRASQCPHIVRIVDVYE 125
Query: 318 ----SKEMYAIVYNLLNG----------SLKQYLKQLKWNERM--DVAIGVAKALEYLHH 361
++ IV L+G + + ER ++ + +A++YLH
Sbjct: 126 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF------TEREASEIMKSIGEAIQYLH- 178
Query: 362 TCDPPIIHRDVKSSNILLSENFHHPQL--SDFGAAMVHHQSHQVSENVKPVNVVGTFGYL 419
I HRDVK N+L + + L +DFG A + ++ T Y+
Sbjct: 179 --SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT------PCYTPYYV 230
Query: 420 APEYMMYGKVDEKIDVYSYGVVL 442
APE + K D+ D++S GV++
Sbjct: 231 APEVLGPEKYDKSCDMWSLGVIM 253
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 8e-19
Identities = 55/222 (24%), Positives = 94/222 (42%), Gaps = 50/222 (22%)
Query: 259 LIGQGGNSKVYR---TNHVDGQVAAVKVLK--CTNWSEEEVLREVELLSSI-KHENIVRI 312
+IG+G +V + AA+K +K + + E+E+L + H NI+ +
Sbjct: 32 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91
Query: 313 IGYC-HSKEMYAIVYNLLNGSLKQYL-------------------KQLKWNERMDVAIGV 352
+G C H +Y + +G+L +L L + + A V
Sbjct: 92 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 151
Query: 353 AKALEYL--HHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPV 410
A+ ++YL IHRD+ + NIL+ EN + +++DFG + + V
Sbjct: 152 ARGMDYLSQKQ-----FIHRDLAARNILVGEN-YVAKIADFGLS-----------RGQEV 194
Query: 411 NVVGTFGYL-----APEYMMYGKVDEKIDVYSYGVVLLELIT 447
V T G L A E + Y DV+SYGV+L E+++
Sbjct: 195 YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 8e-19
Identities = 44/212 (20%), Positives = 87/212 (41%), Gaps = 40/212 (18%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEE-----VLREVELLSSIKHENIVRII 313
+G+G +VY+ + V + A+K ++ + EEE +REV LL ++H NI+ +
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEH--EEEGVPGTAIREVSLLKELQHRNIIELK 99
Query: 314 GYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVA---KALEYLHHTCDPPIIHR 370
H +++ LK+Y+ + + + + + H +HR
Sbjct: 100 SVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR---CLHR 156
Query: 371 DVKSSNILLSENFHHPQ----LSDFGAAM-----VHHQSHQVSENVKPVNVVGTFGYLAP 421
D+K N+LLS + + DFG A + +H++ + T Y P
Sbjct: 157 DLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEI---I-------TLWYRPP 206
Query: 422 EYMM----YGKVDEKIDVYSYGVVLLELITGK 449
E ++ Y +D++S + E++
Sbjct: 207 EILLGSRHYS---TSVDIWSIACIWAEMLMKT 235
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 1e-18
Identities = 46/210 (21%), Positives = 81/210 (38%), Gaps = 38/210 (18%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKH-ENIVRIIG 314
+G+G + V + + GQ A K LK E+L E+ +L K ++ +
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 315 YCHSKEMYAIVYNLLNG----------SLKQYLKQLKWNERMDVAIGVAK----ALEYLH 360
+ ++ G + +E I + K + YLH
Sbjct: 97 VYENTSEIILILEYAAGGEIFSLCLPELAEMV------SEND--VIRLIKQILEGVYYLH 148
Query: 361 HTCDPPIIHRDVKSSNILLSENFHHPQL--SDFGAAMVHHQSHQVSENVKPVNVVGTFGY 418
I+H D+K NILLS + + DFG S ++ + ++GT Y
Sbjct: 149 ---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGM------SRKIGHACELREIMGTPEY 199
Query: 419 LAPEYMMYGKVDEKIDVYSYGVVLLELITG 448
LAPE + Y + D+++ G++ L+T
Sbjct: 200 LAPEILNYDPITTATDMWNIGIIAYMLLTH 229
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 1e-18
Identities = 56/218 (25%), Positives = 102/218 (46%), Gaps = 35/218 (16%)
Query: 251 THNFSPKMLIGQGGNSKVYRTNHVD-GQVAAVK-VLKCTNWSEEEVLREVELLSSIKHEN 308
+++ +IG G VY+ D G++ A+K VL+ + RE++++ + H N
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ----DKRFKNRELQIMRKLDHCN 108
Query: 309 IVRIIGYCHSK-----EMY-AIVYNLLNGSLKQYLKQL-KWNERMDVAIG------VAKA 355
IVR+ + +S E+Y +V + + ++ + + + + + V + ++
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 168
Query: 356 LEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGT 415
L Y+H I HRD+K N+LL + +L DFG+A Q+ V+ + +
Sbjct: 169 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSA------KQLVRGEPNVSYICS 219
Query: 416 FGYLAPEYMM----YGKVDEKIDVYSYGVVLLELITGK 449
Y APE + Y IDV+S G VL EL+ G+
Sbjct: 220 RYYRAPELIFGATDYTS---SIDVWSAGCVLAELLLGQ 254
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 2e-18
Identities = 45/231 (19%), Positives = 94/231 (40%), Gaps = 40/231 (17%)
Query: 259 LIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIK-----------H 306
+G G S V+ + V+ A+K+++ E E++LL +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85
Query: 307 ENIVRIIGY-CHSKEMYA---IVYNLLNGSLKQYLKQLKWNERM-------DVAIGVAKA 355
+I++++ + H +V+ +L +L +K K+ R ++ +
Sbjct: 86 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIK--KYEHRGIPLIYVKQISKQLLLG 143
Query: 356 LEYLHHTCDPPIIHRDVKSSNILLSENFHHPQ-----LSDFGAAMVHHQSHQVSENVKPV 410
L+Y+H C IIH D+K N+L+ ++D G A + + +
Sbjct: 144 LDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY--------T 193
Query: 411 NVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRES 461
N + T Y +PE ++ D++S ++ ELITG + ++ + +
Sbjct: 194 NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 244
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 2e-18
Identities = 53/210 (25%), Positives = 94/210 (44%), Gaps = 41/210 (19%)
Query: 260 IGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEE-----VLREVELLSSIKHENIVRIIG 314
+G+G VY+ G++ A+K ++ E+E +RE+ LL + H NIV +I
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIRLDA--EDEGIPSTAIREISLLKELHHPNIVSLID 86
Query: 315 YCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVA----------KALEYLHHTCD 364
HS+ +V+ + LK+ L + + + + + + H
Sbjct: 87 VIHSERCLTLVFEFMEKDLKKVL------DENKTGLQDSQIKIYLYQLLRGVAHCHQHR- 139
Query: 365 PPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPV-NVVGTFGYLAPEY 423
I+HRD+K N+L++ + +L+DFG A V+ + V T Y AP+
Sbjct: 140 --ILHRDLKPQNLLINSD-GALKLADFGLA------RAFGIPVRSYTHEVVTLWYRAPDV 190
Query: 424 MM----YGKVDEKIDVYSYGVVLLELITGK 449
+M Y +D++S G + E+ITGK
Sbjct: 191 LMGSKKYS---TSVDIWSIGCIFAEMITGK 217
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 2e-18
Identities = 50/214 (23%), Positives = 94/214 (43%), Gaps = 33/214 (15%)
Query: 260 IGQGGNSKVYRTNHVD---GQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYC 316
+G+G VY+ D + A+K ++ T S RE+ LL +KH N++ +
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMS-ACREIALLRELKHPNVISLQKVF 87
Query: 317 HSKEMYAI--VYNLLNGSLKQYLKQLKWNERMDVAIGVA------------KALEYLHHT 362
S + +++ L +K + ++ + + + YLH
Sbjct: 88 LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 147
Query: 363 CDPPIIHRDVKSSNILLSENFHHP---QLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYL 419
++HRD+K +NIL+ +++D G A + + + ++ PV VV TF Y
Sbjct: 148 W---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV-VV-TFWYR 202
Query: 420 APEYMM----YGKVDEKIDVYSYGVVLLELITGK 449
APE ++ Y K ID+++ G + EL+T +
Sbjct: 203 APELLLGARHYTK---AIDIWAIGCIFAELLTSE 233
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 3e-18
Identities = 57/199 (28%), Positives = 94/199 (47%), Gaps = 46/199 (23%)
Query: 280 AVKVLK--CTNWSEEEVLREVELLSSI-KHENIVRIIGYC-HSKEMYAIVYNLLNGSLKQ 335
AVK+LK T +++ E+E++ I KH+NI+ ++G C +Y IV G+L++
Sbjct: 105 AVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 164
Query: 336 YLK-------------------QLKWNERMDVAIGVAKALEYL--HHTCDPPIIHRDVKS 374
YL+ QL + + A VA+ +EYL IHRD+ +
Sbjct: 165 YLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK-----CIHRDLAA 219
Query: 375 SNILLSENFHHPQLSDFGAA-MVHHQSHQVSENVKPVNVVGTFGYL-----APEYMMYGK 428
N+L++E+ + +++DFG A +HH T G L APE +
Sbjct: 220 RNVLVTED-NVMKIADFGLARDIHHID---------YYKKTTNGRLPVKWMAPEALFDRI 269
Query: 429 VDEKIDVYSYGVVLLELIT 447
+ DV+S+GV+L E+ T
Sbjct: 270 YTHQSDVWSFGVLLWEIFT 288
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 4e-18
Identities = 45/222 (20%), Positives = 93/222 (41%), Gaps = 33/222 (14%)
Query: 249 HLTHNFSPKMLIGQGGNSKVYRTNHVD-GQVAAVK-VLKCTNWSEEEVLREVELLSSIKH 306
F + + GQG V G A+K V++ + E L+ ++ L+ + H
Sbjct: 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLAVLHH 78
Query: 307 ENIVRIIGYCHS------KEMY-AIVYNLLNGSLKQYLKQL-KWNERMDVAIG------V 352
NIV++ Y ++ +++Y +V + +L + + + + +
Sbjct: 79 PNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQL 138
Query: 353 AKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA-MVHHQSHQVSENVKPVN 411
+++ LH + HRD+K N+L++E +L DFG+A + V+
Sbjct: 139 IRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAY------ 191
Query: 412 VVGTFGYLAPEYMM----YGKVDEKIDVYSYGVVLLELITGK 449
+ + Y APE + Y +D++S G + E++ G+
Sbjct: 192 -ICSRYYRAPELIFGNQHYTT---AVDIWSVGCIFAEMMLGE 229
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 6e-18
Identities = 54/203 (26%), Positives = 92/203 (45%), Gaps = 47/203 (23%)
Query: 280 AVKVLK--CTNWSEEEVLREVELLSSI-KHENIVRIIGYC-HSKEMYAIVYNLLNGSLKQ 335
AVK+LK + E ++ E+++++ + HENIV ++G C S +Y I G L
Sbjct: 79 AVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLN 138
Query: 336 YLK--------------------------QLKWNERMDVAIGVAKALEYL--HHTCDPPI 367
YL+ L + + + A VAK +E+L
Sbjct: 139 YLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS-----C 193
Query: 368 IHRDVKSSNILLSENFHHPQLSDFGAA-MVHHQSH-QVSENVK-PVNVVGTFGYLAPEYM 424
+HRD+ + N+L++ ++ DFG A + S+ V N + PV ++APE +
Sbjct: 194 VHRDLAARNVLVTHG-KVVKICDFGLARDIMSDSNYVVRGNARLPVK------WMAPESL 246
Query: 425 MYGKVDEKIDVYSYGVVLLELIT 447
G K DV+SYG++L E+ +
Sbjct: 247 FEGIYTIKSDVWSYGILLWEIFS 269
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 7e-18
Identities = 66/271 (24%), Positives = 111/271 (40%), Gaps = 25/271 (9%)
Query: 193 PSSSTSSTTRQESDVGVCIAQETVQ-VPESIKRKIFEKLAVLEAEGSSRRFTSQELCHLT 251
T+ T R E + QE + E + F ++ E +T
Sbjct: 123 RQLVTNCTQRLEQGPCKDLFQELTRLTHEYLSVAPFADYLDSIYFNRFLQWKWLERQPVT 182
Query: 252 -HNFSPKMLIGQGGNSKVYRTNHVD-GQVAAVKVLK----CTNWSEEEVLREVELLSSIK 305
+ F ++G+GG +V G++ A K L+ E L E ++L +
Sbjct: 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN 242
Query: 306 HENIVRIIGYC-HSKEMYAIVYNLLN-GSLKQYLKQLKWNE-RMDVAI----GVAKALEY 358
+V + Y +K+ +V L+N G LK ++ + A+ + LE
Sbjct: 243 SRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLED 301
Query: 359 LHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGY 418
LH I++RD+K NILL ++ H ++SD G A+ V E VGT GY
Sbjct: 302 LH---RERIVYRDLKPENILLDDH-GHIRISDLGLAV------HVPEGQTIKGRVGTVGY 351
Query: 419 LAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
+APE + + D ++ G +L E+I G+
Sbjct: 352 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 9e-18
Identities = 50/206 (24%), Positives = 93/206 (45%), Gaps = 33/206 (16%)
Query: 260 IGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEE-----VLREVELLSSIKHENIVRIIG 314
IG+G VY+ + G+ A+K ++ E+E +RE+ +L +KH NIV++
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEK--EDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 315 YCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAI------GVAKALEYLHHTCDPPII 368
H+K+ +V+ L+ LK+ L ++ + + Y H ++
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRR---VL 122
Query: 369 HRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPV-NVVGTFGYLAPEYMM-- 425
HRD+K N+L++ +++DFG A V+ + + T Y AP+ +M
Sbjct: 123 HRDLKPQNLLINRE-GELKIADFGLA------RAFGIPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 426 --YGKVDEKIDVYSYGVVLLELITGK 449
Y ID++S G + E++ G
Sbjct: 176 KKYS---TTIDIWSVGCIFAEMVNGT 198
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 9e-18
Identities = 56/273 (20%), Positives = 114/273 (41%), Gaps = 26/273 (9%)
Query: 193 PSSSTSSTTRQESDVGVCIAQETVQ-VPESIKRKIFEKLAVLEAEGSSRRFTSQELCHLT 251
+ R + G + Q ++ V + + F++ ++ E +
Sbjct: 124 SFLDAETVARARAGAGDGLFQPLLRAVLAHLGQAPFQEFLDSLYFLRFLQWKWLEAQPMG 183
Query: 252 -HNFSPKMLIGQGGNSKVYRTNHVD-GQVAAVKVLK----CTNWSEEEVLREVELLSSIK 305
F ++G+GG +V+ G++ A K L + + E ++L+ +
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH 243
Query: 306 HENIVRIIGYC-HSKEMYAIVYNLLN-GSLKQYLKQLKWNER---MDVAI----GVAKAL 356
IV + Y +K +V ++N G ++ ++ + + AI + L
Sbjct: 244 SRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 357 EYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTF 416
E+LH II+RD+K N+LL ++ + ++SD G A+ + K GT
Sbjct: 303 EHLH---QRNIIYRDLKPENVLLDDD-GNVRISDLGLAV-----ELKAGQTKTKGYAGTP 353
Query: 417 GYLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
G++APE ++ + D +D ++ GV L E+I +
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 1e-17
Identities = 57/216 (26%), Positives = 99/216 (45%), Gaps = 49/216 (22%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEE------VLREVELLSSIKHENIVRI 312
+G+G + VY+ + Q+ A+K +K + SE + LRE++LL + H NI+ +
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 313 IGYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVA----------KALEYLHHT 362
+ K ++V++ + L+ + + + + + + LEYLH
Sbjct: 78 LDAFGHKSNISLVFDFMETDLEVII------KDNSLVLTPSHIKAYMLMTLQGLEYLHQH 131
Query: 363 CDPPIIHRDVKSSNILLSENFHHPQLSDFGAAM-----VHHQSHQVSENVKPVNVVGTFG 417
I+HRD+K +N+LL EN +L+DFG A +HQV V T
Sbjct: 132 W---ILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAYTHQV---V-------TRW 177
Query: 418 YLAPEYMM----YGKVDEKIDVYSYGVVLLELITGK 449
Y APE + YG +D+++ G +L EL+
Sbjct: 178 YRAPELLFGARMYG---VGVDMWAVGCILAELLLRV 210
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 1e-17
Identities = 53/210 (25%), Positives = 97/210 (46%), Gaps = 41/210 (19%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEV----LREVELLSSIKHENIVRIIG 314
+G+G + VY+ + + + A+K ++ + EE +REV LL +KH NIV +
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKEIRLEH--EEGAPCTAIREVSLLKDLKHANIVTLHD 67
Query: 315 YCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVA------IGVAKALEYLHHTCDPPII 368
H+++ +V+ L+ LKQYL +++ + + L Y H ++
Sbjct: 68 IIHTEKSLTLVFEYLDKDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQK---VL 122
Query: 369 HRDVKSSNILLSENFHHPQLSDFGAAM-----VHHQSHQVSENVKPVNVVGTFGYLAPEY 423
HRD+K N+L++E +L+DFG A ++V V T Y P+
Sbjct: 123 HRDLKPQNLLINER-GELKLADFGLARAKSIPTKTYDNEV---V-------TLWYRPPDI 171
Query: 424 MM----YGKVDEKIDVYSYGVVLLELITGK 449
++ Y +ID++ G + E+ TG+
Sbjct: 172 LLGSTDYS---TQIDMWGVGCIFYEMATGR 198
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 2e-17
Identities = 55/214 (25%), Positives = 94/214 (43%), Gaps = 42/214 (19%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEE-----VLREVELLSSIKHENIVRII 313
IG+G V++ N ++ A+K ++ + ++E LRE+ LL +KH+NIVR+
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDD--DDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 314 GYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIG------VAKALEYLHHTCDPPI 367
HS + +V+ + LK+Y N +D I + K L + H +
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSRN---V 122
Query: 368 IHRDVKSSNILLSENFHHPQLSDFGAAM-----VHHQSHQVSENVKPVNVVGTFGYLAPE 422
+HRD+K N+L++ N +L++FG A V S +V T Y P+
Sbjct: 123 LHRDLKPQNLLINRN-GELKLANFGLARAFGIPVRCYSAEVV----------TLWYRPPD 171
Query: 423 YMM----YGKVDEKIDVYSYGVVLLELITGKEAI 452
+ Y ID++S G + EL +
Sbjct: 172 VLFGAKLYS---TSIDMWSAGCIFAELANAGRPL 202
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 2e-17
Identities = 58/210 (27%), Positives = 95/210 (45%), Gaps = 36/210 (17%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEV----LREVELLSSIKHENIVRIIG 314
+G G + VY+ N G A+K +K + EE +RE+ L+ +KHENIVR+
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVKLDS--EEGTPSTAIREISLMKELKHENIVRLYD 70
Query: 315 YCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVA----------KALEYLHHTCD 364
H++ +V+ ++ LK+Y+ + + + L + H
Sbjct: 71 VIHTENKLTLVFEFMDNDLKKYMDSRTVGN-TPRGLELNLVKYFQWQLLQGLAFCHENK- 128
Query: 365 PPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPV-NVVGTFGYLAPEY 423
I+HRD+K N+L+++ +L DFG A V + V T Y AP+
Sbjct: 129 --ILHRDLKPQNLLINKR-GQLKLGDFGLA------RAFGIPVNTFSSEVVTLWYRAPDV 179
Query: 424 MM----YGKVDEKIDVYSYGVVLLELITGK 449
+M Y ID++S G +L E+ITGK
Sbjct: 180 LMGSRTYS---TSIDIWSCGCILAEMITGK 206
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 3e-17
Identities = 46/204 (22%), Positives = 91/204 (44%), Gaps = 24/204 (11%)
Query: 259 LIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHE------NIVR 311
+IG+G +V + +H Q A+K+++ + E+ +L ++ + N++
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIH 163
Query: 312 IIGYCHSKEMYAIVYNLLNGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPP 366
++ + + + LL+ +L + +K+ A + + L+ LH
Sbjct: 164 MLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH---KNR 220
Query: 367 IIHRDVKSSNILLSENFHHP-QLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMM 425
IIH D+K NILL + ++ DFG++ HQ + + Y APE ++
Sbjct: 221 IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRV--------YTYIQSRFYRAPEVIL 272
Query: 426 YGKVDEKIDVYSYGVVLLELITGK 449
+ ID++S G +L EL+TG
Sbjct: 273 GARYGMPIDMWSLGCILAELLTGY 296
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 3e-17
Identities = 58/218 (26%), Positives = 96/218 (44%), Gaps = 44/218 (20%)
Query: 260 IGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEE-----VLREVELLSSIKHENIVRII 313
IGQG +V++ H GQ A+K + N E+E LRE+++L +KHEN+V +I
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMEN--EKEGFPITALREIKILQLLKHENVVNLI 82
Query: 314 GYCHSKEMYA--------IVYNLLNGSLKQYLKQLKWNERMDVAIGVA----------KA 355
C +K +V++ L L + V ++
Sbjct: 83 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLL------SNVLVKFTLSEIKRVMQMLLNG 136
Query: 356 LEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGT 415
L Y+H I+HRD+K++N+L++ + +L+DFG A + N VV T
Sbjct: 137 LYYIHRNK---ILHRDMKAANVLITRD-GVLKLADFGLARAFSLAKNSQPNRYTNRVV-T 191
Query: 416 FGYLAPEYMM----YGKVDEKIDVYSYGVVLLELITGK 449
Y PE ++ YG ID++ G ++ E+ T
Sbjct: 192 LWYRPPELLLGERDYG---PPIDLWGAGCIMAEMWTRS 226
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 3e-17
Identities = 49/214 (22%), Positives = 90/214 (42%), Gaps = 22/214 (10%)
Query: 249 HLTHNFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHE 307
+ LIG+G +V + + V+ + A+K++K + EV LL +
Sbjct: 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKH 110
Query: 308 ------NIVRIIGYCHSKEMYAIVYNLLNGSLKQYLKQ-----LKWNERMDVAIGVAKAL 356
IV + + + +V+ +L+ +L L+ + N A + AL
Sbjct: 111 DTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTAL 170
Query: 357 EYLHHTCDPPIIHRDVKSSNILLSENFHHP-QLSDFGAAMVHHQSHQVSENVKPVNVVGT 415
+L + IIH D+K NILL ++ DFG++ Q + +
Sbjct: 171 LFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI--------YQYIQS 221
Query: 416 FGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
Y +PE ++ D ID++S G +L+E+ TG+
Sbjct: 222 RFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 6e-17
Identities = 59/217 (27%), Positives = 95/217 (43%), Gaps = 38/217 (17%)
Query: 253 NFSPKMLIGQGGNSKVYRTNHVD-GQVAAVKVLK---CTNWSEEE-VLREVELLSSIKHE 307
+F IG+G KV D ++ A+K + C +E V +E++++ ++H
Sbjct: 16 HFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHP 75
Query: 308 NIVRIIGYCHSKE-MYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVAK--------ALEY 358
+V + +E M+ +V LL G L+ +L+Q N K AL+Y
Sbjct: 76 FLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQ---NVHFK--EETVKLFICELVMALDY 130
Query: 359 LHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGY 418
L + IIHRD+K NILL E+ H ++DF A + + + GT Y
Sbjct: 131 LQNQ---RIIHRDMKPDNILLDEH-GHVHITDFNIAA------MLPRETQITTMAGTKPY 180
Query: 419 LAPEYMM------YGKVDEKIDVYSYGVVLLELITGK 449
+APE Y +D +S GV EL+ G+
Sbjct: 181 MAPEMFSSRKGAGYSFA---VDWWSLGVTAYELLRGR 214
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 6e-17
Identities = 54/215 (25%), Positives = 101/215 (46%), Gaps = 23/215 (10%)
Query: 249 HLTHNFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEE----VLREVELLSS 303
+ ++ IG+G V ++++ A+K K + + + LRE+++L
Sbjct: 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK--KISPFEHQTYCQRTLREIKILLR 81
Query: 304 IKHENIVRII------GYCHSKEMYAIVYNLLNGSLKQYLK-QLKWNERMDVAI-GVAKA 355
+HENI+ I K++Y IV +L+ L + LK Q N+ + + + +
Sbjct: 82 FRHENIIGINDIIRAPTIEQMKDVY-IVQDLMETDLYKLLKTQHLSNDHICYFLYQILRG 140
Query: 356 LEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGT 415
L+Y+H + + ++HRD+K SN+LL+ ++ DFG A V T
Sbjct: 141 LKYIH-SAN--VLHRDLKPSNLLLNTTC-DLKICDFGLA--RVADPDHDHTGFLTEYVAT 194
Query: 416 FGYLAPEYMM-YGKVDEKIDVYSYGVVLLELITGK 449
Y APE M+ + ID++S G +L E+++ +
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 6e-17
Identities = 51/241 (21%), Positives = 91/241 (37%), Gaps = 35/241 (14%)
Query: 233 LEAEGSSRRFT-SQELCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSE 291
++A+G + EL + ++ + I G V +G A+K + T
Sbjct: 2 MQAKGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDG 61
Query: 292 EE------------VLREVELLSSIKHENIVRII------GYCHSKEMYAIVYNLLNGSL 333
VLRE+ LL+ H NI+ + ++Y +V L+ L
Sbjct: 62 RTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLY-LVTELMRTDL 120
Query: 334 KQYLKQLKW---NERMDVAI-GVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLS 389
Q + + + + + + L LH ++HRD+ NILL++N +
Sbjct: 121 AQVIHDQRIVISPQHIQYFMYHILLGLHVLH-EAG--VVHRDLHPGNILLADNN-DITIC 176
Query: 390 DFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMM-YGKVDEKIDVYSYGVVLLELITG 448
DF A + V Y APE +M + + +D++S G V+ E+
Sbjct: 177 DFNLAREDTADANKTHY------VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNR 230
Query: 449 K 449
K
Sbjct: 231 K 231
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 8e-17
Identities = 52/203 (25%), Positives = 98/203 (48%), Gaps = 27/203 (13%)
Query: 260 IGQGGNSKVYRTNHVD-GQVAAVKVL---KCTNWSEEEVLREVELLSSIKHENIVRIIGY 315
IG+G +KV H+ G+ A+K++ + S +++ REV ++ + H NIV++
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 316 CHSKEMYAIVYNLL-NGSLKQYLKQLKWNERM--DVAIG----VAKALEYLHHTCDPPII 368
+++ ++ G + YL + RM A + A++Y H I+
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVA---HGRMKEKEARSKFRQIVSAVQYCHQKR---IV 136
Query: 369 HRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGK 428
HRD+K+ N+LL + + +++DFG + ++ G Y APE + GK
Sbjct: 137 HRDLKAENLLLDAD-MNIKIADFGFSNEFTVGGKLDA------FCGAPPYAAPE-LFQGK 188
Query: 429 VDE--KIDVYSYGVVLLELITGK 449
+ ++DV+S GV+L L++G
Sbjct: 189 KYDGPEVDVWSLGVILYTLVSGS 211
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 53/232 (22%), Positives = 101/232 (43%), Gaps = 35/232 (15%)
Query: 238 SSRRFTSQELC----HLTHNFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEE 292
+ F QE+ + + +G G V + G A+K K +
Sbjct: 7 ARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIK--KLYRPFQS 64
Query: 293 EV-----LREVELLSSIKHENIVRII-------GYCHSKEMYAIVYNLLNGSLKQYLK-Q 339
E+ RE+ LL ++HEN++ ++ + Y +V + L + +K +
Sbjct: 65 ELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFY-LVMPFMGTDLGKLMKHE 123
Query: 340 LKWNERMDVAI-GVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398
+R+ + + K L Y+H IIHRD+K N+ ++E+ ++ DFG A
Sbjct: 124 KLGEDRIQFLVYQMLKGLRYIH-AAG--IIHRDLKPGNLAVNEDC-ELKILDFGLA--RQ 177
Query: 399 QSHQVSENVKPVNVVGTFGYLAPEYMM-YGKVDEKIDVYSYGVVLLELITGK 449
+++ V T Y APE ++ + + + +D++S G ++ E+ITGK
Sbjct: 178 ADSEMTGY------VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 1e-16
Identities = 59/228 (25%), Positives = 108/228 (47%), Gaps = 35/228 (15%)
Query: 242 FTSQELC----HLTHNFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEV-- 294
F QEL + + +G G V + G AVK K + + +
Sbjct: 15 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHA 72
Query: 295 ---LREVELLSSIKHENIVRII-------GYCHSKEMYAIVYNLLNGSLKQYLK-QLKWN 343
RE+ LL +KHEN++ ++ ++Y +V +L+ L +K Q +
Sbjct: 73 KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY-LVTHLMGADLNNIVKCQKLTD 131
Query: 344 ERMDVAI-GVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402
+ + I + + L+Y+H + D IIHRD+K SN+ ++E+ ++ DFG A H + +
Sbjct: 132 DHVQFLIYQILRGLKYIH-SAD--IIHRDLKPSNLAVNEDC-ELKILDFGLA--RHTADE 185
Query: 403 VSENVKPVNVVGTFGYLAPEYMM-YGKVDEKIDVYSYGVVLLELITGK 449
++ V T Y APE M+ + ++ +D++S G ++ EL+TG+
Sbjct: 186 MTGY------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 1e-16
Identities = 48/209 (22%), Positives = 90/209 (43%), Gaps = 34/209 (16%)
Query: 260 IGQGGNSKVYRTNHV-DGQVAAVKV-----LKCTNWSEEEVL----REVELLSSIKHENI 309
+G G V+ + VK + W E+ L E+ +LS ++H NI
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 310 VRIIGYCHSKEMYAIV--YNLLNGSLKQYLKQLKWNERMDVAIG------VAKALEYLHH 361
++++ ++ + +V + L ++ + + R+D + + A+ YL
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLVSAVGYLRL 148
Query: 362 TCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAP 421
IIHRD+K NI+++E+F +L DFG+A + GT Y AP
Sbjct: 149 KD---IIHRDIKDENIVIAEDF-TIKLIDFGSAAYLERGKLFY------TFCGTIEYCAP 198
Query: 422 EYMMYGK--VDEKIDVYSYGVVLLELITG 448
E ++ G +++++S GV L L+
Sbjct: 199 E-VLMGNPYRGPELEMWSLGVTLYTLVFE 226
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-16
Identities = 56/212 (26%), Positives = 97/212 (45%), Gaps = 28/212 (13%)
Query: 253 NFSPKMLIGQGGNSKVYRTNHVD-GQVAAVKVLK----CTNWSEEEVLREVELLSSIKHE 307
+F ++G+G S V + + A+K+L+ V RE +++S + H
Sbjct: 31 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 308 NIVRIIGYCHSKE-MYAIVYNLLNGSLKQYLKQLKWNERMDVAIG------VAKALEYLH 360
V++ E +Y + NG L +Y++++ D + ALEYLH
Sbjct: 91 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLH 147
Query: 361 HTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLA 420
IIHRD+K NILL+E+ H Q++DFG A S+ + + VGT Y++
Sbjct: 148 GK---GIIHRDLKPENILLNEDM-HIQITDFGTA---KVLSPESKQARANSFVGTAQYVS 200
Query: 421 PEYMM---YGKVDEKIDVYSYGVVLLELITGK 449
PE + K D+++ G ++ +L+ G
Sbjct: 201 PELLTEKSACKS---SDLWALGCIIYQLVAGL 229
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 79.1 bits (196), Expect = 2e-16
Identities = 52/211 (24%), Positives = 92/211 (43%), Gaps = 42/211 (19%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEV-----LREVELLSSIKHENIVRII 313
IG+G V++ N GQ+ A+K K ++ V LRE+ +L +KH N+V ++
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIK--KFLESEDDPVIKKIALREIRMLKQLKHPNLVNLL 68
Query: 314 GYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIG------VAKALEYLHHTCDPPI 367
K +V+ + ++ L + + + +A+ + H
Sbjct: 69 EVFRRKRRLHLVFEYCDHTVLHELDRY--QRGVPEHLVKSITWQTLQAVNFCHKHN---C 123
Query: 368 IHRDVKSSNILLSENFHHPQLSDFGAA-----MVHHQSHQVSENVKPVNVVGTFGYLAPE 422
IHRDVK NIL++++ +L DFG A + +V+ T Y +PE
Sbjct: 124 IHRDVKPENILITKH-SVIKLCDFGFARLLTGPSDYYDDEVA----------TRWYRSPE 172
Query: 423 YMM----YGKVDEKIDVYSYGVVLLELITGK 449
++ YG +DV++ G V EL++G
Sbjct: 173 LLVGDTQYGP---PVDVWAIGCVFAELLSGV 200
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-16
Identities = 50/215 (23%), Positives = 97/215 (45%), Gaps = 50/215 (23%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEV-----LREVELLSSIKHENIVRII 313
+G+G V + N G++ A+K ++ ++++ +RE++LL ++HEN+V ++
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESD--DDKMVKKIAMREIKLLKQLRHENLVNLL 90
Query: 314 GYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVA----------KALEYLHHTC 363
C K+ + +V+ ++ ++ L E + + + H
Sbjct: 91 EVCKKKKRWYLVFEFVDHTILDDL------ELFPNGLDYQVVQKYLFQIINGIGFCHSHN 144
Query: 364 DPPIIHRDVKSSNILLSENFHHPQLSDFGAAM-----VHHQSHQVSENVKPVNVVGTFGY 418
IIHRD+K NIL+S++ +L DFG A +V+ T Y
Sbjct: 145 ---IIHRDIKPENILVSQS-GVVKLCDFGFARTLAAPGEVYDDEVA----------TRWY 190
Query: 419 LAPEYMM----YGKVDEKIDVYSYGVVLLELITGK 449
APE ++ YGK +DV++ G ++ E+ G+
Sbjct: 191 RAPELLVGDVKYGK---AVDVWAIGCLVTEMFMGE 222
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-16
Identities = 60/221 (27%), Positives = 105/221 (47%), Gaps = 28/221 (12%)
Query: 249 HLTHNFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEE----VLREVELLSS 303
+++ +F K L+G+G V T+ G++ A+K K + + LRE+++L
Sbjct: 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIK--KIEPFDKPLFALRTLREIKILKH 65
Query: 304 IKHENIVRII------GYCHSKEMYAIVYNLLNGSLKQYLK--QLKWNERMDVAI-GVAK 354
KHENI+ I + + E+Y I+ L+ L + + L ++ + I +
Sbjct: 66 FKHENIITIFNIQRPDSFENFNEVY-IIQELMQTDLHRVISTQMLS-DDHIQYFIYQTLR 123
Query: 355 ALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNV-- 412
A++ LH + +IHRD+K SN+L++ N ++ DFG A + +S +
Sbjct: 124 AVKVLH-GSN--VIHRDLKPSNLLINSNC-DLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 413 ---VGTFGYLAPEYMM-YGKVDEKIDVYSYGVVLLELITGK 449
V T Y APE M+ K +DV+S G +L EL +
Sbjct: 180 VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 3e-16
Identities = 53/213 (24%), Positives = 89/213 (41%), Gaps = 36/213 (16%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEE--------VLREVELL---SSIKHE 307
IG G VY+ + G A+K ++ N +REV LL + +H
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPN--GGGGGGGLPISTVREVALLRRLEAFEHP 74
Query: 308 NIVRIIGYCHSKEMYA-----IVYNLLNGSLKQYLKQLKWNERMDVAIG------VAKAL 356
N+VR++ C + +V+ ++ L+ YL + + + L
Sbjct: 75 NVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAP-PPGLPAETIKDLMRQFLRGL 133
Query: 357 EYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTF 416
++LH C I+HRD+K NIL++ +L+DFG A S + VV T
Sbjct: 134 DFLHANC---IVHRDLKPENILVTSG-GTVKLADFGLA------RIYSYQMALTPVVVTL 183
Query: 417 GYLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
Y APE ++ +D++S G + E+ K
Sbjct: 184 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 5e-16
Identities = 49/209 (23%), Positives = 90/209 (43%), Gaps = 28/209 (13%)
Query: 259 LIGQGGNSKVYRTNHVD-GQVAAVKVLK-----CTNWSEEEVLREVELLSSIKHENIVR- 311
L+G+G KV + AVK+LK E V +E++LL ++H+N+++
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 312 --IIGYCHSKEMYAIVYNLLNGSLKQ---YLKQLKWNERMDVAIG----VAKALEYLHHT 362
++ ++MY +V +++ + + ++ A G + LEYLH
Sbjct: 72 VDVLYNEEKQKMY-MVMEYCVCGMQEMLDSVPEKRFPV--CQAHGYFCQLIDGLEYLHSQ 128
Query: 363 CDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPE 422
I+H+D+K N+LL+ ++S G A H + + G+ + PE
Sbjct: 129 G---IVHKDIKPGNLLLTTG-GTLKISALGVA---EALHPFAADDTCRTSQGSPAFQPPE 181
Query: 423 YMMYGKVDE--KIDVYSYGVVLLELITGK 449
K+D++S GV L + TG
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 6e-16
Identities = 52/211 (24%), Positives = 92/211 (43%), Gaps = 34/211 (16%)
Query: 260 IGQGGNSKVY--RTNHVDGQVAAVKVLKCTNWSEEE-----VLREVELL---SSIKHENI 309
IG+G KV+ R G+ A+K ++ EE +REV +L + +H N+
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQT--GEEGMPLSTIREVAVLRHLETFEHPNV 76
Query: 310 VRIIGYCHSKEMYA-----IVYNLLNGSLKQYLKQLKWNERMDVAIG------VAKALEY 358
VR+ C +V+ ++ L YL ++ + + + L++
Sbjct: 77 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDF 135
Query: 359 LHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGY 418
LH ++HRD+K NIL++ + +L+DFG A S + +VV T Y
Sbjct: 136 LHSHR---VVHRDLKPQNILVTSS-GQIKLADFGLA------RIYSFQMALTSVVVTLWY 185
Query: 419 LAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
APE ++ +D++S G + E+ K
Sbjct: 186 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 8e-16
Identities = 53/243 (21%), Positives = 86/243 (35%), Gaps = 77/243 (31%)
Query: 259 LIGQGGNSKVYR-TNHVDGQVAAVKVL---------------------------KCTNWS 290
IG+G V N D A+KVL
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 291 EEEVLREVELLSSIKHENIVR---------------IIGYCHSKEMYAIVYNLLNGSLK- 334
E+V +E+ +L + H N+V+ + + + + L
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSE 136
Query: 335 ----QYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSD 390
Y + L K +EYLH+ IIHRD+K SN+L+ E+ H +++D
Sbjct: 137 DQARFYFQDL------------IKGIEYLHYQK---IIHRDIKPSNLLVGED-GHIKIAD 180
Query: 391 FGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDE----KIDVYSYGVVLLELI 446
FG + S + N VGT ++APE + +DV++ GV L +
Sbjct: 181 FGVSNEFKGSDALLS-----NTVGTPAFMAPE-SLSETRKIFSGKALDVWAMGVTLYCFV 234
Query: 447 TGK 449
G+
Sbjct: 235 FGQ 237
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 1e-15
Identities = 46/213 (21%), Positives = 88/213 (41%), Gaps = 45/213 (21%)
Query: 259 LIGQGGNSKVYRTNHVD-GQVAAVKVL--KCTNWSEEEVLREVELLSSIKHENIVRIIGY 315
+G+G +V + + AVK++ K E + +E+ + + HEN+V+ G+
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 316 CHSKEMYAIV-----------YNLLNGSLKQ-----YLKQLKWNERMDVAIGVAKALEYL 359
+ + + + + + QL + + YL
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL---------MA---GVVYL 121
Query: 360 HHTCDPPIIHRDVKSSNILLSENFHHPQLSDFG--AAMVHHQSHQVSENVKPVNVVGTFG 417
H I HRD+K N+LL E + ++SDFG ++ ++ + GT
Sbjct: 122 HGIG---ITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLN-----KMCGTLP 172
Query: 418 YLAPEYMMYGK--VDEKIDVYSYGVVLLELITG 448
Y+APE ++ + E +DV+S G+VL ++ G
Sbjct: 173 YVAPE-LLKRREFHAEPVDVWSCGIVLTAMLAG 204
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 1e-15
Identities = 55/206 (26%), Positives = 82/206 (39%), Gaps = 34/206 (16%)
Query: 259 LIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCH 317
IG G ++ AVK ++ +E V RE+ S++H NIVR
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVIL 86
Query: 318 SKEMYAIV--YNLLNGSLKQYLKQLKWNERM--DVA-------IGVAKALEYLHHTCDPP 366
+ AI+ Y G L + + R D A + + Y H
Sbjct: 87 TPTHLAIIMEY-ASGGELYERICN---AGRFSEDEARFFFQQLLS---GVSYCHSMQ--- 136
Query: 367 IIHRDVKSSNILLSENFHHPQL--SDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYM 424
I HRD+K N LL + P+L DFG + Q P + VGT Y+APE +
Sbjct: 137 ICHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHSQ------PKSTVGTPAYIAPE-V 188
Query: 425 MYGK--VDEKIDVYSYGVVLLELITG 448
+ + + DV+S GV L ++ G
Sbjct: 189 LLRQEYDGKIADVWSCGVTLYVMLVG 214
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 3e-15
Identities = 70/256 (27%), Positives = 123/256 (48%), Gaps = 34/256 (13%)
Query: 213 QETVQVPESIKRKIFEKLAVLEAEGSSRRFTSQEL-CHLT-HNFSPKMLIGQGGNSKVYR 270
++ ++++ +F+K + ++ + EL HLT ++FS +IG+GG +VY
Sbjct: 148 PYIEEICQNLRGDVFQKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYG 207
Query: 271 TNHVD-GQVAAVKVLK-----------CTNWSEEEVLREVELLSSIKHENIVRIIGYCHS 318
D G++ A+K L +E +L L+S+ IV + H+
Sbjct: 208 CRKADTGKMYAMKCLDKKRIKMKQGETLAL-NERIML---SLVSTGDCPFIVCMSYAFHT 263
Query: 319 KEMYAIVYNLLN-GSLKQYLKQL-KWNERMDV--AIGVAKALEYLHHTCDPPIIHRDVKS 374
+ + + +L+N G L +L Q ++E A + LE++H + +++RD+K
Sbjct: 264 PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKP 320
Query: 375 SNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKV-DEKI 433
+NILL E+ H ++SD G A S+ KP VGT GY+APE + G D
Sbjct: 321 ANILLDEH-GHVRISDLGLAC------DFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSA 372
Query: 434 DVYSYGVVLLELITGK 449
D +S G +L +L+ G
Sbjct: 373 DWFSLGCMLFKLLRGH 388
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 4e-15
Identities = 46/213 (21%), Positives = 88/213 (41%), Gaps = 45/213 (21%)
Query: 259 LIGQGGNSKVYRTNHVD-GQVAAVKVL--KCTNWSEEEVLREVELLSSIKHENIVRIIGY 315
+G+G +V + + AVK++ K E + +E+ + + HEN+V+ G+
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 316 CHSKEMYAIV-----------YNLLNGSLKQ-----YLKQLKWNERMDVAIGVAKALEYL 359
+ + + + + + QL + + YL
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL---------MA---GVVYL 121
Query: 360 HHTCDPPIIHRDVKSSNILLSENFHHPQLSDFG--AAMVHHQSHQVSENVKPVNVVGTFG 417
H I HRD+K N+LL E + ++SDFG ++ ++ + GT
Sbjct: 122 HGIG---ITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLN-----KMCGTLP 172
Query: 418 YLAPEYMMYGK--VDEKIDVYSYGVVLLELITG 448
Y+APE ++ + E +DV+S G+VL ++ G
Sbjct: 173 YVAPE-LLKRREFHAEPVDVWSCGIVLTAMLAG 204
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 5e-15
Identities = 59/285 (20%), Positives = 110/285 (38%), Gaps = 42/285 (14%)
Query: 184 RQLQKSLTAPSSSTSSTTRQESDVGVCIAQETVQVPESIKRKIFEKLAVLEAEGSSRRFT 243
++ L P S +S D + + + P K K + + + + +
Sbjct: 7 EKMDNLLRDPKSEVNSDCL--LDGLDALVYD-LDFPALRKNKNIDNF-LSRYKDTINKIR 62
Query: 244 SQELCHLTHNFSPKMLIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEEVLR------ 296
+ ++ +IG+G +V H +V A+K+L + E+++
Sbjct: 63 DLRMK--AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLS-----KFEMIKRSDSAF 115
Query: 297 ---EVELLSSIKHENIVRIIGYCHSKEMYAIVYNLLNG-SLKQYLKQLKWNERMDV--AI 350
E ++++ +V++ +V + G L + E+
Sbjct: 116 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTA 175
Query: 351 GVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPV 410
V AL+ +H IHRDVK N+LL ++ H +L+DFG M ++ V +
Sbjct: 176 EVVLALDAIHSMG---FIHRDVKPDNMLLDKS-GHLKLADFGTCMKMNKEGMVRCDT--- 228
Query: 411 NVVGTFGYLAPE-------YMMYGKVDEKIDVYSYGVVLLELITG 448
VGT Y++PE YG+ D +S GV L E++ G
Sbjct: 229 -AVGTPDYISPEVLKSQGGDGYYGRE---CDWWSVGVFLYEMLVG 269
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 57/259 (22%), Positives = 97/259 (37%), Gaps = 64/259 (24%)
Query: 249 HLTHNFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEV-----LREVELLS 302
H+ N+ K LIG+G VY + + A+K K E+ + LRE+ +L+
Sbjct: 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIK--KVNRMFEDLIDCKRILREITILN 80
Query: 303 SIKHENIVRII------GYCHSKEMYAIVYNLLNGSLKQYLK---------------QLK 341
+K + I+R+ E+Y IV + + LK+ K L
Sbjct: 81 RLKSDYIIRLYDLIIPDDLLKFDELY-IVLEIADSDLKKLFKTPIFLTEEHIKTILYNL- 138
Query: 342 WNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401
++H IIHRD+K +N LL+++ ++ DFG A +
Sbjct: 139 -----------LLGENFIH-ESG--IIHRDLKPANCLLNQDC-SVKVCDFGLARTINSEK 183
Query: 402 QVSENVKPVNV-----------------VGTFGYLAPEYMM-YGKVDEKIDVYSYGVVLL 443
+ V T Y APE ++ + ID++S G +
Sbjct: 184 DTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFA 243
Query: 444 ELITGKEAIQTNKANRESL 462
EL+ ++ + NR L
Sbjct: 244 ELLNMLQSHINDPTNRFPL 262
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 2e-14
Identities = 49/267 (18%), Positives = 98/267 (36%), Gaps = 75/267 (28%)
Query: 249 HLTHNFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEV-----LREVELLS 302
+ + + LIG G V + ++ +V A+K K E+ + LRE+ +L+
Sbjct: 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIK--KILRVFEDLIDCKRILREIAILN 107
Query: 303 SIKHENIVRIIGYCHS------KEMYAIVYNLLNGSLKQYLK---------------QLK 341
+ H+++V+++ E+Y +V + + K+ + L
Sbjct: 108 RLNHDHVVKVLDIVIPKDVEKFDELY-VVLEIADSDFKKLFRTPVYLTELHIKTLLYNL- 165
Query: 342 WNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401
++Y+H + I+HRD+K +N L++++ ++ DFG A
Sbjct: 166 -----------LVGVKYVH-SAG--ILHRDLKPANCLVNQDC-SVKVCDFGLARTVDYPE 210
Query: 402 QVSENVKPVNVVGTFG----------------------YLAPEYMM----YGKVDEKIDV 435
+ + Y APE ++ Y + IDV
Sbjct: 211 NGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTE---AIDV 267
Query: 436 YSYGVVLLELITGKEAIQTNKANRESL 462
+S G + EL+ + A+R L
Sbjct: 268 WSIGCIFAELLNMIKENVAYHADRGPL 294
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 51/204 (25%), Positives = 92/204 (45%), Gaps = 27/204 (13%)
Query: 259 LIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSE----EEVLREVELLSSIKHENIVRII 313
+G+G KV H Q A+K + + V RE+ L ++H +I+++
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75
Query: 314 GYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVAK------ALEYLHHTCDPPI 367
+ +V G L Y+ + +RM G A+EY H I
Sbjct: 76 DVITTPTDIVMVIEYAGGELFDYIVE---KKRMTEDEGRRFFQQIICAIEYCHRHK---I 129
Query: 368 IHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYG 427
+HRD+K N+LL +N + +++DFG + + + + G+ Y APE ++ G
Sbjct: 130 VHRDLKPENLLLDDN-LNVKIADFGLSNIMTDGNFLK------TSCGSPNYAAPE-VING 181
Query: 428 KVDE--KIDVYSYGVVLLELITGK 449
K+ ++DV+S G+VL ++ G+
Sbjct: 182 KLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 46/224 (20%), Positives = 94/224 (41%), Gaps = 32/224 (14%)
Query: 249 HLTHNFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEE---VLREVELLSSI 304
L + +G GGN V+ ++ + A+K K + LRE++++ +
Sbjct: 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIK--KIVLTDPQSVKHALREIKIIRRL 65
Query: 305 KHENIVRII---------------GYCHSKEMYAIVYNLLNGSLKQYLK--QLKWNERMD 347
H+NIV++ +Y IV + L L+ L E
Sbjct: 66 DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVY-IVQEYMETDLANVLEQGPLL-EEHAR 123
Query: 348 VAI-GVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSEN 406
+ + + + L+Y+H + + ++HRD+K +N+ ++ ++ DFG A + S
Sbjct: 124 LFMYQLLRGLKYIH-SAN--VLHRDLKPANLFINTEDLVLKIGDFGLARI--MDPHYSHK 178
Query: 407 VKPVNVVGTFGYLAPEYMM-YGKVDEKIDVYSYGVVLLELITGK 449
+ T Y +P ++ + ID+++ G + E++TGK
Sbjct: 179 GHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 7e-14
Identities = 47/216 (21%), Positives = 92/216 (42%), Gaps = 50/216 (23%)
Query: 259 LIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEEVL----REVELLSSIKHENIVR-- 311
+G G KV H G AVK+L +V+ RE++ L +H +I++
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77
Query: 312 -----------IIGYCHSKEMYAIVYNLLNGSLK-----QYLKQLKWNERMDVAIGVAKA 355
++ Y E++ Y +G ++ + +Q+ A
Sbjct: 78 QVISTPTDFFMVMEYVSGGELFD--YICKHGRVEEMEARRLFQQI------------LSA 123
Query: 356 LEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGT 415
++Y H ++HRD+K N+LL + + +++DFG + + + G+
Sbjct: 124 VDYCHRHM---VVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDGEFLR------TSCGS 173
Query: 416 FGYLAPEYMMYGKVDE--KIDVYSYGVVLLELITGK 449
Y APE ++ G++ ++D++S GV+L L+ G
Sbjct: 174 PNYAAPE-VISGRLYAGPEVDIWSCGVILYALLCGT 208
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 53/236 (22%), Positives = 88/236 (37%), Gaps = 46/236 (19%)
Query: 249 HLTHNFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHE 307
L + F +G G +V + + + AVKV++ E ++L I+++
Sbjct: 32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQND 91
Query: 308 -----NIVRIIGYCHSKEMYAIVYNLLNGSLKQYLKQ-----LKWNERMDVAIGVAKALE 357
NIV+ G + +++ L SL + + + + I + KAL
Sbjct: 92 DINNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALN 151
Query: 358 YLHHTCDPPIIHRDVKSSNILLSENFHHPQLS------------------------DFGA 393
YL + H D+K NILL + + L DFG
Sbjct: 152 YLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGC 208
Query: 394 AMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
A H +++ T Y APE ++ D D++S+G VL EL TG
Sbjct: 209 ATFKSDYH--------GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGS 256
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 5e-13
Identities = 48/203 (23%), Positives = 78/203 (38%), Gaps = 60/203 (29%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSI-KHENIVRIIGYCH 317
+G G N KV + N + A+K+L+ + REVEL + +IVRI+
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQ----DCPKARREVELHWRASQCPHIVRIVDVYE 81
Query: 318 ----SKEMYAIVYNLLNG----------SLKQYLKQLKWNERM--DVAIGVAKALEYLHH 361
++ IV L+G + + ER ++ + +A++YLH
Sbjct: 82 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF------TEREASEIMKSIGEAIQYLH- 134
Query: 362 TCDPPIIHRDVKSSNILLSENFHHPQL--SDFGAAMVHHQSHQVSENVKPVNVVGTFGYL 419
I HRDVK N+L + + L +DFG
Sbjct: 135 --SINIAHRDVKPENLLYTSKRPNAILKLTDFG--------------------------F 166
Query: 420 APEYMMYGKVDEKIDVYSYGVVL 442
A E K D+ D++S GV++
Sbjct: 167 AKE-TTGEKYDKSCDMWSLGVIM 188
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 6e-13
Identities = 53/219 (24%), Positives = 93/219 (42%), Gaps = 39/219 (17%)
Query: 253 NFSPKMLIGQGGNSKVYRTNHVD-GQVAAVKVL-KCTNWSEEEV---LREVELLSSIKHE 307
+F +IG+G +V + +V A+K+L K E E ++L + +
Sbjct: 75 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSK 134
Query: 308 NIVRIIGYC--HSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVAK--------ALE 357
I + Y +Y ++ + G L L K+ +R+ +A+ A++
Sbjct: 135 WITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLS--KFEDRLPEE--MARFYLAEMVIAID 189
Query: 358 YLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFG 417
+H +HRD+K NIL+ N H +L+DFG+ + + V +V VGT
Sbjct: 190 SVHQLH---YVHRDIKPDNILMDMN-GHIRLADFGSCLKLMEDGTVQSSV----AVGTPD 241
Query: 418 YLAPE--------YMMYGKVDEKIDVYSYGVVLLELITG 448
Y++PE YG D +S GV + E++ G
Sbjct: 242 YISPEILQAMEGGKGRYGPE---CDWWSLGVCMYEMLYG 277
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 54/226 (23%), Positives = 87/226 (38%), Gaps = 51/226 (22%)
Query: 253 NFSPKMLIGQGGNSKVYRTNHVD-GQVAAVKVLK-----------CTNWSEEEVLREVEL 300
+F +IG+G S+V GQV A+K++ C E +VL
Sbjct: 62 DFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCF-REERDVL----- 115
Query: 301 LSSIKHENIVRIIGYC--HSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIG------V 352
+ I ++ + +Y ++ + G L L K+ ER+ + +
Sbjct: 116 -VNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLS--KFGERIPAEMARFYLAEI 171
Query: 353 AKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNV 412
A++ +H +HRD+K NILL H +L+DFG+ + V V
Sbjct: 172 VMAIDSVHRLG---YVHRDIKPDNILLDRC-GHIRLADFGSCLKLRADGTVRSLV----A 223
Query: 413 VGTFGYLAPE----------YMMYGKVDEKIDVYSYGVVLLELITG 448
VGT YL+PE YG D ++ GV E+ G
Sbjct: 224 VGTPDYLSPEILQAVGGGPGTGSYGPE---CDWWALGVFAYEMFYG 266
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 56/242 (23%), Positives = 104/242 (42%), Gaps = 60/242 (24%)
Query: 249 HLTHNFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEV-----LREVELLS 302
H+ + +G+G V++ + G+V AVK K + + RE+ +L+
Sbjct: 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVK--KIFDAFQNSTDAQRTFREIMILT 63
Query: 303 SIK-HENIVRIIGYCHS---KEMYAIVYNLLNGSLKQYLK--------------QLKWNE 344
+ HENIV ++ + +++Y +V++ + L ++ QL
Sbjct: 64 ELSGHENIVNLLNVLRADNDRDVY-LVFDYMETDLHAVIRANILEPVHKQYVVYQL---- 118
Query: 345 RMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404
K ++YL H+ ++HRD+K SNILL+ H +++DFG + +V+
Sbjct: 119 --------IKVIKYL-HSGG--LLHRDMKPSNILLNAEC-HVKVADFGLSRSFVNIRRVT 166
Query: 405 ENVKPVNVVGTFG----------------YLAPEYMM-YGKVDEKIDVYSYGVVLLELIT 447
N+ T Y APE ++ K + ID++S G +L E++
Sbjct: 167 NNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILC 226
Query: 448 GK 449
GK
Sbjct: 227 GK 228
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 48/216 (22%), Positives = 90/216 (41%), Gaps = 50/216 (23%)
Query: 259 LIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEEVL----REVELLSSIKHENIVR-- 311
+G G KV H G AVK+L +V+ RE++ L +H +I++
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 312 -----------IIGYCHSKEMYAIVYNLLNGSLK-----QYLKQLKWNERMDVAIGVAKA 355
++ Y E++ Y NG L + +Q+
Sbjct: 83 QVISTPSDIFMVMEYVSGGELFD--YICKNGRLDEKESRRLFQQI------------LSG 128
Query: 356 LEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGT 415
++Y H ++HRD+K N+LL + + +++DFG + + + G+
Sbjct: 129 VDYCHRHM---VVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDGEFLR------TSCGS 178
Query: 416 FGYLAPEYMMYGKVDE--KIDVYSYGVVLLELITGK 449
Y APE ++ G++ ++D++S GV+L L+ G
Sbjct: 179 PNYAAPE-VISGRLYAGPEVDIWSSGVILYALLCGT 213
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 49/214 (22%), Positives = 87/214 (40%), Gaps = 37/214 (17%)
Query: 252 HNFSPKMLIGQGGNSKVYRTNHVD-GQVAAVKVLK---CTNWSEEE-VLREVELLSSIKH 306
F +G G +V H + G A+K+L + E L E +L ++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 307 ENIVRIIGYCHSKEMYAIVYNLLNG-SLKQYL-KQLKWNERMDV--AIGVAKALEYLHHT 362
+V++ +V + G + +L + +++E A + EYLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 363 CDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVV-----GTFG 417
+I+RD+K N+L+ + + Q++DFG A K V GT
Sbjct: 161 D---LIYRDLKPENLLIDQQ-GYIQVTDFGFA-------------KRVKGRTWTLCGTPE 203
Query: 418 YLAPEYMM---YGKVDEKIDVYSYGVVLLELITG 448
LAPE ++ Y K +D ++ GV++ E+ G
Sbjct: 204 ALAPEIILSKGYNKA---VDWWALGVLIYEMAAG 234
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 49/235 (20%), Positives = 91/235 (38%), Gaps = 48/235 (20%)
Query: 249 HLTHNFSPKMLIGQGGNSKVYR--TNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKH 306
L+ + +G+G KV + G+ AVK++K + E E+++L +
Sbjct: 11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNT 70
Query: 307 E------NIVRIIGYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERM--------DVAIGV 352
V+++ + IV+ LL S ++K+ N + +A +
Sbjct: 71 TDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKE---NGFLPFRLDHIRKMAYQI 127
Query: 353 AKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLS------------------DFGAA 394
K++ +LH + H D+K NIL ++ + + DFG+A
Sbjct: 128 CKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA 184
Query: 395 MVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
+ H +V T Y APE ++ + DV+S G +L+E G
Sbjct: 185 TYDDEHH--------STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGF 231
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 3e-12
Identities = 49/232 (21%), Positives = 85/232 (36%), Gaps = 42/232 (18%)
Query: 249 HLTHNFSPKMLIGQGGNSKVYR-TNHVDGQ-VAAVKVLKCTNWSEEEVLREVELLSSIKH 306
L + +G+G KV +H G+ A+K+++ E E+ +L IK
Sbjct: 16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKE 75
Query: 307 E------NIVRIIGYCHSKEMYAIVYNLLNGSLKQYLKQ-----LKWNERMDVAIGVAKA 355
+ V + + + I + LL + ++LK+ +A + A
Sbjct: 76 KDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHA 135
Query: 356 LEYLHHTCDPPIIHRDVKSSNILLSENFHHPQ------------------LSDFGAAMVH 397
L +LH + H D+K NIL + ++DFG+A
Sbjct: 136 LRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFD 192
Query: 398 HQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
H+ H +V T Y PE ++ + DV+S G +L E G
Sbjct: 193 HEHH--------TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGF 236
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 49/248 (19%), Positives = 94/248 (37%), Gaps = 67/248 (27%)
Query: 253 NFSPKMLIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVR 311
+S +G G V ++ G+ A+K K RE++++ + H NI++
Sbjct: 8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALK--KVLQ-DPRYKNRELDIMKVLDHVNIIK 64
Query: 312 IIGYCHSKEMYA--------------------------------------IVYNLLNGSL 333
++ Y ++ ++ + +L
Sbjct: 65 LVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTL 124
Query: 334 KQYLKQ-LKWNERMDVAIG------VAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHP 386
+ LK ++ + + + + +A+ ++H I HRD+K N+L++ +
Sbjct: 125 HKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNSKDNTL 181
Query: 387 QLSDFGAAMVHHQSHQ-VSENVKPVNVVGTFGYLAPEYMM----YGKVDEKIDVYSYGVV 441
+L DFG+A S V+ + + Y APE M+ Y ID++S G V
Sbjct: 182 KLCDFGSAKKLIPSEPSVAY-------ICSRFYRAPELMLGATEYTP---SIDLWSIGCV 231
Query: 442 LLELITGK 449
ELI GK
Sbjct: 232 FGELILGK 239
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 53/211 (25%), Positives = 96/211 (45%), Gaps = 27/211 (12%)
Query: 253 NFSPKMLIGQGGNSKVYRTNHVD-GQVAAVKVL-KCTNWSEEEV---LREVELLSSIKHE 307
F L+G+G KV G+ A+K+L K +++EV L E +L + +H
Sbjct: 149 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 208
Query: 308 NIVRIIGYC-HSKEMYAIVYNLLNG-SLKQYL-KQLKWNERMDV--AIGVAKALEYLHHT 362
+ + Y + + V NG L +L ++ ++E + AL+YLH
Sbjct: 209 FLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE 267
Query: 363 CDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTF----GY 418
+ +++RD+K N++L ++ H +++DFG E +K + TF Y
Sbjct: 268 KN--VVYRDLKLENLMLDKD-GHIKITDFGLC---------KEGIKDGATMKTFCGTPEY 315
Query: 419 LAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
LAPE + +D + GVV+ E++ G+
Sbjct: 316 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 1e-11
Identities = 67/225 (29%), Positives = 102/225 (45%), Gaps = 59/225 (26%)
Query: 252 HNFSPKMLIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEEVLR--EVE-------LL 301
+F +G G +V+ G+ A+KVLK +E V+R +VE +L
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLK-----KEIVVRLKQVEHTNDERLML 60
Query: 302 SSIKHENIVRIIGYCHSKEMYAIVYNLLNG-SLKQYL-KQLKWNERMDVAIGVAK----- 354
S + H I+R+ G + ++ + + G L L K ++ VAK
Sbjct: 61 SIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNP------VAKFYAAE 114
Query: 355 ---ALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVN 411
ALEYLH D II+RD+K NILL +N H +++DFG A K V
Sbjct: 115 VCLALEYLHS-KD--IIYRDLKPENILLDKN-GHIKITDFGFA-------------KYVP 157
Query: 412 VV-----GTFGYLAPEYMM---YGKVDEKIDVYSYGVVLLELITG 448
V GT Y+APE + Y K ID +S+G+++ E++ G
Sbjct: 158 DVTYTLCGTPDYIAPEVVSTKPYNKS---IDWWSFGILIYEMLAG 199
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 66/304 (21%), Positives = 120/304 (39%), Gaps = 52/304 (17%)
Query: 169 SSSSKYPAFGQPATTRQLQKSLTAPSSSTSSTTRQESDVGVCIAQETVQVPESIKRKIFE 228
S K G Q + + E + Q ++ + K
Sbjct: 265 SELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTAN 324
Query: 229 KLAVLEAEGSSRRFTSQELCHLTHNFSPKMLIGQGGNSKVYRTNHVD-GQVAAVKVLKCT 287
++ + G+ R +F+ M++G+G KV + ++ AVK+LK
Sbjct: 325 TISKFDNNGNRDRMKLT-------DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILK-- 375
Query: 288 NWSEEEVLR--EVE--------LLSSIKHENIVRIIGYC-HSKEMYAIVYNLLNG-SLKQ 335
++ V++ +VE L K + ++ C + + V +NG L
Sbjct: 376 ---KDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMY 431
Query: 336 YL-KQLKWNERMDV--AIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFG 392
++ + ++ E V A +A L +L II+RD+K N++L H +++DFG
Sbjct: 432 HIQQVGRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSE-GHIKIADFG 487
Query: 393 AAMVHHQSHQVSENVKPVNVVGTF-G---YLAPE---YMMYGKVDEKIDVYSYGVVLLEL 445
EN+ TF G Y+APE Y YGK +D +++GV+L E+
Sbjct: 488 MCK---------ENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKS---VDWWAFGVLLYEM 535
Query: 446 ITGK 449
+ G+
Sbjct: 536 LAGQ 539
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 2e-11
Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 34/215 (15%)
Query: 253 NFSPKMLIGQGGNSKVY----RTNHVDGQVAAVKVLK---CTNWSEEEVLREVELLSSIK 305
F ++GQG KV+ + Q+ A+KVLK E ++L +
Sbjct: 25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN 84
Query: 306 HENIVRIIGYC---HSKEMYAIVYNLLN-GSLKQYL-KQLKWNERMDV--AIGVAKALEY 358
H IV++ Y K +Y ++ + L G L L K++ + E +A AL++
Sbjct: 85 HPFIVKLH-YAFQTEGK-LY-LILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDH 141
Query: 359 LHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTF-G 417
LH II+RD+K NILL E H +L+DFG + E++ +F G
Sbjct: 142 LH---SLGIIYRDLKPENILLDEE-GHIKLTDFGLS---------KESIDHEKKAYSFCG 188
Query: 418 ---YLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
Y+APE + + D +S+GV++ E++TG
Sbjct: 189 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 53/263 (20%), Positives = 87/263 (33%), Gaps = 90/263 (34%)
Query: 260 IGQGGNSKVY--RTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIK--------HENI 309
+G G S V+ VA +KV+K E L E+ LL S++ E +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVA-MKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMV 103
Query: 310 VRIIGY--------CHSKEMYAIVYNLLNGSLKQYLKQLKWNERM-------DVAIGVAK 354
V+++ H +V+ +L L +++ K N + + V +
Sbjct: 104 VQLLDDFKISGVNGTH----ICMVFEVLGHHLLKWII--KSNYQGLPLPCVKKIIQQVLQ 157
Query: 355 ALEYLHHTCDPPIIHRDVKSSNILLSEN-------------------------------- 382
L+YLH C IIH D+K NILLS N
Sbjct: 158 GLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215
Query: 383 ----------------FHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY 426
+++D G A H+ + T Y + E ++
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFT--------EDIQTRQYRSLEVLIG 267
Query: 427 GKVDEKIDVYSYGVVLLELITGK 449
+ D++S + EL TG
Sbjct: 268 SGYNTPADIWSTACMAFELATGD 290
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 4e-10
Identities = 63/221 (28%), Positives = 103/221 (46%), Gaps = 44/221 (19%)
Query: 253 NFSPKMLIGQGGNSKVY----RTNHVDGQVAAVKVLK----CTNWSEEE-VLREVELLSS 303
F ++G+GG KV+ T G++ A+KVLK N + E +L
Sbjct: 18 CFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEE 77
Query: 304 IKHENIVRIIGYC---HSKEMYAIVYNLLN-GSLKQYLKQLKWNERM---DVA---IG-V 352
+KH IV +I Y K +Y ++ L+ G L L++ E + D A + +
Sbjct: 78 VKHPFIVDLI-YAFQTGGK-LY-LILEYLSGGELFMQLER----EGIFMEDTACFYLAEI 130
Query: 353 AKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNV 412
+ AL +LH II+RD+K NI+L+ H +L+DFG E++ V
Sbjct: 131 SMALGHLH---QKGIIYRDLKPENIMLNHQ-GHVKLTDFGLC---------KESIHDGTV 177
Query: 413 VGTF-G---YLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
TF G Y+APE +M + +D +S G ++ +++TG
Sbjct: 178 THTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 5e-10
Identities = 53/211 (25%), Positives = 95/211 (45%), Gaps = 28/211 (13%)
Query: 253 NFSPKMLIGQGGNSKVYRTNHVD-GQVAAVKVL-KCTNWSEEEV---LREVELLSSIKHE 307
+F L+G+G KV G+ A+K+L K +++EV + E +L + +H
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 308 NIVRIIGYC-HSKEMYAIVYNLLNG-SLKQYL-KQLKWNERMDV--AIGVAKALEYLHHT 362
+ + Y + + V NG L +L ++ + E + ALEYLH
Sbjct: 66 FLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH-- 122
Query: 363 CDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTF-G---Y 418
+++RD+K N++L ++ H +++DFG E + + TF G Y
Sbjct: 123 -SRDVVYRDIKLENLMLDKD-GHIKITDFGLC---------KEGISDGATMKTFCGTPEY 171
Query: 419 LAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
LAPE + +D + GVV+ E++ G+
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 5e-10
Identities = 61/220 (27%), Positives = 99/220 (45%), Gaps = 45/220 (20%)
Query: 253 NFSPKMLIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEEVLR--EVE--------LL 301
NF ++G+G KV + G + AVKVLK ++ +L+ +VE L
Sbjct: 24 NFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLK-----KDVILQDDDVECTMTEKRILS 78
Query: 302 SSIKHENIVRIIGYC-HSKEMYAIVYNLLNG-SLKQYL-KQLKWNERMDV--AIGVAKAL 356
+ H + ++ C + + V +NG L ++ K +++E A + AL
Sbjct: 79 LARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISAL 137
Query: 357 EYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTF 416
+LH D II+RD+K N+LL H +L+DFG E + TF
Sbjct: 138 MFLH---DKGIIYRDLKLDNVLLDHE-GHCKLADFGMCK---------EGICNGVTTATF 184
Query: 417 -G---YLAPE---YMMYGKVDEKIDVYSYGVVLLELITGK 449
G Y+APE M+YG +D ++ GV+L E++ G
Sbjct: 185 CGTPDYIAPEILQEMLYGPA---VDWWAMGVLLYEMLCGH 221
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 9e-10
Identities = 62/217 (28%), Positives = 97/217 (44%), Gaps = 39/217 (17%)
Query: 253 NFSPKMLIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEEVL--REVE--------LL 301
+F +IG+G KV H AVKVL+ ++ +L +E + LL
Sbjct: 39 DFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQ-----KKAILKKKEEKHIMSERNVLL 93
Query: 302 SSIKHENIVRIIGYC-HSKEMYAIVYNLLNG-SLKQYL-KQLKWNERMDV--AIGVAKAL 356
++KH +V + + + + V + +NG L +L ++ + E A +A AL
Sbjct: 94 KNVKHPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASAL 152
Query: 357 EYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTF 416
YLH I++RD+K NILL H L+DFG EN++ + TF
Sbjct: 153 GYLH---SLNIVYRDLKPENILLDSQ-GHIVLTDFGLC---------KENIEHNSTTSTF 199
Query: 417 -G---YLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
G YLAPE + D +D + G VL E++ G
Sbjct: 200 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 1e-09
Identities = 57/219 (26%), Positives = 95/219 (43%), Gaps = 45/219 (20%)
Query: 253 NFSPKMLIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEEVLR--EVE--------LL 301
+F ++G+G KV+ Q A+K LK ++ VL +VE L
Sbjct: 18 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALK-----KDVVLMDDDVECTMVEKRVLS 72
Query: 302 SSIKHENIVRIIGYC-HSKEMYAIVYNLLN-GSLKQYLKQL-KWNERMDV--AIGVAKAL 356
+ +H + + +KE V LN G L +++ K++ A + L
Sbjct: 73 LAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGL 131
Query: 357 EYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTF 416
++LH I++RD+K NILL ++ H +++DFG EN+ TF
Sbjct: 132 QFLH---SKGIVYRDLKLDNILLDKD-GHIKIADFGMCK---------ENMLGDAKTNTF 178
Query: 417 -G---YLAPE---YMMYGKVDEKIDVYSYGVVLLELITG 448
G Y+APE Y +D +S+GV+L E++ G
Sbjct: 179 CGTPDYIAPEILLGQKYNHS---VDWWSFGVLLYEMLIG 214
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 1e-09
Identities = 33/102 (32%), Positives = 52/102 (50%), Gaps = 23/102 (22%)
Query: 355 ALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVG 414
AL YLH + II+RD+K N+LL H +L+D+G E ++P +
Sbjct: 122 ALNYLH---ERGIIYRDLKLDNVLLDSE-GHIKLTDYGMCK---------EGLRPGDTTS 168
Query: 415 TF-G---YLAPE---YMMYGKVDEKIDVYSYGVVLLELITGK 449
TF G Y+APE YG +D ++ GV++ E++ G+
Sbjct: 169 TFCGTPNYIAPEILRGEDYGFS---VDWWALGVLMFEMMAGR 207
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 2e-09
Identities = 57/220 (25%), Positives = 101/220 (45%), Gaps = 45/220 (20%)
Query: 253 NFSPKMLIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEEVLR--EVE--------LL 301
+F+ M++G+G KV + ++ AVK+LK ++ V++ +VE L
Sbjct: 21 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILK-----KDVVIQDDDVECTMVEKRVLA 75
Query: 302 SSIKHENIVRIIGYC-HSKEMYAIVYNLLNG-SLKQYL-KQLKWNERMDV--AIGVAKAL 356
K + ++ C + + V +NG L ++ + ++ E V A +A L
Sbjct: 76 LPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGL 134
Query: 357 EYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTF 416
+L II+RD+K N++L H +++DFG EN+ TF
Sbjct: 135 FFLQ---SKGIIYRDLKLDNVMLDSE-GHIKIADFGMCK---------ENIWDGVTTKTF 181
Query: 417 -G---YLAPE---YMMYGKVDEKIDVYSYGVVLLELITGK 449
G Y+APE Y YGK +D +++GV+L E++ G+
Sbjct: 182 CGTPDYIAPEIIAYQPYGKS---VDWWAFGVLLYEMLAGQ 218
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 33/105 (31%), Positives = 54/105 (51%), Gaps = 23/105 (21%)
Query: 352 VAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVN 411
++ AL YLH + II+RD+K N+LL H +L+D+G E ++P +
Sbjct: 162 ISLALNYLH---ERGIIYRDLKLDNVLLDSE-GHIKLTDYGMCK---------EGLRPGD 208
Query: 412 VVGTF-G---YLAPE---YMMYGKVDEKIDVYSYGVVLLELITGK 449
TF G Y+APE YG +D ++ GV++ E++ G+
Sbjct: 209 TTSTFCGTPNYIAPEILRGEDYGFS---VDWWALGVLMFEMMAGR 250
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 3e-09
Identities = 48/207 (23%), Positives = 78/207 (37%), Gaps = 28/207 (13%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEVL-REVELLSSIKH-ENIVRIIGYC 316
IG G +Y T+ G+ A+K+ ++ L E ++ ++ I I
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIPTIRWCG 74
Query: 317 HSKEMYAIVYNLLNGSLKQYLKQLKWNERMD------VAIGVAKALEYLHHTCDPPIIHR 370
+ +V LL SL+ + + +A + +EY+H IHR
Sbjct: 75 AEGDYNVMVMELLGPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHR 129
Query: 371 DVKSSNILLS--ENFHHPQLSDFGAAM--VHHQSHQVSENVKPVNVVGTFGYLAPEYMMY 426
DVK N L+ + + + DFG A ++HQ + N+ GT Y A
Sbjct: 130 DVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY-ASINTHL 188
Query: 427 GKV----DEKIDVYSYGVVLLELITGK 449
G D D+ S G VL+ G
Sbjct: 189 GIEQSRRD---DLESLGYVLMYFNLGS 212
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 58.3 bits (140), Expect = 4e-09
Identities = 78/529 (14%), Positives = 158/529 (29%), Gaps = 143/529 (27%)
Query: 1 MVGKLSIEKNFFSVLRTRTLKKRTVIFG----LKSDHYSR-EILLQLLTVI--AKPGDNV 53
++ + E+ S++ +++R ++ + SR + L+L + +P NV
Sbjct: 94 LMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNV 153
Query: 54 ------------LAVHVEEQNDTLDLNTFHIH-----EDLCKSKKVDFLVKVC--IGDSY 94
+A+ V F I ++ L K+ I ++
Sbjct: 154 LIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNW 213
Query: 95 ITELSNQVRISYATILALGCSLSGLKDSEVLTRCLRALPPACTILVMDN----------- 143
+ + I I ++ L L S+ CL LV+ N
Sbjct: 214 TSRSDHSSNIKL-RIHSIQAELRRLLKSKPYENCL---------LVLLNVQNAKAWNAFN 263
Query: 144 LG-RILVQRQGTSQQGSTNVL---LKSSLSSSSKYPAFGQPATTRQLQKSLTAPSSSTSS 199
L +IL+ T + T+ L + +S L K L
Sbjct: 264 LSCKILLT---TRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPR 320
Query: 200 TTRQESDVGVCIAQETVQVP----ESIKRKIFEKLA-VLEAEGSSRRFTSQELCHLTHNF 254
+ + I E+++ ++ K +KL ++E+ S E +
Sbjct: 321 EVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIES--SLNVLEPAEYRKMFDRL 378
Query: 255 S--PKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRI 312
S P ++ + +L W + +V + +
Sbjct: 379 SVFPP-------SAHI-----------PTILL-SLIWFDVIK-SDVMV-----------V 407
Query: 313 IGYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRD- 371
+ H +L+ K+ + + LE + +HR
Sbjct: 408 VNKLHKY-------SLVEKQPKESTISI-----PSI------YLELKVKLENEYALHRSI 449
Query: 372 VKSSNILL---SENFHHPQLSD-FGAAMVHH-----QSHQVSENVKPVNVVGTFGYLAPE 422
V NI S++ P L F + + HH +++ F +
Sbjct: 450 VDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTL----------FRMV--- 496
Query: 423 YMMYGKVDEKI--DVYSYGV------VLLELITGKEAIQTNKANRESLV 463
++ + +++KI D ++ L +L K I N E LV
Sbjct: 497 FLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLV 545
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.9 bits (100), Expect = 2e-04
Identities = 42/245 (17%), Positives = 78/245 (31%), Gaps = 58/245 (23%)
Query: 201 TRQESDVGVCIAQETVQVPESIKR--KIFEKLAVLEAEGSS--RRFTSQELCHLTHNF-- 254
+++E D + +++ ++F L ++ ++F + L + + F
Sbjct: 47 SKEEID-------HIIMSKDAVSGTLRLFW---TLLSKQEEMVQKFVEEVL-RINYKFLM 95
Query: 255 SP--KMLIGQGGNSKVYRTNHV----DGQVAAVKVLKCTNWSEEEVLREVELLSSIKHEN 308
SP +++Y D QV K + L+ + L ++
Sbjct: 96 SPIKTEQRQPSMMTRMYIEQRDRLYNDNQV----FAKYNVSRLQPYLKLRQALLELRPAK 151
Query: 309 IVRIIGYCHSKEMYAIVYNLLNGSLKQYL-----KQLKWNERMDVAI------------G 351
V I G + GS K ++ K +MD I
Sbjct: 152 NVLIDG------V--------LGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPET 197
Query: 352 VAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVN 411
V + L+ L + DP R SSNI L + +L + + V NV+
Sbjct: 198 VLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAK 257
Query: 412 VVGTF 416
F
Sbjct: 258 AWNAF 262
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 56.9 bits (137), Expect = 5e-09
Identities = 49/207 (23%), Positives = 82/207 (39%), Gaps = 22/207 (10%)
Query: 251 THNFSPKMLI---GQGGNSKVY-RTNHVDGQVAAVKVLKCTNWSEEEVLREVEL---LSS 303
T P M+I + GN Y R+ + K + + V+L L S
Sbjct: 96 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDS 155
Query: 304 IKHENIVRIIGYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVAKALEYLHHTC 363
I G+ K + + L Y L + + VAK +E+L
Sbjct: 156 ITSSQSSASSGFVEEKSLSDVEEEEAPEDL--YKDFLTLEHLICYSFQVAKGMEFL---A 210
Query: 364 DPPIIHRDVKSSNILLSENFHHPQLSDFGAA--MVHHQSHQVSENVK-PVNVVGTFGYLA 420
IHRD+ + NILLSE + ++ DFG A + + + + P+ ++A
Sbjct: 211 SRKCIHRDLAARNILLSEK-NVVKICDFGLARDIYKDPDYVRKGDARLPLK------WMA 263
Query: 421 PEYMMYGKVDEKIDVYSYGVVLLELIT 447
PE + + DV+S+GV+L E+ +
Sbjct: 264 PETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 6e-06
Identities = 28/136 (20%), Positives = 52/136 (38%), Gaps = 15/136 (11%)
Query: 260 IGQGGNSKVYR------TNHVDGQVAAVKVLK--CTNWSEEEVLREVELLSSI-KHENIV 310
+G+G +V + AVK+LK T+ ++ E+++L I H N+V
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89
Query: 311 RIIGYC--HSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPII 368
++G C + IV G+L YL ++R + K + I
Sbjct: 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYL----RSKRNEFVPYKTKGARFRQGKDYVGAI 145
Query: 369 HRDVKSSNILLSENFH 384
D+K ++ +
Sbjct: 146 PVDLKRRLDSITSSQS 161
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 7e-09
Identities = 29/151 (19%), Positives = 55/151 (36%), Gaps = 26/151 (17%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLK-----CTNWSEEEVLREVELLSSIKHENIVRII 313
IG G ++ N + A+K+ E +++ + I ++
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLG-----SGDGIPQVY 71
Query: 314 GYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMD------VAIGVAKALEYLHHTCDPPI 367
+ + A+V LL SL+ + +AI + +EY+H +
Sbjct: 72 YFGPCGKYNAMVLELLGPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---L 126
Query: 368 IHRDVKSSNILL----SENFHHPQLSDFGAA 394
I+RDVK N L+ ++ + DF A
Sbjct: 127 IYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 42/206 (20%), Positives = 80/206 (38%), Gaps = 26/206 (12%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEVL-REVELLSSIK-HENIVRIIGYC 316
IG G ++Y TN + A+K+ ++ L E ++ ++ I + +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLLYESKIYRILQGGTGIPNVRWFG 72
Query: 317 HSKEMYAIVYNLLNGSLKQYLKQLKWNERMDV------AIGVAKALEYLHHTCDPPIIHR 370
+ +V +LL SL+ + ++ + A + +E++H +HR
Sbjct: 73 VEGDYNVLVMDLLGPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKS---FLHR 127
Query: 371 DVKSSNILL--SENFHHPQLSDFGAAM--VHHQSHQVSENVKPVNVVGTFGYL---APEY 423
D+K N L+ + + DFG A +HQ + N+ GT Y
Sbjct: 128 DIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLG 187
Query: 424 MMYGKVDEKIDVYSYGVVLLELITGK 449
+ + D D+ S G VL+ + G
Sbjct: 188 IEQSRRD---DLESLGYVLMYFLRGS 210
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 62/233 (26%), Positives = 102/233 (43%), Gaps = 64/233 (27%)
Query: 253 NFSPKMLIGQGGNSKVY----RTNHVDGQVAAVKVLK------------CTNWSEEEVLR 296
NF ++G G KV+ + H G++ A+KVLK T +E +VL
Sbjct: 55 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTR-TERQVLE 113
Query: 297 EVELLSSIKHENIVRIIGYC---HSKEMYAIVYNLLN-GSLKQYL-KQLKWNERMDVAIG 351
+ + +V + Y +K ++ ++ + +N G L +L ++ ++ E
Sbjct: 114 HIR-----QSPFLVTLH-YAFQTETK-LH-LILDYINGGELFTHLSQRERFTEHE----- 160
Query: 352 VAK--------ALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403
+ ALE+LH II+RD+K NILL N H L+DFG +
Sbjct: 161 -VQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSN-GHVVLTDFGLS--------- 206
Query: 404 SENVKPVNVV-----GTFGYLAPEYMMYGKV--DEKIDVYSYGVVLLELITGK 449
E V GT Y+AP+ + G D+ +D +S GV++ EL+TG
Sbjct: 207 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 28/147 (19%), Positives = 56/147 (38%), Gaps = 18/147 (12%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKH-ENIVRIIGYCH 317
IG+G ++ TN ++ Q A+K + ++ E + I + +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQ 76
Query: 318 SKEMYAIVYNLLNGSLKQYLKQLKWNERMD------VAIGVAKALEYLHHTCDPPIIHRD 371
+V +LL SL+ L + A + ++ +H +++RD
Sbjct: 77 EGLHNVLVIDLLGPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRD 131
Query: 372 VKSSNILL----SENFHHPQLSDFGAA 394
+K N L+ S+N + + DFG
Sbjct: 132 IKPDNFLIGRPNSKNANMIYVVDFGMV 158
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 52.2 bits (124), Expect = 1e-07
Identities = 43/277 (15%), Positives = 74/277 (26%), Gaps = 71/277 (25%)
Query: 260 IGQGGNSKVYRTNHVDGQVAAVKVLKCTN---------------WSEEEVLREVELLSSI 304
IG+G +V++T VA +K++ E + +E+ LLS
Sbjct: 28 IGEGVFGEVFQTIADHTPVA-IKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGE 86
Query: 305 ---KHENIVRIIGYCHSKEMYA-------IVYNLLNGSLKQYL----------------- 337
+ E + + + Y YN GS
Sbjct: 87 VCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFG 146
Query: 338 ---------KQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQL 388
K + + +L + HRD+ N+LL +
Sbjct: 147 GIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWGNVLLKKTSLKKLH 204
Query: 389 SDFGAAMVHHQSHQV---------SENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYG 439
S + S + VV + + G D + D+Y
Sbjct: 205 YTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFT-GDGDYQFDIYRLM 263
Query: 440 VVLLELITGKEAIQTNKANRESLVLWYYVLAGKVFAQ 476
G+ +N VLW + L K+ Q
Sbjct: 264 KKENNNRWGEYHPYSN-------VLWLHYLTDKMLKQ 293
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 6e-07
Identities = 30/163 (18%), Positives = 54/163 (33%), Gaps = 33/163 (20%)
Query: 259 LIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEVLREVELL---------------S 302
IG GG +Y + A V+K + E++
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 303 SIKHENIVRIIGY----CHSKEMYAIVYNLLNGSLKQYLKQLKWNERMD------VAIGV 352
+ + I G + +V L L++ N + I +
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISG---QNGTFKKSTVLQLGIRM 160
Query: 353 AKALEYLHHTCDPPIIHRDVKSSNILLS-ENFHHPQLSDFGAA 394
LEY+H +H D+K++N+LL +N L+D+G +
Sbjct: 161 LDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLS 200
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 29/165 (17%), Positives = 56/165 (33%), Gaps = 36/165 (21%)
Query: 260 IGQGG---------NSKVYRTNHVDGQVAAVKV------LKCTNWSEEEVLREVEL---- 300
+ S + + Q ++K+ L + + +++
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 301 -LSSIKHENIVRIIGY-CHSKEMYAIVYNLLNGSLKQYLKQLKWNERMD--------VAI 350
L S I +G+ H + +V L SL+ L + + VA
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALD---VSPKHVLSERSVLQVAC 166
Query: 351 GVAKALEYLHHTCDPPIIHRDVKSSNILLS-ENFHHPQLSDFGAA 394
+ ALE+LH +H +V + NI + E+ L+ +G A
Sbjct: 167 RLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFA 208
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 32/166 (19%), Positives = 64/166 (38%), Gaps = 36/166 (21%)
Query: 259 LIGQGGNSKVY------RTNHVDGQVAAVKVLKCTN------------WSEEEVLREVEL 300
IGQGG +Y + VKV N ++ E +++
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 301 LSSIKHENIVRIIGY----CHSKEMYAIVYNLLNGSLKQYLKQLKWNER-------MDVA 349
+K+ + + G + K ++ + L++ + N + + ++
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYE---ANAKRFSRKTVLQLS 158
Query: 350 IGVAKALEYLHHTCDPPIIHRDVKSSNILLS-ENFHHPQLSDFGAA 394
+ + LEY+H +H D+K+SN+LL+ +N L D+G A
Sbjct: 159 LRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLA 201
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 480 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.98 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.83 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.64 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.26 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.23 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.02 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.97 | |
| 3hgm_A | 147 | Universal stress protein TEAD; rossman fold, signa | 98.76 | |
| 3idf_A | 138 | USP-like protein; universal, stress, PSI, MCSG, st | 98.76 | |
| 3s3t_A | 146 | Nucleotide-binding protein, universal stress PROT | 98.74 | |
| 1tq8_A | 163 | Hypothetical protein RV1636; MTCY01B2.28, structur | 98.63 | |
| 1mjh_A | 162 | Protein (ATP-binding domain of protein MJ0577); hy | 98.61 | |
| 3dlo_A | 155 | Universal stress protein; unknown function, struct | 98.6 | |
| 2dum_A | 170 | Hypothetical protein PH0823; conserved hypothetica | 98.59 | |
| 3fdx_A | 143 | Putative filament protein / universal stress PROT; | 98.59 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.57 | |
| 2gm3_A | 175 | Unknown protein; AT3G01520, putative ethylene-resp | 98.54 | |
| 3fg9_A | 156 | Protein of universal stress protein USPA family; A | 98.53 | |
| 2z08_A | 137 | Universal stress protein family; uncharacterized c | 98.53 | |
| 3tnj_A | 150 | Universal stress protein (USP); structural genomic | 98.47 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.38 | |
| 1jmv_A | 141 | USPA, universal stress protein A; chaperone; 1.85A | 98.37 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.35 | |
| 1q77_A | 138 | Hypothetical protein AQ_178; structural genomics, | 98.28 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.26 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.25 | |
| 3loq_A | 294 | Universal stress protein; structural genomics, PSI | 98.08 | |
| 3mt0_A | 290 | Uncharacterized protein PA1789; structural genomic | 98.07 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.04 | |
| 3mt0_A | 290 | Uncharacterized protein PA1789; structural genomic | 98.02 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.0 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.98 | |
| 3cis_A | 309 | Uncharacterized protein; alpha/beta hydrolase, ATP | 97.89 | |
| 3cis_A | 309 | Uncharacterized protein; alpha/beta hydrolase, ATP | 97.82 | |
| 3ab8_A | 268 | Putative uncharacterized protein TTHA0350; tandem- | 97.77 | |
| 3olq_A | 319 | Universal stress protein E; structural genomics, P | 97.7 | |
| 3loq_A | 294 | Universal stress protein; structural genomics, PSI | 97.64 | |
| 3olq_A | 319 | Universal stress protein E; structural genomics, P | 97.58 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.5 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.46 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.35 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.31 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.31 | |
| 3ab8_A | 268 | Putative uncharacterized protein TTHA0350; tandem- | 97.31 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.24 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.17 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.89 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.86 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.85 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.57 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.16 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.35 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.75 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 92.78 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 91.12 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 87.45 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-50 Score=397.07 Aligned_cols=198 Identities=27% Similarity=0.428 Sum_probs=176.8
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccC----CccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCT----NWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 326 (480)
++|++.+.||+|+||+||+|.+ .+|+.||+|++++. ....+.+.+|+++|+.++||||+++++++++++.+|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 4699999999999999999976 56999999999753 234567899999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccc
Q 011660 327 NLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 327 e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (480)
||+ +|+|.+++++ +++.++..++.||+.||+|||++ +||||||||+|||++.+ +++||+|||+|+.....
T Consensus 112 Ey~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~-g~vKl~DFGla~~~~~~-- 185 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNED-MHIQITDFGTAKVLSPE-- 185 (311)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTT-SCEEECCCTTCEECCTT--
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCC-CCEEEEEcCCceecCCC--
Confidence 999 6799999954 88999999999999999999999 99999999999999998 79999999999865432
Q ss_pred cccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 403 ~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.......+.+||+.|||||++.+..|+.++||||+||+||||+||++||.+.+
T Consensus 186 -~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~ 238 (311)
T 4aw0_A 186 -SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 238 (311)
T ss_dssp -TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred -CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 12233456799999999999999999999999999999999999999998754
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=399.24 Aligned_cols=196 Identities=30% Similarity=0.418 Sum_probs=168.7
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCccH---HHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEe
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSE---EEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~~---~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e 327 (480)
++|++.+.||+|+||+||+|.+ .+|+.||||++++..... +.+.+|+++|++|+|||||++++++++++.+|+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 5799999999999999999976 569999999997665433 468899999999999999999999999999999999
Q ss_pred cc-CCCHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccc
Q 011660 328 LL-NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (480)
Q Consensus 328 ~~-~GsL~~~l~~-----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (480)
|+ +|+|.++|.. +++.++..++.||+.||.|||++ +||||||||+||||+.+ +++||+|||+|+......
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~-g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKD-GTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTT-CCEEECSTTEESCCCHHH
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCC-CCEEEcccccceeecCCc
Confidence 99 6899999953 57788899999999999999999 99999999999999998 799999999997643311
Q ss_pred ccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 402 QVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 402 ~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
......+||+.|||||++.+..|+.++|||||||+||||+||+.||.+.+
T Consensus 180 -----~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~ 229 (350)
T 4b9d_A 180 -----ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS 229 (350)
T ss_dssp -----HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred -----ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 12345689999999999999999999999999999999999999998754
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=394.46 Aligned_cols=196 Identities=26% Similarity=0.419 Sum_probs=175.0
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCC-ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN-WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~ 329 (480)
..|++.+.||+|+||+||+|.+ .+|+.||||+++... ...+.+.+|+++|+.++|||||+++++|.+++.+||||||+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 4688999999999999999977 569999999996543 33456889999999999999999999999999999999999
Q ss_pred -CCCHHHHHH--hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccC
Q 011660 330 -NGSLKQYLK--QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSEN 406 (480)
Q Consensus 330 -~GsL~~~l~--~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~ 406 (480)
+|+|.+++. .+++.++..++.||+.||+|||++ +||||||||+||||+.+ +++||+|||+|+..... .
T Consensus 154 ~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~-g~vKl~DFGla~~~~~~-----~ 224 (346)
T 4fih_A 154 EGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHD-GRVKLSDFGFCAQVSKE-----V 224 (346)
T ss_dssp TTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT-CCEEECCCTTCEECCSS-----S
T ss_pred CCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCC-CCEEEecCcCceecCCC-----C
Confidence 678999985 488999999999999999999999 99999999999999998 79999999999764332 2
Q ss_pred ccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 407 VKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 407 ~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
....+.+||+.|||||++.+..|+.++|||||||+||||++|++||.+.+
T Consensus 225 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~ 274 (346)
T 4fih_A 225 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP 274 (346)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 23346799999999999999999999999999999999999999998754
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-49 Score=394.66 Aligned_cols=199 Identities=27% Similarity=0.356 Sum_probs=170.3
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc-
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL- 329 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~- 329 (480)
+.|.+.+.||+|+||.||+|.+ .+|+.||||+++.... ..+|+.+|+.++|||||++++++.+++.+||||||+
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~ 133 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLE 133 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccC
Confidence 4578888999999999999976 5699999999986543 247999999999999999999999999999999999
Q ss_pred CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccC
Q 011660 330 NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSEN 406 (480)
Q Consensus 330 ~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~ 406 (480)
+|+|.+++++ +++.++..++.||+.||+|||++ +||||||||+||||+.+..++||+|||+|+...........
T Consensus 134 gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~ 210 (336)
T 4g3f_A 134 GGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSL 210 (336)
T ss_dssp TCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC---------
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccce
Confidence 6899999954 89999999999999999999999 99999999999999988336999999999875543222222
Q ss_pred ccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 407 VKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 407 ~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
.....++||+.|||||++.+..|+.++|||||||+||||+||+.||...+.
T Consensus 211 ~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~ 261 (336)
T 4g3f_A 211 LTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFR 261 (336)
T ss_dssp ---CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCC
T ss_pred ecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH
Confidence 233457899999999999999999999999999999999999999987654
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=401.54 Aligned_cols=196 Identities=26% Similarity=0.419 Sum_probs=175.5
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc-cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW-SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~ 329 (480)
+.|++.+.||+|+||.||+|.+ .+|+.||||+++.... ..+.+.+|+++|+.++|||||+++++|.+++.+||||||+
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 5699999999999999999977 5699999999976543 3456889999999999999999999999999999999999
Q ss_pred -CCCHHHHHH--hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccC
Q 011660 330 -NGSLKQYLK--QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSEN 406 (480)
Q Consensus 330 -~GsL~~~l~--~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~ 406 (480)
+|+|.++++ .+++.++..++.||+.||.|||++ +||||||||+||||+.+ +++||+|||+|+..... .
T Consensus 231 ~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~-g~vKl~DFGla~~~~~~-----~ 301 (423)
T 4fie_A 231 EGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHD-GRVKLSDFGFCAQVSKE-----V 301 (423)
T ss_dssp TTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTT-CCEEECCCTTCEECCSS-----C
T ss_pred CCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCC-CCEEEecCccceECCCC-----C
Confidence 678999985 488999999999999999999999 99999999999999998 79999999999764332 2
Q ss_pred ccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 407 VKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 407 ~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
....+.+||+.|||||++.+..|+.++|||||||+||||++|++||.+.+
T Consensus 302 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~ 351 (423)
T 4fie_A 302 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP 351 (423)
T ss_dssp CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 23346799999999999999999999999999999999999999998654
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=381.13 Aligned_cols=195 Identities=25% Similarity=0.398 Sum_probs=161.9
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc----cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~----~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 326 (480)
++|++.+.||+|+||+||+|.+ .+|+.||+|++++... ....+.+|+++|+.++||||+++++++++++.+|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 5799999999999999999976 5699999999976532 2356889999999999999999999999999999999
Q ss_pred eccCCCHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccc
Q 011660 327 NLLNGSLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (480)
Q Consensus 327 e~~~GsL~~~l~---~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (480)
||++|+|.+++. .+++.++..++.||+.||+|||++ +|+||||||+|||++.+ +++||+|||+|+....
T Consensus 93 Ey~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~-~~vkl~DFGla~~~~~---- 164 (275)
T 3hyh_A 93 EYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEH-LNVKIADFGLSNIMTD---- 164 (275)
T ss_dssp ECCCEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTT-CCEEECCSSCC---------
T ss_pred eCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCC-CCEEEeecCCCeecCC----
Confidence 999999999985 389999999999999999999999 99999999999999998 7999999999975432
Q ss_pred ccCccccccccCCCccccccccCCCC-CchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 404 SENVKPVNVVGTFGYLAPEYMMYGKV-DEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 404 ~~~~~~~~~~GT~~y~APE~~~~~~~-~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.....+.+||+.|||||++.+..| +.++||||+||+||||+||+.||.+.+
T Consensus 165 --~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~ 216 (275)
T 3hyh_A 165 --GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES 216 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred --CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC
Confidence 222345789999999999998886 589999999999999999999998654
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-49 Score=389.79 Aligned_cols=199 Identities=30% Similarity=0.484 Sum_probs=172.1
Q ss_pred cCCCCceeecccCceEEEEEEec------CCcEEEEEEeccCCc-cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHV------DGQVAAVKVLKCTNW-SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAI 324 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 324 (480)
++|.+.+.||+|+||+||+|.+. +++.||||+++.... ..++|.+|+++|++++|||||+++|+|.+++.+++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 56888999999999999999753 477899999976543 24578999999999999999999999999999999
Q ss_pred EEecc-CCCHHHHHHh----------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceE
Q 011660 325 VYNLL-NGSLKQYLKQ----------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQ 387 (480)
Q Consensus 325 V~e~~-~GsL~~~l~~----------------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~k 387 (480)
||||+ +|+|.++|.. +++.++..++.||++||.|||++ +||||||||+||||+++ +.+|
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~-~~~K 168 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGEN-LLVK 168 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGG-GCEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCC-CcEE
Confidence 99999 7899999953 78999999999999999999999 99999999999999999 6899
Q ss_pred EeeeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCcc
Q 011660 388 LSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKA 457 (480)
Q Consensus 388 L~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~~ 457 (480)
|+|||+|+....... .......+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+.
T Consensus 169 i~DFGla~~~~~~~~---~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~ 236 (299)
T 4asz_A 169 IGDFGMSRDVYSTDY---YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN 236 (299)
T ss_dssp ECCCSCHHHHTGGGC---EEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred ECCcccceecCCCCc---eeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 999999976543221 112234579999999999999999999999999999999999 9999987653
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-48 Score=384.91 Aligned_cols=197 Identities=32% Similarity=0.460 Sum_probs=164.8
Q ss_pred hcCCCCceeecccCceEEEEEEecCCcEEEEEEeccCCcc---HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEe
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e 327 (480)
.++|.+.+.||+|+||+||+|.+. ..+|||+++..... .+.|.+|+++|++++|||||+++|+|.+ +.+++|||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 356888999999999999999864 35899999765433 3568899999999999999999999865 56789999
Q ss_pred cc-CCCHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccc
Q 011660 328 LL-NGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 328 ~~-~GsL~~~l~----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (480)
|+ +|+|.++|. .+++.++..++.||++||.|||++ +||||||||+||||+++ +++||+|||+|+.....
T Consensus 112 y~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~-~~~Ki~DFGla~~~~~~-- 185 (307)
T 3omv_A 112 WCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEG-LTVKIGDFGLATVKSRW-- 185 (307)
T ss_dssp CCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETT-EEEEECCCSSCBC------
T ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCC-CcEEEeeccCceecccC--
Confidence 99 789999994 388999999999999999999999 99999999999999998 68999999999764432
Q ss_pred cccCccccccccCCCccccccccC---CCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 403 VSENVKPVNVVGTFGYLAPEYMMY---GKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 403 ~~~~~~~~~~~GT~~y~APE~~~~---~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
.........+||+.|||||++.+ +.|+.++|||||||+||||+||+.||.+.+.
T Consensus 186 -~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~ 242 (307)
T 3omv_A 186 -SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN 242 (307)
T ss_dssp ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred -CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh
Confidence 12223346789999999999863 4699999999999999999999999987553
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=379.40 Aligned_cols=191 Identities=30% Similarity=0.455 Sum_probs=164.4
Q ss_pred CCceeecccCceEEEEEEe-cCCcEEEEEEeccCCcc---HHHHHHHHHHHhcCCCCCeeeEEEEEec----CCeeEEEE
Q 011660 255 SPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHS----KEMYAIVY 326 (480)
Q Consensus 255 ~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~~lV~ 326 (480)
++.+.||+|+||+||+|.+ .+++.||+|++...... .+.+.+|+++|++++|||||+++++|++ ++.+++||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 5667899999999999976 56899999999754332 3468899999999999999999999864 45689999
Q ss_pred ecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeccCCCCCEEEecCCCceEEeeeccccccccc
Q 011660 327 NLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPP--IIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (480)
Q Consensus 327 e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~--IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (480)
||+ +|+|.+++.+ +++.++..++.||+.||.|||++ + ||||||||+||||+...+.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~- 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA- 184 (290)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT-
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC-
Confidence 999 6899999954 88999999999999999999998 6 999999999999985337899999999975322
Q ss_pred cccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 401 ~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
....+.+||+.|||||++.+ .|+.++|||||||+||||+||+.||....
T Consensus 185 ------~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~ 233 (290)
T 3fpq_A 185 ------SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ 233 (290)
T ss_dssp ------TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS
T ss_pred ------CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 22346789999999998864 69999999999999999999999997654
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-48 Score=384.44 Aligned_cols=199 Identities=25% Similarity=0.391 Sum_probs=172.4
Q ss_pred cCCCCceeecccCceEEEEEEec------CCcEEEEEEeccCC--ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHV------DGQVAAVKVLKCTN--WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYA 323 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 323 (480)
+++++.+.||+|+||+||+|.+. +++.||||+++... ...++|.+|+.+|++++|||||+++|+|.+++.++
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 34667788999999999999752 46899999997543 33578999999999999999999999999999999
Q ss_pred EEEecc-CCCHHHHHH-------------------hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCC
Q 011660 324 IVYNLL-NGSLKQYLK-------------------QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENF 383 (480)
Q Consensus 324 lV~e~~-~GsL~~~l~-------------------~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~ 383 (480)
+||||+ +|+|.++|. .+++.++..++.||++||.|||++ +||||||||+||||+++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~- 181 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDK- 181 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGG-
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCC-
Confidence 999999 789999994 278899999999999999999999 99999999999999998
Q ss_pred CceEEeeeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCcc
Q 011660 384 HHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKA 457 (480)
Q Consensus 384 ~~~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~~ 457 (480)
+++||+|||+|+...... ........+||+.|||||++.++.|+.++|||||||+||||+| |+.||.+.+.
T Consensus 182 ~~~Ki~DFGlar~~~~~~---~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~ 253 (308)
T 4gt4_A 182 LNVKISDLGLFREVYAAD---YYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN 253 (308)
T ss_dssp GCEEECCSCCBCGGGGGG---CBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH
T ss_pred CCEEECCcccceeccCCC---ceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH
Confidence 689999999997654322 1223345689999999999999999999999999999999998 8999987653
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-48 Score=389.21 Aligned_cols=199 Identities=28% Similarity=0.464 Sum_probs=166.7
Q ss_pred cCCCCceeecccCceEEEEEEec------CCcEEEEEEeccCCc-cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHV------DGQVAAVKVLKCTNW-SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAI 324 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 324 (480)
++|.+.+.||+|+||+||+|.+. +++.||||+++.... ..++|.+|+++|++++|||||+++|+|.+++.+++
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45778889999999999999753 478999999976543 23578999999999999999999999999999999
Q ss_pred EEecc-CCCHHHHHHh------------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCc
Q 011660 325 VYNLL-NGSLKQYLKQ------------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHH 385 (480)
Q Consensus 325 V~e~~-~GsL~~~l~~------------------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~ 385 (480)
||||+ +|+|.+++.. +++.++..++.||++||.|||+. +||||||||+||||+++ ++
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~-~~ 196 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQG-LV 196 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETT-TE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCC-Cc
Confidence 99999 7899999853 78899999999999999999999 99999999999999999 69
Q ss_pred eEEeeeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCcc
Q 011660 386 PQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKA 457 (480)
Q Consensus 386 ~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~~ 457 (480)
+||+|||+|+...... ........+||+.|||||++.+..|+.++|||||||+||||+| |+.||...+.
T Consensus 197 ~Ki~DFGla~~~~~~~---~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~ 266 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTD---YYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN 266 (329)
T ss_dssp EEECCCC-------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH
T ss_pred EEEcccccceeccCCC---cceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH
Confidence 9999999997654322 1222345689999999999999999999999999999999999 9999987653
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=386.09 Aligned_cols=196 Identities=29% Similarity=0.409 Sum_probs=167.1
Q ss_pred cCCCCceeecccCceEEEEEEec----CCcEEEEEEeccCCc---cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHV----DGQVAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAI 324 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~----~g~~vAvK~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 324 (480)
++|++.+.||+|+||+||+|.+. +++.||+|++++... ....+.+|+++|++++||||+++++++++++.+|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 46999999999999999999762 478999999975432 22467899999999999999999999999999999
Q ss_pred EEecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccc
Q 011660 325 VYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (480)
Q Consensus 325 V~e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (480)
||||+ +|+|.+++.+ +++.++..++.||+.||+|||++ +||||||||+|||++.+ +++||+|||+|+.....
T Consensus 104 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~-g~vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEE-GHIKLTDFGLSKESIDH 179 (304)
T ss_dssp EECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTT-SCEEEESSEEEEC----
T ss_pred EEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCC-CCEEecccccceeccCC
Confidence 99999 6899999954 88999999999999999999999 99999999999999998 79999999999754321
Q ss_pred cccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 401 ~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.....+.+||+.|||||++.+..|+.++|||||||+||||+||+.||.+.+
T Consensus 180 -----~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~ 230 (304)
T 3ubd_A 180 -----EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD 230 (304)
T ss_dssp ------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred -----CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC
Confidence 223346789999999999999999999999999999999999999998754
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=374.08 Aligned_cols=201 Identities=27% Similarity=0.382 Sum_probs=162.4
Q ss_pred cCCCCceeecccCceEEEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEEEecCC----eeEEEEe
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKE----MYAIVYN 327 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----~~~lV~e 327 (480)
.+|.+.+.||+|+||+||+|.+ +|+.||||+++........+..|+.++.+++||||++++|+|.+++ .+++|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 4577888999999999999987 6899999999755433333445666678899999999999997653 5899999
Q ss_pred cc-CCCHHHHHHh--CCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEeccCCCCCEEEecCCCceEEeeecccccccc
Q 011660 328 LL-NGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHT-----CDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (480)
Q Consensus 328 ~~-~GsL~~~l~~--~~~~~~~~i~~~ia~aL~yLH~~-----~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~ 399 (480)
|+ +|+|.++|+. +++.++..++.|++.||.|||+. +.++||||||||+||||+.+ +++||+|||+|+....
T Consensus 82 y~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~-~~~Ki~DFGla~~~~~ 160 (303)
T 3hmm_A 82 YHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVRHDS 160 (303)
T ss_dssp CCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTT-SCEEECCCTTCEEEET
T ss_pred CCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCC-CCEEEEeCCCCccccC
Confidence 99 6899999964 78999999999999999999976 34589999999999999999 6899999999976543
Q ss_pred ccccccCccccccccCCCccccccccCC------CCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 011660 400 SHQVSENVKPVNVVGTFGYLAPEYMMYG------KVDEKIDVYSYGVVLLELITGKEAIQTN 455 (480)
Q Consensus 400 ~~~~~~~~~~~~~~GT~~y~APE~~~~~------~~~~k~DvwSlGvil~eLltG~~pf~~~ 455 (480)
.... ........+||+.|||||++.+. .|+.++|||||||+||||+||++||...
T Consensus 161 ~~~~-~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~ 221 (303)
T 3hmm_A 161 ATDT-IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 221 (303)
T ss_dssp TTTE-ESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBC
T ss_pred CCCc-eeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcc
Confidence 2211 12223456899999999998754 4788999999999999999998876543
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=378.91 Aligned_cols=215 Identities=26% Similarity=0.357 Sum_probs=180.0
Q ss_pred HhhhhcCCCCceeecccCceEEEEEEec----CCcEEEEEEeccCCccHHHHHHHHHHHhcC-CCCCeeeEEEEEecCCe
Q 011660 247 LCHLTHNFSPKMLIGQGGNSKVYRTNHV----DGQVAAVKVLKCTNWSEEEVLREVELLSSI-KHENIVRIIGYCHSKEM 321 (480)
Q Consensus 247 l~~~~~~f~~~~~LG~G~fg~Vy~~~~~----~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~ 321 (480)
+..+.++|++.+.||+|+||+||+|.+. +++.||+|.+.... ....+.+|+++|+.+ +||||+++++++++++.
T Consensus 16 ~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 16 VPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp SGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred cCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 3456778999999999999999999652 46899999987554 456788999999988 69999999999999999
Q ss_pred eEEEEecc-CCCHHHHHHhCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccc
Q 011660 322 YAIVYNLL-NGSLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (480)
Q Consensus 322 ~~lV~e~~-~GsL~~~l~~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (480)
+++||||+ +|+|.++++.+++.++..++.|++.||.|||++ +||||||||+|||++.+.+.+||+|||+|+.....
T Consensus 95 ~~lvmE~~~g~~L~~~~~~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~ 171 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILNSLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDT 171 (361)
T ss_dssp EEEEEECCCCCCHHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECTTC
T ss_pred EEEEEeCCCcccHHHHHcCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCc
Confidence 99999999 689999999999999999999999999999999 99999999999999987679999999999764432
Q ss_pred ccc-----------------------ccCccccccccCCCccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 401 HQV-----------------------SENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 401 ~~~-----------------------~~~~~~~~~~GT~~y~APE~~~~~-~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
... .......+.+||+.|||||++.+. .|+.++||||+||++|||+||+.||...+
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~ 251 (361)
T 4f9c_A 172 KIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKAS 251 (361)
T ss_dssp SCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCC
Confidence 111 011123456899999999999876 58999999999999999999999998766
Q ss_pred ccchhHHHH
Q 011660 457 ANRESLVLW 465 (480)
Q Consensus 457 ~~~e~l~~~ 465 (480)
++.+.+...
T Consensus 252 ~~~~~l~~I 260 (361)
T 4f9c_A 252 DDLTALAQI 260 (361)
T ss_dssp SHHHHHHHH
T ss_pred CHHHHHHHH
Confidence 555544443
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=369.44 Aligned_cols=197 Identities=28% Similarity=0.493 Sum_probs=156.7
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCcc--HHHHHHHHHHHhcCCCCCeeeEEEEEecCC--------
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSKE-------- 320 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-------- 320 (480)
++|++.+.||+|+||+||+|.+ .+|+.||||+++..... .+.+.+|+++|++++|||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 4599999999999999999976 56999999999765432 356889999999999999999999986544
Q ss_pred ----eeEEEEecc-CCCHHHHHHh------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEe
Q 011660 321 ----MYAIVYNLL-NGSLKQYLKQ------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLS 389 (480)
Q Consensus 321 ----~~~lV~e~~-~GsL~~~l~~------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~ 389 (480)
.+|+||||+ +|+|.+++.. ..+..+..++.||++||+|||++ +||||||||+|||++.+ +.+||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~-~~vKl~ 160 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMD-DVVKVG 160 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTT-CCEEEC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCC-CcEEEc
Confidence 378999999 6899999964 34556788999999999999999 99999999999999998 799999
Q ss_pred eeccccccccccccc-------cCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 011660 390 DFGAAMVHHQSHQVS-------ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTN 455 (480)
Q Consensus 390 DFGla~~~~~~~~~~-------~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~ 455 (480)
|||+|+......... ........+||+.|||||++.+..|+.++|||||||+||||++ ||...
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~ 230 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ 230 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc
Confidence 999997654422111 1122345689999999999999999999999999999999996 78653
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=381.35 Aligned_cols=202 Identities=26% Similarity=0.374 Sum_probs=172.8
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCccH---HHHHHHHHHHhcCCCCCeeeEEEEEec------CC
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSE---EEVLREVELLSSIKHENIVRIIGYCHS------KE 320 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~~---~~~~~Ei~il~~l~HpnIv~l~~~~~~------~~ 320 (480)
.++|++.+.||+|+||+||+|.+ .+|+.||||++++..... +.+.+|+++|+.++||||+++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 46799999999999999999976 579999999997654333 457899999999999999999998753 36
Q ss_pred eeEEEEeccCCCHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccc
Q 011660 321 MYAIVYNLLNGSLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVH 397 (480)
Q Consensus 321 ~~~lV~e~~~GsL~~~l~---~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~ 397 (480)
.+|+||||++|+|.+++. .+++.++..++.||+.||.|||++ +||||||||+|||++.+ +.+||+|||+|+..
T Consensus 133 ~~~ivmE~~~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~-~~~Ki~DFGla~~~ 208 (398)
T 4b99_A 133 SVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNEN-CELKIGDFGMARGL 208 (398)
T ss_dssp CEEEEEECCSEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTT-CCEEECCCTTCBCC
T ss_pred EEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCC-CCEEEeecceeeec
Confidence 789999999999999995 488999999999999999999999 99999999999999998 79999999999765
Q ss_pred ccccccccCccccccccCCCccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 398 HQSHQVSENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 398 ~~~~~~~~~~~~~~~~GT~~y~APE~~~~~-~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
..... .......+.+||+.|||||++.+. .|+.++||||+||++|||++|++||.+.+.
T Consensus 209 ~~~~~-~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~ 268 (398)
T 4b99_A 209 CTSPA-EHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNY 268 (398)
T ss_dssp --------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSH
T ss_pred ccCcc-ccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCH
Confidence 43221 122334567999999999998875 469999999999999999999999987653
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=377.93 Aligned_cols=204 Identities=26% Similarity=0.409 Sum_probs=173.8
Q ss_pred hhhcCCCCceeecccCceEEEEEEecC------CcEEEEEEeccCCcc--HHHHHHHHHHHhcCCC-CCeeeEEEEEec-
Q 011660 249 HLTHNFSPKMLIGQGGNSKVYRTNHVD------GQVAAVKVLKCTNWS--EEEVLREVELLSSIKH-ENIVRIIGYCHS- 318 (480)
Q Consensus 249 ~~~~~f~~~~~LG~G~fg~Vy~~~~~~------g~~vAvK~~~~~~~~--~~~~~~Ei~il~~l~H-pnIv~l~~~~~~- 318 (480)
...++|++.+.||+|+||+||+|.+.. ++.||||.++..... .+.+.+|+++|++++| ||||+++|+|.+
T Consensus 61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~ 140 (353)
T 4ase_A 61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 140 (353)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence 345679999999999999999997532 368999999765432 3568999999999965 999999999965
Q ss_pred CCeeEEEEecc-CCCHHHHHHh-------------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEE
Q 011660 319 KEMYAIVYNLL-NGSLKQYLKQ-------------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNIL 378 (480)
Q Consensus 319 ~~~~~lV~e~~-~GsL~~~l~~-------------------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NIL 378 (480)
++.+++||||+ +|+|.++|+. +++.++..++.||++||.|||++ +||||||||+|||
T Consensus 141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NIL 217 (353)
T 4ase_A 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNIL 217 (353)
T ss_dssp TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCcccee
Confidence 46789999999 7899999953 67889999999999999999999 9999999999999
Q ss_pred EecCCCceEEeeeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCcc
Q 011660 379 LSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKA 457 (480)
Q Consensus 379 l~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~~ 457 (480)
++++ +.+||+|||+|+...... ........+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+.
T Consensus 218 l~~~-~~vKi~DFGlar~~~~~~---~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~ 293 (353)
T 4ase_A 218 LSEK-NVVKICDFGLARDIYKDP---DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 293 (353)
T ss_dssp ECGG-GCEEECCCGGGSCTTTCT---TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred eCCC-CCEEECcchhhhhcccCC---CceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH
Confidence 9998 689999999997654321 2223345689999999999999999999999999999999998 9999987665
Q ss_pred cc
Q 011660 458 NR 459 (480)
Q Consensus 458 ~~ 459 (480)
.+
T Consensus 294 ~~ 295 (353)
T 4ase_A 294 DE 295 (353)
T ss_dssp SH
T ss_pred HH
Confidence 43
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=385.60 Aligned_cols=195 Identities=31% Similarity=0.456 Sum_probs=169.8
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCC----ccHHHHHHH---HHHHhcCCCCCeeeEEEEEecCCeeE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLRE---VELLSSIKHENIVRIIGYCHSKEMYA 323 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~E---i~il~~l~HpnIv~l~~~~~~~~~~~ 323 (480)
++|++.+.||+|+||+||+|.+ .+|+.||+|++++.. .....+.+| +.+++.++||||++++++|++.+.+|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 5799999999999999999977 569999999996532 222334444 66778889999999999999999999
Q ss_pred EEEecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccc
Q 011660 324 IVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (480)
Q Consensus 324 lV~e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~ 399 (480)
+||||+ +|+|.++|.+ +++.++..++.||+.||+|||++ +||||||||+||||+.+ +++||+|||+|+....
T Consensus 269 lVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~-G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEH-GHVRISDLGLACDFSK 344 (689)
T ss_dssp EEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTT-SCEEECCCTTCEECSS
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCC-CCEEecccceeeecCC
Confidence 999999 6899999954 88999999999999999999999 99999999999999998 7999999999975432
Q ss_pred ccccccCccccccccCCCccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 400 SHQVSENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 400 ~~~~~~~~~~~~~~GT~~y~APE~~~~-~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
....+.+||+.|||||++.. ..|+.++|||||||+||||++|++||.+.+.
T Consensus 345 -------~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~ 396 (689)
T 3v5w_A 345 -------KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 396 (689)
T ss_dssp -------CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGC
T ss_pred -------CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 22346799999999999974 5799999999999999999999999987654
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-43 Score=375.23 Aligned_cols=198 Identities=22% Similarity=0.323 Sum_probs=175.4
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCcc-HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEec
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS-EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~-~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~ 328 (480)
.++|++.+.||+|+||.||+|.+ .+|+.||+|+++..... .+.+.+|+++|+.++||||++++++|++++.+++||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 46799999999999999999976 56999999999766533 45688999999999999999999999999999999999
Q ss_pred c-CCCHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecC-CCceEEeeeccccccccccc
Q 011660 329 L-NGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN-FHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 329 ~-~GsL~~~l~----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~-~~~~kL~DFGla~~~~~~~~ 402 (480)
+ +|+|.++|. .+++.++..++.||+.||.|||++ +|+||||||+|||++.+ .+.+||+|||+|+.....
T Consensus 236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~-- 310 (573)
T 3uto_A 236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-- 310 (573)
T ss_dssp CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT--
T ss_pred cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCC--
Confidence 9 679999994 377889999999999999999999 99999999999999853 368999999999765432
Q ss_pred cccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 403 ~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
......+||+.|||||++.+..|+.++|||||||+||||++|++||.+.+.
T Consensus 311 ----~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~ 361 (573)
T 3uto_A 311 ----QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND 361 (573)
T ss_dssp ----SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH
T ss_pred ----CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH
Confidence 223456899999999999999999999999999999999999999987653
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=327.67 Aligned_cols=219 Identities=25% Similarity=0.441 Sum_probs=181.2
Q ss_pred hhcCCCCceeecccCceEEEEEEecCCcEEEEEEeccCCcc---HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEE
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 326 (480)
+.++|++.+.||+|+||.||+|...+++.+|+|+++..... ...+.+|+++++.++||||+++++++.+++.+++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 35679999999999999999999888999999999754332 356889999999999999999999999999999999
Q ss_pred eccCCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccc
Q 011660 327 NLLNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 327 e~~~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (480)
||+.|+|.+++.. +++.++..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||++......
T Consensus 99 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~-~~~kl~Dfg~a~~~~~~-- 172 (311)
T 3niz_A 99 EFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSD-GALKLADFGLARAFGIP-- 172 (311)
T ss_dssp ECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTT-CCEEECCCTTCEETTSC--
T ss_pred cCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCC-CCEEEccCcCceecCCC--
Confidence 9999999998854 78889999999999999999999 99999999999999998 68999999999754321
Q ss_pred cccCccccccccCCCccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHhCCCCCCCCC
Q 011660 403 VSENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWYYVLAGKVFAQQWP 479 (480)
Q Consensus 403 ~~~~~~~~~~~GT~~y~APE~~~~-~~~~~k~DvwSlGvil~eLltG~~pf~~~~~~~e~l~~~~~~~~~~~~~~~~~ 479 (480)
........||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ........+.+.++.||
T Consensus 173 ---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~ 245 (311)
T 3niz_A 173 ---VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ--LPKIFSILGTPNPREWP 245 (311)
T ss_dssp ---CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH--HHHHHHHHCCCCTTTSG
T ss_pred ---cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHHCCCChHHhh
Confidence 112234578999999999876 5689999999999999999999999987654322 23334455555565554
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=330.36 Aligned_cols=196 Identities=23% Similarity=0.361 Sum_probs=173.5
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccC----CccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCT----NWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 326 (480)
++|++.+.||+|+||+||++.. .+|+.||+|++++. ......+.+|+++|+.++||||+++++++.+.+.+++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 5799999999999999999977 46999999999753 234467889999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccc
Q 011660 327 NLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 327 e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (480)
||+ +|+|.+++.. +++.++..++.||+.||.|||++ +|+||||||+|||++.+ +++||+|||+++....
T Consensus 85 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~-g~vkL~DFG~a~~~~~--- 157 (337)
T 1o6l_A 85 EYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKD-GHIKITDFGLCKEGIS--- 157 (337)
T ss_dssp ECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTT-SCEEECCCTTCBCSCC---
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCC-CCEEEeeccchhhccc---
Confidence 999 6799999853 78899999999999999999999 99999999999999998 7999999999864221
Q ss_pred cccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 403 ~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 158 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 209 (337)
T 1o6l_A 158 --DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209 (337)
T ss_dssp --TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred --CCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC
Confidence 1223346789999999999999999999999999999999999999998654
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=334.30 Aligned_cols=198 Identities=26% Similarity=0.362 Sum_probs=169.1
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCC----ccHHHHHHHHHHHhcC-CCCCeeeEEEEEecCCeeEE
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVELLSSI-KHENIVRIIGYCHSKEMYAI 324 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~l 324 (480)
.++|++.+.||+|+||+||+|.+ .+++.||+|++++.. ...+.+.+|.++++.+ +||||+++++++.+.+.+++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 35799999999999999999976 468999999997532 2345678999999988 79999999999999999999
Q ss_pred EEecc-CCCHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccc
Q 011660 325 VYNLL-NGSLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (480)
Q Consensus 325 V~e~~-~GsL~~~l~---~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (480)
||||+ +|+|.+++. .+++.++..++.||+.||.|||+. +|+||||||+|||++.+ +++||+|||+|+....
T Consensus 102 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~-g~ikL~DFG~a~~~~~- 176 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHE-GHCKLADFGMCKEGIC- 176 (353)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTT-SCEEECCCTTCBCSCC-
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCC-CCEEEccccceeeccc-
Confidence 99999 679999985 388999999999999999999999 99999999999999998 7999999999964221
Q ss_pred cccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 401 ~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
........+||+.|+|||++.+..|+.++|||||||++|||++|+.||...+.
T Consensus 177 ----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~ 229 (353)
T 3txo_A 177 ----NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE 229 (353)
T ss_dssp -------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ----CCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH
Confidence 22234467899999999999999999999999999999999999999987643
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=320.76 Aligned_cols=198 Identities=27% Similarity=0.432 Sum_probs=175.6
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCC-ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEec
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN-WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~ 328 (480)
.++|++.+.||+|+||.||+|.. .+++.||+|++.... ...+.+.+|+.+++.++||||+++++++.+++.+++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 46799999999999999999976 668999999986543 3456788999999999999999999999999999999999
Q ss_pred c-CCCHHHHHHh--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccccc
Q 011660 329 L-NGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE 405 (480)
Q Consensus 329 ~-~GsL~~~l~~--~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~ 405 (480)
+ +|+|.+++.. +++.++..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||++.......
T Consensus 99 ~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~---- 170 (297)
T 3fxz_A 99 LAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQ---- 170 (297)
T ss_dssp CTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT-CCEEECCCTTCEECCSTT----
T ss_pred CCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCC-CCEEEeeCCCceecCCcc----
Confidence 9 7899999965 78889999999999999999999 99999999999999998 689999999986543321
Q ss_pred CccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 406 NVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 406 ~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.
T Consensus 171 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 221 (297)
T 3fxz_A 171 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP 221 (297)
T ss_dssp -CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred -cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 223356799999999999999999999999999999999999999987653
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=320.18 Aligned_cols=217 Identities=24% Similarity=0.450 Sum_probs=177.9
Q ss_pred cCCCCceeecccCceEEEEEEecCCcEEEEEEeccCCcc---HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEec
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~ 328 (480)
++|.+.+.||+|+||.||+|...+++.+|+|+++..... ...+.+|+++++.++||||+++++++.+.+.+++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 468899999999999999998878999999999755432 36788999999999999999999999999999999999
Q ss_pred cCCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccc
Q 011660 329 LNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (480)
Q Consensus 329 ~~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (480)
+.|+|.+++.. +++.++..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||++......
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~---- 153 (288)
T 1ob3_A 82 LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINRE-GELKIADFGLARAFGIP---- 153 (288)
T ss_dssp CSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTT-SCEEECCTTHHHHHCC-----
T ss_pred cCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCC-CCEEEeECccccccCcc----
Confidence 99999999853 78889999999999999999999 99999999999999998 78999999998654321
Q ss_pred cCccccccccCCCccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHhCCCCCCCCC
Q 011660 405 ENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWYYVLAGKVFAQQWP 479 (480)
Q Consensus 405 ~~~~~~~~~GT~~y~APE~~~~~-~~~~k~DvwSlGvil~eLltG~~pf~~~~~~~e~l~~~~~~~~~~~~~~~~~ 479 (480)
........||+.|+|||++.+. .++.++|||||||++|||++|+.||...... +. ..-.....+.+....||
T Consensus 154 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~-~~~~~~~~~~~~~~~~~ 226 (288)
T 1ob3_A 154 -VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA-DQ-LMRIFRILGTPNSKNWP 226 (288)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HH-HHHHHHHHCCCCTTTST
T ss_pred -ccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HH-HHHHHHHHCCCChhhch
Confidence 1122345789999999998764 5899999999999999999999999876532 22 22233344555555554
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=329.01 Aligned_cols=197 Identities=26% Similarity=0.415 Sum_probs=173.8
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccC----CccHHHHHHHHHHHhcC-CCCCeeeEEEEEecCCeeEE
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCT----NWSEEEVLREVELLSSI-KHENIVRIIGYCHSKEMYAI 324 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~----~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~l 324 (480)
.++|.+.+.||+|+||.||+|.+ .+++.||+|++++. ......+..|..++..+ +||||+++++++.+.+.+++
T Consensus 16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~l 95 (345)
T 1xjd_A 16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 95 (345)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEE
Confidence 46799999999999999999987 46899999999754 23445678899999876 99999999999999999999
Q ss_pred EEecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccc
Q 011660 325 VYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (480)
Q Consensus 325 V~e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (480)
||||+ +|+|.+++.. +++.++..++.||+.||.|||++ +|+||||||+|||++.+ +++||+|||+|+....
T Consensus 96 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~-g~vkL~DFG~a~~~~~- 170 (345)
T 1xjd_A 96 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKD-GHIKIADFGMCKENML- 170 (345)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTT-SCEEECCCTTCBCCCC-
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCC-CCEEEeEChhhhhccc-
Confidence 99999 6799999954 88999999999999999999999 99999999999999998 7999999999964322
Q ss_pred cccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 401 ~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 171 ----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 222 (345)
T 1xjd_A 171 ----GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 222 (345)
T ss_dssp ----TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ----CCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC
Confidence 1223346789999999999999999999999999999999999999998654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=325.62 Aligned_cols=196 Identities=27% Similarity=0.455 Sum_probs=173.6
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCcc---HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEE
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 326 (480)
..+|.+.+.||+|+||.||+|.+ .+|+.||+|++...... .+.+.+|+++|+.++||||+++++++.+.+.+++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 45799999999999999999987 67999999999765433 345789999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccc
Q 011660 327 NLL-NGSLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 327 e~~-~GsL~~~l~---~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (480)
||+ +|+|.+++. .+++.++..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~~-- 167 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDAD-MNIKIADFGFSNEFTVG-- 167 (328)
T ss_dssp CCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTT-SCEEECSTTCCGGGSSS--
T ss_pred ECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCC-CCEEEeeccCceecCCC--
Confidence 999 679999984 488999999999999999999999 99999999999999998 68999999999654322
Q ss_pred cccCccccccccCCCccccccccCCCCC-chHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 403 VSENVKPVNVVGTFGYLAPEYMMYGKVD-EKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 403 ~~~~~~~~~~~GT~~y~APE~~~~~~~~-~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
......+||+.|+|||++.+..++ .++|||||||++|||++|+.||.+.+
T Consensus 168 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 218 (328)
T 3fe3_A 168 ----GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218 (328)
T ss_dssp ----CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ----CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC
Confidence 223456899999999999988875 89999999999999999999998765
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=341.08 Aligned_cols=205 Identities=23% Similarity=0.337 Sum_probs=176.5
Q ss_pred HHHhhhhcCCCCceeecccCceEEEEEEec-CCcEEEEEEeccCC----ccHHHHHHHHHHHhcCCCCCeeeEEEEEecC
Q 011660 245 QELCHLTHNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTN----WSEEEVLREVELLSSIKHENIVRIIGYCHSK 319 (480)
Q Consensus 245 ~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 319 (480)
.++....++|.+.+.||+|+||+||++.+. +++.||+|++++.. .....+.+|+.+++.++||||++++++|.++
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 345556788999999999999999999874 58999999996522 2224578999999999999999999999999
Q ss_pred CeeEEEEecc-CCCHHHHHHh--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccc
Q 011660 320 EMYAIVYNLL-NGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMV 396 (480)
Q Consensus 320 ~~~~lV~e~~-~GsL~~~l~~--~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~ 396 (480)
+.+++||||+ +|+|.++++. +++..+..++.||+.||.|||+. +|+||||||+|||++.+ +++||+|||+|+.
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~-g~ikL~DFG~a~~ 217 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKS-GHLKLADFGTCMK 217 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT-SCEEECCCTTCEE
T ss_pred CEEEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCC-CCEEEeccceeEe
Confidence 9999999999 7799999965 78888999999999999999999 99999999999999998 7999999999975
Q ss_pred cccccccccCccccccccCCCccccccccCCC----CCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 397 HHQSHQVSENVKPVNVVGTFGYLAPEYMMYGK----VDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 397 ~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~----~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
..... .......+||+.|+|||++.+.. |+.++|||||||++|||++|+.||...+.
T Consensus 218 ~~~~~----~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~ 278 (410)
T 3v8s_A 218 MNKEG----MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL 278 (410)
T ss_dssp CCTTS----EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred eccCC----cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh
Confidence 43321 11234678999999999998765 88999999999999999999999987653
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=316.94 Aligned_cols=218 Identities=25% Similarity=0.421 Sum_probs=182.1
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCcc---HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEe
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e 327 (480)
++|++.+.||+|+||.||+|.+ .+++.||+|+++..... ...+.+|+++++.++||||+++++++.+++.+++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 4689999999999999999977 46899999999755432 3568899999999999999999999999999999999
Q ss_pred ccCCCHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccc
Q 011660 328 LLNGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (480)
Q Consensus 328 ~~~GsL~~~l~----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (480)
|+.|++.+++. .+++.++..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||++......
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~-~~~kl~Dfg~~~~~~~~--- 154 (292)
T 3o0g_A 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRN-GELKLANFGLARAFGIP--- 154 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT-SCEEECCCTTCEECCSC---
T ss_pred cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCC-CCEEEeecccceecCCc---
Confidence 99999888774 388899999999999999999999 99999999999999998 78999999999754321
Q ss_pred ccCccccccccCCCccccccccCCC-CCchHHHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHhCCCCCCCCC
Q 011660 404 SENVKPVNVVGTFGYLAPEYMMYGK-VDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWYYVLAGKVFAQQWP 479 (480)
Q Consensus 404 ~~~~~~~~~~GT~~y~APE~~~~~~-~~~k~DvwSlGvil~eLltG~~pf~~~~~~~e~l~~~~~~~~~~~~~~~~~ 479 (480)
........||+.|+|||++.+.. ++.++|||||||++|||++|..||.......+.+.. .....+.+..+.||
T Consensus 155 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~-i~~~~~~~~~~~~~ 228 (292)
T 3o0g_A 155 --VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKR-IFRLLGTPTEEQWP 228 (292)
T ss_dssp --CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHH-HHHHHCCCCTTTCT
T ss_pred --cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHH-HHHHhCCCChhhhh
Confidence 12223457899999999998766 799999999999999999998887655544333333 33455666666665
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=322.21 Aligned_cols=218 Identities=28% Similarity=0.471 Sum_probs=167.4
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCC--ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEe
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN--WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e 327 (480)
.++|++.+.||+|+||.||+|.. .+++.||+|+++... .....+.+|+++++.++||||+++++++.+++.+++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 45799999999999999999976 468999999997543 234678899999999999999999999999999999999
Q ss_pred ccCCCHHHHHHh---------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccc
Q 011660 328 LLNGSLKQYLKQ---------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (480)
Q Consensus 328 ~~~GsL~~~l~~---------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~ 398 (480)
|+.|+|.+++.. +++..+..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||++....
T Consensus 84 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~-~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKR-GQLKLGDFGLARAFG 159 (317)
T ss_dssp CCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTT-CCEEECCCSSCEETT
T ss_pred ecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCC-CCEEECcCccceecC
Confidence 999999999842 77888999999999999999999 99999999999999998 789999999997543
Q ss_pred cccccccCccccccccCCCccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHhCCCCCCC
Q 011660 399 QSHQVSENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWYYVLAGKVFAQQ 477 (480)
Q Consensus 399 ~~~~~~~~~~~~~~~GT~~y~APE~~~~-~~~~~k~DvwSlGvil~eLltG~~pf~~~~~~~e~l~~~~~~~~~~~~~~~ 477 (480)
.. ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+.. +. ........+.+..+.
T Consensus 160 ~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~-~~~i~~~~~~~~~~~ 232 (317)
T 2pmi_A 160 IP-----VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE-EQ-LKLIFDIMGTPNESL 232 (317)
T ss_dssp SC-----CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HH-HHHHHHHHCSCCTTT
T ss_pred CC-----cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HH-HHHHHHHhCCCChhH
Confidence 21 112234579999999999886 46899999999999999999999999876532 22 222333445555555
Q ss_pred CC
Q 011660 478 WP 479 (480)
Q Consensus 478 ~~ 479 (480)
||
T Consensus 233 ~~ 234 (317)
T 2pmi_A 233 WP 234 (317)
T ss_dssp CG
T ss_pred hh
Confidence 53
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=343.67 Aligned_cols=206 Identities=22% Similarity=0.311 Sum_probs=177.0
Q ss_pred HHHHhhhhcCCCCceeecccCceEEEEEEec-CCcEEEEEEeccCC----ccHHHHHHHHHHHhcCCCCCeeeEEEEEec
Q 011660 244 SQELCHLTHNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTN----WSEEEVLREVELLSSIKHENIVRIIGYCHS 318 (480)
Q Consensus 244 ~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 318 (480)
..++....++|++.+.||+|+||+||+|.+. +++.||+|++++.. .....+.+|+.++..++||||++++++|.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 4455566788999999999999999999875 58899999997532 122347899999999999999999999999
Q ss_pred CCeeEEEEecc-CCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecc
Q 011660 319 KEMYAIVYNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGA 393 (480)
Q Consensus 319 ~~~~~lV~e~~-~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGl 393 (480)
++.+++||||+ +|+|.+++.. +++..+..++.|++.||.|||+. +||||||||+|||++.+ +++||+|||+
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~-g~vkL~DFGl 221 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMN-GHIRLADFGS 221 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT-SCEEECCCTT
T ss_pred CCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCC-CCEEEcchhh
Confidence 99999999999 7899999954 78899999999999999999999 99999999999999998 7999999999
Q ss_pred ccccccccccccCccccccccCCCcccccccc-----CCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 394 AMVHHQSHQVSENVKPVNVVGTFGYLAPEYMM-----YGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 394 a~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
|+...... .......+||+.|+|||++. ...|+.++|||||||++|||++|+.||...+.
T Consensus 222 a~~~~~~~----~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~ 286 (437)
T 4aw2_A 222 CLKLMEDG----TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL 286 (437)
T ss_dssp CEECCTTS----CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred hhhcccCC----CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh
Confidence 96543321 11223468999999999987 56789999999999999999999999987653
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=332.62 Aligned_cols=196 Identities=27% Similarity=0.405 Sum_probs=172.5
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCC----ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 326 (480)
++|.+.+.||+|+||.||++.. .+++.||+|++++.. .....+.+|+++|+.++||||+++++++.+.+.+++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 5699999999999999999976 458899999996432 33467889999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccc
Q 011660 327 NLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 327 e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (480)
||+ +|+|.+++.. +++..+..++.||+.||.|||+. +|+||||||+|||++.+ +++||+|||+|.....
T Consensus 95 e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~-g~vkL~DFG~a~~~~~--- 167 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEH-GHVHITDFNIAAMLPR--- 167 (384)
T ss_dssp CCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT-SCEEECCCTTCEECCT---
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCC-CCEEEeccceeeeccC---
Confidence 999 6799999964 78899999999999999999999 99999999999999998 7999999999975432
Q ss_pred cccCccccccccCCCccccccccC---CCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 403 VSENVKPVNVVGTFGYLAPEYMMY---GKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 403 ~~~~~~~~~~~GT~~y~APE~~~~---~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
.......+||+.|+|||++.. ..|+.++|||||||++|||++|+.||.....
T Consensus 168 ---~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~ 222 (384)
T 4fr4_A 168 ---ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS 222 (384)
T ss_dssp ---TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTT
T ss_pred ---CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCC
Confidence 223346789999999999873 4689999999999999999999999986544
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=324.46 Aligned_cols=211 Identities=43% Similarity=0.727 Sum_probs=185.7
Q ss_pred CccccCHHHHhhhhcCCCCceeecccCceEEEEEEecCCcEEEEEEeccCCc--cHHHHHHHHHHHhcCCCCCeeeEEEE
Q 011660 238 SSRRFTSQELCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGY 315 (480)
Q Consensus 238 ~~~~~~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~ 315 (480)
....|+..++....++|.+.+.||+|+||.||+|...+++.||+|+++.... ....+.+|+++++.++||||++++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 4567899999999999999999999999999999887899999999975432 22368899999999999999999999
Q ss_pred EecCCeeEEEEecc-CCCHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceE
Q 011660 316 CHSKEMYAIVYNLL-NGSLKQYLKQ-------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQ 387 (480)
Q Consensus 316 ~~~~~~~~lV~e~~-~GsL~~~l~~-------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~k 387 (480)
+.+.+..++||||+ +|+|.+++.. +++..+..++.|++.||.|||+.+..+|+||||||+|||++.+ +.+|
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~-~~~k 174 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEE-FEAV 174 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTT-CCEE
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCC-CCEE
Confidence 99999999999999 6799999964 7888999999999999999999877799999999999999998 6899
Q ss_pred EeeeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCC
Q 011660 388 LSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQ 453 (480)
Q Consensus 388 L~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~ 453 (480)
|+|||++....... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 175 l~Dfg~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 175 VGDFGLAKLMDYKD----THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp ECCCSSCEECCSSS----SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred eccCccccccCccc----ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence 99999997643321 122234569999999999998999999999999999999999999996
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=328.54 Aligned_cols=198 Identities=27% Similarity=0.402 Sum_probs=175.0
Q ss_pred hhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc-------cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCe
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW-------SEEEVLREVELLSSIKHENIVRIIGYCHSKEM 321 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~-------~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 321 (480)
+.++|.+.+.||+|+||.||++.+ .+|+.||+|++++... ..+.+.+|+.+|+.++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 456799999999999999999977 4689999999976532 24678999999999999999999999999999
Q ss_pred eEEEEecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCC---ceEEeeeccc
Q 011660 322 YAIVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFH---HPQLSDFGAA 394 (480)
Q Consensus 322 ~~lV~e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~---~~kL~DFGla 394 (480)
+++||||+ +|+|.+++.. +++.++..++.||+.||.|||+. +|+||||||+|||++.+.. .+||+|||++
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 99999999 7899999954 78999999999999999999999 9999999999999987732 7999999999
Q ss_pred cccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 395 MVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
...... ......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+
T Consensus 167 ~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~ 222 (361)
T 2yab_A 167 HEIEDG------VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 222 (361)
T ss_dssp EECCTT------CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred eEcCCC------CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 754331 22345689999999999999999999999999999999999999998754
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=324.39 Aligned_cols=221 Identities=38% Similarity=0.644 Sum_probs=186.5
Q ss_pred cCHHHHhhhhcCCCCceeecccCceEEEEEEecCCcEEEEEEeccCCc-cHHHHHHHHHHHhcCCCCCeeeEEEEEecCC
Q 011660 242 FTSQELCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNW-SEEEVLREVELLSSIKHENIVRIIGYCHSKE 320 (480)
Q Consensus 242 ~~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 320 (480)
++..++...+++|.+.+.||+|+||.||+|...+++.||+|++..... ..+.+.+|+++++.++||||+++++++.+.+
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 444556667889999999999999999999988899999999876543 3467899999999999999999999999999
Q ss_pred eeEEEEecc-CCCHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeec
Q 011660 321 MYAIVYNLL-NGSLKQYLK-------QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFG 392 (480)
Q Consensus 321 ~~~lV~e~~-~GsL~~~l~-------~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFG 392 (480)
.+++||||+ +|+|.+++. .+++.++..++.|++.||.|||+. +|+||||||+||+++.+ +.+||+|||
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~-~~~kl~Dfg 184 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDEN-FVPKITDFG 184 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTT-CCEEECCCT
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCC-CCEEEeecc
Confidence 999999999 679999884 378899999999999999999999 99999999999999998 689999999
Q ss_pred cccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc-cchhHHHHHHHH
Q 011660 393 AAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA-NRESLVLWYYVL 469 (480)
Q Consensus 393 la~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~-~~e~l~~~~~~~ 469 (480)
++....... .........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....+..|....
T Consensus 185 ~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~ 259 (321)
T 2qkw_B 185 ISKKGTELD---QTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES 259 (321)
T ss_dssp TCEECSSSS---CCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHH
T ss_pred ccccccccc---ccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhc
Confidence 997543211 11222345699999999999999999999999999999999999999987654 333455554433
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=323.74 Aligned_cols=193 Identities=29% Similarity=0.414 Sum_probs=172.5
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCC----ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 326 (480)
++|++.+.||+|+||.||++.. .+|+.||+|++++.. ...+.+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 5699999999999999999977 469999999997532 23466789999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccc
Q 011660 327 NLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 327 e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (480)
||+ +|+|.+++.. +++..+..++.||+.||.|||+. +|+||||||+|||++.+ +++||+|||+++....
T Consensus 86 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~-g~~kL~Dfg~a~~~~~--- 158 (318)
T 1fot_A 86 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKN-GHIKITDFGFAKYVPD--- 158 (318)
T ss_dssp CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTT-SCEEECCCSSCEECSS---
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCC-CCEEEeecCcceecCC---
Confidence 999 6799999954 78899999999999999999999 99999999999999998 7999999999965332
Q ss_pred cccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 403 ~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 159 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 207 (318)
T 1fot_A 159 -----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN 207 (318)
T ss_dssp -----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred -----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence 2235689999999999999999999999999999999999999998754
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=332.17 Aligned_cols=195 Identities=23% Similarity=0.346 Sum_probs=171.3
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCcc----HHHHHHHHHHHhcC-CCCCeeeEEEEEecCCeeEEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS----EEEVLREVELLSSI-KHENIVRIIGYCHSKEMYAIV 325 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~----~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV 325 (480)
++|++.+.||+|+||+||++.+ .+++.||+|++++.... ...+.+|..++..+ +||||+++++++.+.+.+++|
T Consensus 52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV 131 (396)
T 4dc2_A 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 131 (396)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence 5699999999999999999977 45889999999764322 23478899999876 899999999999999999999
Q ss_pred Eecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccc
Q 011660 326 YNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (480)
Q Consensus 326 ~e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (480)
|||+ +|+|..++.. +++..+..++.||+.||.|||+. +|+||||||+|||++.+ +++||+|||+|+....
T Consensus 132 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~-g~ikL~DFGla~~~~~-- 205 (396)
T 4dc2_A 132 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLR-- 205 (396)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTT-SCEEECCCTTCBCCCC--
T ss_pred EEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCC-CCEEEeecceeeeccc--
Confidence 9999 6799998853 88999999999999999999999 99999999999999998 7999999999964221
Q ss_pred ccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 011660 402 QVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTN 455 (480)
Q Consensus 402 ~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~ 455 (480)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 206 ---~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~ 256 (396)
T 4dc2_A 206 ---PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 256 (396)
T ss_dssp ---TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTT
T ss_pred ---CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence 222344678999999999999999999999999999999999999999754
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=319.19 Aligned_cols=218 Identities=28% Similarity=0.474 Sum_probs=178.2
Q ss_pred hhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCC------ccHHHHHHHHHHHhcCC---CCCeeeEEEEEecC
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN------WSEEEVLREVELLSSIK---HENIVRIIGYCHSK 319 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~------~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~ 319 (480)
+.++|++.+.||+|+||.||+|.+ .+++.||+|+++... .....+.+|+.+++.++ ||||+++++++.+.
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 457899999999999999999986 568999999986432 12356778888877764 99999999999765
Q ss_pred C-----eeEEEEeccCCCHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEe
Q 011660 320 E-----MYAIVYNLLNGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLS 389 (480)
Q Consensus 320 ~-----~~~lV~e~~~GsL~~~l~~-----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~ 389 (480)
. .+++|||+++|+|.+++.. +++.++..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~-~~~kl~ 162 (308)
T 3g33_A 87 RTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSG-GTVKLA 162 (308)
T ss_dssp CSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTT-SCEEEC
T ss_pred CCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCC-CCEEEe
Confidence 4 5899999999999999964 78899999999999999999999 99999999999999998 689999
Q ss_pred eeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHH
Q 011660 390 DFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWYYVL 469 (480)
Q Consensus 390 DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~~~e~l~~~~~~~ 469 (480)
|||++..... .......+||+.|+|||++.+..++.++|||||||++|||++|++||...... + ........
T Consensus 163 Dfg~a~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~-~~~~i~~~ 234 (308)
T 3g33_A 163 DFGLARIYSY------QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA-D-QLGKIFDL 234 (308)
T ss_dssp SCSCTTTSTT------CCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH-H-HHHHHHHH
T ss_pred eCccccccCC------CcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH-H-HHHHHHHH
Confidence 9999965432 22234568999999999999999999999999999999999999999876532 2 22223344
Q ss_pred hCCCCCCCCC
Q 011660 470 AGKVFAQQWP 479 (480)
Q Consensus 470 ~~~~~~~~~~ 479 (480)
.+.+..+.||
T Consensus 235 ~~~~~~~~~~ 244 (308)
T 3g33_A 235 IGLPPEDDWP 244 (308)
T ss_dssp HCCCCTTTSC
T ss_pred hCCCChhhcc
Confidence 5555556664
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=330.07 Aligned_cols=198 Identities=18% Similarity=0.220 Sum_probs=171.1
Q ss_pred hhcCCCCceeecccCceEEEEEE------ecCCcEEEEEEeccCCccHHHHHHHHHHHhcCC---CCCeeeEEEEEecCC
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTN------HVDGQVAAVKVLKCTNWSEEEVLREVELLSSIK---HENIVRIIGYCHSKE 320 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~------~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~ 320 (480)
..++|.+.+.||+|+||.||+|. ..+++.||+|+++.. ...++..|+++++.++ |+||+++++++...+
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~ 140 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN 140 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC--CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence 45679999999999999999993 456889999999754 3567888888888887 999999999999999
Q ss_pred eeEEEEecc-CCCHHHHHH--------hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEec----------
Q 011660 321 MYAIVYNLL-NGSLKQYLK--------QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSE---------- 381 (480)
Q Consensus 321 ~~~lV~e~~-~GsL~~~l~--------~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~---------- 381 (480)
..++||||+ +|+|.+++. .+++.++..++.||+.||.|||+. +||||||||+|||++.
T Consensus 141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~ 217 (365)
T 3e7e_A 141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDD 217 (365)
T ss_dssp CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC-----
T ss_pred CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCcccccc
Confidence 999999999 689999995 288899999999999999999998 9999999999999988
Q ss_pred -CCCceEEeeeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 382 -NFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 382 -~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
+ +.+||+|||+|+..... .........+||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 218 ~~-~~~kl~DFG~a~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 289 (365)
T 3e7e_A 218 LS-AGLALIDLGQSIDMKLF---PKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNE 289 (365)
T ss_dssp -C-TTEEECCCTTCEEGGGS---CTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEE
T ss_pred cc-CCEEEeeCchhhhhhcc---CCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCC
Confidence 6 68999999999654321 12223345689999999999999999999999999999999999999986543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=323.24 Aligned_cols=198 Identities=20% Similarity=0.283 Sum_probs=175.4
Q ss_pred hhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEec
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~ 328 (480)
+.++|.+.+.||+|+||.||++.+ .+++.+|+|+++........+.+|+.+++.++||||+++++++.+.+.+++||||
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 456899999999999999999976 4689999999987665666788999999999999999999999999999999999
Q ss_pred c-CCCHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecC-CCceEEeeeccccccccccc
Q 011660 329 L-NGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN-FHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 329 ~-~GsL~~~l~----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~-~~~~kL~DFGla~~~~~~~~ 402 (480)
+ +|+|.+++. .+++.++..++.|++.||.|||+. +|+||||||+|||++.+ .+.+||+|||++......
T Consensus 83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~-- 157 (321)
T 1tki_A 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-- 157 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT--
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC--
Confidence 9 569999995 378899999999999999999999 99999999999999862 268999999999764332
Q ss_pred cccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 403 ~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 158 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 207 (321)
T 1tki_A 158 ----DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET 207 (321)
T ss_dssp ----CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ----CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC
Confidence 12335679999999999999889999999999999999999999998754
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=338.03 Aligned_cols=207 Identities=23% Similarity=0.328 Sum_probs=177.4
Q ss_pred CHHHHhhhhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc----cHHHHHHHHHHHhcCCCCCeeeEEEEEe
Q 011660 243 TSQELCHLTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLREVELLSSIKHENIVRIIGYCH 317 (480)
Q Consensus 243 ~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~----~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 317 (480)
..++.....++|++.+.||+|+||+||++.+ .+++.||+|++++... ....+.+|..++..++||||++++++++
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 3445555678899999999999999999987 4699999999975321 1234788999999999999999999999
Q ss_pred cCCeeEEEEecc-CCCHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeec
Q 011660 318 SKEMYAIVYNLL-NGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFG 392 (480)
Q Consensus 318 ~~~~~~lV~e~~-~GsL~~~l~----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFG 392 (480)
+.+.+++||||+ +|+|.+++. .+++..+..++.||+.||.|||++ +||||||||+|||++.+ +++||+|||
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~-g~vkL~DFG 207 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRC-GHIRLADFG 207 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT-SCEEECCCT
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCC-CCEEEeech
Confidence 999999999999 789999995 378889999999999999999999 99999999999999998 799999999
Q ss_pred cccccccccccccCccccccccCCCcccccccc-------CCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 393 AAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMM-------YGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 393 la~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-------~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
+|+...... .......+||+.|+|||++. ...|+.++|||||||++|||++|+.||...+.
T Consensus 208 la~~~~~~~----~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~ 275 (412)
T 2vd5_A 208 SCLKLRADG----TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST 275 (412)
T ss_dssp TCEECCTTS----CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred hheeccCCC----ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH
Confidence 997543321 11223568999999999987 45789999999999999999999999987653
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=326.62 Aligned_cols=197 Identities=24% Similarity=0.386 Sum_probs=173.6
Q ss_pred hcCCCCceeecccCceEEEEEEec-CCcEEEEEEeccC----CccHHHHHHHHHHHhcC-CCCCeeeEEEEEecCCeeEE
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCT----NWSEEEVLREVELLSSI-KHENIVRIIGYCHSKEMYAI 324 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~----~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~l 324 (480)
.++|.+.+.||+|+||+||++.+. +++.||+|++++. ....+.+..|..++..+ +||||+++++++++.+.+++
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 357999999999999999999875 4889999999753 23346688999999988 89999999999999999999
Q ss_pred EEecc-CCCHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccc
Q 011660 325 VYNLL-NGSLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (480)
Q Consensus 325 V~e~~-~GsL~~~l~---~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (480)
||||+ +|+|.+++. .+++.++..++.||+.||.|||+. +|+||||||+|||++.+ +++||+|||+|+....
T Consensus 99 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~-g~vkL~DFG~a~~~~~- 173 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSE-GHIKIADFGMCKENIW- 173 (353)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTT-SCEEECCCTTCBCCCC-
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCC-CcEEEEeCCccccccc-
Confidence 99999 679999985 488999999999999999999999 99999999999999998 7999999999964221
Q ss_pred cccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 401 ~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 174 ----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~ 225 (353)
T 2i0e_A 174 ----DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 225 (353)
T ss_dssp ----TTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ----CCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC
Confidence 1223446789999999999999999999999999999999999999998754
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=327.51 Aligned_cols=207 Identities=27% Similarity=0.367 Sum_probs=182.1
Q ss_pred ccccCHHHHhhhhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCccHHHHHHHHHHHhcCC-----CCCeeeE
Q 011660 239 SRRFTSQELCHLTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIK-----HENIVRI 312 (480)
Q Consensus 239 ~~~~~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~-----HpnIv~l 312 (480)
...++.++...+.++|.+.+.||+|+||.||+|.+ .+++.||+|+++........+..|+++++.+. ||||+++
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~ 101 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKY 101 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence 34566666677788999999999999999999977 56899999999865555567888999999886 9999999
Q ss_pred EEEEecCCeeEEEEeccCCCHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEec------
Q 011660 313 IGYCHSKEMYAIVYNLLNGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSE------ 381 (480)
Q Consensus 313 ~~~~~~~~~~~lV~e~~~GsL~~~l~~-----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~------ 381 (480)
++++...+.+++||||++++|.+++.. +++.++..++.||+.||.|||+. +|+||||||+|||++.
T Consensus 102 ~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~ 178 (360)
T 3llt_A 102 HGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKS 178 (360)
T ss_dssp EEEEEETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEE
T ss_pred cceeeECCeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEcccccccc
Confidence 999999999999999999999999954 77889999999999999999999 9999999999999974
Q ss_pred -------------------CCCceEEeeeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHH
Q 011660 382 -------------------NFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVL 442 (480)
Q Consensus 382 -------------------~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil 442 (480)
+ +.+||+|||+|..... ......||+.|+|||++.+..++.++|||||||++
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~-~~~kl~DFG~a~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 249 (360)
T 3llt_A 179 LITVRRVTDGKKIQIYRTKS-TGIKLIDFGCATFKSD--------YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVL 249 (360)
T ss_dssp EEEEECTTTCCEEEEEEESC-CCEEECCCTTCEETTS--------CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHH
T ss_pred ccchhcccccccccccccCC-CCEEEEeccCceecCC--------CCcCccCcccccCcHHHcCCCCCCccchHHHHHHH
Confidence 4 6899999999965332 12356799999999999999999999999999999
Q ss_pred HHHHcCCCCCCCCcc
Q 011660 443 LELITGKEAIQTNKA 457 (480)
Q Consensus 443 ~eLltG~~pf~~~~~ 457 (480)
|||++|+.||...+.
T Consensus 250 ~ell~g~~pf~~~~~ 264 (360)
T 3llt_A 250 AELYTGSLLFRTHEH 264 (360)
T ss_dssp HHHHHSSCSCCCSSH
T ss_pred HHHHHCCCCCCCCcH
Confidence 999999999987653
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=318.14 Aligned_cols=202 Identities=29% Similarity=0.487 Sum_probs=172.2
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCC-ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEec
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN-WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~ 328 (480)
.++|.+.+.||+|+||.||++.+ .+++.+|+|++.... ...+.+.+|+++++.++||||+++++++.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 35689999999999999999977 468999999886543 2345688999999999999999999999999999999999
Q ss_pred c-CCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccc
Q 011660 329 L-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (480)
Q Consensus 329 ~-~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (480)
+ +|+|.+++.. +++.++..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||++.........
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVREN-KNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTT-SCEEECCCTTCEECC-----
T ss_pred cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCC-CCEEEeecccceeccccccc
Confidence 9 6799999964 78899999999999999999999 99999999999999998 68999999999765432211
Q ss_pred cc---------CccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 404 SE---------NVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 404 ~~---------~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.. .......+||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~ 226 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYL 226 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTS
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchh
Confidence 11 111225689999999999999999999999999999999999999997654
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=325.92 Aligned_cols=194 Identities=23% Similarity=0.341 Sum_probs=173.5
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCC----ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEE
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 325 (480)
.++|++.+.||+|+||.||++.+ .+|+.||+|++++.. ...+.+.+|+++++.++||||+++++++.+.+.+++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 35799999999999999999987 469999999996532 2346788999999999999999999999999999999
Q ss_pred Eecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccc
Q 011660 326 YNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (480)
Q Consensus 326 ~e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (480)
|||+ +|+|.+++.. +++.++..++.||+.||.|||+. +|+||||||+|||++.+ +++||+|||+++....
T Consensus 120 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~-g~~kL~DFg~a~~~~~-- 193 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKG-- 193 (350)
T ss_dssp EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT-SCEEECCCTTCEECSS--
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCC-CCEEEcccccceeccC--
Confidence 9999 6899999954 78999999999999999999999 99999999999999998 7999999999965432
Q ss_pred ccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 402 QVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 402 ~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 194 ------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 242 (350)
T 1rdq_E 194 ------RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242 (350)
T ss_dssp ------CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ------CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC
Confidence 1235689999999999999999999999999999999999999998754
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=324.07 Aligned_cols=196 Identities=24% Similarity=0.365 Sum_probs=172.9
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCC----ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEE
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 325 (480)
..+|.+.+.||+|+||.||+|.+ .+++.||+|++.+.. .....+.+|+++++.++||||+++++++.+.+.+++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 35799999999999999999987 678999999986432 2235688999999999999999999999999999999
Q ss_pred EeccCCCHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccc
Q 011660 326 YNLLNGSLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 326 ~e~~~GsL~~~l~---~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (480)
|||++|+|.+++. .+++.++..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||++......
T Consensus 88 ~E~~~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~-~~~kl~DFG~s~~~~~~-- 161 (336)
T 3h4j_B 88 IEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDN-LNVKIADFGLSNIMTDG-- 161 (336)
T ss_dssp ECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTT-CCEEECCSSCTBTTTTS--
T ss_pred EECCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCC-CCEEEEEeccceeccCC--
Confidence 9999999999884 488999999999999999999999 99999999999999998 68999999999654332
Q ss_pred cccCccccccccCCCccccccccCCCC-CchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 403 VSENVKPVNVVGTFGYLAPEYMMYGKV-DEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 403 ~~~~~~~~~~~GT~~y~APE~~~~~~~-~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
......+||+.|+|||++.+..+ ++++|||||||++|||++|+.||....
T Consensus 162 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~ 212 (336)
T 3h4j_B 162 ----NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF 212 (336)
T ss_dssp ----BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSS
T ss_pred ----cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCcc
Confidence 22345689999999999988876 789999999999999999999998653
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=324.66 Aligned_cols=194 Identities=24% Similarity=0.352 Sum_probs=171.1
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCcc----HHHHHHHHHHHhcC-CCCCeeeEEEEEecCCeeEEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS----EEEVLREVELLSSI-KHENIVRIIGYCHSKEMYAIV 325 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~----~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV 325 (480)
++|++.+.||+|+||.||++.+ .+++.||+|++++.... .+.+.+|..+++.+ +||||+++++++.+.+.+++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 4699999999999999999987 45899999999765322 24578899999987 899999999999999999999
Q ss_pred Eecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccc
Q 011660 326 YNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (480)
Q Consensus 326 ~e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (480)
|||+ +|+|.+++.. +++.++..++.||+.||.|||+. +|+||||||+|||++.+ +++||+|||+|+....
T Consensus 89 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~-g~~kL~DFG~a~~~~~-- 162 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLR-- 162 (345)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTT-SCEEECCGGGCBCSCC--
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCC-CCEEEEeccccccccC--
Confidence 9999 6799999853 88999999999999999999999 99999999999999998 7999999999964222
Q ss_pred ccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 011660 402 QVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQT 454 (480)
Q Consensus 402 ~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~ 454 (480)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 163 ---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 212 (345)
T 3a8x_A 163 ---PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 212 (345)
T ss_dssp ---TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ---CCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence 12233467899999999999999999999999999999999999999975
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=326.24 Aligned_cols=199 Identities=26% Similarity=0.447 Sum_probs=171.5
Q ss_pred hcCCCCceeecccCceEEEEEEec--------CCcEEEEEEeccCCcc--HHHHHHHHHHHhcC-CCCCeeeEEEEEecC
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHV--------DGQVAAVKVLKCTNWS--EEEVLREVELLSSI-KHENIVRIIGYCHSK 319 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~--------~g~~vAvK~~~~~~~~--~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~ 319 (480)
.++|.+.+.||+|+||.||+|.+. ++..||+|+++..... .+.+.+|+.+++.+ +||||++++++|.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 357899999999999999999752 3567999999765432 34688999999999 899999999999999
Q ss_pred CeeEEEEecc-CCCHHHHHHh-------------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEE
Q 011660 320 EMYAIVYNLL-NGSLKQYLKQ-------------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILL 379 (480)
Q Consensus 320 ~~~~lV~e~~-~GsL~~~l~~-------------------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl 379 (480)
+.+++||||+ +|+|.+++.. +++.++..++.||+.||.|||+. +|+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEE
Confidence 9999999999 6799999954 57788999999999999999999 99999999999999
Q ss_pred ecCCCceEEeeeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 380 SENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 380 ~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
+.+ +.+||+|||+++....... ........||+.|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 237 ~~~-~~~kl~DFG~a~~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~ 310 (370)
T 2psq_A 237 TEN-NVMKIADFGLARDINNIDY---YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 310 (370)
T ss_dssp CTT-CCEEECCCSSCEETTCCCT---TCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred CCC-CCEEEccccCCcccCcccc---eecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 998 7899999999976543221 122234567899999999999999999999999999999999 999998764
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=321.86 Aligned_cols=217 Identities=25% Similarity=0.457 Sum_probs=176.3
Q ss_pred cCCCCceeecccCceEEEEEEec-CCcEEEEEEeccCCccH--HHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEec
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWSE--EEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~--~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~ 328 (480)
++|.+.+.||+|+||.||+|... +++.||+|+++...... ..+.+|+++++.++||||+++++++.+++.+++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 46899999999999999999774 68999999997544222 2356799999999999999999999999999999999
Q ss_pred cCCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccc
Q 011660 329 LNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (480)
Q Consensus 329 ~~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (480)
+.|+|.+++.. +++.++..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||++......
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~-~~~kl~Dfg~a~~~~~~---- 153 (324)
T 3mtl_A 82 LDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINER-GELKLADFGLARAKSIP---- 153 (324)
T ss_dssp CSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTT-CCEEECSSSEEECC-------
T ss_pred cccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCC-CCEEEccCcccccccCC----
Confidence 99999999854 78889999999999999999999 99999999999999998 68999999998653321
Q ss_pred cCccccccccCCCccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHhCCCCCCCCC
Q 011660 405 ENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWYYVLAGKVFAQQWP 479 (480)
Q Consensus 405 ~~~~~~~~~GT~~y~APE~~~~-~~~~~k~DvwSlGvil~eLltG~~pf~~~~~~~e~l~~~~~~~~~~~~~~~~~ 479 (480)
........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+. +..........+.+..+.||
T Consensus 154 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~ 226 (324)
T 3mtl_A 154 -TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV--EEQLHFIFRILGTPTEETWP 226 (324)
T ss_dssp ----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCCCCTTTST
T ss_pred -ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCChHhch
Confidence 122234578999999999876 5689999999999999999999999987653 22344455667777777776
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=322.55 Aligned_cols=204 Identities=23% Similarity=0.384 Sum_probs=173.6
Q ss_pred hhcCCCCceeecccCceEEEEEEec-CCcEEEEEEeccCCc--cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEE
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 326 (480)
+.++|++.+.||+|+||.||+|.+. +++.||+|++..... ..+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 3468999999999999999999764 789999999965432 2356889999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccc
Q 011660 327 NLL-NGSLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 327 e~~-~GsL~~~l~---~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (480)
||+ +|+|.+++. .+++.++..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||++.......
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~~~~~- 159 (323)
T 3tki_A 85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDER-DNLKISDFGLATVFRYNN- 159 (323)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTT-CCEEECCCTTCEECEETT-
T ss_pred EcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCC-CCEEEEEeeccceeccCC-
Confidence 999 568999885 478999999999999999999999 99999999999999998 689999999997543221
Q ss_pred cccCccccccccCCCccccccccCCCC-CchHHHHHHHHHHHHHHcCCCCCCCCcccch
Q 011660 403 VSENVKPVNVVGTFGYLAPEYMMYGKV-DEKIDVYSYGVVLLELITGKEAIQTNKANRE 460 (480)
Q Consensus 403 ~~~~~~~~~~~GT~~y~APE~~~~~~~-~~k~DvwSlGvil~eLltG~~pf~~~~~~~e 460 (480)
........+||+.|+|||++.+..+ +.++|||||||++|||++|+.||........
T Consensus 160 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 216 (323)
T 3tki_A 160 --RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ 216 (323)
T ss_dssp --EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH
T ss_pred --cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH
Confidence 1122335689999999999988776 7899999999999999999999987665433
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=316.29 Aligned_cols=200 Identities=27% Similarity=0.440 Sum_probs=169.4
Q ss_pred hhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCcc----HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEE
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS----EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAI 324 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~----~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 324 (480)
+.++|++.+.||+|+||.||++.+ .+++.+|+|++...... .+.+.+|+.+++.++||||+++++++.+++.+++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 346799999999999999999976 56899999998654322 2467899999999999999999999999999999
Q ss_pred EEecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccc
Q 011660 325 VYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (480)
Q Consensus 325 V~e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (480)
||||+ +|+|.+++.. +++.++..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||++......
T Consensus 89 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSN-KTLKIFDFGIAKALSET 164 (294)
T ss_dssp EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTT-SCEEECCCSSSTTC---
T ss_pred EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCC-CCEEEEeCCCccccccc
Confidence 99999 6699999854 78999999999999999999999 99999999999999998 78999999999654322
Q ss_pred cccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 401 ~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
. .......+||+.|+|||.+.+..++.++|||||||++|||++|+.||.....
T Consensus 165 ~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~ 217 (294)
T 4eqm_A 165 S----LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA 217 (294)
T ss_dssp --------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH
T ss_pred c----ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 1 1122346799999999999999999999999999999999999999987653
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=317.79 Aligned_cols=213 Identities=27% Similarity=0.418 Sum_probs=178.5
Q ss_pred hcCCCCceeecccCceEEEEEEec-CCcEEEEEEeccCC--ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCC--eeEEE
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTN--WSEEEVLREVELLSSIKHENIVRIIGYCHSKE--MYAIV 325 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--~~~lV 325 (480)
.++|.+.+.||+|+||.||+|... +++.||+|+++... ...+.+.+|+++++.++||||+++++++.+.+ .+++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 457999999999999999999774 58999999997543 23467889999999999999999999997655 78999
Q ss_pred Eecc-CCCHHHHHHh------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEE----ecCCCceEEeeeccc
Q 011660 326 YNLL-NGSLKQYLKQ------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILL----SENFHHPQLSDFGAA 394 (480)
Q Consensus 326 ~e~~-~GsL~~~l~~------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl----~~~~~~~kL~DFGla 394 (480)
|||+ +|+|.+++.. +++.++..++.|++.||.|||+. +|+||||||+|||+ +.+ +.+||+|||++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~-~~~kL~Dfg~a 163 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQ-SVYKLTDFGAA 163 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSC-EEEEECCCTTC
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCC-ceEEEccCCCc
Confidence 9999 6899999964 88999999999999999999999 99999999999998 555 57999999999
Q ss_pred cccccccccccCccccccccCCCcccccccc--------CCCCCchHHHHHHHHHHHHHHcCCCCCCCCcccchhHHHHH
Q 011660 395 MVHHQSHQVSENVKPVNVVGTFGYLAPEYMM--------YGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWY 466 (480)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~--------~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~~~e~l~~~~ 466 (480)
+..... .......||+.|+|||++. +..++.++|||||||++|||++|+.||..............
T Consensus 164 ~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 237 (319)
T 4euu_A 164 RELEDD------EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237 (319)
T ss_dssp EECCTT------CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHH
T ss_pred eecCCC------CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHH
Confidence 764332 1223457999999999886 57889999999999999999999999987665444444555
Q ss_pred HHHhCCC
Q 011660 467 YVLAGKV 473 (480)
Q Consensus 467 ~~~~~~~ 473 (480)
+.+.+.+
T Consensus 238 ~~~~~~p 244 (319)
T 4euu_A 238 KIITGKP 244 (319)
T ss_dssp HHHHHCC
T ss_pred HHhcCCC
Confidence 5555543
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=320.53 Aligned_cols=196 Identities=27% Similarity=0.412 Sum_probs=164.4
Q ss_pred cCCCCceeecccCceEEEEEEe----cCCcEEEEEEeccCCc-----cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCee
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH----VDGQVAAVKVLKCTNW-----SEEEVLREVELLSSIKHENIVRIIGYCHSKEMY 322 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~----~~g~~vAvK~~~~~~~-----~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 322 (480)
++|++.+.||+|+||.||++.. .+++.+|+|++++... ....+.+|+.+++.++||||+++++++.+.+.+
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 5699999999999999999976 4689999999976532 234577899999999999999999999999999
Q ss_pred EEEEecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccc
Q 011660 323 AIVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (480)
Q Consensus 323 ~lV~e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~ 398 (480)
++||||+ +|+|.+++.. +.+.++..++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||+++...
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~-~~~kl~Dfg~~~~~~ 172 (327)
T 3a62_A 97 YLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQ-GHVKLTDFGLCKESI 172 (327)
T ss_dssp EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTT-SCEEECCCSCC----
T ss_pred EEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCC-CcEEEEeCCcccccc
Confidence 9999999 5789999854 78889999999999999999999 99999999999999998 789999999986432
Q ss_pred cccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 399 QSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 399 ~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.. .......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 173 ~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 225 (327)
T 3a62_A 173 HD-----GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN 225 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cC-----CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC
Confidence 21 122335689999999999999999999999999999999999999998754
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=318.08 Aligned_cols=196 Identities=26% Similarity=0.395 Sum_probs=173.3
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc-------cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCee
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW-------SEEEVLREVELLSSIKHENIVRIIGYCHSKEMY 322 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~-------~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 322 (480)
.++|.+.+.||+|+||.||++.. .+++.+|+|+++.... ..+.+.+|+.+|+.++||||+++++++.+.+.+
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 45699999999999999999977 4689999999975432 356789999999999999999999999999999
Q ss_pred EEEEecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCC----ceEEeeeccc
Q 011660 323 AIVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFH----HPQLSDFGAA 394 (480)
Q Consensus 323 ~lV~e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~----~~kL~DFGla 394 (480)
++||||+ +|+|.+++.. +++.++..++.|++.||.|||+. +|+||||||+|||++.+ + .+||+|||++
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~-~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDR-NVPKPRIKIIDFGLA 165 (326)
T ss_dssp EEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCS-SSSSCCEEECCCTTC
T ss_pred EEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecC-CCCCCCEEEEECCCC
Confidence 9999999 6799999954 78899999999999999999999 99999999999999877 4 7999999999
Q ss_pred cccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 395 MVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
...... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 166 ~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 221 (326)
T 2y0a_A 166 HKIDFG------NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 221 (326)
T ss_dssp EECCTT------SCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred eECCCC------CccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC
Confidence 754321 12235679999999999999999999999999999999999999997654
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=324.11 Aligned_cols=198 Identities=26% Similarity=0.430 Sum_probs=172.8
Q ss_pred hhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCccH---HHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEE
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSE---EEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~~---~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 325 (480)
+.++|.+.+.||+|+||.||+|.+ .+++.||+|+++...... +.+.+|+.+++.++||||+++++++.+++.+++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 346799999999999999999976 568999999997655433 4578999999999999999999999999999999
Q ss_pred Eecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCC--CceEEeeecccccccc
Q 011660 326 YNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENF--HHPQLSDFGAAMVHHQ 399 (480)
Q Consensus 326 ~e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~--~~~kL~DFGla~~~~~ 399 (480)
|||+ +|+|.+++.. +++.++..++.||+.||.|||+. +|+||||||+|||++.+. +.+||+|||++.....
T Consensus 107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~ 183 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183 (362)
T ss_dssp ECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence 9999 5799999853 78899999999999999999999 999999999999998642 3599999999965432
Q ss_pred ccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 400 SHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 400 ~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
. ......+||+.|+|||++.+..++.++|||||||++|||++|++||...+
T Consensus 184 ~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~ 234 (362)
T 2bdw_A 184 S------EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 234 (362)
T ss_dssp C------CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred C------cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 1 12235689999999999999999999999999999999999999998654
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=318.66 Aligned_cols=199 Identities=32% Similarity=0.487 Sum_probs=166.1
Q ss_pred hhhcCCCCceeecccCceEEEEEEecCCcEEEEEEeccCCccH---HHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEE
Q 011660 249 HLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSE---EEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (480)
Q Consensus 249 ~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~---~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 325 (480)
...++|++.+.||+|+||.||+|.. +++.+|+|++....... +.+.+|++++++++||||+++++++.+.+.+++|
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV 112 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEE
T ss_pred CChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEE
Confidence 3456799999999999999999976 68899999997665433 4578999999999999999999999999999999
Q ss_pred Eecc-CCCHHHHHHh------CCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeccCCCCCEEEecCCCceEEeeeccccc
Q 011660 326 YNLL-NGSLKQYLKQ------LKWNERMDVAIGVAKALEYLHHTCDPP--IIHRDVKSSNILLSENFHHPQLSDFGAAMV 396 (480)
Q Consensus 326 ~e~~-~GsL~~~l~~------~~~~~~~~i~~~ia~aL~yLH~~~~~~--IiHrDlKp~NILl~~~~~~~kL~DFGla~~ 396 (480)
|||+ +|+|.+++.. +++..+..++.|++.||.|||+. + |+||||||+|||++.+ +.+||+|||+++.
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~-~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 113 TEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKK-YTVKVCDFGLSRL 188 (309)
T ss_dssp EECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTT-CCEEECCCC----
T ss_pred EecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCC-CcEEECCCCCCcc
Confidence 9999 6799999954 78889999999999999999998 8 9999999999999998 6899999999964
Q ss_pred cccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 397 HHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 397 ~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||...+.
T Consensus 189 ~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~ 244 (309)
T 3p86_A 189 KAST-----FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP 244 (309)
T ss_dssp ------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH
T ss_pred cccc-----ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 3321 1223356799999999999999999999999999999999999999987653
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=315.91 Aligned_cols=194 Identities=27% Similarity=0.430 Sum_probs=171.6
Q ss_pred CCCceeecccCceEEEEEEec-CCcEEEEEEeccCC-ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc-C
Q 011660 254 FSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTN-WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-N 330 (480)
Q Consensus 254 f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~-~ 330 (480)
|...+.||+|+||.||+|... +|+.||||++.... ...+.+.+|+.+++.++||||+++++++...+..++||||+ +
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 126 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG 126 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCC
Confidence 666778999999999999875 79999999997554 34567889999999999999999999999999999999999 6
Q ss_pred CCHHHHHHh--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccCcc
Q 011660 331 GSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVK 408 (480)
Q Consensus 331 GsL~~~l~~--~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~ 408 (480)
|+|.+++.. +++.++..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||++....... ..
T Consensus 127 ~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~-~~~kl~Dfg~~~~~~~~~-----~~ 197 (321)
T 2c30_A 127 GALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLD-GRVKLSDFGFCAQISKDV-----PK 197 (321)
T ss_dssp CBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT-CCEEECCCTTCEECCSSS-----CC
T ss_pred CCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCC-CcEEEeeeeeeeecccCc-----cc
Confidence 789999864 88999999999999999999999 99999999999999988 689999999986543311 12
Q ss_pred ccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 409 PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 409 ~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~ 245 (321)
T 2c30_A 198 RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS 245 (321)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 235679999999999999999999999999999999999999998654
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=327.71 Aligned_cols=196 Identities=29% Similarity=0.397 Sum_probs=164.9
Q ss_pred cCCCCceeecccCceEEEEEEec-CCcEEEEEEeccCCc----cHHHHHHHHHH-HhcCCCCCeeeEEEEEecCCeeEEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNW----SEEEVLREVEL-LSSIKHENIVRIIGYCHSKEMYAIV 325 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~----~~~~~~~Ei~i-l~~l~HpnIv~l~~~~~~~~~~~lV 325 (480)
++|++.+.||+|+||+||++.+. +++.||+|++++... ....+..|..+ ++.++||||+++++++.+.+.+++|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 46999999999999999999774 588999999976532 23456677777 5788999999999999999999999
Q ss_pred Eecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccc
Q 011660 326 YNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (480)
Q Consensus 326 ~e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (480)
|||+ +|+|.+++.. +.+.++..++.||+.||.|||++ +|+||||||+|||++.+ +++||+|||+++....
T Consensus 118 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~-g~ikL~DFG~a~~~~~-- 191 (373)
T 2r5t_A 118 LDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQ-GHIVLTDFGLCKENIE-- 191 (373)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTT-SCEEECCCCBCGGGBC--
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCC-CCEEEeeCcccccccc--
Confidence 9999 6799999854 78889999999999999999999 99999999999999998 7999999999964322
Q ss_pred ccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 402 QVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 402 ~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 192 ---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~ 243 (373)
T 2r5t_A 192 ---HNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 243 (373)
T ss_dssp ---CCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB
T ss_pred ---CCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 1223446789999999999999999999999999999999999999998754
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=323.17 Aligned_cols=197 Identities=27% Similarity=0.373 Sum_probs=170.9
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccC------CccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeE
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCT------NWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYA 323 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~------~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 323 (480)
.++|++.+.||+|+||.||+|.+ .+++.||+|+++.. ....+.+.+|+.+++.++||||+++++++.+++.++
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 35699999999999999999976 56899999998532 224577899999999999999999999999999999
Q ss_pred EEEecc-CCCHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCC--CceEEeeecc
Q 011660 324 IVYNLL-NGSLKQYLKQ-------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENF--HHPQLSDFGA 393 (480)
Q Consensus 324 lV~e~~-~GsL~~~l~~-------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~--~~~kL~DFGl 393 (480)
+||||+ +|+|.+++.. +++..+..++.||+.||.|||++ +|+||||||+|||++.+. ..+||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999 5789887742 78889999999999999999999 999999999999998652 2499999999
Q ss_pred ccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 011660 394 AMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTN 455 (480)
Q Consensus 394 a~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~ 455 (480)
+....... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 180 a~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 236 (351)
T 3c0i_A 180 AIQLGESG-----LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT 236 (351)
T ss_dssp CEECCTTS-----CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred eeEecCCC-----eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc
Confidence 97644321 1223567999999999999999999999999999999999999999874
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=309.43 Aligned_cols=199 Identities=23% Similarity=0.443 Sum_probs=177.2
Q ss_pred hcCCCCceeecccCceEEEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc-
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL- 329 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~- 329 (480)
.++|++.+.||+|+||.||++.+.+++.+|+|+++......+++.+|++++++++||||+++++++.+++.+++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 3578999999999999999999888999999999988777888999999999999999999999999999999999999
Q ss_pred CCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccccc
Q 011660 330 NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE 405 (480)
Q Consensus 330 ~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~ 405 (480)
+|+|.+++.. +++..+..++.|++.||.|||+. +|+||||||+||+++.+ +.+||+|||++.......
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~---- 160 (269)
T 4hcu_A 89 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQ---- 160 (269)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGG-GCEEECCTTGGGGBCCHH----
T ss_pred CCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCC-CCEEeccccccccccccc----
Confidence 6789999954 78899999999999999999999 99999999999999988 689999999997543321
Q ss_pred CccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCcc
Q 011660 406 NVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKA 457 (480)
Q Consensus 406 ~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~~ 457 (480)
........||+.|+|||++.+..++.++||||||+++|||++ |+.||.....
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~ 213 (269)
T 4hcu_A 161 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN 213 (269)
T ss_dssp HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH
Confidence 112234567889999999999999999999999999999999 9999987543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=322.54 Aligned_cols=199 Identities=26% Similarity=0.337 Sum_probs=164.7
Q ss_pred hcCCCCceeecccCceEEEEEEec-CCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~ 329 (480)
.++|.+.+.||+|+||.||++... +++.||+|++.......+.+.+|+.+++.++||||+++++++.+.+.+++||||+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 98 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA 98 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeC
Confidence 457999999999999999999774 7899999999877666678999999999999999999999999999999999999
Q ss_pred -CCCHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCC-CceEEeeeccccccccccccc
Q 011660 330 -NGSLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENF-HHPQLSDFGAAMVHHQSHQVS 404 (480)
Q Consensus 330 -~GsL~~~l~---~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~-~~~kL~DFGla~~~~~~~~~~ 404 (480)
+|+|.+++. .+++.++..++.|++.||.|||+. +|+||||||+|||++.+. +.+||+|||+++....
T Consensus 99 ~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~----- 170 (361)
T 3uc3_A 99 SGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL----- 170 (361)
T ss_dssp CSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC----------
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccc-----
Confidence 679999984 388999999999999999999999 999999999999998762 2499999999863221
Q ss_pred cCccccccccCCCccccccccCCCCCch-HHHHHHHHHHHHHHcCCCCCCCCccc
Q 011660 405 ENVKPVNVVGTFGYLAPEYMMYGKVDEK-IDVYSYGVVLLELITGKEAIQTNKAN 458 (480)
Q Consensus 405 ~~~~~~~~~GT~~y~APE~~~~~~~~~k-~DvwSlGvil~eLltG~~pf~~~~~~ 458 (480)
.......+||+.|+|||++.+..++.+ +|||||||++|||++|+.||......
T Consensus 171 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 224 (361)
T 3uc3_A 171 -HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 224 (361)
T ss_dssp -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----C
T ss_pred -cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccH
Confidence 122234579999999999988888655 99999999999999999999876543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=320.09 Aligned_cols=203 Identities=19% Similarity=0.262 Sum_probs=175.0
Q ss_pred hhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCccHHHHHHHHHHHhcC-CCCCeeeEEEEEecCCeeEEEEe
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSI-KHENIVRIIGYCHSKEMYAIVYN 327 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~e 327 (480)
+.++|.+.+.||+|+||.||+|.. .+++.||+|++.... ..+.+.+|+++++.+ +||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC-SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 346799999999999999999976 679999999997543 234688999999999 99999999999999999999999
Q ss_pred ccCCCHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCc-----eEEeeeccccccc
Q 011660 328 LLNGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHH-----PQLSDFGAAMVHH 398 (480)
Q Consensus 328 ~~~GsL~~~l~----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~-----~kL~DFGla~~~~ 398 (480)
|++|+|.+++. .+++.++..++.|++.||.|||+. +|+||||||+|||++.+ +. +||+|||+|+...
T Consensus 86 ~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~-~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 86 LLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRP-GNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCG-GGTCTTSEEECCCTTCEESB
T ss_pred eCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccC-CCCCCceEEEEEcccceeee
Confidence 99999999986 378999999999999999999999 99999999999999987 55 9999999997643
Q ss_pred ccccc--ccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 399 QSHQV--SENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 399 ~~~~~--~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
..... .........+||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~ 222 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKA 222 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccc
Confidence 32211 111123467899999999999999999999999999999999999999987643
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=320.10 Aligned_cols=201 Identities=30% Similarity=0.424 Sum_probs=170.6
Q ss_pred hcCCCCceeecccCceEEEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEEEecCC----eeEEEE
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKE----MYAIVY 326 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----~~~lV~ 326 (480)
.++|++.+.||+|+||.||+|... ++.||+|+++...........|+.+++.++||||+++++++.+.. .+++||
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~ 101 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT 101 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence 457999999999999999999874 799999999766555556778999999999999999999997643 479999
Q ss_pred ecc-CCCHHHHHHh--CCHHHHHHHHHHHHHHHHHHHhC-------CCCCeEeccCCCCCEEEecCCCceEEeeeccccc
Q 011660 327 NLL-NGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHT-------CDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMV 396 (480)
Q Consensus 327 e~~-~GsL~~~l~~--~~~~~~~~i~~~ia~aL~yLH~~-------~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~ 396 (480)
||+ +|+|.++++. +++.++..++.|++.||.|||+. +..+|+||||||+|||++.+ +.+||+|||+|+.
T Consensus 102 e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~-~~~kL~DFg~a~~ 180 (322)
T 3soc_A 102 AFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNN-LTACIADFGLALK 180 (322)
T ss_dssp ECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTT-CCEEECCCTTCEE
T ss_pred ecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCC-CeEEEccCCcccc
Confidence 999 6799999965 88999999999999999999975 23489999999999999998 6899999999976
Q ss_pred cccccccccCccccccccCCCccccccccC-----CCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 397 HHQSHQVSENVKPVNVVGTFGYLAPEYMMY-----GKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 397 ~~~~~~~~~~~~~~~~~GT~~y~APE~~~~-----~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
..... .........||+.|+|||++.+ ..++.++|||||||++|||+||+.||....
T Consensus 181 ~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~ 242 (322)
T 3soc_A 181 FEAGK---SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242 (322)
T ss_dssp ECTTS---CCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCC
T ss_pred ccccc---CccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCc
Confidence 54322 1122334679999999999886 356778999999999999999999998754
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=323.67 Aligned_cols=199 Identities=27% Similarity=0.386 Sum_probs=167.1
Q ss_pred hhcCCCCceeecccCceEEEEEEecCCcEEEEEEeccCCccH---HHHHHHHHHHhcCCC--CCeeeEEEEEecCCeeEE
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSE---EEVLREVELLSSIKH--ENIVRIIGYCHSKEMYAI 324 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~---~~~~~Ei~il~~l~H--pnIv~l~~~~~~~~~~~l 324 (480)
..++|++.+.||+|+||.||++...+++.||+|+++...... +.+.+|+.+|+.++| |||+++++++.+++.+++
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 345699999999999999999988889999999997654433 567899999999976 999999999999999999
Q ss_pred EEeccCCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccc
Q 011660 325 VYNLLNGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (480)
Q Consensus 325 V~e~~~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (480)
|||+.+|+|.+++.. +++.++..++.|++.||.|||+. +|+||||||+|||+++ +.+||+|||++.......
T Consensus 87 v~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~~--~~~kl~DFG~a~~~~~~~ 161 (343)
T 3dbq_A 87 VMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD--GMLKLIDFGIANQMQPDT 161 (343)
T ss_dssp EECCCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET--TEEEECCCSSSCCC----
T ss_pred EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEEC--CcEEEeecccccccCccc
Confidence 999889999999954 78889999999999999999999 9999999999999985 479999999997543321
Q ss_pred ccccCccccccccCCCccccccccC-----------CCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 402 QVSENVKPVNVVGTFGYLAPEYMMY-----------GKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 402 ~~~~~~~~~~~~GT~~y~APE~~~~-----------~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 162 ---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 224 (343)
T 3dbq_A 162 ---TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 224 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred ---ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh
Confidence 1122335679999999999865 678999999999999999999999998643
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=327.01 Aligned_cols=193 Identities=28% Similarity=0.398 Sum_probs=160.1
Q ss_pred hcCCCCc-eeecccCceEEEEEEe-cCCcEEEEEEeccCCccHHHHHHHHHHH-hcCCCCCeeeEEEEEec----CCeeE
Q 011660 251 THNFSPK-MLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELL-SSIKHENIVRIIGYCHS----KEMYA 323 (480)
Q Consensus 251 ~~~f~~~-~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ei~il-~~l~HpnIv~l~~~~~~----~~~~~ 323 (480)
.++|.+. +.||+|+||+||++.+ .+++.||+|+++. ...+.+|++++ +..+||||+++++++.. .+.++
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 3457665 6899999999999976 4689999999963 25677899887 45689999999998865 66789
Q ss_pred EEEecc-CCCHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEec---CCCceEEeeeccc
Q 011660 324 IVYNLL-NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSE---NFHHPQLSDFGAA 394 (480)
Q Consensus 324 lV~e~~-~GsL~~~l~~-----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~---~~~~~kL~DFGla 394 (480)
+||||+ +|+|.+++.. +++.++..++.||+.||.|||+. +|+||||||+|||++. + +.+||+|||++
T Consensus 136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~-~~~kl~DFG~a 211 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPN-AILKLTDFGFA 211 (400)
T ss_dssp EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTT-CCEEECCCTTC
T ss_pred EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCC-ccEEEEecccc
Confidence 999999 5799999954 78899999999999999999999 9999999999999987 5 68999999999
Q ss_pred cccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 395 MVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
+.... .......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.....
T Consensus 212 ~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 268 (400)
T 1nxk_A 212 KETTS------HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 268 (400)
T ss_dssp EECC-----------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTT
T ss_pred cccCC------CCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcc
Confidence 75332 1223456899999999999999999999999999999999999999987653
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=325.21 Aligned_cols=204 Identities=26% Similarity=0.428 Sum_probs=162.8
Q ss_pred hhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCcc---HHHHHHHHHHHhcCC-CCCeeeEEEEEecCC--ee
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIK-HENIVRIIGYCHSKE--MY 322 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~---~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~--~~ 322 (480)
+.++|++.+.||+|+||.||+|.+ .+++.||+|++...... ...+.+|+.+++.+. ||||+++++++...+ .+
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 457899999999999999999976 56999999998654322 345789999999997 999999999997543 78
Q ss_pred EEEEeccCCCHHHHHHh--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccc
Q 011660 323 AIVYNLLNGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (480)
Q Consensus 323 ~lV~e~~~GsL~~~l~~--~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (480)
++||||+.|+|.+++.. +.+..+..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 87 ~lv~e~~~~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~~ 162 (388)
T 3oz6_A 87 YLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAE-CHVKVADFGLSRSFVNI 162 (388)
T ss_dssp EEEEECCSEEHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTT-CCEEECCCTTCEESSSC
T ss_pred EEEecccCcCHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCC-CCEEecCCccccccccc
Confidence 99999999999999864 78888899999999999999999 99999999999999998 68999999999764321
Q ss_pred ccc----------------ccCccccccccCCCccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 401 HQV----------------SENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 401 ~~~----------------~~~~~~~~~~GT~~y~APE~~~~-~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
... .........+||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 236 (388)
T 3oz6_A 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST 236 (388)
T ss_dssp CCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 111 11122345689999999999986 6789999999999999999999999987653
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=329.43 Aligned_cols=199 Identities=24% Similarity=0.361 Sum_probs=171.7
Q ss_pred hhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCcc---HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEE
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 325 (480)
+.++|++.+.||+|+||.||+|.+ .+|+.+|+|++...... .+.+.+|+++++.++||||+++++++.+++.+++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 456799999999999999999976 57999999999766533 34578999999999999999999999999999999
Q ss_pred Eecc-CCCHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecC--CCceEEeeecccccccc
Q 011660 326 YNLL-NGSLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN--FHHPQLSDFGAAMVHHQ 399 (480)
Q Consensus 326 ~e~~-~GsL~~~l~---~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~--~~~~kL~DFGla~~~~~ 399 (480)
|||+ +|+|.+++. .+++.++..++.||+.||.|||+. +|+||||||+|||++.+ .+.+||+|||+|.....
T Consensus 89 ~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~ 165 (444)
T 3soa_A 89 FDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165 (444)
T ss_dssp ECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence 9999 679999885 378899999999999999999999 99999999999999842 26799999999965433
Q ss_pred ccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 400 SHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 400 ~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
. .......+||+.|+|||++.+..|+.++|||||||++|||++|++||...+
T Consensus 166 ~-----~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~ 217 (444)
T 3soa_A 166 E-----QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED 217 (444)
T ss_dssp T-----CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred C-----CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc
Confidence 2 122235689999999999999999999999999999999999999997654
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=306.40 Aligned_cols=199 Identities=25% Similarity=0.394 Sum_probs=177.2
Q ss_pred hcCCCCceeecccCceEEEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc-
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL- 329 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~- 329 (480)
.++|++.+.||+|+||.||++...++..+|+|+++......+.+.+|+++++.++||||+++++++.+.+.+++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYIS 86 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccC
Confidence 4679999999999999999999888889999999888777888999999999999999999999999999999999999
Q ss_pred CCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccccc
Q 011660 330 NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE 405 (480)
Q Consensus 330 ~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~ 405 (480)
+|+|.+++.. +++.++..++.|++.||.|||+. +|+||||||+||+++.+ +.++|+|||++........
T Consensus 87 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~-~~~~l~Dfg~~~~~~~~~~--- 159 (268)
T 3sxs_A 87 NGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRD-LCVKVSDFGMTRYVLDDQY--- 159 (268)
T ss_dssp TCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTT-CCEEECCTTCEEECCTTCE---
T ss_pred CCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCC-CCEEEccCccceecchhhh---
Confidence 6789999853 88999999999999999999999 99999999999999998 6899999999976443221
Q ss_pred CccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCcc
Q 011660 406 NVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKA 457 (480)
Q Consensus 406 ~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~~ 457 (480)
.......||+.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 160 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 211 (268)
T 3sxs_A 160 -VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN 211 (268)
T ss_dssp -EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred -hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh
Confidence 11234457788999999998899999999999999999999 9999986653
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=317.34 Aligned_cols=222 Identities=27% Similarity=0.449 Sum_probs=182.9
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc---cHHHHHHHHHHHhcCCCCCeeeEEEEEec--------
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVRIIGYCHS-------- 318 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-------- 318 (480)
.++|.+.+.||+|+||.||+|.. .+|+.||+|++..... ....+.+|+++++.++||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 35799999999999999999977 5789999999865432 23568899999999999999999999876
Q ss_pred CCeeEEEEeccCCCHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccc
Q 011660 319 KEMYAIVYNLLNGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA 394 (480)
Q Consensus 319 ~~~~~lV~e~~~GsL~~~l~----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla 394 (480)
.+.+++||||+.|+|.+.+. .+++.++..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||+|
T Consensus 96 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~-~~~kl~Dfg~a 171 (351)
T 3mi9_A 96 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRD-GVLKLADFGLA 171 (351)
T ss_dssp -CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT-SCEEECCCTTC
T ss_pred CceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCC-CCEEEccchhc
Confidence 45689999999999888884 378999999999999999999999 99999999999999998 68999999999
Q ss_pred cccccccccccCccccccccCCCccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHhCCC
Q 011660 395 MVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWYYVLAGKV 473 (480)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~-~~~~~k~DvwSlGvil~eLltG~~pf~~~~~~~e~l~~~~~~~~~~~ 473 (480)
........ ..........||+.|+|||++.+ ..++.++|||||||++|||++|++||..... .........+.+..
T Consensus 172 ~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~~~i~~~~~~~ 248 (351)
T 3mi9_A 172 RAFSLAKN-SQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE--QHQLALISQLCGSI 248 (351)
T ss_dssp EECCCCSS-SSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCCC
T ss_pred cccccccc-ccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCC
Confidence 76543221 12223345679999999999876 4589999999999999999999999987653 22333444566666
Q ss_pred CCCCCC
Q 011660 474 FAQQWP 479 (480)
Q Consensus 474 ~~~~~~ 479 (480)
..+.||
T Consensus 249 ~~~~~~ 254 (351)
T 3mi9_A 249 TPEVWP 254 (351)
T ss_dssp CTTTST
T ss_pred Chhhcc
Confidence 666665
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=314.65 Aligned_cols=199 Identities=27% Similarity=0.460 Sum_probs=165.1
Q ss_pred hcCCCCceeecccCceEEEEEEec-CCcEEEEEEeccCC--ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCC-------
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTN--WSEEEVLREVELLSSIKHENIVRIIGYCHSKE------- 320 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------- 320 (480)
.++|++.+.||+|+||.||+|.+. +++.||+|+++... ...+.+.+|++++++++||||++++++|.+.+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 456999999999999999999874 79999999997543 23467899999999999999999999985543
Q ss_pred --------------------------------------------------eeEEEEecc-CCCHHHHHHh------CCHH
Q 011660 321 --------------------------------------------------MYAIVYNLL-NGSLKQYLKQ------LKWN 343 (480)
Q Consensus 321 --------------------------------------------------~~~lV~e~~-~GsL~~~l~~------~~~~ 343 (480)
.+++||||+ +|+|.+++.. ..+.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 389999999 6799999964 4556
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccccc-------CccccccccCC
Q 011660 344 ERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE-------NVKPVNVVGTF 416 (480)
Q Consensus 344 ~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~-------~~~~~~~~GT~ 416 (480)
.+..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||++........... .......+||+
T Consensus 165 ~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~-~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTT-CCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCC-CCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 6889999999999999999 99999999999999988 6899999999976544321111 12234567999
Q ss_pred CccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCC
Q 011660 417 GYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQ 453 (480)
Q Consensus 417 ~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~ 453 (480)
.|+|||++.+..++.++|||||||++|||++|..|+.
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~ 277 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM 277 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh
Confidence 9999999999999999999999999999999988764
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=336.37 Aligned_cols=198 Identities=23% Similarity=0.386 Sum_probs=174.4
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCC----ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEE
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 325 (480)
.++|.+.+.||+|+||+||++.+ .+|+.||+|++++.. .....+.+|+++++.++||||+++++++.+.+.+++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 36799999999999999999987 469999999996532 2345688999999999999999999999999999999
Q ss_pred Eecc-CCCHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccc
Q 011660 326 YNLL-NGSLKQYLKQ-------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVH 397 (480)
Q Consensus 326 ~e~~-~GsL~~~l~~-------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~ 397 (480)
|||+ +|+|.+++.. +++..+..++.||+.||.|||+. +|+||||||+|||++.+ +++||+|||+++..
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~-g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDD-GNVRISDLGLAVEL 339 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTT-SCEEECCCTTCEEC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCC-CCEEEeecceeeec
Confidence 9999 6799999853 77888999999999999999999 99999999999999998 79999999999754
Q ss_pred ccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 398 HQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 398 ~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
.... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.....
T Consensus 340 ~~~~-----~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~ 394 (543)
T 3c4z_A 340 KAGQ-----TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGE 394 (543)
T ss_dssp CTTC-----CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTC
T ss_pred cCCC-----cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCcc
Confidence 3321 122346899999999999999999999999999999999999999987653
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=337.82 Aligned_cols=197 Identities=27% Similarity=0.404 Sum_probs=174.9
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccC----CccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEE
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCT----NWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 325 (480)
.++|.+.+.||+|+||.||+|.+ .+|+.||+|++++. ......+.+|+++|+.++||||+++++++.+.+.+++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 46799999999999999999977 46999999999653 22345688999999999999999999999999999999
Q ss_pred Eecc-CCCHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccc
Q 011660 326 YNLL-NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (480)
Q Consensus 326 ~e~~-~GsL~~~l~~-----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~ 399 (480)
|||+ +|+|.+++.. +++..+..++.||+.||.|||+. +||||||||+|||++.+ +++||+|||+|.....
T Consensus 263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~-g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDH-GHIRISDLGLAVHVPE 338 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTT-SCEEECCCTTCEECCT
T ss_pred EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCC-CCeEEEecccceeccc
Confidence 9999 7899999854 78899999999999999999999 99999999999999998 7999999999976433
Q ss_pred ccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 400 SHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 400 ~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
. ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.....
T Consensus 339 ~------~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~ 390 (576)
T 2acx_A 339 G------QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKK 390 (576)
T ss_dssp T------CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSS
T ss_pred C------ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCccccc
Confidence 2 122346899999999999999999999999999999999999999987654
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=311.35 Aligned_cols=212 Identities=29% Similarity=0.433 Sum_probs=171.0
Q ss_pred hhcCCCCceeecccCceEEEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhc--CCCCCeeeEEEEEec----CCeeE
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSS--IKHENIVRIIGYCHS----KEMYA 323 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~~~~~~----~~~~~ 323 (480)
+.++|.+.+.||+|+||.||+|.. +++.||+|++... ....+..|.+++.. ++||||+++++++.+ .+.++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR--DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc--cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 456799999999999999999987 7899999999754 34556677777766 899999999998643 35689
Q ss_pred EEEecc-CCCHHHHHHh--CCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEeccCCCCCEEEecCCCceEEeeec
Q 011660 324 IVYNLL-NGSLKQYLKQ--LKWNERMDVAIGVAKALEYLH--------HTCDPPIIHRDVKSSNILLSENFHHPQLSDFG 392 (480)
Q Consensus 324 lV~e~~-~GsL~~~l~~--~~~~~~~~i~~~ia~aL~yLH--------~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFG 392 (480)
+||||+ +|+|.++++. +++..+..++.|++.||.||| +. +|+||||||+|||++.+ +.+||+|||
T Consensus 83 lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~-~~~kl~Dfg 158 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKN-GQCCIADLG 158 (301)
T ss_dssp EEECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTT-SCEEECCCT
T ss_pred EehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCC-CCEEEeeCC
Confidence 999999 5799999964 788999999999999999999 66 99999999999999988 689999999
Q ss_pred cccccccccccccCccccccccCCCccccccccCC------CCCchHHHHHHHHHHHHHHcC----------CCCCCCCc
Q 011660 393 AAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYG------KVDEKIDVYSYGVVLLELITG----------KEAIQTNK 456 (480)
Q Consensus 393 la~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~------~~~~k~DvwSlGvil~eLltG----------~~pf~~~~ 456 (480)
+|+........ .........||+.|+|||++.+. .++.++|||||||++|||++| +.||....
T Consensus 159 ~a~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~ 237 (301)
T 3q4u_A 159 LAVMHSQSTNQ-LDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237 (301)
T ss_dssp TCEEEETTTTE-EECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred Ceeeccccccc-ccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence 99765432221 11122345799999999999876 456899999999999999999 89997765
Q ss_pred ccchhHHHHHHHH
Q 011660 457 ANRESLVLWYYVL 469 (480)
Q Consensus 457 ~~~e~l~~~~~~~ 469 (480)
........+.+..
T Consensus 238 ~~~~~~~~~~~~~ 250 (301)
T 3q4u_A 238 PNDPSFEDMRKVV 250 (301)
T ss_dssp CSSCCHHHHHHHH
T ss_pred CCCcchhhhhHHH
Confidence 5443333333333
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=315.14 Aligned_cols=194 Identities=24% Similarity=0.267 Sum_probs=163.5
Q ss_pred hcCCCCceeecccCceEEEEEEec-CCcEEEEEEeccCCccH---HHHHHHHHHHhc-CCCCCeeeEEEEEecCCeeEEE
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWSE---EEVLREVELLSS-IKHENIVRIIGYCHSKEMYAIV 325 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~---~~~~~Ei~il~~-l~HpnIv~l~~~~~~~~~~~lV 325 (480)
.++|++.+.||+|+||+||+|... +++.||||++....... .....|+..+.. .+||||++++++|.+++.+++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 367999999999999999999775 79999999987654333 234455555544 4999999999999999999999
Q ss_pred EeccCCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccc
Q 011660 326 YNLLNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (480)
Q Consensus 326 ~e~~~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (480)
|||++|+|.+++.. +++.++..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||++......
T Consensus 136 ~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~-~~~kl~DFG~a~~~~~~- 210 (311)
T 3p1a_A 136 TELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPR-GRCKLGDFGLLVELGTA- 210 (311)
T ss_dssp EECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGG-GCEEECCCTTCEECC---
T ss_pred EeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCC-CCEEEccceeeeecccC-
Confidence 99999999999854 89999999999999999999999 99999999999999998 68999999998654332
Q ss_pred ccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 011660 402 QVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTN 455 (480)
Q Consensus 402 ~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~ 455 (480)
.......||+.|+|||++.+ .++.++|||||||++|||++|..||...
T Consensus 211 -----~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~ 258 (311)
T 3p1a_A 211 -----GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG 258 (311)
T ss_dssp ---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH
T ss_pred -----CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 12234569999999998875 7999999999999999999998777553
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=336.58 Aligned_cols=198 Identities=23% Similarity=0.323 Sum_probs=167.7
Q ss_pred hhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc---cHHHHHHHHHHHhcCCCCCeeeEEEEEecC------
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVRIIGYCHSK------ 319 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------ 319 (480)
..++|++.+.||+|+||.||+|.+ .+++.||+|++..... ..+.+.+|+.+|+.++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 357899999999999999999976 5689999999975432 235678999999999999999999999654
Q ss_pred CeeEEEEeccCCCHHHHHH-hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccc
Q 011660 320 EMYAIVYNLLNGSLKQYLK-QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (480)
Q Consensus 320 ~~~~lV~e~~~GsL~~~l~-~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~ 398 (480)
..+++||||++|+|.+.+. .+++.++..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||+|+...
T Consensus 140 ~~~~lv~E~~~~~l~~~~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~-~~~kl~DFG~a~~~~ 215 (464)
T 3ttj_A 140 QDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSD-CTLKILDFGLARTAG 215 (464)
T ss_dssp CEEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTT-SCEEECCCCCC----
T ss_pred CeEEEEEeCCCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCC-CCEEEEEEEeeeecC
Confidence 4579999999988888875 488899999999999999999999 99999999999999998 689999999997543
Q ss_pred cccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 399 QSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 399 ~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
. .......+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.+.
T Consensus 216 ~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~ 268 (464)
T 3ttj_A 216 T------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY 268 (464)
T ss_dssp -------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred C------CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 2 2223456899999999999999999999999999999999999999987653
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=308.33 Aligned_cols=199 Identities=24% Similarity=0.438 Sum_probs=174.4
Q ss_pred hcCCCCceeecccCceEEEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc-
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL- 329 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~- 329 (480)
.++|++.+.||+|+||.||++.+.+++.+|+|+++......+.+.+|+++++.++||||+++++++.+.+.+++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 102 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 102 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCT
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccC
Confidence 3568999999999999999999888889999999988777888999999999999999999999999999999999999
Q ss_pred CCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccccc
Q 011660 330 NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE 405 (480)
Q Consensus 330 ~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~ 405 (480)
+|+|.+++.. +++.++..++.|++.||.|||+. +|+||||||+||+++.+ +.+||+|||++.......
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~-~~~kl~Dfg~~~~~~~~~---- 174 (283)
T 3gen_A 103 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQ-GVVKVSDFGLSRYVLDDE---- 174 (283)
T ss_dssp TCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTT-SCEEECSTTGGGGBCCHH----
T ss_pred CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCC-CCEEEccccccccccccc----
Confidence 6899999954 88999999999999999999999 99999999999999998 689999999997543321
Q ss_pred CccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCcc
Q 011660 406 NVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKA 457 (480)
Q Consensus 406 ~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~~ 457 (480)
........||+.|+|||++.+..++.++||||||+++|||++ |+.||.....
T Consensus 175 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~ 227 (283)
T 3gen_A 175 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN 227 (283)
T ss_dssp HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh
Confidence 112234457889999999999999999999999999999998 9999987653
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=331.96 Aligned_cols=201 Identities=22% Similarity=0.373 Sum_probs=156.3
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCcc---HHHHHHHHHHHhcCCCCCeeeEEEEEe-----cCCe
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCH-----SKEM 321 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~~~~~-----~~~~ 321 (480)
.++|.+.+.||+|+||.||+|.+ .+++.||||++...... .+.+.+|+++|+.++||||+++++++. ..+.
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 46799999999999999999976 46899999999764333 356889999999999999999999984 3357
Q ss_pred eEEEEeccCCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccc
Q 011660 322 YAIVYNLLNGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (480)
Q Consensus 322 ~~lV~e~~~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~ 398 (480)
+|+||||++|+|.+++.. +++..+..++.||+.||.|||+. +||||||||+|||++.+ +.+||+|||+|+...
T Consensus 132 ~~lv~e~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~-~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 132 LYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQD-CSVKVCDFGLARTVD 207 (458)
T ss_dssp EEEEECCCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTT-CCEEECCCTTCBCTT
T ss_pred EEEEEeccccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCC-CCEeecccccchhcc
Confidence 899999999999999964 78899999999999999999999 99999999999999998 689999999997654
Q ss_pred ccccccc----------------------CccccccccCCCccccccc-cCCCCCchHHHHHHHHHHHHHHc--------
Q 011660 399 QSHQVSE----------------------NVKPVNVVGTFGYLAPEYM-MYGKVDEKIDVYSYGVVLLELIT-------- 447 (480)
Q Consensus 399 ~~~~~~~----------------------~~~~~~~~GT~~y~APE~~-~~~~~~~k~DvwSlGvil~eLlt-------- 447 (480)
....... .......+||+.|+|||++ .+..|+.++|||||||+||||++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~ 287 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY 287 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSS
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccc
Confidence 3211100 1123456899999999976 46679999999999999999999
Q ss_pred ---CCCCCCCC
Q 011660 448 ---GKEAIQTN 455 (480)
Q Consensus 448 ---G~~pf~~~ 455 (480)
|++||.+.
T Consensus 288 ~~~~~p~f~g~ 298 (458)
T 3rp9_A 288 HADRGPLFPGS 298 (458)
T ss_dssp GGGCCCSCC--
T ss_pred cccccccCCCC
Confidence 67777654
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=317.19 Aligned_cols=219 Identities=27% Similarity=0.425 Sum_probs=175.5
Q ss_pred hhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCcc------HHHHHHHHHHHhcCCCCCeeeEEEEEecCCee
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS------EEEVLREVELLSSIKHENIVRIIGYCHSKEMY 322 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~------~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 322 (480)
..++|.+.+.||+|+||.||+|.+ .+|+.||+|+++..... ...+.+|+++++.++||||+++++++.+.+.+
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 356799999999999999999977 45899999999754321 23578999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccc
Q 011660 323 AIVYNLLNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (480)
Q Consensus 323 ~lV~e~~~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~ 398 (480)
++||||+.|+|.+++.. +++.++..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||++....
T Consensus 88 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~-~~~kl~Dfg~a~~~~ 163 (346)
T 1ua2_A 88 SLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDEN-GVLKLADFGLAKSFG 163 (346)
T ss_dssp EEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTT-CCEEECCCGGGSTTT
T ss_pred EEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCC-CCEEEEecccceecc
Confidence 99999999999999854 77889999999999999999999 99999999999999998 789999999996543
Q ss_pred cccccccCccccccccCCCccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHhCCCCCCC
Q 011660 399 QSHQVSENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWYYVLAGKVFAQQ 477 (480)
Q Consensus 399 ~~~~~~~~~~~~~~~GT~~y~APE~~~~~-~~~~k~DvwSlGvil~eLltG~~pf~~~~~~~e~l~~~~~~~~~~~~~~~ 477 (480)
.. .......+||+.|+|||++.+. .++.++|||||||++|||++|.+||...... +.+.. .....+.+..+.
T Consensus 164 ~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~-~~~~~-i~~~~~~~~~~~ 236 (346)
T 1ua2_A 164 SP-----NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL-DQLTR-IFETLGTPTEEQ 236 (346)
T ss_dssp SC-----CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHH-HHHHHCCCCTTT
T ss_pred CC-----cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHH-HHHHcCCCChhh
Confidence 21 1223356799999999998764 5899999999999999999999999876532 22222 223345566666
Q ss_pred CC
Q 011660 478 WP 479 (480)
Q Consensus 478 ~~ 479 (480)
||
T Consensus 237 ~~ 238 (346)
T 1ua2_A 237 WP 238 (346)
T ss_dssp SS
T ss_pred hh
Confidence 65
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=324.94 Aligned_cols=197 Identities=26% Similarity=0.383 Sum_probs=166.5
Q ss_pred cCCCCceeecccCceEEEEEEecCCcEEEEEEeccCCcc---HHHHHHHHHHHhcCC--CCCeeeEEEEEecCCeeEEEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWS---EEEVLREVELLSSIK--HENIVRIIGYCHSKEMYAIVY 326 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~---~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~~~~~lV~ 326 (480)
.+|.+.+.||+|+||.||++...+++.||||+++..... .+.+.+|+.+|+.+. ||||+++++++..++.+++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 459999999999999999998878999999999765433 356889999999996 599999999999999999999
Q ss_pred eccCCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccc
Q 011660 327 NLLNGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (480)
Q Consensus 327 e~~~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (480)
|+.+|+|.+++.. +++.++..++.||+.||.|||+. +|+||||||+|||+++ +.+||+|||+++......
T Consensus 136 E~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~--~~~kl~DFG~a~~~~~~~-- 208 (390)
T 2zmd_A 136 ECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD--GMLKLIDFGIANQMQPDT-- 208 (390)
T ss_dssp ECCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEESS--SCEEECCCSSSCCC------
T ss_pred ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEEC--CeEEEEecCccccccCCC--
Confidence 9878999999964 67888999999999999999999 9999999999999964 579999999997543311
Q ss_pred ccCccccccccCCCccccccccC-----------CCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 404 SENVKPVNVVGTFGYLAPEYMMY-----------GKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 404 ~~~~~~~~~~GT~~y~APE~~~~-----------~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
........+||+.|+|||++.+ ..++.++|||||||+||||++|+.||....
T Consensus 209 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~ 271 (390)
T 2zmd_A 209 -TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 271 (390)
T ss_dssp ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred -ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh
Confidence 1112335679999999999865 468999999999999999999999998654
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=321.30 Aligned_cols=210 Identities=25% Similarity=0.406 Sum_probs=175.2
Q ss_pred cCHHHHhhhhcCCCCceeecccCceEEEEEEe------cCCcEEEEEEeccCCcc--HHHHHHHHHHHhcC-CCCCeeeE
Q 011660 242 FTSQELCHLTHNFSPKMLIGQGGNSKVYRTNH------VDGQVAAVKVLKCTNWS--EEEVLREVELLSSI-KHENIVRI 312 (480)
Q Consensus 242 ~~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~------~~g~~vAvK~~~~~~~~--~~~~~~Ei~il~~l-~HpnIv~l 312 (480)
+...+.....++|.+.+.||+|+||.||+|.+ .+++.||+|+++..... .+.+.+|+++++++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 33444455678899999999999999999963 34689999999765432 24688999999999 79999999
Q ss_pred EEEEecCC-eeEEEEecc-CCCHHHHHHh---------------------------------------------------
Q 011660 313 IGYCHSKE-MYAIVYNLL-NGSLKQYLKQ--------------------------------------------------- 339 (480)
Q Consensus 313 ~~~~~~~~-~~~lV~e~~-~GsL~~~l~~--------------------------------------------------- 339 (480)
++++.+.+ .+++||||+ +|+|.+++..
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 99997754 489999999 6799999853
Q ss_pred ------------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccc
Q 011660 340 ------------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (480)
Q Consensus 340 ------------------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (480)
+++.++..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||++.......
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~-~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEK-NVVKICDFGLARDIYKDP 247 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGG-GCEEECCCGGGSCTTSCT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCC-CcEEEEeccceeeecccc
Confidence 77888899999999999999999 99999999999999988 689999999997543321
Q ss_pred ccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCccc
Q 011660 402 QVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKAN 458 (480)
Q Consensus 402 ~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~~~ 458 (480)
.........||+.|+|||++.+..++.++|||||||++|||++ |+.||......
T Consensus 248 ---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 302 (359)
T 3vhe_A 248 ---DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 302 (359)
T ss_dssp ---TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ---cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh
Confidence 1222345678999999999999999999999999999999998 99999876543
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=320.13 Aligned_cols=203 Identities=18% Similarity=0.225 Sum_probs=167.1
Q ss_pred hcCCCCceeecccCceEEEEEEecC------CcEEEEEEeccCCccH------------HHHHHHHHHHhcCCCCCeeeE
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHVD------GQVAAVKVLKCTNWSE------------EEVLREVELLSSIKHENIVRI 312 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~~------g~~vAvK~~~~~~~~~------------~~~~~Ei~il~~l~HpnIv~l 312 (480)
.++|.+.+.||+|+||.||+|.+.+ ++.||+|++....... ..+..|+..++.++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4579999999999999999997754 4789999987654211 123456667788899999999
Q ss_pred EEEEecC----CeeEEEEeccCCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEe--cC
Q 011660 313 IGYCHSK----EMYAIVYNLLNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLS--EN 382 (480)
Q Consensus 313 ~~~~~~~----~~~~lV~e~~~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~--~~ 382 (480)
++++... ...++||||++|+|.+++.. +++.++..++.||+.||.|||+. +|+||||||+|||++ .+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~~~ 190 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKNP 190 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESSCT
T ss_pred EeeeeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecCCC
Confidence 9998654 46899999998899999953 78999999999999999999999 999999999999998 66
Q ss_pred CCceEEeeecccccccccccccc--CccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 383 FHHPQLSDFGAAMVHHQSHQVSE--NVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 383 ~~~~kL~DFGla~~~~~~~~~~~--~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
+.+||+|||+|+.......... .......+||+.|+|||++.+..++.++|||||||++|||+||+.||.....
T Consensus 191 -~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 191 -DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp -TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred -CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 6899999999976543221111 1222456699999999999999999999999999999999999999986543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=331.68 Aligned_cols=197 Identities=23% Similarity=0.358 Sum_probs=163.5
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccC----CccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEE
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCT----NWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 325 (480)
.++|++.+.||+|+||.||++.. .+++.||+|+++.. ......+.+|+++++.++||||++++++|.+.+.+++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 35699999999999999999976 56899999999753 22234578899999999999999999999999999999
Q ss_pred Eecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccc
Q 011660 326 YNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHH-TCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (480)
Q Consensus 326 ~e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~-~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (480)
|||+ +|+|.+++.. +++..+..++.||+.||.|||+ . +|+||||||+|||++.+ +.+||+|||+|+....
T Consensus 227 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~- 301 (446)
T 4ejn_A 227 MEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIK- 301 (446)
T ss_dssp ECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSS-SCEEECCCCCCCTTCC-
T ss_pred EeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCC-CCEEEccCCCceeccC-
Confidence 9999 6789998853 7899999999999999999998 7 99999999999999998 6899999999964322
Q ss_pred cccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 401 ~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
........+||+.|+|||++.+..++.++|||||||+||||++|+.||...+
T Consensus 302 ----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 353 (446)
T 4ejn_A 302 ----DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 353 (446)
T ss_dssp ---------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ----CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC
Confidence 1222345789999999999999999999999999999999999999997654
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=315.67 Aligned_cols=202 Identities=29% Similarity=0.423 Sum_probs=165.4
Q ss_pred hhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCcc----HHHHHHHHHHHhcCCCCCeeeEEEEEecCC----
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS----EEEVLREVELLSSIKHENIVRIIGYCHSKE---- 320 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~----~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~---- 320 (480)
+.++|++.+.||+|+||.||++.+ .+++.||+|+++..... ...+.+|+++++.++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 356799999999999999999976 67899999999765322 245789999999999999999999987554
Q ss_pred eeEEEEecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccc
Q 011660 321 MYAIVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMV 396 (480)
Q Consensus 321 ~~~lV~e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~ 396 (480)
..++||||+ +|+|.+++.. +++.++..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||++..
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~-~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISAT-NAVKVMDFGIARA 165 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETT-SCEEECCCSCC--
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCC-CCEEEeeccCccc
Confidence 349999999 6799999853 88999999999999999999999 99999999999999998 6899999999975
Q ss_pred cccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 397 HHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 397 ~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
...... .........||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 166 ~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~ 224 (311)
T 3ork_A 166 IADSGN--SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cccccc--ccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 443221 11222346799999999999999999999999999999999999999987653
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=306.50 Aligned_cols=211 Identities=35% Similarity=0.597 Sum_probs=182.1
Q ss_pred CccccCHHHHhhhhcCCCCc------eeecccCceEEEEEEecCCcEEEEEEeccCC-----ccHHHHHHHHHHHhcCCC
Q 011660 238 SSRRFTSQELCHLTHNFSPK------MLIGQGGNSKVYRTNHVDGQVAAVKVLKCTN-----WSEEEVLREVELLSSIKH 306 (480)
Q Consensus 238 ~~~~~~~~el~~~~~~f~~~------~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~-----~~~~~~~~Ei~il~~l~H 306 (480)
....|++.++..++++|... +.||+|+||.||+|.. +++.+|+|++.... ...+.+.+|+.+++.++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 45678999999999999887 8999999999999986 68899999986532 224568899999999999
Q ss_pred CCeeeEEEEEecCCeeEEEEecc-CCCHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEE
Q 011660 307 ENIVRIIGYCHSKEMYAIVYNLL-NGSLKQYLK------QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILL 379 (480)
Q Consensus 307 pnIv~l~~~~~~~~~~~lV~e~~-~GsL~~~l~------~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl 379 (480)
|||+++++++.+.+..++||||+ +|+|.+++. .+++..+..++.|++.||.|||+. +|+||||||+||++
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEE
Confidence 99999999999999999999999 789999985 278899999999999999999999 99999999999999
Q ss_pred ecCCCceEEeeeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 380 SENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 380 ~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
+.+ +.+||+|||++....... .........||+.|+|||.+.+ .++.++|||||||++|||++|+.||.....
T Consensus 167 ~~~-~~~kl~Dfg~~~~~~~~~---~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 239 (307)
T 2nru_A 167 DEA-FTAKISDFGLARASEKFA---QTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHRE 239 (307)
T ss_dssp CTT-CCEEECCCTTCEECCSCS---SCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBS
T ss_pred cCC-CcEEEeeccccccccccc---ccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcc
Confidence 998 689999999987543321 1112234579999999998764 589999999999999999999999987653
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=310.66 Aligned_cols=197 Identities=27% Similarity=0.439 Sum_probs=164.8
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCcc---------------------------HHHHHHHHHHHh
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---------------------------EEEVLREVELLS 302 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~---------------------------~~~~~~Ei~il~ 302 (480)
.++|.+.+.||+|+||.||+|.+ .+++.||+|++...... .+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 35799999999999999999976 56899999999754321 245789999999
Q ss_pred cCCCCCeeeEEEEEec--CCeeEEEEecc-CCCHHHHHH--hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCE
Q 011660 303 SIKHENIVRIIGYCHS--KEMYAIVYNLL-NGSLKQYLK--QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNI 377 (480)
Q Consensus 303 ~l~HpnIv~l~~~~~~--~~~~~lV~e~~-~GsL~~~l~--~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NI 377 (480)
.++||||+++++++.+ .+.+++||||+ +|+|.+++. .+++.++..++.|++.||.|||+. +|+||||||+||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Ni 168 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNL 168 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGE
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHE
Confidence 9999999999999986 56899999999 567777653 488899999999999999999999 999999999999
Q ss_pred EEecCCCceEEeeeccccccccccccccCccccccccCCCccccccccCCC---CCchHHHHHHHHHHHHHHcCCCCCCC
Q 011660 378 LLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGK---VDEKIDVYSYGVVLLELITGKEAIQT 454 (480)
Q Consensus 378 Ll~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~---~~~k~DvwSlGvil~eLltG~~pf~~ 454 (480)
|++.+ +.+||+|||++....... .......||+.|+|||++.+.. ++.++|||||||++|||++|+.||..
T Consensus 169 l~~~~-~~~kl~Dfg~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 169 LVGED-GHIKIADFGVSNEFKGSD-----ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp EECTT-SCEEECCCTTCEECSSSS-----CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred EECCC-CCEEEecCCCcccccccc-----ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 99998 689999999997544321 1223457999999999998765 47899999999999999999999976
Q ss_pred Cc
Q 011660 455 NK 456 (480)
Q Consensus 455 ~~ 456 (480)
..
T Consensus 243 ~~ 244 (298)
T 2zv2_A 243 ER 244 (298)
T ss_dssp SS
T ss_pred cc
Confidence 54
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=315.15 Aligned_cols=199 Identities=20% Similarity=0.362 Sum_probs=164.6
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCcc---HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEE
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 326 (480)
.++|.+.+.||+|+||.||+|.+ .+++.||+|+++..... .+.+.+|+++++.++||||+++++++.+++.+++||
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 112 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence 35699999999999999999976 56899999999765432 245779999999999999999999999999999999
Q ss_pred eccCCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecC----CCceEEeeecccccccc
Q 011660 327 NLLNGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN----FHHPQLSDFGAAMVHHQ 399 (480)
Q Consensus 327 e~~~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~----~~~~kL~DFGla~~~~~ 399 (480)
||+.|+|.+++.. +++.++..++.||+.||.|||+. +|+||||||+|||++.+ .+.+||+|||++.....
T Consensus 113 e~~~~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~ 189 (329)
T 3gbz_A 113 EYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI 189 (329)
T ss_dssp ECCSEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-
T ss_pred ecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCccccCC
Confidence 9999999999954 78899999999999999999999 99999999999999533 14599999999965432
Q ss_pred ccccccCccccccccCCCccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 400 SHQVSENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 400 ~~~~~~~~~~~~~~GT~~y~APE~~~~~-~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
. .......+||+.|+|||++.+. .++.++|||||||++|||++|+.||.....
T Consensus 190 ~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 243 (329)
T 3gbz_A 190 P-----IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE 243 (329)
T ss_dssp ---------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred c-----ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCH
Confidence 1 1122345789999999999875 489999999999999999999999987654
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=319.63 Aligned_cols=196 Identities=27% Similarity=0.386 Sum_probs=168.6
Q ss_pred hhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCccHHHHHHHHHHHhcC-CCCCeeeEEEEEecCCeeEEEEe
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSI-KHENIVRIIGYCHSKEMYAIVYN 327 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~e 327 (480)
+.++|++.+.||+|+||.||++.+ .+++.||+|++++... ...+|++++.++ +||||+++++++.+++.+++|||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 356799999999999999999977 4689999999976543 245788888877 79999999999999999999999
Q ss_pred cc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCC---ceEEeeeccccccccc
Q 011660 328 LL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFH---HPQLSDFGAAMVHHQS 400 (480)
Q Consensus 328 ~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~---~~kL~DFGla~~~~~~ 400 (480)
|+ +|+|.+++.. +++.++..++.||+.||.|||+. +|+||||||+|||+.++.+ .+||+|||++......
T Consensus 97 ~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~ 173 (342)
T 2qr7_A 97 LMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173 (342)
T ss_dssp CCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC
Confidence 99 6799999853 78899999999999999999999 9999999999999854422 4999999999754332
Q ss_pred cccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 401 ~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.......+||+.|+|||++.+..|+.++|||||||++|||++|+.||....
T Consensus 174 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 224 (342)
T 2qr7_A 174 -----NGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGP 224 (342)
T ss_dssp -----TCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSST
T ss_pred -----CCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCC
Confidence 122345689999999999998889999999999999999999999998654
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=318.28 Aligned_cols=197 Identities=27% Similarity=0.438 Sum_probs=158.6
Q ss_pred hhcCCCCceeecccCceEEEEEEec-CCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEec
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~ 328 (480)
+.++|.+.+.||+|+||.||+|... +++.||+|+++... ..+.+.+|+++++.++||||+++++++.+.+.+++||||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 129 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence 4567999999999999999999874 58899999997553 345688999999999999999999999999999999999
Q ss_pred c-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEec---CCCceEEeeecccccccccc
Q 011660 329 L-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSE---NFHHPQLSDFGAAMVHHQSH 401 (480)
Q Consensus 329 ~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~---~~~~~kL~DFGla~~~~~~~ 401 (480)
+ +|+|.+++.. +++.++..++.|++.||.|||+. +|+||||||+|||++. + +.+||+|||+++.....
T Consensus 130 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~-~~~kl~Dfg~a~~~~~~- 204 (349)
T 2w4o_A 130 VTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPD-APLKIADFGLSKIVEHQ- 204 (349)
T ss_dssp CCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTT-CCEEECCCC---------
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCC-CCEEEccCccccccCcc-
Confidence 9 6799999954 78899999999999999999999 9999999999999975 5 68999999998654321
Q ss_pred ccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 402 QVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 402 ~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 205 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 255 (349)
T 2w4o_A 205 -----VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERG 255 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTC
T ss_pred -----cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcc
Confidence 122356799999999999999999999999999999999999999976553
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=315.23 Aligned_cols=201 Identities=24% Similarity=0.402 Sum_probs=169.6
Q ss_pred hcCCCCceeecccCceEEEEEEec----CCcEEEEEEeccCCc--cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEE
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHV----DGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAI 324 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~----~g~~vAvK~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 324 (480)
.++|.+.+.||+|+||.||+|... .+..||+|+++.... ..+.+.+|+++++.++||||+++++++.+++.+++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 356899999999999999999763 345699999976432 23568899999999999999999999999999999
Q ss_pred EEecc-CCCHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccc
Q 011660 325 VYNLL-NGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (480)
Q Consensus 325 V~e~~-~GsL~~~l~----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~ 399 (480)
||||+ +|+|.+++. .+++.++..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||+++....
T Consensus 128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~~~ 203 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSN-LVCKVSDFGLSRVLED 203 (325)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTT-CCEEECCCSSCEECC-
T ss_pred EeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCC-CCEEECCCCccccccc
Confidence 99999 679999994 478899999999999999999999 99999999999999998 6899999999976543
Q ss_pred ccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCcc
Q 011660 400 SHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKA 457 (480)
Q Consensus 400 ~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~~ 457 (480)
... .........||+.|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 204 ~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~ 260 (325)
T 3kul_A 204 DPD--AAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN 260 (325)
T ss_dssp -----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH
T ss_pred Ccc--ceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH
Confidence 211 1112223456889999999999999999999999999999999 9999977543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=320.52 Aligned_cols=197 Identities=19% Similarity=0.274 Sum_probs=172.7
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc-cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEec
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW-SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~ 328 (480)
.++|.+.+.||+|+||.||+|.. .+++.+|+|++..... ....+.+|+++|+.++||||+++++++.+.+.+++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 46799999999999999999976 4689999999976543 334688999999999999999999999999999999999
Q ss_pred c-CCCHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecC-CCceEEeeeccccccccccc
Q 011660 329 L-NGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN-FHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 329 ~-~GsL~~~l~----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~-~~~~kL~DFGla~~~~~~~~ 402 (480)
+ +|+|.+++. .+++.++..++.||+.||.|||+. +|+||||||+|||++.+ .+.+||+|||++......
T Consensus 130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~-- 204 (387)
T 1kob_A 130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-- 204 (387)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT--
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCC--
Confidence 9 679999985 478899999999999999999999 99999999999999743 257999999999754321
Q ss_pred cccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 403 ~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 205 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~ 254 (387)
T 1kob_A 205 ----EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED 254 (387)
T ss_dssp ----SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred ----cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC
Confidence 12234579999999999999999999999999999999999999998754
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=341.50 Aligned_cols=197 Identities=25% Similarity=0.385 Sum_probs=173.9
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccC----CccHHHHHHHHHHHhcC-CCCCeeeEEEEEecCCeeEE
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCT----NWSEEEVLREVELLSSI-KHENIVRIIGYCHSKEMYAI 324 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~----~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~l 324 (480)
.++|++.+.||+|+||.||++.+ .+++.||||++++. ....+.+..|..++..+ +||||+++++++++.+.+++
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 46799999999999999999976 45889999999753 22345678999999988 79999999999999999999
Q ss_pred EEecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccc
Q 011660 325 VYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (480)
Q Consensus 325 V~e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (480)
||||+ +|+|.+++.. +++.++..++.||+.||.|||+. +||||||||+||||+.+ +++||+|||+|+....
T Consensus 420 V~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~-g~ikL~DFGla~~~~~- 494 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSE-GHIKIADFGMCKENIW- 494 (674)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSS-SCEEECCCTTCEECCC-
T ss_pred EEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCC-CcEEEeecceeecccc-
Confidence 99999 6799999964 88999999999999999999999 99999999999999998 7999999999964322
Q ss_pred cccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 401 ~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
........+||+.|+|||++.+..|+.++|||||||+||||++|+.||...+
T Consensus 495 ----~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~ 546 (674)
T 3pfq_A 495 ----DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 546 (674)
T ss_dssp ----TTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ----CCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC
Confidence 1223446789999999999999999999999999999999999999998754
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=319.23 Aligned_cols=204 Identities=25% Similarity=0.298 Sum_probs=173.8
Q ss_pred hcCCCCceeeccc--CceEEEEEEec-CCcEEEEEEeccCCccH---HHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEE
Q 011660 251 THNFSPKMLIGQG--GNSKVYRTNHV-DGQVAAVKVLKCTNWSE---EEVLREVELLSSIKHENIVRIIGYCHSKEMYAI 324 (480)
Q Consensus 251 ~~~f~~~~~LG~G--~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~---~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 324 (480)
.++|++.+.||+| +||.||++.+. +++.||+|+++...... +.+.+|+++++.++||||+++++++.+++.+++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4579999999999 99999999874 69999999997654332 457789999999999999999999999999999
Q ss_pred EEecc-CCCHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccc
Q 011660 325 VYNLL-NGSLKQYLK-----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (480)
Q Consensus 325 V~e~~-~GsL~~~l~-----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~ 398 (480)
||||+ +|+|.+++. .+++..+..++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++....
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~-~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVD-GKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT-CCEEECCGGGCEECE
T ss_pred EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCC-CCEEEcccccceeec
Confidence 99999 689999984 378899999999999999999999 99999999999999988 689999999985432
Q ss_pred ccccc--ccCccccccccCCCccccccccC--CCCCchHHHHHHHHHHHHHHcCCCCCCCCccc
Q 011660 399 QSHQV--SENVKPVNVVGTFGYLAPEYMMY--GKVDEKIDVYSYGVVLLELITGKEAIQTNKAN 458 (480)
Q Consensus 399 ~~~~~--~~~~~~~~~~GT~~y~APE~~~~--~~~~~k~DvwSlGvil~eLltG~~pf~~~~~~ 458 (480)
..... .........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||......
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 243 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPAT 243 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCST
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHH
Confidence 21111 11122234579999999999987 67999999999999999999999999876543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=308.88 Aligned_cols=202 Identities=25% Similarity=0.393 Sum_probs=175.4
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCccHHHHHHHHHHHhcCC-CCCeeeEEEEEec--CCeeEEEEe
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIK-HENIVRIIGYCHS--KEMYAIVYN 327 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~--~~~~~lV~e 327 (480)
++|++.+.||+|+||.||+|.+ .+++.||+|+++.. ..+.+.+|+++++.++ ||||+++++++.+ ....++|||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e 113 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 113 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc--chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEe
Confidence 5799999999999999999976 66899999999744 3577899999999997 9999999999987 667899999
Q ss_pred cc-CCCHHHHHHhCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccC
Q 011660 328 LL-NGSLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSEN 406 (480)
Q Consensus 328 ~~-~GsL~~~l~~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~ 406 (480)
|+ +++|.++++.+++.++..++.|++.||.|||+. +|+||||||+|||++.+...+||+|||+|.......
T Consensus 114 ~~~~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~----- 185 (330)
T 3nsz_A 114 HVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ----- 185 (330)
T ss_dssp CCCCCCHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC-----
T ss_pred ccCchhHHHHHHhCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC-----
Confidence 99 678999999999999999999999999999999 999999999999999774489999999997543321
Q ss_pred ccccccccCCCccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCcccchhHHH
Q 011660 407 VKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVL 464 (480)
Q Consensus 407 ~~~~~~~GT~~y~APE~~~~-~~~~~k~DvwSlGvil~eLltG~~pf~~~~~~~e~l~~ 464 (480)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......+.+..
T Consensus 186 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~ 243 (330)
T 3nsz_A 186 -EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 243 (330)
T ss_dssp -CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHH
T ss_pred -ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHH
Confidence 2234579999999999887 67899999999999999999999999766555444443
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=304.58 Aligned_cols=203 Identities=17% Similarity=0.237 Sum_probs=175.4
Q ss_pred hhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCccHHHHHHHHHHHhcC-CCCCeeeEEEEEecCCeeEEEEe
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSI-KHENIVRIIGYCHSKEMYAIVYN 327 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~e 327 (480)
..++|.+.+.||+|+||.||+|.. .+++.||+|++.... ..+.+.+|+.+++.+ +|+|++++++++.+....++|||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 356799999999999999999976 679999999986543 334688999999999 89999999999999999999999
Q ss_pred ccCCCHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCc-----eEEeeeccccccc
Q 011660 328 LLNGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHH-----PQLSDFGAAMVHH 398 (480)
Q Consensus 328 ~~~GsL~~~l~----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~-----~kL~DFGla~~~~ 398 (480)
|++|+|.+++. .+++.++..++.|++.||.|||+. +|+||||||+|||++.+ +. +||+|||++....
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~-~~~~~~~~kl~Dfg~~~~~~ 162 (298)
T 1csn_A 87 LLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRP-NSKNANMIYVVDFGMVKFYR 162 (298)
T ss_dssp CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCS-SSTTTTCEEECCCTTCEESB
T ss_pred ecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccC-CCCCCCeEEEEECccccccc
Confidence 99999999996 378999999999999999999998 99999999999999876 44 9999999997654
Q ss_pred cccccc--cCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 399 QSHQVS--ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 399 ~~~~~~--~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
...... .........||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 223 (298)
T 1csn_A 163 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 223 (298)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCS
T ss_pred cccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhc
Confidence 322111 11223466899999999999999999999999999999999999999988653
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=324.34 Aligned_cols=220 Identities=23% Similarity=0.384 Sum_probs=165.5
Q ss_pred cCCCC-ceeecccCceEEEEEEec---CCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEEEe--cCCeeEEE
Q 011660 252 HNFSP-KMLIGQGGNSKVYRTNHV---DGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCH--SKEMYAIV 325 (480)
Q Consensus 252 ~~f~~-~~~LG~G~fg~Vy~~~~~---~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~--~~~~~~lV 325 (480)
+.|.+ .++||+|+||.||+|.+. +++.||+|++..... ...+.+|+.+|+.++||||+++++++. .+..+++|
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence 34655 457999999999999864 578999999975543 356889999999999999999999994 46789999
Q ss_pred EeccCCCHHHHHH------------hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEE----ecCCCceEEe
Q 011660 326 YNLLNGSLKQYLK------------QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILL----SENFHHPQLS 389 (480)
Q Consensus 326 ~e~~~GsL~~~l~------------~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl----~~~~~~~kL~ 389 (480)
|||+.|+|.+++. .+++.++..++.||+.||.|||+. +|+||||||+|||+ +.+ +.+||+
T Consensus 99 ~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~-~~~kl~ 174 (405)
T 3rgf_A 99 FDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPER-GRVKIA 174 (405)
T ss_dssp EECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTT-TCEEEC
T ss_pred EeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCC-CcEEEE
Confidence 9999999998884 388889999999999999999999 99999999999999 455 689999
Q ss_pred eeccccccccccccccCccccccccCCCccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCccc--------ch
Q 011660 390 DFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKAN--------RE 460 (480)
Q Consensus 390 DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~-~~~~k~DvwSlGvil~eLltG~~pf~~~~~~--------~e 460 (480)
|||+|+...... .........+||+.|+|||++.+. .++.++|||||||++|||++|++||...... .+
T Consensus 175 Dfg~a~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 252 (405)
T 3rgf_A 175 DMGFARLFNSPL--KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 252 (405)
T ss_dssp CTTCCC------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred ECCCceecCCCC--cccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence 999997654321 111223456899999999999874 5899999999999999999999999765432 22
Q ss_pred hHHHHHHHHhCCCCCCCCC
Q 011660 461 SLVLWYYVLAGKVFAQQWP 479 (480)
Q Consensus 461 ~l~~~~~~~~~~~~~~~~~ 479 (480)
.+.. ....++.+..+.|+
T Consensus 253 ~l~~-i~~~~g~p~~~~~~ 270 (405)
T 3rgf_A 253 QLDR-IFNVMGFPADKDWE 270 (405)
T ss_dssp HHHH-HHHHHCCCCTTTCG
T ss_pred HHHH-HHHhhCCCChhhcc
Confidence 2322 33455666666664
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=324.16 Aligned_cols=200 Identities=25% Similarity=0.370 Sum_probs=165.3
Q ss_pred hhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCcc---HHHHHHHHHHHhcCCCCCeeeEEEEEecC-----C
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSK-----E 320 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~ 320 (480)
+.++|.+.+.||+|+||.||+|.+ .+++.||||+++..... .+.+.+|+++|+.++||||+++++++... +
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 356899999999999999999976 56889999999764333 35688999999999999999999999765 5
Q ss_pred eeEEEEeccCCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccc
Q 011660 321 MYAIVYNLLNGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVH 397 (480)
Q Consensus 321 ~~~lV~e~~~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~ 397 (480)
.+++||||++|+|.++++. +++..+..++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||+|+..
T Consensus 104 ~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~-~~~kL~DFGla~~~ 179 (432)
T 3n9x_A 104 ELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQD-CSVKVCDFGLARTI 179 (432)
T ss_dssp CEEEEEECCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTT-CCEEECCCTTCEEC
T ss_pred eEEEEEecCCcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCC-CCEEEccCCCcccc
Confidence 7899999999999999965 78999999999999999999999 99999999999999998 78999999999765
Q ss_pred ccccccc-----------------cCccccccccCCCccccccc-cCCCCCchHHHHHHHHHHHHHHcCCCCCC
Q 011660 398 HQSHQVS-----------------ENVKPVNVVGTFGYLAPEYM-MYGKVDEKIDVYSYGVVLLELITGKEAIQ 453 (480)
Q Consensus 398 ~~~~~~~-----------------~~~~~~~~~GT~~y~APE~~-~~~~~~~k~DvwSlGvil~eLltG~~pf~ 453 (480)
....... ........+||+.|+|||++ ....|+.++|||||||++|||++|..||.
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 4322110 00123567899999999986 55679999999999999999998544443
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=329.19 Aligned_cols=197 Identities=25% Similarity=0.425 Sum_probs=173.8
Q ss_pred hcCCCCceeecccCceEEEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc-
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL- 329 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~- 329 (480)
.++|.+.+.||+|+||.||+|.+.++..||||+++......+.+.+|+++|+.++||||+++++++. .+.+++||||+
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~ 265 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMA 265 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCT
T ss_pred hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecC
Confidence 4568899999999999999999888899999999887777889999999999999999999999987 56789999999
Q ss_pred CCCHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccc
Q 011660 330 NGSLKQYLK-----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (480)
Q Consensus 330 ~GsL~~~l~-----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (480)
+|+|.+++. .+++.++..++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||+++.......
T Consensus 266 ~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~-~~~kl~DFG~a~~~~~~~~-- 339 (454)
T 1qcf_A 266 KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSAS-LVCKIADFGLARVIEDNEY-- 339 (454)
T ss_dssp TCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTT-CCEEECSTTGGGGBCCHHH--
T ss_pred CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCC-CcEEEeeCCCceEcCCCce--
Confidence 689999995 478888999999999999999999 99999999999999998 6899999999976433211
Q ss_pred cCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 405 ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 405 ~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
.......+|+.|+|||++.+..++.++|||||||+||||+| |+.||....
T Consensus 340 --~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~ 390 (454)
T 1qcf_A 340 --TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS 390 (454)
T ss_dssp --HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred --eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC
Confidence 11123456889999999999999999999999999999999 999998754
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=324.69 Aligned_cols=196 Identities=23% Similarity=0.381 Sum_probs=172.3
Q ss_pred hhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCccHHHHHHHHHHHhcC------CCCCeeeEEEEEecCCee
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSI------KHENIVRIIGYCHSKEMY 322 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l------~HpnIv~l~~~~~~~~~~ 322 (480)
+..+|++.+.||+|+||.||+|.. .+++.||||+++........+.+|+++++.+ +|+||+++++++...+.+
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 345799999999999999999966 5589999999986654456778888888776 678999999999999999
Q ss_pred EEEEeccCCCHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCc--eEEeeecccc
Q 011660 323 AIVYNLLNGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHH--PQLSDFGAAM 395 (480)
Q Consensus 323 ~lV~e~~~GsL~~~l~~-----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~--~kL~DFGla~ 395 (480)
++||||+.|+|.+++.. +++..+..++.||+.||.|||+. +|+||||||+|||++.+ +. +||+|||+|.
T Consensus 175 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~-~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 175 CMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQ-GRSGIKVIDFGSSC 250 (429)
T ss_dssp EEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESST-TSCCEEECCCTTCE
T ss_pred EEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccC-CCcceEEeecccce
Confidence 99999999999999853 78899999999999999999999 99999999999999988 45 9999999996
Q ss_pred ccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 396 VHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
.... .....+||+.|+|||++.+..++.++|||||||+||||++|++||...+.
T Consensus 251 ~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~ 304 (429)
T 3kvw_A 251 YEHQ--------RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE 304 (429)
T ss_dssp ETTC--------CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ecCC--------cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence 4322 22356899999999999999999999999999999999999999987653
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=324.80 Aligned_cols=193 Identities=25% Similarity=0.364 Sum_probs=163.5
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEEEec------CCeeEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHS------KEMYAI 324 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~------~~~~~l 324 (480)
.+|.+.+.||+|+||.||+|.+ .+++.||||++.... ....+|+++|+.++||||++++++|.. ...+++
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK---RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT---TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc---hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 3588999999999999999987 469999999987543 223479999999999999999998843 224679
Q ss_pred EEeccCCCHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccc
Q 011660 325 VYNLLNGSLKQYLK-------QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVH 397 (480)
Q Consensus 325 V~e~~~GsL~~~l~-------~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~ 397 (480)
||||+.++|.+.+. .+++..+..++.||++||.|||+. +|+||||||+|||++.+.+.+||+|||+|+..
T Consensus 131 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~ 207 (420)
T 1j1b_A 131 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207 (420)
T ss_dssp EEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred ehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence 99999988877763 378888999999999999999998 99999999999999976567899999999754
Q ss_pred ccccccccCccccccccCCCccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 398 HQSHQVSENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 398 ~~~~~~~~~~~~~~~~GT~~y~APE~~~~~-~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
... ......+||+.|+|||++.+. .++.++|||||||+||||++|+.||.+.+
T Consensus 208 ~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~ 261 (420)
T 1j1b_A 208 VRG------EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS 261 (420)
T ss_dssp CTT------CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccC------CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 321 122356799999999998765 78999999999999999999999998765
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-38 Score=314.19 Aligned_cols=201 Identities=25% Similarity=0.435 Sum_probs=171.9
Q ss_pred hhhcCCCCceeecccCceEEEEEEec------CCcEEEEEEeccCCcc--HHHHHHHHHHHhcCCCCCeeeEEEEEecCC
Q 011660 249 HLTHNFSPKMLIGQGGNSKVYRTNHV------DGQVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSKE 320 (480)
Q Consensus 249 ~~~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 320 (480)
...++|.+.+.||+|+||.||+|... +++.||+|+++..... .+.+.+|+.+++.++||||+++++++.+++
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 123 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 123 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence 34578999999999999999999764 3489999999765432 356889999999999999999999999999
Q ss_pred eeEEEEecc-CCCHHHHHHh---------------------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccC
Q 011660 321 MYAIVYNLL-NGSLKQYLKQ---------------------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDV 372 (480)
Q Consensus 321 ~~~lV~e~~-~GsL~~~l~~---------------------------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDl 372 (480)
.+++||||+ +|+|.+++.. +++.++..++.||++||.|||+. +|+||||
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dl 200 (343)
T 1luf_A 124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDL 200 (343)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence 999999999 5799999854 67788899999999999999999 9999999
Q ss_pred CCCCEEEecCCCceEEeeeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCC
Q 011660 373 KSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEA 451 (480)
Q Consensus 373 Kp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~p 451 (480)
||+|||++.+ +.+||+|||++....... .........||+.|+|||++.+..++.++|||||||++|||++ |+.|
T Consensus 201 kp~NIl~~~~-~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 276 (343)
T 1luf_A 201 ATRNCLVGEN-MVVKIADFGLSRNIYSAD---YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276 (343)
T ss_dssp SGGGEEECGG-GCEEECCCSCHHHHTGGG---CBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred CcceEEECCC-CeEEEeecCCCcccccCc---cccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCc
Confidence 9999999998 689999999997543321 1122234568999999999999999999999999999999999 9999
Q ss_pred CCCCc
Q 011660 452 IQTNK 456 (480)
Q Consensus 452 f~~~~ 456 (480)
|....
T Consensus 277 ~~~~~ 281 (343)
T 1luf_A 277 YYGMA 281 (343)
T ss_dssp TTTSC
T ss_pred CCCCC
Confidence 98754
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=321.03 Aligned_cols=197 Identities=24% Similarity=0.356 Sum_probs=165.4
Q ss_pred hhhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEEEec---------
Q 011660 249 HLTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHS--------- 318 (480)
Q Consensus 249 ~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--------- 318 (480)
...++|.+.+.||+|+||.||+|.+ .+|+.||+|++..+. ....+|+++++.++||||+++++++..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 80 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP---RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPP 80 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT---TSCCHHHHHHTTCCCTTBCCEEEEEEEC--------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHHcCCCCccchhheeeecCccccccc
Confidence 3467899999999999999999976 679999999987553 223479999999999999999999843
Q ss_pred -----------------------------CCeeEEEEeccCCCHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhC
Q 011660 319 -----------------------------KEMYAIVYNLLNGSLKQYLK-------QLKWNERMDVAIGVAKALEYLHHT 362 (480)
Q Consensus 319 -----------------------------~~~~~lV~e~~~GsL~~~l~-------~~~~~~~~~i~~~ia~aL~yLH~~ 362 (480)
...+++||||+.|+|.+.+. .+++..+..++.||+.||.|||+.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 160 (383)
T 3eb0_A 81 QPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL 160 (383)
T ss_dssp -----------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred ccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 33488999999999888774 378899999999999999999998
Q ss_pred CCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccCccccccccCCCccccccccCC-CCCchHHHHHHHHH
Q 011660 363 CDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVV 441 (480)
Q Consensus 363 ~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~-~~~~k~DvwSlGvi 441 (480)
+|+||||||+|||++.+.+.+||+|||+|+..... .......||+.|+|||++.+. .++.++|||||||+
T Consensus 161 ---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 161 ---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS------EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp ---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT------SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred ---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC------CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 99999999999999853378999999999754322 223355789999999998875 48999999999999
Q ss_pred HHHHHcCCCCCCCCcc
Q 011660 442 LLELITGKEAIQTNKA 457 (480)
Q Consensus 442 l~eLltG~~pf~~~~~ 457 (480)
+|||++|+.||.+...
T Consensus 232 l~ell~g~~pf~~~~~ 247 (383)
T 3eb0_A 232 FGELILGKPLFSGETS 247 (383)
T ss_dssp HHHHHHSSCSSCCSSH
T ss_pred HHHHHhCCCCCCCCCh
Confidence 9999999999987653
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=308.90 Aligned_cols=200 Identities=24% Similarity=0.410 Sum_probs=172.2
Q ss_pred hcCCCCceeecccCceEEEEEEe------cCCcEEEEEEeccCCcc--HHHHHHHHHHHhcCCCCCeeeEEEEEecCCee
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH------VDGQVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSKEMY 322 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~------~~g~~vAvK~~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 322 (480)
.++|.+.+.||+|+||.||++.. .+++.+|+|+++..... .+.+.+|+++++.++||||+++++++.+.+.+
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 46799999999999999999975 23578999999755422 35688999999999999999999999999999
Q ss_pred EEEEecc-CCCHHHHHHh---------------------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCC
Q 011660 323 AIVYNLL-NGSLKQYLKQ---------------------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKS 374 (480)
Q Consensus 323 ~lV~e~~-~GsL~~~l~~---------------------------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp 374 (480)
++||||+ +|+|.+++.. +++.++..++.|++.||.|||+. +|+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccch
Confidence 9999999 5899999964 67888999999999999999999 999999999
Q ss_pred CCEEEecCCCceEEeeeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCC
Q 011660 375 SNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQ 453 (480)
Q Consensus 375 ~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~ 453 (480)
+|||++.+ +.+||+|||++........ ........||+.|+|||++.+..++.++|||||||++|||++ |+.||.
T Consensus 179 ~NIli~~~-~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 254 (314)
T 2ivs_A 179 RNILVAEG-RKMKISDFGLSRDVYEEDS---YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 254 (314)
T ss_dssp GGEEEETT-TEEEECCCTTCEECTTTSC---EECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred heEEEcCC-CCEEEcccccccccccccc---ceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999998 6899999999975443221 112234567899999999999999999999999999999999 999998
Q ss_pred CCcc
Q 011660 454 TNKA 457 (480)
Q Consensus 454 ~~~~ 457 (480)
....
T Consensus 255 ~~~~ 258 (314)
T 2ivs_A 255 GIPP 258 (314)
T ss_dssp TCCG
T ss_pred CCCH
Confidence 7654
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=314.52 Aligned_cols=208 Identities=26% Similarity=0.343 Sum_probs=170.1
Q ss_pred HHhhhhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccC------CccHHHHHHHHHHHhcCCCCCeeeEEEEEec
Q 011660 246 ELCHLTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCT------NWSEEEVLREVELLSSIKHENIVRIIGYCHS 318 (480)
Q Consensus 246 el~~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~------~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 318 (480)
++..+.++|.+.+.||+|+||.||+|.. .+++.+|+|++... ....+.+.+|+++++.++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 3445667899999999999999999976 56889999998643 2334678899999999999999999999999
Q ss_pred CCeeEEEEecc-CCCHHHHHHh-------------------------------------------CCHHHHHHHHHHHHH
Q 011660 319 KEMYAIVYNLL-NGSLKQYLKQ-------------------------------------------LKWNERMDVAIGVAK 354 (480)
Q Consensus 319 ~~~~~lV~e~~-~GsL~~~l~~-------------------------------------------~~~~~~~~i~~~ia~ 354 (480)
.+.+++||||+ +|+|.+++.. +++..+..++.|++.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 99999999999 7899998841 245667789999999
Q ss_pred HHHHHHhCCCCCeEeccCCCCCEEEecCC-CceEEeeeccccccccccccccCccccccccCCCccccccccC--CCCCc
Q 011660 355 ALEYLHHTCDPPIIHRDVKSSNILLSENF-HHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY--GKVDE 431 (480)
Q Consensus 355 aL~yLH~~~~~~IiHrDlKp~NILl~~~~-~~~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~--~~~~~ 431 (480)
||.|||+. +|+||||||+|||++.+. ..+||+|||++........ ..........||+.|+|||++.+ ..++.
T Consensus 180 ~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 255 (345)
T 3hko_A 180 ALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNN-GEYYGMTTKAGTPYFVAPEVLNTTNESYGP 255 (345)
T ss_dssp HHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTC-C--------CCCGGGCCHHHHTCSSSCCCT
T ss_pred HHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCc-cccccccccCCCccccCchhhccCCCCCCc
Confidence 99999999 999999999999998762 2799999999975433211 11122345679999999999875 67899
Q ss_pred hHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 432 KIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 432 k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
++|||||||++|||++|+.||.....
T Consensus 256 ~~DiwslG~il~el~~g~~pf~~~~~ 281 (345)
T 3hko_A 256 KCDAWSAGVLLHLLLMGAVPFPGVND 281 (345)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred HHHHHHHHHHHHHHHHCCCCCCCCCh
Confidence 99999999999999999999987653
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=315.54 Aligned_cols=197 Identities=24% Similarity=0.385 Sum_probs=172.0
Q ss_pred hhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCcc---------HHHHHHHHHHHhcCCCCCeeeEEEEEecC
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---------EEEVLREVELLSSIKHENIVRIIGYCHSK 319 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~---------~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 319 (480)
+.++|.+.+.||+|+||.||+|.+ .+++.||+|+++..... ...+.+|+++++.++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 346799999999999999999976 56899999999765421 23467899999999999999999999999
Q ss_pred CeeEEEEecc-CC-CHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccc
Q 011660 320 EMYAIVYNLL-NG-SLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA 394 (480)
Q Consensus 320 ~~~~lV~e~~-~G-sL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla 394 (480)
+.+++||||+ .| +|.+++.. +++..+..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||++
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~-~~~kL~Dfg~a 177 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAED-FTIKLIDFGSA 177 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTT-SCEEECCCTTC
T ss_pred CEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCC-CcEEEeecccc
Confidence 9999999988 55 89999964 78999999999999999999999 99999999999999998 78999999999
Q ss_pred cccccccccccCccccccccCCCccccccccCCCC-CchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 395 MVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKV-DEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~-~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
...... ......+||+.|+|||++.+..+ +.++|||||||++|||++|+.||....
T Consensus 178 ~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 234 (335)
T 3dls_A 178 AYLERG------KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE 234 (335)
T ss_dssp EECCTT------CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGG
T ss_pred eECCCC------CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHH
Confidence 764332 22235679999999999998887 899999999999999999999997643
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=313.35 Aligned_cols=192 Identities=32% Similarity=0.468 Sum_probs=169.8
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCcc----HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS----EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~----~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 326 (480)
+.|...+.||+|+||.||+|.. .+++.||+|++...... .+.+.+|+++++.++||||+++++++.+++..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4588899999999999999976 67999999999765432 245789999999999999999999999999999999
Q ss_pred eccCCCHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccc
Q 011660 327 NLLNGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 327 e~~~GsL~~~l~----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (480)
||+.|+|.+++. .+++.++..++.|+++||.|||+. +|+||||||+|||++.+ +.+||+|||++.....
T Consensus 134 e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~-~~~kL~DfG~a~~~~~--- 206 (348)
T 1u5q_A 134 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEP-GLVKLGDFGSASIMAP--- 206 (348)
T ss_dssp ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETT-TEEEECCCTTCBSSSS---
T ss_pred ecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCC-CCEEEeeccCceecCC---
Confidence 999999988884 378999999999999999999999 99999999999999998 7999999999865332
Q ss_pred cccCccccccccCCCcccccccc---CCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 403 VSENVKPVNVVGTFGYLAPEYMM---YGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 403 ~~~~~~~~~~~GT~~y~APE~~~---~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
....+||+.|+|||++. ...++.++|||||||++|||++|+.||...+
T Consensus 207 ------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~ 257 (348)
T 1u5q_A 207 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 257 (348)
T ss_dssp ------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred ------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 12457999999999884 5778999999999999999999999998654
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=321.49 Aligned_cols=200 Identities=28% Similarity=0.373 Sum_probs=169.8
Q ss_pred hcCCCCceeecccCceEEEEEEe------cCCcEEEEEEeccCCc--cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCee
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH------VDGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMY 322 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~------~~g~~vAvK~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 322 (480)
.++|.+.+.||+|+||.||+|.. .+++.||||+++.... ....+.+|+.+++.++||||+++++++.+.+..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 35689999999999999999974 2467899999975432 234688999999999999999999999999999
Q ss_pred EEEEecc-CCCHHHHHHh----------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCC--CceEEe
Q 011660 323 AIVYNLL-NGSLKQYLKQ----------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENF--HHPQLS 389 (480)
Q Consensus 323 ~lV~e~~-~GsL~~~l~~----------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~--~~~kL~ 389 (480)
++||||+ +|+|.+++.. +.+.++..++.||+.||.|||+. +|+||||||+|||++.+. ..+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEEC
Confidence 9999999 6799999953 78889999999999999999999 999999999999998541 359999
Q ss_pred eeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 390 DFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 390 DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
|||+|+...... .........||+.|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 227 DFG~a~~~~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~ 291 (367)
T 3l9p_A 227 DFGMARDIYRAG---YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 291 (367)
T ss_dssp CCHHHHHHHHHS---SCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred CCcccccccccc---ccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999997543221 1122334578999999999999999999999999999999998 999998754
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=308.61 Aligned_cols=197 Identities=27% Similarity=0.404 Sum_probs=173.3
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc-------cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCee
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW-------SEEEVLREVELLSSIKHENIVRIIGYCHSKEMY 322 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~-------~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 322 (480)
.++|.+.+.||+|+||.||++.. .+|+.+|+|+++.... ..+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 45699999999999999999977 4689999999975432 356789999999999999999999999999999
Q ss_pred EEEEecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCC---ceEEeeecccc
Q 011660 323 AIVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFH---HPQLSDFGAAM 395 (480)
Q Consensus 323 ~lV~e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~---~~kL~DFGla~ 395 (480)
++||||+ +|+|.+++.. +++.++..++.|++.||.|||+. +|+||||||+|||++.+.. .++|+|||++.
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence 9999999 6799999964 67889999999999999999999 9999999999999988732 69999999996
Q ss_pred ccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 396 VHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 168 ~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 222 (321)
T 2a2a_A 168 EIEDG------VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 222 (321)
T ss_dssp ECCTT------CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred ecCcc------ccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCC
Confidence 54332 12235579999999999999999999999999999999999999998754
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=318.45 Aligned_cols=200 Identities=27% Similarity=0.424 Sum_probs=170.9
Q ss_pred hcCCCCceeecccCceEEEEEEec-CCcEEEEEEeccCCcc--HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEe
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e 327 (480)
.++|.+.+.||+|+||.||+|... +++.||+|+++..... ...+.+|+++|+.++||||+++++++.+++.+++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 456889999999999999999875 6899999999754322 2357899999999999999999999999999999999
Q ss_pred cc-CCCHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccc
Q 011660 328 LL-NGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 328 ~~-~GsL~~~l~----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (480)
|+ +|+|.+++. .+++.++..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||+++.......
T Consensus 193 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~-~~~kl~DfG~s~~~~~~~~ 268 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEK-NVLKISDFGMSREEADGVY 268 (377)
T ss_dssp CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTT-CCEEECCGGGCEECTTSEE
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCC-CcEEECcCCCceecCCCce
Confidence 99 689999985 388899999999999999999999 99999999999999988 6899999999975332211
Q ss_pred cccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCcc
Q 011660 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKA 457 (480)
Q Consensus 403 ~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~~ 457 (480)
. .......+|+.|+|||++.++.++.++|||||||++|||++ |+.||.....
T Consensus 269 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~ 321 (377)
T 3cbl_A 269 A---ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN 321 (377)
T ss_dssp E---CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH
T ss_pred e---ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 1 11112345778999999999999999999999999999998 9999987653
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=317.15 Aligned_cols=194 Identities=24% Similarity=0.365 Sum_probs=163.0
Q ss_pred CCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc-cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc-CC
Q 011660 255 SPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW-SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NG 331 (480)
Q Consensus 255 ~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~-~G 331 (480)
...+.||+|+||.||+|.. .+|+.||+|+++.... ..+.+.+|+++++.++||||+++++++.+.+.+++||||+ +|
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 3356899999999999976 5689999999986553 3457889999999999999999999999999999999999 67
Q ss_pred CHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEec-CCCceEEeeeccccccccccccccC
Q 011660 332 SLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSE-NFHHPQLSDFGAAMVHHQSHQVSEN 406 (480)
Q Consensus 332 sL~~~l~----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~-~~~~~kL~DFGla~~~~~~~~~~~~ 406 (480)
+|.+++. .+++.++..++.||+.||.|||+. +|+||||||+|||++. +.+.+||+|||++.......
T Consensus 172 ~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~----- 243 (373)
T 2x4f_A 172 ELFDRIIDESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE----- 243 (373)
T ss_dssp EEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-----
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-----
Confidence 8988884 378899999999999999999999 9999999999999953 22689999999997643321
Q ss_pred ccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 407 VKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 407 ~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.
T Consensus 244 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 293 (373)
T 2x4f_A 244 -KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND 293 (373)
T ss_dssp -BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred -ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 22345799999999999999999999999999999999999999987653
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=311.78 Aligned_cols=190 Identities=26% Similarity=0.391 Sum_probs=147.8
Q ss_pred ceeecccCceEEEEEEe-cCCcEEEEEEeccCCccHHHHHHHHHHHhcCC-CCCeeeEEEEEecCCeeEEEEecc-CCCH
Q 011660 257 KMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIK-HENIVRIIGYCHSKEMYAIVYNLL-NGSL 333 (480)
Q Consensus 257 ~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~e~~-~GsL 333 (480)
.+.||+|+||.||+|.+ .+++.||+|++... ....+.+|+.+++.+. ||||+++++++.+++..++||||+ +|+|
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 47899999999999977 46899999999753 3467889999999997 999999999999999999999999 6799
Q ss_pred HHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCC--CceEEeeeccccccccccccccCcc
Q 011660 334 KQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENF--HHPQLSDFGAAMVHHQSHQVSENVK 408 (480)
Q Consensus 334 ~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~--~~~kL~DFGla~~~~~~~~~~~~~~ 408 (480)
.+++.. +++.++..++.|++.||.|||+. +|+||||||+|||++.+. ..+||+|||++...... ...
T Consensus 94 ~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~-----~~~ 165 (325)
T 3kn6_A 94 FERIKKKKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD-----NQP 165 (325)
T ss_dssp HHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---------
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCC-----CCc
Confidence 999964 78999999999999999999999 999999999999998652 27999999999754332 122
Q ss_pred ccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 409 PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 409 ~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 213 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHD 213 (325)
T ss_dssp ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC---
T ss_pred ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCc
Confidence 335678999999999999999999999999999999999999998754
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=316.28 Aligned_cols=197 Identities=24% Similarity=0.336 Sum_probs=164.1
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCcc---HHHHHHHHHHHhcCCCCCeeeEEEEEecCC------
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSKE------ 320 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------ 320 (480)
.++|.+.+.||+|+||.||+|.. .+++.||+|++...... .+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 46799999999999999999976 56899999999764332 345789999999999999999999997654
Q ss_pred eeEEEEeccCCCHHHHHH-hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccc
Q 011660 321 MYAIVYNLLNGSLKQYLK-QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (480)
Q Consensus 321 ~~~lV~e~~~GsL~~~l~-~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~ 399 (480)
.+++||||+.|+|.+++. .+++..+..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||+++....
T Consensus 104 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~-~~~kl~Dfg~a~~~~~ 179 (371)
T 2xrw_A 104 DVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSD-CTLKILDFGLARTAGT 179 (371)
T ss_dssp EEEEEEECCSEEHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTT-SCEEECCCCC------
T ss_pred ceEEEEEcCCCCHHHHHhhccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCC-CCEEEEEeeccccccc
Confidence 789999999999998885 488889999999999999999999 99999999999999998 6899999999965332
Q ss_pred ccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 400 SHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 400 ~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.
T Consensus 180 ~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 231 (371)
T 2xrw_A 180 S------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH 231 (371)
T ss_dssp ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred c------cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 1 122356799999999999999999999999999999999999999987653
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=300.15 Aligned_cols=198 Identities=26% Similarity=0.423 Sum_probs=171.9
Q ss_pred hhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCcc---HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEE
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 325 (480)
+.++|++.+.||+|+||.||+|.+ .+++.+|+|++...... .+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 467899999999999999999976 56899999999765433 24578999999999999999999999999999999
Q ss_pred Eecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCC--CceEEeeecccccccc
Q 011660 326 YNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENF--HHPQLSDFGAAMVHHQ 399 (480)
Q Consensus 326 ~e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~--~~~kL~DFGla~~~~~ 399 (480)
|||+ +|+|.+++.. +++.++..++.|++.||.|||+. +|+||||||+||+++.+. +.+||+|||++.....
T Consensus 84 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 9999 5689888743 78999999999999999999999 999999999999998652 2499999999965433
Q ss_pred ccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 400 SHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 400 ~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
. .......||+.|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 161 ~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 211 (284)
T 3kk8_A 161 S------EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 211 (284)
T ss_dssp S------CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred C------ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc
Confidence 2 12234679999999999999999999999999999999999999997654
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=305.32 Aligned_cols=224 Identities=26% Similarity=0.355 Sum_probs=173.0
Q ss_pred ccCHHHHhhhhcCCCCceeecccCceEEEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhc--CCCCCeeeEEEEEec
Q 011660 241 RFTSQELCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSS--IKHENIVRIIGYCHS 318 (480)
Q Consensus 241 ~~~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~~~~~~ 318 (480)
.........+.++|++.+.||+|+||.||+|.+. ++.||+|++.... ......|.+++.. ++||||+++++++.+
T Consensus 26 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~ 102 (337)
T 3mdy_A 26 GLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE--EASWFRETEIYQTVLMRHENILGFIAADIK 102 (337)
T ss_dssp SSCHHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred CCCcccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc--cchhhhHHHHHHHHhhcCCCeeeEEEEEcc
Confidence 3344444556678999999999999999999874 8999999996543 3445566666655 499999999999987
Q ss_pred C----CeeEEEEecc-CCCHHHHHHh--CCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEeccCCCCCEEEecCCCce
Q 011660 319 K----EMYAIVYNLL-NGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHT-----CDPPIIHRDVKSSNILLSENFHHP 386 (480)
Q Consensus 319 ~----~~~~lV~e~~-~GsL~~~l~~--~~~~~~~~i~~~ia~aL~yLH~~-----~~~~IiHrDlKp~NILl~~~~~~~ 386 (480)
. +.+++||||+ +|+|.++++. +++.++..++.|++.||.|||+. +.++|+||||||+|||++.+ +.+
T Consensus 103 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~-~~~ 181 (337)
T 3mdy_A 103 GTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN-GTC 181 (337)
T ss_dssp SCGGGCEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTT-SCE
T ss_pred CCCCCCceEEEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCC-CCE
Confidence 6 7899999999 6699999964 78899999999999999999975 23489999999999999988 689
Q ss_pred EEeeeccccccccccccccCccccccccCCCccccccccCCCCCch------HHHHHHHHHHHHHHcC----------CC
Q 011660 387 QLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEK------IDVYSYGVVLLELITG----------KE 450 (480)
Q Consensus 387 kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k------~DvwSlGvil~eLltG----------~~ 450 (480)
||+|||+|......... .........||+.|+|||++.+..++.+ +|||||||++|||++| +.
T Consensus 182 kl~Dfg~a~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~ 260 (337)
T 3mdy_A 182 CIADLGLAVKFISDTNE-VDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL 260 (337)
T ss_dssp EECCCTTCEECC----------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEeCCCceeecccccc-ccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccc
Confidence 99999999654332211 1112235679999999999987766554 9999999999999999 77
Q ss_pred CCCCCcccchhHHHHHHHH
Q 011660 451 AIQTNKANRESLVLWYYVL 469 (480)
Q Consensus 451 pf~~~~~~~e~l~~~~~~~ 469 (480)
||............+....
T Consensus 261 p~~~~~~~~~~~~~~~~~~ 279 (337)
T 3mdy_A 261 PYHDLVPSDPSYEDMREIV 279 (337)
T ss_dssp TTTTTSCSSCCHHHHHHHH
T ss_pred cHhhhcCCCCchhhhHHHH
Confidence 8876544333333333333
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-38 Score=322.24 Aligned_cols=213 Identities=27% Similarity=0.418 Sum_probs=178.1
Q ss_pred hcCCCCceeecccCceEEEEEEec-CCcEEEEEEeccCC--ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCC--eeEEE
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTN--WSEEEVLREVELLSSIKHENIVRIIGYCHSKE--MYAIV 325 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--~~~lV 325 (480)
.++|.+.+.||+|+||.||+|.+. +++.||+|+++... ...+.+.+|+++++.++||||+++++++.+.+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 457999999999999999999774 58999999997543 23467889999999999999999999997655 78999
Q ss_pred Eecc-CCCHHHHHHh------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEE----ecCCCceEEeeeccc
Q 011660 326 YNLL-NGSLKQYLKQ------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILL----SENFHHPQLSDFGAA 394 (480)
Q Consensus 326 ~e~~-~GsL~~~l~~------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl----~~~~~~~kL~DFGla 394 (480)
|||+ +|+|.+++.. +++.++..++.|++.||.|||+. +|+||||||+|||+ +.+ +.+||+|||++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~-~~~kL~DFG~a 163 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQ-SVYKLTDFGAA 163 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSC-EEEEECCGGGC
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCc-eeEEEecCCCc
Confidence 9999 6799999954 88999999999999999999999 99999999999999 555 57999999999
Q ss_pred cccccccccccCccccccccCCCccccccccC--------CCCCchHHHHHHHHHHHHHHcCCCCCCCCcccchhHHHHH
Q 011660 395 MVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY--------GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWY 466 (480)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~--------~~~~~k~DvwSlGvil~eLltG~~pf~~~~~~~e~l~~~~ 466 (480)
+..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..............
T Consensus 164 ~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~ 237 (396)
T 4eut_A 164 RELEDD------EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237 (396)
T ss_dssp EECCCG------GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHH
T ss_pred eEccCC------CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHH
Confidence 764332 12234679999999998865 5678899999999999999999999987665444445556
Q ss_pred HHHhCCC
Q 011660 467 YVLAGKV 473 (480)
Q Consensus 467 ~~~~~~~ 473 (480)
+.+.+.+
T Consensus 238 ~~~~~~p 244 (396)
T 4eut_A 238 KIITGKP 244 (396)
T ss_dssp HHHHSCC
T ss_pred HHhcCCC
Confidence 6666643
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=299.88 Aligned_cols=198 Identities=23% Similarity=0.434 Sum_probs=175.9
Q ss_pred hcCCCCceeecccCceEEEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc-
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL- 329 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~- 329 (480)
.++|.+.+.||+|+||.||++...+++.+|+|+++......+.+.+|+++++.++||||+++++++.+++.+++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 3568999999999999999999888899999999887777788999999999999999999999999999999999999
Q ss_pred CCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccccc
Q 011660 330 NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE 405 (480)
Q Consensus 330 ~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~ 405 (480)
+|+|.+++.. +++..+..++.|++.||.|||+. +|+||||||+||+++.+ +.++|+|||++.......
T Consensus 87 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~-~~~kl~dfg~~~~~~~~~---- 158 (267)
T 3t9t_A 87 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQ---- 158 (267)
T ss_dssp TCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGG-GCEEECCTTGGGGBCCHH----
T ss_pred CCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCC-CCEEEccccccccccccc----
Confidence 5799999954 68889999999999999999999 99999999999999988 689999999987543211
Q ss_pred CccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 406 NVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 406 ~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
........||+.|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 210 (267)
T 3t9t_A 159 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 210 (267)
T ss_dssp HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC
Confidence 112224467889999999998999999999999999999999 899998754
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=324.96 Aligned_cols=196 Identities=23% Similarity=0.371 Sum_probs=172.9
Q ss_pred hcCCCCceeecccCceEEEEEEec-CCcEEEEEEeccCC----ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEE
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTN----WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 325 (480)
..+|.+.+.||+|+||.||+|.+. +|+.||+|+++... .....+.+|+.+++.++||||+++++++.+.+.+++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 357999999999999999999874 79999999996532 2345688999999999999999999999999999999
Q ss_pred Eecc-CCCHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccc
Q 011660 326 YNLL-NGSLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (480)
Q Consensus 326 ~e~~-~GsL~~~l~---~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (480)
|||+ +|+|.+++. .+++.++..++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++......
T Consensus 95 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~-~~vkL~DFG~a~~~~~~- 169 (476)
T 2y94_A 95 MEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDG- 169 (476)
T ss_dssp EECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTT-CCEEECCCSSCEECCTT-
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecC-CCeEEEeccchhhcccc-
Confidence 9999 679999995 378999999999999999999999 99999999999999998 68999999999764331
Q ss_pred ccccCccccccccCCCccccccccCCCC-CchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 402 QVSENVKPVNVVGTFGYLAPEYMMYGKV-DEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 402 ~~~~~~~~~~~~GT~~y~APE~~~~~~~-~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
......+||+.|+|||++.+..+ +.++|||||||++|||++|+.||....
T Consensus 170 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~ 220 (476)
T 2y94_A 170 -----EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH 220 (476)
T ss_dssp -----CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred -----ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC
Confidence 22335689999999999998876 789999999999999999999998754
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=310.70 Aligned_cols=200 Identities=27% Similarity=0.440 Sum_probs=171.1
Q ss_pred hcCCCCceeecccCceEEEEEEe------cCCcEEEEEEeccCC--ccHHHHHHHHHHHhcC-CCCCeeeEEEEEecCCe
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH------VDGQVAAVKVLKCTN--WSEEEVLREVELLSSI-KHENIVRIIGYCHSKEM 321 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~------~~g~~vAvK~~~~~~--~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~ 321 (480)
.++|.+.+.||+|+||.||+|.+ .+++.||+|+++... ...+.+.+|+.+++.+ +||||+++++++.+.+.
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 123 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence 46799999999999999999975 245689999997543 2335789999999999 89999999999999999
Q ss_pred eEEEEecc-CCCHHHHHHh--------------------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCC
Q 011660 322 YAIVYNLL-NGSLKQYLKQ--------------------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKS 374 (480)
Q Consensus 322 ~~lV~e~~-~GsL~~~l~~--------------------------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp 374 (480)
+++||||+ +|+|.+++.. +++.++..++.|++.||.|||+. +|+||||||
T Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp 200 (344)
T 1rjb_A 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAA 200 (344)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSG
T ss_pred cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCh
Confidence 99999999 6799999954 57888999999999999999999 999999999
Q ss_pred CCEEEecCCCceEEeeeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCC
Q 011660 375 SNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQ 453 (480)
Q Consensus 375 ~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~ 453 (480)
+|||++.+ +.+||+|||++....... .........||+.|+|||++.+..++.++|||||||++|||+| |+.||.
T Consensus 201 ~NIll~~~-~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 276 (344)
T 1rjb_A 201 RNVLVTHG-KVVKICDFGLARDIMSDS---NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276 (344)
T ss_dssp GGEEEETT-TEEEECCCGGGSCGGGCT---TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred hhEEEcCC-CcEEeCCCccCcccccCc---cceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence 99999998 699999999997543321 1122334568899999999999999999999999999999998 999998
Q ss_pred CCcc
Q 011660 454 TNKA 457 (480)
Q Consensus 454 ~~~~ 457 (480)
....
T Consensus 277 ~~~~ 280 (344)
T 1rjb_A 277 GIPV 280 (344)
T ss_dssp TCCC
T ss_pred cCCc
Confidence 7654
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=309.08 Aligned_cols=200 Identities=25% Similarity=0.483 Sum_probs=171.1
Q ss_pred hhhhcCCCCceeecccCceEEEEEEe--cCCcEEEEEEeccCCc---cHHHHHHHHHHHhcC---CCCCeeeEEEEEe--
Q 011660 248 CHLTHNFSPKMLIGQGGNSKVYRTNH--VDGQVAAVKVLKCTNW---SEEEVLREVELLSSI---KHENIVRIIGYCH-- 317 (480)
Q Consensus 248 ~~~~~~f~~~~~LG~G~fg~Vy~~~~--~~g~~vAvK~~~~~~~---~~~~~~~Ei~il~~l---~HpnIv~l~~~~~-- 317 (480)
....++|.+.+.||+|+||.||+|.+ .+++.||+|+++.... ....+.+|+.+++.+ +||||+++++++.
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~ 86 (326)
T 1blx_A 7 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 86 (326)
T ss_dssp CCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred cCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence 34567899999999999999999987 4688999999864322 223567788777666 8999999999987
Q ss_pred ---cCCeeEEEEeccCCCHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEe
Q 011660 318 ---SKEMYAIVYNLLNGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLS 389 (480)
Q Consensus 318 ---~~~~~~lV~e~~~GsL~~~l~~-----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~ 389 (480)
....+++||||+.|+|.+++.. +++.++..++.|++.||.|||+. +|+||||||+||+++.+ +.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~-~~~kl~ 162 (326)
T 1blx_A 87 RTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSS-GQIKLA 162 (326)
T ss_dssp ECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTT-CCEEEC
T ss_pred ccCCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCC-CCEEEe
Confidence 5678899999999999999964 78899999999999999999999 99999999999999998 689999
Q ss_pred eeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 390 DFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 390 DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
|||++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 163 Dfg~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 224 (326)
T 1blx_A 163 DFGLARIYSFQ------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 224 (326)
T ss_dssp SCCSCCCCCGG------GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cCcccccccCC------CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 99998654321 123356799999999999999999999999999999999999999987653
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=316.74 Aligned_cols=199 Identities=27% Similarity=0.441 Sum_probs=171.8
Q ss_pred hcCCCCceeecccCceEEEEEEec--------CCcEEEEEEeccCCcc--HHHHHHHHHHHhcC-CCCCeeeEEEEEecC
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHV--------DGQVAAVKVLKCTNWS--EEEVLREVELLSSI-KHENIVRIIGYCHSK 319 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~--------~g~~vAvK~~~~~~~~--~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~ 319 (480)
.++|.+.+.||+|+||.||+|... ++..+|+|+++..... ...+.+|+++++.+ +||||+++++++.++
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 457899999999999999999752 2357999999765432 25688999999999 999999999999999
Q ss_pred CeeEEEEecc-CCCHHHHHHh-------------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEE
Q 011660 320 EMYAIVYNLL-NGSLKQYLKQ-------------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILL 379 (480)
Q Consensus 320 ~~~~lV~e~~-~GsL~~~l~~-------------------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl 379 (480)
+.+++||||+ +|+|.+++.. +++.++..++.|++.||.|||+. +|+||||||+|||+
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEE
Confidence 9999999999 6799999954 78899999999999999999999 99999999999999
Q ss_pred ecCCCceEEeeeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 380 SENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 380 ~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
+.+ +.+||+|||+|+...... .........||+.|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 225 ~~~-~~~kL~DFG~a~~~~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~ 298 (382)
T 3tt0_A 225 TED-NVMKIADFGLARDIHHID---YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 298 (382)
T ss_dssp CTT-CCEEECSCSCCCCSSCCC---TTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cCC-CcEEEcccCccccccccc---ccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 998 689999999997544321 1122334567899999999999999999999999999999999 999998654
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=314.54 Aligned_cols=203 Identities=24% Similarity=0.331 Sum_probs=168.5
Q ss_pred HHHHhhhhcCCCCceeecccCceEEEEEEecCCcEEEEEEeccCCcc------------HHHHHHHHHHHhcCCCCCeee
Q 011660 244 SQELCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWS------------EEEVLREVELLSSIKHENIVR 311 (480)
Q Consensus 244 ~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~------------~~~~~~Ei~il~~l~HpnIv~ 311 (480)
..++..+.++|.+.+.||+|+||.||+|...+++.||+|++...... .+.+.+|+++++.++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 45667778999999999999999999998888999999998643221 266889999999999999999
Q ss_pred EEEEEe-----cCCeeEEEEeccCCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecC
Q 011660 312 IIGYCH-----SKEMYAIVYNLLNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN 382 (480)
Q Consensus 312 l~~~~~-----~~~~~~lV~e~~~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~ 382 (480)
+++++. ....+++||||+.|+|.+++.. +++.++..++.|++.||.|||+. +|+||||||+|||++.+
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~ 170 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADN 170 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTT
T ss_pred eeeeEEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEcCC
Confidence 999984 3347899999999999999853 78899999999999999999999 99999999999999988
Q ss_pred CCceEEeeeccccccccccccccCccccccccCCCccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 383 FHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 383 ~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~-~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
+.+||+|||++..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 171 -~~~kl~Dfg~~~~~~~------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 238 (362)
T 3pg1_A 171 -NDITICDFNLAREDTA------DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST 238 (362)
T ss_dssp -CCEEECCTTC---------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred -CCEEEEecCccccccc------ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC
Confidence 6899999999964322 222335679999999999887 678999999999999999999999998765
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=301.31 Aligned_cols=198 Identities=27% Similarity=0.432 Sum_probs=174.0
Q ss_pred hhcCCCCceeecccCceEEEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~ 329 (480)
..++|++.+.||+|+||.||+|...+++.+|+|+++......+.+.+|+++++.++||||+++++++.+ +..++||||+
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 89 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecC
Confidence 356799999999999999999998888899999998777677889999999999999999999999875 4578999999
Q ss_pred -CCCHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccc
Q 011660 330 -NGSLKQYLK-----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (480)
Q Consensus 330 -~GsL~~~l~-----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (480)
+|+|.+++. .+++.++..++.|++.||.|||+. +|+||||||+||+++.+ +.+||+|||++........
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~- 164 (279)
T 1qpc_A 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDT-LSCKIADFGLARLIEDNEY- 164 (279)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTT-SCEEECCCTTCEECSSSCE-
T ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCC-CCEEECCCcccccccCccc-
Confidence 689999985 488999999999999999999999 99999999999999988 6899999999976543221
Q ss_pred ccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 404 SENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 404 ~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
.......||+.|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 165 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 215 (279)
T 1qpc_A 165 ---TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT 215 (279)
T ss_dssp ---ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred ---ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccC
Confidence 11224457889999999998899999999999999999999 999998754
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=313.69 Aligned_cols=203 Identities=26% Similarity=0.394 Sum_probs=172.8
Q ss_pred hhhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCcc--HHHHHHHHHHHhcCCCCCeeeEEEEEecC-----C
Q 011660 249 HLTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSK-----E 320 (480)
Q Consensus 249 ~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~ 320 (480)
.+.++|++.+.||+|+||.||+|.. .+++.||+|++...... ...+.+|+++++.++||||+++++++... .
T Consensus 24 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 3456899999999999999999976 56889999999754422 25688999999999999999999999654 4
Q ss_pred eeEEEEeccCCCHHHHHHh--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccc
Q 011660 321 MYAIVYNLLNGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (480)
Q Consensus 321 ~~~lV~e~~~GsL~~~l~~--~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~ 398 (480)
.+++|||+++|+|.++++. +++.++..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||++....
T Consensus 104 ~~~iv~e~~~~~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~-~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 104 DVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTT-CDLKICDFGLARVAD 179 (364)
T ss_dssp CEEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTT-CCEEECCCTTCEECC
T ss_pred eEEEEEcccCcCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCC-CCEEEEeCcceEecC
Confidence 6899999999999999864 78899999999999999999999 99999999999999998 689999999997654
Q ss_pred cccccccCccccccccCCCccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 399 QSHQVSENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 399 ~~~~~~~~~~~~~~~GT~~y~APE~~~~-~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
.... ........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 180 ~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 237 (364)
T 3qyz_A 180 PDHD--HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 237 (364)
T ss_dssp GGGC--BCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSG
T ss_pred CCCC--ccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCCh
Confidence 3221 1112345689999999998764 4589999999999999999999999987654
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=316.57 Aligned_cols=195 Identities=25% Similarity=0.393 Sum_probs=164.5
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCcc---HHHHHHHHHHHhcCCCCCeeeEEEEEecC------C
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSK------E 320 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------~ 320 (480)
.++|.+.+.||+|+||.||+|.+ .+|+.||+|++...... .+.+.+|+++++.++||||+++++++... .
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 46799999999999999999976 56999999999654433 34678999999999999999999999765 3
Q ss_pred eeEEEEeccCCCHHHHHHh--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccc
Q 011660 321 MYAIVYNLLNGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (480)
Q Consensus 321 ~~~lV~e~~~GsL~~~l~~--~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~ 398 (480)
.+++||||++++|.++++. +++..+..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||+|+...
T Consensus 104 ~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 104 DFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNED-CELKILDFGLARQAD 179 (367)
T ss_dssp CCEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTT-CCEEECCCTTCEECC
T ss_pred eEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCC-CCEEEEeeecccccc
Confidence 4699999999999999864 78889999999999999999999 99999999999999998 689999999997533
Q ss_pred cccccccCccccccccCCCccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 399 QSHQVSENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 399 ~~~~~~~~~~~~~~~GT~~y~APE~~~~-~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
. .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.
T Consensus 180 ~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 231 (367)
T 1cm8_A 180 S--------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH 231 (367)
T ss_dssp S--------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred c--------ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 2 1235679999999999887 6799999999999999999999999987653
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-37 Score=297.99 Aligned_cols=196 Identities=22% Similarity=0.307 Sum_probs=170.4
Q ss_pred hhcCCCCceeecccCceEEEEEEec-CCcEEEEEEeccC-CccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEe
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCT-NWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e 327 (480)
+.++|.+.+.||+|+||.||+|... ++..+|+|.+... ....+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 3457999999999999999999774 5779999998654 3345778999999999999999999999999999999999
Q ss_pred cc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEE---ecCCCceEEeeeccccccccc
Q 011660 328 LL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILL---SENFHHPQLSDFGAAMVHHQS 400 (480)
Q Consensus 328 ~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl---~~~~~~~kL~DFGla~~~~~~ 400 (480)
|+ +++|.+++.. +++.++..++.|++.||.|||+. +|+||||||+||++ +.+ +.++|+|||++......
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~-~~~~l~Dfg~~~~~~~~ 162 (277)
T 3f3z_A 87 LCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPD-SPLKLIDFGLAARFKPG 162 (277)
T ss_dssp CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTT-CCEEECCCTTCEECCTT
T ss_pred ccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCC-CcEEEEecccceeccCc
Confidence 99 6789888843 78999999999999999999999 99999999999999 666 68999999998654332
Q ss_pred cccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 401 ~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.......||+.|+|||++.+ .++.++||||||+++|||++|+.||....
T Consensus 163 ------~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 211 (277)
T 3f3z_A 163 ------KMMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPT 211 (277)
T ss_dssp ------SCBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ------cchhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCC
Confidence 12234579999999998865 49999999999999999999999998754
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=311.10 Aligned_cols=198 Identities=24% Similarity=0.468 Sum_probs=161.0
Q ss_pred cCCCCceeecccCceEEEEEEec-CCc----EEEEEEeccCC--ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHV-DGQ----VAAVKVLKCTN--WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAI 324 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~----~vAvK~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 324 (480)
++|++.+.||+|+||.||+|.+. +++ .+|+|.++... ...+.+.+|+.++++++||||++++++|.+.+ .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 56999999999999999999763 444 35888875433 34567899999999999999999999998876 455
Q ss_pred EEecc-CCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccc
Q 011660 325 VYNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (480)
Q Consensus 325 V~e~~-~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~ 399 (480)
+++++ +|+|.+++.. +++..+..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||+|+....
T Consensus 94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~-~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTP-QHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEET-TEEEECCTTHHHHHTT
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCC-CCEEEccCcceeEccC
Confidence 66666 8899999854 78899999999999999999999 99999999999999998 6899999999976543
Q ss_pred ccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCcc
Q 011660 400 SHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKA 457 (480)
Q Consensus 400 ~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~~ 457 (480)
.. .........||+.|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 170 ~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 225 (327)
T 3poz_A 170 EE---KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 225 (327)
T ss_dssp TC---C-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred Cc---ccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH
Confidence 22 1122234467889999999999999999999999999999999 9999987654
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=329.06 Aligned_cols=199 Identities=28% Similarity=0.464 Sum_probs=175.4
Q ss_pred hcCCCCceeecccCceEEEEEEecC-CcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~~-g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~ 329 (480)
.++|.+.+.||+|+||.||+|.+.. +..||||+++......+.+.+|+.+|++++||||++++++|.+.+.+++||||+
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~ 298 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 298 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEcc
Confidence 3468889999999999999998754 889999999877777788999999999999999999999999999999999999
Q ss_pred -CCCHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccc
Q 011660 330 -NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (480)
Q Consensus 330 -~GsL~~~l~~-----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (480)
+|+|.+++.. +++..+..++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||+++.......
T Consensus 299 ~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~~~~- 373 (495)
T 1opk_A 299 TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGEN-HLVKVADFGLSRLMTGDTY- 373 (495)
T ss_dssp TTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGG-GCEEECCTTCEECCTTCCE-
T ss_pred CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCC-CcEEEeecccceeccCCce-
Confidence 5899999953 77888999999999999999999 99999999999999988 6899999999976533211
Q ss_pred ccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCcc
Q 011660 404 SENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKA 457 (480)
Q Consensus 404 ~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~~ 457 (480)
.......+|+.|+|||++.+..++.++|||||||+||||++ |+.||...+.
T Consensus 374 ---~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~ 425 (495)
T 1opk_A 374 ---TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 425 (495)
T ss_dssp ---ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred ---eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH
Confidence 11223456889999999999999999999999999999999 9999987653
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=316.31 Aligned_cols=200 Identities=26% Similarity=0.415 Sum_probs=160.2
Q ss_pred hcCCCCceeecccCceEEEEEEec----CCcEEEEEEeccCCc--cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEE
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHV----DGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAI 324 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~----~g~~vAvK~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 324 (480)
.++|.+.+.||+|+||.||+|.+. ++..||+|+++.... ..+.+.+|+.+++.++||||+++++++.+.+.+++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 357999999999999999999764 467899999976532 23568899999999999999999999999999999
Q ss_pred EEecc-CCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccc
Q 011660 325 VYNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (480)
Q Consensus 325 V~e~~-~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~ 399 (480)
||||+ +|+|.+++.. +++.++..++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||+++....
T Consensus 124 v~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSN-LVCKVSDFGLGRVLED 199 (373)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTT-CCEEECCC--------
T ss_pred EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCC-CCEEECcCcccccccc
Confidence 99999 7899999953 78899999999999999999999 99999999999999998 6899999999976543
Q ss_pred ccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 400 SHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 400 ~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
.... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 200 ~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~ 255 (373)
T 2qol_A 200 DPEA--AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC
T ss_pred CCcc--ceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCC
Confidence 2111 111122346789999999999999999999999999999998 999997654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=321.21 Aligned_cols=193 Identities=26% Similarity=0.429 Sum_probs=168.2
Q ss_pred hcCCCCceeecccCceEEEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEEEecCC-eeEEEEecc
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKE-MYAIVYNLL 329 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-~~~lV~e~~ 329 (480)
.++|.+.+.||+|+||.||+|... ++.||||+++... ..+.+.+|+++|++++||||+++++++.+.+ .+++||||+
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~ 269 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 269 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence 456889999999999999999874 7899999998654 5578999999999999999999999986654 789999999
Q ss_pred -CCCHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccc
Q 011660 330 -NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (480)
Q Consensus 330 -~GsL~~~l~~-----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (480)
+|+|.+++.. +++..+..++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||+++.....
T Consensus 270 ~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~-~~~kl~DfG~a~~~~~~--- 342 (450)
T 1k9a_A 270 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSED-NVAKVSDFGLTKEASST--- 342 (450)
T ss_dssp TTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTT-SCEEECCCTTCEECC-----
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCC-CCEEEeeCCCccccccc---
Confidence 6799999964 57888999999999999999999 99999999999999998 68999999999643221
Q ss_pred ccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCcc
Q 011660 404 SENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKA 457 (480)
Q Consensus 404 ~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~~ 457 (480)
.....+|+.|+|||++.+..++.++|||||||+||||+| |+.||.....
T Consensus 343 -----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~ 392 (450)
T 1k9a_A 343 -----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 392 (450)
T ss_dssp ---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCT
T ss_pred -----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 122357899999999999999999999999999999998 9999987654
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=304.48 Aligned_cols=200 Identities=27% Similarity=0.408 Sum_probs=172.8
Q ss_pred hcCCCCceeecccCceEEEEEEe------cCCcEEEEEEeccCCc--cHHHHHHHHHHHhcC-CCCCeeeEEEEEecCCe
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH------VDGQVAAVKVLKCTNW--SEEEVLREVELLSSI-KHENIVRIIGYCHSKEM 321 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~------~~g~~vAvK~~~~~~~--~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~ 321 (480)
.++|.+.+.||+|+||.||+|.. .+++.+|+|+++.... ..+.+.+|+++++.+ +||||+++++++.+++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 46799999999999999999974 3467999999976543 235688999999999 99999999999999999
Q ss_pred eEEEEecc-CCCHHHHHHh---------------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEE
Q 011660 322 YAIVYNLL-NGSLKQYLKQ---------------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILL 379 (480)
Q Consensus 322 ~~lV~e~~-~GsL~~~l~~---------------------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl 379 (480)
.++||||+ +|+|.+++.. +++.++..++.|++.||.|||+. +|+||||||+||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEE
Confidence 99999999 5699999953 67889999999999999999999 99999999999999
Q ss_pred ecCCCceEEeeeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCcc
Q 011660 380 SENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKA 457 (480)
Q Consensus 380 ~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~~ 457 (480)
+.+ +.+||+|||++........ ........||+.|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 179 ~~~-~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 253 (313)
T 1t46_A 179 THG-RITKICDFGLARDIKNDSN---YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (313)
T ss_dssp ETT-TEEEECCCGGGSCTTSCTT---SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred cCC-CCEEEcccccccccccccc---ceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence 998 7899999999976543221 112234567899999999999999999999999999999999 9999987654
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=321.90 Aligned_cols=193 Identities=18% Similarity=0.273 Sum_probs=160.5
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCC----ccHHHHHHHH---HHHhcCCCCCeeeEE-------EE
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREV---ELLSSIKHENIVRII-------GY 315 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ei---~il~~l~HpnIv~l~-------~~ 315 (480)
.++|.+.+.||+|+||.||+|.+ .+|+.||||+++... ...+.+.+|+ ++++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46788999999999999999986 569999999997432 2346788999 455666899999998 66
Q ss_pred EecCC-----------------eeEEEEeccCCCHHHHHHh---CCH-------HHHHHHHHHHHHHHHHHHhCCCCCeE
Q 011660 316 CHSKE-----------------MYAIVYNLLNGSLKQYLKQ---LKW-------NERMDVAIGVAKALEYLHHTCDPPII 368 (480)
Q Consensus 316 ~~~~~-----------------~~~lV~e~~~GsL~~~l~~---~~~-------~~~~~i~~~ia~aL~yLH~~~~~~Ii 368 (480)
+.+.+ ..++||||++|+|.+++.. ++. ..+..++.||+.||.|||+. +|+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iv 228 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLV 228 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 66553 3889999999999999963 433 77788999999999999999 999
Q ss_pred eccCCCCCEEEecCCCceEEeeeccccccccccccccCccccccccCCCccccccccCC-----------CCCchHHHHH
Q 011660 369 HRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYG-----------KVDEKIDVYS 437 (480)
Q Consensus 369 HrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~-----------~~~~k~DvwS 437 (480)
||||||+|||++.+ +.+||+|||+|+.... .....+| +.|+|||++.+. .++.++||||
T Consensus 229 HrDikp~NIll~~~-~~~kL~DFG~a~~~~~--------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwS 298 (377)
T 3byv_A 229 HTYLRPVDIVLDQR-GGVFLTGFEHLVRDGA--------RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWA 298 (377)
T ss_dssp CSCCCGGGEEECTT-CCEEECCGGGCEETTC--------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHH
T ss_pred cCCCCHHHEEEcCC-CCEEEEechhheecCC--------cccCCCC-cCccChhhhcccccccccccccccCChhhhHHH
Confidence 99999999999998 7999999999964221 2335578 999999999887 8999999999
Q ss_pred HHHHHHHHHcCCCCCCCCc
Q 011660 438 YGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 438 lGvil~eLltG~~pf~~~~ 456 (480)
|||+||||++|+.||....
T Consensus 299 lG~il~elltg~~Pf~~~~ 317 (377)
T 3byv_A 299 LGLVIYWIWCADLPITKDA 317 (377)
T ss_dssp HHHHHHHHHHSSCCC----
T ss_pred HHHHHHHHHHCCCCCcccc
Confidence 9999999999999997654
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=314.26 Aligned_cols=198 Identities=28% Similarity=0.399 Sum_probs=168.8
Q ss_pred cCCCCceeecccCceEEEEEEe----cCCcEEEEEEeccCC-----ccHHHHHHHHHHHhcC-CCCCeeeEEEEEecCCe
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH----VDGQVAAVKVLKCTN-----WSEEEVLREVELLSSI-KHENIVRIIGYCHSKEM 321 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~----~~g~~vAvK~~~~~~-----~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~ 321 (480)
++|.+.+.||+|+||.||++.. .+++.||+|+++... ...+.+.+|+++++.+ +||||+++++++.+.+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 5699999999999999999977 368999999987532 2335577899999999 79999999999999999
Q ss_pred eEEEEecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccc
Q 011660 322 YAIVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVH 397 (480)
Q Consensus 322 ~~lV~e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~ 397 (480)
+++||||+ +|+|.+++.. +++.++..++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||+++..
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~-~~~kl~DfG~a~~~ 209 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSN-GHVVLTDFGLSKEF 209 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTT-SCEEESCSSEEEEC
T ss_pred EEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCC-CcEEEeeCCCCeec
Confidence 99999999 6799999853 78899999999999999999999 99999999999999998 68999999999754
Q ss_pred ccccccccCccccccccCCCccccccccC--CCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 398 HQSHQVSENVKPVNVVGTFGYLAPEYMMY--GKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 398 ~~~~~~~~~~~~~~~~GT~~y~APE~~~~--~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
.... .......+||+.|+|||++.+ ..++.++|||||||+||||++|+.||.....
T Consensus 210 ~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~ 267 (355)
T 1vzo_A 210 VADE----TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGE 267 (355)
T ss_dssp CGGG----GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTS
T ss_pred ccCC----CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCc
Confidence 3211 122335679999999999986 3478999999999999999999999986543
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=312.18 Aligned_cols=203 Identities=19% Similarity=0.228 Sum_probs=165.6
Q ss_pred hcCCCCceeecccCceEEEEEEec----CCcEEEEEEeccCCcc------------HHHHHHHHHHHhcCCCCCeeeEEE
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHV----DGQVAAVKVLKCTNWS------------EEEVLREVELLSSIKHENIVRIIG 314 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~----~g~~vAvK~~~~~~~~------------~~~~~~Ei~il~~l~HpnIv~l~~ 314 (480)
.++|.+.+.||+|+||.||+|... ++..+|+|++...... ...+.+|+.+++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 356999999999999999999774 5778999999765421 123667889999999999999999
Q ss_pred EEec----CCeeEEEEeccCCCHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCC--c
Q 011660 315 YCHS----KEMYAIVYNLLNGSLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFH--H 385 (480)
Q Consensus 315 ~~~~----~~~~~lV~e~~~GsL~~~l~---~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~--~ 385 (480)
++.+ ...+++||||++|+|.+++. .+++.++..++.||+.||.|||+. +|+||||||+|||++.+ + .
T Consensus 116 ~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~-~~~~ 191 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYK-NPDQ 191 (345)
T ss_dssp EEEEESSSCEEEEEEEECEEEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESS-STTS
T ss_pred ccccccCCCcEEEEEEeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccC-CCCc
Confidence 9977 77899999999889999995 489999999999999999999999 99999999999999977 5 8
Q ss_pred eEEeeeccccccccccccc--cCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 386 PQLSDFGAAMVHHQSHQVS--ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 386 ~kL~DFGla~~~~~~~~~~--~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
+||+|||+|+......... .........||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~ 265 (345)
T 2v62_A 192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLK 265 (345)
T ss_dssp EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTT
T ss_pred EEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 9999999997654322111 11222456899999999999999999999999999999999999999976443
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=304.85 Aligned_cols=200 Identities=29% Similarity=0.459 Sum_probs=176.7
Q ss_pred hhcCCCCceeecccCceEEEEEEec-CCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEec
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~ 328 (480)
..++|.+.+.||+|+||.||+|.+. +++.+|+|+++......+.+.+|+++++.++||||+++++++.+++.+++||||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 90 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 90 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEc
Confidence 4567999999999999999999774 488999999987776778899999999999999999999999999999999999
Q ss_pred cC-CCHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccc
Q 011660 329 LN-GSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 329 ~~-GsL~~~l~~-----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (480)
+. |+|.+++.. +++..+..++.|++.||.|||+. +|+||||||+||+++.+ +.++|+|||++.......
T Consensus 91 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~-~~~~l~Dfg~~~~~~~~~- 165 (288)
T 3kfa_A 91 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDT- 165 (288)
T ss_dssp CTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGG-GCEEECCCCGGGTSCSSS-
T ss_pred CCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCC-CCEEEccCccceeccCCc-
Confidence 95 799999954 78889999999999999999999 99999999999999988 689999999997544321
Q ss_pred cccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCcc
Q 011660 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKA 457 (480)
Q Consensus 403 ~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~~ 457 (480)
........||+.|+|||++.+..++.++||||||+++|||++ |..||.....
T Consensus 166 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~ 218 (288)
T 3kfa_A 166 ---YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 218 (288)
T ss_dssp ---SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred ---cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 112234467889999999999999999999999999999999 9999987653
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=309.59 Aligned_cols=203 Identities=22% Similarity=0.338 Sum_probs=157.3
Q ss_pred hhhhcCCCCceeecccCceEEEEEEecC-Cc---EEEEEEeccCC---ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCC
Q 011660 248 CHLTHNFSPKMLIGQGGNSKVYRTNHVD-GQ---VAAVKVLKCTN---WSEEEVLREVELLSSIKHENIVRIIGYCHSKE 320 (480)
Q Consensus 248 ~~~~~~f~~~~~LG~G~fg~Vy~~~~~~-g~---~vAvK~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 320 (480)
....++|.+.+.||+|+||.||+|.... +. .+|+|+++... ...+.+.+|+++++.++||||+++++++.+.+
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence 3445689999999999999999997643 32 79999997643 23467889999999999999999999998766
Q ss_pred ee------EEEEecc-CCCHHHHHH---------hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCC
Q 011660 321 MY------AIVYNLL-NGSLKQYLK---------QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFH 384 (480)
Q Consensus 321 ~~------~lV~e~~-~GsL~~~l~---------~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~ 384 (480)
.. ++||||+ +|+|.+++. .+++.++..++.|++.||.|||+. +|+||||||+|||++.+ +
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~-~ 174 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAED-M 174 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTT-S
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCC-C
Confidence 54 8999999 679999984 378899999999999999999999 99999999999999998 7
Q ss_pred ceEEeeeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCcc
Q 011660 385 HPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKA 457 (480)
Q Consensus 385 ~~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~~ 457 (480)
.+||+|||++........ ........||+.|+|||.+.+..++.++|||||||++|||++ |+.||.....
T Consensus 175 ~~kl~Dfg~a~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~ 245 (323)
T 3qup_A 175 TVCVADFGLSRKIYSGDY---YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN 245 (323)
T ss_dssp CEEECCCCC--------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred CEEEeecccccccccccc---ccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccCh
Confidence 899999999976433221 112234457889999999999999999999999999999999 9999987654
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=297.91 Aligned_cols=197 Identities=27% Similarity=0.412 Sum_probs=170.3
Q ss_pred hcCCCCceeecccCceEEEEEEec-CCcEEEEEEeccCCc-------cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCee
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNW-------SEEEVLREVELLSSIKHENIVRIIGYCHSKEMY 322 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~-------~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 322 (480)
.++|.+.+.||+|+||.||++... +++.+|+|+++.... ..+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 356899999999999999999775 689999999975432 356789999999999999999999999999999
Q ss_pred EEEEecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCC---CceEEeeecccc
Q 011660 323 AIVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENF---HHPQLSDFGAAM 395 (480)
Q Consensus 323 ~lV~e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~---~~~kL~DFGla~ 395 (480)
++||||+ +++|.+++.. +++.++..++.|++.||.|||+. +|+||||||+||+++.+. ..++|+|||++.
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence 9999999 6899999953 88999999999999999999999 999999999999998762 179999999986
Q ss_pred ccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 396 VHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 161 ~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 215 (283)
T 3bhy_A 161 KIEAG------NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET 215 (283)
T ss_dssp ECC--------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred eccCC------CcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc
Confidence 54321 12234579999999999999999999999999999999999999998754
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=301.06 Aligned_cols=196 Identities=27% Similarity=0.377 Sum_probs=165.8
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCC--ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEe
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN--WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e 327 (480)
.++|.+.+.||+|+||.||++.. .+++.+|+|++.... ...+.+.+|+++++.++||||+++++++.+.+.+++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 35699999999999999999976 568899999996543 345788999999999999999999999999999999999
Q ss_pred cc-CCCHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecC--CCceEEeeecccccc
Q 011660 328 LL-NGSLKQYLK-------QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN--FHHPQLSDFGAAMVH 397 (480)
Q Consensus 328 ~~-~GsL~~~l~-------~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~--~~~~kL~DFGla~~~ 397 (480)
|+ +|+|.+++. .+++..+..++.|++.||.|||+. +|+||||||+|||++.+ .+.+||+|||++...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99 569998883 388899999999999999999999 99999999999999432 257999999999654
Q ss_pred ccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 398 HQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 398 ~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
... .......||+.|+|||++. +.++.++|||||||++|||++|+.||....
T Consensus 178 ~~~------~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~ 229 (285)
T 3is5_A 178 KSD------EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS 229 (285)
T ss_dssp ---------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCc------ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCC
Confidence 321 2233567999999999875 578999999999999999999999998754
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-37 Score=304.15 Aligned_cols=194 Identities=26% Similarity=0.431 Sum_probs=161.3
Q ss_pred cCCCCceeecccCceEEEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc-C
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-N 330 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~-~ 330 (480)
++|++.+.||+|+||.||++.. .++.+|+|++.... ..+.+.+|++++++++||||+++++++.+ ..++||||+ +
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~ 83 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESES-ERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEG 83 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSSTT-HHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTT
T ss_pred hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecChh-HHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCC
Confidence 4688999999999999999987 47889999997443 45678999999999999999999999874 478999999 6
Q ss_pred CCHHHHHHh------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccc
Q 011660 331 GSLKQYLKQ------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (480)
Q Consensus 331 GsL~~~l~~------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (480)
|+|.+++.. +....+..++.|+++||.|||+.+.++|+||||||+|||++.+...+||+|||++.....
T Consensus 84 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~----- 158 (307)
T 2eva_A 84 GSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT----- 158 (307)
T ss_dssp CBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----------
T ss_pred CCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc-----
Confidence 799999964 567888999999999999999954449999999999999998833489999999864322
Q ss_pred cCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 405 ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 405 ~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 159 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 208 (307)
T 2eva_A 159 ---HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGG 208 (307)
T ss_dssp ---------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCS
T ss_pred ---ccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCc
Confidence 12234699999999999999999999999999999999999999986543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=304.15 Aligned_cols=199 Identities=29% Similarity=0.433 Sum_probs=166.2
Q ss_pred hcCCCCceeecccCceEEEEEEe-----cCCcEEEEEEeccCCcc-HHHHHHHHHHHhcCCCCCeeeEEEEEec--CCee
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-----VDGQVAAVKVLKCTNWS-EEEVLREVELLSSIKHENIVRIIGYCHS--KEMY 322 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-----~~g~~vAvK~~~~~~~~-~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~ 322 (480)
.++|++.+.||+|+||.||++.+ .+++.||+|+++..... .+.+.+|+++++.++||||+++++++.. ...+
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 45799999999999999999973 35889999999765432 3568899999999999999999999854 4568
Q ss_pred EEEEecc-CCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccc
Q 011660 323 AIVYNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVH 397 (480)
Q Consensus 323 ~lV~e~~-~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~ 397 (480)
++||||+ +|+|.+++.. +++.++..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||++...
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~-~~~kl~Dfg~~~~~ 164 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENE-NRVKIGDFGLTKVL 164 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEET-TEEEECCCCSCC--
T ss_pred EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCC-CeEEEccCcccccc
Confidence 9999999 6799999954 88899999999999999999999 99999999999999998 68999999999765
Q ss_pred ccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 011660 398 HQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTN 455 (480)
Q Consensus 398 ~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~ 455 (480)
...... ........||+.|+|||++.+..++.++|||||||++|||++|..||...
T Consensus 165 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~ 220 (295)
T 3ugc_A 165 PQDKEF--FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP 220 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSH
T ss_pred cCCcce--eeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCC
Confidence 432211 11223445788899999999999999999999999999999999998764
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-37 Score=302.51 Aligned_cols=198 Identities=24% Similarity=0.361 Sum_probs=164.7
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCcc---HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEE
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 326 (480)
.++|++.+.||+|+||.||+|.. .+++.+|+|++...... .+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 35799999999999999999977 45899999998765543 245789999999999999999999999999999999
Q ss_pred eccC-CCHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccc
Q 011660 327 NLLN-GSLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 327 e~~~-GsL~~~l~---~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (480)
||+. ++|.+++. .+++..+..++.|++.||.|||+. +|+||||||+||+++.+ +.+||+|||++.......
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~- 156 (311)
T 4agu_A 82 EYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKH-SVIKLCDFGFARLLTGPS- 156 (311)
T ss_dssp ECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT-SCEEECCCTTCEECC----
T ss_pred EeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCC-CCEEEeeCCCchhccCcc-
Confidence 9995 45777664 378899999999999999999999 99999999999999998 689999999996543221
Q ss_pred cccCccccccccCCCccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 403 VSENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 403 ~~~~~~~~~~~GT~~y~APE~~~~-~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 157 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 208 (311)
T 4agu_A 157 ----DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSD 208 (311)
T ss_dssp -------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ----cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 12234579999999999876 6689999999999999999999999987654
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-37 Score=299.01 Aligned_cols=195 Identities=29% Similarity=0.483 Sum_probs=168.3
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCC----ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEE
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 325 (480)
.++|++.+.||+|+||.||+|.+ .+++.+|+|++.... .....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 45799999999999999999976 457899999986432 2245688999999999999999999999999999999
Q ss_pred Eecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccc
Q 011660 326 YNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (480)
Q Consensus 326 ~e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (480)
|||+ +|+|.+++.. +++..+..++.|++.||.|||+. +|+||||||+|||++.+ +.++|+|||++.....
T Consensus 88 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~-~~~~l~Dfg~~~~~~~-- 161 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSA-GELKIADFGWSVHAPS-- 161 (279)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTT-SCEEECSCCEESCC----
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCC-CCEEEEeccccccCCc--
Confidence 9999 5689998854 78899999999999999999998 99999999999999998 6899999999854322
Q ss_pred ccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 402 QVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 402 ~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.......||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 162 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 211 (279)
T 3fdn_A 162 -----SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 211 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred -----ccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc
Confidence 12235579999999999999999999999999999999999999998654
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=323.56 Aligned_cols=197 Identities=28% Similarity=0.450 Sum_probs=168.7
Q ss_pred hcCCCCceeecccCceEEEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc-
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL- 329 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~- 329 (480)
.++|.+.+.||+|+||.||+|.+.++..||||+++......+.+.+|+++|+.++||||+++++++.+ +.+++||||+
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~ 261 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 261 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhc
Confidence 34688899999999999999998888889999998777677889999999999999999999999976 6788999999
Q ss_pred CCCHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccc
Q 011660 330 NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (480)
Q Consensus 330 ~GsL~~~l~~-----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (480)
+|+|.+++.. +++.++..++.|++.||.|||++ +|+||||||+|||++.+ +.+||+|||+++.......
T Consensus 262 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~-~~~kl~DfG~a~~~~~~~~-- 335 (452)
T 1fmk_A 262 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGEN-LVCKVADFGLARLIEDNEY-- 335 (452)
T ss_dssp TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGG-GCEEECCCCTTC---------
T ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCC-CCEEECCCccceecCCCce--
Confidence 6799999952 78899999999999999999999 99999999999999988 6899999999976443211
Q ss_pred cCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 405 ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 405 ~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
.......+|+.|+|||++.+..++.++|||||||+||||++ |+.||....
T Consensus 336 --~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~ 386 (452)
T 1fmk_A 336 --TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV 386 (452)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred --ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCC
Confidence 11223457889999999999999999999999999999999 999998754
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=298.02 Aligned_cols=194 Identities=28% Similarity=0.509 Sum_probs=165.5
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCccH--------HHHHHHHHHHhcCCCCCeeeEEEEEecCCe
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSE--------EEVLREVELLSSIKHENIVRIIGYCHSKEM 321 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~~--------~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 321 (480)
.++|++.+.||+|+||.||+|.+ .+++.||+|++....... +.+.+|+++++.++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 45799999999999999999977 578999999996543221 56889999999999999999999997665
Q ss_pred eEEEEecc-CCCHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeccCCCCCEEEecCCCc-----eEEe
Q 011660 322 YAIVYNLL-NGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPP--IIHRDVKSSNILLSENFHH-----PQLS 389 (480)
Q Consensus 322 ~~lV~e~~-~GsL~~~l~----~~~~~~~~~i~~~ia~aL~yLH~~~~~~--IiHrDlKp~NILl~~~~~~-----~kL~ 389 (480)
++||||+ +|+|.+++. .+++..+..++.|++.||.|||+. + |+||||||+|||++.+ +. +||+
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~-~~~~~~~~kl~ 171 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSL-DENAPVCAKVA 171 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCC-CTTCSCCEEEC
T ss_pred -eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEecc-CCCCceeEEeC
Confidence 6899999 589988883 378899999999999999999998 8 9999999999999876 44 9999
Q ss_pred eeccccccccccccccCccccccccCCCccccccc--cCCCCCchHHHHHHHHHHHHHHcCCCCCCCCccc
Q 011660 390 DFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYM--MYGKVDEKIDVYSYGVVLLELITGKEAIQTNKAN 458 (480)
Q Consensus 390 DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~--~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~~ 458 (480)
|||++..... ......||+.|+|||++ ....++.++|||||||++|||++|+.||......
T Consensus 172 Dfg~~~~~~~--------~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 234 (287)
T 4f0f_A 172 DFGLSQQSVH--------SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG 234 (287)
T ss_dssp CCTTCBCCSS--------CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCC
T ss_pred CCCccccccc--------cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccccc
Confidence 9999863221 23356799999999998 3556789999999999999999999999876544
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=298.97 Aligned_cols=198 Identities=32% Similarity=0.535 Sum_probs=160.2
Q ss_pred hcCCCCceeecccCceEEEEEEecCCcEEEEEEeccCCc-----cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEE
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNW-----SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~-----~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 325 (480)
.++|++.+.||+|+||.||+|.+. ++.+|+|+++.... ..+.+.+|+++++.++||||+++++++.+++.+++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 357899999999999999999874 88999999875432 235688999999999999999999999999999999
Q ss_pred Eecc-CCCHHHHHH--hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecC-------CCceEEeeecccc
Q 011660 326 YNLL-NGSLKQYLK--QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN-------FHHPQLSDFGAAM 395 (480)
Q Consensus 326 ~e~~-~GsL~~~l~--~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~-------~~~~kL~DFGla~ 395 (480)
|||+ +|+|.+++. .+++.++..++.|++.||.|||+....+|+||||||+|||++.+ .+.+||+|||++.
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~ 164 (271)
T 3dtc_A 85 MEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164 (271)
T ss_dssp EECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC--
T ss_pred EEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccc
Confidence 9999 678999984 47889999999999999999999911129999999999999862 2679999999996
Q ss_pred ccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 396 VHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
..... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 165 ~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 218 (271)
T 3dtc_A 165 EWHRT-------TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID 218 (271)
T ss_dssp ------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSC
T ss_pred ccccc-------cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 53321 1224579999999999999999999999999999999999999998754
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=322.30 Aligned_cols=197 Identities=26% Similarity=0.439 Sum_probs=168.6
Q ss_pred hhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCC--------------ccHHHHHHHHHHHhcCCCCCeeeEEE
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN--------------WSEEEVLREVELLSSIKHENIVRIIG 314 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~--------------~~~~~~~~Ei~il~~l~HpnIv~l~~ 314 (480)
+.++|.+.+.||+|+||.||+|.+ .+++.+|+|+++... ...+.+.+|+.+++.++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 456799999999999999999977 458899999997643 22356889999999999999999999
Q ss_pred EEecCCeeEEEEecc-CCCHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCC--ceEE
Q 011660 315 YCHSKEMYAIVYNLL-NGSLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFH--HPQL 388 (480)
Q Consensus 315 ~~~~~~~~~lV~e~~-~GsL~~~l~---~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~--~~kL 388 (480)
++.+.+.+++||||+ +|+|.+++. .+++.++..++.||+.||.|||+. +|+||||||+|||++.+.. .+||
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl 190 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKI 190 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSEEE
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccEEE
Confidence 999999999999999 679988884 488999999999999999999999 9999999999999987621 6999
Q ss_pred eeeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 389 SDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 389 ~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
+|||++...... ......+||+.|+|||++. +.++.++|||||||++|+|++|+.||...+
T Consensus 191 ~Dfg~a~~~~~~------~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 251 (504)
T 3q5i_A 191 VDFGLSSFFSKD------YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQN 251 (504)
T ss_dssp CCCTTCEECCTT------SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EECCCCEEcCCC------CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999754332 2233567999999999877 569999999999999999999999998765
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-37 Score=297.32 Aligned_cols=208 Identities=23% Similarity=0.386 Sum_probs=175.8
Q ss_pred hcCCCCceeecccCceEEEEEEec-CCcEEEEEEeccCC--ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEe
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTN--WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e 327 (480)
.++|++.+.||+|+||.||+|... +++.+|+|+++... ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 456999999999999999999774 68999999996433 234678899999999999999999999999999999999
Q ss_pred cc-CCCHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccc
Q 011660 328 LL-NGSLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (480)
Q Consensus 328 ~~-~GsL~~~l~---~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (480)
|+ +|+|.+++. .+++.++..++.|++.||.|||+. +|+||||||+||+++.+ +.++|+|||++.......
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~-~~~kl~dfg~~~~~~~~~-- 159 (276)
T 2yex_A 86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDER-DNLKISDFGLATVFRYNN-- 159 (276)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTT-CCEEECCCTTCEECEETT--
T ss_pred ecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccC-CCEEEeeCCCccccCCCc--
Confidence 99 468999885 378899999999999999999999 99999999999999998 689999999986543211
Q ss_pred ccCccccccccCCCccccccccCCCC-CchHHHHHHHHHHHHHHcCCCCCCCCcccchhHHHH
Q 011660 404 SENVKPVNVVGTFGYLAPEYMMYGKV-DEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLW 465 (480)
Q Consensus 404 ~~~~~~~~~~GT~~y~APE~~~~~~~-~~k~DvwSlGvil~eLltG~~pf~~~~~~~e~l~~~ 465 (480)
.........||+.|+|||.+.+..+ +.++||||||+++|||++|+.||.........+..|
T Consensus 160 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 221 (276)
T 2yex_A 160 -RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 221 (276)
T ss_dssp -EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHH
T ss_pred -chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHh
Confidence 1112235679999999999988776 789999999999999999999998776544333333
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=306.00 Aligned_cols=204 Identities=28% Similarity=0.427 Sum_probs=170.8
Q ss_pred hhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCcc--HHHHHHHHHHHhcCCCCCeeeEEEEEecC-----Ce
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSK-----EM 321 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~ 321 (480)
+.++|.+.+.||+|+||.||+|.+ .+|+.||+|+++..... ...+.+|+++++.++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 457899999999999999999977 46899999999754322 34578999999999999999999988654 67
Q ss_pred eEEEEeccCCCHHHHHHh--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccc
Q 011660 322 YAIVYNLLNGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (480)
Q Consensus 322 ~~lV~e~~~GsL~~~l~~--~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~ 399 (480)
.++||||+.|+|.+++.. +++.++..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||++.....
T Consensus 89 ~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~-~~~kl~Dfg~a~~~~~ 164 (353)
T 2b9h_A 89 VYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSN-CDLKVCDFGLARIIDE 164 (353)
T ss_dssp EEEEECCCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTT-CCEEECCCTTCEECC-
T ss_pred EEEEEeccCccHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCC-CcEEEEeccccccccc
Confidence 899999999999999864 88899999999999999999999 99999999999999998 6899999999976543
Q ss_pred cccccc-----CccccccccCCCccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 400 SHQVSE-----NVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 400 ~~~~~~-----~~~~~~~~GT~~y~APE~~~~-~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
...... .......+||+.|+|||++.. ..++.++|||||||++|||++|+.||...+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 228 (353)
T 2b9h_A 165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY 228 (353)
T ss_dssp ---------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 221111 111234679999999998764 6789999999999999999999999987653
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=315.10 Aligned_cols=198 Identities=25% Similarity=0.375 Sum_probs=170.8
Q ss_pred hhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCccHHHHHHHHHHHhcCC--------CCCeeeEEEEEe---
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIK--------HENIVRIIGYCH--- 317 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~--------HpnIv~l~~~~~--- 317 (480)
+.++|.+.+.||+|+||.||+|.. .+++.||+|+++......+.+.+|+++++.+. ||||+++++++.
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 357899999999999999999976 56899999999866555577889999999885 788999999987
Q ss_pred -cCCeeEEEEeccCCCHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCC--------
Q 011660 318 -SKEMYAIVYNLLNGSLKQYLK-----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENF-------- 383 (480)
Q Consensus 318 -~~~~~~lV~e~~~GsL~~~l~-----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~-------- 383 (480)
+...+++||||++|+|.+++. .+++.++..++.||+.||.|||+.+ +|+||||||+|||++.+.
T Consensus 115 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~~~ 192 (397)
T 1wak_A 115 VNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAA 192 (397)
T ss_dssp TTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHHHH
T ss_pred CCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhhhh
Confidence 566899999999999888873 2788999999999999999999853 899999999999998762
Q ss_pred ----------------------------------------CceEEeeeccccccccccccccCccccccccCCCcccccc
Q 011660 384 ----------------------------------------HHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEY 423 (480)
Q Consensus 384 ----------------------------------------~~~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~ 423 (480)
..+||+|||+|..... .....+||+.|+|||+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~--------~~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 193 EATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--------HFTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB--------CSCSCCSCGGGCCHHH
T ss_pred hhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc--------cCccCCCCCcccCChh
Confidence 1699999999965432 1234579999999999
Q ss_pred ccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 424 MMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 424 ~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
+.+..++.++|||||||+||||++|+.||.....
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 298 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSG 298 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcc
Confidence 9999999999999999999999999999986653
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=312.93 Aligned_cols=207 Identities=17% Similarity=0.215 Sum_probs=172.4
Q ss_pred cCCCCceeecccCceEEEEEEec---------CCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeee-----------
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHV---------DGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVR----------- 311 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~---------~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~----------- 311 (480)
++|.+.+.||+|+||.||+|... +++.||+|++... +.+.+|+++++.++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 117 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLL 117 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTC
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCcc
Confidence 57999999999999999999775 3789999999754 46889999999999999987
Q ss_pred ----EEEEEec-CCeeEEEEeccCCCHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEec
Q 011660 312 ----IIGYCHS-KEMYAIVYNLLNGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSE 381 (480)
Q Consensus 312 ----l~~~~~~-~~~~~lV~e~~~GsL~~~l~~-----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~ 381 (480)
+++++.. ++.+++||||++|+|.+++.. +++.++..++.||+.||.|||+. +|+||||||+|||++.
T Consensus 118 ~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl~~~ 194 (352)
T 2jii_A 118 AIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFVDP 194 (352)
T ss_dssp SCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEEEET
T ss_pred CccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEEcC
Confidence 6777765 778999999998899999954 78999999999999999999999 9999999999999998
Q ss_pred CCC--ceEEeeeccccccccccccc--cCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 382 NFH--HPQLSDFGAAMVHHQSHQVS--ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 382 ~~~--~~kL~DFGla~~~~~~~~~~--~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
+ + .+||+|||+++......... .........||+.|+|||++.+..++.++|||||||+||||++|+.||.....
T Consensus 195 ~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 273 (352)
T 2jii_A 195 E-DQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLP 273 (352)
T ss_dssp T-EEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred C-CCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCc
Confidence 8 5 79999999997654322111 11222445899999999999999999999999999999999999999998764
Q ss_pred cchhHHHHH
Q 011660 458 NRESLVLWY 466 (480)
Q Consensus 458 ~~e~l~~~~ 466 (480)
..+.+..+.
T Consensus 274 ~~~~~~~~~ 282 (352)
T 2jii_A 274 NTEDIMKQK 282 (352)
T ss_dssp CHHHHHHHH
T ss_pred CHHHHHHHH
Confidence 444443333
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-37 Score=299.31 Aligned_cols=198 Identities=26% Similarity=0.352 Sum_probs=156.9
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCccH--HH-HHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEE
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSE--EE-VLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~~--~~-~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 326 (480)
.++|++.+.||+|+||.||++.. .+++.||+|+++...... .. +.++...++.++||||+++++++.+++..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 46799999999999999999976 579999999997654322 22 344555688899999999999999999999999
Q ss_pred eccCCCHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccc
Q 011660 327 NLLNGSLKQYLK-------QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (480)
Q Consensus 327 e~~~GsL~~~l~-------~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~ 399 (480)
||++|+|.+++. .+++..+..++.|++.||.|||+.. +|+||||||+||+++.+ +.+||+|||++.....
T Consensus 86 e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 86 ELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINAL-GQVKMCDFGISGYLVD 162 (290)
T ss_dssp ECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTT-CCEEBCCC--------
T ss_pred ehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCC-CCEEEeecCCcccccc
Confidence 999999988874 3889999999999999999999842 89999999999999998 6899999999965433
Q ss_pred ccccccCccccccccCCCccccccc----cCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 400 SHQVSENVKPVNVVGTFGYLAPEYM----MYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 400 ~~~~~~~~~~~~~~GT~~y~APE~~----~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
. .......||+.|+|||++ .+..++.++|||||||++|||++|+.||.....
T Consensus 163 ~------~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 218 (290)
T 3fme_A 163 D------VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT 218 (290)
T ss_dssp -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC
T ss_pred c------ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc
Confidence 1 122334799999999996 566789999999999999999999999986443
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=317.32 Aligned_cols=195 Identities=27% Similarity=0.410 Sum_probs=154.6
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCcc---HHHHHHHHHHHhcCCCCCeeeEEEEEecC------C
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSK------E 320 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------~ 320 (480)
.++|.+.+.||+|+||.||+|.. .+|+.||+|++...... .+.+.+|+++++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 46799999999999999999975 56899999999764332 35678999999999999999999998653 5
Q ss_pred eeEEEEeccCCCHHHHHH--hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccc
Q 011660 321 MYAIVYNLLNGSLKQYLK--QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (480)
Q Consensus 321 ~~~lV~e~~~GsL~~~l~--~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~ 398 (480)
.+++|+|+++++|.++++ .+++..+..++.||++||.|||+. +|+||||||+|||++.+ +.+||+|||+++...
T Consensus 108 ~~~lv~e~~~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~-~~~kL~DFG~a~~~~ 183 (367)
T 2fst_X 108 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNED-CELKILDFGLARHTA 183 (367)
T ss_dssp CCEEEEECCCEECC-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTT-CCEEECC--------
T ss_pred eEEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCC-CCEEEeecccccccc
Confidence 689999999999998885 488899999999999999999999 99999999999999998 689999999996532
Q ss_pred cccccccCccccccccCCCccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 399 QSHQVSENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 399 ~~~~~~~~~~~~~~~GT~~y~APE~~~~-~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
. .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.
T Consensus 184 ~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 235 (367)
T 2fst_X 184 D--------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 235 (367)
T ss_dssp ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred c--------cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 2 1234679999999999887 6789999999999999999999999987653
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=303.16 Aligned_cols=223 Identities=26% Similarity=0.386 Sum_probs=179.4
Q ss_pred CHHHHhhhhcCCCCceeecccCceEEEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhc--CCCCCeeeEEEEEecCC
Q 011660 243 TSQELCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSS--IKHENIVRIIGYCHSKE 320 (480)
Q Consensus 243 ~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~~~~~~~~ 320 (480)
.......+.++|.+.+.||+|+||.||+|.. +++.||+|+++.. ....+.+|.+++.. ++||||+++++++...+
T Consensus 33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~ 109 (342)
T 1b6c_B 33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNKDN 109 (342)
T ss_dssp CHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred ceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch--hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence 3333344567899999999999999999987 5899999999643 34667889999887 79999999999998765
Q ss_pred ----eeEEEEecc-CCCHHHHHHh--CCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEeccCCCCCEEEecCCCc
Q 011660 321 ----MYAIVYNLL-NGSLKQYLKQ--LKWNERMDVAIGVAKALEYLH--------HTCDPPIIHRDVKSSNILLSENFHH 385 (480)
Q Consensus 321 ----~~~lV~e~~-~GsL~~~l~~--~~~~~~~~i~~~ia~aL~yLH--------~~~~~~IiHrDlKp~NILl~~~~~~ 385 (480)
.+++||||+ +|+|.+++.. +++.++..++.|++.||.||| +. +|+||||||+|||++.+ +.
T Consensus 110 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~-~~ 185 (342)
T 1b6c_B 110 GTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKN-GT 185 (342)
T ss_dssp SSCCCEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTT-SC
T ss_pred CccceeEEEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCC-CC
Confidence 789999999 5699999965 788999999999999999999 66 99999999999999998 68
Q ss_pred eEEeeeccccccccccccccCccccccccCCCccccccccCC------CCCchHHHHHHHHHHHHHHcC----------C
Q 011660 386 PQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYG------KVDEKIDVYSYGVVLLELITG----------K 449 (480)
Q Consensus 386 ~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~------~~~~k~DvwSlGvil~eLltG----------~ 449 (480)
+||+|||++......... .........||+.|+|||++.+. .++.++|||||||++|||++| +
T Consensus 186 ~kL~Dfg~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~ 264 (342)
T 1b6c_B 186 CCIADLGLAVRHDSATDT-IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 264 (342)
T ss_dssp EEECCCTTCEEEETTTTE-EEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred EEEEECCCceeccccccc-cccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccc
Confidence 999999999764432211 11123456799999999998865 334789999999999999999 7
Q ss_pred CCCCCCcccchhHHHHHHHHhCCC
Q 011660 450 EAIQTNKANRESLVLWYYVLAGKV 473 (480)
Q Consensus 450 ~pf~~~~~~~e~l~~~~~~~~~~~ 473 (480)
.||............+...+....
T Consensus 265 ~p~~~~~~~~~~~~~~~~~~~~~~ 288 (342)
T 1b6c_B 265 LPYYDLVPSDPSVEEMRKVVCEQK 288 (342)
T ss_dssp CTTTTTSCSSCCHHHHHHHHTTSC
T ss_pred cCccccCcCcccHHHHHHHHHHHH
Confidence 899876554444445555554433
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=304.41 Aligned_cols=202 Identities=25% Similarity=0.411 Sum_probs=164.9
Q ss_pred hcCCCCc-eeecccCceEEEEEEe-cCCcEEEEEEeccCC-ccHHHHHHHHHHHhcC-CCCCeeeEEEEEecCCeeEEEE
Q 011660 251 THNFSPK-MLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN-WSEEEVLREVELLSSI-KHENIVRIIGYCHSKEMYAIVY 326 (480)
Q Consensus 251 ~~~f~~~-~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~ 326 (480)
.+.|.+. +.||+|+||.||+|.. .+++.||+|+++... .....+.+|++++.++ +||||+++++++.+++.+++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 4568774 7899999999999976 568999999997654 3356789999999885 7999999999999999999999
Q ss_pred ecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCc---eEEeeecccccccc
Q 011660 327 NLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHH---PQLSDFGAAMVHHQ 399 (480)
Q Consensus 327 e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~---~kL~DFGla~~~~~ 399 (480)
||+ +|+|.+++.. +++.++..++.|++.||.|||+. +|+||||||+|||++.+ +. +||+|||++.....
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~-~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 91 EKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHP-NQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCS-SSSCSEEECCTTCCC----
T ss_pred EcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccC-CCcCceEEEEccCcccccc
Confidence 999 5899999953 78899999999999999999999 99999999999999876 34 99999999865432
Q ss_pred cccc--ccCccccccccCCCccccccccC-----CCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 400 SHQV--SENVKPVNVVGTFGYLAPEYMMY-----GKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 400 ~~~~--~~~~~~~~~~GT~~y~APE~~~~-----~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.... .........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 230 (316)
T 2ac3_A 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRC 230 (316)
T ss_dssp ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccc
Confidence 1111 11122234579999999999875 568899999999999999999999998764
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=299.63 Aligned_cols=197 Identities=28% Similarity=0.472 Sum_probs=151.9
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCC----ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEE
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 325 (480)
.++|.+.+.||+|+||.||+|.. .+++.+|+|++.... ...+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 35699999999999999999976 579999999996432 2236688999999999999999999999999999999
Q ss_pred Eecc-CCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccc
Q 011660 326 YNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (480)
Q Consensus 326 ~e~~-~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (480)
|||+ +|+|.+++.. +++.++..++.|++.||.|||+. +|+||||||+||+++.+ +.++|+|||++......
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~-~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRN-MNIKIADFGLATQLKMP 165 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTT-CCEEECCCTTCEECC--
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCC-CCEEEEeecceeeccCC
Confidence 9999 5689999864 68899999999999999999999 99999999999999998 68999999998654321
Q ss_pred cccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 401 ~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
. .......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 166 ~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 216 (278)
T 3cok_A 166 H-----EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDT 216 (278)
T ss_dssp -------------------------------CTHHHHHHHHHHHHHHSSCSSCCCS
T ss_pred C-----CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChh
Confidence 1 12234579999999999999999999999999999999999999998654
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-37 Score=315.03 Aligned_cols=195 Identities=23% Similarity=0.340 Sum_probs=162.8
Q ss_pred hcCCCCceeecccCceEEEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEEEecCC------eeEE
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKE------MYAI 324 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------~~~l 324 (480)
..+|.+.+.||+|+||.||+|.+..+..+|+|.+..... ...+|+++++.++||||+++++++...+ .+++
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~---~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR---FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc---hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 346999999999999999999987777788888764432 2247999999999999999999985433 3889
Q ss_pred EEeccCCCHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccc
Q 011660 325 VYNLLNGSLKQYLK-------QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVH 397 (480)
Q Consensus 325 V~e~~~GsL~~~l~-------~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~ 397 (480)
||||+.+++.+.+. .+++..+..++.||+.||.|||+. +|+||||||+|||++.+.+.+||+|||+|+..
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 99999888766553 378888999999999999999999 99999999999999943379999999999764
Q ss_pred ccccccccCccccccccCCCccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 398 HQSHQVSENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 398 ~~~~~~~~~~~~~~~~GT~~y~APE~~~~~-~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+.
T Consensus 193 ~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 247 (394)
T 4e7w_A 193 IAG------EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG 247 (394)
T ss_dssp CTT------CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cCC------CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 321 122356789999999998765 589999999999999999999999987653
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-37 Score=304.23 Aligned_cols=209 Identities=25% Similarity=0.400 Sum_probs=174.7
Q ss_pred CHHHHhhhhcCCCCceeecccCceEEEEEEe------cCCcEEEEEEeccCCcc--HHHHHHHHHHHhcC-CCCCeeeEE
Q 011660 243 TSQELCHLTHNFSPKMLIGQGGNSKVYRTNH------VDGQVAAVKVLKCTNWS--EEEVLREVELLSSI-KHENIVRII 313 (480)
Q Consensus 243 ~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~------~~g~~vAvK~~~~~~~~--~~~~~~Ei~il~~l-~HpnIv~l~ 313 (480)
...+.....++|.+.+.||+|+||.||+|.. .+++.||+|+++..... .+.+.+|+++++.+ +||||++++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 3444445567899999999999999999964 34689999999765432 34688999999999 799999999
Q ss_pred EEEecCC-eeEEEEecc-CCCHHHHHHh-------------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccC
Q 011660 314 GYCHSKE-MYAIVYNLL-NGSLKQYLKQ-------------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDV 372 (480)
Q Consensus 314 ~~~~~~~-~~~lV~e~~-~GsL~~~l~~-------------------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDl 372 (480)
+++...+ .+++||||+ +|+|.+++.. +++.++..++.|++.||.|||+. +|+||||
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~di 174 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDL 174 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccC
Confidence 9987654 589999999 5699999954 57788999999999999999999 9999999
Q ss_pred CCCCEEEecCCCceEEeeeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCC
Q 011660 373 KSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEA 451 (480)
Q Consensus 373 Kp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~p 451 (480)
||+||+++.+ +.+||+|||++....... .........||+.|+|||++.+..++.++|||||||++|||++ |+.|
T Consensus 175 kp~Nil~~~~-~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p 250 (316)
T 2xir_A 175 AARNILLSEK-NVVKICDFGLARDIYKDP---DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250 (316)
T ss_dssp SGGGEEECGG-GCEEECCCGGGSCTTTCT---TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred ccceEEECCC-CCEEECCCccccccccCc---cceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCC
Confidence 9999999988 689999999997543321 1122334568999999999999999999999999999999998 9999
Q ss_pred CCCCccc
Q 011660 452 IQTNKAN 458 (480)
Q Consensus 452 f~~~~~~ 458 (480)
|......
T Consensus 251 ~~~~~~~ 257 (316)
T 2xir_A 251 YPGVKID 257 (316)
T ss_dssp STTCCCS
T ss_pred Ccccchh
Confidence 9876543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=307.97 Aligned_cols=198 Identities=25% Similarity=0.421 Sum_probs=164.2
Q ss_pred cCCCCceeecccCceEEEEEEec-CCcE----EEEEEeccCC--ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHV-DGQV----AAVKVLKCTN--WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAI 324 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~----vAvK~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 324 (480)
++|++.+.||+|+||.||+|.+. +++. +|+|.+.... .....+.+|+.+++.++||||+++++++.+ +..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-SSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-CccEE
Confidence 56999999999999999999763 4543 7888775433 223457789999999999999999999975 55778
Q ss_pred EEecc-CCCHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccc
Q 011660 325 VYNLL-NGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (480)
Q Consensus 325 V~e~~-~GsL~~~l~----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~ 399 (480)
||||+ +|+|.+++. .+++..+..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||+++....
T Consensus 92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~-~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSP-SQVQVADFGVADLLPP 167 (325)
T ss_dssp EEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSS-SCEEECSCSGGGGSCC
T ss_pred EEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCC-CeEEECCCCcccccCc
Confidence 88888 689999984 478889999999999999999999 99999999999999988 6899999999976543
Q ss_pred ccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCcc
Q 011660 400 SHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKA 457 (480)
Q Consensus 400 ~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~~ 457 (480)
.. .........||+.|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 168 ~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 223 (325)
T 3kex_A 168 DD---KQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL 223 (325)
T ss_dssp CT---TCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT
T ss_pred cc---ccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCH
Confidence 22 1222335568889999999999999999999999999999999 9999987653
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=305.24 Aligned_cols=203 Identities=30% Similarity=0.430 Sum_probs=155.1
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCC--ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEe
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN--WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e 327 (480)
.++|.+.+.||+|+||.||++.. .+++.||+|++.... ...+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 93 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK 93 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence 46799999999999999999976 468999999986543 234568899999999999999999999999999999999
Q ss_pred cc-CCCHHHHHHh-----------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccc
Q 011660 328 LL-NGSLKQYLKQ-----------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAM 395 (480)
Q Consensus 328 ~~-~GsL~~~l~~-----------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~ 395 (480)
|+ +|+|.+++.. +++.++..++.|++.||.|||+. +|+||||||+||+++.+ +.+||+|||++.
T Consensus 94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~-~~~kl~dfg~~~ 169 (303)
T 2vwi_A 94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGED-GSVQIADFGVSA 169 (303)
T ss_dssp CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTT-CCEEECCCHHHH
T ss_pred hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCC-CCEEEEeccchh
Confidence 99 6799999863 78899999999999999999999 99999999999999998 689999999987
Q ss_pred ccccccccccCccccccccCCCccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 396 VHHQSHQVSENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~-~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
..................||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 232 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPP 232 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCG
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCch
Confidence 6543322222223345679999999999875 5689999999999999999999999987654
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-37 Score=309.45 Aligned_cols=199 Identities=21% Similarity=0.298 Sum_probs=158.3
Q ss_pred hhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEEEecCC-------e
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKE-------M 321 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-------~ 321 (480)
..++|.+.+.||+|+||.||+|.+ .+++.||+|++............|++.++.++||||+++++++...+ .
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 100 (360)
T 3e3p_A 21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIY 100 (360)
T ss_dssp HHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEE
T ss_pred hccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccccccee
Confidence 356799999999999999999987 56899999999776655566778899999999999999999986533 2
Q ss_pred eEEEEeccCCCHHHHHH-------hCCHHHHHHHHHHHHHHHHHHH--hCCCCCeEeccCCCCCEEEecCCCceEEeeec
Q 011660 322 YAIVYNLLNGSLKQYLK-------QLKWNERMDVAIGVAKALEYLH--HTCDPPIIHRDVKSSNILLSENFHHPQLSDFG 392 (480)
Q Consensus 322 ~~lV~e~~~GsL~~~l~-------~~~~~~~~~i~~~ia~aL~yLH--~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFG 392 (480)
+++||||+.|+|.+.+. .+.+..+..++.|++.||.||| +. +|+||||||+|||++.+.+.+||+|||
T Consensus 101 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~kl~Dfg 177 (360)
T 3e3p_A 101 LNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTLKLCDFG 177 (360)
T ss_dssp EEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEEEECCCT
T ss_pred EEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcEEEeeCC
Confidence 78999999998876653 2678888999999999999999 77 999999999999999733799999999
Q ss_pred cccccccccccccCccccccccCCCccccccccCCC-CCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 393 AAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGK-VDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 393 la~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~-~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
++...... .......||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+.
T Consensus 178 ~a~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~ 237 (360)
T 3e3p_A 178 SAKKLSPS------EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS 237 (360)
T ss_dssp TCBCCCTT------SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CceecCCC------CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCCh
Confidence 99754332 1223557899999999987654 89999999999999999999999987653
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=323.96 Aligned_cols=195 Identities=29% Similarity=0.481 Sum_probs=170.8
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCC----ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEE
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 325 (480)
.++|.+.+.||+|+||.||++.+ .+++.||+|++.+.. ...+.+.+|+.+++.++||||+++++++.+.+.+++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 45699999999999999999977 479999999996543 3456789999999999999999999999999999999
Q ss_pred Eecc-CCCHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEe---cCCCceEEeeeccccccc
Q 011660 326 YNLL-NGSLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLS---ENFHHPQLSDFGAAMVHH 398 (480)
Q Consensus 326 ~e~~-~GsL~~~l~---~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~---~~~~~~kL~DFGla~~~~ 398 (480)
|||+ +|+|.+++. .+++.++..++.|++.||.|||+. +|+||||||+|||++ .+ +.+||+|||++....
T Consensus 105 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~-~~~kl~Dfg~a~~~~ 180 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKD-ANIRIIDFGLSTHFE 180 (484)
T ss_dssp ECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTT-CCEEECCTTHHHHBC
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCC-CcEEEEeeeeeEEcc
Confidence 9999 689999884 478899999999999999999999 999999999999994 44 689999999996543
Q ss_pred cccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 399 QSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 399 ~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.. ......+||+.|+|||++.+ .++.++|||||||++|||++|++||...+
T Consensus 181 ~~------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~ 231 (484)
T 3nyv_A 181 AS------KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN 231 (484)
T ss_dssp CC------CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cc------cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC
Confidence 32 22335679999999998875 69999999999999999999999998764
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=297.15 Aligned_cols=194 Identities=27% Similarity=0.470 Sum_probs=171.2
Q ss_pred cCCCCceeecccCceEEEEEEec-CCcEEEEEEeccC----CccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCT----NWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 326 (480)
++|.+.+.||+|+||.||+|... +++.+|+|++... ......+.+|+++++.++||||+++++++.+.+.+++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 56999999999999999999774 5889999999643 223467889999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccc
Q 011660 327 NLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 327 e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (480)
||+ +|+|.+++.. +++.++..++.|++.||.|||+. +|+||||||+||+++.+ +.++|+|||++.....
T Consensus 94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~-~~~kl~Dfg~~~~~~~--- 166 (284)
T 2vgo_A 94 EFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYK-GELKIADFGWSVHAPS--- 166 (284)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTT-CCEEECCCTTCEECSS---
T ss_pred EeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCC-CCEEEecccccccCcc---
Confidence 999 5699999854 78899999999999999999999 99999999999999988 6899999999854332
Q ss_pred cccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 403 ~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 167 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 216 (284)
T 2vgo_A 167 ----LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS 216 (284)
T ss_dssp ----SCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ----cccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC
Confidence 12234579999999999999999999999999999999999999998754
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-37 Score=305.44 Aligned_cols=197 Identities=24% Similarity=0.402 Sum_probs=171.4
Q ss_pred hhcCCCCceeecccCceEEEEEEe--cCCcEEEEEEeccCCccHHHHHHHHHHHhcCCCC------CeeeEEEEEecCCe
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNH--VDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHE------NIVRIIGYCHSKEM 321 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~--~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~Hp------nIv~l~~~~~~~~~ 321 (480)
+.++|++.+.||+|+||.||+|.. .+++.||+|+++......+.+.+|+++++.++|+ +++++++++.+.+.
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 356899999999999999999975 3688999999986554456788999999888665 49999999999999
Q ss_pred eEEEEeccCCCHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecC--------------
Q 011660 322 YAIVYNLLNGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN-------------- 382 (480)
Q Consensus 322 ~~lV~e~~~GsL~~~l~~-----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~-------------- 382 (480)
+++||||++++|.+++.. +++.++..++.|++.||.|||+. +|+||||||+|||++.+
T Consensus 92 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~ 168 (339)
T 1z57_A 92 ICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDE 168 (339)
T ss_dssp EEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----CEE
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCcccccc
Confidence 999999999999999953 67888999999999999999999 99999999999999872
Q ss_pred ----CCceEEeeeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 383 ----FHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 383 ----~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
.+.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.
T Consensus 169 ~~~~~~~~kl~Dfg~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 239 (339)
T 1z57_A 169 RTLINPDIKVVDFGSATYDDE--------HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS 239 (339)
T ss_dssp EEESCCCEEECCCSSCEETTS--------CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred ccccCCCceEeeCcccccCcc--------ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence 15799999999965322 12355799999999999999999999999999999999999999987653
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=321.84 Aligned_cols=197 Identities=28% Similarity=0.429 Sum_probs=166.7
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCC---ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEE
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN---WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 326 (480)
.++|.+.+.||+|+||.||+|.+ .++..+|+|++++.. .....+.+|+.+++.++||||++++++|.+.+.+++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 34699999999999999999977 468899999997643 23467899999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecC--CCceEEeeeccccccccc
Q 011660 327 NLL-NGSLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN--FHHPQLSDFGAAMVHHQS 400 (480)
Q Consensus 327 e~~-~GsL~~~l~---~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~--~~~~kL~DFGla~~~~~~ 400 (480)
||+ +|+|.+++. .+++.++..++.||+.||.|||+. +|+||||||+|||++.+ .+.+||+|||+|......
T Consensus 116 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~ 192 (494)
T 3lij_A 116 ECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192 (494)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence 999 678988884 478899999999999999999999 99999999999999764 245999999999764432
Q ss_pred cccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 401 ~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
......+||+.|+|||++. +.|+.++|||||||++|+|++|++||.....
T Consensus 193 ------~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 242 (494)
T 3lij_A 193 ------KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD 242 (494)
T ss_dssp ------BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ------ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 1233567999999999876 5799999999999999999999999987653
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=299.94 Aligned_cols=199 Identities=25% Similarity=0.378 Sum_probs=158.9
Q ss_pred hhcCCCCceeecccCceEEEEEEecC----CcEEEEEEeccCCcc--HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeE
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNHVD----GQVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSKEMYA 323 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~~~----g~~vAvK~~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 323 (480)
..++|++.+.||+|+||.||+|.+.. +..+|+|+++..... .+.+.+|+.+++.++||||+++++++.+ +..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc-CccE
Confidence 34679999999999999999997632 457999998754322 3568899999999999999999999854 5678
Q ss_pred EEEecc-CCCHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccc
Q 011660 324 IVYNLL-NGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (480)
Q Consensus 324 lV~e~~-~GsL~~~l~----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~ 398 (480)
+||||+ +|+|.+++. .+++.++..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||++....
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSN-DCVKLGDFGLSRYME 167 (281)
T ss_dssp EEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEET-TEEEECC--------
T ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCC-CCEEECccccccccC
Confidence 999999 469999995 378899999999999999999999 99999999999999988 799999999997644
Q ss_pred cccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCcc
Q 011660 399 QSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKA 457 (480)
Q Consensus 399 ~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~~ 457 (480)
.... .......||+.|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 168 ~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~ 223 (281)
T 1mp8_A 168 DSTY----YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 223 (281)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred cccc----cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCH
Confidence 3211 12233457889999999999999999999999999999996 9999987654
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=305.93 Aligned_cols=205 Identities=22% Similarity=0.351 Sum_probs=173.8
Q ss_pred HHHhhhhcCCCCceeecccCceEEEEEEec------CCcEEEEEEeccCCcc--HHHHHHHHHHHhcCCCCCeeeEEEEE
Q 011660 245 QELCHLTHNFSPKMLIGQGGNSKVYRTNHV------DGQVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYC 316 (480)
Q Consensus 245 ~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~~~~ 316 (480)
++.....++|.+.+.||+|+||.||+|.+. +++.+|+|+++..... ...+.+|+++++.++||||+++++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 334445678999999999999999999653 3678999999755432 34588999999999999999999999
Q ss_pred ecCCeeEEEEecc-CCCHHHHHHh-------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecC
Q 011660 317 HSKEMYAIVYNLL-NGSLKQYLKQ-------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN 382 (480)
Q Consensus 317 ~~~~~~~lV~e~~-~GsL~~~l~~-------------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~ 382 (480)
.+.+..++||||+ +|+|.+++.. +++..+..++.|++.||.|||+. +|+||||||+||+++.+
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~ 174 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 174 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTT
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCC
Confidence 9999999999999 5799999853 37788899999999999999999 99999999999999998
Q ss_pred CCceEEeeeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 383 FHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 383 ~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
+.+||+|||++........ ........||+.|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 175 -~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 245 (322)
T 1p4o_A 175 -FTVKIGDFGMTRDIYETDY---YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 245 (322)
T ss_dssp -CCEEECCTTCCCGGGGGGC---EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC
T ss_pred -CeEEECcCccccccccccc---cccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC
Confidence 6899999999975433211 112234467899999999999999999999999999999999 899998754
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=304.70 Aligned_cols=197 Identities=25% Similarity=0.406 Sum_probs=172.2
Q ss_pred hcCCCCceeecccCceEEEEEEec-CCcEEEEEEeccCCc----cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEE
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNW----SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~----~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 325 (480)
.++|.+.+.||+|+||.||++.+. +++.+|+|++..... ..+.+.+|+.+++.++||||+++++++.+.+.+++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 356899999999999999999774 588999999865431 235678999999999999999999999999999999
Q ss_pred Eecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccc
Q 011660 326 YNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (480)
Q Consensus 326 ~e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (480)
|||+ +++|.+++.. +++.++..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||++......
T Consensus 120 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~- 194 (335)
T 2owb_A 120 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYD- 194 (335)
T ss_dssp ECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTT-CCEEECCCTTCEECCST-
T ss_pred EecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCC-CCEEEeeccCceecccC-
Confidence 9999 5789998853 78999999999999999999999 99999999999999998 68999999999754321
Q ss_pred ccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 402 QVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 402 ~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 195 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 245 (335)
T 2owb_A 195 ----GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC 245 (335)
T ss_dssp ----TCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ----cccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC
Confidence 112234679999999999999999999999999999999999999998754
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=321.68 Aligned_cols=196 Identities=30% Similarity=0.465 Sum_probs=168.8
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccC---CccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEE
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCT---NWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 326 (480)
.++|.+.+.||+|+||.||+|.+ .+++.||+|++++. ......+.+|+++++.++||||+++++++.+.+.+++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 45699999999999999999977 47899999998542 334577899999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecC--CCceEEeeeccccccccc
Q 011660 327 NLL-NGSLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN--FHHPQLSDFGAAMVHHQS 400 (480)
Q Consensus 327 e~~-~GsL~~~l~---~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~--~~~~kL~DFGla~~~~~~ 400 (480)
||+ +|+|.+++. .+++.++..++.|++.||.|||+. +|+||||||+|||++.+ .+.+||+|||++......
T Consensus 101 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 177 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (486)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred EcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence 999 678988884 488999999999999999999999 99999999999999532 247999999999654322
Q ss_pred cccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 401 ~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
......+||+.|+|||++.+ .|+.++|||||||++|+|++|++||...+
T Consensus 178 ------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~ 226 (486)
T 3mwu_A 178 ------TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN 226 (486)
T ss_dssp ----------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ------CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 22335679999999998875 59999999999999999999999998754
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=308.03 Aligned_cols=199 Identities=32% Similarity=0.526 Sum_probs=171.9
Q ss_pred hhhhcCCCCceeecccCceEEEEEEec-CCcEEEEEEeccCCcc---------HHHHHHHHHHHhcC-CCCCeeeEEEEE
Q 011660 248 CHLTHNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWS---------EEEVLREVELLSSI-KHENIVRIIGYC 316 (480)
Q Consensus 248 ~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~---------~~~~~~Ei~il~~l-~HpnIv~l~~~~ 316 (480)
..+.++|.+.+.||+|+||.||+|.+. +|+.||||+++..... .+.+.+|+.+++.+ +||||+++++++
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 169 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY 169 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 345567999999999999999999874 7999999999755321 23567899999998 899999999999
Q ss_pred ecCCeeEEEEecc-CCCHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeec
Q 011660 317 HSKEMYAIVYNLL-NGSLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFG 392 (480)
Q Consensus 317 ~~~~~~~lV~e~~-~GsL~~~l~---~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFG 392 (480)
...+..++||||+ +|+|.+++. .+++..+..++.||+.||.|||+. +|+||||||+|||++.+ +.++|+|||
T Consensus 170 ~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~-~~ikl~DfG 245 (365)
T 2y7j_A 170 ESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDN-MQIRLSDFG 245 (365)
T ss_dssp EBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTT-CCEEECCCT
T ss_pred eeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCC-CCEEEEecC
Confidence 9999999999999 569999985 488999999999999999999999 99999999999999998 789999999
Q ss_pred cccccccccccccCccccccccCCCccccccccC------CCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 393 AAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY------GKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 393 la~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~------~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
++...... ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 246 ~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~ 309 (365)
T 2y7j_A 246 FSCHLEPG------EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR 309 (365)
T ss_dssp TCEECCTT------CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccccCCC------cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC
Confidence 98654332 22335689999999998863 368899999999999999999999997654
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=306.20 Aligned_cols=199 Identities=26% Similarity=0.451 Sum_probs=170.3
Q ss_pred hcCCCCceeecccCceEEEEEEec--------CCcEEEEEEeccCCc--cHHHHHHHHHHHhcC-CCCCeeeEEEEEecC
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHV--------DGQVAAVKVLKCTNW--SEEEVLREVELLSSI-KHENIVRIIGYCHSK 319 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~--------~g~~vAvK~~~~~~~--~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~ 319 (480)
.++|.+.+.||+|+||.||+|... +++.||+|+++.... ....+.+|+++++.+ +||||+++++++.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 467999999999999999999763 467899999976543 235688999999999 899999999999999
Q ss_pred CeeEEEEecc-CCCHHHHHHh-------------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEE
Q 011660 320 EMYAIVYNLL-NGSLKQYLKQ-------------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILL 379 (480)
Q Consensus 320 ~~~~lV~e~~-~GsL~~~l~~-------------------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl 379 (480)
+.+++||||+ +|+|.+++.. +++.++..++.|++.||.|||+. +|+||||||+|||+
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEE
Confidence 9999999999 6799999953 67888999999999999999999 99999999999999
Q ss_pred ecCCCceEEeeeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 380 SENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 380 ~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
+.+ +.+||+|||++........ ........||+.|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 191 ~~~-~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 264 (334)
T 2pvf_A 191 TEN-NVMKIADFGLARDINNIDY---YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 264 (334)
T ss_dssp CTT-CCEEECCCTTCEECTTTSS---EECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cCC-CCEEEcccccccccccccc---ccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence 988 6899999999976543221 112234467899999999998899999999999999999999 999998754
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=296.92 Aligned_cols=197 Identities=25% Similarity=0.406 Sum_probs=172.1
Q ss_pred hcCCCCceeecccCceEEEEEEec-CCcEEEEEEeccCCc----cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEE
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNW----SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~----~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 325 (480)
.++|.+.+.||+|+||.||++... +++.+|+|++..... ..+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 456899999999999999999774 588999999865432 235678999999999999999999999999999999
Q ss_pred Eecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccc
Q 011660 326 YNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (480)
Q Consensus 326 ~e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (480)
|||+ +++|.+++.. +++.++..++.|++.||.|||+. +|+||||||+||+++.+ +.+||+|||++......
T Consensus 94 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~-~~~kl~dfg~~~~~~~~- 168 (294)
T 2rku_A 94 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYD- 168 (294)
T ss_dssp EECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTT-CCEEECCCTTCEECCST-
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCC-CCEEEEeccCceecccC-
Confidence 9999 5789998853 78999999999999999999999 99999999999999998 68999999998654321
Q ss_pred ccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 402 QVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 402 ~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
........||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 169 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 219 (294)
T 2rku_A 169 ----GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC 219 (294)
T ss_dssp ----TCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ----ccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 112234679999999999999999999999999999999999999998754
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-37 Score=305.45 Aligned_cols=205 Identities=29% Similarity=0.434 Sum_probs=169.4
Q ss_pred CHHHHhhhhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCccHHHHHHHHHHHhcC-CCCCeeeEEEEEec--
Q 011660 243 TSQELCHLTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSI-KHENIVRIIGYCHS-- 318 (480)
Q Consensus 243 ~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~-- 318 (480)
+..++....++|++.+.||+|+||.||+|.+ .+++.||+|++.......+.+.+|+.+++.+ +||||+++++++..
T Consensus 15 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 94 (326)
T 2x7f_A 15 DLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKN 94 (326)
T ss_dssp -CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred cchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence 3344455677899999999999999999987 5689999999987766678899999999998 89999999999976
Q ss_pred ----CCeeEEEEeccC-CCHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEE
Q 011660 319 ----KEMYAIVYNLLN-GSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQL 388 (480)
Q Consensus 319 ----~~~~~lV~e~~~-GsL~~~l~~-----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL 388 (480)
.+.+++||||+. |+|.+++.. +++..+..++.|++.||.|||+. +|+||||||+|||++.+ +.+||
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~-~~~kl 170 (326)
T 2x7f_A 95 PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTEN-AEVKL 170 (326)
T ss_dssp --CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTT-CCEEE
T ss_pred CccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCC-CCEEE
Confidence 468899999995 599999953 77888999999999999999999 99999999999999988 68999
Q ss_pred eeeccccccccccccccCccccccccCCCcccccccc-----CCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 389 SDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMM-----YGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 389 ~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
+|||++...... ........||+.|+|||++. +..++.++|||||||++|||++|+.||....
T Consensus 171 ~Dfg~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 238 (326)
T 2x7f_A 171 VDFGVSAQLDRT-----VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 238 (326)
T ss_dssp CCCTTTC------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred eeCcCceecCcC-----ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc
Confidence 999998654321 11223457999999999987 5678999999999999999999999997654
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=297.90 Aligned_cols=197 Identities=30% Similarity=0.458 Sum_probs=157.9
Q ss_pred hcCCCCceeecccCceEEEEEEecCCcEEEEEEeccCCccH---HHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEe
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSE---EEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~---~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e 327 (480)
..+|.+.+.||+|+||.||+|... ..+|+|+++...... +.+.+|+++++.++||||+++++++. .+.+++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-CCccEEEEE
Confidence 457999999999999999999753 359999997654333 45889999999999999999999764 456789999
Q ss_pred cc-CCCHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccc
Q 011660 328 LL-NGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 328 ~~-~GsL~~~l~----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (480)
|+ +++|.+++. .+++.++..++.|++.||.|||+. +|+||||||+|||++.+ +.++|+|||++......
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~-- 173 (289)
T 3og7_A 100 WCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHED-NTVKIGDFGLATEKSRW-- 173 (289)
T ss_dssp CCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETT-TEEEECCCC----------
T ss_pred ecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCC-CCEEEccceeccccccc--
Confidence 99 578999984 478899999999999999999999 99999999999999998 79999999998654321
Q ss_pred cccCccccccccCCCcccccccc---CCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 403 VSENVKPVNVVGTFGYLAPEYMM---YGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 403 ~~~~~~~~~~~GT~~y~APE~~~---~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
..........||+.|+|||++. +..++.++|||||||++|||++|+.||.....
T Consensus 174 -~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 230 (289)
T 3og7_A 174 -SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 230 (289)
T ss_dssp -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred -cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch
Confidence 1122233567999999999986 67789999999999999999999999987654
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=297.99 Aligned_cols=200 Identities=24% Similarity=0.342 Sum_probs=167.3
Q ss_pred hhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCC-----ccHHHHHHHHHHHhcCCCCCeeeEEEEE--ecCCe
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN-----WSEEEVLREVELLSSIKHENIVRIIGYC--HSKEM 321 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~-----~~~~~~~~Ei~il~~l~HpnIv~l~~~~--~~~~~ 321 (480)
+.++|.+.+.||+|+||.||++.. .+++.+|+|+++... .....+.+|+++++.++||||+++++++ .+.+.
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 356899999999999999999977 468899999996532 2346789999999999999999999998 45568
Q ss_pred eEEEEeccCCCHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccc
Q 011660 322 YAIVYNLLNGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMV 396 (480)
Q Consensus 322 ~~lV~e~~~GsL~~~l~~-----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~ 396 (480)
+++||||+.++|.+++.. +++.++..++.|++.||.|||+. +|+||||||+||+++.+ +.++|+|||++..
T Consensus 83 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~-~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 83 MYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTG-GTLKISALGVAEA 158 (305)
T ss_dssp EEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTT-CCEEECCCTTCEE
T ss_pred EEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCC-CcEEeeccccccc
Confidence 899999998888888753 78889999999999999999999 99999999999999998 7899999999975
Q ss_pred cccccccccCccccccccCCCccccccccCCC--CCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 397 HHQSHQVSENVKPVNVVGTFGYLAPEYMMYGK--VDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 397 ~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~--~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
..... .........||+.|+|||++.+.. ++.++|||||||++|||++|+.||....
T Consensus 159 ~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 217 (305)
T 2wtk_C 159 LHPFA---ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN 217 (305)
T ss_dssp CCTTC---SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cCccc---cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch
Confidence 43211 122233557999999999988654 3789999999999999999999998754
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=292.23 Aligned_cols=192 Identities=20% Similarity=0.366 Sum_probs=166.3
Q ss_pred hcCCCCceeecccCceEEEEEEecCCcEEEEEEeccCCcc---HHHHHHHHHHHhcCCCCCeeeEEEEEecC--CeeEEE
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSK--EMYAIV 325 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~lV 325 (480)
.++|.+.+.||+|+||.||+|.+ +++.+|+|+++..... .+.+.+|+.+++.++||||+++++++.+. +.+++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 35699999999999999999987 4889999999866533 34688999999999999999999999876 788999
Q ss_pred Eecc-CCCHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeccCCCCCEEEecCCCceEEeeecccccc
Q 011660 326 YNLL-NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPP--IIHRDVKSSNILLSENFHHPQLSDFGAAMVH 397 (480)
Q Consensus 326 ~e~~-~GsL~~~l~~-----~~~~~~~~i~~~ia~aL~yLH~~~~~~--IiHrDlKp~NILl~~~~~~~kL~DFGla~~~ 397 (480)
|||+ +|+|.+++.. +++.++..++.|++.||.|||+. + |+||||||+||+++.+ +.++|+|||++...
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~-~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDED-MTARISMADVKFSF 163 (271)
T ss_dssp EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTT-SCEEEEGGGSCCTT
T ss_pred ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCC-cceeEEeccceeee
Confidence 9999 5799999964 68899999999999999999998 7 9999999999999988 68999999986431
Q ss_pred ccccccccCccccccccCCCccccccccCCCCCc---hHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 398 HQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDE---KIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 398 ~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~---k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
......||+.|+|||++.+..++. ++|||||||++|||++|+.||.....
T Consensus 164 ----------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 216 (271)
T 3kmu_A 164 ----------QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN 216 (271)
T ss_dssp ----------SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH
T ss_pred ----------cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh
Confidence 112347899999999998765544 89999999999999999999987653
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=300.40 Aligned_cols=196 Identities=28% Similarity=0.444 Sum_probs=169.7
Q ss_pred hhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc-cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEe
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW-SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e 327 (480)
+.++|.+.+.||+|+||.||++.. .+|+.+|+|+++.... ....+.+|+.+++.++||||+++++++.+.+.+++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 345799999999999999999977 4699999999976543 34568899999999999999999999999999999999
Q ss_pred cc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEE---ecCCCceEEeeeccccccccc
Q 011660 328 LL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILL---SENFHHPQLSDFGAAMVHHQS 400 (480)
Q Consensus 328 ~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl---~~~~~~~kL~DFGla~~~~~~ 400 (480)
|+ +|+|.+++.. +++.++..++.|++.||.|||+. +|+||||||+||++ +.+ +.++|+|||++.....
T Consensus 87 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~-~~~kl~Dfg~~~~~~~- 161 (304)
T 2jam_A 87 LVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEEN-SKIMITDFGLSKMEQN- 161 (304)
T ss_dssp CCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTT-CCEEBCSCSTTCCCCC-
T ss_pred cCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCC-CCEEEccCCcceecCC-
Confidence 99 5799998853 78899999999999999999999 99999999999999 555 6899999999864322
Q ss_pred cccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 401 ~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 162 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 211 (304)
T 2jam_A 162 ------GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET 211 (304)
T ss_dssp ------BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred ------CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 12234579999999999999999999999999999999999999998754
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=318.81 Aligned_cols=198 Identities=26% Similarity=0.410 Sum_probs=160.4
Q ss_pred hhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc---------cHHHHHHHHHHHhcCCCCCeeeEEEEEecC
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW---------SEEEVLREVELLSSIKHENIVRIIGYCHSK 319 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~---------~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 319 (480)
+.++|.+.+.||+|+||.||+|.. .+++.||+|++.+... ....+.+|+++|++++||||+++++++..
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~- 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 457899999999999999999976 5689999999965321 11247899999999999999999999865
Q ss_pred CeeEEEEecc-CCCHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCC--CceEEeeecc
Q 011660 320 EMYAIVYNLL-NGSLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENF--HHPQLSDFGA 393 (480)
Q Consensus 320 ~~~~lV~e~~-~GsL~~~l~---~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~--~~~kL~DFGl 393 (480)
+.+++||||+ +|+|.+++. .+++.++..++.|++.||.|||+. +|+||||||+|||++.+. ..+||+|||+
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~DFG~ 288 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGH 288 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECCSST
T ss_pred CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEeeccc
Confidence 4578999999 679988884 488999999999999999999999 999999999999997541 3599999999
Q ss_pred ccccccccccccCccccccccCCCccccccccC---CCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 394 AMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY---GKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 394 a~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~---~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
|+.... .......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 289 a~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~ 349 (419)
T 3i6u_A 289 SKILGE------TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 349 (419)
T ss_dssp TTSCC-----------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSS
T ss_pred ceecCC------CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcc
Confidence 976432 122335689999999999863 6788999999999999999999999986543
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=297.58 Aligned_cols=203 Identities=22% Similarity=0.300 Sum_probs=167.4
Q ss_pred hhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEEE-ecCCeeEEEEe
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYC-HSKEMYAIVYN 327 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-~~~~~~~lV~e 327 (480)
+.++|.+.+.||+|+||.||+|.+ .+++.||+|++.... ....+.+|+++++.++|++++..+.++ .+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc-cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence 457899999999999999999976 678999999876443 223578999999999988877666555 67788899999
Q ss_pred ccCCCHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEE---ecCCCceEEeeeccccccccc
Q 011660 328 LLNGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILL---SENFHHPQLSDFGAAMVHHQS 400 (480)
Q Consensus 328 ~~~GsL~~~l~----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl---~~~~~~~kL~DFGla~~~~~~ 400 (480)
|++|+|.+++. .+++.++..++.|++.||.|||+. +|+||||||+|||+ +.+ +.+||+|||++......
T Consensus 86 ~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~-~~~kL~Dfg~a~~~~~~ 161 (296)
T 4hgt_A 86 LLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKG-NLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp CCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGT-TCEEECCCTTCEECBCT
T ss_pred ccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCC-CeEEEecCccceeccCc
Confidence 99999999986 378999999999999999999999 99999999999999 666 68999999999765442
Q ss_pred cccc--cCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 401 HQVS--ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 401 ~~~~--~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
.... .........||+.|+|||.+.+..++.++|||||||++|||++|+.||.....
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 220 (296)
T 4hgt_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA 220 (296)
T ss_dssp TTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred ccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccch
Confidence 2111 11223456899999999999999999999999999999999999999987543
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-37 Score=304.17 Aligned_cols=208 Identities=26% Similarity=0.362 Sum_probs=170.1
Q ss_pred cCHHHHhhhhcCCCCceeecccCceEEEEEEecCCcEEEEEEeccCCcc---HHHHHHHHHHHhcCC--CCCeeeEEEEE
Q 011660 242 FTSQELCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWS---EEEVLREVELLSSIK--HENIVRIIGYC 316 (480)
Q Consensus 242 ~~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~---~~~~~~Ei~il~~l~--HpnIv~l~~~~ 316 (480)
+.++.+....++|.+.+.||+|+||.||++...+++.+|+|+++..... .+.+.+|+++++.++ ||||+++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 4444455556789999999999999999998888999999999765433 356789999999997 59999999999
Q ss_pred ecCCeeEEEEeccCCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecc
Q 011660 317 HSKEMYAIVYNLLNGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGA 393 (480)
Q Consensus 317 ~~~~~~~lV~e~~~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGl 393 (480)
.+++.+++|||+.+|+|.+++.. +++.++..++.|+++||.|||+. +|+||||||+|||+++ +.+||+|||+
T Consensus 98 ~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~--~~~kL~Dfg~ 172 (313)
T 3cek_A 98 ITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD--GMLKLIDFGI 172 (313)
T ss_dssp ECSSEEEEEECCCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET--TEEEECCCSS
T ss_pred ecCCEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC--CeEEEeeccc
Confidence 99999999999889999999954 78889999999999999999999 9999999999999975 5899999999
Q ss_pred ccccccccccccCccccccccCCCccccccccC-----------CCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 394 AMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY-----------GKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 394 a~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~-----------~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
+....... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 173 ~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 244 (313)
T 3cek_A 173 ANQMQPDT---TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN 244 (313)
T ss_dssp SCC-----------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS
T ss_pred cccccCcc---ccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH
Confidence 96543311 1112234579999999999875 4789999999999999999999999986543
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=313.18 Aligned_cols=193 Identities=10% Similarity=0.089 Sum_probs=150.8
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCcc----HHHHHHHH---HHHhcCCCCCeeeEE-------EE
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS----EEEVLREV---ELLSSIKHENIVRII-------GY 315 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~----~~~~~~Ei---~il~~l~HpnIv~l~-------~~ 315 (480)
..+|.+.+.||+|+||.||+|.+ .+++.||+|+++..... .+.+.+|+ .+|+. +||||++++ ++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehh
Confidence 34588999999999999999986 47899999999876532 24466774 55555 799988865 44
Q ss_pred EecC-----------------CeeEEEEeccCCCHHHHHHh----CCHHHH------HHHHHHHHHHHHHHHhCCCCCeE
Q 011660 316 CHSK-----------------EMYAIVYNLLNGSLKQYLKQ----LKWNER------MDVAIGVAKALEYLHHTCDPPII 368 (480)
Q Consensus 316 ~~~~-----------------~~~~lV~e~~~GsL~~~l~~----~~~~~~------~~i~~~ia~aL~yLH~~~~~~Ii 368 (480)
+... ..+++||||+.|+|.+++.. +.+..+ ..++.||+.||.|||++ +|+
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~iv 216 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLV 216 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCc
Confidence 4332 34899999999999999964 455555 67889999999999999 999
Q ss_pred eccCCCCCEEEecCCCceEEeeeccccccccccccccCccccccccCCCccccccccC--CCCCchHHHHHHHHHHHHHH
Q 011660 369 HRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY--GKVDEKIDVYSYGVVLLELI 446 (480)
Q Consensus 369 HrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~--~~~~~k~DvwSlGvil~eLl 446 (480)
||||||+|||++.+ +.+||+|||+|+.... ......||+.|+|||++.+ ..++.++|||||||+||||+
T Consensus 217 HrDikp~NIll~~~-~~~kL~DFG~a~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell 287 (371)
T 3q60_A 217 HGHFTPDNLFIMPD-GRLMLGDVSALWKVGT--------RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW 287 (371)
T ss_dssp ETTCSGGGEEECTT-SCEEECCGGGEEETTC--------EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHH
T ss_pred cCcCCHHHEEECCC-CCEEEEecceeeecCC--------CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHH
Confidence 99999999999998 7899999999965332 1114467799999999987 67999999999999999999
Q ss_pred cCCCCCCCCc
Q 011660 447 TGKEAIQTNK 456 (480)
Q Consensus 447 tG~~pf~~~~ 456 (480)
+|+.||....
T Consensus 288 tg~~Pf~~~~ 297 (371)
T 3q60_A 288 CLFLPFGLVT 297 (371)
T ss_dssp HSSCSTTBCC
T ss_pred hCCCCCCCcC
Confidence 9999998773
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=297.34 Aligned_cols=192 Identities=23% Similarity=0.377 Sum_probs=164.3
Q ss_pred hcCCCCceeecccCceEEEEEEec-CC-------cEEEEEEeccCC-ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCe
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHV-DG-------QVAAVKVLKCTN-WSEEEVLREVELLSSIKHENIVRIIGYCHSKEM 321 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g-------~~vAvK~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 321 (480)
.++|.+.+.||+|+||.||+|... ++ +.+|+|++.... ...+.+.+|+++++.++||||+++++++.+++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 357899999999999999999653 33 579999996544 344678999999999999999999999999999
Q ss_pred eEEEEecc-CCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCc--------eEE
Q 011660 322 YAIVYNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHH--------PQL 388 (480)
Q Consensus 322 ~~lV~e~~-~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~--------~kL 388 (480)
.++||||+ +|+|.+++.. +++..+..++.|++.||.|||+. +|+||||||+|||++.+ +. +||
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~-~~~~~~~~~~~kl 162 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIRE-EDRKTGNPPFIKL 162 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEEC-CBGGGTBCCEEEE
T ss_pred CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecC-Ccccccccceeee
Confidence 99999999 5799999954 88889999999999999999999 99999999999999988 45 999
Q ss_pred eeeccccccccccccccCccccccccCCCccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 011660 389 SDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTN 455 (480)
Q Consensus 389 ~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~-~~~~~k~DvwSlGvil~eLltG~~pf~~~ 455 (480)
+|||++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|..|+...
T Consensus 163 ~Dfg~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~ 221 (289)
T 4fvq_A 163 SDPGISITVLP---------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSA 221 (289)
T ss_dssp CCCCSCTTTSC---------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred ccCcccccccC---------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccc
Confidence 99999854322 123468999999999987 67899999999999999999965554443
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=295.43 Aligned_cols=202 Identities=21% Similarity=0.298 Sum_probs=171.0
Q ss_pred hhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEEE-ecCCeeEEEEe
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYC-HSKEMYAIVYN 327 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-~~~~~~~lV~e 327 (480)
+.++|.+.+.||+|+||.||+|.+ .+++.||+|++.... ..+.+.+|+.+++.++|++++..+.++ .+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS-SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc-chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 457899999999999999999976 679999999987554 234688999999999988876666555 66778899999
Q ss_pred ccCCCHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEe---cCCCceEEeeeccccccccc
Q 011660 328 LLNGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLS---ENFHHPQLSDFGAAMVHHQS 400 (480)
Q Consensus 328 ~~~GsL~~~l~----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~---~~~~~~kL~DFGla~~~~~~ 400 (480)
|++|+|.+++. .+++.++..++.|++.||.|||+. +|+||||||+|||++ .+ +.+||+|||++......
T Consensus 86 ~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~-~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 86 LLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKG-NLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGT-TCEEECCCTTCEECBCT
T ss_pred ecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCC-CeEEEeeCCCccccccc
Confidence 99999999996 478999999999999999999999 999999999999995 55 68999999999765442
Q ss_pred cccc--cCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 401 HQVS--ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 401 ~~~~--~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.... .........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 219 (296)
T 3uzp_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 219 (296)
T ss_dssp TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcC
Confidence 2111 1112345689999999999999999999999999999999999999998754
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=311.25 Aligned_cols=195 Identities=23% Similarity=0.399 Sum_probs=168.6
Q ss_pred hhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCcc---HHHHHHHHHHHhcCCCCCeeeEEEEEecCCee---
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSKEMY--- 322 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~--- 322 (480)
+.++|.+.+.||+|+||.||+|.+ .+|+.||+|+++..... .+.+.+|+.+++.++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 356799999999999999999976 56899999999765433 35678999999999999999999999876654
Q ss_pred ---EEEEeccCCCHHHHHH-hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccc
Q 011660 323 ---AIVYNLLNGSLKQYLK-QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (480)
Q Consensus 323 ---~lV~e~~~GsL~~~l~-~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~ 398 (480)
++||||+.|+|.+++. .+++.++..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||+++...
T Consensus 120 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~-~~~kL~Dfg~a~~~~ 195 (371)
T 4exu_A 120 YDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNED-CELKILDFGLARHAD 195 (371)
T ss_dssp CCCEEEEECCCEEHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTT-CCEEECSTTCC----
T ss_pred eeEEEEEccccccHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCC-CCEEEEecCcccccc
Confidence 9999999999998885 489999999999999999999999 99999999999999998 689999999996432
Q ss_pred cccccccCccccccccCCCccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 399 QSHQVSENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 399 ~~~~~~~~~~~~~~~GT~~y~APE~~~~-~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+
T Consensus 196 ~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 246 (371)
T 4exu_A 196 A--------EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 246 (371)
T ss_dssp ------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred c--------CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 2 2234678999999999887 678999999999999999999999998765
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=308.11 Aligned_cols=197 Identities=30% Similarity=0.433 Sum_probs=170.8
Q ss_pred hcCCCCceeecccCceEEEEEEec-CCcEEEEEEeccCCc--cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEe
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e 327 (480)
.++|.+.+.||+|+||.||++.+. +++.+|+|+++.... ..+.+.+|+.+++.++||||+++++++.+++.+++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 457999999999999999999774 689999999976532 23568899999999999999999999999999999999
Q ss_pred cc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccc
Q 011660 328 LL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (480)
Q Consensus 328 ~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (480)
|+ +|+|.+++.. +++..+..++.|++.||.|||+.+ +|+||||||+|||++.+ +.++|+|||++......
T Consensus 112 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~--- 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS--- 185 (360)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTT-CCEEECCCCCCHHHHHH---
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCC-CCEEEEECCCCcccccc---
Confidence 99 5699999954 788999999999999999999832 89999999999999998 68999999998643221
Q ss_pred ccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 404 SENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 404 ~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 186 ----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 235 (360)
T 3eqc_A 186 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 235 (360)
T ss_dssp ----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCH
T ss_pred ----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 12345799999999999999999999999999999999999999987653
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-37 Score=327.58 Aligned_cols=197 Identities=28% Similarity=0.450 Sum_probs=173.1
Q ss_pred hcCCCCceeecccCceEEEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc-
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL- 329 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~- 329 (480)
.++|.+.+.||+|+||.||+|.+.++..||||+++......+.+.+|+++|+.++||||+++++++.+ +.+++||||+
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~ 344 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 344 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhc
Confidence 45688899999999999999998888889999998777677889999999999999999999999976 6789999999
Q ss_pred CCCHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccc
Q 011660 330 NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (480)
Q Consensus 330 ~GsL~~~l~~-----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (480)
+|+|.+++.. +++.++..++.||+.||.|||++ +||||||||+|||++.+ +.+||+|||+++.......
T Consensus 345 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~~~~-- 418 (535)
T 2h8h_A 345 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGEN-LVCKVADFGLARLIEDNEY-- 418 (535)
T ss_dssp TEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGG-GCEEECCTTSTTTCCCHHH--
T ss_pred CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCC-CcEEEcccccceecCCCce--
Confidence 5799999952 78899999999999999999999 99999999999999988 6899999999976433211
Q ss_pred cCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 405 ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 405 ~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
.......+|+.|+|||++.+..++.++|||||||+||||++ |+.||....
T Consensus 419 --~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~ 469 (535)
T 2h8h_A 419 --TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV 469 (535)
T ss_dssp --HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCC
T ss_pred --ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 11123457889999999999999999999999999999999 999998754
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-37 Score=306.59 Aligned_cols=202 Identities=24% Similarity=0.374 Sum_probs=153.7
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc-cHHHHHHHHHHHhcCC-CCCeeeEEEEE--------ecC
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW-SEEEVLREVELLSSIK-HENIVRIIGYC--------HSK 319 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~-~~~~~~~Ei~il~~l~-HpnIv~l~~~~--------~~~ 319 (480)
..+|.+.+.||+|+||.||++.+ .+++.||+|++..... ..+.+.+|+.+++++. ||||+++++++ ...
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 45799999999999999999976 4689999999865543 3456889999999995 99999999998 344
Q ss_pred CeeEEEEeccCCCHHHHHHh------CCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeccCCCCCEEEecCCCceEEeee
Q 011660 320 EMYAIVYNLLNGSLKQYLKQ------LKWNERMDVAIGVAKALEYLHHTCDPP--IIHRDVKSSNILLSENFHHPQLSDF 391 (480)
Q Consensus 320 ~~~~lV~e~~~GsL~~~l~~------~~~~~~~~i~~~ia~aL~yLH~~~~~~--IiHrDlKp~NILl~~~~~~~kL~DF 391 (480)
..++++|||++|+|.+++.. +++.++..++.|++.||.|||+. + |+||||||+|||++.+ +.+||+||
T Consensus 107 ~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~-~~~kl~Df 182 (337)
T 3ll6_A 107 AEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQ-GTIKLCDF 182 (337)
T ss_dssp EEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTT-SCEEBCCC
T ss_pred ceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCC-CCEEEecC
Confidence 56899999999999999854 88999999999999999999998 8 9999999999999998 68999999
Q ss_pred cccccccccccccc-------CccccccccCCCccccccc---cCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 392 GAAMVHHQSHQVSE-------NVKPVNVVGTFGYLAPEYM---MYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 392 Gla~~~~~~~~~~~-------~~~~~~~~GT~~y~APE~~---~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
|++........... ........||+.|+|||++ .+..++.++|||||||++|||++|+.||....
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 257 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA 257 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence 99976543221110 0112245699999999998 56778999999999999999999999997643
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=299.20 Aligned_cols=198 Identities=27% Similarity=0.434 Sum_probs=167.9
Q ss_pred cCCCCceeecccCceEEEEEEe-----cCCcEEEEEEeccCC--ccHHHHHHHHHHHhcCCCCCeeeEEEEEecC--Cee
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-----VDGQVAAVKVLKCTN--WSEEEVLREVELLSSIKHENIVRIIGYCHSK--EMY 322 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-----~~g~~vAvK~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~ 322 (480)
++|++.+.||+|+||.||+|.+ .+++.||+|+++... ...+.+.+|+++++.++||||+++++++.+. +.+
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 3588899999999999999973 468899999997543 3346789999999999999999999999876 678
Q ss_pred EEEEecc-CCCHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccc
Q 011660 323 AIVYNLL-NGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVH 397 (480)
Q Consensus 323 ~lV~e~~-~GsL~~~l~----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~ 397 (480)
++||||+ +|+|.+++. .+++.++..++.|++.||.|||+. +|+||||||+|||++.+ +.++|+|||++...
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~-~~~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESE-HQVKIGDFGLTKAI 176 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEET-TEEEECCCTTCEEC
T ss_pred EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCC-CCEEECcccccccc
Confidence 9999999 669999983 378899999999999999999999 99999999999999998 69999999999765
Q ss_pred ccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 011660 398 HQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTN 455 (480)
Q Consensus 398 ~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~ 455 (480)
...... ........||+.|+|||++.+..++.++|||||||++|||++|+.|+...
T Consensus 177 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 232 (302)
T 4e5w_A 177 ETDKEY--YTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSP 232 (302)
T ss_dssp CTTCCE--EECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred cCCCcc--eeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcch
Confidence 432211 12233456899999999999999999999999999999999999987543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=299.86 Aligned_cols=203 Identities=23% Similarity=0.353 Sum_probs=164.8
Q ss_pred hhcCCCCceeecccCceEEEEEEec-CCcEEEEEEeccCCc-cHHHHHHHHHHHhcCCCCCeeeEEEEEe----------
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNW-SEEEVLREVELLSSIKHENIVRIIGYCH---------- 317 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~---------- 317 (480)
+.++|.+.+.||+|+||.||+|... +++.||+|++..... ..+.+.+|+++++.++||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence 3567999999999999999999875 589999999976542 3356889999999999999999999873
Q ss_pred ----cCCeeEEEEeccCCCHHHHHHh--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeee
Q 011660 318 ----SKEMYAIVYNLLNGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDF 391 (480)
Q Consensus 318 ----~~~~~~lV~e~~~GsL~~~l~~--~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DF 391 (480)
+.+.+++||||+.|+|.+++.. +.+..+..++.|++.||.|||+. +|+||||||+|||++.+.+.+||+||
T Consensus 89 ~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~Df 165 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDF 165 (320)
T ss_dssp --CCSCSEEEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEECCC
T ss_pred ccccccCceeEEeeccCCCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEEccC
Confidence 4468899999999999999965 78888999999999999999999 99999999999999854468999999
Q ss_pred ccccccccccccccCccccccccCCCccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 392 GAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 392 Gla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~-~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
|++....... ..........||+.|+|||.+.. ..++.++|||||||++|||++|+.||.....
T Consensus 166 g~~~~~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 230 (320)
T 2i6l_A 166 GLARIMDPHY--SHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE 230 (320)
T ss_dssp TTCBCC----------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ccccccCCCc--ccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCH
Confidence 9997643321 11122334568999999998865 6789999999999999999999999987653
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=296.08 Aligned_cols=192 Identities=28% Similarity=0.505 Sum_probs=167.6
Q ss_pred hhcCCCCceeecccCceEEEEEEec-CCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEEEec----------
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHS---------- 318 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~---------- 318 (480)
+..+|++.+.||+|+||.||+|.+. +++.||+|+++... +.+.+|+++++.++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 3456999999999999999999874 79999999997654 457789999999999999999998854
Q ss_pred ------CCeeEEEEecc-CCCHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCce
Q 011660 319 ------KEMYAIVYNLL-NGSLKQYLK-----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHP 386 (480)
Q Consensus 319 ------~~~~~lV~e~~-~GsL~~~l~-----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~ 386 (480)
...+++||||+ +|+|.+++. .+++..+..++.|++.||.|||+. +|+||||||+|||++.+ +.+
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~-~~~ 161 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDT-KQV 161 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEET-TEE
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCC-CCE
Confidence 45689999999 469999994 378889999999999999999999 99999999999999998 689
Q ss_pred EEeeeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 011660 387 QLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQT 454 (480)
Q Consensus 387 kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~ 454 (480)
||+|||++...... .......||+.|+|||++.+..++.++|||||||++|||++|..||..
T Consensus 162 kl~Dfg~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~ 223 (284)
T 2a19_B 162 KIGDFGLVTSLKND------GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE 223 (284)
T ss_dssp EECCCTTCEESSCC------SCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH
T ss_pred EECcchhheecccc------ccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh
Confidence 99999998654332 122345799999999999999999999999999999999999999854
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-36 Score=296.08 Aligned_cols=196 Identities=28% Similarity=0.415 Sum_probs=173.0
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCC--ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEec
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN--WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~ 328 (480)
+.|.+.+.||+|+||.||+|.. .+++.||+|+++... ...+.+.+|+.+++.++||||+++++++.+.+.+++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 4588999999999999999976 568999999997553 3356789999999999999999999999999999999999
Q ss_pred c-CCCHHHHHHh--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccccc
Q 011660 329 L-NGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE 405 (480)
Q Consensus 329 ~-~GsL~~~l~~--~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~ 405 (480)
+ +++|.+++.. +++.++..++.|++.||.|||+. +|+||||||+||+++.+ +.++|+|||++.......
T Consensus 102 ~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~-~~~kl~Dfg~~~~~~~~~---- 173 (303)
T 3a7i_A 102 LGGGSALDLLEPGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEH-GEVKLADFGVAGQLTDTQ---- 173 (303)
T ss_dssp CTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT-SCEEECCCTTCEECBTTB----
T ss_pred CCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCC-CCEEEeecccceecCccc----
Confidence 9 5689999964 78899999999999999999999 99999999999999998 689999999996543321
Q ss_pred CccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 406 NVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 406 ~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 174 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 223 (303)
T 3a7i_A 174 -IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH 223 (303)
T ss_dssp -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred -cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC
Confidence 12235679999999999999999999999999999999999999998654
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=293.62 Aligned_cols=194 Identities=23% Similarity=0.315 Sum_probs=166.2
Q ss_pred hhcCCCCceeecccCceEEEEEEec-CCcEEEEEEeccCC---ccHHHHHHHHHHHhcC-CCCCeeeEEEEEecCCeeEE
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTN---WSEEEVLREVELLSSI-KHENIVRIIGYCHSKEMYAI 324 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~l 324 (480)
+.++|++.+.||+|+||.||+|... +++.||+|+++... .....+.+|+.++..+ +||||+++++++.+++.+++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3567999999999999999999774 79999999997643 2345688999999999 99999999999999999999
Q ss_pred EEecc-CCCHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecC--------------
Q 011660 325 VYNLL-NGSLKQYLKQ-------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN-------------- 382 (480)
Q Consensus 325 V~e~~-~GsL~~~l~~-------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~-------------- 382 (480)
||||+ +|+|.+++.. +++.++..++.|++.||.|||+. +|+||||||+|||++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 99999 5699999954 68899999999999999999999 99999999999999843
Q ss_pred ----CCceEEeeeccccccccccccccCccccccccCCCccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 011660 383 ----FHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTN 455 (480)
Q Consensus 383 ----~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~-~~~~k~DvwSlGvil~eLltG~~pf~~~ 455 (480)
...++|+|||++...... ....||+.|+|||++.+. .+++++|||||||++|||++|.+|+...
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~---------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~ 234 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSP---------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG 234 (289)
T ss_dssp ----CCCEEECCCTTCEETTCS---------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS
T ss_pred ccCCceEEEEcccccccccCCc---------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch
Confidence 137899999998654321 123599999999999876 5678999999999999999999887543
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=312.03 Aligned_cols=204 Identities=25% Similarity=0.347 Sum_probs=173.0
Q ss_pred HHHhhhhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCccHHHHHHHHHHHhcCC-CC-----CeeeEEEEEe
Q 011660 245 QELCHLTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIK-HE-----NIVRIIGYCH 317 (480)
Q Consensus 245 ~el~~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~-Hp-----nIv~l~~~~~ 317 (480)
.....+.++|.+.+.||+|+||.||+|.. .+++.||+|+++........+..|+++++.++ |+ +|+++++++.
T Consensus 47 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~ 126 (382)
T 2vx3_A 47 KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM 126 (382)
T ss_dssp CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred ecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence 33445568899999999999999999976 46889999999865544566788999988874 44 4999999999
Q ss_pred cCCeeEEEEeccCCCHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEec-CCCceEEeee
Q 011660 318 SKEMYAIVYNLLNGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSE-NFHHPQLSDF 391 (480)
Q Consensus 318 ~~~~~~lV~e~~~GsL~~~l~~-----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~-~~~~~kL~DF 391 (480)
..+.+++||||++|+|.+++.. +++..+..++.|++.||.|||+. +.+|+||||||+|||++. +.+.+||+||
T Consensus 127 ~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DF 205 (382)
T 2vx3_A 127 FRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDF 205 (382)
T ss_dssp ETTEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred cCCceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence 9999999999999999999954 67899999999999999999952 239999999999999954 2257999999
Q ss_pred ccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 392 GAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 392 Gla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
|+|..... .....+||+.|+|||++.+..++.++|||||||++|||++|++||...+.
T Consensus 206 G~a~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~ 263 (382)
T 2vx3_A 206 GSSCQLGQ--------RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263 (382)
T ss_dssp TTCEETTC--------CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cCceeccc--------ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99965432 22356799999999999999999999999999999999999999987653
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=304.27 Aligned_cols=200 Identities=27% Similarity=0.433 Sum_probs=171.1
Q ss_pred hcCCCCceeecccCceEEEEEEecC-C-----cEEEEEEeccCCc--cHHHHHHHHHHHhcC-CCCCeeeEEEEEecCCe
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHVD-G-----QVAAVKVLKCTNW--SEEEVLREVELLSSI-KHENIVRIIGYCHSKEM 321 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~~-g-----~~vAvK~~~~~~~--~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~ 321 (480)
.++|.+.+.||+|+||.||+|.... + +.+|+|+++.... ..+.+.+|+++++.+ +||||+++++++.+.+.
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 124 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence 4679999999999999999997632 3 4799999976543 235688999999999 89999999999999999
Q ss_pred eEEEEecc-CCCHHHHHHh-----------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCC
Q 011660 322 YAIVYNLL-NGSLKQYLKQ-----------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENF 383 (480)
Q Consensus 322 ~~lV~e~~-~GsL~~~l~~-----------------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~ 383 (480)
+++||||+ +|+|.+++.. +++.++..++.|++.||.|||+. +|+||||||+|||++.+
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~- 200 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNG- 200 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGG-
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCC-
Confidence 99999999 5699999853 57888999999999999999999 99999999999999998
Q ss_pred CceEEeeeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCcc
Q 011660 384 HHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKA 457 (480)
Q Consensus 384 ~~~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~~ 457 (480)
+.+||+|||++....... .........||+.|+|||++.+..++.++|||||||++|||+| |..||.....
T Consensus 201 ~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 272 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDS---NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV 272 (333)
T ss_dssp GEEEBCCCGGGCCGGGCT---TSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCS
T ss_pred CeEEECcccccccccccc---ceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccch
Confidence 689999999997543321 1112234567889999999999999999999999999999999 9999987654
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=299.34 Aligned_cols=196 Identities=28% Similarity=0.437 Sum_probs=168.2
Q ss_pred hcCCCCceeecccCceEEEEEEec-CCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~ 329 (480)
.++|++.+.||+|+||.||+|... +|+.||+|++.... ..+.+.+|+.+++.++||||+++++++.+.+.+++||||+
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYC 106 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecC
Confidence 457999999999999999999774 58999999997654 4467899999999999999999999999999999999999
Q ss_pred C-CCHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccc
Q 011660 330 N-GSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (480)
Q Consensus 330 ~-GsL~~~l~----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (480)
. |+|.+++. .+++.++..++.|++.||.|||+. +|+|+||||+||+++.+ +.++|+|||++......
T Consensus 107 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~-~~~kl~dfg~~~~~~~~---- 178 (314)
T 3com_A 107 GAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTE-GHAKLADFGVAGQLTDT---- 178 (314)
T ss_dssp TTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT-CCEEECCCTTCEECBTT----
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCC-CCEEEeecccchhhhhh----
Confidence 5 59999985 388999999999999999999999 99999999999999998 68999999998654321
Q ss_pred cCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 405 ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 405 ~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
........||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 179 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 229 (314)
T 3com_A 179 -MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH 229 (314)
T ss_dssp -BSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred -ccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 112234579999999999999999999999999999999999999998654
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=301.00 Aligned_cols=198 Identities=27% Similarity=0.395 Sum_probs=162.4
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCcc----HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEE
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS----EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~----~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 325 (480)
.++|.+.+.||+|+||.||++.. .+++.||+|+++..... .+.+.+|+.+++.++||||+++++++.+++.++++
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 35799999999999999999977 46899999999754322 25688999999999999999999999999999999
Q ss_pred EeccC-CCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccc
Q 011660 326 YNLLN-GSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (480)
Q Consensus 326 ~e~~~-GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (480)
|||+. ++|.+++.. +++.++..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||++.......
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~~ 188 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSAD-DFAYLVDFGIASATTDEK 188 (309)
T ss_dssp EECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTT-SCEEECSCCC--------
T ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCC-CCEEEecCccCccccccc
Confidence 99995 599999854 88999999999999999999999 99999999999999988 689999999986543321
Q ss_pred ccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 402 QVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 402 ~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
........||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 189 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 239 (309)
T 2h34_A 189 ----LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ 239 (309)
T ss_dssp ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCH
T ss_pred ----cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCch
Confidence 112234579999999999999999999999999999999999999998754
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=305.37 Aligned_cols=199 Identities=24% Similarity=0.455 Sum_probs=160.2
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcE----EEEEEeccC--CccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeE
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQV----AAVKVLKCT--NWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYA 323 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~----vAvK~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 323 (480)
.++|++.+.||+|+||.||+|.+ .+++. +|+|.++.. ....+.+.+|+.+++.++||||+++++++.+.+ .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 35799999999999999999976 34543 577777543 234578899999999999999999999998876 45
Q ss_pred EEEecc-CCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccc
Q 011660 324 IVYNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (480)
Q Consensus 324 lV~e~~-~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~ 398 (480)
++++++ +|+|.+++.. +++..+..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||++....
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~-~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTP-QHVKITDFGLAKLLG 168 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEET-TEEEECCTTC-----
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCC-CCEEEccCcceeEcc
Confidence 556665 8899999954 78899999999999999999999 99999999999999998 689999999997653
Q ss_pred cccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCcc
Q 011660 399 QSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKA 457 (480)
Q Consensus 399 ~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~~ 457 (480)
... .........||+.|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 169 ~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~ 225 (327)
T 3lzb_A 169 AEE---KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 225 (327)
T ss_dssp --------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred Ccc---ccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCH
Confidence 321 1122234457889999999999999999999999999999999 9999987654
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-36 Score=292.81 Aligned_cols=195 Identities=29% Similarity=0.448 Sum_probs=165.3
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCcc---HHHHHHHHHHHhcCCCCCeeeEEEEEec----CCeeE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHS----KEMYA 323 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~~ 323 (480)
..|.+.+.||+|+||.||+|.+ .++..+|+|++...... .+.+.+|+.+++.++||||+++++++.. ...++
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 3477888999999999999976 56889999999754433 3457899999999999999999998864 45689
Q ss_pred EEEecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeccCCCCCEEEecCCCceEEeeecccccc
Q 011660 324 IVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPP--IIHRDVKSSNILLSENFHHPQLSDFGAAMVH 397 (480)
Q Consensus 324 lV~e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~--IiHrDlKp~NILl~~~~~~~kL~DFGla~~~ 397 (480)
+||||+ +|+|.+++.. +++..+..++.|++.||.|||+. + |+||||||+|||++.+.+.+||+|||++...
T Consensus 106 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~ 182 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence 999999 6799999964 78899999999999999999998 7 9999999999999843378999999998643
Q ss_pred ccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 398 HQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 398 ~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
.. .......||+.|+|||++. +.++.++|||||||++|||++|+.||.....
T Consensus 183 ~~-------~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 234 (290)
T 1t4h_A 183 RA-------SFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN 234 (290)
T ss_dssp CT-------TSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS
T ss_pred cc-------cccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCc
Confidence 22 1223457999999999876 5699999999999999999999999987543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-37 Score=307.09 Aligned_cols=202 Identities=30% Similarity=0.494 Sum_probs=159.9
Q ss_pred hcCCCCceeecccCceEEEEEEecCCcEEEEEEeccCCccHHHHHHHHHH--HhcCCCCCeeeEEEEEe-----cCCeeE
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVEL--LSSIKHENIVRIIGYCH-----SKEMYA 323 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~i--l~~l~HpnIv~l~~~~~-----~~~~~~ 323 (480)
.++|++.+.||+|+||.||+|.. +++.||+|+++... ...+..|.++ +..++||||+++++++. ....++
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 88 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN--RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL 88 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence 35799999999999999999976 68999999997544 2344444444 55689999999998553 334678
Q ss_pred EEEecc-CCCHHHHHHh--CCHHHHHHHHHHHHHHHHHHHhCC------CCCeEeccCCCCCEEEecCCCceEEeeeccc
Q 011660 324 IVYNLL-NGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTC------DPPIIHRDVKSSNILLSENFHHPQLSDFGAA 394 (480)
Q Consensus 324 lV~e~~-~GsL~~~l~~--~~~~~~~~i~~~ia~aL~yLH~~~------~~~IiHrDlKp~NILl~~~~~~~kL~DFGla 394 (480)
+||||+ +|+|.+++.. .++..+..++.|++.||.|||+.+ .++|+||||||+|||++.+ +.+||+|||++
T Consensus 89 lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~-~~~kL~DFG~a 167 (336)
T 3g2f_A 89 LVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKND-GTCVISDFGLS 167 (336)
T ss_dssp EEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTT-SCEEECCCTTC
T ss_pred EEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCC-CcEEEeeccce
Confidence 999999 6799999954 678888999999999999999763 2389999999999999998 68999999999
Q ss_pred ccccccccc---ccCccccccccCCCccccccccC-------CCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 395 MVHHQSHQV---SENVKPVNVVGTFGYLAPEYMMY-------GKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 395 ~~~~~~~~~---~~~~~~~~~~GT~~y~APE~~~~-------~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
......... .........+||+.|+|||++.+ ..++.++|||||||++|||++|..||....
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~ 239 (336)
T 3g2f_A 168 MRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239 (336)
T ss_dssp EECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTS
T ss_pred eecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCcc
Confidence 765432211 11222335679999999999986 456789999999999999999987775543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=302.00 Aligned_cols=198 Identities=24% Similarity=0.437 Sum_probs=165.7
Q ss_pred hcCCCCceeecccCceEEEEEEec-CCcEEEEEEeccCCccH---HHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEE
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWSE---EEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~---~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 326 (480)
.++|++.+.||+|+||.||+|... +++.||+|++....... +.+.+|+++++.++||||+++++++.+.+.+++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 356999999999999999999774 58999999987654332 45779999999999999999999999999999999
Q ss_pred eccCCC-HHHHH---HhCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccc
Q 011660 327 NLLNGS-LKQYL---KQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 327 e~~~Gs-L~~~l---~~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (480)
||+.|. |.+++ ..+++..+..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||++.......
T Consensus 104 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~- 178 (331)
T 4aaa_A 104 EFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQS-GVVKLCDFGFARTLAAPG- 178 (331)
T ss_dssp ECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTT-SCEEECCCTTC--------
T ss_pred ecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCC-CcEEEEeCCCceeecCCc-
Confidence 999654 55554 3478899999999999999999999 99999999999999998 689999999996543221
Q ss_pred cccCccccccccCCCccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 403 VSENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 403 ~~~~~~~~~~~GT~~y~APE~~~~~-~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
.......||+.|+|||++.+. .++.++|||||||++|||++|+.||.....
T Consensus 179 ----~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 230 (331)
T 4aaa_A 179 ----EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSD 230 (331)
T ss_dssp ---------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ----cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence 122345799999999999875 789999999999999999999999987654
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=302.18 Aligned_cols=196 Identities=26% Similarity=0.393 Sum_probs=170.6
Q ss_pred hhcCCCCceeecccCceEEEEEEe-cCC-cEEEEEEeccCCccHHHHHHHHHHHhcCCCCC------eeeEEEEEecCCe
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDG-QVAAVKVLKCTNWSEEEVLREVELLSSIKHEN------IVRIIGYCHSKEM 321 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g-~~vAvK~~~~~~~~~~~~~~Ei~il~~l~Hpn------Iv~l~~~~~~~~~ 321 (480)
+.++|.+.+.||+|+||.||+|.. .++ +.||+|+++......+.+.+|+++++.++|++ ++.+++++...+.
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 456899999999999999999976 344 78999999866555567889999999887665 9999999999999
Q ss_pred eEEEEeccCCCHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEE-----------------
Q 011660 322 YAIVYNLLNGSLKQYLK-----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILL----------------- 379 (480)
Q Consensus 322 ~~lV~e~~~GsL~~~l~-----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl----------------- 379 (480)
+++||||++|+|.+++. .+++.++..++.||+.||.|||+. +|+||||||+|||+
T Consensus 97 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~ 173 (355)
T 2eu9_A 97 MCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEE 173 (355)
T ss_dssp EEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CCCE
T ss_pred EEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccccccc
Confidence 99999999999988884 377889999999999999999999 99999999999999
Q ss_pred --ecCCCceEEeeeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 380 --SENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 380 --~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
+.+ +.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 174 ~~~~~-~~~kl~Dfg~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 244 (355)
T 2eu9_A 174 KSVKN-TSIRVADFGSATFDHE--------HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN 244 (355)
T ss_dssp EEESC-CCEEECCCTTCEETTS--------CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cccCC-CcEEEeecCccccccc--------cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence 455 6899999999965322 22346799999999999999999999999999999999999999987653
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=292.43 Aligned_cols=198 Identities=25% Similarity=0.381 Sum_probs=166.5
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc-cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW-SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~ 329 (480)
++|....+||+|+||.||+|.. .+++.||+|.++.... ..+.+.+|+.+++.++||||+++++++.+.+.+++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 3466677999999999999976 5688999999976543 3467889999999999999999999999999999999999
Q ss_pred -CCCHHHHHHh------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccc
Q 011660 330 -NGSLKQYLKQ------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 330 -~GsL~~~l~~------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (480)
+|+|.+++.. +.+..+..++.|++.||.|||+. +|+||||||+||+++.+.+.+||+|||++......
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~-- 176 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI-- 176 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCC--
Confidence 6799999964 35777888999999999999999 99999999999999983378999999998654321
Q ss_pred cccCccccccccCCCccccccccCCC--CCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 403 VSENVKPVNVVGTFGYLAPEYMMYGK--VDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 403 ~~~~~~~~~~~GT~~y~APE~~~~~~--~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
........||+.|+|||++.+.. ++.++||||||+++|||++|+.||.....
T Consensus 177 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 230 (295)
T 2clq_A 177 ---NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE 230 (295)
T ss_dssp -------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSS
T ss_pred ---CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCc
Confidence 11223557999999999987654 88999999999999999999999976543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=301.30 Aligned_cols=199 Identities=25% Similarity=0.371 Sum_probs=171.2
Q ss_pred cCCCCceeecccCceEEEEEEe-----cCCcEEEEEEeccCCcc-HHHHHHHHHHHhcCCCCCeeeEEEEEe--cCCeeE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-----VDGQVAAVKVLKCTNWS-EEEVLREVELLSSIKHENIVRIIGYCH--SKEMYA 323 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-----~~g~~vAvK~~~~~~~~-~~~~~~Ei~il~~l~HpnIv~l~~~~~--~~~~~~ 323 (480)
++|++.+.||+|+||.||++.+ .+++.||+|++...... .+.+.+|+++++.++||||+++++++. +.+.++
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5699999999999999999973 45889999999766433 345889999999999999999999886 556789
Q ss_pred EEEecc-CCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccc
Q 011660 324 IVYNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (480)
Q Consensus 324 lV~e~~-~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~ 398 (480)
+||||+ +|+|.+++.. +++.++..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||++....
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~-~~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESE-AHVKIADFGLAKLLP 178 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEET-TEEEECCGGGCEECC
T ss_pred EEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCC-CCEEEcccccceecc
Confidence 999999 7899999854 88999999999999999999999 99999999999999998 789999999997654
Q ss_pred cccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 399 QSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 399 ~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 179 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~ 234 (327)
T 3lxl_A 179 LDKDY--YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPS 234 (327)
T ss_dssp TTCSE--EECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH
T ss_pred cCCcc--ceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCcccc
Confidence 32211 112234568999999999999999999999999999999999999997654
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-36 Score=297.03 Aligned_cols=199 Identities=25% Similarity=0.424 Sum_probs=160.0
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc----cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEE
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~----~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 325 (480)
..+|.+.+.||+|+||.||+|.. .+++.+|+|+++.... ....+.+|+.+++.++||||+++++++.+++.+++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 34699999999999999999976 5799999999975332 234678999999999999999999999999999999
Q ss_pred Eecc-CCCHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccc
Q 011660 326 YNLL-NGSLKQYLKQ-------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVH 397 (480)
Q Consensus 326 ~e~~-~GsL~~~l~~-------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~ 397 (480)
|||+ +|+|.+++.. +++.++..++.|++.||.|||+. +|+||||||+||+++.+ +.++|+|||++...
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~-~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITAT-GVVKLGDLGLGRFF 186 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTT-SCEEECCC------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCC-CCEEEEeccceeee
Confidence 9999 5699999854 78889999999999999999999 99999999999999988 68999999998654
Q ss_pred ccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCccc
Q 011660 398 HQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKAN 458 (480)
Q Consensus 398 ~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~~ 458 (480)
.... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......
T Consensus 187 ~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 242 (310)
T 2wqm_A 187 SSKT-----TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN 242 (310)
T ss_dssp -----------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC
T ss_pred cCCC-----ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh
Confidence 3211 1223457999999999999999999999999999999999999999865433
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=295.85 Aligned_cols=197 Identities=26% Similarity=0.392 Sum_probs=167.9
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCcc---HHHHHHHHHHHhcCCCCCeeeEEEEEe--cCCeeEE
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCH--SKEMYAI 324 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~~~~~--~~~~~~l 324 (480)
.++|++.+.||+|+||.||++.. .+++.+|+|++...... .+.+.+|+++++.++||||+++++++. .++.+++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 45799999999999999999977 46899999999765433 345789999999999999999999874 4678999
Q ss_pred EEecc-CCCHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhCCCCC-----eEeccCCCCCEEEecCCCceEEeee
Q 011660 325 VYNLL-NGSLKQYLKQ-------LKWNERMDVAIGVAKALEYLHHTCDPP-----IIHRDVKSSNILLSENFHHPQLSDF 391 (480)
Q Consensus 325 V~e~~-~GsL~~~l~~-------~~~~~~~~i~~~ia~aL~yLH~~~~~~-----IiHrDlKp~NILl~~~~~~~kL~DF 391 (480)
||||+ +|+|.+++.. +++.++..++.|++.||.|||+. + |+||||||+||+++.+ +.+||+||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~-~~~kl~df 160 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGK-QNVKLGDF 160 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSS-SCEEECCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCC-CCEEEecC
Confidence 99999 4699999953 88999999999999999999998 7 9999999999999988 68999999
Q ss_pred ccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 392 GAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 392 Gla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
|++....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 161 g~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 220 (279)
T 2w5a_A 161 GLARILNHDT-----SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 220 (279)
T ss_dssp CHHHHC---C-----HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred chheeecccc-----ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC
Confidence 9986543211 11224579999999999999999999999999999999999999998764
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=301.22 Aligned_cols=198 Identities=26% Similarity=0.418 Sum_probs=164.9
Q ss_pred hhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc---------cHHHHHHHHHHHhcCCCCCeeeEEEEEecC
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW---------SEEEVLREVELLSSIKHENIVRIIGYCHSK 319 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~---------~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 319 (480)
+.++|.+.+.||+|+||.||+|.+ .+++.||+|++..... ....+.+|+++++.++||||+++++++..+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 346799999999999999999976 4589999999965431 123478999999999999999999999776
Q ss_pred CeeEEEEecc-CCCHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCC--CceEEeeecc
Q 011660 320 EMYAIVYNLL-NGSLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENF--HHPQLSDFGA 393 (480)
Q Consensus 320 ~~~~lV~e~~-~GsL~~~l~---~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~--~~~kL~DFGl 393 (480)
+ +++||||+ +|+|.+++. .+++.+...++.|++.||.|||+. +|+||||||+|||++.+. ..+||+|||+
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 163 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGH 163 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred c-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence 5 89999999 569999884 478889999999999999999999 999999999999998752 2499999999
Q ss_pred ccccccccccccCccccccccCCCcccccccc---CCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 394 AMVHHQSHQVSENVKPVNVVGTFGYLAPEYMM---YGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 394 a~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~---~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
+...... .......||+.|+|||++. ...++.++|||||||++|||++|+.||.....
T Consensus 164 ~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 224 (322)
T 2ycf_A 164 SKILGET------SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 224 (322)
T ss_dssp CEECCCC------HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTC
T ss_pred ceecccc------cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch
Confidence 9654321 1123457999999999874 56789999999999999999999999987654
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=302.10 Aligned_cols=201 Identities=21% Similarity=0.324 Sum_probs=170.0
Q ss_pred HhhhhcCCCCc-eeecccCceEEEEEEe-cCCcEEEEEEeccCC---ccHHHHHHHHHHHhcC-CCCCeeeEEEEEecCC
Q 011660 247 LCHLTHNFSPK-MLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN---WSEEEVLREVELLSSI-KHENIVRIIGYCHSKE 320 (480)
Q Consensus 247 l~~~~~~f~~~-~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 320 (480)
...+.++|.+. +.||+|+||.||+|.. .+++.||+|+++... .....+.+|+.+++.+ +||||+++++++.+.+
T Consensus 23 ~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~ 102 (327)
T 3lm5_A 23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTS 102 (327)
T ss_dssp HHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred HHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCC
Confidence 34456677777 8999999999999976 468999999997532 2356789999999999 5699999999999999
Q ss_pred eeEEEEecc-CCCHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEec---CCCceEEeee
Q 011660 321 MYAIVYNLL-NGSLKQYLK-----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSE---NFHHPQLSDF 391 (480)
Q Consensus 321 ~~~lV~e~~-~GsL~~~l~-----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~---~~~~~kL~DF 391 (480)
.+++||||+ +|+|.+++. .+++.++..++.|++.||.|||+. +|+||||||+|||++. + +.+||+||
T Consensus 103 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~-~~~kL~Df 178 (327)
T 3lm5_A 103 EIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPL-GDIKIVDF 178 (327)
T ss_dssp EEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTB-CCEEECCG
T ss_pred eEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCC-CcEEEeeC
Confidence 999999999 568988873 478899999999999999999999 9999999999999987 4 68999999
Q ss_pred ccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 392 GAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 392 Gla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
|++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 179 g~a~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 238 (327)
T 3lm5_A 179 GMSRKIGHA------CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN 238 (327)
T ss_dssp GGCEEC---------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ccccccCCc------cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 999754322 122346799999999999999999999999999999999999999987653
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=294.74 Aligned_cols=199 Identities=26% Similarity=0.429 Sum_probs=167.6
Q ss_pred hcCCCCce-eecccCceEEEEEEec---CCcEEEEEEeccCCc--cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEE
Q 011660 251 THNFSPKM-LIGQGGNSKVYRTNHV---DGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAI 324 (480)
Q Consensus 251 ~~~f~~~~-~LG~G~fg~Vy~~~~~---~g~~vAvK~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 324 (480)
.++|.+.. .||+|+||.||+|... +++.+|+|+++.... ..+.+.+|+++++.++||||+++++++. .+.+++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CCCcEE
Confidence 34566665 8999999999999753 578899999986532 3456889999999999999999999995 456899
Q ss_pred EEecc-CCCHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccc
Q 011660 325 VYNLL-NGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (480)
Q Consensus 325 V~e~~-~GsL~~~l~----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~ 399 (480)
||||+ +|+|.+++. .+++.++..++.|++.||.|||+. +|+||||||+||+++.+ +.++|+|||++.....
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~-~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNR-HYAKISDFGLSKALGA 162 (287)
T ss_dssp EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEET-TEEEECCCTTCEECTT
T ss_pred EEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCC-CCEEECcccceeeecc
Confidence 99999 569999994 378999999999999999999999 99999999999999998 6899999999976543
Q ss_pred ccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 400 SHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 400 ~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
.... ........||+.|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 163 ~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 218 (287)
T 1u59_A 163 DDSY--YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 218 (287)
T ss_dssp CSCE--ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred Ccce--eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 2211 112233457899999999998899999999999999999998 999998754
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=292.67 Aligned_cols=197 Identities=30% Similarity=0.509 Sum_probs=170.8
Q ss_pred hhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc----------cHHHHHHHHHHHhcCC-CCCeeeEEEEEe
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----------SEEEVLREVELLSSIK-HENIVRIIGYCH 317 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~----------~~~~~~~Ei~il~~l~-HpnIv~l~~~~~ 317 (480)
+.++|.+.+.||+|+||.||+|.+ .+++.||+|+++.... ..+.+.+|+++++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 457899999999999999999977 4689999999976531 1245778999999995 999999999999
Q ss_pred cCCeeEEEEecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecc
Q 011660 318 SKEMYAIVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGA 393 (480)
Q Consensus 318 ~~~~~~lV~e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGl 393 (480)
+++..++||||+ +|+|.+++.. +++.++..++.|++.||.|||+. +|+||||||+||+++.+ +.+||+|||+
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~-~~~kl~dfg~ 170 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDD-MNIKLTDFGF 170 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTT-CCEEECCCTT
T ss_pred cCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCC-CcEEEecccc
Confidence 999999999999 5799999853 78899999999999999999999 99999999999999998 6899999999
Q ss_pred ccccccccccccCccccccccCCCcccccccc------CCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 394 AMVHHQSHQVSENVKPVNVVGTFGYLAPEYMM------YGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 394 a~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~------~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
+...... .......||+.|+|||++. ...++.++||||||+++|||++|+.||...+
T Consensus 171 ~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 233 (298)
T 1phk_A 171 SCQLDPG------EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 233 (298)
T ss_dssp CEECCTT------CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred hhhcCCC------cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc
Confidence 8654322 1223467999999999885 5578999999999999999999999997654
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=293.73 Aligned_cols=193 Identities=27% Similarity=0.430 Sum_probs=161.5
Q ss_pred hcCCCCceeecccCceEEEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEEEec-CCeeEEEEecc
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHS-KEMYAIVYNLL 329 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~lV~e~~ 329 (480)
.++|++.+.||+|+||.||++.. +++.+|+|+++... ..+.+.+|+++++.++||||+++++++.+ .+.+++||||+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 97 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 97 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence 35799999999999999999987 48899999997544 45678999999999999999999998754 45789999999
Q ss_pred C-CCHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccc
Q 011660 330 N-GSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (480)
Q Consensus 330 ~-GsL~~~l~~-----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (480)
. |+|.+++.. +++..+..++.|++.||.|||+. +|+||||||+||+++.+ +.++|+|||++......
T Consensus 98 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~-~~~~l~Dfg~~~~~~~~--- 170 (278)
T 1byg_A 98 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSED-NVAKVSDFGLTKEASST--- 170 (278)
T ss_dssp TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTT-SCEEECCCCC----------
T ss_pred CCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCC-CcEEEeecccccccccc---
Confidence 5 599999953 78888999999999999999999 99999999999999988 68999999998643321
Q ss_pred ccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCcc
Q 011660 404 SENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKA 457 (480)
Q Consensus 404 ~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~~ 457 (480)
.....+|+.|+|||++.+..++.++||||||+++|||++ |+.||.....
T Consensus 171 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 220 (278)
T 1byg_A 171 -----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 220 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG
T ss_pred -----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 123467899999999999999999999999999999998 9999987643
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-36 Score=290.51 Aligned_cols=196 Identities=23% Similarity=0.377 Sum_probs=163.5
Q ss_pred hcCCCCceeecccCceEEEEEEec-CCcEEEEEEeccCC----ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEE
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTN----WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 325 (480)
.++|.+.+.||+|+||.||+|.+. +++.+|+|+++... ...+.+.+|+.+++.++||||+++++++.+.+.+++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 467999999999999999999874 79999999996432 2345788999999999999999999999999999999
Q ss_pred Eecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccc
Q 011660 326 YNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (480)
Q Consensus 326 ~e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (480)
|||+ +++|.+++.. +++.++..++.|++.||.|||+. +|+||||||+||+++.+ +.++|+|||++......
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~-~~~~l~dfg~~~~~~~~- 164 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDG- 164 (276)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTT-SCEEECCCCGGGCCCC--
T ss_pred EeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCC-CCEEEeecccccccCCC-
Confidence 9999 5799999853 78899999999999999999999 99999999999999998 68999999998654331
Q ss_pred ccccCccccccccCCCccccccccCCCC-CchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 402 QVSENVKPVNVVGTFGYLAPEYMMYGKV-DEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 402 ~~~~~~~~~~~~GT~~y~APE~~~~~~~-~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||....
T Consensus 165 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 215 (276)
T 2h6d_A 165 -----EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH 215 (276)
T ss_dssp -----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred -----cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc
Confidence 11234579999999999988766 689999999999999999999997654
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=300.38 Aligned_cols=195 Identities=27% Similarity=0.448 Sum_probs=164.9
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEE--EEEEeccCC--ccHHHHHHHHHHHhcC-CCCCeeeEEEEEecCCeeEEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVA--AVKVLKCTN--WSEEEVLREVELLSSI-KHENIVRIIGYCHSKEMYAIV 325 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~v--AvK~~~~~~--~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV 325 (480)
++|.+.+.||+|+||.||+|.. .++..+ |+|.++... ...+.+.+|+++++++ +||||+++++++.+.+.+++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 4699999999999999999976 456644 999987532 2335688999999999 999999999999999999999
Q ss_pred Eecc-CCCHHHHHHh-------------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCc
Q 011660 326 YNLL-NGSLKQYLKQ-------------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHH 385 (480)
Q Consensus 326 ~e~~-~GsL~~~l~~-------------------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~ 385 (480)
|||+ +|+|.+++.. +++.++..++.|++.||.|||+. +|+||||||+|||++.+ +.
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~-~~ 180 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGEN-YV 180 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGG-GC
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCC-Ce
Confidence 9999 6799999953 67888999999999999999999 99999999999999988 68
Q ss_pred eEEeeeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 386 PQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 386 ~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
+||+|||++..... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 181 ~kL~Dfg~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~ 246 (327)
T 1fvr_A 181 AKIADFGLSRGQEV------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 246 (327)
T ss_dssp EEECCTTCEESSCE------ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred EEEcccCcCccccc------cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc
Confidence 99999999864221 112233457899999999998899999999999999999998 999998764
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-36 Score=299.28 Aligned_cols=197 Identities=27% Similarity=0.395 Sum_probs=167.6
Q ss_pred CCCceeecccCceEEEEEEe-----cCCcEEEEEEeccCCcc--HHHHHHHHHHHhcCCCCCeeeEEEEEec--CCeeEE
Q 011660 254 FSPKMLIGQGGNSKVYRTNH-----VDGQVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHS--KEMYAI 324 (480)
Q Consensus 254 f~~~~~LG~G~fg~Vy~~~~-----~~g~~vAvK~~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~l 324 (480)
|++.+.||+|+||.||++.+ .+++.||+|+++..... .+.+.+|+++++.++||||+++++++.+ ...+++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 48999999999999998854 25889999999865422 3568899999999999999999999976 467899
Q ss_pred EEecc-CCCHHHHHHh--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccc
Q 011660 325 VYNLL-NGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (480)
Q Consensus 325 V~e~~-~GsL~~~l~~--~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (480)
||||+ +|+|.+++.. +++.++..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||++.......
T Consensus 113 v~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~-~~~kl~Dfg~a~~~~~~~ 188 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDND-RLVKIGDFGLAKAVPEGH 188 (318)
T ss_dssp EECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTT-CCEEECCGGGCEECCTTC
T ss_pred EEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCC-CCEEECCccccccccccc
Confidence 99999 5799999965 78899999999999999999999 99999999999999998 689999999997654322
Q ss_pred ccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 402 QVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 402 ~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.. ........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 189 ~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~ 241 (318)
T 3lxp_A 189 EY--YRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPP 241 (318)
T ss_dssp SE--EEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH
T ss_pred cc--cccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccc
Confidence 11 112234568899999999999999999999999999999999999998653
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=301.23 Aligned_cols=201 Identities=27% Similarity=0.425 Sum_probs=165.5
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc-cHHHHHHHHHHHhcCCCCCeeeEEEEEe----cCCeeEE
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW-SEEEVLREVELLSSIKHENIVRIIGYCH----SKEMYAI 324 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~----~~~~~~l 324 (480)
.++|.+.+.||+|+||.||++.. .+++.||+|++..... ..+.+.+|+++++.++||||+++++++. ..+..++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 45799999999999999999976 6799999999865442 3456889999999999999999999986 3457899
Q ss_pred EEecc-CCCHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccc
Q 011660 325 VYNLL-NGSLKQYLKQ-------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMV 396 (480)
Q Consensus 325 V~e~~-~GsL~~~l~~-------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~ 396 (480)
||||+ +|+|.+++.. +++.++..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||++..
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~-~~~kl~dfg~~~~ 183 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDE-GQPVLMDLGSMNQ 183 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTT-SCEEECCCSSCEE
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCC-CCEEEEecCcchh
Confidence 99999 5699999864 78999999999999999999999 99999999999999988 6899999999865
Q ss_pred cccccccc----cCccccccccCCCccccccccCCC---CCchHHHHHHHHHHHHHHcCCCCCCCC
Q 011660 397 HHQSHQVS----ENVKPVNVVGTFGYLAPEYMMYGK---VDEKIDVYSYGVVLLELITGKEAIQTN 455 (480)
Q Consensus 397 ~~~~~~~~----~~~~~~~~~GT~~y~APE~~~~~~---~~~k~DvwSlGvil~eLltG~~pf~~~ 455 (480)
........ .........||+.|+|||++.+.. ++.++|||||||++|||++|+.||...
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 249 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMV 249 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHH
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhh
Confidence 43211100 001112346899999999987554 689999999999999999999999653
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=299.42 Aligned_cols=202 Identities=22% Similarity=0.345 Sum_probs=160.3
Q ss_pred hhhcCCCCceeecccCceEEEEEEec----CCcEEEEEEeccCCccH---HHHHHHHHHHhcCCCCCeeeEEEEEecCC-
Q 011660 249 HLTHNFSPKMLIGQGGNSKVYRTNHV----DGQVAAVKVLKCTNWSE---EEVLREVELLSSIKHENIVRIIGYCHSKE- 320 (480)
Q Consensus 249 ~~~~~f~~~~~LG~G~fg~Vy~~~~~----~g~~vAvK~~~~~~~~~---~~~~~Ei~il~~l~HpnIv~l~~~~~~~~- 320 (480)
...++|.+.+.||+|+||.||+|... +++.+|+|+++...... +.+.+|+.+++.++||||+++++++.+.+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 34567999999999999999999653 34589999997654333 45889999999999999999999997654
Q ss_pred ----eeEEEEecc-CCCHHHHHH---------hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCce
Q 011660 321 ----MYAIVYNLL-NGSLKQYLK---------QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHP 386 (480)
Q Consensus 321 ----~~~lV~e~~-~GsL~~~l~---------~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~ 386 (480)
..++||||+ +|+|.+++. .+++.++..++.|++.||.|||+. +|+||||||+|||++.+ +.+
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~-~~~ 186 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDD-MTV 186 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTT-SCE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCC-CcE
Confidence 458999999 579999982 378899999999999999999999 99999999999999998 689
Q ss_pred EEeeeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCcc
Q 011660 387 QLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKA 457 (480)
Q Consensus 387 kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~~ 457 (480)
||+|||++........ ........||+.|+|||.+.+..++.++|||||||++|||++ |+.||.....
T Consensus 187 kl~Dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 255 (313)
T 3brb_A 187 CVADFGLSKKIYSGDY---YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN 255 (313)
T ss_dssp EECSCSCC-------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred EEeecCcceecccccc---cCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCH
Confidence 9999999965433211 112234457889999999999999999999999999999999 9999987654
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=305.28 Aligned_cols=195 Identities=23% Similarity=0.408 Sum_probs=167.5
Q ss_pred hhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCcc---HHHHHHHHHHHhcCCCCCeeeEEEEEecCCe----
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSKEM---- 321 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~---- 321 (480)
+.++|.+.+.||+|+||.||+|.+ .+|+.||+|++...... .+.+.+|+.+++.++||||+++++++...+.
T Consensus 22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 346799999999999999999976 56999999999765433 3467899999999999999999999976653
Q ss_pred --eEEEEeccCCCHHHHHH-hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccc
Q 011660 322 --YAIVYNLLNGSLKQYLK-QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (480)
Q Consensus 322 --~~lV~e~~~GsL~~~l~-~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~ 398 (480)
+++||||+.|+|.+++. .+++.++..++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++....
T Consensus 102 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~-~~~kl~Dfg~~~~~~ 177 (353)
T 3coi_A 102 YDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNED-CELKILDFGLARHAD 177 (353)
T ss_dssp CCCEEEEECCSEEGGGTTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTT-CCEEECSTTCTTC--
T ss_pred eeEEEEeccccCCHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCC-CcEEEeecccccCCC
Confidence 59999999999988874 588999999999999999999999 99999999999999998 689999999986432
Q ss_pred cccccccCccccccccCCCccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 399 QSHQVSENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 399 ~~~~~~~~~~~~~~~GT~~y~APE~~~~-~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+
T Consensus 178 ~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 228 (353)
T 3coi_A 178 A--------EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 228 (353)
T ss_dssp --------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSC
T ss_pred C--------CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 2 1234578999999999887 678999999999999999999999998765
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=291.45 Aligned_cols=198 Identities=25% Similarity=0.356 Sum_probs=163.9
Q ss_pred CCCCceeecccCceEEEEEEecC-C---cEEEEEEeccCCcc--HHHHHHHHHHHhcCCCCCeeeEEEEEecCCee-EEE
Q 011660 253 NFSPKMLIGQGGNSKVYRTNHVD-G---QVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSKEMY-AIV 325 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~~~-g---~~vAvK~~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~-~lV 325 (480)
.|...+.||+|+||.||+|.+.+ + ..+|+|+++..... .+.+.+|+.+++.++||||+++++++.+.+.. +++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 46667899999999999997532 2 37999999764432 35688999999999999999999999766554 899
Q ss_pred Eecc-CCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccc
Q 011660 326 YNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (480)
Q Consensus 326 ~e~~-~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (480)
+||+ +|+|.+++.. +++.++..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||++......
T Consensus 102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~-~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDES-FTVKVADFGLARDILDR 177 (298)
T ss_dssp ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTT-CCEEECCTTSSCTTTTG
T ss_pred EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCC-CcEEeCcCCCcccccCC
Confidence 9998 7899999964 67888999999999999999999 99999999999999998 68999999999754432
Q ss_pred cccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 011660 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTN 455 (480)
Q Consensus 401 ~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~ 455 (480)
.. ..........||+.|+|||.+.+..++.++|||||||++|||++|..||...
T Consensus 178 ~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~ 231 (298)
T 3pls_A 178 EY-YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRH 231 (298)
T ss_dssp GG-GCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTT
T ss_pred cc-cccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCcc
Confidence 21 1222334567899999999999999999999999999999999965554433
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=296.99 Aligned_cols=198 Identities=26% Similarity=0.389 Sum_probs=166.3
Q ss_pred hhcCCCCceeecccCceEEEEEEec-CCcEEEEEEeccCC-ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEe
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTN-WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e 327 (480)
..++|++.+.||+|+||.||+|... +++.+|+|++.... ...+.+.+|+++++.++||||+++++++.+++.+++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 3567999999999999999999874 58999999986543 345678999999999999999999999999999999999
Q ss_pred cc-CCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccc
Q 011660 328 LL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 328 ~~-~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (480)
|+ +|+|.+++.. +++.++..++.|++.||.|||+. +|+||||||+||+++.+ +.+||+|||++......
T Consensus 97 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~-- 170 (302)
T 2j7t_A 97 FCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLE-GDIRLADFGVSAKNLKT-- 170 (302)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTT-SCEEECCCHHHHHHHHH--
T ss_pred eCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCC-CCEEEEECCCCcccccc--
Confidence 99 5689888743 78999999999999999999999 99999999999999988 68999999987532211
Q ss_pred cccCccccccccCCCccccccc-----cCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 403 VSENVKPVNVVGTFGYLAPEYM-----MYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 403 ~~~~~~~~~~~GT~~y~APE~~-----~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
........||+.|+|||++ ....++.++|||||||++|||++|+.||...+
T Consensus 171 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 226 (302)
T 2j7t_A 171 ---LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN 226 (302)
T ss_dssp ---HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred ---ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC
Confidence 1112345799999999988 46778999999999999999999999998754
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=312.50 Aligned_cols=203 Identities=21% Similarity=0.300 Sum_probs=171.9
Q ss_pred hhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCccHHHHHHHHHHHhcCCC-CCeeeEEEEEecCCeeEEEEe
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIKH-ENIVRIIGYCHSKEMYAIVYN 327 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~~~~~lV~e 327 (480)
+.++|.+.+.||+|+||.||+|.+ .+++.||||+++.... ...+..|+++++.++| ++|..+..++.+.+..++|||
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 356899999999999999999976 5699999999875442 3458899999999987 556666677788889999999
Q ss_pred ccCCCHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEE---ecCCCceEEeeeccccccccc
Q 011660 328 LLNGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILL---SENFHHPQLSDFGAAMVHHQS 400 (480)
Q Consensus 328 ~~~GsL~~~l~----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl---~~~~~~~kL~DFGla~~~~~~ 400 (480)
|++|+|.+++. .+++.++..++.||+.||.|||+. +||||||||+|||| +.+ +.+||+|||+++.....
T Consensus 84 ~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~-~~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 84 LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRA-NQVYIIDFGLAKKYRDT 159 (483)
T ss_dssp CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGT-TCEEECCCTTCEECBCT
T ss_pred CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCC-CeEEEEeCCcceeccCC
Confidence 99999999996 488999999999999999999999 99999999999999 455 68999999999765432
Q ss_pred cccc--cCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 401 HQVS--ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 401 ~~~~--~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
.... .........||+.|+|||++.+..++.++|||||||+||||++|+.||.....
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~ 218 (483)
T 3sv0_A 160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218 (483)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccc
Confidence 2111 11223367899999999999999999999999999999999999999987654
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=293.29 Aligned_cols=200 Identities=25% Similarity=0.376 Sum_probs=164.1
Q ss_pred cCCCCceeecccCceEEEEEEecC----CcEEEEEEeccCCc--cHHHHHHHHHHHhcCCCCCeeeEEEEE-ecCCeeEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHVD----GQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYC-HSKEMYAI 324 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~~----g~~vAvK~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~-~~~~~~~l 324 (480)
.+|.+.+.||+|+||.||+|...+ ...+|+|.++.... ..+.+.+|+.++++++||||+++++++ ..++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 458888999999999999997532 23689999876443 235688999999999999999999986 45668899
Q ss_pred EEecc-CCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccc
Q 011660 325 VYNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (480)
Q Consensus 325 V~e~~-~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~ 399 (480)
||||+ +|+|.+++.. +++.++..++.|++.||.|||+. +|+||||||+||+++.+ +.+||+|||++.....
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~-~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEK-FTVKVADFGLARDMYD 180 (298)
T ss_dssp EEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTT-CCEEECSCGGGCCCSC
T ss_pred EEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCC-CCEEECcccccccccc
Confidence 99999 5699999954 77889999999999999999999 99999999999999998 6899999999976543
Q ss_pred ccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 400 SHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 400 ~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
... ..........||+.|+|||.+.+..++.++|||||||++|||++ |.+||...+
T Consensus 181 ~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~ 237 (298)
T 3f66_A 181 KEY-YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 237 (298)
T ss_dssp GGG-CBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSC
T ss_pred cch-hccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCC
Confidence 221 12223345568899999999999999999999999999999999 566665544
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=291.08 Aligned_cols=198 Identities=23% Similarity=0.373 Sum_probs=165.3
Q ss_pred hcCCCCceeecccCceEEEEEEecC----CcEEEEEEeccCCc--cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEE
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHVD----GQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAI 324 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~~----g~~vAvK~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 324 (480)
.++|.+.+.||+|+||.||+|...+ +..+|+|+++.... ..+.+.+|+.+++.++||||+++++++.++ ..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEE
Confidence 4679999999999999999997532 34699999976532 345688999999999999999999998764 4678
Q ss_pred EEecc-CCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccc
Q 011660 325 VYNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (480)
Q Consensus 325 V~e~~-~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~ 399 (480)
||||+ +|+|.+++.. +++..+..++.|++.||.|||+. +|+||||||+||+++.+ +.+||+|||++.....
T Consensus 90 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~ 165 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASP-ECVKLGDFGLSRYIED 165 (281)
T ss_dssp EEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEET-TEEEECCCCGGGCC--
T ss_pred EEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCC-CcEEeCccCCCccccc
Confidence 99998 5799999953 78899999999999999999999 99999999999999998 6899999999975443
Q ss_pred ccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCcc
Q 011660 400 SHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKA 457 (480)
Q Consensus 400 ~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~~ 457 (480)
.. ........||+.|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 166 ~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~ 220 (281)
T 3cc6_A 166 ED----YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN 220 (281)
T ss_dssp -----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCG
T ss_pred cc----ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCCh
Confidence 21 112234467889999999999999999999999999999998 9999976543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-36 Score=293.98 Aligned_cols=200 Identities=27% Similarity=0.444 Sum_probs=165.2
Q ss_pred hcCCCCce-eecccCceEEEEEEe---cCCcEEEEEEeccCCcc---HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeE
Q 011660 251 THNFSPKM-LIGQGGNSKVYRTNH---VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSKEMYA 323 (480)
Q Consensus 251 ~~~f~~~~-~LG~G~fg~Vy~~~~---~~g~~vAvK~~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 323 (480)
.++|.+.. .||+|+||.||+|.. .+++.+|+|+++..... .+.+.+|+++++.++||||+++++++ +.+.++
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 45688877 999999999999954 34689999999765322 45688999999999999999999999 456788
Q ss_pred EEEecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccc
Q 011660 324 IVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (480)
Q Consensus 324 lV~e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~ 399 (480)
+||||+ +|+|.+++.. +++.++..++.|++.||.|||+. +|+||||||+||+++.+ +.+||+|||++.....
T Consensus 94 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~-~~~kl~Dfg~~~~~~~ 169 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQ-HYAKISDFGLSKALRA 169 (291)
T ss_dssp EEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEET-TEEEECCCTTCEECCT
T ss_pred EEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCC-CcEEEccCCcceeecc
Confidence 999999 5789999964 78899999999999999999999 99999999999999998 6899999999976543
Q ss_pred ccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCcc
Q 011660 400 SHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKA 457 (480)
Q Consensus 400 ~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~~ 457 (480)
..... .......||+.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 170 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 226 (291)
T 1xbb_A 170 DENYY--KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 226 (291)
T ss_dssp TCSEE--EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred CCCcc--cccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 22111 11223457889999999998899999999999999999999 9999987543
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=299.02 Aligned_cols=200 Identities=25% Similarity=0.411 Sum_probs=163.3
Q ss_pred hcCCCCceeecccCceEEEEEEecC-----CcEEEEEEeccCCcc--HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeE
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHVD-----GQVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSKEMYA 323 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~~-----g~~vAvK~~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 323 (480)
.++|...+.||+|+||.||+|.... +..+|+|+++..... ...+.+|+++++.++||||+++++++.+.+.++
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 3567888999999999999996532 246999999765432 346889999999999999999999999999999
Q ss_pred EEEecc-CCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccc
Q 011660 324 IVYNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (480)
Q Consensus 324 lV~e~~-~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~ 398 (480)
+||||+ +|+|.+++.. +++.++..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||++....
T Consensus 123 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~-~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 123 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSN-LVCKVSDFGLSRVLE 198 (333)
T ss_dssp EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTT-CCEEECCCCC-----
T ss_pred EEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCC-CcEEECCCCcchhhc
Confidence 999999 5699999953 78899999999999999999999 99999999999999998 689999999997654
Q ss_pred cccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 399 QSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 399 ~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
..... ........||+.|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 199 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~ 255 (333)
T 1mqb_A 199 DDPEA--TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS 255 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ccccc--ccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCC
Confidence 32111 111223456889999999999999999999999999999999 999997654
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-36 Score=311.92 Aligned_cols=199 Identities=25% Similarity=0.344 Sum_probs=158.6
Q ss_pred cCCCCceeecccCceEEEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhcC-CCCCeeeEEEEEecCCeeEEEEeccC
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSI-KHENIVRIIGYCHSKEMYAIVYNLLN 330 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~e~~~ 330 (480)
+.|...+.||+|+||+||.+...+|+.||||++.... .+.+.+|+++++.+ +||||+++++++.+++.+++||||++
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~--~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF--CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG--HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH--HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 3456678899999999988777789999999986532 35678999999876 89999999999999999999999999
Q ss_pred CCHHHHHHhCC----------HHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecC------------CCceEE
Q 011660 331 GSLKQYLKQLK----------WNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN------------FHHPQL 388 (480)
Q Consensus 331 GsL~~~l~~~~----------~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~------------~~~~kL 388 (480)
|+|.+++.... +.++..++.||+.||.|||+. +|+||||||+|||++.+ ...+||
T Consensus 93 gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL 169 (434)
T 2rio_A 93 LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILI 169 (434)
T ss_dssp EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEE
T ss_pred CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEEE
Confidence 99999996522 223467999999999999999 99999999999999753 247999
Q ss_pred eeeccccccccccccccCccccccccCCCccccccccC-------CCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 389 SDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY-------GKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 389 ~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~-------~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
+|||++......... ........+||+.|+|||++.+ ..++.++|||||||++|||+| |+.||....
T Consensus 170 ~DFG~a~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~ 244 (434)
T 2rio_A 170 SDFGLCKKLDSGQSS-FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244 (434)
T ss_dssp CCCTTCEECCC---------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred cccccceecCCCCcc-ceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence 999999765432211 1112235679999999999975 678999999999999999999 999997654
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=300.76 Aligned_cols=200 Identities=28% Similarity=0.375 Sum_probs=165.7
Q ss_pred hcCCCCceeecccCceEEEEEEe------cCCcEEEEEEeccCCc--cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCee
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH------VDGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMY 322 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~------~~g~~vAvK~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 322 (480)
.++|.+.+.||+|+||.||+|.. .+++.||+|++..... ....+.+|+.+++.++||||+++++++.+.+..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 35699999999999999999973 3477999999965432 335688999999999999999999999999999
Q ss_pred EEEEecc-CCCHHHHHHh----------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecC--CCceEEe
Q 011660 323 AIVYNLL-NGSLKQYLKQ----------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN--FHHPQLS 389 (480)
Q Consensus 323 ~lV~e~~-~GsL~~~l~~----------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~--~~~~kL~ 389 (480)
++||||+ +|+|.+++.. +.+.++..++.|++.||.|||+. +|+||||||+|||++.+ ...++|+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEEC
Confidence 9999999 6799999953 67888999999999999999999 99999999999999843 1469999
Q ss_pred eeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 390 DFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 390 DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
|||++....... .........||+.|+|||++.+..++.++|||||||++|||+| |+.||....
T Consensus 186 Dfg~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 250 (327)
T 2yfx_A 186 DFGMARDIYRAS---YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 250 (327)
T ss_dssp CCHHHHHHHC---------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cccccccccccc---ccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC
Confidence 999986543321 1112234568999999999999999999999999999999998 999998754
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=302.28 Aligned_cols=195 Identities=23% Similarity=0.386 Sum_probs=170.9
Q ss_pred hcCCCCceeecccCceEEEEEEecCCcEEEEEEeccCCccH------------------HHHHHHHHHHhcCCCCCeeeE
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSE------------------EEVLREVELLSSIKHENIVRI 312 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~------------------~~~~~Ei~il~~l~HpnIv~l 312 (480)
.++|.+.+.||+|+||.||+|.. +++.||+|++....... +.+.+|+.+++.++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46799999999999999999988 89999999996432111 778999999999999999999
Q ss_pred EEEEecCCeeEEEEeccC-CCHHHH------HH-----hCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeccCCCCCEEE
Q 011660 313 IGYCHSKEMYAIVYNLLN-GSLKQY------LK-----QLKWNERMDVAIGVAKALEYLHH-TCDPPIIHRDVKSSNILL 379 (480)
Q Consensus 313 ~~~~~~~~~~~lV~e~~~-GsL~~~------l~-----~~~~~~~~~i~~~ia~aL~yLH~-~~~~~IiHrDlKp~NILl 379 (480)
++++.+.+.+++||||+. |+|.++ +. .+++.++..++.|++.||.|||+ . +|+||||||+||++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILM 185 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEE
Confidence 999999999999999994 599888 53 37889999999999999999999 8 99999999999999
Q ss_pred ecCCCceEEeeeccccccccccccccCccccccccCCCccccccccCC-CCCc-hHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 380 SENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYG-KVDE-KIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 380 ~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~-~~~~-k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
+.+ +.++|+|||++...... ......||+.|+|||++.+. .++. ++|||||||++|||++|+.||.....
T Consensus 186 ~~~-~~~kl~dfg~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 257 (348)
T 2pml_X 186 DKN-GRVKLSDFGESEYMVDK-------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS 257 (348)
T ss_dssp CTT-SCEEECCCTTCEECBTT-------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC
T ss_pred cCC-CcEEEeccccccccccc-------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 998 68999999999654321 23356799999999999887 6766 99999999999999999999987654
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=323.07 Aligned_cols=198 Identities=25% Similarity=0.431 Sum_probs=162.5
Q ss_pred CCCCce-eecccCceEEEEEEec---CCcEEEEEEeccCC--ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEE
Q 011660 253 NFSPKM-LIGQGGNSKVYRTNHV---DGQVAAVKVLKCTN--WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (480)
Q Consensus 253 ~f~~~~-~LG~G~fg~Vy~~~~~---~g~~vAvK~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 326 (480)
++.+.. .||+|+||.||+|.+. ++..||||+++... ...+.+.+|+++|+.++||||++++++|.+ +.+++||
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~ 414 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 414 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence 333444 7999999999999653 46689999997643 345789999999999999999999999987 5689999
Q ss_pred ecc-CCCHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccc
Q 011660 327 NLL-NGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (480)
Q Consensus 327 e~~-~GsL~~~l~----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (480)
||+ +|+|.+++. .+++.++..++.||+.||.|||+. +||||||||+|||++.+ +.+||+|||+++......
T Consensus 415 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~-~~vkL~DFGla~~~~~~~ 490 (613)
T 2ozo_A 415 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNR-HYAKISDFGLSKALGADD 490 (613)
T ss_dssp ECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEET-TEEEECCCSTTTTCC---
T ss_pred EeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCC-CcEEEeeccCcccccCCC
Confidence 999 679999994 378999999999999999999999 99999999999999998 689999999997643321
Q ss_pred ccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCcc
Q 011660 402 QVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKA 457 (480)
Q Consensus 402 ~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~~ 457 (480)
.. ........+|+.|+|||++.+..++.++|||||||+||||++ |+.||...+.
T Consensus 491 ~~--~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~ 545 (613)
T 2ozo_A 491 SY--YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 545 (613)
T ss_dssp -------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS
T ss_pred ce--eeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH
Confidence 11 111123346789999999999999999999999999999998 9999987653
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-36 Score=306.72 Aligned_cols=200 Identities=25% Similarity=0.387 Sum_probs=156.4
Q ss_pred CCCCceeecccCceEEEEEEec--CC--cEEEEEEeccCCc--cHHHHHHHHHHHhcCCCCCeeeEEEEEe-cCCeeEEE
Q 011660 253 NFSPKMLIGQGGNSKVYRTNHV--DG--QVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCH-SKEMYAIV 325 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~~--~g--~~vAvK~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~-~~~~~~lV 325 (480)
.|.+.+.||+|+||.||+|... ++ ..+|+|.++.... ..+.+.+|+.+++.++||||++++++|. .++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4677889999999999999753 22 3689999875432 3457899999999999999999999875 45678999
Q ss_pred Eecc-CCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccc
Q 011660 326 YNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (480)
Q Consensus 326 ~e~~-~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (480)
|||+ +|+|.+++.. +++.++..++.|+++||.|||+. +|+||||||+|||++.+ +.+||+|||+++.....
T Consensus 170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~-~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDK 245 (373)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTT-CCEEECCC---------
T ss_pred EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCC-CCEEEeecccccccccc
Confidence 9999 5799999964 67888899999999999999999 99999999999999998 68999999999754332
Q ss_pred cccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCcc
Q 011660 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKA 457 (480)
Q Consensus 401 ~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~~ 457 (480)
.. ..........||+.|+|||++.+..++.++|||||||++|||++ |.+||...+.
T Consensus 246 ~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~ 302 (373)
T 3c1x_A 246 EF-DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 302 (373)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCS
T ss_pred cc-ccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCH
Confidence 11 11112234567889999999999999999999999999999999 7778876543
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=292.07 Aligned_cols=198 Identities=29% Similarity=0.462 Sum_probs=159.9
Q ss_pred hhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEEEec----------
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHS---------- 318 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~---------- 318 (480)
+.++|++.+.||+|+||.||+|.. .+++.||+|+++......+.+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 356799999999999999999976 579999999997655445678899999999999999999998854
Q ss_pred ---CCeeEEEEecc-CCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEee
Q 011660 319 ---KEMYAIVYNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSD 390 (480)
Q Consensus 319 ---~~~~~lV~e~~-~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~D 390 (480)
.+.+++||||+ +|+|.+++.. +++.++..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~-~~~kl~d 159 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDES-RNVKIGD 159 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTT-SCEEECC
T ss_pred cccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCC-CCEEEee
Confidence 45789999999 5799999963 56788889999999999999999 99999999999999998 6899999
Q ss_pred ecccccccccccc---------ccCccccccccCCCccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCC
Q 011660 391 FGAAMVHHQSHQV---------SENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQT 454 (480)
Q Consensus 391 FGla~~~~~~~~~---------~~~~~~~~~~GT~~y~APE~~~~~-~~~~k~DvwSlGvil~eLltG~~pf~~ 454 (480)
||++......... ..........||+.|+|||++.+. .++.++|||||||++|||++ ||..
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~ 230 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFST 230 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCC
Confidence 9999754322100 011223456799999999999865 68999999999999999998 5554
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=305.54 Aligned_cols=196 Identities=22% Similarity=0.372 Sum_probs=166.7
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCccHHHHHHHHHHHhcCC-----------CCCeeeEEEEEec
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIK-----------HENIVRIIGYCHS 318 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~-----------HpnIv~l~~~~~~ 318 (480)
..+|.+.+.||+|+||.||+|.. .+++.||+|+++......+.+.+|+++++.++ ||||+++++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 35799999999999999999976 56899999999866555677889999998886 8999999999875
Q ss_pred CC----eeEEEEeccCCCHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecC-----CC
Q 011660 319 KE----MYAIVYNLLNGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN-----FH 384 (480)
Q Consensus 319 ~~----~~~lV~e~~~GsL~~~l~~-----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~-----~~ 384 (480)
.+ .++++||+++++|.+++.. +++..+..++.||+.||.|||+.+ +|+||||||+|||++.+ .+
T Consensus 98 ~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~~~~ 175 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLI 175 (373)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTEE
T ss_pred cCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCcCcc
Confidence 44 7899999999999999964 788899999999999999999842 89999999999999633 13
Q ss_pred ceEEeeeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 385 HPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 385 ~~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 176 ~~kl~Dfg~a~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 176 QIKIADLGNACWYDE--------HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp EEEECCCTTCEETTB--------CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred eEEEcccccccccCC--------CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence 799999999965432 1234579999999999999999999999999999999999999998664
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-36 Score=298.63 Aligned_cols=198 Identities=23% Similarity=0.391 Sum_probs=169.2
Q ss_pred hhhhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCcc-------HHHHHHHHHHHhcCC--CCCeeeEEEEEe
Q 011660 248 CHLTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS-------EEEVLREVELLSSIK--HENIVRIIGYCH 317 (480)
Q Consensus 248 ~~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~-------~~~~~~Ei~il~~l~--HpnIv~l~~~~~ 317 (480)
..+.++|.+.+.||+|+||.||+|.. .+++.||+|+++..... ...+.+|+.+++.++ ||||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 34567899999999999999999976 56899999999754321 244678999999996 599999999999
Q ss_pred cCCeeEEEEeccC--CCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeec
Q 011660 318 SKEMYAIVYNLLN--GSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFG 392 (480)
Q Consensus 318 ~~~~~~lV~e~~~--GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFG 392 (480)
+.+.+++|+|++. ++|.+++.. +++..+..++.|++.||.|||+. +|+||||||+|||++.+.+.+||+|||
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Dfg 195 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFG 195 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred cCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence 9999999999995 789999853 78899999999999999999999 999999999999999443789999999
Q ss_pred cccccccccccccCccccccccCCCccccccccCCCC-CchHHHHHHHHHHHHHHcCCCCCCCC
Q 011660 393 AAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKV-DEKIDVYSYGVVLLELITGKEAIQTN 455 (480)
Q Consensus 393 la~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~-~~k~DvwSlGvil~eLltG~~pf~~~ 455 (480)
++...... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||...
T Consensus 196 ~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 252 (320)
T 3a99_A 196 SGALLKDT-------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 252 (320)
T ss_dssp TCEECCSS-------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred cccccccc-------cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh
Confidence 98754321 2234579999999999987776 78899999999999999999999764
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=322.70 Aligned_cols=193 Identities=27% Similarity=0.462 Sum_probs=160.3
Q ss_pred eeecccCceEEEEEEe---cCCcEEEEEEeccCCc---cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc-C
Q 011660 258 MLIGQGGNSKVYRTNH---VDGQVAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-N 330 (480)
Q Consensus 258 ~~LG~G~fg~Vy~~~~---~~g~~vAvK~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~-~ 330 (480)
+.||+|+||.||+|.+ .+++.||||+++.... ..+++.+|+++|+.++||||++++++|.+ +.+++||||+ +
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 4799999999999954 2467899999975432 24679999999999999999999999975 4578999999 6
Q ss_pred CCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccCc
Q 011660 331 GSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV 407 (480)
Q Consensus 331 GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~ 407 (480)
|+|.+++.. +++.++..++.||+.||.|||+. +||||||||+|||++.+ +.+||+|||+|+........ ..
T Consensus 454 g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~-~~~kL~DFGla~~~~~~~~~--~~ 527 (635)
T 4fl3_A 454 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQ-HYAKISDFGLSKALRADENY--YK 527 (635)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEET-TEEEECCTTHHHHTTC--------
T ss_pred CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCC-CCEEEEEcCCccccccCccc--cc
Confidence 799999954 78899999999999999999999 99999999999999998 68999999999765432211 11
Q ss_pred cccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCcc
Q 011660 408 KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKA 457 (480)
Q Consensus 408 ~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~~ 457 (480)
......||+.|+|||++.+..++.++|||||||+||||++ |+.||.....
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~ 578 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 578 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 2223457889999999999999999999999999999998 9999987653
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=288.41 Aligned_cols=197 Identities=29% Similarity=0.453 Sum_probs=169.5
Q ss_pred hhcCCCCceeecccCceEEEEEEec-CCcEEEEEEeccCC---ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEE
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTN---WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 325 (480)
+.++|.+.+.||+|+||.||+|... +++.||+|++.... .....+.+|+++++.++||||+++++++.+.+.+++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 3467999999999999999999774 68999999986532 3456789999999999999999999999999999999
Q ss_pred Eecc-CCCHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCC--CceEEeeecccccccc
Q 011660 326 YNLL-NGSLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENF--HHPQLSDFGAAMVHHQ 399 (480)
Q Consensus 326 ~e~~-~GsL~~~l~---~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~--~~~kL~DFGla~~~~~ 399 (480)
+|++ +++|.+++. .+++.++..++.|++.||.|||+. +|+||||||+||+++.+. ..+||+|||++.....
T Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~ 176 (287)
T 2wei_A 100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (287)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC
T ss_pred EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcceeecC
Confidence 9999 678988874 478999999999999999999999 999999999999997641 3699999999865432
Q ss_pred ccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 400 SHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 400 ~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
. .......||+.|+|||.+.+ .++.++||||||+++|+|++|+.||...+
T Consensus 177 ~------~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 226 (287)
T 2wei_A 177 N------TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN 226 (287)
T ss_dssp C------SSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred C------CccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCC
Confidence 1 12234468999999998875 58999999999999999999999998754
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=293.52 Aligned_cols=197 Identities=28% Similarity=0.383 Sum_probs=148.7
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCcc--HHHHHHHHH-HHhcCCCCCeeeEEEEEecCCeeEEEE
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS--EEEVLREVE-LLSSIKHENIVRIIGYCHSKEMYAIVY 326 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~--~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~lV~ 326 (480)
.++|.+.+.||+|+||.||+|.. .+++.||+|+++..... ...+..|+. +++.++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 35789999999999999999977 46899999999765432 234556666 778889999999999999999999999
Q ss_pred eccCCCHHHHHH--------hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccc
Q 011660 327 NLLNGSLKQYLK--------QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (480)
Q Consensus 327 e~~~GsL~~~l~--------~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~ 398 (480)
||+.|+|.+++. .+++..+..++.|++.||.|||+.. +|+||||||+|||++.+ +.+||+|||++....
T Consensus 101 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~-~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 101 ELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRS-GNIKLCDFGISGQLV 177 (327)
T ss_dssp CCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETT-TEEEECCCSSSCC--
T ss_pred eecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCC-CCEEEccCCCceecc
Confidence 999999888874 2678889999999999999999842 79999999999999998 799999999986543
Q ss_pred cccccccCccccccccCCCccccccc----cCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 399 QSHQVSENVKPVNVVGTFGYLAPEYM----MYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 399 ~~~~~~~~~~~~~~~GT~~y~APE~~----~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.. .......||+.|+|||++ .+..++.++|||||||++|||++|+.||....
T Consensus 178 ~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 233 (327)
T 3aln_A 178 DS------IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWN 233 (327)
T ss_dssp ----------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-
T ss_pred cc------cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 21 122344799999999998 46678999999999999999999999997643
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=289.29 Aligned_cols=199 Identities=27% Similarity=0.384 Sum_probs=158.5
Q ss_pred hcCCCCceeecccCceEEEEEEec--CCc--EEEEEEeccCC----ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCee
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHV--DGQ--VAAVKVLKCTN----WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMY 322 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~--~g~--~vAvK~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 322 (480)
.++|++.+.||+|+||.||+|.+. +++ .||+|+++... ...+.+.+|+++++.++||||+++++++.+.+ .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 356999999999999999999752 333 68999987543 22356889999999999999999999998765 7
Q ss_pred EEEEecc-CCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccc
Q 011660 323 AIVYNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVH 397 (480)
Q Consensus 323 ~lV~e~~-~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~ 397 (480)
++|+||+ +|+|.+++.. +++.++..++.|++.||.|||+. +|+||||||+||+++.+ +.+||+|||++...
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~-~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATR-DLVKIGDFGLMRAL 171 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEET-TEEEECCCTTCEEC
T ss_pred eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCC-CCEEEccccccccc
Confidence 8899998 6899999843 88999999999999999999999 99999999999999998 68999999999765
Q ss_pred ccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 398 HQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 398 ~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
...... ........||+.|+|||++.+..++.++||||||+++|||++ |+.||...+
T Consensus 172 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 229 (291)
T 1u46_A 172 PQNDDH--YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN 229 (291)
T ss_dssp CC-CCE--EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cccccc--hhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC
Confidence 432211 112234567889999999998899999999999999999999 999998764
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-35 Score=293.42 Aligned_cols=199 Identities=29% Similarity=0.427 Sum_probs=168.2
Q ss_pred hcCCCCceeecccCceEEEEEEe-----cCCcEEEEEEeccCCc-cHHHHHHHHHHHhcCCCCCeeeEEEEEecC--Cee
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-----VDGQVAAVKVLKCTNW-SEEEVLREVELLSSIKHENIVRIIGYCHSK--EMY 322 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-----~~g~~vAvK~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~ 322 (480)
.++|++.+.||+|+||.||++.. .+++.||+|+++.... ..+.+.+|+++++.++||||+++++++... ..+
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 34688999999999999999973 4688999999976543 235688999999999999999999998654 378
Q ss_pred EEEEecc-CCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccc
Q 011660 323 AIVYNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVH 397 (480)
Q Consensus 323 ~lV~e~~-~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~ 397 (480)
++||||+ +|+|.+++.. +++.++..++.|++.||.|||+. +|+||||||+||+++.+ +.+||+|||++...
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~-~~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENE-NRVKIGDFGLTKVL 195 (326)
T ss_dssp EEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEET-TEEEECCCTTCEEC
T ss_pred EEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCC-CcEEEecCcchhhc
Confidence 9999999 5799999954 78889999999999999999999 99999999999999998 68999999999765
Q ss_pred ccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 011660 398 HQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTN 455 (480)
Q Consensus 398 ~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~ 455 (480)
....... .......||+.|+|||.+.+..++.++|||||||++|||++|..||...
T Consensus 196 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~ 251 (326)
T 2w1i_A 196 PQDKEYY--KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP 251 (326)
T ss_dssp CSSCSEE--ECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSH
T ss_pred ccccccc--ccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCC
Confidence 4322111 1122345788899999999889999999999999999999999998754
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=307.83 Aligned_cols=198 Identities=26% Similarity=0.378 Sum_probs=159.3
Q ss_pred cCCCCceeecccCceEEEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhcC-CCCCeeeEEEEEecCCeeEEEEeccC
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSI-KHENIVRIIGYCHSKEMYAIVYNLLN 330 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~e~~~ 330 (480)
.+|.+.+.||+|+||+||.....+++.||||++..... ..+.+|+++|+.+ +||||+++++++.+.+.+++||||++
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~--~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~ 101 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF--SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA 101 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE--EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH--HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC
Confidence 45888999999999997766567899999999975442 2356899999999 79999999999999999999999999
Q ss_pred CCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecC----CCceEEeeeccccccccccc
Q 011660 331 GSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN----FHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 331 GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~----~~~~kL~DFGla~~~~~~~~ 402 (480)
|+|.+++.. ....++..++.||+.||.|||+. +|+||||||+|||++.+ ...+||+|||+|+.......
T Consensus 102 g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~ 178 (432)
T 3p23_A 102 ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH 178 (432)
T ss_dssp EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-----
T ss_pred CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCc
Confidence 999999964 34456778999999999999999 99999999999999532 12578999999976543211
Q ss_pred cccCccccccccCCCcccccccc---CCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 403 VSENVKPVNVVGTFGYLAPEYMM---YGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 403 ~~~~~~~~~~~GT~~y~APE~~~---~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
........+||+.|+|||++. +..++.++|||||||++|||++ |..||....
T Consensus 179 --~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~ 234 (432)
T 3p23_A 179 --SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL 234 (432)
T ss_dssp ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTT
T ss_pred --ceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhh
Confidence 112234567999999999987 4667889999999999999999 999996543
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-35 Score=289.15 Aligned_cols=197 Identities=27% Similarity=0.359 Sum_probs=151.0
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCccH--HH-HHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEE
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSE--EE-VLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~~--~~-~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 326 (480)
.++|++.+.||+|+||.||+|.+ .+++.||+|+++...... .. +..+..+++.++||||+++++++.+++.+++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 35689999999999999999977 468999999997654332 22 344556788899999999999999999999999
Q ss_pred eccCCCHHHHHH----hCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccc
Q 011660 327 NLLNGSLKQYLK----QLKWNERMDVAIGVAKALEYLHH-TCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (480)
Q Consensus 327 e~~~GsL~~~l~----~~~~~~~~~i~~~ia~aL~yLH~-~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (480)
||+++.+..+.. .+++..+..++.|++.||.|||+ . +|+||||||+||+++.+ +.+||+|||++......
T Consensus 104 e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~-~~~kl~dfg~~~~~~~~- 178 (318)
T 2dyl_A 104 ELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDER-GQIKLCDFGISGRLVDD- 178 (318)
T ss_dssp CCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTT-SCEEECCCTTC-------
T ss_pred eccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCC-CCEEEEECCCchhccCC-
Confidence 999666666553 37889999999999999999998 5 89999999999999998 68999999998654321
Q ss_pred ccccCccccccccCCCcccccccc-----CCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 402 QVSENVKPVNVVGTFGYLAPEYMM-----YGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 402 ~~~~~~~~~~~~GT~~y~APE~~~-----~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||.....
T Consensus 179 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 234 (318)
T 2dyl_A 179 -----KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT 234 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS
T ss_pred -----ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc
Confidence 1223457999999999984 56789999999999999999999999987543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-36 Score=296.59 Aligned_cols=200 Identities=25% Similarity=0.338 Sum_probs=164.1
Q ss_pred hhcCCCCceeecccCceEEEEEEecCCcEEEEEEeccCCc---cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEE
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 326 (480)
..++|++.+.||+|+||.||+|...+ .+|+|+++.... ..+.+.+|+.+++.++||||+++++++.+.+.++++|
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 108 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT 108 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence 35679999999999999999998743 489999875432 2345778999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccc
Q 011660 327 NLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (480)
Q Consensus 327 e~~-~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (480)
||+ +|+|.+++.. +++.++..++.|++.||.|||+. +|+||||||+|||+++ +.++|+|||++.......
T Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~~--~~~~l~Dfg~~~~~~~~~ 183 (319)
T 2y4i_B 109 SLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYDN--GKVVITDFGLFSISGVLQ 183 (319)
T ss_dssp BCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC----CCEECCCSCCC------
T ss_pred ecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEeC--CCEEEeecCCcccccccc
Confidence 999 5799999953 78899999999999999999999 9999999999999984 589999999986543322
Q ss_pred ccccCccccccccCCCccccccccC---------CCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 402 QVSENVKPVNVVGTFGYLAPEYMMY---------GKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 402 ~~~~~~~~~~~~GT~~y~APE~~~~---------~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
............||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 247 (319)
T 2y4i_B 184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP 247 (319)
T ss_dssp ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC
T ss_pred ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 2222233345569999999999874 457999999999999999999999998754
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-35 Score=294.76 Aligned_cols=194 Identities=26% Similarity=0.346 Sum_probs=142.3
Q ss_pred hcCCCCc-eeecccCceEEEEEEec-CCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEEEec----CCeeEE
Q 011660 251 THNFSPK-MLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHS----KEMYAI 324 (480)
Q Consensus 251 ~~~f~~~-~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~~l 324 (480)
.++|.+. ++||+|+||.||+|.+. +++.||+|++.... .........++.++||||+++++++.. +..+++
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 103 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP---KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLI 103 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH---HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH---HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEE
Confidence 5678885 47999999999999774 69999999997532 222233344677899999999999865 456899
Q ss_pred EEecc-CCCHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecC--CCceEEeeeccccc
Q 011660 325 VYNLL-NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN--FHHPQLSDFGAAMV 396 (480)
Q Consensus 325 V~e~~-~GsL~~~l~~-----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~--~~~~kL~DFGla~~ 396 (480)
||||+ +|+|.+++.. +++.++..++.|++.||.|||+. +|+||||||+|||++.+ .+.+||+|||++..
T Consensus 104 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~ 180 (336)
T 3fhr_A 104 IMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE 180 (336)
T ss_dssp EEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEecccccee
Confidence 99999 5699999953 78899999999999999999999 99999999999999763 24599999999965
Q ss_pred cccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 397 HHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 397 ~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 181 ~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 234 (336)
T 3fhr_A 181 TTQ-------NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTG 234 (336)
T ss_dssp C-----------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred ccc-------cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccc
Confidence 332 122345789999999999989999999999999999999999999976653
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=291.86 Aligned_cols=195 Identities=24% Similarity=0.397 Sum_probs=160.0
Q ss_pred hhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCcc-------HHHHHHHHHHHhcC----CCCCeeeEEEEEe
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS-------EEEVLREVELLSSI----KHENIVRIIGYCH 317 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~-------~~~~~~Ei~il~~l----~HpnIv~l~~~~~ 317 (480)
+.++|.+.+.||+|+||.||+|.+ .+++.||+|+++..... ...+.+|+.+++++ +||||+++++++.
T Consensus 29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~ 108 (312)
T 2iwi_A 29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE 108 (312)
T ss_dssp ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence 356799999999999999999976 56889999999765422 12356799999888 8999999999999
Q ss_pred cCCeeEEEEec-c-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEe-cCCCceEEeee
Q 011660 318 SKEMYAIVYNL-L-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLS-ENFHHPQLSDF 391 (480)
Q Consensus 318 ~~~~~~lV~e~-~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~-~~~~~~kL~DF 391 (480)
+.+..++|+|+ + +++|.+++.. +++.++..++.|++.||.|||+. +|+||||||+||+++ .+ +.+||+||
T Consensus 109 ~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~-~~~kl~df 184 (312)
T 2iwi_A 109 TQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRR-GCAKLIDF 184 (312)
T ss_dssp ----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTT-TEEEECCC
T ss_pred cCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCC-CeEEEEEc
Confidence 98999999998 4 6799999954 88999999999999999999999 999999999999999 55 78999999
Q ss_pred ccccccccccccccCccccccccCCCccccccccCCCC-CchHHHHHHHHHHHHHHcCCCCCCCC
Q 011660 392 GAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKV-DEKIDVYSYGVVLLELITGKEAIQTN 455 (480)
Q Consensus 392 Gla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~-~~k~DvwSlGvil~eLltG~~pf~~~ 455 (480)
|++...... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||...
T Consensus 185 g~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 242 (312)
T 2iwi_A 185 GSGALLHDE-------PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD 242 (312)
T ss_dssp SSCEECCSS-------CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred chhhhcccC-------cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh
Confidence 998754331 2234579999999999887776 45899999999999999999999754
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=315.14 Aligned_cols=199 Identities=25% Similarity=0.379 Sum_probs=165.8
Q ss_pred hhcCCCCceeecccCceEEEEEEecC----CcEEEEEEeccCCcc--HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeE
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNHVD----GQVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSKEMYA 323 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~~~----g~~vAvK~~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 323 (480)
..++|.+.+.||+|+||.||+|.+.. +..+|+|.++..... .+.+.+|+.+++.++||||+++++++.+ +..+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceE
Confidence 35678999999999999999997632 467999998754322 3568899999999999999999999854 5688
Q ss_pred EEEecc-CCCHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccc
Q 011660 324 IVYNLL-NGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (480)
Q Consensus 324 lV~e~~-~GsL~~~l~----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~ 398 (480)
+||||+ +|+|.++++ .+++..+..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||+++...
T Consensus 467 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~-~~vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSN-DCVKLGDFGLSRYME 542 (656)
T ss_dssp EEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEET-TEEEECCCCCCCSCC
T ss_pred EEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCC-CCEEEEecCCCeecC
Confidence 999999 589999996 378888999999999999999999 99999999999999998 799999999997653
Q ss_pred cccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCcc
Q 011660 399 QSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKA 457 (480)
Q Consensus 399 ~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~~ 457 (480)
... ........||+.|+|||++.+..++.++|||||||++|||++ |..||.+...
T Consensus 543 ~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~ 598 (656)
T 2j0j_A 543 DST----YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 598 (656)
T ss_dssp C--------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred CCc----ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH
Confidence 321 112224467889999999999999999999999999999997 9999987643
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-36 Score=301.13 Aligned_cols=188 Identities=16% Similarity=0.160 Sum_probs=156.3
Q ss_pred hcCCCCceeecccCceEEEEEEecCCcEEEEEEeccCCc---------cHHHHHHHHHHHhcCC---------CCCeeeE
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNW---------SEEEVLREVELLSSIK---------HENIVRI 312 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~---------~~~~~~~Ei~il~~l~---------HpnIv~l 312 (480)
.++|.+.+.||+|+||.||+|.. +|+.||+|+++.... ..+.+.+|+.+++.++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 34688999999999999999987 789999999976532 2367889999988875 7777777
Q ss_pred EEEEe------------------------------cCCeeEEEEecc-CCCHHHHH--HhCCHHHHHHHHHHHHHHHHHH
Q 011660 313 IGYCH------------------------------SKEMYAIVYNLL-NGSLKQYL--KQLKWNERMDVAIGVAKALEYL 359 (480)
Q Consensus 313 ~~~~~------------------------------~~~~~~lV~e~~-~GsL~~~l--~~~~~~~~~~i~~~ia~aL~yL 359 (480)
.+++. +.+.+++||||+ +|++.+.+ ..+++.++..++.||+.||.||
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~~l 177 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVA 177 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHHHHH
Confidence 76542 267899999999 56555554 3478899999999999999999
Q ss_pred H-hCCCCCeEeccCCCCCEEEecCCC--------------------ceEEeeeccccccccccccccCccccccccCCCc
Q 011660 360 H-HTCDPPIIHRDVKSSNILLSENFH--------------------HPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGY 418 (480)
Q Consensus 360 H-~~~~~~IiHrDlKp~NILl~~~~~--------------------~~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y 418 (480)
| +. +|+||||||+|||++.+ + .+||+|||+|+.... ...+||+.|
T Consensus 178 H~~~---~ivHrDlKp~NILl~~~-~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~----------~~~~gt~~y 243 (336)
T 2vuw_A 178 EASL---RFEHRDLHWGNVLLKKT-SLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD----------GIVVFCDVS 243 (336)
T ss_dssp HHHH---CCBCSCCCGGGEEEEEC-SCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET----------TEEECCCCT
T ss_pred HHhC---CEeECCCCHHHEEEecc-CCcceeeeccCccccccCCCceEEEeeccccEecCC----------CcEEEeecc
Confidence 9 88 99999999999999987 4 899999999975432 134799999
Q ss_pred cccccccCCCCCchHHHHHHHHH-HHHHHcCCCCCCC
Q 011660 419 LAPEYMMYGKVDEKIDVYSYGVV-LLELITGKEAIQT 454 (480)
Q Consensus 419 ~APE~~~~~~~~~k~DvwSlGvi-l~eLltG~~pf~~ 454 (480)
+|||++.+.. +.++||||||++ .+++++|..||..
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~ 279 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN 279 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc
Confidence 9999998766 999999998777 7789999999954
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=318.13 Aligned_cols=190 Identities=25% Similarity=0.352 Sum_probs=162.1
Q ss_pred hcCCCCceeecccCceEEEEEEec--CCcEEEEEEeccCCc--cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCe-----
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHV--DGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEM----- 321 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~--~g~~vAvK~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~----- 321 (480)
.++|.+.+.||+|+||.||++.+. +++.||||++..... ....+.+|+++++.++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 468999999999999999999774 689999999875432 23457899999999999999999999986655
Q ss_pred eEEEEecc-CCCHHHHHH-hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccc
Q 011660 322 YAIVYNLL-NGSLKQYLK-QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (480)
Q Consensus 322 ~~lV~e~~-~GsL~~~l~-~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~ 399 (480)
.|+||||+ +++|.+++. .+++.++..++.||+.||.|||+. +||||||||+|||++.+ .+||+|||+++....
T Consensus 159 ~~lv~E~~~g~~L~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~--~~kl~DFG~a~~~~~ 233 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE--QLKLIDLGAVSRINS 233 (681)
T ss_dssp EEEEEECCCCEECC----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS--CEEECCCTTCEETTC
T ss_pred eEEEEEeCCCCcHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC--cEEEEecccchhccc
Confidence 79999999 568888875 589999999999999999999999 99999999999999986 799999999965432
Q ss_pred ccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 011660 400 SHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTN 455 (480)
Q Consensus 400 ~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~ 455 (480)
. ....||+.|+|||++.++ ++.++|||||||+||||++|.+||...
T Consensus 234 ~---------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~ 279 (681)
T 2pzi_A 234 F---------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGR 279 (681)
T ss_dssp C---------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTE
T ss_pred C---------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccc
Confidence 1 345799999999988765 489999999999999999999998754
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-34 Score=310.09 Aligned_cols=195 Identities=29% Similarity=0.410 Sum_probs=166.9
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc--cHHHHHHHHHHHhcCCCCCeeeEEEEEec------CCee
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHS------KEMY 322 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~------~~~~ 322 (480)
.+|.+.+.||+|+||.||+|.+ .+|+.||+|+++.... ..+.+.+|+++++.++||||+++++++.. ++..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 5799999999999999999976 5689999999876432 23568899999999999999999999765 6788
Q ss_pred EEEEecc-CCCHHHHHHh------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCC--ceEEeeecc
Q 011660 323 AIVYNLL-NGSLKQYLKQ------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFH--HPQLSDFGA 393 (480)
Q Consensus 323 ~lV~e~~-~GsL~~~l~~------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~--~~kL~DFGl 393 (480)
++||||+ +|+|.+++.. +++..+..++.|++.||.|||+. +|+||||||+||+++.+.. .+||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 9999999 7899999964 77889999999999999999999 9999999999999997621 389999999
Q ss_pred ccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 011660 394 AMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTN 455 (480)
Q Consensus 394 a~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~ 455 (480)
+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 171 a~~~~~~------~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~ 226 (676)
T 3qa8_A 171 AKELDQG------ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPN 226 (676)
T ss_dssp CCBTTSC------CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccccccc------cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcc
Confidence 9754332 1223567999999999999999999999999999999999999999764
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-34 Score=295.31 Aligned_cols=193 Identities=17% Similarity=0.242 Sum_probs=152.9
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc----cHHHHHHHHHHHhcCCC-CCe---------------
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLREVELLSSIKH-ENI--------------- 309 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~----~~~~~~~Ei~il~~l~H-pnI--------------- 309 (480)
..+|...++||+|+||.||+|.+ .+|+.||||+++.... ..+.+.+|+.+++.+.| +|.
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 34577888999999999999985 5699999999974322 24678899999999977 221
Q ss_pred ------eeEEEEEec-----CCeeEEEEeccCCCHHHHHHh----------CCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 011660 310 ------VRIIGYCHS-----KEMYAIVYNLLNGSLKQYLKQ----------LKWNERMDVAIGVAKALEYLHHTCDPPII 368 (480)
Q Consensus 310 ------v~l~~~~~~-----~~~~~lV~e~~~GsL~~~l~~----------~~~~~~~~i~~~ia~aL~yLH~~~~~~Ii 368 (480)
..++.++.. ...++++|+++.++|.++++. +++..+..++.|+++||.|||+. +||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ii 233 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLV 233 (413)
T ss_dssp EECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred cccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence 111111111 235788899999999999841 55677888999999999999999 999
Q ss_pred eccCCCCCEEEecCCCceEEeeeccccccccccccccCccccccccCCCccccccc----------cCCCCCchHHHHHH
Q 011660 369 HRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYM----------MYGKVDEKIDVYSY 438 (480)
Q Consensus 369 HrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~----------~~~~~~~k~DvwSl 438 (480)
||||||+|||++.+ +.+||+|||+++..... ....+| +.|+|||++ ....++.++|||||
T Consensus 234 HrDiKp~NILl~~~-~~~kL~DFG~a~~~~~~--------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSl 303 (413)
T 3dzo_A 234 HTYLRPVDIVLDQR-GGVFLTGFEHLVRDGAS--------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTL 303 (413)
T ss_dssp CSCCCGGGEEECTT-CCEEECCGGGCEETTEE--------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHH
T ss_pred cCCcccceEEEecC-CeEEEEeccceeecCCc--------cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHH
Confidence 99999999999999 68999999998653321 345678 999999999 55568899999999
Q ss_pred HHHHHHHHcCCCCCCCCc
Q 011660 439 GVVLLELITGKEAIQTNK 456 (480)
Q Consensus 439 Gvil~eLltG~~pf~~~~ 456 (480)
||++|||++|+.||....
T Consensus 304 Gvil~elltg~~Pf~~~~ 321 (413)
T 3dzo_A 304 GLAIYWIWCADLPNTDDA 321 (413)
T ss_dssp HHHHHHHHHSSCCCCTTG
T ss_pred HHHHHHHHHCCCCCCCcc
Confidence 999999999999998764
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-33 Score=275.26 Aligned_cols=171 Identities=13% Similarity=0.138 Sum_probs=149.6
Q ss_pred hcCCCCceeecccCceEEEEEEec-CCcEEEEEEeccCCccH----HHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEE
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWSE----EEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~----~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 325 (480)
.++|++.+.||+|+||.||+|.+. +++.||+|+++...... +.+.+|+.+++.++||||+++++++.+++.+++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 356999999999999999999774 58999999998664432 5688999999999999999999999999999999
Q ss_pred Eecc-CCCHHHHHHh-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccc
Q 011660 326 YNLL-NGSLKQYLKQ-LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (480)
Q Consensus 326 ~e~~-~GsL~~~l~~-~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (480)
|||+ +++|.++++. ....+...++.|++.||.|||+. +|+||||||+|||++.+ +.+||+++|
T Consensus 110 ~e~~~g~~L~~~l~~~~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~-g~~kl~~~~----------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSID-GDVVLAYPA----------- 174 (286)
T ss_dssp EECCCEEEHHHHHTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETT-SCEEECSCC-----------
T ss_pred EEecCCCCHHHHHhcCCChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCC-CCEEEEecc-----------
Confidence 9999 5799999965 45567888999999999999999 99999999999999998 789987443
Q ss_pred ccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 404 SENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 404 ~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
|++| ++.++|||||||++|||+||+.||...+.
T Consensus 175 --------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~ 207 (286)
T 3uqc_A 175 --------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGV 207 (286)
T ss_dssp --------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSB
T ss_pred --------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence 3333 68999999999999999999999987653
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=8.1e-32 Score=266.30 Aligned_cols=171 Identities=29% Similarity=0.431 Sum_probs=146.9
Q ss_pred hcCCCCc-eeecccCceEEEEEEe-cCCcEEEEEEeccCCccHHHHHHHHHHH-hcCCCCCeeeEEEEEec----CCeeE
Q 011660 251 THNFSPK-MLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELL-SSIKHENIVRIIGYCHS----KEMYA 323 (480)
Q Consensus 251 ~~~f~~~-~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ei~il-~~l~HpnIv~l~~~~~~----~~~~~ 323 (480)
.++|.+. +.||+|+||.||++.. .+++.||+|+++. ...+.+|+.++ +.++||||+++++++.. ...++
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 3567776 7899999999999976 5689999999964 35677899988 66799999999999876 67899
Q ss_pred EEEecc-CCCHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEec---CCCceEEeeeccc
Q 011660 324 IVYNLL-NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSE---NFHHPQLSDFGAA 394 (480)
Q Consensus 324 lV~e~~-~GsL~~~l~~-----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~---~~~~~kL~DFGla 394 (480)
+||||+ +|+|.+++.. +++.++..++.|++.||.|||+. +|+||||||+|||++. + +.+||+|||++
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~-~~~kl~Dfg~a 167 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPN-AILKLTDFGFA 167 (299)
T ss_dssp EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTT-CCEEECCCTTC
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCC-CcEEEeccccc
Confidence 999999 5699999954 78899999999999999999999 9999999999999997 5 68999999998
Q ss_pred cccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 395 MVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
... .+..++.++|||||||++|||++|+.||....
T Consensus 168 ~~~---------------------------~~~~~~~~~DiwslG~il~el~tg~~pf~~~~ 202 (299)
T 3m2w_A 168 KET---------------------------TGEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 202 (299)
T ss_dssp EEC---------------------------TTCGGGGHHHHHHHHHHHHHHHHSSCSCCC--
T ss_pred ccc---------------------------ccccCCchhhHHHHHHHHHHHHHCCCCCCCCc
Confidence 431 12457789999999999999999999996543
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.9e-32 Score=290.58 Aligned_cols=182 Identities=18% Similarity=0.126 Sum_probs=127.5
Q ss_pred ecccCceEEEEEE-ecCCcEEEEEEeccCCc-----------cHHHHHHHHHHHhcC-CCCCeeeEEEEEecCCeeEEEE
Q 011660 260 IGQGGNSKVYRTN-HVDGQVAAVKVLKCTNW-----------SEEEVLREVELLSSI-KHENIVRIIGYCHSKEMYAIVY 326 (480)
Q Consensus 260 LG~G~fg~Vy~~~-~~~g~~vAvK~~~~~~~-----------~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~ 326 (480)
.+.|++|.+..+. +..|+.+|+|++.+... ..+++.+|+++|+++ +|+||+++++++++++.+||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 5567777666653 34588999999976531 124588999999999 7999999999999999999999
Q ss_pred ecc-CCCHHHHHHhCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccccc
Q 011660 327 NLL-NGSLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE 405 (480)
Q Consensus 327 e~~-~GsL~~~l~~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~ 405 (480)
||+ +|+|.++|.+.......+|+.||+.||.|||++ |||||||||+|||++++ +++||+|||+|+.....
T Consensus 322 Eyv~G~~L~d~i~~~~~l~~~~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~d-g~vKL~DFGlAr~~~~~----- 392 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGEEIDREKILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDAR-QHARLIDFGSIVTTPQD----- 392 (569)
T ss_dssp ECCCSEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTT-SCEEECCCTTEESCC-------
T ss_pred ecCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHC---CceeccCchHhEEECCC-CCEEEeecccCeeCCCC-----
Confidence 999 668999997654444557899999999999999 99999999999999998 79999999999754331
Q ss_pred CccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCC
Q 011660 406 NVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEA 451 (480)
Q Consensus 406 ~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~p 451 (480)
.....+.+||+.|||||++.+ .+..++|+||+|+++++|.+|..+
T Consensus 393 ~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 393 CSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp -CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 223346789999999998875 567889999999998887666444
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=8.2e-28 Score=257.34 Aligned_cols=187 Identities=17% Similarity=0.207 Sum_probs=143.9
Q ss_pred CCceeecccCceEEEEEEecCCcEEEEEEeccCCcc---------HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEE
Q 011660 255 SPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWS---------EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (480)
Q Consensus 255 ~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~---------~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 325 (480)
...++||+|+||.||++.. .++.+++|........ .+.+.+|++++++++||||+++..++.+.+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3456899999999999954 5778888886443211 13478999999999999999655555566777999
Q ss_pred Eecc-CCCHHHHHHhCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccc
Q 011660 326 YNLL-NGSLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (480)
Q Consensus 326 ~e~~-~GsL~~~l~~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (480)
|||+ +|+|.+++.. +..++.|+++||.|||++ +|+||||||+|||++. ++||+|||+|+.........
T Consensus 418 mE~~~ggsL~~~l~~-----~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~---~~kL~DFGla~~~~~~~~~~ 486 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK---DLYIIDFGLGKISNLDEDKA 486 (540)
T ss_dssp EECCCSEEHHHHSTT-----CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS---SEEECCCTTCEECCCHHHHH
T ss_pred EECCCCCCHHHHHHH-----HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC---eEEEEECccCEECCCccccc
Confidence 9999 5899999977 668999999999999999 9999999999999988 69999999997654321110
Q ss_pred --cCccccccccCCCccccccccC--CCCCchHHHHHHHHHHHHHHcCCCCCC
Q 011660 405 --ENVKPVNVVGTFGYLAPEYMMY--GKVDEKIDVYSYGVVLLELITGKEAIQ 453 (480)
Q Consensus 405 --~~~~~~~~~GT~~y~APE~~~~--~~~~~k~DvwSlGvil~eLltG~~pf~ 453 (480)
........+||+.|||||++.. ..|+..+|+|+..+-..+.+.++.+|.
T Consensus 487 ~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 487 VDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 0011236789999999999986 678888999999999999998888875
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=4.3e-24 Score=210.06 Aligned_cols=144 Identities=17% Similarity=0.145 Sum_probs=114.9
Q ss_pred hcCCCCceeecccCceEEEEEEecCCcEEEEEEeccCCc-------------------cHHHHHHHHHHHhcCCCCCeee
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNW-------------------SEEEVLREVELLSSIKHENIVR 311 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~-------------------~~~~~~~Ei~il~~l~HpnIv~ 311 (480)
...|.+.+.||+|+||.||+|...+|+.+|+|+++.... ....+.+|+.+++.++| ++
T Consensus 89 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~ 165 (282)
T 1zar_A 89 GKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LA 165 (282)
T ss_dssp TSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SS
T ss_pred CeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CC
Confidence 345667799999999999999887799999999964321 23457899999999984 45
Q ss_pred EEEEEecCCeeEEEEecc-CCCHHHHHHhCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEee
Q 011660 312 IIGYCHSKEMYAIVYNLL-NGSLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSD 390 (480)
Q Consensus 312 l~~~~~~~~~~~lV~e~~-~GsL~~~l~~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~D 390 (480)
+.+++.. +..++||||+ +|+|.+ + ...+...++.|++.||.|||+. +|+||||||+|||++ + +.+||+|
T Consensus 166 v~~~~~~-~~~~lvmE~~~g~~L~~-l---~~~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~-~~vkl~D 235 (282)
T 1zar_A 166 VPKVYAW-EGNAVLMELIDAKELYR-V---RVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-E-EGIWIID 235 (282)
T ss_dssp SCCEEEE-ETTEEEEECCCCEEGGG-C---CCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-T-TEEEECC
T ss_pred cCeEEec-cceEEEEEecCCCcHHH-c---chhhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-C-CcEEEEE
Confidence 5554433 5569999999 558887 4 2244567999999999999999 999999999999999 6 7999999
Q ss_pred eccccccccccccccCccccccccCCCcccccccc
Q 011660 391 FGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMM 425 (480)
Q Consensus 391 FGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~ 425 (480)
||+|+ .+..|+|||++.
T Consensus 236 FG~a~------------------~~~~~~a~e~l~ 252 (282)
T 1zar_A 236 FPQSV------------------EVGEEGWREILE 252 (282)
T ss_dssp CTTCE------------------ETTSTTHHHHHH
T ss_pred CCCCe------------------ECCCCCHHHHHH
Confidence 99984 244589999875
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=1e-20 Score=183.30 Aligned_cols=133 Identities=18% Similarity=0.243 Sum_probs=106.9
Q ss_pred CCCceeecccCceEEEEEEe-cCCcE--EEEEEeccCCcc-------------------------HHHHHHHHHHHhcCC
Q 011660 254 FSPKMLIGQGGNSKVYRTNH-VDGQV--AAVKVLKCTNWS-------------------------EEEVLREVELLSSIK 305 (480)
Q Consensus 254 f~~~~~LG~G~fg~Vy~~~~-~~g~~--vAvK~~~~~~~~-------------------------~~~~~~Ei~il~~l~ 305 (480)
|.+.+.||+|+||.||+|.. .+|+. ||||+++..... ...+.+|+.+|+.++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56778999999999999987 68988 999997643211 125788999999998
Q ss_pred CCCe--eeEEEEEecCCeeEEEEeccC--C----CHHHHHHhCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEeccCCCCC
Q 011660 306 HENI--VRIIGYCHSKEMYAIVYNLLN--G----SLKQYLKQLKWNERMDVAIGVAKALEYLH-HTCDPPIIHRDVKSSN 376 (480)
Q Consensus 306 HpnI--v~l~~~~~~~~~~~lV~e~~~--G----sL~~~l~~~~~~~~~~i~~~ia~aL~yLH-~~~~~~IiHrDlKp~N 376 (480)
|+++ ..++++ +..++||||++ | +|.++....++.+...++.|++.||.||| +. +|+||||||+|
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---givHrDlkp~N 201 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLYQEA---ELVHADLSEYN 201 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGGGGGSCHHHHHHHHHHHHHHHHHTS---CEECSSCSTTS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhccChHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHH
Confidence 8754 444543 35689999994 4 67777655555677889999999999999 88 99999999999
Q ss_pred EEEecCCCceEEeeeccccc
Q 011660 377 ILLSENFHHPQLSDFGAAMV 396 (480)
Q Consensus 377 ILl~~~~~~~kL~DFGla~~ 396 (480)
||+++ .++|+|||+|..
T Consensus 202 ILl~~---~~~liDFG~a~~ 218 (258)
T 1zth_A 202 IMYID---KVYFIDMGQAVT 218 (258)
T ss_dssp EEESS---SEEECCCTTCEE
T ss_pred EEEcC---cEEEEECccccc
Confidence 99987 699999999954
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.64 E-value=2.5e-16 Score=160.31 Aligned_cols=132 Identities=19% Similarity=0.286 Sum_probs=97.8
Q ss_pred CCCceeecccCceEEEEEEecCCcEEEEEEeccCCcc---------------HH--------HHHHHHHHHhcCCCCCee
Q 011660 254 FSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWS---------------EE--------EVLREVELLSSIKHENIV 310 (480)
Q Consensus 254 f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~---------------~~--------~~~~Ei~il~~l~HpnIv 310 (480)
|.+...||+|+||.||+|...+|+.+|||+++..... .. ...+|...|.++.+.++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 8899999999999999999888999999997632110 01 123577777777555432
Q ss_pred --eEEEEEecCCeeEEEEeccCC-CHHHHHHhCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCC---
Q 011660 311 --RIIGYCHSKEMYAIVYNLLNG-SLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFH--- 384 (480)
Q Consensus 311 --~l~~~~~~~~~~~lV~e~~~G-sL~~~l~~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~--- 384 (480)
..+++. ..++||||++| .|.++. ...+...++.|++.+|.|||+. |||||||||.|||++++ +
T Consensus 177 vp~p~~~~----~~~LVME~i~G~~L~~l~---~~~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~d-gd~~ 245 (397)
T 4gyi_A 177 VPEPIAQS----RHTIVMSLVDALPMRQVS---SVPDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREE-KDAE 245 (397)
T ss_dssp CCCEEEEE----TTEEEEECCSCEEGGGCC---CCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEE-ECSS
T ss_pred CCeeeecc----CceEEEEecCCccHhhhc---ccHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCC-CCcc
Confidence 233322 23799999965 454332 2234566889999999999998 99999999999999887 4
Q ss_pred -------ceEEeeeccccc
Q 011660 385 -------HPQLSDFGAAMV 396 (480)
Q Consensus 385 -------~~kL~DFGla~~ 396 (480)
.+.|+||+-+..
T Consensus 246 d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 246 DPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp CTTSEEEEEEECCCTTCEE
T ss_pred cccccccceEEEEeCCccc
Confidence 388999998754
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.26 E-value=1.9e-11 Score=117.51 Aligned_cols=141 Identities=12% Similarity=0.136 Sum_probs=108.8
Q ss_pred cCCCCceeecccCceEEEEEEecCCcEEEEEEeccCC-ccHHHHHHHHHHHhcCC-CCCeeeEEEEEecCCeeEEEEecc
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTN-WSEEEVLREVELLSSIK-HENIVRIIGYCHSKEMYAIVYNLL 329 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~-~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~e~~ 329 (480)
..|.....++.|+.+.||++... ++.+++|+..... .....+.+|+.+++.+. +..+.++++++.+.+..++|||++
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i 92 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEA 92 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred ccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEec
Confidence 45777788888999999999753 6889999986421 22346889999999884 677889999998888999999999
Q ss_pred CC-CHHHHHHhCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------------
Q 011660 330 NG-SLKQYLKQLKWNERMDVAIGVAKALEYLHHTC--------------------------------------------- 363 (480)
Q Consensus 330 ~G-sL~~~l~~~~~~~~~~i~~~ia~aL~yLH~~~--------------------------------------------- 363 (480)
.| +|.+.+. .......++.+++++|..||+..
T Consensus 93 ~G~~l~~~~~--~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 170 (263)
T 3tm0_A 93 DGVLCSEEYE--DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPREL 170 (263)
T ss_dssp SSEEHHHHCC--TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHH
T ss_pred CCeehhhccC--CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHH
Confidence 66 5665431 12234467889999999999821
Q ss_pred -----------CCCeEeccCCCCCEEEecCCCceEEeeeccccc
Q 011660 364 -----------DPPIIHRDVKSSNILLSENFHHPQLSDFGAAMV 396 (480)
Q Consensus 364 -----------~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~ 396 (480)
...++|+|++|.|||++++ +.+.|+||+.+.+
T Consensus 171 ~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~-~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 171 YDFLKTEKPEEELVFSHGDLGDSNIFVKDG-KVSGFIDLGRSGR 213 (263)
T ss_dssp HHHHHHCCCCCCEEEECSSCCTTSEEEETT-EEEEECCCTTCEE
T ss_pred HHHHHhcCCCCCceEECCCCCcCcEEEECC-cEEEEEEchhccc
Confidence 1359999999999999875 4556999998743
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.23 E-value=1.1e-11 Score=118.24 Aligned_cols=136 Identities=18% Similarity=0.145 Sum_probs=98.8
Q ss_pred CCCCceeecccCceEEEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCC--eeeEEEEEecCCeeEEEEeccC
Q 011660 253 NFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHEN--IVRIIGYCHSKEMYAIVYNLLN 330 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~~~~~~~~~lV~e~~~ 330 (480)
+|.+..+.+.|..+.||++...+|+.+++|+.... ....+.+|+.+++.+.+.+ +.+++++..+++..++|||++.
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~ 98 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP 98 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecC
Confidence 44443333456669999998777888999997654 2345788999999885444 5668998888888999999996
Q ss_pred C-CHHHHHHhCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------------
Q 011660 331 G-SLKQYLKQLKWNERMDVAIGVAKALEYLHHTC---------------------------------------------- 363 (480)
Q Consensus 331 G-sL~~~l~~~~~~~~~~i~~~ia~aL~yLH~~~---------------------------------------------- 363 (480)
| +|. .... ....++.++++.|..||+..
T Consensus 99 G~~l~--~~~~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (264)
T 1nd4_A 99 GQDLL--SSHL---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR 173 (264)
T ss_dssp SEETT--TSCC---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred CcccC--cCcC---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHH
Confidence 6 453 2222 22356778888888888752
Q ss_pred ---------CCCeEeccCCCCCEEEecCCCceEEeeeccccc
Q 011660 364 ---------DPPIIHRDVKSSNILLSENFHHPQLSDFGAAMV 396 (480)
Q Consensus 364 ---------~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~ 396 (480)
...++|+|++|.||+++++ +.+.|+||+.|.+
T Consensus 174 l~~~~~~~~~~~l~HgDl~~~Nil~~~~-~~~~liD~~~a~~ 214 (264)
T 1nd4_A 174 LKARMPDGEDLVVTHGDACLPNIMVENG-RFSGFIDCGRLGV 214 (264)
T ss_dssp HHHTCCSSCCEEEECSSCCGGGEEEETT-EEEEECCCTTCEE
T ss_pred HHHhcCCCCCeEEECCCCCCCcEEEECC-cEEEEEcchhccc
Confidence 1139999999999999876 4566999999853
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.02 E-value=4.9e-10 Score=112.90 Aligned_cols=141 Identities=13% Similarity=0.212 Sum_probs=104.4
Q ss_pred CceeecccCceEEEEEEecCCcEEEEEEec--cCC--ccHHHHHHHHHHHhcCC--CCCeeeEEEEEecC---CeeEEEE
Q 011660 256 PKMLIGQGGNSKVYRTNHVDGQVAAVKVLK--CTN--WSEEEVLREVELLSSIK--HENIVRIIGYCHSK---EMYAIVY 326 (480)
Q Consensus 256 ~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~--~~~--~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~---~~~~lV~ 326 (480)
..+.|+.|.++.||+.... +..+++|+.. ... .....+.+|..+++.+. +..+.+++.++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 3457899999999998765 4678888775 332 12346889999999886 45688899998776 4588999
Q ss_pred eccCCC-HH-HHHHhCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------------
Q 011660 327 NLLNGS-LK-QYLKQLKWNERMDVAIGVAKALEYLHHTC----------------------------------------- 363 (480)
Q Consensus 327 e~~~Gs-L~-~~l~~~~~~~~~~i~~~ia~aL~yLH~~~----------------------------------------- 363 (480)
|++.|. +. ..+..++..++..++.++++.|..||...
T Consensus 121 e~v~G~~l~~~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (359)
T 3dxp_A 121 EFVSGRVLWDQSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSL 200 (359)
T ss_dssp ECCCCBCCCCTTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHH
T ss_pred EecCCeecCCCccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHH
Confidence 999763 42 23445677788889999999999999731
Q ss_pred --------------CCCeEeccCCCCCEEEecCCC-ceEEeeecccccc
Q 011660 364 --------------DPPIIHRDVKSSNILLSENFH-HPQLSDFGAAMVH 397 (480)
Q Consensus 364 --------------~~~IiHrDlKp~NILl~~~~~-~~kL~DFGla~~~ 397 (480)
...++|+|++|.|||++++.. .+.|+||+.+.+.
T Consensus 201 ~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 201 MDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 247999999999999997632 2589999998653
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.97 E-value=7.1e-10 Score=109.18 Aligned_cols=184 Identities=21% Similarity=0.269 Sum_probs=122.9
Q ss_pred ceeecccCceEEEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhcC-CCCC--eeeEEEEEecCC---eeEEEEeccC
Q 011660 257 KMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSI-KHEN--IVRIIGYCHSKE---MYAIVYNLLN 330 (480)
Q Consensus 257 ~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l-~Hpn--Iv~l~~~~~~~~---~~~lV~e~~~ 330 (480)
.+.++.|.+..||+.. ..+++|+.... .....+.+|.++|+.+ .+.. +..++.+....+ ..|+||+++.
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 4468999999999863 45888886432 2345688999999887 3332 445666554433 3478899997
Q ss_pred CC-HHH-HHHhCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------------
Q 011660 331 GS-LKQ-YLKQLKWNERMDVAIGVAKALEYLHHTC--------------------------------------------- 363 (480)
Q Consensus 331 Gs-L~~-~l~~~~~~~~~~i~~~ia~aL~yLH~~~--------------------------------------------- 363 (480)
|. |.+ ....++..++..++.+++..|..||...
T Consensus 100 G~~l~~~~~~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 179 (304)
T 3sg8_A 100 GVPLTPLLLNNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRD 179 (304)
T ss_dssp CEECCHHHHHTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHH
T ss_pred CeECCccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHH
Confidence 63 543 4456777888888889999999888621
Q ss_pred ----------CCCeEeccCCCCCEEEecC-CCceEEeeeccccccccccccccCccccccccCCCc---ccccccc----
Q 011660 364 ----------DPPIIHRDVKSSNILLSEN-FHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGY---LAPEYMM---- 425 (480)
Q Consensus 364 ----------~~~IiHrDlKp~NILl~~~-~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y---~APE~~~---- 425 (480)
...++|+|++|.||+++++ .+.+.|+||+.+......... .....+ ..|+...
T Consensus 180 ~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl---------~~~~~~~~~~~~~~~~~~l~ 250 (304)
T 3sg8_A 180 ILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDF---------ISLMEDDEEYGMEFVSKILN 250 (304)
T ss_dssp HHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHH---------HTTCCTTTSCCHHHHHHHHH
T ss_pred HHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHH---------HHHHhhccccCHHHHHHHHH
Confidence 1358999999999999984 246789999998653321111 111111 2222211
Q ss_pred -CCCC---------CchHHHHHHHHHHHHHHcCCCCCCC
Q 011660 426 -YGKV---------DEKIDVYSYGVVLLELITGKEAIQT 454 (480)
Q Consensus 426 -~~~~---------~~k~DvwSlGvil~eLltG~~pf~~ 454 (480)
++.. ..-.+.|++|.++|.+.+|+.+|..
T Consensus 251 ~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~~ 289 (304)
T 3sg8_A 251 HYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWYE 289 (304)
T ss_dssp HHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHHH
T ss_pred HcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHHH
Confidence 1111 1236899999999999999988754
|
| >3hgm_A Universal stress protein TEAD; rossman fold, signaling protein; HET: ATP; 1.90A {Halomonas elongata} SCOP: c.26.2.0 | Back alignment and structure |
|---|
Probab=98.76 E-value=2.2e-08 Score=86.91 Aligned_cols=115 Identities=12% Similarity=0.075 Sum_probs=90.6
Q ss_pred eEEEEEEecChhhHHHHHHHHHhhcCCCCeEEEEEeeccCC----------ccc----c--------chhHHHHhhhccc
Q 011660 23 RTVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVEEQND----------TLD----L--------NTFHIHEDLCKSK 80 (480)
Q Consensus 23 ~~v~v~~~~~~~~~~~l~wal~~~~~~~d~v~~~hv~~~~~----------~~~----~--------~~~~~~~~~c~~~ 80 (480)
++|||++|.+..|+.+|.||+.-..+.|..|++|||..... ... . +.+..+...+...
T Consensus 3 ~~ILv~vD~s~~s~~al~~A~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 82 (147)
T 3hgm_A 3 NRIMVPVDGSKGAVKALEKGVGLQQLTGAELYILCVFKHHSLLEASLSMARPEQLDIPDDALKDYATEIAVQAKTRATEL 82 (147)
T ss_dssp SEEEEECCSBHHHHHHHHHHHHHHHHHCCEEEEEEEECCHHHHHHTBSSCCCGGGCCCTTHHHHHHHHHHHHHHHHHHHT
T ss_pred ceEEEEeCCCHHHHHHHHHHHHHHHhcCCEEEEEEEecCcccccccccccChhhhhhHHHHHHHHHHHHHHHHHHHHHhc
Confidence 68999999999999999999998888999999999985422 000 0 2225566777777
Q ss_pred Ccce---EEEEEecCchhhHHHHHHhhhcceEEEeecccc----CCCchhHHHHhhhcCCCCceEEE
Q 011660 81 KVDF---LVKVCIGDSYITELSNQVRISYATILALGCSLS----GLKDSEVLTRCLRALPPACTILV 140 (480)
Q Consensus 81 ~~~~---~~~v~~~~~~~~~~v~eak~~~~~~l~lg~~~~----~~~~~~v~~~c~~~~~~~c~v~~ 140 (480)
.+++ +..+..| +....|+++|+...++.||+|.+.. +.-.+.++++++++.+ |-|+.
T Consensus 83 g~~~~~~~~~~~~g-~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~~Gs~~~~vl~~~~--~pVlv 146 (147)
T 3hgm_A 83 GVPADKVRAFVKGG-RPSRTIVRFARKRECDLVVIGAQGTNGDKSLLLGSVAQRVAGSAH--CPVLV 146 (147)
T ss_dssp TCCGGGEEEEEEES-CHHHHHHHHHHHTTCSEEEECSSCTTCCSCCCCCHHHHHHHHHCS--SCEEE
T ss_pred CCCccceEEEEecC-CHHHHHHHHHHHhCCCEEEEeCCCCccccceeeccHHHHHHhhCC--CCEEE
Confidence 8877 8888887 6688999999999999999998865 2222349999999887 66654
|
| >3idf_A USP-like protein; universal, stress, PSI, MCSG, structural genomics, midwest center for structural genomics structure initiative; 2.00A {Wolinella succinogenes} | Back alignment and structure |
|---|
Probab=98.76 E-value=4.1e-08 Score=84.44 Aligned_cols=113 Identities=11% Similarity=0.189 Sum_probs=90.3
Q ss_pred eEEEEEEecChhhHHHHHHHHHhh-cCCCCeEEEEEeeccCCcc----------------cc--chhHHHHhhhcccCcc
Q 011660 23 RTVIFGLKSDHYSREILLQLLTVI-AKPGDNVLAVHVEEQNDTL----------------DL--NTFHIHEDLCKSKKVD 83 (480)
Q Consensus 23 ~~v~v~~~~~~~~~~~l~wal~~~-~~~~d~v~~~hv~~~~~~~----------------~~--~~~~~~~~~c~~~~~~ 83 (480)
++|||++|.+..|+.+|.||+.-. .+.|..|++|||..+.... .. +.+..+...+....++
T Consensus 2 ~~ILv~~D~s~~s~~al~~a~~la~~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~g~~ 81 (138)
T 3idf_A 2 KKLLFAIDDTEACERAAQYILDMFGKDADCTLTLIHVKPEFMLYGEAVLAAYDEIEMKEEEKAKLLTQKFSTFFTEKGIN 81 (138)
T ss_dssp EEEEEECCSSHHHHHHHHHHHHHHTTCTTEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTTTCC
T ss_pred ceEEEEeCCCHHHHHHHHHHHHHhccCCCCEEEEEEEecCCCcccccccCcHHHHHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 689999999999999999999999 8999999999999654421 11 2235566777778899
Q ss_pred eEEEEEecCchhhHHHHHHhhhcceEEEeecccc----CCCchhHHHHhhhcCCCCceEEEE
Q 011660 84 FLVKVCIGDSYITELSNQVRISYATILALGCSLS----GLKDSEVLTRCLRALPPACTILVM 141 (480)
Q Consensus 84 ~~~~v~~~~~~~~~~v~eak~~~~~~l~lg~~~~----~~~~~~v~~~c~~~~~~~c~v~~~ 141 (480)
++..+..| +....|+++|+ .++.||+|.+.. +.- +.++++++++.+ |-|+.+
T Consensus 82 ~~~~v~~g-~~~~~I~~~a~--~~dliV~G~~~~~~~~~~~-Gs~~~~vl~~~~--~pVlvv 137 (138)
T 3idf_A 82 PFVVIKEG-EPVEMVLEEAK--DYNLLIIGSSENSFLNKIF-ASHQDDFIQKAP--IPVLIV 137 (138)
T ss_dssp CEEEEEES-CHHHHHHHHHT--TCSEEEEECCTTSTTSSCC-CCTTCHHHHHCS--SCEEEE
T ss_pred eEEEEecC-ChHHHHHHHHh--cCCEEEEeCCCcchHHHHh-CcHHHHHHhcCC--CCEEEe
Confidence 99888888 56789999999 999999999854 222 348899999887 666654
|
| >3s3t_A Nucleotide-binding protein, universal stress PROT family; structural genomics, PSI-biology, midwest center for structu genomics, MCSG; HET: ATP; 1.90A {Lactobacillus plantarum} SCOP: c.26.2.0 | Back alignment and structure |
|---|
Probab=98.74 E-value=1e-07 Score=82.66 Aligned_cols=117 Identities=9% Similarity=0.218 Sum_probs=92.2
Q ss_pred ceEEEEEEecChhhHHHHHHHHHhhcCCCCeEEEEEeeccCCccc-------------c-----chhHHHHhhhcccCc-
Q 011660 22 KRTVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVEEQNDTLD-------------L-----NTFHIHEDLCKSKKV- 82 (480)
Q Consensus 22 ~~~v~v~~~~~~~~~~~l~wal~~~~~~~d~v~~~hv~~~~~~~~-------------~-----~~~~~~~~~c~~~~~- 82 (480)
-++|||++|.+..|+.+|.||+.-..+.|..|++|||........ . +.+..+...+....+
T Consensus 5 ~~~ILv~~D~s~~s~~al~~A~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~g~~ 84 (146)
T 3s3t_A 5 YTNILVPVDSSDAAQAAFTEAVNIAQRHQANLTALYVVDDSAYHTPALDPVLSELLDAEAAHAKDAMRQRQQFVATTSAP 84 (146)
T ss_dssp CCEEEEECCSSHHHHHHHHHHHHHHHHHTCEEEEEEEEECCCCCCGGGHHHHHHHHHHHHHHHHHHHHHHHHHHTTSSCC
T ss_pred cceEEEEcCCCHHHHHHHHHHHHHHHhcCCEEEEEEEecCccccccccccccHHHHHHHHHHHHHHHHHHHHHHHhcCCc
Confidence 479999999999999999999998888899999999986543110 0 222555667777778
Q ss_pred ceEEEEEecCchhhHHHH-HHhhhcceEEEeecccc----CCCchhHHHHhhhcCCCCceEEEE
Q 011660 83 DFLVKVCIGDSYITELSN-QVRISYATILALGCSLS----GLKDSEVLTRCLRALPPACTILVM 141 (480)
Q Consensus 83 ~~~~~v~~~~~~~~~~v~-eak~~~~~~l~lg~~~~----~~~~~~v~~~c~~~~~~~c~v~~~ 141 (480)
+++..+..| +....|++ .|+...++.||+|.+.. +.-.+.++++++++.+ |-|+.+
T Consensus 85 ~~~~~~~~g-~~~~~I~~~~a~~~~~dliV~G~~~~~~~~~~~~Gs~~~~vl~~~~--~pVlvV 145 (146)
T 3s3t_A 85 NLKTEISYG-IPKHTIEDYAKQHPEIDLIVLGATGTNSPHRVAVGSTTSYVVDHAP--CNVIVI 145 (146)
T ss_dssp CCEEEEEEE-CHHHHHHHHHHHSTTCCEEEEESCCSSCTTTCSSCHHHHHHHHHCS--SEEEEE
T ss_pred ceEEEEecC-ChHHHHHHHHHhhcCCCEEEECCCCCCCcceEEEcchHHHHhccCC--CCEEEe
Confidence 889888888 56789999 99999999999998854 2222349999999987 777654
|
| >1tq8_A Hypothetical protein RV1636; MTCY01B2.28, structural target, NYSGXRC, PSI, protein structure initiative; 2.40A {Mycobacterium tuberculosis} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=98.63 E-value=2e-07 Score=83.01 Aligned_cols=119 Identities=13% Similarity=0.139 Sum_probs=89.2
Q ss_pred CCceEEEEEEecChhhHHHHHHHHHhhcCCCCeEEEE--EeeccCCc-c-----------cc-----chhHHHHhhhccc
Q 011660 20 LKKRTVIFGLKSDHYSREILLQLLTVIAKPGDNVLAV--HVEEQNDT-L-----------DL-----NTFHIHEDLCKSK 80 (480)
Q Consensus 20 ~~~~~v~v~~~~~~~~~~~l~wal~~~~~~~d~v~~~--hv~~~~~~-~-----------~~-----~~~~~~~~~c~~~ 80 (480)
...++|||++|.+..|+.+|.||+.-.. .|..|++| ||...... . .. +.+..+...+...
T Consensus 15 ~~~~~ILv~vD~s~~s~~al~~A~~lA~-~~a~l~ll~a~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 93 (163)
T 1tq8_A 15 SAYKTVVVGTDGSDSSMRAVDRAAQIAG-ADAKLIIASAYLPQHEDARAADILKDESYKVTGTAPIYEILHDAKERAHNA 93 (163)
T ss_dssp CCCCEEEEECCSSHHHHHHHHHHHHHHT-TTSEEEEEEECCC--------------------CCTHHHHHHHHHHHHHTT
T ss_pred ccCCEEEEEcCCCHHHHHHHHHHHHHhC-CCCEEEEEEeeeccCcccccccccccHHHHHHHHHHHHHHHHHHHHHHHHc
Confidence 4457999999999999999999999888 99999999 88743221 0 00 2224455666666
Q ss_pred Ccc-eEEEEEecCchhhHHHHHHhhhcceEEEeeccccCC----CchhHHHHhhhcCCCCceEEEEe
Q 011660 81 KVD-FLVKVCIGDSYITELSNQVRISYATILALGCSLSGL----KDSEVLTRCLRALPPACTILVMD 142 (480)
Q Consensus 81 ~~~-~~~~v~~~~~~~~~~v~eak~~~~~~l~lg~~~~~~----~~~~v~~~c~~~~~~~c~v~~~~ 142 (480)
.++ ++..+..| +....|++.|+...|+.||+|.+.... -.+.++++++++.+ |-|+.+.
T Consensus 94 gv~~v~~~v~~G-~~~~~I~~~a~~~~~DLIV~G~~g~~~~~~~~lGSva~~vl~~a~--~PVlvV~ 157 (163)
T 1tq8_A 94 GAKNVEERPIVG-APVDALVNLADEEKADLLVVGNVGLSTIAGRLLGSVPANVSRRAK--VDVLIVH 157 (163)
T ss_dssp TCCEEEEEEECS-SHHHHHHHHHHHTTCSEEEEECCCCCSHHHHHTBBHHHHHHHHTT--CEEEEEC
T ss_pred CCCeEEEEEecC-CHHHHHHHHHHhcCCCEEEECCCCCCcccceeeccHHHHHHHhCC--CCEEEEe
Confidence 787 88888887 568899999999999999999985411 11238999999886 8888774
|
| >1mjh_A Protein (ATP-binding domain of protein MJ0577); hypothetical protein, structural genomics, functional assignment; HET: ATP; 1.70A {Methanocaldococcus jannaschii} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=98.61 E-value=3.8e-07 Score=80.62 Aligned_cols=118 Identities=12% Similarity=0.133 Sum_probs=89.8
Q ss_pred ceEEEEEEecChhhHHHHHHHHHhhcCCCCeEEEEEeeccC-----C---c--------cc-------c---------ch
Q 011660 22 KRTVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVEEQN-----D---T--------LD-------L---------NT 69 (480)
Q Consensus 22 ~~~v~v~~~~~~~~~~~l~wal~~~~~~~d~v~~~hv~~~~-----~---~--------~~-------~---------~~ 69 (480)
-++|||++|.+..|+.+|.||+.-..+.|..|++|||..+. . . .. . +.
T Consensus 5 ~~~ILv~vD~s~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (162)
T 1mjh_A 5 YKKILYPTDFSETAEIALKHVKAFKTLKAEEVILLHVIDEREIKKRDIFSLLLGVAGLNKSVEEFENELKNKLTEEAKNK 84 (162)
T ss_dssp CCEEEEECCSCHHHHHHHHHHHHTCCSSCCEEEEEEEEEGGGTC-----------------CHHHHHHHHHHHHHHHHHH
T ss_pred cceEEEEeCCCHHHHHHHHHHHHHHhhcCCeEEEEEEecCccccccccccccccccccccchhhhHHHHHHHHHHHHHHH
Confidence 46999999999999999999999887789999999998543 1 1 10 0 11
Q ss_pred hHHHHhhhcccCcceEEEEEecCchhhHHHHHHhhhcceEEEeecccc----CCCchhHHHHhhhcCCCCceEEEEe
Q 011660 70 FHIHEDLCKSKKVDFLVKVCIGDSYITELSNQVRISYATILALGCSLS----GLKDSEVLTRCLRALPPACTILVMD 142 (480)
Q Consensus 70 ~~~~~~~c~~~~~~~~~~v~~~~~~~~~~v~eak~~~~~~l~lg~~~~----~~~~~~v~~~c~~~~~~~c~v~~~~ 142 (480)
+..+...+....++++..+..| +....|++.|+...++.||+|.+.. +.-.+.++++++++.+ |-|+.+.
T Consensus 85 l~~~~~~~~~~g~~~~~~v~~G-~~~~~I~~~a~~~~~dlIV~G~~g~~~~~~~~~GSv~~~vl~~~~--~pVlvv~ 158 (162)
T 1mjh_A 85 MENIKKELEDVGFKVKDIIVVG-IPHEEIVKIAEDEGVDIIIMGSHGKTNLKEILLGSVTENVIKKSN--KPVLVVK 158 (162)
T ss_dssp HHHHHHHHHHTTCEEEEEEEEE-CHHHHHHHHHHHTTCSEEEEESCCSSCCTTCSSCHHHHHHHHHCC--SCEEEEC
T ss_pred HHHHHHHHHHcCCceEEEEcCC-CHHHHHHHHHHHcCCCEEEEcCCCCCCccceEecchHHHHHHhCC--CCEEEEe
Confidence 2344555666678888888777 6788999999999999999998854 2222349999999975 7777664
|
| >3dlo_A Universal stress protein; unknown function, structural genomics, PSI-2, protein struct initiative, midwest center for structural genomics; HET: MSE; 1.97A {Archaeoglobus fulgidus} PDB: 3qtb_A* | Back alignment and structure |
|---|
Probab=98.60 E-value=1.9e-07 Score=82.47 Aligned_cols=118 Identities=9% Similarity=0.047 Sum_probs=89.5
Q ss_pred ceEEEEEEec-ChhhHHHHHHHHHhhcCCCCeEEEEEeeccCCcccc-------chhHHHHhhhcccCcceEEEE-EecC
Q 011660 22 KRTVIFGLKS-DHYSREILLQLLTVIAKPGDNVLAVHVEEQNDTLDL-------NTFHIHEDLCKSKKVDFLVKV-CIGD 92 (480)
Q Consensus 22 ~~~v~v~~~~-~~~~~~~l~wal~~~~~~~d~v~~~hv~~~~~~~~~-------~~~~~~~~~c~~~~~~~~~~v-~~~~ 92 (480)
-++|||++|. +..++.+|.||+.-..+.|..|++|||....+.... ..+..+...+....+++++.+ +...
T Consensus 24 ~~~ILv~vD~~s~~s~~al~~A~~la~~~~a~l~llhV~~~~~~~~~~~~~~~~~~l~~~~~~~~~~g~~~~~~~~v~~G 103 (155)
T 3dlo_A 24 YMPIVVAVDKKSDRAERVLRFAAEEARLRGVPVYVVHSLPGGGRTKDEDIIEAKETLSWAVSIIRKEGAEGEEHLLVRGK 103 (155)
T ss_dssp CCCEEEECCSSSHHHHHHHHHHHHHHHHHTCCEEEEEEECCSTTSCHHHHHHHHHHHHHHHHHHHHTTCCEEEEEEESSS
T ss_pred cCeEEEEECCCCHHHHHHHHHHHHHHHhcCCEEEEEEEEcCCCcccHHHHHHHHHHHHHHHHHHHhcCCCceEEEEecCC
Confidence 4699999999 899999999999988888999999999865432111 223445666666778887765 4445
Q ss_pred chhhHHHHHHhhhcceEEEeecccc----CCCchhHHHHhhhcCCCCceEEEE
Q 011660 93 SYITELSNQVRISYATILALGCSLS----GLKDSEVLTRCLRALPPACTILVM 141 (480)
Q Consensus 93 ~~~~~~v~eak~~~~~~l~lg~~~~----~~~~~~v~~~c~~~~~~~c~v~~~ 141 (480)
+...+|++.|+...|+.||+|.... +.-.+.++++.+++.+ |-|+.+
T Consensus 104 ~~~~~I~~~a~~~~~DLIV~G~~g~~~~~~~~lGSv~~~vl~~a~--~PVLvV 154 (155)
T 3dlo_A 104 EPPDDIVDFADEVDAIAIVIGIRKRSPTGKLIFGSVARDVILKAN--KPVICI 154 (155)
T ss_dssp CHHHHHHHHHHHTTCSEEEEECCEECTTSCEECCHHHHHHHHHCS--SCEEEE
T ss_pred CHHHHHHHHHHHcCCCEEEECCCCCCCCCCEEeccHHHHHHHhCC--CCEEEe
Confidence 7788999999999999999998854 1112348999999876 555543
|
| >2dum_A Hypothetical protein PH0823; conserved hypothetical protein, putative universal protein A structural genomics, NPPSFA; 2.75A {Pyrococcus horikoshii} | Back alignment and structure |
|---|
Probab=98.59 E-value=3.4e-07 Score=81.67 Aligned_cols=119 Identities=13% Similarity=0.089 Sum_probs=90.2
Q ss_pred ceEEEEEEecChhhHHHHHHHHHhhcCCCCeEEEEEeeccCCc------c------------cc---------chhHHHH
Q 011660 22 KRTVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVEEQNDT------L------------DL---------NTFHIHE 74 (480)
Q Consensus 22 ~~~v~v~~~~~~~~~~~l~wal~~~~~~~d~v~~~hv~~~~~~------~------------~~---------~~~~~~~ 74 (480)
-++|||++|.+..++.+|.||+.-..+.|..|++|||..+... . .. +.+..+.
T Consensus 5 ~~~ILv~vD~s~~s~~al~~A~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 84 (170)
T 2dum_A 5 FRKVLFPTDFSEGAYRAVEVFEKRNKMEVGEVILLHVIDEGTLEELMDGYSFFYDNAEIELKDIKEKLKEEASRKLQEKA 84 (170)
T ss_dssp CSEEEEECCSSHHHHHHHHHHHHHCCSCCSEEEEEEEEETTGGGCCC------------CCTTSHHHHHHHHHHHHHHHH
T ss_pred cceEEEEecCCHHHHHHHHHHHHHHHhcCCEEEEEEEecCccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH
Confidence 3689999999999999999999988889999999999854311 0 00 1123444
Q ss_pred hhhcccCcceEE--EEEecCchhhHHHHHHhhhcceEEEeecccc----CCCchhHHHHhhhcCCCCceEEEEec
Q 011660 75 DLCKSKKVDFLV--KVCIGDSYITELSNQVRISYATILALGCSLS----GLKDSEVLTRCLRALPPACTILVMDN 143 (480)
Q Consensus 75 ~~c~~~~~~~~~--~v~~~~~~~~~~v~eak~~~~~~l~lg~~~~----~~~~~~v~~~c~~~~~~~c~v~~~~~ 143 (480)
..+....++++. .+..| +....|++.|+...++.||+|.+.. +.-.+.++++++++.+ |-|+.+..
T Consensus 85 ~~~~~~g~~~~~~~~~~~g-~~~~~I~~~a~~~~~DlIV~G~~g~~~~~~~~~Gsv~~~vl~~~~--~PVlvv~~ 156 (170)
T 2dum_A 85 EEVKRAFRAKNVRTIIRFG-IPWDEIVKVAEEENVSLIILPSRGKLSLSHEFLGSTVMRVLRKTK--KPVLIIKE 156 (170)
T ss_dssp HHHHHHTTCSEEEEEEEEE-CHHHHHHHHHHHTTCSEEEEESCCCCC--TTCCCHHHHHHHHHCS--SCEEEECC
T ss_pred HHHHHcCCceeeeeEEecC-ChHHHHHHHHHHcCCCEEEECCCCCCccccceechHHHHHHHhCC--CCEEEEcc
Confidence 455556677777 77777 6788999999999999999998854 2223349999999976 88877643
|
| >3fdx_A Putative filament protein / universal stress PROT; structural genomics, APC60640.1, universal protein F, PSI-2; HET: MSE ATP; 1.58A {Klebsiella pneumoniae subsp} PDB: 3fh0_A* | Back alignment and structure |
|---|
Probab=98.59 E-value=1.7e-07 Score=80.84 Aligned_cols=116 Identities=10% Similarity=0.097 Sum_probs=88.5
Q ss_pred eEEEEEEecChh--hHHHHHHHHHhhcCCCCeEEEEEeeccCCcc------------cc-----chhHHHHhhhcccC--
Q 011660 23 RTVIFGLKSDHY--SREILLQLLTVIAKPGDNVLAVHVEEQNDTL------------DL-----NTFHIHEDLCKSKK-- 81 (480)
Q Consensus 23 ~~v~v~~~~~~~--~~~~l~wal~~~~~~~d~v~~~hv~~~~~~~------------~~-----~~~~~~~~~c~~~~-- 81 (480)
++|||++|.+.. |+.+|.||+.-..+.|..|++|||..+.... .. .....++.+++...
T Consensus 2 k~ILv~vD~s~~~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 81 (143)
T 3fdx_A 2 NAILVPIDISDKEFTERIISHVESEARIDDAEVHFLTVIPSLPYYASLGMAYTAELPGMDELREGSETQLKEIAKKFSIP 81 (143)
T ss_dssp CEEEEECCTTCSSCCTTHHHHHHHHHHHHTCEEEEEEEECC----------------CHHHHHHHHHHHHHHHHTTSCCC
T ss_pred CEEEEEecCChHhhHHHHHHHHHHHHHhcCCeEEEEEEecCCcccccccccccchhhhHHHHHHHHHHHHHHHHHHcCCC
Confidence 789999999999 9999999998888899999999999653210 00 22245566776654
Q ss_pred -cceEEEEEecCchhhHHHHHHhhhcceEEEeecccc---CCCchhHHHHhhhcCCCCceEEEE
Q 011660 82 -VDFLVKVCIGDSYITELSNQVRISYATILALGCSLS---GLKDSEVLTRCLRALPPACTILVM 141 (480)
Q Consensus 82 -~~~~~~v~~~~~~~~~~v~eak~~~~~~l~lg~~~~---~~~~~~v~~~c~~~~~~~c~v~~~ 141 (480)
+.++..+..| +....|+++|+...++.||+|.++. +.-.+.++++++++.+ |-|+.+
T Consensus 82 ~~~v~~~~~~g-~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~Gs~~~~v~~~~~--~pVlvv 142 (143)
T 3fdx_A 82 EDRMHFHVAEG-SPKDKILALAKSLPADLVIIASHRPDITTYLLGSNAAAVVRHAE--CSVLVV 142 (143)
T ss_dssp GGGEEEEEEES-CHHHHHHHHHHHTTCSEEEEESSCTTCCSCSSCHHHHHHHHHCS--SEEEEE
T ss_pred CCceEEEEEec-ChHHHHHHHHHHhCCCEEEEeCCCCCCeeeeeccHHHHHHHhCC--CCEEEe
Confidence 4578888888 6788999999999999999999854 1122348999999876 766654
|
| >2gm3_A Unknown protein; AT3G01520, putative ethylene-responsive protein, USP domain, nucleotide binding domain, AMP; HET: MSE AMP; 2.46A {Arabidopsis thaliana} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=98.54 E-value=4.7e-07 Score=81.21 Aligned_cols=120 Identities=13% Similarity=0.235 Sum_probs=86.9
Q ss_pred CceEEEEEEecCh---------hhHHHHHHHHHhhcCC---CCeEEEEEeeccCCc-c---------c--c---------
Q 011660 21 KKRTVIFGLKSDH---------YSREILLQLLTVIAKP---GDNVLAVHVEEQNDT-L---------D--L--------- 67 (480)
Q Consensus 21 ~~~~v~v~~~~~~---------~~~~~l~wal~~~~~~---~d~v~~~hv~~~~~~-~---------~--~--------- 67 (480)
..++|||++|.+. .++.+|.||+...++. |..|++|||...... . . .
T Consensus 4 ~~~~ILv~vD~s~~~~~~~~~~~s~~al~~a~~la~~~~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 83 (175)
T 2gm3_A 4 EPTKVMVAVNASTIKDYPNPSISCKRAFEWTLEKIVRSNTSDFKILLLHVQVVDEDGFDDVDSIYASPEDFRDMRQSNKA 83 (175)
T ss_dssp -CEEEEEECCBCSSSCTTCBCHHHHHHHHHHHHHTTTTCTTSEEEEEEEEEC----------CCCCSHHHHHHHTTSHHH
T ss_pred CccEEEEEECCCcccccccccHHHHHHHHHHHHHhhcccCCCCEEEEEEEeecccccccccccccCCHHHHHHHHHHHHH
Confidence 3579999999999 9999999999988774 789999999743210 0 0 0
Q ss_pred ---chhHHHHhhhcccCcceEEEEEecCchhhHHHHHHhhhcceEEEeecccc----CCCchhHHHHhhhcCCCCceEEE
Q 011660 68 ---NTFHIHEDLCKSKKVDFLVKVCIGDSYITELSNQVRISYATILALGCSLS----GLKDSEVLTRCLRALPPACTILV 140 (480)
Q Consensus 68 ---~~~~~~~~~c~~~~~~~~~~v~~~~~~~~~~v~eak~~~~~~l~lg~~~~----~~~~~~v~~~c~~~~~~~c~v~~ 140 (480)
+.+..+...+....++++..+..| +....|++.|+...++.||+|.+.. +.-.+.++++++++.+ |-|+.
T Consensus 84 ~~~~~l~~~~~~~~~~g~~~~~~v~~G-~~~~~I~~~a~~~~~DLIVmG~~g~~~~~~~~~Gsva~~vl~~a~--~pVlv 160 (175)
T 2gm3_A 84 KGLHLLEFFVNKCHEIGVGCEAWIKTG-DPKDVICQEVKRVRPDFLVVGSRGLGRFQKVFVGTVSAFCVKHAE--CPVMT 160 (175)
T ss_dssp HHHHHHHHHHHHHHHHTCEEEEEEEES-CHHHHHHHHHHHHCCSEEEEEECCCC--------CHHHHHHHHCS--SCEEE
T ss_pred HHHHHHHHHHHHHHHCCCceEEEEecC-CHHHHHHHHHHHhCCCEEEEeCCCCChhhhhhcCchHHHHHhCCC--CCEEE
Confidence 112334445555667788778887 5688999999999999999998854 2222349999999986 88877
Q ss_pred Eec
Q 011660 141 MDN 143 (480)
Q Consensus 141 ~~~ 143 (480)
+-.
T Consensus 161 v~~ 163 (175)
T 2gm3_A 161 IKR 163 (175)
T ss_dssp EEC
T ss_pred EcC
Confidence 753
|
| >3fg9_A Protein of universal stress protein USPA family; APC60691, nucleotide- binding, lactobacillus plantarum WCFS1, structural genomics PSI-2; 1.47A {Lactobacillus plantarum} | Back alignment and structure |
|---|
Probab=98.53 E-value=4.1e-07 Score=79.90 Aligned_cols=119 Identities=14% Similarity=0.095 Sum_probs=89.5
Q ss_pred CceEEEEEEe--cChhhHHHHHHHHHhhcCCCCeEEEEEeeccCCccc-----------c-----chhHHHHhhhcccCc
Q 011660 21 KKRTVIFGLK--SDHYSREILLQLLTVIAKPGDNVLAVHVEEQNDTLD-----------L-----NTFHIHEDLCKSKKV 82 (480)
Q Consensus 21 ~~~~v~v~~~--~~~~~~~~l~wal~~~~~~~d~v~~~hv~~~~~~~~-----------~-----~~~~~~~~~c~~~~~ 82 (480)
.-++|||++| .+..++.+|.||+.-..+.|..|++|||..+..... . +.+..+...+....+
T Consensus 14 ~~~~ILv~vD~~~s~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~g~ 93 (156)
T 3fg9_A 14 VYRRILLTVDEDDNTSSERAFRYATTLAHDYDVPLGICSVLESEDINIFDSLTPSKIQAKRKHVEDVVAEYVQLAEQRGV 93 (156)
T ss_dssp CCC-EEEECCSCCCHHHHHHHHHHHHHHHHHTCCEEEEEEECCCCTTCCCSSHHHHHHHHHHHHHHHHHHHHHHHHHHTC
T ss_pred cCceEEEEECCCCCHHHHHHHHHHHHHHHhcCCEEEEEEEEeCCCccccccCCHHHHHHHHHHHHHHHHHHHHHHHHcCC
Confidence 3579999999 899999999999998888899999999986543100 0 222445555666677
Q ss_pred -ceEEEEEecCchhhHHHHH-HhhhcceEEEeecccc---CCCchhHHHHhhhcCCCCceEEEE
Q 011660 83 -DFLVKVCIGDSYITELSNQ-VRISYATILALGCSLS---GLKDSEVLTRCLRALPPACTILVM 141 (480)
Q Consensus 83 -~~~~~v~~~~~~~~~~v~e-ak~~~~~~l~lg~~~~---~~~~~~v~~~c~~~~~~~c~v~~~ 141 (480)
.++..+..+.+....|++. |+...++.||+|.+.. ..-.+.++++++++.+ |-|+.+
T Consensus 94 ~~~~~~v~~~g~~~~~I~~~~a~~~~~DlIV~G~~g~~~~~~~~Gs~~~~vl~~a~--~PVlvV 155 (156)
T 3fg9_A 94 NQVEPLVYEGGDVDDVILEQVIPEFKPDLLVTGADTEFPHSKIAGAIGPRLARKAP--ISVIVV 155 (156)
T ss_dssp SSEEEEEEECSCHHHHHHHTHHHHHCCSEEEEETTCCCTTSSSCSCHHHHHHHHCS--SEEEEE
T ss_pred CceEEEEEeCCCHHHHHHHHHHHhcCCCEEEECCCCCCccceeecchHHHHHHhCC--CCEEEe
Confidence 5888888834678899999 9999999999998854 1122348999999876 766654
|
| >2z08_A Universal stress protein family; uncharacterized conserved protein, structural genomics, unknown function, NPPSFA; HET: ATP; 1.55A {Thermus thermophilus} SCOP: c.26.2.4 PDB: 1wjg_A* 2z09_A* 2z3v_A | Back alignment and structure |
|---|
Probab=98.53 E-value=3.3e-07 Score=78.72 Aligned_cols=116 Identities=15% Similarity=0.155 Sum_probs=86.0
Q ss_pred eEEEEEEecChhhHHHHHHHHHhhcCCCCeEEEEEeeccCCc--c-----cc------chhHHHHhhhcccCc-ceEEEE
Q 011660 23 RTVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVEEQNDT--L-----DL------NTFHIHEDLCKSKKV-DFLVKV 88 (480)
Q Consensus 23 ~~v~v~~~~~~~~~~~l~wal~~~~~~~d~v~~~hv~~~~~~--~-----~~------~~~~~~~~~c~~~~~-~~~~~v 88 (480)
++|||++|.+..++.+|.||+.-.-..|..|++|||..+... . .. ..-..++.+++...+ +++..+
T Consensus 3 ~~ILv~~D~s~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~g~~~~~~~~ 82 (137)
T 2z08_A 3 KTILLAYDGSEHARRAAEVAKAEAEAHGARLIVVHAYEPVPDYLGEPFFEEALRRRLERAEGVLEEARALTGVPKEDALL 82 (137)
T ss_dssp SEEEEECCSSHHHHHHHHHHHHHHHHHTCEEEEEEEECC--------------CHHHHHHHHHHHHHHHHHCCCGGGEEE
T ss_pred ceEEEEeCCCHHHHHHHHHHHHHHhhcCCEEEEEEEecCCCccccccchHHHHHHHHHHHHHHHHHHHHHcCCCccEEEE
Confidence 689999999999999999999988788999999999864210 0 00 111334555555556 677777
Q ss_pred EecCchhhHHHHHHhhhcceEEEeecccc----CCCchhHHHHhhhcCCCCceEEEE
Q 011660 89 CIGDSYITELSNQVRISYATILALGCSLS----GLKDSEVLTRCLRALPPACTILVM 141 (480)
Q Consensus 89 ~~~~~~~~~~v~eak~~~~~~l~lg~~~~----~~~~~~v~~~c~~~~~~~c~v~~~ 141 (480)
..| +....|++.|+...++.||+|.+.. +.-.+.++++++++.+ |-|+.+
T Consensus 83 ~~g-~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~~Gs~~~~vl~~~~--~pVlvv 136 (137)
T 2z08_A 83 LEG-VPAEAILQAARAEKADLIVMGTRGLGALGSLFLGSQSQRVVAEAP--CPVLLV 136 (137)
T ss_dssp EES-SHHHHHHHHHHHTTCSEEEEESSCTTCCSCSSSCHHHHHHHHHCS--SCEEEE
T ss_pred Eec-CHHHHHHHHHHHcCCCEEEECCCCCchhhhhhhccHHHHHHhcCC--CCEEEe
Confidence 777 6788999999999999999998864 2223349999999875 666654
|
| >3tnj_A Universal stress protein (USP); structural genomics, PSI-biology, midwest center for structu genomics, MCSG, chaperone; HET: AMP; 2.00A {Nitrosomonas europaea} PDB: 2pfs_A* | Back alignment and structure |
|---|
Probab=98.47 E-value=5.1e-07 Score=78.59 Aligned_cols=118 Identities=8% Similarity=0.092 Sum_probs=86.8
Q ss_pred ceEEEEEEecChhhHHHHHHHHHhhcCCCCeEEEEEeeccCCc-------------ccc------chhHHHHhhhcccCc
Q 011660 22 KRTVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVEEQNDT-------------LDL------NTFHIHEDLCKSKKV 82 (480)
Q Consensus 22 ~~~v~v~~~~~~~~~~~l~wal~~~~~~~d~v~~~hv~~~~~~-------------~~~------~~~~~~~~~c~~~~~ 82 (480)
-++|||++|.+..|+.+|.||+.-..+.|..|++|||..+... ... .+-..++.+++...+
T Consensus 6 ~~~ILv~vD~s~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 85 (150)
T 3tnj_A 6 YHHILLAVDFSSEDSQVVQKVRNLASQIGARLSLIHVLDNIPMPDTPYGTAIPLDTETTYDAMLDVEKQKLSQIGNTLGI 85 (150)
T ss_dssp CSEEEEECCCSTTHHHHHHHHHHHHHHHTCEEEEEEEEC--------CTTCCCSSSCCCHHHHHHHHHHHHHHHHHHHTC
T ss_pred cceEEEEeCCCHHHHHHHHHHHHHHhhcCCEEEEEEEEcCccccccccccccCcCHHHHHHHHHHHHHHHHHHHHHHcCC
Confidence 4799999999999999999999988888999999999854211 000 111445666666566
Q ss_pred c-eEEEEEecCchhhHHHHHHhhhcceEEEeeccccCC---CchhHHHHhhhcCCCCceEEEEe
Q 011660 83 D-FLVKVCIGDSYITELSNQVRISYATILALGCSLSGL---KDSEVLTRCLRALPPACTILVMD 142 (480)
Q Consensus 83 ~-~~~~v~~~~~~~~~~v~eak~~~~~~l~lg~~~~~~---~~~~v~~~c~~~~~~~c~v~~~~ 142 (480)
+ ++..+..| +....|+++|+...++.||+|.+.... -.+.++++++++.+ |-|+.+-
T Consensus 86 ~~~~~~~~~g-~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~Gs~~~~vl~~~~--~pVlvv~ 146 (150)
T 3tnj_A 86 DPAHRWLVWG-EPREEIIRIAEQENVDLIVVGSHGRHGLALLLGSTANSVLHYAK--CDVLAVR 146 (150)
T ss_dssp CGGGEEEEES-CHHHHHHHHHHHTTCSEEEEEEC--------CCCHHHHHHHHCS--SEEEEEE
T ss_pred CcceEEEecC-CHHHHHHHHHHHcCCCEEEEecCCCCCcCeEecchHHHHHHhCC--CCEEEEe
Confidence 5 46677777 567899999999999999999885411 12338999999887 8887764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.38 E-value=2.5e-06 Score=81.80 Aligned_cols=134 Identities=17% Similarity=0.175 Sum_probs=93.6
Q ss_pred eecccCce-EEEEEEec-CCcEEEEEEeccCCccHHHHHHHHHHHhcCC-CCCeeeEEEEEecCCeeEEEEeccCC-CHH
Q 011660 259 LIGQGGNS-KVYRTNHV-DGQVAAVKVLKCTNWSEEEVLREVELLSSIK-HENIVRIIGYCHSKEMYAIVYNLLNG-SLK 334 (480)
Q Consensus 259 ~LG~G~fg-~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~e~~~G-sL~ 334 (480)
.+..|..+ .||+.... ++..+++|+-... ...++.+|..+|+.+. +--+.++++++.+.+..++||+++.| ++.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~ 108 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF 108 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence 34555555 68987654 4678889986532 3456889999998774 33467889999988999999999976 455
Q ss_pred HHHHhCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------------------
Q 011660 335 QYLKQLKWNERMDVAIGVAKALEYLHHTC--------------------------------------------------- 363 (480)
Q Consensus 335 ~~l~~~~~~~~~~i~~~ia~aL~yLH~~~--------------------------------------------------- 363 (480)
+..... ......+..+++..|.-||...
T Consensus 109 ~~~~~~-~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 187 (272)
T 4gkh_A 109 QVLEEY-PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLL 187 (272)
T ss_dssp HHHHHC-GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTC
T ss_pred ccccCC-HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcc
Confidence 544322 2233445566666666666431
Q ss_pred ----CCCeEeccCCCCCEEEecCCCceEEeeeccccc
Q 011660 364 ----DPPIIHRDVKSSNILLSENFHHPQLSDFGAAMV 396 (480)
Q Consensus 364 ----~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~ 396 (480)
...++|+|+.+.|||++++ +.+-|+||+.+.+
T Consensus 188 ~~~~~~~l~HGDl~~~Nil~~~~-~~~~viDwe~a~~ 223 (272)
T 4gkh_A 188 PFSPDSVVTHGDFSLDNLIFDEG-KLIGCIDVGRVGI 223 (272)
T ss_dssp CCCCCEEEECSCCCTTSEEEETT-EEEEECCCTTCEE
T ss_pred cccCCcEEEcCCCCCCeEEEECC-eEEEEEECccccc
Confidence 1138999999999999987 5567999998854
|
| >1jmv_A USPA, universal stress protein A; chaperone; 1.85A {Haemophilus influenzae} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=98.37 E-value=1.6e-06 Score=74.54 Aligned_cols=117 Identities=14% Similarity=0.136 Sum_probs=86.9
Q ss_pred eEEEEEEecChhhHHHHHHHHHhhcCCCCeEEEEEeecc-CC-cc--------------ccchhHHHHhhhcccCcce-E
Q 011660 23 RTVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVEEQ-ND-TL--------------DLNTFHIHEDLCKSKKVDF-L 85 (480)
Q Consensus 23 ~~v~v~~~~~~~~~~~l~wal~~~~~~~d~v~~~hv~~~-~~-~~--------------~~~~~~~~~~~c~~~~~~~-~ 85 (480)
++|||++|.+..++.+|.||+.-....|..|++|||... .. .. ..++-..++.+++...++. +
T Consensus 3 ~~ILv~~D~s~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 82 (141)
T 1jmv_A 3 KHILVAVDLSEESPILLKKAVGIAKRHDAKLSIIHVDVNFSDLYTGLIDVNMSSMQDRISTETQKALLDLAESVDYPISE 82 (141)
T ss_dssp SEEEEEECCSTTHHHHHHHHHHHHHHHTCEEEEEEEEECCGGGCCCCEEHHHHHHTTCCCCHHHHHHHHHHHHSSSCCCC
T ss_pred ceEEEEecCchhhHHHHHHHHHHHHhcCCEEEEEEEecCchhhhccccccchHHHHHHHHHHHHHHHHHHHHHcCCCceE
Confidence 689999999999999999999988888999999999832 21 00 0011244566666656665 4
Q ss_pred EEEEecCchhhHHHHHHhhhcceEEEeeccccCCC--chhHHHHhhhcCCCCceEEEEec
Q 011660 86 VKVCIGDSYITELSNQVRISYATILALGCSLSGLK--DSEVLTRCLRALPPACTILVMDN 143 (480)
Q Consensus 86 ~~v~~~~~~~~~~v~eak~~~~~~l~lg~~~~~~~--~~~v~~~c~~~~~~~c~v~~~~~ 143 (480)
..+..| +....|++.|+...++.||+|.+ .... ...++++++++.+ |-|+.+-.
T Consensus 83 ~~~~~g-~~~~~I~~~a~~~~~dliV~G~~-~~~~~~lgs~~~~vl~~~~--~pVlvv~~ 138 (141)
T 1jmv_A 83 KLSGSG-DLGQVLSDAIEQYDVDLLVTGHH-QDFWSKLMSSTRQVMNTIK--IDMLVVPL 138 (141)
T ss_dssp EEEEEE-CHHHHHHHHHHHTTCCEEEEEEC-CCCHHHHHHHHHHHHTTCC--SEEEEEEC
T ss_pred EEEecC-CHHHHHHHHHHhcCCCEEEEeCC-CchhhhhcchHHHHHhcCC--CCEEEeeC
Confidence 555566 56789999999999999999998 5111 1248999999886 88877643
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.35 E-value=2.5e-06 Score=83.90 Aligned_cols=137 Identities=19% Similarity=0.224 Sum_probs=93.0
Q ss_pred ceeecccCceEEEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhcCCCC---CeeeEEEEEe-cCCeeEEEEeccCCC
Q 011660 257 KMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHE---NIVRIIGYCH-SKEMYAIVYNLLNGS 332 (480)
Q Consensus 257 ~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~Hp---nIv~l~~~~~-~~~~~~lV~e~~~Gs 332 (480)
...++.|....||+. +..+++|+.. .......+.+|.++|+.+.+. .+.+++.++. ..+..+++|+++.|.
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~-~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK-SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES-SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC-CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 456888998999987 5667888753 222345688999999998652 3566777764 445678999999774
Q ss_pred -HHH-HHHhCCHHHHHHHHHHHHHHHHHHHhC------------------------------------------------
Q 011660 333 -LKQ-YLKQLKWNERMDVAIGVAKALEYLHHT------------------------------------------------ 362 (480)
Q Consensus 333 -L~~-~l~~~~~~~~~~i~~~ia~aL~yLH~~------------------------------------------------ 362 (480)
+.+ .+..++..+...++.++++.|..||+.
T Consensus 99 ~l~~~~~~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~ 178 (306)
T 3tdw_A 99 ILGEDGMAVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQS 178 (306)
T ss_dssp ECHHHHHTTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHH
T ss_pred ECchhhhhhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHH
Confidence 443 233344445555555555555555543
Q ss_pred ---------CCCCeEeccCCCCCEEEec---CCCceEEeeeccccccc
Q 011660 363 ---------CDPPIIHRDVKSSNILLSE---NFHHPQLSDFGAAMVHH 398 (480)
Q Consensus 363 ---------~~~~IiHrDlKp~NILl~~---~~~~~kL~DFGla~~~~ 398 (480)
....++|+|++|.||+++. +.....|+||+.+.+..
T Consensus 179 ~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd 226 (306)
T 3tdw_A 179 YMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD 226 (306)
T ss_dssp HHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred HHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence 2235799999999999987 32335799999886543
|
| >1q77_A Hypothetical protein AQ_178; structural genomics, universal stress protein, PSI, protein structure initiative; 2.70A {Aquifex aeolicus} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=98.28 E-value=2.8e-06 Score=72.80 Aligned_cols=110 Identities=14% Similarity=0.074 Sum_probs=81.2
Q ss_pred ceEEEEEEecChhhHHHHHHHHHhhcCCCCeEEEEEee-cc-C--------Ccc--c-c---------chhHHHHhhh--
Q 011660 22 KRTVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVE-EQ-N--------DTL--D-L---------NTFHIHEDLC-- 77 (480)
Q Consensus 22 ~~~v~v~~~~~~~~~~~l~wal~~~~~~~d~v~~~hv~-~~-~--------~~~--~-~---------~~~~~~~~~c-- 77 (480)
-++|||++|.+..++.+|.||+.-..+.|..|++|||. .. . ... . . +.+..+ ..|
T Consensus 4 ~~~ILv~~D~s~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~ 82 (138)
T 1q77_A 4 MKVLLVLTDAYSDCEKAITYAVNFSEKLGAELDILAVLEDVYNLERANVTFGLPFPPEIKEESKKRIERRLREV-WEKLT 82 (138)
T ss_dssp CEEEEEEESTTCCCHHHHHHHHHHHTTTCCEEEEEEECHHHHHHHHHHHHHCCCCCTHHHHHHHHHHHHHHHHH-HHHHH
T ss_pred ccEEEEEccCCHhHHHHHHHHHHHHHHcCCeEEEEEEecccccccccccccCCCCChHHHHHHHHHHHHHHHHH-HHHhh
Confidence 36899999999999999999999888889999999998 52 0 000 0 0 112223 222
Q ss_pred cccCcceEEEEEecCchhhHHHHHHhhhcceEEEeeccccCCCchhHHHHhhhcCCCCceEEEE
Q 011660 78 KSKKVDFLVKVCIGDSYITELSNQVRISYATILALGCSLSGLKDSEVLTRCLRALPPACTILVM 141 (480)
Q Consensus 78 ~~~~~~~~~~v~~~~~~~~~~v~eak~~~~~~l~lg~~~~~~~~~~v~~~c~~~~~~~c~v~~~ 141 (480)
.... +++..+..| +....|++.|+...++.||+|.+.. + ++++++++.+ |-|+.+
T Consensus 83 ~~~~-~~~~~~~~g-~~~~~I~~~a~~~~~dliV~G~~g~----s-v~~~vl~~a~--~PVlvv 137 (138)
T 1q77_A 83 GSTE-IPGVEYRIG-PLSEEVKKFVEGKGYELVVWACYPS----A-YLCKVIDGLN--LASLIV 137 (138)
T ss_dssp SCCC-CCCEEEECS-CHHHHHHHHHTTSCCSEEEECSCCG----G-GTHHHHHHSS--SEEEEC
T ss_pred ccCC-cceEEEEcC-CHHHHHHHHHHhcCCCEEEEeCCCC----c-hHHHHHHhCC--CceEee
Confidence 2233 566666666 5678999999999999999998844 5 8899999887 777654
|
| >3loq_A Universal stress protein; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: AMP; 2.32A {Archaeoglobus fulgidus} | Back alignment and structure |
|---|
Probab=98.08 E-value=1.4e-05 Score=77.77 Aligned_cols=118 Identities=16% Similarity=0.218 Sum_probs=92.4
Q ss_pred CCceEEEEEEecChhhHHHHHHHHHhhcCCCCeEEEEEeeccCCccccchhHHHHhhhcccCcceEEEEEecCchhhHHH
Q 011660 20 LKKRTVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVEEQNDTLDLNTFHIHEDLCKSKKVDFLVKVCIGDSYITELS 99 (480)
Q Consensus 20 ~~~~~v~v~~~~~~~~~~~l~wal~~~~~~~d~v~~~hv~~~~~~~~~~~~~~~~~~c~~~~~~~~~~v~~~~~~~~~~v 99 (480)
...++|+|++|.+..+..+|.||+.-....|..|.+|||..... ....+..+...+....++++..+..| +....|+
T Consensus 168 ~~~~~Ilv~~d~s~~s~~al~~a~~la~~~~~~l~ll~v~~~~~--~~~~l~~~~~~l~~~~~~~~~~~~~g-~~~~~I~ 244 (294)
T 3loq_A 168 SLFDRVLVAYDFSKWADRALEYAKFVVKKTGGELHIIHVSEDGD--KTADLRVMEEVIGAEGIEVHVHIESG-TPHKAIL 244 (294)
T ss_dssp CTTSEEEEECCSSHHHHHHHHHHHHHHHHHTCEEEEEEECSSSC--CHHHHHHHHHHHHHTTCCEEEEEECS-CHHHHHH
T ss_pred ccCCEEEEEECCCHHHHHHHHHHHHHhhhcCCEEEEEEEccCch--HHHHHHHHHHHHHHcCCcEEEEEecC-CHHHHHH
Confidence 45689999999999999999999998878899999999986543 22333444566666778888887777 7788999
Q ss_pred HHHhhhcceEEEeeccccCC----CchhHHHHhhhcCCCCceEEEEe
Q 011660 100 NQVRISYATILALGCSLSGL----KDSEVLTRCLRALPPACTILVMD 142 (480)
Q Consensus 100 ~eak~~~~~~l~lg~~~~~~----~~~~v~~~c~~~~~~~c~v~~~~ 142 (480)
+.|+...++.||+|...... -.+.++++.+++.+ |-|+.+.
T Consensus 245 ~~a~~~~~dLlV~G~~~~~~~~~~~~Gs~~~~vl~~~~--~pvLvv~ 289 (294)
T 3loq_A 245 AKREEINATTIFMGSRGAGSVMTMILGSTSESVIRRSP--VPVFVCK 289 (294)
T ss_dssp HHHHHTTCSEEEEECCCCSCHHHHHHHCHHHHHHHHCS--SCEEEEC
T ss_pred HHHHhcCcCEEEEeCCCCCCccceeeCcHHHHHHhcCC--CCEEEEC
Confidence 99999999999999986521 12347888888776 6666654
|
| >3mt0_A Uncharacterized protein PA1789; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: MSE; 1.58A {Pseudomonas aeruginosa} | Back alignment and structure |
|---|
Probab=98.07 E-value=2.1e-05 Score=76.41 Aligned_cols=117 Identities=10% Similarity=0.081 Sum_probs=90.3
Q ss_pred ceEEEEEEecChhhHHHHHHHHHhhcCCCCeEEEEEeeccCCccccchhHHHHhhhcccCcceEEEEEecCchhhHHHHH
Q 011660 22 KRTVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVEEQNDTLDLNTFHIHEDLCKSKKVDFLVKVCIGDSYITELSNQ 101 (480)
Q Consensus 22 ~~~v~v~~~~~~~~~~~l~wal~~~~~~~d~v~~~hv~~~~~~~~~~~~~~~~~~c~~~~~~~~~~v~~~~~~~~~~v~e 101 (480)
-++|||++|.+..+..+|.||+.-..+.|-.|++|||..+.+ ....+..+...+....++++..+..+.+....|+++
T Consensus 7 ~~~ILv~~D~s~~s~~al~~A~~la~~~~a~l~ll~v~~~~~--~~~~l~~~~~~~~~~~~~~~~~~~~~g~~~~~i~~~ 84 (290)
T 3mt0_A 7 IRSILVVIEPDQLEGLALKRAQLIAGVTQSHLHLLVCEKRRD--HSAALNDLAQELREEGYSVSTNQAWKDSLHQTIIAE 84 (290)
T ss_dssp CCEEEEECCSSCSCCHHHHHHHHHHHHHCCEEEEEEECSSSC--CHHHHHHHHHHHHHTTCCEEEEEECSSSHHHHHHHH
T ss_pred hceEEEEeCCCccchHHHHHHHHHHHhcCCeEEEEEeeCcHH--HHHHHHHHHHHHhhCCCeEEEEEEeCCCHHHHHHHH
Confidence 479999999999999999999999888999999999987411 112233334455567788888888767778899999
Q ss_pred HhhhcceEEEeecccc----CCCchhHHHHhhhcCCCCceEEEEe
Q 011660 102 VRISYATILALGCSLS----GLKDSEVLTRCLRALPPACTILVMD 142 (480)
Q Consensus 102 ak~~~~~~l~lg~~~~----~~~~~~v~~~c~~~~~~~c~v~~~~ 142 (480)
|+...++.||+|.+.. +.-.+.++.+.+++.+ |-|+.+.
T Consensus 85 a~~~~~dliV~G~~~~~~~~~~~~gs~~~~vl~~~~--~PVlvv~ 127 (290)
T 3mt0_A 85 QQAEGCGLIIKQHFPDNPLKKAILTPDDWKLLRFAP--CPVLMTK 127 (290)
T ss_dssp HHHHTCSEEEEECCCSCTTSTTSCCHHHHHHHHHCS--SCEEEEC
T ss_pred HHhcCCCEEEEecccCCchhhcccCHHHHHHHhcCC--CCEEEec
Confidence 9999999999998854 2122338888888876 6666654
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.04 E-value=4.7e-06 Score=83.36 Aligned_cols=75 Identities=9% Similarity=0.030 Sum_probs=53.0
Q ss_pred ceee-cccCceEEEEEEec-------CCcEEEEEEeccCC---c-cHHHHHHHHHHHhcCC-C--CCeeeEEEEEecC--
Q 011660 257 KMLI-GQGGNSKVYRTNHV-------DGQVAAVKVLKCTN---W-SEEEVLREVELLSSIK-H--ENIVRIIGYCHSK-- 319 (480)
Q Consensus 257 ~~~L-G~G~fg~Vy~~~~~-------~g~~vAvK~~~~~~---~-~~~~~~~Ei~il~~l~-H--pnIv~l~~~~~~~-- 319 (480)
.+.| +.|....+|+.... +++.+++|+..... . ....+.+|..+++.+. + ..+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 88989999998654 26788899765322 1 1245788999988874 2 3577888888665
Q ss_pred -CeeEEEEeccCC
Q 011660 320 -EMYAIVYNLLNG 331 (480)
Q Consensus 320 -~~~~lV~e~~~G 331 (480)
+..++|||++.|
T Consensus 105 ~g~~~~v~e~l~G 117 (357)
T 3ats_A 105 LGTPFFLMDYVEG 117 (357)
T ss_dssp TSSCEEEEECCCC
T ss_pred cCCceEEEEecCC
Confidence 356789999966
|
| >3mt0_A Uncharacterized protein PA1789; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: MSE; 1.58A {Pseudomonas aeruginosa} | Back alignment and structure |
|---|
Probab=98.02 E-value=2.8e-05 Score=75.48 Aligned_cols=120 Identities=8% Similarity=0.060 Sum_probs=88.1
Q ss_pred CCceEEEEEEecChh-------hHHHHHHHHHhhcCCCCeEEEEEeeccCCcc------c----c--chhHHHHhhhccc
Q 011660 20 LKKRTVIFGLKSDHY-------SREILLQLLTVIAKPGDNVLAVHVEEQNDTL------D----L--NTFHIHEDLCKSK 80 (480)
Q Consensus 20 ~~~~~v~v~~~~~~~-------~~~~l~wal~~~~~~~d~v~~~hv~~~~~~~------~----~--~~~~~~~~~c~~~ 80 (480)
...++|+|++|.+.+ |..+|.||+.-....|..|++|||..+.... . . .....++.+++..
T Consensus 132 ~~~~~Ilva~D~s~~~~~~~~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 211 (290)
T 3mt0_A 132 WTGGKILAAVDVGNNDGEHRSLHAGIISHAYDIAGLAKATLHVISAHPSPMLSSADPTFQLSETIEARYREACRTFQAEY 211 (290)
T ss_dssp STTCEEEEEECTTCCSHHHHHHHHHHHHHHHHHHHHTTCEEEEEEEEC---------CHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCCeEEEEECCCCcchhhhHHHHHHHHHHHHHHHHcCCeEEEEEEecCccccccCchhHHHHHHHHHHHHHHHHHHHHc
Confidence 367899999999998 9999999999988889999999998643211 0 0 1113334455544
Q ss_pred Cc-ceEEEEEecCchhhHHHHHHhhhcceEEEeecccc----CCCchhHHHHhhhcCCCCceEEEEe
Q 011660 81 KV-DFLVKVCIGDSYITELSNQVRISYATILALGCSLS----GLKDSEVLTRCLRALPPACTILVMD 142 (480)
Q Consensus 81 ~~-~~~~~v~~~~~~~~~~v~eak~~~~~~l~lg~~~~----~~~~~~v~~~c~~~~~~~c~v~~~~ 142 (480)
.+ .....+..| +....|++.|+..+++.||+|.+.. +.-.+.++++.+++.+ |-|+.+-
T Consensus 212 g~~~~~~~v~~g-~~~~~I~~~a~~~~~dLiVmG~~g~~~~~~~~~Gsv~~~vl~~~~--~pVLvv~ 275 (290)
T 3mt0_A 212 GFSDEQLHIEEG-PADVLIPRTAQKLDAVVTVIGTVARTGLSGALIGNTAEVVLDTLE--SDVLVLK 275 (290)
T ss_dssp TCCTTTEEEEES-CHHHHHHHHHHHHTCSEEEEECCSSCCGGGCCSCHHHHHHHTTCS--SEEEEEC
T ss_pred CCCcceEEEecc-CHHHHHHHHHHhcCCCEEEECCCCCcCCcceecchHHHHHHhcCC--CCEEEEC
Confidence 55 355667777 6788999999999999999998855 2222349999999876 8787764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.00 E-value=3.9e-05 Score=75.65 Aligned_cols=134 Identities=18% Similarity=0.287 Sum_probs=77.5
Q ss_pred eeecccCceEEEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhcCCC--CCeeeEEE------EEecCCeeEEEEecc
Q 011660 258 MLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKH--ENIVRIIG------YCHSKEMYAIVYNLL 329 (480)
Q Consensus 258 ~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~~------~~~~~~~~~lV~e~~ 329 (480)
..|+.|..+.||+....+| .+++|+.... ...+..|..+++.|.. -.+.+++. +....+..+++++++
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~---~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i 113 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP---EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI 113 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC---HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC---HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence 4566677899999977554 5889988752 3455566666665531 12333332 123456788999999
Q ss_pred CCC-HH-----------HHH-------HhC-------------CHHHH-------------------------------H
Q 011660 330 NGS-LK-----------QYL-------KQL-------------KWNER-------------------------------M 346 (480)
Q Consensus 330 ~Gs-L~-----------~~l-------~~~-------------~~~~~-------------------------------~ 346 (480)
.|. +. ..| ..+ .|... .
T Consensus 114 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 193 (346)
T 2q83_A 114 EGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEID 193 (346)
T ss_dssp CCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHH
T ss_pred cCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHH
Confidence 662 11 111 111 11110 0
Q ss_pred HHHHHHHHHHHHHHh----------CCCCCeEeccCCCCCEEEecCCCceEEeeeccccc
Q 011660 347 DVAIGVAKALEYLHH----------TCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMV 396 (480)
Q Consensus 347 ~i~~~ia~aL~yLH~----------~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~ 396 (480)
.+...+..++.+|+. .....++|+|+++.|||++.+ +.+.|+||+.+.+
T Consensus 194 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~-~~~~lIDfe~a~~ 252 (346)
T 2q83_A 194 GFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGEN-EQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGG-GCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCC-CcEEEEehhhccc
Confidence 011123446667763 123489999999999999766 5799999998854
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.98 E-value=1.8e-05 Score=80.50 Aligned_cols=73 Identities=16% Similarity=0.069 Sum_probs=48.6
Q ss_pred ceeecccCceEEEEEEec-CCcEEEEEEeccCC--------ccHHHHHHHHHHHhcCCC--C-CeeeEEEEEecCCeeEE
Q 011660 257 KMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTN--------WSEEEVLREVELLSSIKH--E-NIVRIIGYCHSKEMYAI 324 (480)
Q Consensus 257 ~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~--------~~~~~~~~Ei~il~~l~H--p-nIv~l~~~~~~~~~~~l 324 (480)
.+.||.|.++.||++... +++.+++|...... ...+.+..|.++|+.+.. | .+.+++.+. .+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEE
Confidence 457999999999999653 46889999864321 123456789999887732 3 345666543 345679
Q ss_pred EEeccCC
Q 011660 325 VYNLLNG 331 (480)
Q Consensus 325 V~e~~~G 331 (480)
|||++.|
T Consensus 113 vmE~l~g 119 (397)
T 2olc_A 113 VMEDLSH 119 (397)
T ss_dssp EECCCTT
T ss_pred EEEeCCC
Confidence 9999965
|
| >3cis_A Uncharacterized protein; alpha/beta hydrolase, ATP, universal stress protein, unknown function; HET: ATP; 2.90A {Mycobacterium tuberculosis} PDB: 2jax_A* | Back alignment and structure |
|---|
Probab=97.89 E-value=4.8e-05 Score=74.48 Aligned_cols=118 Identities=12% Similarity=0.138 Sum_probs=86.7
Q ss_pred CceEEEEEEecChhhHHHHHHHHHhhcCCCCeEEEEEeeccCCcc------c------c-----chhHHHHhhhccc---
Q 011660 21 KKRTVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVEEQNDTL------D------L-----NTFHIHEDLCKSK--- 80 (480)
Q Consensus 21 ~~~~v~v~~~~~~~~~~~l~wal~~~~~~~d~v~~~hv~~~~~~~------~------~-----~~~~~~~~~c~~~--- 80 (480)
..++|||++|.+..++.+|.||+.-..+.|..|++|||..+.... . . +.+..+...+...
T Consensus 18 ~~~~ILv~~D~s~~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 97 (309)
T 3cis_A 18 SSLGIIVGIDDSPAAQVAVRWAARDAELRKIPLTLVHAVSPEVATWLEVPLPPGVLRWQQDHGRHLIDDALKVVEQASLR 97 (309)
T ss_dssp CTTEEEEECCSSHHHHHHHHHHHHHHHHHTCCEEEEEECCCCCCCTTCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHCSS
T ss_pred CCCeEEEEECCCHHHHHHHHHHHHHHHhcCCcEEEEEEecCcccccccCCCCchhhHHHHHHHHHHHHHHHHHHHHhccc
Confidence 347999999999999999999999888889999999998632110 0 0 1123334444443
Q ss_pred --CcceEEEEEecCchhhHHHHHHhhhcceEEEeecccc----CCCchhHHHHhhhcCCCCceEEEEec
Q 011660 81 --KVDFLVKVCIGDSYITELSNQVRISYATILALGCSLS----GLKDSEVLTRCLRALPPACTILVMDN 143 (480)
Q Consensus 81 --~~~~~~~v~~~~~~~~~~v~eak~~~~~~l~lg~~~~----~~~~~~v~~~c~~~~~~~c~v~~~~~ 143 (480)
.++++..+..| +....|++.|+ .++.||+|.... +.-.+.++++++++. .|-|+.+..
T Consensus 98 ~~~~~~~~~~~~g-~~~~~I~~~a~--~~DliV~G~~g~~~~~~~~~Gs~~~~vl~~~--~~PVlvv~~ 161 (309)
T 3cis_A 98 AGPPTVHSEIVPA-AAVPTLVDMSK--DAVLMVVGCLGSGRWPGRLLGSVSSGLLRHA--HCPVVIIHD 161 (309)
T ss_dssp SCCSCEEEEEESS-CHHHHHHHHGG--GEEEEEEESSCTTCCTTCCSCHHHHHHHHHC--SSCEEEECT
T ss_pred CCCceEEEEEecC-CHHHHHHHHhc--CCCEEEECCCCCccccccccCcHHHHHHHhC--CCCEEEEcC
Confidence 67888877776 56789999997 899999998854 222234899999988 477777643
|
| >3cis_A Uncharacterized protein; alpha/beta hydrolase, ATP, universal stress protein, unknown function; HET: ATP; 2.90A {Mycobacterium tuberculosis} PDB: 2jax_A* | Back alignment and structure |
|---|
Probab=97.82 E-value=9.8e-05 Score=72.26 Aligned_cols=117 Identities=12% Similarity=0.108 Sum_probs=85.1
Q ss_pred CceEEEEEEecChhhHHHHHHHHHhhcCCCCeEEEEEeeccCCcc--------cc-----chh-HHHHhhhcc-cCcceE
Q 011660 21 KKRTVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVEEQNDTL--------DL-----NTF-HIHEDLCKS-KKVDFL 85 (480)
Q Consensus 21 ~~~~v~v~~~~~~~~~~~l~wal~~~~~~~d~v~~~hv~~~~~~~--------~~-----~~~-~~~~~~c~~-~~~~~~ 85 (480)
..++|||++|.+..+..+|.||+......|..|++|||..+.... .. +.+ ...+.++.. ..++++
T Consensus 170 ~~~~Ilv~~D~s~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 249 (309)
T 3cis_A 170 QQAPVLVGVDGSSASELATAIAFDEASRRNVDLVALHAWSDVDVSEWPGIDWPATQSMAEQVLAERLAGWQERYPNVAIT 249 (309)
T ss_dssp CCCCEEEECCSSHHHHHHHHHHHHHHHHTTCCEEEEEESCSSCCTTCSSCCHHHHHHHHHHHHHHHHTTHHHHCTTSCEE
T ss_pred CCCeEEEEeCCChHHHHHHHHHHHHHHhcCCEEEEEEEeecccccCCCcccHHHHHHHHHHHHHHHHHHHHhhCCCCcEE
Confidence 457999999999999999999999888889999999998543211 00 111 111223332 357788
Q ss_pred EEEEecCchhhHHHHHHhhhcceEEEeecccc----CCCchhHHHHhhhcCCCCceEEEEe
Q 011660 86 VKVCIGDSYITELSNQVRISYATILALGCSLS----GLKDSEVLTRCLRALPPACTILVMD 142 (480)
Q Consensus 86 ~~v~~~~~~~~~~v~eak~~~~~~l~lg~~~~----~~~~~~v~~~c~~~~~~~c~v~~~~ 142 (480)
..+..| +....|++.|+ .|+.||+|.... +.-.+.++++.+++.+ |-|+.+.
T Consensus 250 ~~~~~g-~~~~~I~~~a~--~adliV~G~~~~~~~~~~l~Gsv~~~vl~~~~--~pVlvv~ 305 (309)
T 3cis_A 250 RVVVRD-QPARQLVQRSE--EAQLVVVGSRGRGGYAGMLVGSVGETVAQLAR--TPVIVAR 305 (309)
T ss_dssp EEEESS-CHHHHHHHHHT--TCSEEEEESSCSSCCTTCSSCHHHHHHHHHCS--SCEEEEC
T ss_pred EEEEcC-CHHHHHHHhhC--CCCEEEECCCCCCCccccccCcHHHHHHhcCC--CCEEEeC
Confidence 777777 67889999998 899999999865 2222349999999876 7776653
|
| >3ab8_A Putative uncharacterized protein TTHA0350; tandem-type universal stress protein, unknown function; HET: ATP; 1.70A {Thermus thermophilus} PDB: 3ab7_A* | Back alignment and structure |
|---|
Probab=97.77 E-value=6e-05 Score=72.01 Aligned_cols=115 Identities=14% Similarity=0.042 Sum_probs=86.0
Q ss_pred eEEEEEEecChhhHHHHHHHHHhhcCCCCeEEEEEeeccCCc--------c----c--------c--------chhHHHH
Q 011660 23 RTVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVEEQNDT--------L----D--------L--------NTFHIHE 74 (480)
Q Consensus 23 ~~v~v~~~~~~~~~~~l~wal~~~~~~~d~v~~~hv~~~~~~--------~----~--------~--------~~~~~~~ 74 (480)
++|||++|.+..+..+|.||+.-..+.|..|++|||...... . . . +.+..+.
T Consensus 1 k~ILv~vD~s~~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 80 (268)
T 3ab8_A 1 MRILLATDGSPQARGAEALAEWLAYKLSAPLTVLFVVDTRLARIPELLDFGALTVPVPVLRTELERALALRGEAVLERVR 80 (268)
T ss_dssp CCEEEECCSCGGGHHHHHHHHHHHHHHTCCEEEEEEEEHHHHTHHHHC-------CHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CcEEEEcCCCHHHHHHHHHHHHHHHHhCCcEEEEEEeccCCcccccccCchHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 579999999999999999999988888999999999843210 0 0 0 1124455
Q ss_pred hhhcccCcceEEEEEecCchhhHHHHHHhhhcceEEEeeccccC-----CCchhHHHHhhhcCCCCceEEEEe
Q 011660 75 DLCKSKKVDFLVKVCIGDSYITELSNQVRISYATILALGCSLSG-----LKDSEVLTRCLRALPPACTILVMD 142 (480)
Q Consensus 75 ~~c~~~~~~~~~~v~~~~~~~~~~v~eak~~~~~~l~lg~~~~~-----~~~~~v~~~c~~~~~~~c~v~~~~ 142 (480)
..+....++++..+..| +....|++. ...++.||+|.+... .-.+.++++++++.+ |-|+.+.
T Consensus 81 ~~~~~~g~~~~~~~~~g-~~~~~I~~~--~~~~dliV~G~~g~~~~~~~~~~Gs~~~~v~~~a~--~PVlvv~ 148 (268)
T 3ab8_A 81 QSALAAGVAVEAVLEEG-VPHEAILRR--ARAADLLVLGRSGEAHGDGFGGLGSTADRVLRASP--VPVLLAP 148 (268)
T ss_dssp HHHHHTTCCEEEEEEEE-CHHHHHHHH--HTTCSEEEEESSCTTSCTTCCSCCHHHHHHHHHCS--SCEEEEC
T ss_pred HHHHhCCCCeEEEEecC-CHHHHHHhh--ccCCCEEEEeccCCCccccccccchhHHHHHHhCC--CCEEEEC
Confidence 56666778888888877 456688887 889999999987432 122349999999876 7777764
|
| >3olq_A Universal stress protein E; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: UNL; 1.82A {Proteus mirabilis} | Back alignment and structure |
|---|
Probab=97.70 E-value=0.00017 Score=70.69 Aligned_cols=119 Identities=9% Similarity=0.071 Sum_probs=88.3
Q ss_pred ceEEEEEEecChhhHHHHHHHHHhhcCCCCeEEEEEeeccCC--ccc------c------------chhHHHHhhhcccC
Q 011660 22 KRTVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVEEQND--TLD------L------------NTFHIHEDLCKSKK 81 (480)
Q Consensus 22 ~~~v~v~~~~~~~~~~~l~wal~~~~~~~d~v~~~hv~~~~~--~~~------~------------~~~~~~~~~c~~~~ 81 (480)
-++|||++|.+..+..+|.||+.-..+.|-.|++|||..+.. ... . ..+..+...+....
T Consensus 7 ~k~ILv~~D~s~~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 86 (319)
T 3olq_A 7 YQNLLVVIDPNQDDQPALRRAVYIVQRNGGRIKAFLPVYDLSYDMTTLLSPDERNAMRKGVINQKTAWIKQQARYYLEAG 86 (319)
T ss_dssp SCEEEEECCTTCSCCHHHHHHHHHHHHHCCEEEEEEEECCGGGGCTTTSCHHHHHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred cceEEEEECCCcccHHHHHHHHHHHHHcCCeEEEEEEecccchhhccccChhhHHHHHHHHHHHHHHHHHHHHHHHhhcC
Confidence 379999999999999999999999888899999999974211 000 0 11233444556677
Q ss_pred cceEEEEEecCchhhHHHHHHhhhcceEEEeecccc----CCCchhHHHHhhhcCCCCceEEEEe
Q 011660 82 VDFLVKVCIGDSYITELSNQVRISYATILALGCSLS----GLKDSEVLTRCLRALPPACTILVMD 142 (480)
Q Consensus 82 ~~~~~~v~~~~~~~~~~v~eak~~~~~~l~lg~~~~----~~~~~~v~~~c~~~~~~~c~v~~~~ 142 (480)
++++..+....+....|+++|+...++.||+|.+.. +.-.+.++.+.+++.+ |-|+.+.
T Consensus 87 v~~~~~~~~~g~~~~~i~~~a~~~~~DLiV~G~~g~~~~~~~~~Gs~~~~vl~~~~--~PVlvv~ 149 (319)
T 3olq_A 87 IQIDIKVIWHNRPYEAIIEEVITDKHDLLIKMAHQHDKLGSLIFTPLDWQLLRKCP--APVWMVK 149 (319)
T ss_dssp CCEEEEEEECSCHHHHHHHHHHHHTCSEEEEEEBCC--CCSCBCCHHHHHHHHHCS--SCEEEEE
T ss_pred CeEEEEEEecCChHHHHHHHHHhcCCCEEEEecCcCchhhcccccccHHHHHhcCC--CCEEEec
Confidence 888888883346677999999999999999999864 2212338888888876 6666654
|
| >3loq_A Universal stress protein; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: AMP; 2.32A {Archaeoglobus fulgidus} | Back alignment and structure |
|---|
Probab=97.64 E-value=2.9e-05 Score=75.48 Aligned_cols=116 Identities=10% Similarity=0.056 Sum_probs=86.9
Q ss_pred ceEEEEEEecChhhHHHHHHHHHhhcCCCCeEEEEEeeccCCcc---------c----c-----chhHHHHhhhcccCcc
Q 011660 22 KRTVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVEEQNDTL---------D----L-----NTFHIHEDLCKSKKVD 83 (480)
Q Consensus 22 ~~~v~v~~~~~~~~~~~l~wal~~~~~~~d~v~~~hv~~~~~~~---------~----~-----~~~~~~~~~c~~~~~~ 83 (480)
-++|||++|.+..+..+|.||+.-..+-|..|++|||....... . . ..+..+...+....++
T Consensus 22 ~~~ILv~vD~s~~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~g~~ 101 (294)
T 3loq_A 22 SNAMLLPTDLSENSFKVLEYLGDFKKVGVEEIGVLFVINLTKLSTVSGGIDIDHYIDEMSEKAEEVLPEVAQKIEAAGIK 101 (294)
T ss_dssp TCEEEEECCSCTGGGGGGGGHHHHHHTTCCEEEEECCEECTTC-----CCCTTHHHHHHHHHHHHHHHHHHHHHHHTTCE
T ss_pred hccEEEecCCCHHHHHHHHHHHHHHhhcCCEEEEEEEecCcccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 36999999999999999999999888889999999998543310 0 0 2225556677777788
Q ss_pred eEE-EEE-ecCchhhHHHHHHhhhcceEEEeeccccCC----CchhHHHHhhhcCCCCceEEEEe
Q 011660 84 FLV-KVC-IGDSYITELSNQVRISYATILALGCSLSGL----KDSEVLTRCLRALPPACTILVMD 142 (480)
Q Consensus 84 ~~~-~v~-~~~~~~~~~v~eak~~~~~~l~lg~~~~~~----~~~~v~~~c~~~~~~~c~v~~~~ 142 (480)
++. .+. .| +....| .|+...++.||+|.+.... -.+.++++++++.+ |-|+.+.
T Consensus 102 ~~~~~v~~~g-~~~~~I--~a~~~~~DliV~G~~g~~~~~~~~~Gs~~~~vl~~~~--~PVlvv~ 161 (294)
T 3loq_A 102 AEVIKPFPAG-DPVVEI--IKASENYSFIAMGSRGASKFKKILLGSVSEGVLHDSK--VPVYIFK 161 (294)
T ss_dssp EEECSSCCEE-CHHHHH--HHHHTTSSEEEEECCCCCHHHHHHHCCHHHHHHHHCS--SCEEEEC
T ss_pred cceeEeeccC-ChhHhe--eeccCCCCEEEEcCCCCccccceeeccHHHHHHhcCC--CCEEEec
Confidence 887 677 66 445566 8999999999999875411 11237899999887 7777764
|
| >3olq_A Universal stress protein E; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: UNL; 1.82A {Proteus mirabilis} | Back alignment and structure |
|---|
Probab=97.58 E-value=0.00023 Score=69.65 Aligned_cols=121 Identities=9% Similarity=0.013 Sum_probs=86.5
Q ss_pred CCceEEEEEEecChh-------hHHHHHHHHHhhcCC--CCeEEEEEeeccCCccc-----------c------chhHHH
Q 011660 20 LKKRTVIFGLKSDHY-------SREILLQLLTVIAKP--GDNVLAVHVEEQNDTLD-----------L------NTFHIH 73 (480)
Q Consensus 20 ~~~~~v~v~~~~~~~-------~~~~l~wal~~~~~~--~d~v~~~hv~~~~~~~~-----------~------~~~~~~ 73 (480)
...++|+|++|.+.+ ++.+|.||+.-...- |..|.+|||........ . .....+
T Consensus 154 ~~~~~Ilva~D~s~~~~~~~~~s~~al~~a~~la~~~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 233 (319)
T 3olq_A 154 PEYGTIVVAANLSNEESYHDALNLKLIELTNDLSHRIQKDPDVHLLSAYPVAPINIAIELPDFDPNLYNNALRGQHLIAM 233 (319)
T ss_dssp CTTCEEEEECCCSCCSTHHHHHHHHHHHHHHHHHHHHCSSCCEEEEEEECCCSCSCCTTCTTCCHHHHHHHHHHHHHHHH
T ss_pred ccCCeEEEEECCCCcchhHHHHHHHHHHHHHHHHHhccCCCeEEEEEeecCcchhhhccCCcccHHHHHHHHHHHHHHHH
Confidence 356899999999994 699999998766655 99999999985543210 0 111334
Q ss_pred HhhhcccCc-ceEEEEEecCchhhHHHHHHhhhcceEEEeeccccCC----CchhHHHHhhhcCCCCceEEEEec
Q 011660 74 EDLCKSKKV-DFLVKVCIGDSYITELSNQVRISYATILALGCSLSGL----KDSEVLTRCLRALPPACTILVMDN 143 (480)
Q Consensus 74 ~~~c~~~~~-~~~~~v~~~~~~~~~~v~eak~~~~~~l~lg~~~~~~----~~~~v~~~c~~~~~~~c~v~~~~~ 143 (480)
+.+++...+ .++..+..| +....|++.|+...|+.||+|...... -.+.++++.+++.+ |-|+.+-.
T Consensus 234 ~~~~~~~~~~~~~~~v~~g-~~~~~I~~~a~~~~~dLiV~G~~g~~~~~~~~~Gsv~~~vl~~~~--~pVLvv~~ 305 (319)
T 3olq_A 234 KELRQKFSIPEEKTHVKEG-LPEQVIPQVCEELNAGIVVLGILGRTGLSAAFLGNTAEQLIDHIK--CDLLAIKP 305 (319)
T ss_dssp HHHHHHTTCCGGGEEEEES-CHHHHHHHHHHHTTEEEEEEECCSCCSTHHHHHHHHHHHHHTTCC--SEEEEECC
T ss_pred HHHHHHhCCCcccEEEecC-CcHHHHHHHHHHhCCCEEEEeccCccCCccccccHHHHHHHhhCC--CCEEEECC
Confidence 555554443 345566677 558899999999999999999975522 12348999998876 88887743
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.50 E-value=0.00027 Score=72.35 Aligned_cols=80 Identities=11% Similarity=0.130 Sum_probs=48.9
Q ss_pred CCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccCccccccccCCCccccccccCC---CCCchHHHHHHHH
Q 011660 364 DPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYG---KVDEKIDVYSYGV 440 (480)
Q Consensus 364 ~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~---~~~~k~DvwSlGv 440 (480)
...++|+|++|.|||++.+ + +.|+||+.+.+......... .... -...|++|+..... .-....++.+...
T Consensus 231 ~~~liHGDl~~~Nil~~~~-~-~~lID~e~a~~G~p~~Dla~--~l~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQD-S-TQVIDPEFSFYGPMGFDIGA--YLGN--LILAFFAQDGHATQENDRKEYKQWILRTIE 304 (420)
T ss_dssp CCEEECSCCSGGGEEECSS-C-EEECCCTTCEEECHHHHHHH--HHHH--HHHHHHHGGGGCCSSCCSHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCC-C-CEEEeCcccccCchHHHHHH--HHHH--HHHHHHhcccccccccchHHHHHHHHHHHH
Confidence 3489999999999999887 4 99999999865432111100 0000 01346666655321 1123455667888
Q ss_pred HHHHHHcCC
Q 011660 441 VLLELITGK 449 (480)
Q Consensus 441 il~eLltG~ 449 (480)
.+|+.++++
T Consensus 305 ~~~~~y~~~ 313 (420)
T 2pyw_A 305 QTWNLFNKR 313 (420)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 888887653
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.46 E-value=0.00077 Score=66.38 Aligned_cols=72 Identities=18% Similarity=0.185 Sum_probs=57.6
Q ss_pred ceeecccCceEEEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhcCC---CCCeeeEEEEEecCCeeEEEEeccCC
Q 011660 257 KMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIK---HENIVRIIGYCHSKEMYAIVYNLLNG 331 (480)
Q Consensus 257 ~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~lV~e~~~G 331 (480)
...|+.|.+..+|+... +++.+++|+.... ....+..|...|+.|. ...+.+++.++...+..++|||++.|
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 45689999999999875 5678889987643 3466889999988873 35688899998888889999999965
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.35 E-value=0.00044 Score=67.71 Aligned_cols=136 Identities=15% Similarity=0.198 Sum_probs=76.9
Q ss_pred eeecccCceEEEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCC--eeeEEEE------EecCCeeEEEEecc
Q 011660 258 MLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHEN--IVRIIGY------CHSKEMYAIVYNLL 329 (480)
Q Consensus 258 ~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~------~~~~~~~~lV~e~~ 329 (480)
+.|+.|....+|+....+| .+++|+.... .....+..|..+++.+.... +.+++.. ....+..+++++++
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l 105 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFL 105 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECC
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeC
Confidence 4577788899999977555 6789988752 12345667888877663212 2333321 12235678899998
Q ss_pred CCC-H-----H------HHH-------HhCC-----------HHHHHH------------HHHHHHHHHHHHHhC----C
Q 011660 330 NGS-L-----K------QYL-------KQLK-----------WNERMD------------VAIGVAKALEYLHHT----C 363 (480)
Q Consensus 330 ~Gs-L-----~------~~l-------~~~~-----------~~~~~~------------i~~~ia~aL~yLH~~----~ 363 (480)
.|. + . +.+ ..+. |..... +...+...+.+++.. .
T Consensus 106 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~ 185 (322)
T 2ppq_A 106 EGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDL 185 (322)
T ss_dssp CCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSS
T ss_pred CCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccC
Confidence 662 1 1 111 0110 111000 011244455666532 1
Q ss_pred CCCeEeccCCCCCEEEecCCCceEEeeeccccc
Q 011660 364 DPPIIHRDVKSSNILLSENFHHPQLSDFGAAMV 396 (480)
Q Consensus 364 ~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~ 396 (480)
..+++|+|+.+.|||++++ +.+.|+||+.+.+
T Consensus 186 ~~~liHgDl~~~Nil~~~~-~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 186 PAGVIHADLFQDNVFFLGD-ELSGLIDFYFACN 217 (322)
T ss_dssp CEEEECSCCCGGGEEEETT-EEEEECCCTTCEE
T ss_pred CcccCCCCCCccCEEEeCC-ceEEEecchhccC
Confidence 3479999999999999986 4457999998754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.31 E-value=0.0006 Score=66.34 Aligned_cols=71 Identities=7% Similarity=0.008 Sum_probs=44.6
Q ss_pred CCCceeecccCceEEEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCe-eeEEEEEecCCeeEEEEecc-CC
Q 011660 254 FSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENI-VRIIGYCHSKEMYAIVYNLL-NG 331 (480)
Q Consensus 254 f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lV~e~~-~G 331 (480)
+.-.+.|+.|....+|+. +.+++|+.........+..+|..+++.+....+ .++++++.+ .-+++++|+ +|
T Consensus 20 ~~~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~~~--~~~~v~e~i~~g 92 (301)
T 3dxq_A 20 YTGPLERLGGLTNLVFRA-----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVDPA--TGVMVTRYIAGA 92 (301)
T ss_dssp CCSCEEEESCSSEEEEEE-----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEECTT--TCCEEEECCTTC
T ss_pred ccceeEcCCcccccccee-----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEECC--CCEEEEeecCCC
Confidence 334678999999999998 567888876432111224568887776642222 566665433 346788998 76
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.31 E-value=0.0018 Score=63.41 Aligned_cols=136 Identities=18% Similarity=0.342 Sum_probs=81.6
Q ss_pred eeecccCceEEEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhcCCCC--CeeeEEEE-----EecCCeeEEEEeccC
Q 011660 258 MLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHE--NIVRIIGY-----CHSKEMYAIVYNLLN 330 (480)
Q Consensus 258 ~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~~~-----~~~~~~~~lV~e~~~ 330 (480)
..|+ |....||+....+|+.+++|+.+........+..|..+++.+... .+++++.. ....+..+++++++.
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~ 110 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 110 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence 4577 888899998776777899999875544567788898888877421 23444432 122445678999997
Q ss_pred CC------HHH------HH-------Hh--------CCHHHH----HHH---------------HHHHHHHHHHHHhC--
Q 011660 331 GS------LKQ------YL-------KQ--------LKWNER----MDV---------------AIGVAKALEYLHHT-- 362 (480)
Q Consensus 331 Gs------L~~------~l-------~~--------~~~~~~----~~i---------------~~~ia~aL~yLH~~-- 362 (480)
|. ... .+ .. ..+... ..+ ...+...+..+...
T Consensus 111 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 190 (328)
T 1zyl_A 111 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR 190 (328)
T ss_dssp CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhh
Confidence 62 111 11 00 111110 000 01111223333321
Q ss_pred --CCCCeEeccCCCCCEEEecCCCceEEeeecccccc
Q 011660 363 --CDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVH 397 (480)
Q Consensus 363 --~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~ 397 (480)
....++|+|+++.|||++ + .+.|+||+.+...
T Consensus 191 ~~~~~~l~HgD~~~~Nil~~-~--~~~lIDfe~a~~g 224 (328)
T 1zyl_A 191 EDFTVLRLHGDCHAGNILWR-D--GPMFVDLDDARNG 224 (328)
T ss_dssp SCSCCEECCSSCSGGGEEES-S--SEEECCCTTCCEE
T ss_pred hcCCeeeeeCCCCcccEeEc-C--CCEEEECCCCCcC
Confidence 234689999999999998 4 5899999987553
|
| >3ab8_A Putative uncharacterized protein TTHA0350; tandem-type universal stress protein, unknown function; HET: ATP; 1.70A {Thermus thermophilus} PDB: 3ab7_A* | Back alignment and structure |
|---|
Probab=97.31 E-value=0.00066 Score=64.62 Aligned_cols=114 Identities=18% Similarity=0.141 Sum_probs=82.3
Q ss_pred CceEEEEEEecChhhHHHHHHHHHhhcCCCCeEEEEEeeccCCccccchhHHHHhhhcccCcceEEEEEecCchhhHHHH
Q 011660 21 KKRTVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVEEQNDTLDLNTFHIHEDLCKSKKVDFLVKVCIGDSYITELSN 100 (480)
Q Consensus 21 ~~~~v~v~~~~~~~~~~~l~wal~~~~~~~d~v~~~hv~~~~~~~~~~~~~~~~~~c~~~~~~~~~~v~~~~~~~~~~v~ 100 (480)
..++|+|++|.+..+..+|.||..-....|..|.+|||..+.+. ....+..+........++++..+..| +....|++
T Consensus 153 ~~~~ilv~~d~s~~~~~al~~a~~la~~~~a~l~ll~v~~~~~~-~~~~l~~~~~~l~~~~~~~~~~~~~g-~~~~~i~~ 230 (268)
T 3ab8_A 153 ELEGALLGYDASESAVRALHALAPLARALGLGVRVVSVHEDPAR-AEAWALEAEAYLRDHGVEASALVLGG-DAADHLLR 230 (268)
T ss_dssp CCCEEEEECCSCHHHHHHHHHHHHHHHHHTCCEEEEEECSSHHH-HHHHHHHHHHHHHHTTCCEEEEEECS-CHHHHHHH
T ss_pred CCCEEEEEECCCHHHHHHHHHHHHhhhcCCCEEEEEEEcCcHHH-HHHHHHHHHHHHHHcCCceEEEEeCC-ChHHHHHH
Confidence 56799999999999999999998877677888999999854321 11222333445555677888777766 67889999
Q ss_pred HHhhhcceEEEeeccccCCCchhHHHHhhhcCCCCceEEE
Q 011660 101 QVRISYATILALGCSLSGLKDSEVLTRCLRALPPACTILV 140 (480)
Q Consensus 101 eak~~~~~~l~lg~~~~~~~~~~v~~~c~~~~~~~c~v~~ 140 (480)
.|+.. +.||+|....+.-.+.++++.+++.+ |-|+.
T Consensus 231 ~a~~~--dliV~G~~~~~~~~Gs~~~~vl~~~~--~pvlv 266 (268)
T 3ab8_A 231 LQGPG--DLLALGAPVRRLVFGSTAERVIRNAQ--GPVLT 266 (268)
T ss_dssp HCCTT--EEEEEECCCSCCSSCCHHHHHHHHCS--SCEEE
T ss_pred HHHhC--CEEEECCcccccEeccHHHHHHhcCC--CCEEE
Confidence 99988 99999992222223348888888765 55544
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.24 E-value=0.0023 Score=61.67 Aligned_cols=73 Identities=15% Similarity=0.146 Sum_probs=52.4
Q ss_pred CCCceeecccCceEEEEEEecCCcEEEEEEeccCCc-cHHHHHHHHHHHhcCCC---CCeeeEEEEEecCCeeEEEEecc
Q 011660 254 FSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNW-SEEEVLREVELLSSIKH---ENIVRIIGYCHSKEMYAIVYNLL 329 (480)
Q Consensus 254 f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~-~~~~~~~Ei~il~~l~H---pnIv~l~~~~~~~~~~~lV~e~~ 329 (480)
......+|.|..+.||+.+..||+.+++|+...... ....+..|...|+.|.- -.+.+++++.. -+++||++
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~~----~~lv~e~l 92 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWDD----RTLAMEWV 92 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEET----TEEEEECC
T ss_pred eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEeccC----ceEEEEee
Confidence 444567999999999999999999999998754332 23457889999887742 23456665532 36788887
Q ss_pred C
Q 011660 330 N 330 (480)
Q Consensus 330 ~ 330 (480)
.
T Consensus 93 ~ 93 (288)
T 3f7w_A 93 D 93 (288)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.17 E-value=0.0031 Score=62.00 Aligned_cols=136 Identities=14% Similarity=0.142 Sum_probs=70.5
Q ss_pred eecccCceE-EEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhcCCC--CCeeeEEEEEecCCeeEEEEeccCC-CHH
Q 011660 259 LIGQGGNSK-VYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKH--ENIVRIIGYCHSKEMYAIVYNLLNG-SLK 334 (480)
Q Consensus 259 ~LG~G~fg~-Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~~~~~lV~e~~~G-sL~ 334 (480)
.|+.|.... +|+....+++.+++|...... ..++..|+.+++.+.. -.+.+++.+..+.+ +++||+++| .+.
T Consensus 25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~--~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~l~ 100 (333)
T 3csv_A 25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEE--GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDALFT 100 (333)
T ss_dssp C--------CCEEEECTTCCEEEEEECCTTT--TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCBHH
T ss_pred ECCCCCCCceEEEEEcCCCCeEEEEECCCCC--CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcchH
Confidence 466665554 667765446777777654321 1334567777776632 23566777654433 678888855 344
Q ss_pred HHHHhC--------------------------C---HHHHH-------H-H------------HHHHHHHHHHHHh---C
Q 011660 335 QYLKQL--------------------------K---WNERM-------D-V------------AIGVAKALEYLHH---T 362 (480)
Q Consensus 335 ~~l~~~--------------------------~---~~~~~-------~-i------------~~~ia~aL~yLH~---~ 362 (480)
+++... + ..... . + ...+...+..+.. .
T Consensus 101 ~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~~ 180 (333)
T 3csv_A 101 EVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQLE 180 (333)
T ss_dssp HHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHCC
T ss_pred HHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhccc
Confidence 333211 1 00000 0 0 0011112222211 1
Q ss_pred CCCCeEeccCCCCCEEEecC---CCceEEeeeccccccc
Q 011660 363 CDPPIIHRDVKSSNILLSEN---FHHPQLSDFGAAMVHH 398 (480)
Q Consensus 363 ~~~~IiHrDlKp~NILl~~~---~~~~kL~DFGla~~~~ 398 (480)
....++|+|+.+.||+++.+ .+.+.|+||+.+.+..
T Consensus 181 ~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 181 GDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp SCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred CCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence 23479999999999999863 1368999999986543
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.89 E-value=0.0028 Score=65.14 Aligned_cols=70 Identities=9% Similarity=0.105 Sum_probs=48.7
Q ss_pred ceeecccCceEEEEEEecC--------CcEEEEEEeccCCccHHHHHHHHHHHhcCCCCC-eeeEEEEEecCCeeEEEEe
Q 011660 257 KMLIGQGGNSKVYRTNHVD--------GQVAAVKVLKCTNWSEEEVLREVELLSSIKHEN-IVRIIGYCHSKEMYAIVYN 327 (480)
Q Consensus 257 ~~~LG~G~fg~Vy~~~~~~--------g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~~~~~~lV~e 327 (480)
.+.|+.|....+|++...+ ++.+++|+.... ...+.+..|..+++.|...+ ..++++.+.+ .+|++
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 3468888889999997643 578999988432 22256678999988874333 3567776643 27889
Q ss_pred ccCC
Q 011660 328 LLNG 331 (480)
Q Consensus 328 ~~~G 331 (480)
|+.|
T Consensus 153 ~l~G 156 (429)
T 1nw1_A 153 YIPS 156 (429)
T ss_dssp CCCE
T ss_pred EeCC
Confidence 8865
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.86 E-value=0.0026 Score=64.36 Aligned_cols=135 Identities=13% Similarity=0.153 Sum_probs=78.5
Q ss_pred eeecccCceEEEEEEec--------CCcEEEEEEeccCCccHHHHHHHHHHHhcCC-CCCeeeEEEEEecCCeeEEEEec
Q 011660 258 MLIGQGGNSKVYRTNHV--------DGQVAAVKVLKCTNWSEEEVLREVELLSSIK-HENIVRIIGYCHSKEMYAIVYNL 328 (480)
Q Consensus 258 ~~LG~G~fg~Vy~~~~~--------~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~e~ 328 (480)
+.|..|-...+|+.... +++.+++|+..........+.+|.++++.|. +.-..++++++.+. +||||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~e~ 131 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPEG----RLEQY 131 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEEEC
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEEEE
Confidence 45777888899998764 2478999986433234566779999998774 33336777777542 88999
Q ss_pred cCCC------HH---------HHHHh-----------CC--HHHHHHHHHHHH-------------------HHHHHH--
Q 011660 329 LNGS------LK---------QYLKQ-----------LK--WNERMDVAIGVA-------------------KALEYL-- 359 (480)
Q Consensus 329 ~~Gs------L~---------~~l~~-----------~~--~~~~~~i~~~ia-------------------~aL~yL-- 359 (480)
+.|. +. +.|.+ .. +.+..++..++. ..+..|
T Consensus 132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~ 211 (379)
T 3feg_A 132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK 211 (379)
T ss_dssp CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence 8652 11 11110 11 223333332221 122333
Q ss_pred --HhC-CCCCeEeccCCCCCEEEecC---CCceEEeeeccccc
Q 011660 360 --HHT-CDPPIIHRDVKSSNILLSEN---FHHPQLSDFGAAMV 396 (480)
Q Consensus 360 --H~~-~~~~IiHrDlKp~NILl~~~---~~~~kL~DFGla~~ 396 (480)
... ....++|+|+.+.||+++.+ .+.+.|+||..|.+
T Consensus 212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 221 22368999999999999875 24789999998854
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.85 E-value=0.003 Score=65.53 Aligned_cols=71 Identities=11% Similarity=0.126 Sum_probs=46.4
Q ss_pred ceeecccCceEEEEEEecC-CcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCe-eeEEEEEecCCeeEEEEeccCC
Q 011660 257 KMLIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEEVLREVELLSSIKHENI-VRIIGYCHSKEMYAIVYNLLNG 331 (480)
Q Consensus 257 ~~~LG~G~fg~Vy~~~~~~-g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lV~e~~~G 331 (480)
.+.|+.|-...+|+....+ ++.+++|+........-+..+|..+++.|...++ .++++++. +. +||+|+.|
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~G--~v~e~I~G 185 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--NG--RIEEFMDG 185 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--TE--EEEECCCS
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--Ce--EEEEeeCC
Confidence 4568888889999998754 4788899875432111123589999988865444 56777773 22 48999865
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.57 E-value=0.0025 Score=63.80 Aligned_cols=70 Identities=9% Similarity=0.080 Sum_probs=42.0
Q ss_pred eeecccCceEEEEEEecC---------CcEEEEEEeccCCccHHHHHHHHHHHhcCCCCC-eeeEEEEEecCCeeEEEEe
Q 011660 258 MLIGQGGNSKVYRTNHVD---------GQVAAVKVLKCTNWSEEEVLREVELLSSIKHEN-IVRIIGYCHSKEMYAIVYN 327 (480)
Q Consensus 258 ~~LG~G~fg~Vy~~~~~~---------g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~~~~~~lV~e 327 (480)
+.|+.|....+|+....+ ++.+++|+.........+...|.++++.+...+ ..++++.+. -+++|+
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~v~e 114 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTFN----GGRIEE 114 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEecC----CcEEEE
Confidence 457788888999987643 268888987543211113467888888774323 446665542 257899
Q ss_pred ccCC
Q 011660 328 LLNG 331 (480)
Q Consensus 328 ~~~G 331 (480)
|+.|
T Consensus 115 ~i~G 118 (369)
T 3c5i_A 115 WLYG 118 (369)
T ss_dssp CCCS
T ss_pred EecC
Confidence 9866
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.16 E-value=0.011 Score=58.50 Aligned_cols=32 Identities=19% Similarity=0.400 Sum_probs=27.4
Q ss_pred CCeEeccCCCCCEEEecCCCceEEeeecccccc
Q 011660 365 PPIIHRDVKSSNILLSENFHHPQLSDFGAAMVH 397 (480)
Q Consensus 365 ~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~ 397 (480)
..++|+|+.+.||+++++ +.+.|+||+.+.+.
T Consensus 206 ~~~~HgD~~~~N~l~~~~-~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNE-ESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGG-GCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCC-CeEEEEECCCCeeC
Confidence 379999999999999876 57999999987653
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.75 E-value=0.063 Score=54.94 Aligned_cols=70 Identities=11% Similarity=0.088 Sum_probs=45.7
Q ss_pred eeecccCceEEEEEEecC--------CcEEEEEEeccCCccHHHHHHHHHHHhcCC-CCCeeeEEEEEecCCeeEEEEec
Q 011660 258 MLIGQGGNSKVYRTNHVD--------GQVAAVKVLKCTNWSEEEVLREVELLSSIK-HENIVRIIGYCHSKEMYAIVYNL 328 (480)
Q Consensus 258 ~~LG~G~fg~Vy~~~~~~--------g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~e~ 328 (480)
+.|..|-...+|+....+ ++.+++++........-+..+|..+++.+. +.-..++++.+. + +.|++|
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~~--~--~~I~ef 151 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADFP--E--GRIEEF 151 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEET--T--EEEEEC
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEcC--C--CEEEEE
Confidence 457778888999987653 578899986543222223467888888774 333456666443 2 678999
Q ss_pred cCC
Q 011660 329 LNG 331 (480)
Q Consensus 329 ~~G 331 (480)
+.|
T Consensus 152 I~G 154 (424)
T 3mes_A 152 IDG 154 (424)
T ss_dssp CCS
T ss_pred eCC
Confidence 866
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=92.78 E-value=0.3 Score=44.91 Aligned_cols=118 Identities=12% Similarity=0.180 Sum_probs=83.4
Q ss_pred CCCCCeeeEEEEEecCCeeEEEEeccC-CCHHHHHHhCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecC
Q 011660 304 IKHENIVRIIGYCHSKEMYAIVYNLLN-GSLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN 382 (480)
Q Consensus 304 l~HpnIv~l~~~~~~~~~~~lV~e~~~-GsL~~~l~~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~ 382 (480)
..||++++. .+-.+++.+.+.++... +.=...++.++..++++++.+|+....+++.. +|--|.|+||+++.+
T Consensus 42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~NL~f~~~ 115 (215)
T 4ann_A 42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIKSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDELFFTRD 115 (215)
T ss_dssp SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGGGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGGEEECTT
T ss_pred ccCCcccce-EEEEcccEEEEEEEcCcccCCHHHHHhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecceEEEcCC
Confidence 368888876 56667777777666653 32333478999999999999999988776644 888999999999999
Q ss_pred CCceEEeeeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 011660 383 FHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTN 455 (480)
Q Consensus 383 ~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~ 455 (480)
+.+++.-.|+-.. ++|. .++...=.-.+=|++..+++++..|..-
T Consensus 116 -~~p~i~~RGik~~----------------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~l 160 (215)
T 4ann_A 116 -GLPIAKTRGLQNV----------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFDAL 160 (215)
T ss_dssp -SCEEESCCEETTT----------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHHH
T ss_pred -CCEEEEEccCccC----------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHHH
Confidence 6899987776311 1222 1222222345677888888888877644
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=91.12 E-value=1.3 Score=40.82 Aligned_cols=82 Identities=12% Similarity=0.061 Sum_probs=63.8
Q ss_pred CCCCeeeEEEEEecCCeeEEEEecc-CCCHHHHHHhCCHHHHHHHHHHHHHHHH-HHHhCCCCCeEeccCCCCCEEEecC
Q 011660 305 KHENIVRIIGYCHSKEMYAIVYNLL-NGSLKQYLKQLKWNERMDVAIGVAKALE-YLHHTCDPPIIHRDVKSSNILLSEN 382 (480)
Q Consensus 305 ~HpnIv~l~~~~~~~~~~~lV~e~~-~GsL~~~l~~~~~~~~~~i~~~ia~aL~-yLH~~~~~~IiHrDlKp~NILl~~~ 382 (480)
.||++ -..+-.+++.+.+.++.. ++.=...++.++..++++++.+|+.... +++ .-+|--|.|+||+++.+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~NL~f~~~ 120 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRKTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPENLMFNRA 120 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHTSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGGGEEECTT
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHhcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCceEEEeCC
Confidence 67887 344457777888877776 4434557789999999999999888766 555 45888999999999999
Q ss_pred CCceEEeeeccc
Q 011660 383 FHHPQLSDFGAA 394 (480)
Q Consensus 383 ~~~~kL~DFGla 394 (480)
+.+++.-.|+-
T Consensus 121 -~~p~i~hRGi~ 131 (219)
T 4ano_A 121 -LEPFFLHVGVK 131 (219)
T ss_dssp -CCEEESCCEET
T ss_pred -CcEEEEEcCCc
Confidence 68999888863
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=87.45 E-value=2.6 Score=38.81 Aligned_cols=98 Identities=16% Similarity=0.144 Sum_probs=61.3
Q ss_pred CHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccCc
Q 011660 332 SLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV 407 (480)
Q Consensus 332 sL~~~l~----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~ 407 (480)
+|.+.|+ .+.+++++.++.|.+.+|.-+-...+ + ..+=+.|..|++..+ |.+-+.+ +.+.
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~d-G~V~f~~-~~s~------------ 97 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRD-GAVTLAP-AADD------------ 97 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETT-SCEEECC-C---------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecC-Cceeccc-cccc------------
Confidence 5888884 58999999999999999877622111 1 123345688999988 6766553 2110
Q ss_pred cccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCC
Q 011660 408 KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEA 451 (480)
Q Consensus 408 ~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~p 451 (480)
.....+.|||... ...+.+.=|||||+++|.-+-=..|
T Consensus 98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp --------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 0122467888653 4556888999999999987754444
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 480 | ||||
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-52 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-50 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 8e-50 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-48 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-47 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-47 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-46 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-46 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-45 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-45 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-44 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-44 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-44 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-43 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-43 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-43 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 9e-43 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-42 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-42 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-42 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-42 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 7e-41 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-40 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-39 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-39 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-39 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-39 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-39 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 7e-39 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-38 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-38 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-38 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 8e-38 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-37 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-37 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-37 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 5e-37 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-36 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-36 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-36 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-36 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-36 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-36 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-36 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-35 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-35 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-35 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-35 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 6e-35 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 9e-35 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-34 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-33 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-33 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-33 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-32 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-32 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-30 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-30 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 8e-30 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-27 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-27 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-27 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-17 |
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (451), Expect = 1e-52
Identities = 62/235 (26%), Positives = 98/235 (41%), Gaps = 17/235 (7%)
Query: 253 NFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKC--TNWSEEEVLREVELLSSIKHENI 309
+F +G G V++ ++ G V A K++ +++RE+++L I
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 310 VRIIGYCHSKEMYAIVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDP 365
V G +S +I + GSL Q LK+ + V+I V K L YL
Sbjct: 67 VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK- 125
Query: 366 PIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMM 425
I+HRDVK SNIL++ +L DFG + S S VGT Y++PE +
Sbjct: 126 -IMHRDVKPSNILVNSRGE-IKLCDFGVSGQLIDSMANSF-------VGTRSYMSPERLQ 176
Query: 426 YGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWYYVLAGKVFAQQWPM 480
+ D++S G+ L+E+ G+ I A L+ V P
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 5e-50
Identities = 62/202 (30%), Positives = 102/202 (50%), Gaps = 21/202 (10%)
Query: 259 LIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEV---LREVELLSSIKHENIVRIIGY 315
IG G VY+ G VA VK+L T + +++ EV +L +H NI+ +GY
Sbjct: 15 RIGSGSFGTVYKGKW-HGDVA-VKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 316 CHSKEMYAIVYNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHR 370
+ ++ IV SL +L + + +D+A A+ ++YLH IIHR
Sbjct: 73 STAPQLA-IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHR 128
Query: 371 DVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY---G 427
D+KS+NI L E+ ++ DFG A V + S + + + G+ ++APE +
Sbjct: 129 DLKSNNIFLHEDL-TVKIGDFGLATVKSRW---SGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 428 KVDEKIDVYSYGVVLLELITGK 449
+ DVY++G+VL EL+TG+
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQ 206
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 8e-50
Identities = 56/216 (25%), Positives = 101/216 (46%), Gaps = 13/216 (6%)
Query: 252 HNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVR 311
+G G +V+ + AVK LK + S + L E L+ ++H+ +VR
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 312 IIGYCHSKEMYAIVYNLLNGSLKQYLK-----QLKWNERMDVAIGVAKALEYLHHTCDPP 366
+ + +Y I + NGSL +LK +L N+ +D+A +A+ + ++
Sbjct: 73 LYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RN 129
Query: 367 IIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY 426
IHRD++++NIL+S+ +++DFG A + +E + APE + Y
Sbjct: 130 YIHRDLRAANILVSDTLSC-KIADFGLARLIED----NEYTAREGAKFPIKWTAPEAINY 184
Query: 427 GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESL 462
G K DV+S+G++L E++T N E +
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI 220
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 2e-48
Identities = 56/216 (25%), Positives = 103/216 (47%), Gaps = 13/216 (6%)
Query: 252 HNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVR 311
+ ++ +GQG +V+ A+K LK S E L+E +++ ++HE +V+
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 76
Query: 312 IIGYCHSKEMYAIVYNLLNGSLKQYL-----KQLKWNERMDVAIGVAKALEYLHHTCDPP 366
+ + +Y + + GSL +L K L+ + +D+A +A + Y+
Sbjct: 77 LYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--- 133
Query: 367 IIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY 426
+HRD++++NIL+ EN +++DFG A + + + + APE +Y
Sbjct: 134 YVHRDLRAANILVGENL-VCKVADFGLARLIEDNEYTARQ----GAKFPIKWTAPEAALY 188
Query: 427 GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESL 462
G+ K DV+S+G++L EL T NRE L
Sbjct: 189 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 224
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 2e-47
Identities = 46/210 (21%), Positives = 95/210 (45%), Gaps = 7/210 (3%)
Query: 253 NFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRI 312
+ IG G V+ ++ A+K ++ SEE+ + E E++ + H +V++
Sbjct: 6 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQL 65
Query: 313 IGYCHSKEMYAIVYNLL-NGSLKQYLKQLKWNERMDVAIGVAK-ALEYLHHTCDPPIIHR 370
G C + +V+ + +G L YL+ + + +G+ E + + + +IHR
Sbjct: 66 YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHR 125
Query: 371 DVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVD 430
D+ + N L+ EN ++SDFG + + + +PE + +
Sbjct: 126 DLAARNCLVGENQ-VIKVSDFG----MTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 180
Query: 431 EKIDVYSYGVVLLELITGKEAIQTNKANRE 460
K DV+S+GV++ E+ + + N++N E
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYENRSNSE 210
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 4e-47
Identities = 47/203 (23%), Positives = 95/203 (46%), Gaps = 13/203 (6%)
Query: 253 NFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRI 312
+ + +G G V A+K++K + SE+E + E +++ ++ HE +V++
Sbjct: 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQL 64
Query: 313 IGYCHSKEMYAIVYNLL-NGSLKQYL----KQLKWNERMDVAIGVAKALEYLHHTCDPPI 367
G C + I+ + NG L YL + + + +++ V +A+EYL
Sbjct: 65 YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQF 121
Query: 368 IHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYG 427
+HRD+ + N L+++ ++SDFG + E V + PE +MY
Sbjct: 122 LHRDLAARNCLVNDQG-VVKVSDFGLSRYVLD----DEYTSSVGSKFPVRWSPPEVLMYS 176
Query: 428 KVDEKIDVYSYGVVLLELITGKE 450
K K D++++GV++ E+ + +
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGK 199
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 1e-46
Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 21/202 (10%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSE---EEVLREVELLSSIKHENIVRIIGY 315
IG+G VY+ + A L+ ++ + E E+L ++H NIVR
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 316 CHS----KEMYAIVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPI 367
S K+ +V L+ +G+LK YLK+ +K + K L++LH PPI
Sbjct: 77 WESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT-RTPPI 135
Query: 368 IHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYG 427
IHRD+K NI ++ ++ D G A + S + V+GT ++APE
Sbjct: 136 IHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA-------VIGTPEFMAPEMYE-E 187
Query: 428 KVDEKIDVYSYGVVLLELITGK 449
K DE +DVY++G+ +LE+ T +
Sbjct: 188 KYDESVDVYAFGMCMLEMATSE 209
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 2e-46
Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 20/206 (9%)
Query: 253 NFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWS----EEEVLREVELLSSIKHE 307
+F +G+G VY + A+KVL E ++ REVE+ S ++H
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66
Query: 308 NIVRIIGYCHSKEMYAIVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTC 363
NI+R+ GY H ++ G++ + L++ +A AL Y H
Sbjct: 67 NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH--- 123
Query: 364 DPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEY 423
+IHRD+K N+LL +++DFG ++ S + + + GT YL PE
Sbjct: 124 SKRVIHRDIKPENLLLGSAGE-LKIADFGWSVHAPSSRRTT-------LCGTLDYLPPEM 175
Query: 424 MMYGKVDEKIDVYSYGVVLLELITGK 449
+ DEK+D++S GV+ E + GK
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGK 201
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 2e-45
Identities = 52/213 (24%), Positives = 86/213 (40%), Gaps = 22/213 (10%)
Query: 253 NFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEE---VLREVELLSSIKHEN 308
++ IG G + + DG++ K L + +E E ++ EV LL +KH N
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 309 IVRIIGYCHSKE--MYAIVYNLL-NGSLKQYLKQ-------LKWNERMDVAIGVAKALEY 358
IVR + IV G L + + L + V + AL+
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 359 LH--HTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTF 416
H ++HRD+K +N+ L + +L DFG A + + ++ T
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQN-VKLGDFGLARILNHDTSFAKAFVG-----TP 178
Query: 417 GYLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
Y++PE M +EK D++S G +L EL
Sbjct: 179 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM 211
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 157 bits (397), Expect = 5e-45
Identities = 52/229 (22%), Positives = 93/229 (40%), Gaps = 24/229 (10%)
Query: 242 FTSQELCHLTHNFSPKM---------LIGQGGNSKVYRTNHV----DGQVAAVKVLK--C 286
FT ++ F+ ++ +IG G +V + A+K LK
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 287 TNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGSLKQYL----KQLK 341
T + L E ++ H N++ + G I+ + NGSL +L Q
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126
Query: 342 WNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401
+ + + G+A ++YL +HRD+ + NIL++ N ++SDFG +
Sbjct: 127 VIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLV-CKVSDFGLSRFLEDDT 182
Query: 402 QVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKE 450
+ + APE + Y K DV+SYG+V+ E+++ E
Sbjct: 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE 231
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 1e-44
Identities = 60/219 (27%), Positives = 108/219 (49%), Gaps = 27/219 (12%)
Query: 249 HLTHNFSPK------MLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSE-EEVLREVEL 300
H+T + +P+ +G G KVY+ N +AA KV+ + E E+ + E+++
Sbjct: 3 HVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDI 62
Query: 301 LSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGSLKQYL----KQLKWNERMDVAIGVAKA 355
L+S H NIV+++ + + I+ G++ + + L ++ V A
Sbjct: 63 LASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDA 122
Query: 356 LEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGT 415
L YLH D IIHRD+K+ NIL + + +L+DFG + + ++ Q + + +GT
Sbjct: 123 LNYLH---DNKIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTIQRRD-----SFIGT 173
Query: 416 FGYLAPEYMMY-----GKVDEKIDVYSYGVVLLELITGK 449
++APE +M D K DV+S G+ L+E+ +
Sbjct: 174 PYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIE 212
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 156 bits (395), Expect = 2e-44
Identities = 65/232 (28%), Positives = 104/232 (44%), Gaps = 29/232 (12%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEE----VLREVELLSSIKHENIVRIIG 314
IG G VY + + +V A+K + + E +++EV L ++H N ++ G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 315 YCHSKEMYAIVYNLLNGSL----KQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHR 370
+ +V GS + + K L+ E V G + L YLH +IHR
Sbjct: 83 CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHR 139
Query: 371 DVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEY---MMYG 427
DVK+ NILLSE +L DFG+A + ++ VGT ++APE M G
Sbjct: 140 DVKAGNILLSEPG-LVKLGDFGSASIMAPANS---------FVGTPYWMAPEVILAMDEG 189
Query: 428 KVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWYYVLAGKVFAQQWP 479
+ D K+DV+S G+ +EL K + N ++ Y++ + A Q
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLF----NMNAMSALYHIAQNESPALQSG 237
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 5e-44
Identities = 52/235 (22%), Positives = 97/235 (41%), Gaps = 18/235 (7%)
Query: 253 NFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSE--EEVLREVELLSSIKHENI 309
++ +G+G +V N V + AVK++ + E + +E+ + + HEN+
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65
Query: 310 VRIIGYCHSKEMYAIVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDP 365
V+ G+ + + G L ++ + + + + YLH
Sbjct: 66 VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG-- 123
Query: 366 PIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMM 425
I HRD+K N+LL E + ++SDFG A V + + + GT Y+APE +
Sbjct: 124 -ITHRDIKPENLLLDERD-NLKISDFGLATVFRYN---NRERLLNKMCGTLPYVAPELLK 178
Query: 426 YGKVD-EKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWYYVLAGKVFAQQWP 479
+ E +DV+S G+VL ++ G+ +S + K + W
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWD---QPSDSCQEYSDWKEKKTYLNPWK 230
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 1e-43
Identities = 51/215 (23%), Positives = 93/215 (43%), Gaps = 21/215 (9%)
Query: 253 NFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRI 312
IG+G V ++ G AVK +K + + L E +++ ++H N+V++
Sbjct: 8 ELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQL 65
Query: 313 IGYC-HSKEMYAIVYNLL-NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDP 365
+G K IV + GSL YL+ L + + ++ V +A+EYL
Sbjct: 66 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---N 122
Query: 366 PIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMM 425
+HRD+ + N+L+SE+ ++SDFG + + APE +
Sbjct: 123 NFVHRDLAARNVLVSEDNV-AKVSDFGLTKEASSTQD--------TGKLPVKWTAPEALR 173
Query: 426 YGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRE 460
K K DV+S+G++L E+ + ++
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 208
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 1e-43
Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 21/208 (10%)
Query: 260 IGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSK 319
IG+G +V+R G+ AVK+ E+ ++HENI+ I +
Sbjct: 11 IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKD 69
Query: 320 -----EMYAIVYNLLNGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTC-----DPPI 367
+++ + +GSL YL + + + +A+ A L +LH P I
Sbjct: 70 NGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAI 129
Query: 368 IHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEY---- 423
HRD+KS NIL+ +N ++D G V H S + ++ P + VGT Y+APE
Sbjct: 130 AHRDLKSKNILVKKNG-TCCIADLG-LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDS 187
Query: 424 --MMYGKVDEKIDVYSYGVVLLELITGK 449
M + + ++ D+Y+ G+V E+
Sbjct: 188 INMKHFESFKRADIYAMGLVFWEIARRC 215
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 7e-43
Identities = 56/197 (28%), Positives = 97/197 (49%), Gaps = 16/197 (8%)
Query: 259 LIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEE-VLREVELLSSIKHENIVRIIGYC 316
IGQG + VY + GQ A++ + ++E ++ E+ ++ K+ NIV +
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 317 HSKEMYAIVYNLL-NGSLKQYLKQLKWNE--RMDVAIGVAKALEYLHHTCDPPIIHRDVK 373
+ +V L GSL + + +E V +ALE+LH +IHRD+K
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIK 143
Query: 374 SSNILLSENFHHPQLSDFG-AAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEK 432
S NILL + +L+DFG A + + + S +VGT ++APE + K
Sbjct: 144 SDNILLGMD-GSVKLTDFGFCAQITPEQSKRS------TMVGTPYWMAPEVVTRKAYGPK 196
Query: 433 IDVYSYGVVLLELITGK 449
+D++S G++ +E+I G+
Sbjct: 197 VDIWSLGIMAIEMIEGE 213
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (381), Expect = 9e-43
Identities = 51/203 (25%), Positives = 96/203 (47%), Gaps = 10/203 (4%)
Query: 253 NFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEE----VLREVELLSSIKHE 307
+F ++G+G S V + A+K+L+ + +E V RE +++S + H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 308 NIVRIIGYCHSKEMYAIVYNLL-NGSLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPP 366
V++ E + NG L +Y++++ + A+ + L +
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 128
Query: 367 IIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY 426
IIHRD+K NILL+E+ H Q++DFG A V S+ + + VGT Y++PE +
Sbjct: 129 IIHRDLKPENILLNEDM-HIQITDFGTAKVLSPE---SKQARANSFVGTAQYVSPELLTE 184
Query: 427 GKVDEKIDVYSYGVVLLELITGK 449
+ D+++ G ++ +L+ G
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGL 207
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 1e-42
Identities = 49/210 (23%), Positives = 92/210 (43%), Gaps = 15/210 (7%)
Query: 260 IGQGGNSKVYRTNHVD---GQVAAVKVLKCTNWSE---EEVLREVELLSSIKHENIVRII 313
+G G V + + + AVK+LK +E+L E ++ + + IVR+I
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 314 GYCHSKEMYAIVYNLLNGSLKQYL---KQLKWNERMDVAIGVAKALEYLHHTCDPPIIHR 370
G C ++ ++ G L +YL + +K +++ V+ ++YL +HR
Sbjct: 75 GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE---SNFVHR 131
Query: 371 DVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVD 430
D+ + N+LL H+ ++SDFG + + + + APE + Y K
Sbjct: 132 DLAARNVLLVTQ-HYAKISDFGLSKALRADE--NYYKAQTHGKWPVKWYAPECINYYKFS 188
Query: 431 EKIDVYSYGVVLLELITGKEAIQTNKANRE 460
K DV+S+GV++ E + + E
Sbjct: 189 SKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 218
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 151 bits (383), Expect = 2e-42
Identities = 45/209 (21%), Positives = 85/209 (40%), Gaps = 17/209 (8%)
Query: 249 HLTHNFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSE-EEVLREVELLSSIKH 306
H+ ++ +G G V+R T G A K + + S+ E V +E++ +S ++H
Sbjct: 23 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRH 82
Query: 307 ENIVRIIGYCHSKEMYAIVYNLL-NGSLKQYL----KQLKWNERMDVAIGVAKALEYLHH 361
+V + ++Y + G L + + ++ +E ++ V K L ++H
Sbjct: 83 PTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE 142
Query: 362 TCDPPIIHRDVKSSNILLSENFH-HPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLA 420
+H D+K NI+ + +L DFG + GT + A
Sbjct: 143 NN---YVHLDLKPENIMFTTKRSNELKLIDFGLT------AHLDPKQSVKVTTGTAEFAA 193
Query: 421 PEYMMYGKVDEKIDVYSYGVVLLELITGK 449
PE V D++S GV+ L++G
Sbjct: 194 PEVAEGKPVGYYTDMWSVGVLSYILLSGL 222
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 149 bits (378), Expect = 2e-42
Identities = 55/206 (26%), Positives = 95/206 (46%), Gaps = 15/206 (7%)
Query: 252 HNFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIV 310
+ + K +G G +VY AVK LK EE L+E ++ IKH N+V
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 76
Query: 311 RIIGYCHSKEMYAIVYNLL-NGSLKQYL-----KQLKWNERMDVAIGVAKALEYLHHTCD 364
+++G C + + I+ + G+L YL +++ + +A ++ A+EYL
Sbjct: 77 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK--- 133
Query: 365 PPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYM 424
IHRD+ + N L+ EN +++DFG + + + + APE +
Sbjct: 134 KNFIHRDLAARNCLVGENH-LVKVADFGLSRLMTGDTYTAH----AGAKFPIKWTAPESL 188
Query: 425 MYGKVDEKIDVYSYGVVLLELITGKE 450
Y K K DV+++GV+L E+ T
Sbjct: 189 AYNKFSIKSDVWAFGVLLWEIATYGM 214
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 3e-42
Identities = 49/222 (22%), Positives = 95/222 (42%), Gaps = 18/222 (8%)
Query: 260 IGQGGNSKVYRTNHV---DGQVAAVKVLK--CTNWSEEEVLREVELLSSIKHENIVRIIG 314
+G G V + + A+KVLK EE++RE +++ + + IVR+IG
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76
Query: 315 YCHSKEMYAIVYNLLNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHR 370
C ++ + ++ G L ++L + + ++ V+ ++YL +HR
Sbjct: 77 VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHR 133
Query: 371 DVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVD 430
D+ + N+LL + ++SDFG + S + APE + + K
Sbjct: 134 DLAARNVLLVNRH-YAKISDFGLSKALGADD--SYYTARSAGKWPLKWYAPECINFRKFS 190
Query: 431 EKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWYYVLAGK 472
+ DV+SYGV + E ++ + E + ++ GK
Sbjct: 191 SRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMAFIEQGK 229
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 147 bits (373), Expect = 7e-41
Identities = 37/199 (18%), Positives = 78/199 (39%), Gaps = 17/199 (8%)
Query: 259 LIGQGGNSKVYR-TNHVDGQVAAVKVLKCTN-WSEEEVLREVELLSSIKHENIVRIIGYC 316
+G G V+R G+V K + + V E+ +++ + H ++ +
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 317 HSKEMYAIVYNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRD 371
K ++ L G L + + E ++ + L+++H + I+H D
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLD 152
Query: 372 VKSSNILLSENFH-HPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVD 430
+K NI+ ++ DFG A +++ + T + APE + V
Sbjct: 153 IKPENIMCETKKASSVKIIDFGLA------TKLNPDEIVKVTTATAEFAAPEIVDREPVG 206
Query: 431 EKIDVYSYGVVLLELITGK 449
D+++ GV+ L++G
Sbjct: 207 FYTDMWAIGVLGYVLLSGL 225
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 145 bits (367), Expect = 2e-40
Identities = 50/203 (24%), Positives = 90/203 (44%), Gaps = 15/203 (7%)
Query: 253 NFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSE----EEVLREVELLSSIKHE 307
+F +G G +V+ + +G+ A+KVLK E E +LS + H
Sbjct: 5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 64
Query: 308 NIVRIIGYCHSKEMYAIVYNLLNGS-LKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPP 366
I+R+ G + ++ + + G L L++ + A+ L +
Sbjct: 65 FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD 124
Query: 367 IIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY 426
II+RD+K NILL +N H +++DFG A + GT Y+APE +
Sbjct: 125 IIYRDLKPENILLDKNG-HIKITDFGFAKYVPDVTY--------TLCGTPDYIAPEVVST 175
Query: 427 GKVDEKIDVYSYGVVLLELITGK 449
++ ID +S+G+++ E++ G
Sbjct: 176 KPYNKSIDWWSFGILIYEMLAGY 198
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 142 bits (359), Expect = 1e-39
Identities = 57/260 (21%), Positives = 109/260 (41%), Gaps = 46/260 (17%)
Query: 252 HNFSPKMLIGQGGNSKVYR------TNHVDGQVAAVKVLK--CTNWSEEEVLREVELLSS 303
+N IG+G +V++ + + AVK+LK + + + RE L++
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 304 IKHENIVRIIGYCHSKEMYAIVYNLL-NGSLKQYLKQ----------------------- 339
+ NIV+++G C + +++ + G L ++L+
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 340 ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAM 395
L E++ +A VA + YL +HRD+ + N L+ EN +++DFG +
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMV-VKIADFGLSR 188
Query: 396 VHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTN 455
+ + + N ++ PE + Y + + DV++YGVVL E+ +
Sbjct: 189 NIYSADYYKADG---NDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 245
Query: 456 KANRESLVLWYYVLAGKVFA 475
A+ E + YYV G + A
Sbjct: 246 MAHEE---VIYYVRDGNILA 262
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 2e-39
Identities = 39/198 (19%), Positives = 77/198 (38%), Gaps = 16/198 (8%)
Query: 259 LIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCH 317
+G+G V+R + K +K + V +E+ +L+ +H NI+ +
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 318 SKEMYAIVYNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDV 372
S E +++ + + + + L E + V +AL++LH I H D+
Sbjct: 72 SMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDI 128
Query: 373 KSSNILLSENFH-HPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDE 431
+ NI+ ++ +FG A + Y APE + V
Sbjct: 129 RPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR------LLFTAPEYYAPEVHQHDVVST 182
Query: 432 KIDVYSYGVVLLELITGK 449
D++S G ++ L++G
Sbjct: 183 ATDMWSLGTLVYVLLSGI 200
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 2e-39
Identities = 48/213 (22%), Positives = 87/213 (40%), Gaps = 19/213 (8%)
Query: 250 LTHNFSPKMLIGQGGNSKVYRTNHVD----GQVAAVKVLK--CTNWSEEEVLREVELLSS 303
L +F+ +IG+G VY +D AVK L + L E ++
Sbjct: 27 LIVHFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD 84
Query: 304 IKHENIVRIIGYC--HSKEMYAIVYNLLNGSLKQYL----KQLKWNERMDVAIGVAKALE 357
H N++ ++G C ++ + +G L+ ++ + + + VAK +
Sbjct: 85 FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM- 143
Query: 358 YLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFG 417
+HRD+ + N +L E +++DFG A + S + K
Sbjct: 144 --KFLASKKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEFDSVHNK-TGAKLPVK 199
Query: 418 YLAPEYMMYGKVDEKIDVYSYGVVLLELITGKE 450
++A E + K K DV+S+GV+L EL+T
Sbjct: 200 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGA 232
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 5e-39
Identities = 44/208 (21%), Positives = 94/208 (45%), Gaps = 18/208 (8%)
Query: 254 FSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVL------KCTNWSEEEVLREVELLSSIKH 306
F ++G G VY+ +G+ + V + + +E+L E +++S+ +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 307 ENIVRIIGYCHSKEMYAIVYNLLNGSLKQYLKQLK----WNERMDVAIGVAKALEYLHHT 362
++ R++G C + + I + G L Y+++ K ++ + +AK + YL
Sbjct: 71 PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED- 129
Query: 363 CDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPE 422
++HRD+ + N+L+ H +++DFG A + + ++A E
Sbjct: 130 --RRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAE---EKEYHAEGGKVPIKWMALE 183
Query: 423 YMMYGKVDEKIDVYSYGVVLLELITGKE 450
+++ + DV+SYGV + EL+T
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGS 211
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 140 bits (354), Expect = 5e-39
Identities = 57/214 (26%), Positives = 98/214 (45%), Gaps = 19/214 (8%)
Query: 249 HLTHNFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEE----VLREVELLSS 303
HL+ + ++G GG S+V+ + + AVKVL+ + RE + ++
Sbjct: 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 63
Query: 304 IKHENIVRIIGYCHSKE----MYAIVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKA 355
+ H IV + ++ + IV + +L+ + + ++V +A
Sbjct: 64 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQA 123
Query: 356 LEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGT 415
L + IIHRDVK +NI++S + ++ DFG A S + + V+GT
Sbjct: 124 LNFS---HQNGIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSG--NSVTQTAAVIGT 177
Query: 416 FGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
YL+PE VD + DVYS G VL E++TG+
Sbjct: 178 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 211
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 7e-39
Identities = 47/221 (21%), Positives = 90/221 (40%), Gaps = 18/221 (8%)
Query: 252 HNFSPKMLIGQGGNSKVYR-----TNHVDGQVAAVKVLK--CTNWSEEEVLREVELLSSI 304
+ + +IG G +VY+ ++ A+K LK T + L E ++
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 305 KHENIVRIIGYCHSKEMYAIVYNLLNGSLKQYL-----KQLKWNERMDVAIGVAKALEYL 359
H NI+R+ G + I+ + + + + + G+A +
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGM--- 123
Query: 360 HHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYL 419
+ + +HRD+ + NIL++ N ++SDFG + V + + +
Sbjct: 124 KYLANMNYVHRDLAARNILVNSNLV-CKVSDFGLSRVLEDDPEATYTT--SGGKIPIRWT 180
Query: 420 APEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRE 460
APE + Y K DV+S+G+V+ E++T E +N E
Sbjct: 181 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE 221
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 2e-38
Identities = 55/234 (23%), Positives = 93/234 (39%), Gaps = 43/234 (18%)
Query: 253 NFSPKMLIGQGGNSKVYRTNHVD------GQVAAVKVLKCTNWSEE--EVLREVELLSSI 304
N ++G G KV AVK+LK S E ++ E+++++ +
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97
Query: 305 -KHENIVRIIGYCHSKEMYAIVYNLL-NGSLKQYLKQ----------------------- 339
HENIV ++G C +++ G L YL+
Sbjct: 98 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157
Query: 340 ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMV 396
L + + + A VAK +E+L +HRD+ + N+L++ ++ DFG A
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKV-VKICDFGLA-- 211
Query: 397 HHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKE 450
S V N ++APE + G K DV+SYG++L E+ +
Sbjct: 212 -RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV 264
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 2e-38
Identities = 50/225 (22%), Positives = 95/225 (42%), Gaps = 36/225 (16%)
Query: 252 HNFSPKMLIGQGGNSKVYRTNHVDG---QVAAVKVLK--CTNWSEEEVLREVELLSSI-K 305
++ + +IG+G +V + AA+K +K + + E+E+L +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 306 HENIVRIIGYCHSKEMYAIVYNLL-NGSLKQYLKQ-------------------LKWNER 345
H NI+ ++G C + + +G+L +L++ L +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 346 MDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE 405
+ A VA+ ++YL IHRD+ + NIL+ EN + +++DFG +
Sbjct: 130 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGEN-YVAKIADFGLSRGQE------V 179
Query: 406 NVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKE 450
VK ++A E + Y DV+SYGV+L E+++
Sbjct: 180 YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG 224
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 138 bits (349), Expect = 6e-38
Identities = 49/210 (23%), Positives = 87/210 (41%), Gaps = 18/210 (8%)
Query: 249 HLTHNFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLK--CTNWSEEEVLREVELLSSIK 305
+ + + ++G G S+V + ++ A+K + E + E+ +L IK
Sbjct: 6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIK 65
Query: 306 HENIVRIIGYCHSKEMYAIVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHH 361
H NIV + S ++ L+ G L + + + + V A++YLH
Sbjct: 66 HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHD 125
Query: 362 TCDPPIIHRDVKSSNILLSENFH--HPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYL 419
I+HRD+K N+L +SDFG + + +S GT GY+
Sbjct: 126 LG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS------TACGTPGYV 176
Query: 420 APEYMMYGKVDEKIDVYSYGVVLLELITGK 449
APE + + +D +S GV+ L+ G
Sbjct: 177 APEVLAQKPYSKAVDCWSIGVIAYILLCGY 206
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 8e-38
Identities = 52/207 (25%), Positives = 94/207 (45%), Gaps = 19/207 (9%)
Query: 253 NFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLK----CTNWSEEEVLREVELLS-SIKH 306
+F ++G+G KV+ Q A+K LK + E + E +LS + +H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 307 ENIVRIIGYCHSKEMYAIVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHT 362
+ + +KE V L G L +++ + A + L++LH
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK 122
Query: 363 CDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPE 422
I++RD+K NILL ++ H +++DFG + + K GT Y+APE
Sbjct: 123 G---IVYRDLKLDNILLDKDGHI-KIADFGMC-----KENMLGDAKTNTFCGTPDYIAPE 173
Query: 423 YMMYGKVDEKIDVYSYGVVLLELITGK 449
++ K + +D +S+GV+L E++ G+
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQ 200
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 2e-37
Identities = 54/203 (26%), Positives = 97/203 (47%), Gaps = 21/203 (10%)
Query: 259 LIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSE------EEVLREVELLSSIKHENIVR 311
+G+G + VY+ + Q+ A+K +K + SE LRE++LL + H NI+
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 312 IIGYCHSKEMYAIVYNLLNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPI 367
++ K ++V++ + L+ +K L + + + LEYLH I
Sbjct: 65 LLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---I 121
Query: 368 IHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYG 427
+HRD+K +N+LL EN +L+DFG A ++ + V T Y APE +
Sbjct: 122 LHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNR-----AYTHQVVTRWYRAPELLFGA 175
Query: 428 KV-DEKIDVYSYGVVLLELITGK 449
++ +D+++ G +L EL+
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRV 198
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 3e-37
Identities = 50/203 (24%), Positives = 79/203 (38%), Gaps = 18/203 (8%)
Query: 260 IGQGGNSKVYR----TNHVDGQVAAVKVLKCTNWSE----EEVLREVELLSSIKHENIVR 311
+G G V R AVK LK S+ ++ +REV + S+ H N++R
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 312 IIGYCHSKEMYAIVYNLLNGSLKQYL----KQLKWNERMDVAIGVAKALEYLHHTCDPPI 367
+ G + M + GSL L A+ VA+ + YL
Sbjct: 76 LYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---KRF 132
Query: 368 IHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYG 427
IHRD+ + N+LL+ ++ DFG Q+ V + F + APE +
Sbjct: 133 IHRDLAARNLLLATRD-LVKIGDFGLMRALPQND--DHYVMQEHRKVPFAWCAPESLKTR 189
Query: 428 KVDEKIDVYSYGVVLLELITGKE 450
D + +GV L E+ T +
Sbjct: 190 TFSHASDTWMFGVTLWEMFTYGQ 212
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 136 bits (342), Expect = 4e-37
Identities = 45/201 (22%), Positives = 83/201 (41%), Gaps = 14/201 (6%)
Query: 259 LIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCH 317
IG G +Y T+ G+ A+K+ ++ E ++ ++ + I +C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCG 72
Query: 318 S-KEMYAIVYNLLNGSLKQYL----KQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDV 372
+ + +V LL SL+ ++ + +A + +EY+H IHRDV
Sbjct: 73 AEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDV 129
Query: 373 KSSNIL--LSENFHHPQLSDFGAAMVHH--QSHQVSENVKPVNVVGTFGYLAPEYMMYGK 428
K N L L + + + DFG A + ++HQ + N+ GT Y + + +
Sbjct: 130 KPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE 189
Query: 429 VDEKIDVYSYGVVLLELITGK 449
+ D+ S G VL+ G
Sbjct: 190 QSRRDDLESLGYVLMYFNLGS 210
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 5e-37
Identities = 54/245 (22%), Positives = 88/245 (35%), Gaps = 38/245 (15%)
Query: 252 HNFSPKMLIGQGGNSKVYR------TNHVDGQVAAVKVLKCTN--WSEEEVLREVELLSS 303
+ S +G G KV AVK+LK + E ++ E+++LS
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 304 IK-HENIVRIIGYCHSKEMYAIVYNLL-NGSLKQYLKQ---------------------L 340
+ H NIV ++G C ++ G L +L++ L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 341 KWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400
+ + + VAK + +L IHRD+ + NILL+ + DFG A
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITK-ICDFGLARDIKND 198
Query: 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRE 460
S V N ++APE + + DV+SYG+ L EL + +
Sbjct: 199 ---SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255
Query: 461 SLVLW 465
Sbjct: 256 KFYKM 260
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 133 bits (336), Expect = 2e-36
Identities = 57/219 (26%), Positives = 104/219 (47%), Gaps = 32/219 (14%)
Query: 253 NFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSE----------EEVLREVELL 301
N+ PK ++G+G +S V R + + AVK++ T E L+EV++L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 302 SSIK-HENIVRIIGYCHSKEMYAIVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKAL 356
+ H NI+++ + + +V++L+ G L YL + L E + + + +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 123
Query: 357 EYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTF 416
LH I+HRD+K NILL ++ + +L+DFG + ++ V GT
Sbjct: 124 CALHKLN---IVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEKLR------EVCGTP 173
Query: 417 GYLAPEYMM------YGKVDEKIDVYSYGVVLLELITGK 449
YLAPE + + +++D++S GV++ L+ G
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 3e-36
Identities = 46/202 (22%), Positives = 88/202 (43%), Gaps = 18/202 (8%)
Query: 259 LIGQGGNSKVYRTNHVD----GQVAAVKVLK--CTNWSEEEVLREVELLSSIKHENIVRI 312
IG+G V++ ++ A+K K ++ E+ L+E + H +IV++
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 313 IGYCHSKEMYAIVYNLLNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPII 368
IG ++ I+ G L+ +L+ L + A ++ AL YL +
Sbjct: 74 IGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 130
Query: 369 HRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGK 428
HRD+ + N+L+S N +L DFG + + + S K ++APE + + +
Sbjct: 131 HRDIAARNVLVSSND-CVKLGDFGLS----RYMEDSTYYKASKGKLPIKWMAPESINFRR 185
Query: 429 VDEKIDVYSYGVVLLELITGKE 450
DV+ +GV + E++
Sbjct: 186 FTSASDVWMFGVCMWEILMHGV 207
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 4e-36
Identities = 50/207 (24%), Positives = 94/207 (45%), Gaps = 19/207 (9%)
Query: 253 NFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSE---EEVLREVELLSSIKHEN 308
NF IG+G VY+ N + G+V A+K ++ +E +RE+ LL + H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 309 IVRIIGYCHSKEMYAIVYNLLNGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTC 363
IV+++ H++ +V+ L+ LK+++ + + + L + H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 364 DPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPE- 422
++HRD+K N+L++ +L+DFG A + + V T Y APE
Sbjct: 123 ---VLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVR-----TYTHEVVTLWYRAPEI 173
Query: 423 YMMYGKVDEKIDVYSYGVVLLELITGK 449
+ +D++S G + E++T +
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRR 200
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 4e-36
Identities = 43/207 (20%), Positives = 83/207 (40%), Gaps = 26/207 (12%)
Query: 259 LIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSE-------EEVLREVELLSSIK--HEN 308
L+G GG VY D A+K ++ S+ V EV LL +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 309 IVRIIGYCHSKEMYAIVYNLLNG--SLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTC 363
++R++ + + + ++ L ++ + L+ V +A+ +
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC---H 127
Query: 364 DPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEY 423
+ ++HRD+K NIL+ N +L DFG+ + + GT Y PE+
Sbjct: 128 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-------FDGTRVYSPPEW 180
Query: 424 MMYGKV-DEKIDVYSYGVVLLELITGK 449
+ Y + V+S G++L +++ G
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGD 207
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 5e-36
Identities = 47/203 (23%), Positives = 90/203 (44%), Gaps = 18/203 (8%)
Query: 259 LIGQGGNSKVYR-TNHVDGQVAAVKVLKCTN-------WSEEEVLREVELLSSIKHENIV 310
+G G + V + G A K +K S E++ REV +L I+H N++
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 311 RIIGYCHSKEMYAIVYNLLNGS-LKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIH 369
+ +K ++ L+ G L +L + + + + + L +++ I H
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAH 136
Query: 370 RDVKSSNILLSEN---FHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY 426
D+K NI+L + ++ DFG A H++ + N+ GT ++APE + Y
Sbjct: 137 FDLKPENIMLLDRNVPKPRIKIIDFGLA------HKIDFGNEFKNIFGTPEFVAPEIVNY 190
Query: 427 GKVDEKIDVYSYGVVLLELITGK 449
+ + D++S GV+ L++G
Sbjct: 191 EPLGLEADMWSIGVITYILLSGA 213
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 134 bits (339), Expect = 5e-36
Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 24/210 (11%)
Query: 253 NFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEE-------VLREVELLSSI 304
+FS +IG+GG +VY G++ A+K L ++ + L+S+
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 305 KHENIVRIIGYCHSKEMYAIVYNLL-NGSLKQYLKQLK---WNERMDVAIGVAKALEYLH 360
IV + H+ + + + +L+ G L +L Q + A + LE++H
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH 124
Query: 361 HTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLA 420
+ +++RD+K +NILL E+ H ++SD G A + KP VGT GY+A
Sbjct: 125 N---RFVVYRDLKPANILLDEHG-HVRISDLGLACDFSKK-------KPHASVGTHGYMA 173
Query: 421 PEYMMYGK-VDEKIDVYSYGVVLLELITGK 449
PE + G D D +S G +L +L+ G
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGH 203
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 133 bits (334), Expect = 5e-36
Identities = 35/203 (17%), Positives = 72/203 (35%), Gaps = 16/203 (7%)
Query: 259 LIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKH-ENIVRIIGYC 316
IG+G ++ TN ++ Q A+K + ++ E + I + +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFG 70
Query: 317 HSKEMYAIVYNLLNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDV 372
+V +LL SL+ L A + ++ +H +++RD+
Sbjct: 71 QEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDI 127
Query: 373 KSSNILLSENFHHPQ----LSDFGAA--MVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY 426
K N L+ + DFG + Q + N+ GT Y++ +
Sbjct: 128 KPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG 187
Query: 427 GKVDEKIDVYSYGVVLLELITGK 449
+ + D+ + G V + + G
Sbjct: 188 REQSRRDDLEALGHVFMYFLRGS 210
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 2e-35
Identities = 53/202 (26%), Positives = 92/202 (45%), Gaps = 17/202 (8%)
Query: 259 LIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSE--EEVLREVELLSSIKHENIVRIIGY 315
IG+G V ++V+ A+K + + LRE+++L +HENI+ I
Sbjct: 15 YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 74
Query: 316 CHS-----KEMYAIVYNLLNGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPII 368
+ + +V +L+ L + LK L + + + L+Y+H ++
Sbjct: 75 IRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVL 131
Query: 369 HRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGK 428
HRD+K SN+LL+ ++ DFG A V H V T Y APE M+ K
Sbjct: 132 HRDLKPSNLLLNTT-CDLKICDFGLARVADPDH--DHTGFLTEYVATRWYRAPEIMLNSK 188
Query: 429 VD-EKIDVYSYGVVLLELITGK 449
+ ID++S G +L E+++ +
Sbjct: 189 GYTKSIDIWSVGCILAEMLSNR 210
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 2e-35
Identities = 41/203 (20%), Positives = 87/203 (42%), Gaps = 12/203 (5%)
Query: 253 NFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEE----VLREVELLSSIKHE 307
+F L+G+G KV G+ A+K+L+ ++ + E +L + +H
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 308 NIVRIIGYCHSKE-MYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPP 366
+ + + + + ++ G L +L + + A+ + L +
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 367 IIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY 426
+++RD+K N++L ++ H +++DFG +S+ GT YLAPE +
Sbjct: 126 VVYRDIKLENLMLDKDG-HIKITDFGLC-----KEGISDGATMKTFCGTPEYLAPEVLED 179
Query: 427 GKVDEKIDVYSYGVVLLELITGK 449
+D + GVV+ E++ G+
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGR 202
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 4e-35
Identities = 49/245 (20%), Positives = 98/245 (40%), Gaps = 32/245 (13%)
Query: 252 HNFSPKMLIGQGGNSKVYR------TNHVDGQVAAVKVLK--CTNWSEEEVLREVELLSS 303
+ +GQG VY A+K + + E L E ++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 304 IKHENIVRIIGYCHSKEMYAIVYNLL-NGSLKQYLKQ-------------LKWNERMDVA 349
++VR++G + ++ L+ G LK YL+ ++ + +A
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 350 IGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKP 409
+A + YL+ +HRD+ + N +++E+F ++ DFG + ++ K
Sbjct: 140 GEIADGMAYLNA---NKFVHRDLAARNCMVAEDFT-VKIGDFG---MTRDIYETDYYRKG 192
Query: 410 VNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWYYVL 469
+ +++PE + G DV+S+GVVL E+ T E +N + + +V+
Sbjct: 193 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ---VLRFVM 249
Query: 470 AGKVF 474
G +
Sbjct: 250 EGGLL 254
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 5e-35
Identities = 50/221 (22%), Positives = 90/221 (40%), Gaps = 28/221 (12%)
Query: 247 LCHLTHNFSPKMLIGQGGNSKVYRTNHV--DGQVAAVKVLKCTNWSE---EEVLREVEL- 300
LC + IG+G KV++ + G+ A+K ++ E +REV +
Sbjct: 2 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61
Query: 301 --LSSIKHENIVRIIGYCHSKE-----MYAIVYNLLNGSLKQYLKQ-----LKWNERMDV 348
L + +H N+VR+ C +V+ ++ L YL + + D+
Sbjct: 62 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 121
Query: 349 AIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVK 408
+ + L++LH ++HRD+K NIL++ + A + Q S
Sbjct: 122 MFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS---- 174
Query: 409 PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
VV T Y APE ++ +D++S G + E+ K
Sbjct: 175 ---VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 212
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 6e-35
Identities = 49/212 (23%), Positives = 91/212 (42%), Gaps = 27/212 (12%)
Query: 253 NFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVR 311
+++ +IG G VY+ G++ A+K + + RE++++ + H NIVR
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFKNRELQIMRKLDHCNIVR 77
Query: 312 IIGYCHS------KEMYAIVYNLLNGSLKQYLKQ-------LKWNERMDVAIGVAKALEY 358
+ + +S + +V + + ++ + + L + ++L Y
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 359 LHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGY 418
+H I HRD+K N+LL + +L DFG+A Q+ V+ + + Y
Sbjct: 138 IH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSA------KQLVRGEPNVSYICSRYY 188
Query: 419 LAP-EYMMYGKVDEKIDVYSYGVVLLELITGK 449
AP IDV+S G VL EL+ G+
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 130 bits (328), Expect = 9e-35
Identities = 52/234 (22%), Positives = 99/234 (42%), Gaps = 17/234 (7%)
Query: 253 NFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIK-HENIV 310
++ +G+G S+V+ N + + VK+LK ++++ RE+++L +++ NI+
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK--PVKKKKIKREIKILENLRGGPNII 93
Query: 311 RIIGYCH---SKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPI 367
+ S+ + ++ N KQ + L + + KAL+Y H I
Sbjct: 94 TLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMG---I 150
Query: 368 IHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMM-Y 426
+HRDVK N+++ +L D+G A + V + + PE ++ Y
Sbjct: 151 MHRDVKPHNVMIDHEHRKLRLIDWGLA------EFYHPGQEYNVRVASRYFKGPELLVDY 204
Query: 427 GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWYYVLAGKVFAQQWPM 480
D +D++S G +L +I KE N + LV VL +
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 258
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 128 bits (322), Expect = 2e-34
Identities = 50/195 (25%), Positives = 94/195 (48%), Gaps = 11/195 (5%)
Query: 260 IGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSE---EEVLREVELLSSIKHENIVRIIGYC 316
IG+G VY+ + G+ A+K ++ E +RE+ +L +KH NIV++
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 317 HSKEMYAIVYNLLNGSLKQYLKQLKWN-ERMDVAIGVAKALEYLHHTCDPPIIHRDVKSS 375
H+K+ +V+ L+ LK+ L + E + + + L + + D ++HRD+K
Sbjct: 70 HTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQ 129
Query: 376 NILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMM-YGKVDEKID 434
N+L++ +++DFG A + K + + T Y AP+ +M K ID
Sbjct: 130 NLLINREGEL-KIADFGLARAFGIPVR-----KYTHEIVTLWYRAPDVLMGSKKYSTTID 183
Query: 435 VYSYGVVLLELITGK 449
++S G + E++ G
Sbjct: 184 IWSVGCIFAEMVNGT 198
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 2e-33
Identities = 56/229 (24%), Positives = 98/229 (42%), Gaps = 27/229 (11%)
Query: 259 LIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSI-KHENIVRIIGYC 316
++G G N KV + N + A+K+L+ + REVEL + +IVRI+
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQ----DCPKARREVELHWRASQCPHIVRIVDVY 74
Query: 317 HS----KEMYAIVYNLL-NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPP 366
+ ++ IV L G L ++ E ++ + +A++YLH
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SIN 131
Query: 367 IIHRDVKSSNILLSENFH--HPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYM 424
I HRDVK N+L + +L+DFG + + + + T Y+APE +
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFG------FAKETTSHNSLTTPCYTPYYVAPEVL 185
Query: 425 MYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWYYVLAGKV 473
K D+ D++S GV++ L+ G +N S + + G+
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 234
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 2e-33
Identities = 52/217 (23%), Positives = 95/217 (43%), Gaps = 16/217 (7%)
Query: 247 LCHLTHNFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSE---EEVLREVELLS 302
C + IGQG +V++ + GQ A+K + N E LRE+++L
Sbjct: 5 FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQ 64
Query: 303 SIKHENIVRIIGYCHSKE---------MYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVA 353
+KHEN+V +I C +K +Y + + L ++ +
Sbjct: 65 LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQ 124
Query: 354 KALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVV 413
L L++ I+HRD+K++N+L++ + +L+DFG A + S+ + N V
Sbjct: 125 MLLNGLYYIHRNKILHRDMKAANVLITRDG-VLKLADFGLARAFSLAKN-SQPNRYTNRV 182
Query: 414 GTFGYLAPEYMMYGK-VDEKIDVYSYGVVLLELITGK 449
T Y PE ++ + ID++ G ++ E+ T
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 219
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 3e-33
Identities = 51/223 (22%), Positives = 92/223 (41%), Gaps = 38/223 (17%)
Query: 259 LIGQGGNSKVYRTNHV--------DGQVAAVKVLK--CTNWSEEEVLREVELLSSI-KHE 307
+G+G +V + AVK+LK T +++ E+E++ I KH+
Sbjct: 20 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79
Query: 308 NIVRIIGYCHSKEMYAIVYNLL-NGSLKQYLK-------------------QLKWNERMD 347
NI+ ++G C ++ G+L++YL+ QL + +
Sbjct: 80 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 139
Query: 348 VAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV 407
A VA+ +EYL IHRD+ + N+L++E+ A +HH +
Sbjct: 140 CAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196
Query: 408 KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKE 450
++APE + + DV+S+GV+L E+ T
Sbjct: 197 GR----LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG 235
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (308), Expect = 2e-32
Identities = 51/225 (22%), Positives = 91/225 (40%), Gaps = 11/225 (4%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSE---EEVLREVELLSSIKHENIVRIIGY 315
IG+G V++ N ++ A+K ++ + E LRE+ LL +KH+NIVR+
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 316 CHSKEMYAIVY-NLLNGSLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKS 374
HS + +V+ K + + V + + L+ L ++HRD+K
Sbjct: 70 LHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKP 129
Query: 375 SNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKID 434
N+L++ N +L++FG A + VV + ID
Sbjct: 130 QNLLINRNGEL-KLANFGLARAFGIPVRCYSAE----VVTLWYRPPDVLFGAKLYSTSID 184
Query: 435 VYSYGVVLLELITGKEAIQTNKANRESLVLWYYVLAGKVFAQQWP 479
++S G + EL + + L + +L G +QWP
Sbjct: 185 MWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL-GTPTEEQWP 228
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 6e-32
Identities = 54/229 (23%), Positives = 93/229 (40%), Gaps = 37/229 (16%)
Query: 252 HNFSPKMLIGQGGNSKVYR------TNHVDGQVAAVKVLK--CTNWSEEEVLREVELLSS 303
+G+G +V + AVK+LK T+ ++ E+++L
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 304 IKHE-NIVRIIGYCHSKE--MYAIVYNLLNGSLKQYLKQ-------------------LK 341
I H N+V ++G C + IV G+L YL+ L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 342 WNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401
+ + VAK +E+L IHRD+ + NILLSE ++ DFG A +
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNV-VKICDFGLA---RDIY 185
Query: 402 QVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKE 450
+ + V+ + ++APE + + DV+S+GV+L E+ +
Sbjct: 186 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 234
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 119 bits (300), Expect = 1e-30
Identities = 49/251 (19%), Positives = 94/251 (37%), Gaps = 25/251 (9%)
Query: 208 GVCIAQETVQVPESIKRKIFEKLAVLEAEGSSRRFTSQELCHLTHNFSPKMLIGQGGNSK 267
G A + ES+K + + + + + +L F +G G +
Sbjct: 1 GNAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQL----DQFDRIKTLGTGSFGR 56
Query: 268 VYR-TNHVDGQVAAVKVLKCTNWSE----EEVLREVELLSSIKHENIVRIIGYCHSKEMY 322
V + G A+K+L + E L E +L ++ +V++
Sbjct: 57 VMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL 116
Query: 323 AIVYNL-LNGSLKQYL---KQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNIL 378
+V G + +L + A + EYLH +I+RD+K N+L
Sbjct: 117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLL 173
Query: 379 LSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSY 438
+ + + Q++DFG A + GT LAPE ++ ++ +D ++
Sbjct: 174 IDQQ-GYIQVTDFGFAKRVKGRTW--------TLCGTPEALAPEIILSKGYNKAVDWWAL 224
Query: 439 GVVLLELITGK 449
GV++ E+ G
Sbjct: 225 GVLIYEMAAGY 235
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 1e-30
Identities = 47/226 (20%), Positives = 89/226 (39%), Gaps = 23/226 (10%)
Query: 236 EGSSRRFTSQELCHLTHNFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSE--- 291
G R+ ++ + + +G G V + G A+K L SE
Sbjct: 2 SGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFA 61
Query: 292 EEVLREVELLSSIKHENIVRIIGYCHSKEM------YAIVYNLLNGSLKQYLKQ--LKWN 343
+ RE+ LL ++HEN++ ++ E + +V + L + +K L +
Sbjct: 62 KRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGED 121
Query: 344 ERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403
+ + K L Y+H IIHRD+K N+ ++E+ L A +
Sbjct: 122 RIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTG- 177
Query: 404 SENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
VV + + + + + +D++S G ++ E+ITGK
Sbjct: 178 -------YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 216
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 8e-30
Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 18/210 (8%)
Query: 253 NFSPKMLIGQGGNSKVYR----TNHVDGQVAAVKVLKCTNWSE-----EEVLREVELLSS 303
NF ++G G KV+ + H G++ A+KVLK + E E ++L
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84
Query: 304 IKHE-NIVRIIGYCHSKEMYAIVYNLLNG-SLKQYLKQLKWNERMDVAIGVAKALEYLHH 361
I+ +V + ++ ++ + +NG L +L Q + +V I V + + L H
Sbjct: 85 IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEH 144
Query: 362 TCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAP 421
II+RD+K NILL N H L+DFG + + + GT Y+AP
Sbjct: 145 LHKLGIIYRDIKLENILLDSNG-HVVLTDFGLSKEFVADE----TERAYDFCGTIEYMAP 199
Query: 422 EYMMYGK--VDEKIDVYSYGVVLLELITGK 449
+ + G D+ +D +S GV++ EL+TG
Sbjct: 200 DIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 2e-27
Identities = 46/202 (22%), Positives = 87/202 (43%), Gaps = 21/202 (10%)
Query: 259 LIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSE---EEVLREVELLSSIKHENIVRIIG 314
IG G V + V + A+K L ++ + RE+ L+ + H+NI+ ++
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 315 YCHSK------EMYAIVYNLLNGS-LKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPI 367
+ + +V L++ + + +L + + +++LH I
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---I 140
Query: 368 IHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYG 427
IHRD+K SNI++ + L DFG A S ++ V T Y APE ++
Sbjct: 141 IHRDLKPSNIVVKSDCTLKIL-DFGLARTAGTSFMMT------PYVVTRYYRAPEVILGM 193
Query: 428 KVDEKIDVYSYGVVLLELITGK 449
E +D++S G ++ E++ K
Sbjct: 194 GYKENVDIWSVGCIMGEMVRHK 215
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 110 bits (274), Expect = 3e-27
Identities = 39/212 (18%), Positives = 75/212 (35%), Gaps = 26/212 (12%)
Query: 259 LIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCH 317
+G G S V+ + V+ A+K+++ E E++LL + + +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 79
Query: 318 SK--------------------EMYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVAKALE 357
+ + NLL K + + ++ + L+
Sbjct: 80 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139
Query: 358 YLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFG 417
Y+H C IIH D+K N+L+ L + + + N + T
Sbjct: 140 YMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIK---IADLGNACWYDEHYTNSIQTRE 194
Query: 418 YLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
Y +PE ++ D++S ++ ELITG
Sbjct: 195 YRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 4e-27
Identities = 57/225 (25%), Positives = 94/225 (41%), Gaps = 29/225 (12%)
Query: 242 FTSQELC----HLTHNFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSE---EE 293
F QEL + + +G G V + G AVK L S +
Sbjct: 4 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 63
Query: 294 VLREVELLSSIKHENIVRIIGYCHSKE------MYAIVYNLLNGSLKQYLKQ--LKWNER 345
RE+ LL +KHEN++ ++ +V +L+ L +K L +
Sbjct: 64 TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV 123
Query: 346 MDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE 405
+ + + L+Y+H IIHRD+K SN+ ++E+ L DFG A
Sbjct: 124 QFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKIL-DFGLARHTDDEMT--- 176
Query: 406 NVKPVNVVGTFGYLAPEYMM-YGKVDEKIDVYSYGVVLLELITGK 449
V T Y APE M+ + ++ +D++S G ++ EL+TG+
Sbjct: 177 -----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 77.5 bits (190), Expect = 3e-17
Identities = 30/200 (15%), Positives = 67/200 (33%), Gaps = 29/200 (14%)
Query: 259 LIGQGGNSKVYRTNHVDGQVAAVKVLK-----------CTNWSEEEVLREVELLSSIKHE 307
L+G+G S V+ VK K ++ + + +
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 308 NIVRIIGYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERM--DVAIGVAKALEYLHHTCDP 365
+ ++ G K +YA N + L + + +V + + + +H
Sbjct: 67 ALQKLQGLAVPK-VYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRG-- 123
Query: 366 PIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMM 425
I+H D+ N+L+SE + DF ++ + + V + T+
Sbjct: 124 -IVHGDLSQYNVLVSE--EGIWIIDFPQSVEVGEEGWREILERDVRNIITY--------- 171
Query: 426 YGKV-DEKIDVYSYGVVLLE 444
+ + + D+ S +L+
Sbjct: 172 FSRTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 480 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d2gm3a1 | 171 | Putative ethylene-responsive protein AT3g01520/F4P | 99.22 | |
| d2z3va1 | 135 | Hypothetical protein TTHA0895 {Thermus thermophilu | 99.02 | |
| d1mjha_ | 160 | "Hypothetical" protein MJ0577 {Archaeon Methanococ | 98.93 | |
| d1jmva_ | 140 | Universal stress protein A, UspA {Haemophilus infl | 98.82 | |
| d1tq8a_ | 147 | Hypothetical protein Rv1636 {Mycobacterium tubercu | 98.6 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.35 | |
| d1q77a_ | 138 | Hypothetical protein Aq_178 {Aquifex aeolicus [Tax | 98.09 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.91 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.39 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.28 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.89 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.19 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-48 Score=376.51 Aligned_cols=201 Identities=24% Similarity=0.396 Sum_probs=173.6
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc--cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEe
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e 327 (480)
.++|++.+.||+|+||+||+|.+ .+|+.||+|+++.... ..+.+.+|+++|++++||||+++++++.+++.+++|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 45799999999999999999977 5699999999976532 23568899999999999999999999999999999999
Q ss_pred cc-CCCHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccc
Q 011660 328 LL-NGSLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (480)
Q Consensus 328 ~~-~GsL~~~l~---~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (480)
|+ +|+|.+++. .+++.++..++.||++||.|||++ +||||||||+|||++++ +.+||+|||+|+......
T Consensus 84 y~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~-~~~KL~DFG~a~~~~~~~-- 157 (271)
T d1nvra_ 84 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDER-DNLKISDFGLATVFRYNN-- 157 (271)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTT-CCEEECCCTTCEECEETT--
T ss_pred ccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCC-CCEEEccchhheeeccCC--
Confidence 99 579999984 488999999999999999999999 99999999999999988 689999999997654322
Q ss_pred ccCccccccccCCCccccccccCCCC-CchHHHHHHHHHHHHHHcCCCCCCCCccc
Q 011660 404 SENVKPVNVVGTFGYLAPEYMMYGKV-DEKIDVYSYGVVLLELITGKEAIQTNKAN 458 (480)
Q Consensus 404 ~~~~~~~~~~GT~~y~APE~~~~~~~-~~k~DvwSlGvil~eLltG~~pf~~~~~~ 458 (480)
........+||+.|||||++.+..+ +.++|||||||+||||+||+.||......
T Consensus 158 -~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~ 212 (271)
T d1nvra_ 158 -RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 212 (271)
T ss_dssp -EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTT
T ss_pred -ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChH
Confidence 1222346789999999999988886 57899999999999999999999876543
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-46 Score=368.97 Aligned_cols=197 Identities=27% Similarity=0.434 Sum_probs=175.5
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCC-ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN-WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~ 329 (480)
++|++.+.||+|+||+||+|.+ .+|+.||+|+++... ...+.+.+|+++|+.++||||+++++++.+++.+++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 4699999999999999999976 569999999997543 34567899999999999999999999999999999999999
Q ss_pred -CCCHHHHHHh--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccC
Q 011660 330 -NGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSEN 406 (480)
Q Consensus 330 -~GsL~~~l~~--~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~ 406 (480)
+|+|.+++.. +++.++..++.||+.||.|||++ +||||||||+|||++.+ +++||+|||+|+..... .
T Consensus 100 ~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~-~~vkl~DFG~a~~~~~~-----~ 170 (293)
T d1yhwa1 100 AGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPE-----Q 170 (293)
T ss_dssp TTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT-CCEEECCCTTCEECCST-----T
T ss_pred CCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCC-CcEeeccchhheeeccc-----c
Confidence 6799998854 78899999999999999999999 99999999999999998 79999999999764332 2
Q ss_pred ccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 407 VKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 407 ~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
......+||+.|||||++.+..|+.++|||||||++|||+||+.||...+.
T Consensus 171 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~ 221 (293)
T d1yhwa1 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP 221 (293)
T ss_dssp CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH
Confidence 223456899999999999999999999999999999999999999987553
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-47 Score=368.48 Aligned_cols=194 Identities=29% Similarity=0.483 Sum_probs=173.3
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccC----CccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCT----NWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 326 (480)
++|++.+.||+|+||+||+|.+ .+++.||+|++.+. ....+.+.+|+++++.++||||+++++++.+++.+++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 4699999999999999999977 56899999998643 234567889999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccc
Q 011660 327 NLL-NGSLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 327 e~~-~GsL~~~l~---~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (480)
||+ +|+|.+++. .+++.++..++.||++||.|||++ +||||||||+|||++.+ +.+||+|||+|.....
T Consensus 86 Ey~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~-~~~kl~DFG~a~~~~~--- 158 (263)
T d2j4za1 86 EYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSA-GELKIADFGWSVHAPS--- 158 (263)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTT-SCEEECCCCSCSCCCC---
T ss_pred eecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCC-CCEeecccceeeecCC---
Confidence 999 679999985 388999999999999999999999 99999999999999998 6899999999965432
Q ss_pred cccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 403 ~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
......+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+
T Consensus 159 ----~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 208 (263)
T d2j4za1 159 ----SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 208 (263)
T ss_dssp ----CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ----CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC
Confidence 12335689999999999999999999999999999999999999997654
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-47 Score=381.14 Aligned_cols=197 Identities=30% Similarity=0.435 Sum_probs=173.9
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc--cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEe
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e 327 (480)
.++|++.+.||+|+||+||+|.+ .+|+.||+|+++.... ....+.+|+++|+.++||||++++++|.+++.+++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 56899999999999999999976 5689999999976532 34578899999999999999999999999999999999
Q ss_pred cc-CCCHHHHHH---hCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccc
Q 011660 328 LL-NGSLKQYLK---QLKWNERMDVAIGVAKALEYLHH-TCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 328 ~~-~GsL~~~l~---~~~~~~~~~i~~~ia~aL~yLH~-~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (480)
|+ +|+|.+++. .+++.++..++.|++.||.|||+ + +|+||||||+|||++.+ +++||+|||+|+.....
T Consensus 85 y~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~-~~vkl~DFGla~~~~~~-- 158 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS-- 158 (322)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTT-CCEEECCCCCCHHHHHH--
T ss_pred cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCC-CCEEEeeCCCccccCCC--
Confidence 99 579999995 48999999999999999999996 5 89999999999999998 78999999999754321
Q ss_pred cccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCccc
Q 011660 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKAN 458 (480)
Q Consensus 403 ~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~~ 458 (480)
...+.+||+.|||||++.+..|+.++|||||||++|||++|+.||...+..
T Consensus 159 -----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~ 209 (322)
T d1s9ja_ 159 -----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK 209 (322)
T ss_dssp -----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTT
T ss_pred -----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH
Confidence 223568999999999999999999999999999999999999999876543
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-47 Score=372.06 Aligned_cols=198 Identities=27% Similarity=0.422 Sum_probs=172.2
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccC----CccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCT----NWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 326 (480)
++|++.+.||+|+||+||+|.+ .+|+.||||++++. ....+.+.+|+++|++++||||+++++++.+++.+++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 4699999999999999999977 56999999999643 233467899999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccc
Q 011660 327 NLL-NGSLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 327 e~~-~GsL~~~l~---~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (480)
||+ +|+|.+++. .+++.++..++.|++.||.|||++ +||||||||+|||++++ +.+||+|||+|+......
T Consensus 88 Ey~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~-~~vkl~DFG~a~~~~~~~- 162 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNED-MHIQITDFGTAKVLSPES- 162 (288)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTT-SCEEECCCTTCEECC----
T ss_pred EccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCC-ceEEecccccceecccCC-
Confidence 999 579999885 488999999999999999999999 99999999999999998 789999999997654321
Q ss_pred cccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 403 ~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
........+||+.|||||++.+..|+.++|||||||+||||++|+.||...+
T Consensus 163 --~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~ 214 (288)
T d1uu3a_ 163 --KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 214 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred --cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC
Confidence 2223345689999999999999999999999999999999999999998754
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=366.25 Aligned_cols=199 Identities=27% Similarity=0.387 Sum_probs=160.7
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCccH---HHHHHHHHHHhcCCCCCeeeEEEEEec--CCeeEEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSE---EEVLREVELLSSIKHENIVRIIGYCHS--KEMYAIV 325 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~~---~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lV 325 (480)
++|++.+.||+|+||+||+|.+ .+|+.||+|+++...... +.+.+|+++|++++||||+++++++.+ ++.+++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 5799999999999999999976 569999999997765433 457899999999999999999999854 4678999
Q ss_pred Eecc-CCCHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhCC--CCCeEeccCCCCCEEEecCCCceEEeeecccc
Q 011660 326 YNLL-NGSLKQYLKQ-------LKWNERMDVAIGVAKALEYLHHTC--DPPIIHRDVKSSNILLSENFHHPQLSDFGAAM 395 (480)
Q Consensus 326 ~e~~-~GsL~~~l~~-------~~~~~~~~i~~~ia~aL~yLH~~~--~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~ 395 (480)
|||+ +|+|.+++.. +++.++..++.||+.||.|||+.. .++||||||||+|||++.+ +.+||+|||+|+
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~-~~vkl~DFG~a~ 162 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLAR 162 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTT-SCEEECCHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCC-CcEEEeecccee
Confidence 9999 6799999842 889999999999999999999862 1259999999999999998 789999999997
Q ss_pred ccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 396 VHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
..... .......+||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+
T Consensus 163 ~~~~~-----~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~ 218 (269)
T d2java1 163 ILNHD-----TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 218 (269)
T ss_dssp HC----------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ecccC-----CCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC
Confidence 64332 112335789999999999999999999999999999999999999998654
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-46 Score=360.97 Aligned_cols=195 Identities=23% Similarity=0.439 Sum_probs=164.9
Q ss_pred cCCCCceeecccCceEEEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc-C
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-N 330 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~-~ 330 (480)
++|++.+.||+|+||.||+|.+.+++.||||+++......+++.+|++++++++||||++++|+|.+++.+++||||+ +
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~ 84 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 84 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCC
Confidence 578899999999999999999988899999999887777889999999999999999999999999999999999999 7
Q ss_pred CCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccC
Q 011660 331 GSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSEN 406 (480)
Q Consensus 331 GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~ 406 (480)
|+|.+++.. +++..+..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||+|+.......
T Consensus 85 g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~-~~~Kl~DFGla~~~~~~~~---- 156 (263)
T d1sm2a_ 85 GCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQY---- 156 (263)
T ss_dssp CBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGG-GCEEECSCC--------------
T ss_pred CcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCC-CCeEecccchheeccCCCc----
Confidence 899999843 77899999999999999999999 99999999999999998 6899999999976543221
Q ss_pred ccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcC-CCCCCC
Q 011660 407 VKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITG-KEAIQT 454 (480)
Q Consensus 407 ~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG-~~pf~~ 454 (480)
.......||+.|+|||++.+..|+.++|||||||+||||+|| ++||..
T Consensus 157 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~ 205 (263)
T d1sm2a_ 157 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 205 (263)
T ss_dssp --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCC
Confidence 122345799999999999999999999999999999999995 555544
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-46 Score=366.02 Aligned_cols=197 Identities=27% Similarity=0.397 Sum_probs=171.9
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCC-ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN-WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~ 329 (480)
+.|++.+.||+|+||.||+|.+ .+++.||+|+++... ...+.+.+|+++|++++||||+++++++.+++.+++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 4589999999999999999976 568999999997653 33467899999999999999999999999999999999999
Q ss_pred -CCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccc
Q 011660 330 -NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (480)
Q Consensus 330 -~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (480)
+|+|.+++.+ +++.++..++.||+.||.|||++ +||||||||+|||++.+ +.+||+|||+|.......
T Consensus 92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~-~~~Kl~DFG~a~~~~~~~--- 164 (288)
T d2jfla1 92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTI--- 164 (288)
T ss_dssp TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT-SCEEECCCTTCEECHHHH---
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCC-CCEEEEechhhhccCCCc---
Confidence 6789998742 78999999999999999999999 99999999999999998 689999999996543211
Q ss_pred cCccccccccCCCcccccccc-----CCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 405 ENVKPVNVVGTFGYLAPEYMM-----YGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 405 ~~~~~~~~~GT~~y~APE~~~-----~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
......+||+.|||||++. ...|+.++|||||||+||||+||+.||.+.+.
T Consensus 165 --~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~ 220 (288)
T d2jfla1 165 --QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP 220 (288)
T ss_dssp --HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG
T ss_pred --ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH
Confidence 1223568999999999984 45689999999999999999999999987654
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-46 Score=362.23 Aligned_cols=197 Identities=31% Similarity=0.453 Sum_probs=164.2
Q ss_pred hcCCCCceeecccCceEEEEEEecCCcEEEEEEeccCCc---cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEe
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e 327 (480)
.++|.+.+.||+|+||+||+|... ..||||+++.... ..+.+.+|+++|++++||||+++++++.+ +.+++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 467999999999999999999763 3699999975432 34678899999999999999999999865 56789999
Q ss_pred cc-CCCHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccc
Q 011660 328 LL-NGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 328 ~~-~GsL~~~l~----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (480)
|+ +|+|.+++. .+++.++..++.||++||.|||++ +||||||||+|||++.+ +.+||+|||+|+.....
T Consensus 84 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~-~~~Kl~DFGla~~~~~~-- 157 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHED-LTVKIGDFGLATVKSRW-- 157 (276)
T ss_dssp CCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETT-SSEEECCCCCSCC------
T ss_pred cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCC-CCEEEccccceeecccc--
Confidence 99 589999994 378899999999999999999999 99999999999999998 68999999999765432
Q ss_pred cccCccccccccCCCccccccccC---CCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 403 VSENVKPVNVVGTFGYLAPEYMMY---GKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 403 ~~~~~~~~~~~GT~~y~APE~~~~---~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
..........||+.|||||++.+ +.|+.++|||||||+||||+||+.||.+.+.
T Consensus 158 -~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~ 214 (276)
T d1uwha_ 158 -SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 214 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred -CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh
Confidence 12223345689999999999864 4589999999999999999999999987654
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=370.58 Aligned_cols=197 Identities=23% Similarity=0.358 Sum_probs=175.9
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccC----CccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCT----NWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 326 (480)
++|++.+.||+|+||+||+|.+ .+|+.||+|++++. ....+.+.+|+++|+.++||||+++++++++++.+++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 5699999999999999999976 67999999999753 234567889999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccc
Q 011660 327 NLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 327 e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (480)
||+ +|+|.+++.. +++.++..++.||+.||+|||++ +||||||||+|||++.+ +++||+|||+|+....
T Consensus 85 ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~-g~vkl~DFG~a~~~~~--- 157 (337)
T d1o6la_ 85 EYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKD-GHIKITDFGLCKEGIS--- 157 (337)
T ss_dssp ECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTT-SCEEECCCTTCBCSCC---
T ss_pred eccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCC-CCEEEeeccccccccc---
Confidence 999 6889999854 78888999999999999999999 99999999999999998 7999999999975432
Q ss_pred cccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 403 ~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
........+||+.|||||++.+..|+.++|||||||+||||++|++||.+.+.
T Consensus 158 --~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~ 210 (337)
T d1o6la_ 158 --DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 210 (337)
T ss_dssp --TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred --CCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH
Confidence 12234467899999999999999999999999999999999999999987653
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-45 Score=357.83 Aligned_cols=191 Identities=30% Similarity=0.455 Sum_probs=163.3
Q ss_pred CCceeecccCceEEEEEEe-cCCcEEEEEEeccCCcc---HHHHHHHHHHHhcCCCCCeeeEEEEEec----CCeeEEEE
Q 011660 255 SPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHS----KEMYAIVY 326 (480)
Q Consensus 255 ~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~~lV~ 326 (480)
++.+.||+|+||+||+|.+ .+++.||+|++...... .+.+.+|+++|++++||||+++++++.+ ++.+++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 5666899999999999976 46889999998754332 3458899999999999999999999864 45689999
Q ss_pred ecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeccCCCCCEEEecCCCceEEeeeccccccccc
Q 011660 327 NLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPP--IIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (480)
Q Consensus 327 e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~--IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (480)
||+ +|+|.+++.+ +++.++..++.||++||+|||++ + ||||||||+|||++.+.+.+||+|||+|+....
T Consensus 92 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~- 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA- 167 (270)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT-
T ss_pred eCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC-
Confidence 999 6799999954 88899999999999999999998 6 999999999999975336899999999965322
Q ss_pred cccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 401 ~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
......+||+.|||||++.+ .|+.++|||||||+||||++|+.||....
T Consensus 168 ------~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~ 216 (270)
T d1t4ha_ 168 ------SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ 216 (270)
T ss_dssp ------TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS
T ss_pred ------CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcc
Confidence 12335689999999998865 69999999999999999999999997654
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=359.24 Aligned_cols=197 Identities=27% Similarity=0.420 Sum_probs=172.4
Q ss_pred hcCCCCceeecccCceEEEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc-
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL- 329 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~- 329 (480)
.++|++.+.||+|+||.||+|.+.+++.||||+++......+.+.+|+++|++++||||++++|++.+ +.+++||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~ 90 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME 90 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCC
Confidence 35688899999999999999998888999999998877778889999999999999999999998865 4568999999
Q ss_pred CCCHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccc
Q 011660 330 NGSLKQYLK-----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (480)
Q Consensus 330 ~GsL~~~l~-----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (480)
+|+|.+++. .+++.++..++.||++||.|||++ +|+||||||+||||+++ +.+||+|||+|+.......
T Consensus 91 ~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~-~~~Kl~DFGla~~~~~~~~-- 164 (272)
T d1qpca_ 91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDT-LSCKIADFGLARLIEDNEY-- 164 (272)
T ss_dssp TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTT-SCEEECCCTTCEECSSSCE--
T ss_pred CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecc-cceeeccccceEEccCCcc--
Confidence 789988773 489999999999999999999999 99999999999999998 6899999999986544221
Q ss_pred cCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 405 ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 405 ~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.......||+.|||||++.++.++.++|||||||+||||+||..|+....
T Consensus 165 --~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~ 214 (272)
T d1qpca_ 165 --TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 214 (272)
T ss_dssp --ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred --ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCC
Confidence 12234579999999999999999999999999999999999666554443
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.1e-46 Score=367.74 Aligned_cols=198 Identities=24% Similarity=0.376 Sum_probs=159.4
Q ss_pred hhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc--cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEE
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 326 (480)
+.+.|++.+.||+|+||+||+|.+ .+++.||||++.+... ....+.+|+++|+.++||||+++++++.+++.+++||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 456799999999999999999977 4689999999976542 2345789999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEec--CCCceEEeeeccccccccc
Q 011660 327 NLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSE--NFHHPQLSDFGAAMVHHQS 400 (480)
Q Consensus 327 e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~--~~~~~kL~DFGla~~~~~~ 400 (480)
||+ +|+|.+++.. +++.++..++.||+.||.|||++ +||||||||+|||+.. +.+.+||+|||+|+.....
T Consensus 87 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~ 163 (307)
T d1a06a_ 87 QLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 163 (307)
T ss_dssp CCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred eccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence 999 5899999954 89999999999999999999999 9999999999999953 2268999999999754322
Q ss_pred cccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 401 ~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
....+.+||+.|||||++.+..|++++|||||||+||||++|+.||.+..
T Consensus 164 ------~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~ 213 (307)
T d1a06a_ 164 ------SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN 213 (307)
T ss_dssp ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ------CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC
Confidence 22345689999999999999999999999999999999999999998754
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.8e-46 Score=364.07 Aligned_cols=198 Identities=28% Similarity=0.445 Sum_probs=174.9
Q ss_pred hcCCCCceeecccCceEEEEEEec-CCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~ 329 (480)
.++|++.+.||+|+||+||+|.+. +++.||||+++.+....+++.+|+++|++++||||++++++|.+++.+++||||+
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~ 95 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 95 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecc
Confidence 457888999999999999999874 5889999999887777888999999999999999999999999999999999999
Q ss_pred -CCCHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccc
Q 011660 330 -NGSLKQYLK-----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (480)
Q Consensus 330 -~GsL~~~l~-----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (480)
+|+|.+++. .+++..+..++.||+.||.|||++ +||||||||+||||+.+ +.+||+|||+|+......
T Consensus 96 ~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~-~~~Kl~DFG~a~~~~~~~-- 169 (287)
T d1opja_ 96 TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDT-- 169 (287)
T ss_dssp TTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGG-GCEEECCCCCTTTCCSSS--
T ss_pred cCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCC-CcEEEccccceeecCCCC--
Confidence 689999984 368889999999999999999999 99999999999999998 689999999997654322
Q ss_pred ccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 404 SENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 404 ~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
........||+.|+|||++.+..|+.++|||||||++|||++|..||....
T Consensus 170 --~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~ 220 (287)
T d1opja_ 170 --YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 220 (287)
T ss_dssp --SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred --ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc
Confidence 112234568999999999999999999999999999999999877765544
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.2e-45 Score=365.65 Aligned_cols=193 Identities=29% Similarity=0.414 Sum_probs=172.3
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccC----CccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCT----NWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 326 (480)
++|++.+.||+|+||+||+|.+ .+|+.||||++++. ....+.+.+|+.+|+.++||||+++++++.+++.+++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 4699999999999999999987 56999999999643 233467889999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccc
Q 011660 327 NLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 327 e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (480)
||+ +|+|..++.. +.+..+..++.||+.||.|||++ +||||||||+|||++.+ +++||+|||+|+....
T Consensus 84 E~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~-g~vkL~DFG~a~~~~~--- 156 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKN-GHIKITDFGFAKYVPD--- 156 (316)
T ss_dssp CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTT-SCEEECCCSSCEECSS---
T ss_pred eecCCccccccccccccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCC-CCEEEecCccceEecc---
Confidence 999 6788888853 67888888999999999999999 99999999999999998 7999999999976433
Q ss_pred cccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 403 ~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.....+||+.|||||++.+..|+.++|||||||+||||+||+.||.+.+
T Consensus 157 -----~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~ 205 (316)
T d1fota_ 157 -----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN 205 (316)
T ss_dssp -----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred -----ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC
Confidence 2235689999999999999999999999999999999999999998754
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-45 Score=354.06 Aligned_cols=198 Identities=24% Similarity=0.439 Sum_probs=178.6
Q ss_pred cCCCCceeecccCceEEEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc-C
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-N 330 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~-~ 330 (480)
++|++.+.||+|+||+||+|.+.+++.||||++++.....+++.+|++++++++||||++++|+|.+++.+++||||+ +
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~ 83 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN 83 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCC
Confidence 679999999999999999999988999999999988878889999999999999999999999999999999999999 6
Q ss_pred CCHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccC
Q 011660 331 GSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSEN 406 (480)
Q Consensus 331 GsL~~~l~----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~ 406 (480)
|+|.+++. .+.+..+..++.|+++||.|||+. +|+||||||+|||++.+ +.+||+|||+|+.......
T Consensus 84 g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~-~~~kl~DfG~a~~~~~~~~---- 155 (258)
T d1k2pa_ 84 GCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQ-GVVKVSDFGLSRYVLDDEY---- 155 (258)
T ss_dssp EEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTT-CCEEECCCSSCCBCSSSSC----
T ss_pred CcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCC-CcEEECcchhheeccCCCc----
Confidence 88998873 478889999999999999999999 99999999999999998 6899999999976543221
Q ss_pred ccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCcc
Q 011660 407 VKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKA 457 (480)
Q Consensus 407 ~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~~ 457 (480)
.......||+.|+|||++.+..++.++|||||||++|||+| |+.||...+.
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~ 207 (258)
T d1k2pa_ 156 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN 207 (258)
T ss_dssp CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH
T ss_pred eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH
Confidence 22334679999999999999999999999999999999998 8999987653
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=356.41 Aligned_cols=198 Identities=25% Similarity=0.384 Sum_probs=174.4
Q ss_pred hhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc-------cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCe
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW-------SEEEVLREVELLSSIKHENIVRIIGYCHSKEM 321 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~-------~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 321 (480)
+.++|++.+.||+|+||+||+|.+ .+|+.||||++++... ..+.+.+|+++|++++||||+++++++.+++.
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 346799999999999999999987 5699999999965421 34678999999999999999999999999999
Q ss_pred eEEEEecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCC---ceEEeeeccc
Q 011660 322 YAIVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFH---HPQLSDFGAA 394 (480)
Q Consensus 322 ~~lV~e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~---~~kL~DFGla 394 (480)
+++||||+ +|+|.+++.. +++.++..++.|++.||.|||+. +|+||||||+|||++.+.. .+||+|||+|
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhhh
Confidence 99999999 6799999853 89999999999999999999999 9999999999999987621 5999999999
Q ss_pred cccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 395 MVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
...... .......||+.|+|||++.+..++.++|||||||+||||++|+.||.+.+
T Consensus 165 ~~~~~~------~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~ 220 (293)
T d1jksa_ 165 HKIDFG------NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 220 (293)
T ss_dssp EECTTS------CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred hhcCCC------ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC
Confidence 764332 22345679999999999999999999999999999999999999998754
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.7e-45 Score=362.27 Aligned_cols=202 Identities=24% Similarity=0.408 Sum_probs=159.6
Q ss_pred cCCCCceeecccCceEEEEEEec-CCc---EEEEEEeccCCcc--HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHV-DGQ---VAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~---~vAvK~~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 325 (480)
++|++.+.||+|+||+||+|.+. +++ .+|||.+...... .+.+.+|+++|++++||||++++|+|.+++.+++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 45778899999999999999763 333 6889988654432 35689999999999999999999999999999999
Q ss_pred Eecc-CCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccc
Q 011660 326 YNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (480)
Q Consensus 326 ~e~~-~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (480)
|||+ +|+|.+++.. +++.++..++.||++||.|||++ +||||||||+||||+.+ +++||+|||+|+.....
T Consensus 106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~-~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSN-LVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTT-CCEEECCC---------
T ss_pred EEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCC-CcEEECCcccceEccCC
Confidence 9999 6789998853 78999999999999999999999 99999999999999998 68999999999876543
Q ss_pred cccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCcc
Q 011660 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKA 457 (480)
Q Consensus 401 ~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~~ 457 (480)
.............||+.|||||++.++.++.++|||||||+||||+| |+.||.....
T Consensus 182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~ 239 (299)
T d1jpaa_ 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN 239 (299)
T ss_dssp --------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred CCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH
Confidence 33323333334568999999999999999999999999999999998 8999987653
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.1e-44 Score=365.38 Aligned_cols=197 Identities=22% Similarity=0.326 Sum_probs=174.0
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCcc-HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEec
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS-EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~-~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~ 328 (480)
.++|++.+.||+|+||.||+|.+ .+|+.||||++...... .+.+.+|+++|++++||||+++++++.+++.+++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 45799999999999999999976 56999999999765533 35688999999999999999999999999999999999
Q ss_pred c-CCCHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecC-CCceEEeeeccccccccccc
Q 011660 329 L-NGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN-FHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 329 ~-~GsL~~~l~----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~-~~~~kL~DFGla~~~~~~~~ 402 (480)
+ +|+|.+++. .+++.++..++.||+.||.|||++ +||||||||+|||++.+ .+.+||+|||+|+....
T Consensus 105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~--- 178 (350)
T d1koaa2 105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP--- 178 (350)
T ss_dssp CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT---
T ss_pred CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccc---
Confidence 9 689999983 388999999999999999999999 99999999999999643 26899999999976433
Q ss_pred cccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 403 ~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.......+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+
T Consensus 179 ---~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 229 (350)
T d1koaa2 179 ---KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN 229 (350)
T ss_dssp ---TSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ---ccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC
Confidence 222345689999999999999999999999999999999999999998654
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-44 Score=359.17 Aligned_cols=192 Identities=31% Similarity=0.445 Sum_probs=167.6
Q ss_pred CCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCccH----HHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEe
Q 011660 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSE----EEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~~----~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e 327 (480)
.|+..+.||+|+||.||+|.+ .+++.||||+++...... +.+.+|+++|++++||||+++++++.+++.+++|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 488999999999999999976 568999999997655332 457899999999999999999999999999999999
Q ss_pred ccC-CCHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccc
Q 011660 328 LLN-GSLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (480)
Q Consensus 328 ~~~-GsL~~~l~---~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (480)
|+. |+|..++. .+++.++..++.||+.||.|||++ +||||||||+|||++.+ +.+||+|||+|.....
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~-~~~Kl~DFG~a~~~~~---- 167 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEP-GLVKLGDFGSASIMAP---- 167 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETT-TEEEECCCTTCBSSSS----
T ss_pred ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCC-CCEEEeecccccccCC----
Confidence 995 55665553 489999999999999999999999 99999999999999998 7999999999965332
Q ss_pred ccCccccccccCCCccccccccC---CCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 404 SENVKPVNVVGTFGYLAPEYMMY---GKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 404 ~~~~~~~~~~GT~~y~APE~~~~---~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
....+||+.|||||++.+ +.|+.++|||||||++|||++|+.||.+.+.
T Consensus 168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~ 219 (309)
T d1u5ra_ 168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 219 (309)
T ss_dssp -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH
Confidence 224579999999999864 4689999999999999999999999987543
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=9.8e-45 Score=366.05 Aligned_cols=197 Identities=19% Similarity=0.276 Sum_probs=173.6
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc-cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEec
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW-SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~ 328 (480)
.++|++.+.||+|+||.||+|.+ .+|+.||||+++.... ....+.+|+++|++++||||+++++++.+++.+++||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 35799999999999999999976 5799999999976553 234578999999999999999999999999999999999
Q ss_pred c-CCCHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEec-CCCceEEeeeccccccccccc
Q 011660 329 L-NGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSE-NFHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 329 ~-~GsL~~~l~----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~-~~~~~kL~DFGla~~~~~~~~ 402 (480)
+ +|+|.+++. .+++.++..++.||+.||.|||++ +||||||||+|||++. +.+.+||+|||+|.....
T Consensus 108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~--- 181 (352)
T d1koba_ 108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP--- 181 (352)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT---
T ss_pred CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCC---
Confidence 9 689988874 378999999999999999999999 9999999999999973 236899999999976443
Q ss_pred cccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 403 ~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
........||+.|||||++.+..|+.++|||||||+||||+||+.||.+.+
T Consensus 182 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 232 (352)
T d1koba_ 182 ---DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED 232 (352)
T ss_dssp ---TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred ---CCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 223345689999999999999999999999999999999999999998754
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-44 Score=365.26 Aligned_cols=193 Identities=23% Similarity=0.338 Sum_probs=173.2
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccC----CccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCT----NWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 326 (480)
++|++.+.||+|+||.||+|.+ .+|+.||||++++. ....+.+.+|+++|+.++||||+++++++.+.+.+++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 5799999999999999999977 57999999999643 233467889999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccc
Q 011660 327 NLL-NGSLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 327 e~~-~GsL~~~l~---~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (480)
||+ +|+|.+++. .+++.++..++.||+.||.|||++ +||||||||+|||++.+ +++||+|||+|+....
T Consensus 121 e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~-g~ikL~DFG~a~~~~~--- 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKG--- 193 (350)
T ss_dssp ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT-SCEEECCCTTCEECSS---
T ss_pred ccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCC-CCEEeeeceeeeeccc---
Confidence 999 678988884 488999999999999999999999 99999999999999998 7999999999976432
Q ss_pred cccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 403 ~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.....+||+.|||||++.+..|+.++|||||||+||||+||+.||.+.+
T Consensus 194 -----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~ 242 (350)
T d1rdqe_ 194 -----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242 (350)
T ss_dssp -----CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred -----ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC
Confidence 2235689999999999999999999999999999999999999998654
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-44 Score=360.10 Aligned_cols=200 Identities=27% Similarity=0.453 Sum_probs=170.3
Q ss_pred cCCCCceeecccCceEEEEEEecC-C-----cEEEEEEeccCC--ccHHHHHHHHHHHhcC-CCCCeeeEEEEEecCCee
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHVD-G-----QVAAVKVLKCTN--WSEEEVLREVELLSSI-KHENIVRIIGYCHSKEMY 322 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~~-g-----~~vAvK~~~~~~--~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 322 (480)
++|++.+.||+|+||+||+|.+.. + ..||+|.+.... .....+.+|+.+|+++ +||||++++++|.+.+.+
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 568899999999999999997532 2 369999986543 2335688999999988 899999999999999999
Q ss_pred EEEEecc-CCCHHHHHHh--------------------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCC
Q 011660 323 AIVYNLL-NGSLKQYLKQ--------------------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSS 375 (480)
Q Consensus 323 ~lV~e~~-~GsL~~~l~~--------------------------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~ 375 (480)
++||||+ +|+|.++|.. +++.++..++.||++||.|||++ +||||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchh
Confidence 9999999 7899999843 67888999999999999999999 9999999999
Q ss_pred CEEEecCCCceEEeeeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCC
Q 011660 376 NILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQT 454 (480)
Q Consensus 376 NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~ 454 (480)
|||++.+ +++||+|||+|+...... ......+..||+.|||||++.++.|+.++|||||||+||||+| |+.||.+
T Consensus 194 Nill~~~-~~~Kl~DFGla~~~~~~~---~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~ 269 (325)
T d1rjba_ 194 NVLVTHG-KVVKICDFGLARDIMSDS---NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 269 (325)
T ss_dssp GEEEETT-TEEEECCCGGGSCGGGCT---TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred ccccccC-CeEEEeeccccccccCCC---ceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCC
Confidence 9999998 799999999997644322 1222335678999999999999999999999999999999998 8999987
Q ss_pred Cccc
Q 011660 455 NKAN 458 (480)
Q Consensus 455 ~~~~ 458 (480)
.+..
T Consensus 270 ~~~~ 273 (325)
T d1rjba_ 270 IPVD 273 (325)
T ss_dssp CCCS
T ss_pred CCHH
Confidence 6543
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-44 Score=354.93 Aligned_cols=209 Identities=25% Similarity=0.403 Sum_probs=177.7
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccC----CccHHHHHHHHHHHh-cCCCCCeeeEEEEEecCCeeEEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCT----NWSEEEVLREVELLS-SIKHENIVRIIGYCHSKEMYAIV 325 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~----~~~~~~~~~Ei~il~-~l~HpnIv~l~~~~~~~~~~~lV 325 (480)
++|.+.+.||+|+||+||+|.+ .+++.||||++++. ....+.+..|..++. .++||||+++++++.+++.+|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 4799999999999999999977 56999999999643 233456777777765 68999999999999999999999
Q ss_pred Eecc-CCCHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccc
Q 011660 326 YNLL-NGSLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (480)
Q Consensus 326 ~e~~-~GsL~~~l~---~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (480)
|||+ +|+|.+++. .+++.++..++.||+.||+|||++ +||||||||+|||++++ +++||+|||+|+.....
T Consensus 82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~-~~~kl~DFG~a~~~~~~- 156 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKD-GHIKIADFGMCKENMLG- 156 (320)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTT-SCEEECCCTTCBCCCCT-
T ss_pred EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCC-Cceeccccchhhhcccc-
Confidence 9999 679999995 488899999999999999999999 99999999999999998 79999999999754321
Q ss_pred ccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHhCCC
Q 011660 402 QVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWYYVLAGKV 473 (480)
Q Consensus 402 ~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~~~e~l~~~~~~~~~~~ 473 (480)
.......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+.. .++.+...+.+
T Consensus 157 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~----~~~~~i~~~~~ 220 (320)
T d1xjda_ 157 ----DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE----ELFHSIRMDNP 220 (320)
T ss_dssp ----TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHCCC
T ss_pred ----cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH----HHHHHHHcCCC
Confidence 22334568999999999999999999999999999999999999999876532 24555555543
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5.1e-44 Score=362.47 Aligned_cols=195 Identities=30% Similarity=0.451 Sum_probs=168.4
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc----cHHHHHH---HHHHHhcCCCCCeeeEEEEEecCCeeE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLR---EVELLSSIKHENIVRIIGYCHSKEMYA 323 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~----~~~~~~~---Ei~il~~l~HpnIv~l~~~~~~~~~~~ 323 (480)
++|++.++||+|+||.||+|.+ .+|+.||||++.+... ....+.+ |+++++.++||||+++++++.+++.+|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 5799999999999999999977 5699999999864321 2223334 477788889999999999999999999
Q ss_pred EEEecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccc
Q 011660 324 IVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (480)
Q Consensus 324 lV~e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~ 399 (480)
+||||+ +|+|.+++.. +.+.++..++.||+.||.|||++ +||||||||+|||++.+ +.+||+|||+|+....
T Consensus 84 ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~-g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEH-GHVRISDLGLACDFSK 159 (364)
T ss_dssp EEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-SCEEECCCTTCEECSS
T ss_pred EEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCC-CcEEEeeeceeeecCC
Confidence 999999 6899999954 78889999999999999999999 99999999999999998 7899999999975433
Q ss_pred ccccccCccccccccCCCccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 400 SHQVSENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 400 ~~~~~~~~~~~~~~GT~~y~APE~~~~-~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
. .....+||+.|||||++.. ..|+.++|||||||+||||+||+.||.....
T Consensus 160 ~-------~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~ 211 (364)
T d1omwa3 160 K-------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 211 (364)
T ss_dssp S-------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCS
T ss_pred C-------cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCH
Confidence 2 2335689999999999975 5689999999999999999999999987654
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-44 Score=351.24 Aligned_cols=198 Identities=25% Similarity=0.439 Sum_probs=168.2
Q ss_pred cCCCCcee-ecccCceEEEEEEec---CCcEEEEEEeccCCc--cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEE
Q 011660 252 HNFSPKML-IGQGGNSKVYRTNHV---DGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (480)
Q Consensus 252 ~~f~~~~~-LG~G~fg~Vy~~~~~---~g~~vAvK~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 325 (480)
++|.+... ||+|+||.||+|.+. ++..||||+++.... ..+.+.+|+++|++++||||++++|+|.++ .+++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eEEEE
Confidence 45666664 999999999999653 355799999976542 235689999999999999999999999764 57899
Q ss_pred Eecc-CCCHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccc
Q 011660 326 YNLL-NGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (480)
Q Consensus 326 ~e~~-~GsL~~~l~----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (480)
|||+ +|+|.+++. .+++.++..++.||++||.|||++ +||||||||+|||++.+ +.+||+|||+|+.....
T Consensus 87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~-~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNR-HYAKISDFGLSKALGAD 162 (285)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEET-TEEEECCCTTCEECTTC
T ss_pred EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccC-Cceeeccchhhhccccc
Confidence 9999 579999983 378999999999999999999999 99999999999999998 69999999999865443
Q ss_pred cccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 401 ~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
... ........||+.|||||++.++.++.++|||||||++|||+| |+.||...+
T Consensus 163 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~ 217 (285)
T d1u59a_ 163 DSY--YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 217 (285)
T ss_dssp SCE--ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ccc--cccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCC
Confidence 221 122234579999999999999999999999999999999998 999998765
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-44 Score=355.44 Aligned_cols=199 Identities=20% Similarity=0.281 Sum_probs=176.2
Q ss_pred hhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEec
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~ 328 (480)
+.++|++.+.||+|+||+||+|.+ .+++.||+|+++........+.+|+++|+.++||||+++++++++++.+|+||||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 456899999999999999999977 5689999999987776666788999999999999999999999999999999999
Q ss_pred c-CCCHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecC-CCceEEeeeccccccccccc
Q 011660 329 L-NGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN-FHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 329 ~-~GsL~~~l~----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~-~~~~kL~DFGla~~~~~~~~ 402 (480)
+ +|+|.+++. .+++.++..++.||+.||.|||++ +|+||||||+|||++.+ ...+||+|||+++....
T Consensus 83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~--- 156 (321)
T d1tkia_ 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP--- 156 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT---
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhcccc---
Confidence 9 579999995 378999999999999999999999 99999999999999754 24799999999965432
Q ss_pred cccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 403 ~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
........||+.|+|||.+.+..|+.++|||||||++|||++|+.||...+.
T Consensus 157 ---~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~ 208 (321)
T d1tkia_ 157 ---GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN 208 (321)
T ss_dssp ---TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred ---CCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH
Confidence 1223456799999999999999999999999999999999999999987653
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-44 Score=350.21 Aligned_cols=193 Identities=27% Similarity=0.463 Sum_probs=161.2
Q ss_pred eeecccCceEEEEEEecC---CcEEEEEEeccCCcc---HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc-C
Q 011660 258 MLIGQGGNSKVYRTNHVD---GQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-N 330 (480)
Q Consensus 258 ~~LG~G~fg~Vy~~~~~~---g~~vAvK~~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~-~ 330 (480)
+.||+|+||+||+|.+.+ ++.||||+++..... .+.+.+|+++|++++||||++++|+|+++ .+++||||+ +
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence 579999999999997533 568999999754322 35689999999999999999999999764 568999999 6
Q ss_pred CCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccCc
Q 011660 331 GSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV 407 (480)
Q Consensus 331 GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~ 407 (480)
|+|.+++.. +++.++..++.||+.||.|||++ +||||||||+|||++.+ +.+||+|||+|+........ ..
T Consensus 92 g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~-~~~kl~DFGla~~~~~~~~~--~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQ-HYAKISDFGLSKALRADENY--YK 165 (277)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEET-TEEEECCCTTCEECCTTCSE--EE
T ss_pred CcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhccccc-Ccccccchhhhhhccccccc--cc
Confidence 799999954 88999999999999999999999 99999999999999998 79999999999765432211 12
Q ss_pred cccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCcc
Q 011660 408 KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKA 457 (480)
Q Consensus 408 ~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~~ 457 (480)
......||+.|||||++.+..++.++|||||||++|||+| |+.||.+.+.
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~ 216 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 216 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH
Confidence 2234579999999999999999999999999999999998 8999987653
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-44 Score=350.83 Aligned_cols=213 Identities=28% Similarity=0.425 Sum_probs=172.3
Q ss_pred CceeecccCceEEEEEEe-cCCcEEEEEEeccCCcc------HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEec
Q 011660 256 PKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS------EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (480)
Q Consensus 256 ~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~------~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~ 328 (480)
.+++||+|+||+||+|.+ .+|+.||||+++..... .+.+.+|+++|+.++||||+++++++.+++.+++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 357899999999999976 56999999999754322 23578999999999999999999999999999999999
Q ss_pred cCCCHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccc
Q 011660 329 LNGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (480)
Q Consensus 329 ~~GsL~~~l~----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (480)
+.|++...+. .+++.++..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~-~~~KL~DFG~a~~~~~~---- 153 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSP---- 153 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTT-CCEEECCCGGGSTTTSC----
T ss_pred hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCC-CccccccCccccccCCC----
Confidence 9776655553 378889999999999999999999 99999999999999998 78999999999654332
Q ss_pred cCccccccccCCCccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHhCCCCCCCCC
Q 011660 405 ENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWYYVLAGKVFAQQWP 479 (480)
Q Consensus 405 ~~~~~~~~~GT~~y~APE~~~~~-~~~~k~DvwSlGvil~eLltG~~pf~~~~~~~e~l~~~~~~~~~~~~~~~~~ 479 (480)
.......+||+.|+|||++... .|+.++|||||||++|||+||++||...+.. +.+ .-.....+.+..+.||
T Consensus 154 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~-~~l-~~i~~~~~~~~~~~~~ 226 (299)
T d1ua2a_ 154 -NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL-DQL-TRIFETLGTPTEEQWP 226 (299)
T ss_dssp -CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHH-HHHHHHHCCCCTTTSS
T ss_pred -cccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHH-HHH-HHHHHhcCCCChhhcc
Confidence 1223356899999999988754 5799999999999999999999999876532 222 2233455666666665
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=7.1e-44 Score=347.99 Aligned_cols=201 Identities=28% Similarity=0.411 Sum_probs=165.1
Q ss_pred hhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCcc----HHHHHHHHHHHhcCCCCCeeeEEEEEecCC----
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS----EEEVLREVELLSSIKHENIVRIIGYCHSKE---- 320 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~----~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~---- 320 (480)
+.++|++.+.||+|+||.||+|.+ .+|+.||||++++.... ...+.+|+++|+.++||||+++++++...+
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence 456799999999999999999976 57999999999765432 245889999999999999999999987543
Q ss_pred eeEEEEecc-CCCHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccc
Q 011660 321 MYAIVYNLL-NGSLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMV 396 (480)
Q Consensus 321 ~~~lV~e~~-~GsL~~~l~---~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~ 396 (480)
.+|+||||+ +|+|.+++. .+++.++..++.||+.||.|||++ +||||||||+|||++.+ +..+|+|||.+..
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~-~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISAT-NAVKVMDFGIARA 160 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETT-SCEEECCCTTCEE
T ss_pred eEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCcc-ccceeehhhhhhh
Confidence 488999999 578998885 489999999999999999999999 99999999999999998 6899999999865
Q ss_pred cccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 397 HHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 397 ~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
..... .........+||+.|||||++.+..+++++|||||||+||||+||+.||...+
T Consensus 161 ~~~~~--~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 218 (277)
T d1o6ya_ 161 IADSG--NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS 218 (277)
T ss_dssp CC------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred hcccc--ccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC
Confidence 43322 12233446789999999999999999999999999999999999999998754
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-44 Score=349.56 Aligned_cols=200 Identities=28% Similarity=0.444 Sum_probs=168.9
Q ss_pred cCCCCceeecccCceEEEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEecc-C
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-N 330 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~-~ 330 (480)
++|++.+.||+|+||+||+|.+.+++.||||+++......+.+.+|+.++++++||||++++|+|.++ .+++||||+ +
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~-~~~lv~Ey~~~ 95 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSK 95 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCEEEECCCTT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEecC-CeEEEEEecCC
Confidence 46899999999999999999988888999999988877788899999999999999999999999654 578999999 6
Q ss_pred CCHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccccc
Q 011660 331 GSLKQYLK-----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE 405 (480)
Q Consensus 331 GsL~~~l~-----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~ 405 (480)
|+|.+++. .+++.++..++.||+.||.|||++ +|+||||||+||||+.+ +++||+|||+|+......
T Consensus 96 g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~-~~~kl~DfGla~~~~~~~---- 167 (285)
T d1fmka3 96 GSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGEN-LVCKVADFGLARLIEDNE---- 167 (285)
T ss_dssp CBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGG-GCEEECCCCTTC----------
T ss_pred CchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCC-CcEEEcccchhhhccCCC----
Confidence 88888873 389999999999999999999999 99999999999999998 689999999997654322
Q ss_pred CccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcccch
Q 011660 406 NVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRE 460 (480)
Q Consensus 406 ~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~~~e 460 (480)
........||+.|+|||++..+.++.++|||||||+||||+||..||.......+
T Consensus 168 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~ 222 (285)
T d1fmka3 168 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE 222 (285)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH
T ss_pred ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHH
Confidence 1223346799999999999999999999999999999999997777666554433
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-43 Score=347.75 Aligned_cols=199 Identities=25% Similarity=0.393 Sum_probs=161.0
Q ss_pred cCCCCceeecccCceEEEEEEecC-C----cEEEEEEeccCCcc--HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHVD-G----QVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAI 324 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~~-g----~~vAvK~~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 324 (480)
+.|+..++||+|+||.||+|.+.+ + ..||||+++..... ..++.+|+++|++++||||++++|+|.+.+.+++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 468889999999999999997643 2 47999999755432 3468899999999999999999999999999999
Q ss_pred EEecc-CCCHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccc
Q 011660 325 VYNLL-NGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (480)
Q Consensus 325 V~e~~-~GsL~~~l~----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~ 399 (480)
||||+ +|++.+++. .+++.++..++.||+.||.|||+. +||||||||+||||+.+ +.+||+|||+|+....
T Consensus 87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~-~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSN-LVCKVSDFGLSRVLED 162 (283)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTT-CCEEECCCCC------
T ss_pred EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCC-CeEEEcccchhhcccC
Confidence 99999 567777763 388999999999999999999999 99999999999999999 6899999999976544
Q ss_pred ccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 400 SHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 400 ~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.... ........||+.|||||++.++.++.++|||||||+||||++|..||....
T Consensus 163 ~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~ 217 (283)
T d1mqba_ 163 DPEA--TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL 217 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred CCcc--ceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC
Confidence 2211 122234568999999999999999999999999999999999766665544
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.2e-43 Score=343.60 Aligned_cols=196 Identities=31% Similarity=0.509 Sum_probs=172.1
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCcc----------HHHHHHHHHHHhcCC-CCCeeeEEEEEec
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS----------EEEVLREVELLSSIK-HENIVRIIGYCHS 318 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~----------~~~~~~Ei~il~~l~-HpnIv~l~~~~~~ 318 (480)
.++|++.+.||+|+||+||+|.+ .+|+.||||++++.... .+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 46799999999999999999976 57999999999765422 134789999999997 9999999999999
Q ss_pred CCeeEEEEecc-CCCHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccc
Q 011660 319 KEMYAIVYNLL-NGSLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA 394 (480)
Q Consensus 319 ~~~~~lV~e~~-~GsL~~~l~---~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla 394 (480)
++.+|+||||+ +|+|.++++ .+++.++..++.||++||.|||++ +|+||||||+|||++.+ +.+||+|||+|
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~-~~~kl~DFG~a 157 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDD-MNIKLTDFGFS 157 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTT-CCEEECCCTTC
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCC-CCeEEccchhe
Confidence 99999999999 679999995 389999999999999999999999 99999999999999998 78999999999
Q ss_pred cccccccccccCccccccccCCCcccccccc------CCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 395 MVHHQSHQVSENVKPVNVVGTFGYLAPEYMM------YGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~------~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
+.... .......+||+.|+|||++. ...++.++||||+||+||||++|+.||.+.+
T Consensus 158 ~~~~~------~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~ 219 (277)
T d1phka_ 158 CQLDP------GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 219 (277)
T ss_dssp EECCT------TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eEccC------CCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC
Confidence 76543 22234568999999999885 3457899999999999999999999998765
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-43 Score=347.23 Aligned_cols=197 Identities=25% Similarity=0.451 Sum_probs=170.6
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc---cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEe
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e 327 (480)
++|++.+.||+|+||+||+|.+ .+|+.||+|+++.... ..+.+.+|+++|++++||||+++++++.+++.+++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 4799999999999999999976 6799999999965432 24578899999999999999999999999999999999
Q ss_pred ccCCCHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccc
Q 011660 328 LLNGSLKQYLK-----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 328 ~~~GsL~~~l~-----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (480)
|++|++.+++. .+++.++..++.||+.||.|||++ +||||||||+|||++.+ +.+||+|||+|+.....
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~-~~~kl~DFG~a~~~~~~-- 155 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVP-- 155 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTT-SCEEECSTTHHHHHCCC--
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeeccc-CcceeccCCcceeccCC--
Confidence 99888777763 378999999999999999999999 99999999999999988 68999999999764332
Q ss_pred cccCccccccccCCCccccccccCCCC-CchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 403 VSENVKPVNVVGTFGYLAPEYMMYGKV-DEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 403 ~~~~~~~~~~~GT~~y~APE~~~~~~~-~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
........||+.|+|||.+....+ +.++|||||||++|||++|+.||.+.+.
T Consensus 156 ---~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~ 208 (298)
T d1gz8a_ 156 ---VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE 208 (298)
T ss_dssp ---SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ---cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCH
Confidence 223345679999999998877664 8999999999999999999999987653
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-43 Score=351.37 Aligned_cols=199 Identities=24% Similarity=0.444 Sum_probs=163.0
Q ss_pred cCCCCceeecccCceEEEEEEec-CCc----EEEEEEeccCC--ccHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHV-DGQ----VAAVKVLKCTN--WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAI 324 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~----~vAvK~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 324 (480)
++|++.+.||+|+||+||+|.+. +|+ .||+|.++... ...+.+.+|++++++++||||++++|+|.+++.+++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~v 88 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 88 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeeEE
Confidence 46999999999999999999763 454 58888886432 345679999999999999999999999998776665
Q ss_pred EEeccCCCHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccc
Q 011660 325 VYNLLNGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (480)
Q Consensus 325 V~e~~~GsL~~~l~----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (480)
++++.+|+|.+++. .+++.++..++.||+.||.|||++ +||||||||+|||++.+ +++||+|||+|+.....
T Consensus 89 ~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~-~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 89 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTP-QHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEET-TEEEECCCSHHHHTTTT
T ss_pred EEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCC-CCeEeeccccceecccc
Confidence 55555899988874 378899999999999999999999 99999999999999999 68999999999765432
Q ss_pred cccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCcc
Q 011660 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKA 457 (480)
Q Consensus 401 ~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~~ 457 (480)
. .........||+.|||||++.++.|+.++|||||||+||||+| |++||...+.
T Consensus 165 ~---~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~ 219 (317)
T d1xkka_ 165 E---KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 219 (317)
T ss_dssp C---C--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG
T ss_pred c---ccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH
Confidence 2 1222334578999999999999999999999999999999998 7999987654
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-43 Score=353.19 Aligned_cols=193 Identities=28% Similarity=0.383 Sum_probs=166.3
Q ss_pred hcCCCCc-eeecccCceEEEEEEe-cCCcEEEEEEeccCCccHHHHHHHHHHHh-cCCCCCeeeEEEEEec----CCeeE
Q 011660 251 THNFSPK-MLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLS-SIKHENIVRIIGYCHS----KEMYA 323 (480)
Q Consensus 251 ~~~f~~~-~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ei~il~-~l~HpnIv~l~~~~~~----~~~~~ 323 (480)
.++|.+. ++||+|+||+||+|.+ .+++.||||+++.. ..+.+|++++. .++||||++++++|++ ++.+|
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 4578876 5699999999999976 66999999999743 56788999865 4589999999999865 46789
Q ss_pred EEEecc-CCCHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecC--CCceEEeeecccc
Q 011660 324 IVYNLL-NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN--FHHPQLSDFGAAM 395 (480)
Q Consensus 324 lV~e~~-~GsL~~~l~~-----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~--~~~~kL~DFGla~ 395 (480)
+||||+ +|+|.+++.. +++.++..++.||+.||.|||++ +|+||||||+|||++.+ .+.+||+|||+|+
T Consensus 86 ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~ 162 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162 (335)
T ss_dssp EEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccceee
Confidence 999999 5799999954 78899999999999999999999 99999999999999863 2579999999997
Q ss_pred ccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 396 VHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
..... ......+||+.|||||++.+..|+.++|||||||+||||+||+.||.+.+
T Consensus 163 ~~~~~------~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~ 217 (335)
T d2ozaa1 163 ETTSH------NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 217 (335)
T ss_dssp ECCCC------CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETT
T ss_pred eccCC------CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCC
Confidence 64332 22345689999999999999999999999999999999999999997654
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-43 Score=344.25 Aligned_cols=195 Identities=23% Similarity=0.391 Sum_probs=167.7
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCcc-------HHHHHHHHHHHhcCC--CCCeeeEEEEEecCC
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS-------EEEVLREVELLSSIK--HENIVRIIGYCHSKE 320 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~-------~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~~ 320 (480)
.++|++.+.||+|+||.||+|.+ .+|+.||||++++.... ...+.+|+.+|++++ ||||+++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 46799999999999999999976 57999999999753211 133678999999986 899999999999999
Q ss_pred eeEEEEeccC--CCHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccc
Q 011660 321 MYAIVYNLLN--GSLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAM 395 (480)
Q Consensus 321 ~~~lV~e~~~--GsL~~~l~---~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~ 395 (480)
.+++||||+. +++.+++. .+++.++..++.||++||.|||++ +|+||||||+|||++.+.+.+||+|||+|+
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccccce
Confidence 9999999994 46777774 388999999999999999999999 999999999999999765689999999996
Q ss_pred ccccccccccCccccccccCCCccccccccCCCC-CchHHHHHHHHHHHHHHcCCCCCCCC
Q 011660 396 VHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKV-DEKIDVYSYGVVLLELITGKEAIQTN 455 (480)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~-~~k~DvwSlGvil~eLltG~~pf~~~ 455 (480)
.... ....+.+||+.|+|||++.+..+ +.++|||||||+||||+||+.||...
T Consensus 160 ~~~~-------~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 213 (273)
T d1xwsa_ 160 LLKD-------TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 213 (273)
T ss_dssp ECCS-------SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred eccc-------ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc
Confidence 5332 12345689999999999987776 67799999999999999999999864
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.1e-43 Score=346.12 Aligned_cols=203 Identities=25% Similarity=0.417 Sum_probs=172.5
Q ss_pred HhhhhcCCCCceeecccCceEEEEEEec------CCcEEEEEEeccCCcc--HHHHHHHHHHHhcCCCCCeeeEEEEEec
Q 011660 247 LCHLTHNFSPKMLIGQGGNSKVYRTNHV------DGQVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHS 318 (480)
Q Consensus 247 l~~~~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 318 (480)
++...++|++.+.||+|+||+||+|... +++.||||+++..... .+++.+|+++|++++||||++++++|.+
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 87 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 87 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence 3344678999999999999999999753 3578999999765433 3568999999999999999999999999
Q ss_pred CCeeEEEEecc-CCCHHHHHHh---------------------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 011660 319 KEMYAIVYNLL-NGSLKQYLKQ---------------------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHR 370 (480)
Q Consensus 319 ~~~~~lV~e~~-~GsL~~~l~~---------------------------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHr 370 (480)
.+..+++|||+ +|+|.+++.. +.+.++..++.|++.||.|||++ +||||
T Consensus 88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHr 164 (301)
T d1lufa_ 88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHR 164 (301)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEee
Confidence 99999999999 7899999853 67888999999999999999999 99999
Q ss_pred cCCCCCEEEecCCCceEEeeeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCC-
Q 011660 371 DVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGK- 449 (480)
Q Consensus 371 DlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~- 449 (480)
||||+|||++.+ +++||+|||+|+..... ..........||+.|+|||.+.+..|+.++|||||||+||||++|.
T Consensus 165 DlKp~NILld~~-~~~Kl~DFGls~~~~~~---~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~ 240 (301)
T d1lufa_ 165 DLATRNCLVGEN-MVVKIADFGLSRNIYSA---DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240 (301)
T ss_dssp CCSGGGEEECGG-GCEEECCCSCHHHHTGG---GCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred EEcccceEECCC-CcEEEccchhheeccCC---ccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCC
Confidence 999999999998 68999999999754332 2222334567999999999999999999999999999999999996
Q ss_pred CCCCCCc
Q 011660 450 EAIQTNK 456 (480)
Q Consensus 450 ~pf~~~~ 456 (480)
+||....
T Consensus 241 ~p~~~~~ 247 (301)
T d1lufa_ 241 QPYYGMA 247 (301)
T ss_dssp CTTTTSC
T ss_pred CCCCCCC
Confidence 5676553
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.9e-42 Score=339.17 Aligned_cols=197 Identities=25% Similarity=0.435 Sum_probs=168.4
Q ss_pred cCCCCceeecccCceEEEEEEecCCcEEEEEEeccCCcc---HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEec
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e~ 328 (480)
++|++.+.||+|+||+||+|.+.+|+.||||+++..... .+.+.+|+++|++++||||+++++++.+++..++++|+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 479999999999999999999888999999999765432 46789999999999999999999999999999999999
Q ss_pred cCCCHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccc
Q 011660 329 LNGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (480)
Q Consensus 329 ~~GsL~~~l~----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (480)
+.|.+...+. .+++.++..++.||+.||+|||+. +||||||||+|||++.+ +.+||+|||+|......
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~-~~~kl~DfG~a~~~~~~---- 153 (286)
T d1ob3a_ 82 LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINRE-GELKIADFGLARAFGIP---- 153 (286)
T ss_dssp CSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTT-SCEEECCTTHHHHHCC-----
T ss_pred ehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCC-CCEEecccccceecccC----
Confidence 9777655553 378999999999999999999999 99999999999999998 78999999999654332
Q ss_pred cCccccccccCCCccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 405 ENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 405 ~~~~~~~~~GT~~y~APE~~~~~-~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
........||+.|+|||.+.+. .++.++|||||||++|||++|+.||.+.+.
T Consensus 154 -~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~ 206 (286)
T d1ob3a_ 154 -VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE 206 (286)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred -ccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCH
Confidence 1223355799999999998765 469999999999999999999999987653
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-43 Score=344.68 Aligned_cols=218 Identities=24% Similarity=0.454 Sum_probs=173.1
Q ss_pred hhcCCCCceeecccCceEEEEEEe-cC-CcEEEEEEeccCCc---cHHHHHHHHHHHhcC---CCCCeeeEEEEEe----
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNH-VD-GQVAAVKVLKCTNW---SEEEVLREVELLSSI---KHENIVRIIGYCH---- 317 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~-g~~vAvK~~~~~~~---~~~~~~~Ei~il~~l---~HpnIv~l~~~~~---- 317 (480)
..++|++.+.||+|+||+||+|.+ .+ ++.||||+++.... ....+.+|+.+|+.| +||||++++++|.
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 457899999999999999999976 34 67899999865322 223566788877665 8999999999985
Q ss_pred -cCCeeEEEEeccCCCHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeee
Q 011660 318 -SKEMYAIVYNLLNGSLKQYLK-----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDF 391 (480)
Q Consensus 318 -~~~~~~lV~e~~~GsL~~~l~-----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DF 391 (480)
....++++||++.|++..+.. .+++..+..++.|++.||+|||++ +||||||||+|||++.+ +.+||+||
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~-~~~kl~df 160 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSS-GQIKLADF 160 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTT-CCEEECSC
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCC-CCeeecch
Confidence 235789999999877655442 378888999999999999999999 99999999999999998 68999999
Q ss_pred ccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHhC
Q 011660 392 GAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWYYVLAG 471 (480)
Q Consensus 392 Gla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~~~e~l~~~~~~~~~ 471 (480)
|++..... .......+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.+. .+.+.. .....+
T Consensus 161 g~~~~~~~------~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~~~~-i~~~~~ 232 (305)
T d1blxa_ 161 GLARIYSF------QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD-VDQLGK-ILDVIG 232 (305)
T ss_dssp CSCCCCCG------GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHH-HHHHHC
T ss_pred hhhhhhcc------cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCH-HHHHHH-HHHhhC
Confidence 99865332 2233467899999999999999999999999999999999999999987653 222222 223444
Q ss_pred CCCCCCCC
Q 011660 472 KVFAQQWP 479 (480)
Q Consensus 472 ~~~~~~~~ 479 (480)
.+..+.||
T Consensus 233 ~~~~~~~~ 240 (305)
T d1blxa_ 233 LPGEEDWP 240 (305)
T ss_dssp CCCGGGSC
T ss_pred CCchhccc
Confidence 45455554
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-42 Score=336.72 Aligned_cols=191 Identities=27% Similarity=0.437 Sum_probs=160.6
Q ss_pred cCCCCceeecccCceEEEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEEEe-cCCeeEEEEecc-
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCH-SKEMYAIVYNLL- 329 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-~~~~~~lV~e~~- 329 (480)
++|++.+.||+|+||.||+|.+ .|..||||+++.+. ..+.+.+|++++++++||||++++|+|. +++.+++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~ 84 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 84 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHH-HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccC
Confidence 4688899999999999999988 57889999997654 4577999999999999999999999985 456789999999
Q ss_pred CCCHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccc
Q 011660 330 NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (480)
Q Consensus 330 ~GsL~~~l~~-----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (480)
+|+|.+++.. +++..++.++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||+++....
T Consensus 85 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~-~~~kl~dfg~s~~~~~----- 155 (262)
T d1byga_ 85 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSED-NVAKVSDFGLTKEASS----- 155 (262)
T ss_dssp TEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTT-SCEEECCCCC-----------
T ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCC-CCEeecccccceecCC-----
Confidence 7899999842 89999999999999999999999 99999999999999999 6899999999865332
Q ss_pred cCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 405 ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 405 ~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
......+|+.|+|||++.++.+++++|||||||++|||+| |++||...+
T Consensus 156 ---~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~ 205 (262)
T d1byga_ 156 ---TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 205 (262)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC
T ss_pred ---CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCC
Confidence 2234568999999999999999999999999999999998 788887654
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-42 Score=336.57 Aligned_cols=198 Identities=25% Similarity=0.383 Sum_probs=158.4
Q ss_pred hcCCCCceeecccCceEEEEEEecC----CcEEEEEEeccCCcc--HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEE
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHVD----GQVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAI 324 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~~----g~~vAvK~~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 324 (480)
.++|++.+.||+|+||.||+|.+.. +..+|||.++..... .+.+.+|+++|++++||||++++|++.+ +.+++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEE
Confidence 3579999999999999999997632 356889988654332 3568899999999999999999999964 67889
Q ss_pred EEecc-CCCHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccc
Q 011660 325 VYNLL-NGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (480)
Q Consensus 325 V~e~~-~GsL~~~l~----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~ 399 (480)
||||+ +|+|.+++. .+++.++..++.||++||.|||++ +||||||||+||+++.+ +.+||+|||+|+....
T Consensus 85 v~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~-~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSN-DCVKLGDFGLSRYMED 160 (273)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEET-TEEEECC---------
T ss_pred EEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCC-CcEEEccchhheeccC
Confidence 99999 678888874 378899999999999999999999 99999999999999998 6899999999976443
Q ss_pred ccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCcc
Q 011660 400 SHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKA 457 (480)
Q Consensus 400 ~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~~ 457 (480)
.. ........||+.|+|||++.+..|+.++|||||||++|||+| |.+||...+.
T Consensus 161 ~~----~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~ 215 (273)
T d1mp8a_ 161 ST----YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 215 (273)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred Cc----ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH
Confidence 21 122334578999999999999999999999999999999998 8999987654
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-42 Score=340.54 Aligned_cols=201 Identities=26% Similarity=0.404 Sum_probs=159.5
Q ss_pred hcCCCCceeecccCceEEEEEEec------CCcEEEEEEeccCCcc--HHHHHHHHHHHhcC-CCCCeeeEEEEEec-CC
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHV------DGQVAAVKVLKCTNWS--EEEVLREVELLSSI-KHENIVRIIGYCHS-KE 320 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~~~~~~~~--~~~~~~Ei~il~~l-~HpnIv~l~~~~~~-~~ 320 (480)
.++|++.+.||+|+||.||+|.+. +++.||||+++..... .+.+.+|..++.++ +||||+.+++++.+ ++
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 467999999999999999999753 3468999999754432 34577788877766 78999999998865 45
Q ss_pred eeEEEEecc-CCCHHHHHHh-------------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEe
Q 011660 321 MYAIVYNLL-NGSLKQYLKQ-------------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLS 380 (480)
Q Consensus 321 ~~~lV~e~~-~GsL~~~l~~-------------------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~ 380 (480)
.+++||||+ +|+|.+++.. +++.++..++.||++||.|||++ +||||||||+||||+
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEC
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeEC
Confidence 789999999 6899999842 67889999999999999999999 999999999999999
Q ss_pred cCCCceEEeeeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCC-CCCCCCccc
Q 011660 381 ENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGK-EAIQTNKAN 458 (480)
Q Consensus 381 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~-~pf~~~~~~ 458 (480)
.+ +++||+|||+|+..... ..........||+.|||||++.+..++.++|||||||++|||+||. +||......
T Consensus 169 ~~-~~~Kl~DFGla~~~~~~---~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~ 243 (299)
T d1ywna1 169 EK-NVVKICDFGLARDIYKD---PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243 (299)
T ss_dssp GG-GCEEECC------CCSC---TTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred CC-CcEEEccCcchhhcccc---ccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH
Confidence 98 68999999999764432 2222334568999999999999999999999999999999999974 577665443
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-42 Score=337.83 Aligned_cols=201 Identities=27% Similarity=0.376 Sum_probs=161.9
Q ss_pred cCCCCceeecccCceEEEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEEEecCC----eeEEEEe
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKE----MYAIVYN 327 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----~~~lV~e 327 (480)
.+|.+.+.||+|+||.||+|.+ +|+.||||+++.+.........|+..++.++||||++++++|.+.+ .+++|||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E 81 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence 4577788999999999999986 6899999999755432222344555667889999999999997543 6899999
Q ss_pred cc-CCCHHHHHH--hCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEeccCCCCCEEEecCCCceEEeeecccccccc
Q 011660 328 LL-NGSLKQYLK--QLKWNERMDVAIGVAKALEYLHHT-----CDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (480)
Q Consensus 328 ~~-~GsL~~~l~--~~~~~~~~~i~~~ia~aL~yLH~~-----~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~ 399 (480)
|+ +|+|.++++ .+++.++..++.|++.||.|||+. +.++||||||||+||||+.+ +.+||+|||+++....
T Consensus 82 y~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~-~~~Kl~DFGl~~~~~~ 160 (303)
T d1vjya_ 82 YHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVRHDS 160 (303)
T ss_dssp CCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTT-SCEEECCCTTCEEEET
T ss_pred cccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCC-CCeEEEecCccccccC
Confidence 99 789999997 488999999999999999999973 24599999999999999998 6899999999976544
Q ss_pred ccccccCccccccccCCCccccccccCCC------CCchHHHHHHHHHHHHHHcCCCCCCCC
Q 011660 400 SHQVSENVKPVNVVGTFGYLAPEYMMYGK------VDEKIDVYSYGVVLLELITGKEAIQTN 455 (480)
Q Consensus 400 ~~~~~~~~~~~~~~GT~~y~APE~~~~~~------~~~k~DvwSlGvil~eLltG~~pf~~~ 455 (480)
... .........+||+.|||||++.+.. ++.++|||||||+||||+||..||...
T Consensus 161 ~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~ 221 (303)
T d1vjya_ 161 ATD-TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 221 (303)
T ss_dssp TTT-EECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBC
T ss_pred CCc-ceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcc
Confidence 322 1222334578999999999987542 678999999999999999999887543
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-42 Score=333.52 Aligned_cols=198 Identities=27% Similarity=0.384 Sum_probs=157.6
Q ss_pred cCCCCceeecccCceEEEEEEec--CC--cEEEEEEeccCCc----cHHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHV--DG--QVAAVKVLKCTNW----SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYA 323 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~--~g--~~vAvK~~~~~~~----~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 323 (480)
++|++.+.||+|+||.||+|.+. ++ ..||||++++... ..+++.+|+++|++++||||++++|+|.++ .++
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chh
Confidence 46999999999999999999653 23 3689999875432 235689999999999999999999999764 567
Q ss_pred EEEecc-CCCHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccc
Q 011660 324 IVYNLL-NGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (480)
Q Consensus 324 lV~e~~-~GsL~~~l~----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~ 398 (480)
+||||+ .|++.+++. .+++..+..++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||+++...
T Consensus 87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~-~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATR-DLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEET-TEEEECCCTTCEECC
T ss_pred eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccc-cceeeccchhhhhcc
Confidence 899999 688888773 489999999999999999999999 99999999999999998 689999999997654
Q ss_pred cccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 011660 399 QSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNK 456 (480)
Q Consensus 399 ~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~ 456 (480)
..... ........||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+
T Consensus 163 ~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~ 219 (273)
T d1u46a_ 163 QNDDH--YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN 219 (273)
T ss_dssp C-CCE--EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cCCCc--ceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC
Confidence 43211 122334568899999999999999999999999999999998 899998654
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-41 Score=337.70 Aligned_cols=199 Identities=27% Similarity=0.388 Sum_probs=169.8
Q ss_pred hcCCCCceeecccCceEEEEEEe------cCCcEEEEEEeccCCcc--HHHHHHHHHHHhcC-CCCCeeeEEEEEecCCe
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH------VDGQVAAVKVLKCTNWS--EEEVLREVELLSSI-KHENIVRIIGYCHSKEM 321 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~------~~g~~vAvK~~~~~~~~--~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~ 321 (480)
.++|++.+.||+|+||.||+|.+ .+++.||||+++..... ...+.+|+.+++++ +||||++++++|.+++.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 35688899999999999999964 24678999999765432 34688999999999 79999999999999999
Q ss_pred eEEEEecc-CCCHHHHHHh---------------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEE
Q 011660 322 YAIVYNLL-NGSLKQYLKQ---------------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILL 379 (480)
Q Consensus 322 ~~lV~e~~-~GsL~~~l~~---------------------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl 379 (480)
++++|||+ +|+|.+++.. +++.++..++.||+.||.|||++ +||||||||+|||+
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccccccc
Confidence 99999999 6899999853 67889999999999999999999 99999999999999
Q ss_pred ecCCCceEEeeeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcC-CCCCCCCc
Q 011660 380 SENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITG-KEAIQTNK 456 (480)
Q Consensus 380 ~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG-~~pf~~~~ 456 (480)
+.+ +.+||+|||+++...... ........+||+.|+|||++.++.++.++|||||||++|||+|+ .+||...+
T Consensus 179 ~~~-~~~ki~DfG~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~ 252 (311)
T d1t46a_ 179 THG-RITKICDFGLARDIKNDS---NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (311)
T ss_dssp ETT-TEEEECCCGGGSCTTSCT---TSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred ccc-CcccccccchheeccCCC---cceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCC
Confidence 998 689999999997654322 22233456899999999999999999999999999999999995 55555444
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.7e-41 Score=331.49 Aligned_cols=203 Identities=17% Similarity=0.226 Sum_probs=174.0
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCccHHHHHHHHHHHhcCCC-CCeeeEEEEEecCCeeEEEEec
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIKH-ENIVRIIGYCHSKEMYAIVYNL 328 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~~~~~lV~e~ 328 (480)
.++|++.+.||+|+||+||+|.+ .+|+.||||+++... ....+.+|+++++.+.| +|++.+++++.++...++||||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 46799999999999999999986 568999999986543 33457889999999965 8999999999999999999999
Q ss_pred cCCCHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecC----CCceEEeeeccccccccc
Q 011660 329 LNGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN----FHHPQLSDFGAAMVHHQS 400 (480)
Q Consensus 329 ~~GsL~~~l~----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~----~~~~kL~DFGla~~~~~~ 400 (480)
++|+|.+++. .++..+...++.|++.||+|||++ +||||||||+|||++.+ .+.+||+|||+|+.....
T Consensus 83 ~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~ 159 (293)
T d1csna_ 83 LGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 159 (293)
T ss_dssp CCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred cCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEcccC
Confidence 9999999884 378889999999999999999999 99999999999999742 257999999999875443
Q ss_pred ccc--ccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 401 HQV--SENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 401 ~~~--~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
... .........+||+.|||||++.+..+++++|||||||++|||+||+.||.....
T Consensus 160 ~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~ 218 (293)
T d1csna_ 160 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 218 (293)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCS
T ss_pred ccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccc
Confidence 211 122234467899999999999999999999999999999999999999986654
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-41 Score=333.95 Aligned_cols=221 Identities=28% Similarity=0.455 Sum_probs=173.7
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCc---cHHHHHHHHHHHhcCCCCCeeeEEEEEec--------
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVRIIGYCHS-------- 318 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-------- 318 (480)
.++|++.+.||+|+||+||+|.+ .+|+.||||++..... ....+.+|+++|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 36799999999999999999976 5799999999865432 34678899999999999999999998854
Q ss_pred CCeeEEEEeccCCCHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccc
Q 011660 319 KEMYAIVYNLLNGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA 394 (480)
Q Consensus 319 ~~~~~lV~e~~~GsL~~~l~----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla 394 (480)
++.+++||||+.+.+..... .+...+...++.|++.||.|||++ +|+||||||+|||++.+ +.+||+|||+|
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~-~~~kl~dfg~~ 164 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRD-GVLKLADFGLA 164 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTT-SCEEECCCTTC
T ss_pred CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCC-CcEEeeeccee
Confidence 34689999999776655552 477888999999999999999999 99999999999999998 68999999999
Q ss_pred cccccccccccCccccccccCCCccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHhCCC
Q 011660 395 MVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWYYVLAGKV 473 (480)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~-~~~~k~DvwSlGvil~eLltG~~pf~~~~~~~e~l~~~~~~~~~~~ 473 (480)
+....... .........+||+.|+|||++.+. .|++++|||||||++|||++|+.||.+.+. .+.+.+ .....+..
T Consensus 165 ~~~~~~~~-~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~-~~~~~~-i~~~~~~~ 241 (318)
T d3blha1 165 RAFSLAKN-SQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE-QHQLAL-ISQLCGSI 241 (318)
T ss_dssp EECCC------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHH-HHHHHCCC
T ss_pred eecccccc-cccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCH-HHHHHH-HHHhcCCC
Confidence 76543222 122233456899999999998765 689999999999999999999999987543 333333 33444555
Q ss_pred CCCCC
Q 011660 474 FAQQW 478 (480)
Q Consensus 474 ~~~~~ 478 (480)
.++.|
T Consensus 242 ~~~~~ 246 (318)
T d3blha1 242 TPEVW 246 (318)
T ss_dssp CTTTS
T ss_pred Chhhc
Confidence 55544
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-41 Score=340.14 Aligned_cols=202 Identities=26% Similarity=0.395 Sum_probs=169.2
Q ss_pred hhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCcc--HHHHHHHHHHHhcCCCCCeeeEEEEEecCC-----e
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSKE-----M 321 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-----~ 321 (480)
++++|++.+.||+|+||+||+|.+ .+|+.||||++++.... .+.+.+|+++|++++||||+++++++.... .
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 456799999999999999999965 67999999999765432 346889999999999999999999986543 4
Q ss_pred eEEEEeccCCCHHHHHH--hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccc
Q 011660 322 YAIVYNLLNGSLKQYLK--QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (480)
Q Consensus 322 ~~lV~e~~~GsL~~~l~--~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~ 399 (480)
+++++++++|+|.++++ .+++..+..++.|+++||+|||++ +||||||||+|||++.+ +.+||+|||+|.....
T Consensus 86 ~~l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~-~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTT-CDLKICDFGLARVADP 161 (345)
T ss_dssp EEEEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTT-CCEEECCCTTCEECCG
T ss_pred EEEEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCC-CCEEEcccCceeeccC
Confidence 67888877999999995 588999999999999999999999 99999999999999998 7899999999976544
Q ss_pred ccccccCccccccccCCCcccccccc-CCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 400 SHQVSENVKPVNVVGTFGYLAPEYMM-YGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 400 ~~~~~~~~~~~~~~GT~~y~APE~~~-~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
... ........+||+.|+|||++. ...++.++||||+||++|||++|+.||...+.
T Consensus 162 ~~~--~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~ 218 (345)
T d1pmea_ 162 DHD--HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 218 (345)
T ss_dssp GGC--BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred CCc--cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCH
Confidence 321 222334678999999999985 45679999999999999999999999987653
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-41 Score=341.58 Aligned_cols=193 Identities=25% Similarity=0.362 Sum_probs=163.6
Q ss_pred CCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCeeeEEEEEec------CCeeEEE
Q 011660 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHS------KEMYAIV 325 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~------~~~~~lV 325 (480)
+|...++||+|+||+||+|.+ .+|+.||||+++.... ...+|+++|++++||||++++++|.. ...+++|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 97 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 97 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch---HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEE
Confidence 488899999999999999987 5699999999976542 23479999999999999999999843 2357899
Q ss_pred EeccCCCHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccc
Q 011660 326 YNLLNGSLKQYLK-------QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (480)
Q Consensus 326 ~e~~~GsL~~~l~-------~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~ 398 (480)
|||++|++.+.+. .+++.++..++.||+.||+|||++ +|+||||||+|||++.+...+||+|||+|....
T Consensus 98 ~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~ 174 (350)
T d1q5ka_ 98 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174 (350)
T ss_dssp EECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred EeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence 9999887655552 388999999999999999999998 999999999999999874589999999997543
Q ss_pred cccccccCccccccccCCCccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 399 QSHQVSENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 399 ~~~~~~~~~~~~~~~GT~~y~APE~~~~-~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
.. ....+.+||+.|+|||.+.+ ..|+.++|||||||++|||++|++||...+.
T Consensus 175 ~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~ 228 (350)
T d1q5ka_ 175 RG------EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG 228 (350)
T ss_dssp TT------SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSH
T ss_pred CC------cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCH
Confidence 32 22335689999999998775 5689999999999999999999999987653
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=6.7e-41 Score=334.47 Aligned_cols=198 Identities=24% Similarity=0.383 Sum_probs=171.9
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCccHHHHHHHHHHHhcCC-CCCeeeEEEEEec--CCeeEEEEe
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIK-HENIVRIIGYCHS--KEMYAIVYN 327 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~--~~~~~lV~e 327 (480)
++|++.+.||+|+||+||+|.+ .+|+.||||+++... .+.+.+|+++|+.++ ||||+++++++.. ...+++|||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e 112 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 112 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC--HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH--HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence 5799999999999999999977 579999999997543 567899999999995 9999999999874 457899999
Q ss_pred cc-CCCHHHHHHhCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccccC
Q 011660 328 LL-NGSLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSEN 406 (480)
Q Consensus 328 ~~-~GsL~~~l~~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~ 406 (480)
|+ .|+|..+.+.+++.++..++.||+.||.|||++ +||||||||+|||++.+.+.+||+|||+|+.....
T Consensus 113 ~~~~~~L~~~~~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~------ 183 (328)
T d3bqca1 113 HVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG------ 183 (328)
T ss_dssp CCCSCBGGGTTTSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT------
T ss_pred ecCCCcHHHHhcCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccCC------
Confidence 99 578988888999999999999999999999999 99999999999999976457999999999764432
Q ss_pred ccccccccCCCccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCcccch
Q 011660 407 VKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKANRE 460 (480)
Q Consensus 407 ~~~~~~~GT~~y~APE~~~~~-~~~~k~DvwSlGvil~eLltG~~pf~~~~~~~e 460 (480)
......+||+.|+|||.+.+. .++.++||||+||++|||++|+.||.......+
T Consensus 184 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~ 238 (328)
T d3bqca1 184 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD 238 (328)
T ss_dssp CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH
T ss_pred CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHH
Confidence 223456799999999998765 479999999999999999999999987765433
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-41 Score=333.67 Aligned_cols=195 Identities=27% Similarity=0.429 Sum_probs=163.2
Q ss_pred cCCCCceeecccCceEEEEEEec-CCc--EEEEEEeccCC--ccHHHHHHHHHHHhcC-CCCCeeeEEEEEecCCeeEEE
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNHV-DGQ--VAAVKVLKCTN--WSEEEVLREVELLSSI-KHENIVRIIGYCHSKEMYAIV 325 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~--~vAvK~~~~~~--~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV 325 (480)
++|++.+.||+|+||.||+|.+. ++. .||||.++... ...+.+.+|+++|+++ +||||++++|+|.+++.+++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 56899999999999999999764 454 46788875432 2335689999999998 799999999999999999999
Q ss_pred Eecc-CCCHHHHHH-------------------hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCc
Q 011660 326 YNLL-NGSLKQYLK-------------------QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHH 385 (480)
Q Consensus 326 ~e~~-~GsL~~~l~-------------------~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~ 385 (480)
|||+ +|+|.+++. .+++.++..++.||+.||.|||+. +||||||||+|||++.+ +.
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~-~~ 165 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGEN-YV 165 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGG-GC
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCC-Cc
Confidence 9999 689999984 268889999999999999999999 99999999999999998 68
Q ss_pred eEEeeeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCC-CCCCCCc
Q 011660 386 PQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGK-EAIQTNK 456 (480)
Q Consensus 386 ~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~-~pf~~~~ 456 (480)
+||+|||+|+..... .......||+.|+|||.+.++.|+.++|||||||++|||++|. +||...+
T Consensus 166 ~kl~DfG~a~~~~~~------~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~ 231 (309)
T d1fvra_ 166 AKIADFGLSRGQEVY------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 231 (309)
T ss_dssp EEECCTTCEESSCEE------CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred eEEcccccccccccc------ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC
Confidence 999999999653321 1223456999999999999999999999999999999999976 5666543
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-41 Score=335.08 Aligned_cols=200 Identities=28% Similarity=0.445 Sum_probs=166.6
Q ss_pred hcCCCCceeecccCceEEEEEEecC--------CcEEEEEEeccCCcc--HHHHHHHHHHHhcC-CCCCeeeEEEEEecC
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHVD--------GQVAAVKVLKCTNWS--EEEVLREVELLSSI-KHENIVRIIGYCHSK 319 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~~--------g~~vAvK~~~~~~~~--~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~ 319 (480)
.++|.+.+.||+|+||.||+|.... +..||||+++..... ..++.+|..++.++ +||||++++++|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 3578999999999999999996532 247999999765532 35688899988888 899999999999999
Q ss_pred CeeEEEEecc-CCCHHHHHH-------------------hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEE
Q 011660 320 EMYAIVYNLL-NGSLKQYLK-------------------QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILL 379 (480)
Q Consensus 320 ~~~~lV~e~~-~GsL~~~l~-------------------~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl 379 (480)
+..++||||+ +|+|.+++. .+++.++..++.||+.||+|||+. +||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceee
Confidence 9999999999 789999994 268899999999999999999999 99999999999999
Q ss_pred ecCCCceEEeeeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCcc
Q 011660 380 SENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKA 457 (480)
Q Consensus 380 ~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLlt-G~~pf~~~~~ 457 (480)
+.+ +.+||+|||+++...... .........||+.|+|||.+.++.|+.++|||||||++|||++ |++||...+.
T Consensus 169 ~~~-~~~kl~dfg~~~~~~~~~---~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~ 243 (299)
T d1fgka_ 169 TED-NVMKIADFGLARDIHHID---YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243 (299)
T ss_dssp CTT-CCEEECSTTCCCCGGGCC---TTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred cCC-CCeEeccchhhccccccc---cccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH
Confidence 999 689999999997654422 2223345679999999999999999999999999999999998 7888876553
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-41 Score=338.53 Aligned_cols=195 Identities=26% Similarity=0.410 Sum_probs=164.7
Q ss_pred hhcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCccH---HHHHHHHHHHhcCCCCCeeeEEEEEecCC-----
Q 011660 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSE---EEVLREVELLSSIKHENIVRIIGYCHSKE----- 320 (480)
Q Consensus 250 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~~---~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----- 320 (480)
+.++|++.+.||+|+||+||+|.+ .+|+.||||++++..... +.+.+|+++|+.++||||++++++|...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 457899999999999999999976 569999999998654433 45789999999999999999999997654
Q ss_pred -eeEEEEeccCCCHHHHHH--hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccc
Q 011660 321 -MYAIVYNLLNGSLKQYLK--QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVH 397 (480)
Q Consensus 321 -~~~lV~e~~~GsL~~~l~--~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~ 397 (480)
.+++||||++++|..+++ .+++..+..++.||+.||.|||++ +||||||||+|||++.+ +.+||+|||+|+..
T Consensus 96 ~~~~lv~e~~~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~-~~~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 96 TDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNED-CELKILDFGLARQA 171 (346)
T ss_dssp CCCEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTT-CCEEECCCTTCEEC
T ss_pred ceEEEEEecccccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccc-cccccccccceecc
Confidence 579999999888888875 489999999999999999999999 99999999999999999 78999999999653
Q ss_pred ccccccccCccccccccCCCccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 398 HQSHQVSENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 398 ~~~~~~~~~~~~~~~~GT~~y~APE~~~~~-~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.. ......||+.|+|||++.+. .++.++||||+||++|||++|++||.+.+
T Consensus 172 ~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~ 223 (346)
T d1cm8a_ 172 DS--------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD 223 (346)
T ss_dssp CS--------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CC--------ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCC
Confidence 32 23456799999999998764 56899999999999999999999998765
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-41 Score=332.19 Aligned_cols=199 Identities=23% Similarity=0.353 Sum_probs=170.2
Q ss_pred hcCCCCceeecccCceEEEEEEec------CCcEEEEEEeccCCccH--HHHHHHHHHHhcCCCCCeeeEEEEEecCCee
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNHV------DGQVAAVKVLKCTNWSE--EEVLREVELLSSIKHENIVRIIGYCHSKEMY 322 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~~~~~~~~~--~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 322 (480)
.++|.+.+.||+|+||.||+|.+. ++..||||+++...... ..+.+|++++++++||||++++++|..++..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 357888999999999999999653 25789999997654332 3578999999999999999999999999999
Q ss_pred EEEEecc-CCCHHHHHHh-------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEE
Q 011660 323 AIVYNLL-NGSLKQYLKQ-------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQL 388 (480)
Q Consensus 323 ~lV~e~~-~GsL~~~l~~-------------~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL 388 (480)
++||||+ +|+|.+++.. +.+..+..++.|+++||.|||++ +|+||||||+|||++.+ +++||
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~-~~~Kl 174 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED-FTVKI 174 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTT-CCEEE
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCC-ceEEE
Confidence 9999999 7899998842 57788999999999999999999 99999999999999998 68999
Q ss_pred eeeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCC-CCCCCCc
Q 011660 389 SDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGK-EAIQTNK 456 (480)
Q Consensus 389 ~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~-~pf~~~~ 456 (480)
+|||+|+...... .........||+.|+|||.+.++.++.++|||||||++|||+||. +||...+
T Consensus 175 ~DFGla~~~~~~~---~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~ 240 (308)
T d1p4oa_ 175 GDFGMTRDIYETD---YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 240 (308)
T ss_dssp CCTTCCCGGGGGG---CEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC
T ss_pred eecccceeccCCc---ceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC
Confidence 9999997654422 222334557999999999999999999999999999999999985 6676543
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-40 Score=329.86 Aligned_cols=196 Identities=23% Similarity=0.369 Sum_probs=163.0
Q ss_pred ceeecccCceEEEEEEecCC----cEEEEEEeccCCc--cHHHHHHHHHHHhcCCCCCeeeEEEEEec-CCeeEEEEecc
Q 011660 257 KMLIGQGGNSKVYRTNHVDG----QVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHS-KEMYAIVYNLL 329 (480)
Q Consensus 257 ~~~LG~G~fg~Vy~~~~~~g----~~vAvK~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~lV~e~~ 329 (480)
.++||+|+||+||+|.+.++ ..||||+++.... ..+++.+|+++|++++||||++++|+|.+ ++.+++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46899999999999976432 2689999975432 23568999999999999999999999865 56889999999
Q ss_pred -CCCHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccccccccc
Q 011660 330 -NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (480)
Q Consensus 330 -~GsL~~~l~~----~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (480)
+|+|.+++.. ..+.++..++.|++.||.|||+. +|+||||||+|||++++ +.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~-~~~kL~DFG~~~~~~~~~~~- 186 (311)
T d1r0pa_ 112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEFD- 186 (311)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTT-CCEEECSSGGGCCTTTTTCC-
T ss_pred ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCC-CCEEEecccchhhccccccc-
Confidence 6889998853 56788899999999999999999 99999999999999998 68999999999765543222
Q ss_pred cCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 405 ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 405 ~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
.........||+.|+|||.+..+.++.++||||||+++|||+||+.||.....
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~ 239 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 239 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC---
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC
Confidence 22233346799999999999999999999999999999999998888876543
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-40 Score=327.16 Aligned_cols=203 Identities=21% Similarity=0.238 Sum_probs=169.2
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCe-eeEEEEEecCCeeEEEEec
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENI-VRIIGYCHSKEMYAIVYNL 328 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lV~e~ 328 (480)
.++|++.+.||+|+||.||+|.+ .+|+.||||++.... ..+.+..|+++++.++|+|+ +.+.+++.+++.+++||||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT-TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc-cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 45799999999999999999976 568999999987544 23457899999999987665 5555666788899999999
Q ss_pred cCCCHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecC--CCceEEeeeccccccccccc
Q 011660 329 LNGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN--FHHPQLSDFGAAMVHHQSHQ 402 (480)
Q Consensus 329 ~~GsL~~~l~----~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~--~~~~kL~DFGla~~~~~~~~ 402 (480)
++|+|.+.+. .+++.++..++.|++.||+|||++ +||||||||+|||++.. ...++|+|||+|+.......
T Consensus 85 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (299)
T d1ckia_ 85 LGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 161 (299)
T ss_dssp CCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred cCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence 9999888773 489999999999999999999999 99999999999998532 24699999999987654322
Q ss_pred cc--cCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 011660 403 VS--ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (480)
Q Consensus 403 ~~--~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~~ 457 (480)
.. .........||+.|||||++.+..++.++|||||||++|||+||+.||.....
T Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~ 218 (299)
T d1ckia_ 162 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA 218 (299)
T ss_dssp CCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-
T ss_pred ccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccch
Confidence 11 12233467899999999999999999999999999999999999999987654
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-40 Score=320.16 Aligned_cols=218 Identities=24% Similarity=0.389 Sum_probs=178.1
Q ss_pred cCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCcc---HHHHHHHHHHHhcCCCCCeeeEEEEEecCCeeEEEEe
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~e 327 (480)
++|++.+.||+|+||+||+|.+ .+++.||||+++..... ...+.+|+.+|+.++||||++++++|.+.+.+++|++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 4799999999999999999976 57899999999765432 3568899999999999999999999999999999999
Q ss_pred ccCC-CHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccccccc
Q 011660 328 LLNG-SLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (480)
Q Consensus 328 ~~~G-sL~~~l~---~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (480)
++.| +|..++. .+.+.++..++.|+++||+|||++ +||||||||+|||++.+ +.+||+|||.|+......
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~-~~~kl~DFG~a~~~~~~~-- 155 (292)
T d1unla_ 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRN-GELKLANFGLARAFGIPV-- 155 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT-CCEEECCCTTCEECCSCC--
T ss_pred eccccccccccccccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccC-CceeeeecchhhcccCCC--
Confidence 9955 5555553 478889999999999999999999 99999999999999988 689999999997654322
Q ss_pred ccCccccccccCCCccccccccCCC-CCchHHHHHHHHHHHHHHcCCCCCCCCcccchhHHHHHHHHhCCCCCCCCC
Q 011660 404 SENVKPVNVVGTFGYLAPEYMMYGK-VDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWYYVLAGKVFAQQWP 479 (480)
Q Consensus 404 ~~~~~~~~~~GT~~y~APE~~~~~~-~~~k~DvwSlGvil~eLltG~~pf~~~~~~~e~l~~~~~~~~~~~~~~~~~ 479 (480)
.......+++.|+|||++.... ++.++|||||||++|||++|+.||.......+.+.. .....+.+..+.||
T Consensus 156 ---~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 228 (292)
T d1unla_ 156 ---RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKR-IFRLLGTPTEEQWP 228 (292)
T ss_dssp ---SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHH-HHHHHCCCCTTTCT
T ss_pred ---ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHH-HHhhcCCCChhhhh
Confidence 1222446788999999987665 699999999999999999999998665543333322 34455555555554
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-40 Score=328.31 Aligned_cols=201 Identities=28% Similarity=0.410 Sum_probs=170.0
Q ss_pred cCCCCceeecccCceEEEEEEe----cCCcEEEEEEeccCC-----ccHHHHHHHHHHHhcCCC-CCeeeEEEEEecCCe
Q 011660 252 HNFSPKMLIGQGGNSKVYRTNH----VDGQVAAVKVLKCTN-----WSEEEVLREVELLSSIKH-ENIVRIIGYCHSKEM 321 (480)
Q Consensus 252 ~~f~~~~~LG~G~fg~Vy~~~~----~~g~~vAvK~~~~~~-----~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~~~ 321 (480)
++|++.+.||+|+||+||+|.+ .+|+.||||++++.. ...+.+.+|+++|++++| |||+++++++.+.+.
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5699999999999999999965 247899999986532 234567899999999966 899999999999999
Q ss_pred eEEEEecc-CCCHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccc
Q 011660 322 YAIVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVH 397 (480)
Q Consensus 322 ~~lV~e~~-~GsL~~~l~~---~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~ 397 (480)
++++|||+ +|+|.+++.. +.......++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||+|+..
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~-~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSN-GHVVLTDFGLSKEF 179 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTT-SCEEESCSSEEEEC
T ss_pred eeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCC-CCEEEeeccchhhh
Confidence 99999999 6899999854 67788888999999999999999 99999999999999998 78999999999764
Q ss_pred ccccccccCccccccccCCCccccccccCC--CCCchHHHHHHHHHHHHHHcCCCCCCCCcccch
Q 011660 398 HQSHQVSENVKPVNVVGTFGYLAPEYMMYG--KVDEKIDVYSYGVVLLELITGKEAIQTNKANRE 460 (480)
Q Consensus 398 ~~~~~~~~~~~~~~~~GT~~y~APE~~~~~--~~~~k~DvwSlGvil~eLltG~~pf~~~~~~~e 460 (480)
.... ........||+.|+|||.+.+. .++.++|||||||+||||++|+.||...+....
T Consensus 180 ~~~~----~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~ 240 (322)
T d1vzoa_ 180 VADE----TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS 240 (322)
T ss_dssp CGGG----GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC
T ss_pred cccc----cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 4321 2223456799999999998765 468899999999999999999999988765433
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-39 Score=329.44 Aligned_cols=196 Identities=23% Similarity=0.318 Sum_probs=161.7
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCccH---HHHHHHHHHHhcCCCCCeeeEEEEEe------cCC
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSE---EEVLREVELLSSIKHENIVRIIGYCH------SKE 320 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~~---~~~~~Ei~il~~l~HpnIv~l~~~~~------~~~ 320 (480)
.++|++.+.||+|+||+||+|.+ .+|+.||||++++..... ..+.+|+.+|++++||||++++++|. +.+
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 36799999999999999999976 469999999998664433 35789999999999999999999985 346
Q ss_pred eeEEEEeccCCCHHHHH-HhCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccccccc
Q 011660 321 MYAIVYNLLNGSLKQYL-KQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (480)
Q Consensus 321 ~~~lV~e~~~GsL~~~l-~~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~~ 399 (480)
.+|+||||+.|++.+.+ ..+++.++..++.||+.||.|||++ ||+||||||+|||++.+ +.++++|||+++....
T Consensus 96 ~~~iv~Ey~~~~l~~~~~~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~-~~~kl~df~~~~~~~~ 171 (355)
T d2b1pa1 96 DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSD-CTLKILDFGLARTAGT 171 (355)
T ss_dssp EEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTT-CCEEECCCCC------
T ss_pred eeEEEEeccchHHHHhhhcCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccc-cceeeechhhhhcccc
Confidence 88999999988766665 5689999999999999999999999 99999999999999998 6899999999865332
Q ss_pred ccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 400 SHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 400 ~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.......+||+.|+|||++.+..+++++||||+||++|||++|++||.+.+
T Consensus 172 ------~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~ 222 (355)
T d2b1pa1 172 ------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222 (355)
T ss_dssp ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ------ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCC
Confidence 233346689999999999999999999999999999999999999998764
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-40 Score=328.59 Aligned_cols=194 Identities=27% Similarity=0.395 Sum_probs=163.9
Q ss_pred hcCCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCccH---HHHHHHHHHHhcCCCCCeeeEEEEEec------CC
Q 011660 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSE---EEVLREVELLSSIKHENIVRIIGYCHS------KE 320 (480)
Q Consensus 251 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~~---~~~~~Ei~il~~l~HpnIv~l~~~~~~------~~ 320 (480)
.++|++.+.||+|+||+||+|.+ .+|+.||||++++..... +.+.+|+++|++++||||+++++++.. .+
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 56799999999999999999976 579999999998665433 457899999999999999999999853 33
Q ss_pred eeEEEEeccCCCHHHHHH--hCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeeccccccc
Q 011660 321 MYAIVYNLLNGSLKQYLK--QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (480)
Q Consensus 321 ~~~lV~e~~~GsL~~~l~--~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~~~ 398 (480)
.+++++++.+|+|.+++. .+++.++..++.||+.||+|||++ +|+||||||+|||++.+ +.+|++|||+|....
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~-~~~kl~dfg~a~~~~ 172 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNED-CELKILDFGLARHTD 172 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTT-CCEEECCC----CCT
T ss_pred eEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCcccccccc-ccccccccchhcccC
Confidence 466777777899999984 489999999999999999999999 99999999999999998 789999999985432
Q ss_pred cccccccCccccccccCCCccccccccCCC-CCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 399 QSHQVSENVKPVNVVGTFGYLAPEYMMYGK-VDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 399 ~~~~~~~~~~~~~~~GT~~y~APE~~~~~~-~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
.......||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+
T Consensus 173 --------~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~ 223 (348)
T d2gfsa1 173 --------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 223 (348)
T ss_dssp --------GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred --------cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCC
Confidence 2233567999999999877654 5899999999999999999999998765
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.6e-35 Score=297.02 Aligned_cols=193 Identities=20% Similarity=0.313 Sum_probs=155.6
Q ss_pred CCCCceeecccCceEEEEEEe-cCCcEEEEEEeccCCccHHHHHHHHHHHhcCC-----------CCCeeeEEEEEec--
Q 011660 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIK-----------HENIVRIIGYCHS-- 318 (480)
Q Consensus 253 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~-----------HpnIv~l~~~~~~-- 318 (480)
+|++.+.||+|+||+||+|.. .+|+.||||++++.....+.+.+|+++++.++ |+||+++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~ 93 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG 93 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecc
Confidence 599999999999999999976 57999999999877655567889999988775 5789999988754
Q ss_pred CCeeEEEEecc--CCCHHHHH-----HhCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeccCCCCCEEEecCCC-----c
Q 011660 319 KEMYAIVYNLL--NGSLKQYL-----KQLKWNERMDVAIGVAKALEYLHH-TCDPPIIHRDVKSSNILLSENFH-----H 385 (480)
Q Consensus 319 ~~~~~lV~e~~--~GsL~~~l-----~~~~~~~~~~i~~~ia~aL~yLH~-~~~~~IiHrDlKp~NILl~~~~~-----~ 385 (480)
....+++++++ .++..... ..+.+..+..++.||+.||.|||+ . +|+||||||+|||++.+.. .
T Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 94 PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTTEEE
T ss_pred ccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCcccccce
Confidence 34555666555 33433333 237788899999999999999998 5 9999999999999986521 3
Q ss_pred eEEeeeccccccccccccccCccccccccCCCccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 011660 386 PQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456 (480)
Q Consensus 386 ~kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~k~DvwSlGvil~eLltG~~pf~~~~ 456 (480)
++++|||.|..... .....+||+.|+|||++.+..++.++||||+||+++||++|+.||....
T Consensus 171 ~kl~dfg~s~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~ 233 (362)
T d1q8ya_ 171 IKIADLGNACWYDE--------HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 233 (362)
T ss_dssp EEECCCTTCEETTB--------CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred eeEeeccccccccc--------ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCc
Confidence 89999999864332 2235679999999999999999999999999999999999999998654
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=2.4e-24 Score=197.22 Aligned_cols=161 Identities=17% Similarity=0.175 Sum_probs=119.7
Q ss_pred CCceeecccCceEEEEEEecCCcEEEEEEeccCCcc-------------------HHHHHHHHHHHhcCCCCCeeeEEEE
Q 011660 255 SPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWS-------------------EEEVLREVELLSSIKHENIVRIIGY 315 (480)
Q Consensus 255 ~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~-------------------~~~~~~Ei~il~~l~HpnIv~l~~~ 315 (480)
.+.+.||+|+||.||+|...+|+.||||+++..... ......|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 456889999999999998888999999987632111 1224568889999999999998876
Q ss_pred EecCCeeEEEEeccCCCHHHHHHhCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEecCCCceEEeeecccc
Q 011660 316 CHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAM 395 (480)
Q Consensus 316 ~~~~~~~~lV~e~~~GsL~~~l~~~~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~ 395 (480)
.. .+++|||+++... ..+.......++.|++++|.|||++ +|+||||||+|||++++ .++|+|||+|.
T Consensus 83 ~~----~~lvme~~~~~~~---~~l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~--~~~liDFG~a~ 150 (191)
T d1zara2 83 EG----NAVLMELIDAKEL---YRVRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE--GIWIIDFPQSV 150 (191)
T ss_dssp ET----TEEEEECCCCEEG---GGCCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT--EEEECCCTTCE
T ss_pred cC----CEEEEEeeccccc---cchhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC--CEEEEECCCcc
Confidence 42 3789999976432 3455666778999999999999999 99999999999999976 59999999986
Q ss_pred ccccccccccCccccccccCCCcccc------ccccCCCCCchHHHHHHHHH
Q 011660 396 VHHQSHQVSENVKPVNVVGTFGYLAP------EYMMYGKVDEKIDVYSYGVV 441 (480)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~GT~~y~AP------E~~~~~~~~~k~DvwSlGvi 441 (480)
....... ..|... |.+ .+.|+.++|+||+.--
T Consensus 151 ~~~~~~~-------------~~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 151 EVGEEGW-------------REILERDVRNIITYF-SRTYRTEKDINSAIDR 188 (191)
T ss_dssp ETTSTTH-------------HHHHHHHHHHHHHHH-HHHHCCCCCHHHHHHH
T ss_pred cCCCCCc-------------HHHHHHHHHHHHHHH-cCCCCCcccHHHHHHH
Confidence 4322110 011111 112 3667888999997543
|
| >d2gm3a1 c.26.2.4 (A:5-175) Putative ethylene-responsive protein AT3g01520/F4P13_7 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Putative ethylene-responsive protein AT3g01520/F4P13 7 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=99.22 E-value=3.1e-11 Score=106.82 Aligned_cols=118 Identities=13% Similarity=0.224 Sum_probs=90.9
Q ss_pred eEEEEEEecCh---------hhHHHHHHHHHhhcCCCCe---EEEEEeeccCCcc-----------------cc------
Q 011660 23 RTVIFGLKSDH---------YSREILLQLLTVIAKPGDN---VLAVHVEEQNDTL-----------------DL------ 67 (480)
Q Consensus 23 ~~v~v~~~~~~---------~~~~~l~wal~~~~~~~d~---v~~~hv~~~~~~~-----------------~~------ 67 (480)
+||||+||-+. +|+.||.||+.++.+.||. |+++||....... ..
T Consensus 2 ~ki~vavd~s~~~~~~~~~~~S~~Al~wal~~~~~~~~~~~~L~~vhv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (171)
T d2gm3a1 2 TKVMVAVNASTIKDYPNPSISCKRAFEWTLEKIVRSNTSDFKILLLHVQVVDEDGFDDVDSIYASPEDFRDMRQSNKAKG 81 (171)
T ss_dssp EEEEEECCBCSSSCTTCBCHHHHHHHHHHHHHTTTTCTTSEEEEEEEEEC----------CCCCSHHHHHHHTTSHHHHH
T ss_pred CEEEEEEcCCcccCCCCCCHHHHHHHHHHHHHHHHCCCCCcEEEEEEeccccccccccccccccCHHHHHHHHHHHHHHH
Confidence 69999999664 8999999999999999995 9999998543210 00
Q ss_pred -chhHHHHhhhcccCcceEEEEEecCchhhHHHHHHhhhcceEEEeecccc----CCCchhHHHHhhhcCCCCceEEEEe
Q 011660 68 -NTFHIHEDLCKSKKVDFLVKVCIGDSYITELSNQVRISYATILALGCSLS----GLKDSEVLTRCLRALPPACTILVMD 142 (480)
Q Consensus 68 -~~~~~~~~~c~~~~~~~~~~v~~~~~~~~~~v~eak~~~~~~l~lg~~~~----~~~~~~v~~~c~~~~~~~c~v~~~~ 142 (480)
..+..+...|..+.++++..+..| +....|+++|+...++.||+|.+.. +.-.+.+++||+++.+ |-|+.+-
T Consensus 82 ~~~l~~~~~~~~~~~~~~~~~v~~G-~~~~~I~~~a~~~~~dlIV~G~~g~~~~~~~~lGSv~~~vi~~~~--cpVlvV~ 158 (171)
T d2gm3a1 82 LHLLEFFVNKCHEIGVGCEAWIKTG-DPKDVICQEVKRVRPDFLVVGSRGLGRFQKVFVGTVSAFCVKHAE--CPVMTIK 158 (171)
T ss_dssp HHHHHHHHHHHHHHTCEEEEEEEES-CHHHHHHHHHHHHCCSEEEEEECCCC--------CHHHHHHHHCS--SCEEEEE
T ss_pred HHHHHHHHHHHHhcCCceEEEEEeC-ChHHHHHHHHhhcCCcEEEeccCCccccccCccCcHHHHHHhCCC--CCEEEEe
Confidence 112566888988889999999888 5578999999999999999998865 2223349999999987 8888774
Q ss_pred c
Q 011660 143 N 143 (480)
Q Consensus 143 ~ 143 (480)
.
T Consensus 159 ~ 159 (171)
T d2gm3a1 159 R 159 (171)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >d2z3va1 c.26.2.4 (A:2-136) Hypothetical protein TTHA0895 {Thermus thermophilus [TaxId: 274]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein TTHA0895 species: Thermus thermophilus [TaxId: 274]
Probab=99.02 E-value=5e-10 Score=94.47 Aligned_cols=117 Identities=14% Similarity=0.131 Sum_probs=87.4
Q ss_pred eEEEEEEecChhhHHHHHHHHHhhcCCCCeEEEEEeeccCCcccc-------------chhHHHHhhhcccCcceEEEEE
Q 011660 23 RTVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVEEQNDTLDL-------------NTFHIHEDLCKSKKVDFLVKVC 89 (480)
Q Consensus 23 ~~v~v~~~~~~~~~~~l~wal~~~~~~~d~v~~~hv~~~~~~~~~-------------~~~~~~~~~c~~~~~~~~~~v~ 89 (480)
++|||++|.+..|+.++.||+.-..+.|+.|+++||.++...... ++...++.+++..++...-.+.
T Consensus 2 k~Ilv~~D~s~~s~~a~~~a~~~a~~~~~~l~ll~V~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 81 (135)
T d2z3va1 2 KTILLAYDGSEHARRAAEVAKAEAEAHGARLIVVHAYEPVPDYLGEPFFEEALRRRLERAEGVLEEARALTGVPKEDALL 81 (135)
T ss_dssp CEEEEECCSSHHHHHHHHHHHHHHHHHTCEEEEEEEECCCCTTCCTTHHHHHHHHHHHHHHHHHHHHHHHHCCCGGGEEE
T ss_pred CEEEEEECCCHHHHHHHHHHHHHHHHcCCEEEEEEEecCCccccccchhHHHHHHHHHHHHHHHHHHHHhcCCCeEEEEE
Confidence 799999999999999999999999999999999999964331110 1114455666655544333333
Q ss_pred ecCchhhHHHHHHhhhcceEEEeecccc----CCCchhHHHHhhhcCCCCceEEEE
Q 011660 90 IGDSYITELSNQVRISYATILALGCSLS----GLKDSEVLTRCLRALPPACTILVM 141 (480)
Q Consensus 90 ~~~~~~~~~v~eak~~~~~~l~lg~~~~----~~~~~~v~~~c~~~~~~~c~v~~~ 141 (480)
.+.+...+|++.|+..+++.||+|.+.+ +.-.+.+++||+++.+ |.|+.|
T Consensus 82 ~~g~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~~Gs~~~~ll~~~~--~pVlvV 135 (135)
T d2z3va1 82 LEGVPAEAILQAARAEKADLIVMGTRGLGALGSLFLGSQSQRVVAEAP--CPVLLV 135 (135)
T ss_dssp EESCHHHHHHHHHHHTTCSEEEEESSCSSSCBCSSCBHHHHHHHHHCS--SCEEEE
T ss_pred EcCChHHHHHHHhhhhheeeEEeccCCCCcccccccCcHHHHHHHhCC--CCEEeC
Confidence 4446788999999999999999998865 2233349999999987 766653
|
| >d1mjha_ c.26.2.4 (A:) "Hypothetical" protein MJ0577 {Archaeon Methanococcus jannaschii [TaxId: 2190]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: "Hypothetical" protein MJ0577 species: Archaeon Methanococcus jannaschii [TaxId: 2190]
Probab=98.93 E-value=4.2e-09 Score=91.32 Aligned_cols=117 Identities=10% Similarity=0.130 Sum_probs=92.4
Q ss_pred eEEEEEEecChhhHHHHHHHHHhhcCCCCeEEEEEeeccCCccc----------------c----------------chh
Q 011660 23 RTVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVEEQNDTLD----------------L----------------NTF 70 (480)
Q Consensus 23 ~~v~v~~~~~~~~~~~l~wal~~~~~~~d~v~~~hv~~~~~~~~----------------~----------------~~~ 70 (480)
|+|||++|.+.+|+.+|.||+...-..|..|++|||.++..... . +.+
T Consensus 4 ~~ILvavD~s~~s~~al~~a~~la~~~~a~l~llhV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 83 (160)
T d1mjha_ 4 KKILYPTDFSETAEIALKHVKAFKTLKAEEVILLHVIDEREIKKRDIFSLLLGVAGLNKSVEEFENELKNKLTEEAKNKM 83 (160)
T ss_dssp CEEEEECCSCHHHHHHHHHHHHTCCSSCCEEEEEEEEEGGGTC-----------------CHHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEECCCHHHHHHHHHHHHHHHhcCCEEEEEEecccccccccccccccccccccchhHHHHHHHHHHHHHHHHHHHH
Confidence 79999999999999999999999999999999999974432100 0 112
Q ss_pred HHHHhhhcccCcceEEEEEecCchhhHHHHHHhhhcceEEEeecccc----CCCchhHHHHhhhcCCCCceEEEEe
Q 011660 71 HIHEDLCKSKKVDFLVKVCIGDSYITELSNQVRISYATILALGCSLS----GLKDSEVLTRCLRALPPACTILVMD 142 (480)
Q Consensus 71 ~~~~~~c~~~~~~~~~~v~~~~~~~~~~v~eak~~~~~~l~lg~~~~----~~~~~~v~~~c~~~~~~~c~v~~~~ 142 (480)
..+..-|....++++..+..| +....|++.|+..+|+.||+|.+.. +.-.+.++++++++.+ |.|+.+-
T Consensus 84 ~~~~~~~~~~gv~~~~~~~~G-~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~~GS~a~~vl~~s~--~pVlvV~ 156 (160)
T d1mjha_ 84 ENIKKELEDVGFKVKDIIVVG-IPHEEIVKIAEDEGVDIIIMGSHGKTNLKEILLGSVTENVIKKSN--KPVLVVK 156 (160)
T ss_dssp HHHHHHHHHTTCEEEEEEEEE-CHHHHHHHHHHHTTCSEEEEESCCSSCCTTCSSCHHHHHHHHHCC--SCEEEEC
T ss_pred HHHHHHHHhcCCeEEEEEEec-cHHHHHhhhhhccccceEEeccCCCCcccccccCcHHHHHHhcCC--CCEEEEc
Confidence 445566778888888888888 6788999999999999999998754 2222349999999986 7777664
|
| >d1jmva_ c.26.2.4 (A:) Universal stress protein A, UspA {Haemophilus influenzae [TaxId: 727]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Universal stress protein A, UspA species: Haemophilus influenzae [TaxId: 727]
Probab=98.82 E-value=6.3e-09 Score=87.89 Aligned_cols=117 Identities=14% Similarity=0.113 Sum_probs=87.7
Q ss_pred eEEEEEEecChhhHHHHHHHHHhhcCCCCeEEEEEeeccCCc---ccc-------------chhHHHHhhhcccCcceEE
Q 011660 23 RTVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVEEQNDT---LDL-------------NTFHIHEDLCKSKKVDFLV 86 (480)
Q Consensus 23 ~~v~v~~~~~~~~~~~l~wal~~~~~~~d~v~~~hv~~~~~~---~~~-------------~~~~~~~~~c~~~~~~~~~ 86 (480)
++|||++|.+.+|+.+|.||....-+.|+.|+++||.++... ... .....++..+...+.....
T Consensus 3 k~ILv~vD~s~~s~~al~~A~~~a~~~~~~v~~lhv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (140)
T d1jmva_ 3 KHILVAVDLSEESPILLKKAVGIAKRHDAKLSIIHVDVNFSDLYTGLIDVNMSSMQDRISTETQKALLDLAESVDYPISE 82 (140)
T ss_dssp SEEEEEECCSTTHHHHHHHHHHHHHHHTCEEEEEEEEECCGGGCCCCEEHHHHHHTTCCCCHHHHHHHHHHHHSSSCCCC
T ss_pred CeEEEEECCCHHHHHHHHHHHHHHHHcCCeEEEEEEeeecccccccccccchHHHHHHHHHHHHHHHHHHHHhcCCceEE
Confidence 699999999999999999999999999999999999854431 000 1113345556666655555
Q ss_pred EEEecCchhhHHHHHHhhhcceEEEeeccccC-CCchhHHHHhhhcCCCCceEEEE
Q 011660 87 KVCIGDSYITELSNQVRISYATILALGCSLSG-LKDSEVLTRCLRALPPACTILVM 141 (480)
Q Consensus 87 ~v~~~~~~~~~~v~eak~~~~~~l~lg~~~~~-~~~~~v~~~c~~~~~~~c~v~~~ 141 (480)
.+..+.+....|++.|+..+|+.||+|.+... ...+.+++|++++.+ |-|+.+
T Consensus 83 ~~~~~~~~~~~I~~~a~~~~~dliV~G~~~~~~~~lgs~~~~li~~~~--~pVliV 136 (140)
T d1jmva_ 83 KLSGSGDLGQVLSDAIEQYDVDLLVTGHHQDFWSKLMSSTRQVMNTIK--IDMLVV 136 (140)
T ss_dssp EEEEEECHHHHHHHHHHHTTCCEEEEEECCCCHHHHHHHHHHHHTTCC--SEEEEE
T ss_pred EEEEecCHHHHHHHhhhhchhhEEEeccCCCCCCCcccHHHHHHhccC--CCEEEE
Confidence 55556678999999999999999999976441 112348999999986 777665
|
| >d1tq8a_ c.26.2.4 (A:) Hypothetical protein Rv1636 {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein Rv1636 species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=98.60 E-value=1.3e-07 Score=80.25 Aligned_cols=117 Identities=13% Similarity=0.119 Sum_probs=83.8
Q ss_pred ceEEEEEEecChhhHHHHHHHHHhhcCCCCeEEEEEeecc-CCc------------------cccchhHHHHhhhcccCc
Q 011660 22 KRTVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVEEQ-NDT------------------LDLNTFHIHEDLCKSKKV 82 (480)
Q Consensus 22 ~~~v~v~~~~~~~~~~~l~wal~~~~~~~d~v~~~hv~~~-~~~------------------~~~~~~~~~~~~c~~~~~ 82 (480)
-|+|||++|.+..|+.+|.||+.- |++++.++.+|+..+ ... .....+..++.+|....+
T Consensus 5 yk~ILv~vD~s~~s~~al~~A~~l-a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 83 (147)
T d1tq8a_ 5 YKTVVVGTDGSDSSMRAVDRAAQI-AGADAKLIIASAYLPQHEDARAADILKDESYKVTGTAPIYEILHDAKERAHNAGA 83 (147)
T ss_dssp CCEEEEECCSSHHHHHHHHHHHHH-HTTTSEEEEEEECCC--------------------CCTHHHHHHHHHHHHHTTTC
T ss_pred CCEEEEEECCCHHHHHHHHHHHHH-HhcCCCEEEEEEEecccccccccccchhhhHHHHHHHHHHHHHHHHHHHHHHcCC
Confidence 479999999999999999999975 566666666665422 110 000223666777877776
Q ss_pred c-eEEEEEecCchhhHHHHHHhhhcceEEEeeccccCC----CchhHHHHhhhcCCCCceEEEEe
Q 011660 83 D-FLVKVCIGDSYITELSNQVRISYATILALGCSLSGL----KDSEVLTRCLRALPPACTILVMD 142 (480)
Q Consensus 83 ~-~~~~v~~~~~~~~~~v~eak~~~~~~l~lg~~~~~~----~~~~v~~~c~~~~~~~c~v~~~~ 142 (480)
. ++..+..|. ....|+++|+...++.||+|.+.... -.+.+++|++++.+ |-|+.+.
T Consensus 84 ~~~~~~~~~G~-~~~~i~~~a~~~~~dlIv~g~~~~~~~~~~l~Gs~~~~ll~~~~--~pVlvV~ 145 (147)
T d1tq8a_ 84 KNVEERPIVGA-PVDALVNLADEEKADLLVVGNVGLSTIAGRLLGSVPANVSRRAK--VDVLIVH 145 (147)
T ss_dssp CEEEEEEECSS-HHHHHHHHHHHTTCSEEEEECCCCCSHHHHHTBBHHHHHHHHTT--CEEEEEC
T ss_pred CcEEEEEEecC-hHHHHHHhhhccceeEEEecCCCCCcccccccccHHHHHHHhCC--CCEEEEe
Confidence 5 677777774 67899999999999999999885411 11238899999986 7777664
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.35 E-value=1.1e-06 Score=81.55 Aligned_cols=147 Identities=14% Similarity=0.168 Sum_probs=93.7
Q ss_pred HHhhhhcCCCCceeecccCceEEEEEEecCCcEEEEEEeccCC-ccHHHHHHHHHHHhcCC-CCCeeeEEEEEecCCeeE
Q 011660 246 ELCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTN-WSEEEVLREVELLSSIK-HENIVRIIGYCHSKEMYA 323 (480)
Q Consensus 246 el~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~-~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~ 323 (480)
++......|+..+..+-++.+.||+... +++.+++|+..... .....+.+|..++..+. +--+.+++.++.+++..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 3444445566555444444578999864 55667788775332 23345778988887764 444678888888888899
Q ss_pred EEEeccCCC-HHHHHHhCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 011660 324 IVYNLLNGS-LKQYLKQLKWNERMDVAIGVAKALEYLHHTC--------------------------------------- 363 (480)
Q Consensus 324 lV~e~~~Gs-L~~~l~~~~~~~~~~i~~~ia~aL~yLH~~~--------------------------------------- 363 (480)
+||+++.|. +.+..... .....++.++++.|..||+..
T Consensus 87 lv~~~l~G~~~~~~~~~~--~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDE--QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF 164 (263)
T ss_dssp EEEECCSSEEHHHHTTTC--SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSC
T ss_pred EEEEeccccccccccccc--ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccc
Confidence 999999764 43322111 112223444555555555320
Q ss_pred -----------------CCCeEeccCCCCCEEEecCCCceEEeeeccccc
Q 011660 364 -----------------DPPIIHRDVKSSNILLSENFHHPQLSDFGAAMV 396 (480)
Q Consensus 364 -----------------~~~IiHrDlKp~NILl~~~~~~~kL~DFGla~~ 396 (480)
...++|+|+.|.|||++++ +.+-|+||+.+.+
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~-~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDG-KVSGFIDLGRSGR 213 (263)
T ss_dssp SSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETT-EEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCC-ceEEEeechhccc
Confidence 1138999999999999986 4556999998853
|
| >d1q77a_ c.26.2.4 (A:) Hypothetical protein Aq_178 {Aquifex aeolicus [TaxId: 63363]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein Aq 178 species: Aquifex aeolicus [TaxId: 63363]
Probab=98.09 E-value=2.7e-06 Score=70.69 Aligned_cols=93 Identities=11% Similarity=-0.004 Sum_probs=71.4
Q ss_pred eEEEEEEecChhhHHHHHHHHHhhcCCCCeEEEEEeeccCCc----------ccc---------chhHHHHhhhc---cc
Q 011660 23 RTVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVEEQNDT----------LDL---------NTFHIHEDLCK---SK 80 (480)
Q Consensus 23 ~~v~v~~~~~~~~~~~l~wal~~~~~~~d~v~~~hv~~~~~~----------~~~---------~~~~~~~~~c~---~~ 80 (480)
|+|||++|.+..|+.+|.||+.-.-+.|..|+++||..+... ... .....++.+|+ ..
T Consensus 5 k~ILv~~D~S~~s~~al~~A~~~a~~~~a~l~llhv~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~l~~~~~~~~~~ 84 (138)
T d1q77a_ 5 KVLLVLTDAYSDCEKAITYAVNFSEKLGAELDILAVLEDVYNLERANVTFGLPFPPEIKEESKKRIERRLREVWEKLTGS 84 (138)
T ss_dssp EEEEEEESTTCCCHHHHHHHHHHHTTTCCEEEEEEECHHHHHHHHHHHHHCCCCCTHHHHHHHHHHHHHHHHHHHHHHSC
T ss_pred CEEEEEEeCCHHHHHHHHHHHHhhhhccceEEEEEEccCcccccccccccccchhhhhhhhhhhhccccchhhccccccc
Confidence 799999999999999999999999999999999999843210 000 11133344443 34
Q ss_pred CcceEEEEEecCchhhHHHHHHhhhcceEEEeeccc
Q 011660 81 KVDFLVKVCIGDSYITELSNQVRISYATILALGCSL 116 (480)
Q Consensus 81 ~~~~~~~v~~~~~~~~~~v~eak~~~~~~l~lg~~~ 116 (480)
.+.++..|..| +....|.+.|+..+++.||+|..-
T Consensus 85 ~~~~~~~v~~G-~~~~~I~~~a~~~~~DLIV~Gs~g 119 (138)
T d1q77a_ 85 TEIPGVEYRIG-PLSEEVKKFVEGKGYELVVWACYP 119 (138)
T ss_dssp CCCCCEEEECS-CHHHHHHHHHTTSCCSEEEECSCC
T ss_pred ceeEEEeeecc-hhHHHHHHhhhhccCCEEEEecCC
Confidence 46677777777 467799999999999999999873
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.91 E-value=1.9e-05 Score=72.46 Aligned_cols=71 Identities=15% Similarity=0.083 Sum_probs=52.2
Q ss_pred eecccCc-eEEEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhcCCC--CCeeeEEEEEecCCeeEEEEeccCC
Q 011660 259 LIGQGGN-SKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKH--ENIVRIIGYCHSKEMYAIVYNLLNG 331 (480)
Q Consensus 259 ~LG~G~f-g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~~~~~lV~e~~~G 331 (480)
.+..|.. +.||+....++..+++|...... ...+..|...++.+.. -.+.+++.++.+++..++||+++.|
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G 90 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA--LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG 90 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT--TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC--HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeec
Confidence 4455554 67999988778888999876443 2346788888876643 3367788888888889999999965
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.39 E-value=0.0004 Score=68.16 Aligned_cols=72 Identities=18% Similarity=0.129 Sum_probs=46.7
Q ss_pred eeecccCceEEEEEEecC-CcEEEEEEecc----C----CccHHHHHHHHHHHhcCC-C--CCeeeEEEEEecCCeeEEE
Q 011660 258 MLIGQGGNSKVYRTNHVD-GQVAAVKVLKC----T----NWSEEEVLREVELLSSIK-H--ENIVRIIGYCHSKEMYAIV 325 (480)
Q Consensus 258 ~~LG~G~fg~Vy~~~~~~-g~~vAvK~~~~----~----~~~~~~~~~Ei~il~~l~-H--pnIv~l~~~~~~~~~~~lV 325 (480)
+.||.|....||+....+ ++.+++|.-.. . ....+....|.+.|+.+. + ..+.+++.+. .+..+++
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEEE
Confidence 468999999999997644 67889996431 1 123345667888887662 2 3466677654 3455789
Q ss_pred EeccCC
Q 011660 326 YNLLNG 331 (480)
Q Consensus 326 ~e~~~G 331 (480)
||++.|
T Consensus 110 mE~L~~ 115 (392)
T d2pula1 110 MEDLSH 115 (392)
T ss_dssp ECCCTT
T ss_pred EeccCC
Confidence 999854
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.28 E-value=0.00032 Score=66.93 Aligned_cols=129 Identities=16% Similarity=0.328 Sum_probs=79.5
Q ss_pred ceEEEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhcCCCCCe--eeEE-----EEEecCCeeEEEEeccCCC-----
Q 011660 265 NSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENI--VRII-----GYCHSKEMYAIVYNLLNGS----- 332 (480)
Q Consensus 265 fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~HpnI--v~l~-----~~~~~~~~~~lV~e~~~Gs----- 332 (480)
--.||++...+|..+++|+.+....+.+++..|...+..|....+ +..+ ..+..++..+.++++..|.
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred cceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 368999998899999999998777778889999998887742222 1111 1224456778888888652
Q ss_pred -HHHH------H-------Hh--------CCH-------------------HHHHHHHHHHHHHHHHHHh----CCCCCe
Q 011660 333 -LKQY------L-------KQ--------LKW-------------------NERMDVAIGVAKALEYLHH----TCDPPI 367 (480)
Q Consensus 333 -L~~~------l-------~~--------~~~-------------------~~~~~i~~~ia~aL~yLH~----~~~~~I 367 (480)
...+ + .. .+. .....+...+...+..+.. ....++
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 1111 1 00 010 0111122222333333332 223479
Q ss_pred EeccCCCCCEEEecCCCceEEeeeccccc
Q 011660 368 IHRDVKSSNILLSENFHHPQLSDFGAAMV 396 (480)
Q Consensus 368 iHrDlKp~NILl~~~~~~~kL~DFGla~~ 396 (480)
||+|+.+.|||++++ ..++||+.+..
T Consensus 195 iHgDlh~~NvL~~~~---~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG---PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS---EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC---ceEEechhccc
Confidence 999999999999754 45899998854
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.89 E-value=0.0027 Score=59.64 Aligned_cols=62 Identities=11% Similarity=0.179 Sum_probs=39.1
Q ss_pred cCHHHHhhhhcCCCCcee-----ecccCceEEEEEEecCCcEEEEEEeccCCccHHHHHHHHHHHhcCC
Q 011660 242 FTSQELCHLTHNFSPKML-----IGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIK 305 (480)
Q Consensus 242 ~~~~el~~~~~~f~~~~~-----LG~G~fg~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~ 305 (480)
.+.+++..+..+|.+.++ |..|---+.|+....+| .+++|+.... ...+++..|++++..|.
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~-~~~~~l~~~~~~l~~L~ 69 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR-VEKNDLPFFLGLMQHLA 69 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC----CCHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCC-CCHHHHHHHHHHHHhhh
Confidence 355677777778877554 34566678899877655 4889988643 23355667788887774
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.19 E-value=0.009 Score=57.99 Aligned_cols=69 Identities=9% Similarity=0.093 Sum_probs=48.6
Q ss_pred eeecccCceEEEEEEecC--------CcEEEEEEeccCCccHHHHHHHHHHHhcCC-CCCeeeEEEEEecCCeeEEEEec
Q 011660 258 MLIGQGGNSKVYRTNHVD--------GQVAAVKVLKCTNWSEEEVLREVELLSSIK-HENIVRIIGYCHSKEMYAIVYNL 328 (480)
Q Consensus 258 ~~LG~G~fg~Vy~~~~~~--------g~~vAvK~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~e~ 328 (480)
+.|+-|-.-.+|++...+ .+.+.+++... .....+..+|..+++.+. +.-..++++++.+ .+|++|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ef 122 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY 122 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEE
Confidence 468888889999997643 35677777653 334456778999998884 4334578888753 578888
Q ss_pred cCC
Q 011660 329 LNG 331 (480)
Q Consensus 329 ~~G 331 (480)
+.|
T Consensus 123 i~g 125 (395)
T d1nw1a_ 123 IPS 125 (395)
T ss_dssp CCE
T ss_pred ecc
Confidence 865
|